data_1fyb_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1fyb _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 93.6 mtt-85 . . . . . 0 N--CA 1.496 1.841 0 N-CA-C 110.213 -0.292 . . . . 0.0 110.213 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 7.9 tp -83.79 52.92 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 CA-C-N 115.052 -0.976 . . . . 0.0 109.636 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.484 ' HA ' ' HA ' ' A' ' 41' ' ' CYS . 1.5 m -82.72 51.75 1.96 Allowed 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 117.061 2.245 . . . . 0.0 117.061 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 7.2 p -91.75 164.63 13.64 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-N 113.169 -1.832 . . . . 0.0 109.035 179.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 37.7 p-10 -160.88 148.13 15.47 Favored 'General case' 0 N--CA 1.499 1.985 0 C-N-CA 119.917 -0.713 . . . . 0.0 110.058 179.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 18.4 t -67.11 -20.24 65.75 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-N 114.864 -1.062 . . . . 0.0 112.892 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 43.7 t -81.34 -64.46 1.18 Allowed 'General case' 0 N--CA 1.497 1.878 0 O-C-N 123.607 0.567 . . . . 0.0 112.128 -179.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -89.22 45.12 1.26 Allowed 'General case' 0 N--CA 1.5 2.044 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.896 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -84.17 -147.13 7.93 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 110.337 -1.105 . . . . 0.0 110.337 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 40.4 p -137.62 95.29 3.03 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.11 112.98 0.81 Allowed 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 144.97 -34.58 1.55 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 108.301 -1.92 . . . . 0.0 108.301 -179.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 35.4 m -106.09 130.29 54.02 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -83.11 91.61 7.25 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 113.627 -1.624 . . . . 0.0 110.132 -179.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.409 ' N ' ' O ' ' A' ' 25' ' ' CYS . 39.8 m-85 -50.09 122.1 6.32 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-N 114.028 -1.442 . . . . 0.0 109.081 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -132.44 153.32 50.97 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-N 112.316 -2.22 . . . . 0.0 110.643 -179.67 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.501 ' HG ' ' H ' ' A' ' 20' ' ' ASP . 31.2 t -99.15 141.18 32.25 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-N 111.679 -2.509 . . . . 0.0 115.628 -179.548 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -52.17 -25.05 8.1 Favored 'General case' 0 N--CA 1.499 1.983 0 CA-C-N 111.002 -2.817 . . . . 0.0 113.269 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.501 ' H ' ' HG ' ' A' ' 18' ' ' SER . 52.5 p-10 -62.59 -4.79 2.16 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 124.092 0.87 . . . . 0.0 111.609 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 88.92 30.15 15.72 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 108.781 -1.728 . . . . 0.0 108.781 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 87.0 m -141.66 146.87 36.65 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 124.087 0.522 . . . . 0.0 110.585 -179.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 39.9 t80 -73.02 162.81 29.05 Favored 'General case' 0 N--CA 1.496 1.827 0 CA-C-N 114.35 -1.296 . . . . 0.0 110.04 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 58.7 t -127.56 -79.44 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 CA-C-N 115.282 -0.872 . . . . 0.0 108.991 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.57 ' SG ' ' N ' ' A' ' 26' ' ' GLU . 0.1 OUTLIER -156.99 -170.47 3.3 Favored 'General case' 0 N--CA 1.504 2.258 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 179.971 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.57 ' N ' ' SG ' ' A' ' 25' ' ' CYS . 37.6 tt0 -118.64 154.29 32.91 Favored 'General case' 0 N--CA 1.503 2.214 0 N-CA-C 106.079 -1.823 . . . . 0.0 106.079 179.444 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -50.15 116.9 4.38 Favored Glycine 0 N--CA 1.498 2.791 0 C-N-CA 120.088 -1.053 . . . . 0.0 112.721 -179.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -79.66 -17.2 54.24 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 41.1 t -112.38 112.96 24.9 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.547 ' H ' HD22 ' A' ' 33' ' ' ASN . 16.0 t0 -79.38 138.55 55.56 Favored Pre-proline 0 N--CA 1.494 1.735 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_endo -65.48 75.22 0.27 Allowed 'Trans proline' 0 N--CA 1.498 1.746 0 C-N-CA 122.705 2.27 . . . . 0.0 106.577 161.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 43.1 ttp85 -173.0 -53.43 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 104.982 -2.229 . . . . 0.0 104.982 -179.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.547 HD22 ' H ' ' A' ' 30' ' ' ASP . 25.9 p30 -90.7 156.44 44.95 Favored Pre-proline 0 N--CA 1.494 1.759 0 CA-C-N 114.638 -1.165 . . . . 0.0 110.978 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -71.54 177.16 7.11 Favored 'Trans proline' 0 N--CA 1.493 1.469 0 C-N-CA 122.643 2.229 . . . . 0.0 110.311 168.004 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.41 153.07 19.15 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.247 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -148.12 62.37 1.11 Allowed 'General case' 0 N--CA 1.495 1.819 0 CA-C-N 115.067 -0.969 . . . . 0.0 109.127 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 72.4 m -79.57 -50.48 10.64 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-N 114.388 -1.278 . . . . 0.0 109.358 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 26.3 m 64.31 -9.12 0.17 Allowed 'General case' 0 N--CA 1.503 2.176 0 O-C-N 124.781 1.301 . . . . 0.0 113.448 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.405 ' HG ' ' H ' ' A' ' 40' ' ' ASN . 2.1 pp -79.56 -55.59 4.92 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 120.251 -0.58 . . . . 0.0 109.559 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.405 ' H ' ' HG ' ' A' ' 39' ' ' LEU . 33.6 m120 47.42 -177.77 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 115.927 1.825 . . . . 0.0 115.927 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.484 ' HA ' ' HA ' ' A' ' 4' ' ' CYS . 58.1 m 48.63 119.36 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 116.667 2.099 . . . . 0.0 116.667 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 60.1 t0 -152.16 94.97 3.21 Favored Pre-proline 0 N--CA 1.489 1.517 0 CA-C-N 113.789 -1.55 . . . . 0.0 108.46 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -53.63 -17.86 10.69 Favored 'Trans proline' 0 N--CA 1.495 1.591 0 C-N-CA 122.896 2.398 . . . . 0.0 113.046 178.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 10.9 tpt180 -59.06 -50.82 72.61 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.44 ' CG2' ' N ' ' A' ' 46' ' ' ALA . 2.0 mp -62.89 159.2 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 CA-C-O 122.623 1.201 . . . . 0.0 112.264 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.44 ' N ' ' CG2' ' A' ' 45' ' ' ILE . . . -127.29 -48.63 1.44 Allowed 'General case' 0 N--CA 1.492 1.641 0 CA-C-N 111.33 -2.668 . . . . 0.0 106.267 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 51.8 p90 -166.23 -163.42 0.6 Allowed 'General case' 0 N--CA 1.495 1.817 0 CA-C-N 113.637 -1.619 . . . . 0.0 107.373 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -145.83 113.15 0.67 Allowed Glycine 0 N--CA 1.495 2.567 0 N-CA-C 108.621 -1.791 . . . . 0.0 108.621 179.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.7 p -79.77 105.91 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 N-CA-C 114.284 1.216 . . . . 0.0 114.284 -179.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.7 m -81.81 117.45 68.35 Favored Pre-proline 0 N--CA 1.5 2.068 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 179.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo . . . . . 0 N--CA 1.494 1.531 0 C-N-CA 122.05 1.833 . . . . 0.0 110.623 178.383 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 1.6 m . . . . . 0 N--CA 1.495 1.816 0 N-CA-C 115.916 1.821 . . . . 0.0 115.916 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -91.59 148.0 22.6 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-N 112.272 -2.24 . . . . 0.0 107.353 179.512 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 15.2 p30 -162.05 147.78 13.2 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 114.469 1.285 . . . . 0.0 114.469 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -63.25 -20.67 65.66 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-N 114.351 -1.295 . . . . 0.0 112.582 179.621 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 41.8 t -90.65 -74.78 0.48 Allowed 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -89.5 35.57 0.82 Allowed 'General case' 0 N--CA 1.497 1.895 0 CA-C-N 114.433 -1.258 . . . . 0.0 113.139 -179.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -81.04 -112.34 0.32 Allowed Glycine 0 N--CA 1.494 2.531 0 N-CA-C 109.135 -1.586 . . . . 0.0 109.135 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.516 ' H ' ' HA3' ' A' ' 85' ' ' GLY . 38.2 p -153.7 123.03 6.58 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 179.671 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -70.21 93.87 0.87 Allowed 'General case' 0 N--CA 1.502 2.125 0 CA-C-O 122.089 0.947 . . . . 0.0 109.516 179.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 162.99 -27.21 0.23 Allowed Glycine 0 N--CA 1.487 2.058 0 CA-C-N 113.107 -1.86 . . . . 0.0 109.947 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 36.1 m -108.8 141.65 40.51 Favored 'General case' 0 N--CA 1.497 1.902 0 C-N-CA 120.024 -0.67 . . . . 0.0 110.209 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.466 ' HB3' ' CE1' ' A' ' 81' ' ' PHE . 58.6 mtpt -83.7 89.11 7.09 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 113.726 -1.579 . . . . 0.0 109.683 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 27.7 m-85 -59.56 116.45 4.01 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 106.13 -1.804 . . . . 0.0 106.13 179.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -121.14 146.86 46.32 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 111.483 -2.599 . . . . 0.0 112.516 -179.449 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' SER . . . . . 0.494 ' HG ' ' HE ' ' A' ' 102' ' ' ARG . 32.0 t -91.31 144.23 25.81 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-N 112.363 -2.199 . . . . 0.0 116.312 -179.586 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.414 ' C ' ' H ' ' A' ' 79' ' ' GLY . 1.9 p30 -53.09 -21.16 4.39 Favored 'General case' 0 N--CA 1.497 1.901 0 CA-C-N 110.603 -2.999 . . . . 0.0 113.322 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 18.4 p30 -66.77 -0.15 2.79 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 124.183 0.927 . . . . 0.0 110.773 179.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.414 ' H ' ' C ' ' A' ' 77' ' ' ASP . . . 83.48 29.83 31.84 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 93.6 m -142.83 142.86 31.91 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 120.394 -0.522 . . . . 0.0 110.939 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . 0.466 ' CE1' ' HB3' ' A' ' 73' ' ' LYS . 9.7 t80 -73.93 143.41 45.72 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-N 114.373 -1.285 . . . . 0.0 109.705 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 67.6 t -104.58 -77.91 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -166.97 172.85 9.83 Favored 'General case' 0 N--CA 1.503 2.219 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 179.733 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.412 ' HG2' ' N ' ' A' ' 85' ' ' GLY . 22.7 tt0 -79.64 150.22 31.03 Favored 'General case' 0 N--CA 1.501 2.085 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 179.705 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.516 ' HA3' ' H ' ' A' ' 69' ' ' THR . . . -65.74 127.67 31.27 Favored Glycine 0 N--CA 1.494 2.522 0 N-CA-C 104.251 -3.54 . . . . 0.0 104.251 179.721 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -93.75 23.42 4.77 Favored 'General case' 0 N--CA 1.497 1.905 0 CA-C-N 118.049 0.924 . . . . 0.0 113.337 -179.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 25.1 t -84.26 98.53 10.03 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-N 114.529 -1.214 . . . . 0.0 108.288 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -79.86 155.37 75.46 Favored Pre-proline 0 N--CA 1.496 1.834 0 N-CA-C 107.529 -1.285 . . . . 0.0 107.529 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo -38.58 108.21 0.07 OUTLIER 'Trans proline' 0 N--CA 1.493 1.483 0 C-N-CA 122.386 2.057 . . . . 0.0 112.147 162.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER 59.06 50.89 7.63 Favored 'General case' 0 N--CA 1.497 1.92 0 CA-C-N 114.676 -1.147 . . . . 0.0 110.876 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.557 HD21 ' H ' ' A' ' 91' ' ' ASN . 0.5 OUTLIER -79.43 119.61 77.56 Favored Pre-proline 0 N--CA 1.497 1.875 0 CA-C-N 113.898 -1.501 . . . . 0.0 111.878 -179.96 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -79.87 79.36 3.37 Favored 'Trans proline' 0 N--CA 1.493 1.474 0 C-N-CA 123.093 2.529 . . . . 0.0 109.986 172.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 14.1 ptmm? -166.06 144.56 5.79 Favored 'General case' 0 N--CA 1.5 2.029 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.721 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -160.12 103.29 1.46 Allowed 'General case' 0 N--CA 1.496 1.854 0 CA-C-N 114.649 -1.16 . . . . 0.0 108.575 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 35.1 m -79.77 168.67 24.51 Favored Pre-proline 0 N--CA 1.498 1.959 0 CA-C-N 115.122 -0.944 . . . . 0.0 109.297 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -57.91 -5.7 2.14 Favored 'Trans proline' 0 N--CA 1.496 1.672 0 C-N-CA 122.292 1.995 . . . . 0.0 112.404 162.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 35.2 mmt180 -79.52 7.26 8.51 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 123.49 0.494 . . . . 0.0 111.828 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -50.03 117.39 2.3 Favored 'General case' 0 N--CA 1.503 2.196 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 91.4 m 56.07 65.38 1.46 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 124.538 1.149 . . . . 0.0 108.048 -179.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -62.35 109.55 2.45 Favored Pre-proline 0 N--CA 1.498 1.926 0 CA-C-N 114.356 -1.293 . . . . 0.0 112.287 -179.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -69.44 -34.75 14.98 Favored 'Trans proline' 0 N--CA 1.493 1.463 0 C-N-CA 122.049 1.833 . . . . 0.0 109.783 -174.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.494 ' HE ' ' HG ' ' A' ' 76' ' ' SER . 0.0 OUTLIER -63.48 -21.37 66.28 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-N 114.447 -1.252 . . . . 0.0 111.659 -179.96 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 4.4 tp -76.49 177.7 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 C-N-CA 119.218 -0.993 . . . . 0.0 108.403 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -130.37 -61.32 0.97 Allowed 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 -147.73 -161.61 1.37 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 124.48 1.113 . . . . 0.0 109.042 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -142.35 95.13 0.19 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 106.016 -2.834 . . . . 0.0 106.016 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 42.5 mm -78.72 98.86 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 N-CA-C 113.792 1.034 . . . . 0.0 113.792 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 1.6 m -79.52 153.63 76.19 Favored Pre-proline 0 N--CA 1.501 2.091 0 CA-C-N 114.952 -1.022 . . . . 0.0 108.262 179.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo . . . . . 0 N--CA 1.494 1.502 0 C-N-CA 122.542 2.162 . . . . 0.0 109.942 179.445 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 61.7 ttm-85 . . . . . 0 N--CA 1.494 1.728 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.0 tp -79.85 71.88 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 CA-C-N 114.399 -1.273 . . . . 0.0 110.038 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.6 m -89.97 57.47 3.82 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 122.849 1.309 . . . . 0.0 114.159 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.446 ' O ' ' N ' ' A' ' 42' ' ' ASP . 1.1 p -90.06 157.05 17.97 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 104.275 -2.491 . . . . 0.0 104.275 179.204 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.458 ' CG ' ' H ' ' A' ' 7' ' ' CYS . 6.7 t-20 -160.77 -177.3 6.06 Favored 'General case' 0 N--CA 1.5 2.036 0 C-N-CA 118.149 -1.42 . . . . 0.0 112.083 -179.684 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.476 ' SG ' ' CD2' ' A' ' 16' ' ' TYR . 1.8 t -76.78 -32.98 58.04 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-N 113.328 -1.76 . . . . 0.0 107.115 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 34.1 t -82.12 -57.57 3.34 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-N 112.003 -2.362 . . . . 0.0 107.609 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -57.56 -23.43 50.5 Favored 'General case' 0 N--CA 1.497 1.912 0 CA-C-N 114.484 -1.235 . . . . 0.0 110.77 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -71.41 -168.09 8.79 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 110.756 -0.938 . . . . 0.0 110.756 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.429 ' N ' ' HH ' ' A' ' 16' ' ' TYR . 41.1 p -104.71 103.19 12.78 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.435 ' HA ' ' CA ' ' A' ' 27' ' ' GLY . 39.1 ttpt -48.16 104.97 0.07 Allowed 'General case' 0 N--CA 1.5 2.048 0 O-C-N 123.737 0.648 . . . . 0.0 111.322 179.673 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 149.69 -20.42 1.15 Allowed Glycine 0 N--CA 1.491 2.36 0 CA-C-N 114.364 -1.289 . . . . 0.0 111.033 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 96.2 m -107.41 149.45 27.88 Favored 'General case' 0 N--CA 1.499 2.023 0 C-N-CA 120.316 -0.554 . . . . 0.0 112.069 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -83.13 93.71 7.68 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-N 114.273 -1.33 . . . . 0.0 107.754 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.476 ' CD2' ' SG ' ' A' ' 7' ' ' CYS . 48.6 m-85 -52.76 130.07 31.69 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-N 113.997 -1.456 . . . . 0.0 109.027 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -143.47 155.03 44.25 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-N 113.174 -1.83 . . . . 0.0 112.339 -179.438 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 38.3 t -101.37 136.01 41.92 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-N 112.449 -2.16 . . . . 0.0 112.577 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -50.04 -25.11 3.08 Favored 'General case' 0 N--CA 1.502 2.129 0 CA-C-N 112.626 -2.079 . . . . 0.0 114.186 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 27.4 p30 -59.69 -7.49 1.58 Allowed 'General case' 0 N--CA 1.498 1.952 0 O-C-N 124.228 0.955 . . . . 0.0 112.288 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 94.25 28.36 10.82 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 88.5 m -141.43 142.79 33.67 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 124.149 0.558 . . . . 0.0 110.144 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.408 ' CG ' ' N ' ' A' ' 24' ' ' VAL . 40.5 t80 -68.79 166.93 16.52 Favored 'General case' 0 N--CA 1.497 1.878 0 CA-C-N 114.194 -1.366 . . . . 0.0 110.82 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.408 ' N ' ' CG ' ' A' ' 23' ' ' PHE . 97.5 t -128.89 -72.31 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 123.996 0.81 . . . . 0.0 111.82 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.447 ' SG ' ' HD2' ' A' ' 16' ' ' TYR . 20.8 p -154.31 -168.6 2.98 Favored 'General case' 0 N--CA 1.503 2.199 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 -179.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 60.5 tt0 -139.66 151.12 45.69 Favored 'General case' 0 N--CA 1.501 2.096 0 CA-C-O 121.446 0.641 . . . . 0.0 111.369 179.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.435 ' CA ' ' HA ' ' A' ' 12' ' ' LYS . . . -7.25 103.71 0.01 OUTLIER Glycine 0 N--CA 1.497 2.716 0 N-CA-C 119.333 2.493 . . . . 0.0 119.333 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -99.48 -52.25 3.54 Favored 'General case' 0 N--CA 1.501 2.112 0 C-N-CA 119.71 -0.796 . . . . 0.0 110.355 179.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 6.5 p -149.83 142.18 24.24 Favored 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -101.88 144.85 29.4 Favored Pre-proline 0 N--CA 1.498 1.943 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_exo -45.12 -25.2 1.69 Allowed 'Trans proline' 0 N--CA 1.498 1.778 0 C-N-CA 122.918 2.412 . . . . 0.0 112.868 170.087 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 3.6 tpm_? -62.9 -53.45 54.0 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -85.65 129.41 54.95 Favored Pre-proline 0 N--CA 1.494 1.73 0 CA-C-N 115.133 -0.94 . . . . 0.0 109.221 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -65.38 108.2 1.14 Allowed 'Trans proline' 0 N--CA 1.493 1.5 0 C-N-CA 122.317 2.011 . . . . 0.0 109.471 -179.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.447 ' HD3' ' H ' ' A' ' 36' ' ' ALA . 6.1 tmtt? -154.53 142.12 19.81 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.447 ' H ' ' HD3' ' A' ' 35' ' ' LYS . . . -149.3 111.07 4.54 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-N 113.382 -1.736 . . . . 0.0 107.644 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.401 ' H ' HD22 ' A' ' 40' ' ' ASN . 70.3 m -79.96 -168.73 1.73 Allowed 'General case' 0 N--CA 1.495 1.815 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.104 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 9.2 t -104.94 13.84 30.4 Favored 'General case' 0 N--CA 1.497 1.911 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.351 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -160.38 64.66 0.33 Allowed 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.401 HD22 ' H ' ' A' ' 37' ' ' CYS . 12.0 m120 -88.65 46.15 1.36 Allowed 'General case' 0 N--CA 1.498 1.939 0 CA-C-N 114.292 -1.322 . . . . 0.0 111.172 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 80.4 m -145.16 139.29 27.16 Favored 'General case' 0 N--CA 1.499 2.02 0 CA-C-N 115.014 -0.993 . . . . 0.0 108.547 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.446 ' N ' ' O ' ' A' ' 5' ' ' THR . 34.2 t70 -166.2 88.35 0.87 Allowed Pre-proline 0 N--CA 1.497 1.896 0 O-C-N 123.794 0.684 . . . . 0.0 110.207 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_exo -53.53 -15.29 5.98 Favored 'Trans proline' 0 N--CA 1.495 1.617 0 C-N-CA 122.466 2.111 . . . . 0.0 112.961 173.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 41.5 ttm180 -76.89 -39.06 52.31 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 113.302 0.853 . . . . 0.0 113.302 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 7.6 tt -75.8 142.9 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.175 0 C-N-CA 118.746 -1.181 . . . . 0.0 111.714 -179.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -104.84 -49.84 3.41 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-N 113.638 -1.619 . . . . 0.0 107.737 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 52.1 p90 -163.52 -163.07 0.78 Allowed 'General case' 0 N--CA 1.496 1.868 0 CA-C-N 114.07 -1.423 . . . . 0.0 107.423 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -144.98 122.27 1.7 Allowed Glycine 0 N--CA 1.494 2.549 0 N-CA-C 109.13 -1.588 . . . . 0.0 109.13 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.6 p -88.69 108.75 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 CA-C-O 121.545 0.688 . . . . 0.0 112.799 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.7 m -79.78 137.13 54.46 Favored Pre-proline 0 N--CA 1.499 1.987 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.218 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo . . . . . 0 N--CA 1.494 1.507 0 C-N-CA 122.376 2.051 . . . . 0.0 110.063 177.292 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . 0.576 ' HA ' ' HA ' ' A' ' 99' ' ' CYS . 1.7 m . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 123.916 1.817 . . . . 0.0 115.453 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 61.2 m -91.42 139.86 30.32 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 110.399 -3.091 . . . . 0.0 103.189 179.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 38.1 p-10 -160.81 161.32 31.96 Favored 'General case' 0 N--CA 1.497 1.898 0 C-N-CA 119.771 -0.772 . . . . 0.0 112.988 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 1.3 t -55.75 -23.22 28.15 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-N 113.511 -1.677 . . . . 0.0 112.227 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 52.8 t -89.38 -70.46 0.66 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 124.146 0.904 . . . . 0.0 110.502 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.425 ' HB3' ' SG ' ' A' ' 95' ' ' CYS . . . -90.18 62.15 5.38 Favored 'General case' 0 N--CA 1.499 2.007 0 CA-C-O 121.633 0.73 . . . . 0.0 109.497 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -113.19 -137.59 6.85 Favored Glycine 0 N--CA 1.493 2.481 0 CA-C-N 114.396 -1.274 . . . . 0.0 111.478 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.412 ' N ' ' HA3' ' A' ' 85' ' ' GLY . 37.7 p -128.44 117.61 21.67 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-N 114.494 -0.853 . . . . 0.0 109.464 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 61.5 mtpt -69.65 86.91 0.48 Allowed 'General case' 0 N--CA 1.498 1.967 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.018 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 164.75 -31.02 0.24 Allowed Glycine 0 N--CA 1.489 2.196 0 CA-C-N 114.095 -1.412 . . . . 0.0 110.613 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 74.6 m -105.12 131.71 52.27 Favored 'General case' 0 N--CA 1.5 2.034 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.8 mppt? -83.98 87.48 7.12 Favored 'General case' 0 N--CA 1.484 1.254 0 O-C-N 124.808 1.318 . . . . 0.0 110.398 -179.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 8.9 m-30 -51.84 129.43 26.59 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -133.03 157.26 45.67 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-N 113.433 -1.712 . . . . 0.0 111.79 -179.34 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 44.3 t -102.36 136.58 41.94 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-N 113.157 -1.838 . . . . 0.0 112.867 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 8.6 p30 -53.11 -23.57 8.29 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 115.538 1.681 . . . . 0.0 115.538 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 18.7 p-10 -62.61 -7.45 4.76 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 123.704 0.628 . . . . 0.0 111.024 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 94.49 29.96 9.0 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 108.507 -1.837 . . . . 0.0 108.507 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 46.1 m -133.97 135.93 43.81 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 124.162 0.566 . . . . 0.0 110.204 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . 0.462 ' CZ ' ' HA ' ' A' ' 83' ' ' CYS . 8.0 t80 -76.02 141.63 42.07 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-N 114.703 -1.135 . . . . 0.0 108.776 179.787 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 45.5 t -97.29 -78.38 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . 0.462 ' HA ' ' CZ ' ' A' ' 81' ' ' PHE . 0.1 OUTLIER -178.5 171.67 1.54 Allowed 'General case' 0 N--CA 1.505 2.308 0 O-C-N 123.51 0.507 . . . . 0.0 110.005 179.705 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.408 ' O ' ' SG ' ' A' ' 83' ' ' CYS . 39.9 tt0 -86.07 150.93 24.1 Favored 'General case' 0 N--CA 1.503 2.203 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 179.747 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.412 ' HA3' ' N ' ' A' ' 69' ' ' THR . . . -53.25 133.58 41.97 Favored Glycine 0 N--CA 1.5 2.945 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -99.81 29.18 4.28 Favored 'General case' 0 N--CA 1.502 2.15 0 CA-C-O 121.892 0.853 . . . . 0.0 109.445 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 44.9 t -146.38 131.73 18.57 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 107.532 -1.285 . . . . 0.0 107.532 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.469 ' H ' HD22 ' A' ' 91' ' ' ASN . 2.4 t70 -79.38 136.16 56.72 Favored Pre-proline 0 N--CA 1.493 1.71 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_endo -67.95 70.93 0.82 Allowed 'Trans proline' 0 N--CA 1.5 1.872 0 C-N-CA 123.688 2.925 . . . . 0.0 113.554 -176.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 82.8 mtt85 -162.88 -51.7 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 103.74 -2.689 . . . . 0.0 103.74 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.469 HD22 ' H ' ' A' ' 88' ' ' ASP . 1.5 p-10 -91.09 116.0 65.51 Favored Pre-proline 0 N--CA 1.493 1.719 0 CA-C-N 113.275 -1.784 . . . . 0.0 110.748 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -78.17 93.76 1.09 Allowed 'Trans proline' 0 N--CA 1.492 1.398 0 C-N-CA 122.694 2.262 . . . . 0.0 110.041 173.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 44.7 mmtm -70.67 127.48 32.82 Favored 'General case' 0 N--CA 1.497 1.909 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.707 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -85.33 79.37 9.52 Favored 'General case' 0 N--CA 1.495 1.788 0 CA-C-N 114.666 -1.152 . . . . 0.0 108.941 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . 0.425 ' SG ' ' HB3' ' A' ' 67' ' ' ALA . 88.5 m -79.66 146.83 65.89 Favored Pre-proline 0 N--CA 1.494 1.764 0 CA-C-N 114.504 -1.225 . . . . 0.0 111.364 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -73.9 -4.35 15.28 Favored 'Trans proline' 0 N--CA 1.493 1.451 0 C-N-CA 122.891 2.394 . . . . 0.0 110.586 165.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 23.0 tpp180 -79.1 -54.78 5.65 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 38.9 m-80 52.24 -161.14 0.1 Allowed 'General case' 0 N--CA 1.501 2.118 0 O-C-N 124.401 1.063 . . . . 0.0 111.549 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . 0.576 ' HA ' ' HA ' ' A' ' 62' ' ' CYS . 5.2 m -36.67 110.06 0.11 Allowed 'General case' 0 N--CA 1.5 2.045 0 N-CA-C 113.909 1.078 . . . . 0.0 113.909 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 20.5 t0 -91.22 111.85 50.87 Favored Pre-proline 0 N--CA 1.494 1.727 0 CA-C-N 113.843 -1.526 . . . . 0.0 110.564 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -64.7 -21.92 64.66 Favored 'Trans proline' 0 N--CA 1.494 1.522 0 C-N-CA 121.848 1.699 . . . . 0.0 110.312 -179.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 27.6 ttm-85 -82.27 -23.51 35.24 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 113.952 1.093 . . . . 0.0 113.952 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 12.2 tt -70.19 142.38 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 C-N-CA 117.835 -1.546 . . . . 0.0 110.21 -179.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -131.78 -43.77 0.99 Allowed 'General case' 0 N--CA 1.494 1.734 0 CA-C-N 114.486 -1.234 . . . . 0.0 109.748 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 49.8 m-85 -141.23 -164.12 1.69 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 124.398 1.061 . . . . 0.0 109.387 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -153.87 108.69 0.38 Allowed Glycine 0 N--CA 1.492 2.408 0 N-CA-C 106.582 -2.607 . . . . 0.0 106.582 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 50.4 mm -80.6 84.11 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 27.0 m -80.99 149.44 66.76 Favored Pre-proline 0 N--CA 1.494 1.755 0 CA-C-N 114.101 -1.408 . . . . 0.0 108.848 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo . . . . . 0 N--CA 1.495 1.594 0 C-N-CA 122.71 2.273 . . . . 0.0 110.859 175.09 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 2.7 tmt_? . . . . . 0 N--CA 1.504 2.274 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.6 tp -55.44 137.02 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 123.626 0.579 . . . . 0.0 112.123 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.417 ' HA ' ' HA ' ' A' ' 41' ' ' CYS . 1.5 m -140.61 57.88 1.57 Allowed 'General case' 0 C--N 1.31 -1.128 0 CA-C-O 122.797 1.284 . . . . 0.0 114.444 179.615 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 7.1 t -90.73 161.1 15.49 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-N 113.322 -1.763 . . . . 0.0 106.746 179.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 10.5 p-10 -161.1 151.84 18.24 Favored 'General case' 0 N--CA 1.499 2.02 0 C-N-CA 120.118 -0.633 . . . . 0.0 111.693 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.404 ' HA ' ' CE2' ' A' ' 16' ' ' TYR . 19.6 t -57.68 -38.03 74.46 Favored 'General case' 0 N--CA 1.497 1.914 0 CA-C-N 114.639 -1.164 . . . . 0.0 113.303 -179.721 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 46.4 t -61.99 -51.59 67.41 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 125.336 1.647 . . . . 0.0 110.721 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -51.6 -26.08 8.14 Favored 'General case' 0 N--CA 1.503 2.224 0 O-C-N 124.945 1.403 . . . . 0.0 110.376 179.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 63.23 161.06 0.28 Allowed Glycine 0 N--CA 1.479 1.558 0 CA-C-N 114.618 -1.174 . . . . 0.0 115.891 179.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 99.5 m -153.11 53.87 0.76 Allowed 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 104.576 -2.379 . . . . 0.0 104.576 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 63.4 pttt 41.67 -146.11 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.065 0 CA-C-N 114.203 -1.362 . . . . 0.0 112.409 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -70.23 26.69 0.44 Allowed Glycine 0 N--CA 1.494 2.501 0 CA-C-N 114.886 -1.052 . . . . 0.0 114.252 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 88.4 m -105.42 120.99 42.98 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 107.097 -1.445 . . . . 0.0 107.097 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 63.0 mtpt -64.92 100.34 0.41 Allowed 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 113.027 -1.897 . . . . 0.0 113.962 -179.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.404 ' CE2' ' HA ' ' A' ' 7' ' ' CYS . 8.8 m-85 -48.3 128.59 14.59 Favored 'General case' 0 N--CA 1.505 2.316 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 179.48 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -144.3 153.03 41.59 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 115.079 -0.964 . . . . 0.0 113.047 -179.349 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 34.2 t -99.08 134.78 41.43 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-N 112.599 -2.091 . . . . 0.0 112.659 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -50.14 -24.87 3.03 Favored 'General case' 0 N--CA 1.502 2.168 0 CA-C-N 112.713 -2.039 . . . . 0.0 114.009 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 29.7 p30 -59.81 -8.01 1.93 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 124.144 0.902 . . . . 0.0 112.276 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 95.08 29.2 9.2 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 86.9 m -141.91 143.23 33.18 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 124.078 0.517 . . . . 0.0 111.233 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 20.0 t80 -68.96 161.28 29.21 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-N 114.042 -1.435 . . . . 0.0 110.318 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 88.2 t -126.71 -71.29 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 CA-C-N 114.995 -1.002 . . . . 0.0 109.443 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.589 ' SG ' ' N ' ' A' ' 26' ' ' GLU . 0.3 OUTLIER -151.57 -166.67 2.58 Favored 'General case' 0 N--CA 1.5 2.049 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 179.998 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.589 ' N ' ' SG ' ' A' ' 25' ' ' CYS . 2.1 tm-20 -121.07 147.4 45.57 Favored 'General case' 0 N--CA 1.501 2.116 0 N-CA-C 106.374 -1.713 . . . . 0.0 106.374 179.565 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -55.1 109.8 1.46 Allowed Glycine 0 N--CA 1.501 2.972 0 N-CA-C 110.358 -1.097 . . . . 0.0 110.358 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 -86.31 12.29 10.33 Favored 'General case' 0 N--CA 1.501 2.12 0 N-CA-C 113.613 0.968 . . . . 0.0 113.613 -179.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.415 ' HG ' ' H ' ' A' ' 30' ' ' ASP . 20.9 t -169.62 -174.53 1.91 Allowed 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.415 ' H ' ' HG ' ' A' ' 29' ' ' SER . 27.8 t70 -79.23 143.38 60.5 Favored Pre-proline 0 N--CA 1.496 1.845 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo -52.34 -32.36 51.2 Favored 'Trans proline' 0 N--CA 1.498 1.772 0 C-N-CA 122.38 2.053 . . . . 0.0 112.15 175.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 87.6 mtm180 -113.99 35.24 4.21 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-N 114.74 -1.118 . . . . 0.0 109.232 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 24.2 p-10 -65.96 127.05 92.88 Favored Pre-proline 0 N--CA 1.497 1.881 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.98 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_endo -76.51 81.53 2.48 Favored 'Trans proline' 0 N--CA 1.49 1.289 0 C-N-CA 122.492 2.128 . . . . 0.0 107.973 167.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 23.6 tptm -150.85 153.43 35.35 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-N 114.851 -1.068 . . . . 0.0 110.124 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -99.52 155.6 17.48 Favored 'General case' 0 N--CA 1.496 1.826 0 CA-C-N 114.066 -1.424 . . . . 0.0 110.221 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 84.8 m -147.44 177.26 9.38 Favored 'General case' 0 N--CA 1.497 1.879 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.643 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 64.5 p -132.98 -18.28 2.35 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-N 113.893 -1.503 . . . . 0.0 108.976 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.3 tt -89.63 24.6 2.26 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 24.2 m120 -56.83 152.88 11.77 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-N 115.308 -0.86 . . . . 0.0 112.744 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.417 ' HA ' ' HA ' ' A' ' 4' ' ' CYS . 68.0 m 59.68 124.4 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.753 0 CA-C-N 113.467 -1.697 . . . . 0.0 114.318 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -152.33 84.04 4.87 Favored Pre-proline 0 N--CA 1.494 1.728 0 CA-C-N 114.389 -1.278 . . . . 0.0 109.338 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -57.67 -20.11 40.88 Favored 'Trans proline' 0 N--CA 1.493 1.464 0 C-N-CA 122.769 2.313 . . . . 0.0 112.86 178.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 74.5 mtp180 -62.31 -42.29 99.24 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 26.4 mt -68.21 157.77 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 CA-C-O 122.414 1.102 . . . . 0.0 110.691 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -125.37 -51.14 1.64 Allowed 'General case' 0 N--CA 1.491 1.614 0 CA-C-N 111.719 -2.491 . . . . 0.0 107.786 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 13.1 p90 -171.14 160.98 6.58 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-N 114.172 -1.376 . . . . 0.0 111.237 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -96.87 121.39 7.02 Favored Glycine 0 N--CA 1.493 2.456 0 CA-C-N 113.651 -1.613 . . . . 0.0 109.248 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 29.4 m -94.71 103.96 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.7 m -79.88 115.26 52.73 Favored Pre-proline 0 N--CA 1.5 2.045 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 179.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo . . . . . 0 N--CA 1.496 1.657 0 C-N-CA 122.458 2.105 . . . . 0.0 112.457 -171.8 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 1.7 m . . . . . 0 N--CA 1.49 1.528 0 CA-C-O 122.413 1.102 . . . . 0.0 113.337 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 33.9 m -90.22 168.3 12.03 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 113.666 -1.606 . . . . 0.0 109.154 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 24.3 p30 -142.94 176.06 9.36 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 124.416 1.073 . . . . 0.0 109.297 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 47.0 t -92.79 -31.69 14.94 Favored 'General case' 0 N--CA 1.499 2.021 0 N-CA-C 114.469 1.285 . . . . 0.0 114.469 -179.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 42.7 t -63.56 -58.37 7.18 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 123.934 0.771 . . . . 0.0 110.352 -179.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -89.83 36.31 0.85 Allowed 'General case' 0 N--CA 1.495 1.803 0 CA-C-N 114.294 -1.321 . . . . 0.0 110.227 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -76.67 -115.78 0.14 Allowed Glycine 0 N--CA 1.493 2.478 0 N-CA-C 109.317 -1.513 . . . . 0.0 109.317 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 95.6 m -156.27 96.63 1.7 Allowed 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -52.16 104.2 0.08 Allowed 'General case' 0 N--CA 1.501 2.12 0 C-N-CA 120.034 -0.666 . . . . 0.0 111.345 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 146.91 -31.0 1.48 Allowed Glycine 0 N--CA 1.495 2.629 0 CA-C-N 114.835 -1.075 . . . . 0.0 112.625 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 88.2 m -95.26 174.8 6.87 Favored 'General case' 0 N--CA 1.502 2.169 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -121.9 87.35 2.74 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 106.452 -1.684 . . . . 0.0 106.452 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 61.0 m-85 -48.58 140.93 7.55 Favored 'General case' 0 N--CA 1.499 1.984 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.013 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.515 ' CE2' ' HA ' ' A' ' 80' ' ' THR . 4.8 t80 -137.1 164.43 28.45 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 125.207 1.567 . . . . 0.0 114.543 -179.222 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 12.0 t -124.13 130.76 53.09 Favored 'General case' 0 N--CA 1.505 2.275 0 CA-C-N 113.153 -1.839 . . . . 0.0 112.529 -179.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -54.98 -49.61 71.04 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-N 113.405 -1.725 . . . . 0.0 111.025 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 13.5 p-10 -108.1 28.58 8.13 Favored 'General case' 0 N--CA 1.488 1.472 0 CA-C-N 113.123 -1.853 . . . . 0.0 111.22 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -160.79 18.09 0.2 Allowed Glycine 0 N--CA 1.494 2.554 0 C-N-CA 119.356 -1.402 . . . . 0.0 112.341 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.523 ' HG1' ' H ' ' A' ' 81' ' ' PHE . 6.4 t 42.03 -160.23 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.793 0 O-C-N 124.924 1.014 . . . . 0.0 113.1 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . 0.523 ' H ' ' HG1' ' A' ' 80' ' ' THR . 47.1 t80 -42.37 121.11 1.83 Allowed 'General case' 0 N--CA 1.499 1.978 0 CA-C-O 121.459 0.647 . . . . 0.0 111.681 179.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 61.5 t -92.18 -68.2 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 CA-C-N 113.835 -1.529 . . . . 0.0 111.731 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 1.8 p -158.28 -177.28 6.43 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 123.924 0.765 . . . . 0.0 109.597 -179.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -102.46 151.97 21.68 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 104.54 -2.393 . . . . 0.0 104.54 179.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -64.55 128.04 34.98 Favored Glycine 0 N--CA 1.493 2.494 0 N-CA-C 108.638 -1.785 . . . . 0.0 108.638 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 40.7 mm-40 -113.67 11.97 18.29 Favored 'General case' 0 N--CA 1.498 1.929 0 C-N-CA 120.359 -0.536 . . . . 0.0 110.728 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 38.6 t -79.0 87.76 4.79 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -98.36 137.93 20.78 Favored Pre-proline 0 N--CA 1.493 1.688 0 CA-C-N 112.938 -1.937 . . . . 0.0 108.138 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -65.23 -40.47 19.39 Favored 'Trans proline' 0 N--CA 1.493 1.5 0 C-N-CA 122.12 1.88 . . . . 0.0 111.52 -179.074 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 72.5 ttt-85 -81.37 4.27 21.38 Favored 'General case' 0 N--CA 1.498 1.955 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.961 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.473 ' N ' HD21 ' A' ' 91' ' ' ASN . 0.0 OUTLIER -44.75 112.37 1.46 Allowed Pre-proline 0 N--CA 1.502 2.17 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -179.889 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -81.94 43.92 1.61 Allowed 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 123.112 2.541 . . . . 0.0 111.191 178.039 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 24.6 ttmm -164.29 153.44 13.57 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.173 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -94.46 129.04 41.38 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-N 114.095 -1.411 . . . . 0.0 108.186 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 83.1 m -79.82 148.18 68.17 Favored Pre-proline 0 N--CA 1.495 1.825 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -71.99 144.12 42.11 Favored 'Trans proline' 0 N--CA 1.489 1.245 0 C-N-CA 122.791 2.327 . . . . 0.0 109.258 163.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 21.1 tpp180 -100.16 31.88 3.19 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 27.9 m-20 -58.4 163.62 2.97 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 114.6 1.333 . . . . 0.0 114.6 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 66.9 m -100.61 133.95 44.29 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-N 113.358 -1.746 . . . . 0.0 110.868 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 60.5 t0 -117.4 84.39 18.16 Favored Pre-proline 0 N--CA 1.497 1.879 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 179.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_endo -57.29 -36.21 98.95 Favored 'Trans proline' 0 N--CA 1.496 1.657 0 C-N-CA 122.702 2.268 . . . . 0.0 111.283 -174.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 20.9 mmt180 -62.47 -39.63 94.03 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 124.284 0.99 . . . . 0.0 111.848 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 3.1 tt -53.45 155.16 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 O-C-N 123.905 0.753 . . . . 0.0 110.051 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -149.18 -42.24 0.14 Allowed 'General case' 0 N--CA 1.491 1.618 0 CA-C-N 115.364 -0.834 . . . . 0.0 111.458 -179.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 -138.45 -164.35 1.62 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 124.341 1.026 . . . . 0.0 110.599 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -153.23 103.99 0.25 Allowed Glycine 0 N--CA 1.487 2.08 0 N-CA-C 106.063 -2.815 . . . . 0.0 106.063 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 90.3 mt -78.91 88.18 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 57.9 m -81.9 149.53 63.52 Favored Pre-proline 0 N--CA 1.493 1.696 0 CA-C-N 113.944 -1.48 . . . . 0.0 109.006 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.495 1.565 0 C-N-CA 122.618 2.212 . . . . 0.0 111.056 179.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.747 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 7.2 tp -61.48 133.48 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 CA-C-N 114.49 -1.232 . . . . 0.0 109.145 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.7 m -140.38 45.71 1.83 Allowed 'General case' 0 N--CA 1.483 1.19 0 CA-C-O 122.583 1.182 . . . . 0.0 112.683 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 22.7 p -90.35 178.16 6.21 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-N 113.053 -1.885 . . . . 0.0 110.311 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 36.3 p-10 -155.85 -169.57 3.13 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-N 113.958 -1.474 . . . . 0.0 108.77 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.44 ' SG ' ' CD2' ' A' ' 16' ' ' TYR . 2.3 t -81.25 -27.36 35.23 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -179.796 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 23.3 t -80.32 -59.55 2.66 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-N 114.483 -1.235 . . . . 0.0 110.988 -179.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -90.41 64.79 6.01 Favored 'General case' 0 N--CA 1.5 2.036 0 CA-C-O 121.89 0.852 . . . . 0.0 110.074 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -135.89 -115.76 1.5 Allowed Glycine 0 N--CA 1.498 2.824 0 CA-C-N 113.97 -1.468 . . . . 0.0 110.264 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 91.1 m -139.73 111.23 7.16 Favored 'General case' 0 N--CA 1.502 2.146 0 CA-C-O 120.788 0.328 . . . . 0.0 111.264 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.549 ' NZ ' HH21 ' A' ' 32' ' ' ARG . 39.4 ttpt -58.59 146.52 35.59 Favored 'General case' 0 N--CA 1.497 1.883 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.803 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 79.75 -16.49 11.19 Favored Glycine 0 N--CA 1.492 2.418 0 CA-C-N 114.542 -1.208 . . . . 0.0 112.858 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 90.2 m -93.77 129.8 39.99 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -77.6 94.11 4.31 Favored 'General case' 0 N--CA 1.486 1.343 0 CA-C-N 114.435 -1.257 . . . . 0.0 110.19 -179.365 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.703 ' CD2' ' SG ' ' A' ' 25' ' ' CYS . 95.4 m-85 -46.17 137.14 6.33 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 124.925 1.391 . . . . 0.0 109.074 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -147.74 152.73 38.25 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 125.085 1.491 . . . . 0.0 111.876 -179.438 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 28.9 t -107.8 136.44 47.52 Favored 'General case' 0 N--CA 1.497 1.901 0 CA-C-N 111.748 -2.478 . . . . 0.0 113.778 -179.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -52.12 -24.79 7.49 Favored 'General case' 0 N--CA 1.5 2.072 0 CA-C-N 112.645 -2.07 . . . . 0.0 115.157 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -57.27 -17.49 12.14 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 123.849 0.718 . . . . 0.0 110.966 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 105.03 29.63 5.12 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 108.537 -1.825 . . . . 0.0 108.537 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 58.2 m -138.28 154.56 49.03 Favored 'General case' 0 N--CA 1.493 1.702 0 CA-C-O 121.374 0.607 . . . . 0.0 111.03 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 57.7 t80 -73.98 166.76 22.81 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-N 113.663 -1.608 . . . . 0.0 109.615 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 90.3 t -129.06 -68.3 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 123.909 0.756 . . . . 0.0 110.889 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.703 ' SG ' ' CD2' ' A' ' 16' ' ' TYR . 22.8 p -162.32 -171.4 2.79 Favored 'General case' 0 N--CA 1.504 2.255 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -111.95 145.11 40.17 Favored 'General case' 0 N--CA 1.506 2.331 0 CA-C-O 120.74 0.305 . . . . 0.0 111.535 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.516 ' HA2' ' CE2' ' A' ' 16' ' ' TYR . . . -39.98 107.13 0.07 OUTLIER Glycine 0 N--CA 1.496 2.682 0 O-C-N 124.545 1.153 . . . . 0.0 114.613 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -124.73 43.75 2.94 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 105.943 -1.873 . . . . 0.0 105.943 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 10.4 t -125.66 81.16 1.96 Allowed 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 -179.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -88.11 120.36 70.62 Favored Pre-proline 0 N--CA 1.495 1.801 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 179.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -66.73 -29.21 43.08 Favored 'Trans proline' 0 N--CA 1.494 1.538 0 C-N-CA 121.983 1.788 . . . . 0.0 110.773 177.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.549 HH21 ' NZ ' ' A' ' 12' ' ' LYS . 84.9 mtm180 -78.87 3.28 17.36 Favored 'General case' 0 N--CA 1.498 1.95 0 CA-C-N 114.946 -1.025 . . . . 0.0 112.107 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.427 HD21 ' H ' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -60.21 130.63 89.51 Favored Pre-proline 0 N--CA 1.495 1.798 0 O-C-N 123.339 0.399 . . . . 0.0 111.918 -179.86 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -82.28 46.13 2.12 Favored 'Trans proline' 0 N--CA 1.493 1.49 0 C-N-CA 123.026 2.484 . . . . 0.0 108.642 162.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -137.55 -177.0 4.6 Favored 'General case' 0 N--CA 1.497 1.9 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.49 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -143.92 118.13 9.55 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-N 114.867 -1.061 . . . . 0.0 108.423 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 75.4 m -79.76 168.72 18.94 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 8.6 t -85.21 166.47 16.52 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-N 113.856 -1.52 . . . . 0.0 109.558 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.441 ' H ' HD12 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -104.18 19.46 20.11 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-N 114.849 -1.069 . . . . 0.0 111.902 -179.895 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -55.12 135.57 49.13 Favored 'General case' 0 N--CA 1.498 1.951 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.128 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 58.2 m -90.32 131.3 36.19 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-N 114.796 -1.093 . . . . 0.0 110.874 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -127.35 78.02 75.04 Favored Pre-proline 0 N--CA 1.498 1.947 0 O-C-N 124.103 0.877 . . . . 0.0 109.514 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -63.77 -27.12 67.95 Favored 'Trans proline' 0 N--CA 1.494 1.524 0 C-N-CA 122.855 2.37 . . . . 0.0 113.515 -170.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 8.4 ptp180 -56.24 -33.19 65.18 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 123.956 0.785 . . . . 0.0 111.205 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 15.1 tt -50.41 150.91 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 CA-C-N 114.696 -1.138 . . . . 0.0 113.102 -179.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -133.21 -51.43 0.88 Allowed 'General case' 0 N--CA 1.492 1.652 0 CA-C-N 113.492 -1.685 . . . . 0.0 106.903 179.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 51.5 p90 -170.41 177.26 4.13 Favored 'General case' 0 N--CA 1.494 1.748 0 CA-C-N 113.819 -1.537 . . . . 0.0 108.684 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -124.52 120.55 4.07 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 107.341 -2.303 . . . . 0.0 107.341 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.1 p -79.27 100.65 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 CA-C-O 123.015 1.388 . . . . 0.0 108.778 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 3.8 m -79.58 163.66 57.67 Favored Pre-proline 0 N--CA 1.493 1.705 0 CA-C-N 112.889 -1.96 . . . . 0.0 108.383 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_exo . . . . . 0 N--CA 1.499 1.806 0 C-N-CA 122.705 2.27 . . . . 0.0 111.847 175.169 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . 0.455 ' HA ' ' HA ' ' A' ' 99' ' ' CYS . 1.3 m . . . . . 0 N--CA 1.479 1.016 0 N-CA-C 118.037 2.606 . . . . 0.0 118.037 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.3 p -90.75 160.36 15.85 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-N 113.679 -1.601 . . . . 0.0 106.685 179.121 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.491 HD21 HD21 ' A' ' 98' ' ' ASN . 40.0 t30 -160.58 161.59 32.63 Favored 'General case' 0 N--CA 1.497 1.901 0 CA-C-O 122.399 1.095 . . . . 0.0 112.598 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 7.4 t -58.51 -20.35 45.12 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-N 112.014 -2.357 . . . . 0.0 111.836 179.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 40.7 t -86.27 -71.06 0.56 Allowed 'General case' 0 N--CA 1.494 1.756 0 CA-C-N 114.999 -1.0 . . . . 0.0 111.642 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -54.33 -19.71 5.93 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-N 113.881 -1.509 . . . . 0.0 113.097 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -60.58 159.95 25.05 Favored Glycine 0 N--CA 1.491 2.357 0 O-C-N 123.998 0.811 . . . . 0.0 111.837 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.507 ' C ' ' H ' ' A' ' 71' ' ' GLY . 12.4 t -85.56 139.24 31.61 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-N 113.934 -1.133 . . . . 0.0 108.922 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 23.1 ttmm -80.02 35.03 0.31 Allowed 'General case' 0 N--CA 1.499 2.003 0 CA-C-O 122.543 1.164 . . . . 0.0 110.578 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.507 ' H ' ' C ' ' A' ' 69' ' ' THR . . . -123.64 -8.51 6.28 Favored Glycine 0 N--CA 1.491 2.367 0 N-CA-C 108.542 -1.823 . . . . 0.0 108.542 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 78.9 m -137.33 148.12 46.09 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 123.931 0.43 . . . . 0.0 109.915 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.464 ' HB3' ' CE1' ' A' ' 81' ' ' PHE . 27.6 mtpp -101.4 88.59 3.5 Favored 'General case' 0 N--CA 1.485 1.314 0 O-C-N 124.917 1.386 . . . . 0.0 108.203 -179.485 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.479 ' HH ' ' H ' ' A' ' 69' ' ' THR . 93.9 m-85 -49.76 133.99 20.98 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-N 114.175 -1.375 . . . . 0.0 108.688 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.423 ' CE2' ' HA ' ' A' ' 80' ' ' THR . 1.2 t80 -132.72 154.62 50.01 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 113.13 -1.85 . . . . 0.0 114.06 -179.218 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' SER . . . . . 0.4 ' N ' HG21 ' A' ' 82' ' ' VAL . 25.8 t -115.84 129.92 56.63 Favored 'General case' 0 N--CA 1.497 1.913 0 CA-C-N 112.145 -2.298 . . . . 0.0 111.746 -179.747 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.41 ' H ' ' HB1' ' A' ' 104' ' ' ALA . 7.7 p-10 -64.67 -46.74 81.16 Favored 'General case' 0 N--CA 1.497 1.897 0 CA-C-N 114.773 -1.103 . . . . 0.0 108.596 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -92.18 19.71 6.67 Favored 'General case' 0 N--CA 1.485 1.283 0 CA-C-N 112.772 -2.013 . . . . 0.0 110.953 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -165.21 24.53 0.16 Allowed Glycine 0 N--CA 1.497 2.715 0 C-N-CA 118.62 -1.753 . . . . 0.0 113.184 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.423 ' HA ' ' CE2' ' A' ' 75' ' ' PHE . 6.5 t 42.11 -161.55 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.926 0 O-C-N 124.969 1.041 . . . . 0.0 112.887 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . 0.464 ' CE1' ' HB3' ' A' ' 73' ' ' LYS . 11.0 t80 -49.68 121.97 5.84 Favored 'General case' 0 N--CA 1.497 1.882 0 CA-C-O 121.34 0.591 . . . . 0.0 110.879 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.4 HG21 ' N ' ' A' ' 76' ' ' SER . 88.9 t -86.11 -73.34 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . 0.409 ' SG ' ' O ' ' A' ' 84' ' ' GLU . 0.1 OUTLIER -175.49 171.35 2.83 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 124.002 0.813 . . . . 0.0 110.459 179.779 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.409 ' O ' ' SG ' ' A' ' 83' ' ' CYS . 32.3 tt0 -93.28 146.93 23.34 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 105.718 -1.956 . . . . 0.0 105.718 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -53.03 135.38 39.74 Favored Glycine 0 N--CA 1.501 2.967 0 C-N-CA 119.514 -1.327 . . . . 0.0 114.452 -179.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -100.37 27.91 5.39 Favored 'General case' 0 N--CA 1.505 2.301 0 CA-C-O 121.595 0.712 . . . . 0.0 110.032 179.744 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.419 ' HG ' ' H ' ' A' ' 88' ' ' ASP . 22.2 t -160.93 -176.57 5.58 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.422 ' HB3' ' ND2' ' A' ' 91' ' ' ASN . 7.5 t70 -144.61 140.01 16.09 Favored Pre-proline 0 N--CA 1.488 1.438 0 N-CA-C 105.343 -2.095 . . . . 0.0 105.343 179.807 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_exo -41.79 -28.04 0.66 Allowed 'Trans proline' 0 N--CA 1.5 1.895 0 C-N-CA 123.671 2.914 . . . . 0.0 114.824 -174.274 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.87 -51.34 16.54 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 123.93 0.769 . . . . 0.0 111.898 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.422 ' ND2' ' HB3' ' A' ' 88' ' ' ASP . 2.4 p30 -90.23 138.26 27.35 Favored Pre-proline 0 N--CA 1.502 2.166 0 C-N-CA 119.55 -0.86 . . . . 0.0 110.622 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -75.53 170.25 20.64 Favored 'Trans proline' 0 N--CA 1.493 1.476 0 C-N-CA 122.929 2.419 . . . . 0.0 109.861 161.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 27.8 tptp -160.3 154.68 23.58 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 123.67 0.606 . . . . 0.0 110.3 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -98.39 139.51 34.04 Favored 'General case' 0 N--CA 1.498 1.96 0 CA-C-N 114.591 -1.186 . . . . 0.0 111.122 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 98.5 m -159.32 167.46 14.22 Favored Pre-proline 0 N--CA 1.501 2.076 0 O-C-N 124.057 0.848 . . . . 0.0 111.066 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -27.09 -66.13 0.05 OUTLIER 'Trans proline' 0 N--CA 1.494 1.528 0 C-N-CA 124.275 3.316 . . . . 0.0 115.628 170.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 79.0 ttt180 -153.77 -77.92 0.11 Allowed 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.491 HD21 HD21 ' A' ' 64' ' ' ASN . 7.8 m120 133.72 -170.22 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.412 0 O-C-N 126.545 2.403 . . . . 0.0 107.726 -179.559 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . 0.455 ' HA ' ' HA ' ' A' ' 62' ' ' CYS . 61.5 m 62.95 121.45 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 124.952 1.301 . . . . 0.0 112.454 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -141.17 80.98 16.27 Favored Pre-proline 0 N--CA 1.494 1.73 0 CA-C-N 114.372 -1.286 . . . . 0.0 111.252 -179.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -49.16 -27.76 13.16 Favored 'Trans proline' 0 N--CA 1.496 1.669 0 C-N-CA 123.183 2.589 . . . . 0.0 113.812 172.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.06 -27.28 69.29 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 123.687 0.617 . . . . 0.0 111.635 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 12.7 tt -52.35 167.62 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 124.253 0.971 . . . . 0.0 112.625 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.41 ' HB1' ' H ' ' A' ' 77' ' ' ASP . . . -142.8 -55.66 0.42 Allowed 'General case' 0 N--CA 1.49 1.532 0 CA-C-N 114.352 -1.295 . . . . 0.0 109.604 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -149.2 -159.92 1.1 Allowed 'General case' 0 N--CA 1.498 1.925 0 O-C-N 124.465 1.103 . . . . 0.0 109.134 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -142.89 108.97 0.54 Allowed Glycine 0 N--CA 1.489 2.173 0 N-CA-C 105.917 -2.873 . . . . 0.0 105.917 179.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 93.4 mt -79.37 85.68 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 22.2 m -79.68 121.34 82.35 Favored Pre-proline 0 N--CA 1.492 1.634 0 CA-C-N 113.799 -1.546 . . . . 0.0 108.553 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_endo . . . . . 0 N--CA 1.493 1.45 0 C-N-CA 122.394 2.063 . . . . 0.0 110.375 -176.66 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 8.2 ptp180 . . . . . 0 N--CA 1.498 1.957 0 N-CA-C 106.175 -1.787 . . . . 0.0 106.175 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.7 tp -90.16 77.79 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 CA-C-N 113.252 -1.795 . . . . 0.0 108.345 179.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.7 m -85.81 28.99 0.74 Allowed 'General case' 0 N--CA 1.497 1.925 0 N-CA-C 116.201 1.926 . . . . 0.0 116.201 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 12.6 t -92.35 169.51 10.52 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-N 113.058 -1.883 . . . . 0.0 106.508 179.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 40.0 p-10 -160.48 161.87 32.95 Favored 'General case' 0 N--CA 1.497 1.901 0 C-N-CA 119.367 -0.933 . . . . 0.0 112.629 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -63.24 -22.68 67.02 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 113.856 -1.52 . . . . 0.0 112.561 179.729 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 42.4 t -89.96 -69.02 0.74 Allowed 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 115.252 1.575 . . . . 0.0 115.252 -179.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -85.66 63.07 7.85 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 124.598 1.186 . . . . 0.0 111.25 -179.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -119.89 -115.05 2.5 Favored Glycine 0 N--CA 1.492 2.379 0 CA-C-N 113.282 -1.781 . . . . 0.0 109.799 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.0 t -166.31 123.44 1.35 Allowed 'General case' 0 N--CA 1.496 1.848 0 CA-C-O 121.373 0.606 . . . . 0.0 110.585 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.82 143.73 20.28 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-N 114.714 -1.13 . . . . 0.0 109.843 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 106.37 -35.47 5.02 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.195 -1.562 . . . . 0.0 109.195 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 52.1 m -94.64 116.21 28.49 Favored 'General case' 0 N--CA 1.497 1.906 0 C-N-CA 119.422 -0.911 . . . . 0.0 110.222 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 4.0 mptp? -72.24 88.15 1.14 Allowed 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 112.792 -2.003 . . . . 0.0 111.627 -179.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.446 ' N ' ' O ' ' A' ' 25' ' ' CYS . 10.7 m-85 -46.72 127.9 10.14 Favored 'General case' 0 N--CA 1.498 1.96 0 CA-C-O 122.468 1.128 . . . . 0.0 108.237 179.583 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.479 ' CE2' ' HA ' ' A' ' 22' ' ' THR . 0.1 OUTLIER -135.96 158.72 43.73 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-N 111.623 -2.535 . . . . 0.0 113.096 -178.965 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 29.1 t -110.78 128.86 55.91 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-N 112.72 -2.036 . . . . 0.0 111.054 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -62.71 -45.35 93.15 Favored 'General case' 0 N--CA 1.497 1.911 0 CA-C-N 114.119 -1.4 . . . . 0.0 109.203 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -94.25 19.94 8.76 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 112.624 -2.08 . . . . 0.0 111.624 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -171.22 28.89 0.11 Allowed Glycine 0 N--CA 1.497 2.731 0 C-N-CA 118.146 -1.978 . . . . 0.0 113.934 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.479 ' HA ' ' CE2' ' A' ' 17' ' ' PHE . 6.5 t 42.81 -166.68 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 73.9 t80 -40.05 139.81 0.65 Allowed 'General case' 0 N--CA 1.5 2.063 0 N-CA-C 114.074 1.138 . . . . 0.0 114.074 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 88.4 t -114.53 -79.42 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 CA-C-N 113.131 -1.85 . . . . 0.0 108.05 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.525 ' SG ' ' N ' ' A' ' 26' ' ' GLU . 0.1 OUTLIER -152.21 -169.38 3.34 Favored 'General case' 0 N--CA 1.502 2.17 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 179.86 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.525 ' N ' ' SG ' ' A' ' 25' ' ' CYS . 60.8 tt0 -114.62 158.3 21.92 Favored 'General case' 0 N--CA 1.504 2.228 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 179.425 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -54.07 109.65 1.22 Allowed Glycine 0 N--CA 1.497 2.731 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.69 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -85.82 19.55 2.48 Favored 'General case' 0 N--CA 1.5 2.028 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 36.6 t -105.44 92.76 4.33 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.197 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -130.35 142.42 45.4 Favored Pre-proline 0 N--CA 1.495 1.786 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 179.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_endo -63.16 79.0 0.12 Allowed 'Trans proline' 0 N--CA 1.496 1.639 0 C-N-CA 122.561 2.174 . . . . 0.0 109.891 169.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 79.6 ttt180 -178.13 -51.26 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 105.592 -2.003 . . . . 0.0 105.592 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 26.5 p30 -90.44 168.21 14.78 Favored Pre-proline 0 N--CA 1.497 1.9 0 CA-C-N 114.27 -1.332 . . . . 0.0 110.781 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -62.55 127.2 20.13 Favored 'Trans proline' 0 N--CA 1.49 1.304 0 C-N-CA 122.436 2.09 . . . . 0.0 109.021 160.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -92.83 22.44 4.84 Favored 'General case' 0 N--CA 1.5 2.074 0 CA-C-O 122.677 1.227 . . . . 0.0 112.749 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -146.22 153.39 40.56 Favored 'General case' 0 N--CA 1.498 1.947 0 CA-C-N 112.274 -2.239 . . . . 0.0 111.739 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 57.1 m -146.51 -124.19 0.07 Allowed 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 33.5 m -146.76 18.37 1.29 Allowed 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 44.6 tp -79.71 -43.3 22.92 Favored 'General case' 0 N--CA 1.497 1.897 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.334 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 25.2 m-80 53.11 -163.63 0.09 Allowed 'General case' 0 N--CA 1.504 2.243 0 O-C-N 124.064 0.852 . . . . 0.0 112.03 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 56.3 m -43.85 118.85 1.54 Allowed 'General case' 0 N--CA 1.502 2.133 0 O-C-N 124.033 0.833 . . . . 0.0 110.232 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.4 t0 -101.41 106.41 45.62 Favored Pre-proline 0 N--CA 1.495 1.807 0 O-C-N 124.022 0.827 . . . . 0.0 109.398 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -67.6 -33.12 29.33 Favored 'Trans proline' 0 N--CA 1.494 1.525 0 C-N-CA 122.046 1.831 . . . . 0.0 111.101 -168.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 29.0 mmt85 -86.32 -13.36 46.81 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 -179.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 5.9 tt -73.43 179.33 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 C-N-CA 118.68 -1.208 . . . . 0.0 108.738 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -139.92 -58.61 0.56 Allowed 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 120.556 -0.458 . . . . 0.0 112.073 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 7.3 p90 -170.46 160.68 7.57 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 124.146 0.904 . . . . 0.0 112.719 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.402 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -88.92 107.65 3.39 Favored Glycine 0 N--CA 1.487 2.096 0 CA-C-N 113.235 -1.802 . . . . 0.0 108.892 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 23.4 t -78.24 86.75 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 124.287 0.639 . . . . 0.0 112.661 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.6 m -79.27 145.91 65.53 Favored Pre-proline 0 N--CA 1.503 2.212 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 179.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo . . . . . 0 N--CA 1.5 1.861 0 C-N-CA 123.74 2.96 . . . . 0.0 116.465 -170.145 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 1.7 m . . . . . 0 N--CA 1.494 1.738 0 CA-C-O 122.695 1.236 . . . . 0.0 113.94 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 64.3 m -90.54 166.39 13.24 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 113.309 -1.769 . . . . 0.0 108.201 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -146.53 155.05 42.22 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 124.079 0.862 . . . . 0.0 109.765 179.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 41.1 t -56.75 -32.84 65.97 Favored 'General case' 0 N--CA 1.497 1.916 0 CA-C-N 114.767 -1.106 . . . . 0.0 113.582 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 18.1 t -66.54 -46.19 76.91 Favored 'General case' 0 N--CA 1.495 1.796 0 CA-C-N 114.726 -1.124 . . . . 0.0 110.219 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -86.17 62.27 7.33 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-N 113.689 -1.596 . . . . 0.0 110.655 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -143.8 165.11 27.33 Favored Glycine 0 N--CA 1.496 2.637 0 CA-C-N 114.272 -1.331 . . . . 0.0 111.078 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.542 ' H ' ' HH ' ' A' ' 74' ' ' TYR . 9.5 t -85.3 127.33 34.29 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-N 115.036 -0.582 . . . . 0.0 110.517 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -81.09 36.64 0.41 Allowed 'General case' 0 N--CA 1.501 2.078 0 CA-C-O 122.484 1.135 . . . . 0.0 110.432 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.481 ' H ' ' C ' ' A' ' 69' ' ' THR . . . -132.27 -1.28 4.42 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 108.547 -1.821 . . . . 0.0 108.547 179.735 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 64.1 m -143.39 141.62 30.95 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 7.7 ptmm? -92.46 96.61 10.34 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 124.447 1.092 . . . . 0.0 110.95 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.542 ' HH ' ' H ' ' A' ' 69' ' ' THR . 57.4 m-85 -52.15 134.02 33.22 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-N 114.429 -1.26 . . . . 0.0 109.692 179.731 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -141.4 158.37 43.96 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 112.998 -1.91 . . . . 0.0 112.762 -179.37 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 57.8 p -96.08 139.41 32.3 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 114.743 1.386 . . . . 0.0 114.743 -179.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -45.35 -48.23 13.33 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 126.044 2.09 . . . . 0.0 114.848 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -52.27 -30.58 28.59 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 124.329 1.018 . . . . 0.0 111.785 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 119.72 43.83 0.48 Allowed Glycine 0 N--CA 1.491 2.348 0 O-C-N 124.742 1.276 . . . . 0.0 111.043 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 57.3 m -139.13 111.21 7.35 Favored 'General case' 0 N--CA 1.5 2.03 0 C-N-CA 119.648 -0.821 . . . . 0.0 112.077 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 17.4 t80 -53.43 137.21 36.35 Favored 'General case' 0 N--CA 1.494 1.775 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.694 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 64.1 t -98.02 -73.4 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 CA-C-N 114.348 -1.297 . . . . 0.0 111.474 -179.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . 0.48 ' SG ' ' N ' ' A' ' 84' ' ' GLU . 0.5 OUTLIER -167.3 -172.65 2.04 Favored 'General case' 0 N--CA 1.505 2.3 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 -179.854 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.48 ' N ' ' SG ' ' A' ' 83' ' ' CYS . 33.3 tt0 -112.66 145.03 41.16 Favored 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 103.234 -2.876 . . . . 0.0 103.234 179.26 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -52.33 140.58 28.12 Favored Glycine 0 N--CA 1.503 3.157 0 C-N-CA 118.993 -1.575 . . . . 0.0 112.696 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -88.62 -4.98 58.45 Favored 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 27.8 t -117.97 107.91 14.63 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.472 ' H ' HD22 ' A' ' 91' ' ' ASN . 14.3 t70 -79.05 141.49 58.52 Favored Pre-proline 0 N--CA 1.494 1.749 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -34.62 -31.5 0.06 OUTLIER 'Trans proline' 0 N--CA 1.497 1.729 0 C-N-CA 123.712 2.941 . . . . 0.0 113.784 175.004 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -79.33 -53.93 6.44 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 123.869 0.73 . . . . 0.0 110.215 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.472 HD22 ' H ' ' A' ' 88' ' ' ASP . 1.7 p-10 -91.3 126.0 56.29 Favored Pre-proline 0 N--CA 1.5 2.062 0 C-N-CA 119.976 -0.69 . . . . 0.0 112.326 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -75.52 150.67 36.29 Favored 'Trans proline' 0 N--CA 1.492 1.39 0 C-N-CA 122.586 2.191 . . . . 0.0 109.396 165.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 32.4 mmmt -132.99 127.5 34.3 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 124.02 0.825 . . . . 0.0 109.029 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -84.06 73.96 10.32 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 123.97 0.794 . . . . 0.0 108.967 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 85.1 m -79.96 163.33 58.45 Favored Pre-proline 0 N--CA 1.496 1.838 0 CA-C-N 114.404 -1.271 . . . . 0.0 112.848 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_endo -70.0 -151.43 0.03 OUTLIER 'Trans proline' 0 N--CA 1.491 1.376 0 C-N-CA 122.563 2.175 . . . . 0.0 109.292 159.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -154.3 50.38 0.64 Allowed 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 121.754 0.787 . . . . 0.0 111.67 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.411 ' H ' HD21 ' A' ' 98' ' ' ASN . 2.8 m-80 -60.5 157.16 14.7 Favored 'General case' 0 N--CA 1.5 2.065 0 CA-C-N 114.722 -1.126 . . . . 0.0 111.459 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 86.0 m -98.47 131.37 44.78 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-N 114.989 -1.005 . . . . 0.0 111.552 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 51.0 t0 -121.34 79.85 36.69 Favored Pre-proline 0 N--CA 1.496 1.873 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 179.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -54.71 -17.29 12.97 Favored 'Trans proline' 0 N--CA 1.497 1.697 0 C-N-CA 122.696 2.264 . . . . 0.0 113.326 -176.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 73.0 ttp85 -88.49 -35.85 16.77 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 -179.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 11.1 tt -54.35 159.82 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.403 0 O-C-N 123.307 0.38 . . . . 0.0 110.949 -179.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -150.79 -68.01 0.19 Allowed 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 -179.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 51.1 m-85 -114.28 -161.64 0.78 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 124.189 0.931 . . . . 0.0 111.321 -179.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -160.2 106.99 0.3 Allowed Glycine 0 N--CA 1.486 2.024 0 N-CA-C 104.836 -3.306 . . . . 0.0 104.836 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.403 HD11 ' N ' ' A' ' 107' ' ' ILE . 2.1 mp -79.14 104.67 7.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 CA-C-O 121.949 0.881 . . . . 0.0 108.92 -179.653 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 16.0 m -86.79 159.71 51.48 Favored Pre-proline 0 N--CA 1.495 1.777 0 CA-C-N 114.272 -1.331 . . . . 0.0 108.641 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo . . . . . 0 N--CA 1.494 1.549 0 C-N-CA 122.382 2.055 . . . . 0.0 110.015 173.965 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 67.7 mmt-85 . . . . . 0 N--CA 1.499 2.005 0 N-CA-C 111.77 0.285 . . . . 0.0 111.77 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.0 tp -60.46 96.96 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 CA-C-O 121.922 0.867 . . . . 0.0 111.28 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.7 m -93.06 49.04 1.38 Allowed 'General case' 0 N--CA 1.491 1.598 0 CA-C-N 114.486 -1.234 . . . . 0.0 112.293 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 13.5 t -90.57 177.03 6.46 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-N 113.404 -1.725 . . . . 0.0 107.733 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.416 HD21 ' H ' ' A' ' 40' ' ' ASN . 14.3 p30 -160.04 167.98 26.62 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 123.994 0.809 . . . . 0.0 112.136 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 38.0 t -53.99 -42.52 69.11 Favored 'General case' 0 N--CA 1.497 1.877 0 CA-C-N 114.225 -1.352 . . . . 0.0 112.036 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 53.4 t -52.85 -44.48 66.81 Favored 'General case' 0 N--CA 1.496 1.862 0 CA-C-N 113.221 -1.808 . . . . 0.0 109.413 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -89.73 28.94 1.23 Allowed 'General case' 0 N--CA 1.499 2.018 0 CA-C-N 112.944 -1.935 . . . . 0.0 110.835 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -83.31 -138.44 3.36 Favored Glycine 0 N--CA 1.496 2.667 0 N-CA-C 110.743 -0.943 . . . . 0.0 110.743 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 39.9 p -158.09 104.88 1.91 Allowed 'General case' 0 N--CA 1.503 2.183 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 16.2 ptpt -53.55 95.05 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.108 0 CA-C-O 122.586 1.184 . . . . 0.0 111.811 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 168.24 -35.25 0.2 Allowed Glycine 0 N--CA 1.488 2.166 0 CA-C-N 113.788 -1.551 . . . . 0.0 110.345 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 49.9 m -112.12 161.28 16.69 Favored 'General case' 0 N--CA 1.502 2.151 0 C-N-CA 119.47 -0.892 . . . . 0.0 111.913 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -101.18 92.31 4.92 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-N 114.182 -1.372 . . . . 0.0 108.278 -179.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.409 ' N ' ' O ' ' A' ' 25' ' ' CYS . 47.4 m-85 -47.33 136.85 9.0 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 124.636 1.21 . . . . 0.0 110.712 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 10.7 t80 -146.19 159.58 43.12 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-N 112.853 -1.976 . . . . 0.0 112.789 -179.217 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.477 ' HG ' ' HE ' ' A' ' 44' ' ' ARG . 35.1 t -112.75 134.84 54.07 Favored 'General case' 0 N--CA 1.498 1.968 0 CA-C-N 112.285 -2.234 . . . . 0.0 114.753 -179.688 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.407 ' H ' ' HB1' ' A' ' 46' ' ' ALA . 1.2 p30 -51.17 -26.34 6.68 Favored 'General case' 0 N--CA 1.501 2.087 0 CA-C-N 112.457 -2.156 . . . . 0.0 115.031 -179.823 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 24.0 p30 -64.39 -2.12 2.07 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 123.999 0.812 . . . . 0.0 112.085 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 89.61 28.83 18.0 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 58.6 m -134.89 150.54 50.45 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 71.8 t80 -78.24 158.78 28.82 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-N 114.321 -1.309 . . . . 0.0 110.386 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 95.2 t -116.35 -73.77 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 CA-C-N 114.939 -1.028 . . . . 0.0 109.124 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.506 ' SG ' ' N ' ' A' ' 26' ' ' GLU . 1.7 p -168.41 -161.25 0.34 Allowed 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.506 ' N ' ' SG ' ' A' ' 25' ' ' CYS . 40.8 tt0 -127.87 145.57 50.9 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 104.669 -2.345 . . . . 0.0 104.669 179.231 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -32.72 102.13 0.01 OUTLIER Glycine 0 N--CA 1.499 2.891 0 N-CA-C 115.988 1.155 . . . . 0.0 115.988 -179.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -102.82 32.86 3.46 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 29.9 t -122.55 148.08 45.63 Favored 'General case' 0 N--CA 1.497 1.924 0 CA-C-N 114.124 -1.398 . . . . 0.0 107.681 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.49 ' H ' ' HZ2' ' A' ' 35' ' ' LYS . 41.8 t0 -128.2 92.9 40.29 Favored Pre-proline 0 N--CA 1.493 1.722 0 O-C-N 124.717 1.26 . . . . 0.0 110.82 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -52.43 -15.89 4.5 Favored 'Trans proline' 0 N--CA 1.495 1.59 0 C-N-CA 123.002 2.468 . . . . 0.0 113.03 178.239 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 16.7 tpt180 -61.2 -51.82 67.39 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 108.147 -1.056 . . . . 0.0 108.147 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 15.3 p30 -90.65 138.91 26.35 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 124.327 1.017 . . . . 0.0 110.016 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -74.38 116.77 4.74 Favored 'Trans proline' 0 N--CA 1.493 1.458 0 C-N-CA 123.017 2.478 . . . . 0.0 110.394 175.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.49 ' HZ2' ' H ' ' A' ' 30' ' ' ASP . 0.0 OUTLIER -167.51 176.19 6.68 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 123.98 0.8 . . . . 0.0 111.957 179.92 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -160.03 122.19 3.31 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-N 114.89 -1.05 . . . . 0.0 108.784 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 33.4 m -79.87 -71.58 0.45 Allowed 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 47.5 m 34.22 69.91 0.14 Allowed 'General case' 0 N--CA 1.498 1.96 0 O-C-N 124.787 1.305 . . . . 0.0 113.414 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.3 pp -143.55 -36.87 0.35 Allowed 'General case' 0 N--CA 1.495 1.789 0 CA-C-N 114.936 -1.029 . . . . 0.0 108.973 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.416 ' H ' HD21 ' A' ' 6' ' ' ASN . 20.5 m120 -94.02 138.68 31.84 Favored 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 105.648 -1.982 . . . . 0.0 105.648 179.473 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 75.0 m -101.01 131.02 47.08 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 123.698 0.624 . . . . 0.0 112.644 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 62.9 t0 -122.95 76.46 49.73 Favored Pre-proline 0 N--CA 1.497 1.922 0 O-C-N 124.213 0.945 . . . . 0.0 109.149 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -63.74 -37.64 44.67 Favored 'Trans proline' 0 N--CA 1.496 1.63 0 C-N-CA 123.309 2.672 . . . . 0.0 111.584 -176.131 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.477 ' HE ' ' HG ' ' A' ' 18' ' ' SER . 0.0 OUTLIER -74.6 -7.6 53.68 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 115.088 1.514 . . . . 0.0 115.088 -179.758 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 15.9 tt -57.04 156.74 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.25 0 C-N-CA 119.879 -0.729 . . . . 0.0 111.856 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.407 ' HB1' ' H ' ' A' ' 19' ' ' ASP . . . -137.13 -66.95 0.5 Allowed 'General case' 0 N--CA 1.497 1.914 0 O-C-N 124.006 0.816 . . . . 0.0 110.289 179.795 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 46.8 p90 -160.96 167.99 25.45 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-N 115.183 -0.917 . . . . 0.0 109.836 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -115.95 111.44 2.4 Favored Glycine 0 N--CA 1.492 2.428 0 O-C-N 125.17 1.544 . . . . 0.0 109.709 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.5 p -80.04 111.32 16.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 C-N-CA 119.731 -0.788 . . . . 0.0 111.973 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.7 m -79.33 149.48 72.45 Favored Pre-proline 0 N--CA 1.499 1.984 0 CA-C-N 115.135 -0.939 . . . . 0.0 109.055 179.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo . . . . . 0 N--CA 1.495 1.6 0 C-N-CA 122.749 2.299 . . . . 0.0 111.965 -169.619 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . 0.407 ' HA ' ' HA ' ' A' ' 99' ' ' CYS . 1.7 m . . . . . 0 N--CA 1.48 1.054 0 CA-C-O 123.037 1.398 . . . . 0.0 111.897 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 93.2 m -90.3 168.24 12.05 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 112.516 -2.129 . . . . 0.0 108.72 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 42.3 p-10 -152.9 177.64 10.53 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 123.965 0.79 . . . . 0.0 110.072 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 4.5 t -73.17 1.12 9.85 Favored 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 46.1 t -91.64 -36.29 13.73 Favored 'General case' 0 N--CA 1.496 1.845 0 CA-C-N 114.751 -1.113 . . . . 0.0 110.584 179.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -71.1 59.21 0.24 Allowed 'General case' 0 N--CA 1.5 2.063 0 CA-C-N 112.466 -2.152 . . . . 0.0 114.148 -179.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -174.22 -150.33 7.6 Favored Glycine 0 N--CA 1.487 2.06 0 N-CA-C 107.863 -2.095 . . . . 0.0 107.863 179.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.482 ' C ' ' H ' ' A' ' 71' ' ' GLY . 66.5 p -146.11 157.42 43.84 Favored 'General case' 0 N--CA 1.502 2.13 0 C-N-CA 120.781 -0.367 . . . . 0.0 111.211 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 59.4 mtpt -71.07 33.23 0.05 OUTLIER 'General case' 0 N--CA 1.507 2.415 0 O-C-N 125.117 1.511 . . . . 0.0 113.627 179.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.482 ' H ' ' C ' ' A' ' 69' ' ' THR . . . -137.0 14.21 3.81 Favored Glycine 0 N--CA 1.486 1.987 0 N-CA-C 108.054 -2.018 . . . . 0.0 108.054 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 86.8 m -140.44 175.21 9.79 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 123.901 0.412 . . . . 0.0 111.006 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 34.2 mtmm -131.16 106.57 8.43 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 123.953 0.783 . . . . 0.0 110.279 -179.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.681 ' CD2' ' SG ' ' A' ' 83' ' ' CYS . 97.8 m-85 -56.31 137.98 51.48 Favored 'General case' 0 N--CA 1.501 2.102 0 C-N-CA 120.133 -0.627 . . . . 0.0 109.827 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 15.4 t80 -143.07 162.38 35.66 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 124.69 1.244 . . . . 0.0 111.977 -179.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 47.3 t -120.5 139.08 53.41 Favored 'General case' 0 N--CA 1.5 2.058 0 CA-C-N 113.2 -1.818 . . . . 0.0 115.084 -179.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.473 ' H ' ' HB2' ' A' ' 104' ' ' ALA . 4.3 p-10 -48.84 -28.23 3.58 Favored 'General case' 0 N--CA 1.5 2.055 0 CA-C-N 111.341 -2.663 . . . . 0.0 114.033 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 17.8 p30 -61.09 -5.25 1.36 Allowed 'General case' 0 N--CA 1.497 1.886 0 O-C-N 124.35 1.031 . . . . 0.0 112.073 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 89.64 29.08 17.19 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.396 -1.482 . . . . 0.0 109.396 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 88.2 m -142.17 149.96 40.42 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 121.43 0.633 . . . . 0.0 111.008 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 34.0 t80 -67.52 164.69 18.37 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-N 113.583 -1.644 . . . . 0.0 110.508 179.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 92.7 t -126.27 -71.49 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 O-C-N 124.074 0.859 . . . . 0.0 111.146 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . 0.681 ' SG ' ' CD2' ' A' ' 74' ' ' TYR . 17.2 p -155.11 -172.18 4.09 Favored 'General case' 0 N--CA 1.499 2.021 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 -179.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.405 ' CD ' ' N ' ' A' ' 85' ' ' GLY . 10.5 tm-20 -116.77 164.2 15.0 Favored 'General case' 0 N--CA 1.501 2.086 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.405 ' N ' ' CD ' ' A' ' 84' ' ' GLU . . . -49.63 107.82 0.37 Allowed Glycine 0 N--CA 1.494 2.545 0 CA-C-O 119.013 -0.882 . . . . 0.0 110.937 179.659 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -108.84 34.18 3.83 Favored 'General case' 0 N--CA 1.5 2.074 0 CA-C-O 121.535 0.683 . . . . 0.0 110.655 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 45.4 t -145.4 119.43 9.39 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -81.02 127.97 72.67 Favored Pre-proline 0 N--CA 1.494 1.769 0 C-N-CA 119.592 -0.843 . . . . 0.0 110.036 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_endo -58.56 -17.46 34.88 Favored 'Trans proline' 0 N--CA 1.495 1.605 0 C-N-CA 122.549 2.166 . . . . 0.0 113.019 -177.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 30.4 tpt180 -59.74 -41.48 91.06 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 123.717 0.636 . . . . 0.0 110.511 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -90.3 118.93 69.18 Favored Pre-proline 0 N--CA 1.496 1.85 0 O-C-N 124.396 1.06 . . . . 0.0 111.573 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -83.39 41.31 1.05 Allowed 'Trans proline' 0 N--CA 1.494 1.558 0 C-N-CA 123.365 2.71 . . . . 0.0 110.236 166.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.18 175.76 5.76 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-N 114.622 -1.172 . . . . 0.0 112.154 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -103.63 126.95 51.1 Favored 'General case' 0 N--CA 1.495 1.823 0 CA-C-N 114.826 -1.079 . . . . 0.0 109.359 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 42.6 m -79.94 163.74 56.44 Favored Pre-proline 0 N--CA 1.496 1.825 0 O-C-N 123.887 0.742 . . . . 0.0 111.732 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.43 ' C ' ' HE ' ' A' ' 97' ' ' ARG . 13.1 Cg_endo -68.66 155.39 69.01 Favored 'Trans proline' 0 N--CA 1.49 1.285 0 C-N-CA 122.511 2.14 . . . . 0.0 110.196 170.201 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.43 ' HE ' ' C ' ' A' ' 96' ' ' PRO . 0.0 OUTLIER -83.23 16.43 2.46 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-N 114.699 -1.137 . . . . 0.0 111.083 -179.919 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -48.0 131.28 15.63 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 123.89 0.743 . . . . 0.0 109.759 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . 0.407 ' HA ' ' HA ' ' A' ' 62' ' ' CYS . 60.1 m -99.64 132.46 44.97 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 114.005 1.113 . . . . 0.0 114.005 -179.599 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 64.7 t0 -129.49 76.3 78.86 Favored Pre-proline 0 N--CA 1.5 2.058 0 O-C-N 124.231 0.957 . . . . 0.0 110.845 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -59.85 -13.78 24.16 Favored 'Trans proline' 0 N--CA 1.494 1.54 0 C-N-CA 122.501 2.134 . . . . 0.0 112.222 176.234 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 69.5 mtp85 -90.31 18.45 6.07 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 124.011 0.819 . . . . 0.0 111.779 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 9.9 tt -116.34 175.7 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.314 0 O-C-N 123.71 0.631 . . . . 0.0 110.497 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.473 ' HB2' ' H ' ' A' ' 77' ' ' ASP . . . -146.01 -62.64 0.32 Allowed 'General case' 0 N--CA 1.498 1.928 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.863 179.683 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 27.9 p90 -161.22 163.93 30.74 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 124.053 0.846 . . . . 0.0 110.978 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -98.27 112.86 4.57 Favored Glycine 0 N--CA 1.492 2.375 0 CA-C-N 113.688 -1.596 . . . . 0.0 111.979 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 93.8 mt -79.54 105.65 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 N-CA-C 106.5 -1.667 . . . . 0.0 106.5 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 31.2 m -89.07 140.9 29.05 Favored Pre-proline 0 N--CA 1.491 1.599 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo . . . . . 0 N--CA 1.493 1.481 0 C-N-CA 122.41 2.073 . . . . 0.0 109.085 -176.048 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 62.1 ttm-85 . . . . . 0 N--CA 1.502 2.158 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 4.9 tp -62.35 94.77 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 CA-C-N 114.398 -1.274 . . . . 0.0 109.461 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.7 m -89.73 36.77 0.86 Allowed 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 116.881 2.178 . . . . 0.0 116.881 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 14.6 p -91.68 166.37 12.83 Favored 'General case' 0 N--CA 1.496 1.849 0 CA-C-N 113.518 -1.674 . . . . 0.0 108.901 179.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 14.0 p30 -161.42 142.65 11.36 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-N 114.861 -1.063 . . . . 0.0 111.791 179.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -61.69 -18.76 60.89 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-N 114.436 -1.256 . . . . 0.0 112.843 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 46.8 t -89.46 -69.54 0.71 Allowed 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 113.464 0.913 . . . . 0.0 113.464 -179.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.41 ' N ' ' SG ' ' A' ' 37' ' ' CYS . . . -75.45 1.19 14.67 Favored 'General case' 0 N--CA 1.5 2.043 0 N-CA-C 113.547 0.943 . . . . 0.0 113.547 -179.617 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -67.44 165.5 43.54 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 110.426 -1.07 . . . . 0.0 110.426 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.448 ' H ' ' HH ' ' A' ' 16' ' ' TYR . 8.9 t -73.12 125.13 26.97 Favored 'General case' 0 N--CA 1.493 1.711 0 CA-C-O 121.508 0.671 . . . . 0.0 110.204 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 7.1 ttpm? -72.2 87.75 1.11 Allowed 'General case' 0 N--CA 1.49 1.551 0 CA-C-N 114.239 -1.346 . . . . 0.0 108.719 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 171.1 -34.36 0.16 Allowed Glycine 0 N--CA 1.488 2.134 0 CA-C-N 113.282 -1.781 . . . . 0.0 108.882 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 83.9 m -101.55 133.61 45.96 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.469 ' HB3' ' CE1' ' A' ' 23' ' ' PHE . 9.0 mtpm? -81.92 88.96 6.34 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 113.428 -1.714 . . . . 0.0 113.732 -179.278 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.448 ' HH ' ' H ' ' A' ' 11' ' ' THR . 83.8 m-85 -54.48 126.22 22.66 Favored 'General case' 0 N--CA 1.499 2.018 0 N-CA-C 105.911 -1.885 . . . . 0.0 105.911 179.64 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -132.28 146.45 52.0 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 112.788 -2.005 . . . . 0.0 112.969 -179.188 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 40.2 t -84.5 139.81 31.9 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-N 112.563 -2.108 . . . . 0.0 114.866 -179.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -51.91 -32.14 31.45 Favored 'General case' 0 N--CA 1.499 1.981 0 CA-C-N 111.826 -2.443 . . . . 0.0 114.854 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -54.29 -21.67 9.87 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 123.981 0.8 . . . . 0.0 111.62 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 109.16 32.41 3.03 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 108.646 -1.782 . . . . 0.0 108.646 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 90.7 m -137.26 147.38 45.68 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 124.08 0.518 . . . . 0.0 110.961 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.469 ' CE1' ' HB3' ' A' ' 15' ' ' LYS . 8.6 t80 -80.43 140.93 35.74 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-N 114.637 -1.165 . . . . 0.0 110.216 179.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 98.0 t -100.42 -78.26 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 106.22 -1.77 . . . . 0.0 106.22 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -172.12 168.07 5.86 Favored 'General case' 0 N--CA 1.504 2.226 0 O-C-N 123.579 0.549 . . . . 0.0 110.404 179.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -87.59 155.38 19.99 Favored 'General case' 0 N--CA 1.501 2.114 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -48.22 131.71 19.65 Favored Glycine 0 N--CA 1.501 2.994 0 C-N-CA 120.026 -1.083 . . . . 0.0 111.48 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -101.91 33.21 3.11 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 37.1 t -149.58 137.4 20.29 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-N 114.502 -1.226 . . . . 0.0 107.922 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -79.59 134.1 58.35 Favored Pre-proline 0 N--CA 1.494 1.754 0 O-C-N 123.987 0.804 . . . . 0.0 109.007 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -57.0 -13.76 12.64 Favored 'Trans proline' 0 N--CA 1.497 1.7 0 C-N-CA 122.423 2.082 . . . . 0.0 112.789 -177.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 79.8 ttt180 -68.59 -43.04 77.34 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 123.658 0.599 . . . . 0.0 111.878 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -73.64 128.59 86.75 Favored Pre-proline 0 N--CA 1.495 1.792 0 C-N-CA 119.523 -0.871 . . . . 0.0 112.285 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -82.61 85.2 1.65 Allowed 'Trans proline' 0 N--CA 1.492 1.406 0 C-N-CA 123.509 2.806 . . . . 0.0 111.486 169.223 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 20.7 pttp -164.11 166.39 21.32 Favored 'General case' 0 N--CA 1.501 2.101 0 C-N-CA 120.621 -0.432 . . . . 0.0 111.829 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -129.14 158.79 38.0 Favored 'General case' 0 N--CA 1.497 1.883 0 CA-C-N 114.592 -1.186 . . . . 0.0 110.144 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.41 ' SG ' ' N ' ' A' ' 9' ' ' ALA . 85.2 m -88.55 -178.68 5.89 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-N 114.865 -1.061 . . . . 0.0 110.744 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 63.7 p -81.01 -2.16 46.84 Favored 'General case' 0 N--CA 1.497 1.91 0 CA-C-N 114.925 -1.034 . . . . 0.0 110.669 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -79.41 -57.45 3.7 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 33.6 m120 53.52 103.0 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.982 0 O-C-N 124.83 1.331 . . . . 0.0 112.808 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 60.9 m 63.98 135.12 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.937 0 CA-C-N 114.602 -1.181 . . . . 0.0 112.963 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 46.3 t0 -135.81 102.03 10.42 Favored Pre-proline 0 N--CA 1.498 1.951 0 C-N-CA 120.305 -0.558 . . . . 0.0 111.674 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -57.22 -29.39 83.47 Favored 'Trans proline' 0 N--CA 1.494 1.543 0 C-N-CA 122.758 2.305 . . . . 0.0 111.467 174.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -62.75 -39.44 94.12 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 123.997 0.811 . . . . 0.0 109.309 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.426 ' CG2' ' N ' ' A' ' 46' ' ' ALA . 20.3 mt -76.97 161.8 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 CA-C-O 121.927 0.87 . . . . 0.0 109.505 179.776 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.426 ' N ' ' CG2' ' A' ' 45' ' ' ILE . . . -122.65 -54.21 1.86 Allowed 'General case' 0 N--CA 1.494 1.756 0 CA-C-N 112.423 -2.171 . . . . 0.0 109.054 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 14.4 p90 -171.15 159.32 5.88 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-N 114.727 -1.124 . . . . 0.0 111.523 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -92.31 111.55 4.07 Favored Glycine 0 N--CA 1.493 2.484 0 CA-C-N 113.523 -1.671 . . . . 0.0 111.073 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 33.0 m -79.95 98.1 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 N-CA-C 105.068 -2.197 . . . . 0.0 105.068 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 8.0 m -79.63 121.25 82.32 Favored Pre-proline 0 N--CA 1.492 1.633 0 CA-C-N 113.496 -1.684 . . . . 0.0 108.019 -179.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo . . . . . 0 N--CA 1.495 1.602 0 C-N-CA 122.806 2.337 . . . . 0.0 113.173 -165.14 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 56.2 m . . . . . 0 N--CA 1.489 1.484 0 CA-C-O 123.297 1.522 . . . . 0.0 112.593 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 61.3 m -90.7 133.29 35.26 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 111.466 -2.606 . . . . 0.0 104.307 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 34.6 p-10 -153.82 154.45 33.98 Favored 'General case' 0 N--CA 1.503 2.194 0 N-CA-C 113.855 1.058 . . . . 0.0 113.855 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -67.18 -22.92 65.72 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-N 113.74 -1.573 . . . . 0.0 114.513 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 51.4 t -89.81 -68.71 0.76 Allowed 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 113.381 0.882 . . . . 0.0 113.381 -179.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -71.47 -2.05 15.36 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 123.812 0.695 . . . . 0.0 111.833 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -65.88 166.95 35.27 Favored Glycine 0 N--CA 1.491 2.307 0 O-C-N 123.829 0.706 . . . . 0.0 111.621 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 6.8 t -77.47 129.27 35.51 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 124.245 0.615 . . . . 0.0 111.954 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -71.64 81.6 0.84 Allowed 'General case' 0 N--CA 1.494 1.756 0 CA-C-N 114.378 -1.283 . . . . 0.0 110.899 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 174.66 -36.14 0.11 Allowed Glycine 0 N--CA 1.488 2.154 0 CA-C-N 113.11 -1.859 . . . . 0.0 108.728 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 46.3 m -94.86 129.55 41.81 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 13.3 mmmm -75.47 84.96 2.57 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 112.912 -1.949 . . . . 0.0 111.279 -179.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.407 ' HA ' ' HA2' ' A' ' 106' ' ' GLY . 42.8 m-85 -50.61 121.7 6.16 Favored 'General case' 0 N--CA 1.503 2.215 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 179.673 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -129.88 150.64 51.09 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 111.896 -2.411 . . . . 0.0 113.417 -179.182 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 33.1 t -90.33 136.59 32.96 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-N 112.65 -2.068 . . . . 0.0 114.103 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -51.32 -28.15 11.45 Favored 'General case' 0 N--CA 1.5 2.044 0 CA-C-N 112.386 -2.188 . . . . 0.0 114.705 179.833 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -54.16 -22.47 11.32 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 123.93 0.769 . . . . 0.0 111.466 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 110.66 29.74 3.51 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 108.637 -1.785 . . . . 0.0 108.637 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 85.4 m -139.7 146.49 39.69 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 123.985 0.462 . . . . 0.0 111.102 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 21.5 t80 -76.06 154.0 35.98 Favored 'General case' 0 N--CA 1.493 1.725 0 CA-C-N 114.352 -1.295 . . . . 0.0 110.438 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 57.9 t -117.11 -79.68 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -162.69 179.65 7.53 Favored 'General case' 0 N--CA 1.505 2.286 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 179.726 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -97.69 159.37 14.97 Favored 'General case' 0 N--CA 1.507 2.392 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 179.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -53.15 132.32 41.82 Favored Glycine 0 N--CA 1.5 2.944 0 C-N-CA 119.42 -1.372 . . . . 0.0 110.306 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -101.92 33.02 3.18 Favored 'General case' 0 N--CA 1.499 2.0 0 CA-C-O 122.143 0.973 . . . . 0.0 108.391 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 41.2 t -157.6 152.8 25.89 Favored 'General case' 0 N--CA 1.495 1.801 0 CA-C-N 114.533 -1.212 . . . . 0.0 109.345 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -97.14 138.05 21.24 Favored Pre-proline 0 N--CA 1.494 1.74 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -64.48 86.59 0.16 Allowed 'Trans proline' 0 N--CA 1.494 1.53 0 C-N-CA 122.131 1.887 . . . . 0.0 108.178 173.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 3.5 mtp-105 178.25 -31.31 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.011 0 CA-C-N 114.031 -1.44 . . . . 0.0 109.352 -179.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 9.0 p-10 -53.02 125.93 41.99 Favored Pre-proline 0 N--CA 1.497 1.923 0 O-C-N 124.04 0.838 . . . . 0.0 112.919 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -82.73 48.0 2.63 Favored 'Trans proline' 0 N--CA 1.49 1.301 0 C-N-CA 122.916 2.411 . . . . 0.0 108.684 160.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 45.8 mmtm -126.13 169.57 12.67 Favored 'General case' 0 N--CA 1.498 1.965 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.462 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -145.58 135.86 23.95 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-N 114.707 -1.133 . . . . 0.0 109.529 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 86.9 m -79.96 157.76 73.43 Favored Pre-proline 0 N--CA 1.495 1.809 0 CA-C-N 115.076 -0.965 . . . . 0.0 111.696 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -69.28 -5.61 16.32 Favored 'Trans proline' 0 N--CA 1.496 1.639 0 C-N-CA 122.841 2.361 . . . . 0.0 110.369 160.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 17.5 tpp85 -79.31 -50.13 11.37 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 43.3 m-80 54.05 -159.67 0.16 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 124.797 1.311 . . . . 0.0 110.401 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 64.6 m -51.61 120.01 4.75 Favored 'General case' 0 N--CA 1.497 1.913 0 CA-C-N 115.208 -0.905 . . . . 0.0 108.773 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -107.64 99.31 28.48 Favored Pre-proline 0 N--CA 1.499 2.01 0 O-C-N 123.684 0.615 . . . . 0.0 111.293 -179.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -64.18 -27.82 64.66 Favored 'Trans proline' 0 N--CA 1.494 1.555 0 C-N-CA 122.634 2.223 . . . . 0.0 111.328 -176.137 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 25.8 mtm105 -60.01 -39.85 87.22 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 18.0 mt -76.0 160.98 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 CA-C-N 113.927 -1.488 . . . . 0.0 111.121 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -123.79 -61.77 1.35 Allowed 'General case' 0 N--CA 1.491 1.612 0 CA-C-N 112.176 -2.284 . . . . 0.0 109.72 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 20.0 p90 -160.49 157.23 27.19 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-N 114.806 -1.088 . . . . 0.0 111.941 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.407 ' HA2' ' HA ' ' A' ' 74' ' ' TYR . . . -94.96 109.79 3.9 Favored Glycine 0 N--CA 1.488 2.162 0 CA-C-N 112.864 -1.971 . . . . 0.0 111.406 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 65.0 mt -79.17 95.73 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 CA-C-N 114.577 -0.811 . . . . 0.0 110.913 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 1.5 m -79.09 143.32 60.93 Favored Pre-proline 0 N--CA 1.503 2.203 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 179.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo . . . . . 0 N--CA 1.494 1.53 0 C-N-CA 122.613 2.208 . . . . 0.0 111.555 -179.559 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 74.4 ttt-85 . . . . . 0 N--CA 1.495 1.796 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.412 ' O ' ' HA ' ' A' ' 41' ' ' CYS . 9.1 tp -85.89 53.13 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 123.213 0.321 . . . . 0.0 110.647 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.572 ' HA ' ' CA ' ' A' ' 41' ' ' CYS . 1.6 m -79.31 39.08 0.38 Allowed 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 117.279 2.325 . . . . 0.0 117.279 -179.858 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.1 p -91.23 151.05 21.08 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 112.176 -2.284 . . . . 0.0 106.357 179.197 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 45.4 p-10 -160.71 173.86 14.81 Favored 'General case' 0 N--CA 1.494 1.774 0 CA-C-N 113.453 -1.703 . . . . 0.0 109.644 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 4.2 t -72.01 -24.89 61.63 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-N 114.698 -1.137 . . . . 0.0 112.863 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 40.4 t -89.25 -69.54 0.71 Allowed 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 113.68 0.993 . . . . 0.0 113.68 -179.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -81.78 36.83 0.45 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 124.531 1.144 . . . . 0.0 112.543 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -82.0 -119.51 0.54 Allowed Glycine 0 N--CA 1.493 2.473 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 37.0 p -155.74 123.86 5.78 Favored 'General case' 0 N--CA 1.5 2.035 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.67 144.58 42.87 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-N 115.034 -0.985 . . . . 0.0 110.928 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 91.5 -18.18 53.35 Favored Glycine 0 N--CA 1.492 2.43 0 CA-C-N 114.486 -1.234 . . . . 0.0 110.959 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 91.4 m -99.54 171.65 7.8 Favored 'General case' 0 N--CA 1.498 1.935 0 C-N-CA 120.118 -0.633 . . . . 0.0 110.707 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 60.8 mttp -129.79 90.1 2.92 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-N 115.066 -0.97 . . . . 0.0 109.667 -179.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 40.8 m-85 -54.79 133.8 47.59 Favored 'General case' 0 N--CA 1.495 1.777 0 CA-C-N 114.133 -1.394 . . . . 0.0 109.384 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -137.73 157.22 46.93 Favored 'General case' 0 N--CA 1.487 1.415 0 CA-C-N 112.934 -1.939 . . . . 0.0 113.682 -179.22 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 30.9 t -103.82 134.43 47.14 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-N 112.685 -2.052 . . . . 0.0 113.211 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -50.05 -27.16 5.15 Favored 'General case' 0 N--CA 1.503 2.219 0 N-CA-C 115.541 1.682 . . . . 0.0 115.541 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -55.67 -16.66 4.45 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 123.836 0.71 . . . . 0.0 111.749 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 104.26 29.42 5.43 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 108.442 -1.863 . . . . 0.0 108.442 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 59.9 m -137.2 144.39 42.84 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 124.088 0.522 . . . . 0.0 110.579 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 21.7 t80 -77.08 145.36 37.91 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-N 114.266 -1.334 . . . . 0.0 109.59 179.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 91.4 t -100.17 -76.39 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.441 ' SG ' ' O ' ' A' ' 26' ' ' GLU . 0.1 OUTLIER -171.06 179.76 2.97 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 123.399 0.437 . . . . 0.0 110.889 179.823 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.441 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 35.6 tt0 -81.76 149.64 28.32 Favored 'General case' 0 N--CA 1.501 2.11 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.318 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -70.58 118.4 7.72 Favored Glycine 0 N--CA 1.497 2.763 0 N-CA-C 106.643 -2.583 . . . . 0.0 106.643 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -96.87 26.64 4.46 Favored 'General case' 0 N--CA 1.501 2.086 0 CA-C-O 121.481 0.658 . . . . 0.0 111.317 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 45.7 t -106.15 120.51 42.0 Favored 'General case' 0 N--CA 1.495 1.776 0 CA-C-N 114.349 -1.296 . . . . 0.0 109.993 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.418 ' H ' HD22 ' A' ' 33' ' ' ASN . 12.5 t70 -132.27 140.98 39.67 Favored Pre-proline 0 N--CA 1.494 1.75 0 N-CA-C 106.543 -1.651 . . . . 0.0 106.543 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -67.12 79.51 0.4 Allowed 'Trans proline' 0 N--CA 1.494 1.525 0 C-N-CA 122.584 2.19 . . . . 0.0 110.238 175.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 5.2 mmt-85 178.21 -46.13 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.77 0 CA-C-N 113.59 -1.641 . . . . 0.0 108.008 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.418 HD22 ' H ' ' A' ' 30' ' ' ASP . 28.5 p30 -83.02 149.28 58.79 Favored Pre-proline 0 N--CA 1.495 1.776 0 O-C-N 124.043 0.84 . . . . 0.0 111.755 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_endo -76.77 119.2 5.06 Favored 'Trans proline' 0 N--CA 1.491 1.333 0 C-N-CA 122.875 2.383 . . . . 0.0 108.696 165.078 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 41.3 mtmt -72.37 117.73 14.39 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -160.68 101.13 1.31 Allowed 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 113.997 1.11 . . . . 0.0 113.997 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 1.6 m -160.42 -53.05 0.05 Allowed 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 105.193 -2.151 . . . . 0.0 105.193 179.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 95.2 m -121.59 160.5 24.21 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-N 112.808 -1.996 . . . . 0.0 108.844 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -93.21 26.65 2.8 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-N 114.663 -1.153 . . . . 0.0 110.896 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 4.0 m120 60.54 -177.83 0.1 Allowed 'General case' 0 N--CA 1.501 2.095 0 CA-C-N 114.257 -1.338 . . . . 0.0 113.192 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.572 ' CA ' ' HA ' ' A' ' 4' ' ' CYS . 1.7 m 52.27 79.73 0.1 Allowed 'General case' 0 N--CA 1.495 1.803 0 CA-C-O 123.723 1.725 . . . . 0.0 112.674 -179.704 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -91.78 110.13 41.52 Favored Pre-proline 0 N--CA 1.484 1.273 0 CA-C-N 110.091 -3.231 . . . . 0.0 106.844 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_endo -63.92 -19.53 66.81 Favored 'Trans proline' 0 N--CA 1.495 1.614 0 C-N-CA 121.791 1.661 . . . . 0.0 112.365 -170.358 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.456 ' N ' ' HD2' ' A' ' 44' ' ' ARG . 2.1 mpt_? -90.56 -26.89 19.48 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 112.918 0.711 . . . . 0.0 112.918 -179.764 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 6.3 tt -64.56 169.05 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 123.558 0.536 . . . . 0.0 111.939 -179.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.86 -59.12 0.51 Allowed 'General case' 0 N--CA 1.494 1.751 0 CA-C-N 114.806 -1.088 . . . . 0.0 110.044 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 41.4 p90 -165.52 165.52 18.94 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-N 114.659 -1.155 . . . . 0.0 109.416 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -117.18 121.08 5.02 Favored Glycine 0 N--CA 1.491 2.315 0 O-C-N 125.386 1.678 . . . . 0.0 110.878 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 8.4 p -79.29 133.71 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 N-CA-C 106.114 -1.81 . . . . 0.0 106.114 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 7.8 m -114.97 76.24 4.29 Favored Pre-proline 0 N--CA 1.499 1.987 0 O-C-N 123.742 0.651 . . . . 0.0 110.441 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo . . . . . 0 N--CA 1.493 1.447 0 C-N-CA 122.952 2.435 . . . . 0.0 110.704 -176.659 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 1.7 m . . . . . 0 N--CA 1.495 1.778 0 N-CA-C 113.993 1.109 . . . . 0.0 113.993 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.414 ' HG1' ' H ' ' A' ' 64' ' ' ASN . 12.6 t -90.72 -174.93 4.24 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-N 113.379 -1.737 . . . . 0.0 108.195 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.414 ' H ' ' HG1' ' A' ' 63' ' ' THR . 0.7 OUTLIER -157.03 155.04 30.53 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 106.388 -1.708 . . . . 0.0 106.388 179.65 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 27.6 t -54.82 -26.87 37.8 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 114.343 1.238 . . . . 0.0 114.343 -179.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 44.2 t -76.41 -48.47 19.65 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-N 114.386 -1.279 . . . . 0.0 111.391 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -79.49 57.19 2.34 Favored 'General case' 0 N--CA 1.497 1.895 0 CA-C-N 113.348 -1.751 . . . . 0.0 112.829 -179.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -147.46 152.59 24.7 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 6.8 t -65.56 128.4 35.76 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-N 113.255 -1.472 . . . . 0.0 109.565 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -73.53 88.1 1.63 Allowed 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 106.22 -1.77 . . . . 0.0 106.22 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 168.98 -25.46 0.11 Allowed Glycine 0 N--CA 1.488 2.132 0 CA-C-N 112.673 -2.058 . . . . 0.0 110.07 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 56.2 m -100.4 124.08 45.44 Favored 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 122.094 0.95 . . . . 0.0 111.541 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 28.1 mtpp -73.49 93.59 2.01 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 112.681 -2.054 . . . . 0.0 112.157 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.456 ' CD1' HD13 ' A' ' 103' ' ' ILE . 8.3 m-85 -48.83 128.25 15.31 Favored 'General case' 0 N--CA 1.501 2.118 0 N-CA-C 106.704 -1.591 . . . . 0.0 106.704 179.413 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -142.87 155.24 44.73 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 114.706 -1.134 . . . . 0.0 112.348 -179.467 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 40.2 t -101.52 133.83 45.57 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-N 113.231 -1.804 . . . . 0.0 110.939 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -48.87 -28.74 3.98 Favored 'General case' 0 N--CA 1.502 2.132 0 N-CA-C 115.834 1.79 . . . . 0.0 115.834 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -52.0 -24.25 6.32 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 123.946 0.779 . . . . 0.0 111.738 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 113.63 28.27 3.28 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 108.616 -1.794 . . . . 0.0 108.616 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 88.6 m -139.17 140.6 37.88 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 124.045 0.497 . . . . 0.0 110.981 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 12.5 t80 -68.57 159.08 32.59 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-N 114.198 -1.365 . . . . 0.0 110.804 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 91.3 t -121.42 -71.4 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 CA-C-N 114.823 -1.081 . . . . 0.0 110.104 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . 0.576 ' SG ' ' N ' ' A' ' 84' ' ' GLU . 0.5 OUTLIER -153.48 -163.02 1.57 Allowed 'General case' 0 N--CA 1.501 2.105 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 -179.875 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.576 ' N ' ' SG ' ' A' ' 83' ' ' CYS . 12.5 tp10 -129.03 146.62 50.95 Favored 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 179.433 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -59.01 138.65 49.45 Favored Glycine 0 N--CA 1.501 2.991 0 N-CA-C 109.257 -1.537 . . . . 0.0 109.257 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 35.8 mm-40 -113.89 31.76 6.32 Favored 'General case' 0 N--CA 1.501 2.098 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 36.8 t -156.0 105.42 2.35 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -79.26 144.73 62.95 Favored Pre-proline 0 N--CA 1.495 1.796 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -64.76 70.97 0.24 Allowed 'Trans proline' 0 N--CA 1.498 1.744 0 C-N-CA 123.088 2.525 . . . . 0.0 110.861 164.127 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 31.4 mtm105 -163.6 -49.95 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 104.868 -2.271 . . . . 0.0 104.868 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -90.41 133.23 33.43 Favored Pre-proline 0 N--CA 1.489 1.487 0 CA-C-N 114.053 -1.43 . . . . 0.0 110.356 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -79.9 50.26 3.47 Favored 'Trans proline' 0 N--CA 1.495 1.598 0 C-N-CA 123.521 2.814 . . . . 0.0 112.1 173.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -80.47 124.8 29.23 Favored 'General case' 0 N--CA 1.5 2.047 0 C-N-CA 120.126 -0.63 . . . . 0.0 111.076 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -80.1 166.13 21.81 Favored 'General case' 0 N--CA 1.497 1.878 0 CA-C-N 114.679 -1.146 . . . . 0.0 109.525 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 97.0 m -151.44 160.55 31.64 Favored Pre-proline 0 N--CA 1.497 1.906 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -60.33 130.17 32.84 Favored 'Trans proline' 0 N--CA 1.493 1.47 0 C-N-CA 122.709 2.273 . . . . 0.0 109.401 166.128 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.465 ' HA ' ' NE ' ' A' ' 97' ' ' ARG . 3.4 tpm_? -81.27 10.28 5.77 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 123.991 0.807 . . . . 0.0 110.203 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.516 ' H ' HD21 ' A' ' 98' ' ' ASN . 2.7 m-80 -52.47 153.83 2.83 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 114.105 1.15 . . . . 0.0 114.105 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 63.0 m -91.93 137.56 32.26 Favored 'General case' 0 N--CA 1.495 1.776 0 CA-C-N 113.897 -1.501 . . . . 0.0 111.402 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -119.98 88.36 40.43 Favored Pre-proline 0 N--CA 1.497 1.917 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 179.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -63.98 -33.35 63.27 Favored 'Trans proline' 0 N--CA 1.491 1.327 0 C-N-CA 122.683 2.255 . . . . 0.0 112.545 -170.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 15.9 ptm180 -64.98 -30.18 71.15 Favored 'General case' 0 N--CA 1.497 1.895 0 C-N-CA 119.574 -0.85 . . . . 0.0 111.965 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.456 HD13 ' CD1' ' A' ' 74' ' ' TYR . 11.9 mt -70.38 156.04 7.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 C-N-CA 118.907 -1.117 . . . . 0.0 109.66 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -137.94 -40.44 0.54 Allowed 'General case' 0 N--CA 1.491 1.58 0 CA-C-N 112.617 -2.083 . . . . 0.0 110.132 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 46.1 m-85 -143.0 -165.28 2.03 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 124.333 1.02 . . . . 0.0 110.635 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -154.97 94.07 0.14 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 103.907 -3.677 . . . . 0.0 103.907 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 37.7 mm -79.16 96.28 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 N-CA-C 116.066 1.876 . . . . 0.0 116.066 -179.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 1.7 m -79.96 150.94 72.78 Favored Pre-proline 0 N--CA 1.5 2.052 0 N-CA-C 105.861 -1.903 . . . . 0.0 105.861 179.238 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo . . . . . 0 N--CA 1.497 1.682 0 C-N-CA 123.115 2.543 . . . . 0.0 112.394 -172.313 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 47.8 tpt85 . . . . . 0 N--CA 1.494 1.763 0 CA-C-O 120.905 0.383 . . . . 0.0 110.37 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 7.6 tp -84.5 49.21 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 CA-C-N 114.634 -1.166 . . . . 0.0 110.077 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.6 m -82.38 59.76 4.73 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 115.24 1.57 . . . . 0.0 115.24 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 38.6 m -91.03 163.43 14.31 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 105.092 -2.188 . . . . 0.0 105.092 179.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.414 ' ND2' ' H ' ' A' ' 9' ' ' ALA . 40.8 p-10 -158.5 175.66 13.4 Favored 'General case' 0 N--CA 1.499 2.023 0 C-N-CA 118.895 -1.122 . . . . 0.0 113.057 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 45.3 t -78.44 -32.47 48.54 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-N 113.198 -1.819 . . . . 0.0 113.704 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 38.3 t -77.01 -62.86 1.51 Allowed 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 113.892 1.071 . . . . 0.0 113.892 -179.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.414 ' H ' ' ND2' ' A' ' 6' ' ' ASN . . . -84.81 63.97 8.33 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 124.743 1.277 . . . . 0.0 111.376 -179.702 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -137.54 -169.61 11.67 Favored Glycine 0 N--CA 1.498 2.823 0 CA-C-N 113.559 -1.655 . . . . 0.0 111.518 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.414 ' N ' ' OH ' ' A' ' 16' ' ' TYR . 4.5 t -102.62 111.62 24.02 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 114.191 1.182 . . . . 0.0 114.191 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 21.8 pttp -64.87 81.7 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.958 0 CA-C-N 113.608 -1.633 . . . . 0.0 110.789 179.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -175.18 -31.57 0.04 OUTLIER Glycine 0 N--CA 1.486 2.028 0 CA-C-N 113.057 -1.883 . . . . 0.0 109.629 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.435 ' HA ' ' HA ' ' A' ' 50' ' ' CYS . 21.9 m -104.64 148.19 26.81 Favored 'General case' 0 N--CA 1.501 2.085 0 C-N-CA 118.775 -1.17 . . . . 0.0 112.964 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -92.95 88.3 6.1 Favored 'General case' 0 N--CA 1.484 1.23 0 CA-C-N 113.307 -1.77 . . . . 0.0 107.428 -179.397 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.414 ' OH ' ' N ' ' A' ' 11' ' ' THR . 11.0 m-30 -46.4 134.95 8.64 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-N 113.59 -1.641 . . . . 0.0 108.494 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 10.8 t80 -145.16 156.16 43.71 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-N 113.232 -1.804 . . . . 0.0 111.511 -179.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 28.8 t -112.53 136.11 52.45 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-N 111.838 -2.437 . . . . 0.0 115.313 -179.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.427 ' C ' ' H ' ' A' ' 21' ' ' GLY . 1.0 OUTLIER -52.14 -21.47 3.32 Favored 'General case' 0 N--CA 1.499 1.989 0 CA-C-N 112.266 -2.243 . . . . 0.0 113.715 179.796 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 43.6 p30 -64.19 -1.86 1.81 Allowed 'General case' 0 N--CA 1.497 1.917 0 O-C-N 124.04 0.838 . . . . 0.0 111.231 179.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.427 ' H ' ' C ' ' A' ' 19' ' ' ASP . . . 85.74 29.15 27.29 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 108.94 -1.664 . . . . 0.0 108.94 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 95.5 m -141.21 150.47 42.73 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 121.831 0.824 . . . . 0.0 110.557 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 24.2 t80 -73.52 155.65 38.97 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-N 113.144 -1.844 . . . . 0.0 111.979 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 90.9 t -115.27 -77.0 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 CA-C-N 114.673 -1.149 . . . . 0.0 109.056 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.654 ' SG ' ' N ' ' A' ' 26' ' ' GLU . 0.1 OUTLIER -166.97 -168.61 1.13 Allowed 'General case' 0 N--CA 1.507 2.393 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 179.979 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.654 ' N ' ' SG ' ' A' ' 25' ' ' CYS . 3.5 tm-20 -128.36 140.96 51.58 Favored 'General case' 0 N--CA 1.5 2.046 0 N-CA-C 104.52 -2.4 . . . . 0.0 104.52 179.496 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -39.27 117.82 0.78 Allowed Glycine 0 N--CA 1.5 2.928 0 CA-C-O 122.041 0.8 . . . . 0.0 114.869 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -92.87 0.66 57.45 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-N 113.072 -1.564 . . . . 0.0 112.061 -179.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 27.5 t -156.22 170.3 22.56 Favored 'General case' 0 N--CA 1.501 2.103 0 C-N-CA 119.609 -0.837 . . . . 0.0 111.467 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -79.29 143.84 61.12 Favored Pre-proline 0 N--CA 1.493 1.694 0 CA-C-N 114.626 -1.17 . . . . 0.0 107.883 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -70.37 67.67 2.08 Favored 'Trans proline' 0 N--CA 1.5 1.9 0 C-N-CA 123.158 2.572 . . . . 0.0 111.073 172.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 67.0 mtp85 -160.33 -39.44 0.05 Allowed 'General case' 0 N--CA 1.496 1.855 0 CA-C-N 113.246 -1.797 . . . . 0.0 107.764 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.5 ' N ' HD21 ' A' ' 33' ' ' ASN . 0.0 OUTLIER -39.71 102.98 0.27 Allowed Pre-proline 0 N--CA 1.498 1.945 0 O-C-N 124.876 1.36 . . . . 0.0 114.416 -179.877 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -76.4 179.57 6.26 Favored 'Trans proline' 0 N--CA 1.494 1.54 0 C-N-CA 122.821 2.348 . . . . 0.0 111.029 -179.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 25.7 ttpp 62.9 155.25 0.05 OUTLIER 'General case' 0 N--CA 1.5 2.071 0 O-C-N 124.673 1.233 . . . . 0.0 112.618 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -79.87 147.33 31.76 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-N 114.639 -1.164 . . . . 0.0 110.124 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.493 ' H ' HD22 ' A' ' 40' ' ' ASN . 98.4 m -79.66 -87.91 0.07 Allowed 'General case' 0 N--CA 1.492 1.663 0 CA-C-N 114.66 -1.154 . . . . 0.0 110.593 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 7.9 t -168.9 -15.53 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.019 0 O-C-N 123.616 0.573 . . . . 0.0 110.732 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -153.44 64.92 0.75 Allowed 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 103.837 -2.653 . . . . 0.0 103.837 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.493 HD22 ' H ' ' A' ' 37' ' ' CYS . 13.4 m120 -84.15 47.59 1.35 Allowed 'General case' 0 N--CA 1.491 1.602 0 CA-C-N 112.702 -2.045 . . . . 0.0 112.959 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 75.3 m -158.04 126.31 5.42 Favored 'General case' 0 N--CA 1.498 1.93 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.781 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -147.83 81.36 8.43 Favored Pre-proline 0 N--CA 1.496 1.852 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.313 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -60.82 -31.11 91.39 Favored 'Trans proline' 0 N--CA 1.493 1.496 0 C-N-CA 122.744 2.296 . . . . 0.0 114.391 -173.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 7.3 ptm180 -58.59 -30.73 67.43 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 123.813 0.696 . . . . 0.0 111.955 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 13.9 tt -47.33 156.79 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 O-C-N 124.226 0.954 . . . . 0.0 113.279 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -137.85 -50.76 0.6 Allowed 'General case' 0 N--CA 1.492 1.636 0 CA-C-N 113.967 -1.469 . . . . 0.0 107.102 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 46.9 p90 -168.32 167.14 12.22 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-N 113.883 -1.508 . . . . 0.0 109.485 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -118.49 108.69 1.64 Allowed Glycine 0 N--CA 1.491 2.316 0 N-CA-C 107.861 -2.096 . . . . 0.0 107.861 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 5.6 p -80.15 111.42 16.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 C-N-CA 118.895 -1.122 . . . . 0.0 110.233 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.435 ' HA ' ' HA ' ' A' ' 14' ' ' CYS . 1.7 m -78.57 110.15 13.02 Favored Pre-proline 0 N--CA 1.499 2.014 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.484 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo . . . . . 0 N--CA 1.49 1.307 0 C-N-CA 122.816 2.344 . . . . 0.0 108.415 -175.553 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 1.7 m . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 122.814 1.292 . . . . 0.0 114.222 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.6 p -91.25 159.09 16.22 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-N 112.889 -1.96 . . . . 0.0 109.573 179.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.599 HD22 ' H ' ' A' ' 99' ' ' CYS . 64.1 m-20 -152.94 157.02 40.0 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 125.018 1.448 . . . . 0.0 111.259 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' CYS . . . . . 0.441 ' HA ' ' CE2' ' A' ' 74' ' ' TYR . 3.6 t -62.1 -38.37 88.63 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-N 114.541 -1.209 . . . . 0.0 108.427 179.65 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 43.0 t -66.99 -50.85 60.97 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 112.363 -2.199 . . . . 0.0 110.634 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -79.36 -114.2 0.02 OUTLIER 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 113.924 -1.489 . . . . 0.0 110.701 -179.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 46.16 -129.89 10.62 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 111.044 -0.822 . . . . 0.0 111.044 -179.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 40.7 p -150.94 135.19 16.88 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 123.879 0.399 . . . . 0.0 111.689 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -61.1 104.2 0.35 Allowed 'General case' 0 N--CA 1.499 2.015 0 O-C-N 124.249 0.968 . . . . 0.0 110.309 179.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 141.43 -24.75 2.49 Favored Glycine 0 N--CA 1.494 2.551 0 O-C-N 123.93 0.769 . . . . 0.0 111.659 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 94.7 m -91.74 133.29 35.73 Favored 'General case' 0 N--CA 1.498 1.927 0 C-N-CA 120.736 -0.386 . . . . 0.0 110.441 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.7 mppt? -88.04 88.7 7.73 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 124.057 0.848 . . . . 0.0 110.46 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.471 ' CE2' ' HA2' ' A' ' 85' ' ' GLY . 77.7 m-85 -40.71 136.14 1.46 Allowed 'General case' 0 N--CA 1.503 2.176 0 O-C-N 124.613 1.196 . . . . 0.0 109.761 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -148.17 145.23 28.23 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 124.753 1.283 . . . . 0.0 113.399 -179.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 42.0 t -106.81 118.69 37.35 Favored 'General case' 0 N--CA 1.499 1.995 0 CA-C-N 112.653 -2.067 . . . . 0.0 111.902 -179.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.451 ' H ' ' HB1' ' A' ' 104' ' ' ALA . 6.1 p-10 -55.16 -52.89 61.87 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 126.323 2.264 . . . . 0.0 112.703 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -69.55 -0.74 7.14 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 112.108 -2.315 . . . . 0.0 112.541 -179.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -139.46 -84.4 0.1 Allowed Glycine 0 N--CA 1.482 1.702 0 C-N-CA 119.202 -1.475 . . . . 0.0 112.209 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.505 ' CG2' ' H ' ' A' ' 81' ' ' PHE . 1.2 m 175.79 -170.33 0.06 Allowed 'General case' 0 N--CA 1.5 2.04 0 O-C-N 126.22 1.777 . . . . 0.0 106.252 -179.166 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . 0.505 ' H ' ' CG2' ' A' ' 80' ' ' THR . 75.8 t80 -42.62 146.55 0.35 Allowed 'General case' 0 N--CA 1.498 1.955 0 C-N-CA 123.554 0.742 . . . . 0.0 112.636 179.527 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 88.4 t -111.17 -70.93 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 CA-C-N 113.878 -1.51 . . . . 0.0 111.585 -179.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . 0.534 ' SG ' ' N ' ' A' ' 84' ' ' GLU . 0.1 OUTLIER -160.25 -170.57 2.87 Favored 'General case' 0 N--CA 1.506 2.37 0 C-N-CA 120.41 -0.516 . . . . 0.0 110.827 -179.881 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.534 ' N ' ' SG ' ' A' ' 83' ' ' CYS . 38.9 tt0 -114.09 149.74 35.08 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 123.307 0.379 . . . . 0.0 110.716 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.471 ' HA2' ' CE2' ' A' ' 74' ' ' TYR . . . -36.8 105.7 0.04 OUTLIER Glycine 0 N--CA 1.501 2.992 0 O-C-N 124.833 1.333 . . . . 0.0 115.135 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -94.12 -8.86 38.35 Favored 'General case' 0 N--CA 1.502 2.145 0 C-N-CA 119.128 -1.029 . . . . 0.0 113.726 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 15.6 m -85.13 90.86 7.97 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -79.33 106.72 4.96 Favored Pre-proline 0 N--CA 1.49 1.536 0 N-CA-C 104.107 -2.553 . . . . 0.0 104.107 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -40.15 -34.81 1.08 Allowed 'Trans proline' 0 N--CA 1.501 1.938 0 C-N-CA 124.819 3.679 . . . . 0.0 116.265 -145.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 8.9 ptm180 -58.73 -14.02 7.5 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 123.861 0.726 . . . . 0.0 112.891 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.5 HD21 ' H ' ' A' ' 91' ' ' ASN . 0.1 OUTLIER -75.28 129.31 82.74 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 123.948 0.78 . . . . 0.0 110.936 -179.918 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -83.32 44.97 1.74 Allowed 'Trans proline' 0 N--CA 1.493 1.461 0 C-N-CA 123.275 2.65 . . . . 0.0 109.769 162.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.489 ' H ' ' HZ1' ' A' ' 93' ' ' LYS . 0.0 OUTLIER 64.98 168.94 0.19 Allowed 'General case' 0 N--CA 1.507 2.396 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.01 -179.877 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -160.21 44.82 0.21 Allowed 'General case' 0 N--CA 1.5 2.048 0 C-N-CA 120.061 -0.656 . . . . 0.0 112.759 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . 0.416 ' C ' ' H ' ' A' ' 97' ' ' ARG . 61.0 m -156.77 130.76 4.84 Favored Pre-proline 0 N--CA 1.501 2.101 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.829 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_endo -76.4 35.25 0.46 Allowed 'Trans proline' 0 N--CA 1.496 1.624 0 C-N-CA 123.039 2.493 . . . . 0.0 111.209 163.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.416 ' H ' ' C ' ' A' ' 95' ' ' CYS . 83.3 mmt-85 -108.99 37.07 2.66 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.457 HD21 ' H ' ' A' ' 98' ' ' ASN . 4.9 m-80 -54.25 135.51 44.21 Favored 'General case' 0 N--CA 1.495 1.789 0 CA-C-N 113.813 -1.54 . . . . 0.0 112.425 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . 0.599 ' H ' HD22 ' A' ' 64' ' ' ASN . 34.4 m 57.51 127.84 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.822 0 O-C-N 125.232 1.582 . . . . 0.0 114.747 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -122.99 93.12 48.67 Favored Pre-proline 0 N--CA 1.5 2.061 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_endo -62.11 -13.7 33.38 Favored 'Trans proline' 0 N--CA 1.496 1.635 0 C-N-CA 122.126 1.884 . . . . 0.0 113.505 -175.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 77.8 ttt-85 -90.17 -25.36 20.7 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 114.238 1.199 . . . . 0.0 114.238 -179.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 11.6 tt -74.12 141.95 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 C-N-CA 118.658 -1.217 . . . . 0.0 110.473 -179.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.451 ' HB1' ' H ' ' A' ' 77' ' ' ASP . . . -79.82 -58.85 2.97 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 105.791 -1.929 . . . . 0.0 105.791 179.715 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 4.3 p90 174.96 171.83 0.25 Allowed 'General case' 0 N--CA 1.488 1.473 0 CA-C-N 111.402 -2.635 . . . . 0.0 106.819 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -94.8 132.19 11.03 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 110.183 -1.167 . . . . 0.0 110.183 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 39.4 mm -78.45 90.86 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 N-CA-C 103.932 -2.618 . . . . 0.0 103.932 179.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 19.5 m -84.28 127.34 66.67 Favored Pre-proline 0 N--CA 1.493 1.716 0 CA-C-N 113.37 -1.741 . . . . 0.0 111.08 -179.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo . . . . . 0 N--CA 1.491 1.367 0 C-N-CA 122.386 2.057 . . . . 0.0 107.951 146.678 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 71.4 ttt-85 . . . . . 0 N--CA 1.492 1.645 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.419 ' C ' ' CD1' ' A' ' 3' ' ' ILE . 0.0 OUTLIER -73.93 109.6 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 179.997 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.6 m -132.59 29.3 4.22 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 115.78 1.77 . . . . 0.0 115.78 179.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.5 p -92.33 147.34 22.99 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-N 112.427 -2.169 . . . . 0.0 108.588 179.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.55 HD21 ' H ' ' A' ' 41' ' ' CYS . 20.7 p30 -160.61 158.26 28.67 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 124.722 1.263 . . . . 0.0 109.858 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 5.3 t -71.21 -30.12 65.98 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 115.287 1.588 . . . . 0.0 115.287 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 43.1 t -80.81 -65.29 1.03 Allowed 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 -179.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -88.79 39.7 0.94 Allowed 'General case' 0 N--CA 1.499 2.012 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.03 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -76.54 -133.61 0.52 Allowed Glycine 0 N--CA 1.492 2.392 0 CA-C-N 114.943 -1.026 . . . . 0.0 111.23 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.42 ' N ' ' HH ' ' A' ' 16' ' ' TYR . 35.3 p -152.56 103.69 2.83 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 35.2 ttpt -51.87 108.22 0.26 Allowed 'General case' 0 N--CA 1.5 2.041 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.529 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 143.26 -20.89 2.26 Favored Glycine 0 N--CA 1.496 2.659 0 N-CA-C 110.314 -1.114 . . . . 0.0 110.314 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 80.7 m -114.56 150.35 35.11 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 124.244 0.614 . . . . 0.0 109.84 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.401 ' N ' ' HE2' ' A' ' 15' ' ' LYS . 0.2 OUTLIER -93.81 94.43 8.52 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 124.159 0.912 . . . . 0.0 111.503 -179.781 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.421 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 31.3 m-85 -59.34 115.33 3.17 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 106.662 -1.607 . . . . 0.0 106.662 179.695 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.449 ' CE2' ' HA ' ' A' ' 22' ' ' THR . 0.0 OUTLIER -129.42 147.71 51.26 Favored 'General case' 0 N--CA 1.486 1.363 0 CA-C-N 112.008 -2.36 . . . . 0.0 112.836 -179.343 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 46.6 t -98.21 123.93 42.53 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-N 112.87 -1.968 . . . . 0.0 112.05 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.401 ' N ' ' HB2' ' A' ' 46' ' ' ALA . 5.5 p-10 -60.53 -43.15 97.47 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-N 113.916 -1.493 . . . . 0.0 108.444 179.71 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -94.98 18.37 12.14 Favored 'General case' 0 N--CA 1.487 1.394 0 CA-C-N 112.182 -2.281 . . . . 0.0 112.024 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -170.71 31.53 0.14 Allowed Glycine 0 N--CA 1.498 2.777 0 C-N-CA 118.528 -1.796 . . . . 0.0 113.75 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.5 ' HG1' ' H ' ' A' ' 23' ' ' PHE . 6.1 t 44.19 -168.79 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 114.214 1.19 . . . . 0.0 114.214 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.5 ' H ' ' HG1' ' A' ' 22' ' ' THR . 62.8 t80 -47.84 133.62 13.98 Favored 'General case' 0 N--CA 1.498 1.95 0 CA-C-O 121.697 0.761 . . . . 0.0 112.805 -179.776 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 98.2 t -104.04 -78.65 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 CA-C-N 113.044 -1.889 . . . . 0.0 106.799 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.458 ' SG ' ' N ' ' A' ' 26' ' ' GLU . 0.2 OUTLIER -157.31 -171.4 3.59 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 179.732 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.458 ' N ' ' SG ' ' A' ' 25' ' ' CYS . 16.1 mt-10 -109.06 157.12 19.01 Favored 'General case' 0 N--CA 1.495 1.775 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 179.715 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -49.69 106.68 0.24 Allowed Glycine 0 N--CA 1.496 2.663 0 O-C-N 124.124 0.89 . . . . 0.0 112.05 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -79.44 -9.23 59.56 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-N 114.93 -0.635 . . . . 0.0 110.297 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 34.0 t -79.72 97.11 6.45 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.451 ' H ' HD22 ' A' ' 33' ' ' ASN . 10.8 t70 -79.82 137.23 54.29 Favored Pre-proline 0 N--CA 1.495 1.785 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -71.48 68.65 2.76 Favored 'Trans proline' 0 N--CA 1.497 1.711 0 C-N-CA 123.567 2.845 . . . . 0.0 111.411 176.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.406 ' NE ' ' HA ' ' A' ' 32' ' ' ARG . 3.9 mmp_? -158.0 -44.99 0.06 Allowed 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 105.293 -2.114 . . . . 0.0 105.293 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.451 HD22 ' H ' ' A' ' 30' ' ' ASP . 13.4 p30 -90.35 150.54 43.15 Favored Pre-proline 0 N--CA 1.495 1.783 0 O-C-N 124.275 0.985 . . . . 0.0 110.522 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.13 169.82 21.72 Favored 'Trans proline' 0 N--CA 1.491 1.343 0 C-N-CA 122.843 2.362 . . . . 0.0 108.916 159.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 22.4 ptmt -69.56 147.04 51.3 Favored 'General case' 0 N--CA 1.496 1.853 0 C-N-CA 120.124 -0.63 . . . . 0.0 110.4 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -158.81 41.56 0.24 Allowed 'General case' 0 N--CA 1.496 1.839 0 CA-C-N 115.322 -0.854 . . . . 0.0 108.849 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 76.4 m -108.23 178.68 4.43 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-N 114.069 -1.423 . . . . 0.0 111.595 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 8.4 t -134.15 -3.17 2.79 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-N 113.537 -1.665 . . . . 0.0 108.269 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.17 30.59 2.72 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 6.9 m-80 -57.75 123.22 14.96 Favored 'General case' 0 N--CA 1.497 1.923 0 CA-C-N 114.712 -1.131 . . . . 0.0 109.358 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.55 ' H ' HD21 ' A' ' 6' ' ' ASN . 70.9 m 58.01 107.56 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.856 0 O-C-N 125.079 1.487 . . . . 0.0 110.616 -179.612 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -108.76 102.99 50.32 Favored Pre-proline 0 N--CA 1.499 2.007 0 CA-C-N 115.243 -0.889 . . . . 0.0 112.654 -179.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -67.34 -7.05 17.89 Favored 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 121.888 1.725 . . . . 0.0 112.216 178.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 60.9 mtt85 -89.97 -14.59 33.75 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 123.643 0.589 . . . . 0.0 111.967 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 15.3 tt -106.79 160.74 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.401 ' HB2' ' N ' ' A' ' 19' ' ' ASP . . . -83.85 -74.65 0.37 Allowed 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 105.378 -2.082 . . . . 0.0 105.378 179.822 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 50.9 p90 179.71 176.37 0.69 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 124.769 1.293 . . . . 0.0 109.552 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.421 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -79.94 102.02 1.99 Allowed Glycine 0 N--CA 1.49 2.243 0 CA-C-N 114.125 -1.398 . . . . 0.0 111.797 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 17.7 m -78.54 98.38 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 N-CA-C 106.258 -1.756 . . . . 0.0 106.258 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.9 m -79.93 176.29 3.92 Favored Pre-proline 0 N--CA 1.495 1.779 0 CA-C-N 113.218 -1.81 . . . . 0.0 108.26 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo . . . . . 0 N--CA 1.495 1.583 0 C-N-CA 122.219 1.946 . . . . 0.0 112.3 173.05 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 1.7 m . . . . . 0 N--CA 1.487 1.411 0 CA-C-O 123.336 1.541 . . . . 0.0 115.076 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 60.2 m -91.38 118.38 30.48 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-N 111.756 -2.474 . . . . 0.0 104.87 179.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.522 ' ND2' ' H ' ' A' ' 67' ' ' ALA . 20.8 p-10 -140.46 161.02 38.71 Favored 'General case' 0 N--CA 1.502 2.158 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 1.4 t -65.53 -36.69 84.57 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-N 113.539 -1.664 . . . . 0.0 115.296 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 51.0 t -75.35 -64.48 1.05 Allowed 'General case' 0 N--CA 1.497 1.913 0 O-C-N 123.775 0.672 . . . . 0.0 110.669 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.522 ' H ' ' ND2' ' A' ' 64' ' ' ASN . . . -90.13 52.41 2.26 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -88.53 -138.65 6.4 Favored Glycine 0 N--CA 1.493 2.449 0 CA-C-N 114.256 -1.338 . . . . 0.0 112.205 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 94.8 m -140.91 105.75 4.94 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 124.48 0.753 . . . . 0.0 110.758 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 10.9 tptm -56.02 104.19 0.13 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 124.208 0.943 . . . . 0.0 108.613 179.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 140.32 -1.78 2.2 Favored Glycine 0 N--CA 1.492 2.401 0 CA-C-N 114.517 -1.22 . . . . 0.0 110.82 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 91.9 m -141.44 146.95 37.15 Favored 'General case' 0 N--CA 1.498 1.934 0 CA-C-N 117.074 0.437 . . . . 0.0 111.282 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.478 ' HB3' ' CE1' ' A' ' 81' ' ' PHE . 8.0 mtpm? -89.33 90.39 8.31 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-N 114.875 -1.057 . . . . 0.0 111.89 -179.683 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -53.96 120.96 7.06 Favored 'General case' 0 N--CA 1.5 2.052 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -124.38 160.71 27.54 Favored 'General case' 0 N--CA 1.493 1.701 0 CA-C-N 113.184 -1.825 . . . . 0.0 113.731 -179.383 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 29.8 t -104.06 131.89 50.86 Favored 'General case' 0 N--CA 1.498 1.93 0 CA-C-N 113.834 -1.53 . . . . 0.0 112.597 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -46.24 -29.83 1.76 Allowed 'General case' 0 N--CA 1.502 2.17 0 N-CA-C 116.117 1.895 . . . . 0.0 116.117 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -51.82 -24.41 6.05 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 123.955 0.784 . . . . 0.0 111.818 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 113.7 26.95 3.71 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 108.851 -1.7 . . . . 0.0 108.851 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 86.3 m -138.67 139.49 38.49 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 124.005 0.473 . . . . 0.0 110.875 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . 0.478 ' CE1' ' HB3' ' A' ' 73' ' ' LYS . 13.0 t80 -71.97 150.76 43.8 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-N 114.312 -1.313 . . . . 0.0 109.648 179.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 97.2 t -110.1 -78.89 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -159.36 175.21 13.63 Favored 'General case' 0 N--CA 1.501 2.099 0 C-N-CA 120.675 -0.41 . . . . 0.0 110.022 179.818 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -92.72 141.23 28.69 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -45.6 105.59 0.09 OUTLIER Glycine 0 N--CA 1.5 2.956 0 O-C-N 124.166 0.916 . . . . 0.0 111.557 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -79.47 7.15 8.61 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-N 114.526 -0.837 . . . . 0.0 112.456 -179.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 46.9 t -132.93 119.65 20.42 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -79.23 143.92 61.53 Favored Pre-proline 0 N--CA 1.495 1.777 0 O-C-N 124.105 0.878 . . . . 0.0 108.675 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -70.15 64.18 2.03 Favored 'Trans proline' 0 N--CA 1.5 1.903 0 C-N-CA 123.614 2.876 . . . . 0.0 112.402 176.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 53.5 mmm-85 -158.68 -44.42 0.06 Allowed 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 105.616 -1.994 . . . . 0.0 105.616 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -90.78 121.69 67.83 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 124.274 0.984 . . . . 0.0 109.664 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -80.27 50.14 3.44 Favored 'Trans proline' 0 N--CA 1.495 1.604 0 C-N-CA 123.427 2.751 . . . . 0.0 111.686 174.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -82.21 124.72 30.16 Favored 'General case' 0 N--CA 1.496 1.874 0 C-N-CA 120.346 -0.542 . . . . 0.0 111.057 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -87.38 -176.97 5.82 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-N 114.357 -1.292 . . . . 0.0 109.803 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 77.6 m -153.94 158.68 32.51 Favored Pre-proline 0 N--CA 1.496 1.868 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.939 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -70.2 -25.72 26.26 Favored 'Trans proline' 0 N--CA 1.491 1.34 0 C-N-CA 122.069 1.846 . . . . 0.0 108.239 159.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 5.2 mmp_? -83.5 5.04 25.34 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-N 114.324 -1.307 . . . . 0.0 112.319 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -50.27 136.15 20.36 Favored 'General case' 0 N--CA 1.503 2.224 0 C-N-CA 120.499 -0.48 . . . . 0.0 110.927 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 59.8 m 61.96 114.5 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.773 0 O-C-N 125.309 1.63 . . . . 0.0 111.58 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -125.6 97.29 36.67 Favored Pre-proline 0 N--CA 1.499 2.008 0 N-CA-C 113.21 0.819 . . . . 0.0 113.21 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -48.63 -32.49 21.54 Favored 'Trans proline' 0 N--CA 1.495 1.585 0 C-N-CA 123.189 2.593 . . . . 0.0 112.425 174.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 31.1 ttp-105 -61.02 -50.04 74.98 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 106.46 -1.681 . . . . 0.0 106.46 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 4.0 mt -67.91 155.89 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 179.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -141.77 -34.5 0.47 Allowed 'General case' 0 N--CA 1.49 1.57 0 CA-C-N 113.484 -1.689 . . . . 0.0 111.334 -179.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 51.7 m-85 -139.65 -164.3 1.66 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 124.255 0.972 . . . . 0.0 111.149 -179.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -153.33 104.14 0.25 Allowed Glycine 0 N--CA 1.488 2.131 0 N-CA-C 105.983 -2.847 . . . . 0.0 105.983 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 51.2 mm -79.21 93.53 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 -179.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 8.0 m -79.44 149.17 71.6 Favored Pre-proline 0 N--CA 1.493 1.718 0 CA-C-N 113.718 -1.583 . . . . 0.0 108.923 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo . . . . . 0 N--CA 1.494 1.507 0 C-N-CA 122.496 2.131 . . . . 0.0 110.253 -175.631 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 41.6 ttm180 . . . . . 0 N--CA 1.496 1.861 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 8.5 tp -83.67 54.53 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 CA-C-N 114.449 -1.25 . . . . 0.0 109.912 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 42.7 m -87.52 54.66 3.21 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-O 122.479 1.133 . . . . 0.0 112.808 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 17.2 p -89.49 170.8 10.2 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-N 113.128 -1.851 . . . . 0.0 108.809 179.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 18.4 p-10 -162.55 135.76 5.97 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 124.24 0.963 . . . . 0.0 113.548 179.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -59.11 -31.56 69.03 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-N 114.563 -1.199 . . . . 0.0 113.884 179.716 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 48.4 t -68.76 -59.42 3.11 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-N 114.808 -1.087 . . . . 0.0 112.386 -179.584 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -74.5 -96.23 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.863 0 C-N-CA 118.714 -1.194 . . . . 0.0 110.052 -179.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 52.27 -126.57 31.06 Favored Glycine 0 N--CA 1.488 2.105 0 O-C-N 123.567 0.542 . . . . 0.0 112.042 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 92.5 m -152.18 119.21 5.83 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 22.5 ttmm -68.54 91.64 0.42 Allowed 'General case' 0 N--CA 1.494 1.766 0 CA-C-O 122.283 1.039 . . . . 0.0 109.048 179.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 163.59 -34.19 0.29 Allowed Glycine 0 N--CA 1.488 2.163 0 CA-C-N 112.9 -1.954 . . . . 0.0 109.007 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 50.5 m -105.16 130.55 53.3 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-O 121.528 0.68 . . . . 0.0 109.229 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.467 ' HB3' ' CE1' ' A' ' 23' ' ' PHE . 57.5 mtpt -78.36 91.22 4.43 Favored 'General case' 0 N--CA 1.485 1.319 0 CA-C-N 113.171 -1.832 . . . . 0.0 112.55 -179.54 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.414 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 75.5 m-85 -58.87 121.22 10.6 Favored 'General case' 0 N--CA 1.501 2.113 0 N-CA-C 105.784 -1.932 . . . . 0.0 105.784 179.759 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -128.71 147.51 50.76 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 110.664 -2.971 . . . . 0.0 112.933 -179.218 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 40.1 t -83.44 136.32 34.35 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-N 111.83 -2.441 . . . . 0.0 112.895 -179.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -52.18 -30.25 26.05 Favored 'General case' 0 N--CA 1.498 1.958 0 CA-C-N 112.481 -2.145 . . . . 0.0 113.833 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 44.3 p-10 -58.06 -14.16 6.15 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 124.013 0.821 . . . . 0.0 112.268 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 99.97 35.22 4.61 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 108.464 -1.855 . . . . 0.0 108.464 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 55.9 m -136.29 132.49 35.79 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 124.025 0.485 . . . . 0.0 110.241 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.467 ' CE1' ' HB3' ' A' ' 15' ' ' LYS . 8.1 t80 -74.78 141.52 44.37 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 179.671 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 41.0 t -102.53 -79.53 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 N-CA-C 105.666 -1.976 . . . . 0.0 105.666 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -169.0 166.21 11.13 Favored 'General case' 0 N--CA 1.501 2.117 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 179.594 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.412 ' HG2' ' N ' ' A' ' 27' ' ' GLY . 36.8 tt0 -82.13 161.51 22.81 Favored 'General case' 0 N--CA 1.503 2.223 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 179.789 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.412 ' N ' ' HG2' ' A' ' 26' ' ' GLU . . . -61.13 120.39 22.59 Favored Glycine 0 N--CA 1.496 2.657 0 N-CA-C 107.52 -2.232 . . . . 0.0 107.52 179.7 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -86.18 21.33 2.05 Favored 'General case' 0 N--CA 1.499 1.999 0 C-N-CA 119.295 -0.962 . . . . 0.0 110.379 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 35.3 t -139.22 112.57 8.21 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-N 114.801 -1.09 . . . . 0.0 108.537 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -81.01 142.71 52.09 Favored Pre-proline 0 N--CA 1.493 1.721 0 CA-C-N 114.246 -1.343 . . . . 0.0 107.706 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -69.75 68.71 1.68 Allowed 'Trans proline' 0 N--CA 1.499 1.852 0 C-N-CA 122.993 2.462 . . . . 0.0 111.844 176.387 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 35.3 mmt180 -160.65 -39.37 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 CA-C-N 113.546 -1.661 . . . . 0.0 107.416 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 24.7 p30 -71.28 151.94 94.36 Favored Pre-proline 0 N--CA 1.498 1.974 0 C-N-CA 119.902 -0.719 . . . . 0.0 111.253 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo -69.44 167.77 23.06 Favored 'Trans proline' 0 N--CA 1.494 1.514 0 C-N-CA 122.745 2.297 . . . . 0.0 111.7 179.227 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 22.4 ptmt 39.44 -163.81 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.252 0 N-CA-C 115.682 1.734 . . . . 0.0 115.682 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -139.34 179.72 6.37 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-N 115.043 -0.98 . . . . 0.0 109.984 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 87.0 m -79.8 179.51 7.5 Favored 'General case' 0 N--CA 1.497 1.897 0 CA-C-N 114.959 -1.019 . . . . 0.0 112.98 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 69.8 p -130.85 31.82 4.43 Favored 'General case' 0 N--CA 1.495 1.822 0 CA-C-N 113.671 -1.604 . . . . 0.0 108.751 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 39.9 tp -79.86 -1.28 38.36 Favored 'General case' 0 N--CA 1.499 2.01 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.412 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 29.7 m-80 57.56 -174.84 0.07 Allowed 'General case' 0 N--CA 1.499 2.009 0 N-CA-C 114.181 1.178 . . . . 0.0 114.181 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 81.7 m -60.82 134.5 57.15 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-N 114.262 -1.335 . . . . 0.0 111.271 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -128.44 83.79 65.11 Favored Pre-proline 0 N--CA 1.498 1.941 0 O-C-N 123.885 0.74 . . . . 0.0 109.517 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -52.34 -24.44 21.26 Favored 'Trans proline' 0 N--CA 1.495 1.576 0 C-N-CA 122.867 2.378 . . . . 0.0 112.178 176.034 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 28.0 ttt85 -60.73 -50.92 71.55 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 17.6 mt -65.5 153.65 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 CA-C-O 122.066 0.936 . . . . 0.0 109.782 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -124.14 -59.61 1.48 Allowed 'General case' 0 N--CA 1.491 1.589 0 CA-C-N 111.957 -2.383 . . . . 0.0 109.218 -179.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 16.2 p90 -162.64 156.78 21.05 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 124.14 0.9 . . . . 0.0 112.189 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.414 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -88.84 103.7 3.0 Favored Glycine 0 N--CA 1.492 2.389 0 CA-C-N 112.816 -1.993 . . . . 0.0 113.235 -179.821 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 34.2 m -81.25 99.07 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.185 0 CA-C-O 121.531 0.681 . . . . 0.0 109.985 179.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.6 m -79.16 125.89 82.69 Favored Pre-proline 0 N--CA 1.503 2.206 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.233 179.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo . . . . . 0 N--CA 1.492 1.397 0 C-N-CA 122.32 2.013 . . . . 0.0 108.516 171.106 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 3.6 m . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 123.145 1.45 . . . . 0.0 109.88 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 25.5 p -90.07 177.42 6.46 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-N 112.038 -2.347 . . . . 0.0 110.333 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.423 ' ND2' ' H ' ' A' ' 67' ' ' ALA . 46.8 p-10 -161.46 -177.11 5.74 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-N 113.797 -1.547 . . . . 0.0 111.143 179.808 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' CYS . . . . . 0.416 ' SG ' ' CD2' ' A' ' 74' ' ' TYR . 11.1 t -91.51 -20.23 21.94 Favored 'General case' 0 N--CA 1.497 1.923 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.026 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 13.4 t -82.62 -61.78 1.79 Allowed 'General case' 0 N--CA 1.491 1.593 0 CA-C-N 113.731 -1.577 . . . . 0.0 112.731 -179.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.423 ' H ' ' ND2' ' A' ' 64' ' ' ASN . . . -90.35 60.85 4.84 Favored 'General case' 0 N--CA 1.499 1.996 0 CA-C-O 121.588 0.708 . . . . 0.0 112.205 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.406 ' H ' ' HB2' ' A' ' 87' ' ' SER . . . -126.18 -104.68 1.41 Allowed Glycine 0 N--CA 1.498 2.813 0 N-CA-C 108.812 -1.715 . . . . 0.0 108.812 179.755 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 3.4 t -155.65 111.45 3.06 Favored 'General case' 0 N--CA 1.502 2.13 0 N-CA-C 114.074 1.139 . . . . 0.0 114.074 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -65.93 103.59 0.96 Allowed 'General case' 0 N--CA 1.498 1.95 0 CA-C-N 114.331 -1.304 . . . . 0.0 107.679 179.66 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 143.09 -3.18 1.69 Allowed Glycine 0 N--CA 1.49 2.299 0 CA-C-N 114.384 -1.28 . . . . 0.0 110.927 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 72.8 m -124.0 155.14 38.77 Favored 'General case' 0 N--CA 1.499 1.982 0 C-N-CA 120.476 -0.489 . . . . 0.0 109.829 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.0 95.27 6.25 Favored 'General case' 0 N--CA 1.488 1.47 0 CA-C-N 115.036 -0.984 . . . . 0.0 108.644 -179.759 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.654 ' CD2' ' SG ' ' A' ' 83' ' ' CYS . 89.8 m-85 -44.78 137.61 3.9 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 124.694 1.246 . . . . 0.0 109.882 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 21.6 t80 -141.83 159.12 42.87 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 124.834 1.334 . . . . 0.0 110.844 -179.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 30.8 t -121.24 143.4 49.17 Favored 'General case' 0 N--CA 1.495 1.822 0 CA-C-N 112.748 -2.023 . . . . 0.0 116.089 -179.41 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.428 ' C ' ' H ' ' A' ' 79' ' ' GLY . 0.9 OUTLIER -48.91 -23.98 1.31 Allowed 'General case' 0 N--CA 1.498 1.952 0 CA-C-N 110.507 -3.042 . . . . 0.0 113.184 179.872 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 16.3 p30 -64.74 -0.67 1.54 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 124.223 0.952 . . . . 0.0 111.184 179.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.428 ' H ' ' C ' ' A' ' 77' ' ' ASP . . . 82.25 29.22 37.81 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 96.7 m -144.44 153.15 41.61 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 121.425 0.631 . . . . 0.0 111.903 -179.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -64.21 165.2 9.72 Favored 'General case' 0 N--CA 1.497 1.875 0 CA-C-N 113.466 -1.697 . . . . 0.0 110.565 179.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 89.4 t -128.28 -67.74 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 124.061 0.851 . . . . 0.0 112.07 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . 0.654 ' SG ' ' CD2' ' A' ' 74' ' ' TYR . 31.3 p -162.54 -178.07 6.01 Favored 'General case' 0 N--CA 1.503 2.178 0 C-N-CA 120.253 -0.579 . . . . 0.0 110.794 -179.636 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -96.49 158.02 15.63 Favored 'General case' 0 N--CA 1.505 2.306 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.16 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.473 ' HA2' ' CE2' ' A' ' 74' ' ' TYR . . . -58.73 106.05 0.79 Allowed Glycine 0 N--CA 1.498 2.778 0 CA-C-O 118.894 -0.948 . . . . 0.0 111.501 179.756 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 30.1 mm-40 -113.01 37.9 2.99 Favored 'General case' 0 N--CA 1.505 2.283 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 179.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.406 ' HB2' ' H ' ' A' ' 68' ' ' GLY . 9.0 t -115.45 63.31 0.69 Allowed 'General case' 0 N--CA 1.493 1.722 0 CA-C-N 114.267 -1.333 . . . . 0.0 109.491 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -81.57 114.57 50.84 Favored Pre-proline 0 N--CA 1.492 1.627 0 CA-C-N 114.08 -1.418 . . . . 0.0 110.355 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -66.1 -16.89 53.85 Favored 'Trans proline' 0 N--CA 1.492 1.419 0 C-N-CA 122.136 1.891 . . . . 0.0 111.361 -174.599 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 52.7 tpt85 -73.13 -31.07 64.06 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 123.812 0.695 . . . . 0.0 112.203 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -84.4 131.68 49.57 Favored Pre-proline 0 N--CA 1.497 1.9 0 C-N-CA 118.546 -1.262 . . . . 0.0 110.808 -179.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -80.96 71.22 7.18 Favored 'Trans proline' 0 N--CA 1.49 1.287 0 C-N-CA 123.114 2.543 . . . . 0.0 108.325 162.306 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 58.4 tptt -149.87 154.07 37.76 Favored 'General case' 0 N--CA 1.497 1.889 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.607 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -131.32 -172.92 2.97 Favored 'General case' 0 N--CA 1.498 1.957 0 CA-C-N 113.925 -1.488 . . . . 0.0 109.487 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 3.7 m -149.42 150.93 32.5 Favored Pre-proline 0 N--CA 1.5 2.072 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -75.8 98.23 1.17 Allowed 'Trans proline' 0 N--CA 1.493 1.443 0 C-N-CA 122.711 2.274 . . . . 0.0 110.039 172.158 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 -146.73 57.07 1.16 Allowed 'General case' 0 N--CA 1.499 2.018 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -55.35 96.85 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.844 0 CA-C-N 113.446 -1.706 . . . . 0.0 114.618 -179.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 78.6 m 55.01 130.01 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.156 0 N-CA-C 117.331 2.345 . . . . 0.0 117.331 179.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 63.8 t0 -127.79 77.34 76.42 Favored Pre-proline 0 N--CA 1.502 2.142 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.78 179.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -63.07 -24.89 73.41 Favored 'Trans proline' 0 N--CA 1.493 1.442 0 C-N-CA 122.604 2.202 . . . . 0.0 111.611 173.52 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -67.69 -19.8 65.22 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 123.96 0.787 . . . . 0.0 112.105 -179.824 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 10.5 tt -79.61 169.65 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.115 0 C-N-CA 119.133 -1.027 . . . . 0.0 110.241 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -130.99 -55.15 1.05 Allowed 'General case' 0 N--CA 1.495 1.784 0 CA-C-N 114.883 -1.053 . . . . 0.0 108.833 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 27.7 p90 -171.59 168.3 6.37 Favored 'General case' 0 N--CA 1.497 1.904 0 CA-C-N 114.842 -1.072 . . . . 0.0 110.008 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -105.6 121.96 7.0 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 109.716 -1.353 . . . . 0.0 109.716 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 87.2 mt -79.4 94.05 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 14.6 m -79.66 156.16 75.53 Favored Pre-proline 0 N--CA 1.493 1.69 0 CA-C-N 114.117 -1.401 . . . . 0.0 107.38 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo . . . . . 0 N--CA 1.495 1.593 0 C-N-CA 122.631 2.22 . . . . 0.0 111.532 -175.293 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . 0.457 ' HA ' ' NE ' ' A' ' 2' ' ' ARG . 14.5 mmp_? . . . . . 0 N--CA 1.498 1.933 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.3 tp -69.58 84.87 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 CA-C-N 114.835 -1.075 . . . . 0.0 111.552 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 14.8 m -92.2 51.02 1.72 Allowed 'General case' 0 N--CA 1.491 1.619 0 CA-C-N 114.195 -1.366 . . . . 0.0 111.521 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.408 ' HG1' ' H ' ' A' ' 6' ' ' ASN . 15.1 t -90.71 -173.67 3.81 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-N 113.229 -1.805 . . . . 0.0 108.862 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.408 ' H ' ' HG1' ' A' ' 5' ' ' THR . 24.1 p30 -160.22 -175.15 4.89 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 124.742 1.276 . . . . 0.0 108.285 179.696 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.6 t -118.26 -33.35 4.4 Favored 'General case' 0 N--CA 1.499 1.978 0 C-N-CA 119.772 -0.771 . . . . 0.0 110.332 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 25.1 t -62.54 -60.39 3.6 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-N 114.704 -1.135 . . . . 0.0 108.64 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.412 ' HB3' ' SG ' ' A' ' 37' ' ' CYS . . . -90.28 19.82 4.86 Favored 'General case' 0 N--CA 1.498 1.97 0 CA-C-N 113.83 -1.532 . . . . 0.0 109.561 179.785 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -75.19 -151.0 2.67 Favored Glycine 0 N--CA 1.493 2.48 0 CA-C-N 115.445 -0.798 . . . . 0.0 112.472 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 40.1 p -126.98 100.08 5.99 Favored 'General case' 0 N--CA 1.498 1.925 0 CA-C-N 114.709 -0.746 . . . . 0.0 109.299 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -52.12 147.79 7.05 Favored 'General case' 0 N--CA 1.5 2.035 0 CA-C-N 115.787 -0.642 . . . . 0.0 112.249 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 98.92 -33.51 6.06 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 107.88 -2.088 . . . . 0.0 107.88 -179.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 55.3 m -91.39 114.18 26.64 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 10.4 mtmp? -68.72 88.31 0.36 Allowed 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 111.762 -2.472 . . . . 0.0 111.718 -179.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.498 ' HB2' ' SG ' ' A' ' 25' ' ' CYS . 31.6 m-85 -53.01 119.76 5.05 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 105.361 -2.088 . . . . 0.0 105.361 179.456 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -135.16 153.66 51.9 Favored 'General case' 0 C--N 1.296 -1.723 0 CA-C-N 111.876 -2.42 . . . . 0.0 113.347 -179.036 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 41.9 t -92.17 133.33 35.89 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-N 112.838 -1.983 . . . . 0.0 109.389 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.455 ' H ' ' HB2' ' A' ' 46' ' ' ALA . 5.8 p-10 -51.97 -24.01 5.89 Favored 'General case' 0 N--CA 1.498 1.96 0 CA-C-N 113.363 -1.744 . . . . 0.0 114.21 -179.797 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 32.6 p30 -58.99 -10.47 2.55 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 124.197 0.935 . . . . 0.0 112.365 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 99.68 29.39 6.99 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 87.1 m -140.06 138.08 35.08 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 124.026 0.486 . . . . 0.0 110.622 -179.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.403 ' CG ' ' N ' ' A' ' 24' ' ' VAL . 49.1 t80 -70.55 162.0 29.63 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 124.443 1.09 . . . . 0.0 110.46 179.743 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.403 ' N ' ' CG ' ' A' ' 23' ' ' PHE . 61.0 t -129.48 -72.93 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 124.198 0.936 . . . . 0.0 110.978 -179.825 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.498 ' SG ' ' HB2' ' A' ' 16' ' ' TYR . 14.8 p -149.82 -169.62 3.43 Favored 'General case' 0 N--CA 1.504 2.241 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -137.51 147.22 45.03 Favored 'General case' 0 N--CA 1.502 2.128 0 N-CA-C 105.652 -1.981 . . . . 0.0 105.652 179.251 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -50.55 157.92 2.04 Favored Glycine 0 N--CA 1.5 2.915 0 C-N-CA 120.371 -0.918 . . . . 0.0 115.01 -179.577 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -121.11 -33.25 3.75 Favored 'General case' 0 N--CA 1.496 1.851 0 CA-C-N 113.603 -1.298 . . . . 0.0 110.807 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 32.4 m -95.12 131.48 41.09 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 123.595 0.559 . . . . 0.0 111.273 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.481 ' H ' HD22 ' A' ' 33' ' ' ASN . 16.4 t70 -81.33 143.96 52.92 Favored Pre-proline 0 N--CA 1.493 1.715 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_endo -61.77 73.91 0.09 OUTLIER 'Trans proline' 0 N--CA 1.499 1.838 0 C-N-CA 122.904 2.402 . . . . 0.0 112.111 172.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 36.2 mmt180 -162.72 -47.9 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.734 0 CA-C-N 113.387 -1.733 . . . . 0.0 106.802 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.481 HD22 ' H ' ' A' ' 30' ' ' ASP . 6.5 p30 -90.44 119.44 69.13 Favored Pre-proline 0 N--CA 1.494 1.762 0 O-C-N 124.234 0.959 . . . . 0.0 110.816 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -81.02 49.98 3.42 Favored 'Trans proline' 0 N--CA 1.494 1.534 0 C-N-CA 123.419 2.746 . . . . 0.0 111.298 174.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 6.4 mmpt? -74.65 124.5 26.82 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -99.14 96.1 7.55 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-N 114.744 -1.117 . . . . 0.0 110.754 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.412 ' SG ' ' HB3' ' A' ' 9' ' ' ALA . 78.0 m -79.71 -39.82 30.31 Favored 'General case' 0 N--CA 1.497 1.917 0 CA-C-N 114.709 -1.132 . . . . 0.0 108.678 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 63.0 m 59.71 80.45 0.2 Allowed 'General case' 0 N--CA 1.496 1.853 0 CA-C-N 114.049 -1.432 . . . . 0.0 111.295 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 32.4 tp -84.2 7.79 17.86 Favored 'General case' 0 N--CA 1.499 2.006 0 CA-C-N 114.696 -1.138 . . . . 0.0 108.911 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 13.2 m120 55.52 56.2 6.51 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.453 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 80.8 m 61.42 132.93 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.006 0 CA-C-N 113.29 -1.777 . . . . 0.0 114.044 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -115.68 87.27 17.31 Favored Pre-proline 0 N--CA 1.497 1.908 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.447 179.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -64.52 -17.04 58.27 Favored 'Trans proline' 0 N--CA 1.492 1.421 0 C-N-CA 122.844 2.363 . . . . 0.0 111.568 170.058 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.27 -10.4 58.82 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 123.688 0.618 . . . . 0.0 109.992 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.411 ' CG2' ' N ' ' A' ' 46' ' ' ALA . 46.2 mt -119.9 159.98 20.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 CA-C-O 122.14 0.972 . . . . 0.0 110.66 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.455 ' HB2' ' H ' ' A' ' 19' ' ' ASP . . . -119.6 -55.26 2.12 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-N 111.695 -2.502 . . . . 0.0 108.182 179.755 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 5.8 p90 -167.21 153.55 8.12 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 124.129 0.893 . . . . 0.0 112.644 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -81.99 102.39 2.26 Favored Glycine 0 N--CA 1.492 2.428 0 CA-C-N 112.884 -1.962 . . . . 0.0 112.659 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 47.4 t -79.6 90.28 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 124.051 0.5 . . . . 0.0 112.18 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.5 m -79.33 120.38 80.28 Favored Pre-proline 0 N--CA 1.504 2.229 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 179.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo . . . . . 0 N--CA 1.492 1.405 0 C-N-CA 122.534 2.156 . . . . 0.0 109.735 -173.861 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . 0.407 ' HA ' ' HA ' ' A' ' 99' ' ' CYS . 6.8 m . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 123.349 1.547 . . . . 0.0 113.037 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 95.1 m -91.08 138.42 31.62 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-N 111.584 -2.553 . . . . 0.0 106.777 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.465 ' ND2' ' H ' ' A' ' 67' ' ' ALA . 28.4 p-10 -160.74 151.04 17.93 Favored 'General case' 0 N--CA 1.499 2.01 0 C-N-CA 120.011 -0.676 . . . . 0.0 111.286 179.76 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' CYS . . . . . 0.406 ' SG ' ' NH1' ' A' ' 97' ' ' ARG . 0.7 OUTLIER -60.05 -28.78 68.05 Favored 'General case' 0 N--CA 1.495 1.789 0 CA-C-N 114.316 -1.311 . . . . 0.0 114.072 -179.842 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 40.1 t -79.78 -69.05 0.61 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 124.168 0.918 . . . . 0.0 111.81 -179.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.465 ' H ' ' ND2' ' A' ' 64' ' ' ASN . . . -88.37 45.26 1.27 Allowed 'General case' 0 N--CA 1.497 1.898 0 O-C-N 124.848 1.342 . . . . 0.0 109.812 -179.806 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -85.58 -143.55 6.87 Favored Glycine 0 N--CA 1.489 2.201 0 CA-C-N 114.365 -1.288 . . . . 0.0 111.264 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 35.5 p -139.85 116.21 10.6 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 114.826 -0.687 . . . . 0.0 110.523 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -60.69 97.07 0.05 OUTLIER 'General case' 0 N--CA 1.5 2.048 0 O-C-N 124.135 0.897 . . . . 0.0 109.619 179.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 158.21 -17.91 0.31 Allowed Glycine 0 N--CA 1.494 2.558 0 CA-C-N 114.52 -1.218 . . . . 0.0 110.872 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 91.2 m -125.39 155.44 40.36 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 124.015 0.479 . . . . 0.0 110.373 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -103.1 94.3 5.47 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 124.192 0.933 . . . . 0.0 109.763 -179.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -51.02 128.77 22.35 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-N 113.647 -1.615 . . . . 0.0 109.333 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.429 ' CD1' ' C ' ' A' ' 75' ' ' PHE . 0.2 OUTLIER -134.6 153.88 51.76 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-N 113.606 -1.634 . . . . 0.0 113.678 -179.335 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 31.6 t -112.74 129.6 56.36 Favored 'General case' 0 N--CA 1.498 1.964 0 CA-C-N 112.98 -1.918 . . . . 0.0 112.359 -179.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -61.88 -50.03 73.85 Favored 'General case' 0 N--CA 1.499 1.993 0 CA-C-N 114.622 -1.172 . . . . 0.0 109.546 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -90.81 18.24 6.77 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 112.825 -1.989 . . . . 0.0 111.641 -179.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -163.47 25.34 0.2 Allowed Glycine 0 N--CA 1.495 2.628 0 C-N-CA 118.915 -1.612 . . . . 0.0 113.141 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.414 ' HA ' ' CE2' ' A' ' 75' ' ' PHE . 6.7 t 42.48 -163.56 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.794 0 O-C-N 124.998 1.057 . . . . 0.0 113.22 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . 0.409 ' H ' ' HG1' ' A' ' 80' ' ' THR . 22.8 t80 -48.28 127.94 13.55 Favored 'General case' 0 N--CA 1.497 1.889 0 CA-C-O 121.378 0.609 . . . . 0.0 111.592 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 63.5 t -94.79 -76.94 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . 0.488 ' SG ' ' N ' ' A' ' 84' ' ' GLU . 0.4 OUTLIER -168.09 -169.64 1.16 Allowed 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 179.696 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.488 ' N ' ' SG ' ' A' ' 83' ' ' CYS . 37.6 tt0 -96.01 162.01 13.74 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -72.01 107.1 2.09 Favored Glycine 0 N--CA 1.493 2.486 0 N-CA-C 105.078 -3.209 . . . . 0.0 105.078 179.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -93.13 25.06 3.44 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 -179.643 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 29.4 t -129.4 123.39 31.54 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-N 114.338 -1.301 . . . . 0.0 108.97 179.655 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.583 ' H ' HD22 ' A' ' 91' ' ' ASN . 16.4 t70 -85.56 144.61 40.42 Favored Pre-proline 0 N--CA 1.492 1.671 0 CA-C-N 114.442 -1.253 . . . . 0.0 108.126 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_endo -61.86 79.76 0.09 OUTLIER 'Trans proline' 0 N--CA 1.496 1.64 0 C-N-CA 122.574 2.183 . . . . 0.0 108.414 165.131 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 58.2 ttt85 -169.78 -52.86 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 105.515 -2.032 . . . . 0.0 105.515 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.583 HD22 ' H ' ' A' ' 88' ' ' ASP . 2.7 p30 -91.54 115.55 64.71 Favored Pre-proline 0 N--CA 1.497 1.92 0 O-C-N 124.83 1.331 . . . . 0.0 111.237 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -83.45 49.38 2.93 Favored 'Trans proline' 0 N--CA 1.495 1.571 0 C-N-CA 123.484 2.789 . . . . 0.0 109.549 170.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -106.56 152.4 23.75 Favored 'General case' 0 N--CA 1.498 1.938 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.79 -179.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -152.61 154.81 36.11 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-N 115.01 -0.996 . . . . 0.0 111.245 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 66.3 m -84.99 -179.53 1.5 Allowed Pre-proline 0 N--CA 1.498 1.94 0 CA-C-N 114.394 -1.276 . . . . 0.0 108.682 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_endo -62.98 65.94 0.15 Allowed 'Trans proline' 0 N--CA 1.494 1.525 0 C-N-CA 122.13 1.887 . . . . 0.0 110.318 148.485 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.406 ' NH1' ' SG ' ' A' ' 65' ' ' CYS . 34.6 ttm180 -160.14 26.85 0.17 Allowed 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 106.285 -1.746 . . . . 0.0 106.285 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 29.0 m120 -60.68 117.02 4.83 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-N 114.78 -1.1 . . . . 0.0 109.956 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . 0.407 ' HA ' ' HA ' ' A' ' 62' ' ' CYS . 65.0 m 54.1 86.49 0.05 OUTLIER 'General case' 0 N--CA 1.496 1.87 0 O-C-N 124.854 1.346 . . . . 0.0 110.665 -179.878 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -71.01 109.22 4.79 Favored Pre-proline 0 N--CA 1.498 1.942 0 CA-C-N 115.683 -0.689 . . . . 0.0 111.58 -179.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_endo -69.71 -38.9 7.26 Favored 'Trans proline' 0 N--CA 1.494 1.538 0 C-N-CA 122.157 1.905 . . . . 0.0 109.857 -171.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 35.2 mmt180 -71.27 -11.68 61.05 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-N 113.984 -1.462 . . . . 0.0 113.828 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 8.9 tt -73.38 178.55 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 C-N-CA 118.614 -1.234 . . . . 0.0 109.293 -179.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -134.7 -60.23 0.79 Allowed 'General case' 0 N--CA 1.494 1.741 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.788 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 15.8 p90 -168.7 166.69 11.64 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-N 114.757 -1.11 . . . . 0.0 110.366 -179.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -99.38 116.22 5.52 Favored Glycine 0 N--CA 1.49 2.265 0 CA-C-N 113.861 -1.518 . . . . 0.0 109.417 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 96.2 mt -78.65 92.86 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 N-CA-C 105.766 -1.938 . . . . 0.0 105.766 179.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 17.1 m -79.43 121.03 82.32 Favored Pre-proline 0 N--CA 1.493 1.676 0 CA-C-N 113.995 -1.457 . . . . 0.0 109.096 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo . . . . . 0 N--CA 1.493 1.469 0 C-N-CA 122.259 1.972 . . . . 0.0 110.359 -179.07 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 2.5 tmm_? . . . . . 0 N--CA 1.5 2.048 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 8.3 tp -90.43 51.71 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 CA-C-N 114.257 -1.338 . . . . 0.0 110.293 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.44 ' HA ' ' HA ' ' A' ' 41' ' ' CYS . 1.6 m -82.73 41.14 0.71 Allowed 'General case' 0 N--CA 1.495 1.813 0 CA-C-O 123.056 1.408 . . . . 0.0 114.389 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 91.8 m -91.47 112.86 24.95 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-N 112.657 -2.065 . . . . 0.0 109.127 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.468 ' ND2' ' HA ' ' A' ' 40' ' ' ASN . 40.3 p-10 -115.94 176.93 4.87 Favored 'General case' 0 N--CA 1.501 2.092 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 179.545 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.457 ' SG ' ' CD2' ' A' ' 16' ' ' TYR . 1.8 t -73.08 -27.69 61.87 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 114.322 1.23 . . . . 0.0 114.322 -179.557 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.484 ' SG ' ' N ' ' A' ' 37' ' ' CYS . 53.0 t -80.14 -63.14 1.48 Allowed 'General case' 0 N--CA 1.492 1.674 0 CA-C-N 114.374 -1.285 . . . . 0.0 113.936 -179.602 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -90.22 19.38 5.11 Favored 'General case' 0 N--CA 1.502 2.16 0 N-CA-C 113.619 0.97 . . . . 0.0 113.619 -179.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -83.45 -111.57 0.54 Allowed Glycine 0 N--CA 1.499 2.852 0 C-N-CA 120.6 -0.81 . . . . 0.0 111.57 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 40.7 p -137.08 112.22 9.07 Favored 'General case' 0 N--CA 1.504 2.235 0 CA-C-O 121.073 0.463 . . . . 0.0 111.892 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 8.5 tmtt? -62.53 150.19 41.0 Favored 'General case' 0 N--CA 1.487 1.389 0 CA-C-O 121.241 0.543 . . . . 0.0 111.154 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 76.45 -10.27 17.68 Favored Glycine 0 N--CA 1.489 2.195 0 CA-C-N 114.301 -1.318 . . . . 0.0 111.806 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 69.0 m -102.52 127.73 49.46 Favored 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 119.561 -0.856 . . . . 0.0 108.901 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -70.84 92.36 0.9 Allowed 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 113.267 -1.788 . . . . 0.0 109.112 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.665 ' CD2' ' SG ' ' A' ' 25' ' ' CYS . 78.6 m-85 -44.94 131.13 7.35 Favored 'General case' 0 N--CA 1.502 2.161 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 179.753 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -144.99 150.38 36.82 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 125.139 1.524 . . . . 0.0 112.532 -179.421 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 40.5 t -96.1 134.46 39.14 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-N 111.969 -2.378 . . . . 0.0 111.828 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -51.05 -24.73 4.1 Favored 'General case' 0 N--CA 1.501 2.097 0 CA-C-N 112.941 -1.936 . . . . 0.0 113.9 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 25.7 p30 -59.59 -8.86 2.15 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 124.178 0.924 . . . . 0.0 112.361 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 97.07 28.71 8.47 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 86.5 m -140.64 143.07 34.96 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 123.998 0.47 . . . . 0.0 110.399 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.452 ' CG ' ' N ' ' A' ' 24' ' ' VAL . 39.1 t80 -69.54 167.92 15.77 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 124.802 1.314 . . . . 0.0 111.132 179.8 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.452 ' N ' ' CG ' ' A' ' 23' ' ' PHE . 98.6 t -132.51 -74.45 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 123.842 0.714 . . . . 0.0 112.885 -179.79 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.665 ' SG ' ' CD2' ' A' ' 16' ' ' TYR . 20.5 p -147.24 -175.7 4.94 Favored 'General case' 0 N--CA 1.509 2.506 0 C-N-CA 121.04 -0.264 . . . . 0.0 110.708 -179.623 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 7.4 tm-20 -103.74 143.83 32.28 Favored 'General case' 0 N--CA 1.508 2.467 0 N-CA-C 113.402 0.89 . . . . 0.0 113.402 -179.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.571 ' HA2' ' CE2' ' A' ' 16' ' ' TYR . . . -43.98 105.62 0.08 OUTLIER Glycine 0 N--CA 1.501 3.013 0 O-C-N 124.437 1.085 . . . . 0.0 115.039 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -122.63 37.22 4.45 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 17.5 t -121.82 65.97 0.91 Allowed 'General case' 0 N--CA 1.499 1.996 0 CA-C-O 121.815 0.816 . . . . 0.0 110.959 -179.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.428 ' H ' ' ND2' ' A' ' 33' ' ' ASN . 14.3 t70 -88.37 142.61 31.53 Favored Pre-proline 0 N--CA 1.493 1.72 0 CA-C-N 113.886 -1.506 . . . . 0.0 108.528 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -56.64 -4.72 0.92 Allowed 'Trans proline' 0 N--CA 1.497 1.727 0 C-N-CA 122.316 2.011 . . . . 0.0 114.568 175.163 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.424 ' HA ' ' NE ' ' A' ' 32' ' ' ARG . 12.3 mmp_? -94.48 -27.76 15.82 Favored 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 113.148 0.795 . . . . 0.0 113.148 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.428 ' ND2' ' H ' ' A' ' 30' ' ' ASP . 19.2 p30 -66.05 121.85 78.2 Favored Pre-proline 0 N--CA 1.497 1.898 0 C-N-CA 119.039 -1.064 . . . . 0.0 112.006 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -75.09 123.13 7.61 Favored 'Trans proline' 0 N--CA 1.492 1.423 0 C-N-CA 122.714 2.276 . . . . 0.0 109.963 178.086 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 62.64 160.52 0.08 Allowed 'General case' 0 N--CA 1.502 2.16 0 O-C-N 124.614 1.196 . . . . 0.0 112.954 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -79.92 -167.1 1.16 Allowed 'General case' 0 N--CA 1.496 1.841 0 CA-C-N 114.694 -1.139 . . . . 0.0 110.099 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.484 ' N ' ' SG ' ' A' ' 8' ' ' CYS . 4.4 m -129.97 160.19 34.38 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 123.712 0.633 . . . . 0.0 110.016 -179.863 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 77.0 m 42.27 -104.72 0.06 Allowed 'General case' 0 N--CA 1.497 1.899 0 CA-C-N 114.261 -1.336 . . . . 0.0 113.167 179.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 96.1 mt -142.18 4.03 1.6 Allowed 'General case' 0 N--CA 1.498 1.962 0 O-C-N 123.585 0.553 . . . . 0.0 112.441 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.468 ' HA ' ' ND2' ' A' ' 6' ' ' ASN . 1.6 m-80 59.07 -174.33 0.1 Allowed 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 114.174 1.176 . . . . 0.0 114.174 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.44 ' HA ' ' HA ' ' A' ' 4' ' ' CYS . 56.8 m 59.88 100.87 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 CA-C-N 113.185 -1.825 . . . . 0.0 113.04 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -120.56 101.66 45.88 Favored Pre-proline 0 N--CA 1.496 1.873 0 CA-C-N 115.32 -0.855 . . . . 0.0 108.789 179.695 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -60.49 -31.57 92.62 Favored 'Trans proline' 0 N--CA 1.494 1.518 0 C-N-CA 122.622 2.215 . . . . 0.0 111.728 -176.23 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 21.6 tpp85 -57.52 -39.91 77.59 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 124.107 0.879 . . . . 0.0 109.175 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 13.7 mt -71.26 152.49 8.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 CA-C-O 122.192 0.996 . . . . 0.0 109.827 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -121.14 -51.2 2.11 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-N 111.773 -2.467 . . . . 0.0 106.503 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 15.8 p90 -172.7 158.9 4.17 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-N 113.186 -1.825 . . . . 0.0 109.736 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -97.86 123.41 7.82 Favored Glycine 0 N--CA 1.49 2.288 0 CA-C-N 113.313 -1.767 . . . . 0.0 108.973 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 27.2 m -90.2 101.05 11.88 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 CA-C-O 122.052 0.929 . . . . 0.0 110.678 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.6 m -79.03 164.03 57.04 Favored Pre-proline 0 N--CA 1.502 2.14 0 CA-C-N 114.502 -1.226 . . . . 0.0 108.98 179.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo . . . . . 0 N--CA 1.494 1.55 0 C-N-CA 122.369 2.046 . . . . 0.0 111.313 173.059 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . 0.424 ' HA ' ' HA ' ' A' ' 99' ' ' CYS . 1.7 m . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 123.02 1.39 . . . . 0.0 112.075 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 52.0 m -90.66 151.02 21.44 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 112.626 -2.079 . . . . 0.0 108.892 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 52.1 p-10 -127.86 -171.06 2.35 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 17.0 t -101.95 -29.97 11.5 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 123.663 0.602 . . . . 0.0 110.95 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 37.2 t -61.87 -55.35 30.64 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 124.102 0.876 . . . . 0.0 109.947 -179.748 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -87.68 63.86 7.74 Favored 'General case' 0 N--CA 1.499 2.025 0 N-CA-C 106.23 -1.767 . . . . 0.0 106.23 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -106.33 -115.87 4.08 Favored Glycine 0 N--CA 1.488 2.164 0 CA-C-N 113.963 -1.471 . . . . 0.0 112.322 -179.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.466 ' H ' ' CA ' ' A' ' 85' ' ' GLY . 2.6 t 179.29 110.67 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 125.278 1.222 . . . . 0.0 109.402 -179.851 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 11.4 mmmm -64.79 88.38 0.06 Allowed 'General case' 0 N--CA 1.499 1.996 0 CA-C-N 114.954 -1.021 . . . . 0.0 108.307 179.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 171.79 -31.73 0.13 Allowed Glycine 0 N--CA 1.487 2.055 0 CA-C-N 113.908 -1.496 . . . . 0.0 110.937 -179.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 67.9 m -112.71 167.15 10.72 Favored 'General case' 0 N--CA 1.5 2.058 0 C-N-CA 119.46 -0.896 . . . . 0.0 111.139 -179.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 61.1 mtpt -111.14 100.91 9.48 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-N 114.074 -1.421 . . . . 0.0 113.775 -179.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.4 ' N ' ' O ' ' A' ' 83' ' ' CYS . 5.0 m-85 -52.71 141.63 20.56 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 124.265 0.978 . . . . 0.0 109.988 179.466 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -154.77 159.45 40.64 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 113.684 -1.598 . . . . 0.0 112.964 -179.426 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' SER . . . . . 0.483 ' HG ' ' HE ' ' A' ' 102' ' ' ARG . 73.0 p -100.24 135.08 42.21 Favored 'General case' 0 N--CA 1.486 1.358 0 CA-C-N 114.014 -1.448 . . . . 0.0 113.179 -179.768 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.439 ' H ' ' HB1' ' A' ' 104' ' ' ALA . 4.6 p-10 -40.01 -47.19 2.22 Favored 'General case' 0 N--CA 1.499 2.005 0 CA-C-N 112.82 -1.991 . . . . 0.0 115.978 -179.867 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -52.9 -36.05 58.95 Favored 'General case' 0 N--CA 1.497 1.88 0 CA-C-N 114.724 -1.125 . . . . 0.0 112.38 -179.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 128.43 42.68 0.24 Allowed Glycine 0 N--CA 1.494 2.539 0 O-C-N 124.772 1.295 . . . . 0.0 111.594 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 95.1 m -140.84 114.07 8.58 Favored 'General case' 0 N--CA 1.497 1.876 0 C-N-CA 119.469 -0.893 . . . . 0.0 112.739 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -54.18 139.69 34.83 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 99.5 t -103.88 -63.98 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 CA-C-N 114.571 -1.195 . . . . 0.0 112.183 -179.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . 0.415 ' SG ' ' N ' ' A' ' 84' ' ' GLU . 1.8 p -160.28 -162.98 1.03 Allowed 'General case' 0 N--CA 1.501 2.083 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 -179.8 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.415 ' N ' ' SG ' ' A' ' 83' ' ' CYS . 30.4 tt0 -118.36 144.7 45.69 Favored 'General case' 0 N--CA 1.5 2.069 0 N-CA-C 105.992 -1.855 . . . . 0.0 105.992 179.298 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.466 ' CA ' ' H ' ' A' ' 69' ' ' THR . . . -60.17 135.78 50.03 Favored Glycine 0 N--CA 1.496 2.689 0 N-CA-C 108.154 -1.979 . . . . 0.0 108.154 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -105.71 -7.89 18.17 Favored 'General case' 0 N--CA 1.503 2.195 0 N-CA-C 116.722 2.119 . . . . 0.0 116.722 -179.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.413 ' HG ' HD22 ' A' ' 91' ' ' ASN . 26.8 t -70.06 97.09 1.12 Allowed 'General case' 0 N--CA 1.501 2.115 0 C-N-CA 119.001 -1.08 . . . . 0.0 108.757 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -79.74 143.81 59.18 Favored Pre-proline 0 N--CA 1.494 1.74 0 CA-C-N 114.855 -1.066 . . . . 0.0 109.765 -179.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -46.66 -22.34 1.79 Allowed 'Trans proline' 0 N--CA 1.499 1.817 0 C-N-CA 122.887 2.392 . . . . 0.0 113.017 170.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 3.7 tpm_? -62.14 -53.08 60.42 Favored 'General case' 0 N--CA 1.495 1.775 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.413 HD22 ' HG ' ' A' ' 87' ' ' SER . 2.4 p-10 -84.63 131.95 48.16 Favored Pre-proline 0 N--CA 1.492 1.663 0 CA-C-N 115.079 -0.964 . . . . 0.0 108.99 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -79.26 56.9 6.23 Favored 'Trans proline' 0 N--CA 1.492 1.388 0 C-N-CA 123.029 2.486 . . . . 0.0 108.181 163.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 27.7 mtpp 65.29 121.31 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.082 0 CA-C-N 114.585 -1.188 . . . . 0.0 110.923 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -153.25 68.21 0.8 Allowed 'General case' 0 N--CA 1.496 1.839 0 CA-C-N 114.665 -1.152 . . . . 0.0 108.134 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 89.7 m -154.11 160.56 30.8 Favored Pre-proline 0 N--CA 1.496 1.855 0 CA-C-N 114.263 -1.335 . . . . 0.0 111.967 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -73.41 -159.27 0.08 OUTLIER 'Trans proline' 0 N--CA 1.493 1.442 0 C-N-CA 122.973 2.449 . . . . 0.0 109.792 160.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.55 52.25 1.12 Allowed 'General case' 0 N--CA 1.494 1.772 0 CA-C-O 122.392 1.092 . . . . 0.0 108.284 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -47.04 113.9 0.75 Allowed 'General case' 0 N--CA 1.5 2.051 0 CA-C-N 113.054 -1.885 . . . . 0.0 110.565 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . 0.424 ' HA ' ' HA ' ' A' ' 62' ' ' CYS . 56.2 m -60.07 121.7 12.53 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 119.926 -0.709 . . . . 0.0 111.095 -179.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 42.0 t0 -112.22 91.09 15.24 Favored Pre-proline 0 N--CA 1.494 1.762 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -58.34 -31.44 93.88 Favored 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 122.708 2.272 . . . . 0.0 111.143 -169.033 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.483 ' HE ' ' HG ' ' A' ' 76' ' ' SER . 15.7 tpt180 -73.04 -40.39 65.16 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-N 114.366 -1.288 . . . . 0.0 112.305 -179.858 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 3.3 tt -58.67 162.54 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 O-C-N 123.524 0.515 . . . . 0.0 112.048 -179.592 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.439 ' HB1' ' H ' ' A' ' 77' ' ' ASP . . . -139.96 -57.81 0.56 Allowed 'General case' 0 N--CA 1.495 1.824 0 CA-C-N 114.411 -1.268 . . . . 0.0 109.172 179.807 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 15.3 p90 -165.62 163.41 19.25 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-N 114.816 -1.084 . . . . 0.0 110.917 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -111.32 115.22 3.87 Favored Glycine 0 N--CA 1.493 2.444 0 CA-C-N 114.077 -1.419 . . . . 0.0 111.974 -179.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 51.5 mm -93.01 124.54 45.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 124.52 0.777 . . . . 0.0 110.054 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 1.7 m -79.61 148.17 68.99 Favored Pre-proline 0 N--CA 1.495 1.82 0 O-C-N 124.024 0.827 . . . . 0.0 109.706 179.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo . . . . . 0 N--CA 1.494 1.559 0 C-N-CA 122.866 2.378 . . . . 0.0 111.457 -175.249 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 86.3 mtm180 . . . . . 0 N--CA 1.501 2.099 0 CA-C-O 121.619 0.723 . . . . 0.0 111.51 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 8.7 tp -84.04 48.5 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 CA-C-N 114.445 -1.252 . . . . 0.0 109.982 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.47 ' HA ' ' HA ' ' A' ' 41' ' ' CYS . 1.5 m -83.42 57.29 3.94 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 115.668 1.729 . . . . 0.0 115.668 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 37.3 p -91.8 176.6 6.47 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-N 113.143 -1.844 . . . . 0.0 110.183 179.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.488 HD22 ' N ' ' A' ' 37' ' ' CYS . 34.2 p30 -162.04 -172.72 3.35 Favored 'General case' 0 N--CA 1.495 1.807 0 CA-C-N 114.276 -1.329 . . . . 0.0 108.026 179.189 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.8 t -75.98 -10.15 59.19 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 115.737 1.754 . . . . 0.0 115.737 -179.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 6.7 t -91.79 -37.52 12.91 Favored 'General case' 0 N--CA 1.503 2.177 0 CA-C-O 121.587 0.708 . . . . 0.0 111.667 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -74.34 57.76 0.7 Allowed 'General case' 0 N--CA 1.497 1.909 0 CA-C-N 113.085 -1.87 . . . . 0.0 113.568 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -162.16 -121.9 0.59 Allowed Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 86.7 m -140.29 124.28 17.5 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 123.88 0.4 . . . . 0.0 111.851 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 40.4 ttpt -67.42 86.67 0.18 Allowed 'General case' 0 N--CA 1.496 1.865 0 O-C-N 124.618 1.199 . . . . 0.0 109.308 179.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.44 ' H ' ' HA3' ' A' ' 27' ' ' GLY . . . 156.15 -19.13 0.47 Allowed Glycine 0 N--CA 1.494 2.56 0 CA-C-N 114.855 -1.066 . . . . 0.0 110.661 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 87.7 m -89.43 -177.8 5.43 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -130.54 101.97 5.94 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 123.477 0.486 . . . . 0.0 110.218 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.632 ' CD1' ' SG ' ' A' ' 25' ' ' CYS . 85.0 m-85 -55.85 141.66 38.09 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 124.116 0.885 . . . . 0.0 109.08 179.806 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -149.65 151.71 34.18 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 124.874 1.359 . . . . 0.0 112.699 -179.685 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 96.2 p -101.69 132.7 47.25 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-N 113.272 -1.786 . . . . 0.0 112.476 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.425 ' H ' ' CB ' ' A' ' 46' ' ' ALA . 6.1 p-10 -45.24 -31.17 1.42 Allowed 'General case' 0 N--CA 1.504 2.239 0 N-CA-C 116.643 2.09 . . . . 0.0 116.643 -179.709 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -55.2 -15.87 2.7 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 123.989 0.805 . . . . 0.0 112.738 -179.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 108.88 25.28 5.72 Favored Glycine 0 N--CA 1.493 2.448 0 O-C-N 124.419 1.074 . . . . 0.0 111.003 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 57.0 m -135.64 152.06 50.85 Favored 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 120.437 -0.505 . . . . 0.0 110.513 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.406 ' CG ' ' N ' ' A' ' 24' ' ' VAL . 17.5 t80 -74.67 169.54 17.63 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-N 114.546 -1.207 . . . . 0.0 109.824 179.706 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.406 ' N ' ' CG ' ' A' ' 23' ' ' PHE . 93.8 t -131.25 -67.85 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 O-C-N 123.689 0.618 . . . . 0.0 112.635 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.632 ' SG ' ' CD1' ' A' ' 16' ' ' TYR . 11.9 p -153.75 -172.62 4.28 Favored 'General case' 0 N--CA 1.504 2.228 0 C-N-CA 120.256 -0.577 . . . . 0.0 109.469 -179.771 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -126.67 143.2 51.31 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 123.705 0.628 . . . . 0.0 110.906 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.44 ' HA3' ' H ' ' A' ' 13' ' ' GLY . . . -27.41 124.43 0.06 OUTLIER Glycine 0 N--CA 1.495 2.621 0 O-C-N 124.941 1.401 . . . . 0.0 116.09 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -114.69 -22.42 9.72 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 124.582 0.813 . . . . 0.0 110.244 179.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 47.4 t -156.56 154.38 30.17 Favored 'General case' 0 N--CA 1.497 1.916 0 CA-C-O 121.522 0.677 . . . . 0.0 111.153 -179.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -78.85 141.28 59.13 Favored Pre-proline 0 N--CA 1.496 1.856 0 CA-C-N 113.401 -1.727 . . . . 0.0 108.76 -179.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -61.61 -12.94 27.05 Favored 'Trans proline' 0 N--CA 1.496 1.647 0 C-N-CA 122.766 2.311 . . . . 0.0 113.452 -165.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 23.5 mmm180 -56.88 -23.51 45.07 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 123.792 0.683 . . . . 0.0 110.968 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.463 HD21 ' H ' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -64.28 112.95 8.74 Favored Pre-proline 0 N--CA 1.492 1.639 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 179.779 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -81.24 39.02 0.81 Allowed 'Trans proline' 0 N--CA 1.496 1.675 0 C-N-CA 123.222 2.615 . . . . 0.0 112.203 -175.216 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -175.82 155.87 1.73 Allowed 'General case' 0 N--CA 1.497 1.91 0 CA-C-N 115.197 -0.911 . . . . 0.0 111.831 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -82.95 143.48 30.65 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 179.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.488 ' N ' HD22 ' A' ' 6' ' ' ASN . 1.6 m -105.69 -140.58 0.37 Allowed 'General case' 0 N--CA 1.499 2.0 0 O-C-N 123.725 0.641 . . . . 0.0 109.322 -179.788 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 58.5 p 35.33 -141.59 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.186 0 N-CA-C 114.081 1.141 . . . . 0.0 114.081 179.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -80.32 -7.09 58.9 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 123.713 0.633 . . . . 0.0 111.776 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 19.1 m120 62.62 158.07 0.06 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 124.756 1.285 . . . . 0.0 112.972 -179.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.47 ' HA ' ' HA ' ' A' ' 4' ' ' CYS . 82.4 m 54.76 116.51 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 116.341 1.978 . . . . 0.0 116.341 -179.817 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -148.11 90.97 4.93 Favored Pre-proline 0 N--CA 1.491 1.619 0 CA-C-N 113.707 -1.588 . . . . 0.0 108.979 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -62.07 -17.55 56.87 Favored 'Trans proline' 0 N--CA 1.492 1.4 0 C-N-CA 122.58 2.187 . . . . 0.0 111.922 175.515 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 33.3 mmt180 -64.01 -33.6 76.11 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 123.844 0.715 . . . . 0.0 109.987 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 4.3 mt -68.79 137.13 24.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 CA-C-O 121.959 0.885 . . . . 0.0 111.401 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.425 ' CB ' ' H ' ' A' ' 19' ' ' ASP . . . -127.58 -53.73 1.35 Allowed 'General case' 0 N--CA 1.494 1.739 0 CA-C-N 112.327 -2.215 . . . . 0.0 109.372 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 30.5 m-85 -137.01 -166.37 1.9 Allowed 'General case' 0 N--CA 1.494 1.764 0 CA-C-N 114.332 -1.303 . . . . 0.0 108.591 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -160.63 104.81 0.25 Allowed Glycine 0 N--CA 1.489 2.178 0 N-CA-C 107.519 -2.232 . . . . 0.0 107.519 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.2 p -79.75 123.3 36.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 -179.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 57.1 m -102.27 148.55 35.58 Favored Pre-proline 0 N--CA 1.496 1.871 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.919 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo . . . . . 0 N--CA 1.492 1.41 0 C-N-CA 122.652 2.234 . . . . 0.0 108.56 173.307 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 1.8 m . . . . . 0 N--CA 1.493 1.684 0 CA-C-O 122.933 1.349 . . . . 0.0 112.492 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 52.8 m -90.43 167.75 12.38 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 112.628 -2.078 . . . . 0.0 109.088 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 40.8 p30 -151.84 -175.43 5.22 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-N 114.816 -1.084 . . . . 0.0 108.441 179.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 37.1 t -94.19 -29.0 15.34 Favored 'General case' 0 N--CA 1.497 1.893 0 C-N-CA 120.168 -0.613 . . . . 0.0 112.311 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 37.5 t -59.7 -57.85 11.14 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 124.209 0.943 . . . . 0.0 111.166 -179.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -88.11 41.43 1.0 Allowed 'General case' 0 N--CA 1.494 1.768 0 CA-C-N 112.946 -1.934 . . . . 0.0 109.184 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -79.85 -136.0 1.41 Allowed Glycine 0 N--CA 1.492 2.433 0 N-CA-C 110.092 -1.203 . . . . 0.0 110.092 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 97.3 m -159.07 95.8 1.29 Allowed 'General case' 0 N--CA 1.501 2.081 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 39.9 mmtt -45.72 117.04 1.33 Allowed 'General case' 0 N--CA 1.505 2.305 0 O-C-N 123.731 0.644 . . . . 0.0 112.0 179.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 133.04 -34.64 2.42 Favored Glycine 0 N--CA 1.494 2.507 0 O-C-N 124.643 1.214 . . . . 0.0 110.368 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 63.6 m -101.77 136.8 40.99 Favored 'General case' 0 N--CA 1.494 1.743 0 CA-C-O 121.571 0.701 . . . . 0.0 110.686 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 4.3 mptp? -85.02 88.99 7.5 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 113.315 -1.766 . . . . 0.0 109.589 -179.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.41 ' HA ' ' HA2' ' A' ' 106' ' ' GLY . 35.3 m-85 -48.46 129.2 15.8 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 124.346 1.029 . . . . 0.0 109.107 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -141.0 152.54 45.0 Favored 'General case' 0 C--N 1.303 -1.413 0 CA-C-N 112.491 -2.14 . . . . 0.0 113.219 -179.109 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 80.6 p -92.86 136.28 33.39 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-N 113.056 -1.884 . . . . 0.0 114.744 -179.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -49.45 -29.53 6.7 Favored 'General case' 0 N--CA 1.5 2.035 0 CA-C-N 112.689 -2.05 . . . . 0.0 115.523 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -57.91 -15.33 8.35 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 123.855 0.722 . . . . 0.0 112.548 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 108.62 27.7 4.84 Favored Glycine 0 N--CA 1.494 2.526 0 O-C-N 124.33 1.019 . . . . 0.0 111.149 179.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 60.4 m -138.85 160.01 40.75 Favored 'General case' 0 N--CA 1.496 1.852 0 C-N-CA 120.534 -0.466 . . . . 0.0 110.028 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . 0.432 ' CG ' ' N ' ' A' ' 82' ' ' VAL . 57.4 t80 -79.7 168.3 19.52 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-N 114.758 -1.11 . . . . 0.0 110.554 179.761 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.432 ' N ' ' CG ' ' A' ' 81' ' ' PHE . 89.1 t -133.12 -73.52 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 124.054 0.846 . . . . 0.0 110.335 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . 0.422 ' SG ' ' N ' ' A' ' 84' ' ' GLU . 1.1 p -154.72 -167.23 2.54 Favored 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 -179.771 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.422 ' N ' ' SG ' ' A' ' 83' ' ' CYS . 32.4 tt0 -118.93 152.53 36.16 Favored 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 104.124 -2.547 . . . . 0.0 104.124 179.335 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -53.77 127.85 38.6 Favored Glycine 0 N--CA 1.498 2.777 0 C-N-CA 119.834 -1.174 . . . . 0.0 110.187 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -89.58 -25.15 21.49 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 123.905 0.414 . . . . 0.0 111.625 -179.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 70.9 p -69.6 96.14 0.91 Allowed 'General case' 0 N--CA 1.49 1.549 0 CA-C-O 121.765 0.793 . . . . 0.0 111.113 -179.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -97.25 136.4 21.44 Favored Pre-proline 0 N--CA 1.493 1.719 0 N-CA-C 106.807 -1.553 . . . . 0.0 106.807 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo -43.83 -26.52 1.31 Allowed 'Trans proline' 0 N--CA 1.501 1.962 0 C-N-CA 122.659 2.239 . . . . 0.0 111.515 167.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 37.4 ttp85 -65.85 -54.66 23.84 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-N 113.849 -1.523 . . . . 0.0 109.395 179.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 21.6 p30 -90.05 138.93 27.29 Favored Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 124.097 0.873 . . . . 0.0 111.961 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -81.17 49.82 3.35 Favored 'Trans proline' 0 N--CA 1.49 1.268 0 C-N-CA 123.068 2.512 . . . . 0.0 109.25 160.544 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.493 ' NZ ' ' H ' ' A' ' 94' ' ' ALA . 0.2 OUTLIER -67.32 148.47 51.63 Favored 'General case' 0 N--CA 1.498 1.935 0 CA-C-O 121.506 0.669 . . . . 0.0 110.214 -179.961 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.493 ' H ' ' NZ ' ' A' ' 93' ' ' LYS . . . -160.32 152.96 21.04 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-N 113.491 -1.686 . . . . 0.0 110.354 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 86.1 m -156.34 167.47 14.32 Favored Pre-proline 0 N--CA 1.498 1.969 0 CA-C-N 114.644 -1.162 . . . . 0.0 109.245 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -55.37 -161.59 0.01 OUTLIER 'Trans proline' 0 N--CA 1.497 1.721 0 C-N-CA 122.717 2.278 . . . . 0.0 112.642 164.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 79.9 mtp180 -78.88 -43.2 25.47 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 36.3 m-80 46.53 54.98 8.07 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 124.945 1.403 . . . . 0.0 108.874 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 60.2 m -42.93 125.87 3.64 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-N 113.471 -1.695 . . . . 0.0 113.714 -179.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 45.0 t0 -116.93 86.27 19.29 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 124.687 1.242 . . . . 0.0 107.853 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -52.9 -26.52 31.59 Favored 'Trans proline' 0 N--CA 1.496 1.653 0 C-N-CA 122.808 2.339 . . . . 0.0 112.833 -178.138 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 78.0 ttt-85 -82.37 -33.93 28.59 Favored 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 114.552 1.315 . . . . 0.0 114.552 -179.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 8.8 tt -63.97 168.68 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.239 0 C-N-CA 120.192 -0.603 . . . . 0.0 110.92 -179.607 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -145.93 -72.3 0.24 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 123.81 0.694 . . . . 0.0 111.327 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 27.4 p90 -149.8 158.99 44.7 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 123.94 0.775 . . . . 0.0 112.041 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.41 ' HA2' ' HA ' ' A' ' 74' ' ' TYR . . . -98.73 114.28 4.98 Favored Glycine 0 N--CA 1.491 2.323 0 CA-C-N 112.949 -1.932 . . . . 0.0 111.444 -179.837 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 70.6 mt -79.85 97.38 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 CA-C-N 114.282 -0.959 . . . . 0.0 111.137 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 1.6 m -79.35 148.82 71.3 Favored Pre-proline 0 N--CA 1.502 2.172 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 179.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo . . . . . 0 N--CA 1.493 1.458 0 C-N-CA 122.549 2.166 . . . . 0.0 110.527 -179.384 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 8.4 ptp180 . . . . . 0 N--CA 1.496 1.856 0 CA-C-O 120.549 0.214 . . . . 0.0 110.67 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 46.1 mm -77.85 91.61 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 124.132 0.895 . . . . 0.0 108.915 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.422 ' H ' ' HB3' ' A' ' 41' ' ' CYS . 0.5 OUTLIER -84.52 -160.23 0.46 Allowed 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 106.04 -1.837 . . . . 0.0 106.04 -179.997 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.8 t -73.48 -169.26 0.65 Allowed 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 179.536 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.434 ' ND2' HD13 ' A' ' 45' ' ' ILE . 4.4 t-20 -122.65 166.84 14.24 Favored 'General case' 0 N--CA 1.497 1.893 0 CA-C-O 122.614 1.197 . . . . 0.0 112.356 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.465 ' HA ' ' CE2' ' A' ' 16' ' ' TYR . 19.9 t 43.28 26.29 0.09 Allowed 'General case' 0 N--CA 1.493 1.71 0 CA-C-N 111.189 -2.732 . . . . 0.0 113.925 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 28.0 t -90.14 -68.46 0.78 Allowed 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 116.639 2.089 . . . . 0.0 116.639 -179.635 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -57.6 -4.47 0.27 Allowed 'General case' 0 N--CA 1.506 2.37 0 N-CA-C 118.367 2.729 . . . . 0.0 118.367 -179.494 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.414 ' N ' ' OH ' ' A' ' 16' ' ' TYR . . . -65.0 -39.22 96.29 Favored Glycine 0 N--CA 1.493 2.465 0 N-CA-C 110.941 -0.864 . . . . 0.0 110.941 -179.791 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 38.8 m 68.49 112.22 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.844 0 O-C-N 125.62 1.424 . . . . 0.0 107.164 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 14.8 tppt? -37.99 98.43 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.088 0 O-C-N 124.693 1.245 . . . . 0.0 113.0 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 157.82 -22.15 0.39 Allowed Glycine 0 N--CA 1.49 2.262 0 CA-C-N 112.686 -2.052 . . . . 0.0 108.686 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 90.9 m -103.98 169.25 8.61 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 62.3 mttp -124.32 95.12 4.42 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 123.972 0.795 . . . . 0.0 112.18 -179.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.584 ' HB2' ' SG ' ' A' ' 25' ' ' CYS . 6.5 m-85 -49.42 144.76 5.26 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-N 114.104 -1.407 . . . . 0.0 112.122 179.541 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -154.8 164.16 39.21 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 112.914 -1.948 . . . . 0.0 112.057 -179.39 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 40.0 t -118.04 138.83 51.95 Favored 'General case' 0 N--CA 1.495 1.823 0 CA-C-N 113.577 -1.647 . . . . 0.0 112.167 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -46.39 -24.42 0.49 Allowed 'General case' 0 N--CA 1.499 2.025 0 CA-C-N 111.76 -2.473 . . . . 0.0 113.912 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 14.7 p30 -60.87 -6.14 1.67 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 124.117 0.885 . . . . 0.0 112.126 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 92.37 27.2 15.94 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 110.401 -1.08 . . . . 0.0 110.401 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 96.5 m -144.39 141.9 29.98 Favored 'General case' 0 N--CA 1.494 1.761 0 C-N-CA 120.187 -0.605 . . . . 0.0 111.892 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 10.3 t80 -62.77 161.92 11.74 Favored 'General case' 0 N--CA 1.497 1.921 0 CA-C-N 114.14 -1.391 . . . . 0.0 109.915 179.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 62.5 t -131.7 -57.16 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 123.893 0.745 . . . . 0.0 112.745 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.584 ' SG ' ' HB2' ' A' ' 16' ' ' TYR . 7.5 p -158.62 -167.29 2.1 Favored 'General case' 0 N--CA 1.503 2.221 0 C-N-CA 119.657 -0.817 . . . . 0.0 109.749 -179.686 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -122.18 136.89 54.97 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 106.547 -1.649 . . . . 0.0 106.547 179.463 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -40.35 129.41 2.93 Favored Glycine 0 N--CA 1.503 3.127 0 O-C-N 123.657 0.598 . . . . 0.0 112.322 179.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -79.81 -52.78 7.48 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 114.023 1.12 . . . . 0.0 114.023 -179.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 55.7 m -50.28 86.61 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 116.425 2.009 . . . . 0.0 116.425 -179.281 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.59 ' H ' HD22 ' A' ' 33' ' ' ASN . 29.5 t70 -86.63 126.09 65.08 Favored Pre-proline 0 N--CA 1.489 1.511 0 N-CA-C 105.358 -2.09 . . . . 0.0 105.358 179.752 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_endo -63.45 73.83 0.14 Allowed 'Trans proline' 0 N--CA 1.5 1.863 0 C-N-CA 123.687 2.925 . . . . 0.0 113.585 -153.029 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.409 ' N ' ' O ' ' A' ' 30' ' ' ASP . 1.5 mpp_? -158.84 -47.13 0.06 Allowed 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 105.384 -2.08 . . . . 0.0 105.384 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.59 HD22 ' H ' ' A' ' 30' ' ' ASP . 12.6 p30 -78.33 136.59 60.55 Favored Pre-proline 0 N--CA 1.494 1.76 0 C-N-CA 119.526 -0.87 . . . . 0.0 109.708 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -68.8 119.73 6.7 Favored 'Trans proline' 0 N--CA 1.493 1.489 0 C-N-CA 122.736 2.291 . . . . 0.0 110.184 -178.232 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 14.3 ptmm? -107.08 157.4 17.86 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 124.18 0.925 . . . . 0.0 110.415 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -160.39 73.71 0.52 Allowed 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 27.9 m -152.8 -174.45 4.92 Favored 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 121.949 0.881 . . . . 0.0 111.744 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.476 ' HB ' ' SG ' ' A' ' 41' ' ' CYS . 83.6 m -141.51 157.81 44.66 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 104.464 -2.421 . . . . 0.0 104.464 179.638 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.4 HD11 ' N ' ' A' ' 39' ' ' LEU . 5.0 mp -79.45 -21.38 45.56 Favored 'General case' 0 N--CA 1.498 1.946 0 C-N-CA 119.439 -0.904 . . . . 0.0 110.361 -179.788 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -94.37 37.92 1.1 Allowed 'General case' 0 N--CA 1.497 1.879 0 CA-C-O 121.976 0.893 . . . . 0.0 110.165 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.476 ' SG ' ' HB ' ' A' ' 38' ' ' THR . 67.4 m -98.71 -95.5 0.23 Allowed 'General case' 0 N--CA 1.494 1.769 0 CA-C-N 113.598 -1.637 . . . . 0.0 107.409 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.413 ' HB3' ' ND2' ' A' ' 6' ' ' ASN . 16.7 t70 -54.13 131.12 59.9 Favored Pre-proline 0 N--CA 1.501 2.117 0 C-N-CA 120.601 -0.44 . . . . 0.0 110.401 179.796 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -68.78 -23.28 35.82 Favored 'Trans proline' 0 N--CA 1.493 1.489 0 C-N-CA 122.27 1.98 . . . . 0.0 111.633 -164.054 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 58.4 ttt85 -58.14 -38.42 76.54 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 124.031 0.832 . . . . 0.0 110.611 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.542 HD12 ' CD1' ' A' ' 16' ' ' TYR . 15.4 mt -98.85 154.15 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 CA-C-O 122.67 1.224 . . . . 0.0 113.857 -179.826 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -112.17 -56.16 2.43 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-N 110.907 -2.86 . . . . 0.0 107.766 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 53.6 p90 -166.49 173.53 9.77 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-N 114.776 -1.102 . . . . 0.0 109.621 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -125.86 122.13 4.39 Favored Glycine 0 N--CA 1.494 2.502 0 CA-C-N 114.198 -1.365 . . . . 0.0 110.128 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.5 p -79.5 122.71 35.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 11.3 m -100.09 104.93 32.39 Favored Pre-proline 0 N--CA 1.496 1.828 0 CA-C-N 115.083 -0.962 . . . . 0.0 108.729 -179.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo . . . . . 0 N--CA 1.49 1.302 0 C-N-CA 122.381 2.054 . . . . 0.0 109.798 -176.258 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 7.7 m . . . . . 0 N--CA 1.491 1.616 0 N-CA-C 115.601 1.704 . . . . 0.0 115.601 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 7.9 p -90.38 173.67 7.98 Favored 'General case' 0 N--CA 1.495 1.81 0 CA-C-N 114.174 -1.376 . . . . 0.0 109.084 179.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -161.38 149.46 15.43 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-N 114.631 -1.168 . . . . 0.0 108.782 179.772 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 11.2 t -55.86 -17.37 6.2 Favored 'General case' 0 N--CA 1.5 2.069 0 N-CA-C 113.97 1.1 . . . . 0.0 113.97 -179.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 52.1 t -82.72 -43.41 16.85 Favored 'General case' 0 N--CA 1.498 1.96 0 CA-C-N 114.138 -1.392 . . . . 0.0 112.553 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -73.62 61.91 0.75 Allowed 'General case' 0 N--CA 1.5 2.074 0 O-C-N 125.765 1.915 . . . . 0.0 114.784 -179.575 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -169.52 -155.12 9.68 Favored Glycine 0 N--CA 1.486 1.983 0 CA-C-N 112.726 -2.034 . . . . 0.0 108.303 179.599 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.409 ' C ' ' H ' ' A' ' 71' ' ' GLY . 57.5 p -145.31 159.71 42.63 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 124.018 0.481 . . . . 0.0 110.505 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 59.0 mtpt -71.76 38.51 0.07 Allowed 'General case' 0 N--CA 1.502 2.173 0 O-C-N 125.469 1.731 . . . . 0.0 113.938 179.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.409 ' H ' ' C ' ' A' ' 69' ' ' THR . . . -132.83 1.92 4.75 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 108.448 -1.861 . . . . 0.0 108.448 179.675 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . 0.401 ' HA ' ' HA ' ' A' ' 108' ' ' CYS . 96.0 m -135.54 170.73 15.49 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 123.905 0.415 . . . . 0.0 111.729 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 48.6 mtmt -130.06 105.67 8.11 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.234 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.696 ' CD1' ' SG ' ' A' ' 83' ' ' CYS . 88.2 m-85 -53.82 144.29 18.82 Favored 'General case' 0 N--CA 1.505 2.285 0 O-C-N 123.525 0.515 . . . . 0.0 110.122 179.8 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.48 ' CE2' ' HA ' ' A' ' 80' ' ' THR . 9.3 t80 -149.32 158.01 43.82 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 124.653 1.221 . . . . 0.0 113.287 -179.572 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 28.2 t -121.12 129.71 53.41 Favored 'General case' 0 N--CA 1.499 1.993 0 CA-C-N 112.05 -2.341 . . . . 0.0 112.145 -179.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.431 ' CG ' ' H ' ' A' ' 78' ' ' ASP . 9.2 p-10 -47.66 -59.19 3.46 Favored 'General case' 0 N--CA 1.495 1.81 0 CA-C-N 113.127 -1.851 . . . . 0.0 112.74 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.431 ' H ' ' CG ' ' A' ' 77' ' ' ASP . 17.7 p-10 -107.2 25.46 11.38 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-N 114.556 -1.202 . . . . 0.0 110.624 -179.777 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -146.93 15.52 1.55 Allowed Glycine 0 N--CA 1.494 2.507 0 O-C-N 124.179 0.924 . . . . 0.0 111.578 -179.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.48 ' HA ' ' CE2' ' A' ' 75' ' ' PHE . 6.6 t 41.61 -160.56 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.899 0 O-C-N 124.934 1.02 . . . . 0.0 113.405 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . 0.428 ' H ' ' HG1' ' A' ' 80' ' ' THR . 72.4 t80 -40.01 132.4 1.84 Allowed 'General case' 0 N--CA 1.5 2.074 0 O-C-N 123.634 0.584 . . . . 0.0 112.213 179.862 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 76.6 t -107.48 -61.03 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 CA-C-N 114.381 -1.281 . . . . 0.0 109.93 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . 0.696 ' SG ' ' CD1' ' A' ' 74' ' ' TYR . 0.8 OUTLIER -163.66 -166.74 1.25 Allowed 'General case' 0 N--CA 1.502 2.136 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 -179.89 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.475 ' N ' ' SG ' ' A' ' 83' ' ' CYS . 35.2 mt-10 -130.65 163.68 26.66 Favored 'General case' 0 N--CA 1.485 1.316 0 CA-C-N 114.995 -1.002 . . . . 0.0 109.362 179.511 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -43.24 120.15 2.67 Favored Glycine 0 N--CA 1.499 2.891 0 O-C-N 124.092 0.87 . . . . 0.0 113.681 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -108.71 32.1 5.13 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 36.3 t -153.91 129.26 9.8 Favored 'General case' 0 N--CA 1.498 1.958 0 C-N-CA 120.323 -0.551 . . . . 0.0 109.616 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -100.22 144.28 28.12 Favored Pre-proline 0 N--CA 1.494 1.762 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -46.61 -23.37 2.24 Favored 'Trans proline' 0 N--CA 1.499 1.834 0 C-N-CA 122.846 2.364 . . . . 0.0 112.564 170.339 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 52.8 ttp85 -60.68 -53.23 59.96 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-N 114.967 -1.015 . . . . 0.0 108.682 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -90.5 114.42 61.1 Favored Pre-proline 0 N--CA 1.494 1.725 0 O-C-N 124.839 1.337 . . . . 0.0 110.635 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -83.68 45.13 1.73 Allowed 'Trans proline' 0 N--CA 1.495 1.593 0 C-N-CA 123.427 2.752 . . . . 0.0 110.633 173.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 64.2 mtpt -79.13 125.59 29.62 Favored 'General case' 0 N--CA 1.497 1.894 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.954 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -88.75 120.67 30.35 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 114.596 -1.184 . . . . 0.0 109.603 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 31.0 m -79.94 145.37 61.37 Favored Pre-proline 0 N--CA 1.497 1.906 0 CA-C-N 115.202 -0.908 . . . . 0.0 108.928 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -70.31 -87.13 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.482 0 C-N-CA 122.249 1.966 . . . . 0.0 110.253 -177.188 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 86.7 mtm180 -145.32 -67.28 0.31 Allowed 'General case' 0 N--CA 1.497 1.912 0 O-C-N 123.737 0.648 . . . . 0.0 109.397 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 28.5 m120 46.22 48.43 13.12 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 124.39 1.056 . . . . 0.0 110.67 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 90.7 m -36.21 127.26 0.76 Allowed 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 115.251 1.574 . . . . 0.0 115.251 -179.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -122.31 79.99 45.05 Favored Pre-proline 0 N--CA 1.496 1.858 0 O-C-N 124.295 0.997 . . . . 0.0 109.091 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -59.34 -25.91 80.06 Favored 'Trans proline' 0 N--CA 1.495 1.605 0 C-N-CA 123.293 2.662 . . . . 0.0 111.707 -178.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 25.0 tpt180 -66.66 -37.39 84.7 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-N 115.118 -0.946 . . . . 0.0 111.726 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.457 ' CG2' ' N ' ' A' ' 104' ' ' ALA . 6.3 mt -60.06 167.01 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 CA-C-O 121.855 0.836 . . . . 0.0 111.516 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.457 ' N ' ' CG2' ' A' ' 103' ' ' ILE . . . -138.69 -44.81 0.48 Allowed 'General case' 0 N--CA 1.489 1.497 0 CA-C-N 113.462 -1.699 . . . . 0.0 107.762 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 40.7 p90 -173.07 -170.84 0.68 Allowed 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -136.45 130.15 5.14 Favored Glycine 0 N--CA 1.493 2.5 0 C-N-CA 120.554 -0.831 . . . . 0.0 111.228 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.9 mp -79.89 110.46 15.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 N-CA-C 105.788 -1.93 . . . . 0.0 105.788 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' CYS . . . . . 0.401 ' HA ' ' HA ' ' A' ' 72' ' ' CYS . 60.9 m -100.19 109.57 56.95 Favored Pre-proline 0 N--CA 1.495 1.809 0 O-C-N 124.143 0.902 . . . . 0.0 110.405 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo . . . . . 0 N--CA 1.492 1.42 0 C-N-CA 122.6 2.2 . . . . 0.0 109.905 179.528 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 . . . . . 0 N--CA 1.501 2.114 0 CA-C-O 120.6 0.238 . . . . 0.0 111.374 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.1 tp -67.49 91.27 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 CA-C-O 121.985 0.898 . . . . 0.0 110.814 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 7.5 m -90.36 45.28 1.25 Allowed 'General case' 0 N--CA 1.493 1.72 0 CA-C-O 122.726 1.25 . . . . 0.0 112.472 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 51.8 m -90.74 171.07 9.6 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 113.001 -1.909 . . . . 0.0 109.275 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 69.0 m-80 -160.0 171.91 18.5 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 124.567 1.167 . . . . 0.0 107.998 179.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 9.6 t -70.14 -11.14 60.68 Favored 'General case' 0 N--CA 1.501 2.096 0 C-N-CA 118.968 -1.093 . . . . 0.0 110.837 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 34.4 t -91.11 -50.4 5.86 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-N 113.905 -1.498 . . . . 0.0 109.137 179.734 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -39.58 -67.26 0.23 Allowed 'General case' 0 N--CA 1.501 2.084 0 N-CA-C 115.965 1.839 . . . . 0.0 115.965 -179.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -54.66 160.51 5.08 Favored Glycine 0 N--CA 1.502 3.057 0 C-N-CA 121.099 -0.572 . . . . 0.0 112.325 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 7.3 t -71.43 138.29 48.95 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 -179.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -62.33 114.1 3.29 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-N 114.121 -1.399 . . . . 0.0 109.2 179.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 134.39 -21.92 3.79 Favored Glycine 0 N--CA 1.495 2.594 0 O-C-N 124.431 1.082 . . . . 0.0 110.577 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 88.2 m -86.77 -173.08 4.3 Favored 'General case' 0 N--CA 1.5 2.028 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 60.7 mtpt -133.46 103.27 5.86 Favored 'General case' 0 N--CA 1.494 1.765 0 C-N-CA 119.793 -0.763 . . . . 0.0 110.998 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.733 ' CD2' ' SG ' ' A' ' 25' ' ' CYS . 90.8 m-85 -54.75 138.21 42.69 Favored 'General case' 0 N--CA 1.499 2.015 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.67 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -149.22 146.25 27.52 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 124.886 1.366 . . . . 0.0 113.26 -179.701 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 45.4 t -106.03 120.99 43.2 Favored 'General case' 0 N--CA 1.5 2.055 0 CA-C-N 112.822 -1.99 . . . . 0.0 110.722 -179.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.489 ' H ' ' HB2' ' A' ' 46' ' ' ALA . 6.5 p-10 -57.61 -53.34 59.32 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 126.476 2.36 . . . . 0.0 112.19 -179.817 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -72.95 1.61 8.47 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 112.264 -2.244 . . . . 0.0 112.236 -179.665 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -136.39 -85.39 0.18 Allowed Glycine 0 N--CA 1.482 1.727 0 C-N-CA 119.626 -1.273 . . . . 0.0 111.951 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.481 ' CG2' ' H ' ' A' ' 23' ' ' PHE . 1.2 m 172.7 -171.16 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.166 0 N-CA-C 106.002 -1.851 . . . . 0.0 106.002 -179.137 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.481 ' H ' ' CG2' ' A' ' 22' ' ' THR . 33.2 t80 -41.79 144.05 0.45 Allowed 'General case' 0 N--CA 1.502 2.146 0 CA-C-O 121.369 0.605 . . . . 0.0 112.065 179.53 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 71.9 t -110.38 -68.21 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 CA-C-N 114.06 -1.427 . . . . 0.0 112.353 -179.656 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.733 ' SG ' ' CD2' ' A' ' 16' ' ' TYR . 14.5 p -155.14 -167.55 2.6 Favored 'General case' 0 N--CA 1.502 2.153 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 -179.717 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 8.7 tm-20 -117.45 154.89 30.62 Favored 'General case' 0 N--CA 1.505 2.282 0 O-C-N 123.373 0.42 . . . . 0.0 110.735 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.429 ' HA2' ' CE2' ' A' ' 16' ' ' TYR . . . -46.48 110.7 0.55 Allowed Glycine 0 N--CA 1.503 3.128 0 CA-C-O 118.857 -0.968 . . . . 0.0 112.583 179.869 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -97.33 -9.19 27.97 Favored 'General case' 0 N--CA 1.505 2.32 0 N-CA-C 114.684 1.365 . . . . 0.0 114.684 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 38.4 t -156.07 131.17 9.29 Favored 'General case' 0 N--CA 1.501 2.083 0 C-N-CA 119.647 -0.821 . . . . 0.0 111.607 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.531 ' H ' HD22 ' A' ' 33' ' ' ASN . 11.7 t70 -93.54 143.59 26.87 Favored Pre-proline 0 N--CA 1.494 1.771 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 179.812 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -66.26 75.7 0.35 Allowed 'Trans proline' 0 N--CA 1.494 1.558 0 C-N-CA 122.579 2.186 . . . . 0.0 108.236 162.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 35.2 ttp-105 -168.09 -41.28 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 113.208 -1.814 . . . . 0.0 106.832 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.531 HD22 ' H ' ' A' ' 30' ' ' ASP . 29.8 p30 -86.99 152.84 54.02 Favored Pre-proline 0 N--CA 1.493 1.705 0 O-C-N 124.175 0.922 . . . . 0.0 110.936 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -79.85 45.6 2.0 Allowed 'Trans proline' 0 N--CA 1.496 1.635 0 C-N-CA 123.443 2.762 . . . . 0.0 112.319 174.481 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.12 152.9 20.46 Favored 'General case' 0 N--CA 1.501 2.109 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.163 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -156.39 165.24 36.9 Favored 'General case' 0 N--CA 1.498 1.93 0 CA-C-N 114.674 -1.148 . . . . 0.0 109.571 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 28.0 m -146.19 179.16 7.69 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 123.779 0.674 . . . . 0.0 110.282 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 44.5 p -138.72 54.7 1.74 Allowed 'General case' 0 N--CA 1.5 2.066 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.671 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 54.2 tp -93.63 -25.24 17.59 Favored 'General case' 0 N--CA 1.499 2.017 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.005 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 11.4 m120 62.54 153.64 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.118 0 O-C-N 124.487 1.117 . . . . 0.0 113.536 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 59.4 m -18.61 130.38 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.274 0 N-CA-C 116.63 2.085 . . . . 0.0 116.63 -179.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -113.82 86.13 10.53 Favored Pre-proline 0 N--CA 1.498 1.955 0 O-C-N 124.062 0.851 . . . . 0.0 108.971 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -62.13 -18.41 61.78 Favored 'Trans proline' 0 N--CA 1.497 1.724 0 C-N-CA 122.633 2.222 . . . . 0.0 113.803 -170.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 5.9 ptp85 -89.09 -20.15 24.68 Favored 'General case' 0 N--CA 1.501 2.078 0 N-CA-C 116.393 1.997 . . . . 0.0 116.393 -179.636 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 16.3 tt -78.13 155.44 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.303 0 C-N-CA 118.566 -1.254 . . . . 0.0 109.694 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.489 ' HB2' ' H ' ' A' ' 19' ' ' ASP . . . -90.4 -66.3 0.94 Allowed 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 179.627 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 3.3 p90 -177.63 171.91 1.83 Allowed 'General case' 0 N--CA 1.492 1.651 0 CA-C-N 112.786 -2.006 . . . . 0.0 108.513 -179.783 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -91.05 110.37 3.81 Favored Glycine 0 N--CA 1.49 2.279 0 CA-C-N 114.979 -1.009 . . . . 0.0 110.701 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 20.1 m -78.84 105.84 8.76 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 N-CA-C 106.107 -1.812 . . . . 0.0 106.107 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 48.1 m -83.28 161.74 56.23 Favored Pre-proline 0 N--CA 1.495 1.798 0 CA-C-N 113.375 -1.739 . . . . 0.0 111.264 -179.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo . . . . . 0 N--CA 1.494 1.536 0 C-N-CA 122.345 2.03 . . . . 0.0 109.675 166.65 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . 0.45 ' N ' ' SG ' ' A' ' 99' ' ' CYS . 1.6 m . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.5 p -63.91 138.71 58.59 Favored 'General case' 0 N--CA 1.495 1.824 0 C-N-CA 119.067 -1.053 . . . . 0.0 112.558 179.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -155.11 154.59 32.6 Favored 'General case' 0 N--CA 1.499 2.009 0 CA-C-N 112.14 -2.3 . . . . 0.0 110.209 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 52.8 t -52.71 -51.2 61.4 Favored 'General case' 0 N--CA 1.501 2.084 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 179.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 17.7 t -60.91 -54.46 44.78 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-N 110.996 -2.82 . . . . 0.0 112.658 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -39.46 -45.06 1.47 Allowed 'General case' 0 N--CA 1.504 2.227 0 O-C-N 125.921 2.013 . . . . 0.0 110.511 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 73.38 162.94 7.75 Favored Glycine 0 N--CA 1.476 1.351 0 N-CA-C 116.951 1.54 . . . . 0.0 116.951 179.583 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 3.6 t 176.64 42.56 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 104.49 -2.411 . . . . 0.0 104.49 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.422 ' N ' ' HA3' ' A' ' 85' ' ' GLY . 0.6 OUTLIER -10.35 94.08 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.065 0 CA-C-N 113.165 -1.834 . . . . 0.0 115.545 -179.553 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 136.37 -47.56 0.96 Allowed Glycine 0 N--CA 1.493 2.497 0 CA-C-N 114.461 -1.245 . . . . 0.0 111.94 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . 0.425 ' HA ' ' HA ' ' A' ' 108' ' ' CYS . 76.5 m -79.93 122.75 27.09 Favored 'General case' 0 N--CA 1.497 1.914 0 C-N-CA 119.166 -1.014 . . . . 0.0 110.761 -179.79 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 37.0 mtmm -73.2 89.48 1.53 Allowed 'General case' 0 N--CA 1.487 1.384 0 CA-C-N 112.535 -2.12 . . . . 0.0 115.152 -179.604 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.437 ' N ' ' O ' ' A' ' 83' ' ' CYS . 41.9 m-85 -45.55 136.8 5.5 Favored 'General case' 0 N--CA 1.504 2.234 0 O-C-N 124.32 1.012 . . . . 0.0 108.399 179.488 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -154.17 145.8 23.26 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 114.851 -1.068 . . . . 0.0 112.144 -179.478 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 89.0 p -90.12 141.51 28.61 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 112.05 -2.341 . . . . 0.0 115.806 -179.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -51.34 -33.92 31.55 Favored 'General case' 0 N--CA 1.499 2.01 0 CA-C-N 112.288 -2.233 . . . . 0.0 114.313 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -57.85 -13.98 5.27 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 123.994 0.808 . . . . 0.0 112.156 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 102.7 37.46 3.21 Favored Glycine 0 N--CA 1.491 2.325 0 O-C-N 124.311 1.007 . . . . 0.0 111.487 179.783 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 90.7 m -140.79 149.07 41.6 Favored 'General case' 0 N--CA 1.496 1.858 0 C-N-CA 119.8 -0.76 . . . . 0.0 111.826 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 21.3 t80 -77.45 142.86 38.97 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-N 114.937 -1.029 . . . . 0.0 108.253 179.549 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 92.2 t -107.22 -67.27 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 CA-C-N 114.933 -1.031 . . . . 0.0 108.842 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . 0.437 ' O ' ' N ' ' A' ' 74' ' ' TYR . 39.2 m -159.8 -160.56 0.82 Allowed 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -139.41 160.19 40.4 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 102.739 -3.06 . . . . 0.0 102.739 178.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.422 ' HA3' ' N ' ' A' ' 70' ' ' LYS . . . -38.24 100.18 0.01 OUTLIER Glycine 0 N--CA 1.494 2.527 0 CA-C-O 119.301 -0.722 . . . . 0.0 114.463 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -79.08 -3.81 47.14 Favored 'General case' 0 N--CA 1.502 2.169 0 C-N-CA 119.618 -0.833 . . . . 0.0 111.316 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 44.0 t -142.93 128.57 19.18 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.556 ' H ' HD22 ' A' ' 91' ' ' ASN . 15.4 t70 -84.01 145.67 46.98 Favored Pre-proline 0 N--CA 1.493 1.681 0 CA-C-N 114.588 -1.187 . . . . 0.0 109.147 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -56.62 80.97 0.04 OUTLIER 'Trans proline' 0 N--CA 1.499 1.84 0 C-N-CA 123.279 2.653 . . . . 0.0 108.528 163.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 50.8 ttp85 -173.71 -62.54 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 104.027 -2.583 . . . . 0.0 104.027 -179.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.556 HD22 ' H ' ' A' ' 88' ' ' ASP . 0.7 OUTLIER -91.88 113.49 59.08 Favored Pre-proline 0 N--CA 1.492 1.651 0 CA-C-N 114.12 -1.4 . . . . 0.0 109.04 179.915 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -74.38 89.48 1.07 Allowed 'Trans proline' 0 N--CA 1.492 1.393 0 C-N-CA 122.467 2.111 . . . . 0.0 110.571 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -122.15 123.1 40.73 Favored 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -150.64 151.88 33.17 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.46 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 81.6 m -119.46 98.22 50.19 Favored Pre-proline 0 N--CA 1.497 1.898 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -68.53 93.1 0.42 Allowed 'Trans proline' 0 N--CA 1.493 1.452 0 C-N-CA 122.301 2.001 . . . . 0.0 109.013 177.106 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 28.4 mmt85 -134.72 47.88 2.34 Favored 'General case' 0 N--CA 1.498 1.954 0 CA-C-N 114.651 -1.159 . . . . 0.0 108.029 -179.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 14.5 m120 54.42 41.3 32.05 Favored 'General case' 0 N--CA 1.504 2.236 0 CA-C-O 122.797 1.284 . . . . 0.0 108.094 -179.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . 0.45 ' SG ' ' N ' ' A' ' 62' ' ' CYS . 5.3 m 57.95 -167.43 0.14 Allowed 'General case' 0 N--CA 1.488 1.439 0 CA-C-N 112.031 -2.35 . . . . 0.0 108.722 -179.662 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -106.22 99.64 24.72 Favored Pre-proline 0 N--CA 1.498 1.943 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 179.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -64.53 -31.13 61.13 Favored 'Trans proline' 0 N--CA 1.493 1.46 0 C-N-CA 122.336 2.024 . . . . 0.0 111.639 -169.656 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 74.9 ttt-85 -71.89 -31.22 66.19 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 123.967 0.792 . . . . 0.0 111.226 -179.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 12.0 mt -68.53 157.24 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 CA-C-O 122.261 1.029 . . . . 0.0 111.427 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -124.92 -56.41 1.56 Allowed 'General case' 0 N--CA 1.492 1.63 0 CA-C-N 111.969 -2.378 . . . . 0.0 107.555 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 38.1 p90 -164.88 170.12 15.73 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-N 114.254 -1.339 . . . . 0.0 109.922 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -110.84 123.85 6.73 Favored Glycine 0 N--CA 1.492 2.426 0 CA-C-N 113.911 -1.495 . . . . 0.0 110.944 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.414 HD13 ' N ' ' A' ' 107' ' ' ILE . 2.9 mp -79.31 99.65 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' CYS . . . . . 0.425 ' HA ' ' HA ' ' A' ' 72' ' ' CYS . 25.2 m -79.79 163.9 56.01 Favored Pre-proline 0 N--CA 1.491 1.622 0 CA-C-N 114.169 -1.378 . . . . 0.0 108.754 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_exo . . . . . 0 N--CA 1.498 1.76 0 C-N-CA 122.558 2.172 . . . . 0.0 112.589 173.793 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 38.8 ttm180 . . . . . 0 N--CA 1.495 1.818 0 N-CA-C 107.135 -1.431 . . . . 0.0 107.135 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 8.6 tp -86.77 53.67 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 CA-C-N 114.092 -1.413 . . . . 0.0 109.093 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 63.5 m -84.19 40.58 0.77 Allowed 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 115.031 1.493 . . . . 0.0 115.031 -179.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 53.3 m -90.6 158.91 16.71 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 105.167 -2.16 . . . . 0.0 105.167 179.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -147.48 169.36 19.71 Favored 'General case' 0 N--CA 1.497 1.918 0 CA-C-O 122.427 1.108 . . . . 0.0 112.551 -179.761 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.7 t -62.76 -53.14 58.91 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-N 112.268 -2.242 . . . . 0.0 111.952 -179.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 51.4 t -67.63 -55.7 12.26 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-N 113.946 -1.479 . . . . 0.0 109.375 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -54.83 -18.03 4.31 Favored 'General case' 0 N--CA 1.497 1.921 0 CA-C-N 113.786 -1.552 . . . . 0.0 113.062 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -59.53 160.72 17.74 Favored Glycine 0 N--CA 1.496 2.676 0 C-N-CA 120.613 -0.804 . . . . 0.0 111.453 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.46 ' H ' ' HH ' ' A' ' 16' ' ' TYR . 9.7 t -76.45 129.4 36.48 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 115.732 1.753 . . . . 0.0 115.732 -179.768 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 3.1 mmmp? -62.34 93.23 0.05 OUTLIER 'General case' 0 N--CA 1.5 2.073 0 CA-C-N 114.195 -1.366 . . . . 0.0 109.032 179.572 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 157.18 -28.09 0.51 Allowed Glycine 0 N--CA 1.49 2.279 0 CA-C-O 118.52 -1.156 . . . . 0.0 112.913 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 84.2 m -117.55 169.7 9.34 Favored 'General case' 0 N--CA 1.503 2.183 0 C-N-CA 119.438 -0.905 . . . . 0.0 112.603 -179.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 36.0 mtmm -102.69 96.67 7.02 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-N 113.982 -1.463 . . . . 0.0 111.312 -179.714 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.46 ' HH ' ' H ' ' A' ' 11' ' ' THR . 24.0 m-85 -59.94 127.9 34.19 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-O 122.884 1.326 . . . . 0.0 108.023 179.654 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -135.2 151.96 51.12 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 111.29 -2.687 . . . . 0.0 112.655 -179.145 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 87.8 p -91.03 133.06 35.61 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 112.991 -1.913 . . . . 0.0 113.924 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -47.73 -29.12 2.84 Favored 'General case' 0 N--CA 1.5 2.035 0 CA-C-N 113.11 -1.859 . . . . 0.0 116.012 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -57.64 -18.35 19.73 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 123.611 0.57 . . . . 0.0 112.519 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 112.46 26.96 4.05 Favored Glycine 0 N--CA 1.494 2.52 0 O-C-N 124.366 1.041 . . . . 0.0 111.098 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 62.4 m -135.91 156.06 49.35 Favored 'General case' 0 N--CA 1.496 1.853 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.458 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 22.6 t80 -85.85 149.25 25.37 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-N 114.89 -1.05 . . . . 0.0 110.16 179.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 96.0 t -108.47 -79.0 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 N-CA-C 107.03 -1.471 . . . . 0.0 107.03 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.458 ' SG ' ' O ' ' A' ' 26' ' ' GLU . 0.1 OUTLIER -164.76 179.91 6.26 Favored 'General case' 0 N--CA 1.5 2.044 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 179.743 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.458 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 30.7 tt0 -85.64 157.05 20.44 Favored 'General case' 0 N--CA 1.502 2.138 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 179.87 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -74.14 116.43 5.26 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 104.729 -3.349 . . . . 0.0 104.729 179.613 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -98.64 21.94 10.62 Favored 'General case' 0 N--CA 1.505 2.285 0 N-CA-C 114.757 1.392 . . . . 0.0 114.757 -179.633 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 37.7 t -137.97 117.88 13.31 Favored 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 179.671 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.568 ' H ' HD22 ' A' ' 33' ' ' ASN . 16.3 t70 -79.42 132.52 62.06 Favored Pre-proline 0 N--CA 1.493 1.692 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_endo -67.11 85.33 0.33 Allowed 'Trans proline' 0 N--CA 1.492 1.441 0 C-N-CA 122.6 2.2 . . . . 0.0 109.908 178.534 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 12.0 mtp180 176.52 -41.71 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.938 0 CA-C-N 113.925 -1.488 . . . . 0.0 108.216 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.568 HD22 ' H ' ' A' ' 30' ' ' ASP . 24.4 p30 -77.22 146.11 74.08 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 123.991 0.807 . . . . 0.0 111.88 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -81.54 48.23 2.79 Favored 'Trans proline' 0 N--CA 1.492 1.407 0 C-N-CA 123.407 2.738 . . . . 0.0 109.525 163.061 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 65.0 tttp -68.23 150.71 47.95 Favored 'General case' 0 N--CA 1.497 1.891 0 CA-C-O 121.544 0.688 . . . . 0.0 111.617 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -91.42 131.03 37.16 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-N 113.608 -1.633 . . . . 0.0 108.005 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 5.2 m -142.85 -178.41 5.79 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 -179.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 96.2 m -83.25 113.87 20.99 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-N 113.645 -1.616 . . . . 0.0 108.413 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 9.8 mp -79.5 0.58 29.07 Favored 'General case' 0 N--CA 1.498 1.953 0 CA-C-N 115.299 -0.864 . . . . 0.0 112.164 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -59.19 119.61 7.67 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 123.546 0.529 . . . . 0.0 109.719 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 85.0 m -68.55 92.26 0.45 Allowed 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -63.35 101.88 0.29 Allowed Pre-proline 0 N--CA 1.495 1.792 0 CA-C-N 115.252 -0.885 . . . . 0.0 110.19 -179.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo -67.32 -37.88 16.7 Favored 'Trans proline' 0 N--CA 1.492 1.399 0 C-N-CA 122.159 1.906 . . . . 0.0 110.779 -160.234 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 28.0 ptt-85 -78.27 -23.1 47.39 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-N 114.233 -1.349 . . . . 0.0 114.013 -179.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 7.9 tt -55.27 159.04 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.278 0 C-N-CA 120.1 -0.64 . . . . 0.0 110.476 -179.554 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -141.85 -62.64 0.45 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 123.803 0.69 . . . . 0.0 112.575 -179.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 28.1 p90 -156.17 161.63 40.29 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-O 121.871 0.843 . . . . 0.0 113.04 -179.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.426 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -92.17 95.3 2.01 Favored Glycine 0 N--CA 1.489 2.194 0 CA-C-N 112.785 -2.007 . . . . 0.0 110.593 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 4.7 p -81.74 110.55 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 C-N-CA 119.108 -1.037 . . . . 0.0 109.012 179.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.6 m -79.04 154.43 77.55 Favored Pre-proline 0 N--CA 1.498 1.928 0 CA-C-N 115.472 -0.786 . . . . 0.0 109.414 179.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo . . . . . 0 N--CA 1.497 1.692 0 C-N-CA 122.71 2.273 . . . . 0.0 111.623 -173.506 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 1.6 m . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 123.128 1.442 . . . . 0.0 114.455 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.41 ' O ' ' N ' ' A' ' 100' ' ' ASP . 1.8 p -90.86 160.87 15.5 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-N 112.64 -2.073 . . . . 0.0 108.05 179.456 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 32.5 p-10 -161.63 148.48 14.32 Favored 'General case' 0 N--CA 1.501 2.108 0 C-N-CA 119.891 -0.723 . . . . 0.0 110.22 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' CYS . . . . . 0.451 ' HA ' ' CD2' ' A' ' 74' ' ' TYR . 7.1 t -65.45 -15.45 62.64 Favored 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 113.661 0.986 . . . . 0.0 113.661 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 29.4 t -80.52 -66.77 0.84 Allowed 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 116.295 1.961 . . . . 0.0 116.295 -179.499 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -77.82 63.31 2.84 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 125.545 1.778 . . . . 0.0 114.832 -179.25 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -123.98 -150.3 7.91 Favored Glycine 0 N--CA 1.494 2.522 0 CA-C-N 112.729 -2.032 . . . . 0.0 109.946 179.558 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 4.8 t -136.44 121.18 18.51 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-N 114.102 -1.049 . . . . 0.0 108.924 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 6.2 ptpp? -58.16 89.95 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.853 0 CA-C-O 122.648 1.214 . . . . 0.0 111.371 179.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 161.89 -42.08 0.38 Allowed Glycine 0 N--CA 1.49 2.24 0 N-CA-C 108.368 -1.893 . . . . 0.0 108.368 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 90.3 m -79.43 128.29 33.16 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 35.4 mmtp -80.37 83.31 6.22 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 115.581 1.697 . . . . 0.0 115.581 -179.321 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.451 ' CD2' ' HA ' ' A' ' 65' ' ' CYS . 2.1 m-85 -43.55 126.36 4.39 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 124.235 0.959 . . . . 0.0 109.181 179.379 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -141.08 152.04 44.48 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-N 114.321 -1.309 . . . . 0.0 112.325 -179.34 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 30.2 t -101.66 143.24 31.86 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 116.059 1.874 . . . . 0.0 116.059 -179.57 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.413 ' C ' ' H ' ' A' ' 79' ' ' GLY . 1.0 OUTLIER -49.69 -26.11 3.48 Favored 'General case' 0 N--CA 1.5 2.074 0 CA-C-N 111.231 -2.713 . . . . 0.0 113.435 179.746 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 13.8 p30 -62.33 -3.18 1.24 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 124.178 0.924 . . . . 0.0 111.853 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.413 ' H ' ' C ' ' A' ' 77' ' ' ASP . . . 86.87 28.96 24.72 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 90.3 m -142.33 143.93 32.98 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 120.47 -0.492 . . . . 0.0 110.9 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 52.6 t80 -67.94 160.25 28.95 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-N 114.17 -1.377 . . . . 0.0 110.497 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 91.1 t -122.95 -74.77 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 CA-C-N 114.624 -1.171 . . . . 0.0 110.477 -179.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . 0.492 ' SG ' ' N ' ' A' ' 84' ' ' GLU . 0.5 OUTLIER -157.13 -163.07 1.32 Allowed 'General case' 0 N--CA 1.502 2.163 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 -179.874 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.492 ' N ' ' SG ' ' A' ' 83' ' ' CYS . 38.2 tt0 -119.56 164.37 15.93 Favored 'General case' 0 N--CA 1.503 2.205 0 N-CA-C 104.722 -2.325 . . . . 0.0 104.722 179.18 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -60.91 113.57 5.74 Favored Glycine 0 N--CA 1.497 2.743 0 C-N-CA 119.315 -1.422 . . . . 0.0 110.302 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -86.0 21.68 1.9 Allowed 'General case' 0 N--CA 1.501 2.11 0 CA-C-O 121.722 0.772 . . . . 0.0 111.297 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 3.5 m -133.4 160.54 37.08 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 113.996 -1.456 . . . . 0.0 107.224 179.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -79.66 145.9 63.77 Favored Pre-proline 0 N--CA 1.493 1.689 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -47.7 -15.22 0.31 Allowed 'Trans proline' 0 N--CA 1.499 1.848 0 C-N-CA 122.835 2.356 . . . . 0.0 114.037 171.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 72.5 ttt-85 -139.93 53.05 1.68 Allowed 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 18.2 p-10 -90.05 128.28 50.37 Favored Pre-proline 0 N--CA 1.496 1.828 0 CA-C-N 114.522 -1.217 . . . . 0.0 111.447 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -83.89 48.1 2.46 Favored 'Trans proline' 0 N--CA 1.491 1.362 0 C-N-CA 123.245 2.63 . . . . 0.0 109.125 159.22 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -130.39 147.52 52.1 Favored 'General case' 0 N--CA 1.503 2.184 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.681 -179.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -160.54 125.2 3.72 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-N 114.875 -1.057 . . . . 0.0 109.501 179.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 68.7 m -79.74 162.79 61.48 Favored Pre-proline 0 N--CA 1.5 2.03 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -69.97 4.92 2.0 Allowed 'Trans proline' 0 N--CA 1.495 1.587 0 C-N-CA 122.118 1.879 . . . . 0.0 111.146 163.5 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 80.5 mmt-85 -94.21 22.13 6.23 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 123.647 0.592 . . . . 0.0 110.616 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -63.21 158.07 20.95 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.167 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 74.0 m 61.75 125.59 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.888 0 O-C-N 125.193 1.558 . . . . 0.0 112.215 -179.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.41 ' N ' ' O ' ' A' ' 63' ' ' THR . 30.8 t70 -156.22 84.88 3.21 Favored Pre-proline 0 N--CA 1.494 1.761 0 CA-C-N 114.876 -1.056 . . . . 0.0 110.154 -179.778 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_exo -52.44 -18.26 7.85 Favored 'Trans proline' 0 N--CA 1.495 1.594 0 C-N-CA 122.457 2.104 . . . . 0.0 112.455 174.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.69 -54.02 38.25 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 105.974 -1.862 . . . . 0.0 105.974 179.855 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 15.3 tt -79.95 157.52 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 C-N-CA 119.215 -0.994 . . . . 0.0 109.747 -179.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -113.28 -61.35 1.75 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 124.372 1.045 . . . . 0.0 112.588 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 7.4 p90 -162.65 160.06 25.22 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 123.886 0.741 . . . . 0.0 112.162 -179.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -97.13 127.44 9.21 Favored Glycine 0 N--CA 1.492 2.414 0 CA-C-N 113.848 -1.523 . . . . 0.0 111.716 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 48.0 mm -80.91 97.88 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 35.0 m -79.67 143.07 58.06 Favored Pre-proline 0 N--CA 1.494 1.729 0 CA-C-N 114.744 -1.116 . . . . 0.0 109.244 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo . . . . . 0 N--CA 1.496 1.627 0 C-N-CA 122.999 2.466 . . . . 0.0 112.053 -174.136 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 5.9 mmp_? . . . . . 0 N--CA 1.493 1.7 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 10.2 tp -85.15 44.46 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 CA-C-N 114.374 -1.285 . . . . 0.0 109.528 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 5.7 m -85.16 59.5 5.67 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 122.582 1.182 . . . . 0.0 112.938 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.2 t -90.03 167.87 12.43 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-N 113.145 -1.843 . . . . 0.0 107.178 179.675 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 15.9 p30 -145.72 150.59 36.54 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.949 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.7 t -67.34 -20.12 65.54 Favored 'General case' 0 N--CA 1.496 1.847 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.805 -179.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 35.7 t -54.94 -55.67 28.16 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 179.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -71.69 -23.24 61.61 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-N 112.853 -1.976 . . . . 0.0 110.098 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -52.72 142.38 26.09 Favored Glycine 0 N--CA 1.493 2.494 0 O-C-N 124.199 0.937 . . . . 0.0 112.572 -179.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 41.0 p -61.15 109.15 1.03 Allowed 'General case' 0 N--CA 1.492 1.639 0 CA-C-N 111.711 -2.244 . . . . 0.0 111.976 -179.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -68.81 88.64 0.38 Allowed 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 122.457 1.123 . . . . 0.0 108.677 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 163.87 -22.6 0.17 Allowed Glycine 0 N--CA 1.488 2.111 0 CA-C-N 112.611 -2.086 . . . . 0.0 109.639 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 76.0 m -107.63 138.12 44.42 Favored 'General case' 0 N--CA 1.497 1.902 0 CA-C-O 121.533 0.683 . . . . 0.0 110.567 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 61.3 mtpt -83.38 84.82 7.37 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-N 113.821 -1.536 . . . . 0.0 110.914 -179.518 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 -49.78 128.93 19.17 Favored 'General case' 0 N--CA 1.498 1.951 0 CA-C-O 122.37 1.081 . . . . 0.0 109.982 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -136.8 161.01 37.16 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-N 112.262 -2.245 . . . . 0.0 112.554 -179.264 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 32.8 t -104.33 133.12 49.77 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 113.613 -1.63 . . . . 0.0 112.19 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -47.73 -25.06 1.1 Allowed 'General case' 0 N--CA 1.5 2.032 0 CA-C-N 112.895 -1.957 . . . . 0.0 114.18 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 29.3 p30 -60.17 -7.66 2.02 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 124.095 0.872 . . . . 0.0 112.573 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 95.61 27.23 10.74 Favored Glycine 0 N--CA 1.494 2.537 0 N-CA-C 109.894 -1.282 . . . . 0.0 109.894 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 88.3 m -141.29 139.41 33.66 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 123.926 0.427 . . . . 0.0 110.161 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.43 ' CG ' ' N ' ' A' ' 24' ' ' VAL . 48.8 t80 -67.15 164.64 17.63 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 124.63 1.206 . . . . 0.0 110.787 179.809 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.43 ' N ' ' CG ' ' A' ' 23' ' ' PHE . 96.8 t -129.66 -73.05 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 124.093 0.871 . . . . 0.0 112.544 -179.842 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 20.3 p -150.58 -172.01 4.07 Favored 'General case' 0 N--CA 1.501 2.084 0 CA-C-O 121.615 0.721 . . . . 0.0 111.359 -179.496 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -123.51 138.77 54.5 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 104.585 -2.376 . . . . 0.0 104.585 179.447 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -55.99 155.52 12.3 Favored Glycine 0 N--CA 1.503 3.111 0 C-N-CA 120.137 -1.03 . . . . 0.0 114.597 -179.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -112.89 -29.55 7.34 Favored 'General case' 0 N--CA 1.505 2.29 0 CA-C-N 114.837 -0.681 . . . . 0.0 111.891 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 32.0 t -110.44 124.54 51.95 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 107.3 -1.371 . . . . 0.0 107.3 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -77.81 144.1 68.03 Favored Pre-proline 0 N--CA 1.495 1.792 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 -179.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -41.46 -21.36 0.13 Allowed 'Trans proline' 0 N--CA 1.501 1.925 0 C-N-CA 124.02 3.146 . . . . 0.0 115.617 177.551 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 30.9 tpt180 -57.63 -30.34 65.28 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 123.708 0.63 . . . . 0.0 110.657 179.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.472 ' N ' HD21 ' A' ' 33' ' ' ASN . 0.0 OUTLIER -53.96 120.96 26.74 Favored Pre-proline 0 N--CA 1.496 1.839 0 CA-C-N 114.956 -1.02 . . . . 0.0 112.902 179.991 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -82.19 40.51 0.98 Allowed 'Trans proline' 0 N--CA 1.494 1.546 0 C-N-CA 122.979 2.453 . . . . 0.0 110.356 167.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 57.5 tptt -170.07 160.21 8.0 Favored 'General case' 0 N--CA 1.498 1.951 0 CA-C-N 114.577 -1.192 . . . . 0.0 108.578 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -140.4 151.68 45.14 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 123.866 0.729 . . . . 0.0 109.934 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 6.7 m -79.48 143.51 34.87 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 90.2 m -148.79 92.03 1.94 Allowed 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 5.9 tt -157.94 -68.92 0.09 Allowed 'General case' 0 N--CA 1.496 1.839 0 CA-C-N 115.339 -0.846 . . . . 0.0 108.917 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -70.33 146.6 50.4 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 123.766 0.666 . . . . 0.0 111.993 -179.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 79.1 m -105.11 132.17 51.67 Favored 'General case' 0 N--CA 1.496 1.826 0 CA-C-N 114.411 -1.268 . . . . 0.0 109.68 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -135.2 77.44 54.95 Favored Pre-proline 0 N--CA 1.497 1.911 0 O-C-N 123.849 0.718 . . . . 0.0 110.291 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_endo -62.75 -27.19 75.39 Favored 'Trans proline' 0 N--CA 1.494 1.515 0 C-N-CA 123.066 2.511 . . . . 0.0 112.794 -172.473 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 6.0 ptp85 -65.99 -34.8 78.93 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 124.189 0.931 . . . . 0.0 112.47 -179.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.0 mt -59.41 136.96 22.49 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.099 0 C-N-CA 118.642 -1.223 . . . . 0.0 112.347 -179.773 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -123.93 -53.02 1.76 Allowed 'General case' 0 N--CA 1.492 1.675 0 CA-C-N 111.911 -2.404 . . . . 0.0 106.737 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 17.3 p90 -170.1 158.44 6.98 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-N 113.667 -1.606 . . . . 0.0 109.8 179.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -112.83 133.93 11.65 Favored Glycine 0 N--CA 1.494 2.517 0 CA-C-N 113.746 -1.57 . . . . 0.0 112.112 -179.764 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.3 p -82.92 105.22 12.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 8.9 m -79.96 112.18 27.85 Favored Pre-proline 0 N--CA 1.493 1.718 0 CA-C-N 113.93 -1.486 . . . . 0.0 108.681 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_endo . . . . . 0 N--CA 1.492 1.425 0 C-N-CA 122.445 2.096 . . . . 0.0 111.018 -172.899 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 10.1 m . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 122.558 1.17 . . . . 0.0 112.509 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 97.4 m -78.27 162.69 26.35 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 113.355 -1.748 . . . . 0.0 108.52 179.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 46.0 p-10 -160.67 156.65 25.83 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 120.317 -0.553 . . . . 0.0 110.582 179.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' CYS . . . . . 0.541 ' SG ' ' HB2' ' A' ' 74' ' ' TYR . 53.0 t -83.48 -12.56 56.15 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-N 115.043 -0.981 . . . . 0.0 110.169 179.773 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 53.4 t -65.02 -59.83 3.71 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 179.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -90.54 34.55 0.89 Allowed 'General case' 0 N--CA 1.494 1.761 0 CA-C-N 114.167 -1.379 . . . . 0.0 108.69 179.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -74.62 -122.1 0.1 Allowed Glycine 0 N--CA 1.495 2.597 0 CA-C-N 115.353 -0.84 . . . . 0.0 111.053 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 14.8 t -159.81 107.33 1.69 Allowed 'General case' 0 N--CA 1.495 1.807 0 CA-C-O 122.497 1.141 . . . . 0.0 109.465 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 2.7 tmmm? -57.32 101.76 0.07 Allowed 'General case' 0 N--CA 1.493 1.689 0 CA-C-N 113.266 -1.788 . . . . 0.0 107.196 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.404 ' O ' ' SG ' ' A' ' 108' ' ' CYS . . . 165.41 -32.74 0.24 Allowed Glycine 0 N--CA 1.485 1.96 0 CA-C-N 113.225 -1.807 . . . . 0.0 109.366 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 57.7 m -124.36 175.11 7.3 Favored 'General case' 0 N--CA 1.503 2.18 0 C-N-CA 120.017 -0.673 . . . . 0.0 110.733 -179.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.408 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 94.0 mttt -110.61 97.86 7.18 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 124.607 1.192 . . . . 0.0 109.174 -179.796 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.541 ' HB2' ' SG ' ' A' ' 65' ' ' CYS . 26.8 m-85 -54.37 131.36 41.92 Favored 'General case' 0 N--CA 1.497 1.89 0 CA-C-N 114.808 -1.087 . . . . 0.0 109.135 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -139.9 147.51 40.7 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 112.956 -1.929 . . . . 0.0 113.475 -179.366 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 30.9 t -99.58 117.03 33.07 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-N 111.378 -2.646 . . . . 0.0 108.599 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.503 ' H ' ' HB2' ' A' ' 104' ' ' ALA . 7.6 p-10 -59.97 -54.19 49.04 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 125.186 1.553 . . . . 0.0 112.996 -179.652 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -84.14 13.51 5.09 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 113.603 -1.635 . . . . 0.0 110.882 -179.673 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -129.13 -88.87 0.56 Allowed Glycine 0 N--CA 1.48 1.627 0 N-CA-C 108.962 -1.655 . . . . 0.0 108.962 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.451 ' CG2' ' N ' ' A' ' 81' ' ' PHE . 1.2 m 171.78 -175.71 0.05 OUTLIER 'General case' 0 N--CA 1.5 2.066 0 N-CA-C 105.902 -1.888 . . . . 0.0 105.902 -179.381 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . 0.451 ' N ' ' CG2' ' A' ' 80' ' ' THR . 19.2 t80 -53.52 136.3 38.58 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 179.504 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 92.9 t -94.78 -73.61 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 CA-C-N 114.606 -1.179 . . . . 0.0 109.196 -179.558 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . 0.423 ' C ' ' SG ' ' A' ' 65' ' ' CYS . 0.1 OUTLIER -168.44 178.53 4.79 Favored 'General case' 0 N--CA 1.504 2.268 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 179.882 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.408 ' HA ' ' HA ' ' A' ' 73' ' ' LYS . 38.6 tt0 -93.02 152.46 19.29 Favored 'General case' 0 N--CA 1.5 2.034 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -50.29 102.05 0.06 OUTLIER Glycine 0 N--CA 1.495 2.589 0 O-C-N 123.739 0.649 . . . . 0.0 111.513 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -79.83 -12.15 59.78 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-N 114.862 -0.669 . . . . 0.0 110.146 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 35.1 t -77.79 84.31 4.11 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 121.464 0.65 . . . . 0.0 109.708 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -79.38 132.1 63.42 Favored Pre-proline 0 N--CA 1.495 1.803 0 N-CA-C 106.399 -1.704 . . . . 0.0 106.399 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -52.49 -22.39 16.4 Favored 'Trans proline' 0 N--CA 1.498 1.741 0 C-N-CA 122.823 2.349 . . . . 0.0 113.705 -169.701 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 53.0 mmm-85 -83.71 12.82 5.35 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 123.802 0.689 . . . . 0.0 111.648 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.435 ' C ' ' H ' ' A' ' 93' ' ' LYS . 40.6 p-10 -87.71 135.2 34.24 Favored Pre-proline 0 N--CA 1.494 1.742 0 O-C-N 123.45 0.469 . . . . 0.0 111.148 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -81.95 28.97 0.55 Allowed 'Trans proline' 0 N--CA 1.493 1.453 0 C-N-CA 122.967 2.445 . . . . 0.0 111.409 162.317 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.435 ' H ' ' C ' ' A' ' 91' ' ' ASN . 44.3 mmtm 58.21 124.23 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.162 0 CA-C-N 113.76 -1.564 . . . . 0.0 112.846 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -149.32 79.67 1.4 Allowed 'General case' 0 N--CA 1.497 1.913 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.628 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 79.2 m -153.24 124.21 3.57 Favored Pre-proline 0 N--CA 1.496 1.857 0 CA-C-N 114.476 -1.238 . . . . 0.0 108.43 179.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -60.73 -85.57 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.502 0 C-N-CA 122.046 1.831 . . . . 0.0 110.592 177.06 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -142.25 -60.35 0.45 Allowed 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 7.9 m-80 51.51 48.28 23.21 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 124.592 1.182 . . . . 0.0 110.243 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 77.9 m -41.17 128.0 2.83 Favored 'General case' 0 N--CA 1.499 2.009 0 CA-C-N 114.112 -1.404 . . . . 0.0 112.734 -179.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -139.03 79.32 27.09 Favored Pre-proline 0 N--CA 1.496 1.831 0 O-C-N 124.125 0.89 . . . . 0.0 110.882 -179.733 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -59.43 -33.91 97.35 Favored 'Trans proline' 0 N--CA 1.494 1.523 0 C-N-CA 122.87 2.38 . . . . 0.0 113.024 171.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 33.2 ptt180 -63.96 -16.93 62.67 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 123.919 0.762 . . . . 0.0 112.3 -179.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 9.6 tp -48.86 152.64 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 O-C-N 124.019 0.824 . . . . 0.0 112.452 -179.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.503 ' HB2' ' H ' ' A' ' 77' ' ' ASP . . . -124.59 -71.96 0.69 Allowed 'General case' 0 N--CA 1.492 1.659 0 CA-C-N 114.686 -1.143 . . . . 0.0 108.261 179.792 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 76.3 m-85 -156.14 -162.99 1.37 Allowed 'General case' 0 N--CA 1.499 2.001 0 O-C-N 124.685 1.241 . . . . 0.0 109.042 -179.725 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -119.87 93.26 0.54 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 104.966 -3.253 . . . . 0.0 104.966 179.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 43.7 mm -78.77 105.7 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 C-N-CA 119.626 -0.83 . . . . 0.0 110.546 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' CYS . . . . . 0.404 ' SG ' ' O ' ' A' ' 71' ' ' GLY . 1.6 m -78.61 151.4 77.19 Favored Pre-proline 0 N--CA 1.499 1.995 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.688 179.895 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo . . . . . 0 N--CA 1.494 1.528 0 C-N-CA 122.752 2.302 . . . . 0.0 111.151 -172.716 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 10.4 mmm180 . . . . . 0 N--CA 1.496 1.836 0 CA-C-O 119.927 -0.082 . . . . 0.0 111.004 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 4.8 tp -65.62 85.99 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 124.212 0.945 . . . . 0.0 111.228 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.529 ' HA ' ' HA ' ' A' ' 41' ' ' CYS . 1.6 m -92.88 61.03 3.46 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-O 123.372 1.558 . . . . 0.0 113.731 179.814 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 6.8 t -90.15 161.47 15.74 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 104.475 -2.417 . . . . 0.0 104.475 179.517 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.461 ' ND2' ' H ' ' A' ' 9' ' ' ALA . 3.2 p-10 -161.54 -166.42 1.5 Allowed 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 -179.898 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 8.8 t -117.58 -36.88 3.58 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 179.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 49.5 t -62.5 -61.46 2.42 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 123.917 0.761 . . . . 0.0 110.402 -179.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.461 ' H ' ' ND2' ' A' ' 6' ' ' ASN . . . -90.06 27.51 1.59 Allowed 'General case' 0 N--CA 1.496 1.871 0 CA-C-N 113.525 -1.67 . . . . 0.0 109.178 179.859 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -72.67 -117.9 0.06 OUTLIER Glycine 0 N--CA 1.492 2.411 0 CA-C-N 115.141 -0.936 . . . . 0.0 111.271 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 97.3 m -154.62 91.82 1.43 Allowed 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 107.518 -1.289 . . . . 0.0 107.518 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.43 ' HB3' ' NZ ' ' A' ' 12' ' ' LYS . 0.0 OUTLIER -54.6 112.77 1.08 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 123.739 0.649 . . . . 0.0 110.146 -179.847 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 135.16 -30.06 2.86 Favored Glycine 0 N--CA 1.494 2.531 0 CA-C-N 113.641 -1.618 . . . . 0.0 109.781 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 82.6 m -88.97 -178.38 5.7 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 123.659 0.27 . . . . 0.0 110.955 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 33.3 mmtp -129.82 92.26 3.29 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 124.062 0.851 . . . . 0.0 111.294 -179.546 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.425 ' HB2' ' SG ' ' A' ' 25' ' ' CYS . 51.3 m-85 -58.87 131.64 51.59 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 124.53 1.144 . . . . 0.0 108.268 179.72 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -142.04 159.66 41.78 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-N 113.102 -1.863 . . . . 0.0 113.43 -179.162 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 30.6 t -105.11 134.04 48.89 Favored 'General case' 0 N--CA 1.497 1.893 0 CA-C-N 113.689 -1.596 . . . . 0.0 111.619 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -48.22 -28.27 2.93 Favored 'General case' 0 N--CA 1.501 2.122 0 CA-C-N 112.948 -1.933 . . . . 0.0 115.814 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -52.09 -22.75 4.43 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 124.036 0.835 . . . . 0.0 111.602 -179.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 112.13 27.2 4.05 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 108.871 -1.692 . . . . 0.0 108.871 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 89.7 m -138.75 142.06 38.83 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 120.527 -0.469 . . . . 0.0 110.959 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 49.6 t80 -69.41 160.98 30.35 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-N 114.151 -1.386 . . . . 0.0 109.761 179.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 58.5 t -127.2 -71.6 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 124.091 0.87 . . . . 0.0 112.179 -179.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.425 ' SG ' ' HB2' ' A' ' 16' ' ' TYR . 0.5 OUTLIER -144.52 -177.93 5.73 Favored 'General case' 0 N--CA 1.5 2.068 0 CA-C-O 121.402 0.62 . . . . 0.0 110.818 -179.709 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -113.04 145.0 41.63 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 104.067 -2.568 . . . . 0.0 104.067 179.485 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -57.3 152.04 26.23 Favored Glycine 0 N--CA 1.498 2.773 0 C-N-CA 119.301 -1.428 . . . . 0.0 111.184 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -126.42 -10.06 6.32 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 123.976 0.457 . . . . 0.0 111.265 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 33.4 t -71.63 91.26 1.08 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 123.728 0.643 . . . . 0.0 110.714 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -99.11 111.88 61.88 Favored Pre-proline 0 N--CA 1.491 1.586 0 CA-C-N 114.618 -1.173 . . . . 0.0 108.752 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_endo -58.48 -17.07 32.42 Favored 'Trans proline' 0 N--CA 1.495 1.609 0 C-N-CA 122.869 2.38 . . . . 0.0 113.114 -168.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 74.7 ttt-85 -61.01 -50.01 75.1 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -90.84 122.85 66.31 Favored Pre-proline 0 N--CA 1.496 1.843 0 O-C-N 124.271 0.982 . . . . 0.0 110.772 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_endo -78.11 121.62 5.41 Favored 'Trans proline' 0 N--CA 1.492 1.417 0 C-N-CA 122.813 2.342 . . . . 0.0 108.999 165.303 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 56.8 tptt -159.05 153.94 24.87 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 123.62 0.575 . . . . 0.0 110.568 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.85 171.62 9.79 Favored 'General case' 0 N--CA 1.497 1.912 0 CA-C-N 114.321 -1.309 . . . . 0.0 111.315 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 89.7 m -153.58 162.76 40.95 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-N 115.323 -0.853 . . . . 0.0 112.22 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 100.0 m -109.38 91.16 3.53 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 105.46 -2.052 . . . . 0.0 105.46 179.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.416 ' N ' HD12 ' A' ' 39' ' ' LEU . 6.4 mp -79.65 -66.43 0.87 Allowed 'General case' 0 N--CA 1.494 1.725 0 CA-C-N 114.882 -1.054 . . . . 0.0 109.892 -179.728 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 5.6 m120 49.17 31.84 3.82 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 124.637 1.211 . . . . 0.0 111.185 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.529 ' HA ' ' HA ' ' A' ' 4' ' ' CYS . 1.7 m 55.7 131.98 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 116.668 2.099 . . . . 0.0 116.668 -179.831 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -120.37 81.13 30.06 Favored Pre-proline 0 N--CA 1.5 2.064 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.296 179.667 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -58.58 -15.29 24.76 Favored 'Trans proline' 0 N--CA 1.495 1.574 0 C-N-CA 122.578 2.186 . . . . 0.0 112.308 176.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -62.41 -43.23 99.31 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 26.6 mt -83.09 155.81 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 CA-C-O 122.317 1.056 . . . . 0.0 110.201 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -116.2 -53.84 2.51 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-N 111.731 -2.486 . . . . 0.0 108.025 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 50.9 p90 -165.75 167.31 17.14 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-N 114.41 -1.268 . . . . 0.0 109.287 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -119.93 118.48 3.92 Favored Glycine 0 N--CA 1.49 2.251 0 CA-C-N 113.557 -1.656 . . . . 0.0 110.56 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.9 p -79.31 133.99 28.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 20.9 m -111.27 90.76 12.28 Favored Pre-proline 0 N--CA 1.494 1.745 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 -179.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo . . . . . 0 N--CA 1.499 1.801 0 C-N-CA 123.244 2.629 . . . . 0.0 114.423 -177.1 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 1.6 m . . . . . 0 N--CA 1.494 1.76 0 N-CA-C 115.618 1.71 . . . . 0.0 115.618 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 36.0 m -91.51 109.71 21.01 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 113.175 -1.83 . . . . 0.0 107.893 179.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.463 ' ND2' ' H ' ' A' ' 67' ' ' ALA . 29.8 p-10 -107.83 -165.72 1.08 Allowed 'General case' 0 N--CA 1.503 2.184 0 C-N-CA 120.264 -0.574 . . . . 0.0 109.651 179.84 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' CYS . . . . . 0.409 ' SG ' ' O ' ' A' ' 84' ' ' GLU . 1.5 t -121.22 -33.91 3.59 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 123.904 0.753 . . . . 0.0 111.362 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 32.6 t -57.07 -58.6 7.48 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-O 121.71 0.766 . . . . 0.0 110.12 -179.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.463 ' H ' ' ND2' ' A' ' 64' ' ' ASN . . . -79.42 -10.56 59.83 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-N 113.088 -1.869 . . . . 0.0 109.737 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -67.47 156.57 52.31 Favored Glycine 0 N--CA 1.494 2.551 0 C-N-CA 120.823 -0.703 . . . . 0.0 111.588 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.503 ' C ' ' H ' ' A' ' 71' ' ' GLY . 57.0 p -68.49 124.27 23.09 Favored 'General case' 0 N--CA 1.498 1.951 0 CA-C-N 114.14 -1.03 . . . . 0.0 111.127 -179.809 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.86 20.72 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.173 0 N-CA-C 115.958 1.836 . . . . 0.0 115.958 -179.853 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.503 ' H ' ' C ' ' A' ' 69' ' ' THR . . . -119.58 -25.85 2.52 Favored Glycine 0 N--CA 1.49 2.29 0 CA-C-N 113.623 -1.626 . . . . 0.0 109.319 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 94.6 m -93.36 134.54 35.48 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 120.333 -0.547 . . . . 0.0 109.801 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 60.0 mtpt -88.77 84.27 6.69 Favored 'General case' 0 N--CA 1.485 1.316 0 CA-C-N 113.501 -1.681 . . . . 0.0 109.545 -179.632 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.472 ' HB2' ' SG ' ' A' ' 83' ' ' CYS . 82.0 m-85 -50.08 126.11 13.74 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-N 114.855 -1.066 . . . . 0.0 108.418 179.87 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -132.5 162.88 30.08 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 112.986 -1.915 . . . . 0.0 112.625 -179.327 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 42.6 t -109.21 138.52 45.44 Favored 'General case' 0 N--CA 1.497 1.889 0 CA-C-N 114.309 -1.314 . . . . 0.0 112.376 -179.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -47.45 -27.25 1.63 Allowed 'General case' 0 N--CA 1.5 2.042 0 CA-C-N 112.18 -2.282 . . . . 0.0 114.38 -179.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 13.6 p30 -59.11 -7.62 1.21 Allowed 'General case' 0 N--CA 1.497 1.899 0 O-C-N 124.335 1.022 . . . . 0.0 112.492 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 92.91 28.57 11.83 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 95.8 m -143.08 138.8 30.14 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 124.095 0.526 . . . . 0.0 110.554 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . 0.429 ' CG ' ' N ' ' A' ' 82' ' ' VAL . 37.1 t80 -64.19 164.96 10.01 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 124.878 1.361 . . . . 0.0 110.849 179.853 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.429 ' N ' ' CG ' ' A' ' 81' ' ' PHE . 92.4 t -129.03 -71.56 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 124.188 0.93 . . . . 0.0 112.991 -179.805 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . 0.472 ' SG ' ' HB2' ' A' ' 74' ' ' TYR . 25.4 p -152.58 -173.08 4.44 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 123.708 0.63 . . . . 0.0 109.346 -179.561 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.409 ' O ' ' SG ' ' A' ' 65' ' ' CYS . 40.5 tt0 -128.49 149.63 50.51 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 102.602 -3.111 . . . . 0.0 102.602 179.324 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -58.8 169.89 5.36 Favored Glycine 0 N--CA 1.501 3.023 0 C-N-CA 118.631 -1.747 . . . . 0.0 114.966 -179.66 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -126.15 -13.88 6.11 Favored 'General case' 0 N--CA 1.502 2.145 0 CA-C-N 114.218 -0.991 . . . . 0.0 110.991 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 34.5 t -81.55 121.59 26.5 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -98.32 143.3 26.04 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 124.779 1.299 . . . . 0.0 107.785 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_exo -43.18 -28.07 1.29 Allowed 'Trans proline' 0 N--CA 1.5 1.866 0 C-N-CA 123.4 2.733 . . . . 0.0 114.022 175.073 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -60.09 -50.38 73.92 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 123.911 0.757 . . . . 0.0 109.278 179.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -91.06 116.39 66.32 Favored Pre-proline 0 N--CA 1.497 1.892 0 O-C-N 124.748 1.28 . . . . 0.0 111.806 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -85.02 102.76 0.8 Allowed 'Trans proline' 0 N--CA 1.491 1.342 0 C-N-CA 123.072 2.514 . . . . 0.0 108.044 161.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 22.2 ptmt -161.18 162.95 31.49 Favored 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 113.188 0.81 . . . . 0.0 113.188 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -108.86 -166.86 1.15 Allowed 'General case' 0 N--CA 1.496 1.844 0 CA-C-N 113.56 -1.654 . . . . 0.0 108.406 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 76.9 m -146.99 159.94 41.61 Favored Pre-proline 0 N--CA 1.499 1.984 0 O-C-N 123.653 0.595 . . . . 0.0 110.958 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -73.15 -18.19 23.94 Favored 'Trans proline' 0 N--CA 1.493 1.461 0 C-N-CA 122.36 2.04 . . . . 0.0 109.45 161.522 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.406 ' N ' ' NE ' ' A' ' 97' ' ' ARG . 0.0 OUTLIER -79.64 4.44 16.05 Favored 'General case' 0 N--CA 1.497 1.9 0 CA-C-N 114.949 -1.023 . . . . 0.0 111.376 -179.994 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 -54.89 154.41 5.27 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 52.4 m 58.37 104.19 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 CA-C-N 113.227 -1.806 . . . . 0.0 113.583 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -125.36 107.1 27.27 Favored Pre-proline 0 N--CA 1.498 1.97 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.616 179.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -62.4 -25.79 76.4 Favored 'Trans proline' 0 N--CA 1.493 1.491 0 C-N-CA 122.639 2.226 . . . . 0.0 111.453 179.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 23.5 mtp-105 -57.93 -38.18 75.43 Favored 'General case' 0 N--CA 1.5 2.048 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 26.7 mt -79.31 154.85 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 CA-C-N 114.815 -1.084 . . . . 0.0 110.079 179.734 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -132.36 -46.24 0.91 Allowed 'General case' 0 N--CA 1.495 1.794 0 CA-C-N 111.955 -2.384 . . . . 0.0 109.441 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 49.1 m-85 -140.0 -163.55 1.53 Allowed 'General case' 0 N--CA 1.493 1.706 0 CA-C-N 114.519 -1.219 . . . . 0.0 109.594 -179.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -152.65 107.77 0.34 Allowed Glycine 0 N--CA 1.49 2.235 0 N-CA-C 107.339 -2.304 . . . . 0.0 107.339 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 88.9 mt -79.44 84.41 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 N-CA-C 108.245 -1.021 . . . . 0.0 108.245 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 13.6 m -79.97 112.46 30.18 Favored Pre-proline 0 N--CA 1.494 1.729 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo . . . . . 0 N--CA 1.493 1.442 0 C-N-CA 122.236 1.957 . . . . 0.0 111.306 -167.496 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 72.7 mtp85 . . . . . 0 N--CA 1.495 1.801 0 CA-C-O 120.52 0.2 . . . . 0.0 110.472 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 9.8 tp -87.0 44.11 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 124.169 0.918 . . . . 0.0 109.031 179.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.7 m -82.78 60.35 5.28 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 114.336 1.236 . . . . 0.0 114.336 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 17.8 p -90.92 172.4 8.62 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-N 113.501 -1.681 . . . . 0.0 109.37 179.601 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 32.3 p-10 -161.8 146.06 12.73 Favored 'General case' 0 N--CA 1.497 1.925 0 CA-C-N 115.002 -0.999 . . . . 0.0 109.681 179.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 40.3 t -63.4 -16.54 60.82 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 113.469 0.915 . . . . 0.0 113.469 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 43.8 t -80.77 -63.46 1.4 Allowed 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 114.789 1.403 . . . . 0.0 114.789 -179.515 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -85.21 62.33 7.43 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-N 114.664 -1.153 . . . . 0.0 112.377 -179.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -106.96 -111.79 3.61 Favored Glycine 0 N--CA 1.495 2.578 0 CA-C-N 113.699 -1.591 . . . . 0.0 110.257 179.715 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.456 ' H ' ' HA3' ' A' ' 27' ' ' GLY . 53.4 m -166.64 117.83 0.96 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 125.211 1.183 . . . . 0.0 109.622 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 11.0 mmmm -67.9 83.34 0.21 Allowed 'General case' 0 N--CA 1.502 2.158 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 179.504 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 168.48 -20.26 0.08 OUTLIER Glycine 0 N--CA 1.49 2.282 0 CA-C-N 114.758 -1.11 . . . . 0.0 112.226 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 68.1 m -117.71 -176.68 3.08 Favored 'General case' 0 N--CA 1.5 2.031 0 CA-C-N 117.921 0.86 . . . . 0.0 108.879 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.84 116.78 18.4 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 118.463 -1.295 . . . . 0.0 113.494 -179.657 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.44 ' N ' ' O ' ' A' ' 25' ' ' CYS . 8.2 m-85 -56.61 136.31 54.66 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-N 113.784 -1.553 . . . . 0.0 107.759 179.331 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -151.06 149.69 29.83 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 113.322 -1.763 . . . . 0.0 111.261 -179.452 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.495 ' HG ' ' HE ' ' A' ' 44' ' ' ARG . 38.1 t -98.73 134.33 41.78 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-N 111.914 -2.403 . . . . 0.0 112.174 -179.784 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -51.58 -26.44 8.74 Favored 'General case' 0 N--CA 1.5 2.061 0 CA-C-N 112.701 -2.045 . . . . 0.0 114.24 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 52.0 p-10 -59.28 -10.21 2.82 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 124.079 0.862 . . . . 0.0 112.244 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 97.62 29.65 7.67 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 108.718 -1.753 . . . . 0.0 108.718 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 56.2 m -136.06 145.86 46.45 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 124.135 0.55 . . . . 0.0 109.744 -179.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.426 ' CG ' ' N ' ' A' ' 24' ' ' VAL . 54.3 t80 -75.48 164.42 26.38 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 124.61 1.194 . . . . 0.0 110.612 179.753 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.426 ' N ' ' CG ' ' A' ' 23' ' ' PHE . 87.2 t -128.49 -75.9 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 124.075 0.859 . . . . 0.0 110.5 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.54 ' SG ' ' N ' ' A' ' 26' ' ' GLU . 0.5 OUTLIER -155.0 -164.87 1.89 Allowed 'General case' 0 N--CA 1.505 2.296 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 -179.898 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.54 ' N ' ' SG ' ' A' ' 25' ' ' CYS . 3.6 tm-20 -111.43 137.65 48.95 Favored 'General case' 0 N--CA 1.504 2.259 0 N-CA-C 106.63 -1.618 . . . . 0.0 106.63 179.588 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.456 ' HA3' ' H ' ' A' ' 11' ' ' THR . . . -54.9 117.45 8.17 Favored Glycine 0 N--CA 1.5 2.963 0 N-CA-C 110.53 -1.028 . . . . 0.0 110.53 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 39.8 mm-40 -93.5 10.35 32.81 Favored 'General case' 0 N--CA 1.499 2.022 0 N-CA-C 115.808 1.781 . . . . 0.0 115.808 -179.496 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 32.2 t -76.1 96.55 3.87 Favored 'General case' 0 N--CA 1.499 2.019 0 C-N-CA 118.651 -1.22 . . . . 0.0 108.734 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -87.74 145.91 37.93 Favored Pre-proline 0 N--CA 1.493 1.688 0 CA-C-N 114.31 -1.314 . . . . 0.0 108.486 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_exo -47.12 111.95 0.46 Allowed 'Trans proline' 0 N--CA 1.494 1.533 0 C-N-CA 122.366 2.044 . . . . 0.0 110.148 169.399 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 79.1 mtp180 57.07 48.94 14.58 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 124.439 1.087 . . . . 0.0 109.687 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -58.89 140.02 86.62 Favored Pre-proline 0 N--CA 1.498 1.928 0 CA-C-N 114.024 -1.444 . . . . 0.0 110.856 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -66.14 129.18 21.12 Favored 'Trans proline' 0 N--CA 1.492 1.409 0 C-N-CA 122.367 2.045 . . . . 0.0 110.599 -178.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 59.3 mttp 62.42 162.69 0.09 Allowed 'General case' 0 N--CA 1.503 2.222 0 O-C-N 124.742 1.276 . . . . 0.0 113.351 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -89.05 168.55 12.24 Favored 'General case' 0 N--CA 1.498 1.937 0 CA-C-N 114.528 -1.215 . . . . 0.0 110.293 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 71.3 m -79.86 163.5 24.32 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.946 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 43.7 m -138.19 7.98 2.68 Favored 'General case' 0 N--CA 1.497 1.91 0 CA-C-N 114.768 -1.106 . . . . 0.0 110.025 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 88.2 mt -79.33 -65.23 1.03 Allowed 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 7.8 m-80 56.73 116.34 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 114.911 1.448 . . . . 0.0 114.911 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 82.0 m 58.41 122.15 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 116.164 1.913 . . . . 0.0 116.164 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -144.42 90.37 6.6 Favored Pre-proline 0 N--CA 1.496 1.845 0 CA-C-N 114.637 -1.165 . . . . 0.0 109.838 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -57.39 -28.23 79.31 Favored 'Trans proline' 0 N--CA 1.493 1.482 0 C-N-CA 122.805 2.337 . . . . 0.0 113.051 179.372 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.495 ' HE ' ' HG ' ' A' ' 18' ' ' SER . 15.5 tpt180 -58.17 -41.06 83.04 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 123.934 0.771 . . . . 0.0 109.476 179.857 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 14.3 mt -70.24 154.57 8.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 CA-C-O 122.121 0.962 . . . . 0.0 110.163 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -121.15 -50.66 2.13 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-N 111.938 -2.392 . . . . 0.0 107.343 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 19.5 p90 -171.85 164.18 6.39 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-N 114.242 -1.345 . . . . 0.0 111.214 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -104.01 91.36 0.8 Allowed Glycine 0 N--CA 1.492 2.401 0 N-CA-C 107.159 -2.376 . . . . 0.0 107.159 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.1 p -84.25 126.66 40.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 C-N-CA 119.123 -1.031 . . . . 0.0 112.893 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.6 m -79.64 154.0 75.99 Favored Pre-proline 0 N--CA 1.496 1.868 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 179.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo . . . . . 0 N--CA 1.494 1.537 0 C-N-CA 122.739 2.292 . . . . 0.0 109.743 -173.167 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . 0.452 ' HA ' ' HA ' ' A' ' 99' ' ' CYS . 1.7 m . . . . . 0 N--CA 1.479 0.997 0 CA-C-O 123.204 1.478 . . . . 0.0 111.607 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 87.0 m -90.52 171.64 9.27 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-N 112.255 -2.248 . . . . 0.0 107.625 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -160.37 -162.7 1.0 Allowed 'General case' 0 N--CA 1.5 2.061 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' CYS . . . . . 0.469 ' SG ' ' CD2' ' A' ' 74' ' ' TYR . 3.9 t -107.01 -28.26 10.14 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 124.071 0.857 . . . . 0.0 109.78 179.766 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . 0.451 ' SG ' ' CE ' ' A' ' 93' ' ' LYS . 51.0 t -73.88 -57.63 3.85 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 114.918 1.451 . . . . 0.0 114.918 -179.669 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -80.75 60.09 3.9 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 124.833 1.333 . . . . 0.0 112.565 -179.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -145.57 -139.91 3.45 Favored Glycine 0 N--CA 1.497 2.73 0 N-CA-C 108.253 -1.939 . . . . 0.0 108.253 179.625 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.456 ' C ' ' H ' ' A' ' 71' ' ' GLY . 92.4 m -154.03 150.72 28.54 Favored 'General case' 0 N--CA 1.505 2.319 0 N-CA-C 114.434 1.272 . . . . 0.0 114.434 -179.825 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 24.0 mmtt -72.63 35.87 0.07 Allowed 'General case' 0 N--CA 1.505 2.304 0 CA-C-N 113.042 -1.89 . . . . 0.0 112.689 179.634 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.456 ' H ' ' C ' ' A' ' 69' ' ' THR . . . -131.92 2.52 5.19 Favored Glycine 0 N--CA 1.485 1.923 0 N-CA-C 109.141 -1.584 . . . . 0.0 109.141 179.867 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 94.1 m -141.7 167.01 23.17 Favored 'General case' 0 N--CA 1.497 1.916 0 C-N-CA 119.384 -0.926 . . . . 0.0 111.376 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -119.89 105.45 11.1 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 124.184 0.928 . . . . 0.0 109.67 -179.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.648 ' CD2' ' SG ' ' A' ' 83' ' ' CYS . 74.0 m-85 -51.13 135.88 24.81 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 124.047 0.842 . . . . 0.0 110.382 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -146.96 157.22 43.57 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 -179.571 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 42.9 t -110.4 130.99 55.44 Favored 'General case' 0 N--CA 1.501 2.085 0 CA-C-N 113.441 -1.709 . . . . 0.0 113.281 -179.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.465 ' H ' ' HB1' ' A' ' 104' ' ' ALA . 7.3 p-10 -46.08 -31.5 2.37 Favored 'General case' 0 N--CA 1.502 2.141 0 CA-C-N 112.562 -2.108 . . . . 0.0 115.349 -179.861 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 39.1 p30 -57.42 -10.09 1.29 Allowed 'General case' 0 N--CA 1.497 1.901 0 O-C-N 124.268 0.98 . . . . 0.0 112.794 -179.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 99.1 23.84 11.03 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 110.159 -1.177 . . . . 0.0 110.159 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -131.31 146.87 52.48 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 124.211 0.595 . . . . 0.0 109.631 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 45.1 t80 -77.53 154.92 31.97 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 114.124 -1.398 . . . . 0.0 110.714 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 92.8 t -113.08 -73.45 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 124.19 0.931 . . . . 0.0 112.767 -179.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . 0.648 ' SG ' ' CD2' ' A' ' 74' ' ' TYR . 29.7 p -157.3 -174.0 4.69 Favored 'General case' 0 N--CA 1.503 2.181 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 -179.585 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -119.43 155.92 31.11 Favored 'General case' 0 N--CA 1.505 2.282 0 CA-C-O 119.003 -0.522 . . . . 0.0 109.793 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.406 ' HA2' ' CE2' ' A' ' 74' ' ' TYR . . . -31.22 111.78 0.05 OUTLIER Glycine 0 N--CA 1.502 3.048 0 O-C-N 124.838 1.337 . . . . 0.0 112.599 179.901 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -100.84 27.54 5.88 Favored 'General case' 0 N--CA 1.498 1.932 0 C-N-CA 119.97 -0.692 . . . . 0.0 109.199 -179.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.407 ' HG ' HD22 ' A' ' 91' ' ' ASN . 42.6 t -140.55 95.95 2.95 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-O 121.469 0.652 . . . . 0.0 111.959 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -84.72 148.08 50.58 Favored Pre-proline 0 N--CA 1.496 1.845 0 N-CA-C 106.15 -1.796 . . . . 0.0 106.15 179.717 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -64.67 86.56 0.17 Allowed 'Trans proline' 0 N--CA 1.493 1.447 0 N-CA-C 108.265 -1.475 . . . . 0.0 108.265 165.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 44.2 mtm180 150.82 -27.04 0.01 OUTLIER 'General case' 0 N--CA 1.513 2.693 0 O-C-N 125.741 1.901 . . . . 0.0 109.753 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.407 HD22 ' HG ' ' A' ' 87' ' ' SER . 31.3 p-10 -41.51 116.17 1.5 Allowed Pre-proline 0 N--CA 1.501 2.083 0 N-CA-C 114.177 1.177 . . . . 0.0 114.177 -179.713 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -76.62 77.11 3.76 Favored 'Trans proline' 0 N--CA 1.493 1.474 0 C-N-CA 122.721 2.281 . . . . 0.0 109.565 174.423 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.451 ' CE ' ' SG ' ' A' ' 66' ' ' CYS . 21.4 ptmt -167.9 170.46 10.61 Favored 'General case' 0 N--CA 1.498 1.93 0 CA-C-N 114.759 -1.109 . . . . 0.0 110.685 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -160.19 147.42 16.2 Favored 'General case' 0 N--CA 1.497 1.883 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.322 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 58.2 m -153.54 130.31 5.69 Favored Pre-proline 0 N--CA 1.497 1.879 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.379 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.424 ' HD2' HD22 ' A' ' 98' ' ' ASN . 18.4 Cg_endo -63.51 -78.37 0.01 OUTLIER 'Trans proline' 0 N--CA 1.493 1.489 0 C-N-CA 122.316 2.01 . . . . 0.0 111.511 171.721 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 60.6 mmt-85 -135.68 -44.89 0.67 Allowed 'General case' 0 N--CA 1.499 2.007 0 O-C-N 123.995 0.809 . . . . 0.0 112.432 -179.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.424 HD22 ' HD2' ' A' ' 96' ' ' PRO . 3.5 m-80 49.44 58.62 5.21 Favored 'General case' 0 N--CA 1.503 2.197 0 O-C-N 124.313 1.008 . . . . 0.0 108.367 -179.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . 0.452 ' HA ' ' HA ' ' A' ' 62' ' ' CYS . 37.1 m -35.77 127.57 0.67 Allowed 'General case' 0 N--CA 1.494 1.735 0 CA-C-N 113.573 -1.649 . . . . 0.0 115.25 -179.523 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -129.35 98.78 22.34 Favored Pre-proline 0 N--CA 1.493 1.708 0 CA-C-N 114.25 -1.341 . . . . 0.0 110.268 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -63.85 -12.0 29.61 Favored 'Trans proline' 0 N--CA 1.494 1.522 0 C-N-CA 122.011 1.807 . . . . 0.0 112.166 -178.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 80.8 mtm180 -80.28 -30.55 38.32 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 112.675 0.621 . . . . 0.0 112.675 -179.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 11.8 tt -90.88 164.07 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.164 0 C-N-CA 120.036 -0.665 . . . . 0.0 110.097 -179.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.465 ' HB1' ' H ' ' A' ' 77' ' ' ASP . . . -124.15 -59.67 1.47 Allowed 'General case' 0 N--CA 1.496 1.848 0 CA-C-N 114.758 -1.11 . . . . 0.0 108.394 179.826 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 21.7 p90 -161.33 161.79 30.64 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-N 114.631 -1.168 . . . . 0.0 111.03 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -94.95 115.24 5.05 Favored Glycine 0 N--CA 1.492 2.389 0 CA-C-N 113.59 -1.641 . . . . 0.0 111.575 -179.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 12.4 pt -83.63 102.44 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.27 0 N-CA-C 105.725 -1.954 . . . . 0.0 105.725 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 13.4 m -79.48 133.04 60.35 Favored Pre-proline 0 N--CA 1.49 1.554 0 CA-C-N 113.8 -1.545 . . . . 0.0 110.295 -179.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo . . . . . 0 N--CA 1.492 1.433 0 C-N-CA 122.599 2.199 . . . . 0.0 110.46 -177.127 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 120.945 0.402 . . . . 0.0 109.961 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 93.6 mtt-85 -72.65 138.69 46.85 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.213 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 7.9 tp -83.79 52.92 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 CA-C-N 115.052 -0.976 . . . . 0.0 109.636 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.484 ' HA ' ' HA ' ' A' ' 41' ' ' CYS . 1.5 m -82.72 51.75 1.96 Allowed 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 117.061 2.245 . . . . 0.0 117.061 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 7.2 p -91.75 164.63 13.64 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-N 113.169 -1.832 . . . . 0.0 109.035 179.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 37.7 p-10 -160.88 148.13 15.47 Favored 'General case' 0 N--CA 1.499 1.985 0 C-N-CA 119.917 -0.713 . . . . 0.0 110.058 179.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 18.4 t -67.11 -20.24 65.75 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-N 114.864 -1.062 . . . . 0.0 112.892 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 43.7 t -81.34 -64.46 1.18 Allowed 'General case' 0 N--CA 1.497 1.878 0 O-C-N 123.607 0.567 . . . . 0.0 112.128 -179.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -89.22 45.12 1.26 Allowed 'General case' 0 N--CA 1.5 2.044 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.896 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -84.17 -147.13 7.93 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 110.337 -1.105 . . . . 0.0 110.337 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 40.4 p -137.62 95.29 3.03 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.11 112.98 0.81 Allowed 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 144.97 -34.58 1.55 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 108.301 -1.92 . . . . 0.0 108.301 -179.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 35.4 m -106.09 130.29 54.02 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -83.11 91.61 7.25 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 113.627 -1.624 . . . . 0.0 110.132 -179.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.409 ' N ' ' O ' ' A' ' 25' ' ' CYS . 39.8 m-85 -50.09 122.1 6.32 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-N 114.028 -1.442 . . . . 0.0 109.081 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -132.44 153.32 50.97 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-N 112.316 -2.22 . . . . 0.0 110.643 -179.67 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.501 ' HG ' ' H ' ' A' ' 20' ' ' ASP . 31.2 t -99.15 141.18 32.25 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-N 111.679 -2.509 . . . . 0.0 115.628 -179.548 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -52.17 -25.05 8.1 Favored 'General case' 0 N--CA 1.499 1.983 0 CA-C-N 111.002 -2.817 . . . . 0.0 113.269 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.501 ' H ' ' HG ' ' A' ' 18' ' ' SER . 52.5 p-10 -62.59 -4.79 2.16 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 124.092 0.87 . . . . 0.0 111.609 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 88.92 30.15 15.72 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 108.781 -1.728 . . . . 0.0 108.781 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 87.0 m -141.66 146.87 36.65 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 124.087 0.522 . . . . 0.0 110.585 -179.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 39.9 t80 -73.02 162.81 29.05 Favored 'General case' 0 N--CA 1.496 1.827 0 CA-C-N 114.35 -1.296 . . . . 0.0 110.04 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 58.7 t -127.56 -79.44 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 CA-C-N 115.282 -0.872 . . . . 0.0 108.991 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.57 ' SG ' ' N ' ' A' ' 26' ' ' GLU . 0.1 OUTLIER -156.99 -170.47 3.3 Favored 'General case' 0 N--CA 1.504 2.258 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 179.971 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.57 ' N ' ' SG ' ' A' ' 25' ' ' CYS . 37.6 tt0 -118.64 154.29 32.91 Favored 'General case' 0 N--CA 1.503 2.214 0 N-CA-C 106.079 -1.823 . . . . 0.0 106.079 179.444 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -50.15 116.9 4.38 Favored Glycine 0 N--CA 1.498 2.791 0 C-N-CA 120.088 -1.053 . . . . 0.0 112.721 -179.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -79.66 -17.2 54.24 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 41.1 t -112.38 112.96 24.9 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.547 ' H ' HD22 ' A' ' 33' ' ' ASN . 16.0 t0 -79.38 138.55 55.56 Favored Pre-proline 0 N--CA 1.494 1.735 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_endo -65.48 75.22 0.27 Allowed 'Trans proline' 0 N--CA 1.498 1.746 0 C-N-CA 122.705 2.27 . . . . 0.0 106.577 161.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 43.1 ttp85 -173.0 -53.43 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 104.982 -2.229 . . . . 0.0 104.982 -179.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.547 HD22 ' H ' ' A' ' 30' ' ' ASP . 25.9 p30 -90.7 156.44 44.95 Favored Pre-proline 0 N--CA 1.494 1.759 0 CA-C-N 114.638 -1.165 . . . . 0.0 110.978 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -71.54 177.16 7.11 Favored 'Trans proline' 0 N--CA 1.493 1.469 0 C-N-CA 122.643 2.229 . . . . 0.0 110.311 168.004 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.41 153.07 19.15 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.247 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -148.12 62.37 1.11 Allowed 'General case' 0 N--CA 1.495 1.819 0 CA-C-N 115.067 -0.969 . . . . 0.0 109.127 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 72.4 m -79.57 -50.48 10.64 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-N 114.388 -1.278 . . . . 0.0 109.358 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 26.3 m 64.31 -9.12 0.17 Allowed 'General case' 0 N--CA 1.503 2.176 0 O-C-N 124.781 1.301 . . . . 0.0 113.448 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.405 ' HG ' ' H ' ' A' ' 40' ' ' ASN . 2.1 pp -79.56 -55.59 4.92 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 120.251 -0.58 . . . . 0.0 109.559 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.405 ' H ' ' HG ' ' A' ' 39' ' ' LEU . 33.6 m120 47.42 -177.77 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 115.927 1.825 . . . . 0.0 115.927 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.484 ' HA ' ' HA ' ' A' ' 4' ' ' CYS . 58.1 m 48.63 119.36 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 116.667 2.099 . . . . 0.0 116.667 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 60.1 t0 -152.16 94.97 3.21 Favored Pre-proline 0 N--CA 1.489 1.517 0 CA-C-N 113.789 -1.55 . . . . 0.0 108.46 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -53.63 -17.86 10.69 Favored 'Trans proline' 0 N--CA 1.495 1.591 0 C-N-CA 122.896 2.398 . . . . 0.0 113.046 178.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 10.9 tpt180 -59.06 -50.82 72.61 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.44 ' CG2' ' N ' ' A' ' 46' ' ' ALA . 2.0 mp -62.89 159.2 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 CA-C-O 122.623 1.201 . . . . 0.0 112.264 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.44 ' N ' ' CG2' ' A' ' 45' ' ' ILE . . . -127.29 -48.63 1.44 Allowed 'General case' 0 N--CA 1.492 1.641 0 CA-C-N 111.33 -2.668 . . . . 0.0 106.267 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 51.8 p90 -166.23 -163.42 0.6 Allowed 'General case' 0 N--CA 1.495 1.817 0 CA-C-N 113.637 -1.619 . . . . 0.0 107.373 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -145.83 113.15 0.67 Allowed Glycine 0 N--CA 1.495 2.567 0 N-CA-C 108.621 -1.791 . . . . 0.0 108.621 179.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.7 p -79.77 105.91 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 N-CA-C 114.284 1.216 . . . . 0.0 114.284 -179.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.7 m -81.81 117.45 68.35 Favored Pre-proline 0 N--CA 1.5 2.068 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 179.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -67.65 150.26 79.48 Favored 'Trans proline' 0 N--CA 1.494 1.531 0 C-N-CA 122.05 1.833 . . . . 0.0 110.623 178.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.413 ' NE ' ' HA ' ' A' ' 52' ' ' ARG . 6.5 tpm_? -152.92 -66.83 0.16 Allowed 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 22.9 t 52.91 42.27 32.05 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 124.335 1.022 . . . . 0.0 112.313 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -168.39 8.09 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.105 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.996 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -55.81 -42.51 75.77 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 123.776 0.672 . . . . 0.0 110.109 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -73.71 177.37 5.5 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-N 114.867 -1.06 . . . . 0.0 110.714 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 61.6 tttp 51.79 78.2 0.13 Allowed 'General case' 0 N--CA 1.499 1.995 0 O-C-N 124.314 1.009 . . . . 0.0 110.412 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 11.5 p-10 -161.6 -39.82 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.78 0 CA-C-N 113.868 -1.514 . . . . 0.0 108.995 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -72.88 -46.25 53.84 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-N 114.575 -1.193 . . . . 0.0 108.834 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 28.3 mmt85 7.29 -73.59 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.241 0 O-C-N 126.013 2.071 . . . . 0.0 116.471 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 10.3 tp -82.99 50.49 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 123.839 0.712 . . . . 0.0 110.926 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 1.6 m -81.44 29.88 0.36 Allowed 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 115.916 1.821 . . . . 0.0 115.916 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -91.59 148.0 22.6 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-N 112.272 -2.24 . . . . 0.0 107.353 179.512 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 15.2 p30 -162.05 147.78 13.2 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 114.469 1.285 . . . . 0.0 114.469 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -63.25 -20.67 65.66 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-N 114.351 -1.295 . . . . 0.0 112.582 179.621 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 41.8 t -90.65 -74.78 0.48 Allowed 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -89.5 35.57 0.82 Allowed 'General case' 0 N--CA 1.497 1.895 0 CA-C-N 114.433 -1.258 . . . . 0.0 113.139 -179.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -81.04 -112.34 0.32 Allowed Glycine 0 N--CA 1.494 2.531 0 N-CA-C 109.135 -1.586 . . . . 0.0 109.135 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.516 ' H ' ' HA3' ' A' ' 85' ' ' GLY . 38.2 p -153.7 123.03 6.58 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 179.671 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -70.21 93.87 0.87 Allowed 'General case' 0 N--CA 1.502 2.125 0 CA-C-O 122.089 0.947 . . . . 0.0 109.516 179.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 162.99 -27.21 0.23 Allowed Glycine 0 N--CA 1.487 2.058 0 CA-C-N 113.107 -1.86 . . . . 0.0 109.947 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 36.1 m -108.8 141.65 40.51 Favored 'General case' 0 N--CA 1.497 1.902 0 C-N-CA 120.024 -0.67 . . . . 0.0 110.209 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.466 ' HB3' ' CE1' ' A' ' 81' ' ' PHE . 58.6 mtpt -83.7 89.11 7.09 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 113.726 -1.579 . . . . 0.0 109.683 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 27.7 m-85 -59.56 116.45 4.01 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 106.13 -1.804 . . . . 0.0 106.13 179.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -121.14 146.86 46.32 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 111.483 -2.599 . . . . 0.0 112.516 -179.449 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.494 ' HG ' ' HE ' ' A' ' 102' ' ' ARG . 32.0 t -91.31 144.23 25.81 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-N 112.363 -2.199 . . . . 0.0 116.312 -179.586 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.414 ' C ' ' H ' ' A' ' 79' ' ' GLY . 1.9 p30 -53.09 -21.16 4.39 Favored 'General case' 0 N--CA 1.497 1.901 0 CA-C-N 110.603 -2.999 . . . . 0.0 113.322 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 18.4 p30 -66.77 -0.15 2.79 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 124.183 0.927 . . . . 0.0 110.773 179.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.414 ' H ' ' C ' ' A' ' 77' ' ' ASP . . . 83.48 29.83 31.84 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 93.6 m -142.83 142.86 31.91 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 120.394 -0.522 . . . . 0.0 110.939 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . 0.466 ' CE1' ' HB3' ' A' ' 73' ' ' LYS . 9.7 t80 -73.93 143.41 45.72 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-N 114.373 -1.285 . . . . 0.0 109.705 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 67.6 t -104.58 -77.91 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -166.97 172.85 9.83 Favored 'General case' 0 N--CA 1.503 2.219 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 179.733 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.412 ' HG2' ' N ' ' A' ' 85' ' ' GLY . 22.7 tt0 -79.64 150.22 31.03 Favored 'General case' 0 N--CA 1.501 2.085 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 179.705 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.516 ' HA3' ' H ' ' A' ' 69' ' ' THR . . . -65.74 127.67 31.27 Favored Glycine 0 N--CA 1.494 2.522 0 N-CA-C 104.251 -3.54 . . . . 0.0 104.251 179.721 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -93.75 23.42 4.77 Favored 'General case' 0 N--CA 1.497 1.905 0 CA-C-N 118.049 0.924 . . . . 0.0 113.337 -179.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 25.1 t -84.26 98.53 10.03 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-N 114.529 -1.214 . . . . 0.0 108.288 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -79.86 155.37 75.46 Favored Pre-proline 0 N--CA 1.496 1.834 0 N-CA-C 107.529 -1.285 . . . . 0.0 107.529 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo -38.58 108.21 0.07 OUTLIER 'Trans proline' 0 N--CA 1.493 1.483 0 C-N-CA 122.386 2.057 . . . . 0.0 112.147 162.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER 59.06 50.89 7.63 Favored 'General case' 0 N--CA 1.497 1.92 0 CA-C-N 114.676 -1.147 . . . . 0.0 110.876 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.557 HD21 ' H ' ' A' ' 91' ' ' ASN . 0.5 OUTLIER -79.43 119.61 77.56 Favored Pre-proline 0 N--CA 1.497 1.875 0 CA-C-N 113.898 -1.501 . . . . 0.0 111.878 -179.96 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -79.87 79.36 3.37 Favored 'Trans proline' 0 N--CA 1.493 1.474 0 C-N-CA 123.093 2.529 . . . . 0.0 109.986 172.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 14.1 ptmm? -166.06 144.56 5.79 Favored 'General case' 0 N--CA 1.5 2.029 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.721 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -160.12 103.29 1.46 Allowed 'General case' 0 N--CA 1.496 1.854 0 CA-C-N 114.649 -1.16 . . . . 0.0 108.575 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 35.1 m -79.77 168.67 24.51 Favored Pre-proline 0 N--CA 1.498 1.959 0 CA-C-N 115.122 -0.944 . . . . 0.0 109.297 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -57.91 -5.7 2.14 Favored 'Trans proline' 0 N--CA 1.496 1.672 0 C-N-CA 122.292 1.995 . . . . 0.0 112.404 162.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 35.2 mmt180 -79.52 7.26 8.51 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 123.49 0.494 . . . . 0.0 111.828 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -50.03 117.39 2.3 Favored 'General case' 0 N--CA 1.503 2.196 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 91.4 m 56.07 65.38 1.46 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 124.538 1.149 . . . . 0.0 108.048 -179.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -62.35 109.55 2.45 Favored Pre-proline 0 N--CA 1.498 1.926 0 CA-C-N 114.356 -1.293 . . . . 0.0 112.287 -179.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -69.44 -34.75 14.98 Favored 'Trans proline' 0 N--CA 1.493 1.463 0 C-N-CA 122.049 1.833 . . . . 0.0 109.783 -174.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.494 ' HE ' ' HG ' ' A' ' 76' ' ' SER . 0.0 OUTLIER -63.48 -21.37 66.28 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-N 114.447 -1.252 . . . . 0.0 111.659 -179.96 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 4.4 tp -76.49 177.7 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 C-N-CA 119.218 -0.993 . . . . 0.0 108.403 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -130.37 -61.32 0.97 Allowed 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 -147.73 -161.61 1.37 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 124.48 1.113 . . . . 0.0 109.042 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -142.35 95.13 0.19 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 106.016 -2.834 . . . . 0.0 106.016 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 42.5 mm -78.72 98.86 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 N-CA-C 113.792 1.034 . . . . 0.0 113.792 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 1.6 m -79.52 153.63 76.19 Favored Pre-proline 0 N--CA 1.501 2.091 0 CA-C-N 114.952 -1.022 . . . . 0.0 108.262 179.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -64.75 119.79 6.91 Favored 'Trans proline' 0 N--CA 1.494 1.502 0 C-N-CA 122.542 2.162 . . . . 0.0 109.942 179.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.4 tt -79.87 98.41 7.09 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 1.876 0 CA-C-O 116.847 -1.549 . . . . 0.0 110.689 179.948 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 . . . . . 0 N--CA 1.491 1.607 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 61.7 ttm-85 -90.25 62.88 5.56 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.0 tp -79.85 71.88 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 CA-C-N 114.399 -1.273 . . . . 0.0 110.038 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.6 m -89.97 57.47 3.82 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 122.849 1.309 . . . . 0.0 114.159 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.446 ' O ' ' N ' ' A' ' 42' ' ' ASP . 1.1 p -90.06 157.05 17.97 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 104.275 -2.491 . . . . 0.0 104.275 179.204 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.458 ' CG ' ' H ' ' A' ' 7' ' ' CYS . 6.7 t-20 -160.77 -177.3 6.06 Favored 'General case' 0 N--CA 1.5 2.036 0 C-N-CA 118.149 -1.42 . . . . 0.0 112.083 -179.684 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.476 ' SG ' ' CD2' ' A' ' 16' ' ' TYR . 1.8 t -76.78 -32.98 58.04 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-N 113.328 -1.76 . . . . 0.0 107.115 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 34.1 t -82.12 -57.57 3.34 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-N 112.003 -2.362 . . . . 0.0 107.609 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -57.56 -23.43 50.5 Favored 'General case' 0 N--CA 1.497 1.912 0 CA-C-N 114.484 -1.235 . . . . 0.0 110.77 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -71.41 -168.09 8.79 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 110.756 -0.938 . . . . 0.0 110.756 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.429 ' N ' ' HH ' ' A' ' 16' ' ' TYR . 41.1 p -104.71 103.19 12.78 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.435 ' HA ' ' CA ' ' A' ' 27' ' ' GLY . 39.1 ttpt -48.16 104.97 0.07 Allowed 'General case' 0 N--CA 1.5 2.048 0 O-C-N 123.737 0.648 . . . . 0.0 111.322 179.673 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 149.69 -20.42 1.15 Allowed Glycine 0 N--CA 1.491 2.36 0 CA-C-N 114.364 -1.289 . . . . 0.0 111.033 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 96.2 m -107.41 149.45 27.88 Favored 'General case' 0 N--CA 1.499 2.023 0 C-N-CA 120.316 -0.554 . . . . 0.0 112.069 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -83.13 93.71 7.68 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-N 114.273 -1.33 . . . . 0.0 107.754 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.476 ' CD2' ' SG ' ' A' ' 7' ' ' CYS . 48.6 m-85 -52.76 130.07 31.69 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-N 113.997 -1.456 . . . . 0.0 109.027 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -143.47 155.03 44.25 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-N 113.174 -1.83 . . . . 0.0 112.339 -179.438 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 38.3 t -101.37 136.01 41.92 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-N 112.449 -2.16 . . . . 0.0 112.577 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -50.04 -25.11 3.08 Favored 'General case' 0 N--CA 1.502 2.129 0 CA-C-N 112.626 -2.079 . . . . 0.0 114.186 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 27.4 p30 -59.69 -7.49 1.58 Allowed 'General case' 0 N--CA 1.498 1.952 0 O-C-N 124.228 0.955 . . . . 0.0 112.288 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 94.25 28.36 10.82 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 88.5 m -141.43 142.79 33.67 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 124.149 0.558 . . . . 0.0 110.144 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.408 ' CG ' ' N ' ' A' ' 24' ' ' VAL . 40.5 t80 -68.79 166.93 16.52 Favored 'General case' 0 N--CA 1.497 1.878 0 CA-C-N 114.194 -1.366 . . . . 0.0 110.82 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.408 ' N ' ' CG ' ' A' ' 23' ' ' PHE . 97.5 t -128.89 -72.31 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 123.996 0.81 . . . . 0.0 111.82 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.447 ' SG ' ' HD2' ' A' ' 16' ' ' TYR . 20.8 p -154.31 -168.6 2.98 Favored 'General case' 0 N--CA 1.503 2.199 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 -179.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 60.5 tt0 -139.66 151.12 45.69 Favored 'General case' 0 N--CA 1.501 2.096 0 CA-C-O 121.446 0.641 . . . . 0.0 111.369 179.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.435 ' CA ' ' HA ' ' A' ' 12' ' ' LYS . . . -7.25 103.71 0.01 OUTLIER Glycine 0 N--CA 1.497 2.716 0 N-CA-C 119.333 2.493 . . . . 0.0 119.333 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -99.48 -52.25 3.54 Favored 'General case' 0 N--CA 1.501 2.112 0 C-N-CA 119.71 -0.796 . . . . 0.0 110.355 179.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 6.5 p -149.83 142.18 24.24 Favored 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -101.88 144.85 29.4 Favored Pre-proline 0 N--CA 1.498 1.943 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_exo -45.12 -25.2 1.69 Allowed 'Trans proline' 0 N--CA 1.498 1.778 0 C-N-CA 122.918 2.412 . . . . 0.0 112.868 170.087 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 3.6 tpm_? -62.9 -53.45 54.0 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -85.65 129.41 54.95 Favored Pre-proline 0 N--CA 1.494 1.73 0 CA-C-N 115.133 -0.94 . . . . 0.0 109.221 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -65.38 108.2 1.14 Allowed 'Trans proline' 0 N--CA 1.493 1.5 0 C-N-CA 122.317 2.011 . . . . 0.0 109.471 -179.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.447 ' HD3' ' H ' ' A' ' 36' ' ' ALA . 6.1 tmtt? -154.53 142.12 19.81 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.447 ' H ' ' HD3' ' A' ' 35' ' ' LYS . . . -149.3 111.07 4.54 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-N 113.382 -1.736 . . . . 0.0 107.644 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.401 ' H ' HD22 ' A' ' 40' ' ' ASN . 70.3 m -79.96 -168.73 1.73 Allowed 'General case' 0 N--CA 1.495 1.815 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.104 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 9.2 t -104.94 13.84 30.4 Favored 'General case' 0 N--CA 1.497 1.911 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.351 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -160.38 64.66 0.33 Allowed 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.401 HD22 ' H ' ' A' ' 37' ' ' CYS . 12.0 m120 -88.65 46.15 1.36 Allowed 'General case' 0 N--CA 1.498 1.939 0 CA-C-N 114.292 -1.322 . . . . 0.0 111.172 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 80.4 m -145.16 139.29 27.16 Favored 'General case' 0 N--CA 1.499 2.02 0 CA-C-N 115.014 -0.993 . . . . 0.0 108.547 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.446 ' N ' ' O ' ' A' ' 5' ' ' THR . 34.2 t70 -166.2 88.35 0.87 Allowed Pre-proline 0 N--CA 1.497 1.896 0 O-C-N 123.794 0.684 . . . . 0.0 110.207 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_exo -53.53 -15.29 5.98 Favored 'Trans proline' 0 N--CA 1.495 1.617 0 C-N-CA 122.466 2.111 . . . . 0.0 112.961 173.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 41.5 ttm180 -76.89 -39.06 52.31 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 113.302 0.853 . . . . 0.0 113.302 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 7.6 tt -75.8 142.9 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.175 0 C-N-CA 118.746 -1.181 . . . . 0.0 111.714 -179.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -104.84 -49.84 3.41 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-N 113.638 -1.619 . . . . 0.0 107.737 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 52.1 p90 -163.52 -163.07 0.78 Allowed 'General case' 0 N--CA 1.496 1.868 0 CA-C-N 114.07 -1.423 . . . . 0.0 107.423 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -144.98 122.27 1.7 Allowed Glycine 0 N--CA 1.494 2.549 0 N-CA-C 109.13 -1.588 . . . . 0.0 109.13 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.6 p -88.69 108.75 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 CA-C-O 121.545 0.688 . . . . 0.0 112.799 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.7 m -79.78 137.13 54.46 Favored Pre-proline 0 N--CA 1.499 1.987 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.218 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -64.18 -29.97 64.76 Favored 'Trans proline' 0 N--CA 1.494 1.507 0 C-N-CA 122.376 2.051 . . . . 0.0 110.063 177.292 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 11.1 mmm180 -110.49 37.19 2.82 Favored 'General case' 0 N--CA 1.495 1.789 0 CA-C-N 114.734 -1.121 . . . . 0.0 110.086 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 41.2 t -68.45 101.03 1.17 Allowed 'General case' 0 N--CA 1.496 1.829 0 CA-C-N 115.318 -0.855 . . . . 0.0 109.012 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -70.92 146.29 49.63 Favored 'General case' 0 N--CA 1.494 1.766 0 CA-C-N 115.486 -0.779 . . . . 0.0 112.154 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -122.87 -17.59 6.75 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-N 113.165 -1.834 . . . . 0.0 107.502 179.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 6.1 mtpm? -55.14 -67.95 0.23 Allowed 'General case' 0 N--CA 1.492 1.672 0 CA-C-N 114.26 -1.337 . . . . 0.0 111.627 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 7.1 mmpt? 65.62 147.57 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.168 0 O-C-N 125.04 1.462 . . . . 0.0 110.023 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 14.2 m-80 64.48 -78.76 0.03 OUTLIER 'General case' 0 N--CA 1.504 2.243 0 O-C-N 124.124 0.89 . . . . 0.0 109.791 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 22.8 t70 61.98 166.67 0.11 Allowed 'General case' 0 N--CA 1.5 2.064 0 N-CA-C 113.091 0.775 . . . . 0.0 113.091 179.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 5.1 tpp180 -60.84 151.22 30.46 Favored 'General case' 0 N--CA 1.496 1.847 0 CA-C-N 114.752 -1.113 . . . . 0.0 109.972 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 5.7 tp -57.69 85.39 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 124.667 1.229 . . . . 0.0 111.97 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . 0.576 ' HA ' ' HA ' ' A' ' 99' ' ' CYS . 1.7 m -93.26 33.92 1.18 Allowed 'General case' 0 N--CA 1.49 1.572 0 CA-C-O 123.916 1.817 . . . . 0.0 115.453 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 61.2 m -91.42 139.86 30.32 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 110.399 -3.091 . . . . 0.0 103.189 179.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 38.1 p-10 -160.81 161.32 31.96 Favored 'General case' 0 N--CA 1.497 1.898 0 C-N-CA 119.771 -0.772 . . . . 0.0 112.988 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 1.3 t -55.75 -23.22 28.15 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-N 113.511 -1.677 . . . . 0.0 112.227 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 52.8 t -89.38 -70.46 0.66 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 124.146 0.904 . . . . 0.0 110.502 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.425 ' HB3' ' SG ' ' A' ' 95' ' ' CYS . . . -90.18 62.15 5.38 Favored 'General case' 0 N--CA 1.499 2.007 0 CA-C-O 121.633 0.73 . . . . 0.0 109.497 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -113.19 -137.59 6.85 Favored Glycine 0 N--CA 1.493 2.481 0 CA-C-N 114.396 -1.274 . . . . 0.0 111.478 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.412 ' N ' ' HA3' ' A' ' 85' ' ' GLY . 37.7 p -128.44 117.61 21.67 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-N 114.494 -0.853 . . . . 0.0 109.464 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 61.5 mtpt -69.65 86.91 0.48 Allowed 'General case' 0 N--CA 1.498 1.967 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.018 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 164.75 -31.02 0.24 Allowed Glycine 0 N--CA 1.489 2.196 0 CA-C-N 114.095 -1.412 . . . . 0.0 110.613 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 74.6 m -105.12 131.71 52.27 Favored 'General case' 0 N--CA 1.5 2.034 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.8 mppt? -83.98 87.48 7.12 Favored 'General case' 0 N--CA 1.484 1.254 0 O-C-N 124.808 1.318 . . . . 0.0 110.398 -179.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 8.9 m-30 -51.84 129.43 26.59 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -133.03 157.26 45.67 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-N 113.433 -1.712 . . . . 0.0 111.79 -179.34 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 44.3 t -102.36 136.58 41.94 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-N 113.157 -1.838 . . . . 0.0 112.867 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 8.6 p30 -53.11 -23.57 8.29 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 115.538 1.681 . . . . 0.0 115.538 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 18.7 p-10 -62.61 -7.45 4.76 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 123.704 0.628 . . . . 0.0 111.024 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 94.49 29.96 9.0 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 108.507 -1.837 . . . . 0.0 108.507 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 46.1 m -133.97 135.93 43.81 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 124.162 0.566 . . . . 0.0 110.204 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . 0.462 ' CZ ' ' HA ' ' A' ' 83' ' ' CYS . 8.0 t80 -76.02 141.63 42.07 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-N 114.703 -1.135 . . . . 0.0 108.776 179.787 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 45.5 t -97.29 -78.38 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . 0.462 ' HA ' ' CZ ' ' A' ' 81' ' ' PHE . 0.1 OUTLIER -178.5 171.67 1.54 Allowed 'General case' 0 N--CA 1.505 2.308 0 O-C-N 123.51 0.507 . . . . 0.0 110.005 179.705 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.408 ' O ' ' SG ' ' A' ' 83' ' ' CYS . 39.9 tt0 -86.07 150.93 24.1 Favored 'General case' 0 N--CA 1.503 2.203 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 179.747 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.412 ' HA3' ' N ' ' A' ' 69' ' ' THR . . . -53.25 133.58 41.97 Favored Glycine 0 N--CA 1.5 2.945 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -99.81 29.18 4.28 Favored 'General case' 0 N--CA 1.502 2.15 0 CA-C-O 121.892 0.853 . . . . 0.0 109.445 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 44.9 t -146.38 131.73 18.57 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 107.532 -1.285 . . . . 0.0 107.532 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.469 ' H ' HD22 ' A' ' 91' ' ' ASN . 2.4 t70 -79.38 136.16 56.72 Favored Pre-proline 0 N--CA 1.493 1.71 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_endo -67.95 70.93 0.82 Allowed 'Trans proline' 0 N--CA 1.5 1.872 0 C-N-CA 123.688 2.925 . . . . 0.0 113.554 -176.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 82.8 mtt85 -162.88 -51.7 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 103.74 -2.689 . . . . 0.0 103.74 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.469 HD22 ' H ' ' A' ' 88' ' ' ASP . 1.5 p-10 -91.09 116.0 65.51 Favored Pre-proline 0 N--CA 1.493 1.719 0 CA-C-N 113.275 -1.784 . . . . 0.0 110.748 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -78.17 93.76 1.09 Allowed 'Trans proline' 0 N--CA 1.492 1.398 0 C-N-CA 122.694 2.262 . . . . 0.0 110.041 173.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 44.7 mmtm -70.67 127.48 32.82 Favored 'General case' 0 N--CA 1.497 1.909 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.707 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -85.33 79.37 9.52 Favored 'General case' 0 N--CA 1.495 1.788 0 CA-C-N 114.666 -1.152 . . . . 0.0 108.941 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . 0.425 ' SG ' ' HB3' ' A' ' 67' ' ' ALA . 88.5 m -79.66 146.83 65.89 Favored Pre-proline 0 N--CA 1.494 1.764 0 CA-C-N 114.504 -1.225 . . . . 0.0 111.364 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -73.9 -4.35 15.28 Favored 'Trans proline' 0 N--CA 1.493 1.451 0 C-N-CA 122.891 2.394 . . . . 0.0 110.586 165.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 23.0 tpp180 -79.1 -54.78 5.65 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 38.9 m-80 52.24 -161.14 0.1 Allowed 'General case' 0 N--CA 1.501 2.118 0 O-C-N 124.401 1.063 . . . . 0.0 111.549 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . 0.576 ' HA ' ' HA ' ' A' ' 62' ' ' CYS . 5.2 m -36.67 110.06 0.11 Allowed 'General case' 0 N--CA 1.5 2.045 0 N-CA-C 113.909 1.078 . . . . 0.0 113.909 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 20.5 t0 -91.22 111.85 50.87 Favored Pre-proline 0 N--CA 1.494 1.727 0 CA-C-N 113.843 -1.526 . . . . 0.0 110.564 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -64.7 -21.92 64.66 Favored 'Trans proline' 0 N--CA 1.494 1.522 0 C-N-CA 121.848 1.699 . . . . 0.0 110.312 -179.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 27.6 ttm-85 -82.27 -23.51 35.24 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 113.952 1.093 . . . . 0.0 113.952 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 12.2 tt -70.19 142.38 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 C-N-CA 117.835 -1.546 . . . . 0.0 110.21 -179.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -131.78 -43.77 0.99 Allowed 'General case' 0 N--CA 1.494 1.734 0 CA-C-N 114.486 -1.234 . . . . 0.0 109.748 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 49.8 m-85 -141.23 -164.12 1.69 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 124.398 1.061 . . . . 0.0 109.387 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -153.87 108.69 0.38 Allowed Glycine 0 N--CA 1.492 2.408 0 N-CA-C 106.582 -2.607 . . . . 0.0 106.582 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 50.4 mm -80.6 84.11 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 27.0 m -80.99 149.44 66.76 Favored Pre-proline 0 N--CA 1.494 1.755 0 CA-C-N 114.101 -1.408 . . . . 0.0 108.848 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -66.32 -21.3 54.51 Favored 'Trans proline' 0 N--CA 1.495 1.594 0 C-N-CA 122.71 2.273 . . . . 0.0 110.859 175.09 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -159.96 167.76 27.24 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 124.156 0.91 . . . . 0.0 110.147 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.826 0 CA-C-O 116.37 -1.776 . . . . 0.0 110.901 179.887 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 119.549 -0.262 . . . . 0.0 110.814 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 2.7 tmt_? 76.92 -65.8 0.27 Allowed 'General case' 0 N--CA 1.504 2.274 0 O-C-N 125.263 1.602 . . . . 0.0 108.377 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.6 tp -55.44 137.02 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 123.626 0.579 . . . . 0.0 112.123 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.417 ' HA ' ' HA ' ' A' ' 41' ' ' CYS . 1.5 m -140.61 57.88 1.57 Allowed 'General case' 0 C--N 1.31 -1.128 0 CA-C-O 122.797 1.284 . . . . 0.0 114.444 179.615 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 7.1 t -90.73 161.1 15.49 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-N 113.322 -1.763 . . . . 0.0 106.746 179.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 10.5 p-10 -161.1 151.84 18.24 Favored 'General case' 0 N--CA 1.499 2.02 0 C-N-CA 120.118 -0.633 . . . . 0.0 111.693 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.404 ' HA ' ' CE2' ' A' ' 16' ' ' TYR . 19.6 t -57.68 -38.03 74.46 Favored 'General case' 0 N--CA 1.497 1.914 0 CA-C-N 114.639 -1.164 . . . . 0.0 113.303 -179.721 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 46.4 t -61.99 -51.59 67.41 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 125.336 1.647 . . . . 0.0 110.721 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -51.6 -26.08 8.14 Favored 'General case' 0 N--CA 1.503 2.224 0 O-C-N 124.945 1.403 . . . . 0.0 110.376 179.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 63.23 161.06 0.28 Allowed Glycine 0 N--CA 1.479 1.558 0 CA-C-N 114.618 -1.174 . . . . 0.0 115.891 179.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 99.5 m -153.11 53.87 0.76 Allowed 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 104.576 -2.379 . . . . 0.0 104.576 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 63.4 pttt 41.67 -146.11 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.065 0 CA-C-N 114.203 -1.362 . . . . 0.0 112.409 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -70.23 26.69 0.44 Allowed Glycine 0 N--CA 1.494 2.501 0 CA-C-N 114.886 -1.052 . . . . 0.0 114.252 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 88.4 m -105.42 120.99 42.98 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 107.097 -1.445 . . . . 0.0 107.097 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 63.0 mtpt -64.92 100.34 0.41 Allowed 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 113.027 -1.897 . . . . 0.0 113.962 -179.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.404 ' CE2' ' HA ' ' A' ' 7' ' ' CYS . 8.8 m-85 -48.3 128.59 14.59 Favored 'General case' 0 N--CA 1.505 2.316 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 179.48 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -144.3 153.03 41.59 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 115.079 -0.964 . . . . 0.0 113.047 -179.349 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 34.2 t -99.08 134.78 41.43 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-N 112.599 -2.091 . . . . 0.0 112.659 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -50.14 -24.87 3.03 Favored 'General case' 0 N--CA 1.502 2.168 0 CA-C-N 112.713 -2.039 . . . . 0.0 114.009 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 29.7 p30 -59.81 -8.01 1.93 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 124.144 0.902 . . . . 0.0 112.276 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 95.08 29.2 9.2 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 86.9 m -141.91 143.23 33.18 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 124.078 0.517 . . . . 0.0 111.233 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 20.0 t80 -68.96 161.28 29.21 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-N 114.042 -1.435 . . . . 0.0 110.318 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 88.2 t -126.71 -71.29 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 CA-C-N 114.995 -1.002 . . . . 0.0 109.443 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.589 ' SG ' ' N ' ' A' ' 26' ' ' GLU . 0.3 OUTLIER -151.57 -166.67 2.58 Favored 'General case' 0 N--CA 1.5 2.049 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 179.998 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.589 ' N ' ' SG ' ' A' ' 25' ' ' CYS . 2.1 tm-20 -121.07 147.4 45.57 Favored 'General case' 0 N--CA 1.501 2.116 0 N-CA-C 106.374 -1.713 . . . . 0.0 106.374 179.565 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -55.1 109.8 1.46 Allowed Glycine 0 N--CA 1.501 2.972 0 N-CA-C 110.358 -1.097 . . . . 0.0 110.358 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 -86.31 12.29 10.33 Favored 'General case' 0 N--CA 1.501 2.12 0 N-CA-C 113.613 0.968 . . . . 0.0 113.613 -179.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.415 ' HG ' ' H ' ' A' ' 30' ' ' ASP . 20.9 t -169.62 -174.53 1.91 Allowed 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.415 ' H ' ' HG ' ' A' ' 29' ' ' SER . 27.8 t70 -79.23 143.38 60.5 Favored Pre-proline 0 N--CA 1.496 1.845 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo -52.34 -32.36 51.2 Favored 'Trans proline' 0 N--CA 1.498 1.772 0 C-N-CA 122.38 2.053 . . . . 0.0 112.15 175.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 87.6 mtm180 -113.99 35.24 4.21 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-N 114.74 -1.118 . . . . 0.0 109.232 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 24.2 p-10 -65.96 127.05 92.88 Favored Pre-proline 0 N--CA 1.497 1.881 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.98 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_endo -76.51 81.53 2.48 Favored 'Trans proline' 0 N--CA 1.49 1.289 0 C-N-CA 122.492 2.128 . . . . 0.0 107.973 167.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 23.6 tptm -150.85 153.43 35.35 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-N 114.851 -1.068 . . . . 0.0 110.124 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -99.52 155.6 17.48 Favored 'General case' 0 N--CA 1.496 1.826 0 CA-C-N 114.066 -1.424 . . . . 0.0 110.221 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 84.8 m -147.44 177.26 9.38 Favored 'General case' 0 N--CA 1.497 1.879 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.643 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 64.5 p -132.98 -18.28 2.35 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-N 113.893 -1.503 . . . . 0.0 108.976 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.3 tt -89.63 24.6 2.26 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 24.2 m120 -56.83 152.88 11.77 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-N 115.308 -0.86 . . . . 0.0 112.744 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.417 ' HA ' ' HA ' ' A' ' 4' ' ' CYS . 68.0 m 59.68 124.4 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.753 0 CA-C-N 113.467 -1.697 . . . . 0.0 114.318 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -152.33 84.04 4.87 Favored Pre-proline 0 N--CA 1.494 1.728 0 CA-C-N 114.389 -1.278 . . . . 0.0 109.338 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -57.67 -20.11 40.88 Favored 'Trans proline' 0 N--CA 1.493 1.464 0 C-N-CA 122.769 2.313 . . . . 0.0 112.86 178.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 74.5 mtp180 -62.31 -42.29 99.24 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 26.4 mt -68.21 157.77 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 CA-C-O 122.414 1.102 . . . . 0.0 110.691 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -125.37 -51.14 1.64 Allowed 'General case' 0 N--CA 1.491 1.614 0 CA-C-N 111.719 -2.491 . . . . 0.0 107.786 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 13.1 p90 -171.14 160.98 6.58 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-N 114.172 -1.376 . . . . 0.0 111.237 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -96.87 121.39 7.02 Favored Glycine 0 N--CA 1.493 2.456 0 CA-C-N 113.651 -1.613 . . . . 0.0 109.248 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 29.4 m -94.71 103.96 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.7 m -79.88 115.26 52.73 Favored Pre-proline 0 N--CA 1.5 2.045 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 179.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -62.98 167.59 11.99 Favored 'Trans proline' 0 N--CA 1.496 1.657 0 C-N-CA 122.458 2.105 . . . . 0.0 112.457 -171.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.412 ' HD2' ' N ' ' A' ' 52' ' ' ARG . 0.0 OUTLIER -159.72 150.3 19.09 Favored 'General case' 0 N--CA 1.497 1.883 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.218 -179.887 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 49.2 m -77.98 126.06 30.27 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 66.01 118.63 0.03 OUTLIER 'General case' 0 N--CA 1.504 2.239 0 O-C-N 124.755 1.285 . . . . 0.0 109.851 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -158.68 -40.05 0.06 Allowed 'General case' 0 N--CA 1.497 1.876 0 CA-C-N 115.027 -0.988 . . . . 0.0 111.101 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 10.1 mtmp? -110.53 -162.86 0.82 Allowed 'General case' 0 N--CA 1.497 1.92 0 O-C-N 124.139 0.899 . . . . 0.0 109.9 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt 57.63 64.16 1.64 Allowed 'General case' 0 N--CA 1.5 2.045 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 32.3 m120 -134.93 -47.71 0.73 Allowed 'General case' 0 N--CA 1.495 1.811 0 CA-C-N 113.812 -1.54 . . . . 0.0 109.191 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -107.0 -55.56 2.31 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 124.426 1.078 . . . . 0.0 110.71 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 42.6 ptt85 22.27 61.46 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.225 0 O-C-N 125.073 1.483 . . . . 0.0 114.927 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 7.6 tp -61.02 124.82 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 CA-C-N 114.096 -1.411 . . . . 0.0 111.588 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 1.7 m -125.0 46.12 2.41 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-O 122.413 1.102 . . . . 0.0 113.337 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 33.9 m -90.22 168.3 12.03 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 113.666 -1.606 . . . . 0.0 109.154 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 24.3 p30 -142.94 176.06 9.36 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 124.416 1.073 . . . . 0.0 109.297 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 47.0 t -92.79 -31.69 14.94 Favored 'General case' 0 N--CA 1.499 2.021 0 N-CA-C 114.469 1.285 . . . . 0.0 114.469 -179.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 42.7 t -63.56 -58.37 7.18 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 123.934 0.771 . . . . 0.0 110.352 -179.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -89.83 36.31 0.85 Allowed 'General case' 0 N--CA 1.495 1.803 0 CA-C-N 114.294 -1.321 . . . . 0.0 110.227 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -76.67 -115.78 0.14 Allowed Glycine 0 N--CA 1.493 2.478 0 N-CA-C 109.317 -1.513 . . . . 0.0 109.317 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 95.6 m -156.27 96.63 1.7 Allowed 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -52.16 104.2 0.08 Allowed 'General case' 0 N--CA 1.501 2.12 0 C-N-CA 120.034 -0.666 . . . . 0.0 111.345 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 146.91 -31.0 1.48 Allowed Glycine 0 N--CA 1.495 2.629 0 CA-C-N 114.835 -1.075 . . . . 0.0 112.625 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 88.2 m -95.26 174.8 6.87 Favored 'General case' 0 N--CA 1.502 2.169 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -121.9 87.35 2.74 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 106.452 -1.684 . . . . 0.0 106.452 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 61.0 m-85 -48.58 140.93 7.55 Favored 'General case' 0 N--CA 1.499 1.984 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.013 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.515 ' CE2' ' HA ' ' A' ' 80' ' ' THR . 4.8 t80 -137.1 164.43 28.45 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 125.207 1.567 . . . . 0.0 114.543 -179.222 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 12.0 t -124.13 130.76 53.09 Favored 'General case' 0 N--CA 1.505 2.275 0 CA-C-N 113.153 -1.839 . . . . 0.0 112.529 -179.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -54.98 -49.61 71.04 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-N 113.405 -1.725 . . . . 0.0 111.025 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 13.5 p-10 -108.1 28.58 8.13 Favored 'General case' 0 N--CA 1.488 1.472 0 CA-C-N 113.123 -1.853 . . . . 0.0 111.22 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -160.79 18.09 0.2 Allowed Glycine 0 N--CA 1.494 2.554 0 C-N-CA 119.356 -1.402 . . . . 0.0 112.341 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.523 ' HG1' ' H ' ' A' ' 81' ' ' PHE . 6.4 t 42.03 -160.23 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.793 0 O-C-N 124.924 1.014 . . . . 0.0 113.1 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . 0.523 ' H ' ' HG1' ' A' ' 80' ' ' THR . 47.1 t80 -42.37 121.11 1.83 Allowed 'General case' 0 N--CA 1.499 1.978 0 CA-C-O 121.459 0.647 . . . . 0.0 111.681 179.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 61.5 t -92.18 -68.2 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 CA-C-N 113.835 -1.529 . . . . 0.0 111.731 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 1.8 p -158.28 -177.28 6.43 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 123.924 0.765 . . . . 0.0 109.597 -179.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -102.46 151.97 21.68 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 104.54 -2.393 . . . . 0.0 104.54 179.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -64.55 128.04 34.98 Favored Glycine 0 N--CA 1.493 2.494 0 N-CA-C 108.638 -1.785 . . . . 0.0 108.638 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 40.7 mm-40 -113.67 11.97 18.29 Favored 'General case' 0 N--CA 1.498 1.929 0 C-N-CA 120.359 -0.536 . . . . 0.0 110.728 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 38.6 t -79.0 87.76 4.79 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -98.36 137.93 20.78 Favored Pre-proline 0 N--CA 1.493 1.688 0 CA-C-N 112.938 -1.937 . . . . 0.0 108.138 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -65.23 -40.47 19.39 Favored 'Trans proline' 0 N--CA 1.493 1.5 0 C-N-CA 122.12 1.88 . . . . 0.0 111.52 -179.074 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 72.5 ttt-85 -81.37 4.27 21.38 Favored 'General case' 0 N--CA 1.498 1.955 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.961 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.473 ' N ' HD21 ' A' ' 91' ' ' ASN . 0.0 OUTLIER -44.75 112.37 1.46 Allowed Pre-proline 0 N--CA 1.502 2.17 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -179.889 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -81.94 43.92 1.61 Allowed 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 123.112 2.541 . . . . 0.0 111.191 178.039 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 24.6 ttmm -164.29 153.44 13.57 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.173 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -94.46 129.04 41.38 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-N 114.095 -1.411 . . . . 0.0 108.186 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 83.1 m -79.82 148.18 68.17 Favored Pre-proline 0 N--CA 1.495 1.825 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -71.99 144.12 42.11 Favored 'Trans proline' 0 N--CA 1.489 1.245 0 C-N-CA 122.791 2.327 . . . . 0.0 109.258 163.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 21.1 tpp180 -100.16 31.88 3.19 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 27.9 m-20 -58.4 163.62 2.97 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 114.6 1.333 . . . . 0.0 114.6 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 66.9 m -100.61 133.95 44.29 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-N 113.358 -1.746 . . . . 0.0 110.868 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 60.5 t0 -117.4 84.39 18.16 Favored Pre-proline 0 N--CA 1.497 1.879 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 179.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_endo -57.29 -36.21 98.95 Favored 'Trans proline' 0 N--CA 1.496 1.657 0 C-N-CA 122.702 2.268 . . . . 0.0 111.283 -174.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 20.9 mmt180 -62.47 -39.63 94.03 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 124.284 0.99 . . . . 0.0 111.848 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 3.1 tt -53.45 155.16 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 O-C-N 123.905 0.753 . . . . 0.0 110.051 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -149.18 -42.24 0.14 Allowed 'General case' 0 N--CA 1.491 1.618 0 CA-C-N 115.364 -0.834 . . . . 0.0 111.458 -179.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 -138.45 -164.35 1.62 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 124.341 1.026 . . . . 0.0 110.599 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -153.23 103.99 0.25 Allowed Glycine 0 N--CA 1.487 2.08 0 N-CA-C 106.063 -2.815 . . . . 0.0 106.063 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 90.3 mt -78.91 88.18 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 57.9 m -81.9 149.53 63.52 Favored Pre-proline 0 N--CA 1.493 1.696 0 CA-C-N 113.944 -1.48 . . . . 0.0 109.006 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -57.0 140.7 93.26 Favored 'Trans proline' 0 N--CA 1.495 1.565 0 C-N-CA 122.618 2.212 . . . . 0.0 111.056 179.332 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 69.8 tp -79.67 133.21 36.37 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-N 115.179 -0.918 . . . . 0.0 110.473 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.768 0 CA-C-O 116.677 -1.63 . . . . 0.0 110.098 179.864 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 . . . . . 0 N--CA 1.491 1.588 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.77 -48.34 74.84 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 7.2 tp -61.48 133.48 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 CA-C-N 114.49 -1.232 . . . . 0.0 109.145 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.7 m -140.38 45.71 1.83 Allowed 'General case' 0 N--CA 1.483 1.19 0 CA-C-O 122.583 1.182 . . . . 0.0 112.683 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 22.7 p -90.35 178.16 6.21 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-N 113.053 -1.885 . . . . 0.0 110.311 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 36.3 p-10 -155.85 -169.57 3.13 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-N 113.958 -1.474 . . . . 0.0 108.77 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.44 ' SG ' ' CD2' ' A' ' 16' ' ' TYR . 2.3 t -81.25 -27.36 35.23 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -179.796 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 23.3 t -80.32 -59.55 2.66 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-N 114.483 -1.235 . . . . 0.0 110.988 -179.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -90.41 64.79 6.01 Favored 'General case' 0 N--CA 1.5 2.036 0 CA-C-O 121.89 0.852 . . . . 0.0 110.074 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -135.89 -115.76 1.5 Allowed Glycine 0 N--CA 1.498 2.824 0 CA-C-N 113.97 -1.468 . . . . 0.0 110.264 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 91.1 m -139.73 111.23 7.16 Favored 'General case' 0 N--CA 1.502 2.146 0 CA-C-O 120.788 0.328 . . . . 0.0 111.264 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.549 ' NZ ' HH21 ' A' ' 32' ' ' ARG . 39.4 ttpt -58.59 146.52 35.59 Favored 'General case' 0 N--CA 1.497 1.883 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.803 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 79.75 -16.49 11.19 Favored Glycine 0 N--CA 1.492 2.418 0 CA-C-N 114.542 -1.208 . . . . 0.0 112.858 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 90.2 m -93.77 129.8 39.99 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -77.6 94.11 4.31 Favored 'General case' 0 N--CA 1.486 1.343 0 CA-C-N 114.435 -1.257 . . . . 0.0 110.19 -179.365 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.703 ' CD2' ' SG ' ' A' ' 25' ' ' CYS . 95.4 m-85 -46.17 137.14 6.33 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 124.925 1.391 . . . . 0.0 109.074 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -147.74 152.73 38.25 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 125.085 1.491 . . . . 0.0 111.876 -179.438 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 28.9 t -107.8 136.44 47.52 Favored 'General case' 0 N--CA 1.497 1.901 0 CA-C-N 111.748 -2.478 . . . . 0.0 113.778 -179.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -52.12 -24.79 7.49 Favored 'General case' 0 N--CA 1.5 2.072 0 CA-C-N 112.645 -2.07 . . . . 0.0 115.157 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -57.27 -17.49 12.14 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 123.849 0.718 . . . . 0.0 110.966 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 105.03 29.63 5.12 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 108.537 -1.825 . . . . 0.0 108.537 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 58.2 m -138.28 154.56 49.03 Favored 'General case' 0 N--CA 1.493 1.702 0 CA-C-O 121.374 0.607 . . . . 0.0 111.03 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 57.7 t80 -73.98 166.76 22.81 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-N 113.663 -1.608 . . . . 0.0 109.615 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 90.3 t -129.06 -68.3 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 123.909 0.756 . . . . 0.0 110.889 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.703 ' SG ' ' CD2' ' A' ' 16' ' ' TYR . 22.8 p -162.32 -171.4 2.79 Favored 'General case' 0 N--CA 1.504 2.255 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -111.95 145.11 40.17 Favored 'General case' 0 N--CA 1.506 2.331 0 CA-C-O 120.74 0.305 . . . . 0.0 111.535 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.516 ' HA2' ' CE2' ' A' ' 16' ' ' TYR . . . -39.98 107.13 0.07 OUTLIER Glycine 0 N--CA 1.496 2.682 0 O-C-N 124.545 1.153 . . . . 0.0 114.613 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -124.73 43.75 2.94 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 105.943 -1.873 . . . . 0.0 105.943 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 10.4 t -125.66 81.16 1.96 Allowed 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 -179.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -88.11 120.36 70.62 Favored Pre-proline 0 N--CA 1.495 1.801 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 179.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -66.73 -29.21 43.08 Favored 'Trans proline' 0 N--CA 1.494 1.538 0 C-N-CA 121.983 1.788 . . . . 0.0 110.773 177.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.549 HH21 ' NZ ' ' A' ' 12' ' ' LYS . 84.9 mtm180 -78.87 3.28 17.36 Favored 'General case' 0 N--CA 1.498 1.95 0 CA-C-N 114.946 -1.025 . . . . 0.0 112.107 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.427 HD21 ' H ' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -60.21 130.63 89.51 Favored Pre-proline 0 N--CA 1.495 1.798 0 O-C-N 123.339 0.399 . . . . 0.0 111.918 -179.86 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -82.28 46.13 2.12 Favored 'Trans proline' 0 N--CA 1.493 1.49 0 C-N-CA 123.026 2.484 . . . . 0.0 108.642 162.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -137.55 -177.0 4.6 Favored 'General case' 0 N--CA 1.497 1.9 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.49 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -143.92 118.13 9.55 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-N 114.867 -1.061 . . . . 0.0 108.423 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 75.4 m -79.76 168.72 18.94 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 8.6 t -85.21 166.47 16.52 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-N 113.856 -1.52 . . . . 0.0 109.558 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.441 ' H ' HD12 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -104.18 19.46 20.11 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-N 114.849 -1.069 . . . . 0.0 111.902 -179.895 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -55.12 135.57 49.13 Favored 'General case' 0 N--CA 1.498 1.951 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.128 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 58.2 m -90.32 131.3 36.19 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-N 114.796 -1.093 . . . . 0.0 110.874 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -127.35 78.02 75.04 Favored Pre-proline 0 N--CA 1.498 1.947 0 O-C-N 124.103 0.877 . . . . 0.0 109.514 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -63.77 -27.12 67.95 Favored 'Trans proline' 0 N--CA 1.494 1.524 0 C-N-CA 122.855 2.37 . . . . 0.0 113.515 -170.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 8.4 ptp180 -56.24 -33.19 65.18 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 123.956 0.785 . . . . 0.0 111.205 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 15.1 tt -50.41 150.91 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 CA-C-N 114.696 -1.138 . . . . 0.0 113.102 -179.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -133.21 -51.43 0.88 Allowed 'General case' 0 N--CA 1.492 1.652 0 CA-C-N 113.492 -1.685 . . . . 0.0 106.903 179.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 51.5 p90 -170.41 177.26 4.13 Favored 'General case' 0 N--CA 1.494 1.748 0 CA-C-N 113.819 -1.537 . . . . 0.0 108.684 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -124.52 120.55 4.07 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 107.341 -2.303 . . . . 0.0 107.341 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.1 p -79.27 100.65 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 CA-C-O 123.015 1.388 . . . . 0.0 108.778 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 3.8 m -79.58 163.66 57.67 Favored Pre-proline 0 N--CA 1.493 1.705 0 CA-C-N 112.889 -1.96 . . . . 0.0 108.383 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_exo -46.34 -32.45 10.85 Favored 'Trans proline' 0 N--CA 1.499 1.806 0 C-N-CA 122.705 2.27 . . . . 0.0 111.847 175.169 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 63.5 mtp85 -79.79 -86.58 0.08 Allowed 'General case' 0 N--CA 1.491 1.605 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.037 179.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 64.3 m 50.31 90.41 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.993 0 O-C-N 124.219 0.949 . . . . 0.0 112.188 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -88.59 25.7 1.65 Allowed 'General case' 0 N--CA 1.498 1.951 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.07 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.402 ' CD ' ' N ' ' A' ' 55' ' ' GLU . 14.8 mp0 -121.46 118.72 30.07 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 106.509 -1.663 . . . . 0.0 106.509 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 32.3 mmtp -136.37 165.88 24.77 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 123.745 0.653 . . . . 0.0 111.925 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 28.5 tptp -77.16 -106.75 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 114.47 1.285 . . . . 0.0 114.47 -179.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 30.4 m120 -74.86 -57.92 3.61 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 113.781 1.03 . . . . 0.0 113.781 -179.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 67.45 156.49 0.12 Allowed 'General case' 0 N--CA 1.503 2.196 0 O-C-N 124.692 1.245 . . . . 0.0 111.213 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 16.5 ptm180 41.03 22.57 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.419 0 N-CA-C 114.401 1.259 . . . . 0.0 114.401 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.412 ' C ' HD13 ' A' ' 61' ' ' ILE . 0.0 OUTLIER -90.57 116.79 32.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 CA-C-N 114.993 -1.003 . . . . 0.0 109.197 -179.887 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . 0.455 ' HA ' ' HA ' ' A' ' 99' ' ' CYS . 1.3 m -139.36 43.9 2.0 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 118.037 2.606 . . . . 0.0 118.037 179.45 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.3 p -90.75 160.36 15.85 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-N 113.679 -1.601 . . . . 0.0 106.685 179.121 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.491 HD21 HD21 ' A' ' 98' ' ' ASN . 40.0 t30 -160.58 161.59 32.63 Favored 'General case' 0 N--CA 1.497 1.901 0 CA-C-O 122.399 1.095 . . . . 0.0 112.598 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 7.4 t -58.51 -20.35 45.12 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-N 112.014 -2.357 . . . . 0.0 111.836 179.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 40.7 t -86.27 -71.06 0.56 Allowed 'General case' 0 N--CA 1.494 1.756 0 CA-C-N 114.999 -1.0 . . . . 0.0 111.642 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -54.33 -19.71 5.93 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-N 113.881 -1.509 . . . . 0.0 113.097 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -60.58 159.95 25.05 Favored Glycine 0 N--CA 1.491 2.357 0 O-C-N 123.998 0.811 . . . . 0.0 111.837 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.507 ' C ' ' H ' ' A' ' 71' ' ' GLY . 12.4 t -85.56 139.24 31.61 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-N 113.934 -1.133 . . . . 0.0 108.922 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 23.1 ttmm -80.02 35.03 0.31 Allowed 'General case' 0 N--CA 1.499 2.003 0 CA-C-O 122.543 1.164 . . . . 0.0 110.578 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.507 ' H ' ' C ' ' A' ' 69' ' ' THR . . . -123.64 -8.51 6.28 Favored Glycine 0 N--CA 1.491 2.367 0 N-CA-C 108.542 -1.823 . . . . 0.0 108.542 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 78.9 m -137.33 148.12 46.09 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 123.931 0.43 . . . . 0.0 109.915 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.464 ' HB3' ' CE1' ' A' ' 81' ' ' PHE . 27.6 mtpp -101.4 88.59 3.5 Favored 'General case' 0 N--CA 1.485 1.314 0 O-C-N 124.917 1.386 . . . . 0.0 108.203 -179.485 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.479 ' HH ' ' H ' ' A' ' 69' ' ' THR . 93.9 m-85 -49.76 133.99 20.98 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-N 114.175 -1.375 . . . . 0.0 108.688 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.423 ' CE2' ' HA ' ' A' ' 80' ' ' THR . 1.2 t80 -132.72 154.62 50.01 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 113.13 -1.85 . . . . 0.0 114.06 -179.218 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.4 ' N ' HG21 ' A' ' 82' ' ' VAL . 25.8 t -115.84 129.92 56.63 Favored 'General case' 0 N--CA 1.497 1.913 0 CA-C-N 112.145 -2.298 . . . . 0.0 111.746 -179.747 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.41 ' H ' ' HB1' ' A' ' 104' ' ' ALA . 7.7 p-10 -64.67 -46.74 81.16 Favored 'General case' 0 N--CA 1.497 1.897 0 CA-C-N 114.773 -1.103 . . . . 0.0 108.596 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -92.18 19.71 6.67 Favored 'General case' 0 N--CA 1.485 1.283 0 CA-C-N 112.772 -2.013 . . . . 0.0 110.953 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -165.21 24.53 0.16 Allowed Glycine 0 N--CA 1.497 2.715 0 C-N-CA 118.62 -1.753 . . . . 0.0 113.184 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.423 ' HA ' ' CE2' ' A' ' 75' ' ' PHE . 6.5 t 42.11 -161.55 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.926 0 O-C-N 124.969 1.041 . . . . 0.0 112.887 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . 0.464 ' CE1' ' HB3' ' A' ' 73' ' ' LYS . 11.0 t80 -49.68 121.97 5.84 Favored 'General case' 0 N--CA 1.497 1.882 0 CA-C-O 121.34 0.591 . . . . 0.0 110.879 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.4 HG21 ' N ' ' A' ' 76' ' ' SER . 88.9 t -86.11 -73.34 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . 0.409 ' SG ' ' O ' ' A' ' 84' ' ' GLU . 0.1 OUTLIER -175.49 171.35 2.83 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 124.002 0.813 . . . . 0.0 110.459 179.779 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.409 ' O ' ' SG ' ' A' ' 83' ' ' CYS . 32.3 tt0 -93.28 146.93 23.34 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 105.718 -1.956 . . . . 0.0 105.718 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -53.03 135.38 39.74 Favored Glycine 0 N--CA 1.501 2.967 0 C-N-CA 119.514 -1.327 . . . . 0.0 114.452 -179.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -100.37 27.91 5.39 Favored 'General case' 0 N--CA 1.505 2.301 0 CA-C-O 121.595 0.712 . . . . 0.0 110.032 179.744 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.419 ' HG ' ' H ' ' A' ' 88' ' ' ASP . 22.2 t -160.93 -176.57 5.58 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.422 ' HB3' ' ND2' ' A' ' 91' ' ' ASN . 7.5 t70 -144.61 140.01 16.09 Favored Pre-proline 0 N--CA 1.488 1.438 0 N-CA-C 105.343 -2.095 . . . . 0.0 105.343 179.807 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_exo -41.79 -28.04 0.66 Allowed 'Trans proline' 0 N--CA 1.5 1.895 0 C-N-CA 123.671 2.914 . . . . 0.0 114.824 -174.274 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.87 -51.34 16.54 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 123.93 0.769 . . . . 0.0 111.898 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.422 ' ND2' ' HB3' ' A' ' 88' ' ' ASP . 2.4 p30 -90.23 138.26 27.35 Favored Pre-proline 0 N--CA 1.502 2.166 0 C-N-CA 119.55 -0.86 . . . . 0.0 110.622 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -75.53 170.25 20.64 Favored 'Trans proline' 0 N--CA 1.493 1.476 0 C-N-CA 122.929 2.419 . . . . 0.0 109.861 161.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 27.8 tptp -160.3 154.68 23.58 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 123.67 0.606 . . . . 0.0 110.3 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -98.39 139.51 34.04 Favored 'General case' 0 N--CA 1.498 1.96 0 CA-C-N 114.591 -1.186 . . . . 0.0 111.122 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 98.5 m -159.32 167.46 14.22 Favored Pre-proline 0 N--CA 1.501 2.076 0 O-C-N 124.057 0.848 . . . . 0.0 111.066 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -27.09 -66.13 0.05 OUTLIER 'Trans proline' 0 N--CA 1.494 1.528 0 C-N-CA 124.275 3.316 . . . . 0.0 115.628 170.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 79.0 ttt180 -153.77 -77.92 0.11 Allowed 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.491 HD21 HD21 ' A' ' 64' ' ' ASN . 7.8 m120 133.72 -170.22 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.412 0 O-C-N 126.545 2.403 . . . . 0.0 107.726 -179.559 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . 0.455 ' HA ' ' HA ' ' A' ' 62' ' ' CYS . 61.5 m 62.95 121.45 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 124.952 1.301 . . . . 0.0 112.454 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -141.17 80.98 16.27 Favored Pre-proline 0 N--CA 1.494 1.73 0 CA-C-N 114.372 -1.286 . . . . 0.0 111.252 -179.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -49.16 -27.76 13.16 Favored 'Trans proline' 0 N--CA 1.496 1.669 0 C-N-CA 123.183 2.589 . . . . 0.0 113.812 172.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.06 -27.28 69.29 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 123.687 0.617 . . . . 0.0 111.635 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 12.7 tt -52.35 167.62 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 124.253 0.971 . . . . 0.0 112.625 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.41 ' HB1' ' H ' ' A' ' 77' ' ' ASP . . . -142.8 -55.66 0.42 Allowed 'General case' 0 N--CA 1.49 1.532 0 CA-C-N 114.352 -1.295 . . . . 0.0 109.604 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -149.2 -159.92 1.1 Allowed 'General case' 0 N--CA 1.498 1.925 0 O-C-N 124.465 1.103 . . . . 0.0 109.134 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -142.89 108.97 0.54 Allowed Glycine 0 N--CA 1.489 2.173 0 N-CA-C 105.917 -2.873 . . . . 0.0 105.917 179.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 93.4 mt -79.37 85.68 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 22.2 m -79.68 121.34 82.35 Favored Pre-proline 0 N--CA 1.492 1.634 0 CA-C-N 113.799 -1.546 . . . . 0.0 108.553 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_endo -61.6 112.5 1.48 Allowed 'Trans proline' 0 N--CA 1.493 1.45 0 C-N-CA 122.394 2.063 . . . . 0.0 110.375 -176.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 74.5 mt -79.8 -3.16 46.51 Favored 'General case' 0 N--CA 1.498 1.926 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.245 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.827 0 CA-C-O 116.97 -1.49 . . . . 0.0 109.892 179.913 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 . . . . . 0 N--CA 1.489 1.523 0 CA-C-O 120.404 0.145 . . . . 0.0 110.889 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 8.2 ptp180 -67.73 -36.31 80.35 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 106.175 -1.787 . . . . 0.0 106.175 179.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.7 tp -90.16 77.79 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 CA-C-N 113.252 -1.795 . . . . 0.0 108.345 179.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.7 m -85.81 28.99 0.74 Allowed 'General case' 0 N--CA 1.497 1.925 0 N-CA-C 116.201 1.926 . . . . 0.0 116.201 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 12.6 t -92.35 169.51 10.52 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-N 113.058 -1.883 . . . . 0.0 106.508 179.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 40.0 p-10 -160.48 161.87 32.95 Favored 'General case' 0 N--CA 1.497 1.901 0 C-N-CA 119.367 -0.933 . . . . 0.0 112.629 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -63.24 -22.68 67.02 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 113.856 -1.52 . . . . 0.0 112.561 179.729 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 42.4 t -89.96 -69.02 0.74 Allowed 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 115.252 1.575 . . . . 0.0 115.252 -179.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -85.66 63.07 7.85 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 124.598 1.186 . . . . 0.0 111.25 -179.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -119.89 -115.05 2.5 Favored Glycine 0 N--CA 1.492 2.379 0 CA-C-N 113.282 -1.781 . . . . 0.0 109.799 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.0 t -166.31 123.44 1.35 Allowed 'General case' 0 N--CA 1.496 1.848 0 CA-C-O 121.373 0.606 . . . . 0.0 110.585 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.82 143.73 20.28 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-N 114.714 -1.13 . . . . 0.0 109.843 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 106.37 -35.47 5.02 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.195 -1.562 . . . . 0.0 109.195 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 52.1 m -94.64 116.21 28.49 Favored 'General case' 0 N--CA 1.497 1.906 0 C-N-CA 119.422 -0.911 . . . . 0.0 110.222 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 4.0 mptp? -72.24 88.15 1.14 Allowed 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 112.792 -2.003 . . . . 0.0 111.627 -179.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.446 ' N ' ' O ' ' A' ' 25' ' ' CYS . 10.7 m-85 -46.72 127.9 10.14 Favored 'General case' 0 N--CA 1.498 1.96 0 CA-C-O 122.468 1.128 . . . . 0.0 108.237 179.583 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.479 ' CE2' ' HA ' ' A' ' 22' ' ' THR . 0.1 OUTLIER -135.96 158.72 43.73 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-N 111.623 -2.535 . . . . 0.0 113.096 -178.965 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 29.1 t -110.78 128.86 55.91 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-N 112.72 -2.036 . . . . 0.0 111.054 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -62.71 -45.35 93.15 Favored 'General case' 0 N--CA 1.497 1.911 0 CA-C-N 114.119 -1.4 . . . . 0.0 109.203 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -94.25 19.94 8.76 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 112.624 -2.08 . . . . 0.0 111.624 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -171.22 28.89 0.11 Allowed Glycine 0 N--CA 1.497 2.731 0 C-N-CA 118.146 -1.978 . . . . 0.0 113.934 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.479 ' HA ' ' CE2' ' A' ' 17' ' ' PHE . 6.5 t 42.81 -166.68 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 73.9 t80 -40.05 139.81 0.65 Allowed 'General case' 0 N--CA 1.5 2.063 0 N-CA-C 114.074 1.138 . . . . 0.0 114.074 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 88.4 t -114.53 -79.42 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 CA-C-N 113.131 -1.85 . . . . 0.0 108.05 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.525 ' SG ' ' N ' ' A' ' 26' ' ' GLU . 0.1 OUTLIER -152.21 -169.38 3.34 Favored 'General case' 0 N--CA 1.502 2.17 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 179.86 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.525 ' N ' ' SG ' ' A' ' 25' ' ' CYS . 60.8 tt0 -114.62 158.3 21.92 Favored 'General case' 0 N--CA 1.504 2.228 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 179.425 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -54.07 109.65 1.22 Allowed Glycine 0 N--CA 1.497 2.731 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.69 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -85.82 19.55 2.48 Favored 'General case' 0 N--CA 1.5 2.028 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 36.6 t -105.44 92.76 4.33 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.197 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -130.35 142.42 45.4 Favored Pre-proline 0 N--CA 1.495 1.786 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 179.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_endo -63.16 79.0 0.12 Allowed 'Trans proline' 0 N--CA 1.496 1.639 0 C-N-CA 122.561 2.174 . . . . 0.0 109.891 169.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 79.6 ttt180 -178.13 -51.26 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 105.592 -2.003 . . . . 0.0 105.592 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 26.5 p30 -90.44 168.21 14.78 Favored Pre-proline 0 N--CA 1.497 1.9 0 CA-C-N 114.27 -1.332 . . . . 0.0 110.781 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -62.55 127.2 20.13 Favored 'Trans proline' 0 N--CA 1.49 1.304 0 C-N-CA 122.436 2.09 . . . . 0.0 109.021 160.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -92.83 22.44 4.84 Favored 'General case' 0 N--CA 1.5 2.074 0 CA-C-O 122.677 1.227 . . . . 0.0 112.749 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -146.22 153.39 40.56 Favored 'General case' 0 N--CA 1.498 1.947 0 CA-C-N 112.274 -2.239 . . . . 0.0 111.739 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 57.1 m -146.51 -124.19 0.07 Allowed 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 33.5 m -146.76 18.37 1.29 Allowed 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 44.6 tp -79.71 -43.3 22.92 Favored 'General case' 0 N--CA 1.497 1.897 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.334 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 25.2 m-80 53.11 -163.63 0.09 Allowed 'General case' 0 N--CA 1.504 2.243 0 O-C-N 124.064 0.852 . . . . 0.0 112.03 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 56.3 m -43.85 118.85 1.54 Allowed 'General case' 0 N--CA 1.502 2.133 0 O-C-N 124.033 0.833 . . . . 0.0 110.232 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.4 t0 -101.41 106.41 45.62 Favored Pre-proline 0 N--CA 1.495 1.807 0 O-C-N 124.022 0.827 . . . . 0.0 109.398 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -67.6 -33.12 29.33 Favored 'Trans proline' 0 N--CA 1.494 1.525 0 C-N-CA 122.046 1.831 . . . . 0.0 111.101 -168.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 29.0 mmt85 -86.32 -13.36 46.81 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 -179.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 5.9 tt -73.43 179.33 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 C-N-CA 118.68 -1.208 . . . . 0.0 108.738 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -139.92 -58.61 0.56 Allowed 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 120.556 -0.458 . . . . 0.0 112.073 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 7.3 p90 -170.46 160.68 7.57 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 124.146 0.904 . . . . 0.0 112.719 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.402 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -88.92 107.65 3.39 Favored Glycine 0 N--CA 1.487 2.096 0 CA-C-N 113.235 -1.802 . . . . 0.0 108.892 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 23.4 t -78.24 86.75 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 124.287 0.639 . . . . 0.0 112.661 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.6 m -79.27 145.91 65.53 Favored Pre-proline 0 N--CA 1.503 2.212 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 179.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -75.87 54.22 3.98 Favored 'Trans proline' 0 N--CA 1.5 1.861 0 C-N-CA 123.74 2.96 . . . . 0.0 116.465 -170.145 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.61 169.22 23.34 Favored 'General case' 0 N--CA 1.501 2.097 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 28.3 t 62.64 170.29 0.14 Allowed 'General case' 0 N--CA 1.503 2.21 0 O-C-N 124.454 1.097 . . . . 0.0 111.299 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -144.72 -112.51 0.1 Allowed 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 60.95 129.73 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.113 0 C-N-CA 124.184 0.994 . . . . 0.0 113.445 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 32.3 mmtp -141.9 -159.69 1.0 Allowed 'General case' 0 N--CA 1.498 1.929 0 CA-C-N 114.426 -1.261 . . . . 0.0 107.96 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 3.0 mppt? 56.49 -167.99 0.11 Allowed 'General case' 0 N--CA 1.504 2.228 0 O-C-N 123.433 0.458 . . . . 0.0 110.17 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 7.5 m-80 -74.97 -7.04 52.46 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 179.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -66.61 120.03 12.74 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.801 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 56.6 ttt85 -174.29 -106.02 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 105.508 -2.034 . . . . 0.0 105.508 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 5.9 tp -79.03 84.29 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 179.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 1.7 m -85.81 44.54 1.12 Allowed 'General case' 0 N--CA 1.494 1.738 0 CA-C-N 114.474 -1.239 . . . . 0.0 113.94 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 64.3 m -90.54 166.39 13.24 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 113.309 -1.769 . . . . 0.0 108.201 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -146.53 155.05 42.22 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 124.079 0.862 . . . . 0.0 109.765 179.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 41.1 t -56.75 -32.84 65.97 Favored 'General case' 0 N--CA 1.497 1.916 0 CA-C-N 114.767 -1.106 . . . . 0.0 113.582 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 18.1 t -66.54 -46.19 76.91 Favored 'General case' 0 N--CA 1.495 1.796 0 CA-C-N 114.726 -1.124 . . . . 0.0 110.219 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -86.17 62.27 7.33 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-N 113.689 -1.596 . . . . 0.0 110.655 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -143.8 165.11 27.33 Favored Glycine 0 N--CA 1.496 2.637 0 CA-C-N 114.272 -1.331 . . . . 0.0 111.078 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.542 ' H ' ' HH ' ' A' ' 74' ' ' TYR . 9.5 t -85.3 127.33 34.29 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-N 115.036 -0.582 . . . . 0.0 110.517 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -81.09 36.64 0.41 Allowed 'General case' 0 N--CA 1.501 2.078 0 CA-C-O 122.484 1.135 . . . . 0.0 110.432 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.481 ' H ' ' C ' ' A' ' 69' ' ' THR . . . -132.27 -1.28 4.42 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 108.547 -1.821 . . . . 0.0 108.547 179.735 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 64.1 m -143.39 141.62 30.95 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 7.7 ptmm? -92.46 96.61 10.34 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 124.447 1.092 . . . . 0.0 110.95 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.542 ' HH ' ' H ' ' A' ' 69' ' ' THR . 57.4 m-85 -52.15 134.02 33.22 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-N 114.429 -1.26 . . . . 0.0 109.692 179.731 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -141.4 158.37 43.96 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 112.998 -1.91 . . . . 0.0 112.762 -179.37 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 57.8 p -96.08 139.41 32.3 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 114.743 1.386 . . . . 0.0 114.743 -179.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -45.35 -48.23 13.33 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 126.044 2.09 . . . . 0.0 114.848 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -52.27 -30.58 28.59 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 124.329 1.018 . . . . 0.0 111.785 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 119.72 43.83 0.48 Allowed Glycine 0 N--CA 1.491 2.348 0 O-C-N 124.742 1.276 . . . . 0.0 111.043 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 57.3 m -139.13 111.21 7.35 Favored 'General case' 0 N--CA 1.5 2.03 0 C-N-CA 119.648 -0.821 . . . . 0.0 112.077 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 17.4 t80 -53.43 137.21 36.35 Favored 'General case' 0 N--CA 1.494 1.775 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.694 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 64.1 t -98.02 -73.4 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 CA-C-N 114.348 -1.297 . . . . 0.0 111.474 -179.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . 0.48 ' SG ' ' N ' ' A' ' 84' ' ' GLU . 0.5 OUTLIER -167.3 -172.65 2.04 Favored 'General case' 0 N--CA 1.505 2.3 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 -179.854 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.48 ' N ' ' SG ' ' A' ' 83' ' ' CYS . 33.3 tt0 -112.66 145.03 41.16 Favored 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 103.234 -2.876 . . . . 0.0 103.234 179.26 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -52.33 140.58 28.12 Favored Glycine 0 N--CA 1.503 3.157 0 C-N-CA 118.993 -1.575 . . . . 0.0 112.696 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -88.62 -4.98 58.45 Favored 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 27.8 t -117.97 107.91 14.63 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.472 ' H ' HD22 ' A' ' 91' ' ' ASN . 14.3 t70 -79.05 141.49 58.52 Favored Pre-proline 0 N--CA 1.494 1.749 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -34.62 -31.5 0.06 OUTLIER 'Trans proline' 0 N--CA 1.497 1.729 0 C-N-CA 123.712 2.941 . . . . 0.0 113.784 175.004 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -79.33 -53.93 6.44 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 123.869 0.73 . . . . 0.0 110.215 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.472 HD22 ' H ' ' A' ' 88' ' ' ASP . 1.7 p-10 -91.3 126.0 56.29 Favored Pre-proline 0 N--CA 1.5 2.062 0 C-N-CA 119.976 -0.69 . . . . 0.0 112.326 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -75.52 150.67 36.29 Favored 'Trans proline' 0 N--CA 1.492 1.39 0 C-N-CA 122.586 2.191 . . . . 0.0 109.396 165.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 32.4 mmmt -132.99 127.5 34.3 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 124.02 0.825 . . . . 0.0 109.029 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -84.06 73.96 10.32 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 123.97 0.794 . . . . 0.0 108.967 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 85.1 m -79.96 163.33 58.45 Favored Pre-proline 0 N--CA 1.496 1.838 0 CA-C-N 114.404 -1.271 . . . . 0.0 112.848 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_endo -70.0 -151.43 0.03 OUTLIER 'Trans proline' 0 N--CA 1.491 1.376 0 C-N-CA 122.563 2.175 . . . . 0.0 109.292 159.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -154.3 50.38 0.64 Allowed 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 121.754 0.787 . . . . 0.0 111.67 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.411 ' H ' HD21 ' A' ' 98' ' ' ASN . 2.8 m-80 -60.5 157.16 14.7 Favored 'General case' 0 N--CA 1.5 2.065 0 CA-C-N 114.722 -1.126 . . . . 0.0 111.459 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 86.0 m -98.47 131.37 44.78 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-N 114.989 -1.005 . . . . 0.0 111.552 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 51.0 t0 -121.34 79.85 36.69 Favored Pre-proline 0 N--CA 1.496 1.873 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 179.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -54.71 -17.29 12.97 Favored 'Trans proline' 0 N--CA 1.497 1.697 0 C-N-CA 122.696 2.264 . . . . 0.0 113.326 -176.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 73.0 ttp85 -88.49 -35.85 16.77 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 -179.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 11.1 tt -54.35 159.82 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.403 0 O-C-N 123.307 0.38 . . . . 0.0 110.949 -179.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -150.79 -68.01 0.19 Allowed 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 -179.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 51.1 m-85 -114.28 -161.64 0.78 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 124.189 0.931 . . . . 0.0 111.321 -179.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -160.2 106.99 0.3 Allowed Glycine 0 N--CA 1.486 2.024 0 N-CA-C 104.836 -3.306 . . . . 0.0 104.836 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.403 HD11 ' N ' ' A' ' 107' ' ' ILE . 2.1 mp -79.14 104.67 7.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 CA-C-O 121.949 0.881 . . . . 0.0 108.92 -179.653 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 16.0 m -86.79 159.71 51.48 Favored Pre-proline 0 N--CA 1.495 1.777 0 CA-C-N 114.272 -1.331 . . . . 0.0 108.641 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -58.8 -36.64 96.73 Favored 'Trans proline' 0 N--CA 1.494 1.549 0 C-N-CA 122.382 2.055 . . . . 0.0 110.015 173.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.4 pp -79.58 -16.43 55.89 Favored 'General case' 0 N--CA 1.495 1.807 0 CA-C-N 114.914 -1.039 . . . . 0.0 111.096 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.787 0 CA-C-O 116.685 -1.626 . . . . 0.0 109.889 179.946 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 . . . . . 0 N--CA 1.491 1.575 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 67.7 mmt-85 -71.74 4.6 3.1 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 123.174 0.297 . . . . 0.0 111.77 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.0 tp -60.46 96.96 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 CA-C-O 121.922 0.867 . . . . 0.0 111.28 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.7 m -93.06 49.04 1.38 Allowed 'General case' 0 N--CA 1.491 1.598 0 CA-C-N 114.486 -1.234 . . . . 0.0 112.293 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 13.5 t -90.57 177.03 6.46 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-N 113.404 -1.725 . . . . 0.0 107.733 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.416 HD21 ' H ' ' A' ' 40' ' ' ASN . 14.3 p30 -160.04 167.98 26.62 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 123.994 0.809 . . . . 0.0 112.136 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 38.0 t -53.99 -42.52 69.11 Favored 'General case' 0 N--CA 1.497 1.877 0 CA-C-N 114.225 -1.352 . . . . 0.0 112.036 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 53.4 t -52.85 -44.48 66.81 Favored 'General case' 0 N--CA 1.496 1.862 0 CA-C-N 113.221 -1.808 . . . . 0.0 109.413 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -89.73 28.94 1.23 Allowed 'General case' 0 N--CA 1.499 2.018 0 CA-C-N 112.944 -1.935 . . . . 0.0 110.835 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -83.31 -138.44 3.36 Favored Glycine 0 N--CA 1.496 2.667 0 N-CA-C 110.743 -0.943 . . . . 0.0 110.743 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 39.9 p -158.09 104.88 1.91 Allowed 'General case' 0 N--CA 1.503 2.183 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 16.2 ptpt -53.55 95.05 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.108 0 CA-C-O 122.586 1.184 . . . . 0.0 111.811 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 168.24 -35.25 0.2 Allowed Glycine 0 N--CA 1.488 2.166 0 CA-C-N 113.788 -1.551 . . . . 0.0 110.345 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 49.9 m -112.12 161.28 16.69 Favored 'General case' 0 N--CA 1.502 2.151 0 C-N-CA 119.47 -0.892 . . . . 0.0 111.913 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -101.18 92.31 4.92 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-N 114.182 -1.372 . . . . 0.0 108.278 -179.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.409 ' N ' ' O ' ' A' ' 25' ' ' CYS . 47.4 m-85 -47.33 136.85 9.0 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 124.636 1.21 . . . . 0.0 110.712 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 10.7 t80 -146.19 159.58 43.12 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-N 112.853 -1.976 . . . . 0.0 112.789 -179.217 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.477 ' HG ' ' HE ' ' A' ' 44' ' ' ARG . 35.1 t -112.75 134.84 54.07 Favored 'General case' 0 N--CA 1.498 1.968 0 CA-C-N 112.285 -2.234 . . . . 0.0 114.753 -179.688 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.407 ' H ' ' HB1' ' A' ' 46' ' ' ALA . 1.2 p30 -51.17 -26.34 6.68 Favored 'General case' 0 N--CA 1.501 2.087 0 CA-C-N 112.457 -2.156 . . . . 0.0 115.031 -179.823 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 24.0 p30 -64.39 -2.12 2.07 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 123.999 0.812 . . . . 0.0 112.085 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 89.61 28.83 18.0 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 58.6 m -134.89 150.54 50.45 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 71.8 t80 -78.24 158.78 28.82 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-N 114.321 -1.309 . . . . 0.0 110.386 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 95.2 t -116.35 -73.77 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 CA-C-N 114.939 -1.028 . . . . 0.0 109.124 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.506 ' SG ' ' N ' ' A' ' 26' ' ' GLU . 1.7 p -168.41 -161.25 0.34 Allowed 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.506 ' N ' ' SG ' ' A' ' 25' ' ' CYS . 40.8 tt0 -127.87 145.57 50.9 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 104.669 -2.345 . . . . 0.0 104.669 179.231 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -32.72 102.13 0.01 OUTLIER Glycine 0 N--CA 1.499 2.891 0 N-CA-C 115.988 1.155 . . . . 0.0 115.988 -179.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -102.82 32.86 3.46 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 29.9 t -122.55 148.08 45.63 Favored 'General case' 0 N--CA 1.497 1.924 0 CA-C-N 114.124 -1.398 . . . . 0.0 107.681 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.49 ' H ' ' HZ2' ' A' ' 35' ' ' LYS . 41.8 t0 -128.2 92.9 40.29 Favored Pre-proline 0 N--CA 1.493 1.722 0 O-C-N 124.717 1.26 . . . . 0.0 110.82 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -52.43 -15.89 4.5 Favored 'Trans proline' 0 N--CA 1.495 1.59 0 C-N-CA 123.002 2.468 . . . . 0.0 113.03 178.239 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 16.7 tpt180 -61.2 -51.82 67.39 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 108.147 -1.056 . . . . 0.0 108.147 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 15.3 p30 -90.65 138.91 26.35 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 124.327 1.017 . . . . 0.0 110.016 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -74.38 116.77 4.74 Favored 'Trans proline' 0 N--CA 1.493 1.458 0 C-N-CA 123.017 2.478 . . . . 0.0 110.394 175.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.49 ' HZ2' ' H ' ' A' ' 30' ' ' ASP . 0.0 OUTLIER -167.51 176.19 6.68 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 123.98 0.8 . . . . 0.0 111.957 179.92 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -160.03 122.19 3.31 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-N 114.89 -1.05 . . . . 0.0 108.784 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 33.4 m -79.87 -71.58 0.45 Allowed 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 47.5 m 34.22 69.91 0.14 Allowed 'General case' 0 N--CA 1.498 1.96 0 O-C-N 124.787 1.305 . . . . 0.0 113.414 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.3 pp -143.55 -36.87 0.35 Allowed 'General case' 0 N--CA 1.495 1.789 0 CA-C-N 114.936 -1.029 . . . . 0.0 108.973 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.416 ' H ' HD21 ' A' ' 6' ' ' ASN . 20.5 m120 -94.02 138.68 31.84 Favored 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 105.648 -1.982 . . . . 0.0 105.648 179.473 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 75.0 m -101.01 131.02 47.08 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 123.698 0.624 . . . . 0.0 112.644 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 62.9 t0 -122.95 76.46 49.73 Favored Pre-proline 0 N--CA 1.497 1.922 0 O-C-N 124.213 0.945 . . . . 0.0 109.149 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -63.74 -37.64 44.67 Favored 'Trans proline' 0 N--CA 1.496 1.63 0 C-N-CA 123.309 2.672 . . . . 0.0 111.584 -176.131 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.477 ' HE ' ' HG ' ' A' ' 18' ' ' SER . 0.0 OUTLIER -74.6 -7.6 53.68 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 115.088 1.514 . . . . 0.0 115.088 -179.758 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 15.9 tt -57.04 156.74 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.25 0 C-N-CA 119.879 -0.729 . . . . 0.0 111.856 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.407 ' HB1' ' H ' ' A' ' 19' ' ' ASP . . . -137.13 -66.95 0.5 Allowed 'General case' 0 N--CA 1.497 1.914 0 O-C-N 124.006 0.816 . . . . 0.0 110.289 179.795 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 46.8 p90 -160.96 167.99 25.45 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-N 115.183 -0.917 . . . . 0.0 109.836 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -115.95 111.44 2.4 Favored Glycine 0 N--CA 1.492 2.428 0 O-C-N 125.17 1.544 . . . . 0.0 109.709 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.5 p -80.04 111.32 16.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 C-N-CA 119.731 -0.788 . . . . 0.0 111.973 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.7 m -79.33 149.48 72.45 Favored Pre-proline 0 N--CA 1.499 1.984 0 CA-C-N 115.135 -0.939 . . . . 0.0 109.055 179.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -61.68 -68.66 0.04 OUTLIER 'Trans proline' 0 N--CA 1.495 1.6 0 C-N-CA 122.749 2.299 . . . . 0.0 111.965 -169.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 12.6 ptp180 -155.0 -116.06 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.882 0 O-C-N 124.068 0.855 . . . . 0.0 110.889 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 45.9 m 58.54 46.15 15.28 Favored 'General case' 0 N--CA 1.502 2.135 0 CA-C-O 122.005 0.907 . . . . 0.0 109.782 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -143.35 -34.17 0.42 Allowed 'General case' 0 N--CA 1.496 1.847 0 CA-C-N 113.603 -1.635 . . . . 0.0 109.136 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 52.1 36.32 18.66 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 124.277 0.985 . . . . 0.0 112.264 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 2.5 ttpm? -54.2 -71.26 0.08 Allowed 'General case' 0 N--CA 1.498 1.927 0 CA-C-N 114.739 -1.119 . . . . 0.0 109.214 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 4.9 ttmp? -88.91 94.31 9.89 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 105.975 -1.861 . . . . 0.0 105.975 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 65.61 168.23 0.2 Allowed 'General case' 0 N--CA 1.502 2.127 0 O-C-N 124.678 1.236 . . . . 0.0 110.928 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -65.75 165.46 12.68 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-N 115.173 -0.921 . . . . 0.0 112.095 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.12 123.61 15.06 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 124.168 0.917 . . . . 0.0 111.087 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.422 ' C ' ' CD1' ' A' ' 61' ' ' ILE . 0.0 OUTLIER -90.21 114.22 27.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 N-CA-C 107.78 -1.192 . . . . 0.0 107.78 179.957 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . 0.407 ' HA ' ' HA ' ' A' ' 99' ' ' CYS . 1.7 m -139.58 52.33 1.72 Allowed 'General case' 0 C--N 1.311 -1.087 0 CA-C-O 123.037 1.398 . . . . 0.0 111.897 179.632 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 93.2 m -90.3 168.24 12.05 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 112.516 -2.129 . . . . 0.0 108.72 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 42.3 p-10 -152.9 177.64 10.53 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 123.965 0.79 . . . . 0.0 110.072 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 4.5 t -73.17 1.12 9.85 Favored 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 46.1 t -91.64 -36.29 13.73 Favored 'General case' 0 N--CA 1.496 1.845 0 CA-C-N 114.751 -1.113 . . . . 0.0 110.584 179.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -71.1 59.21 0.24 Allowed 'General case' 0 N--CA 1.5 2.063 0 CA-C-N 112.466 -2.152 . . . . 0.0 114.148 -179.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -174.22 -150.33 7.6 Favored Glycine 0 N--CA 1.487 2.06 0 N-CA-C 107.863 -2.095 . . . . 0.0 107.863 179.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.482 ' C ' ' H ' ' A' ' 71' ' ' GLY . 66.5 p -146.11 157.42 43.84 Favored 'General case' 0 N--CA 1.502 2.13 0 C-N-CA 120.781 -0.367 . . . . 0.0 111.211 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 59.4 mtpt -71.07 33.23 0.05 OUTLIER 'General case' 0 N--CA 1.507 2.415 0 O-C-N 125.117 1.511 . . . . 0.0 113.627 179.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.482 ' H ' ' C ' ' A' ' 69' ' ' THR . . . -137.0 14.21 3.81 Favored Glycine 0 N--CA 1.486 1.987 0 N-CA-C 108.054 -2.018 . . . . 0.0 108.054 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 86.8 m -140.44 175.21 9.79 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 123.901 0.412 . . . . 0.0 111.006 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 34.2 mtmm -131.16 106.57 8.43 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 123.953 0.783 . . . . 0.0 110.279 -179.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.681 ' CD2' ' SG ' ' A' ' 83' ' ' CYS . 97.8 m-85 -56.31 137.98 51.48 Favored 'General case' 0 N--CA 1.501 2.102 0 C-N-CA 120.133 -0.627 . . . . 0.0 109.827 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 15.4 t80 -143.07 162.38 35.66 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 124.69 1.244 . . . . 0.0 111.977 -179.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 47.3 t -120.5 139.08 53.41 Favored 'General case' 0 N--CA 1.5 2.058 0 CA-C-N 113.2 -1.818 . . . . 0.0 115.084 -179.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.473 ' H ' ' HB2' ' A' ' 104' ' ' ALA . 4.3 p-10 -48.84 -28.23 3.58 Favored 'General case' 0 N--CA 1.5 2.055 0 CA-C-N 111.341 -2.663 . . . . 0.0 114.033 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 17.8 p30 -61.09 -5.25 1.36 Allowed 'General case' 0 N--CA 1.497 1.886 0 O-C-N 124.35 1.031 . . . . 0.0 112.073 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 89.64 29.08 17.19 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.396 -1.482 . . . . 0.0 109.396 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 88.2 m -142.17 149.96 40.42 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 121.43 0.633 . . . . 0.0 111.008 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 34.0 t80 -67.52 164.69 18.37 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-N 113.583 -1.644 . . . . 0.0 110.508 179.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 92.7 t -126.27 -71.49 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 O-C-N 124.074 0.859 . . . . 0.0 111.146 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . 0.681 ' SG ' ' CD2' ' A' ' 74' ' ' TYR . 17.2 p -155.11 -172.18 4.09 Favored 'General case' 0 N--CA 1.499 2.021 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 -179.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.405 ' CD ' ' N ' ' A' ' 85' ' ' GLY . 10.5 tm-20 -116.77 164.2 15.0 Favored 'General case' 0 N--CA 1.501 2.086 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.405 ' N ' ' CD ' ' A' ' 84' ' ' GLU . . . -49.63 107.82 0.37 Allowed Glycine 0 N--CA 1.494 2.545 0 CA-C-O 119.013 -0.882 . . . . 0.0 110.937 179.659 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -108.84 34.18 3.83 Favored 'General case' 0 N--CA 1.5 2.074 0 CA-C-O 121.535 0.683 . . . . 0.0 110.655 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 45.4 t -145.4 119.43 9.39 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -81.02 127.97 72.67 Favored Pre-proline 0 N--CA 1.494 1.769 0 C-N-CA 119.592 -0.843 . . . . 0.0 110.036 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_endo -58.56 -17.46 34.88 Favored 'Trans proline' 0 N--CA 1.495 1.605 0 C-N-CA 122.549 2.166 . . . . 0.0 113.019 -177.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 30.4 tpt180 -59.74 -41.48 91.06 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 123.717 0.636 . . . . 0.0 110.511 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -90.3 118.93 69.18 Favored Pre-proline 0 N--CA 1.496 1.85 0 O-C-N 124.396 1.06 . . . . 0.0 111.573 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -83.39 41.31 1.05 Allowed 'Trans proline' 0 N--CA 1.494 1.558 0 C-N-CA 123.365 2.71 . . . . 0.0 110.236 166.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.18 175.76 5.76 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-N 114.622 -1.172 . . . . 0.0 112.154 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -103.63 126.95 51.1 Favored 'General case' 0 N--CA 1.495 1.823 0 CA-C-N 114.826 -1.079 . . . . 0.0 109.359 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 42.6 m -79.94 163.74 56.44 Favored Pre-proline 0 N--CA 1.496 1.825 0 O-C-N 123.887 0.742 . . . . 0.0 111.732 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.43 ' C ' ' HE ' ' A' ' 97' ' ' ARG . 13.1 Cg_endo -68.66 155.39 69.01 Favored 'Trans proline' 0 N--CA 1.49 1.285 0 C-N-CA 122.511 2.14 . . . . 0.0 110.196 170.201 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.43 ' HE ' ' C ' ' A' ' 96' ' ' PRO . 0.0 OUTLIER -83.23 16.43 2.46 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-N 114.699 -1.137 . . . . 0.0 111.083 -179.919 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -48.0 131.28 15.63 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 123.89 0.743 . . . . 0.0 109.759 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . 0.407 ' HA ' ' HA ' ' A' ' 62' ' ' CYS . 60.1 m -99.64 132.46 44.97 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 114.005 1.113 . . . . 0.0 114.005 -179.599 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 64.7 t0 -129.49 76.3 78.86 Favored Pre-proline 0 N--CA 1.5 2.058 0 O-C-N 124.231 0.957 . . . . 0.0 110.845 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -59.85 -13.78 24.16 Favored 'Trans proline' 0 N--CA 1.494 1.54 0 C-N-CA 122.501 2.134 . . . . 0.0 112.222 176.234 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 69.5 mtp85 -90.31 18.45 6.07 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 124.011 0.819 . . . . 0.0 111.779 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 9.9 tt -116.34 175.7 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.314 0 O-C-N 123.71 0.631 . . . . 0.0 110.497 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.473 ' HB2' ' H ' ' A' ' 77' ' ' ASP . . . -146.01 -62.64 0.32 Allowed 'General case' 0 N--CA 1.498 1.928 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.863 179.683 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 27.9 p90 -161.22 163.93 30.74 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 124.053 0.846 . . . . 0.0 110.978 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -98.27 112.86 4.57 Favored Glycine 0 N--CA 1.492 2.375 0 CA-C-N 113.688 -1.596 . . . . 0.0 111.979 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 93.8 mt -79.54 105.65 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 N-CA-C 106.5 -1.667 . . . . 0.0 106.5 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 31.2 m -89.07 140.9 29.05 Favored Pre-proline 0 N--CA 1.491 1.599 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -70.87 87.2 0.7 Allowed 'Trans proline' 0 N--CA 1.493 1.481 0 C-N-CA 122.41 2.073 . . . . 0.0 109.085 -176.048 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 68.4 tp -159.98 -50.88 0.05 Allowed 'General case' 0 N--CA 1.495 1.796 0 CA-C-N 114.237 -1.347 . . . . 0.0 108.035 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.855 0 CA-C-O 116.658 -1.639 . . . . 0.0 110.9 179.966 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 62.1 ttm-85 63.14 151.79 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.158 0 O-C-N 124.824 1.328 . . . . 0.0 112.871 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 4.9 tp -62.35 94.77 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 CA-C-N 114.398 -1.274 . . . . 0.0 109.461 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.7 m -89.73 36.77 0.86 Allowed 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 116.881 2.178 . . . . 0.0 116.881 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 14.6 p -91.68 166.37 12.83 Favored 'General case' 0 N--CA 1.496 1.849 0 CA-C-N 113.518 -1.674 . . . . 0.0 108.901 179.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 14.0 p30 -161.42 142.65 11.36 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-N 114.861 -1.063 . . . . 0.0 111.791 179.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -61.69 -18.76 60.89 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-N 114.436 -1.256 . . . . 0.0 112.843 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 46.8 t -89.46 -69.54 0.71 Allowed 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 113.464 0.913 . . . . 0.0 113.464 -179.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.41 ' N ' ' SG ' ' A' ' 37' ' ' CYS . . . -75.45 1.19 14.67 Favored 'General case' 0 N--CA 1.5 2.043 0 N-CA-C 113.547 0.943 . . . . 0.0 113.547 -179.617 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -67.44 165.5 43.54 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 110.426 -1.07 . . . . 0.0 110.426 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.448 ' H ' ' HH ' ' A' ' 16' ' ' TYR . 8.9 t -73.12 125.13 26.97 Favored 'General case' 0 N--CA 1.493 1.711 0 CA-C-O 121.508 0.671 . . . . 0.0 110.204 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 7.1 ttpm? -72.2 87.75 1.11 Allowed 'General case' 0 N--CA 1.49 1.551 0 CA-C-N 114.239 -1.346 . . . . 0.0 108.719 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 171.1 -34.36 0.16 Allowed Glycine 0 N--CA 1.488 2.134 0 CA-C-N 113.282 -1.781 . . . . 0.0 108.882 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 83.9 m -101.55 133.61 45.96 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.469 ' HB3' ' CE1' ' A' ' 23' ' ' PHE . 9.0 mtpm? -81.92 88.96 6.34 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 113.428 -1.714 . . . . 0.0 113.732 -179.278 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.448 ' HH ' ' H ' ' A' ' 11' ' ' THR . 83.8 m-85 -54.48 126.22 22.66 Favored 'General case' 0 N--CA 1.499 2.018 0 N-CA-C 105.911 -1.885 . . . . 0.0 105.911 179.64 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -132.28 146.45 52.0 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 112.788 -2.005 . . . . 0.0 112.969 -179.188 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 40.2 t -84.5 139.81 31.9 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-N 112.563 -2.108 . . . . 0.0 114.866 -179.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -51.91 -32.14 31.45 Favored 'General case' 0 N--CA 1.499 1.981 0 CA-C-N 111.826 -2.443 . . . . 0.0 114.854 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -54.29 -21.67 9.87 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 123.981 0.8 . . . . 0.0 111.62 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 109.16 32.41 3.03 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 108.646 -1.782 . . . . 0.0 108.646 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 90.7 m -137.26 147.38 45.68 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 124.08 0.518 . . . . 0.0 110.961 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.469 ' CE1' ' HB3' ' A' ' 15' ' ' LYS . 8.6 t80 -80.43 140.93 35.74 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-N 114.637 -1.165 . . . . 0.0 110.216 179.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 98.0 t -100.42 -78.26 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 106.22 -1.77 . . . . 0.0 106.22 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -172.12 168.07 5.86 Favored 'General case' 0 N--CA 1.504 2.226 0 O-C-N 123.579 0.549 . . . . 0.0 110.404 179.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -87.59 155.38 19.99 Favored 'General case' 0 N--CA 1.501 2.114 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -48.22 131.71 19.65 Favored Glycine 0 N--CA 1.501 2.994 0 C-N-CA 120.026 -1.083 . . . . 0.0 111.48 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -101.91 33.21 3.11 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 37.1 t -149.58 137.4 20.29 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-N 114.502 -1.226 . . . . 0.0 107.922 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -79.59 134.1 58.35 Favored Pre-proline 0 N--CA 1.494 1.754 0 O-C-N 123.987 0.804 . . . . 0.0 109.007 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -57.0 -13.76 12.64 Favored 'Trans proline' 0 N--CA 1.497 1.7 0 C-N-CA 122.423 2.082 . . . . 0.0 112.789 -177.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 79.8 ttt180 -68.59 -43.04 77.34 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 123.658 0.599 . . . . 0.0 111.878 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -73.64 128.59 86.75 Favored Pre-proline 0 N--CA 1.495 1.792 0 C-N-CA 119.523 -0.871 . . . . 0.0 112.285 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -82.61 85.2 1.65 Allowed 'Trans proline' 0 N--CA 1.492 1.406 0 C-N-CA 123.509 2.806 . . . . 0.0 111.486 169.223 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 20.7 pttp -164.11 166.39 21.32 Favored 'General case' 0 N--CA 1.501 2.101 0 C-N-CA 120.621 -0.432 . . . . 0.0 111.829 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -129.14 158.79 38.0 Favored 'General case' 0 N--CA 1.497 1.883 0 CA-C-N 114.592 -1.186 . . . . 0.0 110.144 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.41 ' SG ' ' N ' ' A' ' 9' ' ' ALA . 85.2 m -88.55 -178.68 5.89 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-N 114.865 -1.061 . . . . 0.0 110.744 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 63.7 p -81.01 -2.16 46.84 Favored 'General case' 0 N--CA 1.497 1.91 0 CA-C-N 114.925 -1.034 . . . . 0.0 110.669 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -79.41 -57.45 3.7 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 33.6 m120 53.52 103.0 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.982 0 O-C-N 124.83 1.331 . . . . 0.0 112.808 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 60.9 m 63.98 135.12 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.937 0 CA-C-N 114.602 -1.181 . . . . 0.0 112.963 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 46.3 t0 -135.81 102.03 10.42 Favored Pre-proline 0 N--CA 1.498 1.951 0 C-N-CA 120.305 -0.558 . . . . 0.0 111.674 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -57.22 -29.39 83.47 Favored 'Trans proline' 0 N--CA 1.494 1.543 0 C-N-CA 122.758 2.305 . . . . 0.0 111.467 174.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -62.75 -39.44 94.12 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 123.997 0.811 . . . . 0.0 109.309 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.426 ' CG2' ' N ' ' A' ' 46' ' ' ALA . 20.3 mt -76.97 161.8 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 CA-C-O 121.927 0.87 . . . . 0.0 109.505 179.776 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.426 ' N ' ' CG2' ' A' ' 45' ' ' ILE . . . -122.65 -54.21 1.86 Allowed 'General case' 0 N--CA 1.494 1.756 0 CA-C-N 112.423 -2.171 . . . . 0.0 109.054 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 14.4 p90 -171.15 159.32 5.88 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-N 114.727 -1.124 . . . . 0.0 111.523 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -92.31 111.55 4.07 Favored Glycine 0 N--CA 1.493 2.484 0 CA-C-N 113.523 -1.671 . . . . 0.0 111.073 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 33.0 m -79.95 98.1 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 N-CA-C 105.068 -2.197 . . . . 0.0 105.068 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 8.0 m -79.63 121.25 82.32 Favored Pre-proline 0 N--CA 1.492 1.633 0 CA-C-N 113.496 -1.684 . . . . 0.0 108.019 -179.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -62.58 128.85 24.59 Favored 'Trans proline' 0 N--CA 1.495 1.602 0 C-N-CA 122.806 2.337 . . . . 0.0 113.173 -165.14 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.98 76.14 9.43 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 104.594 -2.372 . . . . 0.0 104.594 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 68.4 p -103.29 -45.24 4.95 Favored 'General case' 0 N--CA 1.498 1.94 0 CA-C-N 114.169 -1.378 . . . . 0.0 110.679 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.42 ' N ' ' CD ' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -51.43 -22.64 3.16 Favored 'General case' 0 N--CA 1.497 1.904 0 CA-C-N 114.226 -1.352 . . . . 0.0 112.757 179.902 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 25.3 tp10 50.42 53.96 11.99 Favored 'General case' 0 N--CA 1.498 1.941 0 CA-C-O 122.192 0.996 . . . . 0.0 109.693 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 17.6 tppt? -86.76 114.7 23.65 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-N 113.746 -1.57 . . . . 0.0 112.833 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -83.2 167.17 17.96 Favored 'General case' 0 N--CA 1.501 2.075 0 CA-C-N 114.836 -1.075 . . . . 0.0 108.772 179.72 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 17.3 t-20 -90.33 48.13 1.52 Allowed 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 59.88 10.05 1.96 Allowed 'General case' 0 N--CA 1.502 2.154 0 CA-C-N 114.455 -1.248 . . . . 0.0 111.978 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 40.8 mmt180 -141.41 143.44 33.93 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 6.1 tp -84.1 65.99 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 CA-C-O 122.116 0.96 . . . . 0.0 109.851 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 56.2 m -90.75 36.54 0.9 Allowed 'General case' 0 N--CA 1.489 1.484 0 CA-C-O 123.297 1.522 . . . . 0.0 112.593 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 61.3 m -90.7 133.29 35.26 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 111.466 -2.606 . . . . 0.0 104.307 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 34.6 p-10 -153.82 154.45 33.98 Favored 'General case' 0 N--CA 1.503 2.194 0 N-CA-C 113.855 1.058 . . . . 0.0 113.855 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -67.18 -22.92 65.72 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-N 113.74 -1.573 . . . . 0.0 114.513 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 51.4 t -89.81 -68.71 0.76 Allowed 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 113.381 0.882 . . . . 0.0 113.381 -179.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -71.47 -2.05 15.36 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 123.812 0.695 . . . . 0.0 111.833 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -65.88 166.95 35.27 Favored Glycine 0 N--CA 1.491 2.307 0 O-C-N 123.829 0.706 . . . . 0.0 111.621 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 6.8 t -77.47 129.27 35.51 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 124.245 0.615 . . . . 0.0 111.954 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -71.64 81.6 0.84 Allowed 'General case' 0 N--CA 1.494 1.756 0 CA-C-N 114.378 -1.283 . . . . 0.0 110.899 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 174.66 -36.14 0.11 Allowed Glycine 0 N--CA 1.488 2.154 0 CA-C-N 113.11 -1.859 . . . . 0.0 108.728 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 46.3 m -94.86 129.55 41.81 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 13.3 mmmm -75.47 84.96 2.57 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 112.912 -1.949 . . . . 0.0 111.279 -179.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.407 ' HA ' ' HA2' ' A' ' 106' ' ' GLY . 42.8 m-85 -50.61 121.7 6.16 Favored 'General case' 0 N--CA 1.503 2.215 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 179.673 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -129.88 150.64 51.09 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 111.896 -2.411 . . . . 0.0 113.417 -179.182 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 33.1 t -90.33 136.59 32.96 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-N 112.65 -2.068 . . . . 0.0 114.103 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -51.32 -28.15 11.45 Favored 'General case' 0 N--CA 1.5 2.044 0 CA-C-N 112.386 -2.188 . . . . 0.0 114.705 179.833 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -54.16 -22.47 11.32 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 123.93 0.769 . . . . 0.0 111.466 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 110.66 29.74 3.51 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 108.637 -1.785 . . . . 0.0 108.637 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 85.4 m -139.7 146.49 39.69 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 123.985 0.462 . . . . 0.0 111.102 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 21.5 t80 -76.06 154.0 35.98 Favored 'General case' 0 N--CA 1.493 1.725 0 CA-C-N 114.352 -1.295 . . . . 0.0 110.438 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 57.9 t -117.11 -79.68 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -162.69 179.65 7.53 Favored 'General case' 0 N--CA 1.505 2.286 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 179.726 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -97.69 159.37 14.97 Favored 'General case' 0 N--CA 1.507 2.392 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 179.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -53.15 132.32 41.82 Favored Glycine 0 N--CA 1.5 2.944 0 C-N-CA 119.42 -1.372 . . . . 0.0 110.306 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -101.92 33.02 3.18 Favored 'General case' 0 N--CA 1.499 2.0 0 CA-C-O 122.143 0.973 . . . . 0.0 108.391 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 41.2 t -157.6 152.8 25.89 Favored 'General case' 0 N--CA 1.495 1.801 0 CA-C-N 114.533 -1.212 . . . . 0.0 109.345 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -97.14 138.05 21.24 Favored Pre-proline 0 N--CA 1.494 1.74 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -64.48 86.59 0.16 Allowed 'Trans proline' 0 N--CA 1.494 1.53 0 C-N-CA 122.131 1.887 . . . . 0.0 108.178 173.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 3.5 mtp-105 178.25 -31.31 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.011 0 CA-C-N 114.031 -1.44 . . . . 0.0 109.352 -179.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 9.0 p-10 -53.02 125.93 41.99 Favored Pre-proline 0 N--CA 1.497 1.923 0 O-C-N 124.04 0.838 . . . . 0.0 112.919 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -82.73 48.0 2.63 Favored 'Trans proline' 0 N--CA 1.49 1.301 0 C-N-CA 122.916 2.411 . . . . 0.0 108.684 160.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 45.8 mmtm -126.13 169.57 12.67 Favored 'General case' 0 N--CA 1.498 1.965 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.462 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -145.58 135.86 23.95 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-N 114.707 -1.133 . . . . 0.0 109.529 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 86.9 m -79.96 157.76 73.43 Favored Pre-proline 0 N--CA 1.495 1.809 0 CA-C-N 115.076 -0.965 . . . . 0.0 111.696 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -69.28 -5.61 16.32 Favored 'Trans proline' 0 N--CA 1.496 1.639 0 C-N-CA 122.841 2.361 . . . . 0.0 110.369 160.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 17.5 tpp85 -79.31 -50.13 11.37 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 43.3 m-80 54.05 -159.67 0.16 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 124.797 1.311 . . . . 0.0 110.401 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 64.6 m -51.61 120.01 4.75 Favored 'General case' 0 N--CA 1.497 1.913 0 CA-C-N 115.208 -0.905 . . . . 0.0 108.773 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -107.64 99.31 28.48 Favored Pre-proline 0 N--CA 1.499 2.01 0 O-C-N 123.684 0.615 . . . . 0.0 111.293 -179.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -64.18 -27.82 64.66 Favored 'Trans proline' 0 N--CA 1.494 1.555 0 C-N-CA 122.634 2.223 . . . . 0.0 111.328 -176.137 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 25.8 mtm105 -60.01 -39.85 87.22 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 18.0 mt -76.0 160.98 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 CA-C-N 113.927 -1.488 . . . . 0.0 111.121 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -123.79 -61.77 1.35 Allowed 'General case' 0 N--CA 1.491 1.612 0 CA-C-N 112.176 -2.284 . . . . 0.0 109.72 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 20.0 p90 -160.49 157.23 27.19 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-N 114.806 -1.088 . . . . 0.0 111.941 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.407 ' HA2' ' HA ' ' A' ' 74' ' ' TYR . . . -94.96 109.79 3.9 Favored Glycine 0 N--CA 1.488 2.162 0 CA-C-N 112.864 -1.971 . . . . 0.0 111.406 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 65.0 mt -79.17 95.73 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 CA-C-N 114.577 -0.811 . . . . 0.0 110.913 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 1.5 m -79.09 143.32 60.93 Favored Pre-proline 0 N--CA 1.503 2.203 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 179.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -65.4 164.99 23.87 Favored 'Trans proline' 0 N--CA 1.494 1.53 0 C-N-CA 122.613 2.208 . . . . 0.0 111.555 -179.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 64.2 tp -153.93 -47.21 0.09 Allowed 'General case' 0 N--CA 1.496 1.868 0 CA-C-N 114.969 -1.014 . . . . 0.0 109.465 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.503 2.177 0 CA-C-O 117.644 -1.169 . . . . 0.0 112.753 -179.942 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 74.4 ttt-85 -87.44 -108.24 0.07 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 124.118 0.886 . . . . 0.0 109.004 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.412 ' O ' ' HA ' ' A' ' 41' ' ' CYS . 9.1 tp -85.89 53.13 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 123.213 0.321 . . . . 0.0 110.647 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.572 ' HA ' ' CA ' ' A' ' 41' ' ' CYS . 1.6 m -79.31 39.08 0.38 Allowed 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 117.279 2.325 . . . . 0.0 117.279 -179.858 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.1 p -91.23 151.05 21.08 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 112.176 -2.284 . . . . 0.0 106.357 179.197 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 45.4 p-10 -160.71 173.86 14.81 Favored 'General case' 0 N--CA 1.494 1.774 0 CA-C-N 113.453 -1.703 . . . . 0.0 109.644 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 4.2 t -72.01 -24.89 61.63 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-N 114.698 -1.137 . . . . 0.0 112.863 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 40.4 t -89.25 -69.54 0.71 Allowed 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 113.68 0.993 . . . . 0.0 113.68 -179.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -81.78 36.83 0.45 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 124.531 1.144 . . . . 0.0 112.543 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -82.0 -119.51 0.54 Allowed Glycine 0 N--CA 1.493 2.473 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 37.0 p -155.74 123.86 5.78 Favored 'General case' 0 N--CA 1.5 2.035 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.67 144.58 42.87 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-N 115.034 -0.985 . . . . 0.0 110.928 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 91.5 -18.18 53.35 Favored Glycine 0 N--CA 1.492 2.43 0 CA-C-N 114.486 -1.234 . . . . 0.0 110.959 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 91.4 m -99.54 171.65 7.8 Favored 'General case' 0 N--CA 1.498 1.935 0 C-N-CA 120.118 -0.633 . . . . 0.0 110.707 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 60.8 mttp -129.79 90.1 2.92 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-N 115.066 -0.97 . . . . 0.0 109.667 -179.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 40.8 m-85 -54.79 133.8 47.59 Favored 'General case' 0 N--CA 1.495 1.777 0 CA-C-N 114.133 -1.394 . . . . 0.0 109.384 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -137.73 157.22 46.93 Favored 'General case' 0 N--CA 1.487 1.415 0 CA-C-N 112.934 -1.939 . . . . 0.0 113.682 -179.22 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 30.9 t -103.82 134.43 47.14 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-N 112.685 -2.052 . . . . 0.0 113.211 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -50.05 -27.16 5.15 Favored 'General case' 0 N--CA 1.503 2.219 0 N-CA-C 115.541 1.682 . . . . 0.0 115.541 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -55.67 -16.66 4.45 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 123.836 0.71 . . . . 0.0 111.749 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 104.26 29.42 5.43 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 108.442 -1.863 . . . . 0.0 108.442 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 59.9 m -137.2 144.39 42.84 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 124.088 0.522 . . . . 0.0 110.579 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 21.7 t80 -77.08 145.36 37.91 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-N 114.266 -1.334 . . . . 0.0 109.59 179.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 91.4 t -100.17 -76.39 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.441 ' SG ' ' O ' ' A' ' 26' ' ' GLU . 0.1 OUTLIER -171.06 179.76 2.97 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 123.399 0.437 . . . . 0.0 110.889 179.823 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.441 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 35.6 tt0 -81.76 149.64 28.32 Favored 'General case' 0 N--CA 1.501 2.11 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.318 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -70.58 118.4 7.72 Favored Glycine 0 N--CA 1.497 2.763 0 N-CA-C 106.643 -2.583 . . . . 0.0 106.643 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -96.87 26.64 4.46 Favored 'General case' 0 N--CA 1.501 2.086 0 CA-C-O 121.481 0.658 . . . . 0.0 111.317 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 45.7 t -106.15 120.51 42.0 Favored 'General case' 0 N--CA 1.495 1.776 0 CA-C-N 114.349 -1.296 . . . . 0.0 109.993 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.418 ' H ' HD22 ' A' ' 33' ' ' ASN . 12.5 t70 -132.27 140.98 39.67 Favored Pre-proline 0 N--CA 1.494 1.75 0 N-CA-C 106.543 -1.651 . . . . 0.0 106.543 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -67.12 79.51 0.4 Allowed 'Trans proline' 0 N--CA 1.494 1.525 0 C-N-CA 122.584 2.19 . . . . 0.0 110.238 175.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 5.2 mmt-85 178.21 -46.13 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.77 0 CA-C-N 113.59 -1.641 . . . . 0.0 108.008 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.418 HD22 ' H ' ' A' ' 30' ' ' ASP . 28.5 p30 -83.02 149.28 58.79 Favored Pre-proline 0 N--CA 1.495 1.776 0 O-C-N 124.043 0.84 . . . . 0.0 111.755 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_endo -76.77 119.2 5.06 Favored 'Trans proline' 0 N--CA 1.491 1.333 0 C-N-CA 122.875 2.383 . . . . 0.0 108.696 165.078 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 41.3 mtmt -72.37 117.73 14.39 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -160.68 101.13 1.31 Allowed 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 113.997 1.11 . . . . 0.0 113.997 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 1.6 m -160.42 -53.05 0.05 Allowed 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 105.193 -2.151 . . . . 0.0 105.193 179.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 95.2 m -121.59 160.5 24.21 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-N 112.808 -1.996 . . . . 0.0 108.844 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -93.21 26.65 2.8 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-N 114.663 -1.153 . . . . 0.0 110.896 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 4.0 m120 60.54 -177.83 0.1 Allowed 'General case' 0 N--CA 1.501 2.095 0 CA-C-N 114.257 -1.338 . . . . 0.0 113.192 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.572 ' CA ' ' HA ' ' A' ' 4' ' ' CYS . 1.7 m 52.27 79.73 0.1 Allowed 'General case' 0 N--CA 1.495 1.803 0 CA-C-O 123.723 1.725 . . . . 0.0 112.674 -179.704 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -91.78 110.13 41.52 Favored Pre-proline 0 N--CA 1.484 1.273 0 CA-C-N 110.091 -3.231 . . . . 0.0 106.844 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_endo -63.92 -19.53 66.81 Favored 'Trans proline' 0 N--CA 1.495 1.614 0 C-N-CA 121.791 1.661 . . . . 0.0 112.365 -170.358 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.456 ' N ' ' HD2' ' A' ' 44' ' ' ARG . 2.1 mpt_? -90.56 -26.89 19.48 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 112.918 0.711 . . . . 0.0 112.918 -179.764 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 6.3 tt -64.56 169.05 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 123.558 0.536 . . . . 0.0 111.939 -179.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.86 -59.12 0.51 Allowed 'General case' 0 N--CA 1.494 1.751 0 CA-C-N 114.806 -1.088 . . . . 0.0 110.044 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 41.4 p90 -165.52 165.52 18.94 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-N 114.659 -1.155 . . . . 0.0 109.416 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -117.18 121.08 5.02 Favored Glycine 0 N--CA 1.491 2.315 0 O-C-N 125.386 1.678 . . . . 0.0 110.878 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 8.4 p -79.29 133.71 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 N-CA-C 106.114 -1.81 . . . . 0.0 106.114 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 7.8 m -114.97 76.24 4.29 Favored Pre-proline 0 N--CA 1.499 1.987 0 O-C-N 123.742 0.651 . . . . 0.0 110.441 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -73.65 -54.17 0.11 Allowed 'Trans proline' 0 N--CA 1.493 1.447 0 C-N-CA 122.952 2.435 . . . . 0.0 110.704 -176.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.48 HH12 ' H ' ' A' ' 56' ' ' LYS . 4.1 mmp_? -119.32 73.1 0.93 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 124.69 1.244 . . . . 0.0 110.733 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 43.3 t -82.6 -44.99 15.15 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 179.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 43.7 mm-40 -117.72 116.03 26.22 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -63.14 113.74 3.33 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 123.974 0.796 . . . . 0.0 109.021 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.48 ' H ' HH12 ' A' ' 52' ' ' ARG . 25.0 pttm -87.27 63.28 7.7 Favored 'General case' 0 N--CA 1.5 2.027 0 CA-C-N 115.131 -0.94 . . . . 0.0 113.456 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 24.4 ttmm 55.99 97.17 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.114 0 CA-C-N 114.818 -1.083 . . . . 0.0 112.471 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -168.83 -27.25 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.971 0 CA-C-N 113.871 -1.513 . . . . 0.0 107.221 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -42.03 -36.79 1.21 Allowed 'General case' 0 N--CA 1.497 1.922 0 O-C-N 125.012 1.445 . . . . 0.0 112.163 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 16.1 ptm180 -53.49 114.11 1.4 Allowed 'General case' 0 N--CA 1.494 1.751 0 CA-C-N 114.575 -1.193 . . . . 0.0 111.02 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 7.7 tp -87.92 65.82 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 CA-C-N 114.498 -1.228 . . . . 0.0 111.147 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 1.7 m -85.16 40.24 0.81 Allowed 'General case' 0 N--CA 1.495 1.778 0 CA-C-N 114.608 -1.178 . . . . 0.0 113.993 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.414 ' HG1' ' H ' ' A' ' 64' ' ' ASN . 12.6 t -90.72 -174.93 4.24 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-N 113.379 -1.737 . . . . 0.0 108.195 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.414 ' H ' ' HG1' ' A' ' 63' ' ' THR . 0.7 OUTLIER -157.03 155.04 30.53 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 106.388 -1.708 . . . . 0.0 106.388 179.65 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 27.6 t -54.82 -26.87 37.8 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 114.343 1.238 . . . . 0.0 114.343 -179.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 44.2 t -76.41 -48.47 19.65 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-N 114.386 -1.279 . . . . 0.0 111.391 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -79.49 57.19 2.34 Favored 'General case' 0 N--CA 1.497 1.895 0 CA-C-N 113.348 -1.751 . . . . 0.0 112.829 -179.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -147.46 152.59 24.7 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 6.8 t -65.56 128.4 35.76 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-N 113.255 -1.472 . . . . 0.0 109.565 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -73.53 88.1 1.63 Allowed 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 106.22 -1.77 . . . . 0.0 106.22 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 168.98 -25.46 0.11 Allowed Glycine 0 N--CA 1.488 2.132 0 CA-C-N 112.673 -2.058 . . . . 0.0 110.07 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 56.2 m -100.4 124.08 45.44 Favored 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 122.094 0.95 . . . . 0.0 111.541 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 28.1 mtpp -73.49 93.59 2.01 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 112.681 -2.054 . . . . 0.0 112.157 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.456 ' CD1' HD13 ' A' ' 103' ' ' ILE . 8.3 m-85 -48.83 128.25 15.31 Favored 'General case' 0 N--CA 1.501 2.118 0 N-CA-C 106.704 -1.591 . . . . 0.0 106.704 179.413 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -142.87 155.24 44.73 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 114.706 -1.134 . . . . 0.0 112.348 -179.467 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 40.2 t -101.52 133.83 45.57 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-N 113.231 -1.804 . . . . 0.0 110.939 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -48.87 -28.74 3.98 Favored 'General case' 0 N--CA 1.502 2.132 0 N-CA-C 115.834 1.79 . . . . 0.0 115.834 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -52.0 -24.25 6.32 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 123.946 0.779 . . . . 0.0 111.738 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 113.63 28.27 3.28 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 108.616 -1.794 . . . . 0.0 108.616 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 88.6 m -139.17 140.6 37.88 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 124.045 0.497 . . . . 0.0 110.981 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 12.5 t80 -68.57 159.08 32.59 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-N 114.198 -1.365 . . . . 0.0 110.804 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 91.3 t -121.42 -71.4 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 CA-C-N 114.823 -1.081 . . . . 0.0 110.104 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . 0.576 ' SG ' ' N ' ' A' ' 84' ' ' GLU . 0.5 OUTLIER -153.48 -163.02 1.57 Allowed 'General case' 0 N--CA 1.501 2.105 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 -179.875 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.576 ' N ' ' SG ' ' A' ' 83' ' ' CYS . 12.5 tp10 -129.03 146.62 50.95 Favored 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 179.433 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -59.01 138.65 49.45 Favored Glycine 0 N--CA 1.501 2.991 0 N-CA-C 109.257 -1.537 . . . . 0.0 109.257 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 35.8 mm-40 -113.89 31.76 6.32 Favored 'General case' 0 N--CA 1.501 2.098 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 36.8 t -156.0 105.42 2.35 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -79.26 144.73 62.95 Favored Pre-proline 0 N--CA 1.495 1.796 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -64.76 70.97 0.24 Allowed 'Trans proline' 0 N--CA 1.498 1.744 0 C-N-CA 123.088 2.525 . . . . 0.0 110.861 164.127 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 31.4 mtm105 -163.6 -49.95 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 104.868 -2.271 . . . . 0.0 104.868 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -90.41 133.23 33.43 Favored Pre-proline 0 N--CA 1.489 1.487 0 CA-C-N 114.053 -1.43 . . . . 0.0 110.356 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -79.9 50.26 3.47 Favored 'Trans proline' 0 N--CA 1.495 1.598 0 C-N-CA 123.521 2.814 . . . . 0.0 112.1 173.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -80.47 124.8 29.23 Favored 'General case' 0 N--CA 1.5 2.047 0 C-N-CA 120.126 -0.63 . . . . 0.0 111.076 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -80.1 166.13 21.81 Favored 'General case' 0 N--CA 1.497 1.878 0 CA-C-N 114.679 -1.146 . . . . 0.0 109.525 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 97.0 m -151.44 160.55 31.64 Favored Pre-proline 0 N--CA 1.497 1.906 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -60.33 130.17 32.84 Favored 'Trans proline' 0 N--CA 1.493 1.47 0 C-N-CA 122.709 2.273 . . . . 0.0 109.401 166.128 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.465 ' HA ' ' NE ' ' A' ' 97' ' ' ARG . 3.4 tpm_? -81.27 10.28 5.77 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 123.991 0.807 . . . . 0.0 110.203 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.516 ' H ' HD21 ' A' ' 98' ' ' ASN . 2.7 m-80 -52.47 153.83 2.83 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 114.105 1.15 . . . . 0.0 114.105 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 63.0 m -91.93 137.56 32.26 Favored 'General case' 0 N--CA 1.495 1.776 0 CA-C-N 113.897 -1.501 . . . . 0.0 111.402 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -119.98 88.36 40.43 Favored Pre-proline 0 N--CA 1.497 1.917 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 179.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -63.98 -33.35 63.27 Favored 'Trans proline' 0 N--CA 1.491 1.327 0 C-N-CA 122.683 2.255 . . . . 0.0 112.545 -170.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 15.9 ptm180 -64.98 -30.18 71.15 Favored 'General case' 0 N--CA 1.497 1.895 0 C-N-CA 119.574 -0.85 . . . . 0.0 111.965 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.456 HD13 ' CD1' ' A' ' 74' ' ' TYR . 11.9 mt -70.38 156.04 7.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 C-N-CA 118.907 -1.117 . . . . 0.0 109.66 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -137.94 -40.44 0.54 Allowed 'General case' 0 N--CA 1.491 1.58 0 CA-C-N 112.617 -2.083 . . . . 0.0 110.132 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 46.1 m-85 -143.0 -165.28 2.03 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 124.333 1.02 . . . . 0.0 110.635 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -154.97 94.07 0.14 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 103.907 -3.677 . . . . 0.0 103.907 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 37.7 mm -79.16 96.28 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 N-CA-C 116.066 1.876 . . . . 0.0 116.066 -179.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 1.7 m -79.96 150.94 72.78 Favored Pre-proline 0 N--CA 1.5 2.052 0 N-CA-C 105.861 -1.903 . . . . 0.0 105.861 179.238 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -44.82 111.82 0.32 Allowed 'Trans proline' 0 N--CA 1.497 1.682 0 C-N-CA 123.115 2.543 . . . . 0.0 112.394 -172.313 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 3.9 pp -148.53 0.4 0.58 Allowed 'General case' 0 N--CA 1.497 1.897 0 CA-C-N 114.867 -1.061 . . . . 0.0 112.327 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 1.99 0 CA-C-O 115.056 -2.402 . . . . 0.0 111.726 -179.967 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 47.8 tpt85 -68.66 133.43 48.43 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-N 115.179 -0.918 . . . . 0.0 110.37 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 7.6 tp -84.5 49.21 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 CA-C-N 114.634 -1.166 . . . . 0.0 110.077 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.6 m -82.38 59.76 4.73 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 115.24 1.57 . . . . 0.0 115.24 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 38.6 m -91.03 163.43 14.31 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 105.092 -2.188 . . . . 0.0 105.092 179.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.414 ' ND2' ' H ' ' A' ' 9' ' ' ALA . 40.8 p-10 -158.5 175.66 13.4 Favored 'General case' 0 N--CA 1.499 2.023 0 C-N-CA 118.895 -1.122 . . . . 0.0 113.057 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 45.3 t -78.44 -32.47 48.54 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-N 113.198 -1.819 . . . . 0.0 113.704 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 38.3 t -77.01 -62.86 1.51 Allowed 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 113.892 1.071 . . . . 0.0 113.892 -179.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.414 ' H ' ' ND2' ' A' ' 6' ' ' ASN . . . -84.81 63.97 8.33 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 124.743 1.277 . . . . 0.0 111.376 -179.702 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -137.54 -169.61 11.67 Favored Glycine 0 N--CA 1.498 2.823 0 CA-C-N 113.559 -1.655 . . . . 0.0 111.518 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.414 ' N ' ' OH ' ' A' ' 16' ' ' TYR . 4.5 t -102.62 111.62 24.02 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 114.191 1.182 . . . . 0.0 114.191 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 21.8 pttp -64.87 81.7 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.958 0 CA-C-N 113.608 -1.633 . . . . 0.0 110.789 179.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -175.18 -31.57 0.04 OUTLIER Glycine 0 N--CA 1.486 2.028 0 CA-C-N 113.057 -1.883 . . . . 0.0 109.629 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.435 ' HA ' ' HA ' ' A' ' 50' ' ' CYS . 21.9 m -104.64 148.19 26.81 Favored 'General case' 0 N--CA 1.501 2.085 0 C-N-CA 118.775 -1.17 . . . . 0.0 112.964 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.498 ' NZ ' HH12 ' A' ' 60' ' ' ARG . 38.2 ttpt -92.95 88.3 6.1 Favored 'General case' 0 N--CA 1.484 1.23 0 CA-C-N 113.307 -1.77 . . . . 0.0 107.428 -179.397 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.414 ' OH ' ' N ' ' A' ' 11' ' ' THR . 11.0 m-30 -46.4 134.95 8.64 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-N 113.59 -1.641 . . . . 0.0 108.494 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 10.8 t80 -145.16 156.16 43.71 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-N 113.232 -1.804 . . . . 0.0 111.511 -179.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 28.8 t -112.53 136.11 52.45 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-N 111.838 -2.437 . . . . 0.0 115.313 -179.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.427 ' C ' ' H ' ' A' ' 21' ' ' GLY . 1.0 OUTLIER -52.14 -21.47 3.32 Favored 'General case' 0 N--CA 1.499 1.989 0 CA-C-N 112.266 -2.243 . . . . 0.0 113.715 179.796 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 43.6 p30 -64.19 -1.86 1.81 Allowed 'General case' 0 N--CA 1.497 1.917 0 O-C-N 124.04 0.838 . . . . 0.0 111.231 179.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.427 ' H ' ' C ' ' A' ' 19' ' ' ASP . . . 85.74 29.15 27.29 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 108.94 -1.664 . . . . 0.0 108.94 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 95.5 m -141.21 150.47 42.73 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 121.831 0.824 . . . . 0.0 110.557 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 24.2 t80 -73.52 155.65 38.97 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-N 113.144 -1.844 . . . . 0.0 111.979 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 90.9 t -115.27 -77.0 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 CA-C-N 114.673 -1.149 . . . . 0.0 109.056 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.654 ' SG ' ' N ' ' A' ' 26' ' ' GLU . 0.1 OUTLIER -166.97 -168.61 1.13 Allowed 'General case' 0 N--CA 1.507 2.393 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 179.979 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.654 ' N ' ' SG ' ' A' ' 25' ' ' CYS . 3.5 tm-20 -128.36 140.96 51.58 Favored 'General case' 0 N--CA 1.5 2.046 0 N-CA-C 104.52 -2.4 . . . . 0.0 104.52 179.496 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -39.27 117.82 0.78 Allowed Glycine 0 N--CA 1.5 2.928 0 CA-C-O 122.041 0.8 . . . . 0.0 114.869 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -92.87 0.66 57.45 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-N 113.072 -1.564 . . . . 0.0 112.061 -179.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 27.5 t -156.22 170.3 22.56 Favored 'General case' 0 N--CA 1.501 2.103 0 C-N-CA 119.609 -0.837 . . . . 0.0 111.467 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -79.29 143.84 61.12 Favored Pre-proline 0 N--CA 1.493 1.694 0 CA-C-N 114.626 -1.17 . . . . 0.0 107.883 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -70.37 67.67 2.08 Favored 'Trans proline' 0 N--CA 1.5 1.9 0 C-N-CA 123.158 2.572 . . . . 0.0 111.073 172.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 67.0 mtp85 -160.33 -39.44 0.05 Allowed 'General case' 0 N--CA 1.496 1.855 0 CA-C-N 113.246 -1.797 . . . . 0.0 107.764 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.5 ' N ' HD21 ' A' ' 33' ' ' ASN . 0.0 OUTLIER -39.71 102.98 0.27 Allowed Pre-proline 0 N--CA 1.498 1.945 0 O-C-N 124.876 1.36 . . . . 0.0 114.416 -179.877 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -76.4 179.57 6.26 Favored 'Trans proline' 0 N--CA 1.494 1.54 0 C-N-CA 122.821 2.348 . . . . 0.0 111.029 -179.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 25.7 ttpp 62.9 155.25 0.05 OUTLIER 'General case' 0 N--CA 1.5 2.071 0 O-C-N 124.673 1.233 . . . . 0.0 112.618 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -79.87 147.33 31.76 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-N 114.639 -1.164 . . . . 0.0 110.124 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.493 ' H ' HD22 ' A' ' 40' ' ' ASN . 98.4 m -79.66 -87.91 0.07 Allowed 'General case' 0 N--CA 1.492 1.663 0 CA-C-N 114.66 -1.154 . . . . 0.0 110.593 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 7.9 t -168.9 -15.53 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.019 0 O-C-N 123.616 0.573 . . . . 0.0 110.732 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -153.44 64.92 0.75 Allowed 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 103.837 -2.653 . . . . 0.0 103.837 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.493 HD22 ' H ' ' A' ' 37' ' ' CYS . 13.4 m120 -84.15 47.59 1.35 Allowed 'General case' 0 N--CA 1.491 1.602 0 CA-C-N 112.702 -2.045 . . . . 0.0 112.959 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 75.3 m -158.04 126.31 5.42 Favored 'General case' 0 N--CA 1.498 1.93 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.781 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -147.83 81.36 8.43 Favored Pre-proline 0 N--CA 1.496 1.852 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.313 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -60.82 -31.11 91.39 Favored 'Trans proline' 0 N--CA 1.493 1.496 0 C-N-CA 122.744 2.296 . . . . 0.0 114.391 -173.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 7.3 ptm180 -58.59 -30.73 67.43 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 123.813 0.696 . . . . 0.0 111.955 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 13.9 tt -47.33 156.79 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 O-C-N 124.226 0.954 . . . . 0.0 113.279 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -137.85 -50.76 0.6 Allowed 'General case' 0 N--CA 1.492 1.636 0 CA-C-N 113.967 -1.469 . . . . 0.0 107.102 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 46.9 p90 -168.32 167.14 12.22 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-N 113.883 -1.508 . . . . 0.0 109.485 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -118.49 108.69 1.64 Allowed Glycine 0 N--CA 1.491 2.316 0 N-CA-C 107.861 -2.096 . . . . 0.0 107.861 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 5.6 p -80.15 111.42 16.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 C-N-CA 118.895 -1.122 . . . . 0.0 110.233 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.435 ' HA ' ' HA ' ' A' ' 14' ' ' CYS . 1.7 m -78.57 110.15 13.02 Favored Pre-proline 0 N--CA 1.499 2.014 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.484 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -82.44 102.87 1.21 Allowed 'Trans proline' 0 N--CA 1.49 1.307 0 C-N-CA 122.816 2.344 . . . . 0.0 108.415 -175.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 15.2 ptp180 -160.08 -22.27 0.06 Allowed 'General case' 0 N--CA 1.498 1.93 0 CA-C-N 115.417 -0.81 . . . . 0.0 111.313 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 40.6 t -64.01 138.6 58.53 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 123.917 0.761 . . . . 0.0 109.832 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 59.88 111.91 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.116 0 O-C-N 124.872 1.358 . . . . 0.0 113.181 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -91.2 73.27 6.25 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 28.7 tptp -161.07 56.54 0.3 Allowed 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 83.7 tttt 49.63 44.1 24.39 Favored 'General case' 0 N--CA 1.501 2.09 0 CA-C-N 114.045 -1.434 . . . . 0.0 109.989 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -60.75 -60.18 4.21 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-N 114.203 -1.362 . . . . 0.0 110.217 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -74.8 -78.69 0.1 Allowed 'General case' 0 N--CA 1.492 1.674 0 CA-C-N 115.248 -0.887 . . . . 0.0 108.72 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.498 HH12 ' NZ ' ' A' ' 15' ' ' LYS . 84.9 mtm-85 -142.92 -162.95 1.53 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 124.247 0.967 . . . . 0.0 108.67 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 9.6 tp -82.41 49.93 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 CA-C-O 121.768 0.795 . . . . 0.0 110.145 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 1.7 m -83.53 38.94 0.65 Allowed 'General case' 0 N--CA 1.492 1.663 0 CA-C-O 122.814 1.292 . . . . 0.0 114.222 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.6 p -91.25 159.09 16.22 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-N 112.889 -1.96 . . . . 0.0 109.573 179.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.599 HD22 ' H ' ' A' ' 99' ' ' CYS . 64.1 m-20 -152.94 157.02 40.0 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 125.018 1.448 . . . . 0.0 111.259 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' CYS . . . . . 0.441 ' HA ' ' CE2' ' A' ' 74' ' ' TYR . 3.6 t -62.1 -38.37 88.63 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-N 114.541 -1.209 . . . . 0.0 108.427 179.65 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 43.0 t -66.99 -50.85 60.97 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 112.363 -2.199 . . . . 0.0 110.634 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -79.36 -114.2 0.02 OUTLIER 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 113.924 -1.489 . . . . 0.0 110.701 -179.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 46.16 -129.89 10.62 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 111.044 -0.822 . . . . 0.0 111.044 -179.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 40.7 p -150.94 135.19 16.88 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 123.879 0.399 . . . . 0.0 111.689 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -61.1 104.2 0.35 Allowed 'General case' 0 N--CA 1.499 2.015 0 O-C-N 124.249 0.968 . . . . 0.0 110.309 179.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 141.43 -24.75 2.49 Favored Glycine 0 N--CA 1.494 2.551 0 O-C-N 123.93 0.769 . . . . 0.0 111.659 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 94.7 m -91.74 133.29 35.73 Favored 'General case' 0 N--CA 1.498 1.927 0 C-N-CA 120.736 -0.386 . . . . 0.0 110.441 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.7 mppt? -88.04 88.7 7.73 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 124.057 0.848 . . . . 0.0 110.46 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.471 ' CE2' ' HA2' ' A' ' 85' ' ' GLY . 77.7 m-85 -40.71 136.14 1.46 Allowed 'General case' 0 N--CA 1.503 2.176 0 O-C-N 124.613 1.196 . . . . 0.0 109.761 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -148.17 145.23 28.23 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 124.753 1.283 . . . . 0.0 113.399 -179.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 42.0 t -106.81 118.69 37.35 Favored 'General case' 0 N--CA 1.499 1.995 0 CA-C-N 112.653 -2.067 . . . . 0.0 111.902 -179.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.451 ' H ' ' HB1' ' A' ' 104' ' ' ALA . 6.1 p-10 -55.16 -52.89 61.87 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 126.323 2.264 . . . . 0.0 112.703 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -69.55 -0.74 7.14 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 112.108 -2.315 . . . . 0.0 112.541 -179.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -139.46 -84.4 0.1 Allowed Glycine 0 N--CA 1.482 1.702 0 C-N-CA 119.202 -1.475 . . . . 0.0 112.209 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.505 ' CG2' ' H ' ' A' ' 81' ' ' PHE . 1.2 m 175.79 -170.33 0.06 Allowed 'General case' 0 N--CA 1.5 2.04 0 O-C-N 126.22 1.777 . . . . 0.0 106.252 -179.166 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . 0.505 ' H ' ' CG2' ' A' ' 80' ' ' THR . 75.8 t80 -42.62 146.55 0.35 Allowed 'General case' 0 N--CA 1.498 1.955 0 C-N-CA 123.554 0.742 . . . . 0.0 112.636 179.527 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 88.4 t -111.17 -70.93 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 CA-C-N 113.878 -1.51 . . . . 0.0 111.585 -179.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . 0.534 ' SG ' ' N ' ' A' ' 84' ' ' GLU . 0.1 OUTLIER -160.25 -170.57 2.87 Favored 'General case' 0 N--CA 1.506 2.37 0 C-N-CA 120.41 -0.516 . . . . 0.0 110.827 -179.881 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.534 ' N ' ' SG ' ' A' ' 83' ' ' CYS . 38.9 tt0 -114.09 149.74 35.08 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 123.307 0.379 . . . . 0.0 110.716 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.471 ' HA2' ' CE2' ' A' ' 74' ' ' TYR . . . -36.8 105.7 0.04 OUTLIER Glycine 0 N--CA 1.501 2.992 0 O-C-N 124.833 1.333 . . . . 0.0 115.135 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -94.12 -8.86 38.35 Favored 'General case' 0 N--CA 1.502 2.145 0 C-N-CA 119.128 -1.029 . . . . 0.0 113.726 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 15.6 m -85.13 90.86 7.97 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -79.33 106.72 4.96 Favored Pre-proline 0 N--CA 1.49 1.536 0 N-CA-C 104.107 -2.553 . . . . 0.0 104.107 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -40.15 -34.81 1.08 Allowed 'Trans proline' 0 N--CA 1.501 1.938 0 C-N-CA 124.819 3.679 . . . . 0.0 116.265 -145.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 8.9 ptm180 -58.73 -14.02 7.5 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 123.861 0.726 . . . . 0.0 112.891 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.5 HD21 ' H ' ' A' ' 91' ' ' ASN . 0.1 OUTLIER -75.28 129.31 82.74 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 123.948 0.78 . . . . 0.0 110.936 -179.918 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -83.32 44.97 1.74 Allowed 'Trans proline' 0 N--CA 1.493 1.461 0 C-N-CA 123.275 2.65 . . . . 0.0 109.769 162.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.489 ' H ' ' HZ1' ' A' ' 93' ' ' LYS . 0.0 OUTLIER 64.98 168.94 0.19 Allowed 'General case' 0 N--CA 1.507 2.396 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.01 -179.877 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -160.21 44.82 0.21 Allowed 'General case' 0 N--CA 1.5 2.048 0 C-N-CA 120.061 -0.656 . . . . 0.0 112.759 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . 0.416 ' C ' ' H ' ' A' ' 97' ' ' ARG . 61.0 m -156.77 130.76 4.84 Favored Pre-proline 0 N--CA 1.501 2.101 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.829 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_endo -76.4 35.25 0.46 Allowed 'Trans proline' 0 N--CA 1.496 1.624 0 C-N-CA 123.039 2.493 . . . . 0.0 111.209 163.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.416 ' H ' ' C ' ' A' ' 95' ' ' CYS . 83.3 mmt-85 -108.99 37.07 2.66 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.457 HD21 ' H ' ' A' ' 98' ' ' ASN . 4.9 m-80 -54.25 135.51 44.21 Favored 'General case' 0 N--CA 1.495 1.789 0 CA-C-N 113.813 -1.54 . . . . 0.0 112.425 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . 0.599 ' H ' HD22 ' A' ' 64' ' ' ASN . 34.4 m 57.51 127.84 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.822 0 O-C-N 125.232 1.582 . . . . 0.0 114.747 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -122.99 93.12 48.67 Favored Pre-proline 0 N--CA 1.5 2.061 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_endo -62.11 -13.7 33.38 Favored 'Trans proline' 0 N--CA 1.496 1.635 0 C-N-CA 122.126 1.884 . . . . 0.0 113.505 -175.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 77.8 ttt-85 -90.17 -25.36 20.7 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 114.238 1.199 . . . . 0.0 114.238 -179.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 11.6 tt -74.12 141.95 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 C-N-CA 118.658 -1.217 . . . . 0.0 110.473 -179.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.451 ' HB1' ' H ' ' A' ' 77' ' ' ASP . . . -79.82 -58.85 2.97 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 105.791 -1.929 . . . . 0.0 105.791 179.715 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 4.3 p90 174.96 171.83 0.25 Allowed 'General case' 0 N--CA 1.488 1.473 0 CA-C-N 111.402 -2.635 . . . . 0.0 106.819 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -94.8 132.19 11.03 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 110.183 -1.167 . . . . 0.0 110.183 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 39.4 mm -78.45 90.86 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 N-CA-C 103.932 -2.618 . . . . 0.0 103.932 179.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 19.5 m -84.28 127.34 66.67 Favored Pre-proline 0 N--CA 1.493 1.716 0 CA-C-N 113.37 -1.741 . . . . 0.0 111.08 -179.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -73.96 -32.73 6.83 Favored 'Trans proline' 0 N--CA 1.491 1.367 0 C-N-CA 122.386 2.057 . . . . 0.0 107.951 146.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -159.75 162.75 34.96 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-N 114.692 -1.14 . . . . 0.0 109.482 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 2.012 0 CA-C-O 115.748 -2.072 . . . . 0.0 111.884 -179.858 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 27.9 t70 . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 121.283 0.563 . . . . 0.0 110.362 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 71.4 ttt-85 -151.79 64.69 0.86 Allowed 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.419 ' C ' ' CD1' ' A' ' 3' ' ' ILE . 0.0 OUTLIER -73.93 109.6 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 179.997 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.6 m -132.59 29.3 4.22 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 115.78 1.77 . . . . 0.0 115.78 179.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.5 p -92.33 147.34 22.99 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-N 112.427 -2.169 . . . . 0.0 108.588 179.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.55 HD21 ' H ' ' A' ' 41' ' ' CYS . 20.7 p30 -160.61 158.26 28.67 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 124.722 1.263 . . . . 0.0 109.858 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 5.3 t -71.21 -30.12 65.98 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 115.287 1.588 . . . . 0.0 115.287 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 43.1 t -80.81 -65.29 1.03 Allowed 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 -179.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -88.79 39.7 0.94 Allowed 'General case' 0 N--CA 1.499 2.012 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.03 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -76.54 -133.61 0.52 Allowed Glycine 0 N--CA 1.492 2.392 0 CA-C-N 114.943 -1.026 . . . . 0.0 111.23 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.42 ' N ' ' HH ' ' A' ' 16' ' ' TYR . 35.3 p -152.56 103.69 2.83 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 35.2 ttpt -51.87 108.22 0.26 Allowed 'General case' 0 N--CA 1.5 2.041 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.529 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 143.26 -20.89 2.26 Favored Glycine 0 N--CA 1.496 2.659 0 N-CA-C 110.314 -1.114 . . . . 0.0 110.314 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 80.7 m -114.56 150.35 35.11 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 124.244 0.614 . . . . 0.0 109.84 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.401 ' N ' ' HE2' ' A' ' 15' ' ' LYS . 0.2 OUTLIER -93.81 94.43 8.52 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 124.159 0.912 . . . . 0.0 111.503 -179.781 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.421 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 31.3 m-85 -59.34 115.33 3.17 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 106.662 -1.607 . . . . 0.0 106.662 179.695 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.449 ' CE2' ' HA ' ' A' ' 22' ' ' THR . 0.0 OUTLIER -129.42 147.71 51.26 Favored 'General case' 0 N--CA 1.486 1.363 0 CA-C-N 112.008 -2.36 . . . . 0.0 112.836 -179.343 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 46.6 t -98.21 123.93 42.53 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-N 112.87 -1.968 . . . . 0.0 112.05 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.401 ' N ' ' HB2' ' A' ' 46' ' ' ALA . 5.5 p-10 -60.53 -43.15 97.47 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-N 113.916 -1.493 . . . . 0.0 108.444 179.71 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -94.98 18.37 12.14 Favored 'General case' 0 N--CA 1.487 1.394 0 CA-C-N 112.182 -2.281 . . . . 0.0 112.024 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -170.71 31.53 0.14 Allowed Glycine 0 N--CA 1.498 2.777 0 C-N-CA 118.528 -1.796 . . . . 0.0 113.75 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.5 ' HG1' ' H ' ' A' ' 23' ' ' PHE . 6.1 t 44.19 -168.79 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 114.214 1.19 . . . . 0.0 114.214 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.5 ' H ' ' HG1' ' A' ' 22' ' ' THR . 62.8 t80 -47.84 133.62 13.98 Favored 'General case' 0 N--CA 1.498 1.95 0 CA-C-O 121.697 0.761 . . . . 0.0 112.805 -179.776 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 98.2 t -104.04 -78.65 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 CA-C-N 113.044 -1.889 . . . . 0.0 106.799 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.458 ' SG ' ' N ' ' A' ' 26' ' ' GLU . 0.2 OUTLIER -157.31 -171.4 3.59 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 179.732 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.458 ' N ' ' SG ' ' A' ' 25' ' ' CYS . 16.1 mt-10 -109.06 157.12 19.01 Favored 'General case' 0 N--CA 1.495 1.775 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 179.715 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -49.69 106.68 0.24 Allowed Glycine 0 N--CA 1.496 2.663 0 O-C-N 124.124 0.89 . . . . 0.0 112.05 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -79.44 -9.23 59.56 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-N 114.93 -0.635 . . . . 0.0 110.297 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 34.0 t -79.72 97.11 6.45 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.451 ' H ' HD22 ' A' ' 33' ' ' ASN . 10.8 t70 -79.82 137.23 54.29 Favored Pre-proline 0 N--CA 1.495 1.785 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -71.48 68.65 2.76 Favored 'Trans proline' 0 N--CA 1.497 1.711 0 C-N-CA 123.567 2.845 . . . . 0.0 111.411 176.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.406 ' NE ' ' HA ' ' A' ' 32' ' ' ARG . 3.9 mmp_? -158.0 -44.99 0.06 Allowed 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 105.293 -2.114 . . . . 0.0 105.293 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.451 HD22 ' H ' ' A' ' 30' ' ' ASP . 13.4 p30 -90.35 150.54 43.15 Favored Pre-proline 0 N--CA 1.495 1.783 0 O-C-N 124.275 0.985 . . . . 0.0 110.522 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.13 169.82 21.72 Favored 'Trans proline' 0 N--CA 1.491 1.343 0 C-N-CA 122.843 2.362 . . . . 0.0 108.916 159.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 22.4 ptmt -69.56 147.04 51.3 Favored 'General case' 0 N--CA 1.496 1.853 0 C-N-CA 120.124 -0.63 . . . . 0.0 110.4 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -158.81 41.56 0.24 Allowed 'General case' 0 N--CA 1.496 1.839 0 CA-C-N 115.322 -0.854 . . . . 0.0 108.849 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 76.4 m -108.23 178.68 4.43 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-N 114.069 -1.423 . . . . 0.0 111.595 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 8.4 t -134.15 -3.17 2.79 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-N 113.537 -1.665 . . . . 0.0 108.269 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.17 30.59 2.72 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 6.9 m-80 -57.75 123.22 14.96 Favored 'General case' 0 N--CA 1.497 1.923 0 CA-C-N 114.712 -1.131 . . . . 0.0 109.358 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.55 ' H ' HD21 ' A' ' 6' ' ' ASN . 70.9 m 58.01 107.56 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.856 0 O-C-N 125.079 1.487 . . . . 0.0 110.616 -179.612 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -108.76 102.99 50.32 Favored Pre-proline 0 N--CA 1.499 2.007 0 CA-C-N 115.243 -0.889 . . . . 0.0 112.654 -179.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -67.34 -7.05 17.89 Favored 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 121.888 1.725 . . . . 0.0 112.216 178.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 60.9 mtt85 -89.97 -14.59 33.75 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 123.643 0.589 . . . . 0.0 111.967 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 15.3 tt -106.79 160.74 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.401 ' HB2' ' N ' ' A' ' 19' ' ' ASP . . . -83.85 -74.65 0.37 Allowed 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 105.378 -2.082 . . . . 0.0 105.378 179.822 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 50.9 p90 179.71 176.37 0.69 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 124.769 1.293 . . . . 0.0 109.552 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.421 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -79.94 102.02 1.99 Allowed Glycine 0 N--CA 1.49 2.243 0 CA-C-N 114.125 -1.398 . . . . 0.0 111.797 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 17.7 m -78.54 98.38 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 N-CA-C 106.258 -1.756 . . . . 0.0 106.258 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.9 m -79.93 176.29 3.92 Favored Pre-proline 0 N--CA 1.495 1.779 0 CA-C-N 113.218 -1.81 . . . . 0.0 108.26 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -70.35 2.69 3.62 Favored 'Trans proline' 0 N--CA 1.495 1.583 0 C-N-CA 122.219 1.946 . . . . 0.0 112.3 173.05 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.421 ' C ' ' H ' ' A' ' 54' ' ' GLU . 12.2 mmm180 -88.28 4.47 45.81 Favored 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 -179.864 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 12.5 t 74.38 -26.62 0.19 Allowed 'General case' 0 N--CA 1.508 2.459 0 O-C-N 124.206 0.941 . . . . 0.0 112.033 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.421 ' H ' ' C ' ' A' ' 52' ' ' ARG . 6.3 mp0 55.72 80.16 0.15 Allowed 'General case' 0 N--CA 1.497 1.913 0 CA-C-O 121.746 0.784 . . . . 0.0 111.844 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -102.36 109.5 21.17 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 105.892 -1.892 . . . . 0.0 105.892 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.433 ' N ' ' HD3' ' A' ' 56' ' ' LYS . 0.1 OUTLIER -156.66 151.97 26.53 Favored 'General case' 0 N--CA 1.494 1.759 0 CA-C-N 115.463 -0.789 . . . . 0.0 112.377 -179.759 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -164.16 81.33 0.41 Allowed 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 103.896 -2.631 . . . . 0.0 103.896 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 -118.62 89.41 3.12 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-N 114.015 -1.448 . . . . 0.0 108.769 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -163.92 57.35 0.16 Allowed 'General case' 0 N--CA 1.495 1.785 0 CA-C-N 114.127 -1.397 . . . . 0.0 109.287 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? -146.09 -40.3 0.22 Allowed 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.478 HD13 ' H ' ' A' ' 63' ' ' THR . 0.0 OUTLIER -48.91 110.87 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.838 -179.977 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 1.7 m -130.68 30.9 4.6 Favored 'General case' 0 N--CA 1.487 1.411 0 CA-C-O 123.336 1.541 . . . . 0.0 115.076 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.478 ' H ' HD13 ' A' ' 61' ' ' ILE . 60.2 m -91.38 118.38 30.48 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-N 111.756 -2.474 . . . . 0.0 104.87 179.57 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.522 ' ND2' ' H ' ' A' ' 67' ' ' ALA . 20.8 p-10 -140.46 161.02 38.71 Favored 'General case' 0 N--CA 1.502 2.158 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 1.4 t -65.53 -36.69 84.57 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-N 113.539 -1.664 . . . . 0.0 115.296 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 51.0 t -75.35 -64.48 1.05 Allowed 'General case' 0 N--CA 1.497 1.913 0 O-C-N 123.775 0.672 . . . . 0.0 110.669 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.522 ' H ' ' ND2' ' A' ' 64' ' ' ASN . . . -90.13 52.41 2.26 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -88.53 -138.65 6.4 Favored Glycine 0 N--CA 1.493 2.449 0 CA-C-N 114.256 -1.338 . . . . 0.0 112.205 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 94.8 m -140.91 105.75 4.94 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 124.48 0.753 . . . . 0.0 110.758 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 10.9 tptm -56.02 104.19 0.13 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 124.208 0.943 . . . . 0.0 108.613 179.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 140.32 -1.78 2.2 Favored Glycine 0 N--CA 1.492 2.401 0 CA-C-N 114.517 -1.22 . . . . 0.0 110.82 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 91.9 m -141.44 146.95 37.15 Favored 'General case' 0 N--CA 1.498 1.934 0 CA-C-N 117.074 0.437 . . . . 0.0 111.282 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.478 ' HB3' ' CE1' ' A' ' 81' ' ' PHE . 8.0 mtpm? -89.33 90.39 8.31 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-N 114.875 -1.057 . . . . 0.0 111.89 -179.683 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -53.96 120.96 7.06 Favored 'General case' 0 N--CA 1.5 2.052 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -124.38 160.71 27.54 Favored 'General case' 0 N--CA 1.493 1.701 0 CA-C-N 113.184 -1.825 . . . . 0.0 113.731 -179.383 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 29.8 t -104.06 131.89 50.86 Favored 'General case' 0 N--CA 1.498 1.93 0 CA-C-N 113.834 -1.53 . . . . 0.0 112.597 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -46.24 -29.83 1.76 Allowed 'General case' 0 N--CA 1.502 2.17 0 N-CA-C 116.117 1.895 . . . . 0.0 116.117 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -51.82 -24.41 6.05 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 123.955 0.784 . . . . 0.0 111.818 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 113.7 26.95 3.71 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 108.851 -1.7 . . . . 0.0 108.851 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 86.3 m -138.67 139.49 38.49 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 124.005 0.473 . . . . 0.0 110.875 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . 0.478 ' CE1' ' HB3' ' A' ' 73' ' ' LYS . 13.0 t80 -71.97 150.76 43.8 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-N 114.312 -1.313 . . . . 0.0 109.648 179.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 97.2 t -110.1 -78.89 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -159.36 175.21 13.63 Favored 'General case' 0 N--CA 1.501 2.099 0 C-N-CA 120.675 -0.41 . . . . 0.0 110.022 179.818 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -92.72 141.23 28.69 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -45.6 105.59 0.09 OUTLIER Glycine 0 N--CA 1.5 2.956 0 O-C-N 124.166 0.916 . . . . 0.0 111.557 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -79.47 7.15 8.61 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-N 114.526 -0.837 . . . . 0.0 112.456 -179.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 46.9 t -132.93 119.65 20.42 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -79.23 143.92 61.53 Favored Pre-proline 0 N--CA 1.495 1.777 0 O-C-N 124.105 0.878 . . . . 0.0 108.675 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -70.15 64.18 2.03 Favored 'Trans proline' 0 N--CA 1.5 1.903 0 C-N-CA 123.614 2.876 . . . . 0.0 112.402 176.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 53.5 mmm-85 -158.68 -44.42 0.06 Allowed 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 105.616 -1.994 . . . . 0.0 105.616 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -90.78 121.69 67.83 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 124.274 0.984 . . . . 0.0 109.664 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -80.27 50.14 3.44 Favored 'Trans proline' 0 N--CA 1.495 1.604 0 C-N-CA 123.427 2.751 . . . . 0.0 111.686 174.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -82.21 124.72 30.16 Favored 'General case' 0 N--CA 1.496 1.874 0 C-N-CA 120.346 -0.542 . . . . 0.0 111.057 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -87.38 -176.97 5.82 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-N 114.357 -1.292 . . . . 0.0 109.803 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 77.6 m -153.94 158.68 32.51 Favored Pre-proline 0 N--CA 1.496 1.868 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.939 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -70.2 -25.72 26.26 Favored 'Trans proline' 0 N--CA 1.491 1.34 0 C-N-CA 122.069 1.846 . . . . 0.0 108.239 159.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 5.2 mmp_? -83.5 5.04 25.34 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-N 114.324 -1.307 . . . . 0.0 112.319 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -50.27 136.15 20.36 Favored 'General case' 0 N--CA 1.503 2.224 0 C-N-CA 120.499 -0.48 . . . . 0.0 110.927 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 59.8 m 61.96 114.5 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.773 0 O-C-N 125.309 1.63 . . . . 0.0 111.58 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -125.6 97.29 36.67 Favored Pre-proline 0 N--CA 1.499 2.008 0 N-CA-C 113.21 0.819 . . . . 0.0 113.21 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -48.63 -32.49 21.54 Favored 'Trans proline' 0 N--CA 1.495 1.585 0 C-N-CA 123.189 2.593 . . . . 0.0 112.425 174.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 31.1 ttp-105 -61.02 -50.04 74.98 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 106.46 -1.681 . . . . 0.0 106.46 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 4.0 mt -67.91 155.89 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 179.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -141.77 -34.5 0.47 Allowed 'General case' 0 N--CA 1.49 1.57 0 CA-C-N 113.484 -1.689 . . . . 0.0 111.334 -179.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 51.7 m-85 -139.65 -164.3 1.66 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 124.255 0.972 . . . . 0.0 111.149 -179.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -153.33 104.14 0.25 Allowed Glycine 0 N--CA 1.488 2.131 0 N-CA-C 105.983 -2.847 . . . . 0.0 105.983 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 51.2 mm -79.21 93.53 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 -179.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 8.0 m -79.44 149.17 71.6 Favored Pre-proline 0 N--CA 1.493 1.718 0 CA-C-N 113.718 -1.583 . . . . 0.0 108.923 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -64.73 104.87 0.59 Allowed 'Trans proline' 0 N--CA 1.494 1.507 0 C-N-CA 122.496 2.131 . . . . 0.0 110.253 -175.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 64.6 tp -79.91 -46.58 16.52 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-N 114.963 -1.017 . . . . 0.0 109.778 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.502 2.138 0 CA-C-O 117.005 -1.474 . . . . 0.0 113.279 -179.969 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 13.2 t70 . . . . . 0 N--CA 1.489 1.514 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 41.6 ttm180 57.95 85.9 0.08 Allowed 'General case' 0 N--CA 1.496 1.861 0 O-C-N 124.793 1.308 . . . . 0.0 109.086 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 8.5 tp -83.67 54.53 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 CA-C-N 114.449 -1.25 . . . . 0.0 109.912 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 42.7 m -87.52 54.66 3.21 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-O 122.479 1.133 . . . . 0.0 112.808 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 17.2 p -89.49 170.8 10.2 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-N 113.128 -1.851 . . . . 0.0 108.809 179.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 18.4 p-10 -162.55 135.76 5.97 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 124.24 0.963 . . . . 0.0 113.548 179.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -59.11 -31.56 69.03 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-N 114.563 -1.199 . . . . 0.0 113.884 179.716 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 48.4 t -68.76 -59.42 3.11 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-N 114.808 -1.087 . . . . 0.0 112.386 -179.584 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -74.5 -96.23 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.863 0 C-N-CA 118.714 -1.194 . . . . 0.0 110.052 -179.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 52.27 -126.57 31.06 Favored Glycine 0 N--CA 1.488 2.105 0 O-C-N 123.567 0.542 . . . . 0.0 112.042 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 92.5 m -152.18 119.21 5.83 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 22.5 ttmm -68.54 91.64 0.42 Allowed 'General case' 0 N--CA 1.494 1.766 0 CA-C-O 122.283 1.039 . . . . 0.0 109.048 179.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 163.59 -34.19 0.29 Allowed Glycine 0 N--CA 1.488 2.163 0 CA-C-N 112.9 -1.954 . . . . 0.0 109.007 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 50.5 m -105.16 130.55 53.3 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-O 121.528 0.68 . . . . 0.0 109.229 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.467 ' HB3' ' CE1' ' A' ' 23' ' ' PHE . 57.5 mtpt -78.36 91.22 4.43 Favored 'General case' 0 N--CA 1.485 1.319 0 CA-C-N 113.171 -1.832 . . . . 0.0 112.55 -179.54 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.414 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 75.5 m-85 -58.87 121.22 10.6 Favored 'General case' 0 N--CA 1.501 2.113 0 N-CA-C 105.784 -1.932 . . . . 0.0 105.784 179.759 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -128.71 147.51 50.76 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 110.664 -2.971 . . . . 0.0 112.933 -179.218 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 40.1 t -83.44 136.32 34.35 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-N 111.83 -2.441 . . . . 0.0 112.895 -179.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -52.18 -30.25 26.05 Favored 'General case' 0 N--CA 1.498 1.958 0 CA-C-N 112.481 -2.145 . . . . 0.0 113.833 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 44.3 p-10 -58.06 -14.16 6.15 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 124.013 0.821 . . . . 0.0 112.268 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 99.97 35.22 4.61 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 108.464 -1.855 . . . . 0.0 108.464 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 55.9 m -136.29 132.49 35.79 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 124.025 0.485 . . . . 0.0 110.241 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.467 ' CE1' ' HB3' ' A' ' 15' ' ' LYS . 8.1 t80 -74.78 141.52 44.37 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 179.671 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 41.0 t -102.53 -79.53 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 N-CA-C 105.666 -1.976 . . . . 0.0 105.666 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -169.0 166.21 11.13 Favored 'General case' 0 N--CA 1.501 2.117 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 179.594 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.412 ' HG2' ' N ' ' A' ' 27' ' ' GLY . 36.8 tt0 -82.13 161.51 22.81 Favored 'General case' 0 N--CA 1.503 2.223 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 179.789 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.412 ' N ' ' HG2' ' A' ' 26' ' ' GLU . . . -61.13 120.39 22.59 Favored Glycine 0 N--CA 1.496 2.657 0 N-CA-C 107.52 -2.232 . . . . 0.0 107.52 179.7 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -86.18 21.33 2.05 Favored 'General case' 0 N--CA 1.499 1.999 0 C-N-CA 119.295 -0.962 . . . . 0.0 110.379 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 35.3 t -139.22 112.57 8.21 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-N 114.801 -1.09 . . . . 0.0 108.537 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -81.01 142.71 52.09 Favored Pre-proline 0 N--CA 1.493 1.721 0 CA-C-N 114.246 -1.343 . . . . 0.0 107.706 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -69.75 68.71 1.68 Allowed 'Trans proline' 0 N--CA 1.499 1.852 0 C-N-CA 122.993 2.462 . . . . 0.0 111.844 176.387 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 35.3 mmt180 -160.65 -39.37 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 CA-C-N 113.546 -1.661 . . . . 0.0 107.416 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 24.7 p30 -71.28 151.94 94.36 Favored Pre-proline 0 N--CA 1.498 1.974 0 C-N-CA 119.902 -0.719 . . . . 0.0 111.253 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo -69.44 167.77 23.06 Favored 'Trans proline' 0 N--CA 1.494 1.514 0 C-N-CA 122.745 2.297 . . . . 0.0 111.7 179.227 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 22.4 ptmt 39.44 -163.81 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.252 0 N-CA-C 115.682 1.734 . . . . 0.0 115.682 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -139.34 179.72 6.37 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-N 115.043 -0.98 . . . . 0.0 109.984 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 87.0 m -79.8 179.51 7.5 Favored 'General case' 0 N--CA 1.497 1.897 0 CA-C-N 114.959 -1.019 . . . . 0.0 112.98 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 69.8 p -130.85 31.82 4.43 Favored 'General case' 0 N--CA 1.495 1.822 0 CA-C-N 113.671 -1.604 . . . . 0.0 108.751 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 39.9 tp -79.86 -1.28 38.36 Favored 'General case' 0 N--CA 1.499 2.01 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.412 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 29.7 m-80 57.56 -174.84 0.07 Allowed 'General case' 0 N--CA 1.499 2.009 0 N-CA-C 114.181 1.178 . . . . 0.0 114.181 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 81.7 m -60.82 134.5 57.15 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-N 114.262 -1.335 . . . . 0.0 111.271 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -128.44 83.79 65.11 Favored Pre-proline 0 N--CA 1.498 1.941 0 O-C-N 123.885 0.74 . . . . 0.0 109.517 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -52.34 -24.44 21.26 Favored 'Trans proline' 0 N--CA 1.495 1.576 0 C-N-CA 122.867 2.378 . . . . 0.0 112.178 176.034 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 28.0 ttt85 -60.73 -50.92 71.55 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 17.6 mt -65.5 153.65 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 CA-C-O 122.066 0.936 . . . . 0.0 109.782 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -124.14 -59.61 1.48 Allowed 'General case' 0 N--CA 1.491 1.589 0 CA-C-N 111.957 -2.383 . . . . 0.0 109.218 -179.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 16.2 p90 -162.64 156.78 21.05 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 124.14 0.9 . . . . 0.0 112.189 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.414 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -88.84 103.7 3.0 Favored Glycine 0 N--CA 1.492 2.389 0 CA-C-N 112.816 -1.993 . . . . 0.0 113.235 -179.821 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 34.2 m -81.25 99.07 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.185 0 CA-C-O 121.531 0.681 . . . . 0.0 109.985 179.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.6 m -79.16 125.89 82.69 Favored Pre-proline 0 N--CA 1.503 2.206 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.233 179.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -70.52 -60.61 0.06 OUTLIER 'Trans proline' 0 N--CA 1.492 1.397 0 C-N-CA 122.32 2.013 . . . . 0.0 108.516 171.106 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.16 108.52 1.69 Allowed 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 106.521 -1.659 . . . . 0.0 106.521 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 33.7 t -162.0 157.87 24.25 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 123.702 0.626 . . . . 0.0 110.586 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.9 tm-20 66.76 138.14 0.03 OUTLIER 'General case' 0 N--CA 1.504 2.266 0 O-C-N 124.873 1.358 . . . . 0.0 111.345 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -149.54 119.23 7.01 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-N 114.65 -1.159 . . . . 0.0 108.041 179.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.421 ' HZ2' HH21 ' A' ' 60' ' ' ARG . 35.4 mmtp 58.09 89.99 0.05 OUTLIER 'General case' 0 N--CA 1.501 2.102 0 O-C-N 124.44 1.087 . . . . 0.0 112.232 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.73 -36.57 11.67 Favored 'General case' 0 N--CA 1.499 2.02 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.889 179.806 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 25.8 m120 -148.3 84.95 1.51 Allowed 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -153.9 -65.23 0.14 Allowed 'General case' 0 N--CA 1.494 1.758 0 CA-C-N 114.208 -1.36 . . . . 0.0 108.117 -179.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.421 HH21 ' HZ2' ' A' ' 56' ' ' LYS . 17.2 ptp180 -86.22 33.11 0.61 Allowed 'General case' 0 N--CA 1.494 1.725 0 CA-C-N 114.047 -1.433 . . . . 0.0 110.554 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 10.6 tp -85.29 41.46 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 CA-C-O 122.059 0.933 . . . . 0.0 110.586 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 3.6 m -87.95 56.93 4.07 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-O 123.145 1.45 . . . . 0.0 109.88 179.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 25.5 p -90.07 177.42 6.46 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-N 112.038 -2.347 . . . . 0.0 110.333 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.423 ' ND2' ' H ' ' A' ' 67' ' ' ALA . 46.8 p-10 -161.46 -177.11 5.74 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-N 113.797 -1.547 . . . . 0.0 111.143 179.808 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' CYS . . . . . 0.416 ' SG ' ' CD2' ' A' ' 74' ' ' TYR . 11.1 t -91.51 -20.23 21.94 Favored 'General case' 0 N--CA 1.497 1.923 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.026 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 13.4 t -82.62 -61.78 1.79 Allowed 'General case' 0 N--CA 1.491 1.593 0 CA-C-N 113.731 -1.577 . . . . 0.0 112.731 -179.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.423 ' H ' ' ND2' ' A' ' 64' ' ' ASN . . . -90.35 60.85 4.84 Favored 'General case' 0 N--CA 1.499 1.996 0 CA-C-O 121.588 0.708 . . . . 0.0 112.205 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.406 ' H ' ' HB2' ' A' ' 87' ' ' SER . . . -126.18 -104.68 1.41 Allowed Glycine 0 N--CA 1.498 2.813 0 N-CA-C 108.812 -1.715 . . . . 0.0 108.812 179.755 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 3.4 t -155.65 111.45 3.06 Favored 'General case' 0 N--CA 1.502 2.13 0 N-CA-C 114.074 1.139 . . . . 0.0 114.074 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -65.93 103.59 0.96 Allowed 'General case' 0 N--CA 1.498 1.95 0 CA-C-N 114.331 -1.304 . . . . 0.0 107.679 179.66 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 143.09 -3.18 1.69 Allowed Glycine 0 N--CA 1.49 2.299 0 CA-C-N 114.384 -1.28 . . . . 0.0 110.927 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 72.8 m -124.0 155.14 38.77 Favored 'General case' 0 N--CA 1.499 1.982 0 C-N-CA 120.476 -0.489 . . . . 0.0 109.829 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.0 95.27 6.25 Favored 'General case' 0 N--CA 1.488 1.47 0 CA-C-N 115.036 -0.984 . . . . 0.0 108.644 -179.759 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.654 ' CD2' ' SG ' ' A' ' 83' ' ' CYS . 89.8 m-85 -44.78 137.61 3.9 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 124.694 1.246 . . . . 0.0 109.882 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 21.6 t80 -141.83 159.12 42.87 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 124.834 1.334 . . . . 0.0 110.844 -179.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 30.8 t -121.24 143.4 49.17 Favored 'General case' 0 N--CA 1.495 1.822 0 CA-C-N 112.748 -2.023 . . . . 0.0 116.089 -179.41 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.428 ' C ' ' H ' ' A' ' 79' ' ' GLY . 0.9 OUTLIER -48.91 -23.98 1.31 Allowed 'General case' 0 N--CA 1.498 1.952 0 CA-C-N 110.507 -3.042 . . . . 0.0 113.184 179.872 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 16.3 p30 -64.74 -0.67 1.54 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 124.223 0.952 . . . . 0.0 111.184 179.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.428 ' H ' ' C ' ' A' ' 77' ' ' ASP . . . 82.25 29.22 37.81 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 96.7 m -144.44 153.15 41.61 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 121.425 0.631 . . . . 0.0 111.903 -179.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -64.21 165.2 9.72 Favored 'General case' 0 N--CA 1.497 1.875 0 CA-C-N 113.466 -1.697 . . . . 0.0 110.565 179.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 89.4 t -128.28 -67.74 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 124.061 0.851 . . . . 0.0 112.07 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . 0.654 ' SG ' ' CD2' ' A' ' 74' ' ' TYR . 31.3 p -162.54 -178.07 6.01 Favored 'General case' 0 N--CA 1.503 2.178 0 C-N-CA 120.253 -0.579 . . . . 0.0 110.794 -179.636 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -96.49 158.02 15.63 Favored 'General case' 0 N--CA 1.505 2.306 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.16 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.473 ' HA2' ' CE2' ' A' ' 74' ' ' TYR . . . -58.73 106.05 0.79 Allowed Glycine 0 N--CA 1.498 2.778 0 CA-C-O 118.894 -0.948 . . . . 0.0 111.501 179.756 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 30.1 mm-40 -113.01 37.9 2.99 Favored 'General case' 0 N--CA 1.505 2.283 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 179.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.406 ' HB2' ' H ' ' A' ' 68' ' ' GLY . 9.0 t -115.45 63.31 0.69 Allowed 'General case' 0 N--CA 1.493 1.722 0 CA-C-N 114.267 -1.333 . . . . 0.0 109.491 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -81.57 114.57 50.84 Favored Pre-proline 0 N--CA 1.492 1.627 0 CA-C-N 114.08 -1.418 . . . . 0.0 110.355 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -66.1 -16.89 53.85 Favored 'Trans proline' 0 N--CA 1.492 1.419 0 C-N-CA 122.136 1.891 . . . . 0.0 111.361 -174.599 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 52.7 tpt85 -73.13 -31.07 64.06 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 123.812 0.695 . . . . 0.0 112.203 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -84.4 131.68 49.57 Favored Pre-proline 0 N--CA 1.497 1.9 0 C-N-CA 118.546 -1.262 . . . . 0.0 110.808 -179.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -80.96 71.22 7.18 Favored 'Trans proline' 0 N--CA 1.49 1.287 0 C-N-CA 123.114 2.543 . . . . 0.0 108.325 162.306 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 58.4 tptt -149.87 154.07 37.76 Favored 'General case' 0 N--CA 1.497 1.889 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.607 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -131.32 -172.92 2.97 Favored 'General case' 0 N--CA 1.498 1.957 0 CA-C-N 113.925 -1.488 . . . . 0.0 109.487 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 3.7 m -149.42 150.93 32.5 Favored Pre-proline 0 N--CA 1.5 2.072 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -75.8 98.23 1.17 Allowed 'Trans proline' 0 N--CA 1.493 1.443 0 C-N-CA 122.711 2.274 . . . . 0.0 110.039 172.158 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 -146.73 57.07 1.16 Allowed 'General case' 0 N--CA 1.499 2.018 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -55.35 96.85 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.844 0 CA-C-N 113.446 -1.706 . . . . 0.0 114.618 -179.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 78.6 m 55.01 130.01 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.156 0 N-CA-C 117.331 2.345 . . . . 0.0 117.331 179.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 63.8 t0 -127.79 77.34 76.42 Favored Pre-proline 0 N--CA 1.502 2.142 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.78 179.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -63.07 -24.89 73.41 Favored 'Trans proline' 0 N--CA 1.493 1.442 0 C-N-CA 122.604 2.202 . . . . 0.0 111.611 173.52 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -67.69 -19.8 65.22 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 123.96 0.787 . . . . 0.0 112.105 -179.824 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 10.5 tt -79.61 169.65 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.115 0 C-N-CA 119.133 -1.027 . . . . 0.0 110.241 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -130.99 -55.15 1.05 Allowed 'General case' 0 N--CA 1.495 1.784 0 CA-C-N 114.883 -1.053 . . . . 0.0 108.833 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 27.7 p90 -171.59 168.3 6.37 Favored 'General case' 0 N--CA 1.497 1.904 0 CA-C-N 114.842 -1.072 . . . . 0.0 110.008 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -105.6 121.96 7.0 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 109.716 -1.353 . . . . 0.0 109.716 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 87.2 mt -79.4 94.05 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 14.6 m -79.66 156.16 75.53 Favored Pre-proline 0 N--CA 1.493 1.69 0 CA-C-N 114.117 -1.401 . . . . 0.0 107.38 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -51.36 -46.29 32.26 Favored 'Trans proline' 0 N--CA 1.495 1.593 0 C-N-CA 122.631 2.22 . . . . 0.0 111.532 -175.293 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.422 ' H ' HD21 ' A' ' 110' ' ' LEU . 2.0 pt? -79.55 -27.67 41.24 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-N 114.935 -1.03 . . . . 0.0 111.199 179.844 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 1.908 0 CA-C-O 116.877 -1.535 . . . . 0.0 110.837 -179.987 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 50.7 t0 . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.457 ' HA ' ' NE ' ' A' ' 2' ' ' ARG . 14.5 mmp_? -77.2 133.39 38.93 Favored 'General case' 0 N--CA 1.498 1.933 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.5 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.3 tp -69.58 84.87 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 CA-C-N 114.835 -1.075 . . . . 0.0 111.552 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 14.8 m -92.2 51.02 1.72 Allowed 'General case' 0 N--CA 1.491 1.619 0 CA-C-N 114.195 -1.366 . . . . 0.0 111.521 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.408 ' HG1' ' H ' ' A' ' 6' ' ' ASN . 15.1 t -90.71 -173.67 3.81 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-N 113.229 -1.805 . . . . 0.0 108.862 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.408 ' H ' ' HG1' ' A' ' 5' ' ' THR . 24.1 p30 -160.22 -175.15 4.89 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 124.742 1.276 . . . . 0.0 108.285 179.696 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.6 t -118.26 -33.35 4.4 Favored 'General case' 0 N--CA 1.499 1.978 0 C-N-CA 119.772 -0.771 . . . . 0.0 110.332 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 25.1 t -62.54 -60.39 3.6 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-N 114.704 -1.135 . . . . 0.0 108.64 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.412 ' HB3' ' SG ' ' A' ' 37' ' ' CYS . . . -90.28 19.82 4.86 Favored 'General case' 0 N--CA 1.498 1.97 0 CA-C-N 113.83 -1.532 . . . . 0.0 109.561 179.785 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -75.19 -151.0 2.67 Favored Glycine 0 N--CA 1.493 2.48 0 CA-C-N 115.445 -0.798 . . . . 0.0 112.472 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 40.1 p -126.98 100.08 5.99 Favored 'General case' 0 N--CA 1.498 1.925 0 CA-C-N 114.709 -0.746 . . . . 0.0 109.299 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -52.12 147.79 7.05 Favored 'General case' 0 N--CA 1.5 2.035 0 CA-C-N 115.787 -0.642 . . . . 0.0 112.249 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 98.92 -33.51 6.06 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 107.88 -2.088 . . . . 0.0 107.88 -179.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 55.3 m -91.39 114.18 26.64 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 10.4 mtmp? -68.72 88.31 0.36 Allowed 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 111.762 -2.472 . . . . 0.0 111.718 -179.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.498 ' HB2' ' SG ' ' A' ' 25' ' ' CYS . 31.6 m-85 -53.01 119.76 5.05 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 105.361 -2.088 . . . . 0.0 105.361 179.456 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -135.16 153.66 51.9 Favored 'General case' 0 C--N 1.296 -1.723 0 CA-C-N 111.876 -2.42 . . . . 0.0 113.347 -179.036 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 41.9 t -92.17 133.33 35.89 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-N 112.838 -1.983 . . . . 0.0 109.389 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.455 ' H ' ' HB2' ' A' ' 46' ' ' ALA . 5.8 p-10 -51.97 -24.01 5.89 Favored 'General case' 0 N--CA 1.498 1.96 0 CA-C-N 113.363 -1.744 . . . . 0.0 114.21 -179.797 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 32.6 p30 -58.99 -10.47 2.55 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 124.197 0.935 . . . . 0.0 112.365 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 99.68 29.39 6.99 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 87.1 m -140.06 138.08 35.08 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 124.026 0.486 . . . . 0.0 110.622 -179.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.403 ' CG ' ' N ' ' A' ' 24' ' ' VAL . 49.1 t80 -70.55 162.0 29.63 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 124.443 1.09 . . . . 0.0 110.46 179.743 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.403 ' N ' ' CG ' ' A' ' 23' ' ' PHE . 61.0 t -129.48 -72.93 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 124.198 0.936 . . . . 0.0 110.978 -179.825 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.498 ' SG ' ' HB2' ' A' ' 16' ' ' TYR . 14.8 p -149.82 -169.62 3.43 Favored 'General case' 0 N--CA 1.504 2.241 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -137.51 147.22 45.03 Favored 'General case' 0 N--CA 1.502 2.128 0 N-CA-C 105.652 -1.981 . . . . 0.0 105.652 179.251 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -50.55 157.92 2.04 Favored Glycine 0 N--CA 1.5 2.915 0 C-N-CA 120.371 -0.918 . . . . 0.0 115.01 -179.577 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -121.11 -33.25 3.75 Favored 'General case' 0 N--CA 1.496 1.851 0 CA-C-N 113.603 -1.298 . . . . 0.0 110.807 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 32.4 m -95.12 131.48 41.09 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 123.595 0.559 . . . . 0.0 111.273 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.481 ' H ' HD22 ' A' ' 33' ' ' ASN . 16.4 t70 -81.33 143.96 52.92 Favored Pre-proline 0 N--CA 1.493 1.715 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_endo -61.77 73.91 0.09 OUTLIER 'Trans proline' 0 N--CA 1.499 1.838 0 C-N-CA 122.904 2.402 . . . . 0.0 112.111 172.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 36.2 mmt180 -162.72 -47.9 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.734 0 CA-C-N 113.387 -1.733 . . . . 0.0 106.802 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.481 HD22 ' H ' ' A' ' 30' ' ' ASP . 6.5 p30 -90.44 119.44 69.13 Favored Pre-proline 0 N--CA 1.494 1.762 0 O-C-N 124.234 0.959 . . . . 0.0 110.816 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -81.02 49.98 3.42 Favored 'Trans proline' 0 N--CA 1.494 1.534 0 C-N-CA 123.419 2.746 . . . . 0.0 111.298 174.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 6.4 mmpt? -74.65 124.5 26.82 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -99.14 96.1 7.55 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-N 114.744 -1.117 . . . . 0.0 110.754 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.412 ' SG ' ' HB3' ' A' ' 9' ' ' ALA . 78.0 m -79.71 -39.82 30.31 Favored 'General case' 0 N--CA 1.497 1.917 0 CA-C-N 114.709 -1.132 . . . . 0.0 108.678 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 63.0 m 59.71 80.45 0.2 Allowed 'General case' 0 N--CA 1.496 1.853 0 CA-C-N 114.049 -1.432 . . . . 0.0 111.295 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 32.4 tp -84.2 7.79 17.86 Favored 'General case' 0 N--CA 1.499 2.006 0 CA-C-N 114.696 -1.138 . . . . 0.0 108.911 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 13.2 m120 55.52 56.2 6.51 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.453 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 80.8 m 61.42 132.93 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.006 0 CA-C-N 113.29 -1.777 . . . . 0.0 114.044 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -115.68 87.27 17.31 Favored Pre-proline 0 N--CA 1.497 1.908 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.447 179.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -64.52 -17.04 58.27 Favored 'Trans proline' 0 N--CA 1.492 1.421 0 C-N-CA 122.844 2.363 . . . . 0.0 111.568 170.058 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.27 -10.4 58.82 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 123.688 0.618 . . . . 0.0 109.992 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.411 ' CG2' ' N ' ' A' ' 46' ' ' ALA . 46.2 mt -119.9 159.98 20.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 CA-C-O 122.14 0.972 . . . . 0.0 110.66 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.455 ' HB2' ' H ' ' A' ' 19' ' ' ASP . . . -119.6 -55.26 2.12 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-N 111.695 -2.502 . . . . 0.0 108.182 179.755 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 5.8 p90 -167.21 153.55 8.12 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 124.129 0.893 . . . . 0.0 112.644 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -81.99 102.39 2.26 Favored Glycine 0 N--CA 1.492 2.428 0 CA-C-N 112.884 -1.962 . . . . 0.0 112.659 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 47.4 t -79.6 90.28 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 124.051 0.5 . . . . 0.0 112.18 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.5 m -79.33 120.38 80.28 Favored Pre-proline 0 N--CA 1.504 2.229 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 179.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -71.1 -60.13 0.06 OUTLIER 'Trans proline' 0 N--CA 1.492 1.405 0 C-N-CA 122.534 2.156 . . . . 0.0 109.735 -173.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -80.17 128.72 33.85 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-N 114.482 -1.236 . . . . 0.0 109.577 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 82.0 p 44.96 -158.78 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.182 0 O-C-N 125.034 1.459 . . . . 0.0 113.194 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -70.59 -50.95 31.82 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 109.165 -0.679 . . . . 0.0 109.165 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 179.3 -173.23 0.18 Allowed 'General case' 0 N--CA 1.502 2.154 0 O-C-N 124.485 1.116 . . . . 0.0 109.587 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.453 ' HZ1' ' H ' ' A' ' 57' ' ' LYS . 0.0 OUTLIER -62.41 133.53 55.17 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 105.963 -1.866 . . . . 0.0 105.963 179.462 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.453 ' H ' ' HZ1' ' A' ' 56' ' ' LYS . 5.9 ptpp? 38.7 47.79 1.21 Allowed 'General case' 0 N--CA 1.504 2.227 0 O-C-N 124.874 1.359 . . . . 0.0 110.982 -179.78 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.417 ' C ' ' H ' ' A' ' 60' ' ' ARG . 10.5 m-80 -6.82 127.07 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.142 0 CA-C-N 111.16 -2.745 . . . . 0.0 117.273 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -77.92 28.97 0.17 Allowed 'General case' 0 N--CA 1.499 2.013 0 CA-C-N 114.808 -1.087 . . . . 0.0 111.627 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.417 ' H ' ' C ' ' A' ' 58' ' ' ASN . 2.0 mpt_? 68.49 137.97 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.098 0 C-N-CA 123.929 0.892 . . . . 0.0 109.806 -179.739 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 7.2 tp -39.61 94.97 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 O-C-N 124.811 1.319 . . . . 0.0 113.49 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . 0.407 ' HA ' ' HA ' ' A' ' 99' ' ' CYS . 6.8 m -99.88 34.7 2.21 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 123.349 1.547 . . . . 0.0 113.037 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 95.1 m -91.08 138.42 31.62 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-N 111.584 -2.553 . . . . 0.0 106.777 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.465 ' ND2' ' H ' ' A' ' 67' ' ' ALA . 28.4 p-10 -160.74 151.04 17.93 Favored 'General case' 0 N--CA 1.499 2.01 0 C-N-CA 120.011 -0.676 . . . . 0.0 111.286 179.76 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' CYS . . . . . 0.406 ' SG ' ' NH1' ' A' ' 97' ' ' ARG . 0.7 OUTLIER -60.05 -28.78 68.05 Favored 'General case' 0 N--CA 1.495 1.789 0 CA-C-N 114.316 -1.311 . . . . 0.0 114.072 -179.842 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 40.1 t -79.78 -69.05 0.61 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 124.168 0.918 . . . . 0.0 111.81 -179.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.465 ' H ' ' ND2' ' A' ' 64' ' ' ASN . . . -88.37 45.26 1.27 Allowed 'General case' 0 N--CA 1.497 1.898 0 O-C-N 124.848 1.342 . . . . 0.0 109.812 -179.806 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -85.58 -143.55 6.87 Favored Glycine 0 N--CA 1.489 2.201 0 CA-C-N 114.365 -1.288 . . . . 0.0 111.264 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 35.5 p -139.85 116.21 10.6 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 114.826 -0.687 . . . . 0.0 110.523 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -60.69 97.07 0.05 OUTLIER 'General case' 0 N--CA 1.5 2.048 0 O-C-N 124.135 0.897 . . . . 0.0 109.619 179.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 158.21 -17.91 0.31 Allowed Glycine 0 N--CA 1.494 2.558 0 CA-C-N 114.52 -1.218 . . . . 0.0 110.872 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 91.2 m -125.39 155.44 40.36 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 124.015 0.479 . . . . 0.0 110.373 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -103.1 94.3 5.47 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 124.192 0.933 . . . . 0.0 109.763 -179.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -51.02 128.77 22.35 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-N 113.647 -1.615 . . . . 0.0 109.333 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.429 ' CD1' ' C ' ' A' ' 75' ' ' PHE . 0.2 OUTLIER -134.6 153.88 51.76 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-N 113.606 -1.634 . . . . 0.0 113.678 -179.335 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 31.6 t -112.74 129.6 56.36 Favored 'General case' 0 N--CA 1.498 1.964 0 CA-C-N 112.98 -1.918 . . . . 0.0 112.359 -179.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -61.88 -50.03 73.85 Favored 'General case' 0 N--CA 1.499 1.993 0 CA-C-N 114.622 -1.172 . . . . 0.0 109.546 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -90.81 18.24 6.77 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 112.825 -1.989 . . . . 0.0 111.641 -179.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -163.47 25.34 0.2 Allowed Glycine 0 N--CA 1.495 2.628 0 C-N-CA 118.915 -1.612 . . . . 0.0 113.141 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.414 ' HA ' ' CE2' ' A' ' 75' ' ' PHE . 6.7 t 42.48 -163.56 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.794 0 O-C-N 124.998 1.057 . . . . 0.0 113.22 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . 0.409 ' H ' ' HG1' ' A' ' 80' ' ' THR . 22.8 t80 -48.28 127.94 13.55 Favored 'General case' 0 N--CA 1.497 1.889 0 CA-C-O 121.378 0.609 . . . . 0.0 111.592 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 63.5 t -94.79 -76.94 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . 0.488 ' SG ' ' N ' ' A' ' 84' ' ' GLU . 0.4 OUTLIER -168.09 -169.64 1.16 Allowed 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 179.696 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.488 ' N ' ' SG ' ' A' ' 83' ' ' CYS . 37.6 tt0 -96.01 162.01 13.74 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -72.01 107.1 2.09 Favored Glycine 0 N--CA 1.493 2.486 0 N-CA-C 105.078 -3.209 . . . . 0.0 105.078 179.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -93.13 25.06 3.44 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 -179.643 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 29.4 t -129.4 123.39 31.54 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-N 114.338 -1.301 . . . . 0.0 108.97 179.655 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.583 ' H ' HD22 ' A' ' 91' ' ' ASN . 16.4 t70 -85.56 144.61 40.42 Favored Pre-proline 0 N--CA 1.492 1.671 0 CA-C-N 114.442 -1.253 . . . . 0.0 108.126 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_endo -61.86 79.76 0.09 OUTLIER 'Trans proline' 0 N--CA 1.496 1.64 0 C-N-CA 122.574 2.183 . . . . 0.0 108.414 165.131 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 58.2 ttt85 -169.78 -52.86 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 105.515 -2.032 . . . . 0.0 105.515 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.583 HD22 ' H ' ' A' ' 88' ' ' ASP . 2.7 p30 -91.54 115.55 64.71 Favored Pre-proline 0 N--CA 1.497 1.92 0 O-C-N 124.83 1.331 . . . . 0.0 111.237 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -83.45 49.38 2.93 Favored 'Trans proline' 0 N--CA 1.495 1.571 0 C-N-CA 123.484 2.789 . . . . 0.0 109.549 170.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -106.56 152.4 23.75 Favored 'General case' 0 N--CA 1.498 1.938 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.79 -179.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -152.61 154.81 36.11 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-N 115.01 -0.996 . . . . 0.0 111.245 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 66.3 m -84.99 -179.53 1.5 Allowed Pre-proline 0 N--CA 1.498 1.94 0 CA-C-N 114.394 -1.276 . . . . 0.0 108.682 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_endo -62.98 65.94 0.15 Allowed 'Trans proline' 0 N--CA 1.494 1.525 0 C-N-CA 122.13 1.887 . . . . 0.0 110.318 148.485 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.406 ' NH1' ' SG ' ' A' ' 65' ' ' CYS . 34.6 ttm180 -160.14 26.85 0.17 Allowed 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 106.285 -1.746 . . . . 0.0 106.285 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 29.0 m120 -60.68 117.02 4.83 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-N 114.78 -1.1 . . . . 0.0 109.956 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . 0.407 ' HA ' ' HA ' ' A' ' 62' ' ' CYS . 65.0 m 54.1 86.49 0.05 OUTLIER 'General case' 0 N--CA 1.496 1.87 0 O-C-N 124.854 1.346 . . . . 0.0 110.665 -179.878 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -71.01 109.22 4.79 Favored Pre-proline 0 N--CA 1.498 1.942 0 CA-C-N 115.683 -0.689 . . . . 0.0 111.58 -179.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_endo -69.71 -38.9 7.26 Favored 'Trans proline' 0 N--CA 1.494 1.538 0 C-N-CA 122.157 1.905 . . . . 0.0 109.857 -171.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 35.2 mmt180 -71.27 -11.68 61.05 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-N 113.984 -1.462 . . . . 0.0 113.828 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 8.9 tt -73.38 178.55 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 C-N-CA 118.614 -1.234 . . . . 0.0 109.293 -179.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -134.7 -60.23 0.79 Allowed 'General case' 0 N--CA 1.494 1.741 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.788 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 15.8 p90 -168.7 166.69 11.64 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-N 114.757 -1.11 . . . . 0.0 110.366 -179.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -99.38 116.22 5.52 Favored Glycine 0 N--CA 1.49 2.265 0 CA-C-N 113.861 -1.518 . . . . 0.0 109.417 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 96.2 mt -78.65 92.86 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 N-CA-C 105.766 -1.938 . . . . 0.0 105.766 179.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 17.1 m -79.43 121.03 82.32 Favored Pre-proline 0 N--CA 1.493 1.676 0 CA-C-N 113.995 -1.457 . . . . 0.0 109.096 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -66.19 127.18 17.02 Favored 'Trans proline' 0 N--CA 1.493 1.469 0 C-N-CA 122.259 1.972 . . . . 0.0 110.359 -179.07 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -79.59 104.13 9.97 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 105.688 -1.967 . . . . 0.0 105.688 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.501 2.102 0 CA-C-O 117.568 -1.206 . . . . 0.0 112.198 -179.946 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 30.7 t70 . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 2.5 tmm_? 55.55 64.5 1.74 Allowed 'General case' 0 N--CA 1.5 2.048 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 8.3 tp -90.43 51.71 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 CA-C-N 114.257 -1.338 . . . . 0.0 110.293 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.44 ' HA ' ' HA ' ' A' ' 41' ' ' CYS . 1.6 m -82.73 41.14 0.71 Allowed 'General case' 0 N--CA 1.495 1.813 0 CA-C-O 123.056 1.408 . . . . 0.0 114.389 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 91.8 m -91.47 112.86 24.95 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-N 112.657 -2.065 . . . . 0.0 109.127 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.468 ' ND2' ' HA ' ' A' ' 40' ' ' ASN . 40.3 p-10 -115.94 176.93 4.87 Favored 'General case' 0 N--CA 1.501 2.092 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 179.545 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.457 ' SG ' ' CD2' ' A' ' 16' ' ' TYR . 1.8 t -73.08 -27.69 61.87 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 114.322 1.23 . . . . 0.0 114.322 -179.557 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.484 ' SG ' ' N ' ' A' ' 37' ' ' CYS . 53.0 t -80.14 -63.14 1.48 Allowed 'General case' 0 N--CA 1.492 1.674 0 CA-C-N 114.374 -1.285 . . . . 0.0 113.936 -179.602 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -90.22 19.38 5.11 Favored 'General case' 0 N--CA 1.502 2.16 0 N-CA-C 113.619 0.97 . . . . 0.0 113.619 -179.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -83.45 -111.57 0.54 Allowed Glycine 0 N--CA 1.499 2.852 0 C-N-CA 120.6 -0.81 . . . . 0.0 111.57 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 40.7 p -137.08 112.22 9.07 Favored 'General case' 0 N--CA 1.504 2.235 0 CA-C-O 121.073 0.463 . . . . 0.0 111.892 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 8.5 tmtt? -62.53 150.19 41.0 Favored 'General case' 0 N--CA 1.487 1.389 0 CA-C-O 121.241 0.543 . . . . 0.0 111.154 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 76.45 -10.27 17.68 Favored Glycine 0 N--CA 1.489 2.195 0 CA-C-N 114.301 -1.318 . . . . 0.0 111.806 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 69.0 m -102.52 127.73 49.46 Favored 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 119.561 -0.856 . . . . 0.0 108.901 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -70.84 92.36 0.9 Allowed 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 113.267 -1.788 . . . . 0.0 109.112 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.665 ' CD2' ' SG ' ' A' ' 25' ' ' CYS . 78.6 m-85 -44.94 131.13 7.35 Favored 'General case' 0 N--CA 1.502 2.161 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 179.753 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -144.99 150.38 36.82 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 125.139 1.524 . . . . 0.0 112.532 -179.421 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 40.5 t -96.1 134.46 39.14 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-N 111.969 -2.378 . . . . 0.0 111.828 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -51.05 -24.73 4.1 Favored 'General case' 0 N--CA 1.501 2.097 0 CA-C-N 112.941 -1.936 . . . . 0.0 113.9 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 25.7 p30 -59.59 -8.86 2.15 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 124.178 0.924 . . . . 0.0 112.361 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 97.07 28.71 8.47 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 86.5 m -140.64 143.07 34.96 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 123.998 0.47 . . . . 0.0 110.399 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.452 ' CG ' ' N ' ' A' ' 24' ' ' VAL . 39.1 t80 -69.54 167.92 15.77 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 124.802 1.314 . . . . 0.0 111.132 179.8 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.452 ' N ' ' CG ' ' A' ' 23' ' ' PHE . 98.6 t -132.51 -74.45 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 123.842 0.714 . . . . 0.0 112.885 -179.79 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.665 ' SG ' ' CD2' ' A' ' 16' ' ' TYR . 20.5 p -147.24 -175.7 4.94 Favored 'General case' 0 N--CA 1.509 2.506 0 C-N-CA 121.04 -0.264 . . . . 0.0 110.708 -179.623 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 7.4 tm-20 -103.74 143.83 32.28 Favored 'General case' 0 N--CA 1.508 2.467 0 N-CA-C 113.402 0.89 . . . . 0.0 113.402 -179.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.571 ' HA2' ' CE2' ' A' ' 16' ' ' TYR . . . -43.98 105.62 0.08 OUTLIER Glycine 0 N--CA 1.501 3.013 0 O-C-N 124.437 1.085 . . . . 0.0 115.039 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -122.63 37.22 4.45 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 17.5 t -121.82 65.97 0.91 Allowed 'General case' 0 N--CA 1.499 1.996 0 CA-C-O 121.815 0.816 . . . . 0.0 110.959 -179.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.428 ' H ' ' ND2' ' A' ' 33' ' ' ASN . 14.3 t70 -88.37 142.61 31.53 Favored Pre-proline 0 N--CA 1.493 1.72 0 CA-C-N 113.886 -1.506 . . . . 0.0 108.528 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -56.64 -4.72 0.92 Allowed 'Trans proline' 0 N--CA 1.497 1.727 0 C-N-CA 122.316 2.011 . . . . 0.0 114.568 175.163 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.424 ' HA ' ' NE ' ' A' ' 32' ' ' ARG . 12.3 mmp_? -94.48 -27.76 15.82 Favored 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 113.148 0.795 . . . . 0.0 113.148 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.428 ' ND2' ' H ' ' A' ' 30' ' ' ASP . 19.2 p30 -66.05 121.85 78.2 Favored Pre-proline 0 N--CA 1.497 1.898 0 C-N-CA 119.039 -1.064 . . . . 0.0 112.006 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -75.09 123.13 7.61 Favored 'Trans proline' 0 N--CA 1.492 1.423 0 C-N-CA 122.714 2.276 . . . . 0.0 109.963 178.086 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 62.64 160.52 0.08 Allowed 'General case' 0 N--CA 1.502 2.16 0 O-C-N 124.614 1.196 . . . . 0.0 112.954 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -79.92 -167.1 1.16 Allowed 'General case' 0 N--CA 1.496 1.841 0 CA-C-N 114.694 -1.139 . . . . 0.0 110.099 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.484 ' N ' ' SG ' ' A' ' 8' ' ' CYS . 4.4 m -129.97 160.19 34.38 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 123.712 0.633 . . . . 0.0 110.016 -179.863 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 77.0 m 42.27 -104.72 0.06 Allowed 'General case' 0 N--CA 1.497 1.899 0 CA-C-N 114.261 -1.336 . . . . 0.0 113.167 179.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 96.1 mt -142.18 4.03 1.6 Allowed 'General case' 0 N--CA 1.498 1.962 0 O-C-N 123.585 0.553 . . . . 0.0 112.441 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.468 ' HA ' ' ND2' ' A' ' 6' ' ' ASN . 1.6 m-80 59.07 -174.33 0.1 Allowed 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 114.174 1.176 . . . . 0.0 114.174 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.44 ' HA ' ' HA ' ' A' ' 4' ' ' CYS . 56.8 m 59.88 100.87 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 CA-C-N 113.185 -1.825 . . . . 0.0 113.04 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -120.56 101.66 45.88 Favored Pre-proline 0 N--CA 1.496 1.873 0 CA-C-N 115.32 -0.855 . . . . 0.0 108.789 179.695 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -60.49 -31.57 92.62 Favored 'Trans proline' 0 N--CA 1.494 1.518 0 C-N-CA 122.622 2.215 . . . . 0.0 111.728 -176.23 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 21.6 tpp85 -57.52 -39.91 77.59 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 124.107 0.879 . . . . 0.0 109.175 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 13.7 mt -71.26 152.49 8.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 CA-C-O 122.192 0.996 . . . . 0.0 109.827 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -121.14 -51.2 2.11 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-N 111.773 -2.467 . . . . 0.0 106.503 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 15.8 p90 -172.7 158.9 4.17 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-N 113.186 -1.825 . . . . 0.0 109.736 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -97.86 123.41 7.82 Favored Glycine 0 N--CA 1.49 2.288 0 CA-C-N 113.313 -1.767 . . . . 0.0 108.973 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 27.2 m -90.2 101.05 11.88 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 CA-C-O 122.052 0.929 . . . . 0.0 110.678 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.6 m -79.03 164.03 57.04 Favored Pre-proline 0 N--CA 1.502 2.14 0 CA-C-N 114.502 -1.226 . . . . 0.0 108.98 179.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -57.21 154.0 36.66 Favored 'Trans proline' 0 N--CA 1.494 1.55 0 C-N-CA 122.369 2.046 . . . . 0.0 111.313 173.059 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.457 ' NE ' ' HA ' ' A' ' 52' ' ' ARG . 14.8 mmp_? -79.94 115.76 19.7 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-N 115.183 -0.917 . . . . 0.0 109.988 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 56.4 m -66.37 149.42 50.42 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-N 114.882 -1.054 . . . . 0.0 109.708 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -153.92 131.83 11.65 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-N 115.265 -0.88 . . . . 0.0 109.943 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 27.5 mm-40 -106.46 79.99 1.43 Allowed 'General case' 0 N--CA 1.492 1.657 0 CA-C-N 114.927 -1.033 . . . . 0.0 111.185 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 9.2 mtpm? -85.67 -71.77 0.52 Allowed 'General case' 0 N--CA 1.494 1.758 0 CA-C-N 113.844 -1.526 . . . . 0.0 109.763 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -160.0 150.96 19.15 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 123.954 0.784 . . . . 0.0 109.397 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 26.9 m120 49.51 34.14 6.52 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 124.24 0.962 . . . . 0.0 112.275 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -65.14 166.9 8.86 Favored 'General case' 0 N--CA 1.495 1.822 0 CA-C-N 115.064 -0.971 . . . . 0.0 111.251 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 62.4 ttm-85 -44.31 -38.42 3.89 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 124.473 1.108 . . . . 0.0 112.576 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 6.7 tp -69.52 86.56 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 124.296 0.998 . . . . 0.0 111.554 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . 0.424 ' HA ' ' HA ' ' A' ' 99' ' ' CYS . 1.7 m -94.34 44.07 1.11 Allowed 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 123.02 1.39 . . . . 0.0 112.075 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 52.0 m -90.66 151.02 21.44 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 112.626 -2.079 . . . . 0.0 108.892 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 52.1 p-10 -127.86 -171.06 2.35 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 17.0 t -101.95 -29.97 11.5 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 123.663 0.602 . . . . 0.0 110.95 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 37.2 t -61.87 -55.35 30.64 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 124.102 0.876 . . . . 0.0 109.947 -179.748 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -87.68 63.86 7.74 Favored 'General case' 0 N--CA 1.499 2.025 0 N-CA-C 106.23 -1.767 . . . . 0.0 106.23 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -106.33 -115.87 4.08 Favored Glycine 0 N--CA 1.488 2.164 0 CA-C-N 113.963 -1.471 . . . . 0.0 112.322 -179.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.466 ' H ' ' CA ' ' A' ' 85' ' ' GLY . 2.6 t 179.29 110.67 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 125.278 1.222 . . . . 0.0 109.402 -179.851 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 11.4 mmmm -64.79 88.38 0.06 Allowed 'General case' 0 N--CA 1.499 1.996 0 CA-C-N 114.954 -1.021 . . . . 0.0 108.307 179.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 171.79 -31.73 0.13 Allowed Glycine 0 N--CA 1.487 2.055 0 CA-C-N 113.908 -1.496 . . . . 0.0 110.937 -179.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 67.9 m -112.71 167.15 10.72 Favored 'General case' 0 N--CA 1.5 2.058 0 C-N-CA 119.46 -0.896 . . . . 0.0 111.139 -179.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 61.1 mtpt -111.14 100.91 9.48 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-N 114.074 -1.421 . . . . 0.0 113.775 -179.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.4 ' N ' ' O ' ' A' ' 83' ' ' CYS . 5.0 m-85 -52.71 141.63 20.56 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 124.265 0.978 . . . . 0.0 109.988 179.466 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -154.77 159.45 40.64 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 113.684 -1.598 . . . . 0.0 112.964 -179.426 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.483 ' HG ' ' HE ' ' A' ' 102' ' ' ARG . 73.0 p -100.24 135.08 42.21 Favored 'General case' 0 N--CA 1.486 1.358 0 CA-C-N 114.014 -1.448 . . . . 0.0 113.179 -179.768 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.439 ' H ' ' HB1' ' A' ' 104' ' ' ALA . 4.6 p-10 -40.01 -47.19 2.22 Favored 'General case' 0 N--CA 1.499 2.005 0 CA-C-N 112.82 -1.991 . . . . 0.0 115.978 -179.867 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -52.9 -36.05 58.95 Favored 'General case' 0 N--CA 1.497 1.88 0 CA-C-N 114.724 -1.125 . . . . 0.0 112.38 -179.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 128.43 42.68 0.24 Allowed Glycine 0 N--CA 1.494 2.539 0 O-C-N 124.772 1.295 . . . . 0.0 111.594 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 95.1 m -140.84 114.07 8.58 Favored 'General case' 0 N--CA 1.497 1.876 0 C-N-CA 119.469 -0.893 . . . . 0.0 112.739 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -54.18 139.69 34.83 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 99.5 t -103.88 -63.98 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 CA-C-N 114.571 -1.195 . . . . 0.0 112.183 -179.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . 0.415 ' SG ' ' N ' ' A' ' 84' ' ' GLU . 1.8 p -160.28 -162.98 1.03 Allowed 'General case' 0 N--CA 1.501 2.083 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 -179.8 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.415 ' N ' ' SG ' ' A' ' 83' ' ' CYS . 30.4 tt0 -118.36 144.7 45.69 Favored 'General case' 0 N--CA 1.5 2.069 0 N-CA-C 105.992 -1.855 . . . . 0.0 105.992 179.298 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.466 ' CA ' ' H ' ' A' ' 69' ' ' THR . . . -60.17 135.78 50.03 Favored Glycine 0 N--CA 1.496 2.689 0 N-CA-C 108.154 -1.979 . . . . 0.0 108.154 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -105.71 -7.89 18.17 Favored 'General case' 0 N--CA 1.503 2.195 0 N-CA-C 116.722 2.119 . . . . 0.0 116.722 -179.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.413 ' HG ' HD22 ' A' ' 91' ' ' ASN . 26.8 t -70.06 97.09 1.12 Allowed 'General case' 0 N--CA 1.501 2.115 0 C-N-CA 119.001 -1.08 . . . . 0.0 108.757 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -79.74 143.81 59.18 Favored Pre-proline 0 N--CA 1.494 1.74 0 CA-C-N 114.855 -1.066 . . . . 0.0 109.765 -179.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -46.66 -22.34 1.79 Allowed 'Trans proline' 0 N--CA 1.499 1.817 0 C-N-CA 122.887 2.392 . . . . 0.0 113.017 170.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 3.7 tpm_? -62.14 -53.08 60.42 Favored 'General case' 0 N--CA 1.495 1.775 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.413 HD22 ' HG ' ' A' ' 87' ' ' SER . 2.4 p-10 -84.63 131.95 48.16 Favored Pre-proline 0 N--CA 1.492 1.663 0 CA-C-N 115.079 -0.964 . . . . 0.0 108.99 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -79.26 56.9 6.23 Favored 'Trans proline' 0 N--CA 1.492 1.388 0 C-N-CA 123.029 2.486 . . . . 0.0 108.181 163.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 27.7 mtpp 65.29 121.31 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.082 0 CA-C-N 114.585 -1.188 . . . . 0.0 110.923 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -153.25 68.21 0.8 Allowed 'General case' 0 N--CA 1.496 1.839 0 CA-C-N 114.665 -1.152 . . . . 0.0 108.134 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 89.7 m -154.11 160.56 30.8 Favored Pre-proline 0 N--CA 1.496 1.855 0 CA-C-N 114.263 -1.335 . . . . 0.0 111.967 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -73.41 -159.27 0.08 OUTLIER 'Trans proline' 0 N--CA 1.493 1.442 0 C-N-CA 122.973 2.449 . . . . 0.0 109.792 160.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.55 52.25 1.12 Allowed 'General case' 0 N--CA 1.494 1.772 0 CA-C-O 122.392 1.092 . . . . 0.0 108.284 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -47.04 113.9 0.75 Allowed 'General case' 0 N--CA 1.5 2.051 0 CA-C-N 113.054 -1.885 . . . . 0.0 110.565 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . 0.424 ' HA ' ' HA ' ' A' ' 62' ' ' CYS . 56.2 m -60.07 121.7 12.53 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 119.926 -0.709 . . . . 0.0 111.095 -179.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 42.0 t0 -112.22 91.09 15.24 Favored Pre-proline 0 N--CA 1.494 1.762 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -58.34 -31.44 93.88 Favored 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 122.708 2.272 . . . . 0.0 111.143 -169.033 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.483 ' HE ' ' HG ' ' A' ' 76' ' ' SER . 15.7 tpt180 -73.04 -40.39 65.16 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-N 114.366 -1.288 . . . . 0.0 112.305 -179.858 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 3.3 tt -58.67 162.54 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 O-C-N 123.524 0.515 . . . . 0.0 112.048 -179.592 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.439 ' HB1' ' H ' ' A' ' 77' ' ' ASP . . . -139.96 -57.81 0.56 Allowed 'General case' 0 N--CA 1.495 1.824 0 CA-C-N 114.411 -1.268 . . . . 0.0 109.172 179.807 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 15.3 p90 -165.62 163.41 19.25 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-N 114.816 -1.084 . . . . 0.0 110.917 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -111.32 115.22 3.87 Favored Glycine 0 N--CA 1.493 2.444 0 CA-C-N 114.077 -1.419 . . . . 0.0 111.974 -179.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 51.5 mm -93.01 124.54 45.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 124.52 0.777 . . . . 0.0 110.054 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 1.7 m -79.61 148.17 68.99 Favored Pre-proline 0 N--CA 1.495 1.82 0 O-C-N 124.024 0.827 . . . . 0.0 109.706 179.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -56.47 144.59 83.49 Favored 'Trans proline' 0 N--CA 1.494 1.559 0 C-N-CA 122.866 2.378 . . . . 0.0 111.457 -175.249 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 3.2 pp -154.48 175.17 13.92 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 124.406 1.066 . . . . 0.0 111.281 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.85 0 CA-C-O 116.308 -1.806 . . . . 0.0 110.52 -179.997 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 86.3 mtm180 51.94 39.81 26.82 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 124.31 1.006 . . . . 0.0 111.51 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 8.7 tp -84.04 48.5 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 CA-C-N 114.445 -1.252 . . . . 0.0 109.982 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.47 ' HA ' ' HA ' ' A' ' 41' ' ' CYS . 1.5 m -83.42 57.29 3.94 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 115.668 1.729 . . . . 0.0 115.668 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 37.3 p -91.8 176.6 6.47 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-N 113.143 -1.844 . . . . 0.0 110.183 179.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.488 HD22 ' N ' ' A' ' 37' ' ' CYS . 34.2 p30 -162.04 -172.72 3.35 Favored 'General case' 0 N--CA 1.495 1.807 0 CA-C-N 114.276 -1.329 . . . . 0.0 108.026 179.189 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.8 t -75.98 -10.15 59.19 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 115.737 1.754 . . . . 0.0 115.737 -179.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 6.7 t -91.79 -37.52 12.91 Favored 'General case' 0 N--CA 1.503 2.177 0 CA-C-O 121.587 0.708 . . . . 0.0 111.667 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -74.34 57.76 0.7 Allowed 'General case' 0 N--CA 1.497 1.909 0 CA-C-N 113.085 -1.87 . . . . 0.0 113.568 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -162.16 -121.9 0.59 Allowed Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 86.7 m -140.29 124.28 17.5 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 123.88 0.4 . . . . 0.0 111.851 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 40.4 ttpt -67.42 86.67 0.18 Allowed 'General case' 0 N--CA 1.496 1.865 0 O-C-N 124.618 1.199 . . . . 0.0 109.308 179.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.44 ' H ' ' HA3' ' A' ' 27' ' ' GLY . . . 156.15 -19.13 0.47 Allowed Glycine 0 N--CA 1.494 2.56 0 CA-C-N 114.855 -1.066 . . . . 0.0 110.661 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 87.7 m -89.43 -177.8 5.43 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -130.54 101.97 5.94 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 123.477 0.486 . . . . 0.0 110.218 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.632 ' CD1' ' SG ' ' A' ' 25' ' ' CYS . 85.0 m-85 -55.85 141.66 38.09 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 124.116 0.885 . . . . 0.0 109.08 179.806 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -149.65 151.71 34.18 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 124.874 1.359 . . . . 0.0 112.699 -179.685 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 96.2 p -101.69 132.7 47.25 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-N 113.272 -1.786 . . . . 0.0 112.476 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.425 ' H ' ' CB ' ' A' ' 46' ' ' ALA . 6.1 p-10 -45.24 -31.17 1.42 Allowed 'General case' 0 N--CA 1.504 2.239 0 N-CA-C 116.643 2.09 . . . . 0.0 116.643 -179.709 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -55.2 -15.87 2.7 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 123.989 0.805 . . . . 0.0 112.738 -179.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 108.88 25.28 5.72 Favored Glycine 0 N--CA 1.493 2.448 0 O-C-N 124.419 1.074 . . . . 0.0 111.003 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 57.0 m -135.64 152.06 50.85 Favored 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 120.437 -0.505 . . . . 0.0 110.513 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.406 ' CG ' ' N ' ' A' ' 24' ' ' VAL . 17.5 t80 -74.67 169.54 17.63 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-N 114.546 -1.207 . . . . 0.0 109.824 179.706 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.406 ' N ' ' CG ' ' A' ' 23' ' ' PHE . 93.8 t -131.25 -67.85 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 O-C-N 123.689 0.618 . . . . 0.0 112.635 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.632 ' SG ' ' CD1' ' A' ' 16' ' ' TYR . 11.9 p -153.75 -172.62 4.28 Favored 'General case' 0 N--CA 1.504 2.228 0 C-N-CA 120.256 -0.577 . . . . 0.0 109.469 -179.771 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -126.67 143.2 51.31 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 123.705 0.628 . . . . 0.0 110.906 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.44 ' HA3' ' H ' ' A' ' 13' ' ' GLY . . . -27.41 124.43 0.06 OUTLIER Glycine 0 N--CA 1.495 2.621 0 O-C-N 124.941 1.401 . . . . 0.0 116.09 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -114.69 -22.42 9.72 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 124.582 0.813 . . . . 0.0 110.244 179.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 47.4 t -156.56 154.38 30.17 Favored 'General case' 0 N--CA 1.497 1.916 0 CA-C-O 121.522 0.677 . . . . 0.0 111.153 -179.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -78.85 141.28 59.13 Favored Pre-proline 0 N--CA 1.496 1.856 0 CA-C-N 113.401 -1.727 . . . . 0.0 108.76 -179.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -61.61 -12.94 27.05 Favored 'Trans proline' 0 N--CA 1.496 1.647 0 C-N-CA 122.766 2.311 . . . . 0.0 113.452 -165.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 23.5 mmm180 -56.88 -23.51 45.07 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 123.792 0.683 . . . . 0.0 110.968 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.463 HD21 ' H ' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -64.28 112.95 8.74 Favored Pre-proline 0 N--CA 1.492 1.639 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 179.779 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -81.24 39.02 0.81 Allowed 'Trans proline' 0 N--CA 1.496 1.675 0 C-N-CA 123.222 2.615 . . . . 0.0 112.203 -175.216 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -175.82 155.87 1.73 Allowed 'General case' 0 N--CA 1.497 1.91 0 CA-C-N 115.197 -0.911 . . . . 0.0 111.831 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -82.95 143.48 30.65 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 179.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.488 ' N ' HD22 ' A' ' 6' ' ' ASN . 1.6 m -105.69 -140.58 0.37 Allowed 'General case' 0 N--CA 1.499 2.0 0 O-C-N 123.725 0.641 . . . . 0.0 109.322 -179.788 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 58.5 p 35.33 -141.59 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.186 0 N-CA-C 114.081 1.141 . . . . 0.0 114.081 179.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -80.32 -7.09 58.9 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 123.713 0.633 . . . . 0.0 111.776 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 19.1 m120 62.62 158.07 0.06 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 124.756 1.285 . . . . 0.0 112.972 -179.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.47 ' HA ' ' HA ' ' A' ' 4' ' ' CYS . 82.4 m 54.76 116.51 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 116.341 1.978 . . . . 0.0 116.341 -179.817 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -148.11 90.97 4.93 Favored Pre-proline 0 N--CA 1.491 1.619 0 CA-C-N 113.707 -1.588 . . . . 0.0 108.979 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -62.07 -17.55 56.87 Favored 'Trans proline' 0 N--CA 1.492 1.4 0 C-N-CA 122.58 2.187 . . . . 0.0 111.922 175.515 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 33.3 mmt180 -64.01 -33.6 76.11 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 123.844 0.715 . . . . 0.0 109.987 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 4.3 mt -68.79 137.13 24.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 CA-C-O 121.959 0.885 . . . . 0.0 111.401 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.425 ' CB ' ' H ' ' A' ' 19' ' ' ASP . . . -127.58 -53.73 1.35 Allowed 'General case' 0 N--CA 1.494 1.739 0 CA-C-N 112.327 -2.215 . . . . 0.0 109.372 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 30.5 m-85 -137.01 -166.37 1.9 Allowed 'General case' 0 N--CA 1.494 1.764 0 CA-C-N 114.332 -1.303 . . . . 0.0 108.591 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -160.63 104.81 0.25 Allowed Glycine 0 N--CA 1.489 2.178 0 N-CA-C 107.519 -2.232 . . . . 0.0 107.519 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.2 p -79.75 123.3 36.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 -179.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 57.1 m -102.27 148.55 35.58 Favored Pre-proline 0 N--CA 1.496 1.871 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.919 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -72.68 107.0 2.22 Favored 'Trans proline' 0 N--CA 1.492 1.41 0 C-N-CA 122.652 2.234 . . . . 0.0 108.56 173.307 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 32.3 ttp-105 -79.53 -25.3 41.74 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 123.996 0.81 . . . . 0.0 110.374 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 36.9 t -146.4 137.46 24.33 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 123.762 0.664 . . . . 0.0 110.26 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 63.27 139.29 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.107 0 O-C-N 125.071 1.482 . . . . 0.0 113.248 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.423 ' H ' ' CD ' ' A' ' 55' ' ' GLU . 0.0 OUTLIER -86.52 -167.3 1.82 Allowed 'General case' 0 N--CA 1.498 1.975 0 CA-C-N 114.152 -1.386 . . . . 0.0 110.012 179.876 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.66 2.59 2.94 Favored 'General case' 0 N--CA 1.496 1.875 0 CA-C-N 115.001 -1.0 . . . . 0.0 110.679 179.745 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 41.2 ttmt -151.9 135.08 15.86 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 23.9 m120 -86.61 53.81 2.94 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.603 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -103.57 40.31 1.44 Allowed 'General case' 0 N--CA 1.496 1.864 0 CA-C-N 114.617 -1.174 . . . . 0.0 109.58 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -53.07 -35.53 59.65 Favored 'General case' 0 N--CA 1.499 1.981 0 CA-C-N 115.036 -0.984 . . . . 0.0 109.656 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 5.8 tp -77.84 80.73 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 179.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 1.8 m -85.91 44.87 1.16 Allowed 'General case' 0 N--CA 1.493 1.684 0 CA-C-O 122.933 1.349 . . . . 0.0 112.492 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 52.8 m -90.43 167.75 12.38 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 112.628 -2.078 . . . . 0.0 109.088 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 40.8 p30 -151.84 -175.43 5.22 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-N 114.816 -1.084 . . . . 0.0 108.441 179.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 37.1 t -94.19 -29.0 15.34 Favored 'General case' 0 N--CA 1.497 1.893 0 C-N-CA 120.168 -0.613 . . . . 0.0 112.311 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 37.5 t -59.7 -57.85 11.14 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 124.209 0.943 . . . . 0.0 111.166 -179.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -88.11 41.43 1.0 Allowed 'General case' 0 N--CA 1.494 1.768 0 CA-C-N 112.946 -1.934 . . . . 0.0 109.184 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -79.85 -136.0 1.41 Allowed Glycine 0 N--CA 1.492 2.433 0 N-CA-C 110.092 -1.203 . . . . 0.0 110.092 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 97.3 m -159.07 95.8 1.29 Allowed 'General case' 0 N--CA 1.501 2.081 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 39.9 mmtt -45.72 117.04 1.33 Allowed 'General case' 0 N--CA 1.505 2.305 0 O-C-N 123.731 0.644 . . . . 0.0 112.0 179.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 133.04 -34.64 2.42 Favored Glycine 0 N--CA 1.494 2.507 0 O-C-N 124.643 1.214 . . . . 0.0 110.368 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 63.6 m -101.77 136.8 40.99 Favored 'General case' 0 N--CA 1.494 1.743 0 CA-C-O 121.571 0.701 . . . . 0.0 110.686 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 4.3 mptp? -85.02 88.99 7.5 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 113.315 -1.766 . . . . 0.0 109.589 -179.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.41 ' HA ' ' HA2' ' A' ' 106' ' ' GLY . 35.3 m-85 -48.46 129.2 15.8 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 124.346 1.029 . . . . 0.0 109.107 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -141.0 152.54 45.0 Favored 'General case' 0 C--N 1.303 -1.413 0 CA-C-N 112.491 -2.14 . . . . 0.0 113.219 -179.109 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 80.6 p -92.86 136.28 33.39 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-N 113.056 -1.884 . . . . 0.0 114.744 -179.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -49.45 -29.53 6.7 Favored 'General case' 0 N--CA 1.5 2.035 0 CA-C-N 112.689 -2.05 . . . . 0.0 115.523 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -57.91 -15.33 8.35 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 123.855 0.722 . . . . 0.0 112.548 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 108.62 27.7 4.84 Favored Glycine 0 N--CA 1.494 2.526 0 O-C-N 124.33 1.019 . . . . 0.0 111.149 179.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 60.4 m -138.85 160.01 40.75 Favored 'General case' 0 N--CA 1.496 1.852 0 C-N-CA 120.534 -0.466 . . . . 0.0 110.028 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . 0.432 ' CG ' ' N ' ' A' ' 82' ' ' VAL . 57.4 t80 -79.7 168.3 19.52 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-N 114.758 -1.11 . . . . 0.0 110.554 179.761 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.432 ' N ' ' CG ' ' A' ' 81' ' ' PHE . 89.1 t -133.12 -73.52 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 124.054 0.846 . . . . 0.0 110.335 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . 0.422 ' SG ' ' N ' ' A' ' 84' ' ' GLU . 1.1 p -154.72 -167.23 2.54 Favored 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 -179.771 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.422 ' N ' ' SG ' ' A' ' 83' ' ' CYS . 32.4 tt0 -118.93 152.53 36.16 Favored 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 104.124 -2.547 . . . . 0.0 104.124 179.335 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -53.77 127.85 38.6 Favored Glycine 0 N--CA 1.498 2.777 0 C-N-CA 119.834 -1.174 . . . . 0.0 110.187 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -89.58 -25.15 21.49 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 123.905 0.414 . . . . 0.0 111.625 -179.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 70.9 p -69.6 96.14 0.91 Allowed 'General case' 0 N--CA 1.49 1.549 0 CA-C-O 121.765 0.793 . . . . 0.0 111.113 -179.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -97.25 136.4 21.44 Favored Pre-proline 0 N--CA 1.493 1.719 0 N-CA-C 106.807 -1.553 . . . . 0.0 106.807 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo -43.83 -26.52 1.31 Allowed 'Trans proline' 0 N--CA 1.501 1.962 0 C-N-CA 122.659 2.239 . . . . 0.0 111.515 167.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 37.4 ttp85 -65.85 -54.66 23.84 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-N 113.849 -1.523 . . . . 0.0 109.395 179.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 21.6 p30 -90.05 138.93 27.29 Favored Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 124.097 0.873 . . . . 0.0 111.961 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -81.17 49.82 3.35 Favored 'Trans proline' 0 N--CA 1.49 1.268 0 C-N-CA 123.068 2.512 . . . . 0.0 109.25 160.544 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.493 ' NZ ' ' H ' ' A' ' 94' ' ' ALA . 0.2 OUTLIER -67.32 148.47 51.63 Favored 'General case' 0 N--CA 1.498 1.935 0 CA-C-O 121.506 0.669 . . . . 0.0 110.214 -179.961 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.493 ' H ' ' NZ ' ' A' ' 93' ' ' LYS . . . -160.32 152.96 21.04 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-N 113.491 -1.686 . . . . 0.0 110.354 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 86.1 m -156.34 167.47 14.32 Favored Pre-proline 0 N--CA 1.498 1.969 0 CA-C-N 114.644 -1.162 . . . . 0.0 109.245 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -55.37 -161.59 0.01 OUTLIER 'Trans proline' 0 N--CA 1.497 1.721 0 C-N-CA 122.717 2.278 . . . . 0.0 112.642 164.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 79.9 mtp180 -78.88 -43.2 25.47 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 36.3 m-80 46.53 54.98 8.07 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 124.945 1.403 . . . . 0.0 108.874 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 60.2 m -42.93 125.87 3.64 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-N 113.471 -1.695 . . . . 0.0 113.714 -179.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 45.0 t0 -116.93 86.27 19.29 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 124.687 1.242 . . . . 0.0 107.853 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -52.9 -26.52 31.59 Favored 'Trans proline' 0 N--CA 1.496 1.653 0 C-N-CA 122.808 2.339 . . . . 0.0 112.833 -178.138 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 78.0 ttt-85 -82.37 -33.93 28.59 Favored 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 114.552 1.315 . . . . 0.0 114.552 -179.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 8.8 tt -63.97 168.68 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.239 0 C-N-CA 120.192 -0.603 . . . . 0.0 110.92 -179.607 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -145.93 -72.3 0.24 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 123.81 0.694 . . . . 0.0 111.327 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 27.4 p90 -149.8 158.99 44.7 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 123.94 0.775 . . . . 0.0 112.041 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.41 ' HA2' ' HA ' ' A' ' 74' ' ' TYR . . . -98.73 114.28 4.98 Favored Glycine 0 N--CA 1.491 2.323 0 CA-C-N 112.949 -1.932 . . . . 0.0 111.444 -179.837 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 70.6 mt -79.85 97.38 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 CA-C-N 114.282 -0.959 . . . . 0.0 111.137 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 1.6 m -79.35 148.82 71.3 Favored Pre-proline 0 N--CA 1.502 2.172 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 179.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -65.74 141.26 65.09 Favored 'Trans proline' 0 N--CA 1.493 1.458 0 C-N-CA 122.549 2.166 . . . . 0.0 110.527 -179.384 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -79.88 113.42 18.02 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.09 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 1.881 0 CA-C-O 116.331 -1.795 . . . . 0.0 111.297 -179.999 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 18.7 t70 . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 8.4 ptp180 -157.11 -23.8 0.09 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 124.34 1.025 . . . . 0.0 110.67 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 46.1 mm -77.85 91.61 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 124.132 0.895 . . . . 0.0 108.915 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.422 ' H ' ' HB3' ' A' ' 41' ' ' CYS . 0.5 OUTLIER -84.52 -160.23 0.46 Allowed 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 106.04 -1.837 . . . . 0.0 106.04 -179.997 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.8 t -73.48 -169.26 0.65 Allowed 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 179.536 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.434 ' ND2' HD13 ' A' ' 45' ' ' ILE . 4.4 t-20 -122.65 166.84 14.24 Favored 'General case' 0 N--CA 1.497 1.893 0 CA-C-O 122.614 1.197 . . . . 0.0 112.356 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.465 ' HA ' ' CE2' ' A' ' 16' ' ' TYR . 19.9 t 43.28 26.29 0.09 Allowed 'General case' 0 N--CA 1.493 1.71 0 CA-C-N 111.189 -2.732 . . . . 0.0 113.925 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 28.0 t -90.14 -68.46 0.78 Allowed 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 116.639 2.089 . . . . 0.0 116.639 -179.635 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -57.6 -4.47 0.27 Allowed 'General case' 0 N--CA 1.506 2.37 0 N-CA-C 118.367 2.729 . . . . 0.0 118.367 -179.494 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.414 ' N ' ' OH ' ' A' ' 16' ' ' TYR . . . -65.0 -39.22 96.29 Favored Glycine 0 N--CA 1.493 2.465 0 N-CA-C 110.941 -0.864 . . . . 0.0 110.941 -179.791 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 38.8 m 68.49 112.22 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.844 0 O-C-N 125.62 1.424 . . . . 0.0 107.164 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 14.8 tppt? -37.99 98.43 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.088 0 O-C-N 124.693 1.245 . . . . 0.0 113.0 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 157.82 -22.15 0.39 Allowed Glycine 0 N--CA 1.49 2.262 0 CA-C-N 112.686 -2.052 . . . . 0.0 108.686 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 90.9 m -103.98 169.25 8.61 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 62.3 mttp -124.32 95.12 4.42 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 123.972 0.795 . . . . 0.0 112.18 -179.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.584 ' HB2' ' SG ' ' A' ' 25' ' ' CYS . 6.5 m-85 -49.42 144.76 5.26 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-N 114.104 -1.407 . . . . 0.0 112.122 179.541 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -154.8 164.16 39.21 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 112.914 -1.948 . . . . 0.0 112.057 -179.39 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 40.0 t -118.04 138.83 51.95 Favored 'General case' 0 N--CA 1.495 1.823 0 CA-C-N 113.577 -1.647 . . . . 0.0 112.167 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -46.39 -24.42 0.49 Allowed 'General case' 0 N--CA 1.499 2.025 0 CA-C-N 111.76 -2.473 . . . . 0.0 113.912 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 14.7 p30 -60.87 -6.14 1.67 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 124.117 0.885 . . . . 0.0 112.126 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 92.37 27.2 15.94 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 110.401 -1.08 . . . . 0.0 110.401 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 96.5 m -144.39 141.9 29.98 Favored 'General case' 0 N--CA 1.494 1.761 0 C-N-CA 120.187 -0.605 . . . . 0.0 111.892 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 10.3 t80 -62.77 161.92 11.74 Favored 'General case' 0 N--CA 1.497 1.921 0 CA-C-N 114.14 -1.391 . . . . 0.0 109.915 179.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 62.5 t -131.7 -57.16 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 123.893 0.745 . . . . 0.0 112.745 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.584 ' SG ' ' HB2' ' A' ' 16' ' ' TYR . 7.5 p -158.62 -167.29 2.1 Favored 'General case' 0 N--CA 1.503 2.221 0 C-N-CA 119.657 -0.817 . . . . 0.0 109.749 -179.686 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -122.18 136.89 54.97 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 106.547 -1.649 . . . . 0.0 106.547 179.463 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -40.35 129.41 2.93 Favored Glycine 0 N--CA 1.503 3.127 0 O-C-N 123.657 0.598 . . . . 0.0 112.322 179.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -79.81 -52.78 7.48 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 114.023 1.12 . . . . 0.0 114.023 -179.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 55.7 m -50.28 86.61 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 116.425 2.009 . . . . 0.0 116.425 -179.281 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.59 ' H ' HD22 ' A' ' 33' ' ' ASN . 29.5 t70 -86.63 126.09 65.08 Favored Pre-proline 0 N--CA 1.489 1.511 0 N-CA-C 105.358 -2.09 . . . . 0.0 105.358 179.752 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_endo -63.45 73.83 0.14 Allowed 'Trans proline' 0 N--CA 1.5 1.863 0 C-N-CA 123.687 2.925 . . . . 0.0 113.585 -153.029 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.409 ' N ' ' O ' ' A' ' 30' ' ' ASP . 1.5 mpp_? -158.84 -47.13 0.06 Allowed 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 105.384 -2.08 . . . . 0.0 105.384 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.59 HD22 ' H ' ' A' ' 30' ' ' ASP . 12.6 p30 -78.33 136.59 60.55 Favored Pre-proline 0 N--CA 1.494 1.76 0 C-N-CA 119.526 -0.87 . . . . 0.0 109.708 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -68.8 119.73 6.7 Favored 'Trans proline' 0 N--CA 1.493 1.489 0 C-N-CA 122.736 2.291 . . . . 0.0 110.184 -178.232 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 14.3 ptmm? -107.08 157.4 17.86 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 124.18 0.925 . . . . 0.0 110.415 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -160.39 73.71 0.52 Allowed 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 27.9 m -152.8 -174.45 4.92 Favored 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 121.949 0.881 . . . . 0.0 111.744 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.476 ' HB ' ' SG ' ' A' ' 41' ' ' CYS . 83.6 m -141.51 157.81 44.66 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 104.464 -2.421 . . . . 0.0 104.464 179.638 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.4 HD11 ' N ' ' A' ' 39' ' ' LEU . 5.0 mp -79.45 -21.38 45.56 Favored 'General case' 0 N--CA 1.498 1.946 0 C-N-CA 119.439 -0.904 . . . . 0.0 110.361 -179.788 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -94.37 37.92 1.1 Allowed 'General case' 0 N--CA 1.497 1.879 0 CA-C-O 121.976 0.893 . . . . 0.0 110.165 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.476 ' SG ' ' HB ' ' A' ' 38' ' ' THR . 67.4 m -98.71 -95.5 0.23 Allowed 'General case' 0 N--CA 1.494 1.769 0 CA-C-N 113.598 -1.637 . . . . 0.0 107.409 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.413 ' HB3' ' ND2' ' A' ' 6' ' ' ASN . 16.7 t70 -54.13 131.12 59.9 Favored Pre-proline 0 N--CA 1.501 2.117 0 C-N-CA 120.601 -0.44 . . . . 0.0 110.401 179.796 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -68.78 -23.28 35.82 Favored 'Trans proline' 0 N--CA 1.493 1.489 0 C-N-CA 122.27 1.98 . . . . 0.0 111.633 -164.054 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 58.4 ttt85 -58.14 -38.42 76.54 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 124.031 0.832 . . . . 0.0 110.611 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.542 HD12 ' CD1' ' A' ' 16' ' ' TYR . 15.4 mt -98.85 154.15 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 CA-C-O 122.67 1.224 . . . . 0.0 113.857 -179.826 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -112.17 -56.16 2.43 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-N 110.907 -2.86 . . . . 0.0 107.766 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 53.6 p90 -166.49 173.53 9.77 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-N 114.776 -1.102 . . . . 0.0 109.621 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -125.86 122.13 4.39 Favored Glycine 0 N--CA 1.494 2.502 0 CA-C-N 114.198 -1.365 . . . . 0.0 110.128 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.5 p -79.5 122.71 35.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 11.3 m -100.09 104.93 32.39 Favored Pre-proline 0 N--CA 1.496 1.828 0 CA-C-N 115.083 -0.962 . . . . 0.0 108.729 -179.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -79.41 -69.25 0.02 OUTLIER 'Trans proline' 0 N--CA 1.49 1.302 0 C-N-CA 122.381 2.054 . . . . 0.0 109.798 -176.258 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 8.3 ptp180 -160.32 -15.36 0.05 Allowed 'General case' 0 N--CA 1.497 1.896 0 CA-C-N 114.393 -1.276 . . . . 0.0 110.751 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 61.7 m -56.04 153.23 9.22 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 124.057 0.848 . . . . 0.0 113.138 -179.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -171.26 -33.69 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.883 0 CA-C-N 114.077 -1.42 . . . . 0.0 108.273 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 69.41 131.2 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.134 0 O-C-N 125.202 1.564 . . . . 0.0 112.149 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 24.8 ttpp -65.6 -38.06 88.41 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-N 114.499 -1.228 . . . . 0.0 108.611 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 4.9 ttmp? -144.12 129.15 18.57 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-N 114.425 -1.261 . . . . 0.0 107.991 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -158.67 161.39 37.12 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-N 114.876 -1.056 . . . . 0.0 108.195 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 38.0 t70 58.98 14.93 3.62 Favored 'General case' 0 N--CA 1.504 2.268 0 O-C-N 123.996 0.81 . . . . 0.0 110.175 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.22 8.24 1.78 Allowed 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 113.955 1.094 . . . . 0.0 113.955 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 3.5 tp -39.69 102.45 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 O-C-N 124.475 1.11 . . . . 0.0 111.495 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 7.7 m -86.14 55.17 3.42 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 115.601 1.704 . . . . 0.0 115.601 -179.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 7.9 p -90.38 173.67 7.98 Favored 'General case' 0 N--CA 1.495 1.81 0 CA-C-N 114.174 -1.376 . . . . 0.0 109.084 179.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -161.38 149.46 15.43 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-N 114.631 -1.168 . . . . 0.0 108.782 179.772 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 11.2 t -55.86 -17.37 6.2 Favored 'General case' 0 N--CA 1.5 2.069 0 N-CA-C 113.97 1.1 . . . . 0.0 113.97 -179.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 52.1 t -82.72 -43.41 16.85 Favored 'General case' 0 N--CA 1.498 1.96 0 CA-C-N 114.138 -1.392 . . . . 0.0 112.553 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -73.62 61.91 0.75 Allowed 'General case' 0 N--CA 1.5 2.074 0 O-C-N 125.765 1.915 . . . . 0.0 114.784 -179.575 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -169.52 -155.12 9.68 Favored Glycine 0 N--CA 1.486 1.983 0 CA-C-N 112.726 -2.034 . . . . 0.0 108.303 179.599 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.409 ' C ' ' H ' ' A' ' 71' ' ' GLY . 57.5 p -145.31 159.71 42.63 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 124.018 0.481 . . . . 0.0 110.505 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 59.0 mtpt -71.76 38.51 0.07 Allowed 'General case' 0 N--CA 1.502 2.173 0 O-C-N 125.469 1.731 . . . . 0.0 113.938 179.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.409 ' H ' ' C ' ' A' ' 69' ' ' THR . . . -132.83 1.92 4.75 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 108.448 -1.861 . . . . 0.0 108.448 179.675 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . 0.401 ' HA ' ' HA ' ' A' ' 108' ' ' CYS . 96.0 m -135.54 170.73 15.49 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 123.905 0.415 . . . . 0.0 111.729 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 48.6 mtmt -130.06 105.67 8.11 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.234 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.696 ' CD1' ' SG ' ' A' ' 83' ' ' CYS . 88.2 m-85 -53.82 144.29 18.82 Favored 'General case' 0 N--CA 1.505 2.285 0 O-C-N 123.525 0.515 . . . . 0.0 110.122 179.8 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.48 ' CE2' ' HA ' ' A' ' 80' ' ' THR . 9.3 t80 -149.32 158.01 43.82 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 124.653 1.221 . . . . 0.0 113.287 -179.572 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 28.2 t -121.12 129.71 53.41 Favored 'General case' 0 N--CA 1.499 1.993 0 CA-C-N 112.05 -2.341 . . . . 0.0 112.145 -179.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.431 ' CG ' ' H ' ' A' ' 78' ' ' ASP . 9.2 p-10 -47.66 -59.19 3.46 Favored 'General case' 0 N--CA 1.495 1.81 0 CA-C-N 113.127 -1.851 . . . . 0.0 112.74 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.431 ' H ' ' CG ' ' A' ' 77' ' ' ASP . 17.7 p-10 -107.2 25.46 11.38 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-N 114.556 -1.202 . . . . 0.0 110.624 -179.777 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -146.93 15.52 1.55 Allowed Glycine 0 N--CA 1.494 2.507 0 O-C-N 124.179 0.924 . . . . 0.0 111.578 -179.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.48 ' HA ' ' CE2' ' A' ' 75' ' ' PHE . 6.6 t 41.61 -160.56 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.899 0 O-C-N 124.934 1.02 . . . . 0.0 113.405 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . 0.428 ' H ' ' HG1' ' A' ' 80' ' ' THR . 72.4 t80 -40.01 132.4 1.84 Allowed 'General case' 0 N--CA 1.5 2.074 0 O-C-N 123.634 0.584 . . . . 0.0 112.213 179.862 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 76.6 t -107.48 -61.03 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 CA-C-N 114.381 -1.281 . . . . 0.0 109.93 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . 0.696 ' SG ' ' CD1' ' A' ' 74' ' ' TYR . 0.8 OUTLIER -163.66 -166.74 1.25 Allowed 'General case' 0 N--CA 1.502 2.136 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 -179.89 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.475 ' N ' ' SG ' ' A' ' 83' ' ' CYS . 35.2 mt-10 -130.65 163.68 26.66 Favored 'General case' 0 N--CA 1.485 1.316 0 CA-C-N 114.995 -1.002 . . . . 0.0 109.362 179.511 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -43.24 120.15 2.67 Favored Glycine 0 N--CA 1.499 2.891 0 O-C-N 124.092 0.87 . . . . 0.0 113.681 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -108.71 32.1 5.13 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 36.3 t -153.91 129.26 9.8 Favored 'General case' 0 N--CA 1.498 1.958 0 C-N-CA 120.323 -0.551 . . . . 0.0 109.616 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -100.22 144.28 28.12 Favored Pre-proline 0 N--CA 1.494 1.762 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -46.61 -23.37 2.24 Favored 'Trans proline' 0 N--CA 1.499 1.834 0 C-N-CA 122.846 2.364 . . . . 0.0 112.564 170.339 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 52.8 ttp85 -60.68 -53.23 59.96 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-N 114.967 -1.015 . . . . 0.0 108.682 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -90.5 114.42 61.1 Favored Pre-proline 0 N--CA 1.494 1.725 0 O-C-N 124.839 1.337 . . . . 0.0 110.635 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -83.68 45.13 1.73 Allowed 'Trans proline' 0 N--CA 1.495 1.593 0 C-N-CA 123.427 2.752 . . . . 0.0 110.633 173.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 64.2 mtpt -79.13 125.59 29.62 Favored 'General case' 0 N--CA 1.497 1.894 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.954 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -88.75 120.67 30.35 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 114.596 -1.184 . . . . 0.0 109.603 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 31.0 m -79.94 145.37 61.37 Favored Pre-proline 0 N--CA 1.497 1.906 0 CA-C-N 115.202 -0.908 . . . . 0.0 108.928 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -70.31 -87.13 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.482 0 C-N-CA 122.249 1.966 . . . . 0.0 110.253 -177.188 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 86.7 mtm180 -145.32 -67.28 0.31 Allowed 'General case' 0 N--CA 1.497 1.912 0 O-C-N 123.737 0.648 . . . . 0.0 109.397 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 28.5 m120 46.22 48.43 13.12 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 124.39 1.056 . . . . 0.0 110.67 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 90.7 m -36.21 127.26 0.76 Allowed 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 115.251 1.574 . . . . 0.0 115.251 -179.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -122.31 79.99 45.05 Favored Pre-proline 0 N--CA 1.496 1.858 0 O-C-N 124.295 0.997 . . . . 0.0 109.091 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -59.34 -25.91 80.06 Favored 'Trans proline' 0 N--CA 1.495 1.605 0 C-N-CA 123.293 2.662 . . . . 0.0 111.707 -178.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 25.0 tpt180 -66.66 -37.39 84.7 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-N 115.118 -0.946 . . . . 0.0 111.726 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.457 ' CG2' ' N ' ' A' ' 104' ' ' ALA . 6.3 mt -60.06 167.01 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 CA-C-O 121.855 0.836 . . . . 0.0 111.516 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.457 ' N ' ' CG2' ' A' ' 103' ' ' ILE . . . -138.69 -44.81 0.48 Allowed 'General case' 0 N--CA 1.489 1.497 0 CA-C-N 113.462 -1.699 . . . . 0.0 107.762 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 40.7 p90 -173.07 -170.84 0.68 Allowed 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -136.45 130.15 5.14 Favored Glycine 0 N--CA 1.493 2.5 0 C-N-CA 120.554 -0.831 . . . . 0.0 111.228 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.9 mp -79.89 110.46 15.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 N-CA-C 105.788 -1.93 . . . . 0.0 105.788 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' CYS . . . . . 0.401 ' HA ' ' HA ' ' A' ' 72' ' ' CYS . 60.9 m -100.19 109.57 56.95 Favored Pre-proline 0 N--CA 1.495 1.809 0 O-C-N 124.143 0.902 . . . . 0.0 110.405 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.31 -55.68 0.08 OUTLIER 'Trans proline' 0 N--CA 1.492 1.42 0 C-N-CA 122.6 2.2 . . . . 0.0 109.905 179.528 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 85.9 mt -79.72 -54.91 5.4 Favored 'General case' 0 N--CA 1.495 1.78 0 CA-C-N 114.514 -1.221 . . . . 0.0 109.048 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 1.911 0 CA-C-O 116.668 -1.634 . . . . 0.0 111.258 179.862 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 24.8 t70 . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 58.83 -169.46 0.13 Allowed 'General case' 0 N--CA 1.501 2.114 0 O-C-N 124.446 1.092 . . . . 0.0 111.374 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.1 tp -67.49 91.27 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 CA-C-O 121.985 0.898 . . . . 0.0 110.814 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 7.5 m -90.36 45.28 1.25 Allowed 'General case' 0 N--CA 1.493 1.72 0 CA-C-O 122.726 1.25 . . . . 0.0 112.472 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 51.8 m -90.74 171.07 9.6 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 113.001 -1.909 . . . . 0.0 109.275 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 69.0 m-80 -160.0 171.91 18.5 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 124.567 1.167 . . . . 0.0 107.998 179.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 9.6 t -70.14 -11.14 60.68 Favored 'General case' 0 N--CA 1.501 2.096 0 C-N-CA 118.968 -1.093 . . . . 0.0 110.837 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 34.4 t -91.11 -50.4 5.86 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-N 113.905 -1.498 . . . . 0.0 109.137 179.734 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -39.58 -67.26 0.23 Allowed 'General case' 0 N--CA 1.501 2.084 0 N-CA-C 115.965 1.839 . . . . 0.0 115.965 -179.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -54.66 160.51 5.08 Favored Glycine 0 N--CA 1.502 3.057 0 C-N-CA 121.099 -0.572 . . . . 0.0 112.325 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 7.3 t -71.43 138.29 48.95 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 -179.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -62.33 114.1 3.29 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-N 114.121 -1.399 . . . . 0.0 109.2 179.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 134.39 -21.92 3.79 Favored Glycine 0 N--CA 1.495 2.594 0 O-C-N 124.431 1.082 . . . . 0.0 110.577 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 88.2 m -86.77 -173.08 4.3 Favored 'General case' 0 N--CA 1.5 2.028 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 60.7 mtpt -133.46 103.27 5.86 Favored 'General case' 0 N--CA 1.494 1.765 0 C-N-CA 119.793 -0.763 . . . . 0.0 110.998 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.733 ' CD2' ' SG ' ' A' ' 25' ' ' CYS . 90.8 m-85 -54.75 138.21 42.69 Favored 'General case' 0 N--CA 1.499 2.015 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.67 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -149.22 146.25 27.52 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 124.886 1.366 . . . . 0.0 113.26 -179.701 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 45.4 t -106.03 120.99 43.2 Favored 'General case' 0 N--CA 1.5 2.055 0 CA-C-N 112.822 -1.99 . . . . 0.0 110.722 -179.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.489 ' H ' ' HB2' ' A' ' 46' ' ' ALA . 6.5 p-10 -57.61 -53.34 59.32 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 126.476 2.36 . . . . 0.0 112.19 -179.817 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -72.95 1.61 8.47 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 112.264 -2.244 . . . . 0.0 112.236 -179.665 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -136.39 -85.39 0.18 Allowed Glycine 0 N--CA 1.482 1.727 0 C-N-CA 119.626 -1.273 . . . . 0.0 111.951 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.481 ' CG2' ' H ' ' A' ' 23' ' ' PHE . 1.2 m 172.7 -171.16 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.166 0 N-CA-C 106.002 -1.851 . . . . 0.0 106.002 -179.137 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.481 ' H ' ' CG2' ' A' ' 22' ' ' THR . 33.2 t80 -41.79 144.05 0.45 Allowed 'General case' 0 N--CA 1.502 2.146 0 CA-C-O 121.369 0.605 . . . . 0.0 112.065 179.53 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 71.9 t -110.38 -68.21 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 CA-C-N 114.06 -1.427 . . . . 0.0 112.353 -179.656 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.733 ' SG ' ' CD2' ' A' ' 16' ' ' TYR . 14.5 p -155.14 -167.55 2.6 Favored 'General case' 0 N--CA 1.502 2.153 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 -179.717 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 8.7 tm-20 -117.45 154.89 30.62 Favored 'General case' 0 N--CA 1.505 2.282 0 O-C-N 123.373 0.42 . . . . 0.0 110.735 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.429 ' HA2' ' CE2' ' A' ' 16' ' ' TYR . . . -46.48 110.7 0.55 Allowed Glycine 0 N--CA 1.503 3.128 0 CA-C-O 118.857 -0.968 . . . . 0.0 112.583 179.869 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -97.33 -9.19 27.97 Favored 'General case' 0 N--CA 1.505 2.32 0 N-CA-C 114.684 1.365 . . . . 0.0 114.684 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 38.4 t -156.07 131.17 9.29 Favored 'General case' 0 N--CA 1.501 2.083 0 C-N-CA 119.647 -0.821 . . . . 0.0 111.607 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.531 ' H ' HD22 ' A' ' 33' ' ' ASN . 11.7 t70 -93.54 143.59 26.87 Favored Pre-proline 0 N--CA 1.494 1.771 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 179.812 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -66.26 75.7 0.35 Allowed 'Trans proline' 0 N--CA 1.494 1.558 0 C-N-CA 122.579 2.186 . . . . 0.0 108.236 162.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 35.2 ttp-105 -168.09 -41.28 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 113.208 -1.814 . . . . 0.0 106.832 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.531 HD22 ' H ' ' A' ' 30' ' ' ASP . 29.8 p30 -86.99 152.84 54.02 Favored Pre-proline 0 N--CA 1.493 1.705 0 O-C-N 124.175 0.922 . . . . 0.0 110.936 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -79.85 45.6 2.0 Allowed 'Trans proline' 0 N--CA 1.496 1.635 0 C-N-CA 123.443 2.762 . . . . 0.0 112.319 174.481 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.12 152.9 20.46 Favored 'General case' 0 N--CA 1.501 2.109 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.163 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -156.39 165.24 36.9 Favored 'General case' 0 N--CA 1.498 1.93 0 CA-C-N 114.674 -1.148 . . . . 0.0 109.571 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 28.0 m -146.19 179.16 7.69 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 123.779 0.674 . . . . 0.0 110.282 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 44.5 p -138.72 54.7 1.74 Allowed 'General case' 0 N--CA 1.5 2.066 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.671 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 54.2 tp -93.63 -25.24 17.59 Favored 'General case' 0 N--CA 1.499 2.017 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.005 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 11.4 m120 62.54 153.64 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.118 0 O-C-N 124.487 1.117 . . . . 0.0 113.536 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 59.4 m -18.61 130.38 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.274 0 N-CA-C 116.63 2.085 . . . . 0.0 116.63 -179.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -113.82 86.13 10.53 Favored Pre-proline 0 N--CA 1.498 1.955 0 O-C-N 124.062 0.851 . . . . 0.0 108.971 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -62.13 -18.41 61.78 Favored 'Trans proline' 0 N--CA 1.497 1.724 0 C-N-CA 122.633 2.222 . . . . 0.0 113.803 -170.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 5.9 ptp85 -89.09 -20.15 24.68 Favored 'General case' 0 N--CA 1.501 2.078 0 N-CA-C 116.393 1.997 . . . . 0.0 116.393 -179.636 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 16.3 tt -78.13 155.44 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.303 0 C-N-CA 118.566 -1.254 . . . . 0.0 109.694 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.489 ' HB2' ' H ' ' A' ' 19' ' ' ASP . . . -90.4 -66.3 0.94 Allowed 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 179.627 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 3.3 p90 -177.63 171.91 1.83 Allowed 'General case' 0 N--CA 1.492 1.651 0 CA-C-N 112.786 -2.006 . . . . 0.0 108.513 -179.783 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -91.05 110.37 3.81 Favored Glycine 0 N--CA 1.49 2.279 0 CA-C-N 114.979 -1.009 . . . . 0.0 110.701 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 20.1 m -78.84 105.84 8.76 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 N-CA-C 106.107 -1.812 . . . . 0.0 106.107 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 48.1 m -83.28 161.74 56.23 Favored Pre-proline 0 N--CA 1.495 1.798 0 CA-C-N 113.375 -1.739 . . . . 0.0 111.264 -179.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -52.44 -47.95 24.37 Favored 'Trans proline' 0 N--CA 1.494 1.536 0 C-N-CA 122.345 2.03 . . . . 0.0 109.675 166.65 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 39.7 mtm105 -146.23 157.08 43.79 Favored 'General case' 0 N--CA 1.497 1.912 0 CA-C-N 114.751 -1.113 . . . . 0.0 109.55 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 67.1 m -140.04 38.54 1.95 Allowed 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 179.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -67.68 144.44 55.48 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-N 114.033 -1.44 . . . . 0.0 111.544 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.42 ' HG2' ' N ' ' A' ' 56' ' ' LYS . 33.3 tt0 -108.91 166.28 10.94 Favored 'General case' 0 N--CA 1.497 1.883 0 CA-C-N 113.879 -1.51 . . . . 0.0 107.648 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.42 ' N ' ' HG2' ' A' ' 55' ' ' GLU . 85.0 tttt -146.43 45.08 1.22 Allowed 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 106.009 -1.848 . . . . 0.0 106.009 179.579 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 4.6 tmmm? -113.29 -72.03 0.72 Allowed 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 104.288 -2.486 . . . . 0.0 104.288 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 33.8 t-20 -150.92 83.19 1.33 Allowed 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 105.742 -1.947 . . . . 0.0 105.742 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -162.64 -39.47 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 CA-C-N 113.498 -1.683 . . . . 0.0 108.775 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 22.2 mmm180 -65.22 -68.87 0.33 Allowed 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.408 ' CG1' ' H ' ' A' ' 99' ' ' CYS . 1.9 tp -90.45 175.06 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 N-CA-C 105.345 -2.095 . . . . 0.0 105.345 179.693 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . 0.45 ' N ' ' SG ' ' A' ' 99' ' ' CYS . 1.6 m -79.98 -165.06 0.76 Allowed 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 119.569 -0.853 . . . . 0.0 109.166 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.5 p -63.91 138.71 58.59 Favored 'General case' 0 N--CA 1.495 1.824 0 C-N-CA 119.067 -1.053 . . . . 0.0 112.558 179.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -155.11 154.59 32.6 Favored 'General case' 0 N--CA 1.499 2.009 0 CA-C-N 112.14 -2.3 . . . . 0.0 110.209 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 52.8 t -52.71 -51.2 61.4 Favored 'General case' 0 N--CA 1.501 2.084 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 179.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 17.7 t -60.91 -54.46 44.78 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-N 110.996 -2.82 . . . . 0.0 112.658 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -39.46 -45.06 1.47 Allowed 'General case' 0 N--CA 1.504 2.227 0 O-C-N 125.921 2.013 . . . . 0.0 110.511 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 73.38 162.94 7.75 Favored Glycine 0 N--CA 1.476 1.351 0 N-CA-C 116.951 1.54 . . . . 0.0 116.951 179.583 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 3.6 t 176.64 42.56 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 104.49 -2.411 . . . . 0.0 104.49 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.422 ' N ' ' HA3' ' A' ' 85' ' ' GLY . 0.6 OUTLIER -10.35 94.08 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.065 0 CA-C-N 113.165 -1.834 . . . . 0.0 115.545 -179.553 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 136.37 -47.56 0.96 Allowed Glycine 0 N--CA 1.493 2.497 0 CA-C-N 114.461 -1.245 . . . . 0.0 111.94 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . 0.425 ' HA ' ' HA ' ' A' ' 108' ' ' CYS . 76.5 m -79.93 122.75 27.09 Favored 'General case' 0 N--CA 1.497 1.914 0 C-N-CA 119.166 -1.014 . . . . 0.0 110.761 -179.79 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 37.0 mtmm -73.2 89.48 1.53 Allowed 'General case' 0 N--CA 1.487 1.384 0 CA-C-N 112.535 -2.12 . . . . 0.0 115.152 -179.604 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.437 ' N ' ' O ' ' A' ' 83' ' ' CYS . 41.9 m-85 -45.55 136.8 5.5 Favored 'General case' 0 N--CA 1.504 2.234 0 O-C-N 124.32 1.012 . . . . 0.0 108.399 179.488 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -154.17 145.8 23.26 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 114.851 -1.068 . . . . 0.0 112.144 -179.478 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 89.0 p -90.12 141.51 28.61 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 112.05 -2.341 . . . . 0.0 115.806 -179.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -51.34 -33.92 31.55 Favored 'General case' 0 N--CA 1.499 2.01 0 CA-C-N 112.288 -2.233 . . . . 0.0 114.313 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -57.85 -13.98 5.27 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 123.994 0.808 . . . . 0.0 112.156 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 102.7 37.46 3.21 Favored Glycine 0 N--CA 1.491 2.325 0 O-C-N 124.311 1.007 . . . . 0.0 111.487 179.783 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 90.7 m -140.79 149.07 41.6 Favored 'General case' 0 N--CA 1.496 1.858 0 C-N-CA 119.8 -0.76 . . . . 0.0 111.826 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 21.3 t80 -77.45 142.86 38.97 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-N 114.937 -1.029 . . . . 0.0 108.253 179.549 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 92.2 t -107.22 -67.27 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 CA-C-N 114.933 -1.031 . . . . 0.0 108.842 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . 0.437 ' O ' ' N ' ' A' ' 74' ' ' TYR . 39.2 m -159.8 -160.56 0.82 Allowed 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -139.41 160.19 40.4 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 102.739 -3.06 . . . . 0.0 102.739 178.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.422 ' HA3' ' N ' ' A' ' 70' ' ' LYS . . . -38.24 100.18 0.01 OUTLIER Glycine 0 N--CA 1.494 2.527 0 CA-C-O 119.301 -0.722 . . . . 0.0 114.463 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -79.08 -3.81 47.14 Favored 'General case' 0 N--CA 1.502 2.169 0 C-N-CA 119.618 -0.833 . . . . 0.0 111.316 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 44.0 t -142.93 128.57 19.18 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.556 ' H ' HD22 ' A' ' 91' ' ' ASN . 15.4 t70 -84.01 145.67 46.98 Favored Pre-proline 0 N--CA 1.493 1.681 0 CA-C-N 114.588 -1.187 . . . . 0.0 109.147 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -56.62 80.97 0.04 OUTLIER 'Trans proline' 0 N--CA 1.499 1.84 0 C-N-CA 123.279 2.653 . . . . 0.0 108.528 163.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 50.8 ttp85 -173.71 -62.54 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 104.027 -2.583 . . . . 0.0 104.027 -179.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.556 HD22 ' H ' ' A' ' 88' ' ' ASP . 0.7 OUTLIER -91.88 113.49 59.08 Favored Pre-proline 0 N--CA 1.492 1.651 0 CA-C-N 114.12 -1.4 . . . . 0.0 109.04 179.915 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -74.38 89.48 1.07 Allowed 'Trans proline' 0 N--CA 1.492 1.393 0 C-N-CA 122.467 2.111 . . . . 0.0 110.571 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -122.15 123.1 40.73 Favored 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -150.64 151.88 33.17 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.46 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 81.6 m -119.46 98.22 50.19 Favored Pre-proline 0 N--CA 1.497 1.898 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -68.53 93.1 0.42 Allowed 'Trans proline' 0 N--CA 1.493 1.452 0 C-N-CA 122.301 2.001 . . . . 0.0 109.013 177.106 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 28.4 mmt85 -134.72 47.88 2.34 Favored 'General case' 0 N--CA 1.498 1.954 0 CA-C-N 114.651 -1.159 . . . . 0.0 108.029 -179.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 14.5 m120 54.42 41.3 32.05 Favored 'General case' 0 N--CA 1.504 2.236 0 CA-C-O 122.797 1.284 . . . . 0.0 108.094 -179.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . 0.45 ' SG ' ' N ' ' A' ' 62' ' ' CYS . 5.3 m 57.95 -167.43 0.14 Allowed 'General case' 0 N--CA 1.488 1.439 0 CA-C-N 112.031 -2.35 . . . . 0.0 108.722 -179.662 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -106.22 99.64 24.72 Favored Pre-proline 0 N--CA 1.498 1.943 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 179.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -64.53 -31.13 61.13 Favored 'Trans proline' 0 N--CA 1.493 1.46 0 C-N-CA 122.336 2.024 . . . . 0.0 111.639 -169.656 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 74.9 ttt-85 -71.89 -31.22 66.19 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 123.967 0.792 . . . . 0.0 111.226 -179.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 12.0 mt -68.53 157.24 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 CA-C-O 122.261 1.029 . . . . 0.0 111.427 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -124.92 -56.41 1.56 Allowed 'General case' 0 N--CA 1.492 1.63 0 CA-C-N 111.969 -2.378 . . . . 0.0 107.555 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 38.1 p90 -164.88 170.12 15.73 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-N 114.254 -1.339 . . . . 0.0 109.922 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -110.84 123.85 6.73 Favored Glycine 0 N--CA 1.492 2.426 0 CA-C-N 113.911 -1.495 . . . . 0.0 110.944 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.414 HD13 ' N ' ' A' ' 107' ' ' ILE . 2.9 mp -79.31 99.65 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' CYS . . . . . 0.425 ' HA ' ' HA ' ' A' ' 72' ' ' CYS . 25.2 m -79.79 163.9 56.01 Favored Pre-proline 0 N--CA 1.491 1.622 0 CA-C-N 114.169 -1.378 . . . . 0.0 108.754 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_exo -47.85 -23.46 4.11 Favored 'Trans proline' 0 N--CA 1.498 1.76 0 C-N-CA 122.558 2.172 . . . . 0.0 112.589 173.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 83.9 mt -118.95 -55.81 2.15 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 124.218 0.949 . . . . 0.0 108.511 179.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 1.983 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.837 179.936 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 38.8 ttm180 -140.37 57.48 1.59 Allowed 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 107.135 -1.431 . . . . 0.0 107.135 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 8.6 tp -86.77 53.67 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 CA-C-N 114.092 -1.413 . . . . 0.0 109.093 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 63.5 m -84.19 40.58 0.77 Allowed 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 115.031 1.493 . . . . 0.0 115.031 -179.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 53.3 m -90.6 158.91 16.71 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 105.167 -2.16 . . . . 0.0 105.167 179.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -147.48 169.36 19.71 Favored 'General case' 0 N--CA 1.497 1.918 0 CA-C-O 122.427 1.108 . . . . 0.0 112.551 -179.761 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.7 t -62.76 -53.14 58.91 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-N 112.268 -2.242 . . . . 0.0 111.952 -179.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 51.4 t -67.63 -55.7 12.26 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-N 113.946 -1.479 . . . . 0.0 109.375 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -54.83 -18.03 4.31 Favored 'General case' 0 N--CA 1.497 1.921 0 CA-C-N 113.786 -1.552 . . . . 0.0 113.062 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -59.53 160.72 17.74 Favored Glycine 0 N--CA 1.496 2.676 0 C-N-CA 120.613 -0.804 . . . . 0.0 111.453 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.46 ' H ' ' HH ' ' A' ' 16' ' ' TYR . 9.7 t -76.45 129.4 36.48 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 115.732 1.753 . . . . 0.0 115.732 -179.768 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 3.1 mmmp? -62.34 93.23 0.05 OUTLIER 'General case' 0 N--CA 1.5 2.073 0 CA-C-N 114.195 -1.366 . . . . 0.0 109.032 179.572 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 157.18 -28.09 0.51 Allowed Glycine 0 N--CA 1.49 2.279 0 CA-C-O 118.52 -1.156 . . . . 0.0 112.913 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 84.2 m -117.55 169.7 9.34 Favored 'General case' 0 N--CA 1.503 2.183 0 C-N-CA 119.438 -0.905 . . . . 0.0 112.603 -179.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 36.0 mtmm -102.69 96.67 7.02 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-N 113.982 -1.463 . . . . 0.0 111.312 -179.714 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.46 ' HH ' ' H ' ' A' ' 11' ' ' THR . 24.0 m-85 -59.94 127.9 34.19 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-O 122.884 1.326 . . . . 0.0 108.023 179.654 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -135.2 151.96 51.12 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 111.29 -2.687 . . . . 0.0 112.655 -179.145 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 87.8 p -91.03 133.06 35.61 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 112.991 -1.913 . . . . 0.0 113.924 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -47.73 -29.12 2.84 Favored 'General case' 0 N--CA 1.5 2.035 0 CA-C-N 113.11 -1.859 . . . . 0.0 116.012 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -57.64 -18.35 19.73 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 123.611 0.57 . . . . 0.0 112.519 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 112.46 26.96 4.05 Favored Glycine 0 N--CA 1.494 2.52 0 O-C-N 124.366 1.041 . . . . 0.0 111.098 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 62.4 m -135.91 156.06 49.35 Favored 'General case' 0 N--CA 1.496 1.853 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.458 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 22.6 t80 -85.85 149.25 25.37 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-N 114.89 -1.05 . . . . 0.0 110.16 179.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 96.0 t -108.47 -79.0 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 N-CA-C 107.03 -1.471 . . . . 0.0 107.03 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.458 ' SG ' ' O ' ' A' ' 26' ' ' GLU . 0.1 OUTLIER -164.76 179.91 6.26 Favored 'General case' 0 N--CA 1.5 2.044 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 179.743 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.458 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 30.7 tt0 -85.64 157.05 20.44 Favored 'General case' 0 N--CA 1.502 2.138 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 179.87 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -74.14 116.43 5.26 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 104.729 -3.349 . . . . 0.0 104.729 179.613 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -98.64 21.94 10.62 Favored 'General case' 0 N--CA 1.505 2.285 0 N-CA-C 114.757 1.392 . . . . 0.0 114.757 -179.633 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 37.7 t -137.97 117.88 13.31 Favored 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 179.671 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.568 ' H ' HD22 ' A' ' 33' ' ' ASN . 16.3 t70 -79.42 132.52 62.06 Favored Pre-proline 0 N--CA 1.493 1.692 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_endo -67.11 85.33 0.33 Allowed 'Trans proline' 0 N--CA 1.492 1.441 0 C-N-CA 122.6 2.2 . . . . 0.0 109.908 178.534 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 12.0 mtp180 176.52 -41.71 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.938 0 CA-C-N 113.925 -1.488 . . . . 0.0 108.216 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.568 HD22 ' H ' ' A' ' 30' ' ' ASP . 24.4 p30 -77.22 146.11 74.08 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 123.991 0.807 . . . . 0.0 111.88 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -81.54 48.23 2.79 Favored 'Trans proline' 0 N--CA 1.492 1.407 0 C-N-CA 123.407 2.738 . . . . 0.0 109.525 163.061 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 65.0 tttp -68.23 150.71 47.95 Favored 'General case' 0 N--CA 1.497 1.891 0 CA-C-O 121.544 0.688 . . . . 0.0 111.617 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -91.42 131.03 37.16 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-N 113.608 -1.633 . . . . 0.0 108.005 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 5.2 m -142.85 -178.41 5.79 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 -179.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 96.2 m -83.25 113.87 20.99 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-N 113.645 -1.616 . . . . 0.0 108.413 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 9.8 mp -79.5 0.58 29.07 Favored 'General case' 0 N--CA 1.498 1.953 0 CA-C-N 115.299 -0.864 . . . . 0.0 112.164 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -59.19 119.61 7.67 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 123.546 0.529 . . . . 0.0 109.719 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 85.0 m -68.55 92.26 0.45 Allowed 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -63.35 101.88 0.29 Allowed Pre-proline 0 N--CA 1.495 1.792 0 CA-C-N 115.252 -0.885 . . . . 0.0 110.19 -179.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo -67.32 -37.88 16.7 Favored 'Trans proline' 0 N--CA 1.492 1.399 0 C-N-CA 122.159 1.906 . . . . 0.0 110.779 -160.234 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 28.0 ptt-85 -78.27 -23.1 47.39 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-N 114.233 -1.349 . . . . 0.0 114.013 -179.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 7.9 tt -55.27 159.04 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.278 0 C-N-CA 120.1 -0.64 . . . . 0.0 110.476 -179.554 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -141.85 -62.64 0.45 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 123.803 0.69 . . . . 0.0 112.575 -179.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 28.1 p90 -156.17 161.63 40.29 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-O 121.871 0.843 . . . . 0.0 113.04 -179.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.426 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -92.17 95.3 2.01 Favored Glycine 0 N--CA 1.489 2.194 0 CA-C-N 112.785 -2.007 . . . . 0.0 110.593 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 4.7 p -81.74 110.55 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 C-N-CA 119.108 -1.037 . . . . 0.0 109.012 179.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.6 m -79.04 154.43 77.55 Favored Pre-proline 0 N--CA 1.498 1.928 0 CA-C-N 115.472 -0.786 . . . . 0.0 109.414 179.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -56.35 -33.51 91.76 Favored 'Trans proline' 0 N--CA 1.497 1.692 0 C-N-CA 122.71 2.273 . . . . 0.0 111.623 -173.506 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.89 169.99 22.35 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 124.28 0.987 . . . . 0.0 109.855 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 57.2 m -71.2 105.28 3.37 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -68.61 124.86 24.75 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 107.529 -1.286 . . . . 0.0 107.529 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 21.1 mm-40 -104.46 -71.43 0.74 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 123.933 0.77 . . . . 0.0 111.07 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 7.0 ttpm? 53.39 87.7 0.04 OUTLIER 'General case' 0 N--CA 1.504 2.228 0 O-C-N 124.108 0.88 . . . . 0.0 110.73 -179.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 41.7 ttmt -155.64 129.71 8.74 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-N 114.698 -1.137 . . . . 0.0 108.982 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -160.4 143.43 13.43 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.518 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -85.57 76.26 10.04 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-N 114.957 -1.02 . . . . 0.0 108.453 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 58.1 mmm-85 -66.82 96.77 0.43 Allowed 'General case' 0 N--CA 1.496 1.832 0 CA-C-N 114.414 -1.266 . . . . 0.0 110.398 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 5.9 tp -80.39 68.25 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 CA-C-N 114.022 -1.444 . . . . 0.0 110.647 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 1.6 m -89.37 55.67 3.34 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 123.128 1.442 . . . . 0.0 114.455 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.41 ' O ' ' N ' ' A' ' 100' ' ' ASP . 1.8 p -90.86 160.87 15.5 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-N 112.64 -2.073 . . . . 0.0 108.05 179.456 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 32.5 p-10 -161.63 148.48 14.32 Favored 'General case' 0 N--CA 1.501 2.108 0 C-N-CA 119.891 -0.723 . . . . 0.0 110.22 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' CYS . . . . . 0.451 ' HA ' ' CD2' ' A' ' 74' ' ' TYR . 7.1 t -65.45 -15.45 62.64 Favored 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 113.661 0.986 . . . . 0.0 113.661 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 29.4 t -80.52 -66.77 0.84 Allowed 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 116.295 1.961 . . . . 0.0 116.295 -179.499 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -77.82 63.31 2.84 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 125.545 1.778 . . . . 0.0 114.832 -179.25 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -123.98 -150.3 7.91 Favored Glycine 0 N--CA 1.494 2.522 0 CA-C-N 112.729 -2.032 . . . . 0.0 109.946 179.558 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 4.8 t -136.44 121.18 18.51 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-N 114.102 -1.049 . . . . 0.0 108.924 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 6.2 ptpp? -58.16 89.95 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.853 0 CA-C-O 122.648 1.214 . . . . 0.0 111.371 179.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 161.89 -42.08 0.38 Allowed Glycine 0 N--CA 1.49 2.24 0 N-CA-C 108.368 -1.893 . . . . 0.0 108.368 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 90.3 m -79.43 128.29 33.16 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 35.4 mmtp -80.37 83.31 6.22 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 115.581 1.697 . . . . 0.0 115.581 -179.321 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.451 ' CD2' ' HA ' ' A' ' 65' ' ' CYS . 2.1 m-85 -43.55 126.36 4.39 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 124.235 0.959 . . . . 0.0 109.181 179.379 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -141.08 152.04 44.48 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-N 114.321 -1.309 . . . . 0.0 112.325 -179.34 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 30.2 t -101.66 143.24 31.86 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 116.059 1.874 . . . . 0.0 116.059 -179.57 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.413 ' C ' ' H ' ' A' ' 79' ' ' GLY . 1.0 OUTLIER -49.69 -26.11 3.48 Favored 'General case' 0 N--CA 1.5 2.074 0 CA-C-N 111.231 -2.713 . . . . 0.0 113.435 179.746 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 13.8 p30 -62.33 -3.18 1.24 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 124.178 0.924 . . . . 0.0 111.853 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.413 ' H ' ' C ' ' A' ' 77' ' ' ASP . . . 86.87 28.96 24.72 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 90.3 m -142.33 143.93 32.98 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 120.47 -0.492 . . . . 0.0 110.9 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 52.6 t80 -67.94 160.25 28.95 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-N 114.17 -1.377 . . . . 0.0 110.497 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 91.1 t -122.95 -74.77 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 CA-C-N 114.624 -1.171 . . . . 0.0 110.477 -179.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . 0.492 ' SG ' ' N ' ' A' ' 84' ' ' GLU . 0.5 OUTLIER -157.13 -163.07 1.32 Allowed 'General case' 0 N--CA 1.502 2.163 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 -179.874 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.492 ' N ' ' SG ' ' A' ' 83' ' ' CYS . 38.2 tt0 -119.56 164.37 15.93 Favored 'General case' 0 N--CA 1.503 2.205 0 N-CA-C 104.722 -2.325 . . . . 0.0 104.722 179.18 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -60.91 113.57 5.74 Favored Glycine 0 N--CA 1.497 2.743 0 C-N-CA 119.315 -1.422 . . . . 0.0 110.302 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -86.0 21.68 1.9 Allowed 'General case' 0 N--CA 1.501 2.11 0 CA-C-O 121.722 0.772 . . . . 0.0 111.297 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 3.5 m -133.4 160.54 37.08 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 113.996 -1.456 . . . . 0.0 107.224 179.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -79.66 145.9 63.77 Favored Pre-proline 0 N--CA 1.493 1.689 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -47.7 -15.22 0.31 Allowed 'Trans proline' 0 N--CA 1.499 1.848 0 C-N-CA 122.835 2.356 . . . . 0.0 114.037 171.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 72.5 ttt-85 -139.93 53.05 1.68 Allowed 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 18.2 p-10 -90.05 128.28 50.37 Favored Pre-proline 0 N--CA 1.496 1.828 0 CA-C-N 114.522 -1.217 . . . . 0.0 111.447 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -83.89 48.1 2.46 Favored 'Trans proline' 0 N--CA 1.491 1.362 0 C-N-CA 123.245 2.63 . . . . 0.0 109.125 159.22 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -130.39 147.52 52.1 Favored 'General case' 0 N--CA 1.503 2.184 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.681 -179.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -160.54 125.2 3.72 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-N 114.875 -1.057 . . . . 0.0 109.501 179.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 68.7 m -79.74 162.79 61.48 Favored Pre-proline 0 N--CA 1.5 2.03 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -69.97 4.92 2.0 Allowed 'Trans proline' 0 N--CA 1.495 1.587 0 C-N-CA 122.118 1.879 . . . . 0.0 111.146 163.5 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 80.5 mmt-85 -94.21 22.13 6.23 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 123.647 0.592 . . . . 0.0 110.616 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -63.21 158.07 20.95 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.167 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 74.0 m 61.75 125.59 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.888 0 O-C-N 125.193 1.558 . . . . 0.0 112.215 -179.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.41 ' N ' ' O ' ' A' ' 63' ' ' THR . 30.8 t70 -156.22 84.88 3.21 Favored Pre-proline 0 N--CA 1.494 1.761 0 CA-C-N 114.876 -1.056 . . . . 0.0 110.154 -179.778 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_exo -52.44 -18.26 7.85 Favored 'Trans proline' 0 N--CA 1.495 1.594 0 C-N-CA 122.457 2.104 . . . . 0.0 112.455 174.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.69 -54.02 38.25 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 105.974 -1.862 . . . . 0.0 105.974 179.855 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 15.3 tt -79.95 157.52 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 C-N-CA 119.215 -0.994 . . . . 0.0 109.747 -179.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -113.28 -61.35 1.75 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 124.372 1.045 . . . . 0.0 112.588 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 7.4 p90 -162.65 160.06 25.22 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 123.886 0.741 . . . . 0.0 112.162 -179.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -97.13 127.44 9.21 Favored Glycine 0 N--CA 1.492 2.414 0 CA-C-N 113.848 -1.523 . . . . 0.0 111.716 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 48.0 mm -80.91 97.88 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 35.0 m -79.67 143.07 58.06 Favored Pre-proline 0 N--CA 1.494 1.729 0 CA-C-N 114.744 -1.116 . . . . 0.0 109.244 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -51.13 137.76 45.12 Favored 'Trans proline' 0 N--CA 1.496 1.627 0 C-N-CA 122.999 2.466 . . . . 0.0 112.053 -174.136 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -157.66 -9.32 0.08 Allowed 'General case' 0 N--CA 1.497 1.893 0 CA-C-N 114.803 -1.09 . . . . 0.0 110.999 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 1.987 0 CA-C-O 114.74 -2.552 . . . . 0.0 110.704 -179.948 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 25.0 t70 . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 5.9 mmp_? -87.78 58.52 4.92 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-N 114.783 -1.099 . . . . 0.0 108.209 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 10.2 tp -85.15 44.46 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 CA-C-N 114.374 -1.285 . . . . 0.0 109.528 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 5.7 m -85.16 59.5 5.67 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 122.582 1.182 . . . . 0.0 112.938 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.2 t -90.03 167.87 12.43 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-N 113.145 -1.843 . . . . 0.0 107.178 179.675 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 15.9 p30 -145.72 150.59 36.54 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.949 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.7 t -67.34 -20.12 65.54 Favored 'General case' 0 N--CA 1.496 1.847 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.805 -179.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 35.7 t -54.94 -55.67 28.16 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 179.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -71.69 -23.24 61.61 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-N 112.853 -1.976 . . . . 0.0 110.098 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -52.72 142.38 26.09 Favored Glycine 0 N--CA 1.493 2.494 0 O-C-N 124.199 0.937 . . . . 0.0 112.572 -179.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 41.0 p -61.15 109.15 1.03 Allowed 'General case' 0 N--CA 1.492 1.639 0 CA-C-N 111.711 -2.244 . . . . 0.0 111.976 -179.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -68.81 88.64 0.38 Allowed 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 122.457 1.123 . . . . 0.0 108.677 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 163.87 -22.6 0.17 Allowed Glycine 0 N--CA 1.488 2.111 0 CA-C-N 112.611 -2.086 . . . . 0.0 109.639 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 76.0 m -107.63 138.12 44.42 Favored 'General case' 0 N--CA 1.497 1.902 0 CA-C-O 121.533 0.683 . . . . 0.0 110.567 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 61.3 mtpt -83.38 84.82 7.37 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-N 113.821 -1.536 . . . . 0.0 110.914 -179.518 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 -49.78 128.93 19.17 Favored 'General case' 0 N--CA 1.498 1.951 0 CA-C-O 122.37 1.081 . . . . 0.0 109.982 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -136.8 161.01 37.16 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-N 112.262 -2.245 . . . . 0.0 112.554 -179.264 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 32.8 t -104.33 133.12 49.77 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 113.613 -1.63 . . . . 0.0 112.19 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -47.73 -25.06 1.1 Allowed 'General case' 0 N--CA 1.5 2.032 0 CA-C-N 112.895 -1.957 . . . . 0.0 114.18 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 29.3 p30 -60.17 -7.66 2.02 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 124.095 0.872 . . . . 0.0 112.573 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 95.61 27.23 10.74 Favored Glycine 0 N--CA 1.494 2.537 0 N-CA-C 109.894 -1.282 . . . . 0.0 109.894 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 88.3 m -141.29 139.41 33.66 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 123.926 0.427 . . . . 0.0 110.161 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.43 ' CG ' ' N ' ' A' ' 24' ' ' VAL . 48.8 t80 -67.15 164.64 17.63 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 124.63 1.206 . . . . 0.0 110.787 179.809 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.43 ' N ' ' CG ' ' A' ' 23' ' ' PHE . 96.8 t -129.66 -73.05 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 124.093 0.871 . . . . 0.0 112.544 -179.842 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 20.3 p -150.58 -172.01 4.07 Favored 'General case' 0 N--CA 1.501 2.084 0 CA-C-O 121.615 0.721 . . . . 0.0 111.359 -179.496 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -123.51 138.77 54.5 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 104.585 -2.376 . . . . 0.0 104.585 179.447 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -55.99 155.52 12.3 Favored Glycine 0 N--CA 1.503 3.111 0 C-N-CA 120.137 -1.03 . . . . 0.0 114.597 -179.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -112.89 -29.55 7.34 Favored 'General case' 0 N--CA 1.505 2.29 0 CA-C-N 114.837 -0.681 . . . . 0.0 111.891 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 32.0 t -110.44 124.54 51.95 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 107.3 -1.371 . . . . 0.0 107.3 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -77.81 144.1 68.03 Favored Pre-proline 0 N--CA 1.495 1.792 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 -179.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -41.46 -21.36 0.13 Allowed 'Trans proline' 0 N--CA 1.501 1.925 0 C-N-CA 124.02 3.146 . . . . 0.0 115.617 177.551 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 30.9 tpt180 -57.63 -30.34 65.28 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 123.708 0.63 . . . . 0.0 110.657 179.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.472 ' N ' HD21 ' A' ' 33' ' ' ASN . 0.0 OUTLIER -53.96 120.96 26.74 Favored Pre-proline 0 N--CA 1.496 1.839 0 CA-C-N 114.956 -1.02 . . . . 0.0 112.902 179.991 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -82.19 40.51 0.98 Allowed 'Trans proline' 0 N--CA 1.494 1.546 0 C-N-CA 122.979 2.453 . . . . 0.0 110.356 167.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 57.5 tptt -170.07 160.21 8.0 Favored 'General case' 0 N--CA 1.498 1.951 0 CA-C-N 114.577 -1.192 . . . . 0.0 108.578 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -140.4 151.68 45.14 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 123.866 0.729 . . . . 0.0 109.934 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 6.7 m -79.48 143.51 34.87 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 90.2 m -148.79 92.03 1.94 Allowed 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 5.9 tt -157.94 -68.92 0.09 Allowed 'General case' 0 N--CA 1.496 1.839 0 CA-C-N 115.339 -0.846 . . . . 0.0 108.917 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -70.33 146.6 50.4 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 123.766 0.666 . . . . 0.0 111.993 -179.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 79.1 m -105.11 132.17 51.67 Favored 'General case' 0 N--CA 1.496 1.826 0 CA-C-N 114.411 -1.268 . . . . 0.0 109.68 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -135.2 77.44 54.95 Favored Pre-proline 0 N--CA 1.497 1.911 0 O-C-N 123.849 0.718 . . . . 0.0 110.291 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_endo -62.75 -27.19 75.39 Favored 'Trans proline' 0 N--CA 1.494 1.515 0 C-N-CA 123.066 2.511 . . . . 0.0 112.794 -172.473 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 6.0 ptp85 -65.99 -34.8 78.93 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 124.189 0.931 . . . . 0.0 112.47 -179.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.0 mt -59.41 136.96 22.49 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.099 0 C-N-CA 118.642 -1.223 . . . . 0.0 112.347 -179.773 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -123.93 -53.02 1.76 Allowed 'General case' 0 N--CA 1.492 1.675 0 CA-C-N 111.911 -2.404 . . . . 0.0 106.737 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 17.3 p90 -170.1 158.44 6.98 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-N 113.667 -1.606 . . . . 0.0 109.8 179.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -112.83 133.93 11.65 Favored Glycine 0 N--CA 1.494 2.517 0 CA-C-N 113.746 -1.57 . . . . 0.0 112.112 -179.764 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.3 p -82.92 105.22 12.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 8.9 m -79.96 112.18 27.85 Favored Pre-proline 0 N--CA 1.493 1.718 0 CA-C-N 113.93 -1.486 . . . . 0.0 108.681 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_endo -73.72 148.07 40.98 Favored 'Trans proline' 0 N--CA 1.492 1.425 0 C-N-CA 122.445 2.096 . . . . 0.0 111.018 -172.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 86.7 mtm180 -83.59 179.36 7.65 Favored 'General case' 0 N--CA 1.498 1.926 0 CA-C-N 114.968 -1.015 . . . . 0.0 110.471 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 80.8 p -70.99 -179.53 2.32 Favored 'General case' 0 N--CA 1.499 1.979 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.501 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -68.65 172.89 5.67 Favored 'General case' 0 N--CA 1.497 1.905 0 C-N-CA 120.268 -0.573 . . . . 0.0 111.59 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 22.1 pt-20 -78.65 153.59 30.9 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-N 114.341 -1.3 . . . . 0.0 108.845 179.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.419 ' HZ2' ' HZ2' ' A' ' 57' ' ' LYS . 2.6 tmtp? -137.04 -62.04 0.64 Allowed 'General case' 0 N--CA 1.502 2.17 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 -179.772 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.419 ' HZ2' ' HZ2' ' A' ' 56' ' ' LYS . 13.5 mptt -78.97 17.63 0.72 Allowed 'General case' 0 N--CA 1.504 2.27 0 CA-C-O 121.45 0.643 . . . . 0.0 111.638 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.544 ' ND2' ' H ' ' A' ' 60' ' ' ARG . 10.1 p-10 -77.38 -42.33 36.82 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-N 114.834 -1.076 . . . . 0.0 112.152 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 59.24 37.53 23.7 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 124.432 1.083 . . . . 0.0 108.764 -179.715 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.544 ' H ' ' ND2' ' A' ' 58' ' ' ASN . 2.0 tpp180 -99.62 172.21 7.43 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-N 113.074 -1.876 . . . . 0.0 108.476 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 6.6 tp -61.26 85.93 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 124.107 0.88 . . . . 0.0 111.512 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 10.1 m -93.97 56.82 2.34 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-O 122.558 1.17 . . . . 0.0 112.509 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 97.4 m -78.27 162.69 26.35 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 113.355 -1.748 . . . . 0.0 108.52 179.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 46.0 p-10 -160.67 156.65 25.83 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 120.317 -0.553 . . . . 0.0 110.582 179.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' CYS . . . . . 0.541 ' SG ' ' HB2' ' A' ' 74' ' ' TYR . 53.0 t -83.48 -12.56 56.15 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-N 115.043 -0.981 . . . . 0.0 110.169 179.773 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 53.4 t -65.02 -59.83 3.71 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 179.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -90.54 34.55 0.89 Allowed 'General case' 0 N--CA 1.494 1.761 0 CA-C-N 114.167 -1.379 . . . . 0.0 108.69 179.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -74.62 -122.1 0.1 Allowed Glycine 0 N--CA 1.495 2.597 0 CA-C-N 115.353 -0.84 . . . . 0.0 111.053 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 14.8 t -159.81 107.33 1.69 Allowed 'General case' 0 N--CA 1.495 1.807 0 CA-C-O 122.497 1.141 . . . . 0.0 109.465 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 2.7 tmmm? -57.32 101.76 0.07 Allowed 'General case' 0 N--CA 1.493 1.689 0 CA-C-N 113.266 -1.788 . . . . 0.0 107.196 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.404 ' O ' ' SG ' ' A' ' 108' ' ' CYS . . . 165.41 -32.74 0.24 Allowed Glycine 0 N--CA 1.485 1.96 0 CA-C-N 113.225 -1.807 . . . . 0.0 109.366 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 57.7 m -124.36 175.11 7.3 Favored 'General case' 0 N--CA 1.503 2.18 0 C-N-CA 120.017 -0.673 . . . . 0.0 110.733 -179.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.408 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 94.0 mttt -110.61 97.86 7.18 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 124.607 1.192 . . . . 0.0 109.174 -179.796 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.541 ' HB2' ' SG ' ' A' ' 65' ' ' CYS . 26.8 m-85 -54.37 131.36 41.92 Favored 'General case' 0 N--CA 1.497 1.89 0 CA-C-N 114.808 -1.087 . . . . 0.0 109.135 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -139.9 147.51 40.7 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 112.956 -1.929 . . . . 0.0 113.475 -179.366 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 30.9 t -99.58 117.03 33.07 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-N 111.378 -2.646 . . . . 0.0 108.599 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.503 ' H ' ' HB2' ' A' ' 104' ' ' ALA . 7.6 p-10 -59.97 -54.19 49.04 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 125.186 1.553 . . . . 0.0 112.996 -179.652 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -84.14 13.51 5.09 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 113.603 -1.635 . . . . 0.0 110.882 -179.673 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -129.13 -88.87 0.56 Allowed Glycine 0 N--CA 1.48 1.627 0 N-CA-C 108.962 -1.655 . . . . 0.0 108.962 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.451 ' CG2' ' N ' ' A' ' 81' ' ' PHE . 1.2 m 171.78 -175.71 0.05 OUTLIER 'General case' 0 N--CA 1.5 2.066 0 N-CA-C 105.902 -1.888 . . . . 0.0 105.902 -179.381 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . 0.451 ' N ' ' CG2' ' A' ' 80' ' ' THR . 19.2 t80 -53.52 136.3 38.58 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 179.504 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 92.9 t -94.78 -73.61 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 CA-C-N 114.606 -1.179 . . . . 0.0 109.196 -179.558 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . 0.423 ' C ' ' SG ' ' A' ' 65' ' ' CYS . 0.1 OUTLIER -168.44 178.53 4.79 Favored 'General case' 0 N--CA 1.504 2.268 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 179.882 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.408 ' HA ' ' HA ' ' A' ' 73' ' ' LYS . 38.6 tt0 -93.02 152.46 19.29 Favored 'General case' 0 N--CA 1.5 2.034 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -50.29 102.05 0.06 OUTLIER Glycine 0 N--CA 1.495 2.589 0 O-C-N 123.739 0.649 . . . . 0.0 111.513 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -79.83 -12.15 59.78 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-N 114.862 -0.669 . . . . 0.0 110.146 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 35.1 t -77.79 84.31 4.11 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 121.464 0.65 . . . . 0.0 109.708 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -79.38 132.1 63.42 Favored Pre-proline 0 N--CA 1.495 1.803 0 N-CA-C 106.399 -1.704 . . . . 0.0 106.399 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -52.49 -22.39 16.4 Favored 'Trans proline' 0 N--CA 1.498 1.741 0 C-N-CA 122.823 2.349 . . . . 0.0 113.705 -169.701 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 53.0 mmm-85 -83.71 12.82 5.35 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 123.802 0.689 . . . . 0.0 111.648 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.435 ' C ' ' H ' ' A' ' 93' ' ' LYS . 40.6 p-10 -87.71 135.2 34.24 Favored Pre-proline 0 N--CA 1.494 1.742 0 O-C-N 123.45 0.469 . . . . 0.0 111.148 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -81.95 28.97 0.55 Allowed 'Trans proline' 0 N--CA 1.493 1.453 0 C-N-CA 122.967 2.445 . . . . 0.0 111.409 162.317 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.435 ' H ' ' C ' ' A' ' 91' ' ' ASN . 44.3 mmtm 58.21 124.23 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.162 0 CA-C-N 113.76 -1.564 . . . . 0.0 112.846 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -149.32 79.67 1.4 Allowed 'General case' 0 N--CA 1.497 1.913 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.628 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 79.2 m -153.24 124.21 3.57 Favored Pre-proline 0 N--CA 1.496 1.857 0 CA-C-N 114.476 -1.238 . . . . 0.0 108.43 179.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -60.73 -85.57 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.502 0 C-N-CA 122.046 1.831 . . . . 0.0 110.592 177.06 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -142.25 -60.35 0.45 Allowed 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 7.9 m-80 51.51 48.28 23.21 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 124.592 1.182 . . . . 0.0 110.243 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 77.9 m -41.17 128.0 2.83 Favored 'General case' 0 N--CA 1.499 2.009 0 CA-C-N 114.112 -1.404 . . . . 0.0 112.734 -179.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -139.03 79.32 27.09 Favored Pre-proline 0 N--CA 1.496 1.831 0 O-C-N 124.125 0.89 . . . . 0.0 110.882 -179.733 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -59.43 -33.91 97.35 Favored 'Trans proline' 0 N--CA 1.494 1.523 0 C-N-CA 122.87 2.38 . . . . 0.0 113.024 171.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 33.2 ptt180 -63.96 -16.93 62.67 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 123.919 0.762 . . . . 0.0 112.3 -179.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 9.6 tp -48.86 152.64 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 O-C-N 124.019 0.824 . . . . 0.0 112.452 -179.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.503 ' HB2' ' H ' ' A' ' 77' ' ' ASP . . . -124.59 -71.96 0.69 Allowed 'General case' 0 N--CA 1.492 1.659 0 CA-C-N 114.686 -1.143 . . . . 0.0 108.261 179.792 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 76.3 m-85 -156.14 -162.99 1.37 Allowed 'General case' 0 N--CA 1.499 2.001 0 O-C-N 124.685 1.241 . . . . 0.0 109.042 -179.725 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -119.87 93.26 0.54 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 104.966 -3.253 . . . . 0.0 104.966 179.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 43.7 mm -78.77 105.7 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 C-N-CA 119.626 -0.83 . . . . 0.0 110.546 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' CYS . . . . . 0.404 ' SG ' ' O ' ' A' ' 71' ' ' GLY . 1.6 m -78.61 151.4 77.19 Favored Pre-proline 0 N--CA 1.499 1.995 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.688 179.895 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -59.56 114.3 1.99 Allowed 'Trans proline' 0 N--CA 1.494 1.528 0 C-N-CA 122.752 2.302 . . . . 0.0 111.151 -172.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 2.3 pp -79.86 -177.3 5.88 Favored 'General case' 0 N--CA 1.496 1.827 0 CA-C-N 114.928 -1.033 . . . . 0.0 111.892 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.836 0 CA-C-O 116.209 -1.853 . . . . 0.0 110.718 -179.911 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 24.3 t70 . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 109.489 -0.559 . . . . 0.0 109.489 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 10.4 mmm180 -102.83 -47.56 4.35 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-N 114.954 -1.021 . . . . 0.0 111.004 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 4.8 tp -65.62 85.99 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 124.212 0.945 . . . . 0.0 111.228 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.529 ' HA ' ' HA ' ' A' ' 41' ' ' CYS . 1.6 m -92.88 61.03 3.46 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-O 123.372 1.558 . . . . 0.0 113.731 179.814 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 6.8 t -90.15 161.47 15.74 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 104.475 -2.417 . . . . 0.0 104.475 179.517 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.461 ' ND2' ' H ' ' A' ' 9' ' ' ALA . 3.2 p-10 -161.54 -166.42 1.5 Allowed 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 -179.898 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 8.8 t -117.58 -36.88 3.58 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 179.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 49.5 t -62.5 -61.46 2.42 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 123.917 0.761 . . . . 0.0 110.402 -179.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.461 ' H ' ' ND2' ' A' ' 6' ' ' ASN . . . -90.06 27.51 1.59 Allowed 'General case' 0 N--CA 1.496 1.871 0 CA-C-N 113.525 -1.67 . . . . 0.0 109.178 179.859 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -72.67 -117.9 0.06 OUTLIER Glycine 0 N--CA 1.492 2.411 0 CA-C-N 115.141 -0.936 . . . . 0.0 111.271 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 97.3 m -154.62 91.82 1.43 Allowed 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 107.518 -1.289 . . . . 0.0 107.518 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.43 ' HB3' ' NZ ' ' A' ' 12' ' ' LYS . 0.0 OUTLIER -54.6 112.77 1.08 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 123.739 0.649 . . . . 0.0 110.146 -179.847 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 135.16 -30.06 2.86 Favored Glycine 0 N--CA 1.494 2.531 0 CA-C-N 113.641 -1.618 . . . . 0.0 109.781 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 82.6 m -88.97 -178.38 5.7 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 123.659 0.27 . . . . 0.0 110.955 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 33.3 mmtp -129.82 92.26 3.29 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 124.062 0.851 . . . . 0.0 111.294 -179.546 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.425 ' HB2' ' SG ' ' A' ' 25' ' ' CYS . 51.3 m-85 -58.87 131.64 51.59 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 124.53 1.144 . . . . 0.0 108.268 179.72 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -142.04 159.66 41.78 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-N 113.102 -1.863 . . . . 0.0 113.43 -179.162 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 30.6 t -105.11 134.04 48.89 Favored 'General case' 0 N--CA 1.497 1.893 0 CA-C-N 113.689 -1.596 . . . . 0.0 111.619 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -48.22 -28.27 2.93 Favored 'General case' 0 N--CA 1.501 2.122 0 CA-C-N 112.948 -1.933 . . . . 0.0 115.814 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -52.09 -22.75 4.43 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 124.036 0.835 . . . . 0.0 111.602 -179.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 112.13 27.2 4.05 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 108.871 -1.692 . . . . 0.0 108.871 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 89.7 m -138.75 142.06 38.83 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 120.527 -0.469 . . . . 0.0 110.959 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 49.6 t80 -69.41 160.98 30.35 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-N 114.151 -1.386 . . . . 0.0 109.761 179.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 58.5 t -127.2 -71.6 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 124.091 0.87 . . . . 0.0 112.179 -179.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.425 ' SG ' ' HB2' ' A' ' 16' ' ' TYR . 0.5 OUTLIER -144.52 -177.93 5.73 Favored 'General case' 0 N--CA 1.5 2.068 0 CA-C-O 121.402 0.62 . . . . 0.0 110.818 -179.709 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -113.04 145.0 41.63 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 104.067 -2.568 . . . . 0.0 104.067 179.485 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -57.3 152.04 26.23 Favored Glycine 0 N--CA 1.498 2.773 0 C-N-CA 119.301 -1.428 . . . . 0.0 111.184 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -126.42 -10.06 6.32 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 123.976 0.457 . . . . 0.0 111.265 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 33.4 t -71.63 91.26 1.08 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 123.728 0.643 . . . . 0.0 110.714 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -99.11 111.88 61.88 Favored Pre-proline 0 N--CA 1.491 1.586 0 CA-C-N 114.618 -1.173 . . . . 0.0 108.752 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_endo -58.48 -17.07 32.42 Favored 'Trans proline' 0 N--CA 1.495 1.609 0 C-N-CA 122.869 2.38 . . . . 0.0 113.114 -168.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 74.7 ttt-85 -61.01 -50.01 75.1 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -90.84 122.85 66.31 Favored Pre-proline 0 N--CA 1.496 1.843 0 O-C-N 124.271 0.982 . . . . 0.0 110.772 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_endo -78.11 121.62 5.41 Favored 'Trans proline' 0 N--CA 1.492 1.417 0 C-N-CA 122.813 2.342 . . . . 0.0 108.999 165.303 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 56.8 tptt -159.05 153.94 24.87 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 123.62 0.575 . . . . 0.0 110.568 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.85 171.62 9.79 Favored 'General case' 0 N--CA 1.497 1.912 0 CA-C-N 114.321 -1.309 . . . . 0.0 111.315 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 89.7 m -153.58 162.76 40.95 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-N 115.323 -0.853 . . . . 0.0 112.22 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 100.0 m -109.38 91.16 3.53 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 105.46 -2.052 . . . . 0.0 105.46 179.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.416 ' N ' HD12 ' A' ' 39' ' ' LEU . 6.4 mp -79.65 -66.43 0.87 Allowed 'General case' 0 N--CA 1.494 1.725 0 CA-C-N 114.882 -1.054 . . . . 0.0 109.892 -179.728 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 5.6 m120 49.17 31.84 3.82 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 124.637 1.211 . . . . 0.0 111.185 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.529 ' HA ' ' HA ' ' A' ' 4' ' ' CYS . 1.7 m 55.7 131.98 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 116.668 2.099 . . . . 0.0 116.668 -179.831 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -120.37 81.13 30.06 Favored Pre-proline 0 N--CA 1.5 2.064 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.296 179.667 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -58.58 -15.29 24.76 Favored 'Trans proline' 0 N--CA 1.495 1.574 0 C-N-CA 122.578 2.186 . . . . 0.0 112.308 176.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -62.41 -43.23 99.31 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 26.6 mt -83.09 155.81 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 CA-C-O 122.317 1.056 . . . . 0.0 110.201 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -116.2 -53.84 2.51 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-N 111.731 -2.486 . . . . 0.0 108.025 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 50.9 p90 -165.75 167.31 17.14 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-N 114.41 -1.268 . . . . 0.0 109.287 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -119.93 118.48 3.92 Favored Glycine 0 N--CA 1.49 2.251 0 CA-C-N 113.557 -1.656 . . . . 0.0 110.56 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.9 p -79.31 133.99 28.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 20.9 m -111.27 90.76 12.28 Favored Pre-proline 0 N--CA 1.494 1.745 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 -179.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -51.91 -16.95 4.76 Favored 'Trans proline' 0 N--CA 1.499 1.801 0 C-N-CA 123.244 2.629 . . . . 0.0 114.423 -177.1 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.495 ' HD2' ' H ' ' A' ' 52' ' ' ARG . 0.0 OUTLIER -81.02 66.57 6.6 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-O 122.292 1.044 . . . . 0.0 110.524 179.959 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 63.3 p -116.03 149.89 38.16 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-N 113.715 -1.584 . . . . 0.0 109.389 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 67.38 148.24 0.05 Allowed 'General case' 0 N--CA 1.504 2.248 0 O-C-N 124.608 1.193 . . . . 0.0 110.339 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 57.87 -168.32 0.13 Allowed 'General case' 0 N--CA 1.504 2.258 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.581 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.442 ' H ' ' ND2' ' A' ' 58' ' ' ASN . 0.0 OUTLIER -161.84 -152.09 0.23 Allowed 'General case' 0 N--CA 1.495 1.799 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.249 -179.977 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.444 ' C ' ' H ' ' A' ' 59' ' ' ASP . 0.0 OUTLIER -77.0 23.16 0.18 Allowed 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 113.489 0.922 . . . . 0.0 113.489 179.989 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.442 ' ND2' ' H ' ' A' ' 56' ' ' LYS . 3.8 p30 -72.52 18.31 0.09 Allowed 'General case' 0 N--CA 1.502 2.14 0 CA-C-N 115.853 -0.612 . . . . 0.0 112.442 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.444 ' H ' ' C ' ' A' ' 57' ' ' LYS . 5.8 m-20 -70.78 -79.66 0.06 Allowed 'General case' 0 N--CA 1.491 1.613 0 CA-C-N 115.69 -0.687 . . . . 0.0 110.47 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 22.2 tpp85 -168.53 135.36 1.95 Allowed 'General case' 0 N--CA 1.499 1.984 0 O-C-N 123.774 0.671 . . . . 0.0 111.132 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 6.6 tp -84.27 68.15 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 CA-C-N 114.704 -1.135 . . . . 0.0 109.17 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 1.6 m -84.24 40.44 0.77 Allowed 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 115.618 1.71 . . . . 0.0 115.618 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 36.0 m -91.51 109.71 21.01 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 113.175 -1.83 . . . . 0.0 107.893 179.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.463 ' ND2' ' H ' ' A' ' 67' ' ' ALA . 29.8 p-10 -107.83 -165.72 1.08 Allowed 'General case' 0 N--CA 1.503 2.184 0 C-N-CA 120.264 -0.574 . . . . 0.0 109.651 179.84 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' CYS . . . . . 0.409 ' SG ' ' O ' ' A' ' 84' ' ' GLU . 1.5 t -121.22 -33.91 3.59 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 123.904 0.753 . . . . 0.0 111.362 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 32.6 t -57.07 -58.6 7.48 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-O 121.71 0.766 . . . . 0.0 110.12 -179.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.463 ' H ' ' ND2' ' A' ' 64' ' ' ASN . . . -79.42 -10.56 59.83 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-N 113.088 -1.869 . . . . 0.0 109.737 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -67.47 156.57 52.31 Favored Glycine 0 N--CA 1.494 2.551 0 C-N-CA 120.823 -0.703 . . . . 0.0 111.588 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.503 ' C ' ' H ' ' A' ' 71' ' ' GLY . 57.0 p -68.49 124.27 23.09 Favored 'General case' 0 N--CA 1.498 1.951 0 CA-C-N 114.14 -1.03 . . . . 0.0 111.127 -179.809 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.86 20.72 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.173 0 N-CA-C 115.958 1.836 . . . . 0.0 115.958 -179.853 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.503 ' H ' ' C ' ' A' ' 69' ' ' THR . . . -119.58 -25.85 2.52 Favored Glycine 0 N--CA 1.49 2.29 0 CA-C-N 113.623 -1.626 . . . . 0.0 109.319 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 94.6 m -93.36 134.54 35.48 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 120.333 -0.547 . . . . 0.0 109.801 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 60.0 mtpt -88.77 84.27 6.69 Favored 'General case' 0 N--CA 1.485 1.316 0 CA-C-N 113.501 -1.681 . . . . 0.0 109.545 -179.632 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.472 ' HB2' ' SG ' ' A' ' 83' ' ' CYS . 82.0 m-85 -50.08 126.11 13.74 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-N 114.855 -1.066 . . . . 0.0 108.418 179.87 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -132.5 162.88 30.08 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 112.986 -1.915 . . . . 0.0 112.625 -179.327 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 42.6 t -109.21 138.52 45.44 Favored 'General case' 0 N--CA 1.497 1.889 0 CA-C-N 114.309 -1.314 . . . . 0.0 112.376 -179.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -47.45 -27.25 1.63 Allowed 'General case' 0 N--CA 1.5 2.042 0 CA-C-N 112.18 -2.282 . . . . 0.0 114.38 -179.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 13.6 p30 -59.11 -7.62 1.21 Allowed 'General case' 0 N--CA 1.497 1.899 0 O-C-N 124.335 1.022 . . . . 0.0 112.492 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 92.91 28.57 11.83 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 95.8 m -143.08 138.8 30.14 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 124.095 0.526 . . . . 0.0 110.554 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . 0.429 ' CG ' ' N ' ' A' ' 82' ' ' VAL . 37.1 t80 -64.19 164.96 10.01 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 124.878 1.361 . . . . 0.0 110.849 179.853 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.429 ' N ' ' CG ' ' A' ' 81' ' ' PHE . 92.4 t -129.03 -71.56 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 124.188 0.93 . . . . 0.0 112.991 -179.805 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . 0.472 ' SG ' ' HB2' ' A' ' 74' ' ' TYR . 25.4 p -152.58 -173.08 4.44 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 123.708 0.63 . . . . 0.0 109.346 -179.561 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.409 ' O ' ' SG ' ' A' ' 65' ' ' CYS . 40.5 tt0 -128.49 149.63 50.51 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 102.602 -3.111 . . . . 0.0 102.602 179.324 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -58.8 169.89 5.36 Favored Glycine 0 N--CA 1.501 3.023 0 C-N-CA 118.631 -1.747 . . . . 0.0 114.966 -179.66 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -126.15 -13.88 6.11 Favored 'General case' 0 N--CA 1.502 2.145 0 CA-C-N 114.218 -0.991 . . . . 0.0 110.991 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 34.5 t -81.55 121.59 26.5 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -98.32 143.3 26.04 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 124.779 1.299 . . . . 0.0 107.785 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_exo -43.18 -28.07 1.29 Allowed 'Trans proline' 0 N--CA 1.5 1.866 0 C-N-CA 123.4 2.733 . . . . 0.0 114.022 175.073 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -60.09 -50.38 73.92 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 123.911 0.757 . . . . 0.0 109.278 179.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -91.06 116.39 66.32 Favored Pre-proline 0 N--CA 1.497 1.892 0 O-C-N 124.748 1.28 . . . . 0.0 111.806 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -85.02 102.76 0.8 Allowed 'Trans proline' 0 N--CA 1.491 1.342 0 C-N-CA 123.072 2.514 . . . . 0.0 108.044 161.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 22.2 ptmt -161.18 162.95 31.49 Favored 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 113.188 0.81 . . . . 0.0 113.188 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -108.86 -166.86 1.15 Allowed 'General case' 0 N--CA 1.496 1.844 0 CA-C-N 113.56 -1.654 . . . . 0.0 108.406 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 76.9 m -146.99 159.94 41.61 Favored Pre-proline 0 N--CA 1.499 1.984 0 O-C-N 123.653 0.595 . . . . 0.0 110.958 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -73.15 -18.19 23.94 Favored 'Trans proline' 0 N--CA 1.493 1.461 0 C-N-CA 122.36 2.04 . . . . 0.0 109.45 161.522 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.406 ' N ' ' NE ' ' A' ' 97' ' ' ARG . 0.0 OUTLIER -79.64 4.44 16.05 Favored 'General case' 0 N--CA 1.497 1.9 0 CA-C-N 114.949 -1.023 . . . . 0.0 111.376 -179.994 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 -54.89 154.41 5.27 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 52.4 m 58.37 104.19 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 CA-C-N 113.227 -1.806 . . . . 0.0 113.583 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -125.36 107.1 27.27 Favored Pre-proline 0 N--CA 1.498 1.97 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.616 179.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -62.4 -25.79 76.4 Favored 'Trans proline' 0 N--CA 1.493 1.491 0 C-N-CA 122.639 2.226 . . . . 0.0 111.453 179.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 23.5 mtp-105 -57.93 -38.18 75.43 Favored 'General case' 0 N--CA 1.5 2.048 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 26.7 mt -79.31 154.85 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 CA-C-N 114.815 -1.084 . . . . 0.0 110.079 179.734 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -132.36 -46.24 0.91 Allowed 'General case' 0 N--CA 1.495 1.794 0 CA-C-N 111.955 -2.384 . . . . 0.0 109.441 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 49.1 m-85 -140.0 -163.55 1.53 Allowed 'General case' 0 N--CA 1.493 1.706 0 CA-C-N 114.519 -1.219 . . . . 0.0 109.594 -179.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -152.65 107.77 0.34 Allowed Glycine 0 N--CA 1.49 2.235 0 N-CA-C 107.339 -2.304 . . . . 0.0 107.339 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 88.9 mt -79.44 84.41 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 N-CA-C 108.245 -1.021 . . . . 0.0 108.245 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 13.6 m -79.97 112.46 30.18 Favored Pre-proline 0 N--CA 1.494 1.729 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -69.65 -71.0 0.02 OUTLIER 'Trans proline' 0 N--CA 1.493 1.442 0 C-N-CA 122.236 1.957 . . . . 0.0 111.306 -167.496 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 84.5 mt -90.02 45.08 1.24 Allowed 'General case' 0 N--CA 1.498 1.963 0 O-C-N 124.211 0.945 . . . . 0.0 110.402 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 1.968 0 CA-C-O 116.362 -1.78 . . . . 0.0 110.7 -179.987 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 31.6 t70 . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 121.059 0.457 . . . . 0.0 109.972 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 72.7 mtp85 -70.76 127.57 33.09 Favored 'General case' 0 N--CA 1.495 1.801 0 CA-C-N 114.774 -1.103 . . . . 0.0 110.472 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 9.8 tp -87.0 44.11 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 124.169 0.918 . . . . 0.0 109.031 179.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.7 m -82.78 60.35 5.28 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 114.336 1.236 . . . . 0.0 114.336 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 17.8 p -90.92 172.4 8.62 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-N 113.501 -1.681 . . . . 0.0 109.37 179.601 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 32.3 p-10 -161.8 146.06 12.73 Favored 'General case' 0 N--CA 1.497 1.925 0 CA-C-N 115.002 -0.999 . . . . 0.0 109.681 179.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 40.3 t -63.4 -16.54 60.82 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 113.469 0.915 . . . . 0.0 113.469 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 43.8 t -80.77 -63.46 1.4 Allowed 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 114.789 1.403 . . . . 0.0 114.789 -179.515 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -85.21 62.33 7.43 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-N 114.664 -1.153 . . . . 0.0 112.377 -179.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -106.96 -111.79 3.61 Favored Glycine 0 N--CA 1.495 2.578 0 CA-C-N 113.699 -1.591 . . . . 0.0 110.257 179.715 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.456 ' H ' ' HA3' ' A' ' 27' ' ' GLY . 53.4 m -166.64 117.83 0.96 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 125.211 1.183 . . . . 0.0 109.622 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 11.0 mmmm -67.9 83.34 0.21 Allowed 'General case' 0 N--CA 1.502 2.158 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 179.504 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 168.48 -20.26 0.08 OUTLIER Glycine 0 N--CA 1.49 2.282 0 CA-C-N 114.758 -1.11 . . . . 0.0 112.226 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 68.1 m -117.71 -176.68 3.08 Favored 'General case' 0 N--CA 1.5 2.031 0 CA-C-N 117.921 0.86 . . . . 0.0 108.879 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.84 116.78 18.4 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 118.463 -1.295 . . . . 0.0 113.494 -179.657 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.44 ' N ' ' O ' ' A' ' 25' ' ' CYS . 8.2 m-85 -56.61 136.31 54.66 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-N 113.784 -1.553 . . . . 0.0 107.759 179.331 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -151.06 149.69 29.83 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 113.322 -1.763 . . . . 0.0 111.261 -179.452 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.495 ' HG ' ' HE ' ' A' ' 44' ' ' ARG . 38.1 t -98.73 134.33 41.78 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-N 111.914 -2.403 . . . . 0.0 112.174 -179.784 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -51.58 -26.44 8.74 Favored 'General case' 0 N--CA 1.5 2.061 0 CA-C-N 112.701 -2.045 . . . . 0.0 114.24 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 52.0 p-10 -59.28 -10.21 2.82 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 124.079 0.862 . . . . 0.0 112.244 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 97.62 29.65 7.67 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 108.718 -1.753 . . . . 0.0 108.718 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 56.2 m -136.06 145.86 46.45 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 124.135 0.55 . . . . 0.0 109.744 -179.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.426 ' CG ' ' N ' ' A' ' 24' ' ' VAL . 54.3 t80 -75.48 164.42 26.38 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 124.61 1.194 . . . . 0.0 110.612 179.753 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.426 ' N ' ' CG ' ' A' ' 23' ' ' PHE . 87.2 t -128.49 -75.9 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 124.075 0.859 . . . . 0.0 110.5 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.54 ' SG ' ' N ' ' A' ' 26' ' ' GLU . 0.5 OUTLIER -155.0 -164.87 1.89 Allowed 'General case' 0 N--CA 1.505 2.296 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 -179.898 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.54 ' N ' ' SG ' ' A' ' 25' ' ' CYS . 3.6 tm-20 -111.43 137.65 48.95 Favored 'General case' 0 N--CA 1.504 2.259 0 N-CA-C 106.63 -1.618 . . . . 0.0 106.63 179.588 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.456 ' HA3' ' H ' ' A' ' 11' ' ' THR . . . -54.9 117.45 8.17 Favored Glycine 0 N--CA 1.5 2.963 0 N-CA-C 110.53 -1.028 . . . . 0.0 110.53 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 39.8 mm-40 -93.5 10.35 32.81 Favored 'General case' 0 N--CA 1.499 2.022 0 N-CA-C 115.808 1.781 . . . . 0.0 115.808 -179.496 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 32.2 t -76.1 96.55 3.87 Favored 'General case' 0 N--CA 1.499 2.019 0 C-N-CA 118.651 -1.22 . . . . 0.0 108.734 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -87.74 145.91 37.93 Favored Pre-proline 0 N--CA 1.493 1.688 0 CA-C-N 114.31 -1.314 . . . . 0.0 108.486 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_exo -47.12 111.95 0.46 Allowed 'Trans proline' 0 N--CA 1.494 1.533 0 C-N-CA 122.366 2.044 . . . . 0.0 110.148 169.399 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 79.1 mtp180 57.07 48.94 14.58 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 124.439 1.087 . . . . 0.0 109.687 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -58.89 140.02 86.62 Favored Pre-proline 0 N--CA 1.498 1.928 0 CA-C-N 114.024 -1.444 . . . . 0.0 110.856 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -66.14 129.18 21.12 Favored 'Trans proline' 0 N--CA 1.492 1.409 0 C-N-CA 122.367 2.045 . . . . 0.0 110.599 -178.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 59.3 mttp 62.42 162.69 0.09 Allowed 'General case' 0 N--CA 1.503 2.222 0 O-C-N 124.742 1.276 . . . . 0.0 113.351 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -89.05 168.55 12.24 Favored 'General case' 0 N--CA 1.498 1.937 0 CA-C-N 114.528 -1.215 . . . . 0.0 110.293 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 71.3 m -79.86 163.5 24.32 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.946 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 43.7 m -138.19 7.98 2.68 Favored 'General case' 0 N--CA 1.497 1.91 0 CA-C-N 114.768 -1.106 . . . . 0.0 110.025 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 88.2 mt -79.33 -65.23 1.03 Allowed 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 7.8 m-80 56.73 116.34 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 114.911 1.448 . . . . 0.0 114.911 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 82.0 m 58.41 122.15 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 116.164 1.913 . . . . 0.0 116.164 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -144.42 90.37 6.6 Favored Pre-proline 0 N--CA 1.496 1.845 0 CA-C-N 114.637 -1.165 . . . . 0.0 109.838 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -57.39 -28.23 79.31 Favored 'Trans proline' 0 N--CA 1.493 1.482 0 C-N-CA 122.805 2.337 . . . . 0.0 113.051 179.372 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.495 ' HE ' ' HG ' ' A' ' 18' ' ' SER . 15.5 tpt180 -58.17 -41.06 83.04 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 123.934 0.771 . . . . 0.0 109.476 179.857 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 14.3 mt -70.24 154.57 8.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 CA-C-O 122.121 0.962 . . . . 0.0 110.163 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -121.15 -50.66 2.13 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-N 111.938 -2.392 . . . . 0.0 107.343 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 19.5 p90 -171.85 164.18 6.39 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-N 114.242 -1.345 . . . . 0.0 111.214 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -104.01 91.36 0.8 Allowed Glycine 0 N--CA 1.492 2.401 0 N-CA-C 107.159 -2.376 . . . . 0.0 107.159 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.1 p -84.25 126.66 40.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 C-N-CA 119.123 -1.031 . . . . 0.0 112.893 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.6 m -79.64 154.0 75.99 Favored Pre-proline 0 N--CA 1.496 1.868 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 179.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -71.35 81.6 1.2 Allowed 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 122.739 2.292 . . . . 0.0 109.743 -173.167 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 25.5 mtp-105 -148.54 161.3 41.94 Favored 'General case' 0 N--CA 1.496 1.856 0 CA-C-N 114.199 -1.364 . . . . 0.0 108.656 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 45.1 t -69.52 115.62 8.98 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -66.29 -43.6 85.89 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 123.879 0.737 . . . . 0.0 109.878 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.432 ' HG2' ' H ' ' A' ' 62' ' ' CYS . 19.4 mp0 -93.43 121.15 34.52 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 179.715 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 10.4 mtmp? -139.16 -50.47 0.52 Allowed 'General case' 0 N--CA 1.495 1.791 0 CA-C-N 114.44 -1.254 . . . . 0.0 108.875 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -86.73 -76.97 0.34 Allowed 'General case' 0 N--CA 1.496 1.827 0 CA-C-N 115.047 -0.979 . . . . 0.0 110.002 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 36.8 t30 -162.07 51.76 0.22 Allowed 'General case' 0 N--CA 1.498 1.974 0 CA-C-O 121.976 0.893 . . . . 0.0 109.126 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -92.76 37.61 1.02 Allowed 'General case' 0 N--CA 1.498 1.948 0 CA-C-N 114.501 -1.227 . . . . 0.0 109.362 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 59.3 ttt85 57.45 95.01 0.03 OUTLIER 'General case' 0 N--CA 1.504 2.243 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 -179.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 8.2 tp -39.4 102.93 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 124.364 1.04 . . . . 0.0 113.685 -179.655 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . 0.452 ' HA ' ' HA ' ' A' ' 99' ' ' CYS . 1.7 m -131.47 39.34 3.52 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 113.852 -1.522 . . . . 0.0 111.607 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 87.0 m -90.52 171.64 9.27 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-N 112.255 -2.248 . . . . 0.0 107.625 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -160.37 -162.7 1.0 Allowed 'General case' 0 N--CA 1.5 2.061 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' CYS . . . . . 0.469 ' SG ' ' CD2' ' A' ' 74' ' ' TYR . 3.9 t -107.01 -28.26 10.14 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 124.071 0.857 . . . . 0.0 109.78 179.766 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . 0.451 ' SG ' ' CE ' ' A' ' 93' ' ' LYS . 51.0 t -73.88 -57.63 3.85 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 114.918 1.451 . . . . 0.0 114.918 -179.669 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -80.75 60.09 3.9 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 124.833 1.333 . . . . 0.0 112.565 -179.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -145.57 -139.91 3.45 Favored Glycine 0 N--CA 1.497 2.73 0 N-CA-C 108.253 -1.939 . . . . 0.0 108.253 179.625 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.456 ' C ' ' H ' ' A' ' 71' ' ' GLY . 92.4 m -154.03 150.72 28.54 Favored 'General case' 0 N--CA 1.505 2.319 0 N-CA-C 114.434 1.272 . . . . 0.0 114.434 -179.825 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 24.0 mmtt -72.63 35.87 0.07 Allowed 'General case' 0 N--CA 1.505 2.304 0 CA-C-N 113.042 -1.89 . . . . 0.0 112.689 179.634 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.456 ' H ' ' C ' ' A' ' 69' ' ' THR . . . -131.92 2.52 5.19 Favored Glycine 0 N--CA 1.485 1.923 0 N-CA-C 109.141 -1.584 . . . . 0.0 109.141 179.867 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 94.1 m -141.7 167.01 23.17 Favored 'General case' 0 N--CA 1.497 1.916 0 C-N-CA 119.384 -0.926 . . . . 0.0 111.376 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -119.89 105.45 11.1 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 124.184 0.928 . . . . 0.0 109.67 -179.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.648 ' CD2' ' SG ' ' A' ' 83' ' ' CYS . 74.0 m-85 -51.13 135.88 24.81 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 124.047 0.842 . . . . 0.0 110.382 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -146.96 157.22 43.57 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 -179.571 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 42.9 t -110.4 130.99 55.44 Favored 'General case' 0 N--CA 1.501 2.085 0 CA-C-N 113.441 -1.709 . . . . 0.0 113.281 -179.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.465 ' H ' ' HB1' ' A' ' 104' ' ' ALA . 7.3 p-10 -46.08 -31.5 2.37 Favored 'General case' 0 N--CA 1.502 2.141 0 CA-C-N 112.562 -2.108 . . . . 0.0 115.349 -179.861 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 39.1 p30 -57.42 -10.09 1.29 Allowed 'General case' 0 N--CA 1.497 1.901 0 O-C-N 124.268 0.98 . . . . 0.0 112.794 -179.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 99.1 23.84 11.03 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 110.159 -1.177 . . . . 0.0 110.159 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -131.31 146.87 52.48 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 124.211 0.595 . . . . 0.0 109.631 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 45.1 t80 -77.53 154.92 31.97 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 114.124 -1.398 . . . . 0.0 110.714 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 92.8 t -113.08 -73.45 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 124.19 0.931 . . . . 0.0 112.767 -179.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . 0.648 ' SG ' ' CD2' ' A' ' 74' ' ' TYR . 29.7 p -157.3 -174.0 4.69 Favored 'General case' 0 N--CA 1.503 2.181 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 -179.585 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -119.43 155.92 31.11 Favored 'General case' 0 N--CA 1.505 2.282 0 CA-C-O 119.003 -0.522 . . . . 0.0 109.793 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.406 ' HA2' ' CE2' ' A' ' 74' ' ' TYR . . . -31.22 111.78 0.05 OUTLIER Glycine 0 N--CA 1.502 3.048 0 O-C-N 124.838 1.337 . . . . 0.0 112.599 179.901 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -100.84 27.54 5.88 Favored 'General case' 0 N--CA 1.498 1.932 0 C-N-CA 119.97 -0.692 . . . . 0.0 109.199 -179.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.407 ' HG ' HD22 ' A' ' 91' ' ' ASN . 42.6 t -140.55 95.95 2.95 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-O 121.469 0.652 . . . . 0.0 111.959 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -84.72 148.08 50.58 Favored Pre-proline 0 N--CA 1.496 1.845 0 N-CA-C 106.15 -1.796 . . . . 0.0 106.15 179.717 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -64.67 86.56 0.17 Allowed 'Trans proline' 0 N--CA 1.493 1.447 0 N-CA-C 108.265 -1.475 . . . . 0.0 108.265 165.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 44.2 mtm180 150.82 -27.04 0.01 OUTLIER 'General case' 0 N--CA 1.513 2.693 0 O-C-N 125.741 1.901 . . . . 0.0 109.753 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.407 HD22 ' HG ' ' A' ' 87' ' ' SER . 31.3 p-10 -41.51 116.17 1.5 Allowed Pre-proline 0 N--CA 1.501 2.083 0 N-CA-C 114.177 1.177 . . . . 0.0 114.177 -179.713 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -76.62 77.11 3.76 Favored 'Trans proline' 0 N--CA 1.493 1.474 0 C-N-CA 122.721 2.281 . . . . 0.0 109.565 174.423 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.451 ' CE ' ' SG ' ' A' ' 66' ' ' CYS . 21.4 ptmt -167.9 170.46 10.61 Favored 'General case' 0 N--CA 1.498 1.93 0 CA-C-N 114.759 -1.109 . . . . 0.0 110.685 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -160.19 147.42 16.2 Favored 'General case' 0 N--CA 1.497 1.883 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.322 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 58.2 m -153.54 130.31 5.69 Favored Pre-proline 0 N--CA 1.497 1.879 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.379 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.424 ' HD2' HD22 ' A' ' 98' ' ' ASN . 18.4 Cg_endo -63.51 -78.37 0.01 OUTLIER 'Trans proline' 0 N--CA 1.493 1.489 0 C-N-CA 122.316 2.01 . . . . 0.0 111.511 171.721 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 60.6 mmt-85 -135.68 -44.89 0.67 Allowed 'General case' 0 N--CA 1.499 2.007 0 O-C-N 123.995 0.809 . . . . 0.0 112.432 -179.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.424 HD22 ' HD2' ' A' ' 96' ' ' PRO . 3.5 m-80 49.44 58.62 5.21 Favored 'General case' 0 N--CA 1.503 2.197 0 O-C-N 124.313 1.008 . . . . 0.0 108.367 -179.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . 0.452 ' HA ' ' HA ' ' A' ' 62' ' ' CYS . 37.1 m -35.77 127.57 0.67 Allowed 'General case' 0 N--CA 1.494 1.735 0 CA-C-N 113.573 -1.649 . . . . 0.0 115.25 -179.523 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -129.35 98.78 22.34 Favored Pre-proline 0 N--CA 1.493 1.708 0 CA-C-N 114.25 -1.341 . . . . 0.0 110.268 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -63.85 -12.0 29.61 Favored 'Trans proline' 0 N--CA 1.494 1.522 0 C-N-CA 122.011 1.807 . . . . 0.0 112.166 -178.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 80.8 mtm180 -80.28 -30.55 38.32 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 112.675 0.621 . . . . 0.0 112.675 -179.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 11.8 tt -90.88 164.07 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.164 0 C-N-CA 120.036 -0.665 . . . . 0.0 110.097 -179.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.465 ' HB1' ' H ' ' A' ' 77' ' ' ASP . . . -124.15 -59.67 1.47 Allowed 'General case' 0 N--CA 1.496 1.848 0 CA-C-N 114.758 -1.11 . . . . 0.0 108.394 179.826 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 21.7 p90 -161.33 161.79 30.64 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-N 114.631 -1.168 . . . . 0.0 111.03 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -94.95 115.24 5.05 Favored Glycine 0 N--CA 1.492 2.389 0 CA-C-N 113.59 -1.641 . . . . 0.0 111.575 -179.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 12.4 pt -83.63 102.44 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.27 0 N-CA-C 105.725 -1.954 . . . . 0.0 105.725 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 13.4 m -79.48 133.04 60.35 Favored Pre-proline 0 N--CA 1.49 1.554 0 CA-C-N 113.8 -1.545 . . . . 0.0 110.295 -179.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -73.72 88.15 1.07 Allowed 'Trans proline' 0 N--CA 1.492 1.433 0 C-N-CA 122.599 2.199 . . . . 0.0 110.46 -177.127 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 84.7 mt -79.75 -42.39 24.65 Favored 'General case' 0 N--CA 1.498 1.949 0 CA-C-N 115.261 -0.881 . . . . 0.0 108.867 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.833 0 CA-C-O 116.773 -1.584 . . . . 0.0 110.66 179.972 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 93.6 mtt-85 . . . . . 0 N--CA 1.496 1.841 0 N-CA-C 110.213 -0.292 . . . . 0.0 110.213 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 7.9 tp -83.79 52.92 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 CA-C-N 115.052 -0.976 . . . . 0.0 109.636 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.514 ' HA ' ' HA ' ' A' ' 41' ' ' CYS . 1.5 m -82.72 51.75 1.96 Allowed 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 117.061 2.245 . . . . 0.0 117.061 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 7.2 p -91.75 164.63 13.64 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-N 113.169 -1.832 . . . . 0.0 109.035 179.545 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.464 ' ND2' ' H ' ' A' ' 9' ' ' ALA . 37.7 p-10 -160.88 148.13 15.47 Favored 'General case' 0 N--CA 1.499 1.985 0 C-N-CA 119.917 -0.713 . . . . 0.0 110.058 179.777 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 18.4 t -67.11 -20.24 65.75 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-N 114.864 -1.062 . . . . 0.0 112.892 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 43.7 t -81.34 -64.46 1.18 Allowed 'General case' 0 N--CA 1.497 1.878 0 O-C-N 123.607 0.567 . . . . 0.0 112.128 -179.713 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.464 ' H ' ' ND2' ' A' ' 6' ' ' ASN . . . -89.22 45.12 1.26 Allowed 'General case' 0 N--CA 1.5 2.044 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.896 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -84.17 -147.13 7.93 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 110.337 -1.105 . . . . 0.0 110.337 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 40.4 p -137.62 95.29 3.03 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.11 112.98 0.81 Allowed 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 144.97 -34.58 1.55 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 108.301 -1.92 . . . . 0.0 108.301 -179.739 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 35.4 m -106.09 130.29 54.02 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -83.11 91.61 7.25 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 113.627 -1.624 . . . . 0.0 110.132 -179.675 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.409 ' N ' ' O ' ' A' ' 25' ' ' CYS . 39.8 m-85 -50.09 122.1 6.32 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-N 114.028 -1.442 . . . . 0.0 109.081 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -132.44 153.32 50.97 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-N 112.316 -2.22 . . . . 0.0 110.643 -179.67 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 31.2 t -99.15 141.18 32.25 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-N 111.679 -2.509 . . . . 0.0 115.628 -179.548 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -52.17 -25.05 8.1 Favored 'General case' 0 N--CA 1.499 1.983 0 CA-C-N 111.002 -2.817 . . . . 0.0 113.269 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 52.5 p-10 -62.59 -4.79 2.16 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 124.092 0.87 . . . . 0.0 111.609 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 88.92 30.15 15.72 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 108.781 -1.728 . . . . 0.0 108.781 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 87.0 m -141.66 146.87 36.65 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 124.087 0.522 . . . . 0.0 110.585 -179.764 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 39.9 t80 -73.02 162.81 29.05 Favored 'General case' 0 N--CA 1.496 1.827 0 CA-C-N 114.35 -1.296 . . . . 0.0 110.04 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 58.7 t -127.56 -79.44 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 CA-C-N 115.282 -0.872 . . . . 0.0 108.991 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.57 ' SG ' ' N ' ' A' ' 26' ' ' GLU . 0.1 OUTLIER -156.99 -170.47 3.3 Favored 'General case' 0 N--CA 1.504 2.258 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 179.971 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.57 ' N ' ' SG ' ' A' ' 25' ' ' CYS . 37.6 tt0 -118.64 154.29 32.91 Favored 'General case' 0 N--CA 1.503 2.214 0 N-CA-C 106.079 -1.823 . . . . 0.0 106.079 179.444 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -50.15 116.9 4.38 Favored Glycine 0 N--CA 1.498 2.791 0 C-N-CA 120.088 -1.053 . . . . 0.0 112.721 -179.781 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -79.66 -17.2 54.24 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 41.1 t -112.38 112.96 24.9 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.646 ' H ' HD21 ' A' ' 33' ' ' ASN . 16.0 t0 -79.38 138.55 55.56 Favored Pre-proline 0 N--CA 1.494 1.735 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_endo -65.48 75.22 0.27 Allowed 'Trans proline' 0 N--CA 1.498 1.746 0 C-N-CA 122.705 2.27 . . . . 0.0 106.577 161.509 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 43.1 ttp85 -173.0 -53.43 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 104.982 -2.229 . . . . 0.0 104.982 -179.604 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.646 HD21 ' H ' ' A' ' 30' ' ' ASP . 25.9 p30 -90.7 156.44 44.95 Favored Pre-proline 0 N--CA 1.494 1.759 0 CA-C-N 114.638 -1.165 . . . . 0.0 110.978 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -71.54 177.16 7.11 Favored 'Trans proline' 0 N--CA 1.493 1.469 0 C-N-CA 122.643 2.229 . . . . 0.0 110.311 168.004 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.439 ' HD2' ' N ' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -161.41 153.07 19.15 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.247 179.983 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -148.12 62.37 1.11 Allowed 'General case' 0 N--CA 1.495 1.819 0 CA-C-N 115.067 -0.969 . . . . 0.0 109.127 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 72.4 m -79.57 -50.48 10.64 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-N 114.388 -1.278 . . . . 0.0 109.358 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 26.3 m 64.31 -9.12 0.17 Allowed 'General case' 0 N--CA 1.503 2.176 0 O-C-N 124.781 1.301 . . . . 0.0 113.448 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.441 ' HG ' ' H ' ' A' ' 40' ' ' ASN . 2.1 pp -79.56 -55.59 4.92 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 120.251 -0.58 . . . . 0.0 109.559 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.441 ' H ' ' HG ' ' A' ' 39' ' ' LEU . 33.6 m120 47.42 -177.77 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 115.927 1.825 . . . . 0.0 115.927 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.514 ' HA ' ' HA ' ' A' ' 4' ' ' CYS . 58.1 m 48.63 119.36 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 116.667 2.099 . . . . 0.0 116.667 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 60.1 t0 -152.16 94.97 3.21 Favored Pre-proline 0 N--CA 1.489 1.517 0 CA-C-N 113.789 -1.55 . . . . 0.0 108.46 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -53.63 -17.86 10.69 Favored 'Trans proline' 0 N--CA 1.495 1.591 0 C-N-CA 122.896 2.398 . . . . 0.0 113.046 178.61 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 10.9 tpt180 -59.06 -50.82 72.61 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.44 ' CG2' ' N ' ' A' ' 46' ' ' ALA . 2.0 mp -62.89 159.2 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 CA-C-O 122.623 1.201 . . . . 0.0 112.264 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.44 ' N ' ' CG2' ' A' ' 45' ' ' ILE . . . -127.29 -48.63 1.44 Allowed 'General case' 0 N--CA 1.492 1.641 0 CA-C-N 111.33 -2.668 . . . . 0.0 106.267 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 51.8 p90 -166.23 -163.42 0.6 Allowed 'General case' 0 N--CA 1.495 1.817 0 CA-C-N 113.637 -1.619 . . . . 0.0 107.373 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -145.83 113.15 0.67 Allowed Glycine 0 N--CA 1.495 2.567 0 N-CA-C 108.621 -1.791 . . . . 0.0 108.621 179.736 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.7 p -79.77 105.91 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 N-CA-C 114.284 1.216 . . . . 0.0 114.284 -179.834 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.7 m -81.81 117.45 68.35 Favored Pre-proline 0 N--CA 1.5 2.068 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 179.483 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo . . . . . 0 N--CA 1.494 1.531 0 C-N-CA 122.05 1.833 . . . . 0.0 110.623 178.383 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.501 ' HA ' ' HA ' ' A' ' 99' ' ' CYS . 1.6 m . . . . . 0 N--CA 1.495 1.816 0 N-CA-C 115.916 1.821 . . . . 0.0 115.916 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -91.59 148.0 22.6 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-N 112.272 -2.24 . . . . 0.0 107.353 179.512 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.419 ' HB3' ' H ' ' A' ' 100' ' ' ASP . 15.2 p30 -162.05 147.78 13.2 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 114.469 1.285 . . . . 0.0 114.469 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -63.25 -20.67 65.66 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-N 114.351 -1.295 . . . . 0.0 112.582 179.621 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 41.8 t -90.65 -74.78 0.48 Allowed 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -89.5 35.57 0.82 Allowed 'General case' 0 N--CA 1.497 1.895 0 CA-C-N 114.433 -1.258 . . . . 0.0 113.139 -179.518 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.415 ' HA3' ' CZ ' ' A' ' 74' ' ' TYR . . . -81.04 -112.34 0.32 Allowed Glycine 0 N--CA 1.494 2.531 0 N-CA-C 109.135 -1.586 . . . . 0.0 109.135 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.54 ' H ' ' HA3' ' A' ' 85' ' ' GLY . 38.2 p -153.7 123.03 6.58 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 179.671 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -70.21 93.87 0.87 Allowed 'General case' 0 N--CA 1.502 2.125 0 CA-C-O 122.089 0.947 . . . . 0.0 109.516 179.766 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 162.99 -27.21 0.23 Allowed Glycine 0 N--CA 1.487 2.058 0 CA-C-N 113.107 -1.86 . . . . 0.0 109.947 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 36.1 m -108.8 141.65 40.51 Favored 'General case' 0 N--CA 1.497 1.902 0 C-N-CA 120.024 -0.67 . . . . 0.0 110.209 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.471 ' HB3' ' CE1' ' A' ' 81' ' ' PHE . 58.6 mtpt -83.7 89.11 7.09 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 113.726 -1.579 . . . . 0.0 109.683 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.415 ' CZ ' ' HA3' ' A' ' 68' ' ' GLY . 27.7 m-85 -59.56 116.45 4.01 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 106.13 -1.804 . . . . 0.0 106.13 179.734 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -121.14 146.86 46.32 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 111.483 -2.599 . . . . 0.0 112.516 -179.449 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.416 ' CB ' ' HE ' ' A' ' 102' ' ' ARG . 32.0 t -91.31 144.23 25.81 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-N 112.363 -2.199 . . . . 0.0 116.312 -179.586 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -53.09 -21.16 4.39 Favored 'General case' 0 N--CA 1.497 1.901 0 CA-C-N 110.603 -2.999 . . . . 0.0 113.322 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 18.4 p30 -66.77 -0.15 2.79 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 124.183 0.927 . . . . 0.0 110.773 179.671 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 83.48 29.83 31.84 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 93.6 m -142.83 142.86 31.91 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 120.394 -0.522 . . . . 0.0 110.939 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.471 ' CE1' ' HB3' ' A' ' 73' ' ' LYS . 9.7 t80 -73.93 143.41 45.72 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-N 114.373 -1.285 . . . . 0.0 109.705 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 67.6 t -104.58 -77.91 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -166.97 172.85 9.83 Favored 'General case' 0 N--CA 1.503 2.219 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 179.733 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.456 ' HG2' ' N ' ' A' ' 85' ' ' GLY . 22.7 tt0 -79.64 150.22 31.03 Favored 'General case' 0 N--CA 1.501 2.085 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 179.705 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.54 ' HA3' ' H ' ' A' ' 69' ' ' THR . . . -65.74 127.67 31.27 Favored Glycine 0 N--CA 1.494 2.522 0 N-CA-C 104.251 -3.54 . . . . 0.0 104.251 179.721 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -93.75 23.42 4.77 Favored 'General case' 0 N--CA 1.497 1.905 0 CA-C-N 118.049 0.924 . . . . 0.0 113.337 -179.488 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 25.1 t -84.26 98.53 10.03 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-N 114.529 -1.214 . . . . 0.0 108.288 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -79.86 155.37 75.46 Favored Pre-proline 0 N--CA 1.496 1.834 0 N-CA-C 107.529 -1.285 . . . . 0.0 107.529 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo -38.58 108.21 0.07 OUTLIER 'Trans proline' 0 N--CA 1.493 1.483 0 C-N-CA 122.386 2.057 . . . . 0.0 112.147 162.659 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER 59.06 50.89 7.63 Favored 'General case' 0 N--CA 1.497 1.92 0 CA-C-N 114.676 -1.147 . . . . 0.0 110.876 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.676 ' H ' HD22 ' A' ' 91' ' ' ASN . 0.5 OUTLIER -79.43 119.61 77.56 Favored Pre-proline 0 N--CA 1.497 1.875 0 CA-C-N 113.898 -1.501 . . . . 0.0 111.878 -179.96 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -79.87 79.36 3.37 Favored 'Trans proline' 0 N--CA 1.493 1.474 0 C-N-CA 123.093 2.529 . . . . 0.0 109.986 172.651 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 14.1 ptmm? -166.06 144.56 5.79 Favored 'General case' 0 N--CA 1.5 2.029 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.721 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -160.12 103.29 1.46 Allowed 'General case' 0 N--CA 1.496 1.854 0 CA-C-N 114.649 -1.16 . . . . 0.0 108.575 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 35.1 m -79.77 168.67 24.51 Favored Pre-proline 0 N--CA 1.498 1.959 0 CA-C-N 115.122 -0.944 . . . . 0.0 109.297 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -57.91 -5.7 2.14 Favored 'Trans proline' 0 N--CA 1.496 1.672 0 C-N-CA 122.292 1.995 . . . . 0.0 112.404 162.693 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 35.2 mmt180 -79.52 7.26 8.51 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 123.49 0.494 . . . . 0.0 111.828 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -50.03 117.39 2.3 Favored 'General case' 0 N--CA 1.503 2.196 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.501 ' HA ' ' HA ' ' A' ' 62' ' ' CYS . 91.4 m 56.07 65.38 1.46 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 124.538 1.149 . . . . 0.0 108.048 -179.572 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.419 ' H ' ' HB3' ' A' ' 64' ' ' ASN . 18.9 t70 -62.35 109.55 2.45 Favored Pre-proline 0 N--CA 1.498 1.926 0 CA-C-N 114.356 -1.293 . . . . 0.0 112.287 -179.582 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -69.44 -34.75 14.98 Favored 'Trans proline' 0 N--CA 1.493 1.463 0 C-N-CA 122.049 1.833 . . . . 0.0 109.783 -174.806 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.416 ' HE ' ' CB ' ' A' ' 76' ' ' SER . 0.0 OUTLIER -63.48 -21.37 66.28 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-N 114.447 -1.252 . . . . 0.0 111.659 -179.96 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 4.4 tp -76.49 177.7 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 C-N-CA 119.218 -0.993 . . . . 0.0 108.403 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -130.37 -61.32 0.97 Allowed 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 -147.73 -161.61 1.37 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 124.48 1.113 . . . . 0.0 109.042 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -142.35 95.13 0.19 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 106.016 -2.834 . . . . 0.0 106.016 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 42.5 mm -78.72 98.86 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 N-CA-C 113.792 1.034 . . . . 0.0 113.792 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 1.6 m -79.52 153.63 76.19 Favored Pre-proline 0 N--CA 1.501 2.091 0 CA-C-N 114.952 -1.022 . . . . 0.0 108.262 179.499 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo . . . . . 0 N--CA 1.494 1.502 0 C-N-CA 122.542 2.162 . . . . 0.0 109.942 179.445 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 61.7 ttm-85 . . . . . 0 N--CA 1.494 1.728 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.405 HG22 ' H ' ' A' ' 3' ' ' ILE . 6.0 tp -79.85 71.88 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 CA-C-N 114.399 -1.273 . . . . 0.0 110.038 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.6 m -89.97 57.47 3.82 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 122.849 1.309 . . . . 0.0 114.159 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.446 ' O ' ' N ' ' A' ' 42' ' ' ASP . 1.1 p -90.06 157.05 17.97 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 104.275 -2.491 . . . . 0.0 104.275 179.204 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.424 ' HB3' ' H ' ' A' ' 9' ' ' ALA . 6.7 t-20 -160.77 -177.3 6.06 Favored 'General case' 0 N--CA 1.5 2.036 0 C-N-CA 118.149 -1.42 . . . . 0.0 112.083 -179.684 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.476 ' SG ' ' CD2' ' A' ' 16' ' ' TYR . 1.8 t -76.78 -32.98 58.04 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-N 113.328 -1.76 . . . . 0.0 107.115 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 34.1 t -82.12 -57.57 3.34 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-N 112.003 -2.362 . . . . 0.0 107.609 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.424 ' H ' ' HB3' ' A' ' 6' ' ' ASN . . . -57.56 -23.43 50.5 Favored 'General case' 0 N--CA 1.497 1.912 0 CA-C-N 114.484 -1.235 . . . . 0.0 110.77 179.85 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -71.41 -168.09 8.79 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 110.756 -0.938 . . . . 0.0 110.756 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 41.1 p -104.71 103.19 12.78 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.462 ' HA ' ' CA ' ' A' ' 27' ' ' GLY . 39.1 ttpt -48.16 104.97 0.07 Allowed 'General case' 0 N--CA 1.5 2.048 0 O-C-N 123.737 0.648 . . . . 0.0 111.322 179.673 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 149.69 -20.42 1.15 Allowed Glycine 0 N--CA 1.491 2.36 0 CA-C-N 114.364 -1.289 . . . . 0.0 111.033 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 96.2 m -107.41 149.45 27.88 Favored 'General case' 0 N--CA 1.499 2.023 0 C-N-CA 120.316 -0.554 . . . . 0.0 112.069 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -83.13 93.71 7.68 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-N 114.273 -1.33 . . . . 0.0 107.754 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.476 ' CD2' ' SG ' ' A' ' 7' ' ' CYS . 48.6 m-85 -52.76 130.07 31.69 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-N 113.997 -1.456 . . . . 0.0 109.027 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -143.47 155.03 44.25 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-N 113.174 -1.83 . . . . 0.0 112.339 -179.438 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 38.3 t -101.37 136.01 41.92 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-N 112.449 -2.16 . . . . 0.0 112.577 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.473 ' H ' ' HB2' ' A' ' 46' ' ' ALA . 5.6 p-10 -50.04 -25.11 3.08 Favored 'General case' 0 N--CA 1.502 2.129 0 CA-C-N 112.626 -2.079 . . . . 0.0 114.186 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 27.4 p30 -59.69 -7.49 1.58 Allowed 'General case' 0 N--CA 1.498 1.952 0 O-C-N 124.228 0.955 . . . . 0.0 112.288 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 94.25 28.36 10.82 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 88.5 m -141.43 142.79 33.67 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 124.149 0.558 . . . . 0.0 110.144 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.408 ' CG ' ' N ' ' A' ' 24' ' ' VAL . 40.5 t80 -68.79 166.93 16.52 Favored 'General case' 0 N--CA 1.497 1.878 0 CA-C-N 114.194 -1.366 . . . . 0.0 110.82 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.408 ' N ' ' CG ' ' A' ' 23' ' ' PHE . 97.5 t -128.89 -72.31 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 123.996 0.81 . . . . 0.0 111.82 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.462 ' SG ' ' HD2' ' A' ' 16' ' ' TYR . 20.8 p -154.31 -168.6 2.98 Favored 'General case' 0 N--CA 1.503 2.199 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 -179.745 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 60.5 tt0 -139.66 151.12 45.69 Favored 'General case' 0 N--CA 1.501 2.096 0 CA-C-O 121.446 0.641 . . . . 0.0 111.369 179.752 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.462 ' CA ' ' HA ' ' A' ' 12' ' ' LYS . . . -7.25 103.71 0.01 OUTLIER Glycine 0 N--CA 1.497 2.716 0 N-CA-C 119.333 2.493 . . . . 0.0 119.333 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -99.48 -52.25 3.54 Favored 'General case' 0 N--CA 1.501 2.112 0 C-N-CA 119.71 -0.796 . . . . 0.0 110.355 179.715 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.425 ' CA ' ' HB2' ' A' ' 12' ' ' LYS . 6.5 p -149.83 142.18 24.24 Favored 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.419 ' HB2' ' HB3' ' A' ' 12' ' ' LYS . 10.5 t70 -101.88 144.85 29.4 Favored Pre-proline 0 N--CA 1.498 1.943 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_exo -45.12 -25.2 1.69 Allowed 'Trans proline' 0 N--CA 1.498 1.778 0 C-N-CA 122.918 2.412 . . . . 0.0 112.868 170.087 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.437 ' NE ' ' HA ' ' A' ' 32' ' ' ARG . 3.6 tpm_? -62.9 -53.45 54.0 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -85.65 129.41 54.95 Favored Pre-proline 0 N--CA 1.494 1.73 0 CA-C-N 115.133 -0.94 . . . . 0.0 109.221 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -65.38 108.2 1.14 Allowed 'Trans proline' 0 N--CA 1.493 1.5 0 C-N-CA 122.317 2.011 . . . . 0.0 109.471 -179.7 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.504 ' HD3' ' H ' ' A' ' 36' ' ' ALA . 6.1 tmtt? -154.53 142.12 19.81 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.504 ' H ' ' HD3' ' A' ' 35' ' ' LYS . . . -149.3 111.07 4.54 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-N 113.382 -1.736 . . . . 0.0 107.644 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.461 ' H ' HD21 ' A' ' 40' ' ' ASN . 70.3 m -79.96 -168.73 1.73 Allowed 'General case' 0 N--CA 1.495 1.815 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.104 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 9.2 t -104.94 13.84 30.4 Favored 'General case' 0 N--CA 1.497 1.911 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.351 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -160.38 64.66 0.33 Allowed 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.461 HD21 ' H ' ' A' ' 37' ' ' CYS . 12.0 m120 -88.65 46.15 1.36 Allowed 'General case' 0 N--CA 1.498 1.939 0 CA-C-N 114.292 -1.322 . . . . 0.0 111.172 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 80.4 m -145.16 139.29 27.16 Favored 'General case' 0 N--CA 1.499 2.02 0 CA-C-N 115.014 -0.993 . . . . 0.0 108.547 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.446 ' N ' ' O ' ' A' ' 5' ' ' THR . 34.2 t70 -166.2 88.35 0.87 Allowed Pre-proline 0 N--CA 1.497 1.896 0 O-C-N 123.794 0.684 . . . . 0.0 110.207 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_exo -53.53 -15.29 5.98 Favored 'Trans proline' 0 N--CA 1.495 1.617 0 C-N-CA 122.466 2.111 . . . . 0.0 112.961 173.667 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 41.5 ttm180 -76.89 -39.06 52.31 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 113.302 0.853 . . . . 0.0 113.302 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 7.6 tt -75.8 142.9 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.175 0 C-N-CA 118.746 -1.181 . . . . 0.0 111.714 -179.62 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.473 ' HB2' ' H ' ' A' ' 19' ' ' ASP . . . -104.84 -49.84 3.41 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-N 113.638 -1.619 . . . . 0.0 107.737 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 52.1 p90 -163.52 -163.07 0.78 Allowed 'General case' 0 N--CA 1.496 1.868 0 CA-C-N 114.07 -1.423 . . . . 0.0 107.423 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -144.98 122.27 1.7 Allowed Glycine 0 N--CA 1.494 2.549 0 N-CA-C 109.13 -1.588 . . . . 0.0 109.13 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.6 p -88.69 108.75 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 CA-C-O 121.545 0.688 . . . . 0.0 112.799 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.7 m -79.78 137.13 54.46 Favored Pre-proline 0 N--CA 1.499 1.987 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.218 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo . . . . . 0 N--CA 1.494 1.507 0 C-N-CA 122.376 2.051 . . . . 0.0 110.063 177.292 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.696 ' HA ' ' HA ' ' A' ' 99' ' ' CYS . 1.7 m . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 123.916 1.817 . . . . 0.0 115.453 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 61.2 m -91.42 139.86 30.32 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 110.399 -3.091 . . . . 0.0 103.189 179.247 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 38.1 p-10 -160.81 161.32 31.96 Favored 'General case' 0 N--CA 1.497 1.898 0 C-N-CA 119.771 -0.772 . . . . 0.0 112.988 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 1.3 t -55.75 -23.22 28.15 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-N 113.511 -1.677 . . . . 0.0 112.227 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 52.8 t -89.38 -70.46 0.66 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 124.146 0.904 . . . . 0.0 110.502 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.441 ' HB2' ' SG ' ' A' ' 95' ' ' CYS . . . -90.18 62.15 5.38 Favored 'General case' 0 N--CA 1.499 2.007 0 CA-C-O 121.633 0.73 . . . . 0.0 109.497 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -113.19 -137.59 6.85 Favored Glycine 0 N--CA 1.493 2.481 0 CA-C-N 114.396 -1.274 . . . . 0.0 111.478 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.436 ' N ' ' HA3' ' A' ' 85' ' ' GLY . 37.7 p -128.44 117.61 21.67 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-N 114.494 -0.853 . . . . 0.0 109.464 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 61.5 mtpt -69.65 86.91 0.48 Allowed 'General case' 0 N--CA 1.498 1.967 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.018 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 164.75 -31.02 0.24 Allowed Glycine 0 N--CA 1.489 2.196 0 CA-C-N 114.095 -1.412 . . . . 0.0 110.613 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 74.6 m -105.12 131.71 52.27 Favored 'General case' 0 N--CA 1.5 2.034 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.8 mppt? -83.98 87.48 7.12 Favored 'General case' 0 N--CA 1.484 1.254 0 O-C-N 124.808 1.318 . . . . 0.0 110.398 -179.51 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 8.9 m-30 -51.84 129.43 26.59 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -133.03 157.26 45.67 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-N 113.433 -1.712 . . . . 0.0 111.79 -179.34 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 44.3 t -102.36 136.58 41.94 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-N 113.157 -1.838 . . . . 0.0 112.867 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 8.6 p30 -53.11 -23.57 8.29 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 115.538 1.681 . . . . 0.0 115.538 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 18.7 p-10 -62.61 -7.45 4.76 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 123.704 0.628 . . . . 0.0 111.024 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 94.49 29.96 9.0 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 108.507 -1.837 . . . . 0.0 108.507 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 46.1 m -133.97 135.93 43.81 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 124.162 0.566 . . . . 0.0 110.204 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.484 ' CZ ' ' HA ' ' A' ' 83' ' ' CYS . 8.0 t80 -76.02 141.63 42.07 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-N 114.703 -1.135 . . . . 0.0 108.776 179.787 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 45.5 t -97.29 -78.38 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' CYS . . . . . 0.484 ' HA ' ' CZ ' ' A' ' 81' ' ' PHE . 0.1 OUTLIER -178.5 171.67 1.54 Allowed 'General case' 0 N--CA 1.505 2.308 0 O-C-N 123.51 0.507 . . . . 0.0 110.005 179.705 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.408 ' O ' ' SG ' ' A' ' 83' ' ' CYS . 39.9 tt0 -86.07 150.93 24.1 Favored 'General case' 0 N--CA 1.503 2.203 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 179.747 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.436 ' HA3' ' N ' ' A' ' 69' ' ' THR . . . -53.25 133.58 41.97 Favored Glycine 0 N--CA 1.5 2.945 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -99.81 29.18 4.28 Favored 'General case' 0 N--CA 1.502 2.15 0 CA-C-O 121.892 0.853 . . . . 0.0 109.445 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 44.9 t -146.38 131.73 18.57 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 107.532 -1.285 . . . . 0.0 107.532 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.909 ' HB3' HD22 ' A' ' 91' ' ' ASN . 2.4 t70 -79.38 136.16 56.72 Favored Pre-proline 0 N--CA 1.493 1.71 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_endo -67.95 70.93 0.82 Allowed 'Trans proline' 0 N--CA 1.5 1.872 0 C-N-CA 123.688 2.925 . . . . 0.0 113.554 -176.346 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 82.8 mtt85 -162.88 -51.7 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 103.74 -2.689 . . . . 0.0 103.74 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.909 HD22 ' HB3' ' A' ' 88' ' ' ASP . 2.3 p30 -91.09 116.0 65.51 Favored Pre-proline 0 N--CA 1.493 1.719 0 CA-C-N 113.275 -1.784 . . . . 0.0 110.748 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -78.17 93.76 1.09 Allowed 'Trans proline' 0 N--CA 1.492 1.398 0 C-N-CA 122.694 2.262 . . . . 0.0 110.041 173.366 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 44.7 mmtm -70.67 127.48 32.82 Favored 'General case' 0 N--CA 1.497 1.909 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.707 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -85.33 79.37 9.52 Favored 'General case' 0 N--CA 1.495 1.788 0 CA-C-N 114.666 -1.152 . . . . 0.0 108.941 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' CYS . . . . . 0.441 ' SG ' ' HB2' ' A' ' 67' ' ' ALA . 88.5 m -79.66 146.83 65.89 Favored Pre-proline 0 N--CA 1.494 1.764 0 CA-C-N 114.504 -1.225 . . . . 0.0 111.364 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -73.9 -4.35 15.28 Favored 'Trans proline' 0 N--CA 1.493 1.451 0 C-N-CA 122.891 2.394 . . . . 0.0 110.586 165.393 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 23.0 tpp180 -79.1 -54.78 5.65 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 19.8 m120 52.24 -161.14 0.1 Allowed 'General case' 0 N--CA 1.501 2.118 0 O-C-N 124.401 1.063 . . . . 0.0 111.549 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.696 ' HA ' ' HA ' ' A' ' 62' ' ' CYS . 5.2 m -36.67 110.06 0.11 Allowed 'General case' 0 N--CA 1.5 2.045 0 N-CA-C 113.909 1.078 . . . . 0.0 113.909 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 20.5 t0 -91.22 111.85 50.87 Favored Pre-proline 0 N--CA 1.494 1.727 0 CA-C-N 113.843 -1.526 . . . . 0.0 110.564 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -64.7 -21.92 64.66 Favored 'Trans proline' 0 N--CA 1.494 1.522 0 C-N-CA 121.848 1.699 . . . . 0.0 110.312 -179.274 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 27.6 ttm-85 -82.27 -23.51 35.24 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 113.952 1.093 . . . . 0.0 113.952 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 12.2 tt -70.19 142.38 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 C-N-CA 117.835 -1.546 . . . . 0.0 110.21 -179.761 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -131.78 -43.77 0.99 Allowed 'General case' 0 N--CA 1.494 1.734 0 CA-C-N 114.486 -1.234 . . . . 0.0 109.748 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 49.8 m-85 -141.23 -164.12 1.69 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 124.398 1.061 . . . . 0.0 109.387 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -153.87 108.69 0.38 Allowed Glycine 0 N--CA 1.492 2.408 0 N-CA-C 106.582 -2.607 . . . . 0.0 106.582 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 50.4 mm -80.6 84.11 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 27.0 m -80.99 149.44 66.76 Favored Pre-proline 0 N--CA 1.494 1.755 0 CA-C-N 114.101 -1.408 . . . . 0.0 108.848 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo . . . . . 0 N--CA 1.495 1.594 0 C-N-CA 122.71 2.273 . . . . 0.0 110.859 175.09 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 2.7 tmt_? . . . . . 0 N--CA 1.504 2.274 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.6 tp -55.44 137.02 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 123.626 0.579 . . . . 0.0 112.123 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.472 ' HA ' ' HA ' ' A' ' 41' ' ' CYS . 1.5 m -140.61 57.88 1.57 Allowed 'General case' 0 C--N 1.31 -1.128 0 CA-C-O 122.797 1.284 . . . . 0.0 114.444 179.615 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 7.1 t -90.73 161.1 15.49 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-N 113.322 -1.763 . . . . 0.0 106.746 179.579 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 10.5 p-10 -161.1 151.84 18.24 Favored 'General case' 0 N--CA 1.499 2.02 0 C-N-CA 120.118 -0.633 . . . . 0.0 111.693 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.45 ' HA ' ' CE2' ' A' ' 16' ' ' TYR . 19.6 t -57.68 -38.03 74.46 Favored 'General case' 0 N--CA 1.497 1.914 0 CA-C-N 114.639 -1.164 . . . . 0.0 113.303 -179.721 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 46.4 t -61.99 -51.59 67.41 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 125.336 1.647 . . . . 0.0 110.721 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -51.6 -26.08 8.14 Favored 'General case' 0 N--CA 1.503 2.224 0 O-C-N 124.945 1.403 . . . . 0.0 110.376 179.824 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.407 ' HA3' ' N ' ' A' ' 29' ' ' SER . . . 63.23 161.06 0.28 Allowed Glycine 0 N--CA 1.479 1.558 0 CA-C-N 114.618 -1.174 . . . . 0.0 115.891 179.529 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.456 ' H ' ' HA3' ' A' ' 27' ' ' GLY . 99.5 m -153.11 53.87 0.76 Allowed 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 104.576 -2.379 . . . . 0.0 104.576 179.741 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 63.4 pttt 41.67 -146.11 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.065 0 CA-C-N 114.203 -1.362 . . . . 0.0 112.409 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -70.23 26.69 0.44 Allowed Glycine 0 N--CA 1.494 2.501 0 CA-C-N 114.886 -1.052 . . . . 0.0 114.252 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 88.4 m -105.42 120.99 42.98 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 107.097 -1.445 . . . . 0.0 107.097 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.425 ' HA ' ' HA ' ' A' ' 26' ' ' GLU . 63.0 mtpt -64.92 100.34 0.41 Allowed 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 113.027 -1.897 . . . . 0.0 113.962 -179.666 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.45 ' CE2' ' HA ' ' A' ' 7' ' ' CYS . 8.8 m-85 -48.3 128.59 14.59 Favored 'General case' 0 N--CA 1.505 2.316 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 179.48 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -144.3 153.03 41.59 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 115.079 -0.964 . . . . 0.0 113.047 -179.349 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 34.2 t -99.08 134.78 41.43 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-N 112.599 -2.091 . . . . 0.0 112.659 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -50.14 -24.87 3.03 Favored 'General case' 0 N--CA 1.502 2.168 0 CA-C-N 112.713 -2.039 . . . . 0.0 114.009 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 29.7 p30 -59.81 -8.01 1.93 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 124.144 0.902 . . . . 0.0 112.276 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 95.08 29.2 9.2 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 86.9 m -141.91 143.23 33.18 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 124.078 0.517 . . . . 0.0 111.233 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 20.0 t80 -68.96 161.28 29.21 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-N 114.042 -1.435 . . . . 0.0 110.318 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 88.2 t -126.71 -71.29 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 CA-C-N 114.995 -1.002 . . . . 0.0 109.443 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.589 ' SG ' ' N ' ' A' ' 26' ' ' GLU . 0.3 OUTLIER -151.57 -166.67 2.58 Favored 'General case' 0 N--CA 1.5 2.049 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 179.998 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.589 ' N ' ' SG ' ' A' ' 25' ' ' CYS . 2.1 tm-20 -121.07 147.4 45.57 Favored 'General case' 0 N--CA 1.501 2.116 0 N-CA-C 106.374 -1.713 . . . . 0.0 106.374 179.565 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.456 ' HA3' ' H ' ' A' ' 11' ' ' THR . . . -55.1 109.8 1.46 Allowed Glycine 0 N--CA 1.501 2.972 0 N-CA-C 110.358 -1.097 . . . . 0.0 110.358 179.822 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 -86.31 12.29 10.33 Favored 'General case' 0 N--CA 1.501 2.12 0 N-CA-C 113.613 0.968 . . . . 0.0 113.613 -179.539 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.407 ' N ' ' HA3' ' A' ' 10' ' ' GLY . 20.9 t -169.62 -174.53 1.91 Allowed 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -79.23 143.38 60.5 Favored Pre-proline 0 N--CA 1.496 1.845 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo -52.34 -32.36 51.2 Favored 'Trans proline' 0 N--CA 1.498 1.772 0 C-N-CA 122.38 2.053 . . . . 0.0 112.15 175.81 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 87.6 mtm180 -113.99 35.24 4.21 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-N 114.74 -1.118 . . . . 0.0 109.232 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 24.2 p-10 -65.96 127.05 92.88 Favored Pre-proline 0 N--CA 1.497 1.881 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.98 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_endo -76.51 81.53 2.48 Favored 'Trans proline' 0 N--CA 1.49 1.289 0 C-N-CA 122.492 2.128 . . . . 0.0 107.973 167.664 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 23.6 tptm -150.85 153.43 35.35 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-N 114.851 -1.068 . . . . 0.0 110.124 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -99.52 155.6 17.48 Favored 'General case' 0 N--CA 1.496 1.826 0 CA-C-N 114.066 -1.424 . . . . 0.0 110.221 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 84.8 m -147.44 177.26 9.38 Favored 'General case' 0 N--CA 1.497 1.879 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.643 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 64.5 p -132.98 -18.28 2.35 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-N 113.893 -1.503 . . . . 0.0 108.976 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.3 tt -89.63 24.6 2.26 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 24.2 m120 -56.83 152.88 11.77 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-N 115.308 -0.86 . . . . 0.0 112.744 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.472 ' HA ' ' HA ' ' A' ' 4' ' ' CYS . 68.0 m 59.68 124.4 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.753 0 CA-C-N 113.467 -1.697 . . . . 0.0 114.318 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -152.33 84.04 4.87 Favored Pre-proline 0 N--CA 1.494 1.728 0 CA-C-N 114.389 -1.278 . . . . 0.0 109.338 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -57.67 -20.11 40.88 Favored 'Trans proline' 0 N--CA 1.493 1.464 0 C-N-CA 122.769 2.313 . . . . 0.0 112.86 178.796 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 74.5 mtp180 -62.31 -42.29 99.24 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 26.4 mt -68.21 157.77 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 CA-C-O 122.414 1.102 . . . . 0.0 110.691 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -125.37 -51.14 1.64 Allowed 'General case' 0 N--CA 1.491 1.614 0 CA-C-N 111.719 -2.491 . . . . 0.0 107.786 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 13.1 p90 -171.14 160.98 6.58 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-N 114.172 -1.376 . . . . 0.0 111.237 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -96.87 121.39 7.02 Favored Glycine 0 N--CA 1.493 2.456 0 CA-C-N 113.651 -1.613 . . . . 0.0 109.248 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 29.4 m -94.71 103.96 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.7 m -79.88 115.26 52.73 Favored Pre-proline 0 N--CA 1.5 2.045 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 179.523 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo . . . . . 0 N--CA 1.496 1.657 0 C-N-CA 122.458 2.105 . . . . 0.0 112.457 -171.8 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 1.7 m . . . . . 0 N--CA 1.49 1.528 0 CA-C-O 122.413 1.102 . . . . 0.0 113.337 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 33.9 m -90.22 168.3 12.03 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 113.666 -1.606 . . . . 0.0 109.154 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 24.3 p30 -142.94 176.06 9.36 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 124.416 1.073 . . . . 0.0 109.297 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 47.0 t -92.79 -31.69 14.94 Favored 'General case' 0 N--CA 1.499 2.021 0 N-CA-C 114.469 1.285 . . . . 0.0 114.469 -179.806 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 42.7 t -63.56 -58.37 7.18 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 123.934 0.771 . . . . 0.0 110.352 -179.688 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -89.83 36.31 0.85 Allowed 'General case' 0 N--CA 1.495 1.803 0 CA-C-N 114.294 -1.321 . . . . 0.0 110.227 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -76.67 -115.78 0.14 Allowed Glycine 0 N--CA 1.493 2.478 0 N-CA-C 109.317 -1.513 . . . . 0.0 109.317 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 95.6 m -156.27 96.63 1.7 Allowed 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -52.16 104.2 0.08 Allowed 'General case' 0 N--CA 1.501 2.12 0 C-N-CA 120.034 -0.666 . . . . 0.0 111.345 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 146.91 -31.0 1.48 Allowed Glycine 0 N--CA 1.495 2.629 0 CA-C-N 114.835 -1.075 . . . . 0.0 112.625 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 88.2 m -95.26 174.8 6.87 Favored 'General case' 0 N--CA 1.502 2.169 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -121.9 87.35 2.74 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 106.452 -1.684 . . . . 0.0 106.452 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 61.0 m-85 -48.58 140.93 7.55 Favored 'General case' 0 N--CA 1.499 1.984 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.013 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.582 ' CE2' ' HA ' ' A' ' 80' ' ' THR . 4.8 t80 -137.1 164.43 28.45 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 125.207 1.567 . . . . 0.0 114.543 -179.222 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 12.0 t -124.13 130.76 53.09 Favored 'General case' 0 N--CA 1.505 2.275 0 CA-C-N 113.153 -1.839 . . . . 0.0 112.529 -179.664 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -54.98 -49.61 71.04 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-N 113.405 -1.725 . . . . 0.0 111.025 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 13.5 p-10 -108.1 28.58 8.13 Favored 'General case' 0 N--CA 1.488 1.472 0 CA-C-N 113.123 -1.853 . . . . 0.0 111.22 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -160.79 18.09 0.2 Allowed Glycine 0 N--CA 1.494 2.554 0 C-N-CA 119.356 -1.402 . . . . 0.0 112.341 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.582 ' HA ' ' CE2' ' A' ' 75' ' ' PHE . 6.4 t 42.03 -160.23 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.793 0 O-C-N 124.924 1.014 . . . . 0.0 113.1 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 47.1 t80 -42.37 121.11 1.83 Allowed 'General case' 0 N--CA 1.499 1.978 0 CA-C-O 121.459 0.647 . . . . 0.0 111.681 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 61.5 t -92.18 -68.2 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 CA-C-N 113.835 -1.529 . . . . 0.0 111.731 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 1.8 p -158.28 -177.28 6.43 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 123.924 0.765 . . . . 0.0 109.597 -179.669 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -102.46 151.97 21.68 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 104.54 -2.393 . . . . 0.0 104.54 179.466 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -64.55 128.04 34.98 Favored Glycine 0 N--CA 1.493 2.494 0 N-CA-C 108.638 -1.785 . . . . 0.0 108.638 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 40.7 mm-40 -113.67 11.97 18.29 Favored 'General case' 0 N--CA 1.498 1.929 0 C-N-CA 120.359 -0.536 . . . . 0.0 110.728 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 38.6 t -79.0 87.76 4.79 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -98.36 137.93 20.78 Favored Pre-proline 0 N--CA 1.493 1.688 0 CA-C-N 112.938 -1.937 . . . . 0.0 108.138 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -65.23 -40.47 19.39 Favored 'Trans proline' 0 N--CA 1.493 1.5 0 C-N-CA 122.12 1.88 . . . . 0.0 111.52 -179.074 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 72.5 ttt-85 -81.37 4.27 21.38 Favored 'General case' 0 N--CA 1.498 1.955 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.961 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 21.4 p-10 -44.75 112.37 1.46 Allowed Pre-proline 0 N--CA 1.502 2.17 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -81.94 43.92 1.61 Allowed 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 123.112 2.541 . . . . 0.0 111.191 178.039 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 24.6 ttmm -164.29 153.44 13.57 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.173 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -94.46 129.04 41.38 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-N 114.095 -1.411 . . . . 0.0 108.186 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 83.1 m -79.82 148.18 68.17 Favored Pre-proline 0 N--CA 1.495 1.825 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -71.99 144.12 42.11 Favored 'Trans proline' 0 N--CA 1.489 1.245 0 C-N-CA 122.791 2.327 . . . . 0.0 109.258 163.746 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 21.1 tpp180 -100.16 31.88 3.19 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 27.9 m-20 -58.4 163.62 2.97 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 114.6 1.333 . . . . 0.0 114.6 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 66.9 m -100.61 133.95 44.29 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-N 113.358 -1.746 . . . . 0.0 110.868 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 60.5 t0 -117.4 84.39 18.16 Favored Pre-proline 0 N--CA 1.497 1.879 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 179.715 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_endo -57.29 -36.21 98.95 Favored 'Trans proline' 0 N--CA 1.496 1.657 0 C-N-CA 122.702 2.268 . . . . 0.0 111.283 -174.433 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 20.9 mmt180 -62.47 -39.63 94.03 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 124.284 0.99 . . . . 0.0 111.848 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 3.1 tt -53.45 155.16 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 O-C-N 123.905 0.753 . . . . 0.0 110.051 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -149.18 -42.24 0.14 Allowed 'General case' 0 N--CA 1.491 1.618 0 CA-C-N 115.364 -0.834 . . . . 0.0 111.458 -179.652 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 -138.45 -164.35 1.62 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 124.341 1.026 . . . . 0.0 110.599 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -153.23 103.99 0.25 Allowed Glycine 0 N--CA 1.487 2.08 0 N-CA-C 106.063 -2.815 . . . . 0.0 106.063 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 90.3 mt -78.91 88.18 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 57.9 m -81.9 149.53 63.52 Favored Pre-proline 0 N--CA 1.493 1.696 0 CA-C-N 113.944 -1.48 . . . . 0.0 109.006 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.495 1.565 0 C-N-CA 122.618 2.212 . . . . 0.0 111.056 179.332 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.747 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 7.2 tp -61.48 133.48 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 CA-C-N 114.49 -1.232 . . . . 0.0 109.145 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.428 ' HA ' ' HA ' ' A' ' 41' ' ' CYS . 1.7 m -140.38 45.71 1.83 Allowed 'General case' 0 N--CA 1.483 1.19 0 CA-C-O 122.583 1.182 . . . . 0.0 112.683 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 22.7 p -90.35 178.16 6.21 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-N 113.053 -1.885 . . . . 0.0 110.311 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 36.3 p-10 -155.85 -169.57 3.13 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-N 113.958 -1.474 . . . . 0.0 108.77 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.44 ' SG ' ' CD2' ' A' ' 16' ' ' TYR . 2.3 t -81.25 -27.36 35.23 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -179.796 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 23.3 t -80.32 -59.55 2.66 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-N 114.483 -1.235 . . . . 0.0 110.988 -179.771 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -90.41 64.79 6.01 Favored 'General case' 0 N--CA 1.5 2.036 0 CA-C-O 121.89 0.852 . . . . 0.0 110.074 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.47 ' H ' ' HB2' ' A' ' 29' ' ' SER . . . -135.89 -115.76 1.5 Allowed Glycine 0 N--CA 1.498 2.824 0 CA-C-N 113.97 -1.468 . . . . 0.0 110.264 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 91.1 m -139.73 111.23 7.16 Favored 'General case' 0 N--CA 1.502 2.146 0 CA-C-O 120.788 0.328 . . . . 0.0 111.264 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.574 ' NZ ' HH21 ' A' ' 32' ' ' ARG . 39.4 ttpt -58.59 146.52 35.59 Favored 'General case' 0 N--CA 1.497 1.883 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.803 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 79.75 -16.49 11.19 Favored Glycine 0 N--CA 1.492 2.418 0 CA-C-N 114.542 -1.208 . . . . 0.0 112.858 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 90.2 m -93.77 129.8 39.99 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.43 ' HD2' ' N ' ' A' ' 15' ' ' LYS . 0.9 OUTLIER -77.6 94.11 4.31 Favored 'General case' 0 N--CA 1.486 1.343 0 CA-C-N 114.435 -1.257 . . . . 0.0 110.19 -179.365 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.703 ' CD2' ' SG ' ' A' ' 25' ' ' CYS . 95.4 m-85 -46.17 137.14 6.33 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 124.925 1.391 . . . . 0.0 109.074 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -147.74 152.73 38.25 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 125.085 1.491 . . . . 0.0 111.876 -179.438 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 28.9 t -107.8 136.44 47.52 Favored 'General case' 0 N--CA 1.497 1.901 0 CA-C-N 111.748 -2.478 . . . . 0.0 113.778 -179.586 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -52.12 -24.79 7.49 Favored 'General case' 0 N--CA 1.5 2.072 0 CA-C-N 112.645 -2.07 . . . . 0.0 115.157 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -57.27 -17.49 12.14 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 123.849 0.718 . . . . 0.0 110.966 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 105.03 29.63 5.12 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 108.537 -1.825 . . . . 0.0 108.537 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 58.2 m -138.28 154.56 49.03 Favored 'General case' 0 N--CA 1.493 1.702 0 CA-C-O 121.374 0.607 . . . . 0.0 111.03 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 57.7 t80 -73.98 166.76 22.81 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-N 113.663 -1.608 . . . . 0.0 109.615 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 90.3 t -129.06 -68.3 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 123.909 0.756 . . . . 0.0 110.889 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.703 ' SG ' ' CD2' ' A' ' 16' ' ' TYR . 22.8 p -162.32 -171.4 2.79 Favored 'General case' 0 N--CA 1.504 2.255 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -111.95 145.11 40.17 Favored 'General case' 0 N--CA 1.506 2.331 0 CA-C-O 120.74 0.305 . . . . 0.0 111.535 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.56 ' HA2' ' CE2' ' A' ' 16' ' ' TYR . . . -39.98 107.13 0.07 OUTLIER Glycine 0 N--CA 1.496 2.682 0 O-C-N 124.545 1.153 . . . . 0.0 114.613 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -124.73 43.75 2.94 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 105.943 -1.873 . . . . 0.0 105.943 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.47 ' HB2' ' H ' ' A' ' 10' ' ' GLY . 10.4 t -125.66 81.16 1.96 Allowed 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 -179.634 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -88.11 120.36 70.62 Favored Pre-proline 0 N--CA 1.495 1.801 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 179.737 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -66.73 -29.21 43.08 Favored 'Trans proline' 0 N--CA 1.494 1.538 0 C-N-CA 121.983 1.788 . . . . 0.0 110.773 177.343 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.574 HH21 ' NZ ' ' A' ' 12' ' ' LYS . 84.9 mtm180 -78.87 3.28 17.36 Favored 'General case' 0 N--CA 1.498 1.95 0 CA-C-N 114.946 -1.025 . . . . 0.0 112.107 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 18.2 p-10 -60.21 130.63 89.51 Favored Pre-proline 0 N--CA 1.495 1.798 0 O-C-N 123.339 0.399 . . . . 0.0 111.918 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -82.28 46.13 2.12 Favored 'Trans proline' 0 N--CA 1.493 1.49 0 C-N-CA 123.026 2.484 . . . . 0.0 108.642 162.157 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -137.55 -177.0 4.6 Favored 'General case' 0 N--CA 1.497 1.9 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.49 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -143.92 118.13 9.55 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-N 114.867 -1.061 . . . . 0.0 108.423 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 75.4 m -79.76 168.72 18.94 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 8.6 t -85.21 166.47 16.52 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-N 113.856 -1.52 . . . . 0.0 109.558 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.54 HD13 ' H ' ' A' ' 39' ' ' LEU . 0.0 OUTLIER -104.18 19.46 20.11 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-N 114.849 -1.069 . . . . 0.0 111.902 -179.895 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 70.4 m-20 -55.12 135.57 49.13 Favored 'General case' 0 N--CA 1.498 1.951 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.128 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.428 ' HA ' ' HA ' ' A' ' 4' ' ' CYS . 58.2 m -90.32 131.3 36.19 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-N 114.796 -1.093 . . . . 0.0 110.874 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -127.35 78.02 75.04 Favored Pre-proline 0 N--CA 1.498 1.947 0 O-C-N 124.103 0.877 . . . . 0.0 109.514 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -63.77 -27.12 67.95 Favored 'Trans proline' 0 N--CA 1.494 1.524 0 C-N-CA 122.855 2.37 . . . . 0.0 113.515 -170.922 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 8.4 ptp180 -56.24 -33.19 65.18 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 123.956 0.785 . . . . 0.0 111.205 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 15.1 tt -50.41 150.91 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 CA-C-N 114.696 -1.138 . . . . 0.0 113.102 -179.721 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -133.21 -51.43 0.88 Allowed 'General case' 0 N--CA 1.492 1.652 0 CA-C-N 113.492 -1.685 . . . . 0.0 106.903 179.668 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 51.5 p90 -170.41 177.26 4.13 Favored 'General case' 0 N--CA 1.494 1.748 0 CA-C-N 113.819 -1.537 . . . . 0.0 108.684 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -124.52 120.55 4.07 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 107.341 -2.303 . . . . 0.0 107.341 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.1 p -79.27 100.65 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 CA-C-O 123.015 1.388 . . . . 0.0 108.778 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 3.8 m -79.58 163.66 57.67 Favored Pre-proline 0 N--CA 1.493 1.705 0 CA-C-N 112.889 -1.96 . . . . 0.0 108.383 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_exo . . . . . 0 N--CA 1.499 1.806 0 C-N-CA 122.705 2.27 . . . . 0.0 111.847 175.169 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.59 ' HA ' ' HA ' ' A' ' 99' ' ' CYS . 1.3 m . . . . . 0 N--CA 1.479 1.016 0 N-CA-C 118.037 2.606 . . . . 0.0 118.037 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.3 p -90.75 160.36 15.85 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-N 113.679 -1.601 . . . . 0.0 106.685 179.121 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.402 ' ND2' ' HA ' ' A' ' 98' ' ' ASN . 40.0 t30 -160.58 161.59 32.63 Favored 'General case' 0 N--CA 1.497 1.901 0 CA-C-O 122.399 1.095 . . . . 0.0 112.598 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 7.4 t -58.51 -20.35 45.12 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-N 112.014 -2.357 . . . . 0.0 111.836 179.819 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 40.7 t -86.27 -71.06 0.56 Allowed 'General case' 0 N--CA 1.494 1.756 0 CA-C-N 114.999 -1.0 . . . . 0.0 111.642 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -54.33 -19.71 5.93 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-N 113.881 -1.509 . . . . 0.0 113.097 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -60.58 159.95 25.05 Favored Glycine 0 N--CA 1.491 2.357 0 O-C-N 123.998 0.811 . . . . 0.0 111.837 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.481 ' C ' ' H ' ' A' ' 71' ' ' GLY . 12.4 t -85.56 139.24 31.61 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-N 113.934 -1.133 . . . . 0.0 108.922 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 23.1 ttmm -80.02 35.03 0.31 Allowed 'General case' 0 N--CA 1.499 2.003 0 CA-C-O 122.543 1.164 . . . . 0.0 110.578 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.481 ' H ' ' C ' ' A' ' 69' ' ' THR . . . -123.64 -8.51 6.28 Favored Glycine 0 N--CA 1.491 2.367 0 N-CA-C 108.542 -1.823 . . . . 0.0 108.542 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' CYS . . . . . 0.407 ' HA ' ' HA ' ' A' ' 108' ' ' CYS . 78.9 m -137.33 148.12 46.09 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 123.931 0.43 . . . . 0.0 109.915 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.474 ' HB3' ' CE1' ' A' ' 81' ' ' PHE . 27.6 mtpp -101.4 88.59 3.5 Favored 'General case' 0 N--CA 1.485 1.314 0 O-C-N 124.917 1.386 . . . . 0.0 108.203 -179.485 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -49.76 133.99 20.98 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-N 114.175 -1.375 . . . . 0.0 108.688 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.489 ' CE2' ' HA ' ' A' ' 80' ' ' THR . 1.2 t80 -132.72 154.62 50.01 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 113.13 -1.85 . . . . 0.0 114.06 -179.218 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.427 ' N ' HG23 ' A' ' 82' ' ' VAL . 25.8 t -115.84 129.92 56.63 Favored 'General case' 0 N--CA 1.497 1.913 0 CA-C-N 112.145 -2.298 . . . . 0.0 111.746 -179.747 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.479 ' H ' ' HB2' ' A' ' 104' ' ' ALA . 7.7 p-10 -64.67 -46.74 81.16 Favored 'General case' 0 N--CA 1.497 1.897 0 CA-C-N 114.773 -1.103 . . . . 0.0 108.596 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -92.18 19.71 6.67 Favored 'General case' 0 N--CA 1.485 1.283 0 CA-C-N 112.772 -2.013 . . . . 0.0 110.953 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -165.21 24.53 0.16 Allowed Glycine 0 N--CA 1.497 2.715 0 C-N-CA 118.62 -1.753 . . . . 0.0 113.184 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.489 ' HA ' ' CE2' ' A' ' 75' ' ' PHE . 6.5 t 42.11 -161.55 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.926 0 O-C-N 124.969 1.041 . . . . 0.0 112.887 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.474 ' CE1' ' HB3' ' A' ' 73' ' ' LYS . 11.0 t80 -49.68 121.97 5.84 Favored 'General case' 0 N--CA 1.497 1.882 0 CA-C-O 121.34 0.591 . . . . 0.0 110.879 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.427 HG23 ' N ' ' A' ' 76' ' ' SER . 88.9 t -86.11 -73.34 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' CYS . . . . . 0.409 ' SG ' ' O ' ' A' ' 84' ' ' GLU . 0.1 OUTLIER -175.49 171.35 2.83 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 124.002 0.813 . . . . 0.0 110.459 179.779 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.462 ' HA ' ' HA ' ' A' ' 73' ' ' LYS . 32.3 tt0 -93.28 146.93 23.34 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 105.718 -1.956 . . . . 0.0 105.718 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -53.03 135.38 39.74 Favored Glycine 0 N--CA 1.501 2.967 0 C-N-CA 119.514 -1.327 . . . . 0.0 114.452 -179.677 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -100.37 27.91 5.39 Favored 'General case' 0 N--CA 1.505 2.301 0 CA-C-O 121.595 0.712 . . . . 0.0 110.032 179.744 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 22.2 t -160.93 -176.57 5.58 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -144.61 140.01 16.09 Favored Pre-proline 0 N--CA 1.488 1.438 0 N-CA-C 105.343 -2.095 . . . . 0.0 105.343 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_exo -41.79 -28.04 0.66 Allowed 'Trans proline' 0 N--CA 1.5 1.895 0 C-N-CA 123.671 2.914 . . . . 0.0 114.824 -174.274 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.87 -51.34 16.54 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 123.93 0.769 . . . . 0.0 111.898 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 8.2 p-10 -90.23 138.26 27.35 Favored Pre-proline 0 N--CA 1.502 2.166 0 C-N-CA 119.55 -0.86 . . . . 0.0 110.622 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -75.53 170.25 20.64 Favored 'Trans proline' 0 N--CA 1.493 1.476 0 C-N-CA 122.929 2.419 . . . . 0.0 109.861 161.81 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 27.8 tptp -160.3 154.68 23.58 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 123.67 0.606 . . . . 0.0 110.3 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -98.39 139.51 34.04 Favored 'General case' 0 N--CA 1.498 1.96 0 CA-C-N 114.591 -1.186 . . . . 0.0 111.122 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' CYS . . . . . 0.419 ' HB3' ' HD2' ' A' ' 96' ' ' PRO . 98.5 m -159.32 167.46 14.22 Favored Pre-proline 0 N--CA 1.501 2.076 0 O-C-N 124.057 0.848 . . . . 0.0 111.066 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.419 ' HD2' ' HB3' ' A' ' 95' ' ' CYS . 50.1 Cg_exo -27.09 -66.13 0.05 OUTLIER 'Trans proline' 0 N--CA 1.494 1.528 0 C-N-CA 124.275 3.316 . . . . 0.0 115.628 170.81 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 79.0 ttt180 -153.77 -77.92 0.11 Allowed 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.402 ' HA ' ' ND2' ' A' ' 64' ' ' ASN . 64.1 m-20 133.72 -170.22 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.412 0 O-C-N 126.545 2.403 . . . . 0.0 107.726 -179.559 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.59 ' HA ' ' HA ' ' A' ' 62' ' ' CYS . 61.5 m 62.95 121.45 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 124.952 1.301 . . . . 0.0 112.454 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -141.17 80.98 16.27 Favored Pre-proline 0 N--CA 1.494 1.73 0 CA-C-N 114.372 -1.286 . . . . 0.0 111.252 -179.756 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -49.16 -27.76 13.16 Favored 'Trans proline' 0 N--CA 1.496 1.669 0 C-N-CA 123.183 2.589 . . . . 0.0 113.812 172.919 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.06 -27.28 69.29 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 123.687 0.617 . . . . 0.0 111.635 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 12.7 tt -52.35 167.62 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 124.253 0.971 . . . . 0.0 112.625 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.479 ' HB2' ' H ' ' A' ' 77' ' ' ASP . . . -142.8 -55.66 0.42 Allowed 'General case' 0 N--CA 1.49 1.532 0 CA-C-N 114.352 -1.295 . . . . 0.0 109.604 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -149.2 -159.92 1.1 Allowed 'General case' 0 N--CA 1.498 1.925 0 O-C-N 124.465 1.103 . . . . 0.0 109.134 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -142.89 108.97 0.54 Allowed Glycine 0 N--CA 1.489 2.173 0 N-CA-C 105.917 -2.873 . . . . 0.0 105.917 179.771 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 93.4 mt -79.37 85.68 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' CYS . . . . . 0.407 ' HA ' ' HA ' ' A' ' 72' ' ' CYS . 22.2 m -79.68 121.34 82.35 Favored Pre-proline 0 N--CA 1.492 1.634 0 CA-C-N 113.799 -1.546 . . . . 0.0 108.553 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_endo . . . . . 0 N--CA 1.493 1.45 0 C-N-CA 122.394 2.063 . . . . 0.0 110.375 -176.66 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 8.2 ptp180 . . . . . 0 N--CA 1.498 1.957 0 N-CA-C 106.175 -1.787 . . . . 0.0 106.175 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.7 tp -90.16 77.79 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 CA-C-N 113.252 -1.795 . . . . 0.0 108.345 179.79 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.7 m -85.81 28.99 0.74 Allowed 'General case' 0 N--CA 1.497 1.925 0 N-CA-C 116.201 1.926 . . . . 0.0 116.201 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 12.6 t -92.35 169.51 10.52 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-N 113.058 -1.883 . . . . 0.0 106.508 179.768 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.42 ' ND2' ' H ' ' A' ' 9' ' ' ALA . 40.0 p-10 -160.48 161.87 32.95 Favored 'General case' 0 N--CA 1.497 1.901 0 C-N-CA 119.367 -0.933 . . . . 0.0 112.629 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -63.24 -22.68 67.02 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 113.856 -1.52 . . . . 0.0 112.561 179.729 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 42.4 t -89.96 -69.02 0.74 Allowed 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 115.252 1.575 . . . . 0.0 115.252 -179.722 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.42 ' H ' ' ND2' ' A' ' 6' ' ' ASN . . . -85.66 63.07 7.85 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 124.598 1.186 . . . . 0.0 111.25 -179.556 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -119.89 -115.05 2.5 Favored Glycine 0 N--CA 1.492 2.379 0 CA-C-N 113.282 -1.781 . . . . 0.0 109.799 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.0 t -166.31 123.44 1.35 Allowed 'General case' 0 N--CA 1.496 1.848 0 CA-C-O 121.373 0.606 . . . . 0.0 110.585 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.82 143.73 20.28 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-N 114.714 -1.13 . . . . 0.0 109.843 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 106.37 -35.47 5.02 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.195 -1.562 . . . . 0.0 109.195 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.401 ' HB3' ' HA3' ' A' ' 48' ' ' GLY . 52.1 m -94.64 116.21 28.49 Favored 'General case' 0 N--CA 1.497 1.906 0 C-N-CA 119.422 -0.911 . . . . 0.0 110.222 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 4.0 mptp? -72.24 88.15 1.14 Allowed 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 112.792 -2.003 . . . . 0.0 111.627 -179.737 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.446 ' N ' ' O ' ' A' ' 25' ' ' CYS . 10.7 m-85 -46.72 127.9 10.14 Favored 'General case' 0 N--CA 1.498 1.96 0 CA-C-O 122.468 1.128 . . . . 0.0 108.237 179.583 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.547 ' CE2' ' HA ' ' A' ' 22' ' ' THR . 0.1 OUTLIER -135.96 158.72 43.73 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-N 111.623 -2.535 . . . . 0.0 113.096 -178.965 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 29.1 t -110.78 128.86 55.91 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-N 112.72 -2.036 . . . . 0.0 111.054 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.461 ' H ' ' HB2' ' A' ' 46' ' ' ALA . 7.7 p-10 -62.71 -45.35 93.15 Favored 'General case' 0 N--CA 1.497 1.911 0 CA-C-N 114.119 -1.4 . . . . 0.0 109.203 179.803 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -94.25 19.94 8.76 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 112.624 -2.08 . . . . 0.0 111.624 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -171.22 28.89 0.11 Allowed Glycine 0 N--CA 1.497 2.731 0 C-N-CA 118.146 -1.978 . . . . 0.0 113.934 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.547 ' HA ' ' CE2' ' A' ' 17' ' ' PHE . 6.5 t 42.81 -166.68 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 73.9 t80 -40.05 139.81 0.65 Allowed 'General case' 0 N--CA 1.5 2.063 0 N-CA-C 114.074 1.138 . . . . 0.0 114.074 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 88.4 t -114.53 -79.42 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 CA-C-N 113.131 -1.85 . . . . 0.0 108.05 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.525 ' SG ' ' N ' ' A' ' 26' ' ' GLU . 0.1 OUTLIER -152.21 -169.38 3.34 Favored 'General case' 0 N--CA 1.502 2.17 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 179.86 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.525 ' N ' ' SG ' ' A' ' 25' ' ' CYS . 60.8 tt0 -114.62 158.3 21.92 Favored 'General case' 0 N--CA 1.504 2.228 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 179.425 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -54.07 109.65 1.22 Allowed Glycine 0 N--CA 1.497 2.731 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.69 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -85.82 19.55 2.48 Favored 'General case' 0 N--CA 1.5 2.028 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 36.6 t -105.44 92.76 4.33 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.197 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -130.35 142.42 45.4 Favored Pre-proline 0 N--CA 1.495 1.786 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 179.745 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_endo -63.16 79.0 0.12 Allowed 'Trans proline' 0 N--CA 1.496 1.639 0 C-N-CA 122.561 2.174 . . . . 0.0 109.891 169.915 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 79.6 ttt180 -178.13 -51.26 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 105.592 -2.003 . . . . 0.0 105.592 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 26.5 p30 -90.44 168.21 14.78 Favored Pre-proline 0 N--CA 1.497 1.9 0 CA-C-N 114.27 -1.332 . . . . 0.0 110.781 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -62.55 127.2 20.13 Favored 'Trans proline' 0 N--CA 1.49 1.304 0 C-N-CA 122.436 2.09 . . . . 0.0 109.021 160.241 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -92.83 22.44 4.84 Favored 'General case' 0 N--CA 1.5 2.074 0 CA-C-O 122.677 1.227 . . . . 0.0 112.749 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -146.22 153.39 40.56 Favored 'General case' 0 N--CA 1.498 1.947 0 CA-C-N 112.274 -2.239 . . . . 0.0 111.739 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 57.1 m -146.51 -124.19 0.07 Allowed 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 33.5 m -146.76 18.37 1.29 Allowed 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 44.6 tp -79.71 -43.3 22.92 Favored 'General case' 0 N--CA 1.497 1.897 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.334 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 14.4 m120 53.11 -163.63 0.09 Allowed 'General case' 0 N--CA 1.504 2.243 0 O-C-N 124.064 0.852 . . . . 0.0 112.03 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 56.3 m -43.85 118.85 1.54 Allowed 'General case' 0 N--CA 1.502 2.133 0 O-C-N 124.033 0.833 . . . . 0.0 110.232 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.4 t0 -101.41 106.41 45.62 Favored Pre-proline 0 N--CA 1.495 1.807 0 O-C-N 124.022 0.827 . . . . 0.0 109.398 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -67.6 -33.12 29.33 Favored 'Trans proline' 0 N--CA 1.494 1.525 0 C-N-CA 122.046 1.831 . . . . 0.0 111.101 -168.578 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 29.0 mmt85 -86.32 -13.36 46.81 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 -179.737 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 5.9 tt -73.43 179.33 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 C-N-CA 118.68 -1.208 . . . . 0.0 108.738 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.461 ' HB2' ' H ' ' A' ' 19' ' ' ASP . . . -139.92 -58.61 0.56 Allowed 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 120.556 -0.458 . . . . 0.0 112.073 -179.824 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 7.3 p90 -170.46 160.68 7.57 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 124.146 0.904 . . . . 0.0 112.719 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.407 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -88.92 107.65 3.39 Favored Glycine 0 N--CA 1.487 2.096 0 CA-C-N 113.235 -1.802 . . . . 0.0 108.892 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 23.4 t -78.24 86.75 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 124.287 0.639 . . . . 0.0 112.661 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.6 m -79.27 145.91 65.53 Favored Pre-proline 0 N--CA 1.503 2.212 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 179.459 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo . . . . . 0 N--CA 1.5 1.861 0 C-N-CA 123.74 2.96 . . . . 0.0 116.465 -170.145 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.4 ' HA ' ' HA ' ' A' ' 99' ' ' CYS . 1.7 m . . . . . 0 N--CA 1.494 1.738 0 CA-C-O 122.695 1.236 . . . . 0.0 113.94 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 64.3 m -90.54 166.39 13.24 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 113.309 -1.769 . . . . 0.0 108.201 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -146.53 155.05 42.22 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 124.079 0.862 . . . . 0.0 109.765 179.794 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 41.1 t -56.75 -32.84 65.97 Favored 'General case' 0 N--CA 1.497 1.916 0 CA-C-N 114.767 -1.106 . . . . 0.0 113.582 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 18.1 t -66.54 -46.19 76.91 Favored 'General case' 0 N--CA 1.495 1.796 0 CA-C-N 114.726 -1.124 . . . . 0.0 110.219 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -86.17 62.27 7.33 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-N 113.689 -1.596 . . . . 0.0 110.655 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -143.8 165.11 27.33 Favored Glycine 0 N--CA 1.496 2.637 0 CA-C-N 114.272 -1.331 . . . . 0.0 111.078 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.463 ' C ' ' H ' ' A' ' 71' ' ' GLY . 9.5 t -85.3 127.33 34.29 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-N 115.036 -0.582 . . . . 0.0 110.517 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -81.09 36.64 0.41 Allowed 'General case' 0 N--CA 1.501 2.078 0 CA-C-O 122.484 1.135 . . . . 0.0 110.432 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.463 ' H ' ' C ' ' A' ' 69' ' ' THR . . . -132.27 -1.28 4.42 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 108.547 -1.821 . . . . 0.0 108.547 179.735 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 64.1 m -143.39 141.62 30.95 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.464 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 7.7 ptmm? -92.46 96.61 10.34 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 124.447 1.092 . . . . 0.0 110.95 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.416 ' N ' ' O ' ' A' ' 83' ' ' CYS . 57.4 m-85 -52.15 134.02 33.22 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-N 114.429 -1.26 . . . . 0.0 109.692 179.731 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -141.4 158.37 43.96 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 112.998 -1.91 . . . . 0.0 112.762 -179.37 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 57.8 p -96.08 139.41 32.3 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 114.743 1.386 . . . . 0.0 114.743 -179.659 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.409 ' H ' ' HB2' ' A' ' 104' ' ' ALA . 5.5 p-10 -45.35 -48.23 13.33 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 126.044 2.09 . . . . 0.0 114.848 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -52.27 -30.58 28.59 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 124.329 1.018 . . . . 0.0 111.785 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 119.72 43.83 0.48 Allowed Glycine 0 N--CA 1.491 2.348 0 O-C-N 124.742 1.276 . . . . 0.0 111.043 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 57.3 m -139.13 111.21 7.35 Favored 'General case' 0 N--CA 1.5 2.03 0 C-N-CA 119.648 -0.821 . . . . 0.0 112.077 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 17.4 t80 -53.43 137.21 36.35 Favored 'General case' 0 N--CA 1.494 1.775 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.694 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 64.1 t -98.02 -73.4 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 CA-C-N 114.348 -1.297 . . . . 0.0 111.474 -179.525 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' CYS . . . . . 0.48 ' SG ' ' N ' ' A' ' 84' ' ' GLU . 0.5 OUTLIER -167.3 -172.65 2.04 Favored 'General case' 0 N--CA 1.505 2.3 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 -179.854 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.48 ' N ' ' SG ' ' A' ' 83' ' ' CYS . 33.3 tt0 -112.66 145.03 41.16 Favored 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 103.234 -2.876 . . . . 0.0 103.234 179.26 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -52.33 140.58 28.12 Favored Glycine 0 N--CA 1.503 3.157 0 C-N-CA 118.993 -1.575 . . . . 0.0 112.696 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -88.62 -4.98 58.45 Favored 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 27.8 t -117.97 107.91 14.63 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.475 ' HB3' ' ND2' ' A' ' 91' ' ' ASN . 14.3 t70 -79.05 141.49 58.52 Favored Pre-proline 0 N--CA 1.494 1.749 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -34.62 -31.5 0.06 OUTLIER 'Trans proline' 0 N--CA 1.497 1.729 0 C-N-CA 123.712 2.941 . . . . 0.0 113.784 175.004 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.437 ' N ' ' HD2' ' A' ' 90' ' ' ARG . 1.7 mpt_? -79.33 -53.93 6.44 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 123.869 0.73 . . . . 0.0 110.215 179.766 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.475 ' ND2' ' HB3' ' A' ' 88' ' ' ASP . 11.5 p30 -91.3 126.0 56.29 Favored Pre-proline 0 N--CA 1.5 2.062 0 C-N-CA 119.976 -0.69 . . . . 0.0 112.326 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -75.52 150.67 36.29 Favored 'Trans proline' 0 N--CA 1.492 1.39 0 C-N-CA 122.586 2.191 . . . . 0.0 109.396 165.294 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 32.4 mmmt -132.99 127.5 34.3 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 124.02 0.825 . . . . 0.0 109.029 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -84.06 73.96 10.32 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 123.97 0.794 . . . . 0.0 108.967 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 85.1 m -79.96 163.33 58.45 Favored Pre-proline 0 N--CA 1.496 1.838 0 CA-C-N 114.404 -1.271 . . . . 0.0 112.848 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.405 ' HA ' ' CZ ' ' A' ' 97' ' ' ARG . 4.9 Cg_endo -70.0 -151.43 0.03 OUTLIER 'Trans proline' 0 N--CA 1.491 1.376 0 C-N-CA 122.563 2.175 . . . . 0.0 109.292 159.392 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.425 ' HD2' ' N ' ' A' ' 97' ' ' ARG . 0.1 OUTLIER -154.3 50.38 0.64 Allowed 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 121.754 0.787 . . . . 0.0 111.67 179.991 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -60.5 157.16 14.7 Favored 'General case' 0 N--CA 1.5 2.065 0 CA-C-N 114.722 -1.126 . . . . 0.0 111.459 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.4 ' HA ' ' HA ' ' A' ' 62' ' ' CYS . 86.0 m -98.47 131.37 44.78 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-N 114.989 -1.005 . . . . 0.0 111.552 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.406 ' O ' HG22 ' A' ' 103' ' ' ILE . 51.0 t0 -121.34 79.85 36.69 Favored Pre-proline 0 N--CA 1.496 1.873 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 179.665 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -54.71 -17.29 12.97 Favored 'Trans proline' 0 N--CA 1.497 1.697 0 C-N-CA 122.696 2.264 . . . . 0.0 113.326 -176.477 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 73.0 ttp85 -88.49 -35.85 16.77 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 -179.777 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.406 HG22 ' O ' ' A' ' 100' ' ' ASP . 11.1 tt -54.35 159.82 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.403 0 O-C-N 123.307 0.38 . . . . 0.0 110.949 -179.704 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.409 ' HB2' ' H ' ' A' ' 77' ' ' ASP . . . -150.79 -68.01 0.19 Allowed 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 -179.756 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 51.1 m-85 -114.28 -161.64 0.78 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 124.189 0.931 . . . . 0.0 111.321 -179.634 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -160.2 106.99 0.3 Allowed Glycine 0 N--CA 1.486 2.024 0 N-CA-C 104.836 -3.306 . . . . 0.0 104.836 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.469 ' N ' HD12 ' A' ' 107' ' ' ILE . 2.1 mp -79.14 104.67 7.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 CA-C-O 121.949 0.881 . . . . 0.0 108.92 -179.653 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 16.0 m -86.79 159.71 51.48 Favored Pre-proline 0 N--CA 1.495 1.777 0 CA-C-N 114.272 -1.331 . . . . 0.0 108.641 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo . . . . . 0 N--CA 1.494 1.549 0 C-N-CA 122.382 2.055 . . . . 0.0 110.015 173.965 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 67.7 mmt-85 . . . . . 0 N--CA 1.499 2.005 0 N-CA-C 111.77 0.285 . . . . 0.0 111.77 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.0 tp -60.46 96.96 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 CA-C-O 121.922 0.867 . . . . 0.0 111.28 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.7 m -93.06 49.04 1.38 Allowed 'General case' 0 N--CA 1.491 1.598 0 CA-C-N 114.486 -1.234 . . . . 0.0 112.293 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 13.5 t -90.57 177.03 6.46 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-N 113.404 -1.725 . . . . 0.0 107.733 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.518 HD22 ' H ' ' A' ' 40' ' ' ASN . 14.3 p30 -160.04 167.98 26.62 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 123.994 0.809 . . . . 0.0 112.136 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 38.0 t -53.99 -42.52 69.11 Favored 'General case' 0 N--CA 1.497 1.877 0 CA-C-N 114.225 -1.352 . . . . 0.0 112.036 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 53.4 t -52.85 -44.48 66.81 Favored 'General case' 0 N--CA 1.496 1.862 0 CA-C-N 113.221 -1.808 . . . . 0.0 109.413 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -89.73 28.94 1.23 Allowed 'General case' 0 N--CA 1.499 2.018 0 CA-C-N 112.944 -1.935 . . . . 0.0 110.835 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -83.31 -138.44 3.36 Favored Glycine 0 N--CA 1.496 2.667 0 N-CA-C 110.743 -0.943 . . . . 0.0 110.743 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 39.9 p -158.09 104.88 1.91 Allowed 'General case' 0 N--CA 1.503 2.183 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 16.2 ptpt -53.55 95.05 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.108 0 CA-C-O 122.586 1.184 . . . . 0.0 111.811 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 168.24 -35.25 0.2 Allowed Glycine 0 N--CA 1.488 2.166 0 CA-C-N 113.788 -1.551 . . . . 0.0 110.345 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 49.9 m -112.12 161.28 16.69 Favored 'General case' 0 N--CA 1.502 2.151 0 C-N-CA 119.47 -0.892 . . . . 0.0 111.913 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -101.18 92.31 4.92 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-N 114.182 -1.372 . . . . 0.0 108.278 -179.677 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.409 ' N ' ' O ' ' A' ' 25' ' ' CYS . 47.4 m-85 -47.33 136.85 9.0 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 124.636 1.21 . . . . 0.0 110.712 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 10.7 t80 -146.19 159.58 43.12 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-N 112.853 -1.976 . . . . 0.0 112.789 -179.217 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 35.1 t -112.75 134.84 54.07 Favored 'General case' 0 N--CA 1.498 1.968 0 CA-C-N 112.285 -2.234 . . . . 0.0 114.753 -179.688 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.49 ' H ' ' HB2' ' A' ' 46' ' ' ALA . 1.2 p30 -51.17 -26.34 6.68 Favored 'General case' 0 N--CA 1.501 2.087 0 CA-C-N 112.457 -2.156 . . . . 0.0 115.031 -179.823 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 24.0 p30 -64.39 -2.12 2.07 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 123.999 0.812 . . . . 0.0 112.085 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 89.61 28.83 18.0 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 58.6 m -134.89 150.54 50.45 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 71.8 t80 -78.24 158.78 28.82 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-N 114.321 -1.309 . . . . 0.0 110.386 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 95.2 t -116.35 -73.77 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 CA-C-N 114.939 -1.028 . . . . 0.0 109.124 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.506 ' SG ' ' N ' ' A' ' 26' ' ' GLU . 1.7 p -168.41 -161.25 0.34 Allowed 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.506 ' N ' ' SG ' ' A' ' 25' ' ' CYS . 40.8 tt0 -127.87 145.57 50.9 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 104.669 -2.345 . . . . 0.0 104.669 179.231 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -32.72 102.13 0.01 OUTLIER Glycine 0 N--CA 1.499 2.891 0 N-CA-C 115.988 1.155 . . . . 0.0 115.988 -179.756 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -102.82 32.86 3.46 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 29.9 t -122.55 148.08 45.63 Favored 'General case' 0 N--CA 1.497 1.924 0 CA-C-N 114.124 -1.398 . . . . 0.0 107.681 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.401 ' H ' ' HZ1' ' A' ' 35' ' ' LYS . 41.8 t0 -128.2 92.9 40.29 Favored Pre-proline 0 N--CA 1.493 1.722 0 O-C-N 124.717 1.26 . . . . 0.0 110.82 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -52.43 -15.89 4.5 Favored 'Trans proline' 0 N--CA 1.495 1.59 0 C-N-CA 123.002 2.468 . . . . 0.0 113.03 178.239 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 16.7 tpt180 -61.2 -51.82 67.39 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 108.147 -1.056 . . . . 0.0 108.147 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 15.3 p30 -90.65 138.91 26.35 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 124.327 1.017 . . . . 0.0 110.016 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -74.38 116.77 4.74 Favored 'Trans proline' 0 N--CA 1.493 1.458 0 C-N-CA 123.017 2.478 . . . . 0.0 110.394 175.311 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.401 ' HZ1' ' H ' ' A' ' 30' ' ' ASP . 0.0 OUTLIER -167.51 176.19 6.68 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 123.98 0.8 . . . . 0.0 111.957 179.92 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -160.03 122.19 3.31 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-N 114.89 -1.05 . . . . 0.0 108.784 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 33.4 m -79.87 -71.58 0.45 Allowed 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 47.5 m 34.22 69.91 0.14 Allowed 'General case' 0 N--CA 1.498 1.96 0 O-C-N 124.787 1.305 . . . . 0.0 113.414 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.3 pp -143.55 -36.87 0.35 Allowed 'General case' 0 N--CA 1.495 1.789 0 CA-C-N 114.936 -1.029 . . . . 0.0 108.973 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.518 ' H ' HD22 ' A' ' 6' ' ' ASN . 20.5 m120 -94.02 138.68 31.84 Favored 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 105.648 -1.982 . . . . 0.0 105.648 179.473 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 75.0 m -101.01 131.02 47.08 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 123.698 0.624 . . . . 0.0 112.644 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 62.9 t0 -122.95 76.46 49.73 Favored Pre-proline 0 N--CA 1.497 1.922 0 O-C-N 124.213 0.945 . . . . 0.0 109.149 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -63.74 -37.64 44.67 Favored 'Trans proline' 0 N--CA 1.496 1.63 0 C-N-CA 123.309 2.672 . . . . 0.0 111.584 -176.131 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.402 ' H ' ' HG3' ' A' ' 44' ' ' ARG . 0.0 OUTLIER -74.6 -7.6 53.68 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 115.088 1.514 . . . . 0.0 115.088 -179.758 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 15.9 tt -57.04 156.74 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.25 0 C-N-CA 119.879 -0.729 . . . . 0.0 111.856 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.49 ' HB2' ' H ' ' A' ' 19' ' ' ASP . . . -137.13 -66.95 0.5 Allowed 'General case' 0 N--CA 1.497 1.914 0 O-C-N 124.006 0.816 . . . . 0.0 110.289 179.795 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 46.8 p90 -160.96 167.99 25.45 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-N 115.183 -0.917 . . . . 0.0 109.836 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -115.95 111.44 2.4 Favored Glycine 0 N--CA 1.492 2.428 0 O-C-N 125.17 1.544 . . . . 0.0 109.709 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.5 p -80.04 111.32 16.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 C-N-CA 119.731 -0.788 . . . . 0.0 111.973 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.7 m -79.33 149.48 72.45 Favored Pre-proline 0 N--CA 1.499 1.984 0 CA-C-N 115.135 -0.939 . . . . 0.0 109.055 179.66 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo . . . . . 0 N--CA 1.495 1.6 0 C-N-CA 122.749 2.299 . . . . 0.0 111.965 -169.619 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.477 ' HA ' ' HA ' ' A' ' 99' ' ' CYS . 1.7 m . . . . . 0 N--CA 1.48 1.054 0 CA-C-O 123.037 1.398 . . . . 0.0 111.897 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 93.2 m -90.3 168.24 12.05 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 112.516 -2.129 . . . . 0.0 108.72 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 42.3 p-10 -152.9 177.64 10.53 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 123.965 0.79 . . . . 0.0 110.072 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 4.5 t -73.17 1.12 9.85 Favored 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 46.1 t -91.64 -36.29 13.73 Favored 'General case' 0 N--CA 1.496 1.845 0 CA-C-N 114.751 -1.113 . . . . 0.0 110.584 179.701 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -71.1 59.21 0.24 Allowed 'General case' 0 N--CA 1.5 2.063 0 CA-C-N 112.466 -2.152 . . . . 0.0 114.148 -179.754 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -174.22 -150.33 7.6 Favored Glycine 0 N--CA 1.487 2.06 0 N-CA-C 107.863 -2.095 . . . . 0.0 107.863 179.761 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.458 ' C ' ' H ' ' A' ' 71' ' ' GLY . 66.5 p -146.11 157.42 43.84 Favored 'General case' 0 N--CA 1.502 2.13 0 C-N-CA 120.781 -0.367 . . . . 0.0 111.211 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 59.4 mtpt -71.07 33.23 0.05 OUTLIER 'General case' 0 N--CA 1.507 2.415 0 O-C-N 125.117 1.511 . . . . 0.0 113.627 179.699 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.458 ' H ' ' C ' ' A' ' 69' ' ' THR . . . -137.0 14.21 3.81 Favored Glycine 0 N--CA 1.486 1.987 0 N-CA-C 108.054 -2.018 . . . . 0.0 108.054 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' CYS . . . . . 0.421 ' HA ' ' HA ' ' A' ' 108' ' ' CYS . 86.8 m -140.44 175.21 9.79 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 123.901 0.412 . . . . 0.0 111.006 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 34.2 mtmm -131.16 106.57 8.43 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 123.953 0.783 . . . . 0.0 110.279 -179.694 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.681 ' CD2' ' SG ' ' A' ' 83' ' ' CYS . 97.8 m-85 -56.31 137.98 51.48 Favored 'General case' 0 N--CA 1.501 2.102 0 C-N-CA 120.133 -0.627 . . . . 0.0 109.827 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 15.4 t80 -143.07 162.38 35.66 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 124.69 1.244 . . . . 0.0 111.977 -179.672 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 47.3 t -120.5 139.08 53.41 Favored 'General case' 0 N--CA 1.5 2.058 0 CA-C-N 113.2 -1.818 . . . . 0.0 115.084 -179.726 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.588 ' H ' ' HB2' ' A' ' 104' ' ' ALA . 4.3 p-10 -48.84 -28.23 3.58 Favored 'General case' 0 N--CA 1.5 2.055 0 CA-C-N 111.341 -2.663 . . . . 0.0 114.033 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 17.8 p30 -61.09 -5.25 1.36 Allowed 'General case' 0 N--CA 1.497 1.886 0 O-C-N 124.35 1.031 . . . . 0.0 112.073 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 89.64 29.08 17.19 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.396 -1.482 . . . . 0.0 109.396 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 88.2 m -142.17 149.96 40.42 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 121.43 0.633 . . . . 0.0 111.008 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 34.0 t80 -67.52 164.69 18.37 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-N 113.583 -1.644 . . . . 0.0 110.508 179.78 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 92.7 t -126.27 -71.49 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 O-C-N 124.074 0.859 . . . . 0.0 111.146 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' CYS . . . . . 0.681 ' SG ' ' CD2' ' A' ' 74' ' ' TYR . 17.2 p -155.11 -172.18 4.09 Favored 'General case' 0 N--CA 1.499 2.021 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 -179.801 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.405 ' CD ' ' N ' ' A' ' 85' ' ' GLY . 10.5 tm-20 -116.77 164.2 15.0 Favored 'General case' 0 N--CA 1.501 2.086 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.447 ' HA3' ' O ' ' A' ' 69' ' ' THR . . . -49.63 107.82 0.37 Allowed Glycine 0 N--CA 1.494 2.545 0 CA-C-O 119.013 -0.882 . . . . 0.0 110.937 179.659 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -108.84 34.18 3.83 Favored 'General case' 0 N--CA 1.5 2.074 0 CA-C-O 121.535 0.683 . . . . 0.0 110.655 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 45.4 t -145.4 119.43 9.39 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -81.02 127.97 72.67 Favored Pre-proline 0 N--CA 1.494 1.769 0 C-N-CA 119.592 -0.843 . . . . 0.0 110.036 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_endo -58.56 -17.46 34.88 Favored 'Trans proline' 0 N--CA 1.495 1.605 0 C-N-CA 122.549 2.166 . . . . 0.0 113.019 -177.38 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 30.4 tpt180 -59.74 -41.48 91.06 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 123.717 0.636 . . . . 0.0 110.511 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -90.3 118.93 69.18 Favored Pre-proline 0 N--CA 1.496 1.85 0 O-C-N 124.396 1.06 . . . . 0.0 111.573 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -83.39 41.31 1.05 Allowed 'Trans proline' 0 N--CA 1.494 1.558 0 C-N-CA 123.365 2.71 . . . . 0.0 110.236 166.411 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.18 175.76 5.76 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-N 114.622 -1.172 . . . . 0.0 112.154 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -103.63 126.95 51.1 Favored 'General case' 0 N--CA 1.495 1.823 0 CA-C-N 114.826 -1.079 . . . . 0.0 109.359 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 42.6 m -79.94 163.74 56.44 Favored Pre-proline 0 N--CA 1.496 1.825 0 O-C-N 123.887 0.742 . . . . 0.0 111.732 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.451 ' C ' ' HE ' ' A' ' 97' ' ' ARG . 13.1 Cg_endo -68.66 155.39 69.01 Favored 'Trans proline' 0 N--CA 1.49 1.285 0 C-N-CA 122.511 2.14 . . . . 0.0 110.196 170.201 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.451 ' HE ' ' C ' ' A' ' 96' ' ' PRO . 0.0 OUTLIER -83.23 16.43 2.46 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-N 114.699 -1.137 . . . . 0.0 111.083 -179.919 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -48.0 131.28 15.63 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 123.89 0.743 . . . . 0.0 109.759 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.477 ' HA ' ' HA ' ' A' ' 62' ' ' CYS . 60.1 m -99.64 132.46 44.97 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 114.005 1.113 . . . . 0.0 114.005 -179.599 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 64.7 t0 -129.49 76.3 78.86 Favored Pre-proline 0 N--CA 1.5 2.058 0 O-C-N 124.231 0.957 . . . . 0.0 110.845 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -59.85 -13.78 24.16 Favored 'Trans proline' 0 N--CA 1.494 1.54 0 C-N-CA 122.501 2.134 . . . . 0.0 112.222 176.234 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 69.5 mtp85 -90.31 18.45 6.07 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 124.011 0.819 . . . . 0.0 111.779 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 9.9 tt -116.34 175.7 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.314 0 O-C-N 123.71 0.631 . . . . 0.0 110.497 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.588 ' HB2' ' H ' ' A' ' 77' ' ' ASP . . . -146.01 -62.64 0.32 Allowed 'General case' 0 N--CA 1.498 1.928 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.863 179.683 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 27.9 p90 -161.22 163.93 30.74 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 124.053 0.846 . . . . 0.0 110.978 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -98.27 112.86 4.57 Favored Glycine 0 N--CA 1.492 2.375 0 CA-C-N 113.688 -1.596 . . . . 0.0 111.979 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 93.8 mt -79.54 105.65 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 N-CA-C 106.5 -1.667 . . . . 0.0 106.5 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' CYS . . . . . 0.421 ' HA ' ' HA ' ' A' ' 72' ' ' CYS . 31.2 m -89.07 140.9 29.05 Favored Pre-proline 0 N--CA 1.491 1.599 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo . . . . . 0 N--CA 1.493 1.481 0 C-N-CA 122.41 2.073 . . . . 0.0 109.085 -176.048 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 62.1 ttm-85 . . . . . 0 N--CA 1.502 2.158 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 4.9 tp -62.35 94.77 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 CA-C-N 114.398 -1.274 . . . . 0.0 109.461 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.7 m -89.73 36.77 0.86 Allowed 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 116.881 2.178 . . . . 0.0 116.881 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 14.6 p -91.68 166.37 12.83 Favored 'General case' 0 N--CA 1.496 1.849 0 CA-C-N 113.518 -1.674 . . . . 0.0 108.901 179.521 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 14.0 p30 -161.42 142.65 11.36 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-N 114.861 -1.063 . . . . 0.0 111.791 179.735 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -61.69 -18.76 60.89 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-N 114.436 -1.256 . . . . 0.0 112.843 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 46.8 t -89.46 -69.54 0.71 Allowed 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 113.464 0.913 . . . . 0.0 113.464 -179.668 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.41 ' N ' ' SG ' ' A' ' 37' ' ' CYS . . . -75.45 1.19 14.67 Favored 'General case' 0 N--CA 1.5 2.043 0 N-CA-C 113.547 0.943 . . . . 0.0 113.547 -179.617 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -67.44 165.5 43.54 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 110.426 -1.07 . . . . 0.0 110.426 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 8.9 t -73.12 125.13 26.97 Favored 'General case' 0 N--CA 1.493 1.711 0 CA-C-O 121.508 0.671 . . . . 0.0 110.204 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 7.1 ttpm? -72.2 87.75 1.11 Allowed 'General case' 0 N--CA 1.49 1.551 0 CA-C-N 114.239 -1.346 . . . . 0.0 108.719 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 171.1 -34.36 0.16 Allowed Glycine 0 N--CA 1.488 2.134 0 CA-C-N 113.282 -1.781 . . . . 0.0 108.882 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 83.9 m -101.55 133.61 45.96 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.487 ' HB3' ' CE1' ' A' ' 23' ' ' PHE . 9.0 mtpm? -81.92 88.96 6.34 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 113.428 -1.714 . . . . 0.0 113.732 -179.278 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -54.48 126.22 22.66 Favored 'General case' 0 N--CA 1.499 2.018 0 N-CA-C 105.911 -1.885 . . . . 0.0 105.911 179.64 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -132.28 146.45 52.0 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 112.788 -2.005 . . . . 0.0 112.969 -179.188 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 40.2 t -84.5 139.81 31.9 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-N 112.563 -2.108 . . . . 0.0 114.866 -179.619 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -51.91 -32.14 31.45 Favored 'General case' 0 N--CA 1.499 1.981 0 CA-C-N 111.826 -2.443 . . . . 0.0 114.854 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -54.29 -21.67 9.87 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 123.981 0.8 . . . . 0.0 111.62 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 109.16 32.41 3.03 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 108.646 -1.782 . . . . 0.0 108.646 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 90.7 m -137.26 147.38 45.68 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 124.08 0.518 . . . . 0.0 110.961 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.487 ' CE1' ' HB3' ' A' ' 15' ' ' LYS . 8.6 t80 -80.43 140.93 35.74 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-N 114.637 -1.165 . . . . 0.0 110.216 179.813 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 98.0 t -100.42 -78.26 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 106.22 -1.77 . . . . 0.0 106.22 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -172.12 168.07 5.86 Favored 'General case' 0 N--CA 1.504 2.226 0 O-C-N 123.579 0.549 . . . . 0.0 110.404 179.78 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -87.59 155.38 19.99 Favored 'General case' 0 N--CA 1.501 2.114 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -48.22 131.71 19.65 Favored Glycine 0 N--CA 1.501 2.994 0 C-N-CA 120.026 -1.083 . . . . 0.0 111.48 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -101.91 33.21 3.11 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 37.1 t -149.58 137.4 20.29 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-N 114.502 -1.226 . . . . 0.0 107.922 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -79.59 134.1 58.35 Favored Pre-proline 0 N--CA 1.494 1.754 0 O-C-N 123.987 0.804 . . . . 0.0 109.007 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -57.0 -13.76 12.64 Favored 'Trans proline' 0 N--CA 1.497 1.7 0 C-N-CA 122.423 2.082 . . . . 0.0 112.789 -177.795 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 79.8 ttt180 -68.59 -43.04 77.34 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 123.658 0.599 . . . . 0.0 111.878 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 16.5 p30 -73.64 128.59 86.75 Favored Pre-proline 0 N--CA 1.495 1.792 0 C-N-CA 119.523 -0.871 . . . . 0.0 112.285 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -82.61 85.2 1.65 Allowed 'Trans proline' 0 N--CA 1.492 1.406 0 C-N-CA 123.509 2.806 . . . . 0.0 111.486 169.223 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 20.7 pttp -164.11 166.39 21.32 Favored 'General case' 0 N--CA 1.501 2.101 0 C-N-CA 120.621 -0.432 . . . . 0.0 111.829 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -129.14 158.79 38.0 Favored 'General case' 0 N--CA 1.497 1.883 0 CA-C-N 114.592 -1.186 . . . . 0.0 110.144 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.41 ' SG ' ' N ' ' A' ' 9' ' ' ALA . 85.2 m -88.55 -178.68 5.89 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-N 114.865 -1.061 . . . . 0.0 110.744 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 63.7 p -81.01 -2.16 46.84 Favored 'General case' 0 N--CA 1.497 1.91 0 CA-C-N 114.925 -1.034 . . . . 0.0 110.669 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.44 ' N ' HD22 ' A' ' 39' ' ' LEU . 3.1 mm? -79.41 -57.45 3.7 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 33.6 m120 53.52 103.0 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.982 0 O-C-N 124.83 1.331 . . . . 0.0 112.808 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 60.9 m 63.98 135.12 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.937 0 CA-C-N 114.602 -1.181 . . . . 0.0 112.963 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 46.3 t0 -135.81 102.03 10.42 Favored Pre-proline 0 N--CA 1.498 1.951 0 C-N-CA 120.305 -0.558 . . . . 0.0 111.674 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -57.22 -29.39 83.47 Favored 'Trans proline' 0 N--CA 1.494 1.543 0 C-N-CA 122.758 2.305 . . . . 0.0 111.467 174.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -62.75 -39.44 94.12 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 123.997 0.811 . . . . 0.0 109.309 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.426 ' CG2' ' N ' ' A' ' 46' ' ' ALA . 20.3 mt -76.97 161.8 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 CA-C-O 121.927 0.87 . . . . 0.0 109.505 179.776 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.426 ' N ' ' CG2' ' A' ' 45' ' ' ILE . . . -122.65 -54.21 1.86 Allowed 'General case' 0 N--CA 1.494 1.756 0 CA-C-N 112.423 -2.171 . . . . 0.0 109.054 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 14.4 p90 -171.15 159.32 5.88 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-N 114.727 -1.124 . . . . 0.0 111.523 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -92.31 111.55 4.07 Favored Glycine 0 N--CA 1.493 2.484 0 CA-C-N 113.523 -1.671 . . . . 0.0 111.073 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 33.0 m -79.95 98.1 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 N-CA-C 105.068 -2.197 . . . . 0.0 105.068 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 8.0 m -79.63 121.25 82.32 Favored Pre-proline 0 N--CA 1.492 1.633 0 CA-C-N 113.496 -1.684 . . . . 0.0 108.019 -179.768 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo . . . . . 0 N--CA 1.495 1.602 0 C-N-CA 122.806 2.337 . . . . 0.0 113.173 -165.14 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.425 ' HA ' ' HA ' ' A' ' 99' ' ' CYS . 56.2 m . . . . . 0 N--CA 1.489 1.484 0 CA-C-O 123.297 1.522 . . . . 0.0 112.593 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 61.3 m -90.7 133.29 35.26 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 111.466 -2.606 . . . . 0.0 104.307 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.453 ' ND2' ' H ' ' A' ' 67' ' ' ALA . 34.6 p-10 -153.82 154.45 33.98 Favored 'General case' 0 N--CA 1.503 2.194 0 N-CA-C 113.855 1.058 . . . . 0.0 113.855 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -67.18 -22.92 65.72 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-N 113.74 -1.573 . . . . 0.0 114.513 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 51.4 t -89.81 -68.71 0.76 Allowed 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 113.381 0.882 . . . . 0.0 113.381 -179.729 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.453 ' H ' ' ND2' ' A' ' 64' ' ' ASN . . . -71.47 -2.05 15.36 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 123.812 0.695 . . . . 0.0 111.833 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.425 ' HA3' ' CZ ' ' A' ' 74' ' ' TYR . . . -65.88 166.95 35.27 Favored Glycine 0 N--CA 1.491 2.307 0 O-C-N 123.829 0.706 . . . . 0.0 111.621 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 6.8 t -77.47 129.27 35.51 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 124.245 0.615 . . . . 0.0 111.954 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -71.64 81.6 0.84 Allowed 'General case' 0 N--CA 1.494 1.756 0 CA-C-N 114.378 -1.283 . . . . 0.0 110.899 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 174.66 -36.14 0.11 Allowed Glycine 0 N--CA 1.488 2.154 0 CA-C-N 113.11 -1.859 . . . . 0.0 108.728 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 46.3 m -94.86 129.55 41.81 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 13.3 mmmm -75.47 84.96 2.57 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 112.912 -1.949 . . . . 0.0 111.279 -179.673 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.425 ' CZ ' ' HA3' ' A' ' 68' ' ' GLY . 42.8 m-85 -50.61 121.7 6.16 Favored 'General case' 0 N--CA 1.503 2.215 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 179.673 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -129.88 150.64 51.09 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 111.896 -2.411 . . . . 0.0 113.417 -179.182 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 33.1 t -90.33 136.59 32.96 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-N 112.65 -2.068 . . . . 0.0 114.103 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.438 ' HB3' ' HB2' ' A' ' 104' ' ' ALA . 0.9 OUTLIER -51.32 -28.15 11.45 Favored 'General case' 0 N--CA 1.5 2.044 0 CA-C-N 112.386 -2.188 . . . . 0.0 114.705 179.833 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -54.16 -22.47 11.32 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 123.93 0.769 . . . . 0.0 111.466 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 110.66 29.74 3.51 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 108.637 -1.785 . . . . 0.0 108.637 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 85.4 m -139.7 146.49 39.69 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 123.985 0.462 . . . . 0.0 111.102 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.405 ' CZ ' ' HA ' ' A' ' 83' ' ' CYS . 21.5 t80 -76.06 154.0 35.98 Favored 'General case' 0 N--CA 1.493 1.725 0 CA-C-N 114.352 -1.295 . . . . 0.0 110.438 179.778 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 57.9 t -117.11 -79.68 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' CYS . . . . . 0.405 ' HA ' ' CZ ' ' A' ' 81' ' ' PHE . 0.2 OUTLIER -162.69 179.65 7.53 Favored 'General case' 0 N--CA 1.505 2.286 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 179.726 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -97.69 159.37 14.97 Favored 'General case' 0 N--CA 1.507 2.392 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 179.669 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -53.15 132.32 41.82 Favored Glycine 0 N--CA 1.5 2.944 0 C-N-CA 119.42 -1.372 . . . . 0.0 110.306 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -101.92 33.02 3.18 Favored 'General case' 0 N--CA 1.499 2.0 0 CA-C-O 122.143 0.973 . . . . 0.0 108.391 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 41.2 t -157.6 152.8 25.89 Favored 'General case' 0 N--CA 1.495 1.801 0 CA-C-N 114.533 -1.212 . . . . 0.0 109.345 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -97.14 138.05 21.24 Favored Pre-proline 0 N--CA 1.494 1.74 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -64.48 86.59 0.16 Allowed 'Trans proline' 0 N--CA 1.494 1.53 0 C-N-CA 122.131 1.887 . . . . 0.0 108.178 173.483 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 3.5 mtp-105 178.25 -31.31 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.011 0 CA-C-N 114.031 -1.44 . . . . 0.0 109.352 -179.789 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 3.0 p30 -53.02 125.93 41.99 Favored Pre-proline 0 N--CA 1.497 1.923 0 O-C-N 124.04 0.838 . . . . 0.0 112.919 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -82.73 48.0 2.63 Favored 'Trans proline' 0 N--CA 1.49 1.301 0 C-N-CA 122.916 2.411 . . . . 0.0 108.684 160.8 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 45.8 mmtm -126.13 169.57 12.67 Favored 'General case' 0 N--CA 1.498 1.965 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.462 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -145.58 135.86 23.95 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-N 114.707 -1.133 . . . . 0.0 109.529 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' CYS . . . . . 0.478 ' HB3' ' H ' ' A' ' 97' ' ' ARG . 86.9 m -79.96 157.76 73.43 Favored Pre-proline 0 N--CA 1.495 1.809 0 CA-C-N 115.076 -0.965 . . . . 0.0 111.696 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -69.28 -5.61 16.32 Favored 'Trans proline' 0 N--CA 1.496 1.639 0 C-N-CA 122.841 2.361 . . . . 0.0 110.369 160.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.478 ' H ' ' HB3' ' A' ' 95' ' ' CYS . 17.5 tpp85 -79.31 -50.13 11.37 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 21.0 m120 54.05 -159.67 0.16 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 124.797 1.311 . . . . 0.0 110.401 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.425 ' HA ' ' HA ' ' A' ' 62' ' ' CYS . 64.6 m -51.61 120.01 4.75 Favored 'General case' 0 N--CA 1.497 1.913 0 CA-C-N 115.208 -0.905 . . . . 0.0 108.773 179.769 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -107.64 99.31 28.48 Favored Pre-proline 0 N--CA 1.499 2.01 0 O-C-N 123.684 0.615 . . . . 0.0 111.293 -179.766 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -64.18 -27.82 64.66 Favored 'Trans proline' 0 N--CA 1.494 1.555 0 C-N-CA 122.634 2.223 . . . . 0.0 111.328 -176.137 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 25.8 mtm105 -60.01 -39.85 87.22 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 18.0 mt -76.0 160.98 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 CA-C-N 113.927 -1.488 . . . . 0.0 111.121 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.438 ' HB2' ' HB3' ' A' ' 77' ' ' ASP . . . -123.79 -61.77 1.35 Allowed 'General case' 0 N--CA 1.491 1.612 0 CA-C-N 112.176 -2.284 . . . . 0.0 109.72 -179.787 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 20.0 p90 -160.49 157.23 27.19 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-N 114.806 -1.088 . . . . 0.0 111.941 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.415 ' HA2' ' HA ' ' A' ' 74' ' ' TYR . . . -94.96 109.79 3.9 Favored Glycine 0 N--CA 1.488 2.162 0 CA-C-N 112.864 -1.971 . . . . 0.0 111.406 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 65.0 mt -79.17 95.73 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 CA-C-N 114.577 -0.811 . . . . 0.0 110.913 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 1.5 m -79.09 143.32 60.93 Favored Pre-proline 0 N--CA 1.503 2.203 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 179.557 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo . . . . . 0 N--CA 1.494 1.53 0 C-N-CA 122.613 2.208 . . . . 0.0 111.555 -179.559 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 74.4 ttt-85 . . . . . 0 N--CA 1.495 1.796 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.433 ' O ' ' HA ' ' A' ' 41' ' ' CYS . 9.1 tp -85.89 53.13 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 123.213 0.321 . . . . 0.0 110.647 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.61 ' HA ' ' CA ' ' A' ' 41' ' ' CYS . 1.6 m -79.31 39.08 0.38 Allowed 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 117.279 2.325 . . . . 0.0 117.279 -179.858 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.1 p -91.23 151.05 21.08 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 112.176 -2.284 . . . . 0.0 106.357 179.197 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 45.4 p-10 -160.71 173.86 14.81 Favored 'General case' 0 N--CA 1.494 1.774 0 CA-C-N 113.453 -1.703 . . . . 0.0 109.644 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 4.2 t -72.01 -24.89 61.63 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-N 114.698 -1.137 . . . . 0.0 112.863 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 40.4 t -89.25 -69.54 0.71 Allowed 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 113.68 0.993 . . . . 0.0 113.68 -179.605 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -81.78 36.83 0.45 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 124.531 1.144 . . . . 0.0 112.543 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -82.0 -119.51 0.54 Allowed Glycine 0 N--CA 1.493 2.473 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 37.0 p -155.74 123.86 5.78 Favored 'General case' 0 N--CA 1.5 2.035 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.67 144.58 42.87 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-N 115.034 -0.985 . . . . 0.0 110.928 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 91.5 -18.18 53.35 Favored Glycine 0 N--CA 1.492 2.43 0 CA-C-N 114.486 -1.234 . . . . 0.0 110.959 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 91.4 m -99.54 171.65 7.8 Favored 'General case' 0 N--CA 1.498 1.935 0 C-N-CA 120.118 -0.633 . . . . 0.0 110.707 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 60.8 mttp -129.79 90.1 2.92 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-N 115.066 -0.97 . . . . 0.0 109.667 -179.514 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 40.8 m-85 -54.79 133.8 47.59 Favored 'General case' 0 N--CA 1.495 1.777 0 CA-C-N 114.133 -1.394 . . . . 0.0 109.384 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -137.73 157.22 46.93 Favored 'General case' 0 N--CA 1.487 1.415 0 CA-C-N 112.934 -1.939 . . . . 0.0 113.682 -179.22 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 30.9 t -103.82 134.43 47.14 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-N 112.685 -2.052 . . . . 0.0 113.211 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.42 ' HB3' ' HB2' ' A' ' 46' ' ' ALA . 1.0 OUTLIER -50.05 -27.16 5.15 Favored 'General case' 0 N--CA 1.503 2.219 0 N-CA-C 115.541 1.682 . . . . 0.0 115.541 -179.99 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -55.67 -16.66 4.45 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 123.836 0.71 . . . . 0.0 111.749 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 104.26 29.42 5.43 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 108.442 -1.863 . . . . 0.0 108.442 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 59.9 m -137.2 144.39 42.84 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 124.088 0.522 . . . . 0.0 110.579 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 21.7 t80 -77.08 145.36 37.91 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-N 114.266 -1.334 . . . . 0.0 109.59 179.771 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 91.4 t -100.17 -76.39 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.441 ' SG ' ' O ' ' A' ' 26' ' ' GLU . 0.1 OUTLIER -171.06 179.76 2.97 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 123.399 0.437 . . . . 0.0 110.889 179.823 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.441 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 35.6 tt0 -81.76 149.64 28.32 Favored 'General case' 0 N--CA 1.501 2.11 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.318 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -70.58 118.4 7.72 Favored Glycine 0 N--CA 1.497 2.763 0 N-CA-C 106.643 -2.583 . . . . 0.0 106.643 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -96.87 26.64 4.46 Favored 'General case' 0 N--CA 1.501 2.086 0 CA-C-O 121.481 0.658 . . . . 0.0 111.317 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 45.7 t -106.15 120.51 42.0 Favored 'General case' 0 N--CA 1.495 1.776 0 CA-C-N 114.349 -1.296 . . . . 0.0 109.993 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.455 ' H ' HD21 ' A' ' 33' ' ' ASN . 12.5 t70 -132.27 140.98 39.67 Favored Pre-proline 0 N--CA 1.494 1.75 0 N-CA-C 106.543 -1.651 . . . . 0.0 106.543 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -67.12 79.51 0.4 Allowed 'Trans proline' 0 N--CA 1.494 1.525 0 C-N-CA 122.584 2.19 . . . . 0.0 110.238 175.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 5.2 mmt-85 178.21 -46.13 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.77 0 CA-C-N 113.59 -1.641 . . . . 0.0 108.008 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.455 HD21 ' H ' ' A' ' 30' ' ' ASP . 28.5 p30 -83.02 149.28 58.79 Favored Pre-proline 0 N--CA 1.495 1.776 0 O-C-N 124.043 0.84 . . . . 0.0 111.755 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_endo -76.77 119.2 5.06 Favored 'Trans proline' 0 N--CA 1.491 1.333 0 C-N-CA 122.875 2.383 . . . . 0.0 108.696 165.078 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 41.3 mtmt -72.37 117.73 14.39 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -160.68 101.13 1.31 Allowed 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 113.997 1.11 . . . . 0.0 113.997 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 1.6 m -160.42 -53.05 0.05 Allowed 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 105.193 -2.151 . . . . 0.0 105.193 179.665 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 95.2 m -121.59 160.5 24.21 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-N 112.808 -1.996 . . . . 0.0 108.844 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -93.21 26.65 2.8 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-N 114.663 -1.153 . . . . 0.0 110.896 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 4.0 m120 60.54 -177.83 0.1 Allowed 'General case' 0 N--CA 1.501 2.095 0 CA-C-N 114.257 -1.338 . . . . 0.0 113.192 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.61 ' CA ' ' HA ' ' A' ' 4' ' ' CYS . 1.7 m 52.27 79.73 0.1 Allowed 'General case' 0 N--CA 1.495 1.803 0 CA-C-O 123.723 1.725 . . . . 0.0 112.674 -179.704 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.4 ' O ' HG22 ' A' ' 45' ' ' ILE . 11.2 t70 -91.78 110.13 41.52 Favored Pre-proline 0 N--CA 1.484 1.273 0 CA-C-N 110.091 -3.231 . . . . 0.0 106.844 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_endo -63.92 -19.53 66.81 Favored 'Trans proline' 0 N--CA 1.495 1.614 0 C-N-CA 121.791 1.661 . . . . 0.0 112.365 -170.358 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.502 ' N ' ' HD2' ' A' ' 44' ' ' ARG . 2.1 mpt_? -90.56 -26.89 19.48 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 112.918 0.711 . . . . 0.0 112.918 -179.764 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.4 HG22 ' O ' ' A' ' 42' ' ' ASP . 6.3 tt -64.56 169.05 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 123.558 0.536 . . . . 0.0 111.939 -179.536 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.42 ' HB2' ' HB3' ' A' ' 19' ' ' ASP . . . -140.86 -59.12 0.51 Allowed 'General case' 0 N--CA 1.494 1.751 0 CA-C-N 114.806 -1.088 . . . . 0.0 110.044 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 41.4 p90 -165.52 165.52 18.94 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-N 114.659 -1.155 . . . . 0.0 109.416 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -117.18 121.08 5.02 Favored Glycine 0 N--CA 1.491 2.315 0 O-C-N 125.386 1.678 . . . . 0.0 110.878 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 8.4 p -79.29 133.71 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 N-CA-C 106.114 -1.81 . . . . 0.0 106.114 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 7.8 m -114.97 76.24 4.29 Favored Pre-proline 0 N--CA 1.499 1.987 0 O-C-N 123.742 0.651 . . . . 0.0 110.441 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo . . . . . 0 N--CA 1.493 1.447 0 C-N-CA 122.952 2.435 . . . . 0.0 110.704 -176.659 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 1.7 m . . . . . 0 N--CA 1.495 1.778 0 N-CA-C 113.993 1.109 . . . . 0.0 113.993 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 12.6 t -90.72 -174.93 4.24 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-N 113.379 -1.737 . . . . 0.0 108.195 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -157.03 155.04 30.53 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 106.388 -1.708 . . . . 0.0 106.388 179.65 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 27.6 t -54.82 -26.87 37.8 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 114.343 1.238 . . . . 0.0 114.343 -179.411 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 44.2 t -76.41 -48.47 19.65 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-N 114.386 -1.279 . . . . 0.0 111.391 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -79.49 57.19 2.34 Favored 'General case' 0 N--CA 1.497 1.895 0 CA-C-N 113.348 -1.751 . . . . 0.0 112.829 -179.71 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -147.46 152.59 24.7 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 6.8 t -65.56 128.4 35.76 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-N 113.255 -1.472 . . . . 0.0 109.565 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -73.53 88.1 1.63 Allowed 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 106.22 -1.77 . . . . 0.0 106.22 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 168.98 -25.46 0.11 Allowed Glycine 0 N--CA 1.488 2.132 0 CA-C-N 112.673 -2.058 . . . . 0.0 110.07 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 56.2 m -100.4 124.08 45.44 Favored 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 122.094 0.95 . . . . 0.0 111.541 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 28.1 mtpp -73.49 93.59 2.01 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 112.681 -2.054 . . . . 0.0 112.157 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.473 ' CD1' HD13 ' A' ' 103' ' ' ILE . 8.3 m-85 -48.83 128.25 15.31 Favored 'General case' 0 N--CA 1.501 2.118 0 N-CA-C 106.704 -1.591 . . . . 0.0 106.704 179.413 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -142.87 155.24 44.73 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 114.706 -1.134 . . . . 0.0 112.348 -179.467 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 40.2 t -101.52 133.83 45.57 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-N 113.231 -1.804 . . . . 0.0 110.939 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -48.87 -28.74 3.98 Favored 'General case' 0 N--CA 1.502 2.132 0 N-CA-C 115.834 1.79 . . . . 0.0 115.834 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -52.0 -24.25 6.32 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 123.946 0.779 . . . . 0.0 111.738 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 113.63 28.27 3.28 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 108.616 -1.794 . . . . 0.0 108.616 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 88.6 m -139.17 140.6 37.88 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 124.045 0.497 . . . . 0.0 110.981 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 12.5 t80 -68.57 159.08 32.59 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-N 114.198 -1.365 . . . . 0.0 110.804 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 91.3 t -121.42 -71.4 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 CA-C-N 114.823 -1.081 . . . . 0.0 110.104 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' CYS . . . . . 0.576 ' SG ' ' N ' ' A' ' 84' ' ' GLU . 0.5 OUTLIER -153.48 -163.02 1.57 Allowed 'General case' 0 N--CA 1.501 2.105 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 -179.875 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.576 ' N ' ' SG ' ' A' ' 83' ' ' CYS . 12.5 tp10 -129.03 146.62 50.95 Favored 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 179.433 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -59.01 138.65 49.45 Favored Glycine 0 N--CA 1.501 2.991 0 N-CA-C 109.257 -1.537 . . . . 0.0 109.257 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 35.8 mm-40 -113.89 31.76 6.32 Favored 'General case' 0 N--CA 1.501 2.098 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 36.8 t -156.0 105.42 2.35 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -79.26 144.73 62.95 Favored Pre-proline 0 N--CA 1.495 1.796 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -64.76 70.97 0.24 Allowed 'Trans proline' 0 N--CA 1.498 1.744 0 C-N-CA 123.088 2.525 . . . . 0.0 110.861 164.127 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 31.4 mtm105 -163.6 -49.95 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 104.868 -2.271 . . . . 0.0 104.868 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -90.41 133.23 33.43 Favored Pre-proline 0 N--CA 1.489 1.487 0 CA-C-N 114.053 -1.43 . . . . 0.0 110.356 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -79.9 50.26 3.47 Favored 'Trans proline' 0 N--CA 1.495 1.598 0 C-N-CA 123.521 2.814 . . . . 0.0 112.1 173.584 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -80.47 124.8 29.23 Favored 'General case' 0 N--CA 1.5 2.047 0 C-N-CA 120.126 -0.63 . . . . 0.0 111.076 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -80.1 166.13 21.81 Favored 'General case' 0 N--CA 1.497 1.878 0 CA-C-N 114.679 -1.146 . . . . 0.0 109.525 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 97.0 m -151.44 160.55 31.64 Favored Pre-proline 0 N--CA 1.497 1.906 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -60.33 130.17 32.84 Favored 'Trans proline' 0 N--CA 1.493 1.47 0 C-N-CA 122.709 2.273 . . . . 0.0 109.401 166.128 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.527 ' HA ' ' NE ' ' A' ' 97' ' ' ARG . 3.4 tpm_? -81.27 10.28 5.77 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 123.991 0.807 . . . . 0.0 110.203 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -52.47 153.83 2.83 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 114.105 1.15 . . . . 0.0 114.105 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 63.0 m -91.93 137.56 32.26 Favored 'General case' 0 N--CA 1.495 1.776 0 CA-C-N 113.897 -1.501 . . . . 0.0 111.402 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -119.98 88.36 40.43 Favored Pre-proline 0 N--CA 1.497 1.917 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 179.645 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -63.98 -33.35 63.27 Favored 'Trans proline' 0 N--CA 1.491 1.327 0 C-N-CA 122.683 2.255 . . . . 0.0 112.545 -170.743 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 15.9 ptm180 -64.98 -30.18 71.15 Favored 'General case' 0 N--CA 1.497 1.895 0 C-N-CA 119.574 -0.85 . . . . 0.0 111.965 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.473 HD13 ' CD1' ' A' ' 74' ' ' TYR . 11.9 mt -70.38 156.04 7.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 C-N-CA 118.907 -1.117 . . . . 0.0 109.66 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -137.94 -40.44 0.54 Allowed 'General case' 0 N--CA 1.491 1.58 0 CA-C-N 112.617 -2.083 . . . . 0.0 110.132 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 46.1 m-85 -143.0 -165.28 2.03 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 124.333 1.02 . . . . 0.0 110.635 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -154.97 94.07 0.14 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 103.907 -3.677 . . . . 0.0 103.907 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 37.7 mm -79.16 96.28 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 N-CA-C 116.066 1.876 . . . . 0.0 116.066 -179.464 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 1.7 m -79.96 150.94 72.78 Favored Pre-proline 0 N--CA 1.5 2.052 0 N-CA-C 105.861 -1.903 . . . . 0.0 105.861 179.238 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo . . . . . 0 N--CA 1.497 1.682 0 C-N-CA 123.115 2.543 . . . . 0.0 112.394 -172.313 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 47.8 tpt85 . . . . . 0 N--CA 1.494 1.763 0 CA-C-O 120.905 0.383 . . . . 0.0 110.37 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 7.6 tp -84.5 49.21 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 CA-C-N 114.634 -1.166 . . . . 0.0 110.077 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.434 ' HA ' ' HA ' ' A' ' 41' ' ' CYS . 1.6 m -82.38 59.76 4.73 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 115.24 1.57 . . . . 0.0 115.24 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 38.6 m -91.03 163.43 14.31 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 105.092 -2.188 . . . . 0.0 105.092 179.393 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.477 ' ND2' ' H ' ' A' ' 9' ' ' ALA . 40.8 p-10 -158.5 175.66 13.4 Favored 'General case' 0 N--CA 1.499 2.023 0 C-N-CA 118.895 -1.122 . . . . 0.0 113.057 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 45.3 t -78.44 -32.47 48.54 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-N 113.198 -1.819 . . . . 0.0 113.704 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 38.3 t -77.01 -62.86 1.51 Allowed 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 113.892 1.071 . . . . 0.0 113.892 -179.596 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.477 ' H ' ' ND2' ' A' ' 6' ' ' ASN . . . -84.81 63.97 8.33 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 124.743 1.277 . . . . 0.0 111.376 -179.702 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -137.54 -169.61 11.67 Favored Glycine 0 N--CA 1.498 2.823 0 CA-C-N 113.559 -1.655 . . . . 0.0 111.518 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.414 ' N ' ' OH ' ' A' ' 16' ' ' TYR . 4.5 t -102.62 111.62 24.02 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 114.191 1.182 . . . . 0.0 114.191 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.404 ' HA ' ' HA3' ' A' ' 27' ' ' GLY . 21.8 pttp -64.87 81.7 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.958 0 CA-C-N 113.608 -1.633 . . . . 0.0 110.789 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -175.18 -31.57 0.04 OUTLIER Glycine 0 N--CA 1.486 2.028 0 CA-C-N 113.057 -1.883 . . . . 0.0 109.629 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.445 ' HA ' ' HA ' ' A' ' 50' ' ' CYS . 21.9 m -104.64 148.19 26.81 Favored 'General case' 0 N--CA 1.501 2.085 0 C-N-CA 118.775 -1.17 . . . . 0.0 112.964 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -92.95 88.3 6.1 Favored 'General case' 0 N--CA 1.484 1.23 0 CA-C-N 113.307 -1.77 . . . . 0.0 107.428 -179.397 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.414 ' OH ' ' N ' ' A' ' 11' ' ' THR . 11.0 m-30 -46.4 134.95 8.64 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-N 113.59 -1.641 . . . . 0.0 108.494 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 10.8 t80 -145.16 156.16 43.71 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-N 113.232 -1.804 . . . . 0.0 111.511 -179.336 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 28.8 t -112.53 136.11 52.45 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-N 111.838 -2.437 . . . . 0.0 115.313 -179.462 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -52.14 -21.47 3.32 Favored 'General case' 0 N--CA 1.499 1.989 0 CA-C-N 112.266 -2.243 . . . . 0.0 113.715 179.796 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 43.6 p30 -64.19 -1.86 1.81 Allowed 'General case' 0 N--CA 1.497 1.917 0 O-C-N 124.04 0.838 . . . . 0.0 111.231 179.758 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 85.74 29.15 27.29 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 108.94 -1.664 . . . . 0.0 108.94 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 95.5 m -141.21 150.47 42.73 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 121.831 0.824 . . . . 0.0 110.557 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 24.2 t80 -73.52 155.65 38.97 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-N 113.144 -1.844 . . . . 0.0 111.979 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 90.9 t -115.27 -77.0 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 CA-C-N 114.673 -1.149 . . . . 0.0 109.056 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.654 ' SG ' ' N ' ' A' ' 26' ' ' GLU . 0.1 OUTLIER -166.97 -168.61 1.13 Allowed 'General case' 0 N--CA 1.507 2.393 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 179.979 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.654 ' N ' ' SG ' ' A' ' 25' ' ' CYS . 3.5 tm-20 -128.36 140.96 51.58 Favored 'General case' 0 N--CA 1.5 2.046 0 N-CA-C 104.52 -2.4 . . . . 0.0 104.52 179.496 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.404 ' HA3' ' HA ' ' A' ' 12' ' ' LYS . . . -39.27 117.82 0.78 Allowed Glycine 0 N--CA 1.5 2.928 0 CA-C-O 122.041 0.8 . . . . 0.0 114.869 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -92.87 0.66 57.45 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-N 113.072 -1.564 . . . . 0.0 112.061 -179.686 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 27.5 t -156.22 170.3 22.56 Favored 'General case' 0 N--CA 1.501 2.103 0 C-N-CA 119.609 -0.837 . . . . 0.0 111.467 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -79.29 143.84 61.12 Favored Pre-proline 0 N--CA 1.493 1.694 0 CA-C-N 114.626 -1.17 . . . . 0.0 107.883 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -70.37 67.67 2.08 Favored 'Trans proline' 0 N--CA 1.5 1.9 0 C-N-CA 123.158 2.572 . . . . 0.0 111.073 172.578 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 67.0 mtp85 -160.33 -39.44 0.05 Allowed 'General case' 0 N--CA 1.496 1.855 0 CA-C-N 113.246 -1.797 . . . . 0.0 107.764 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.537 HD22 ' N ' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -39.71 102.98 0.27 Allowed Pre-proline 0 N--CA 1.498 1.945 0 O-C-N 124.876 1.36 . . . . 0.0 114.416 -179.877 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -76.4 179.57 6.26 Favored 'Trans proline' 0 N--CA 1.494 1.54 0 C-N-CA 122.821 2.348 . . . . 0.0 111.029 -179.516 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 25.7 ttpp 62.9 155.25 0.05 OUTLIER 'General case' 0 N--CA 1.5 2.071 0 O-C-N 124.673 1.233 . . . . 0.0 112.618 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -79.87 147.33 31.76 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-N 114.639 -1.164 . . . . 0.0 110.124 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.579 ' H ' HD21 ' A' ' 40' ' ' ASN . 98.4 m -79.66 -87.91 0.07 Allowed 'General case' 0 N--CA 1.492 1.663 0 CA-C-N 114.66 -1.154 . . . . 0.0 110.593 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.418 ' H ' ' H ' ' A' ' 39' ' ' LEU . 7.9 t -168.9 -15.53 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.019 0 O-C-N 123.616 0.573 . . . . 0.0 110.732 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.418 ' H ' ' H ' ' A' ' 38' ' ' THR . 0.8 OUTLIER -153.44 64.92 0.75 Allowed 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 103.837 -2.653 . . . . 0.0 103.837 -179.955 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.579 HD21 ' H ' ' A' ' 37' ' ' CYS . 13.4 m120 -84.15 47.59 1.35 Allowed 'General case' 0 N--CA 1.491 1.602 0 CA-C-N 112.702 -2.045 . . . . 0.0 112.959 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.434 ' HA ' ' HA ' ' A' ' 4' ' ' CYS . 75.3 m -158.04 126.31 5.42 Favored 'General case' 0 N--CA 1.498 1.93 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.781 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -147.83 81.36 8.43 Favored Pre-proline 0 N--CA 1.496 1.852 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.313 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -60.82 -31.11 91.39 Favored 'Trans proline' 0 N--CA 1.493 1.496 0 C-N-CA 122.744 2.296 . . . . 0.0 114.391 -173.749 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 7.3 ptm180 -58.59 -30.73 67.43 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 123.813 0.696 . . . . 0.0 111.955 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 13.9 tt -47.33 156.79 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 O-C-N 124.226 0.954 . . . . 0.0 113.279 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -137.85 -50.76 0.6 Allowed 'General case' 0 N--CA 1.492 1.636 0 CA-C-N 113.967 -1.469 . . . . 0.0 107.102 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 46.9 p90 -168.32 167.14 12.22 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-N 113.883 -1.508 . . . . 0.0 109.485 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -118.49 108.69 1.64 Allowed Glycine 0 N--CA 1.491 2.316 0 N-CA-C 107.861 -2.096 . . . . 0.0 107.861 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 5.6 p -80.15 111.42 16.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 C-N-CA 118.895 -1.122 . . . . 0.0 110.233 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.445 ' HA ' ' HA ' ' A' ' 14' ' ' CYS . 1.7 m -78.57 110.15 13.02 Favored Pre-proline 0 N--CA 1.499 2.014 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.484 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo . . . . . 0 N--CA 1.49 1.307 0 C-N-CA 122.816 2.344 . . . . 0.0 108.415 -175.553 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.419 ' HA ' ' HA ' ' A' ' 99' ' ' CYS . 1.7 m . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 122.814 1.292 . . . . 0.0 114.222 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.6 p -91.25 159.09 16.22 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-N 112.889 -1.96 . . . . 0.0 109.573 179.724 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.62 HD21 ' H ' ' A' ' 99' ' ' CYS . 64.1 m-20 -152.94 157.02 40.0 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 125.018 1.448 . . . . 0.0 111.259 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' CYS . . . . . 0.492 ' HA ' ' CD2' ' A' ' 74' ' ' TYR . 3.6 t -62.1 -38.37 88.63 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-N 114.541 -1.209 . . . . 0.0 108.427 179.65 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 43.0 t -66.99 -50.85 60.97 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 112.363 -2.199 . . . . 0.0 110.634 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -79.36 -114.2 0.02 OUTLIER 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 113.924 -1.489 . . . . 0.0 110.701 -179.635 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 46.16 -129.89 10.62 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 111.044 -0.822 . . . . 0.0 111.044 -179.512 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 40.7 p -150.94 135.19 16.88 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 123.879 0.399 . . . . 0.0 111.689 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -61.1 104.2 0.35 Allowed 'General case' 0 N--CA 1.499 2.015 0 O-C-N 124.249 0.968 . . . . 0.0 110.309 179.791 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 141.43 -24.75 2.49 Favored Glycine 0 N--CA 1.494 2.551 0 O-C-N 123.93 0.769 . . . . 0.0 111.659 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 94.7 m -91.74 133.29 35.73 Favored 'General case' 0 N--CA 1.498 1.927 0 C-N-CA 120.736 -0.386 . . . . 0.0 110.441 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.7 mppt? -88.04 88.7 7.73 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 124.057 0.848 . . . . 0.0 110.46 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.515 ' CE2' ' HA2' ' A' ' 85' ' ' GLY . 77.7 m-85 -40.71 136.14 1.46 Allowed 'General case' 0 N--CA 1.503 2.176 0 O-C-N 124.613 1.196 . . . . 0.0 109.761 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -148.17 145.23 28.23 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 124.753 1.283 . . . . 0.0 113.399 -179.605 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.409 ' N ' HG23 ' A' ' 82' ' ' VAL . 42.0 t -106.81 118.69 37.35 Favored 'General case' 0 N--CA 1.499 1.995 0 CA-C-N 112.653 -2.067 . . . . 0.0 111.902 -179.675 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.516 ' HB3' ' HB2' ' A' ' 104' ' ' ALA . 6.1 p-10 -55.16 -52.89 61.87 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 126.323 2.264 . . . . 0.0 112.703 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -69.55 -0.74 7.14 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 112.108 -2.315 . . . . 0.0 112.541 -179.568 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -139.46 -84.4 0.1 Allowed Glycine 0 N--CA 1.482 1.702 0 C-N-CA 119.202 -1.475 . . . . 0.0 112.209 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.485 ' CG2' ' H ' ' A' ' 81' ' ' PHE . 1.2 m 175.79 -170.33 0.06 Allowed 'General case' 0 N--CA 1.5 2.04 0 O-C-N 126.22 1.777 . . . . 0.0 106.252 -179.166 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.485 ' H ' ' CG2' ' A' ' 80' ' ' THR . 75.8 t80 -42.62 146.55 0.35 Allowed 'General case' 0 N--CA 1.498 1.955 0 C-N-CA 123.554 0.742 . . . . 0.0 112.636 179.527 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.409 HG23 ' N ' ' A' ' 76' ' ' SER . 88.4 t -111.17 -70.93 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 CA-C-N 113.878 -1.51 . . . . 0.0 111.585 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' CYS . . . . . 0.534 ' SG ' ' N ' ' A' ' 84' ' ' GLU . 0.1 OUTLIER -160.25 -170.57 2.87 Favored 'General case' 0 N--CA 1.506 2.37 0 C-N-CA 120.41 -0.516 . . . . 0.0 110.827 -179.881 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.534 ' N ' ' SG ' ' A' ' 83' ' ' CYS . 38.9 tt0 -114.09 149.74 35.08 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 123.307 0.379 . . . . 0.0 110.716 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.515 ' HA2' ' CE2' ' A' ' 74' ' ' TYR . . . -36.8 105.7 0.04 OUTLIER Glycine 0 N--CA 1.501 2.992 0 O-C-N 124.833 1.333 . . . . 0.0 115.135 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -94.12 -8.86 38.35 Favored 'General case' 0 N--CA 1.502 2.145 0 C-N-CA 119.128 -1.029 . . . . 0.0 113.726 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 15.6 m -85.13 90.86 7.97 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -79.33 106.72 4.96 Favored Pre-proline 0 N--CA 1.49 1.536 0 N-CA-C 104.107 -2.553 . . . . 0.0 104.107 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -40.15 -34.81 1.08 Allowed 'Trans proline' 0 N--CA 1.501 1.938 0 C-N-CA 124.819 3.679 . . . . 0.0 116.265 -145.12 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 8.9 ptm180 -58.73 -14.02 7.5 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 123.861 0.726 . . . . 0.0 112.891 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 14.1 p-10 -75.28 129.31 82.74 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 123.948 0.78 . . . . 0.0 110.936 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -83.32 44.97 1.74 Allowed 'Trans proline' 0 N--CA 1.493 1.461 0 C-N-CA 123.275 2.65 . . . . 0.0 109.769 162.842 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.553 ' HZ2' ' H ' ' A' ' 93' ' ' LYS . 0.0 OUTLIER 64.98 168.94 0.19 Allowed 'General case' 0 N--CA 1.507 2.396 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.01 -179.877 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -160.21 44.82 0.21 Allowed 'General case' 0 N--CA 1.5 2.048 0 C-N-CA 120.061 -0.656 . . . . 0.0 112.759 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 61.0 m -156.77 130.76 4.84 Favored Pre-proline 0 N--CA 1.501 2.101 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.829 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_endo -76.4 35.25 0.46 Allowed 'Trans proline' 0 N--CA 1.496 1.624 0 C-N-CA 123.039 2.493 . . . . 0.0 111.209 163.498 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 83.3 mmt-85 -108.99 37.07 2.66 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -54.25 135.51 44.21 Favored 'General case' 0 N--CA 1.495 1.789 0 CA-C-N 113.813 -1.54 . . . . 0.0 112.425 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.62 ' H ' HD21 ' A' ' 64' ' ' ASN . 34.4 m 57.51 127.84 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.822 0 O-C-N 125.232 1.582 . . . . 0.0 114.747 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -122.99 93.12 48.67 Favored Pre-proline 0 N--CA 1.5 2.061 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_endo -62.11 -13.7 33.38 Favored 'Trans proline' 0 N--CA 1.496 1.635 0 C-N-CA 122.126 1.884 . . . . 0.0 113.505 -175.374 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 77.8 ttt-85 -90.17 -25.36 20.7 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 114.238 1.199 . . . . 0.0 114.238 -179.771 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 11.6 tt -74.12 141.95 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 C-N-CA 118.658 -1.217 . . . . 0.0 110.473 -179.578 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.516 ' HB2' ' HB3' ' A' ' 77' ' ' ASP . . . -79.82 -58.85 2.97 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 105.791 -1.929 . . . . 0.0 105.791 179.715 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 4.3 p90 174.96 171.83 0.25 Allowed 'General case' 0 N--CA 1.488 1.473 0 CA-C-N 111.402 -2.635 . . . . 0.0 106.819 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -94.8 132.19 11.03 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 110.183 -1.167 . . . . 0.0 110.183 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 39.4 mm -78.45 90.86 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 N-CA-C 103.932 -2.618 . . . . 0.0 103.932 179.711 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 19.5 m -84.28 127.34 66.67 Favored Pre-proline 0 N--CA 1.493 1.716 0 CA-C-N 113.37 -1.741 . . . . 0.0 111.08 -179.836 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo . . . . . 0 N--CA 1.491 1.367 0 C-N-CA 122.386 2.057 . . . . 0.0 107.951 146.678 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 71.4 ttt-85 . . . . . 0 N--CA 1.492 1.645 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.427 HD13 ' H ' ' A' ' 5' ' ' THR . 0.0 OUTLIER -73.93 109.6 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 179.997 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.514 ' HA ' ' HA ' ' A' ' 41' ' ' CYS . 1.6 m -132.59 29.3 4.22 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 115.78 1.77 . . . . 0.0 115.78 179.625 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.427 ' H ' HD13 ' A' ' 3' ' ' ILE . 2.5 p -92.33 147.34 22.99 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-N 112.427 -2.169 . . . . 0.0 108.588 179.631 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.616 HD22 ' H ' ' A' ' 41' ' ' CYS . 20.7 p30 -160.61 158.26 28.67 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 124.722 1.263 . . . . 0.0 109.858 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 5.3 t -71.21 -30.12 65.98 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 115.287 1.588 . . . . 0.0 115.287 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 43.1 t -80.81 -65.29 1.03 Allowed 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 -179.604 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -88.79 39.7 0.94 Allowed 'General case' 0 N--CA 1.499 2.012 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.03 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -76.54 -133.61 0.52 Allowed Glycine 0 N--CA 1.492 2.392 0 CA-C-N 114.943 -1.026 . . . . 0.0 111.23 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 35.3 p -152.56 103.69 2.83 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 35.2 ttpt -51.87 108.22 0.26 Allowed 'General case' 0 N--CA 1.5 2.041 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.529 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 143.26 -20.89 2.26 Favored Glycine 0 N--CA 1.496 2.659 0 N-CA-C 110.314 -1.114 . . . . 0.0 110.314 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 80.7 m -114.56 150.35 35.11 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 124.244 0.614 . . . . 0.0 109.84 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.432 ' N ' ' HE2' ' A' ' 15' ' ' LYS . 0.2 OUTLIER -93.81 94.43 8.52 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 124.159 0.912 . . . . 0.0 111.503 -179.781 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 31.3 m-85 -59.34 115.33 3.17 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 106.662 -1.607 . . . . 0.0 106.662 179.695 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.525 ' CE2' ' HA ' ' A' ' 22' ' ' THR . 0.0 OUTLIER -129.42 147.71 51.26 Favored 'General case' 0 N--CA 1.486 1.363 0 CA-C-N 112.008 -2.36 . . . . 0.0 112.836 -179.343 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.427 ' HA ' ' H ' ' A' ' 46' ' ' ALA . 46.6 t -98.21 123.93 42.53 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-N 112.87 -1.968 . . . . 0.0 112.05 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.461 ' HB3' ' HB2' ' A' ' 46' ' ' ALA . 5.5 p-10 -60.53 -43.15 97.47 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-N 113.916 -1.493 . . . . 0.0 108.444 179.71 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -94.98 18.37 12.14 Favored 'General case' 0 N--CA 1.487 1.394 0 CA-C-N 112.182 -2.281 . . . . 0.0 112.024 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -170.71 31.53 0.14 Allowed Glycine 0 N--CA 1.498 2.777 0 C-N-CA 118.528 -1.796 . . . . 0.0 113.75 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.525 ' HA ' ' CE2' ' A' ' 17' ' ' PHE . 6.1 t 44.19 -168.79 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 114.214 1.19 . . . . 0.0 114.214 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 62.8 t80 -47.84 133.62 13.98 Favored 'General case' 0 N--CA 1.498 1.95 0 CA-C-O 121.697 0.761 . . . . 0.0 112.805 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 98.2 t -104.04 -78.65 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 CA-C-N 113.044 -1.889 . . . . 0.0 106.799 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.458 ' SG ' ' N ' ' A' ' 26' ' ' GLU . 0.2 OUTLIER -157.31 -171.4 3.59 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 179.732 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.458 ' N ' ' SG ' ' A' ' 25' ' ' CYS . 16.1 mt-10 -109.06 157.12 19.01 Favored 'General case' 0 N--CA 1.495 1.775 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 179.715 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -49.69 106.68 0.24 Allowed Glycine 0 N--CA 1.496 2.663 0 O-C-N 124.124 0.89 . . . . 0.0 112.05 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -79.44 -9.23 59.56 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-N 114.93 -0.635 . . . . 0.0 110.297 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 34.0 t -79.72 97.11 6.45 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -79.82 137.23 54.29 Favored Pre-proline 0 N--CA 1.495 1.785 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -71.48 68.65 2.76 Favored 'Trans proline' 0 N--CA 1.497 1.711 0 C-N-CA 123.567 2.845 . . . . 0.0 111.411 176.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.497 ' HA ' ' NE ' ' A' ' 32' ' ' ARG . 3.9 mmp_? -158.0 -44.99 0.06 Allowed 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 105.293 -2.114 . . . . 0.0 105.293 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -90.35 150.54 43.15 Favored Pre-proline 0 N--CA 1.495 1.783 0 O-C-N 124.275 0.985 . . . . 0.0 110.522 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.13 169.82 21.72 Favored 'Trans proline' 0 N--CA 1.491 1.343 0 C-N-CA 122.843 2.362 . . . . 0.0 108.916 159.827 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 22.4 ptmt -69.56 147.04 51.3 Favored 'General case' 0 N--CA 1.496 1.853 0 C-N-CA 120.124 -0.63 . . . . 0.0 110.4 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -158.81 41.56 0.24 Allowed 'General case' 0 N--CA 1.496 1.839 0 CA-C-N 115.322 -0.854 . . . . 0.0 108.849 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 76.4 m -108.23 178.68 4.43 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-N 114.069 -1.423 . . . . 0.0 111.595 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 8.4 t -134.15 -3.17 2.79 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-N 113.537 -1.665 . . . . 0.0 108.269 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.17 30.59 2.72 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 10.4 m120 -57.75 123.22 14.96 Favored 'General case' 0 N--CA 1.497 1.923 0 CA-C-N 114.712 -1.131 . . . . 0.0 109.358 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.616 ' H ' HD22 ' A' ' 6' ' ' ASN . 70.9 m 58.01 107.56 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.856 0 O-C-N 125.079 1.487 . . . . 0.0 110.616 -179.612 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -108.76 102.99 50.32 Favored Pre-proline 0 N--CA 1.499 2.007 0 CA-C-N 115.243 -0.889 . . . . 0.0 112.654 -179.704 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -67.34 -7.05 17.89 Favored 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 121.888 1.725 . . . . 0.0 112.216 178.732 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 60.9 mtt85 -89.97 -14.59 33.75 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 123.643 0.589 . . . . 0.0 111.967 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 15.3 tt -106.79 160.74 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.461 ' HB2' ' HB3' ' A' ' 19' ' ' ASP . . . -83.85 -74.65 0.37 Allowed 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 105.378 -2.082 . . . . 0.0 105.378 179.822 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 50.9 p90 179.71 176.37 0.69 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 124.769 1.293 . . . . 0.0 109.552 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -79.94 102.02 1.99 Allowed Glycine 0 N--CA 1.49 2.243 0 CA-C-N 114.125 -1.398 . . . . 0.0 111.797 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 17.7 m -78.54 98.38 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 N-CA-C 106.258 -1.756 . . . . 0.0 106.258 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.9 m -79.93 176.29 3.92 Favored Pre-proline 0 N--CA 1.495 1.779 0 CA-C-N 113.218 -1.81 . . . . 0.0 108.26 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo . . . . . 0 N--CA 1.495 1.583 0 C-N-CA 122.219 1.946 . . . . 0.0 112.3 173.05 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.507 ' HA ' ' HA ' ' A' ' 99' ' ' CYS . 1.7 m . . . . . 0 N--CA 1.487 1.411 0 CA-C-O 123.336 1.541 . . . . 0.0 115.076 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 60.2 m -91.38 118.38 30.48 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-N 111.756 -2.474 . . . . 0.0 104.87 179.57 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.593 ' ND2' ' H ' ' A' ' 67' ' ' ALA . 20.8 p-10 -140.46 161.02 38.71 Favored 'General case' 0 N--CA 1.502 2.158 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 1.4 t -65.53 -36.69 84.57 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-N 113.539 -1.664 . . . . 0.0 115.296 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 51.0 t -75.35 -64.48 1.05 Allowed 'General case' 0 N--CA 1.497 1.913 0 O-C-N 123.775 0.672 . . . . 0.0 110.669 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.593 ' H ' ' ND2' ' A' ' 64' ' ' ASN . . . -90.13 52.41 2.26 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -88.53 -138.65 6.4 Favored Glycine 0 N--CA 1.493 2.449 0 CA-C-N 114.256 -1.338 . . . . 0.0 112.205 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 94.8 m -140.91 105.75 4.94 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 124.48 0.753 . . . . 0.0 110.758 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 10.9 tptm -56.02 104.19 0.13 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 124.208 0.943 . . . . 0.0 108.613 179.64 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 140.32 -1.78 2.2 Favored Glycine 0 N--CA 1.492 2.401 0 CA-C-N 114.517 -1.22 . . . . 0.0 110.82 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 91.9 m -141.44 146.95 37.15 Favored 'General case' 0 N--CA 1.498 1.934 0 CA-C-N 117.074 0.437 . . . . 0.0 111.282 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.475 ' HB3' ' CE1' ' A' ' 81' ' ' PHE . 8.0 mtpm? -89.33 90.39 8.31 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-N 114.875 -1.057 . . . . 0.0 111.89 -179.683 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -53.96 120.96 7.06 Favored 'General case' 0 N--CA 1.5 2.052 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -124.38 160.71 27.54 Favored 'General case' 0 N--CA 1.493 1.701 0 CA-C-N 113.184 -1.825 . . . . 0.0 113.731 -179.383 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 29.8 t -104.06 131.89 50.86 Favored 'General case' 0 N--CA 1.498 1.93 0 CA-C-N 113.834 -1.53 . . . . 0.0 112.597 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.408 ' HB3' ' CB ' ' A' ' 104' ' ' ALA . 4.1 p-10 -46.24 -29.83 1.76 Allowed 'General case' 0 N--CA 1.502 2.17 0 N-CA-C 116.117 1.895 . . . . 0.0 116.117 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -51.82 -24.41 6.05 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 123.955 0.784 . . . . 0.0 111.818 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 113.7 26.95 3.71 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 108.851 -1.7 . . . . 0.0 108.851 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 86.3 m -138.67 139.49 38.49 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 124.005 0.473 . . . . 0.0 110.875 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.475 ' CE1' ' HB3' ' A' ' 73' ' ' LYS . 13.0 t80 -71.97 150.76 43.8 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-N 114.312 -1.313 . . . . 0.0 109.648 179.793 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 97.2 t -110.1 -78.89 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -159.36 175.21 13.63 Favored 'General case' 0 N--CA 1.501 2.099 0 C-N-CA 120.675 -0.41 . . . . 0.0 110.022 179.818 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -92.72 141.23 28.69 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -45.6 105.59 0.09 OUTLIER Glycine 0 N--CA 1.5 2.956 0 O-C-N 124.166 0.916 . . . . 0.0 111.557 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -79.47 7.15 8.61 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-N 114.526 -0.837 . . . . 0.0 112.456 -179.613 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 46.9 t -132.93 119.65 20.42 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -79.23 143.92 61.53 Favored Pre-proline 0 N--CA 1.495 1.777 0 O-C-N 124.105 0.878 . . . . 0.0 108.675 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -70.15 64.18 2.03 Favored 'Trans proline' 0 N--CA 1.5 1.903 0 C-N-CA 123.614 2.876 . . . . 0.0 112.402 176.526 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 53.5 mmm-85 -158.68 -44.42 0.06 Allowed 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 105.616 -1.994 . . . . 0.0 105.616 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -90.78 121.69 67.83 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 124.274 0.984 . . . . 0.0 109.664 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -80.27 50.14 3.44 Favored 'Trans proline' 0 N--CA 1.495 1.604 0 C-N-CA 123.427 2.751 . . . . 0.0 111.686 174.914 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -82.21 124.72 30.16 Favored 'General case' 0 N--CA 1.496 1.874 0 C-N-CA 120.346 -0.542 . . . . 0.0 111.057 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -87.38 -176.97 5.82 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-N 114.357 -1.292 . . . . 0.0 109.803 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 77.6 m -153.94 158.68 32.51 Favored Pre-proline 0 N--CA 1.496 1.868 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.939 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -70.2 -25.72 26.26 Favored 'Trans proline' 0 N--CA 1.491 1.34 0 C-N-CA 122.069 1.846 . . . . 0.0 108.239 159.698 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 5.2 mmp_? -83.5 5.04 25.34 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-N 114.324 -1.307 . . . . 0.0 112.319 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -50.27 136.15 20.36 Favored 'General case' 0 N--CA 1.503 2.224 0 C-N-CA 120.499 -0.48 . . . . 0.0 110.927 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.507 ' HA ' ' HA ' ' A' ' 62' ' ' CYS . 59.8 m 61.96 114.5 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.773 0 O-C-N 125.309 1.63 . . . . 0.0 111.58 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -125.6 97.29 36.67 Favored Pre-proline 0 N--CA 1.499 2.008 0 N-CA-C 113.21 0.819 . . . . 0.0 113.21 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -48.63 -32.49 21.54 Favored 'Trans proline' 0 N--CA 1.495 1.585 0 C-N-CA 123.189 2.593 . . . . 0.0 112.425 174.874 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 31.1 ttp-105 -61.02 -50.04 74.98 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 106.46 -1.681 . . . . 0.0 106.46 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 4.0 mt -67.91 155.89 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 179.661 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.408 ' CB ' ' HB3' ' A' ' 77' ' ' ASP . . . -141.77 -34.5 0.47 Allowed 'General case' 0 N--CA 1.49 1.57 0 CA-C-N 113.484 -1.689 . . . . 0.0 111.334 -179.695 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 51.7 m-85 -139.65 -164.3 1.66 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 124.255 0.972 . . . . 0.0 111.149 -179.735 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -153.33 104.14 0.25 Allowed Glycine 0 N--CA 1.488 2.131 0 N-CA-C 105.983 -2.847 . . . . 0.0 105.983 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 51.2 mm -79.21 93.53 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 -179.714 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 8.0 m -79.44 149.17 71.6 Favored Pre-proline 0 N--CA 1.493 1.718 0 CA-C-N 113.718 -1.583 . . . . 0.0 108.923 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo . . . . . 0 N--CA 1.494 1.507 0 C-N-CA 122.496 2.131 . . . . 0.0 110.253 -175.631 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 41.6 ttm180 . . . . . 0 N--CA 1.496 1.861 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 8.5 tp -83.67 54.53 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 CA-C-N 114.449 -1.25 . . . . 0.0 109.912 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 42.7 m -87.52 54.66 3.21 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-O 122.479 1.133 . . . . 0.0 112.808 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 17.2 p -89.49 170.8 10.2 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-N 113.128 -1.851 . . . . 0.0 108.809 179.698 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 18.4 p-10 -162.55 135.76 5.97 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 124.24 0.963 . . . . 0.0 113.548 179.804 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -59.11 -31.56 69.03 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-N 114.563 -1.199 . . . . 0.0 113.884 179.716 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 48.4 t -68.76 -59.42 3.11 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-N 114.808 -1.087 . . . . 0.0 112.386 -179.584 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -74.5 -96.23 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.863 0 C-N-CA 118.714 -1.194 . . . . 0.0 110.052 -179.833 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 52.27 -126.57 31.06 Favored Glycine 0 N--CA 1.488 2.105 0 O-C-N 123.567 0.542 . . . . 0.0 112.042 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 92.5 m -152.18 119.21 5.83 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 22.5 ttmm -68.54 91.64 0.42 Allowed 'General case' 0 N--CA 1.494 1.766 0 CA-C-O 122.283 1.039 . . . . 0.0 109.048 179.772 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 163.59 -34.19 0.29 Allowed Glycine 0 N--CA 1.488 2.163 0 CA-C-N 112.9 -1.954 . . . . 0.0 109.007 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 50.5 m -105.16 130.55 53.3 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-O 121.528 0.68 . . . . 0.0 109.229 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.485 ' HB3' ' CE1' ' A' ' 23' ' ' PHE . 57.5 mtpt -78.36 91.22 4.43 Favored 'General case' 0 N--CA 1.485 1.319 0 CA-C-N 113.171 -1.832 . . . . 0.0 112.55 -179.54 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 75.5 m-85 -58.87 121.22 10.6 Favored 'General case' 0 N--CA 1.501 2.113 0 N-CA-C 105.784 -1.932 . . . . 0.0 105.784 179.759 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -128.71 147.51 50.76 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 110.664 -2.971 . . . . 0.0 112.933 -179.218 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 40.1 t -83.44 136.32 34.35 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-N 111.83 -2.441 . . . . 0.0 112.895 -179.748 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -52.18 -30.25 26.05 Favored 'General case' 0 N--CA 1.498 1.958 0 CA-C-N 112.481 -2.145 . . . . 0.0 113.833 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 44.3 p-10 -58.06 -14.16 6.15 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 124.013 0.821 . . . . 0.0 112.268 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 99.97 35.22 4.61 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 108.464 -1.855 . . . . 0.0 108.464 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 55.9 m -136.29 132.49 35.79 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 124.025 0.485 . . . . 0.0 110.241 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.485 ' CE1' ' HB3' ' A' ' 15' ' ' LYS . 8.1 t80 -74.78 141.52 44.37 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 179.671 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 41.0 t -102.53 -79.53 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 N-CA-C 105.666 -1.976 . . . . 0.0 105.666 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -169.0 166.21 11.13 Favored 'General case' 0 N--CA 1.501 2.117 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 179.594 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.469 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 36.8 tt0 -82.13 161.51 22.81 Favored 'General case' 0 N--CA 1.503 2.223 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 179.789 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.443 ' N ' ' HG2' ' A' ' 26' ' ' GLU . . . -61.13 120.39 22.59 Favored Glycine 0 N--CA 1.496 2.657 0 N-CA-C 107.52 -2.232 . . . . 0.0 107.52 179.7 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -86.18 21.33 2.05 Favored 'General case' 0 N--CA 1.499 1.999 0 C-N-CA 119.295 -0.962 . . . . 0.0 110.379 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 35.3 t -139.22 112.57 8.21 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-N 114.801 -1.09 . . . . 0.0 108.537 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -81.01 142.71 52.09 Favored Pre-proline 0 N--CA 1.493 1.721 0 CA-C-N 114.246 -1.343 . . . . 0.0 107.706 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -69.75 68.71 1.68 Allowed 'Trans proline' 0 N--CA 1.499 1.852 0 C-N-CA 122.993 2.462 . . . . 0.0 111.844 176.387 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 35.3 mmt180 -160.65 -39.37 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 CA-C-N 113.546 -1.661 . . . . 0.0 107.416 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -71.28 151.94 94.36 Favored Pre-proline 0 N--CA 1.498 1.974 0 C-N-CA 119.902 -0.719 . . . . 0.0 111.253 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo -69.44 167.77 23.06 Favored 'Trans proline' 0 N--CA 1.494 1.514 0 C-N-CA 122.745 2.297 . . . . 0.0 111.7 179.227 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 22.4 ptmt 39.44 -163.81 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.252 0 N-CA-C 115.682 1.734 . . . . 0.0 115.682 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -139.34 179.72 6.37 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-N 115.043 -0.98 . . . . 0.0 109.984 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 87.0 m -79.8 179.51 7.5 Favored 'General case' 0 N--CA 1.497 1.897 0 CA-C-N 114.959 -1.019 . . . . 0.0 112.98 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 69.8 p -130.85 31.82 4.43 Favored 'General case' 0 N--CA 1.495 1.822 0 CA-C-N 113.671 -1.604 . . . . 0.0 108.751 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 39.9 tp -79.86 -1.28 38.36 Favored 'General case' 0 N--CA 1.499 2.01 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.412 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 29.7 m-80 57.56 -174.84 0.07 Allowed 'General case' 0 N--CA 1.499 2.009 0 N-CA-C 114.181 1.178 . . . . 0.0 114.181 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 81.7 m -60.82 134.5 57.15 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-N 114.262 -1.335 . . . . 0.0 111.271 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -128.44 83.79 65.11 Favored Pre-proline 0 N--CA 1.498 1.941 0 O-C-N 123.885 0.74 . . . . 0.0 109.517 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -52.34 -24.44 21.26 Favored 'Trans proline' 0 N--CA 1.495 1.576 0 C-N-CA 122.867 2.378 . . . . 0.0 112.178 176.034 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 28.0 ttt85 -60.73 -50.92 71.55 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 17.6 mt -65.5 153.65 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 CA-C-O 122.066 0.936 . . . . 0.0 109.782 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -124.14 -59.61 1.48 Allowed 'General case' 0 N--CA 1.491 1.589 0 CA-C-N 111.957 -2.383 . . . . 0.0 109.218 -179.833 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 16.2 p90 -162.64 156.78 21.05 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 124.14 0.9 . . . . 0.0 112.189 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -88.84 103.7 3.0 Favored Glycine 0 N--CA 1.492 2.389 0 CA-C-N 112.816 -1.993 . . . . 0.0 113.235 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 34.2 m -81.25 99.07 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.185 0 CA-C-O 121.531 0.681 . . . . 0.0 109.985 179.708 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.6 m -79.16 125.89 82.69 Favored Pre-proline 0 N--CA 1.503 2.206 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.233 179.754 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo . . . . . 0 N--CA 1.492 1.397 0 C-N-CA 122.32 2.013 . . . . 0.0 108.516 171.106 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 3.6 m . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 123.145 1.45 . . . . 0.0 109.88 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 25.5 p -90.07 177.42 6.46 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-N 112.038 -2.347 . . . . 0.0 110.333 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.49 ' ND2' ' H ' ' A' ' 67' ' ' ALA . 46.8 p-10 -161.46 -177.11 5.74 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-N 113.797 -1.547 . . . . 0.0 111.143 179.808 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' CYS . . . . . 0.416 ' SG ' ' CD2' ' A' ' 74' ' ' TYR . 11.1 t -91.51 -20.23 21.94 Favored 'General case' 0 N--CA 1.497 1.923 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.026 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 13.4 t -82.62 -61.78 1.79 Allowed 'General case' 0 N--CA 1.491 1.593 0 CA-C-N 113.731 -1.577 . . . . 0.0 112.731 -179.657 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.49 ' H ' ' ND2' ' A' ' 64' ' ' ASN . . . -90.35 60.85 4.84 Favored 'General case' 0 N--CA 1.499 1.996 0 CA-C-O 121.588 0.708 . . . . 0.0 112.205 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.484 ' H ' ' HB2' ' A' ' 87' ' ' SER . . . -126.18 -104.68 1.41 Allowed Glycine 0 N--CA 1.498 2.813 0 N-CA-C 108.812 -1.715 . . . . 0.0 108.812 179.755 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 3.4 t -155.65 111.45 3.06 Favored 'General case' 0 N--CA 1.502 2.13 0 N-CA-C 114.074 1.139 . . . . 0.0 114.074 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -65.93 103.59 0.96 Allowed 'General case' 0 N--CA 1.498 1.95 0 CA-C-N 114.331 -1.304 . . . . 0.0 107.679 179.66 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 143.09 -3.18 1.69 Allowed Glycine 0 N--CA 1.49 2.299 0 CA-C-N 114.384 -1.28 . . . . 0.0 110.927 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 72.8 m -124.0 155.14 38.77 Favored 'General case' 0 N--CA 1.499 1.982 0 C-N-CA 120.476 -0.489 . . . . 0.0 109.829 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.0 95.27 6.25 Favored 'General case' 0 N--CA 1.488 1.47 0 CA-C-N 115.036 -0.984 . . . . 0.0 108.644 -179.759 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.654 ' CD2' ' SG ' ' A' ' 83' ' ' CYS . 89.8 m-85 -44.78 137.61 3.9 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 124.694 1.246 . . . . 0.0 109.882 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 21.6 t80 -141.83 159.12 42.87 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 124.834 1.334 . . . . 0.0 110.844 -179.679 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 30.8 t -121.24 143.4 49.17 Favored 'General case' 0 N--CA 1.495 1.822 0 CA-C-N 112.748 -2.023 . . . . 0.0 116.089 -179.41 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.407 ' C ' ' H ' ' A' ' 79' ' ' GLY . 0.9 OUTLIER -48.91 -23.98 1.31 Allowed 'General case' 0 N--CA 1.498 1.952 0 CA-C-N 110.507 -3.042 . . . . 0.0 113.184 179.872 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 16.3 p30 -64.74 -0.67 1.54 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 124.223 0.952 . . . . 0.0 111.184 179.768 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.407 ' H ' ' C ' ' A' ' 77' ' ' ASP . . . 82.25 29.22 37.81 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 96.7 m -144.44 153.15 41.61 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 121.425 0.631 . . . . 0.0 111.903 -179.755 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -64.21 165.2 9.72 Favored 'General case' 0 N--CA 1.497 1.875 0 CA-C-N 113.466 -1.697 . . . . 0.0 110.565 179.806 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 89.4 t -128.28 -67.74 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 124.061 0.851 . . . . 0.0 112.07 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' CYS . . . . . 0.654 ' SG ' ' CD2' ' A' ' 74' ' ' TYR . 31.3 p -162.54 -178.07 6.01 Favored 'General case' 0 N--CA 1.503 2.178 0 C-N-CA 120.253 -0.579 . . . . 0.0 110.794 -179.636 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.401 ' HG2' ' N ' ' A' ' 85' ' ' GLY . 35.3 tt0 -96.49 158.02 15.63 Favored 'General case' 0 N--CA 1.505 2.306 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.16 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.501 ' HA2' ' CE2' ' A' ' 74' ' ' TYR . . . -58.73 106.05 0.79 Allowed Glycine 0 N--CA 1.498 2.778 0 CA-C-O 118.894 -0.948 . . . . 0.0 111.501 179.756 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 30.1 mm-40 -113.01 37.9 2.99 Favored 'General case' 0 N--CA 1.505 2.283 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 179.803 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.484 ' HB2' ' H ' ' A' ' 68' ' ' GLY . 9.0 t -115.45 63.31 0.69 Allowed 'General case' 0 N--CA 1.493 1.722 0 CA-C-N 114.267 -1.333 . . . . 0.0 109.491 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.411 ' HB3' ' ND2' ' A' ' 91' ' ' ASN . 3.5 t70 -81.57 114.57 50.84 Favored Pre-proline 0 N--CA 1.492 1.627 0 CA-C-N 114.08 -1.418 . . . . 0.0 110.355 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -66.1 -16.89 53.85 Favored 'Trans proline' 0 N--CA 1.492 1.419 0 C-N-CA 122.136 1.891 . . . . 0.0 111.361 -174.599 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 52.7 tpt85 -73.13 -31.07 64.06 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 123.812 0.695 . . . . 0.0 112.203 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.411 ' ND2' ' HB3' ' A' ' 88' ' ' ASP . 15.3 p30 -84.4 131.68 49.57 Favored Pre-proline 0 N--CA 1.497 1.9 0 C-N-CA 118.546 -1.262 . . . . 0.0 110.808 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -80.96 71.22 7.18 Favored 'Trans proline' 0 N--CA 1.49 1.287 0 C-N-CA 123.114 2.543 . . . . 0.0 108.325 162.306 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 58.4 tptt -149.87 154.07 37.76 Favored 'General case' 0 N--CA 1.497 1.889 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.607 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -131.32 -172.92 2.97 Favored 'General case' 0 N--CA 1.498 1.957 0 CA-C-N 113.925 -1.488 . . . . 0.0 109.487 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 3.7 m -149.42 150.93 32.5 Favored Pre-proline 0 N--CA 1.5 2.072 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -75.8 98.23 1.17 Allowed 'Trans proline' 0 N--CA 1.493 1.443 0 C-N-CA 122.711 2.274 . . . . 0.0 110.039 172.158 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 -146.73 57.07 1.16 Allowed 'General case' 0 N--CA 1.499 2.018 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -55.35 96.85 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.844 0 CA-C-N 113.446 -1.706 . . . . 0.0 114.618 -179.738 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 78.6 m 55.01 130.01 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.156 0 N-CA-C 117.331 2.345 . . . . 0.0 117.331 179.683 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 63.8 t0 -127.79 77.34 76.42 Favored Pre-proline 0 N--CA 1.502 2.142 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.78 179.704 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -63.07 -24.89 73.41 Favored 'Trans proline' 0 N--CA 1.493 1.442 0 C-N-CA 122.604 2.202 . . . . 0.0 111.611 173.52 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -67.69 -19.8 65.22 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 123.96 0.787 . . . . 0.0 112.105 -179.824 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 10.5 tt -79.61 169.65 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.115 0 C-N-CA 119.133 -1.027 . . . . 0.0 110.241 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -130.99 -55.15 1.05 Allowed 'General case' 0 N--CA 1.495 1.784 0 CA-C-N 114.883 -1.053 . . . . 0.0 108.833 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 27.7 p90 -171.59 168.3 6.37 Favored 'General case' 0 N--CA 1.497 1.904 0 CA-C-N 114.842 -1.072 . . . . 0.0 110.008 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -105.6 121.96 7.0 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 109.716 -1.353 . . . . 0.0 109.716 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 87.2 mt -79.4 94.05 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 14.6 m -79.66 156.16 75.53 Favored Pre-proline 0 N--CA 1.493 1.69 0 CA-C-N 114.117 -1.401 . . . . 0.0 107.38 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo . . . . . 0 N--CA 1.495 1.593 0 C-N-CA 122.631 2.22 . . . . 0.0 111.532 -175.293 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' ARG . . . . . 0.489 ' NE ' ' HA ' ' A' ' 2' ' ' ARG . 14.5 mmp_? . . . . . 0 N--CA 1.498 1.933 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.3 tp -69.58 84.87 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 CA-C-N 114.835 -1.075 . . . . 0.0 111.552 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 14.8 m -92.2 51.02 1.72 Allowed 'General case' 0 N--CA 1.491 1.619 0 CA-C-N 114.195 -1.366 . . . . 0.0 111.521 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 15.1 t -90.71 -173.67 3.81 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-N 113.229 -1.805 . . . . 0.0 108.862 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 24.1 p30 -160.22 -175.15 4.89 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 124.742 1.276 . . . . 0.0 108.285 179.696 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.6 t -118.26 -33.35 4.4 Favored 'General case' 0 N--CA 1.499 1.978 0 C-N-CA 119.772 -0.771 . . . . 0.0 110.332 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 25.1 t -62.54 -60.39 3.6 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-N 114.704 -1.135 . . . . 0.0 108.64 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.436 ' HB2' ' SG ' ' A' ' 37' ' ' CYS . . . -90.28 19.82 4.86 Favored 'General case' 0 N--CA 1.498 1.97 0 CA-C-N 113.83 -1.532 . . . . 0.0 109.561 179.785 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -75.19 -151.0 2.67 Favored Glycine 0 N--CA 1.493 2.48 0 CA-C-N 115.445 -0.798 . . . . 0.0 112.472 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 40.1 p -126.98 100.08 5.99 Favored 'General case' 0 N--CA 1.498 1.925 0 CA-C-N 114.709 -0.746 . . . . 0.0 109.299 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -52.12 147.79 7.05 Favored 'General case' 0 N--CA 1.5 2.035 0 CA-C-N 115.787 -0.642 . . . . 0.0 112.249 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 98.92 -33.51 6.06 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 107.88 -2.088 . . . . 0.0 107.88 -179.649 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 55.3 m -91.39 114.18 26.64 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.421 ' HB2' ' NZ ' ' A' ' 15' ' ' LYS . 10.4 mtmp? -68.72 88.31 0.36 Allowed 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 111.762 -2.472 . . . . 0.0 111.718 -179.675 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.515 ' HB2' ' SG ' ' A' ' 25' ' ' CYS . 31.6 m-85 -53.01 119.76 5.05 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 105.361 -2.088 . . . . 0.0 105.361 179.456 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -135.16 153.66 51.9 Favored 'General case' 0 C--N 1.296 -1.723 0 CA-C-N 111.876 -2.42 . . . . 0.0 113.347 -179.036 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 41.9 t -92.17 133.33 35.89 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-N 112.838 -1.983 . . . . 0.0 109.389 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.561 ' H ' ' HB2' ' A' ' 46' ' ' ALA . 5.8 p-10 -51.97 -24.01 5.89 Favored 'General case' 0 N--CA 1.498 1.96 0 CA-C-N 113.363 -1.744 . . . . 0.0 114.21 -179.797 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 32.6 p30 -58.99 -10.47 2.55 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 124.197 0.935 . . . . 0.0 112.365 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 99.68 29.39 6.99 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 87.1 m -140.06 138.08 35.08 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 124.026 0.486 . . . . 0.0 110.622 -179.871 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.403 ' CG ' ' N ' ' A' ' 24' ' ' VAL . 49.1 t80 -70.55 162.0 29.63 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 124.443 1.09 . . . . 0.0 110.46 179.743 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.403 ' N ' ' CG ' ' A' ' 23' ' ' PHE . 61.0 t -129.48 -72.93 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 124.198 0.936 . . . . 0.0 110.978 -179.825 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.515 ' SG ' ' HB2' ' A' ' 16' ' ' TYR . 14.8 p -149.82 -169.62 3.43 Favored 'General case' 0 N--CA 1.504 2.241 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -137.51 147.22 45.03 Favored 'General case' 0 N--CA 1.502 2.128 0 N-CA-C 105.652 -1.981 . . . . 0.0 105.652 179.251 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -50.55 157.92 2.04 Favored Glycine 0 N--CA 1.5 2.915 0 C-N-CA 120.371 -0.918 . . . . 0.0 115.01 -179.577 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -121.11 -33.25 3.75 Favored 'General case' 0 N--CA 1.496 1.851 0 CA-C-N 113.603 -1.298 . . . . 0.0 110.807 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 32.4 m -95.12 131.48 41.09 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 123.595 0.559 . . . . 0.0 111.273 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.529 ' H ' HD21 ' A' ' 33' ' ' ASN . 16.4 t70 -81.33 143.96 52.92 Favored Pre-proline 0 N--CA 1.493 1.715 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_endo -61.77 73.91 0.09 OUTLIER 'Trans proline' 0 N--CA 1.499 1.838 0 C-N-CA 122.904 2.402 . . . . 0.0 112.111 172.721 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 36.2 mmt180 -162.72 -47.9 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.734 0 CA-C-N 113.387 -1.733 . . . . 0.0 106.802 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.529 HD21 ' H ' ' A' ' 30' ' ' ASP . 6.5 p30 -90.44 119.44 69.13 Favored Pre-proline 0 N--CA 1.494 1.762 0 O-C-N 124.234 0.959 . . . . 0.0 110.816 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -81.02 49.98 3.42 Favored 'Trans proline' 0 N--CA 1.494 1.534 0 C-N-CA 123.419 2.746 . . . . 0.0 111.298 174.528 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.4 ' HE2' ' HA ' ' A' ' 35' ' ' LYS . 6.4 mmpt? -74.65 124.5 26.82 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -99.14 96.1 7.55 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-N 114.744 -1.117 . . . . 0.0 110.754 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.436 ' SG ' ' HB2' ' A' ' 9' ' ' ALA . 78.0 m -79.71 -39.82 30.31 Favored 'General case' 0 N--CA 1.497 1.917 0 CA-C-N 114.709 -1.132 . . . . 0.0 108.678 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 63.0 m 59.71 80.45 0.2 Allowed 'General case' 0 N--CA 1.496 1.853 0 CA-C-N 114.049 -1.432 . . . . 0.0 111.295 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 32.4 tp -84.2 7.79 17.86 Favored 'General case' 0 N--CA 1.499 2.006 0 CA-C-N 114.696 -1.138 . . . . 0.0 108.911 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 13.2 m120 55.52 56.2 6.51 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.453 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 80.8 m 61.42 132.93 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.006 0 CA-C-N 113.29 -1.777 . . . . 0.0 114.044 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -115.68 87.27 17.31 Favored Pre-proline 0 N--CA 1.497 1.908 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.447 179.667 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -64.52 -17.04 58.27 Favored 'Trans proline' 0 N--CA 1.492 1.421 0 C-N-CA 122.844 2.363 . . . . 0.0 111.568 170.058 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.434 ' N ' ' HD3' ' A' ' 44' ' ' ARG . 0.0 OUTLIER -70.27 -10.4 58.82 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 123.688 0.618 . . . . 0.0 109.992 -179.971 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.411 ' CG2' ' N ' ' A' ' 46' ' ' ALA . 46.2 mt -119.9 159.98 20.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 CA-C-O 122.14 0.972 . . . . 0.0 110.66 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.561 ' HB2' ' H ' ' A' ' 19' ' ' ASP . . . -119.6 -55.26 2.12 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-N 111.695 -2.502 . . . . 0.0 108.182 179.755 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 5.8 p90 -167.21 153.55 8.12 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 124.129 0.893 . . . . 0.0 112.644 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -81.99 102.39 2.26 Favored Glycine 0 N--CA 1.492 2.428 0 CA-C-N 112.884 -1.962 . . . . 0.0 112.659 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 47.4 t -79.6 90.28 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 124.051 0.5 . . . . 0.0 112.18 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.5 m -79.33 120.38 80.28 Favored Pre-proline 0 N--CA 1.504 2.229 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 179.459 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo . . . . . 0 N--CA 1.492 1.405 0 C-N-CA 122.534 2.156 . . . . 0.0 109.735 -173.861 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.52 ' HA ' ' HA ' ' A' ' 99' ' ' CYS . 6.8 m . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 123.349 1.547 . . . . 0.0 113.037 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 95.1 m -91.08 138.42 31.62 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-N 111.584 -2.553 . . . . 0.0 106.777 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.526 ' ND2' ' H ' ' A' ' 67' ' ' ALA . 28.4 p-10 -160.74 151.04 17.93 Favored 'General case' 0 N--CA 1.499 2.01 0 C-N-CA 120.011 -0.676 . . . . 0.0 111.286 179.76 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' CYS . . . . . 0.406 ' SG ' ' NH1' ' A' ' 97' ' ' ARG . 0.7 OUTLIER -60.05 -28.78 68.05 Favored 'General case' 0 N--CA 1.495 1.789 0 CA-C-N 114.316 -1.311 . . . . 0.0 114.072 -179.842 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 40.1 t -79.78 -69.05 0.61 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 124.168 0.918 . . . . 0.0 111.81 -179.691 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.526 ' H ' ' ND2' ' A' ' 64' ' ' ASN . . . -88.37 45.26 1.27 Allowed 'General case' 0 N--CA 1.497 1.898 0 O-C-N 124.848 1.342 . . . . 0.0 109.812 -179.806 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -85.58 -143.55 6.87 Favored Glycine 0 N--CA 1.489 2.201 0 CA-C-N 114.365 -1.288 . . . . 0.0 111.264 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 35.5 p -139.85 116.21 10.6 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 114.826 -0.687 . . . . 0.0 110.523 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -60.69 97.07 0.05 OUTLIER 'General case' 0 N--CA 1.5 2.048 0 O-C-N 124.135 0.897 . . . . 0.0 109.619 179.706 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 158.21 -17.91 0.31 Allowed Glycine 0 N--CA 1.494 2.558 0 CA-C-N 114.52 -1.218 . . . . 0.0 110.872 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 91.2 m -125.39 155.44 40.36 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 124.015 0.479 . . . . 0.0 110.373 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -103.1 94.3 5.47 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 124.192 0.933 . . . . 0.0 109.763 -179.809 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -51.02 128.77 22.35 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-N 113.647 -1.615 . . . . 0.0 109.333 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.475 ' CE2' ' HA ' ' A' ' 80' ' ' THR . 0.2 OUTLIER -134.6 153.88 51.76 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-N 113.606 -1.634 . . . . 0.0 113.678 -179.335 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.407 ' N ' HG23 ' A' ' 82' ' ' VAL . 31.6 t -112.74 129.6 56.36 Favored 'General case' 0 N--CA 1.498 1.964 0 CA-C-N 112.98 -1.918 . . . . 0.0 112.359 -179.718 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.446 ' H ' ' HB2' ' A' ' 104' ' ' ALA . 8.4 p-10 -61.88 -50.03 73.85 Favored 'General case' 0 N--CA 1.499 1.993 0 CA-C-N 114.622 -1.172 . . . . 0.0 109.546 179.833 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -90.81 18.24 6.77 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 112.825 -1.989 . . . . 0.0 111.641 -179.829 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -163.47 25.34 0.2 Allowed Glycine 0 N--CA 1.495 2.628 0 C-N-CA 118.915 -1.612 . . . . 0.0 113.141 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.475 ' HA ' ' CE2' ' A' ' 75' ' ' PHE . 6.7 t 42.48 -163.56 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.794 0 O-C-N 124.998 1.057 . . . . 0.0 113.22 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 22.8 t80 -48.28 127.94 13.55 Favored 'General case' 0 N--CA 1.497 1.889 0 CA-C-O 121.378 0.609 . . . . 0.0 111.592 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.407 HG23 ' N ' ' A' ' 76' ' ' SER . 63.5 t -94.79 -76.94 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' CYS . . . . . 0.488 ' SG ' ' N ' ' A' ' 84' ' ' GLU . 0.4 OUTLIER -168.09 -169.64 1.16 Allowed 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 179.696 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.488 ' N ' ' SG ' ' A' ' 83' ' ' CYS . 37.6 tt0 -96.01 162.01 13.74 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -72.01 107.1 2.09 Favored Glycine 0 N--CA 1.493 2.486 0 N-CA-C 105.078 -3.209 . . . . 0.0 105.078 179.63 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -93.13 25.06 3.44 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 -179.643 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 29.4 t -129.4 123.39 31.54 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-N 114.338 -1.301 . . . . 0.0 108.97 179.655 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -85.56 144.61 40.42 Favored Pre-proline 0 N--CA 1.492 1.671 0 CA-C-N 114.442 -1.253 . . . . 0.0 108.126 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_endo -61.86 79.76 0.09 OUTLIER 'Trans proline' 0 N--CA 1.496 1.64 0 C-N-CA 122.574 2.183 . . . . 0.0 108.414 165.131 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 58.2 ttt85 -169.78 -52.86 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 105.515 -2.032 . . . . 0.0 105.515 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -91.54 115.55 64.71 Favored Pre-proline 0 N--CA 1.497 1.92 0 O-C-N 124.83 1.331 . . . . 0.0 111.237 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -83.45 49.38 2.93 Favored 'Trans proline' 0 N--CA 1.495 1.571 0 C-N-CA 123.484 2.789 . . . . 0.0 109.549 170.835 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -106.56 152.4 23.75 Favored 'General case' 0 N--CA 1.498 1.938 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.79 -179.797 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -152.61 154.81 36.11 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-N 115.01 -0.996 . . . . 0.0 111.245 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 66.3 m -84.99 -179.53 1.5 Allowed Pre-proline 0 N--CA 1.498 1.94 0 CA-C-N 114.394 -1.276 . . . . 0.0 108.682 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_endo -62.98 65.94 0.15 Allowed 'Trans proline' 0 N--CA 1.494 1.525 0 C-N-CA 122.13 1.887 . . . . 0.0 110.318 148.485 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.406 ' NH1' ' SG ' ' A' ' 65' ' ' CYS . 34.6 ttm180 -160.14 26.85 0.17 Allowed 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 106.285 -1.746 . . . . 0.0 106.285 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 29.0 m120 -60.68 117.02 4.83 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-N 114.78 -1.1 . . . . 0.0 109.956 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.52 ' HA ' ' HA ' ' A' ' 62' ' ' CYS . 65.0 m 54.1 86.49 0.05 OUTLIER 'General case' 0 N--CA 1.496 1.87 0 O-C-N 124.854 1.346 . . . . 0.0 110.665 -179.878 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.41 ' O ' HG22 ' A' ' 103' ' ' ILE . 10.7 t70 -71.01 109.22 4.79 Favored Pre-proline 0 N--CA 1.498 1.942 0 CA-C-N 115.683 -0.689 . . . . 0.0 111.58 -179.769 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_endo -69.71 -38.9 7.26 Favored 'Trans proline' 0 N--CA 1.494 1.538 0 C-N-CA 122.157 1.905 . . . . 0.0 109.857 -171.377 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 35.2 mmt180 -71.27 -11.68 61.05 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-N 113.984 -1.462 . . . . 0.0 113.828 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.41 HG22 ' O ' ' A' ' 100' ' ' ASP . 8.9 tt -73.38 178.55 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 C-N-CA 118.614 -1.234 . . . . 0.0 109.293 -179.792 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.446 ' HB2' ' H ' ' A' ' 77' ' ' ASP . . . -134.7 -60.23 0.79 Allowed 'General case' 0 N--CA 1.494 1.741 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.788 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 15.8 p90 -168.7 166.69 11.64 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-N 114.757 -1.11 . . . . 0.0 110.366 -179.809 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -99.38 116.22 5.52 Favored Glycine 0 N--CA 1.49 2.265 0 CA-C-N 113.861 -1.518 . . . . 0.0 109.417 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 96.2 mt -78.65 92.86 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 N-CA-C 105.766 -1.938 . . . . 0.0 105.766 179.816 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 17.1 m -79.43 121.03 82.32 Favored Pre-proline 0 N--CA 1.493 1.676 0 CA-C-N 113.995 -1.457 . . . . 0.0 109.096 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo . . . . . 0 N--CA 1.493 1.469 0 C-N-CA 122.259 1.972 . . . . 0.0 110.359 -179.07 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' ARG . . . . . 0.439 HH11 ' HB2' ' A' ' 4' ' ' CYS . 2.5 tmm_? . . . . . 0 N--CA 1.5 2.048 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 8.3 tp -90.43 51.71 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 CA-C-N 114.257 -1.338 . . . . 0.0 110.293 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.519 ' HA ' ' HA ' ' A' ' 41' ' ' CYS . 1.6 m -82.73 41.14 0.71 Allowed 'General case' 0 N--CA 1.495 1.813 0 CA-C-O 123.056 1.408 . . . . 0.0 114.389 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 91.8 m -91.47 112.86 24.95 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-N 112.657 -2.065 . . . . 0.0 109.127 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.466 ' ND2' ' HA ' ' A' ' 40' ' ' ASN . 40.3 p-10 -115.94 176.93 4.87 Favored 'General case' 0 N--CA 1.501 2.092 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 179.545 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.457 ' SG ' ' CD2' ' A' ' 16' ' ' TYR . 1.8 t -73.08 -27.69 61.87 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 114.322 1.23 . . . . 0.0 114.322 -179.557 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.484 ' SG ' ' N ' ' A' ' 37' ' ' CYS . 53.0 t -80.14 -63.14 1.48 Allowed 'General case' 0 N--CA 1.492 1.674 0 CA-C-N 114.374 -1.285 . . . . 0.0 113.936 -179.602 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -90.22 19.38 5.11 Favored 'General case' 0 N--CA 1.502 2.16 0 N-CA-C 113.619 0.97 . . . . 0.0 113.619 -179.792 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -83.45 -111.57 0.54 Allowed Glycine 0 N--CA 1.499 2.852 0 C-N-CA 120.6 -0.81 . . . . 0.0 111.57 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 40.7 p -137.08 112.22 9.07 Favored 'General case' 0 N--CA 1.504 2.235 0 CA-C-O 121.073 0.463 . . . . 0.0 111.892 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 8.5 tmtt? -62.53 150.19 41.0 Favored 'General case' 0 N--CA 1.487 1.389 0 CA-C-O 121.241 0.543 . . . . 0.0 111.154 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 76.45 -10.27 17.68 Favored Glycine 0 N--CA 1.489 2.195 0 CA-C-N 114.301 -1.318 . . . . 0.0 111.806 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 69.0 m -102.52 127.73 49.46 Favored 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 119.561 -0.856 . . . . 0.0 108.901 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -70.84 92.36 0.9 Allowed 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 113.267 -1.788 . . . . 0.0 109.112 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.665 ' CD2' ' SG ' ' A' ' 25' ' ' CYS . 78.6 m-85 -44.94 131.13 7.35 Favored 'General case' 0 N--CA 1.502 2.161 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 179.753 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -144.99 150.38 36.82 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 125.139 1.524 . . . . 0.0 112.532 -179.421 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 40.5 t -96.1 134.46 39.14 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-N 111.969 -2.378 . . . . 0.0 111.828 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.427 ' H ' ' HB2' ' A' ' 46' ' ' ALA . 4.5 p-10 -51.05 -24.73 4.1 Favored 'General case' 0 N--CA 1.501 2.097 0 CA-C-N 112.941 -1.936 . . . . 0.0 113.9 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 25.7 p30 -59.59 -8.86 2.15 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 124.178 0.924 . . . . 0.0 112.361 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 97.07 28.71 8.47 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 86.5 m -140.64 143.07 34.96 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 123.998 0.47 . . . . 0.0 110.399 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.452 ' CG ' ' N ' ' A' ' 24' ' ' VAL . 39.1 t80 -69.54 167.92 15.77 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 124.802 1.314 . . . . 0.0 111.132 179.8 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.452 ' N ' ' CG ' ' A' ' 23' ' ' PHE . 98.6 t -132.51 -74.45 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 123.842 0.714 . . . . 0.0 112.885 -179.79 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.665 ' SG ' ' CD2' ' A' ' 16' ' ' TYR . 20.5 p -147.24 -175.7 4.94 Favored 'General case' 0 N--CA 1.509 2.506 0 C-N-CA 121.04 -0.264 . . . . 0.0 110.708 -179.623 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 7.4 tm-20 -103.74 143.83 32.28 Favored 'General case' 0 N--CA 1.508 2.467 0 N-CA-C 113.402 0.89 . . . . 0.0 113.402 -179.776 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.622 ' HA2' ' CE2' ' A' ' 16' ' ' TYR . . . -43.98 105.62 0.08 OUTLIER Glycine 0 N--CA 1.501 3.013 0 O-C-N 124.437 1.085 . . . . 0.0 115.039 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -122.63 37.22 4.45 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 17.5 t -121.82 65.97 0.91 Allowed 'General case' 0 N--CA 1.499 1.996 0 CA-C-O 121.815 0.816 . . . . 0.0 110.959 -179.866 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -88.37 142.61 31.53 Favored Pre-proline 0 N--CA 1.493 1.72 0 CA-C-N 113.886 -1.506 . . . . 0.0 108.528 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -56.64 -4.72 0.92 Allowed 'Trans proline' 0 N--CA 1.497 1.727 0 C-N-CA 122.316 2.011 . . . . 0.0 114.568 175.163 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.419 ' NE ' ' HA ' ' A' ' 32' ' ' ARG . 12.3 mmp_? -94.48 -27.76 15.82 Favored 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 113.148 0.795 . . . . 0.0 113.148 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -66.05 121.85 78.2 Favored Pre-proline 0 N--CA 1.497 1.898 0 C-N-CA 119.039 -1.064 . . . . 0.0 112.006 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -75.09 123.13 7.61 Favored 'Trans proline' 0 N--CA 1.492 1.423 0 C-N-CA 122.714 2.276 . . . . 0.0 109.963 178.086 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 62.64 160.52 0.08 Allowed 'General case' 0 N--CA 1.502 2.16 0 O-C-N 124.614 1.196 . . . . 0.0 112.954 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -79.92 -167.1 1.16 Allowed 'General case' 0 N--CA 1.496 1.841 0 CA-C-N 114.694 -1.139 . . . . 0.0 110.099 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.484 ' N ' ' SG ' ' A' ' 8' ' ' CYS . 4.4 m -129.97 160.19 34.38 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 123.712 0.633 . . . . 0.0 110.016 -179.863 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 77.0 m 42.27 -104.72 0.06 Allowed 'General case' 0 N--CA 1.497 1.899 0 CA-C-N 114.261 -1.336 . . . . 0.0 113.167 179.736 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 96.1 mt -142.18 4.03 1.6 Allowed 'General case' 0 N--CA 1.498 1.962 0 O-C-N 123.585 0.553 . . . . 0.0 112.441 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.466 ' HA ' ' ND2' ' A' ' 6' ' ' ASN . 1.6 m-80 59.07 -174.33 0.1 Allowed 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 114.174 1.176 . . . . 0.0 114.174 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.519 ' HA ' ' HA ' ' A' ' 4' ' ' CYS . 56.8 m 59.88 100.87 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 CA-C-N 113.185 -1.825 . . . . 0.0 113.04 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -120.56 101.66 45.88 Favored Pre-proline 0 N--CA 1.496 1.873 0 CA-C-N 115.32 -0.855 . . . . 0.0 108.789 179.695 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -60.49 -31.57 92.62 Favored 'Trans proline' 0 N--CA 1.494 1.518 0 C-N-CA 122.622 2.215 . . . . 0.0 111.728 -176.23 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 21.6 tpp85 -57.52 -39.91 77.59 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 124.107 0.879 . . . . 0.0 109.175 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 13.7 mt -71.26 152.49 8.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 CA-C-O 122.192 0.996 . . . . 0.0 109.827 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.427 ' HB2' ' H ' ' A' ' 19' ' ' ASP . . . -121.14 -51.2 2.11 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-N 111.773 -2.467 . . . . 0.0 106.503 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 15.8 p90 -172.7 158.9 4.17 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-N 113.186 -1.825 . . . . 0.0 109.736 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -97.86 123.41 7.82 Favored Glycine 0 N--CA 1.49 2.288 0 CA-C-N 113.313 -1.767 . . . . 0.0 108.973 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 27.2 m -90.2 101.05 11.88 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 CA-C-O 122.052 0.929 . . . . 0.0 110.678 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.6 m -79.03 164.03 57.04 Favored Pre-proline 0 N--CA 1.502 2.14 0 CA-C-N 114.502 -1.226 . . . . 0.0 108.98 179.729 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo . . . . . 0 N--CA 1.494 1.55 0 C-N-CA 122.369 2.046 . . . . 0.0 111.313 173.059 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.524 ' HA ' ' HA ' ' A' ' 99' ' ' CYS . 1.7 m . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 123.02 1.39 . . . . 0.0 112.075 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 52.0 m -90.66 151.02 21.44 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 112.626 -2.079 . . . . 0.0 108.892 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 52.1 p-10 -127.86 -171.06 2.35 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 17.0 t -101.95 -29.97 11.5 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 123.663 0.602 . . . . 0.0 110.95 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 37.2 t -61.87 -55.35 30.64 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 124.102 0.876 . . . . 0.0 109.947 -179.748 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -87.68 63.86 7.74 Favored 'General case' 0 N--CA 1.499 2.025 0 N-CA-C 106.23 -1.767 . . . . 0.0 106.23 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -106.33 -115.87 4.08 Favored Glycine 0 N--CA 1.488 2.164 0 CA-C-N 113.963 -1.471 . . . . 0.0 112.322 -179.762 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.509 ' H ' ' CA ' ' A' ' 85' ' ' GLY . 2.6 t 179.29 110.67 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 125.278 1.222 . . . . 0.0 109.402 -179.851 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 11.4 mmmm -64.79 88.38 0.06 Allowed 'General case' 0 N--CA 1.499 1.996 0 CA-C-N 114.954 -1.021 . . . . 0.0 108.307 179.731 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 171.79 -31.73 0.13 Allowed Glycine 0 N--CA 1.487 2.055 0 CA-C-N 113.908 -1.496 . . . . 0.0 110.937 -179.82 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' CYS . . . . . 0.419 ' HA ' ' HA ' ' A' ' 108' ' ' CYS . 67.9 m -112.71 167.15 10.72 Favored 'General case' 0 N--CA 1.5 2.058 0 C-N-CA 119.46 -0.896 . . . . 0.0 111.139 -179.818 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 61.1 mtpt -111.14 100.91 9.48 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-N 114.074 -1.421 . . . . 0.0 113.775 -179.673 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.414 ' CG ' HD11 ' A' ' 103' ' ' ILE . 5.0 m-85 -52.71 141.63 20.56 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 124.265 0.978 . . . . 0.0 109.988 179.466 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -154.77 159.45 40.64 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 113.684 -1.598 . . . . 0.0 112.964 -179.426 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 73.0 p -100.24 135.08 42.21 Favored 'General case' 0 N--CA 1.486 1.358 0 CA-C-N 114.014 -1.448 . . . . 0.0 113.179 -179.768 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.547 ' H ' ' HB2' ' A' ' 104' ' ' ALA . 4.6 p-10 -40.01 -47.19 2.22 Favored 'General case' 0 N--CA 1.499 2.005 0 CA-C-N 112.82 -1.991 . . . . 0.0 115.978 -179.867 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -52.9 -36.05 58.95 Favored 'General case' 0 N--CA 1.497 1.88 0 CA-C-N 114.724 -1.125 . . . . 0.0 112.38 -179.794 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 128.43 42.68 0.24 Allowed Glycine 0 N--CA 1.494 2.539 0 O-C-N 124.772 1.295 . . . . 0.0 111.594 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 95.1 m -140.84 114.07 8.58 Favored 'General case' 0 N--CA 1.497 1.876 0 C-N-CA 119.469 -0.893 . . . . 0.0 112.739 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -54.18 139.69 34.83 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.639 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 99.5 t -103.88 -63.98 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 CA-C-N 114.571 -1.195 . . . . 0.0 112.183 -179.702 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' CYS . . . . . 0.415 ' SG ' ' N ' ' A' ' 84' ' ' GLU . 1.8 p -160.28 -162.98 1.03 Allowed 'General case' 0 N--CA 1.501 2.083 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 -179.8 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.415 ' N ' ' SG ' ' A' ' 83' ' ' CYS . 30.4 tt0 -118.36 144.7 45.69 Favored 'General case' 0 N--CA 1.5 2.069 0 N-CA-C 105.992 -1.855 . . . . 0.0 105.992 179.298 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.509 ' CA ' ' H ' ' A' ' 69' ' ' THR . . . -60.17 135.78 50.03 Favored Glycine 0 N--CA 1.496 2.689 0 N-CA-C 108.154 -1.979 . . . . 0.0 108.154 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -105.71 -7.89 18.17 Favored 'General case' 0 N--CA 1.503 2.195 0 N-CA-C 116.722 2.119 . . . . 0.0 116.722 -179.581 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 26.8 t -70.06 97.09 1.12 Allowed 'General case' 0 N--CA 1.501 2.115 0 C-N-CA 119.001 -1.08 . . . . 0.0 108.757 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -79.74 143.81 59.18 Favored Pre-proline 0 N--CA 1.494 1.74 0 CA-C-N 114.855 -1.066 . . . . 0.0 109.765 -179.792 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -46.66 -22.34 1.79 Allowed 'Trans proline' 0 N--CA 1.499 1.817 0 C-N-CA 122.887 2.392 . . . . 0.0 113.017 170.717 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.432 ' NE ' ' HA ' ' A' ' 90' ' ' ARG . 3.7 tpm_? -62.14 -53.08 60.42 Favored 'General case' 0 N--CA 1.495 1.775 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.412 HD22 ' H ' ' A' ' 93' ' ' LYS . 2.4 p-10 -84.63 131.95 48.16 Favored Pre-proline 0 N--CA 1.492 1.663 0 CA-C-N 115.079 -0.964 . . . . 0.0 108.99 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -79.26 56.9 6.23 Favored 'Trans proline' 0 N--CA 1.492 1.388 0 C-N-CA 123.029 2.486 . . . . 0.0 108.181 163.912 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.412 ' H ' HD22 ' A' ' 91' ' ' ASN . 27.7 mtpp 65.29 121.31 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.082 0 CA-C-N 114.585 -1.188 . . . . 0.0 110.923 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -153.25 68.21 0.8 Allowed 'General case' 0 N--CA 1.496 1.839 0 CA-C-N 114.665 -1.152 . . . . 0.0 108.134 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 89.7 m -154.11 160.56 30.8 Favored Pre-proline 0 N--CA 1.496 1.855 0 CA-C-N 114.263 -1.335 . . . . 0.0 111.967 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -73.41 -159.27 0.08 OUTLIER 'Trans proline' 0 N--CA 1.493 1.442 0 C-N-CA 122.973 2.449 . . . . 0.0 109.792 160.864 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.55 52.25 1.12 Allowed 'General case' 0 N--CA 1.494 1.772 0 CA-C-O 122.392 1.092 . . . . 0.0 108.284 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -47.04 113.9 0.75 Allowed 'General case' 0 N--CA 1.5 2.051 0 CA-C-N 113.054 -1.885 . . . . 0.0 110.565 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.524 ' HA ' ' HA ' ' A' ' 62' ' ' CYS . 56.2 m -60.07 121.7 12.53 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 119.926 -0.709 . . . . 0.0 111.095 -179.836 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 42.0 t0 -112.22 91.09 15.24 Favored Pre-proline 0 N--CA 1.494 1.762 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -58.34 -31.44 93.88 Favored 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 122.708 2.272 . . . . 0.0 111.143 -169.033 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 15.7 tpt180 -73.04 -40.39 65.16 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-N 114.366 -1.288 . . . . 0.0 112.305 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.414 HD11 ' CG ' ' A' ' 74' ' ' TYR . 3.3 tt -58.67 162.54 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 O-C-N 123.524 0.515 . . . . 0.0 112.048 -179.592 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.547 ' HB2' ' H ' ' A' ' 77' ' ' ASP . . . -139.96 -57.81 0.56 Allowed 'General case' 0 N--CA 1.495 1.824 0 CA-C-N 114.411 -1.268 . . . . 0.0 109.172 179.807 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 15.3 p90 -165.62 163.41 19.25 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-N 114.816 -1.084 . . . . 0.0 110.917 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -111.32 115.22 3.87 Favored Glycine 0 N--CA 1.493 2.444 0 CA-C-N 114.077 -1.419 . . . . 0.0 111.974 -179.826 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 51.5 mm -93.01 124.54 45.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 124.52 0.777 . . . . 0.0 110.054 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' CYS . . . . . 0.419 ' HA ' ' HA ' ' A' ' 72' ' ' CYS . 1.7 m -79.61 148.17 68.99 Favored Pre-proline 0 N--CA 1.495 1.82 0 O-C-N 124.024 0.827 . . . . 0.0 109.706 179.685 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo . . . . . 0 N--CA 1.494 1.559 0 C-N-CA 122.866 2.378 . . . . 0.0 111.457 -175.249 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 86.3 mtm180 . . . . . 0 N--CA 1.501 2.099 0 CA-C-O 121.619 0.723 . . . . 0.0 111.51 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 8.7 tp -84.04 48.5 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 CA-C-N 114.445 -1.252 . . . . 0.0 109.982 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.494 ' HA ' ' HA ' ' A' ' 41' ' ' CYS . 1.5 m -83.42 57.29 3.94 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 115.668 1.729 . . . . 0.0 115.668 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 37.3 p -91.8 176.6 6.47 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-N 113.143 -1.844 . . . . 0.0 110.183 179.657 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.524 HD21 ' N ' ' A' ' 37' ' ' CYS . 34.2 p30 -162.04 -172.72 3.35 Favored 'General case' 0 N--CA 1.495 1.807 0 CA-C-N 114.276 -1.329 . . . . 0.0 108.026 179.189 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.8 t -75.98 -10.15 59.19 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 115.737 1.754 . . . . 0.0 115.737 -179.472 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 6.7 t -91.79 -37.52 12.91 Favored 'General case' 0 N--CA 1.503 2.177 0 CA-C-O 121.587 0.708 . . . . 0.0 111.667 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -74.34 57.76 0.7 Allowed 'General case' 0 N--CA 1.497 1.909 0 CA-C-N 113.085 -1.87 . . . . 0.0 113.568 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -162.16 -121.9 0.59 Allowed Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.763 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 86.7 m -140.29 124.28 17.5 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 123.88 0.4 . . . . 0.0 111.851 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 40.4 ttpt -67.42 86.67 0.18 Allowed 'General case' 0 N--CA 1.496 1.865 0 O-C-N 124.618 1.199 . . . . 0.0 109.308 179.7 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.459 ' H ' ' HA3' ' A' ' 27' ' ' GLY . . . 156.15 -19.13 0.47 Allowed Glycine 0 N--CA 1.494 2.56 0 CA-C-N 114.855 -1.066 . . . . 0.0 110.661 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 87.7 m -89.43 -177.8 5.43 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -130.54 101.97 5.94 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 123.477 0.486 . . . . 0.0 110.218 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.632 ' CD1' ' SG ' ' A' ' 25' ' ' CYS . 85.0 m-85 -55.85 141.66 38.09 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 124.116 0.885 . . . . 0.0 109.08 179.806 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -149.65 151.71 34.18 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 124.874 1.359 . . . . 0.0 112.699 -179.685 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 96.2 p -101.69 132.7 47.25 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-N 113.272 -1.786 . . . . 0.0 112.476 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.469 ' H ' ' CB ' ' A' ' 46' ' ' ALA . 6.1 p-10 -45.24 -31.17 1.42 Allowed 'General case' 0 N--CA 1.504 2.239 0 N-CA-C 116.643 2.09 . . . . 0.0 116.643 -179.709 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -55.2 -15.87 2.7 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 123.989 0.805 . . . . 0.0 112.738 -179.807 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 108.88 25.28 5.72 Favored Glycine 0 N--CA 1.493 2.448 0 O-C-N 124.419 1.074 . . . . 0.0 111.003 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 57.0 m -135.64 152.06 50.85 Favored 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 120.437 -0.505 . . . . 0.0 110.513 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.406 ' CG ' ' N ' ' A' ' 24' ' ' VAL . 17.5 t80 -74.67 169.54 17.63 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-N 114.546 -1.207 . . . . 0.0 109.824 179.706 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.406 ' N ' ' CG ' ' A' ' 23' ' ' PHE . 93.8 t -131.25 -67.85 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 O-C-N 123.689 0.618 . . . . 0.0 112.635 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.632 ' SG ' ' CD1' ' A' ' 16' ' ' TYR . 11.9 p -153.75 -172.62 4.28 Favored 'General case' 0 N--CA 1.504 2.228 0 C-N-CA 120.256 -0.577 . . . . 0.0 109.469 -179.771 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -126.67 143.2 51.31 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 123.705 0.628 . . . . 0.0 110.906 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.459 ' HA3' ' H ' ' A' ' 13' ' ' GLY . . . -27.41 124.43 0.06 OUTLIER Glycine 0 N--CA 1.495 2.621 0 O-C-N 124.941 1.401 . . . . 0.0 116.09 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -114.69 -22.42 9.72 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 124.582 0.813 . . . . 0.0 110.244 179.849 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 47.4 t -156.56 154.38 30.17 Favored 'General case' 0 N--CA 1.497 1.916 0 CA-C-O 121.522 0.677 . . . . 0.0 111.153 -179.798 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -78.85 141.28 59.13 Favored Pre-proline 0 N--CA 1.496 1.856 0 CA-C-N 113.401 -1.727 . . . . 0.0 108.76 -179.813 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -61.61 -12.94 27.05 Favored 'Trans proline' 0 N--CA 1.496 1.647 0 C-N-CA 122.766 2.311 . . . . 0.0 113.452 -165.889 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 23.5 mmm180 -56.88 -23.51 45.07 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 123.792 0.683 . . . . 0.0 110.968 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 22.1 p-10 -64.28 112.95 8.74 Favored Pre-proline 0 N--CA 1.492 1.639 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 179.779 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -81.24 39.02 0.81 Allowed 'Trans proline' 0 N--CA 1.496 1.675 0 C-N-CA 123.222 2.615 . . . . 0.0 112.203 -175.216 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -175.82 155.87 1.73 Allowed 'General case' 0 N--CA 1.497 1.91 0 CA-C-N 115.197 -0.911 . . . . 0.0 111.831 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -82.95 143.48 30.65 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 179.666 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.524 ' N ' HD21 ' A' ' 6' ' ' ASN . 1.6 m -105.69 -140.58 0.37 Allowed 'General case' 0 N--CA 1.499 2.0 0 O-C-N 123.725 0.641 . . . . 0.0 109.322 -179.788 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 58.5 p 35.33 -141.59 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.186 0 N-CA-C 114.081 1.141 . . . . 0.0 114.081 179.728 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.459 ' CD2' ' H ' ' A' ' 39' ' ' LEU . 1.6 pt? -80.32 -7.09 58.9 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 123.713 0.633 . . . . 0.0 111.776 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 39.4 m-80 62.62 158.07 0.06 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 124.756 1.285 . . . . 0.0 112.972 -179.825 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.494 ' HA ' ' HA ' ' A' ' 4' ' ' CYS . 82.4 m 54.76 116.51 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 116.341 1.978 . . . . 0.0 116.341 -179.817 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -148.11 90.97 4.93 Favored Pre-proline 0 N--CA 1.491 1.619 0 CA-C-N 113.707 -1.588 . . . . 0.0 108.979 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -62.07 -17.55 56.87 Favored 'Trans proline' 0 N--CA 1.492 1.4 0 C-N-CA 122.58 2.187 . . . . 0.0 111.922 175.515 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 33.3 mmt180 -64.01 -33.6 76.11 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 123.844 0.715 . . . . 0.0 109.987 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 4.3 mt -68.79 137.13 24.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 CA-C-O 121.959 0.885 . . . . 0.0 111.401 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.469 ' CB ' ' H ' ' A' ' 19' ' ' ASP . . . -127.58 -53.73 1.35 Allowed 'General case' 0 N--CA 1.494 1.739 0 CA-C-N 112.327 -2.215 . . . . 0.0 109.372 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 30.5 m-85 -137.01 -166.37 1.9 Allowed 'General case' 0 N--CA 1.494 1.764 0 CA-C-N 114.332 -1.303 . . . . 0.0 108.591 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -160.63 104.81 0.25 Allowed Glycine 0 N--CA 1.489 2.178 0 N-CA-C 107.519 -2.232 . . . . 0.0 107.519 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.2 p -79.75 123.3 36.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 -179.837 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 57.1 m -102.27 148.55 35.58 Favored Pre-proline 0 N--CA 1.496 1.871 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.919 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo . . . . . 0 N--CA 1.492 1.41 0 C-N-CA 122.652 2.234 . . . . 0.0 108.56 173.307 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.449 ' HA ' ' HA ' ' A' ' 99' ' ' CYS . 1.8 m . . . . . 0 N--CA 1.493 1.684 0 CA-C-O 122.933 1.349 . . . . 0.0 112.492 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 52.8 m -90.43 167.75 12.38 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 112.628 -2.078 . . . . 0.0 109.088 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 40.8 p30 -151.84 -175.43 5.22 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-N 114.816 -1.084 . . . . 0.0 108.441 179.818 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 37.1 t -94.19 -29.0 15.34 Favored 'General case' 0 N--CA 1.497 1.893 0 C-N-CA 120.168 -0.613 . . . . 0.0 112.311 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 37.5 t -59.7 -57.85 11.14 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 124.209 0.943 . . . . 0.0 111.166 -179.735 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -88.11 41.43 1.0 Allowed 'General case' 0 N--CA 1.494 1.768 0 CA-C-N 112.946 -1.934 . . . . 0.0 109.184 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -79.85 -136.0 1.41 Allowed Glycine 0 N--CA 1.492 2.433 0 N-CA-C 110.092 -1.203 . . . . 0.0 110.092 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 97.3 m -159.07 95.8 1.29 Allowed 'General case' 0 N--CA 1.501 2.081 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 39.9 mmtt -45.72 117.04 1.33 Allowed 'General case' 0 N--CA 1.505 2.305 0 O-C-N 123.731 0.644 . . . . 0.0 112.0 179.817 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 133.04 -34.64 2.42 Favored Glycine 0 N--CA 1.494 2.507 0 O-C-N 124.643 1.214 . . . . 0.0 110.368 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 63.6 m -101.77 136.8 40.99 Favored 'General case' 0 N--CA 1.494 1.743 0 CA-C-O 121.571 0.701 . . . . 0.0 110.686 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.444 ' HD2' ' N ' ' A' ' 73' ' ' LYS . 4.3 mptp? -85.02 88.99 7.5 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 113.315 -1.766 . . . . 0.0 109.589 -179.834 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.439 ' HA ' ' HA2' ' A' ' 106' ' ' GLY . 35.3 m-85 -48.46 129.2 15.8 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 124.346 1.029 . . . . 0.0 109.107 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -141.0 152.54 45.0 Favored 'General case' 0 C--N 1.303 -1.413 0 CA-C-N 112.491 -2.14 . . . . 0.0 113.219 -179.109 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 80.6 p -92.86 136.28 33.39 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-N 113.056 -1.884 . . . . 0.0 114.744 -179.859 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -49.45 -29.53 6.7 Favored 'General case' 0 N--CA 1.5 2.035 0 CA-C-N 112.689 -2.05 . . . . 0.0 115.523 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -57.91 -15.33 8.35 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 123.855 0.722 . . . . 0.0 112.548 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 108.62 27.7 4.84 Favored Glycine 0 N--CA 1.494 2.526 0 O-C-N 124.33 1.019 . . . . 0.0 111.149 179.784 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 60.4 m -138.85 160.01 40.75 Favored 'General case' 0 N--CA 1.496 1.852 0 C-N-CA 120.534 -0.466 . . . . 0.0 110.028 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.432 ' CG ' ' N ' ' A' ' 82' ' ' VAL . 57.4 t80 -79.7 168.3 19.52 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-N 114.758 -1.11 . . . . 0.0 110.554 179.761 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.432 ' N ' ' CG ' ' A' ' 81' ' ' PHE . 89.1 t -133.12 -73.52 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 124.054 0.846 . . . . 0.0 110.335 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' CYS . . . . . 0.422 ' SG ' ' N ' ' A' ' 84' ' ' GLU . 1.1 p -154.72 -167.23 2.54 Favored 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 -179.771 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.422 ' N ' ' SG ' ' A' ' 83' ' ' CYS . 32.4 tt0 -118.93 152.53 36.16 Favored 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 104.124 -2.547 . . . . 0.0 104.124 179.335 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -53.77 127.85 38.6 Favored Glycine 0 N--CA 1.498 2.777 0 C-N-CA 119.834 -1.174 . . . . 0.0 110.187 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -89.58 -25.15 21.49 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 123.905 0.414 . . . . 0.0 111.625 -179.859 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 70.9 p -69.6 96.14 0.91 Allowed 'General case' 0 N--CA 1.49 1.549 0 CA-C-O 121.765 0.793 . . . . 0.0 111.113 -179.779 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -97.25 136.4 21.44 Favored Pre-proline 0 N--CA 1.493 1.719 0 N-CA-C 106.807 -1.553 . . . . 0.0 106.807 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo -43.83 -26.52 1.31 Allowed 'Trans proline' 0 N--CA 1.501 1.962 0 C-N-CA 122.659 2.239 . . . . 0.0 111.515 167.902 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 37.4 ttp85 -65.85 -54.66 23.84 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-N 113.849 -1.523 . . . . 0.0 109.395 179.772 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 21.6 p30 -90.05 138.93 27.29 Favored Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 124.097 0.873 . . . . 0.0 111.961 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -81.17 49.82 3.35 Favored 'Trans proline' 0 N--CA 1.49 1.268 0 C-N-CA 123.068 2.512 . . . . 0.0 109.25 160.544 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.514 ' NZ ' ' H ' ' A' ' 94' ' ' ALA . 0.2 OUTLIER -67.32 148.47 51.63 Favored 'General case' 0 N--CA 1.498 1.935 0 CA-C-O 121.506 0.669 . . . . 0.0 110.214 -179.961 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.514 ' H ' ' NZ ' ' A' ' 93' ' ' LYS . . . -160.32 152.96 21.04 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-N 113.491 -1.686 . . . . 0.0 110.354 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 86.1 m -156.34 167.47 14.32 Favored Pre-proline 0 N--CA 1.498 1.969 0 CA-C-N 114.644 -1.162 . . . . 0.0 109.245 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -55.37 -161.59 0.01 OUTLIER 'Trans proline' 0 N--CA 1.497 1.721 0 C-N-CA 122.717 2.278 . . . . 0.0 112.642 164.901 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 79.9 mtp180 -78.88 -43.2 25.47 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 18.4 m120 46.53 54.98 8.07 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 124.945 1.403 . . . . 0.0 108.874 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.449 ' HA ' ' HA ' ' A' ' 62' ' ' CYS . 60.2 m -42.93 125.87 3.64 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-N 113.471 -1.695 . . . . 0.0 113.714 -179.675 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 45.0 t0 -116.93 86.27 19.29 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 124.687 1.242 . . . . 0.0 107.853 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -52.9 -26.52 31.59 Favored 'Trans proline' 0 N--CA 1.496 1.653 0 C-N-CA 122.808 2.339 . . . . 0.0 112.833 -178.138 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 78.0 ttt-85 -82.37 -33.93 28.59 Favored 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 114.552 1.315 . . . . 0.0 114.552 -179.622 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 8.8 tt -63.97 168.68 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.239 0 C-N-CA 120.192 -0.603 . . . . 0.0 110.92 -179.607 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -145.93 -72.3 0.24 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 123.81 0.694 . . . . 0.0 111.327 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 27.4 p90 -149.8 158.99 44.7 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 123.94 0.775 . . . . 0.0 112.041 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.439 ' HA2' ' HA ' ' A' ' 74' ' ' TYR . . . -98.73 114.28 4.98 Favored Glycine 0 N--CA 1.491 2.323 0 CA-C-N 112.949 -1.932 . . . . 0.0 111.444 -179.837 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 70.6 mt -79.85 97.38 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 CA-C-N 114.282 -0.959 . . . . 0.0 111.137 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 1.6 m -79.35 148.82 71.3 Favored Pre-proline 0 N--CA 1.502 2.172 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 179.521 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo . . . . . 0 N--CA 1.493 1.458 0 C-N-CA 122.549 2.166 . . . . 0.0 110.527 -179.384 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 8.4 ptp180 . . . . . 0 N--CA 1.496 1.856 0 CA-C-O 120.549 0.214 . . . . 0.0 110.67 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 46.1 mm -77.85 91.61 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 124.132 0.895 . . . . 0.0 108.915 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.525 ' H ' ' HB3' ' A' ' 41' ' ' CYS . 0.5 OUTLIER -84.52 -160.23 0.46 Allowed 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 106.04 -1.837 . . . . 0.0 106.04 -179.997 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.8 t -73.48 -169.26 0.65 Allowed 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 179.536 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 58.8 t30 -122.65 166.84 14.24 Favored 'General case' 0 N--CA 1.497 1.893 0 CA-C-O 122.614 1.197 . . . . 0.0 112.356 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.534 ' HA ' ' CE2' ' A' ' 16' ' ' TYR . 19.9 t 43.28 26.29 0.09 Allowed 'General case' 0 N--CA 1.493 1.71 0 CA-C-N 111.189 -2.732 . . . . 0.0 113.925 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 28.0 t -90.14 -68.46 0.78 Allowed 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 116.639 2.089 . . . . 0.0 116.639 -179.635 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -57.6 -4.47 0.27 Allowed 'General case' 0 N--CA 1.506 2.37 0 N-CA-C 118.367 2.729 . . . . 0.0 118.367 -179.494 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.414 ' N ' ' OH ' ' A' ' 16' ' ' TYR . . . -65.0 -39.22 96.29 Favored Glycine 0 N--CA 1.493 2.465 0 N-CA-C 110.941 -0.864 . . . . 0.0 110.941 -179.791 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 38.8 m 68.49 112.22 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.844 0 O-C-N 125.62 1.424 . . . . 0.0 107.164 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 14.8 tppt? -37.99 98.43 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.088 0 O-C-N 124.693 1.245 . . . . 0.0 113.0 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 157.82 -22.15 0.39 Allowed Glycine 0 N--CA 1.49 2.262 0 CA-C-N 112.686 -2.052 . . . . 0.0 108.686 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 90.9 m -103.98 169.25 8.61 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 62.3 mttp -124.32 95.12 4.42 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 123.972 0.795 . . . . 0.0 112.18 -179.637 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.612 ' HB2' ' SG ' ' A' ' 25' ' ' CYS . 6.5 m-85 -49.42 144.76 5.26 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-N 114.104 -1.407 . . . . 0.0 112.122 179.541 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -154.8 164.16 39.21 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 112.914 -1.948 . . . . 0.0 112.057 -179.39 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 40.0 t -118.04 138.83 51.95 Favored 'General case' 0 N--CA 1.495 1.823 0 CA-C-N 113.577 -1.647 . . . . 0.0 112.167 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.403 ' H ' ' HB2' ' A' ' 46' ' ' ALA . 5.3 p-10 -46.39 -24.42 0.49 Allowed 'General case' 0 N--CA 1.499 2.025 0 CA-C-N 111.76 -2.473 . . . . 0.0 113.912 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 14.7 p30 -60.87 -6.14 1.67 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 124.117 0.885 . . . . 0.0 112.126 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 92.37 27.2 15.94 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 110.401 -1.08 . . . . 0.0 110.401 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 96.5 m -144.39 141.9 29.98 Favored 'General case' 0 N--CA 1.494 1.761 0 C-N-CA 120.187 -0.605 . . . . 0.0 111.892 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 10.3 t80 -62.77 161.92 11.74 Favored 'General case' 0 N--CA 1.497 1.921 0 CA-C-N 114.14 -1.391 . . . . 0.0 109.915 179.727 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 62.5 t -131.7 -57.16 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 123.893 0.745 . . . . 0.0 112.745 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.612 ' SG ' ' HB2' ' A' ' 16' ' ' TYR . 7.5 p -158.62 -167.29 2.1 Favored 'General case' 0 N--CA 1.503 2.221 0 C-N-CA 119.657 -0.817 . . . . 0.0 109.749 -179.686 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -122.18 136.89 54.97 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 106.547 -1.649 . . . . 0.0 106.547 179.463 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -40.35 129.41 2.93 Favored Glycine 0 N--CA 1.503 3.127 0 O-C-N 123.657 0.598 . . . . 0.0 112.322 179.857 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -79.81 -52.78 7.48 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 114.023 1.12 . . . . 0.0 114.023 -179.806 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 55.7 m -50.28 86.61 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 116.425 2.009 . . . . 0.0 116.425 -179.281 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.642 ' H ' HD21 ' A' ' 33' ' ' ASN . 29.5 t70 -86.63 126.09 65.08 Favored Pre-proline 0 N--CA 1.489 1.511 0 N-CA-C 105.358 -2.09 . . . . 0.0 105.358 179.752 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_endo -63.45 73.83 0.14 Allowed 'Trans proline' 0 N--CA 1.5 1.863 0 C-N-CA 123.687 2.925 . . . . 0.0 113.585 -153.029 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.409 ' N ' ' O ' ' A' ' 30' ' ' ASP . 1.5 mpp_? -158.84 -47.13 0.06 Allowed 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 105.384 -2.08 . . . . 0.0 105.384 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.642 HD21 ' H ' ' A' ' 30' ' ' ASP . 12.6 p30 -78.33 136.59 60.55 Favored Pre-proline 0 N--CA 1.494 1.76 0 C-N-CA 119.526 -0.87 . . . . 0.0 109.708 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -68.8 119.73 6.7 Favored 'Trans proline' 0 N--CA 1.493 1.489 0 C-N-CA 122.736 2.291 . . . . 0.0 110.184 -178.232 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 14.3 ptmm? -107.08 157.4 17.86 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 124.18 0.925 . . . . 0.0 110.415 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -160.39 73.71 0.52 Allowed 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 27.9 m -152.8 -174.45 4.92 Favored 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 121.949 0.881 . . . . 0.0 111.744 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.486 ' HB ' ' SG ' ' A' ' 41' ' ' CYS . 83.6 m -141.51 157.81 44.66 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 104.464 -2.421 . . . . 0.0 104.464 179.638 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.461 HD12 ' N ' ' A' ' 39' ' ' LEU . 5.0 mp -79.45 -21.38 45.56 Favored 'General case' 0 N--CA 1.498 1.946 0 C-N-CA 119.439 -0.904 . . . . 0.0 110.361 -179.788 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -94.37 37.92 1.1 Allowed 'General case' 0 N--CA 1.497 1.879 0 CA-C-O 121.976 0.893 . . . . 0.0 110.165 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.525 ' HB3' ' H ' ' A' ' 4' ' ' CYS . 67.4 m -98.71 -95.5 0.23 Allowed 'General case' 0 N--CA 1.494 1.769 0 CA-C-N 113.598 -1.637 . . . . 0.0 107.409 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -54.13 131.12 59.9 Favored Pre-proline 0 N--CA 1.501 2.117 0 C-N-CA 120.601 -0.44 . . . . 0.0 110.401 179.796 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -68.78 -23.28 35.82 Favored 'Trans proline' 0 N--CA 1.493 1.489 0 C-N-CA 122.27 1.98 . . . . 0.0 111.633 -164.054 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 58.4 ttt85 -58.14 -38.42 76.54 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 124.031 0.832 . . . . 0.0 110.611 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.578 HD13 ' CD1' ' A' ' 16' ' ' TYR . 15.4 mt -98.85 154.15 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 CA-C-O 122.67 1.224 . . . . 0.0 113.857 -179.826 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.403 ' HB2' ' H ' ' A' ' 19' ' ' ASP . . . -112.17 -56.16 2.43 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-N 110.907 -2.86 . . . . 0.0 107.766 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 53.6 p90 -166.49 173.53 9.77 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-N 114.776 -1.102 . . . . 0.0 109.621 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -125.86 122.13 4.39 Favored Glycine 0 N--CA 1.494 2.502 0 CA-C-N 114.198 -1.365 . . . . 0.0 110.128 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.5 p -79.5 122.71 35.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 11.3 m -100.09 104.93 32.39 Favored Pre-proline 0 N--CA 1.496 1.828 0 CA-C-N 115.083 -0.962 . . . . 0.0 108.729 -179.838 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo . . . . . 0 N--CA 1.49 1.302 0 C-N-CA 122.381 2.054 . . . . 0.0 109.798 -176.258 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 7.7 m . . . . . 0 N--CA 1.491 1.616 0 N-CA-C 115.601 1.704 . . . . 0.0 115.601 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 7.9 p -90.38 173.67 7.98 Favored 'General case' 0 N--CA 1.495 1.81 0 CA-C-N 114.174 -1.376 . . . . 0.0 109.084 179.616 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -161.38 149.46 15.43 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-N 114.631 -1.168 . . . . 0.0 108.782 179.772 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 11.2 t -55.86 -17.37 6.2 Favored 'General case' 0 N--CA 1.5 2.069 0 N-CA-C 113.97 1.1 . . . . 0.0 113.97 -179.659 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 52.1 t -82.72 -43.41 16.85 Favored 'General case' 0 N--CA 1.498 1.96 0 CA-C-N 114.138 -1.392 . . . . 0.0 112.553 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -73.62 61.91 0.75 Allowed 'General case' 0 N--CA 1.5 2.074 0 O-C-N 125.765 1.915 . . . . 0.0 114.784 -179.575 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -169.52 -155.12 9.68 Favored Glycine 0 N--CA 1.486 1.983 0 CA-C-N 112.726 -2.034 . . . . 0.0 108.303 179.599 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 57.5 p -145.31 159.71 42.63 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 124.018 0.481 . . . . 0.0 110.505 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 59.0 mtpt -71.76 38.51 0.07 Allowed 'General case' 0 N--CA 1.502 2.173 0 O-C-N 125.469 1.731 . . . . 0.0 113.938 179.695 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -132.83 1.92 4.75 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 108.448 -1.861 . . . . 0.0 108.448 179.675 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' CYS . . . . . 0.411 ' HA ' ' HA ' ' A' ' 108' ' ' CYS . 96.0 m -135.54 170.73 15.49 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 123.905 0.415 . . . . 0.0 111.729 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 48.6 mtmt -130.06 105.67 8.11 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.234 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.696 ' CD1' ' SG ' ' A' ' 83' ' ' CYS . 88.2 m-85 -53.82 144.29 18.82 Favored 'General case' 0 N--CA 1.505 2.285 0 O-C-N 123.525 0.515 . . . . 0.0 110.122 179.8 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.548 ' CE2' ' HA ' ' A' ' 80' ' ' THR . 9.3 t80 -149.32 158.01 43.82 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 124.653 1.221 . . . . 0.0 113.287 -179.572 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 28.2 t -121.12 129.71 53.41 Favored 'General case' 0 N--CA 1.499 1.993 0 CA-C-N 112.05 -2.341 . . . . 0.0 112.145 -179.723 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.429 ' H ' ' HB2' ' A' ' 104' ' ' ALA . 9.2 p-10 -47.66 -59.19 3.46 Favored 'General case' 0 N--CA 1.495 1.81 0 CA-C-N 113.127 -1.851 . . . . 0.0 112.74 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.408 ' H ' ' CG ' ' A' ' 77' ' ' ASP . 17.7 p-10 -107.2 25.46 11.38 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-N 114.556 -1.202 . . . . 0.0 110.624 -179.777 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -146.93 15.52 1.55 Allowed Glycine 0 N--CA 1.494 2.507 0 O-C-N 124.179 0.924 . . . . 0.0 111.578 -179.863 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.548 ' HA ' ' CE2' ' A' ' 75' ' ' PHE . 6.6 t 41.61 -160.56 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.899 0 O-C-N 124.934 1.02 . . . . 0.0 113.405 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 72.4 t80 -40.01 132.4 1.84 Allowed 'General case' 0 N--CA 1.5 2.074 0 O-C-N 123.634 0.584 . . . . 0.0 112.213 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 76.6 t -107.48 -61.03 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 CA-C-N 114.381 -1.281 . . . . 0.0 109.93 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' CYS . . . . . 0.696 ' SG ' ' CD1' ' A' ' 74' ' ' TYR . 0.8 OUTLIER -163.66 -166.74 1.25 Allowed 'General case' 0 N--CA 1.502 2.136 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 -179.89 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.475 ' N ' ' SG ' ' A' ' 83' ' ' CYS . 35.2 mt-10 -130.65 163.68 26.66 Favored 'General case' 0 N--CA 1.485 1.316 0 CA-C-N 114.995 -1.002 . . . . 0.0 109.362 179.511 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -43.24 120.15 2.67 Favored Glycine 0 N--CA 1.499 2.891 0 O-C-N 124.092 0.87 . . . . 0.0 113.681 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -108.71 32.1 5.13 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 36.3 t -153.91 129.26 9.8 Favored 'General case' 0 N--CA 1.498 1.958 0 C-N-CA 120.323 -0.551 . . . . 0.0 109.616 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -100.22 144.28 28.12 Favored Pre-proline 0 N--CA 1.494 1.762 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -46.61 -23.37 2.24 Favored 'Trans proline' 0 N--CA 1.499 1.834 0 C-N-CA 122.846 2.364 . . . . 0.0 112.564 170.339 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 52.8 ttp85 -60.68 -53.23 59.96 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-N 114.967 -1.015 . . . . 0.0 108.682 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -90.5 114.42 61.1 Favored Pre-proline 0 N--CA 1.494 1.725 0 O-C-N 124.839 1.337 . . . . 0.0 110.635 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -83.68 45.13 1.73 Allowed 'Trans proline' 0 N--CA 1.495 1.593 0 C-N-CA 123.427 2.752 . . . . 0.0 110.633 173.912 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 64.2 mtpt -79.13 125.59 29.62 Favored 'General case' 0 N--CA 1.497 1.894 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.954 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -88.75 120.67 30.35 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 114.596 -1.184 . . . . 0.0 109.603 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 31.0 m -79.94 145.37 61.37 Favored Pre-proline 0 N--CA 1.497 1.906 0 CA-C-N 115.202 -0.908 . . . . 0.0 108.928 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -70.31 -87.13 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.482 0 C-N-CA 122.249 1.966 . . . . 0.0 110.253 -177.188 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 86.7 mtm180 -145.32 -67.28 0.31 Allowed 'General case' 0 N--CA 1.497 1.912 0 O-C-N 123.737 0.648 . . . . 0.0 109.397 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 28.5 m120 46.22 48.43 13.12 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 124.39 1.056 . . . . 0.0 110.67 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 90.7 m -36.21 127.26 0.76 Allowed 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 115.251 1.574 . . . . 0.0 115.251 -179.716 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -122.31 79.99 45.05 Favored Pre-proline 0 N--CA 1.496 1.858 0 O-C-N 124.295 0.997 . . . . 0.0 109.091 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -59.34 -25.91 80.06 Favored 'Trans proline' 0 N--CA 1.495 1.605 0 C-N-CA 123.293 2.662 . . . . 0.0 111.707 -178.704 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 25.0 tpt180 -66.66 -37.39 84.7 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-N 115.118 -0.946 . . . . 0.0 111.726 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.457 ' CG2' ' N ' ' A' ' 104' ' ' ALA . 6.3 mt -60.06 167.01 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 CA-C-O 121.855 0.836 . . . . 0.0 111.516 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.457 ' N ' ' CG2' ' A' ' 103' ' ' ILE . . . -138.69 -44.81 0.48 Allowed 'General case' 0 N--CA 1.489 1.497 0 CA-C-N 113.462 -1.699 . . . . 0.0 107.762 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 40.7 p90 -173.07 -170.84 0.68 Allowed 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -136.45 130.15 5.14 Favored Glycine 0 N--CA 1.493 2.5 0 C-N-CA 120.554 -0.831 . . . . 0.0 111.228 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.451 ' N ' HD12 ' A' ' 107' ' ' ILE . 2.9 mp -79.89 110.46 15.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 N-CA-C 105.788 -1.93 . . . . 0.0 105.788 179.893 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' CYS . . . . . 0.411 ' HA ' ' HA ' ' A' ' 72' ' ' CYS . 60.9 m -100.19 109.57 56.95 Favored Pre-proline 0 N--CA 1.495 1.809 0 O-C-N 124.143 0.902 . . . . 0.0 110.405 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo . . . . . 0 N--CA 1.492 1.42 0 C-N-CA 122.6 2.2 . . . . 0.0 109.905 179.528 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 . . . . . 0 N--CA 1.501 2.114 0 CA-C-O 120.6 0.238 . . . . 0.0 111.374 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.1 tp -67.49 91.27 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 CA-C-O 121.985 0.898 . . . . 0.0 110.814 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 7.5 m -90.36 45.28 1.25 Allowed 'General case' 0 N--CA 1.493 1.72 0 CA-C-O 122.726 1.25 . . . . 0.0 112.472 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 51.8 m -90.74 171.07 9.6 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 113.001 -1.909 . . . . 0.0 109.275 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 28.0 m120 -160.0 171.91 18.5 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 124.567 1.167 . . . . 0.0 107.998 179.798 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 9.6 t -70.14 -11.14 60.68 Favored 'General case' 0 N--CA 1.501 2.096 0 C-N-CA 118.968 -1.093 . . . . 0.0 110.837 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 34.4 t -91.11 -50.4 5.86 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-N 113.905 -1.498 . . . . 0.0 109.137 179.734 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -39.58 -67.26 0.23 Allowed 'General case' 0 N--CA 1.501 2.084 0 N-CA-C 115.965 1.839 . . . . 0.0 115.965 -179.662 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -54.66 160.51 5.08 Favored Glycine 0 N--CA 1.502 3.057 0 C-N-CA 121.099 -0.572 . . . . 0.0 112.325 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 7.3 t -71.43 138.29 48.95 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 -179.744 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -62.33 114.1 3.29 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-N 114.121 -1.399 . . . . 0.0 109.2 179.769 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 134.39 -21.92 3.79 Favored Glycine 0 N--CA 1.495 2.594 0 O-C-N 124.431 1.082 . . . . 0.0 110.577 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 88.2 m -86.77 -173.08 4.3 Favored 'General case' 0 N--CA 1.5 2.028 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 60.7 mtpt -133.46 103.27 5.86 Favored 'General case' 0 N--CA 1.494 1.765 0 C-N-CA 119.793 -0.763 . . . . 0.0 110.998 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.733 ' CD2' ' SG ' ' A' ' 25' ' ' CYS . 90.8 m-85 -54.75 138.21 42.69 Favored 'General case' 0 N--CA 1.499 2.015 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.67 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -149.22 146.25 27.52 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 124.886 1.366 . . . . 0.0 113.26 -179.701 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 45.4 t -106.03 120.99 43.2 Favored 'General case' 0 N--CA 1.5 2.055 0 CA-C-N 112.822 -1.99 . . . . 0.0 110.722 -179.821 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.564 ' H ' ' HB2' ' A' ' 46' ' ' ALA . 6.5 p-10 -57.61 -53.34 59.32 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 126.476 2.36 . . . . 0.0 112.19 -179.817 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -72.95 1.61 8.47 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 112.264 -2.244 . . . . 0.0 112.236 -179.665 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -136.39 -85.39 0.18 Allowed Glycine 0 N--CA 1.482 1.727 0 C-N-CA 119.626 -1.273 . . . . 0.0 111.951 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.469 ' CG2' ' N ' ' A' ' 23' ' ' PHE . 1.2 m 172.7 -171.16 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.166 0 N-CA-C 106.002 -1.851 . . . . 0.0 106.002 -179.137 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.469 ' N ' ' CG2' ' A' ' 22' ' ' THR . 33.2 t80 -41.79 144.05 0.45 Allowed 'General case' 0 N--CA 1.502 2.146 0 CA-C-O 121.369 0.605 . . . . 0.0 112.065 179.53 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 71.9 t -110.38 -68.21 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 CA-C-N 114.06 -1.427 . . . . 0.0 112.353 -179.656 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.733 ' SG ' ' CD2' ' A' ' 16' ' ' TYR . 14.5 p -155.14 -167.55 2.6 Favored 'General case' 0 N--CA 1.502 2.153 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 -179.717 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 8.7 tm-20 -117.45 154.89 30.62 Favored 'General case' 0 N--CA 1.505 2.282 0 O-C-N 123.373 0.42 . . . . 0.0 110.735 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.474 ' HA2' ' CE2' ' A' ' 16' ' ' TYR . . . -46.48 110.7 0.55 Allowed Glycine 0 N--CA 1.503 3.128 0 CA-C-O 118.857 -0.968 . . . . 0.0 112.583 179.869 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -97.33 -9.19 27.97 Favored 'General case' 0 N--CA 1.505 2.32 0 N-CA-C 114.684 1.365 . . . . 0.0 114.684 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 38.4 t -156.07 131.17 9.29 Favored 'General case' 0 N--CA 1.501 2.083 0 C-N-CA 119.647 -0.821 . . . . 0.0 111.607 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -93.54 143.59 26.87 Favored Pre-proline 0 N--CA 1.494 1.771 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 179.812 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -66.26 75.7 0.35 Allowed 'Trans proline' 0 N--CA 1.494 1.558 0 C-N-CA 122.579 2.186 . . . . 0.0 108.236 162.963 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 35.2 ttp-105 -168.09 -41.28 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 113.208 -1.814 . . . . 0.0 106.832 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.514 ' C ' HD21 ' A' ' 33' ' ' ASN . 0.3 OUTLIER -86.99 152.84 54.02 Favored Pre-proline 0 N--CA 1.493 1.705 0 O-C-N 124.175 0.922 . . . . 0.0 110.936 -179.934 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -79.85 45.6 2.0 Allowed 'Trans proline' 0 N--CA 1.496 1.635 0 C-N-CA 123.443 2.762 . . . . 0.0 112.319 174.481 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.483 ' HE3' ' HA ' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -102.12 152.9 20.46 Favored 'General case' 0 N--CA 1.501 2.109 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.163 -179.981 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -156.39 165.24 36.9 Favored 'General case' 0 N--CA 1.498 1.93 0 CA-C-N 114.674 -1.148 . . . . 0.0 109.571 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 28.0 m -146.19 179.16 7.69 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 123.779 0.674 . . . . 0.0 110.282 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 44.5 p -138.72 54.7 1.74 Allowed 'General case' 0 N--CA 1.5 2.066 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.671 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 54.2 tp -93.63 -25.24 17.59 Favored 'General case' 0 N--CA 1.499 2.017 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.005 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 11.4 m120 62.54 153.64 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.118 0 O-C-N 124.487 1.117 . . . . 0.0 113.536 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 59.4 m -18.61 130.38 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.274 0 N-CA-C 116.63 2.085 . . . . 0.0 116.63 -179.849 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -113.82 86.13 10.53 Favored Pre-proline 0 N--CA 1.498 1.955 0 O-C-N 124.062 0.851 . . . . 0.0 108.971 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -62.13 -18.41 61.78 Favored 'Trans proline' 0 N--CA 1.497 1.724 0 C-N-CA 122.633 2.222 . . . . 0.0 113.803 -170.753 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 5.9 ptp85 -89.09 -20.15 24.68 Favored 'General case' 0 N--CA 1.501 2.078 0 N-CA-C 116.393 1.997 . . . . 0.0 116.393 -179.636 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 16.3 tt -78.13 155.44 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.303 0 C-N-CA 118.566 -1.254 . . . . 0.0 109.694 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.564 ' HB2' ' H ' ' A' ' 19' ' ' ASP . . . -90.4 -66.3 0.94 Allowed 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 179.627 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 3.3 p90 -177.63 171.91 1.83 Allowed 'General case' 0 N--CA 1.492 1.651 0 CA-C-N 112.786 -2.006 . . . . 0.0 108.513 -179.783 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.406 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -91.05 110.37 3.81 Favored Glycine 0 N--CA 1.49 2.279 0 CA-C-N 114.979 -1.009 . . . . 0.0 110.701 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 20.1 m -78.84 105.84 8.76 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 N-CA-C 106.107 -1.812 . . . . 0.0 106.107 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 48.1 m -83.28 161.74 56.23 Favored Pre-proline 0 N--CA 1.495 1.798 0 CA-C-N 113.375 -1.739 . . . . 0.0 111.264 -179.772 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo . . . . . 0 N--CA 1.494 1.536 0 C-N-CA 122.345 2.03 . . . . 0.0 109.675 166.65 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.5 ' N ' ' SG ' ' A' ' 99' ' ' CYS . 1.6 m . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.5 p -63.91 138.71 58.59 Favored 'General case' 0 N--CA 1.495 1.824 0 C-N-CA 119.067 -1.053 . . . . 0.0 112.558 179.872 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -155.11 154.59 32.6 Favored 'General case' 0 N--CA 1.499 2.009 0 CA-C-N 112.14 -2.3 . . . . 0.0 110.209 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 52.8 t -52.71 -51.2 61.4 Favored 'General case' 0 N--CA 1.501 2.084 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 179.745 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 17.7 t -60.91 -54.46 44.78 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-N 110.996 -2.82 . . . . 0.0 112.658 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -39.46 -45.06 1.47 Allowed 'General case' 0 N--CA 1.504 2.227 0 O-C-N 125.921 2.013 . . . . 0.0 110.511 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.424 ' HA3' ' H ' ' A' ' 87' ' ' SER . . . 73.38 162.94 7.75 Favored Glycine 0 N--CA 1.476 1.351 0 N-CA-C 116.951 1.54 . . . . 0.0 116.951 179.583 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 3.6 t 176.64 42.56 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 104.49 -2.411 . . . . 0.0 104.49 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.519 ' HA ' ' HE2' ' A' ' 70' ' ' LYS . 0.6 OUTLIER -10.35 94.08 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.065 0 CA-C-N 113.165 -1.834 . . . . 0.0 115.545 -179.553 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 136.37 -47.56 0.96 Allowed Glycine 0 N--CA 1.493 2.497 0 CA-C-N 114.461 -1.245 . . . . 0.0 111.94 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' CYS . . . . . 0.438 ' HA ' ' HA ' ' A' ' 108' ' ' CYS . 76.5 m -79.93 122.75 27.09 Favored 'General case' 0 N--CA 1.497 1.914 0 C-N-CA 119.166 -1.014 . . . . 0.0 110.761 -179.79 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.476 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 37.0 mtmm -73.2 89.48 1.53 Allowed 'General case' 0 N--CA 1.487 1.384 0 CA-C-N 112.535 -2.12 . . . . 0.0 115.152 -179.604 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.437 ' N ' ' O ' ' A' ' 83' ' ' CYS . 41.9 m-85 -45.55 136.8 5.5 Favored 'General case' 0 N--CA 1.504 2.234 0 O-C-N 124.32 1.012 . . . . 0.0 108.399 179.488 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -154.17 145.8 23.26 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 114.851 -1.068 . . . . 0.0 112.144 -179.478 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 89.0 p -90.12 141.51 28.61 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 112.05 -2.341 . . . . 0.0 115.806 -179.667 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -51.34 -33.92 31.55 Favored 'General case' 0 N--CA 1.499 2.01 0 CA-C-N 112.288 -2.233 . . . . 0.0 114.313 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -57.85 -13.98 5.27 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 123.994 0.808 . . . . 0.0 112.156 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 102.7 37.46 3.21 Favored Glycine 0 N--CA 1.491 2.325 0 O-C-N 124.311 1.007 . . . . 0.0 111.487 179.783 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 90.7 m -140.79 149.07 41.6 Favored 'General case' 0 N--CA 1.496 1.858 0 C-N-CA 119.8 -0.76 . . . . 0.0 111.826 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 21.3 t80 -77.45 142.86 38.97 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-N 114.937 -1.029 . . . . 0.0 108.253 179.549 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 92.2 t -107.22 -67.27 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 CA-C-N 114.933 -1.031 . . . . 0.0 108.842 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' CYS . . . . . 0.437 ' O ' ' N ' ' A' ' 74' ' ' TYR . 39.2 m -159.8 -160.56 0.82 Allowed 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.476 ' HA ' ' HA ' ' A' ' 73' ' ' LYS . 36.3 tt0 -139.41 160.19 40.4 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 102.739 -3.06 . . . . 0.0 102.739 178.986 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.445 ' HA3' ' N ' ' A' ' 70' ' ' LYS . . . -38.24 100.18 0.01 OUTLIER Glycine 0 N--CA 1.494 2.527 0 CA-C-O 119.301 -0.722 . . . . 0.0 114.463 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -79.08 -3.81 47.14 Favored 'General case' 0 N--CA 1.502 2.169 0 C-N-CA 119.618 -0.833 . . . . 0.0 111.316 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.424 ' H ' ' HA3' ' A' ' 68' ' ' GLY . 44.0 t -142.93 128.57 19.18 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -84.01 145.67 46.98 Favored Pre-proline 0 N--CA 1.493 1.681 0 CA-C-N 114.588 -1.187 . . . . 0.0 109.147 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -56.62 80.97 0.04 OUTLIER 'Trans proline' 0 N--CA 1.499 1.84 0 C-N-CA 123.279 2.653 . . . . 0.0 108.528 163.996 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 50.8 ttp85 -173.71 -62.54 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 104.027 -2.583 . . . . 0.0 104.027 -179.635 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 11.2 p-10 -91.88 113.49 59.08 Favored Pre-proline 0 N--CA 1.492 1.651 0 CA-C-N 114.12 -1.4 . . . . 0.0 109.04 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -74.38 89.48 1.07 Allowed 'Trans proline' 0 N--CA 1.492 1.393 0 C-N-CA 122.467 2.111 . . . . 0.0 110.571 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -122.15 123.1 40.73 Favored 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -150.64 151.88 33.17 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.46 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 81.6 m -119.46 98.22 50.19 Favored Pre-proline 0 N--CA 1.497 1.898 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -68.53 93.1 0.42 Allowed 'Trans proline' 0 N--CA 1.493 1.452 0 C-N-CA 122.301 2.001 . . . . 0.0 109.013 177.106 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 28.4 mmt85 -134.72 47.88 2.34 Favored 'General case' 0 N--CA 1.498 1.954 0 CA-C-N 114.651 -1.159 . . . . 0.0 108.029 -179.856 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 14.5 m120 54.42 41.3 32.05 Favored 'General case' 0 N--CA 1.504 2.236 0 CA-C-O 122.797 1.284 . . . . 0.0 108.094 -179.742 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.5 ' SG ' ' N ' ' A' ' 62' ' ' CYS . 5.3 m 57.95 -167.43 0.14 Allowed 'General case' 0 N--CA 1.488 1.439 0 CA-C-N 112.031 -2.35 . . . . 0.0 108.722 -179.662 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -106.22 99.64 24.72 Favored Pre-proline 0 N--CA 1.498 1.943 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 179.75 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -64.53 -31.13 61.13 Favored 'Trans proline' 0 N--CA 1.493 1.46 0 C-N-CA 122.336 2.024 . . . . 0.0 111.639 -169.656 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 74.9 ttt-85 -71.89 -31.22 66.19 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 123.967 0.792 . . . . 0.0 111.226 -179.842 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 12.0 mt -68.53 157.24 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 CA-C-O 122.261 1.029 . . . . 0.0 111.427 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -124.92 -56.41 1.56 Allowed 'General case' 0 N--CA 1.492 1.63 0 CA-C-N 111.969 -2.378 . . . . 0.0 107.555 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 38.1 p90 -164.88 170.12 15.73 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-N 114.254 -1.339 . . . . 0.0 109.922 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -110.84 123.85 6.73 Favored Glycine 0 N--CA 1.492 2.426 0 CA-C-N 113.911 -1.495 . . . . 0.0 110.944 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.486 ' N ' HD12 ' A' ' 107' ' ' ILE . 2.9 mp -79.31 99.65 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' CYS . . . . . 0.438 ' HA ' ' HA ' ' A' ' 72' ' ' CYS . 25.2 m -79.79 163.9 56.01 Favored Pre-proline 0 N--CA 1.491 1.622 0 CA-C-N 114.169 -1.378 . . . . 0.0 108.754 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_exo . . . . . 0 N--CA 1.498 1.76 0 C-N-CA 122.558 2.172 . . . . 0.0 112.589 173.793 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 38.8 ttm180 . . . . . 0 N--CA 1.495 1.818 0 N-CA-C 107.135 -1.431 . . . . 0.0 107.135 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 8.6 tp -86.77 53.67 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 CA-C-N 114.092 -1.413 . . . . 0.0 109.093 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.473 ' HA ' ' HA ' ' A' ' 41' ' ' CYS . 63.5 m -84.19 40.58 0.77 Allowed 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 115.031 1.493 . . . . 0.0 115.031 -179.829 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.409 ' HB ' HG21 ' A' ' 45' ' ' ILE . 53.3 m -90.6 158.91 16.71 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 105.167 -2.16 . . . . 0.0 105.167 179.641 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -147.48 169.36 19.71 Favored 'General case' 0 N--CA 1.497 1.918 0 CA-C-O 122.427 1.108 . . . . 0.0 112.551 -179.761 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.7 t -62.76 -53.14 58.91 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-N 112.268 -2.242 . . . . 0.0 111.952 -179.836 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 51.4 t -67.63 -55.7 12.26 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-N 113.946 -1.479 . . . . 0.0 109.375 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -54.83 -18.03 4.31 Favored 'General case' 0 N--CA 1.497 1.921 0 CA-C-N 113.786 -1.552 . . . . 0.0 113.062 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -59.53 160.72 17.74 Favored Glycine 0 N--CA 1.496 2.676 0 C-N-CA 120.613 -0.804 . . . . 0.0 111.453 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 9.7 t -76.45 129.4 36.48 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 115.732 1.753 . . . . 0.0 115.732 -179.768 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.423 ' HB3' ' NZ ' ' A' ' 12' ' ' LYS . 3.1 mmmp? -62.34 93.23 0.05 OUTLIER 'General case' 0 N--CA 1.5 2.073 0 CA-C-N 114.195 -1.366 . . . . 0.0 109.032 179.572 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 157.18 -28.09 0.51 Allowed Glycine 0 N--CA 1.49 2.279 0 CA-C-O 118.52 -1.156 . . . . 0.0 112.913 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 84.2 m -117.55 169.7 9.34 Favored 'General case' 0 N--CA 1.503 2.183 0 C-N-CA 119.438 -0.905 . . . . 0.0 112.603 -179.766 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 36.0 mtmm -102.69 96.67 7.02 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-N 113.982 -1.463 . . . . 0.0 111.312 -179.714 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.423 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 24.0 m-85 -59.94 127.9 34.19 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-O 122.884 1.326 . . . . 0.0 108.023 179.654 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -135.2 151.96 51.12 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 111.29 -2.687 . . . . 0.0 112.655 -179.145 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 87.8 p -91.03 133.06 35.61 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 112.991 -1.913 . . . . 0.0 113.924 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -47.73 -29.12 2.84 Favored 'General case' 0 N--CA 1.5 2.035 0 CA-C-N 113.11 -1.859 . . . . 0.0 116.012 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -57.64 -18.35 19.73 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 123.611 0.57 . . . . 0.0 112.519 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 112.46 26.96 4.05 Favored Glycine 0 N--CA 1.494 2.52 0 O-C-N 124.366 1.041 . . . . 0.0 111.098 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 62.4 m -135.91 156.06 49.35 Favored 'General case' 0 N--CA 1.496 1.853 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.458 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 22.6 t80 -85.85 149.25 25.37 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-N 114.89 -1.05 . . . . 0.0 110.16 179.727 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 96.0 t -108.47 -79.0 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 N-CA-C 107.03 -1.471 . . . . 0.0 107.03 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.458 ' SG ' ' O ' ' A' ' 26' ' ' GLU . 0.1 OUTLIER -164.76 179.91 6.26 Favored 'General case' 0 N--CA 1.5 2.044 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 179.743 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.458 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 30.7 tt0 -85.64 157.05 20.44 Favored 'General case' 0 N--CA 1.502 2.138 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 179.87 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -74.14 116.43 5.26 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 104.729 -3.349 . . . . 0.0 104.729 179.613 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -98.64 21.94 10.62 Favored 'General case' 0 N--CA 1.505 2.285 0 N-CA-C 114.757 1.392 . . . . 0.0 114.757 -179.633 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 37.7 t -137.97 117.88 13.31 Favored 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 179.671 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -79.42 132.52 62.06 Favored Pre-proline 0 N--CA 1.493 1.692 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_endo -67.11 85.33 0.33 Allowed 'Trans proline' 0 N--CA 1.492 1.441 0 C-N-CA 122.6 2.2 . . . . 0.0 109.908 178.534 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 12.0 mtp180 176.52 -41.71 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.938 0 CA-C-N 113.925 -1.488 . . . . 0.0 108.216 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -77.22 146.11 74.08 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 123.991 0.807 . . . . 0.0 111.88 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -81.54 48.23 2.79 Favored 'Trans proline' 0 N--CA 1.492 1.407 0 C-N-CA 123.407 2.738 . . . . 0.0 109.525 163.061 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 65.0 tttp -68.23 150.71 47.95 Favored 'General case' 0 N--CA 1.497 1.891 0 CA-C-O 121.544 0.688 . . . . 0.0 111.617 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -91.42 131.03 37.16 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-N 113.608 -1.633 . . . . 0.0 108.005 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 5.2 m -142.85 -178.41 5.79 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 -179.868 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 96.2 m -83.25 113.87 20.99 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-N 113.645 -1.616 . . . . 0.0 108.413 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 9.8 mp -79.5 0.58 29.07 Favored 'General case' 0 N--CA 1.498 1.953 0 CA-C-N 115.299 -0.864 . . . . 0.0 112.164 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -59.19 119.61 7.67 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 123.546 0.529 . . . . 0.0 109.719 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.473 ' HA ' ' HA ' ' A' ' 4' ' ' CYS . 85.0 m -68.55 92.26 0.45 Allowed 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.412 ' O ' HG22 ' A' ' 45' ' ' ILE . 10.0 t70 -63.35 101.88 0.29 Allowed Pre-proline 0 N--CA 1.495 1.792 0 CA-C-N 115.252 -0.885 . . . . 0.0 110.19 -179.681 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo -67.32 -37.88 16.7 Favored 'Trans proline' 0 N--CA 1.492 1.399 0 C-N-CA 122.159 1.906 . . . . 0.0 110.779 -160.234 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 28.0 ptt-85 -78.27 -23.1 47.39 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-N 114.233 -1.349 . . . . 0.0 114.013 -179.77 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.412 HG22 ' O ' ' A' ' 42' ' ' ASP . 7.9 tt -55.27 159.04 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.278 0 C-N-CA 120.1 -0.64 . . . . 0.0 110.476 -179.554 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -141.85 -62.64 0.45 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 123.803 0.69 . . . . 0.0 112.575 -179.812 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 28.1 p90 -156.17 161.63 40.29 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-O 121.871 0.843 . . . . 0.0 113.04 -179.79 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.423 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -92.17 95.3 2.01 Favored Glycine 0 N--CA 1.489 2.194 0 CA-C-N 112.785 -2.007 . . . . 0.0 110.593 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 4.7 p -81.74 110.55 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 C-N-CA 119.108 -1.037 . . . . 0.0 109.012 179.649 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.6 m -79.04 154.43 77.55 Favored Pre-proline 0 N--CA 1.498 1.928 0 CA-C-N 115.472 -0.786 . . . . 0.0 109.414 179.832 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo . . . . . 0 N--CA 1.497 1.692 0 C-N-CA 122.71 2.273 . . . . 0.0 111.623 -173.506 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.462 ' HA ' ' HA ' ' A' ' 99' ' ' CYS . 1.6 m . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 123.128 1.442 . . . . 0.0 114.455 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.41 ' O ' ' N ' ' A' ' 100' ' ' ASP . 1.8 p -90.86 160.87 15.5 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-N 112.64 -2.073 . . . . 0.0 108.05 179.456 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 32.5 p-10 -161.63 148.48 14.32 Favored 'General case' 0 N--CA 1.501 2.108 0 C-N-CA 119.891 -0.723 . . . . 0.0 110.22 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' CYS . . . . . 0.489 ' HA ' ' CD2' ' A' ' 74' ' ' TYR . 7.1 t -65.45 -15.45 62.64 Favored 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 113.661 0.986 . . . . 0.0 113.661 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 29.4 t -80.52 -66.77 0.84 Allowed 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 116.295 1.961 . . . . 0.0 116.295 -179.499 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -77.82 63.31 2.84 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 125.545 1.778 . . . . 0.0 114.832 -179.25 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -123.98 -150.3 7.91 Favored Glycine 0 N--CA 1.494 2.522 0 CA-C-N 112.729 -2.032 . . . . 0.0 109.946 179.558 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 4.8 t -136.44 121.18 18.51 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-N 114.102 -1.049 . . . . 0.0 108.924 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 6.2 ptpp? -58.16 89.95 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.853 0 CA-C-O 122.648 1.214 . . . . 0.0 111.371 179.678 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 161.89 -42.08 0.38 Allowed Glycine 0 N--CA 1.49 2.24 0 N-CA-C 108.368 -1.893 . . . . 0.0 108.368 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' CYS . . . . . 0.434 ' HA ' ' HA ' ' A' ' 108' ' ' CYS . 90.3 m -79.43 128.29 33.16 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 179.925 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 35.4 mmtp -80.37 83.31 6.22 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 115.581 1.697 . . . . 0.0 115.581 -179.321 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.489 ' CD2' ' HA ' ' A' ' 65' ' ' CYS . 2.1 m-85 -43.55 126.36 4.39 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 124.235 0.959 . . . . 0.0 109.181 179.379 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -141.08 152.04 44.48 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-N 114.321 -1.309 . . . . 0.0 112.325 -179.34 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 30.2 t -101.66 143.24 31.86 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 116.059 1.874 . . . . 0.0 116.059 -179.57 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -49.69 -26.11 3.48 Favored 'General case' 0 N--CA 1.5 2.074 0 CA-C-N 111.231 -2.713 . . . . 0.0 113.435 179.746 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 13.8 p30 -62.33 -3.18 1.24 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 124.178 0.924 . . . . 0.0 111.853 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 86.87 28.96 24.72 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 90.3 m -142.33 143.93 32.98 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 120.47 -0.492 . . . . 0.0 110.9 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 52.6 t80 -67.94 160.25 28.95 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-N 114.17 -1.377 . . . . 0.0 110.497 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 91.1 t -122.95 -74.77 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 CA-C-N 114.624 -1.171 . . . . 0.0 110.477 -179.831 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' CYS . . . . . 0.492 ' SG ' ' N ' ' A' ' 84' ' ' GLU . 0.5 OUTLIER -157.13 -163.07 1.32 Allowed 'General case' 0 N--CA 1.502 2.163 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 -179.874 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.492 ' N ' ' SG ' ' A' ' 83' ' ' CYS . 38.2 tt0 -119.56 164.37 15.93 Favored 'General case' 0 N--CA 1.503 2.205 0 N-CA-C 104.722 -2.325 . . . . 0.0 104.722 179.18 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.42 ' N ' ' HG2' ' A' ' 84' ' ' GLU . . . -60.91 113.57 5.74 Favored Glycine 0 N--CA 1.497 2.743 0 C-N-CA 119.315 -1.422 . . . . 0.0 110.302 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -86.0 21.68 1.9 Allowed 'General case' 0 N--CA 1.501 2.11 0 CA-C-O 121.722 0.772 . . . . 0.0 111.297 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 3.5 m -133.4 160.54 37.08 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 113.996 -1.456 . . . . 0.0 107.224 179.735 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.406 ' H ' ' HB3' ' A' ' 91' ' ' ASN . 21.3 t70 -79.66 145.9 63.77 Favored Pre-proline 0 N--CA 1.493 1.689 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -47.7 -15.22 0.31 Allowed 'Trans proline' 0 N--CA 1.499 1.848 0 C-N-CA 122.835 2.356 . . . . 0.0 114.037 171.397 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 72.5 ttt-85 -139.93 53.05 1.68 Allowed 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.406 ' HB3' ' H ' ' A' ' 88' ' ' ASP . 18.2 p-10 -90.05 128.28 50.37 Favored Pre-proline 0 N--CA 1.496 1.828 0 CA-C-N 114.522 -1.217 . . . . 0.0 111.447 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -83.89 48.1 2.46 Favored 'Trans proline' 0 N--CA 1.491 1.362 0 C-N-CA 123.245 2.63 . . . . 0.0 109.125 159.22 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -130.39 147.52 52.1 Favored 'General case' 0 N--CA 1.503 2.184 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.681 -179.804 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -160.54 125.2 3.72 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-N 114.875 -1.057 . . . . 0.0 109.501 179.856 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 68.7 m -79.74 162.79 61.48 Favored Pre-proline 0 N--CA 1.5 2.03 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -69.97 4.92 2.0 Allowed 'Trans proline' 0 N--CA 1.495 1.587 0 C-N-CA 122.118 1.879 . . . . 0.0 111.146 163.5 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 80.5 mmt-85 -94.21 22.13 6.23 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 123.647 0.592 . . . . 0.0 110.616 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -63.21 158.07 20.95 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.167 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.462 ' HA ' ' HA ' ' A' ' 62' ' ' CYS . 74.0 m 61.75 125.59 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.888 0 O-C-N 125.193 1.558 . . . . 0.0 112.215 -179.771 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.41 ' N ' ' O ' ' A' ' 63' ' ' THR . 30.8 t70 -156.22 84.88 3.21 Favored Pre-proline 0 N--CA 1.494 1.761 0 CA-C-N 114.876 -1.056 . . . . 0.0 110.154 -179.778 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_exo -52.44 -18.26 7.85 Favored 'Trans proline' 0 N--CA 1.495 1.594 0 C-N-CA 122.457 2.104 . . . . 0.0 112.455 174.731 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.69 -54.02 38.25 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 105.974 -1.862 . . . . 0.0 105.974 179.855 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 15.3 tt -79.95 157.52 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 C-N-CA 119.215 -0.994 . . . . 0.0 109.747 -179.777 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -113.28 -61.35 1.75 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 124.372 1.045 . . . . 0.0 112.588 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 7.4 p90 -162.65 160.06 25.22 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 123.886 0.741 . . . . 0.0 112.162 -179.799 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -97.13 127.44 9.21 Favored Glycine 0 N--CA 1.492 2.414 0 CA-C-N 113.848 -1.523 . . . . 0.0 111.716 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 48.0 mm -80.91 97.88 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' CYS . . . . . 0.434 ' HA ' ' HA ' ' A' ' 72' ' ' CYS . 35.0 m -79.67 143.07 58.06 Favored Pre-proline 0 N--CA 1.494 1.729 0 CA-C-N 114.744 -1.116 . . . . 0.0 109.244 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo . . . . . 0 N--CA 1.496 1.627 0 C-N-CA 122.999 2.466 . . . . 0.0 112.053 -174.136 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 5.9 mmp_? . . . . . 0 N--CA 1.493 1.7 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 10.2 tp -85.15 44.46 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 CA-C-N 114.374 -1.285 . . . . 0.0 109.528 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.409 ' HA ' ' HA ' ' A' ' 41' ' ' CYS . 5.7 m -85.16 59.5 5.67 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 122.582 1.182 . . . . 0.0 112.938 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.2 t -90.03 167.87 12.43 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-N 113.145 -1.843 . . . . 0.0 107.178 179.675 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 15.9 p30 -145.72 150.59 36.54 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.949 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.7 t -67.34 -20.12 65.54 Favored 'General case' 0 N--CA 1.496 1.847 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.805 -179.794 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 35.7 t -54.94 -55.67 28.16 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 179.765 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -71.69 -23.24 61.61 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-N 112.853 -1.976 . . . . 0.0 110.098 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -52.72 142.38 26.09 Favored Glycine 0 N--CA 1.493 2.494 0 O-C-N 124.199 0.937 . . . . 0.0 112.572 -179.805 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 41.0 p -61.15 109.15 1.03 Allowed 'General case' 0 N--CA 1.492 1.639 0 CA-C-N 111.711 -2.244 . . . . 0.0 111.976 -179.713 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -68.81 88.64 0.38 Allowed 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 122.457 1.123 . . . . 0.0 108.677 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 163.87 -22.6 0.17 Allowed Glycine 0 N--CA 1.488 2.111 0 CA-C-N 112.611 -2.086 . . . . 0.0 109.639 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 76.0 m -107.63 138.12 44.42 Favored 'General case' 0 N--CA 1.497 1.902 0 CA-C-O 121.533 0.683 . . . . 0.0 110.567 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 61.3 mtpt -83.38 84.82 7.37 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-N 113.821 -1.536 . . . . 0.0 110.914 -179.518 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 -49.78 128.93 19.17 Favored 'General case' 0 N--CA 1.498 1.951 0 CA-C-O 122.37 1.081 . . . . 0.0 109.982 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -136.8 161.01 37.16 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-N 112.262 -2.245 . . . . 0.0 112.554 -179.264 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 32.8 t -104.33 133.12 49.77 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 113.613 -1.63 . . . . 0.0 112.19 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -47.73 -25.06 1.1 Allowed 'General case' 0 N--CA 1.5 2.032 0 CA-C-N 112.895 -1.957 . . . . 0.0 114.18 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 29.3 p30 -60.17 -7.66 2.02 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 124.095 0.872 . . . . 0.0 112.573 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 95.61 27.23 10.74 Favored Glycine 0 N--CA 1.494 2.537 0 N-CA-C 109.894 -1.282 . . . . 0.0 109.894 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 88.3 m -141.29 139.41 33.66 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 123.926 0.427 . . . . 0.0 110.161 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.43 ' CG ' ' N ' ' A' ' 24' ' ' VAL . 48.8 t80 -67.15 164.64 17.63 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 124.63 1.206 . . . . 0.0 110.787 179.809 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.43 ' N ' ' CG ' ' A' ' 23' ' ' PHE . 96.8 t -129.66 -73.05 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 124.093 0.871 . . . . 0.0 112.544 -179.842 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 20.3 p -150.58 -172.01 4.07 Favored 'General case' 0 N--CA 1.501 2.084 0 CA-C-O 121.615 0.721 . . . . 0.0 111.359 -179.496 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -123.51 138.77 54.5 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 104.585 -2.376 . . . . 0.0 104.585 179.447 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -55.99 155.52 12.3 Favored Glycine 0 N--CA 1.503 3.111 0 C-N-CA 120.137 -1.03 . . . . 0.0 114.597 -179.712 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -112.89 -29.55 7.34 Favored 'General case' 0 N--CA 1.505 2.29 0 CA-C-N 114.837 -0.681 . . . . 0.0 111.891 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 32.0 t -110.44 124.54 51.95 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 107.3 -1.371 . . . . 0.0 107.3 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -77.81 144.1 68.03 Favored Pre-proline 0 N--CA 1.495 1.792 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 -179.714 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -41.46 -21.36 0.13 Allowed 'Trans proline' 0 N--CA 1.501 1.925 0 C-N-CA 124.02 3.146 . . . . 0.0 115.617 177.551 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 30.9 tpt180 -57.63 -30.34 65.28 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 123.708 0.63 . . . . 0.0 110.657 179.831 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.506 ' N ' HD22 ' A' ' 33' ' ' ASN . 0.0 OUTLIER -53.96 120.96 26.74 Favored Pre-proline 0 N--CA 1.496 1.839 0 CA-C-N 114.956 -1.02 . . . . 0.0 112.902 179.991 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -82.19 40.51 0.98 Allowed 'Trans proline' 0 N--CA 1.494 1.546 0 C-N-CA 122.979 2.453 . . . . 0.0 110.356 167.854 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 57.5 tptt -170.07 160.21 8.0 Favored 'General case' 0 N--CA 1.498 1.951 0 CA-C-N 114.577 -1.192 . . . . 0.0 108.578 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -140.4 151.68 45.14 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 123.866 0.729 . . . . 0.0 109.934 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 6.7 m -79.48 143.51 34.87 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 90.2 m -148.79 92.03 1.94 Allowed 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.4 HD23 ' C ' ' A' ' 39' ' ' LEU . 5.9 tt -157.94 -68.92 0.09 Allowed 'General case' 0 N--CA 1.496 1.839 0 CA-C-N 115.339 -0.846 . . . . 0.0 108.917 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -70.33 146.6 50.4 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 123.766 0.666 . . . . 0.0 111.993 -179.836 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.409 ' HA ' ' HA ' ' A' ' 4' ' ' CYS . 79.1 m -105.11 132.17 51.67 Favored 'General case' 0 N--CA 1.496 1.826 0 CA-C-N 114.411 -1.268 . . . . 0.0 109.68 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -135.2 77.44 54.95 Favored Pre-proline 0 N--CA 1.497 1.911 0 O-C-N 123.849 0.718 . . . . 0.0 110.291 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_endo -62.75 -27.19 75.39 Favored 'Trans proline' 0 N--CA 1.494 1.515 0 C-N-CA 123.066 2.511 . . . . 0.0 112.794 -172.473 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 6.0 ptp85 -65.99 -34.8 78.93 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 124.189 0.931 . . . . 0.0 112.47 -179.797 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.0 mt -59.41 136.96 22.49 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.099 0 C-N-CA 118.642 -1.223 . . . . 0.0 112.347 -179.773 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -123.93 -53.02 1.76 Allowed 'General case' 0 N--CA 1.492 1.675 0 CA-C-N 111.911 -2.404 . . . . 0.0 106.737 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 17.3 p90 -170.1 158.44 6.98 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-N 113.667 -1.606 . . . . 0.0 109.8 179.842 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -112.83 133.93 11.65 Favored Glycine 0 N--CA 1.494 2.517 0 CA-C-N 113.746 -1.57 . . . . 0.0 112.112 -179.764 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.3 p -82.92 105.22 12.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 8.9 m -79.96 112.18 27.85 Favored Pre-proline 0 N--CA 1.493 1.718 0 CA-C-N 113.93 -1.486 . . . . 0.0 108.681 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_endo . . . . . 0 N--CA 1.492 1.425 0 C-N-CA 122.445 2.096 . . . . 0.0 111.018 -172.899 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 10.1 m . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 122.558 1.17 . . . . 0.0 112.509 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 97.4 m -78.27 162.69 26.35 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 113.355 -1.748 . . . . 0.0 108.52 179.772 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 46.0 p-10 -160.67 156.65 25.83 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 120.317 -0.553 . . . . 0.0 110.582 179.802 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' CYS . . . . . 0.551 ' SG ' ' HB2' ' A' ' 74' ' ' TYR . 53.0 t -83.48 -12.56 56.15 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-N 115.043 -0.981 . . . . 0.0 110.169 179.773 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 53.4 t -65.02 -59.83 3.71 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 179.844 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -90.54 34.55 0.89 Allowed 'General case' 0 N--CA 1.494 1.761 0 CA-C-N 114.167 -1.379 . . . . 0.0 108.69 179.706 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -74.62 -122.1 0.1 Allowed Glycine 0 N--CA 1.495 2.597 0 CA-C-N 115.353 -0.84 . . . . 0.0 111.053 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 14.8 t -159.81 107.33 1.69 Allowed 'General case' 0 N--CA 1.495 1.807 0 CA-C-O 122.497 1.141 . . . . 0.0 109.465 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 2.7 tmmm? -57.32 101.76 0.07 Allowed 'General case' 0 N--CA 1.493 1.689 0 CA-C-N 113.266 -1.788 . . . . 0.0 107.196 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.404 ' O ' ' SG ' ' A' ' 108' ' ' CYS . . . 165.41 -32.74 0.24 Allowed Glycine 0 N--CA 1.485 1.96 0 CA-C-N 113.225 -1.807 . . . . 0.0 109.366 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 57.7 m -124.36 175.11 7.3 Favored 'General case' 0 N--CA 1.503 2.18 0 C-N-CA 120.017 -0.673 . . . . 0.0 110.733 -179.88 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.448 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 94.0 mttt -110.61 97.86 7.18 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 124.607 1.192 . . . . 0.0 109.174 -179.796 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.551 ' HB2' ' SG ' ' A' ' 65' ' ' CYS . 26.8 m-85 -54.37 131.36 41.92 Favored 'General case' 0 N--CA 1.497 1.89 0 CA-C-N 114.808 -1.087 . . . . 0.0 109.135 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -139.9 147.51 40.7 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 112.956 -1.929 . . . . 0.0 113.475 -179.366 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.403 ' N ' HG23 ' A' ' 82' ' ' VAL . 30.9 t -99.58 117.03 33.07 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-N 111.378 -2.646 . . . . 0.0 108.599 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.578 ' H ' ' HB2' ' A' ' 104' ' ' ALA . 7.6 p-10 -59.97 -54.19 49.04 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 125.186 1.553 . . . . 0.0 112.996 -179.652 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -84.14 13.51 5.09 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 113.603 -1.635 . . . . 0.0 110.882 -179.673 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -129.13 -88.87 0.56 Allowed Glycine 0 N--CA 1.48 1.627 0 N-CA-C 108.962 -1.655 . . . . 0.0 108.962 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.451 ' CG2' ' N ' ' A' ' 81' ' ' PHE . 1.2 m 171.78 -175.71 0.05 OUTLIER 'General case' 0 N--CA 1.5 2.066 0 N-CA-C 105.902 -1.888 . . . . 0.0 105.902 -179.381 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.451 ' N ' ' CG2' ' A' ' 80' ' ' THR . 19.2 t80 -53.52 136.3 38.58 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 179.504 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.403 HG23 ' N ' ' A' ' 76' ' ' SER . 92.9 t -94.78 -73.61 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 CA-C-N 114.606 -1.179 . . . . 0.0 109.196 -179.558 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' CYS . . . . . 0.423 ' C ' ' SG ' ' A' ' 65' ' ' CYS . 0.1 OUTLIER -168.44 178.53 4.79 Favored 'General case' 0 N--CA 1.504 2.268 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 179.882 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.448 ' HA ' ' HA ' ' A' ' 73' ' ' LYS . 38.6 tt0 -93.02 152.46 19.29 Favored 'General case' 0 N--CA 1.5 2.034 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -50.29 102.05 0.06 OUTLIER Glycine 0 N--CA 1.495 2.589 0 O-C-N 123.739 0.649 . . . . 0.0 111.513 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -79.83 -12.15 59.78 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-N 114.862 -0.669 . . . . 0.0 110.146 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 35.1 t -77.79 84.31 4.11 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 121.464 0.65 . . . . 0.0 109.708 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -79.38 132.1 63.42 Favored Pre-proline 0 N--CA 1.495 1.803 0 N-CA-C 106.399 -1.704 . . . . 0.0 106.399 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -52.49 -22.39 16.4 Favored 'Trans proline' 0 N--CA 1.498 1.741 0 C-N-CA 122.823 2.349 . . . . 0.0 113.705 -169.701 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 53.0 mmm-85 -83.71 12.82 5.35 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 123.802 0.689 . . . . 0.0 111.648 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.411 ' C ' ' H ' ' A' ' 93' ' ' LYS . 40.6 p-10 -87.71 135.2 34.24 Favored Pre-proline 0 N--CA 1.494 1.742 0 O-C-N 123.45 0.469 . . . . 0.0 111.148 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -81.95 28.97 0.55 Allowed 'Trans proline' 0 N--CA 1.493 1.453 0 C-N-CA 122.967 2.445 . . . . 0.0 111.409 162.317 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.411 ' H ' ' C ' ' A' ' 91' ' ' ASN . 44.3 mmtm 58.21 124.23 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.162 0 CA-C-N 113.76 -1.564 . . . . 0.0 112.846 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -149.32 79.67 1.4 Allowed 'General case' 0 N--CA 1.497 1.913 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.628 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 79.2 m -153.24 124.21 3.57 Favored Pre-proline 0 N--CA 1.496 1.857 0 CA-C-N 114.476 -1.238 . . . . 0.0 108.43 179.831 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -60.73 -85.57 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.502 0 C-N-CA 122.046 1.831 . . . . 0.0 110.592 177.06 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -142.25 -60.35 0.45 Allowed 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 10.3 m120 51.51 48.28 23.21 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 124.592 1.182 . . . . 0.0 110.243 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 77.9 m -41.17 128.0 2.83 Favored 'General case' 0 N--CA 1.499 2.009 0 CA-C-N 114.112 -1.404 . . . . 0.0 112.734 -179.88 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -139.03 79.32 27.09 Favored Pre-proline 0 N--CA 1.496 1.831 0 O-C-N 124.125 0.89 . . . . 0.0 110.882 -179.733 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -59.43 -33.91 97.35 Favored 'Trans proline' 0 N--CA 1.494 1.523 0 C-N-CA 122.87 2.38 . . . . 0.0 113.024 171.606 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 33.2 ptt180 -63.96 -16.93 62.67 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 123.919 0.762 . . . . 0.0 112.3 -179.878 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 9.6 tp -48.86 152.64 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 O-C-N 124.019 0.824 . . . . 0.0 112.452 -179.83 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.578 ' HB2' ' H ' ' A' ' 77' ' ' ASP . . . -124.59 -71.96 0.69 Allowed 'General case' 0 N--CA 1.492 1.659 0 CA-C-N 114.686 -1.143 . . . . 0.0 108.261 179.792 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 76.3 m-85 -156.14 -162.99 1.37 Allowed 'General case' 0 N--CA 1.499 2.001 0 O-C-N 124.685 1.241 . . . . 0.0 109.042 -179.725 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -119.87 93.26 0.54 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 104.966 -3.253 . . . . 0.0 104.966 179.714 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 43.7 mm -78.77 105.7 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 C-N-CA 119.626 -0.83 . . . . 0.0 110.546 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' CYS . . . . . 0.404 ' SG ' ' O ' ' A' ' 71' ' ' GLY . 1.6 m -78.61 151.4 77.19 Favored Pre-proline 0 N--CA 1.499 1.995 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.688 179.895 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo . . . . . 0 N--CA 1.494 1.528 0 C-N-CA 122.752 2.302 . . . . 0.0 111.151 -172.716 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 10.4 mmm180 . . . . . 0 N--CA 1.496 1.836 0 CA-C-O 119.927 -0.082 . . . . 0.0 111.004 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 4.8 tp -65.62 85.99 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 124.212 0.945 . . . . 0.0 111.228 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.558 ' HA ' ' HA ' ' A' ' 41' ' ' CYS . 1.6 m -92.88 61.03 3.46 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-O 123.372 1.558 . . . . 0.0 113.731 179.814 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 6.8 t -90.15 161.47 15.74 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 104.475 -2.417 . . . . 0.0 104.475 179.517 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -161.54 -166.42 1.5 Allowed 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 8.8 t -117.58 -36.88 3.58 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 179.832 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 49.5 t -62.5 -61.46 2.42 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 123.917 0.761 . . . . 0.0 110.402 -179.59 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -90.06 27.51 1.59 Allowed 'General case' 0 N--CA 1.496 1.871 0 CA-C-N 113.525 -1.67 . . . . 0.0 109.178 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -72.67 -117.9 0.06 OUTLIER Glycine 0 N--CA 1.492 2.411 0 CA-C-N 115.141 -0.936 . . . . 0.0 111.271 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 97.3 m -154.62 91.82 1.43 Allowed 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 107.518 -1.289 . . . . 0.0 107.518 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.484 ' HB3' ' NZ ' ' A' ' 12' ' ' LYS . 0.0 OUTLIER -54.6 112.77 1.08 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 123.739 0.649 . . . . 0.0 110.146 -179.847 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 135.16 -30.06 2.86 Favored Glycine 0 N--CA 1.494 2.531 0 CA-C-N 113.641 -1.618 . . . . 0.0 109.781 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 82.6 m -88.97 -178.38 5.7 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 123.659 0.27 . . . . 0.0 110.955 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 33.3 mmtp -129.82 92.26 3.29 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 124.062 0.851 . . . . 0.0 111.294 -179.546 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.436 ' HB2' ' SG ' ' A' ' 25' ' ' CYS . 51.3 m-85 -58.87 131.64 51.59 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 124.53 1.144 . . . . 0.0 108.268 179.72 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -142.04 159.66 41.78 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-N 113.102 -1.863 . . . . 0.0 113.43 -179.162 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 30.6 t -105.11 134.04 48.89 Favored 'General case' 0 N--CA 1.497 1.893 0 CA-C-N 113.689 -1.596 . . . . 0.0 111.619 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -48.22 -28.27 2.93 Favored 'General case' 0 N--CA 1.501 2.122 0 CA-C-N 112.948 -1.933 . . . . 0.0 115.814 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -52.09 -22.75 4.43 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 124.036 0.835 . . . . 0.0 111.602 -179.843 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 112.13 27.2 4.05 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 108.871 -1.692 . . . . 0.0 108.871 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 89.7 m -138.75 142.06 38.83 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 120.527 -0.469 . . . . 0.0 110.959 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 49.6 t80 -69.41 160.98 30.35 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-N 114.151 -1.386 . . . . 0.0 109.761 179.745 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 58.5 t -127.2 -71.6 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 124.091 0.87 . . . . 0.0 112.179 -179.832 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.436 ' SG ' ' HB2' ' A' ' 16' ' ' TYR . 0.5 OUTLIER -144.52 -177.93 5.73 Favored 'General case' 0 N--CA 1.5 2.068 0 CA-C-O 121.402 0.62 . . . . 0.0 110.818 -179.709 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -113.04 145.0 41.63 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 104.067 -2.568 . . . . 0.0 104.067 179.485 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -57.3 152.04 26.23 Favored Glycine 0 N--CA 1.498 2.773 0 C-N-CA 119.301 -1.428 . . . . 0.0 111.184 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -126.42 -10.06 6.32 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 123.976 0.457 . . . . 0.0 111.265 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 33.4 t -71.63 91.26 1.08 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 123.728 0.643 . . . . 0.0 110.714 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -99.11 111.88 61.88 Favored Pre-proline 0 N--CA 1.491 1.586 0 CA-C-N 114.618 -1.173 . . . . 0.0 108.752 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_endo -58.48 -17.07 32.42 Favored 'Trans proline' 0 N--CA 1.495 1.609 0 C-N-CA 122.869 2.38 . . . . 0.0 113.114 -168.968 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 74.7 ttt-85 -61.01 -50.01 75.1 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -90.84 122.85 66.31 Favored Pre-proline 0 N--CA 1.496 1.843 0 O-C-N 124.271 0.982 . . . . 0.0 110.772 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_endo -78.11 121.62 5.41 Favored 'Trans proline' 0 N--CA 1.492 1.417 0 C-N-CA 122.813 2.342 . . . . 0.0 108.999 165.303 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 56.8 tptt -159.05 153.94 24.87 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 123.62 0.575 . . . . 0.0 110.568 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.85 171.62 9.79 Favored 'General case' 0 N--CA 1.497 1.912 0 CA-C-N 114.321 -1.309 . . . . 0.0 111.315 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 89.7 m -153.58 162.76 40.95 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-N 115.323 -0.853 . . . . 0.0 112.22 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 100.0 m -109.38 91.16 3.53 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 105.46 -2.052 . . . . 0.0 105.46 179.745 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.479 ' N ' HD12 ' A' ' 39' ' ' LEU . 6.4 mp -79.65 -66.43 0.87 Allowed 'General case' 0 N--CA 1.494 1.725 0 CA-C-N 114.882 -1.054 . . . . 0.0 109.892 -179.728 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 5.6 m120 49.17 31.84 3.82 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 124.637 1.211 . . . . 0.0 111.185 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.558 ' HA ' ' HA ' ' A' ' 4' ' ' CYS . 1.7 m 55.7 131.98 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 116.668 2.099 . . . . 0.0 116.668 -179.831 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -120.37 81.13 30.06 Favored Pre-proline 0 N--CA 1.5 2.064 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.296 179.667 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -58.58 -15.29 24.76 Favored 'Trans proline' 0 N--CA 1.495 1.574 0 C-N-CA 122.578 2.186 . . . . 0.0 112.308 176.863 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.456 ' H ' ' CD ' ' A' ' 44' ' ' ARG . 1.4 mpt_? -62.41 -43.23 99.31 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 26.6 mt -83.09 155.81 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 CA-C-O 122.317 1.056 . . . . 0.0 110.201 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -116.2 -53.84 2.51 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-N 111.731 -2.486 . . . . 0.0 108.025 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 50.9 p90 -165.75 167.31 17.14 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-N 114.41 -1.268 . . . . 0.0 109.287 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -119.93 118.48 3.92 Favored Glycine 0 N--CA 1.49 2.251 0 CA-C-N 113.557 -1.656 . . . . 0.0 110.56 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.9 p -79.31 133.99 28.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 20.9 m -111.27 90.76 12.28 Favored Pre-proline 0 N--CA 1.494 1.745 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 -179.806 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo . . . . . 0 N--CA 1.499 1.801 0 C-N-CA 123.244 2.629 . . . . 0.0 114.423 -177.1 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.46 ' HA ' ' HA ' ' A' ' 99' ' ' CYS . 1.6 m . . . . . 0 N--CA 1.494 1.76 0 N-CA-C 115.618 1.71 . . . . 0.0 115.618 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 36.0 m -91.51 109.71 21.01 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 113.175 -1.83 . . . . 0.0 107.893 179.816 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.57 HD22 ' HB3' ' A' ' 67' ' ' ALA . 0.1 OUTLIER -107.83 -165.72 1.08 Allowed 'General case' 0 N--CA 1.503 2.184 0 C-N-CA 120.264 -0.574 . . . . 0.0 109.651 179.84 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 65' ' ' CYS . . . . . 0.409 ' SG ' ' O ' ' A' ' 84' ' ' GLU . 1.5 t -121.22 -33.91 3.59 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 123.904 0.753 . . . . 0.0 111.362 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 32.6 t -57.07 -58.6 7.48 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-O 121.71 0.766 . . . . 0.0 110.12 -179.805 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.57 ' HB3' HD22 ' A' ' 64' ' ' ASN . . . -79.42 -10.56 59.83 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-N 113.088 -1.869 . . . . 0.0 109.737 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -67.47 156.57 52.31 Favored Glycine 0 N--CA 1.494 2.551 0 C-N-CA 120.823 -0.703 . . . . 0.0 111.588 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.461 ' C ' ' H ' ' A' ' 71' ' ' GLY . 57.0 p -68.49 124.27 23.09 Favored 'General case' 0 N--CA 1.498 1.951 0 CA-C-N 114.14 -1.03 . . . . 0.0 111.127 -179.809 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.86 20.72 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.173 0 N-CA-C 115.958 1.836 . . . . 0.0 115.958 -179.853 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.461 ' H ' ' C ' ' A' ' 69' ' ' THR . . . -119.58 -25.85 2.52 Favored Glycine 0 N--CA 1.49 2.29 0 CA-C-N 113.623 -1.626 . . . . 0.0 109.319 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' CYS . . . . . 0.4 ' HA ' ' HA ' ' A' ' 108' ' ' CYS . 94.6 m -93.36 134.54 35.48 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 120.333 -0.547 . . . . 0.0 109.801 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 60.0 mtpt -88.77 84.27 6.69 Favored 'General case' 0 N--CA 1.485 1.316 0 CA-C-N 113.501 -1.681 . . . . 0.0 109.545 -179.632 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.487 ' HB2' ' SG ' ' A' ' 83' ' ' CYS . 82.0 m-85 -50.08 126.11 13.74 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-N 114.855 -1.066 . . . . 0.0 108.418 179.87 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -132.5 162.88 30.08 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 112.986 -1.915 . . . . 0.0 112.625 -179.327 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 42.6 t -109.21 138.52 45.44 Favored 'General case' 0 N--CA 1.497 1.889 0 CA-C-N 114.309 -1.314 . . . . 0.0 112.376 -179.864 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.44 ' H ' ' CB ' ' A' ' 104' ' ' ALA . 7.0 p-10 -47.45 -27.25 1.63 Allowed 'General case' 0 N--CA 1.5 2.042 0 CA-C-N 112.18 -2.282 . . . . 0.0 114.38 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 13.6 p30 -59.11 -7.62 1.21 Allowed 'General case' 0 N--CA 1.497 1.899 0 O-C-N 124.335 1.022 . . . . 0.0 112.492 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 92.91 28.57 11.83 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 95.8 m -143.08 138.8 30.14 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 124.095 0.526 . . . . 0.0 110.554 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.429 ' CG ' ' N ' ' A' ' 82' ' ' VAL . 37.1 t80 -64.19 164.96 10.01 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 124.878 1.361 . . . . 0.0 110.849 179.853 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.429 ' N ' ' CG ' ' A' ' 81' ' ' PHE . 92.4 t -129.03 -71.56 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 124.188 0.93 . . . . 0.0 112.991 -179.805 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' CYS . . . . . 0.487 ' SG ' ' HB2' ' A' ' 74' ' ' TYR . 25.4 p -152.58 -173.08 4.44 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 123.708 0.63 . . . . 0.0 109.346 -179.561 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.409 ' O ' ' SG ' ' A' ' 65' ' ' CYS . 40.5 tt0 -128.49 149.63 50.51 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 102.602 -3.111 . . . . 0.0 102.602 179.324 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -58.8 169.89 5.36 Favored Glycine 0 N--CA 1.501 3.023 0 C-N-CA 118.631 -1.747 . . . . 0.0 114.966 -179.66 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -126.15 -13.88 6.11 Favored 'General case' 0 N--CA 1.502 2.145 0 CA-C-N 114.218 -0.991 . . . . 0.0 110.991 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 34.5 t -81.55 121.59 26.5 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -98.32 143.3 26.04 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 124.779 1.299 . . . . 0.0 107.785 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_exo -43.18 -28.07 1.29 Allowed 'Trans proline' 0 N--CA 1.5 1.866 0 C-N-CA 123.4 2.733 . . . . 0.0 114.022 175.073 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -60.09 -50.38 73.92 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 123.911 0.757 . . . . 0.0 109.278 179.863 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -91.06 116.39 66.32 Favored Pre-proline 0 N--CA 1.497 1.892 0 O-C-N 124.748 1.28 . . . . 0.0 111.806 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -85.02 102.76 0.8 Allowed 'Trans proline' 0 N--CA 1.491 1.342 0 C-N-CA 123.072 2.514 . . . . 0.0 108.044 161.476 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 22.2 ptmt -161.18 162.95 31.49 Favored 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 113.188 0.81 . . . . 0.0 113.188 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -108.86 -166.86 1.15 Allowed 'General case' 0 N--CA 1.496 1.844 0 CA-C-N 113.56 -1.654 . . . . 0.0 108.406 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 76.9 m -146.99 159.94 41.61 Favored Pre-proline 0 N--CA 1.499 1.984 0 O-C-N 123.653 0.595 . . . . 0.0 110.958 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.418 ' C ' ' HE ' ' A' ' 97' ' ' ARG . 11.9 Cg_endo -73.15 -18.19 23.94 Favored 'Trans proline' 0 N--CA 1.493 1.461 0 C-N-CA 122.36 2.04 . . . . 0.0 109.45 161.522 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.418 ' HE ' ' C ' ' A' ' 96' ' ' PRO . 0.0 OUTLIER -79.64 4.44 16.05 Favored 'General case' 0 N--CA 1.497 1.9 0 CA-C-N 114.949 -1.023 . . . . 0.0 111.376 -179.994 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 -54.89 154.41 5.27 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.46 ' HA ' ' HA ' ' A' ' 62' ' ' CYS . 52.4 m 58.37 104.19 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 CA-C-N 113.227 -1.806 . . . . 0.0 113.583 -179.896 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -125.36 107.1 27.27 Favored Pre-proline 0 N--CA 1.498 1.97 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.616 179.814 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -62.4 -25.79 76.4 Favored 'Trans proline' 0 N--CA 1.493 1.491 0 C-N-CA 122.639 2.226 . . . . 0.0 111.453 179.824 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 23.5 mtp-105 -57.93 -38.18 75.43 Favored 'General case' 0 N--CA 1.5 2.048 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 26.7 mt -79.31 154.85 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 CA-C-N 114.815 -1.084 . . . . 0.0 110.079 179.734 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.44 ' CB ' ' H ' ' A' ' 77' ' ' ASP . . . -132.36 -46.24 0.91 Allowed 'General case' 0 N--CA 1.495 1.794 0 CA-C-N 111.955 -2.384 . . . . 0.0 109.441 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 49.1 m-85 -140.0 -163.55 1.53 Allowed 'General case' 0 N--CA 1.493 1.706 0 CA-C-N 114.519 -1.219 . . . . 0.0 109.594 -179.846 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -152.65 107.77 0.34 Allowed Glycine 0 N--CA 1.49 2.235 0 N-CA-C 107.339 -2.304 . . . . 0.0 107.339 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 88.9 mt -79.44 84.41 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 N-CA-C 108.245 -1.021 . . . . 0.0 108.245 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' CYS . . . . . 0.4 ' HA ' ' HA ' ' A' ' 72' ' ' CYS . 13.6 m -79.97 112.46 30.18 Favored Pre-proline 0 N--CA 1.494 1.729 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo . . . . . 0 N--CA 1.493 1.442 0 C-N-CA 122.236 1.957 . . . . 0.0 111.306 -167.496 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 72.7 mtp85 . . . . . 0 N--CA 1.495 1.801 0 CA-C-O 120.52 0.2 . . . . 0.0 110.472 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 9.8 tp -87.0 44.11 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 124.169 0.918 . . . . 0.0 109.031 179.856 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.408 ' HA ' ' HA ' ' A' ' 41' ' ' CYS . 1.7 m -82.78 60.35 5.28 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 114.336 1.236 . . . . 0.0 114.336 -179.851 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 17.8 p -90.92 172.4 8.62 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-N 113.501 -1.681 . . . . 0.0 109.37 179.601 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 32.3 p-10 -161.8 146.06 12.73 Favored 'General case' 0 N--CA 1.497 1.925 0 CA-C-N 115.002 -0.999 . . . . 0.0 109.681 179.687 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.4 ' HA ' ' CD2' ' A' ' 16' ' ' TYR . 40.3 t -63.4 -16.54 60.82 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 113.469 0.915 . . . . 0.0 113.469 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 43.8 t -80.77 -63.46 1.4 Allowed 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 114.789 1.403 . . . . 0.0 114.789 -179.515 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -85.21 62.33 7.43 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-N 114.664 -1.153 . . . . 0.0 112.377 -179.646 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -106.96 -111.79 3.61 Favored Glycine 0 N--CA 1.495 2.578 0 CA-C-N 113.699 -1.591 . . . . 0.0 110.257 179.715 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.561 ' H ' ' HA3' ' A' ' 27' ' ' GLY . 53.4 m -166.64 117.83 0.96 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 125.211 1.183 . . . . 0.0 109.622 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 11.0 mmmm -67.9 83.34 0.21 Allowed 'General case' 0 N--CA 1.502 2.158 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 179.504 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 168.48 -20.26 0.08 OUTLIER Glycine 0 N--CA 1.49 2.282 0 CA-C-N 114.758 -1.11 . . . . 0.0 112.226 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 68.1 m -117.71 -176.68 3.08 Favored 'General case' 0 N--CA 1.5 2.031 0 CA-C-N 117.921 0.86 . . . . 0.0 108.879 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.431 ' HB3' ' HZ2' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -130.84 116.78 18.4 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 118.463 -1.295 . . . . 0.0 113.494 -179.657 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.44 ' N ' ' O ' ' A' ' 25' ' ' CYS . 8.2 m-85 -56.61 136.31 54.66 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-N 113.784 -1.553 . . . . 0.0 107.759 179.331 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -151.06 149.69 29.83 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 113.322 -1.763 . . . . 0.0 111.261 -179.452 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 38.1 t -98.73 134.33 41.78 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-N 111.914 -2.403 . . . . 0.0 112.174 -179.784 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.446 ' H ' ' HB2' ' A' ' 46' ' ' ALA . 3.3 p30 -51.58 -26.44 8.74 Favored 'General case' 0 N--CA 1.5 2.061 0 CA-C-N 112.701 -2.045 . . . . 0.0 114.24 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 52.0 p-10 -59.28 -10.21 2.82 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 124.079 0.862 . . . . 0.0 112.244 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 97.62 29.65 7.67 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 108.718 -1.753 . . . . 0.0 108.718 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 56.2 m -136.06 145.86 46.45 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 124.135 0.55 . . . . 0.0 109.744 -179.799 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.426 ' CG ' ' N ' ' A' ' 24' ' ' VAL . 54.3 t80 -75.48 164.42 26.38 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 124.61 1.194 . . . . 0.0 110.612 179.753 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.426 ' N ' ' CG ' ' A' ' 23' ' ' PHE . 87.2 t -128.49 -75.9 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 124.075 0.859 . . . . 0.0 110.5 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.54 ' SG ' ' N ' ' A' ' 26' ' ' GLU . 0.5 OUTLIER -155.0 -164.87 1.89 Allowed 'General case' 0 N--CA 1.505 2.296 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 -179.898 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.54 ' N ' ' SG ' ' A' ' 25' ' ' CYS . 3.6 tm-20 -111.43 137.65 48.95 Favored 'General case' 0 N--CA 1.504 2.259 0 N-CA-C 106.63 -1.618 . . . . 0.0 106.63 179.588 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.561 ' HA3' ' H ' ' A' ' 11' ' ' THR . . . -54.9 117.45 8.17 Favored Glycine 0 N--CA 1.5 2.963 0 N-CA-C 110.53 -1.028 . . . . 0.0 110.53 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 39.8 mm-40 -93.5 10.35 32.81 Favored 'General case' 0 N--CA 1.499 2.022 0 N-CA-C 115.808 1.781 . . . . 0.0 115.808 -179.496 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 32.2 t -76.1 96.55 3.87 Favored 'General case' 0 N--CA 1.499 2.019 0 C-N-CA 118.651 -1.22 . . . . 0.0 108.734 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -87.74 145.91 37.93 Favored Pre-proline 0 N--CA 1.493 1.688 0 CA-C-N 114.31 -1.314 . . . . 0.0 108.486 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_exo -47.12 111.95 0.46 Allowed 'Trans proline' 0 N--CA 1.494 1.533 0 C-N-CA 122.366 2.044 . . . . 0.0 110.148 169.399 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 79.1 mtp180 57.07 48.94 14.58 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 124.439 1.087 . . . . 0.0 109.687 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -58.89 140.02 86.62 Favored Pre-proline 0 N--CA 1.498 1.928 0 CA-C-N 114.024 -1.444 . . . . 0.0 110.856 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -66.14 129.18 21.12 Favored 'Trans proline' 0 N--CA 1.492 1.409 0 C-N-CA 122.367 2.045 . . . . 0.0 110.599 -178.998 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 59.3 mttp 62.42 162.69 0.09 Allowed 'General case' 0 N--CA 1.503 2.222 0 O-C-N 124.742 1.276 . . . . 0.0 113.351 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -89.05 168.55 12.24 Favored 'General case' 0 N--CA 1.498 1.937 0 CA-C-N 114.528 -1.215 . . . . 0.0 110.293 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 71.3 m -79.86 163.5 24.32 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.946 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 43.7 m -138.19 7.98 2.68 Favored 'General case' 0 N--CA 1.497 1.91 0 CA-C-N 114.768 -1.106 . . . . 0.0 110.025 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 88.2 mt -79.33 -65.23 1.03 Allowed 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 10.5 m120 56.73 116.34 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 114.911 1.448 . . . . 0.0 114.911 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.408 ' HA ' ' HA ' ' A' ' 4' ' ' CYS . 82.0 m 58.41 122.15 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 116.164 1.913 . . . . 0.0 116.164 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -144.42 90.37 6.6 Favored Pre-proline 0 N--CA 1.496 1.845 0 CA-C-N 114.637 -1.165 . . . . 0.0 109.838 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -57.39 -28.23 79.31 Favored 'Trans proline' 0 N--CA 1.493 1.482 0 C-N-CA 122.805 2.337 . . . . 0.0 113.051 179.372 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 15.5 tpt180 -58.17 -41.06 83.04 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 123.934 0.771 . . . . 0.0 109.476 179.857 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 14.3 mt -70.24 154.57 8.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 CA-C-O 122.121 0.962 . . . . 0.0 110.163 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.446 ' HB2' ' H ' ' A' ' 19' ' ' ASP . . . -121.15 -50.66 2.13 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-N 111.938 -2.392 . . . . 0.0 107.343 179.884 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 19.5 p90 -171.85 164.18 6.39 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-N 114.242 -1.345 . . . . 0.0 111.214 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -104.01 91.36 0.8 Allowed Glycine 0 N--CA 1.492 2.401 0 N-CA-C 107.159 -2.376 . . . . 0.0 107.159 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.1 p -84.25 126.66 40.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 C-N-CA 119.123 -1.031 . . . . 0.0 112.893 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.6 m -79.64 154.0 75.99 Favored Pre-proline 0 N--CA 1.496 1.868 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 179.615 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo . . . . . 0 N--CA 1.494 1.537 0 C-N-CA 122.739 2.292 . . . . 0.0 109.743 -173.167 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.545 ' HA ' ' HA ' ' A' ' 99' ' ' CYS . 1.7 m . . . . . 0 N--CA 1.479 0.997 0 CA-C-O 123.204 1.478 . . . . 0.0 111.607 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 87.0 m -90.52 171.64 9.27 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-N 112.255 -2.248 . . . . 0.0 107.625 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.452 HD21 ' HB3' ' A' ' 67' ' ' ALA . 0.1 OUTLIER -160.37 -162.7 1.0 Allowed 'General case' 0 N--CA 1.5 2.061 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 179.952 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 65' ' ' CYS . . . . . 0.469 ' SG ' ' CD2' ' A' ' 74' ' ' TYR . 3.9 t -107.01 -28.26 10.14 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 124.071 0.857 . . . . 0.0 109.78 179.766 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' CYS . . . . . 0.451 ' SG ' ' CE ' ' A' ' 93' ' ' LYS . 51.0 t -73.88 -57.63 3.85 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 114.918 1.451 . . . . 0.0 114.918 -179.669 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.452 ' HB3' HD21 ' A' ' 64' ' ' ASN . . . -80.75 60.09 3.9 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 124.833 1.333 . . . . 0.0 112.565 -179.782 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -145.57 -139.91 3.45 Favored Glycine 0 N--CA 1.497 2.73 0 N-CA-C 108.253 -1.939 . . . . 0.0 108.253 179.625 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.432 ' C ' ' H ' ' A' ' 71' ' ' GLY . 92.4 m -154.03 150.72 28.54 Favored 'General case' 0 N--CA 1.505 2.319 0 N-CA-C 114.434 1.272 . . . . 0.0 114.434 -179.825 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 24.0 mmtt -72.63 35.87 0.07 Allowed 'General case' 0 N--CA 1.505 2.304 0 CA-C-N 113.042 -1.89 . . . . 0.0 112.689 179.634 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.432 ' H ' ' C ' ' A' ' 69' ' ' THR . . . -131.92 2.52 5.19 Favored Glycine 0 N--CA 1.485 1.923 0 N-CA-C 109.141 -1.584 . . . . 0.0 109.141 179.867 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 94.1 m -141.7 167.01 23.17 Favored 'General case' 0 N--CA 1.497 1.916 0 C-N-CA 119.384 -0.926 . . . . 0.0 111.376 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -119.89 105.45 11.1 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 124.184 0.928 . . . . 0.0 109.67 -179.637 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.648 ' CD2' ' SG ' ' A' ' 83' ' ' CYS . 74.0 m-85 -51.13 135.88 24.81 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 124.047 0.842 . . . . 0.0 110.382 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -146.96 157.22 43.57 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 -179.571 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 42.9 t -110.4 130.99 55.44 Favored 'General case' 0 N--CA 1.501 2.085 0 CA-C-N 113.441 -1.709 . . . . 0.0 113.281 -179.725 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.585 ' H ' ' HB2' ' A' ' 104' ' ' ALA . 7.3 p-10 -46.08 -31.5 2.37 Favored 'General case' 0 N--CA 1.502 2.141 0 CA-C-N 112.562 -2.108 . . . . 0.0 115.349 -179.861 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 39.1 p30 -57.42 -10.09 1.29 Allowed 'General case' 0 N--CA 1.497 1.901 0 O-C-N 124.268 0.98 . . . . 0.0 112.794 -179.833 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 99.1 23.84 11.03 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 110.159 -1.177 . . . . 0.0 110.159 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -131.31 146.87 52.48 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 124.211 0.595 . . . . 0.0 109.631 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 45.1 t80 -77.53 154.92 31.97 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 114.124 -1.398 . . . . 0.0 110.714 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 92.8 t -113.08 -73.45 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 124.19 0.931 . . . . 0.0 112.767 -179.723 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' CYS . . . . . 0.648 ' SG ' ' CD2' ' A' ' 74' ' ' TYR . 29.7 p -157.3 -174.0 4.69 Favored 'General case' 0 N--CA 1.503 2.181 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 -179.585 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -119.43 155.92 31.11 Favored 'General case' 0 N--CA 1.505 2.282 0 CA-C-O 119.003 -0.522 . . . . 0.0 109.793 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.44 ' HA2' ' CE2' ' A' ' 74' ' ' TYR . . . -31.22 111.78 0.05 OUTLIER Glycine 0 N--CA 1.502 3.048 0 O-C-N 124.838 1.337 . . . . 0.0 112.599 179.901 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -100.84 27.54 5.88 Favored 'General case' 0 N--CA 1.498 1.932 0 C-N-CA 119.97 -0.692 . . . . 0.0 109.199 -179.788 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 42.6 t -140.55 95.95 2.95 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-O 121.469 0.652 . . . . 0.0 111.959 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -84.72 148.08 50.58 Favored Pre-proline 0 N--CA 1.496 1.845 0 N-CA-C 106.15 -1.796 . . . . 0.0 106.15 179.717 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.411 ' O ' ' HG3' ' A' ' 90' ' ' ARG . 10.1 Cg_endo -64.67 86.56 0.17 Allowed 'Trans proline' 0 N--CA 1.493 1.447 0 N-CA-C 108.265 -1.475 . . . . 0.0 108.265 165.99 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.411 ' HG3' ' O ' ' A' ' 89' ' ' PRO . 44.2 mtm180 150.82 -27.04 0.01 OUTLIER 'General case' 0 N--CA 1.513 2.693 0 O-C-N 125.741 1.901 . . . . 0.0 109.753 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.446 ' N ' HD21 ' A' ' 91' ' ' ASN . 0.1 OUTLIER -41.51 116.17 1.5 Allowed Pre-proline 0 N--CA 1.501 2.083 0 N-CA-C 114.177 1.177 . . . . 0.0 114.177 -179.713 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -76.62 77.11 3.76 Favored 'Trans proline' 0 N--CA 1.493 1.474 0 C-N-CA 122.721 2.281 . . . . 0.0 109.565 174.423 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.451 ' CE ' ' SG ' ' A' ' 66' ' ' CYS . 21.4 ptmt -167.9 170.46 10.61 Favored 'General case' 0 N--CA 1.498 1.93 0 CA-C-N 114.759 -1.109 . . . . 0.0 110.685 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -160.19 147.42 16.2 Favored 'General case' 0 N--CA 1.497 1.883 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.322 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 58.2 m -153.54 130.31 5.69 Favored Pre-proline 0 N--CA 1.497 1.879 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.379 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -63.51 -78.37 0.01 OUTLIER 'Trans proline' 0 N--CA 1.493 1.489 0 C-N-CA 122.316 2.01 . . . . 0.0 111.511 171.721 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 60.6 mmt-85 -135.68 -44.89 0.67 Allowed 'General case' 0 N--CA 1.499 2.007 0 O-C-N 123.995 0.809 . . . . 0.0 112.432 -179.829 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 8.8 m120 49.44 58.62 5.21 Favored 'General case' 0 N--CA 1.503 2.197 0 O-C-N 124.313 1.008 . . . . 0.0 108.367 -179.864 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.545 ' HA ' ' HA ' ' A' ' 62' ' ' CYS . 37.1 m -35.77 127.57 0.67 Allowed 'General case' 0 N--CA 1.494 1.735 0 CA-C-N 113.573 -1.649 . . . . 0.0 115.25 -179.523 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -129.35 98.78 22.34 Favored Pre-proline 0 N--CA 1.493 1.708 0 CA-C-N 114.25 -1.341 . . . . 0.0 110.268 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -63.85 -12.0 29.61 Favored 'Trans proline' 0 N--CA 1.494 1.522 0 C-N-CA 122.011 1.807 . . . . 0.0 112.166 -178.975 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 80.8 mtm180 -80.28 -30.55 38.32 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 112.675 0.621 . . . . 0.0 112.675 -179.847 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.414 HG12 ' N ' ' A' ' 104' ' ' ALA . 11.8 tt -90.88 164.07 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.164 0 C-N-CA 120.036 -0.665 . . . . 0.0 110.097 -179.864 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.585 ' HB2' ' H ' ' A' ' 77' ' ' ASP . . . -124.15 -59.67 1.47 Allowed 'General case' 0 N--CA 1.496 1.848 0 CA-C-N 114.758 -1.11 . . . . 0.0 108.394 179.826 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 21.7 p90 -161.33 161.79 30.64 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-N 114.631 -1.168 . . . . 0.0 111.03 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -94.95 115.24 5.05 Favored Glycine 0 N--CA 1.492 2.389 0 CA-C-N 113.59 -1.641 . . . . 0.0 111.575 -179.847 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 12.4 pt -83.63 102.44 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.27 0 N-CA-C 105.725 -1.954 . . . . 0.0 105.725 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 13.4 m -79.48 133.04 60.35 Favored Pre-proline 0 N--CA 1.49 1.554 0 CA-C-N 113.8 -1.545 . . . . 0.0 110.295 -179.632 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo . . . . . 0 N--CA 1.492 1.433 0 C-N-CA 122.599 2.199 . . . . 0.0 110.46 -177.127 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 120.945 0.402 . . . . 0.0 109.961 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 93.6 mtt-85 -72.65 138.69 46.85 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.213 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 7.9 tp -83.79 52.92 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 CA-C-N 115.052 -0.976 . . . . 0.0 109.636 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.514 ' HA ' ' HA ' ' A' ' 41' ' ' CYS . 1.5 m -82.72 51.75 1.96 Allowed 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 117.061 2.245 . . . . 0.0 117.061 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 7.2 p -91.75 164.63 13.64 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-N 113.169 -1.832 . . . . 0.0 109.035 179.545 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.464 ' ND2' ' H ' ' A' ' 9' ' ' ALA . 37.7 p-10 -160.88 148.13 15.47 Favored 'General case' 0 N--CA 1.499 1.985 0 C-N-CA 119.917 -0.713 . . . . 0.0 110.058 179.777 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 18.4 t -67.11 -20.24 65.75 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-N 114.864 -1.062 . . . . 0.0 112.892 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 43.7 t -81.34 -64.46 1.18 Allowed 'General case' 0 N--CA 1.497 1.878 0 O-C-N 123.607 0.567 . . . . 0.0 112.128 -179.713 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.464 ' H ' ' ND2' ' A' ' 6' ' ' ASN . . . -89.22 45.12 1.26 Allowed 'General case' 0 N--CA 1.5 2.044 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.896 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -84.17 -147.13 7.93 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 110.337 -1.105 . . . . 0.0 110.337 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 40.4 p -137.62 95.29 3.03 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.11 112.98 0.81 Allowed 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 144.97 -34.58 1.55 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 108.301 -1.92 . . . . 0.0 108.301 -179.739 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 35.4 m -106.09 130.29 54.02 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -83.11 91.61 7.25 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 113.627 -1.624 . . . . 0.0 110.132 -179.675 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.409 ' N ' ' O ' ' A' ' 25' ' ' CYS . 39.8 m-85 -50.09 122.1 6.32 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-N 114.028 -1.442 . . . . 0.0 109.081 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -132.44 153.32 50.97 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-N 112.316 -2.22 . . . . 0.0 110.643 -179.67 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 31.2 t -99.15 141.18 32.25 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-N 111.679 -2.509 . . . . 0.0 115.628 -179.548 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -52.17 -25.05 8.1 Favored 'General case' 0 N--CA 1.499 1.983 0 CA-C-N 111.002 -2.817 . . . . 0.0 113.269 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 52.5 p-10 -62.59 -4.79 2.16 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 124.092 0.87 . . . . 0.0 111.609 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 88.92 30.15 15.72 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 108.781 -1.728 . . . . 0.0 108.781 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 87.0 m -141.66 146.87 36.65 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 124.087 0.522 . . . . 0.0 110.585 -179.764 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 39.9 t80 -73.02 162.81 29.05 Favored 'General case' 0 N--CA 1.496 1.827 0 CA-C-N 114.35 -1.296 . . . . 0.0 110.04 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 58.7 t -127.56 -79.44 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 CA-C-N 115.282 -0.872 . . . . 0.0 108.991 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.57 ' SG ' ' N ' ' A' ' 26' ' ' GLU . 0.1 OUTLIER -156.99 -170.47 3.3 Favored 'General case' 0 N--CA 1.504 2.258 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 179.971 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.57 ' N ' ' SG ' ' A' ' 25' ' ' CYS . 37.6 tt0 -118.64 154.29 32.91 Favored 'General case' 0 N--CA 1.503 2.214 0 N-CA-C 106.079 -1.823 . . . . 0.0 106.079 179.444 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -50.15 116.9 4.38 Favored Glycine 0 N--CA 1.498 2.791 0 C-N-CA 120.088 -1.053 . . . . 0.0 112.721 -179.781 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -79.66 -17.2 54.24 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 41.1 t -112.38 112.96 24.9 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.646 ' H ' HD21 ' A' ' 33' ' ' ASN . 16.0 t0 -79.38 138.55 55.56 Favored Pre-proline 0 N--CA 1.494 1.735 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_endo -65.48 75.22 0.27 Allowed 'Trans proline' 0 N--CA 1.498 1.746 0 C-N-CA 122.705 2.27 . . . . 0.0 106.577 161.509 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 43.1 ttp85 -173.0 -53.43 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 104.982 -2.229 . . . . 0.0 104.982 -179.604 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.646 HD21 ' H ' ' A' ' 30' ' ' ASP . 25.9 p30 -90.7 156.44 44.95 Favored Pre-proline 0 N--CA 1.494 1.759 0 CA-C-N 114.638 -1.165 . . . . 0.0 110.978 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -71.54 177.16 7.11 Favored 'Trans proline' 0 N--CA 1.493 1.469 0 C-N-CA 122.643 2.229 . . . . 0.0 110.311 168.004 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.439 ' HD2' ' N ' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -161.41 153.07 19.15 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.247 179.983 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -148.12 62.37 1.11 Allowed 'General case' 0 N--CA 1.495 1.819 0 CA-C-N 115.067 -0.969 . . . . 0.0 109.127 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 72.4 m -79.57 -50.48 10.64 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-N 114.388 -1.278 . . . . 0.0 109.358 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 26.3 m 64.31 -9.12 0.17 Allowed 'General case' 0 N--CA 1.503 2.176 0 O-C-N 124.781 1.301 . . . . 0.0 113.448 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.441 ' HG ' ' H ' ' A' ' 40' ' ' ASN . 2.1 pp -79.56 -55.59 4.92 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 120.251 -0.58 . . . . 0.0 109.559 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.441 ' H ' ' HG ' ' A' ' 39' ' ' LEU . 33.6 m120 47.42 -177.77 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 115.927 1.825 . . . . 0.0 115.927 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.514 ' HA ' ' HA ' ' A' ' 4' ' ' CYS . 58.1 m 48.63 119.36 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 116.667 2.099 . . . . 0.0 116.667 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 60.1 t0 -152.16 94.97 3.21 Favored Pre-proline 0 N--CA 1.489 1.517 0 CA-C-N 113.789 -1.55 . . . . 0.0 108.46 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -53.63 -17.86 10.69 Favored 'Trans proline' 0 N--CA 1.495 1.591 0 C-N-CA 122.896 2.398 . . . . 0.0 113.046 178.61 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 10.9 tpt180 -59.06 -50.82 72.61 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.44 ' CG2' ' N ' ' A' ' 46' ' ' ALA . 2.0 mp -62.89 159.2 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 CA-C-O 122.623 1.201 . . . . 0.0 112.264 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.44 ' N ' ' CG2' ' A' ' 45' ' ' ILE . . . -127.29 -48.63 1.44 Allowed 'General case' 0 N--CA 1.492 1.641 0 CA-C-N 111.33 -2.668 . . . . 0.0 106.267 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 51.8 p90 -166.23 -163.42 0.6 Allowed 'General case' 0 N--CA 1.495 1.817 0 CA-C-N 113.637 -1.619 . . . . 0.0 107.373 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -145.83 113.15 0.67 Allowed Glycine 0 N--CA 1.495 2.567 0 N-CA-C 108.621 -1.791 . . . . 0.0 108.621 179.736 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.7 p -79.77 105.91 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 N-CA-C 114.284 1.216 . . . . 0.0 114.284 -179.834 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.7 m -81.81 117.45 68.35 Favored Pre-proline 0 N--CA 1.5 2.068 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 179.483 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -67.65 150.26 79.48 Favored 'Trans proline' 0 N--CA 1.494 1.531 0 C-N-CA 122.05 1.833 . . . . 0.0 110.623 178.383 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.485 ' NE ' ' HA ' ' A' ' 52' ' ' ARG . 6.5 tpm_? -152.92 -66.83 0.16 Allowed 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 22.9 t 52.91 42.27 32.05 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 124.335 1.022 . . . . 0.0 112.313 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -168.39 8.09 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.105 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.996 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -55.81 -42.51 75.77 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 123.776 0.672 . . . . 0.0 110.109 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -73.71 177.37 5.5 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-N 114.867 -1.06 . . . . 0.0 110.714 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 61.6 tttp 51.79 78.2 0.13 Allowed 'General case' 0 N--CA 1.499 1.995 0 O-C-N 124.314 1.009 . . . . 0.0 110.412 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 11.5 p-10 -161.6 -39.82 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.78 0 CA-C-N 113.868 -1.514 . . . . 0.0 108.995 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -72.88 -46.25 53.84 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-N 114.575 -1.193 . . . . 0.0 108.834 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 28.3 mmt85 7.29 -73.59 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.241 0 O-C-N 126.013 2.071 . . . . 0.0 116.471 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 10.3 tp -82.99 50.49 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 123.839 0.712 . . . . 0.0 110.926 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.501 ' HA ' ' HA ' ' A' ' 99' ' ' CYS . 1.6 m -81.44 29.88 0.36 Allowed 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 115.916 1.821 . . . . 0.0 115.916 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -91.59 148.0 22.6 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-N 112.272 -2.24 . . . . 0.0 107.353 179.512 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.419 ' HB3' ' H ' ' A' ' 100' ' ' ASP . 15.2 p30 -162.05 147.78 13.2 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 114.469 1.285 . . . . 0.0 114.469 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -63.25 -20.67 65.66 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-N 114.351 -1.295 . . . . 0.0 112.582 179.621 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 41.8 t -90.65 -74.78 0.48 Allowed 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -89.5 35.57 0.82 Allowed 'General case' 0 N--CA 1.497 1.895 0 CA-C-N 114.433 -1.258 . . . . 0.0 113.139 -179.518 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.415 ' HA3' ' CZ ' ' A' ' 74' ' ' TYR . . . -81.04 -112.34 0.32 Allowed Glycine 0 N--CA 1.494 2.531 0 N-CA-C 109.135 -1.586 . . . . 0.0 109.135 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.54 ' H ' ' HA3' ' A' ' 85' ' ' GLY . 38.2 p -153.7 123.03 6.58 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 179.671 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -70.21 93.87 0.87 Allowed 'General case' 0 N--CA 1.502 2.125 0 CA-C-O 122.089 0.947 . . . . 0.0 109.516 179.766 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 162.99 -27.21 0.23 Allowed Glycine 0 N--CA 1.487 2.058 0 CA-C-N 113.107 -1.86 . . . . 0.0 109.947 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 36.1 m -108.8 141.65 40.51 Favored 'General case' 0 N--CA 1.497 1.902 0 C-N-CA 120.024 -0.67 . . . . 0.0 110.209 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.471 ' HB3' ' CE1' ' A' ' 81' ' ' PHE . 58.6 mtpt -83.7 89.11 7.09 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 113.726 -1.579 . . . . 0.0 109.683 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.415 ' CZ ' ' HA3' ' A' ' 68' ' ' GLY . 27.7 m-85 -59.56 116.45 4.01 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 106.13 -1.804 . . . . 0.0 106.13 179.734 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -121.14 146.86 46.32 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 111.483 -2.599 . . . . 0.0 112.516 -179.449 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.416 ' CB ' ' HE ' ' A' ' 102' ' ' ARG . 32.0 t -91.31 144.23 25.81 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-N 112.363 -2.199 . . . . 0.0 116.312 -179.586 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -53.09 -21.16 4.39 Favored 'General case' 0 N--CA 1.497 1.901 0 CA-C-N 110.603 -2.999 . . . . 0.0 113.322 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 18.4 p30 -66.77 -0.15 2.79 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 124.183 0.927 . . . . 0.0 110.773 179.671 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 83.48 29.83 31.84 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 93.6 m -142.83 142.86 31.91 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 120.394 -0.522 . . . . 0.0 110.939 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.471 ' CE1' ' HB3' ' A' ' 73' ' ' LYS . 9.7 t80 -73.93 143.41 45.72 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-N 114.373 -1.285 . . . . 0.0 109.705 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 67.6 t -104.58 -77.91 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -166.97 172.85 9.83 Favored 'General case' 0 N--CA 1.503 2.219 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 179.733 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.456 ' HG2' ' N ' ' A' ' 85' ' ' GLY . 22.7 tt0 -79.64 150.22 31.03 Favored 'General case' 0 N--CA 1.501 2.085 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 179.705 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.54 ' HA3' ' H ' ' A' ' 69' ' ' THR . . . -65.74 127.67 31.27 Favored Glycine 0 N--CA 1.494 2.522 0 N-CA-C 104.251 -3.54 . . . . 0.0 104.251 179.721 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -93.75 23.42 4.77 Favored 'General case' 0 N--CA 1.497 1.905 0 CA-C-N 118.049 0.924 . . . . 0.0 113.337 -179.488 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 25.1 t -84.26 98.53 10.03 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-N 114.529 -1.214 . . . . 0.0 108.288 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -79.86 155.37 75.46 Favored Pre-proline 0 N--CA 1.496 1.834 0 N-CA-C 107.529 -1.285 . . . . 0.0 107.529 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo -38.58 108.21 0.07 OUTLIER 'Trans proline' 0 N--CA 1.493 1.483 0 C-N-CA 122.386 2.057 . . . . 0.0 112.147 162.659 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER 59.06 50.89 7.63 Favored 'General case' 0 N--CA 1.497 1.92 0 CA-C-N 114.676 -1.147 . . . . 0.0 110.876 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.676 ' H ' HD22 ' A' ' 91' ' ' ASN . 0.5 OUTLIER -79.43 119.61 77.56 Favored Pre-proline 0 N--CA 1.497 1.875 0 CA-C-N 113.898 -1.501 . . . . 0.0 111.878 -179.96 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -79.87 79.36 3.37 Favored 'Trans proline' 0 N--CA 1.493 1.474 0 C-N-CA 123.093 2.529 . . . . 0.0 109.986 172.651 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 14.1 ptmm? -166.06 144.56 5.79 Favored 'General case' 0 N--CA 1.5 2.029 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.721 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -160.12 103.29 1.46 Allowed 'General case' 0 N--CA 1.496 1.854 0 CA-C-N 114.649 -1.16 . . . . 0.0 108.575 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 35.1 m -79.77 168.67 24.51 Favored Pre-proline 0 N--CA 1.498 1.959 0 CA-C-N 115.122 -0.944 . . . . 0.0 109.297 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -57.91 -5.7 2.14 Favored 'Trans proline' 0 N--CA 1.496 1.672 0 C-N-CA 122.292 1.995 . . . . 0.0 112.404 162.693 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 35.2 mmt180 -79.52 7.26 8.51 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 123.49 0.494 . . . . 0.0 111.828 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -50.03 117.39 2.3 Favored 'General case' 0 N--CA 1.503 2.196 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.501 ' HA ' ' HA ' ' A' ' 62' ' ' CYS . 91.4 m 56.07 65.38 1.46 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 124.538 1.149 . . . . 0.0 108.048 -179.572 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.419 ' H ' ' HB3' ' A' ' 64' ' ' ASN . 18.9 t70 -62.35 109.55 2.45 Favored Pre-proline 0 N--CA 1.498 1.926 0 CA-C-N 114.356 -1.293 . . . . 0.0 112.287 -179.582 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -69.44 -34.75 14.98 Favored 'Trans proline' 0 N--CA 1.493 1.463 0 C-N-CA 122.049 1.833 . . . . 0.0 109.783 -174.806 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.416 ' HE ' ' CB ' ' A' ' 76' ' ' SER . 0.0 OUTLIER -63.48 -21.37 66.28 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-N 114.447 -1.252 . . . . 0.0 111.659 -179.96 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 4.4 tp -76.49 177.7 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 C-N-CA 119.218 -0.993 . . . . 0.0 108.403 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -130.37 -61.32 0.97 Allowed 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 -147.73 -161.61 1.37 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 124.48 1.113 . . . . 0.0 109.042 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -142.35 95.13 0.19 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 106.016 -2.834 . . . . 0.0 106.016 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 42.5 mm -78.72 98.86 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 N-CA-C 113.792 1.034 . . . . 0.0 113.792 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 1.6 m -79.52 153.63 76.19 Favored Pre-proline 0 N--CA 1.501 2.091 0 CA-C-N 114.952 -1.022 . . . . 0.0 108.262 179.499 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -64.75 119.79 6.91 Favored 'Trans proline' 0 N--CA 1.494 1.502 0 C-N-CA 122.542 2.162 . . . . 0.0 109.942 179.445 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.4 tt -79.87 98.41 7.09 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 1.876 0 CA-C-O 116.847 -1.549 . . . . 0.0 110.689 179.948 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 . . . . . 0 N--CA 1.491 1.607 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 61.7 ttm-85 -90.25 62.88 5.56 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.405 HG22 ' H ' ' A' ' 3' ' ' ILE . 6.0 tp -79.85 71.88 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 CA-C-N 114.399 -1.273 . . . . 0.0 110.038 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.6 m -89.97 57.47 3.82 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 122.849 1.309 . . . . 0.0 114.159 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.446 ' O ' ' N ' ' A' ' 42' ' ' ASP . 1.1 p -90.06 157.05 17.97 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 104.275 -2.491 . . . . 0.0 104.275 179.204 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.424 ' HB3' ' H ' ' A' ' 9' ' ' ALA . 6.7 t-20 -160.77 -177.3 6.06 Favored 'General case' 0 N--CA 1.5 2.036 0 C-N-CA 118.149 -1.42 . . . . 0.0 112.083 -179.684 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.476 ' SG ' ' CD2' ' A' ' 16' ' ' TYR . 1.8 t -76.78 -32.98 58.04 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-N 113.328 -1.76 . . . . 0.0 107.115 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 34.1 t -82.12 -57.57 3.34 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-N 112.003 -2.362 . . . . 0.0 107.609 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.424 ' H ' ' HB3' ' A' ' 6' ' ' ASN . . . -57.56 -23.43 50.5 Favored 'General case' 0 N--CA 1.497 1.912 0 CA-C-N 114.484 -1.235 . . . . 0.0 110.77 179.85 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -71.41 -168.09 8.79 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 110.756 -0.938 . . . . 0.0 110.756 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 41.1 p -104.71 103.19 12.78 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.462 ' HA ' ' CA ' ' A' ' 27' ' ' GLY . 39.1 ttpt -48.16 104.97 0.07 Allowed 'General case' 0 N--CA 1.5 2.048 0 O-C-N 123.737 0.648 . . . . 0.0 111.322 179.673 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 149.69 -20.42 1.15 Allowed Glycine 0 N--CA 1.491 2.36 0 CA-C-N 114.364 -1.289 . . . . 0.0 111.033 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 96.2 m -107.41 149.45 27.88 Favored 'General case' 0 N--CA 1.499 2.023 0 C-N-CA 120.316 -0.554 . . . . 0.0 112.069 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -83.13 93.71 7.68 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-N 114.273 -1.33 . . . . 0.0 107.754 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.476 ' CD2' ' SG ' ' A' ' 7' ' ' CYS . 48.6 m-85 -52.76 130.07 31.69 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-N 113.997 -1.456 . . . . 0.0 109.027 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -143.47 155.03 44.25 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-N 113.174 -1.83 . . . . 0.0 112.339 -179.438 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 38.3 t -101.37 136.01 41.92 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-N 112.449 -2.16 . . . . 0.0 112.577 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.473 ' H ' ' HB2' ' A' ' 46' ' ' ALA . 5.6 p-10 -50.04 -25.11 3.08 Favored 'General case' 0 N--CA 1.502 2.129 0 CA-C-N 112.626 -2.079 . . . . 0.0 114.186 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 27.4 p30 -59.69 -7.49 1.58 Allowed 'General case' 0 N--CA 1.498 1.952 0 O-C-N 124.228 0.955 . . . . 0.0 112.288 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 94.25 28.36 10.82 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 88.5 m -141.43 142.79 33.67 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 124.149 0.558 . . . . 0.0 110.144 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.408 ' CG ' ' N ' ' A' ' 24' ' ' VAL . 40.5 t80 -68.79 166.93 16.52 Favored 'General case' 0 N--CA 1.497 1.878 0 CA-C-N 114.194 -1.366 . . . . 0.0 110.82 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.408 ' N ' ' CG ' ' A' ' 23' ' ' PHE . 97.5 t -128.89 -72.31 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 123.996 0.81 . . . . 0.0 111.82 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.462 ' SG ' ' HD2' ' A' ' 16' ' ' TYR . 20.8 p -154.31 -168.6 2.98 Favored 'General case' 0 N--CA 1.503 2.199 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 -179.745 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 60.5 tt0 -139.66 151.12 45.69 Favored 'General case' 0 N--CA 1.501 2.096 0 CA-C-O 121.446 0.641 . . . . 0.0 111.369 179.752 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.462 ' CA ' ' HA ' ' A' ' 12' ' ' LYS . . . -7.25 103.71 0.01 OUTLIER Glycine 0 N--CA 1.497 2.716 0 N-CA-C 119.333 2.493 . . . . 0.0 119.333 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -99.48 -52.25 3.54 Favored 'General case' 0 N--CA 1.501 2.112 0 C-N-CA 119.71 -0.796 . . . . 0.0 110.355 179.715 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.425 ' CA ' ' HB2' ' A' ' 12' ' ' LYS . 6.5 p -149.83 142.18 24.24 Favored 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.419 ' HB2' ' HB3' ' A' ' 12' ' ' LYS . 10.5 t70 -101.88 144.85 29.4 Favored Pre-proline 0 N--CA 1.498 1.943 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_exo -45.12 -25.2 1.69 Allowed 'Trans proline' 0 N--CA 1.498 1.778 0 C-N-CA 122.918 2.412 . . . . 0.0 112.868 170.087 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.437 ' NE ' ' HA ' ' A' ' 32' ' ' ARG . 3.6 tpm_? -62.9 -53.45 54.0 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -85.65 129.41 54.95 Favored Pre-proline 0 N--CA 1.494 1.73 0 CA-C-N 115.133 -0.94 . . . . 0.0 109.221 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -65.38 108.2 1.14 Allowed 'Trans proline' 0 N--CA 1.493 1.5 0 C-N-CA 122.317 2.011 . . . . 0.0 109.471 -179.7 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.504 ' HD3' ' H ' ' A' ' 36' ' ' ALA . 6.1 tmtt? -154.53 142.12 19.81 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.504 ' H ' ' HD3' ' A' ' 35' ' ' LYS . . . -149.3 111.07 4.54 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-N 113.382 -1.736 . . . . 0.0 107.644 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.461 ' H ' HD21 ' A' ' 40' ' ' ASN . 70.3 m -79.96 -168.73 1.73 Allowed 'General case' 0 N--CA 1.495 1.815 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.104 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 9.2 t -104.94 13.84 30.4 Favored 'General case' 0 N--CA 1.497 1.911 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.351 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -160.38 64.66 0.33 Allowed 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.461 HD21 ' H ' ' A' ' 37' ' ' CYS . 12.0 m120 -88.65 46.15 1.36 Allowed 'General case' 0 N--CA 1.498 1.939 0 CA-C-N 114.292 -1.322 . . . . 0.0 111.172 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 80.4 m -145.16 139.29 27.16 Favored 'General case' 0 N--CA 1.499 2.02 0 CA-C-N 115.014 -0.993 . . . . 0.0 108.547 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.446 ' N ' ' O ' ' A' ' 5' ' ' THR . 34.2 t70 -166.2 88.35 0.87 Allowed Pre-proline 0 N--CA 1.497 1.896 0 O-C-N 123.794 0.684 . . . . 0.0 110.207 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_exo -53.53 -15.29 5.98 Favored 'Trans proline' 0 N--CA 1.495 1.617 0 C-N-CA 122.466 2.111 . . . . 0.0 112.961 173.667 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 41.5 ttm180 -76.89 -39.06 52.31 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 113.302 0.853 . . . . 0.0 113.302 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 7.6 tt -75.8 142.9 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.175 0 C-N-CA 118.746 -1.181 . . . . 0.0 111.714 -179.62 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.473 ' HB2' ' H ' ' A' ' 19' ' ' ASP . . . -104.84 -49.84 3.41 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-N 113.638 -1.619 . . . . 0.0 107.737 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 52.1 p90 -163.52 -163.07 0.78 Allowed 'General case' 0 N--CA 1.496 1.868 0 CA-C-N 114.07 -1.423 . . . . 0.0 107.423 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -144.98 122.27 1.7 Allowed Glycine 0 N--CA 1.494 2.549 0 N-CA-C 109.13 -1.588 . . . . 0.0 109.13 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.6 p -88.69 108.75 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 CA-C-O 121.545 0.688 . . . . 0.0 112.799 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.7 m -79.78 137.13 54.46 Favored Pre-proline 0 N--CA 1.499 1.987 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.218 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -64.18 -29.97 64.76 Favored 'Trans proline' 0 N--CA 1.494 1.507 0 C-N-CA 122.376 2.051 . . . . 0.0 110.063 177.292 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 11.1 mmm180 -110.49 37.19 2.82 Favored 'General case' 0 N--CA 1.495 1.789 0 CA-C-N 114.734 -1.121 . . . . 0.0 110.086 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 41.2 t -68.45 101.03 1.17 Allowed 'General case' 0 N--CA 1.496 1.829 0 CA-C-N 115.318 -0.855 . . . . 0.0 109.012 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -70.92 146.29 49.63 Favored 'General case' 0 N--CA 1.494 1.766 0 CA-C-N 115.486 -0.779 . . . . 0.0 112.154 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -122.87 -17.59 6.75 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-N 113.165 -1.834 . . . . 0.0 107.502 179.694 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 6.1 mtpm? -55.14 -67.95 0.23 Allowed 'General case' 0 N--CA 1.492 1.672 0 CA-C-N 114.26 -1.337 . . . . 0.0 111.627 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.421 ' HE2' ' HA ' ' A' ' 57' ' ' LYS . 7.1 mmpt? 65.62 147.57 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.168 0 O-C-N 125.04 1.462 . . . . 0.0 110.023 -179.802 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 11.9 m120 64.48 -78.76 0.03 OUTLIER 'General case' 0 N--CA 1.504 2.243 0 O-C-N 124.124 0.89 . . . . 0.0 109.791 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 22.8 t70 61.98 166.67 0.11 Allowed 'General case' 0 N--CA 1.5 2.064 0 N-CA-C 113.091 0.775 . . . . 0.0 113.091 179.753 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 5.1 tpp180 -60.84 151.22 30.46 Favored 'General case' 0 N--CA 1.496 1.847 0 CA-C-N 114.752 -1.113 . . . . 0.0 109.972 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 5.7 tp -57.69 85.39 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 124.667 1.229 . . . . 0.0 111.97 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.696 ' HA ' ' HA ' ' A' ' 99' ' ' CYS . 1.7 m -93.26 33.92 1.18 Allowed 'General case' 0 N--CA 1.49 1.572 0 CA-C-O 123.916 1.817 . . . . 0.0 115.453 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 61.2 m -91.42 139.86 30.32 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 110.399 -3.091 . . . . 0.0 103.189 179.247 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 38.1 p-10 -160.81 161.32 31.96 Favored 'General case' 0 N--CA 1.497 1.898 0 C-N-CA 119.771 -0.772 . . . . 0.0 112.988 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 1.3 t -55.75 -23.22 28.15 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-N 113.511 -1.677 . . . . 0.0 112.227 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 52.8 t -89.38 -70.46 0.66 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 124.146 0.904 . . . . 0.0 110.502 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.441 ' HB2' ' SG ' ' A' ' 95' ' ' CYS . . . -90.18 62.15 5.38 Favored 'General case' 0 N--CA 1.499 2.007 0 CA-C-O 121.633 0.73 . . . . 0.0 109.497 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -113.19 -137.59 6.85 Favored Glycine 0 N--CA 1.493 2.481 0 CA-C-N 114.396 -1.274 . . . . 0.0 111.478 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.436 ' N ' ' HA3' ' A' ' 85' ' ' GLY . 37.7 p -128.44 117.61 21.67 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-N 114.494 -0.853 . . . . 0.0 109.464 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 61.5 mtpt -69.65 86.91 0.48 Allowed 'General case' 0 N--CA 1.498 1.967 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.018 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 164.75 -31.02 0.24 Allowed Glycine 0 N--CA 1.489 2.196 0 CA-C-N 114.095 -1.412 . . . . 0.0 110.613 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 74.6 m -105.12 131.71 52.27 Favored 'General case' 0 N--CA 1.5 2.034 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.8 mppt? -83.98 87.48 7.12 Favored 'General case' 0 N--CA 1.484 1.254 0 O-C-N 124.808 1.318 . . . . 0.0 110.398 -179.51 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 8.9 m-30 -51.84 129.43 26.59 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -133.03 157.26 45.67 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-N 113.433 -1.712 . . . . 0.0 111.79 -179.34 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 44.3 t -102.36 136.58 41.94 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-N 113.157 -1.838 . . . . 0.0 112.867 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 8.6 p30 -53.11 -23.57 8.29 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 115.538 1.681 . . . . 0.0 115.538 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 18.7 p-10 -62.61 -7.45 4.76 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 123.704 0.628 . . . . 0.0 111.024 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 94.49 29.96 9.0 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 108.507 -1.837 . . . . 0.0 108.507 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 46.1 m -133.97 135.93 43.81 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 124.162 0.566 . . . . 0.0 110.204 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.484 ' CZ ' ' HA ' ' A' ' 83' ' ' CYS . 8.0 t80 -76.02 141.63 42.07 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-N 114.703 -1.135 . . . . 0.0 108.776 179.787 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 45.5 t -97.29 -78.38 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' CYS . . . . . 0.484 ' HA ' ' CZ ' ' A' ' 81' ' ' PHE . 0.1 OUTLIER -178.5 171.67 1.54 Allowed 'General case' 0 N--CA 1.505 2.308 0 O-C-N 123.51 0.507 . . . . 0.0 110.005 179.705 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.408 ' O ' ' SG ' ' A' ' 83' ' ' CYS . 39.9 tt0 -86.07 150.93 24.1 Favored 'General case' 0 N--CA 1.503 2.203 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 179.747 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.436 ' HA3' ' N ' ' A' ' 69' ' ' THR . . . -53.25 133.58 41.97 Favored Glycine 0 N--CA 1.5 2.945 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -99.81 29.18 4.28 Favored 'General case' 0 N--CA 1.502 2.15 0 CA-C-O 121.892 0.853 . . . . 0.0 109.445 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 44.9 t -146.38 131.73 18.57 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 107.532 -1.285 . . . . 0.0 107.532 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.909 ' HB3' HD22 ' A' ' 91' ' ' ASN . 2.4 t70 -79.38 136.16 56.72 Favored Pre-proline 0 N--CA 1.493 1.71 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_endo -67.95 70.93 0.82 Allowed 'Trans proline' 0 N--CA 1.5 1.872 0 C-N-CA 123.688 2.925 . . . . 0.0 113.554 -176.346 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 82.8 mtt85 -162.88 -51.7 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 103.74 -2.689 . . . . 0.0 103.74 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.909 HD22 ' HB3' ' A' ' 88' ' ' ASP . 2.3 p30 -91.09 116.0 65.51 Favored Pre-proline 0 N--CA 1.493 1.719 0 CA-C-N 113.275 -1.784 . . . . 0.0 110.748 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -78.17 93.76 1.09 Allowed 'Trans proline' 0 N--CA 1.492 1.398 0 C-N-CA 122.694 2.262 . . . . 0.0 110.041 173.366 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 44.7 mmtm -70.67 127.48 32.82 Favored 'General case' 0 N--CA 1.497 1.909 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.707 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -85.33 79.37 9.52 Favored 'General case' 0 N--CA 1.495 1.788 0 CA-C-N 114.666 -1.152 . . . . 0.0 108.941 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' CYS . . . . . 0.441 ' SG ' ' HB2' ' A' ' 67' ' ' ALA . 88.5 m -79.66 146.83 65.89 Favored Pre-proline 0 N--CA 1.494 1.764 0 CA-C-N 114.504 -1.225 . . . . 0.0 111.364 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -73.9 -4.35 15.28 Favored 'Trans proline' 0 N--CA 1.493 1.451 0 C-N-CA 122.891 2.394 . . . . 0.0 110.586 165.393 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 23.0 tpp180 -79.1 -54.78 5.65 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 19.8 m120 52.24 -161.14 0.1 Allowed 'General case' 0 N--CA 1.501 2.118 0 O-C-N 124.401 1.063 . . . . 0.0 111.549 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.696 ' HA ' ' HA ' ' A' ' 62' ' ' CYS . 5.2 m -36.67 110.06 0.11 Allowed 'General case' 0 N--CA 1.5 2.045 0 N-CA-C 113.909 1.078 . . . . 0.0 113.909 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 20.5 t0 -91.22 111.85 50.87 Favored Pre-proline 0 N--CA 1.494 1.727 0 CA-C-N 113.843 -1.526 . . . . 0.0 110.564 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -64.7 -21.92 64.66 Favored 'Trans proline' 0 N--CA 1.494 1.522 0 C-N-CA 121.848 1.699 . . . . 0.0 110.312 -179.274 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 27.6 ttm-85 -82.27 -23.51 35.24 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 113.952 1.093 . . . . 0.0 113.952 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 12.2 tt -70.19 142.38 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 C-N-CA 117.835 -1.546 . . . . 0.0 110.21 -179.761 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -131.78 -43.77 0.99 Allowed 'General case' 0 N--CA 1.494 1.734 0 CA-C-N 114.486 -1.234 . . . . 0.0 109.748 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 49.8 m-85 -141.23 -164.12 1.69 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 124.398 1.061 . . . . 0.0 109.387 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -153.87 108.69 0.38 Allowed Glycine 0 N--CA 1.492 2.408 0 N-CA-C 106.582 -2.607 . . . . 0.0 106.582 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 50.4 mm -80.6 84.11 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 27.0 m -80.99 149.44 66.76 Favored Pre-proline 0 N--CA 1.494 1.755 0 CA-C-N 114.101 -1.408 . . . . 0.0 108.848 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -66.32 -21.3 54.51 Favored 'Trans proline' 0 N--CA 1.495 1.594 0 C-N-CA 122.71 2.273 . . . . 0.0 110.859 175.09 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.458 HD23 ' N ' ' A' ' 110' ' ' LEU . 2.0 pt? -159.96 167.76 27.24 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 124.156 0.91 . . . . 0.0 110.147 -180.0 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.826 0 CA-C-O 116.37 -1.776 . . . . 0.0 110.901 179.887 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 119.549 -0.262 . . . . 0.0 110.814 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 2.7 tmt_? 76.92 -65.8 0.27 Allowed 'General case' 0 N--CA 1.504 2.274 0 O-C-N 125.263 1.602 . . . . 0.0 108.377 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.6 tp -55.44 137.02 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 123.626 0.579 . . . . 0.0 112.123 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.472 ' HA ' ' HA ' ' A' ' 41' ' ' CYS . 1.5 m -140.61 57.88 1.57 Allowed 'General case' 0 C--N 1.31 -1.128 0 CA-C-O 122.797 1.284 . . . . 0.0 114.444 179.615 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 7.1 t -90.73 161.1 15.49 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-N 113.322 -1.763 . . . . 0.0 106.746 179.579 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 10.5 p-10 -161.1 151.84 18.24 Favored 'General case' 0 N--CA 1.499 2.02 0 C-N-CA 120.118 -0.633 . . . . 0.0 111.693 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.45 ' HA ' ' CE2' ' A' ' 16' ' ' TYR . 19.6 t -57.68 -38.03 74.46 Favored 'General case' 0 N--CA 1.497 1.914 0 CA-C-N 114.639 -1.164 . . . . 0.0 113.303 -179.721 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 46.4 t -61.99 -51.59 67.41 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 125.336 1.647 . . . . 0.0 110.721 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -51.6 -26.08 8.14 Favored 'General case' 0 N--CA 1.503 2.224 0 O-C-N 124.945 1.403 . . . . 0.0 110.376 179.824 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.407 ' HA3' ' N ' ' A' ' 29' ' ' SER . . . 63.23 161.06 0.28 Allowed Glycine 0 N--CA 1.479 1.558 0 CA-C-N 114.618 -1.174 . . . . 0.0 115.891 179.529 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.456 ' H ' ' HA3' ' A' ' 27' ' ' GLY . 99.5 m -153.11 53.87 0.76 Allowed 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 104.576 -2.379 . . . . 0.0 104.576 179.741 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 63.4 pttt 41.67 -146.11 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.065 0 CA-C-N 114.203 -1.362 . . . . 0.0 112.409 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -70.23 26.69 0.44 Allowed Glycine 0 N--CA 1.494 2.501 0 CA-C-N 114.886 -1.052 . . . . 0.0 114.252 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 88.4 m -105.42 120.99 42.98 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 107.097 -1.445 . . . . 0.0 107.097 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.425 ' HA ' ' HA ' ' A' ' 26' ' ' GLU . 63.0 mtpt -64.92 100.34 0.41 Allowed 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 113.027 -1.897 . . . . 0.0 113.962 -179.666 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.45 ' CE2' ' HA ' ' A' ' 7' ' ' CYS . 8.8 m-85 -48.3 128.59 14.59 Favored 'General case' 0 N--CA 1.505 2.316 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 179.48 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -144.3 153.03 41.59 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 115.079 -0.964 . . . . 0.0 113.047 -179.349 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 34.2 t -99.08 134.78 41.43 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-N 112.599 -2.091 . . . . 0.0 112.659 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -50.14 -24.87 3.03 Favored 'General case' 0 N--CA 1.502 2.168 0 CA-C-N 112.713 -2.039 . . . . 0.0 114.009 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 29.7 p30 -59.81 -8.01 1.93 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 124.144 0.902 . . . . 0.0 112.276 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 95.08 29.2 9.2 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 86.9 m -141.91 143.23 33.18 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 124.078 0.517 . . . . 0.0 111.233 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 20.0 t80 -68.96 161.28 29.21 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-N 114.042 -1.435 . . . . 0.0 110.318 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 88.2 t -126.71 -71.29 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 CA-C-N 114.995 -1.002 . . . . 0.0 109.443 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.589 ' SG ' ' N ' ' A' ' 26' ' ' GLU . 0.3 OUTLIER -151.57 -166.67 2.58 Favored 'General case' 0 N--CA 1.5 2.049 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 179.998 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.589 ' N ' ' SG ' ' A' ' 25' ' ' CYS . 2.1 tm-20 -121.07 147.4 45.57 Favored 'General case' 0 N--CA 1.501 2.116 0 N-CA-C 106.374 -1.713 . . . . 0.0 106.374 179.565 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.456 ' HA3' ' H ' ' A' ' 11' ' ' THR . . . -55.1 109.8 1.46 Allowed Glycine 0 N--CA 1.501 2.972 0 N-CA-C 110.358 -1.097 . . . . 0.0 110.358 179.822 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 -86.31 12.29 10.33 Favored 'General case' 0 N--CA 1.501 2.12 0 N-CA-C 113.613 0.968 . . . . 0.0 113.613 -179.539 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.407 ' N ' ' HA3' ' A' ' 10' ' ' GLY . 20.9 t -169.62 -174.53 1.91 Allowed 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -79.23 143.38 60.5 Favored Pre-proline 0 N--CA 1.496 1.845 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo -52.34 -32.36 51.2 Favored 'Trans proline' 0 N--CA 1.498 1.772 0 C-N-CA 122.38 2.053 . . . . 0.0 112.15 175.81 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 87.6 mtm180 -113.99 35.24 4.21 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-N 114.74 -1.118 . . . . 0.0 109.232 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 24.2 p-10 -65.96 127.05 92.88 Favored Pre-proline 0 N--CA 1.497 1.881 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.98 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_endo -76.51 81.53 2.48 Favored 'Trans proline' 0 N--CA 1.49 1.289 0 C-N-CA 122.492 2.128 . . . . 0.0 107.973 167.664 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 23.6 tptm -150.85 153.43 35.35 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-N 114.851 -1.068 . . . . 0.0 110.124 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -99.52 155.6 17.48 Favored 'General case' 0 N--CA 1.496 1.826 0 CA-C-N 114.066 -1.424 . . . . 0.0 110.221 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 84.8 m -147.44 177.26 9.38 Favored 'General case' 0 N--CA 1.497 1.879 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.643 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 64.5 p -132.98 -18.28 2.35 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-N 113.893 -1.503 . . . . 0.0 108.976 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.3 tt -89.63 24.6 2.26 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 24.2 m120 -56.83 152.88 11.77 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-N 115.308 -0.86 . . . . 0.0 112.744 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.472 ' HA ' ' HA ' ' A' ' 4' ' ' CYS . 68.0 m 59.68 124.4 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.753 0 CA-C-N 113.467 -1.697 . . . . 0.0 114.318 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -152.33 84.04 4.87 Favored Pre-proline 0 N--CA 1.494 1.728 0 CA-C-N 114.389 -1.278 . . . . 0.0 109.338 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -57.67 -20.11 40.88 Favored 'Trans proline' 0 N--CA 1.493 1.464 0 C-N-CA 122.769 2.313 . . . . 0.0 112.86 178.796 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 74.5 mtp180 -62.31 -42.29 99.24 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 26.4 mt -68.21 157.77 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 CA-C-O 122.414 1.102 . . . . 0.0 110.691 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -125.37 -51.14 1.64 Allowed 'General case' 0 N--CA 1.491 1.614 0 CA-C-N 111.719 -2.491 . . . . 0.0 107.786 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 13.1 p90 -171.14 160.98 6.58 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-N 114.172 -1.376 . . . . 0.0 111.237 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -96.87 121.39 7.02 Favored Glycine 0 N--CA 1.493 2.456 0 CA-C-N 113.651 -1.613 . . . . 0.0 109.248 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 29.4 m -94.71 103.96 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.7 m -79.88 115.26 52.73 Favored Pre-proline 0 N--CA 1.5 2.045 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 179.523 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -62.98 167.59 11.99 Favored 'Trans proline' 0 N--CA 1.496 1.657 0 C-N-CA 122.458 2.105 . . . . 0.0 112.457 -171.8 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.422 ' N ' ' HD2' ' A' ' 52' ' ' ARG . 0.0 OUTLIER -159.72 150.3 19.09 Favored 'General case' 0 N--CA 1.497 1.883 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.218 -179.887 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 49.2 m -77.98 126.06 30.27 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 66.01 118.63 0.03 OUTLIER 'General case' 0 N--CA 1.504 2.239 0 O-C-N 124.755 1.285 . . . . 0.0 109.851 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -158.68 -40.05 0.06 Allowed 'General case' 0 N--CA 1.497 1.876 0 CA-C-N 115.027 -0.988 . . . . 0.0 111.101 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.429 ' NZ ' ' HB2' ' A' ' 56' ' ' LYS . 10.1 mtmp? -110.53 -162.86 0.82 Allowed 'General case' 0 N--CA 1.497 1.92 0 O-C-N 124.139 0.899 . . . . 0.0 109.9 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt 57.63 64.16 1.64 Allowed 'General case' 0 N--CA 1.5 2.045 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 32.3 m120 -134.93 -47.71 0.73 Allowed 'General case' 0 N--CA 1.495 1.811 0 CA-C-N 113.812 -1.54 . . . . 0.0 109.191 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -107.0 -55.56 2.31 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 124.426 1.078 . . . . 0.0 110.71 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 42.6 ptt85 22.27 61.46 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.225 0 O-C-N 125.073 1.483 . . . . 0.0 114.927 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 7.6 tp -61.02 124.82 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 CA-C-N 114.096 -1.411 . . . . 0.0 111.588 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 1.7 m -125.0 46.12 2.41 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-O 122.413 1.102 . . . . 0.0 113.337 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 33.9 m -90.22 168.3 12.03 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 113.666 -1.606 . . . . 0.0 109.154 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 24.3 p30 -142.94 176.06 9.36 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 124.416 1.073 . . . . 0.0 109.297 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 47.0 t -92.79 -31.69 14.94 Favored 'General case' 0 N--CA 1.499 2.021 0 N-CA-C 114.469 1.285 . . . . 0.0 114.469 -179.806 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 42.7 t -63.56 -58.37 7.18 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 123.934 0.771 . . . . 0.0 110.352 -179.688 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -89.83 36.31 0.85 Allowed 'General case' 0 N--CA 1.495 1.803 0 CA-C-N 114.294 -1.321 . . . . 0.0 110.227 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -76.67 -115.78 0.14 Allowed Glycine 0 N--CA 1.493 2.478 0 N-CA-C 109.317 -1.513 . . . . 0.0 109.317 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 95.6 m -156.27 96.63 1.7 Allowed 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -52.16 104.2 0.08 Allowed 'General case' 0 N--CA 1.501 2.12 0 C-N-CA 120.034 -0.666 . . . . 0.0 111.345 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 146.91 -31.0 1.48 Allowed Glycine 0 N--CA 1.495 2.629 0 CA-C-N 114.835 -1.075 . . . . 0.0 112.625 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 88.2 m -95.26 174.8 6.87 Favored 'General case' 0 N--CA 1.502 2.169 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -121.9 87.35 2.74 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 106.452 -1.684 . . . . 0.0 106.452 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 61.0 m-85 -48.58 140.93 7.55 Favored 'General case' 0 N--CA 1.499 1.984 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.013 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.582 ' CE2' ' HA ' ' A' ' 80' ' ' THR . 4.8 t80 -137.1 164.43 28.45 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 125.207 1.567 . . . . 0.0 114.543 -179.222 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 12.0 t -124.13 130.76 53.09 Favored 'General case' 0 N--CA 1.505 2.275 0 CA-C-N 113.153 -1.839 . . . . 0.0 112.529 -179.664 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -54.98 -49.61 71.04 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-N 113.405 -1.725 . . . . 0.0 111.025 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 13.5 p-10 -108.1 28.58 8.13 Favored 'General case' 0 N--CA 1.488 1.472 0 CA-C-N 113.123 -1.853 . . . . 0.0 111.22 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -160.79 18.09 0.2 Allowed Glycine 0 N--CA 1.494 2.554 0 C-N-CA 119.356 -1.402 . . . . 0.0 112.341 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.582 ' HA ' ' CE2' ' A' ' 75' ' ' PHE . 6.4 t 42.03 -160.23 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.793 0 O-C-N 124.924 1.014 . . . . 0.0 113.1 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 47.1 t80 -42.37 121.11 1.83 Allowed 'General case' 0 N--CA 1.499 1.978 0 CA-C-O 121.459 0.647 . . . . 0.0 111.681 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 61.5 t -92.18 -68.2 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 CA-C-N 113.835 -1.529 . . . . 0.0 111.731 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 1.8 p -158.28 -177.28 6.43 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 123.924 0.765 . . . . 0.0 109.597 -179.669 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -102.46 151.97 21.68 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 104.54 -2.393 . . . . 0.0 104.54 179.466 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -64.55 128.04 34.98 Favored Glycine 0 N--CA 1.493 2.494 0 N-CA-C 108.638 -1.785 . . . . 0.0 108.638 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 40.7 mm-40 -113.67 11.97 18.29 Favored 'General case' 0 N--CA 1.498 1.929 0 C-N-CA 120.359 -0.536 . . . . 0.0 110.728 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 38.6 t -79.0 87.76 4.79 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -98.36 137.93 20.78 Favored Pre-proline 0 N--CA 1.493 1.688 0 CA-C-N 112.938 -1.937 . . . . 0.0 108.138 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -65.23 -40.47 19.39 Favored 'Trans proline' 0 N--CA 1.493 1.5 0 C-N-CA 122.12 1.88 . . . . 0.0 111.52 -179.074 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 72.5 ttt-85 -81.37 4.27 21.38 Favored 'General case' 0 N--CA 1.498 1.955 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.961 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 21.4 p-10 -44.75 112.37 1.46 Allowed Pre-proline 0 N--CA 1.502 2.17 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -81.94 43.92 1.61 Allowed 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 123.112 2.541 . . . . 0.0 111.191 178.039 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 24.6 ttmm -164.29 153.44 13.57 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.173 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -94.46 129.04 41.38 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-N 114.095 -1.411 . . . . 0.0 108.186 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 83.1 m -79.82 148.18 68.17 Favored Pre-proline 0 N--CA 1.495 1.825 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -71.99 144.12 42.11 Favored 'Trans proline' 0 N--CA 1.489 1.245 0 C-N-CA 122.791 2.327 . . . . 0.0 109.258 163.746 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 21.1 tpp180 -100.16 31.88 3.19 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 27.9 m-20 -58.4 163.62 2.97 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 114.6 1.333 . . . . 0.0 114.6 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 66.9 m -100.61 133.95 44.29 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-N 113.358 -1.746 . . . . 0.0 110.868 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 60.5 t0 -117.4 84.39 18.16 Favored Pre-proline 0 N--CA 1.497 1.879 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 179.715 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_endo -57.29 -36.21 98.95 Favored 'Trans proline' 0 N--CA 1.496 1.657 0 C-N-CA 122.702 2.268 . . . . 0.0 111.283 -174.433 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 20.9 mmt180 -62.47 -39.63 94.03 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 124.284 0.99 . . . . 0.0 111.848 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 3.1 tt -53.45 155.16 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 O-C-N 123.905 0.753 . . . . 0.0 110.051 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -149.18 -42.24 0.14 Allowed 'General case' 0 N--CA 1.491 1.618 0 CA-C-N 115.364 -0.834 . . . . 0.0 111.458 -179.652 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 -138.45 -164.35 1.62 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 124.341 1.026 . . . . 0.0 110.599 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -153.23 103.99 0.25 Allowed Glycine 0 N--CA 1.487 2.08 0 N-CA-C 106.063 -2.815 . . . . 0.0 106.063 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 90.3 mt -78.91 88.18 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 57.9 m -81.9 149.53 63.52 Favored Pre-proline 0 N--CA 1.493 1.696 0 CA-C-N 113.944 -1.48 . . . . 0.0 109.006 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -57.0 140.7 93.26 Favored 'Trans proline' 0 N--CA 1.495 1.565 0 C-N-CA 122.618 2.212 . . . . 0.0 111.056 179.332 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 69.8 tp -79.67 133.21 36.37 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-N 115.179 -0.918 . . . . 0.0 110.473 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.768 0 CA-C-O 116.677 -1.63 . . . . 0.0 110.098 179.864 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 . . . . . 0 N--CA 1.491 1.588 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.77 -48.34 74.84 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 7.2 tp -61.48 133.48 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 CA-C-N 114.49 -1.232 . . . . 0.0 109.145 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.428 ' HA ' ' HA ' ' A' ' 41' ' ' CYS . 1.7 m -140.38 45.71 1.83 Allowed 'General case' 0 N--CA 1.483 1.19 0 CA-C-O 122.583 1.182 . . . . 0.0 112.683 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 22.7 p -90.35 178.16 6.21 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-N 113.053 -1.885 . . . . 0.0 110.311 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 36.3 p-10 -155.85 -169.57 3.13 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-N 113.958 -1.474 . . . . 0.0 108.77 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.44 ' SG ' ' CD2' ' A' ' 16' ' ' TYR . 2.3 t -81.25 -27.36 35.23 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -179.796 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 23.3 t -80.32 -59.55 2.66 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-N 114.483 -1.235 . . . . 0.0 110.988 -179.771 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -90.41 64.79 6.01 Favored 'General case' 0 N--CA 1.5 2.036 0 CA-C-O 121.89 0.852 . . . . 0.0 110.074 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.47 ' H ' ' HB2' ' A' ' 29' ' ' SER . . . -135.89 -115.76 1.5 Allowed Glycine 0 N--CA 1.498 2.824 0 CA-C-N 113.97 -1.468 . . . . 0.0 110.264 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 91.1 m -139.73 111.23 7.16 Favored 'General case' 0 N--CA 1.502 2.146 0 CA-C-O 120.788 0.328 . . . . 0.0 111.264 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.574 ' NZ ' HH21 ' A' ' 32' ' ' ARG . 39.4 ttpt -58.59 146.52 35.59 Favored 'General case' 0 N--CA 1.497 1.883 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.803 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 79.75 -16.49 11.19 Favored Glycine 0 N--CA 1.492 2.418 0 CA-C-N 114.542 -1.208 . . . . 0.0 112.858 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 90.2 m -93.77 129.8 39.99 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.43 ' HD2' ' N ' ' A' ' 15' ' ' LYS . 0.9 OUTLIER -77.6 94.11 4.31 Favored 'General case' 0 N--CA 1.486 1.343 0 CA-C-N 114.435 -1.257 . . . . 0.0 110.19 -179.365 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.703 ' CD2' ' SG ' ' A' ' 25' ' ' CYS . 95.4 m-85 -46.17 137.14 6.33 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 124.925 1.391 . . . . 0.0 109.074 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -147.74 152.73 38.25 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 125.085 1.491 . . . . 0.0 111.876 -179.438 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 28.9 t -107.8 136.44 47.52 Favored 'General case' 0 N--CA 1.497 1.901 0 CA-C-N 111.748 -2.478 . . . . 0.0 113.778 -179.586 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -52.12 -24.79 7.49 Favored 'General case' 0 N--CA 1.5 2.072 0 CA-C-N 112.645 -2.07 . . . . 0.0 115.157 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -57.27 -17.49 12.14 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 123.849 0.718 . . . . 0.0 110.966 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 105.03 29.63 5.12 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 108.537 -1.825 . . . . 0.0 108.537 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 58.2 m -138.28 154.56 49.03 Favored 'General case' 0 N--CA 1.493 1.702 0 CA-C-O 121.374 0.607 . . . . 0.0 111.03 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 57.7 t80 -73.98 166.76 22.81 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-N 113.663 -1.608 . . . . 0.0 109.615 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 90.3 t -129.06 -68.3 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 123.909 0.756 . . . . 0.0 110.889 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.703 ' SG ' ' CD2' ' A' ' 16' ' ' TYR . 22.8 p -162.32 -171.4 2.79 Favored 'General case' 0 N--CA 1.504 2.255 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -111.95 145.11 40.17 Favored 'General case' 0 N--CA 1.506 2.331 0 CA-C-O 120.74 0.305 . . . . 0.0 111.535 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.56 ' HA2' ' CE2' ' A' ' 16' ' ' TYR . . . -39.98 107.13 0.07 OUTLIER Glycine 0 N--CA 1.496 2.682 0 O-C-N 124.545 1.153 . . . . 0.0 114.613 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -124.73 43.75 2.94 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 105.943 -1.873 . . . . 0.0 105.943 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.47 ' HB2' ' H ' ' A' ' 10' ' ' GLY . 10.4 t -125.66 81.16 1.96 Allowed 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 -179.634 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -88.11 120.36 70.62 Favored Pre-proline 0 N--CA 1.495 1.801 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 179.737 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -66.73 -29.21 43.08 Favored 'Trans proline' 0 N--CA 1.494 1.538 0 C-N-CA 121.983 1.788 . . . . 0.0 110.773 177.343 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.574 HH21 ' NZ ' ' A' ' 12' ' ' LYS . 84.9 mtm180 -78.87 3.28 17.36 Favored 'General case' 0 N--CA 1.498 1.95 0 CA-C-N 114.946 -1.025 . . . . 0.0 112.107 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 18.2 p-10 -60.21 130.63 89.51 Favored Pre-proline 0 N--CA 1.495 1.798 0 O-C-N 123.339 0.399 . . . . 0.0 111.918 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -82.28 46.13 2.12 Favored 'Trans proline' 0 N--CA 1.493 1.49 0 C-N-CA 123.026 2.484 . . . . 0.0 108.642 162.157 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -137.55 -177.0 4.6 Favored 'General case' 0 N--CA 1.497 1.9 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.49 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -143.92 118.13 9.55 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-N 114.867 -1.061 . . . . 0.0 108.423 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 75.4 m -79.76 168.72 18.94 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 8.6 t -85.21 166.47 16.52 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-N 113.856 -1.52 . . . . 0.0 109.558 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.54 HD13 ' H ' ' A' ' 39' ' ' LEU . 0.0 OUTLIER -104.18 19.46 20.11 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-N 114.849 -1.069 . . . . 0.0 111.902 -179.895 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 70.4 m-20 -55.12 135.57 49.13 Favored 'General case' 0 N--CA 1.498 1.951 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.128 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.428 ' HA ' ' HA ' ' A' ' 4' ' ' CYS . 58.2 m -90.32 131.3 36.19 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-N 114.796 -1.093 . . . . 0.0 110.874 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -127.35 78.02 75.04 Favored Pre-proline 0 N--CA 1.498 1.947 0 O-C-N 124.103 0.877 . . . . 0.0 109.514 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -63.77 -27.12 67.95 Favored 'Trans proline' 0 N--CA 1.494 1.524 0 C-N-CA 122.855 2.37 . . . . 0.0 113.515 -170.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 8.4 ptp180 -56.24 -33.19 65.18 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 123.956 0.785 . . . . 0.0 111.205 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 15.1 tt -50.41 150.91 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 CA-C-N 114.696 -1.138 . . . . 0.0 113.102 -179.721 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -133.21 -51.43 0.88 Allowed 'General case' 0 N--CA 1.492 1.652 0 CA-C-N 113.492 -1.685 . . . . 0.0 106.903 179.668 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 51.5 p90 -170.41 177.26 4.13 Favored 'General case' 0 N--CA 1.494 1.748 0 CA-C-N 113.819 -1.537 . . . . 0.0 108.684 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -124.52 120.55 4.07 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 107.341 -2.303 . . . . 0.0 107.341 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.1 p -79.27 100.65 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 CA-C-O 123.015 1.388 . . . . 0.0 108.778 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 3.8 m -79.58 163.66 57.67 Favored Pre-proline 0 N--CA 1.493 1.705 0 CA-C-N 112.889 -1.96 . . . . 0.0 108.383 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_exo -46.34 -32.45 10.85 Favored 'Trans proline' 0 N--CA 1.499 1.806 0 C-N-CA 122.705 2.27 . . . . 0.0 111.847 175.169 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 63.5 mtp85 -79.79 -86.58 0.08 Allowed 'General case' 0 N--CA 1.491 1.605 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.037 179.816 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 64.3 m 50.31 90.41 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.993 0 O-C-N 124.219 0.949 . . . . 0.0 112.188 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -88.59 25.7 1.65 Allowed 'General case' 0 N--CA 1.498 1.951 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.07 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.402 ' CD ' ' N ' ' A' ' 55' ' ' GLU . 14.8 mp0 -121.46 118.72 30.07 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 106.509 -1.663 . . . . 0.0 106.509 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 32.3 mmtp -136.37 165.88 24.77 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 123.745 0.653 . . . . 0.0 111.925 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 28.5 tptp -77.16 -106.75 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 114.47 1.285 . . . . 0.0 114.47 -179.633 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 -74.86 -57.92 3.61 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 113.781 1.03 . . . . 0.0 113.781 -179.54 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 67.45 156.49 0.12 Allowed 'General case' 0 N--CA 1.503 2.196 0 O-C-N 124.692 1.245 . . . . 0.0 111.213 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 16.5 ptm180 41.03 22.57 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.419 0 N-CA-C 114.401 1.259 . . . . 0.0 114.401 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.517 ' C ' HD13 ' A' ' 61' ' ' ILE . 0.0 OUTLIER -90.57 116.79 32.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 CA-C-N 114.993 -1.003 . . . . 0.0 109.197 -179.887 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.59 ' HA ' ' HA ' ' A' ' 99' ' ' CYS . 1.3 m -139.36 43.9 2.0 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 118.037 2.606 . . . . 0.0 118.037 179.45 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.3 p -90.75 160.36 15.85 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-N 113.679 -1.601 . . . . 0.0 106.685 179.121 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.402 ' ND2' ' HA ' ' A' ' 98' ' ' ASN . 40.0 t30 -160.58 161.59 32.63 Favored 'General case' 0 N--CA 1.497 1.901 0 CA-C-O 122.399 1.095 . . . . 0.0 112.598 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 7.4 t -58.51 -20.35 45.12 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-N 112.014 -2.357 . . . . 0.0 111.836 179.819 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 40.7 t -86.27 -71.06 0.56 Allowed 'General case' 0 N--CA 1.494 1.756 0 CA-C-N 114.999 -1.0 . . . . 0.0 111.642 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -54.33 -19.71 5.93 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-N 113.881 -1.509 . . . . 0.0 113.097 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -60.58 159.95 25.05 Favored Glycine 0 N--CA 1.491 2.357 0 O-C-N 123.998 0.811 . . . . 0.0 111.837 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.481 ' C ' ' H ' ' A' ' 71' ' ' GLY . 12.4 t -85.56 139.24 31.61 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-N 113.934 -1.133 . . . . 0.0 108.922 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 23.1 ttmm -80.02 35.03 0.31 Allowed 'General case' 0 N--CA 1.499 2.003 0 CA-C-O 122.543 1.164 . . . . 0.0 110.578 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.481 ' H ' ' C ' ' A' ' 69' ' ' THR . . . -123.64 -8.51 6.28 Favored Glycine 0 N--CA 1.491 2.367 0 N-CA-C 108.542 -1.823 . . . . 0.0 108.542 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' CYS . . . . . 0.407 ' HA ' ' HA ' ' A' ' 108' ' ' CYS . 78.9 m -137.33 148.12 46.09 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 123.931 0.43 . . . . 0.0 109.915 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.474 ' HB3' ' CE1' ' A' ' 81' ' ' PHE . 27.6 mtpp -101.4 88.59 3.5 Favored 'General case' 0 N--CA 1.485 1.314 0 O-C-N 124.917 1.386 . . . . 0.0 108.203 -179.485 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -49.76 133.99 20.98 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-N 114.175 -1.375 . . . . 0.0 108.688 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.489 ' CE2' ' HA ' ' A' ' 80' ' ' THR . 1.2 t80 -132.72 154.62 50.01 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 113.13 -1.85 . . . . 0.0 114.06 -179.218 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.427 ' N ' HG23 ' A' ' 82' ' ' VAL . 25.8 t -115.84 129.92 56.63 Favored 'General case' 0 N--CA 1.497 1.913 0 CA-C-N 112.145 -2.298 . . . . 0.0 111.746 -179.747 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.479 ' H ' ' HB2' ' A' ' 104' ' ' ALA . 7.7 p-10 -64.67 -46.74 81.16 Favored 'General case' 0 N--CA 1.497 1.897 0 CA-C-N 114.773 -1.103 . . . . 0.0 108.596 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -92.18 19.71 6.67 Favored 'General case' 0 N--CA 1.485 1.283 0 CA-C-N 112.772 -2.013 . . . . 0.0 110.953 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -165.21 24.53 0.16 Allowed Glycine 0 N--CA 1.497 2.715 0 C-N-CA 118.62 -1.753 . . . . 0.0 113.184 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.489 ' HA ' ' CE2' ' A' ' 75' ' ' PHE . 6.5 t 42.11 -161.55 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.926 0 O-C-N 124.969 1.041 . . . . 0.0 112.887 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.474 ' CE1' ' HB3' ' A' ' 73' ' ' LYS . 11.0 t80 -49.68 121.97 5.84 Favored 'General case' 0 N--CA 1.497 1.882 0 CA-C-O 121.34 0.591 . . . . 0.0 110.879 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.427 HG23 ' N ' ' A' ' 76' ' ' SER . 88.9 t -86.11 -73.34 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' CYS . . . . . 0.409 ' SG ' ' O ' ' A' ' 84' ' ' GLU . 0.1 OUTLIER -175.49 171.35 2.83 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 124.002 0.813 . . . . 0.0 110.459 179.779 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.462 ' HA ' ' HA ' ' A' ' 73' ' ' LYS . 32.3 tt0 -93.28 146.93 23.34 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 105.718 -1.956 . . . . 0.0 105.718 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -53.03 135.38 39.74 Favored Glycine 0 N--CA 1.501 2.967 0 C-N-CA 119.514 -1.327 . . . . 0.0 114.452 -179.677 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -100.37 27.91 5.39 Favored 'General case' 0 N--CA 1.505 2.301 0 CA-C-O 121.595 0.712 . . . . 0.0 110.032 179.744 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 22.2 t -160.93 -176.57 5.58 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -144.61 140.01 16.09 Favored Pre-proline 0 N--CA 1.488 1.438 0 N-CA-C 105.343 -2.095 . . . . 0.0 105.343 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_exo -41.79 -28.04 0.66 Allowed 'Trans proline' 0 N--CA 1.5 1.895 0 C-N-CA 123.671 2.914 . . . . 0.0 114.824 -174.274 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.87 -51.34 16.54 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 123.93 0.769 . . . . 0.0 111.898 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 8.2 p-10 -90.23 138.26 27.35 Favored Pre-proline 0 N--CA 1.502 2.166 0 C-N-CA 119.55 -0.86 . . . . 0.0 110.622 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -75.53 170.25 20.64 Favored 'Trans proline' 0 N--CA 1.493 1.476 0 C-N-CA 122.929 2.419 . . . . 0.0 109.861 161.81 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 27.8 tptp -160.3 154.68 23.58 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 123.67 0.606 . . . . 0.0 110.3 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -98.39 139.51 34.04 Favored 'General case' 0 N--CA 1.498 1.96 0 CA-C-N 114.591 -1.186 . . . . 0.0 111.122 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' CYS . . . . . 0.419 ' HB3' ' HD2' ' A' ' 96' ' ' PRO . 98.5 m -159.32 167.46 14.22 Favored Pre-proline 0 N--CA 1.501 2.076 0 O-C-N 124.057 0.848 . . . . 0.0 111.066 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.419 ' HD2' ' HB3' ' A' ' 95' ' ' CYS . 50.1 Cg_exo -27.09 -66.13 0.05 OUTLIER 'Trans proline' 0 N--CA 1.494 1.528 0 C-N-CA 124.275 3.316 . . . . 0.0 115.628 170.81 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 79.0 ttt180 -153.77 -77.92 0.11 Allowed 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.402 ' HA ' ' ND2' ' A' ' 64' ' ' ASN . 64.1 m-20 133.72 -170.22 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.412 0 O-C-N 126.545 2.403 . . . . 0.0 107.726 -179.559 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.59 ' HA ' ' HA ' ' A' ' 62' ' ' CYS . 61.5 m 62.95 121.45 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 124.952 1.301 . . . . 0.0 112.454 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -141.17 80.98 16.27 Favored Pre-proline 0 N--CA 1.494 1.73 0 CA-C-N 114.372 -1.286 . . . . 0.0 111.252 -179.756 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -49.16 -27.76 13.16 Favored 'Trans proline' 0 N--CA 1.496 1.669 0 C-N-CA 123.183 2.589 . . . . 0.0 113.812 172.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.06 -27.28 69.29 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 123.687 0.617 . . . . 0.0 111.635 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 12.7 tt -52.35 167.62 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 124.253 0.971 . . . . 0.0 112.625 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.479 ' HB2' ' H ' ' A' ' 77' ' ' ASP . . . -142.8 -55.66 0.42 Allowed 'General case' 0 N--CA 1.49 1.532 0 CA-C-N 114.352 -1.295 . . . . 0.0 109.604 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -149.2 -159.92 1.1 Allowed 'General case' 0 N--CA 1.498 1.925 0 O-C-N 124.465 1.103 . . . . 0.0 109.134 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -142.89 108.97 0.54 Allowed Glycine 0 N--CA 1.489 2.173 0 N-CA-C 105.917 -2.873 . . . . 0.0 105.917 179.771 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 93.4 mt -79.37 85.68 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' CYS . . . . . 0.407 ' HA ' ' HA ' ' A' ' 72' ' ' CYS . 22.2 m -79.68 121.34 82.35 Favored Pre-proline 0 N--CA 1.492 1.634 0 CA-C-N 113.799 -1.546 . . . . 0.0 108.553 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_endo -61.6 112.5 1.48 Allowed 'Trans proline' 0 N--CA 1.493 1.45 0 C-N-CA 122.394 2.063 . . . . 0.0 110.375 -176.66 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 74.5 mt -79.8 -3.16 46.51 Favored 'General case' 0 N--CA 1.498 1.926 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.245 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.827 0 CA-C-O 116.97 -1.49 . . . . 0.0 109.892 179.913 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 . . . . . 0 N--CA 1.489 1.523 0 CA-C-O 120.404 0.145 . . . . 0.0 110.889 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 8.2 ptp180 -67.73 -36.31 80.35 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 106.175 -1.787 . . . . 0.0 106.175 179.527 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.7 tp -90.16 77.79 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 CA-C-N 113.252 -1.795 . . . . 0.0 108.345 179.79 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.7 m -85.81 28.99 0.74 Allowed 'General case' 0 N--CA 1.497 1.925 0 N-CA-C 116.201 1.926 . . . . 0.0 116.201 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 12.6 t -92.35 169.51 10.52 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-N 113.058 -1.883 . . . . 0.0 106.508 179.768 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.42 ' ND2' ' H ' ' A' ' 9' ' ' ALA . 40.0 p-10 -160.48 161.87 32.95 Favored 'General case' 0 N--CA 1.497 1.901 0 C-N-CA 119.367 -0.933 . . . . 0.0 112.629 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -63.24 -22.68 67.02 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 113.856 -1.52 . . . . 0.0 112.561 179.729 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 42.4 t -89.96 -69.02 0.74 Allowed 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 115.252 1.575 . . . . 0.0 115.252 -179.722 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.42 ' H ' ' ND2' ' A' ' 6' ' ' ASN . . . -85.66 63.07 7.85 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 124.598 1.186 . . . . 0.0 111.25 -179.556 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -119.89 -115.05 2.5 Favored Glycine 0 N--CA 1.492 2.379 0 CA-C-N 113.282 -1.781 . . . . 0.0 109.799 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.0 t -166.31 123.44 1.35 Allowed 'General case' 0 N--CA 1.496 1.848 0 CA-C-O 121.373 0.606 . . . . 0.0 110.585 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.82 143.73 20.28 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-N 114.714 -1.13 . . . . 0.0 109.843 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 106.37 -35.47 5.02 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.195 -1.562 . . . . 0.0 109.195 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.401 ' HB3' ' HA3' ' A' ' 48' ' ' GLY . 52.1 m -94.64 116.21 28.49 Favored 'General case' 0 N--CA 1.497 1.906 0 C-N-CA 119.422 -0.911 . . . . 0.0 110.222 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 4.0 mptp? -72.24 88.15 1.14 Allowed 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 112.792 -2.003 . . . . 0.0 111.627 -179.737 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.446 ' N ' ' O ' ' A' ' 25' ' ' CYS . 10.7 m-85 -46.72 127.9 10.14 Favored 'General case' 0 N--CA 1.498 1.96 0 CA-C-O 122.468 1.128 . . . . 0.0 108.237 179.583 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.547 ' CE2' ' HA ' ' A' ' 22' ' ' THR . 0.1 OUTLIER -135.96 158.72 43.73 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-N 111.623 -2.535 . . . . 0.0 113.096 -178.965 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 29.1 t -110.78 128.86 55.91 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-N 112.72 -2.036 . . . . 0.0 111.054 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.461 ' H ' ' HB2' ' A' ' 46' ' ' ALA . 7.7 p-10 -62.71 -45.35 93.15 Favored 'General case' 0 N--CA 1.497 1.911 0 CA-C-N 114.119 -1.4 . . . . 0.0 109.203 179.803 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -94.25 19.94 8.76 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 112.624 -2.08 . . . . 0.0 111.624 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -171.22 28.89 0.11 Allowed Glycine 0 N--CA 1.497 2.731 0 C-N-CA 118.146 -1.978 . . . . 0.0 113.934 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.547 ' HA ' ' CE2' ' A' ' 17' ' ' PHE . 6.5 t 42.81 -166.68 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 73.9 t80 -40.05 139.81 0.65 Allowed 'General case' 0 N--CA 1.5 2.063 0 N-CA-C 114.074 1.138 . . . . 0.0 114.074 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 88.4 t -114.53 -79.42 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 CA-C-N 113.131 -1.85 . . . . 0.0 108.05 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.525 ' SG ' ' N ' ' A' ' 26' ' ' GLU . 0.1 OUTLIER -152.21 -169.38 3.34 Favored 'General case' 0 N--CA 1.502 2.17 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 179.86 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.525 ' N ' ' SG ' ' A' ' 25' ' ' CYS . 60.8 tt0 -114.62 158.3 21.92 Favored 'General case' 0 N--CA 1.504 2.228 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 179.425 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -54.07 109.65 1.22 Allowed Glycine 0 N--CA 1.497 2.731 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.69 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -85.82 19.55 2.48 Favored 'General case' 0 N--CA 1.5 2.028 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 36.6 t -105.44 92.76 4.33 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.197 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -130.35 142.42 45.4 Favored Pre-proline 0 N--CA 1.495 1.786 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 179.745 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_endo -63.16 79.0 0.12 Allowed 'Trans proline' 0 N--CA 1.496 1.639 0 C-N-CA 122.561 2.174 . . . . 0.0 109.891 169.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 79.6 ttt180 -178.13 -51.26 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 105.592 -2.003 . . . . 0.0 105.592 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 26.5 p30 -90.44 168.21 14.78 Favored Pre-proline 0 N--CA 1.497 1.9 0 CA-C-N 114.27 -1.332 . . . . 0.0 110.781 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -62.55 127.2 20.13 Favored 'Trans proline' 0 N--CA 1.49 1.304 0 C-N-CA 122.436 2.09 . . . . 0.0 109.021 160.241 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -92.83 22.44 4.84 Favored 'General case' 0 N--CA 1.5 2.074 0 CA-C-O 122.677 1.227 . . . . 0.0 112.749 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -146.22 153.39 40.56 Favored 'General case' 0 N--CA 1.498 1.947 0 CA-C-N 112.274 -2.239 . . . . 0.0 111.739 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 57.1 m -146.51 -124.19 0.07 Allowed 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 33.5 m -146.76 18.37 1.29 Allowed 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 44.6 tp -79.71 -43.3 22.92 Favored 'General case' 0 N--CA 1.497 1.897 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.334 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 14.4 m120 53.11 -163.63 0.09 Allowed 'General case' 0 N--CA 1.504 2.243 0 O-C-N 124.064 0.852 . . . . 0.0 112.03 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 56.3 m -43.85 118.85 1.54 Allowed 'General case' 0 N--CA 1.502 2.133 0 O-C-N 124.033 0.833 . . . . 0.0 110.232 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.4 t0 -101.41 106.41 45.62 Favored Pre-proline 0 N--CA 1.495 1.807 0 O-C-N 124.022 0.827 . . . . 0.0 109.398 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -67.6 -33.12 29.33 Favored 'Trans proline' 0 N--CA 1.494 1.525 0 C-N-CA 122.046 1.831 . . . . 0.0 111.101 -168.578 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 29.0 mmt85 -86.32 -13.36 46.81 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 -179.737 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 5.9 tt -73.43 179.33 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 C-N-CA 118.68 -1.208 . . . . 0.0 108.738 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.461 ' HB2' ' H ' ' A' ' 19' ' ' ASP . . . -139.92 -58.61 0.56 Allowed 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 120.556 -0.458 . . . . 0.0 112.073 -179.824 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 7.3 p90 -170.46 160.68 7.57 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 124.146 0.904 . . . . 0.0 112.719 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.407 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -88.92 107.65 3.39 Favored Glycine 0 N--CA 1.487 2.096 0 CA-C-N 113.235 -1.802 . . . . 0.0 108.892 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 23.4 t -78.24 86.75 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 124.287 0.639 . . . . 0.0 112.661 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.6 m -79.27 145.91 65.53 Favored Pre-proline 0 N--CA 1.503 2.212 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 179.459 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -75.87 54.22 3.98 Favored 'Trans proline' 0 N--CA 1.5 1.861 0 C-N-CA 123.74 2.96 . . . . 0.0 116.465 -170.145 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.61 169.22 23.34 Favored 'General case' 0 N--CA 1.501 2.097 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 28.3 t 62.64 170.29 0.14 Allowed 'General case' 0 N--CA 1.503 2.21 0 O-C-N 124.454 1.097 . . . . 0.0 111.299 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -144.72 -112.51 0.1 Allowed 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 60.95 129.73 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.113 0 C-N-CA 124.184 0.994 . . . . 0.0 113.445 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 32.3 mmtp -141.9 -159.69 1.0 Allowed 'General case' 0 N--CA 1.498 1.929 0 CA-C-N 114.426 -1.261 . . . . 0.0 107.96 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.421 ' N ' ' HD3' ' A' ' 57' ' ' LYS . 3.0 mppt? 56.49 -167.99 0.11 Allowed 'General case' 0 N--CA 1.504 2.228 0 O-C-N 123.433 0.458 . . . . 0.0 110.17 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -74.97 -7.04 52.46 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 179.614 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -66.61 120.03 12.74 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.801 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 56.6 ttt85 -174.29 -106.02 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 105.508 -2.034 . . . . 0.0 105.508 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 5.9 tp -79.03 84.29 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 179.718 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.4 ' HA ' ' HA ' ' A' ' 99' ' ' CYS . 1.7 m -85.81 44.54 1.12 Allowed 'General case' 0 N--CA 1.494 1.738 0 CA-C-N 114.474 -1.239 . . . . 0.0 113.94 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 64.3 m -90.54 166.39 13.24 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 113.309 -1.769 . . . . 0.0 108.201 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -146.53 155.05 42.22 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 124.079 0.862 . . . . 0.0 109.765 179.794 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 41.1 t -56.75 -32.84 65.97 Favored 'General case' 0 N--CA 1.497 1.916 0 CA-C-N 114.767 -1.106 . . . . 0.0 113.582 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 18.1 t -66.54 -46.19 76.91 Favored 'General case' 0 N--CA 1.495 1.796 0 CA-C-N 114.726 -1.124 . . . . 0.0 110.219 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -86.17 62.27 7.33 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-N 113.689 -1.596 . . . . 0.0 110.655 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -143.8 165.11 27.33 Favored Glycine 0 N--CA 1.496 2.637 0 CA-C-N 114.272 -1.331 . . . . 0.0 111.078 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.463 ' C ' ' H ' ' A' ' 71' ' ' GLY . 9.5 t -85.3 127.33 34.29 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-N 115.036 -0.582 . . . . 0.0 110.517 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -81.09 36.64 0.41 Allowed 'General case' 0 N--CA 1.501 2.078 0 CA-C-O 122.484 1.135 . . . . 0.0 110.432 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.463 ' H ' ' C ' ' A' ' 69' ' ' THR . . . -132.27 -1.28 4.42 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 108.547 -1.821 . . . . 0.0 108.547 179.735 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 64.1 m -143.39 141.62 30.95 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.464 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 7.7 ptmm? -92.46 96.61 10.34 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 124.447 1.092 . . . . 0.0 110.95 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.416 ' N ' ' O ' ' A' ' 83' ' ' CYS . 57.4 m-85 -52.15 134.02 33.22 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-N 114.429 -1.26 . . . . 0.0 109.692 179.731 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -141.4 158.37 43.96 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 112.998 -1.91 . . . . 0.0 112.762 -179.37 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 57.8 p -96.08 139.41 32.3 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 114.743 1.386 . . . . 0.0 114.743 -179.659 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.409 ' H ' ' HB2' ' A' ' 104' ' ' ALA . 5.5 p-10 -45.35 -48.23 13.33 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 126.044 2.09 . . . . 0.0 114.848 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -52.27 -30.58 28.59 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 124.329 1.018 . . . . 0.0 111.785 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 119.72 43.83 0.48 Allowed Glycine 0 N--CA 1.491 2.348 0 O-C-N 124.742 1.276 . . . . 0.0 111.043 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 57.3 m -139.13 111.21 7.35 Favored 'General case' 0 N--CA 1.5 2.03 0 C-N-CA 119.648 -0.821 . . . . 0.0 112.077 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 17.4 t80 -53.43 137.21 36.35 Favored 'General case' 0 N--CA 1.494 1.775 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.694 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 64.1 t -98.02 -73.4 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 CA-C-N 114.348 -1.297 . . . . 0.0 111.474 -179.525 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' CYS . . . . . 0.48 ' SG ' ' N ' ' A' ' 84' ' ' GLU . 0.5 OUTLIER -167.3 -172.65 2.04 Favored 'General case' 0 N--CA 1.505 2.3 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 -179.854 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.48 ' N ' ' SG ' ' A' ' 83' ' ' CYS . 33.3 tt0 -112.66 145.03 41.16 Favored 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 103.234 -2.876 . . . . 0.0 103.234 179.26 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -52.33 140.58 28.12 Favored Glycine 0 N--CA 1.503 3.157 0 C-N-CA 118.993 -1.575 . . . . 0.0 112.696 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -88.62 -4.98 58.45 Favored 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 27.8 t -117.97 107.91 14.63 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.475 ' HB3' ' ND2' ' A' ' 91' ' ' ASN . 14.3 t70 -79.05 141.49 58.52 Favored Pre-proline 0 N--CA 1.494 1.749 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -34.62 -31.5 0.06 OUTLIER 'Trans proline' 0 N--CA 1.497 1.729 0 C-N-CA 123.712 2.941 . . . . 0.0 113.784 175.004 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.437 ' N ' ' HD2' ' A' ' 90' ' ' ARG . 1.7 mpt_? -79.33 -53.93 6.44 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 123.869 0.73 . . . . 0.0 110.215 179.766 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.475 ' ND2' ' HB3' ' A' ' 88' ' ' ASP . 11.5 p30 -91.3 126.0 56.29 Favored Pre-proline 0 N--CA 1.5 2.062 0 C-N-CA 119.976 -0.69 . . . . 0.0 112.326 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -75.52 150.67 36.29 Favored 'Trans proline' 0 N--CA 1.492 1.39 0 C-N-CA 122.586 2.191 . . . . 0.0 109.396 165.294 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 32.4 mmmt -132.99 127.5 34.3 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 124.02 0.825 . . . . 0.0 109.029 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -84.06 73.96 10.32 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 123.97 0.794 . . . . 0.0 108.967 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 85.1 m -79.96 163.33 58.45 Favored Pre-proline 0 N--CA 1.496 1.838 0 CA-C-N 114.404 -1.271 . . . . 0.0 112.848 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.405 ' HA ' ' CZ ' ' A' ' 97' ' ' ARG . 4.9 Cg_endo -70.0 -151.43 0.03 OUTLIER 'Trans proline' 0 N--CA 1.491 1.376 0 C-N-CA 122.563 2.175 . . . . 0.0 109.292 159.392 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.425 ' HD2' ' N ' ' A' ' 97' ' ' ARG . 0.1 OUTLIER -154.3 50.38 0.64 Allowed 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 121.754 0.787 . . . . 0.0 111.67 179.991 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -60.5 157.16 14.7 Favored 'General case' 0 N--CA 1.5 2.065 0 CA-C-N 114.722 -1.126 . . . . 0.0 111.459 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.4 ' HA ' ' HA ' ' A' ' 62' ' ' CYS . 86.0 m -98.47 131.37 44.78 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-N 114.989 -1.005 . . . . 0.0 111.552 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.406 ' O ' HG22 ' A' ' 103' ' ' ILE . 51.0 t0 -121.34 79.85 36.69 Favored Pre-proline 0 N--CA 1.496 1.873 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 179.665 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -54.71 -17.29 12.97 Favored 'Trans proline' 0 N--CA 1.497 1.697 0 C-N-CA 122.696 2.264 . . . . 0.0 113.326 -176.477 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 73.0 ttp85 -88.49 -35.85 16.77 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 -179.777 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.406 HG22 ' O ' ' A' ' 100' ' ' ASP . 11.1 tt -54.35 159.82 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.403 0 O-C-N 123.307 0.38 . . . . 0.0 110.949 -179.704 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.409 ' HB2' ' H ' ' A' ' 77' ' ' ASP . . . -150.79 -68.01 0.19 Allowed 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 -179.756 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 51.1 m-85 -114.28 -161.64 0.78 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 124.189 0.931 . . . . 0.0 111.321 -179.634 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -160.2 106.99 0.3 Allowed Glycine 0 N--CA 1.486 2.024 0 N-CA-C 104.836 -3.306 . . . . 0.0 104.836 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.469 ' N ' HD12 ' A' ' 107' ' ' ILE . 2.1 mp -79.14 104.67 7.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 CA-C-O 121.949 0.881 . . . . 0.0 108.92 -179.653 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 16.0 m -86.79 159.71 51.48 Favored Pre-proline 0 N--CA 1.495 1.777 0 CA-C-N 114.272 -1.331 . . . . 0.0 108.641 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -58.8 -36.64 96.73 Favored 'Trans proline' 0 N--CA 1.494 1.549 0 C-N-CA 122.382 2.055 . . . . 0.0 110.015 173.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.4 pp -79.58 -16.43 55.89 Favored 'General case' 0 N--CA 1.495 1.807 0 CA-C-N 114.914 -1.039 . . . . 0.0 111.096 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.787 0 CA-C-O 116.685 -1.626 . . . . 0.0 109.889 179.946 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 . . . . . 0 N--CA 1.491 1.575 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 67.7 mmt-85 -71.74 4.6 3.1 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 123.174 0.297 . . . . 0.0 111.77 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.0 tp -60.46 96.96 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 CA-C-O 121.922 0.867 . . . . 0.0 111.28 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.7 m -93.06 49.04 1.38 Allowed 'General case' 0 N--CA 1.491 1.598 0 CA-C-N 114.486 -1.234 . . . . 0.0 112.293 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 13.5 t -90.57 177.03 6.46 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-N 113.404 -1.725 . . . . 0.0 107.733 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.518 HD22 ' H ' ' A' ' 40' ' ' ASN . 14.3 p30 -160.04 167.98 26.62 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 123.994 0.809 . . . . 0.0 112.136 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 38.0 t -53.99 -42.52 69.11 Favored 'General case' 0 N--CA 1.497 1.877 0 CA-C-N 114.225 -1.352 . . . . 0.0 112.036 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 53.4 t -52.85 -44.48 66.81 Favored 'General case' 0 N--CA 1.496 1.862 0 CA-C-N 113.221 -1.808 . . . . 0.0 109.413 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -89.73 28.94 1.23 Allowed 'General case' 0 N--CA 1.499 2.018 0 CA-C-N 112.944 -1.935 . . . . 0.0 110.835 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -83.31 -138.44 3.36 Favored Glycine 0 N--CA 1.496 2.667 0 N-CA-C 110.743 -0.943 . . . . 0.0 110.743 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 39.9 p -158.09 104.88 1.91 Allowed 'General case' 0 N--CA 1.503 2.183 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 16.2 ptpt -53.55 95.05 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.108 0 CA-C-O 122.586 1.184 . . . . 0.0 111.811 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 168.24 -35.25 0.2 Allowed Glycine 0 N--CA 1.488 2.166 0 CA-C-N 113.788 -1.551 . . . . 0.0 110.345 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 49.9 m -112.12 161.28 16.69 Favored 'General case' 0 N--CA 1.502 2.151 0 C-N-CA 119.47 -0.892 . . . . 0.0 111.913 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -101.18 92.31 4.92 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-N 114.182 -1.372 . . . . 0.0 108.278 -179.677 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.409 ' N ' ' O ' ' A' ' 25' ' ' CYS . 47.4 m-85 -47.33 136.85 9.0 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 124.636 1.21 . . . . 0.0 110.712 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 10.7 t80 -146.19 159.58 43.12 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-N 112.853 -1.976 . . . . 0.0 112.789 -179.217 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 35.1 t -112.75 134.84 54.07 Favored 'General case' 0 N--CA 1.498 1.968 0 CA-C-N 112.285 -2.234 . . . . 0.0 114.753 -179.688 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.49 ' H ' ' HB2' ' A' ' 46' ' ' ALA . 1.2 p30 -51.17 -26.34 6.68 Favored 'General case' 0 N--CA 1.501 2.087 0 CA-C-N 112.457 -2.156 . . . . 0.0 115.031 -179.823 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 24.0 p30 -64.39 -2.12 2.07 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 123.999 0.812 . . . . 0.0 112.085 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 89.61 28.83 18.0 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 58.6 m -134.89 150.54 50.45 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 71.8 t80 -78.24 158.78 28.82 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-N 114.321 -1.309 . . . . 0.0 110.386 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 95.2 t -116.35 -73.77 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 CA-C-N 114.939 -1.028 . . . . 0.0 109.124 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.506 ' SG ' ' N ' ' A' ' 26' ' ' GLU . 1.7 p -168.41 -161.25 0.34 Allowed 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.506 ' N ' ' SG ' ' A' ' 25' ' ' CYS . 40.8 tt0 -127.87 145.57 50.9 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 104.669 -2.345 . . . . 0.0 104.669 179.231 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -32.72 102.13 0.01 OUTLIER Glycine 0 N--CA 1.499 2.891 0 N-CA-C 115.988 1.155 . . . . 0.0 115.988 -179.756 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -102.82 32.86 3.46 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 29.9 t -122.55 148.08 45.63 Favored 'General case' 0 N--CA 1.497 1.924 0 CA-C-N 114.124 -1.398 . . . . 0.0 107.681 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.401 ' H ' ' HZ1' ' A' ' 35' ' ' LYS . 41.8 t0 -128.2 92.9 40.29 Favored Pre-proline 0 N--CA 1.493 1.722 0 O-C-N 124.717 1.26 . . . . 0.0 110.82 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -52.43 -15.89 4.5 Favored 'Trans proline' 0 N--CA 1.495 1.59 0 C-N-CA 123.002 2.468 . . . . 0.0 113.03 178.239 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 16.7 tpt180 -61.2 -51.82 67.39 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 108.147 -1.056 . . . . 0.0 108.147 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 15.3 p30 -90.65 138.91 26.35 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 124.327 1.017 . . . . 0.0 110.016 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -74.38 116.77 4.74 Favored 'Trans proline' 0 N--CA 1.493 1.458 0 C-N-CA 123.017 2.478 . . . . 0.0 110.394 175.311 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.401 ' HZ1' ' H ' ' A' ' 30' ' ' ASP . 0.0 OUTLIER -167.51 176.19 6.68 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 123.98 0.8 . . . . 0.0 111.957 179.92 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -160.03 122.19 3.31 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-N 114.89 -1.05 . . . . 0.0 108.784 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 33.4 m -79.87 -71.58 0.45 Allowed 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 47.5 m 34.22 69.91 0.14 Allowed 'General case' 0 N--CA 1.498 1.96 0 O-C-N 124.787 1.305 . . . . 0.0 113.414 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.3 pp -143.55 -36.87 0.35 Allowed 'General case' 0 N--CA 1.495 1.789 0 CA-C-N 114.936 -1.029 . . . . 0.0 108.973 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.518 ' H ' HD22 ' A' ' 6' ' ' ASN . 20.5 m120 -94.02 138.68 31.84 Favored 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 105.648 -1.982 . . . . 0.0 105.648 179.473 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 75.0 m -101.01 131.02 47.08 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 123.698 0.624 . . . . 0.0 112.644 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 62.9 t0 -122.95 76.46 49.73 Favored Pre-proline 0 N--CA 1.497 1.922 0 O-C-N 124.213 0.945 . . . . 0.0 109.149 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -63.74 -37.64 44.67 Favored 'Trans proline' 0 N--CA 1.496 1.63 0 C-N-CA 123.309 2.672 . . . . 0.0 111.584 -176.131 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.402 ' H ' ' HG3' ' A' ' 44' ' ' ARG . 0.0 OUTLIER -74.6 -7.6 53.68 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 115.088 1.514 . . . . 0.0 115.088 -179.758 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 15.9 tt -57.04 156.74 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.25 0 C-N-CA 119.879 -0.729 . . . . 0.0 111.856 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.49 ' HB2' ' H ' ' A' ' 19' ' ' ASP . . . -137.13 -66.95 0.5 Allowed 'General case' 0 N--CA 1.497 1.914 0 O-C-N 124.006 0.816 . . . . 0.0 110.289 179.795 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 46.8 p90 -160.96 167.99 25.45 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-N 115.183 -0.917 . . . . 0.0 109.836 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -115.95 111.44 2.4 Favored Glycine 0 N--CA 1.492 2.428 0 O-C-N 125.17 1.544 . . . . 0.0 109.709 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.5 p -80.04 111.32 16.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 C-N-CA 119.731 -0.788 . . . . 0.0 111.973 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.7 m -79.33 149.48 72.45 Favored Pre-proline 0 N--CA 1.499 1.984 0 CA-C-N 115.135 -0.939 . . . . 0.0 109.055 179.66 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -61.68 -68.66 0.04 OUTLIER 'Trans proline' 0 N--CA 1.495 1.6 0 C-N-CA 122.749 2.299 . . . . 0.0 111.965 -169.619 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 12.6 ptp180 -155.0 -116.06 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.882 0 O-C-N 124.068 0.855 . . . . 0.0 110.889 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 45.9 m 58.54 46.15 15.28 Favored 'General case' 0 N--CA 1.502 2.135 0 CA-C-O 122.005 0.907 . . . . 0.0 109.782 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -143.35 -34.17 0.42 Allowed 'General case' 0 N--CA 1.496 1.847 0 CA-C-N 113.603 -1.635 . . . . 0.0 109.136 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 52.1 36.32 18.66 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 124.277 0.985 . . . . 0.0 112.264 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.445 ' NZ ' ' HB3' ' A' ' 56' ' ' LYS . 2.5 ttpm? -54.2 -71.26 0.08 Allowed 'General case' 0 N--CA 1.498 1.927 0 CA-C-N 114.739 -1.119 . . . . 0.0 109.214 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.422 ' HB2' ' NZ ' ' A' ' 57' ' ' LYS . 4.9 ttmp? -88.91 94.31 9.89 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 105.975 -1.861 . . . . 0.0 105.975 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 65.61 168.23 0.2 Allowed 'General case' 0 N--CA 1.502 2.127 0 O-C-N 124.678 1.236 . . . . 0.0 110.928 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -65.75 165.46 12.68 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-N 115.173 -0.921 . . . . 0.0 112.095 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.414 ' N ' ' HD3' ' A' ' 60' ' ' ARG . 0.0 OUTLIER -56.12 123.61 15.06 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 124.168 0.917 . . . . 0.0 111.087 -179.988 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.422 ' CD1' ' C ' ' A' ' 61' ' ' ILE . 0.0 OUTLIER -90.21 114.22 27.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 N-CA-C 107.78 -1.192 . . . . 0.0 107.78 179.957 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.477 ' HA ' ' HA ' ' A' ' 99' ' ' CYS . 1.7 m -139.58 52.33 1.72 Allowed 'General case' 0 C--N 1.311 -1.087 0 CA-C-O 123.037 1.398 . . . . 0.0 111.897 179.632 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.416 ' H ' HD13 ' A' ' 61' ' ' ILE . 93.2 m -90.3 168.24 12.05 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 112.516 -2.129 . . . . 0.0 108.72 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 42.3 p-10 -152.9 177.64 10.53 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 123.965 0.79 . . . . 0.0 110.072 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 4.5 t -73.17 1.12 9.85 Favored 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 46.1 t -91.64 -36.29 13.73 Favored 'General case' 0 N--CA 1.496 1.845 0 CA-C-N 114.751 -1.113 . . . . 0.0 110.584 179.701 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -71.1 59.21 0.24 Allowed 'General case' 0 N--CA 1.5 2.063 0 CA-C-N 112.466 -2.152 . . . . 0.0 114.148 -179.754 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -174.22 -150.33 7.6 Favored Glycine 0 N--CA 1.487 2.06 0 N-CA-C 107.863 -2.095 . . . . 0.0 107.863 179.761 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.458 ' C ' ' H ' ' A' ' 71' ' ' GLY . 66.5 p -146.11 157.42 43.84 Favored 'General case' 0 N--CA 1.502 2.13 0 C-N-CA 120.781 -0.367 . . . . 0.0 111.211 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 59.4 mtpt -71.07 33.23 0.05 OUTLIER 'General case' 0 N--CA 1.507 2.415 0 O-C-N 125.117 1.511 . . . . 0.0 113.627 179.699 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.458 ' H ' ' C ' ' A' ' 69' ' ' THR . . . -137.0 14.21 3.81 Favored Glycine 0 N--CA 1.486 1.987 0 N-CA-C 108.054 -2.018 . . . . 0.0 108.054 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' CYS . . . . . 0.421 ' HA ' ' HA ' ' A' ' 108' ' ' CYS . 86.8 m -140.44 175.21 9.79 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 123.901 0.412 . . . . 0.0 111.006 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 34.2 mtmm -131.16 106.57 8.43 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 123.953 0.783 . . . . 0.0 110.279 -179.694 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.681 ' CD2' ' SG ' ' A' ' 83' ' ' CYS . 97.8 m-85 -56.31 137.98 51.48 Favored 'General case' 0 N--CA 1.501 2.102 0 C-N-CA 120.133 -0.627 . . . . 0.0 109.827 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 15.4 t80 -143.07 162.38 35.66 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 124.69 1.244 . . . . 0.0 111.977 -179.672 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 47.3 t -120.5 139.08 53.41 Favored 'General case' 0 N--CA 1.5 2.058 0 CA-C-N 113.2 -1.818 . . . . 0.0 115.084 -179.726 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.588 ' H ' ' HB2' ' A' ' 104' ' ' ALA . 4.3 p-10 -48.84 -28.23 3.58 Favored 'General case' 0 N--CA 1.5 2.055 0 CA-C-N 111.341 -2.663 . . . . 0.0 114.033 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 17.8 p30 -61.09 -5.25 1.36 Allowed 'General case' 0 N--CA 1.497 1.886 0 O-C-N 124.35 1.031 . . . . 0.0 112.073 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 89.64 29.08 17.19 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.396 -1.482 . . . . 0.0 109.396 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 88.2 m -142.17 149.96 40.42 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 121.43 0.633 . . . . 0.0 111.008 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 34.0 t80 -67.52 164.69 18.37 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-N 113.583 -1.644 . . . . 0.0 110.508 179.78 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 92.7 t -126.27 -71.49 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 O-C-N 124.074 0.859 . . . . 0.0 111.146 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' CYS . . . . . 0.681 ' SG ' ' CD2' ' A' ' 74' ' ' TYR . 17.2 p -155.11 -172.18 4.09 Favored 'General case' 0 N--CA 1.499 2.021 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 -179.801 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.405 ' CD ' ' N ' ' A' ' 85' ' ' GLY . 10.5 tm-20 -116.77 164.2 15.0 Favored 'General case' 0 N--CA 1.501 2.086 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.447 ' HA3' ' O ' ' A' ' 69' ' ' THR . . . -49.63 107.82 0.37 Allowed Glycine 0 N--CA 1.494 2.545 0 CA-C-O 119.013 -0.882 . . . . 0.0 110.937 179.659 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -108.84 34.18 3.83 Favored 'General case' 0 N--CA 1.5 2.074 0 CA-C-O 121.535 0.683 . . . . 0.0 110.655 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 45.4 t -145.4 119.43 9.39 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -81.02 127.97 72.67 Favored Pre-proline 0 N--CA 1.494 1.769 0 C-N-CA 119.592 -0.843 . . . . 0.0 110.036 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_endo -58.56 -17.46 34.88 Favored 'Trans proline' 0 N--CA 1.495 1.605 0 C-N-CA 122.549 2.166 . . . . 0.0 113.019 -177.38 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 30.4 tpt180 -59.74 -41.48 91.06 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 123.717 0.636 . . . . 0.0 110.511 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -90.3 118.93 69.18 Favored Pre-proline 0 N--CA 1.496 1.85 0 O-C-N 124.396 1.06 . . . . 0.0 111.573 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -83.39 41.31 1.05 Allowed 'Trans proline' 0 N--CA 1.494 1.558 0 C-N-CA 123.365 2.71 . . . . 0.0 110.236 166.411 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.18 175.76 5.76 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-N 114.622 -1.172 . . . . 0.0 112.154 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -103.63 126.95 51.1 Favored 'General case' 0 N--CA 1.495 1.823 0 CA-C-N 114.826 -1.079 . . . . 0.0 109.359 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 42.6 m -79.94 163.74 56.44 Favored Pre-proline 0 N--CA 1.496 1.825 0 O-C-N 123.887 0.742 . . . . 0.0 111.732 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.451 ' C ' ' HE ' ' A' ' 97' ' ' ARG . 13.1 Cg_endo -68.66 155.39 69.01 Favored 'Trans proline' 0 N--CA 1.49 1.285 0 C-N-CA 122.511 2.14 . . . . 0.0 110.196 170.201 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.451 ' HE ' ' C ' ' A' ' 96' ' ' PRO . 0.0 OUTLIER -83.23 16.43 2.46 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-N 114.699 -1.137 . . . . 0.0 111.083 -179.919 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -48.0 131.28 15.63 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 123.89 0.743 . . . . 0.0 109.759 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.477 ' HA ' ' HA ' ' A' ' 62' ' ' CYS . 60.1 m -99.64 132.46 44.97 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 114.005 1.113 . . . . 0.0 114.005 -179.599 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 64.7 t0 -129.49 76.3 78.86 Favored Pre-proline 0 N--CA 1.5 2.058 0 O-C-N 124.231 0.957 . . . . 0.0 110.845 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -59.85 -13.78 24.16 Favored 'Trans proline' 0 N--CA 1.494 1.54 0 C-N-CA 122.501 2.134 . . . . 0.0 112.222 176.234 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 69.5 mtp85 -90.31 18.45 6.07 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 124.011 0.819 . . . . 0.0 111.779 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 9.9 tt -116.34 175.7 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.314 0 O-C-N 123.71 0.631 . . . . 0.0 110.497 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.588 ' HB2' ' H ' ' A' ' 77' ' ' ASP . . . -146.01 -62.64 0.32 Allowed 'General case' 0 N--CA 1.498 1.928 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.863 179.683 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 27.9 p90 -161.22 163.93 30.74 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 124.053 0.846 . . . . 0.0 110.978 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -98.27 112.86 4.57 Favored Glycine 0 N--CA 1.492 2.375 0 CA-C-N 113.688 -1.596 . . . . 0.0 111.979 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 93.8 mt -79.54 105.65 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 N-CA-C 106.5 -1.667 . . . . 0.0 106.5 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' CYS . . . . . 0.421 ' HA ' ' HA ' ' A' ' 72' ' ' CYS . 31.2 m -89.07 140.9 29.05 Favored Pre-proline 0 N--CA 1.491 1.599 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -70.87 87.2 0.7 Allowed 'Trans proline' 0 N--CA 1.493 1.481 0 C-N-CA 122.41 2.073 . . . . 0.0 109.085 -176.048 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 68.4 tp -159.98 -50.88 0.05 Allowed 'General case' 0 N--CA 1.495 1.796 0 CA-C-N 114.237 -1.347 . . . . 0.0 108.035 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.855 0 CA-C-O 116.658 -1.639 . . . . 0.0 110.9 179.966 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 62.1 ttm-85 63.14 151.79 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.158 0 O-C-N 124.824 1.328 . . . . 0.0 112.871 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 4.9 tp -62.35 94.77 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 CA-C-N 114.398 -1.274 . . . . 0.0 109.461 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.7 m -89.73 36.77 0.86 Allowed 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 116.881 2.178 . . . . 0.0 116.881 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 14.6 p -91.68 166.37 12.83 Favored 'General case' 0 N--CA 1.496 1.849 0 CA-C-N 113.518 -1.674 . . . . 0.0 108.901 179.521 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 14.0 p30 -161.42 142.65 11.36 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-N 114.861 -1.063 . . . . 0.0 111.791 179.735 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -61.69 -18.76 60.89 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-N 114.436 -1.256 . . . . 0.0 112.843 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 46.8 t -89.46 -69.54 0.71 Allowed 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 113.464 0.913 . . . . 0.0 113.464 -179.668 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.41 ' N ' ' SG ' ' A' ' 37' ' ' CYS . . . -75.45 1.19 14.67 Favored 'General case' 0 N--CA 1.5 2.043 0 N-CA-C 113.547 0.943 . . . . 0.0 113.547 -179.617 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -67.44 165.5 43.54 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 110.426 -1.07 . . . . 0.0 110.426 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 8.9 t -73.12 125.13 26.97 Favored 'General case' 0 N--CA 1.493 1.711 0 CA-C-O 121.508 0.671 . . . . 0.0 110.204 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 7.1 ttpm? -72.2 87.75 1.11 Allowed 'General case' 0 N--CA 1.49 1.551 0 CA-C-N 114.239 -1.346 . . . . 0.0 108.719 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 171.1 -34.36 0.16 Allowed Glycine 0 N--CA 1.488 2.134 0 CA-C-N 113.282 -1.781 . . . . 0.0 108.882 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 83.9 m -101.55 133.61 45.96 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.487 ' HB3' ' CE1' ' A' ' 23' ' ' PHE . 9.0 mtpm? -81.92 88.96 6.34 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 113.428 -1.714 . . . . 0.0 113.732 -179.278 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -54.48 126.22 22.66 Favored 'General case' 0 N--CA 1.499 2.018 0 N-CA-C 105.911 -1.885 . . . . 0.0 105.911 179.64 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -132.28 146.45 52.0 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 112.788 -2.005 . . . . 0.0 112.969 -179.188 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 40.2 t -84.5 139.81 31.9 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-N 112.563 -2.108 . . . . 0.0 114.866 -179.619 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -51.91 -32.14 31.45 Favored 'General case' 0 N--CA 1.499 1.981 0 CA-C-N 111.826 -2.443 . . . . 0.0 114.854 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -54.29 -21.67 9.87 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 123.981 0.8 . . . . 0.0 111.62 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 109.16 32.41 3.03 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 108.646 -1.782 . . . . 0.0 108.646 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 90.7 m -137.26 147.38 45.68 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 124.08 0.518 . . . . 0.0 110.961 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.487 ' CE1' ' HB3' ' A' ' 15' ' ' LYS . 8.6 t80 -80.43 140.93 35.74 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-N 114.637 -1.165 . . . . 0.0 110.216 179.813 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 98.0 t -100.42 -78.26 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 106.22 -1.77 . . . . 0.0 106.22 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -172.12 168.07 5.86 Favored 'General case' 0 N--CA 1.504 2.226 0 O-C-N 123.579 0.549 . . . . 0.0 110.404 179.78 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -87.59 155.38 19.99 Favored 'General case' 0 N--CA 1.501 2.114 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -48.22 131.71 19.65 Favored Glycine 0 N--CA 1.501 2.994 0 C-N-CA 120.026 -1.083 . . . . 0.0 111.48 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -101.91 33.21 3.11 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 37.1 t -149.58 137.4 20.29 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-N 114.502 -1.226 . . . . 0.0 107.922 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -79.59 134.1 58.35 Favored Pre-proline 0 N--CA 1.494 1.754 0 O-C-N 123.987 0.804 . . . . 0.0 109.007 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -57.0 -13.76 12.64 Favored 'Trans proline' 0 N--CA 1.497 1.7 0 C-N-CA 122.423 2.082 . . . . 0.0 112.789 -177.795 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 79.8 ttt180 -68.59 -43.04 77.34 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 123.658 0.599 . . . . 0.0 111.878 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 16.5 p30 -73.64 128.59 86.75 Favored Pre-proline 0 N--CA 1.495 1.792 0 C-N-CA 119.523 -0.871 . . . . 0.0 112.285 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -82.61 85.2 1.65 Allowed 'Trans proline' 0 N--CA 1.492 1.406 0 C-N-CA 123.509 2.806 . . . . 0.0 111.486 169.223 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 20.7 pttp -164.11 166.39 21.32 Favored 'General case' 0 N--CA 1.501 2.101 0 C-N-CA 120.621 -0.432 . . . . 0.0 111.829 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -129.14 158.79 38.0 Favored 'General case' 0 N--CA 1.497 1.883 0 CA-C-N 114.592 -1.186 . . . . 0.0 110.144 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.41 ' SG ' ' N ' ' A' ' 9' ' ' ALA . 85.2 m -88.55 -178.68 5.89 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-N 114.865 -1.061 . . . . 0.0 110.744 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 63.7 p -81.01 -2.16 46.84 Favored 'General case' 0 N--CA 1.497 1.91 0 CA-C-N 114.925 -1.034 . . . . 0.0 110.669 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.44 ' N ' HD22 ' A' ' 39' ' ' LEU . 3.1 mm? -79.41 -57.45 3.7 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 33.6 m120 53.52 103.0 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.982 0 O-C-N 124.83 1.331 . . . . 0.0 112.808 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 60.9 m 63.98 135.12 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.937 0 CA-C-N 114.602 -1.181 . . . . 0.0 112.963 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 46.3 t0 -135.81 102.03 10.42 Favored Pre-proline 0 N--CA 1.498 1.951 0 C-N-CA 120.305 -0.558 . . . . 0.0 111.674 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -57.22 -29.39 83.47 Favored 'Trans proline' 0 N--CA 1.494 1.543 0 C-N-CA 122.758 2.305 . . . . 0.0 111.467 174.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -62.75 -39.44 94.12 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 123.997 0.811 . . . . 0.0 109.309 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.426 ' CG2' ' N ' ' A' ' 46' ' ' ALA . 20.3 mt -76.97 161.8 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 CA-C-O 121.927 0.87 . . . . 0.0 109.505 179.776 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.426 ' N ' ' CG2' ' A' ' 45' ' ' ILE . . . -122.65 -54.21 1.86 Allowed 'General case' 0 N--CA 1.494 1.756 0 CA-C-N 112.423 -2.171 . . . . 0.0 109.054 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 14.4 p90 -171.15 159.32 5.88 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-N 114.727 -1.124 . . . . 0.0 111.523 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -92.31 111.55 4.07 Favored Glycine 0 N--CA 1.493 2.484 0 CA-C-N 113.523 -1.671 . . . . 0.0 111.073 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 33.0 m -79.95 98.1 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 N-CA-C 105.068 -2.197 . . . . 0.0 105.068 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 8.0 m -79.63 121.25 82.32 Favored Pre-proline 0 N--CA 1.492 1.633 0 CA-C-N 113.496 -1.684 . . . . 0.0 108.019 -179.768 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -62.58 128.85 24.59 Favored 'Trans proline' 0 N--CA 1.495 1.602 0 C-N-CA 122.806 2.337 . . . . 0.0 113.173 -165.14 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.98 76.14 9.43 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 104.594 -2.372 . . . . 0.0 104.594 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 68.4 p -103.29 -45.24 4.95 Favored 'General case' 0 N--CA 1.498 1.94 0 CA-C-N 114.169 -1.378 . . . . 0.0 110.679 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.42 ' N ' ' CD ' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -51.43 -22.64 3.16 Favored 'General case' 0 N--CA 1.497 1.904 0 CA-C-N 114.226 -1.352 . . . . 0.0 112.757 179.902 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 25.3 tp10 50.42 53.96 11.99 Favored 'General case' 0 N--CA 1.498 1.941 0 CA-C-O 122.192 0.996 . . . . 0.0 109.693 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 17.6 tppt? -86.76 114.7 23.65 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-N 113.746 -1.57 . . . . 0.0 112.833 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -83.2 167.17 17.96 Favored 'General case' 0 N--CA 1.501 2.075 0 CA-C-N 114.836 -1.075 . . . . 0.0 108.772 179.72 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 17.3 t-20 -90.33 48.13 1.52 Allowed 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 59.88 10.05 1.96 Allowed 'General case' 0 N--CA 1.502 2.154 0 CA-C-N 114.455 -1.248 . . . . 0.0 111.978 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 40.8 mmt180 -141.41 143.44 33.93 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 6.1 tp -84.1 65.99 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 CA-C-O 122.116 0.96 . . . . 0.0 109.851 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.425 ' HA ' ' HA ' ' A' ' 99' ' ' CYS . 56.2 m -90.75 36.54 0.9 Allowed 'General case' 0 N--CA 1.489 1.484 0 CA-C-O 123.297 1.522 . . . . 0.0 112.593 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 61.3 m -90.7 133.29 35.26 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 111.466 -2.606 . . . . 0.0 104.307 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.453 ' ND2' ' H ' ' A' ' 67' ' ' ALA . 34.6 p-10 -153.82 154.45 33.98 Favored 'General case' 0 N--CA 1.503 2.194 0 N-CA-C 113.855 1.058 . . . . 0.0 113.855 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -67.18 -22.92 65.72 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-N 113.74 -1.573 . . . . 0.0 114.513 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 51.4 t -89.81 -68.71 0.76 Allowed 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 113.381 0.882 . . . . 0.0 113.381 -179.729 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.453 ' H ' ' ND2' ' A' ' 64' ' ' ASN . . . -71.47 -2.05 15.36 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 123.812 0.695 . . . . 0.0 111.833 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.425 ' HA3' ' CZ ' ' A' ' 74' ' ' TYR . . . -65.88 166.95 35.27 Favored Glycine 0 N--CA 1.491 2.307 0 O-C-N 123.829 0.706 . . . . 0.0 111.621 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 6.8 t -77.47 129.27 35.51 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 124.245 0.615 . . . . 0.0 111.954 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -71.64 81.6 0.84 Allowed 'General case' 0 N--CA 1.494 1.756 0 CA-C-N 114.378 -1.283 . . . . 0.0 110.899 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 174.66 -36.14 0.11 Allowed Glycine 0 N--CA 1.488 2.154 0 CA-C-N 113.11 -1.859 . . . . 0.0 108.728 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 46.3 m -94.86 129.55 41.81 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 13.3 mmmm -75.47 84.96 2.57 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 112.912 -1.949 . . . . 0.0 111.279 -179.673 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.425 ' CZ ' ' HA3' ' A' ' 68' ' ' GLY . 42.8 m-85 -50.61 121.7 6.16 Favored 'General case' 0 N--CA 1.503 2.215 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 179.673 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -129.88 150.64 51.09 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 111.896 -2.411 . . . . 0.0 113.417 -179.182 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 33.1 t -90.33 136.59 32.96 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-N 112.65 -2.068 . . . . 0.0 114.103 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.438 ' HB3' ' HB2' ' A' ' 104' ' ' ALA . 0.9 OUTLIER -51.32 -28.15 11.45 Favored 'General case' 0 N--CA 1.5 2.044 0 CA-C-N 112.386 -2.188 . . . . 0.0 114.705 179.833 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -54.16 -22.47 11.32 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 123.93 0.769 . . . . 0.0 111.466 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 110.66 29.74 3.51 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 108.637 -1.785 . . . . 0.0 108.637 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 85.4 m -139.7 146.49 39.69 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 123.985 0.462 . . . . 0.0 111.102 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.405 ' CZ ' ' HA ' ' A' ' 83' ' ' CYS . 21.5 t80 -76.06 154.0 35.98 Favored 'General case' 0 N--CA 1.493 1.725 0 CA-C-N 114.352 -1.295 . . . . 0.0 110.438 179.778 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 57.9 t -117.11 -79.68 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' CYS . . . . . 0.405 ' HA ' ' CZ ' ' A' ' 81' ' ' PHE . 0.2 OUTLIER -162.69 179.65 7.53 Favored 'General case' 0 N--CA 1.505 2.286 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 179.726 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -97.69 159.37 14.97 Favored 'General case' 0 N--CA 1.507 2.392 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 179.669 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -53.15 132.32 41.82 Favored Glycine 0 N--CA 1.5 2.944 0 C-N-CA 119.42 -1.372 . . . . 0.0 110.306 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -101.92 33.02 3.18 Favored 'General case' 0 N--CA 1.499 2.0 0 CA-C-O 122.143 0.973 . . . . 0.0 108.391 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 41.2 t -157.6 152.8 25.89 Favored 'General case' 0 N--CA 1.495 1.801 0 CA-C-N 114.533 -1.212 . . . . 0.0 109.345 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -97.14 138.05 21.24 Favored Pre-proline 0 N--CA 1.494 1.74 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -64.48 86.59 0.16 Allowed 'Trans proline' 0 N--CA 1.494 1.53 0 C-N-CA 122.131 1.887 . . . . 0.0 108.178 173.483 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 3.5 mtp-105 178.25 -31.31 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.011 0 CA-C-N 114.031 -1.44 . . . . 0.0 109.352 -179.789 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 3.0 p30 -53.02 125.93 41.99 Favored Pre-proline 0 N--CA 1.497 1.923 0 O-C-N 124.04 0.838 . . . . 0.0 112.919 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -82.73 48.0 2.63 Favored 'Trans proline' 0 N--CA 1.49 1.301 0 C-N-CA 122.916 2.411 . . . . 0.0 108.684 160.8 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 45.8 mmtm -126.13 169.57 12.67 Favored 'General case' 0 N--CA 1.498 1.965 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.462 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -145.58 135.86 23.95 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-N 114.707 -1.133 . . . . 0.0 109.529 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' CYS . . . . . 0.478 ' HB3' ' H ' ' A' ' 97' ' ' ARG . 86.9 m -79.96 157.76 73.43 Favored Pre-proline 0 N--CA 1.495 1.809 0 CA-C-N 115.076 -0.965 . . . . 0.0 111.696 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -69.28 -5.61 16.32 Favored 'Trans proline' 0 N--CA 1.496 1.639 0 C-N-CA 122.841 2.361 . . . . 0.0 110.369 160.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.478 ' H ' ' HB3' ' A' ' 95' ' ' CYS . 17.5 tpp85 -79.31 -50.13 11.37 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 21.0 m120 54.05 -159.67 0.16 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 124.797 1.311 . . . . 0.0 110.401 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.425 ' HA ' ' HA ' ' A' ' 62' ' ' CYS . 64.6 m -51.61 120.01 4.75 Favored 'General case' 0 N--CA 1.497 1.913 0 CA-C-N 115.208 -0.905 . . . . 0.0 108.773 179.769 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -107.64 99.31 28.48 Favored Pre-proline 0 N--CA 1.499 2.01 0 O-C-N 123.684 0.615 . . . . 0.0 111.293 -179.766 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -64.18 -27.82 64.66 Favored 'Trans proline' 0 N--CA 1.494 1.555 0 C-N-CA 122.634 2.223 . . . . 0.0 111.328 -176.137 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 25.8 mtm105 -60.01 -39.85 87.22 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 18.0 mt -76.0 160.98 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 CA-C-N 113.927 -1.488 . . . . 0.0 111.121 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.438 ' HB2' ' HB3' ' A' ' 77' ' ' ASP . . . -123.79 -61.77 1.35 Allowed 'General case' 0 N--CA 1.491 1.612 0 CA-C-N 112.176 -2.284 . . . . 0.0 109.72 -179.787 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 20.0 p90 -160.49 157.23 27.19 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-N 114.806 -1.088 . . . . 0.0 111.941 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.415 ' HA2' ' HA ' ' A' ' 74' ' ' TYR . . . -94.96 109.79 3.9 Favored Glycine 0 N--CA 1.488 2.162 0 CA-C-N 112.864 -1.971 . . . . 0.0 111.406 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 65.0 mt -79.17 95.73 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 CA-C-N 114.577 -0.811 . . . . 0.0 110.913 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 1.5 m -79.09 143.32 60.93 Favored Pre-proline 0 N--CA 1.503 2.203 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 179.557 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -65.4 164.99 23.87 Favored 'Trans proline' 0 N--CA 1.494 1.53 0 C-N-CA 122.613 2.208 . . . . 0.0 111.555 -179.559 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 64.2 tp -153.93 -47.21 0.09 Allowed 'General case' 0 N--CA 1.496 1.868 0 CA-C-N 114.969 -1.014 . . . . 0.0 109.465 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.503 2.177 0 CA-C-O 117.644 -1.169 . . . . 0.0 112.753 -179.942 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 74.4 ttt-85 -87.44 -108.24 0.07 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 124.118 0.886 . . . . 0.0 109.004 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.433 ' O ' ' HA ' ' A' ' 41' ' ' CYS . 9.1 tp -85.89 53.13 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 123.213 0.321 . . . . 0.0 110.647 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.61 ' HA ' ' CA ' ' A' ' 41' ' ' CYS . 1.6 m -79.31 39.08 0.38 Allowed 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 117.279 2.325 . . . . 0.0 117.279 -179.858 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.1 p -91.23 151.05 21.08 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 112.176 -2.284 . . . . 0.0 106.357 179.197 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 45.4 p-10 -160.71 173.86 14.81 Favored 'General case' 0 N--CA 1.494 1.774 0 CA-C-N 113.453 -1.703 . . . . 0.0 109.644 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 4.2 t -72.01 -24.89 61.63 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-N 114.698 -1.137 . . . . 0.0 112.863 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 40.4 t -89.25 -69.54 0.71 Allowed 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 113.68 0.993 . . . . 0.0 113.68 -179.605 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -81.78 36.83 0.45 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 124.531 1.144 . . . . 0.0 112.543 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -82.0 -119.51 0.54 Allowed Glycine 0 N--CA 1.493 2.473 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 37.0 p -155.74 123.86 5.78 Favored 'General case' 0 N--CA 1.5 2.035 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.67 144.58 42.87 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-N 115.034 -0.985 . . . . 0.0 110.928 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 91.5 -18.18 53.35 Favored Glycine 0 N--CA 1.492 2.43 0 CA-C-N 114.486 -1.234 . . . . 0.0 110.959 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 91.4 m -99.54 171.65 7.8 Favored 'General case' 0 N--CA 1.498 1.935 0 C-N-CA 120.118 -0.633 . . . . 0.0 110.707 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 60.8 mttp -129.79 90.1 2.92 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-N 115.066 -0.97 . . . . 0.0 109.667 -179.514 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 40.8 m-85 -54.79 133.8 47.59 Favored 'General case' 0 N--CA 1.495 1.777 0 CA-C-N 114.133 -1.394 . . . . 0.0 109.384 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -137.73 157.22 46.93 Favored 'General case' 0 N--CA 1.487 1.415 0 CA-C-N 112.934 -1.939 . . . . 0.0 113.682 -179.22 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 30.9 t -103.82 134.43 47.14 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-N 112.685 -2.052 . . . . 0.0 113.211 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.42 ' HB3' ' HB2' ' A' ' 46' ' ' ALA . 1.0 OUTLIER -50.05 -27.16 5.15 Favored 'General case' 0 N--CA 1.503 2.219 0 N-CA-C 115.541 1.682 . . . . 0.0 115.541 -179.99 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -55.67 -16.66 4.45 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 123.836 0.71 . . . . 0.0 111.749 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 104.26 29.42 5.43 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 108.442 -1.863 . . . . 0.0 108.442 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 59.9 m -137.2 144.39 42.84 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 124.088 0.522 . . . . 0.0 110.579 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 21.7 t80 -77.08 145.36 37.91 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-N 114.266 -1.334 . . . . 0.0 109.59 179.771 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 91.4 t -100.17 -76.39 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.441 ' SG ' ' O ' ' A' ' 26' ' ' GLU . 0.1 OUTLIER -171.06 179.76 2.97 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 123.399 0.437 . . . . 0.0 110.889 179.823 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.441 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 35.6 tt0 -81.76 149.64 28.32 Favored 'General case' 0 N--CA 1.501 2.11 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.318 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -70.58 118.4 7.72 Favored Glycine 0 N--CA 1.497 2.763 0 N-CA-C 106.643 -2.583 . . . . 0.0 106.643 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -96.87 26.64 4.46 Favored 'General case' 0 N--CA 1.501 2.086 0 CA-C-O 121.481 0.658 . . . . 0.0 111.317 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 45.7 t -106.15 120.51 42.0 Favored 'General case' 0 N--CA 1.495 1.776 0 CA-C-N 114.349 -1.296 . . . . 0.0 109.993 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.455 ' H ' HD21 ' A' ' 33' ' ' ASN . 12.5 t70 -132.27 140.98 39.67 Favored Pre-proline 0 N--CA 1.494 1.75 0 N-CA-C 106.543 -1.651 . . . . 0.0 106.543 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -67.12 79.51 0.4 Allowed 'Trans proline' 0 N--CA 1.494 1.525 0 C-N-CA 122.584 2.19 . . . . 0.0 110.238 175.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 5.2 mmt-85 178.21 -46.13 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.77 0 CA-C-N 113.59 -1.641 . . . . 0.0 108.008 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.455 HD21 ' H ' ' A' ' 30' ' ' ASP . 28.5 p30 -83.02 149.28 58.79 Favored Pre-proline 0 N--CA 1.495 1.776 0 O-C-N 124.043 0.84 . . . . 0.0 111.755 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_endo -76.77 119.2 5.06 Favored 'Trans proline' 0 N--CA 1.491 1.333 0 C-N-CA 122.875 2.383 . . . . 0.0 108.696 165.078 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 41.3 mtmt -72.37 117.73 14.39 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -160.68 101.13 1.31 Allowed 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 113.997 1.11 . . . . 0.0 113.997 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 1.6 m -160.42 -53.05 0.05 Allowed 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 105.193 -2.151 . . . . 0.0 105.193 179.665 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 95.2 m -121.59 160.5 24.21 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-N 112.808 -1.996 . . . . 0.0 108.844 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -93.21 26.65 2.8 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-N 114.663 -1.153 . . . . 0.0 110.896 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 4.0 m120 60.54 -177.83 0.1 Allowed 'General case' 0 N--CA 1.501 2.095 0 CA-C-N 114.257 -1.338 . . . . 0.0 113.192 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.61 ' CA ' ' HA ' ' A' ' 4' ' ' CYS . 1.7 m 52.27 79.73 0.1 Allowed 'General case' 0 N--CA 1.495 1.803 0 CA-C-O 123.723 1.725 . . . . 0.0 112.674 -179.704 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.4 ' O ' HG22 ' A' ' 45' ' ' ILE . 11.2 t70 -91.78 110.13 41.52 Favored Pre-proline 0 N--CA 1.484 1.273 0 CA-C-N 110.091 -3.231 . . . . 0.0 106.844 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_endo -63.92 -19.53 66.81 Favored 'Trans proline' 0 N--CA 1.495 1.614 0 C-N-CA 121.791 1.661 . . . . 0.0 112.365 -170.358 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.502 ' N ' ' HD2' ' A' ' 44' ' ' ARG . 2.1 mpt_? -90.56 -26.89 19.48 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 112.918 0.711 . . . . 0.0 112.918 -179.764 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.4 HG22 ' O ' ' A' ' 42' ' ' ASP . 6.3 tt -64.56 169.05 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 123.558 0.536 . . . . 0.0 111.939 -179.536 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.42 ' HB2' ' HB3' ' A' ' 19' ' ' ASP . . . -140.86 -59.12 0.51 Allowed 'General case' 0 N--CA 1.494 1.751 0 CA-C-N 114.806 -1.088 . . . . 0.0 110.044 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 41.4 p90 -165.52 165.52 18.94 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-N 114.659 -1.155 . . . . 0.0 109.416 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -117.18 121.08 5.02 Favored Glycine 0 N--CA 1.491 2.315 0 O-C-N 125.386 1.678 . . . . 0.0 110.878 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 8.4 p -79.29 133.71 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 N-CA-C 106.114 -1.81 . . . . 0.0 106.114 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 7.8 m -114.97 76.24 4.29 Favored Pre-proline 0 N--CA 1.499 1.987 0 O-C-N 123.742 0.651 . . . . 0.0 110.441 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -73.65 -54.17 0.11 Allowed 'Trans proline' 0 N--CA 1.493 1.447 0 C-N-CA 122.952 2.435 . . . . 0.0 110.704 -176.659 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.486 HH12 ' H ' ' A' ' 56' ' ' LYS . 4.1 mmp_? -119.32 73.1 0.93 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 124.69 1.244 . . . . 0.0 110.733 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 43.3 t -82.6 -44.99 15.15 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 179.767 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 43.7 mm-40 -117.72 116.03 26.22 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -63.14 113.74 3.33 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 123.974 0.796 . . . . 0.0 109.021 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.486 ' H ' HH12 ' A' ' 52' ' ' ARG . 25.0 pttm -87.27 63.28 7.7 Favored 'General case' 0 N--CA 1.5 2.027 0 CA-C-N 115.131 -0.94 . . . . 0.0 113.456 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 24.4 ttmm 55.99 97.17 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.114 0 CA-C-N 114.818 -1.083 . . . . 0.0 112.471 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -168.83 -27.25 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.971 0 CA-C-N 113.871 -1.513 . . . . 0.0 107.221 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -42.03 -36.79 1.21 Allowed 'General case' 0 N--CA 1.497 1.922 0 O-C-N 125.012 1.445 . . . . 0.0 112.163 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 16.1 ptm180 -53.49 114.11 1.4 Allowed 'General case' 0 N--CA 1.494 1.751 0 CA-C-N 114.575 -1.193 . . . . 0.0 111.02 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 7.7 tp -87.92 65.82 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 CA-C-N 114.498 -1.228 . . . . 0.0 111.147 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 1.7 m -85.16 40.24 0.81 Allowed 'General case' 0 N--CA 1.495 1.778 0 CA-C-N 114.608 -1.178 . . . . 0.0 113.993 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 12.6 t -90.72 -174.93 4.24 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-N 113.379 -1.737 . . . . 0.0 108.195 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -157.03 155.04 30.53 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 106.388 -1.708 . . . . 0.0 106.388 179.65 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 27.6 t -54.82 -26.87 37.8 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 114.343 1.238 . . . . 0.0 114.343 -179.411 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 44.2 t -76.41 -48.47 19.65 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-N 114.386 -1.279 . . . . 0.0 111.391 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -79.49 57.19 2.34 Favored 'General case' 0 N--CA 1.497 1.895 0 CA-C-N 113.348 -1.751 . . . . 0.0 112.829 -179.71 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -147.46 152.59 24.7 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 6.8 t -65.56 128.4 35.76 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-N 113.255 -1.472 . . . . 0.0 109.565 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -73.53 88.1 1.63 Allowed 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 106.22 -1.77 . . . . 0.0 106.22 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 168.98 -25.46 0.11 Allowed Glycine 0 N--CA 1.488 2.132 0 CA-C-N 112.673 -2.058 . . . . 0.0 110.07 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 56.2 m -100.4 124.08 45.44 Favored 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 122.094 0.95 . . . . 0.0 111.541 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 28.1 mtpp -73.49 93.59 2.01 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 112.681 -2.054 . . . . 0.0 112.157 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.473 ' CD1' HD13 ' A' ' 103' ' ' ILE . 8.3 m-85 -48.83 128.25 15.31 Favored 'General case' 0 N--CA 1.501 2.118 0 N-CA-C 106.704 -1.591 . . . . 0.0 106.704 179.413 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -142.87 155.24 44.73 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 114.706 -1.134 . . . . 0.0 112.348 -179.467 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 40.2 t -101.52 133.83 45.57 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-N 113.231 -1.804 . . . . 0.0 110.939 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -48.87 -28.74 3.98 Favored 'General case' 0 N--CA 1.502 2.132 0 N-CA-C 115.834 1.79 . . . . 0.0 115.834 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -52.0 -24.25 6.32 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 123.946 0.779 . . . . 0.0 111.738 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 113.63 28.27 3.28 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 108.616 -1.794 . . . . 0.0 108.616 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 88.6 m -139.17 140.6 37.88 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 124.045 0.497 . . . . 0.0 110.981 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 12.5 t80 -68.57 159.08 32.59 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-N 114.198 -1.365 . . . . 0.0 110.804 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 91.3 t -121.42 -71.4 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 CA-C-N 114.823 -1.081 . . . . 0.0 110.104 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' CYS . . . . . 0.576 ' SG ' ' N ' ' A' ' 84' ' ' GLU . 0.5 OUTLIER -153.48 -163.02 1.57 Allowed 'General case' 0 N--CA 1.501 2.105 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 -179.875 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.576 ' N ' ' SG ' ' A' ' 83' ' ' CYS . 12.5 tp10 -129.03 146.62 50.95 Favored 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 179.433 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -59.01 138.65 49.45 Favored Glycine 0 N--CA 1.501 2.991 0 N-CA-C 109.257 -1.537 . . . . 0.0 109.257 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 35.8 mm-40 -113.89 31.76 6.32 Favored 'General case' 0 N--CA 1.501 2.098 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 36.8 t -156.0 105.42 2.35 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -79.26 144.73 62.95 Favored Pre-proline 0 N--CA 1.495 1.796 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -64.76 70.97 0.24 Allowed 'Trans proline' 0 N--CA 1.498 1.744 0 C-N-CA 123.088 2.525 . . . . 0.0 110.861 164.127 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 31.4 mtm105 -163.6 -49.95 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 104.868 -2.271 . . . . 0.0 104.868 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -90.41 133.23 33.43 Favored Pre-proline 0 N--CA 1.489 1.487 0 CA-C-N 114.053 -1.43 . . . . 0.0 110.356 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -79.9 50.26 3.47 Favored 'Trans proline' 0 N--CA 1.495 1.598 0 C-N-CA 123.521 2.814 . . . . 0.0 112.1 173.584 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -80.47 124.8 29.23 Favored 'General case' 0 N--CA 1.5 2.047 0 C-N-CA 120.126 -0.63 . . . . 0.0 111.076 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -80.1 166.13 21.81 Favored 'General case' 0 N--CA 1.497 1.878 0 CA-C-N 114.679 -1.146 . . . . 0.0 109.525 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 97.0 m -151.44 160.55 31.64 Favored Pre-proline 0 N--CA 1.497 1.906 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -60.33 130.17 32.84 Favored 'Trans proline' 0 N--CA 1.493 1.47 0 C-N-CA 122.709 2.273 . . . . 0.0 109.401 166.128 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.527 ' HA ' ' NE ' ' A' ' 97' ' ' ARG . 3.4 tpm_? -81.27 10.28 5.77 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 123.991 0.807 . . . . 0.0 110.203 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -52.47 153.83 2.83 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 114.105 1.15 . . . . 0.0 114.105 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 63.0 m -91.93 137.56 32.26 Favored 'General case' 0 N--CA 1.495 1.776 0 CA-C-N 113.897 -1.501 . . . . 0.0 111.402 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -119.98 88.36 40.43 Favored Pre-proline 0 N--CA 1.497 1.917 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 179.645 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -63.98 -33.35 63.27 Favored 'Trans proline' 0 N--CA 1.491 1.327 0 C-N-CA 122.683 2.255 . . . . 0.0 112.545 -170.743 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 15.9 ptm180 -64.98 -30.18 71.15 Favored 'General case' 0 N--CA 1.497 1.895 0 C-N-CA 119.574 -0.85 . . . . 0.0 111.965 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.473 HD13 ' CD1' ' A' ' 74' ' ' TYR . 11.9 mt -70.38 156.04 7.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 C-N-CA 118.907 -1.117 . . . . 0.0 109.66 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -137.94 -40.44 0.54 Allowed 'General case' 0 N--CA 1.491 1.58 0 CA-C-N 112.617 -2.083 . . . . 0.0 110.132 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 46.1 m-85 -143.0 -165.28 2.03 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 124.333 1.02 . . . . 0.0 110.635 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -154.97 94.07 0.14 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 103.907 -3.677 . . . . 0.0 103.907 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 37.7 mm -79.16 96.28 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 N-CA-C 116.066 1.876 . . . . 0.0 116.066 -179.464 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 1.7 m -79.96 150.94 72.78 Favored Pre-proline 0 N--CA 1.5 2.052 0 N-CA-C 105.861 -1.903 . . . . 0.0 105.861 179.238 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -44.82 111.82 0.32 Allowed 'Trans proline' 0 N--CA 1.497 1.682 0 C-N-CA 123.115 2.543 . . . . 0.0 112.394 -172.313 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.4 ' C ' HD12 ' A' ' 110' ' ' LEU . 3.9 pp -148.53 0.4 0.58 Allowed 'General case' 0 N--CA 1.497 1.897 0 CA-C-N 114.867 -1.061 . . . . 0.0 112.327 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 1.99 0 CA-C-O 115.056 -2.402 . . . . 0.0 111.726 -179.967 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 47.8 tpt85 -68.66 133.43 48.43 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-N 115.179 -0.918 . . . . 0.0 110.37 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 7.6 tp -84.5 49.21 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 CA-C-N 114.634 -1.166 . . . . 0.0 110.077 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.434 ' HA ' ' HA ' ' A' ' 41' ' ' CYS . 1.6 m -82.38 59.76 4.73 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 115.24 1.57 . . . . 0.0 115.24 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 38.6 m -91.03 163.43 14.31 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 105.092 -2.188 . . . . 0.0 105.092 179.393 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.477 ' ND2' ' H ' ' A' ' 9' ' ' ALA . 40.8 p-10 -158.5 175.66 13.4 Favored 'General case' 0 N--CA 1.499 2.023 0 C-N-CA 118.895 -1.122 . . . . 0.0 113.057 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 45.3 t -78.44 -32.47 48.54 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-N 113.198 -1.819 . . . . 0.0 113.704 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 38.3 t -77.01 -62.86 1.51 Allowed 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 113.892 1.071 . . . . 0.0 113.892 -179.596 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.477 ' H ' ' ND2' ' A' ' 6' ' ' ASN . . . -84.81 63.97 8.33 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 124.743 1.277 . . . . 0.0 111.376 -179.702 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -137.54 -169.61 11.67 Favored Glycine 0 N--CA 1.498 2.823 0 CA-C-N 113.559 -1.655 . . . . 0.0 111.518 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.414 ' N ' ' OH ' ' A' ' 16' ' ' TYR . 4.5 t -102.62 111.62 24.02 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 114.191 1.182 . . . . 0.0 114.191 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.404 ' HA ' ' HA3' ' A' ' 27' ' ' GLY . 21.8 pttp -64.87 81.7 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.958 0 CA-C-N 113.608 -1.633 . . . . 0.0 110.789 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -175.18 -31.57 0.04 OUTLIER Glycine 0 N--CA 1.486 2.028 0 CA-C-N 113.057 -1.883 . . . . 0.0 109.629 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.445 ' HA ' ' HA ' ' A' ' 50' ' ' CYS . 21.9 m -104.64 148.19 26.81 Favored 'General case' 0 N--CA 1.501 2.085 0 C-N-CA 118.775 -1.17 . . . . 0.0 112.964 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.654 ' HZ2' HH12 ' A' ' 60' ' ' ARG . 38.2 ttpt -92.95 88.3 6.1 Favored 'General case' 0 N--CA 1.484 1.23 0 CA-C-N 113.307 -1.77 . . . . 0.0 107.428 -179.397 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.414 ' OH ' ' N ' ' A' ' 11' ' ' THR . 11.0 m-30 -46.4 134.95 8.64 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-N 113.59 -1.641 . . . . 0.0 108.494 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 10.8 t80 -145.16 156.16 43.71 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-N 113.232 -1.804 . . . . 0.0 111.511 -179.336 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 28.8 t -112.53 136.11 52.45 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-N 111.838 -2.437 . . . . 0.0 115.313 -179.462 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -52.14 -21.47 3.32 Favored 'General case' 0 N--CA 1.499 1.989 0 CA-C-N 112.266 -2.243 . . . . 0.0 113.715 179.796 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 43.6 p30 -64.19 -1.86 1.81 Allowed 'General case' 0 N--CA 1.497 1.917 0 O-C-N 124.04 0.838 . . . . 0.0 111.231 179.758 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 85.74 29.15 27.29 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 108.94 -1.664 . . . . 0.0 108.94 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 95.5 m -141.21 150.47 42.73 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 121.831 0.824 . . . . 0.0 110.557 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 24.2 t80 -73.52 155.65 38.97 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-N 113.144 -1.844 . . . . 0.0 111.979 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 90.9 t -115.27 -77.0 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 CA-C-N 114.673 -1.149 . . . . 0.0 109.056 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.654 ' SG ' ' N ' ' A' ' 26' ' ' GLU . 0.1 OUTLIER -166.97 -168.61 1.13 Allowed 'General case' 0 N--CA 1.507 2.393 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 179.979 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.654 ' N ' ' SG ' ' A' ' 25' ' ' CYS . 3.5 tm-20 -128.36 140.96 51.58 Favored 'General case' 0 N--CA 1.5 2.046 0 N-CA-C 104.52 -2.4 . . . . 0.0 104.52 179.496 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.404 ' HA3' ' HA ' ' A' ' 12' ' ' LYS . . . -39.27 117.82 0.78 Allowed Glycine 0 N--CA 1.5 2.928 0 CA-C-O 122.041 0.8 . . . . 0.0 114.869 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -92.87 0.66 57.45 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-N 113.072 -1.564 . . . . 0.0 112.061 -179.686 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 27.5 t -156.22 170.3 22.56 Favored 'General case' 0 N--CA 1.501 2.103 0 C-N-CA 119.609 -0.837 . . . . 0.0 111.467 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -79.29 143.84 61.12 Favored Pre-proline 0 N--CA 1.493 1.694 0 CA-C-N 114.626 -1.17 . . . . 0.0 107.883 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -70.37 67.67 2.08 Favored 'Trans proline' 0 N--CA 1.5 1.9 0 C-N-CA 123.158 2.572 . . . . 0.0 111.073 172.578 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 67.0 mtp85 -160.33 -39.44 0.05 Allowed 'General case' 0 N--CA 1.496 1.855 0 CA-C-N 113.246 -1.797 . . . . 0.0 107.764 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.537 HD22 ' N ' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -39.71 102.98 0.27 Allowed Pre-proline 0 N--CA 1.498 1.945 0 O-C-N 124.876 1.36 . . . . 0.0 114.416 -179.877 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -76.4 179.57 6.26 Favored 'Trans proline' 0 N--CA 1.494 1.54 0 C-N-CA 122.821 2.348 . . . . 0.0 111.029 -179.516 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 25.7 ttpp 62.9 155.25 0.05 OUTLIER 'General case' 0 N--CA 1.5 2.071 0 O-C-N 124.673 1.233 . . . . 0.0 112.618 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -79.87 147.33 31.76 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-N 114.639 -1.164 . . . . 0.0 110.124 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.579 ' H ' HD21 ' A' ' 40' ' ' ASN . 98.4 m -79.66 -87.91 0.07 Allowed 'General case' 0 N--CA 1.492 1.663 0 CA-C-N 114.66 -1.154 . . . . 0.0 110.593 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.418 ' H ' ' H ' ' A' ' 39' ' ' LEU . 7.9 t -168.9 -15.53 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.019 0 O-C-N 123.616 0.573 . . . . 0.0 110.732 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.418 ' H ' ' H ' ' A' ' 38' ' ' THR . 0.8 OUTLIER -153.44 64.92 0.75 Allowed 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 103.837 -2.653 . . . . 0.0 103.837 -179.955 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.579 HD21 ' H ' ' A' ' 37' ' ' CYS . 13.4 m120 -84.15 47.59 1.35 Allowed 'General case' 0 N--CA 1.491 1.602 0 CA-C-N 112.702 -2.045 . . . . 0.0 112.959 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.434 ' HA ' ' HA ' ' A' ' 4' ' ' CYS . 75.3 m -158.04 126.31 5.42 Favored 'General case' 0 N--CA 1.498 1.93 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.781 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -147.83 81.36 8.43 Favored Pre-proline 0 N--CA 1.496 1.852 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.313 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -60.82 -31.11 91.39 Favored 'Trans proline' 0 N--CA 1.493 1.496 0 C-N-CA 122.744 2.296 . . . . 0.0 114.391 -173.749 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 7.3 ptm180 -58.59 -30.73 67.43 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 123.813 0.696 . . . . 0.0 111.955 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 13.9 tt -47.33 156.79 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 O-C-N 124.226 0.954 . . . . 0.0 113.279 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -137.85 -50.76 0.6 Allowed 'General case' 0 N--CA 1.492 1.636 0 CA-C-N 113.967 -1.469 . . . . 0.0 107.102 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 46.9 p90 -168.32 167.14 12.22 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-N 113.883 -1.508 . . . . 0.0 109.485 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -118.49 108.69 1.64 Allowed Glycine 0 N--CA 1.491 2.316 0 N-CA-C 107.861 -2.096 . . . . 0.0 107.861 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 5.6 p -80.15 111.42 16.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 C-N-CA 118.895 -1.122 . . . . 0.0 110.233 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.445 ' HA ' ' HA ' ' A' ' 14' ' ' CYS . 1.7 m -78.57 110.15 13.02 Favored Pre-proline 0 N--CA 1.499 2.014 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.484 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -82.44 102.87 1.21 Allowed 'Trans proline' 0 N--CA 1.49 1.307 0 C-N-CA 122.816 2.344 . . . . 0.0 108.415 -175.553 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 15.2 ptp180 -160.08 -22.27 0.06 Allowed 'General case' 0 N--CA 1.498 1.93 0 CA-C-N 115.417 -0.81 . . . . 0.0 111.313 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 40.6 t -64.01 138.6 58.53 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 123.917 0.761 . . . . 0.0 109.832 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 59.88 111.91 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.116 0 O-C-N 124.872 1.358 . . . . 0.0 113.181 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -91.2 73.27 6.25 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 28.7 tptp -161.07 56.54 0.3 Allowed 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 83.7 tttt 49.63 44.1 24.39 Favored 'General case' 0 N--CA 1.501 2.09 0 CA-C-N 114.045 -1.434 . . . . 0.0 109.989 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -60.75 -60.18 4.21 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-N 114.203 -1.362 . . . . 0.0 110.217 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -74.8 -78.69 0.1 Allowed 'General case' 0 N--CA 1.492 1.674 0 CA-C-N 115.248 -0.887 . . . . 0.0 108.72 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.654 HH12 ' HZ2' ' A' ' 15' ' ' LYS . 84.9 mtm-85 -142.92 -162.95 1.53 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 124.247 0.967 . . . . 0.0 108.67 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 9.6 tp -82.41 49.93 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 CA-C-O 121.768 0.795 . . . . 0.0 110.145 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.419 ' HA ' ' HA ' ' A' ' 99' ' ' CYS . 1.7 m -83.53 38.94 0.65 Allowed 'General case' 0 N--CA 1.492 1.663 0 CA-C-O 122.814 1.292 . . . . 0.0 114.222 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.6 p -91.25 159.09 16.22 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-N 112.889 -1.96 . . . . 0.0 109.573 179.724 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.62 HD21 ' H ' ' A' ' 99' ' ' CYS . 64.1 m-20 -152.94 157.02 40.0 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 125.018 1.448 . . . . 0.0 111.259 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' CYS . . . . . 0.492 ' HA ' ' CD2' ' A' ' 74' ' ' TYR . 3.6 t -62.1 -38.37 88.63 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-N 114.541 -1.209 . . . . 0.0 108.427 179.65 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 43.0 t -66.99 -50.85 60.97 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 112.363 -2.199 . . . . 0.0 110.634 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -79.36 -114.2 0.02 OUTLIER 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 113.924 -1.489 . . . . 0.0 110.701 -179.635 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 46.16 -129.89 10.62 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 111.044 -0.822 . . . . 0.0 111.044 -179.512 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 40.7 p -150.94 135.19 16.88 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 123.879 0.399 . . . . 0.0 111.689 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -61.1 104.2 0.35 Allowed 'General case' 0 N--CA 1.499 2.015 0 O-C-N 124.249 0.968 . . . . 0.0 110.309 179.791 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 141.43 -24.75 2.49 Favored Glycine 0 N--CA 1.494 2.551 0 O-C-N 123.93 0.769 . . . . 0.0 111.659 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' CYS . . . . . 0.422 ' SG ' ' HA ' ' A' ' 111' ' ' ALA . 94.7 m -91.74 133.29 35.73 Favored 'General case' 0 N--CA 1.498 1.927 0 C-N-CA 120.736 -0.386 . . . . 0.0 110.441 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.7 mppt? -88.04 88.7 7.73 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 124.057 0.848 . . . . 0.0 110.46 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.515 ' CE2' ' HA2' ' A' ' 85' ' ' GLY . 77.7 m-85 -40.71 136.14 1.46 Allowed 'General case' 0 N--CA 1.503 2.176 0 O-C-N 124.613 1.196 . . . . 0.0 109.761 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -148.17 145.23 28.23 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 124.753 1.283 . . . . 0.0 113.399 -179.605 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.409 ' N ' HG23 ' A' ' 82' ' ' VAL . 42.0 t -106.81 118.69 37.35 Favored 'General case' 0 N--CA 1.499 1.995 0 CA-C-N 112.653 -2.067 . . . . 0.0 111.902 -179.675 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.516 ' HB3' ' HB2' ' A' ' 104' ' ' ALA . 6.1 p-10 -55.16 -52.89 61.87 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 126.323 2.264 . . . . 0.0 112.703 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -69.55 -0.74 7.14 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 112.108 -2.315 . . . . 0.0 112.541 -179.568 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -139.46 -84.4 0.1 Allowed Glycine 0 N--CA 1.482 1.702 0 C-N-CA 119.202 -1.475 . . . . 0.0 112.209 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.485 ' CG2' ' H ' ' A' ' 81' ' ' PHE . 1.2 m 175.79 -170.33 0.06 Allowed 'General case' 0 N--CA 1.5 2.04 0 O-C-N 126.22 1.777 . . . . 0.0 106.252 -179.166 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.485 ' H ' ' CG2' ' A' ' 80' ' ' THR . 75.8 t80 -42.62 146.55 0.35 Allowed 'General case' 0 N--CA 1.498 1.955 0 C-N-CA 123.554 0.742 . . . . 0.0 112.636 179.527 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.409 HG23 ' N ' ' A' ' 76' ' ' SER . 88.4 t -111.17 -70.93 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 CA-C-N 113.878 -1.51 . . . . 0.0 111.585 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' CYS . . . . . 0.534 ' SG ' ' N ' ' A' ' 84' ' ' GLU . 0.1 OUTLIER -160.25 -170.57 2.87 Favored 'General case' 0 N--CA 1.506 2.37 0 C-N-CA 120.41 -0.516 . . . . 0.0 110.827 -179.881 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.534 ' N ' ' SG ' ' A' ' 83' ' ' CYS . 38.9 tt0 -114.09 149.74 35.08 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 123.307 0.379 . . . . 0.0 110.716 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.515 ' HA2' ' CE2' ' A' ' 74' ' ' TYR . . . -36.8 105.7 0.04 OUTLIER Glycine 0 N--CA 1.501 2.992 0 O-C-N 124.833 1.333 . . . . 0.0 115.135 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -94.12 -8.86 38.35 Favored 'General case' 0 N--CA 1.502 2.145 0 C-N-CA 119.128 -1.029 . . . . 0.0 113.726 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 15.6 m -85.13 90.86 7.97 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -79.33 106.72 4.96 Favored Pre-proline 0 N--CA 1.49 1.536 0 N-CA-C 104.107 -2.553 . . . . 0.0 104.107 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -40.15 -34.81 1.08 Allowed 'Trans proline' 0 N--CA 1.501 1.938 0 C-N-CA 124.819 3.679 . . . . 0.0 116.265 -145.12 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 8.9 ptm180 -58.73 -14.02 7.5 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 123.861 0.726 . . . . 0.0 112.891 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 14.1 p-10 -75.28 129.31 82.74 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 123.948 0.78 . . . . 0.0 110.936 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -83.32 44.97 1.74 Allowed 'Trans proline' 0 N--CA 1.493 1.461 0 C-N-CA 123.275 2.65 . . . . 0.0 109.769 162.842 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.553 ' HZ2' ' H ' ' A' ' 93' ' ' LYS . 0.0 OUTLIER 64.98 168.94 0.19 Allowed 'General case' 0 N--CA 1.507 2.396 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.01 -179.877 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -160.21 44.82 0.21 Allowed 'General case' 0 N--CA 1.5 2.048 0 C-N-CA 120.061 -0.656 . . . . 0.0 112.759 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 61.0 m -156.77 130.76 4.84 Favored Pre-proline 0 N--CA 1.501 2.101 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.829 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_endo -76.4 35.25 0.46 Allowed 'Trans proline' 0 N--CA 1.496 1.624 0 C-N-CA 123.039 2.493 . . . . 0.0 111.209 163.498 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 83.3 mmt-85 -108.99 37.07 2.66 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -54.25 135.51 44.21 Favored 'General case' 0 N--CA 1.495 1.789 0 CA-C-N 113.813 -1.54 . . . . 0.0 112.425 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.62 ' H ' HD21 ' A' ' 64' ' ' ASN . 34.4 m 57.51 127.84 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.822 0 O-C-N 125.232 1.582 . . . . 0.0 114.747 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -122.99 93.12 48.67 Favored Pre-proline 0 N--CA 1.5 2.061 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_endo -62.11 -13.7 33.38 Favored 'Trans proline' 0 N--CA 1.496 1.635 0 C-N-CA 122.126 1.884 . . . . 0.0 113.505 -175.374 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 77.8 ttt-85 -90.17 -25.36 20.7 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 114.238 1.199 . . . . 0.0 114.238 -179.771 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 11.6 tt -74.12 141.95 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 C-N-CA 118.658 -1.217 . . . . 0.0 110.473 -179.578 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.516 ' HB2' ' HB3' ' A' ' 77' ' ' ASP . . . -79.82 -58.85 2.97 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 105.791 -1.929 . . . . 0.0 105.791 179.715 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 4.3 p90 174.96 171.83 0.25 Allowed 'General case' 0 N--CA 1.488 1.473 0 CA-C-N 111.402 -2.635 . . . . 0.0 106.819 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -94.8 132.19 11.03 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 110.183 -1.167 . . . . 0.0 110.183 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 39.4 mm -78.45 90.86 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 N-CA-C 103.932 -2.618 . . . . 0.0 103.932 179.711 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 19.5 m -84.28 127.34 66.67 Favored Pre-proline 0 N--CA 1.493 1.716 0 CA-C-N 113.37 -1.741 . . . . 0.0 111.08 -179.836 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -73.96 -32.73 6.83 Favored 'Trans proline' 0 N--CA 1.491 1.367 0 C-N-CA 122.386 2.057 . . . . 0.0 107.951 146.678 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -159.75 162.75 34.96 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-N 114.692 -1.14 . . . . 0.0 109.482 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.422 ' HA ' ' SG ' ' A' ' 72' ' ' CYS . . . . . . . . 0 N--CA 1.499 2.012 0 CA-C-O 115.748 -2.072 . . . . 0.0 111.884 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 27.9 t70 . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 121.283 0.563 . . . . 0.0 110.362 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 71.4 ttt-85 -151.79 64.69 0.86 Allowed 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.427 HD13 ' H ' ' A' ' 5' ' ' THR . 0.0 OUTLIER -73.93 109.6 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 179.997 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.514 ' HA ' ' HA ' ' A' ' 41' ' ' CYS . 1.6 m -132.59 29.3 4.22 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 115.78 1.77 . . . . 0.0 115.78 179.625 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.427 ' H ' HD13 ' A' ' 3' ' ' ILE . 2.5 p -92.33 147.34 22.99 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-N 112.427 -2.169 . . . . 0.0 108.588 179.631 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.616 HD22 ' H ' ' A' ' 41' ' ' CYS . 20.7 p30 -160.61 158.26 28.67 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 124.722 1.263 . . . . 0.0 109.858 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 5.3 t -71.21 -30.12 65.98 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 115.287 1.588 . . . . 0.0 115.287 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 43.1 t -80.81 -65.29 1.03 Allowed 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 -179.604 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -88.79 39.7 0.94 Allowed 'General case' 0 N--CA 1.499 2.012 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.03 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -76.54 -133.61 0.52 Allowed Glycine 0 N--CA 1.492 2.392 0 CA-C-N 114.943 -1.026 . . . . 0.0 111.23 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 35.3 p -152.56 103.69 2.83 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 35.2 ttpt -51.87 108.22 0.26 Allowed 'General case' 0 N--CA 1.5 2.041 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.529 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 143.26 -20.89 2.26 Favored Glycine 0 N--CA 1.496 2.659 0 N-CA-C 110.314 -1.114 . . . . 0.0 110.314 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 80.7 m -114.56 150.35 35.11 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 124.244 0.614 . . . . 0.0 109.84 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.432 ' N ' ' HE2' ' A' ' 15' ' ' LYS . 0.2 OUTLIER -93.81 94.43 8.52 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 124.159 0.912 . . . . 0.0 111.503 -179.781 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 31.3 m-85 -59.34 115.33 3.17 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 106.662 -1.607 . . . . 0.0 106.662 179.695 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.525 ' CE2' ' HA ' ' A' ' 22' ' ' THR . 0.0 OUTLIER -129.42 147.71 51.26 Favored 'General case' 0 N--CA 1.486 1.363 0 CA-C-N 112.008 -2.36 . . . . 0.0 112.836 -179.343 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.427 ' HA ' ' H ' ' A' ' 46' ' ' ALA . 46.6 t -98.21 123.93 42.53 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-N 112.87 -1.968 . . . . 0.0 112.05 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.461 ' HB3' ' HB2' ' A' ' 46' ' ' ALA . 5.5 p-10 -60.53 -43.15 97.47 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-N 113.916 -1.493 . . . . 0.0 108.444 179.71 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -94.98 18.37 12.14 Favored 'General case' 0 N--CA 1.487 1.394 0 CA-C-N 112.182 -2.281 . . . . 0.0 112.024 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -170.71 31.53 0.14 Allowed Glycine 0 N--CA 1.498 2.777 0 C-N-CA 118.528 -1.796 . . . . 0.0 113.75 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.525 ' HA ' ' CE2' ' A' ' 17' ' ' PHE . 6.1 t 44.19 -168.79 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 114.214 1.19 . . . . 0.0 114.214 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 62.8 t80 -47.84 133.62 13.98 Favored 'General case' 0 N--CA 1.498 1.95 0 CA-C-O 121.697 0.761 . . . . 0.0 112.805 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 98.2 t -104.04 -78.65 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 CA-C-N 113.044 -1.889 . . . . 0.0 106.799 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.458 ' SG ' ' N ' ' A' ' 26' ' ' GLU . 0.2 OUTLIER -157.31 -171.4 3.59 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 179.732 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.458 ' N ' ' SG ' ' A' ' 25' ' ' CYS . 16.1 mt-10 -109.06 157.12 19.01 Favored 'General case' 0 N--CA 1.495 1.775 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 179.715 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -49.69 106.68 0.24 Allowed Glycine 0 N--CA 1.496 2.663 0 O-C-N 124.124 0.89 . . . . 0.0 112.05 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -79.44 -9.23 59.56 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-N 114.93 -0.635 . . . . 0.0 110.297 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 34.0 t -79.72 97.11 6.45 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -79.82 137.23 54.29 Favored Pre-proline 0 N--CA 1.495 1.785 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -71.48 68.65 2.76 Favored 'Trans proline' 0 N--CA 1.497 1.711 0 C-N-CA 123.567 2.845 . . . . 0.0 111.411 176.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.497 ' NE ' ' HA ' ' A' ' 32' ' ' ARG . 3.9 mmp_? -158.0 -44.99 0.06 Allowed 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 105.293 -2.114 . . . . 0.0 105.293 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -90.35 150.54 43.15 Favored Pre-proline 0 N--CA 1.495 1.783 0 O-C-N 124.275 0.985 . . . . 0.0 110.522 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.13 169.82 21.72 Favored 'Trans proline' 0 N--CA 1.491 1.343 0 C-N-CA 122.843 2.362 . . . . 0.0 108.916 159.827 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 22.4 ptmt -69.56 147.04 51.3 Favored 'General case' 0 N--CA 1.496 1.853 0 C-N-CA 120.124 -0.63 . . . . 0.0 110.4 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -158.81 41.56 0.24 Allowed 'General case' 0 N--CA 1.496 1.839 0 CA-C-N 115.322 -0.854 . . . . 0.0 108.849 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 76.4 m -108.23 178.68 4.43 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-N 114.069 -1.423 . . . . 0.0 111.595 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 8.4 t -134.15 -3.17 2.79 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-N 113.537 -1.665 . . . . 0.0 108.269 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.17 30.59 2.72 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 10.4 m120 -57.75 123.22 14.96 Favored 'General case' 0 N--CA 1.497 1.923 0 CA-C-N 114.712 -1.131 . . . . 0.0 109.358 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.616 ' H ' HD22 ' A' ' 6' ' ' ASN . 70.9 m 58.01 107.56 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.856 0 O-C-N 125.079 1.487 . . . . 0.0 110.616 -179.612 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -108.76 102.99 50.32 Favored Pre-proline 0 N--CA 1.499 2.007 0 CA-C-N 115.243 -0.889 . . . . 0.0 112.654 -179.704 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -67.34 -7.05 17.89 Favored 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 121.888 1.725 . . . . 0.0 112.216 178.732 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 60.9 mtt85 -89.97 -14.59 33.75 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 123.643 0.589 . . . . 0.0 111.967 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 15.3 tt -106.79 160.74 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.461 ' HB2' ' HB3' ' A' ' 19' ' ' ASP . . . -83.85 -74.65 0.37 Allowed 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 105.378 -2.082 . . . . 0.0 105.378 179.822 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 50.9 p90 179.71 176.37 0.69 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 124.769 1.293 . . . . 0.0 109.552 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -79.94 102.02 1.99 Allowed Glycine 0 N--CA 1.49 2.243 0 CA-C-N 114.125 -1.398 . . . . 0.0 111.797 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 17.7 m -78.54 98.38 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 N-CA-C 106.258 -1.756 . . . . 0.0 106.258 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.9 m -79.93 176.29 3.92 Favored Pre-proline 0 N--CA 1.495 1.779 0 CA-C-N 113.218 -1.81 . . . . 0.0 108.26 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -70.35 2.69 3.62 Favored 'Trans proline' 0 N--CA 1.495 1.583 0 C-N-CA 122.219 1.946 . . . . 0.0 112.3 173.05 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 12.2 mmm180 -88.28 4.47 45.81 Favored 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 12.5 t 74.38 -26.62 0.19 Allowed 'General case' 0 N--CA 1.508 2.459 0 O-C-N 124.206 0.941 . . . . 0.0 112.033 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.414 ' N ' ' CD ' ' A' ' 54' ' ' GLU . 6.3 mp0 55.72 80.16 0.15 Allowed 'General case' 0 N--CA 1.497 1.913 0 CA-C-O 121.746 0.784 . . . . 0.0 111.844 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -102.36 109.5 21.17 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 105.892 -1.892 . . . . 0.0 105.892 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.487 ' N ' ' HD3' ' A' ' 56' ' ' LYS . 0.1 OUTLIER -156.66 151.97 26.53 Favored 'General case' 0 N--CA 1.494 1.759 0 CA-C-N 115.463 -0.789 . . . . 0.0 112.377 -179.759 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -164.16 81.33 0.41 Allowed 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 103.896 -2.631 . . . . 0.0 103.896 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -118.62 89.41 3.12 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-N 114.015 -1.448 . . . . 0.0 108.769 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -163.92 57.35 0.16 Allowed 'General case' 0 N--CA 1.495 1.785 0 CA-C-N 114.127 -1.397 . . . . 0.0 109.287 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? -146.09 -40.3 0.22 Allowed 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.53 HD13 ' H ' ' A' ' 63' ' ' THR . 0.0 OUTLIER -48.91 110.87 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.838 -179.977 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.507 ' HA ' ' HA ' ' A' ' 99' ' ' CYS . 1.7 m -130.68 30.9 4.6 Favored 'General case' 0 N--CA 1.487 1.411 0 CA-C-O 123.336 1.541 . . . . 0.0 115.076 179.822 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.53 ' H ' HD13 ' A' ' 61' ' ' ILE . 60.2 m -91.38 118.38 30.48 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-N 111.756 -2.474 . . . . 0.0 104.87 179.57 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.593 ' ND2' ' H ' ' A' ' 67' ' ' ALA . 20.8 p-10 -140.46 161.02 38.71 Favored 'General case' 0 N--CA 1.502 2.158 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 1.4 t -65.53 -36.69 84.57 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-N 113.539 -1.664 . . . . 0.0 115.296 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 51.0 t -75.35 -64.48 1.05 Allowed 'General case' 0 N--CA 1.497 1.913 0 O-C-N 123.775 0.672 . . . . 0.0 110.669 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.593 ' H ' ' ND2' ' A' ' 64' ' ' ASN . . . -90.13 52.41 2.26 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -88.53 -138.65 6.4 Favored Glycine 0 N--CA 1.493 2.449 0 CA-C-N 114.256 -1.338 . . . . 0.0 112.205 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 94.8 m -140.91 105.75 4.94 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 124.48 0.753 . . . . 0.0 110.758 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 10.9 tptm -56.02 104.19 0.13 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 124.208 0.943 . . . . 0.0 108.613 179.64 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 140.32 -1.78 2.2 Favored Glycine 0 N--CA 1.492 2.401 0 CA-C-N 114.517 -1.22 . . . . 0.0 110.82 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 91.9 m -141.44 146.95 37.15 Favored 'General case' 0 N--CA 1.498 1.934 0 CA-C-N 117.074 0.437 . . . . 0.0 111.282 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.475 ' HB3' ' CE1' ' A' ' 81' ' ' PHE . 8.0 mtpm? -89.33 90.39 8.31 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-N 114.875 -1.057 . . . . 0.0 111.89 -179.683 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -53.96 120.96 7.06 Favored 'General case' 0 N--CA 1.5 2.052 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -124.38 160.71 27.54 Favored 'General case' 0 N--CA 1.493 1.701 0 CA-C-N 113.184 -1.825 . . . . 0.0 113.731 -179.383 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 29.8 t -104.06 131.89 50.86 Favored 'General case' 0 N--CA 1.498 1.93 0 CA-C-N 113.834 -1.53 . . . . 0.0 112.597 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.408 ' HB3' ' CB ' ' A' ' 104' ' ' ALA . 4.1 p-10 -46.24 -29.83 1.76 Allowed 'General case' 0 N--CA 1.502 2.17 0 N-CA-C 116.117 1.895 . . . . 0.0 116.117 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -51.82 -24.41 6.05 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 123.955 0.784 . . . . 0.0 111.818 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 113.7 26.95 3.71 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 108.851 -1.7 . . . . 0.0 108.851 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 86.3 m -138.67 139.49 38.49 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 124.005 0.473 . . . . 0.0 110.875 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.475 ' CE1' ' HB3' ' A' ' 73' ' ' LYS . 13.0 t80 -71.97 150.76 43.8 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-N 114.312 -1.313 . . . . 0.0 109.648 179.793 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 97.2 t -110.1 -78.89 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -159.36 175.21 13.63 Favored 'General case' 0 N--CA 1.501 2.099 0 C-N-CA 120.675 -0.41 . . . . 0.0 110.022 179.818 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -92.72 141.23 28.69 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -45.6 105.59 0.09 OUTLIER Glycine 0 N--CA 1.5 2.956 0 O-C-N 124.166 0.916 . . . . 0.0 111.557 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -79.47 7.15 8.61 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-N 114.526 -0.837 . . . . 0.0 112.456 -179.613 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 46.9 t -132.93 119.65 20.42 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -79.23 143.92 61.53 Favored Pre-proline 0 N--CA 1.495 1.777 0 O-C-N 124.105 0.878 . . . . 0.0 108.675 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -70.15 64.18 2.03 Favored 'Trans proline' 0 N--CA 1.5 1.903 0 C-N-CA 123.614 2.876 . . . . 0.0 112.402 176.526 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 53.5 mmm-85 -158.68 -44.42 0.06 Allowed 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 105.616 -1.994 . . . . 0.0 105.616 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -90.78 121.69 67.83 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 124.274 0.984 . . . . 0.0 109.664 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -80.27 50.14 3.44 Favored 'Trans proline' 0 N--CA 1.495 1.604 0 C-N-CA 123.427 2.751 . . . . 0.0 111.686 174.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -82.21 124.72 30.16 Favored 'General case' 0 N--CA 1.496 1.874 0 C-N-CA 120.346 -0.542 . . . . 0.0 111.057 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -87.38 -176.97 5.82 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-N 114.357 -1.292 . . . . 0.0 109.803 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 77.6 m -153.94 158.68 32.51 Favored Pre-proline 0 N--CA 1.496 1.868 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.939 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -70.2 -25.72 26.26 Favored 'Trans proline' 0 N--CA 1.491 1.34 0 C-N-CA 122.069 1.846 . . . . 0.0 108.239 159.698 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 5.2 mmp_? -83.5 5.04 25.34 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-N 114.324 -1.307 . . . . 0.0 112.319 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -50.27 136.15 20.36 Favored 'General case' 0 N--CA 1.503 2.224 0 C-N-CA 120.499 -0.48 . . . . 0.0 110.927 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.507 ' HA ' ' HA ' ' A' ' 62' ' ' CYS . 59.8 m 61.96 114.5 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.773 0 O-C-N 125.309 1.63 . . . . 0.0 111.58 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -125.6 97.29 36.67 Favored Pre-proline 0 N--CA 1.499 2.008 0 N-CA-C 113.21 0.819 . . . . 0.0 113.21 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -48.63 -32.49 21.54 Favored 'Trans proline' 0 N--CA 1.495 1.585 0 C-N-CA 123.189 2.593 . . . . 0.0 112.425 174.874 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 31.1 ttp-105 -61.02 -50.04 74.98 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 106.46 -1.681 . . . . 0.0 106.46 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 4.0 mt -67.91 155.89 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 179.661 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.408 ' CB ' ' HB3' ' A' ' 77' ' ' ASP . . . -141.77 -34.5 0.47 Allowed 'General case' 0 N--CA 1.49 1.57 0 CA-C-N 113.484 -1.689 . . . . 0.0 111.334 -179.695 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 51.7 m-85 -139.65 -164.3 1.66 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 124.255 0.972 . . . . 0.0 111.149 -179.735 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -153.33 104.14 0.25 Allowed Glycine 0 N--CA 1.488 2.131 0 N-CA-C 105.983 -2.847 . . . . 0.0 105.983 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 51.2 mm -79.21 93.53 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 -179.714 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 8.0 m -79.44 149.17 71.6 Favored Pre-proline 0 N--CA 1.493 1.718 0 CA-C-N 113.718 -1.583 . . . . 0.0 108.923 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -64.73 104.87 0.59 Allowed 'Trans proline' 0 N--CA 1.494 1.507 0 C-N-CA 122.496 2.131 . . . . 0.0 110.253 -175.631 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 64.6 tp -79.91 -46.58 16.52 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-N 114.963 -1.017 . . . . 0.0 109.778 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.502 2.138 0 CA-C-O 117.005 -1.474 . . . . 0.0 113.279 -179.969 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 13.2 t70 . . . . . 0 N--CA 1.489 1.514 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 41.6 ttm180 57.95 85.9 0.08 Allowed 'General case' 0 N--CA 1.496 1.861 0 O-C-N 124.793 1.308 . . . . 0.0 109.086 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 8.5 tp -83.67 54.53 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 CA-C-N 114.449 -1.25 . . . . 0.0 109.912 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 42.7 m -87.52 54.66 3.21 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-O 122.479 1.133 . . . . 0.0 112.808 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 17.2 p -89.49 170.8 10.2 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-N 113.128 -1.851 . . . . 0.0 108.809 179.698 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 18.4 p-10 -162.55 135.76 5.97 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 124.24 0.963 . . . . 0.0 113.548 179.804 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -59.11 -31.56 69.03 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-N 114.563 -1.199 . . . . 0.0 113.884 179.716 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 48.4 t -68.76 -59.42 3.11 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-N 114.808 -1.087 . . . . 0.0 112.386 -179.584 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -74.5 -96.23 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.863 0 C-N-CA 118.714 -1.194 . . . . 0.0 110.052 -179.833 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 52.27 -126.57 31.06 Favored Glycine 0 N--CA 1.488 2.105 0 O-C-N 123.567 0.542 . . . . 0.0 112.042 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 92.5 m -152.18 119.21 5.83 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 22.5 ttmm -68.54 91.64 0.42 Allowed 'General case' 0 N--CA 1.494 1.766 0 CA-C-O 122.283 1.039 . . . . 0.0 109.048 179.772 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 163.59 -34.19 0.29 Allowed Glycine 0 N--CA 1.488 2.163 0 CA-C-N 112.9 -1.954 . . . . 0.0 109.007 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 50.5 m -105.16 130.55 53.3 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-O 121.528 0.68 . . . . 0.0 109.229 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.485 ' HB3' ' CE1' ' A' ' 23' ' ' PHE . 57.5 mtpt -78.36 91.22 4.43 Favored 'General case' 0 N--CA 1.485 1.319 0 CA-C-N 113.171 -1.832 . . . . 0.0 112.55 -179.54 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 75.5 m-85 -58.87 121.22 10.6 Favored 'General case' 0 N--CA 1.501 2.113 0 N-CA-C 105.784 -1.932 . . . . 0.0 105.784 179.759 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -128.71 147.51 50.76 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 110.664 -2.971 . . . . 0.0 112.933 -179.218 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 40.1 t -83.44 136.32 34.35 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-N 111.83 -2.441 . . . . 0.0 112.895 -179.748 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -52.18 -30.25 26.05 Favored 'General case' 0 N--CA 1.498 1.958 0 CA-C-N 112.481 -2.145 . . . . 0.0 113.833 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 44.3 p-10 -58.06 -14.16 6.15 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 124.013 0.821 . . . . 0.0 112.268 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 99.97 35.22 4.61 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 108.464 -1.855 . . . . 0.0 108.464 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 55.9 m -136.29 132.49 35.79 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 124.025 0.485 . . . . 0.0 110.241 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.485 ' CE1' ' HB3' ' A' ' 15' ' ' LYS . 8.1 t80 -74.78 141.52 44.37 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 179.671 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 41.0 t -102.53 -79.53 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 N-CA-C 105.666 -1.976 . . . . 0.0 105.666 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -169.0 166.21 11.13 Favored 'General case' 0 N--CA 1.501 2.117 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 179.594 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.469 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 36.8 tt0 -82.13 161.51 22.81 Favored 'General case' 0 N--CA 1.503 2.223 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 179.789 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.443 ' N ' ' HG2' ' A' ' 26' ' ' GLU . . . -61.13 120.39 22.59 Favored Glycine 0 N--CA 1.496 2.657 0 N-CA-C 107.52 -2.232 . . . . 0.0 107.52 179.7 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -86.18 21.33 2.05 Favored 'General case' 0 N--CA 1.499 1.999 0 C-N-CA 119.295 -0.962 . . . . 0.0 110.379 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 35.3 t -139.22 112.57 8.21 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-N 114.801 -1.09 . . . . 0.0 108.537 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -81.01 142.71 52.09 Favored Pre-proline 0 N--CA 1.493 1.721 0 CA-C-N 114.246 -1.343 . . . . 0.0 107.706 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -69.75 68.71 1.68 Allowed 'Trans proline' 0 N--CA 1.499 1.852 0 C-N-CA 122.993 2.462 . . . . 0.0 111.844 176.387 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 35.3 mmt180 -160.65 -39.37 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 CA-C-N 113.546 -1.661 . . . . 0.0 107.416 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -71.28 151.94 94.36 Favored Pre-proline 0 N--CA 1.498 1.974 0 C-N-CA 119.902 -0.719 . . . . 0.0 111.253 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo -69.44 167.77 23.06 Favored 'Trans proline' 0 N--CA 1.494 1.514 0 C-N-CA 122.745 2.297 . . . . 0.0 111.7 179.227 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 22.4 ptmt 39.44 -163.81 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.252 0 N-CA-C 115.682 1.734 . . . . 0.0 115.682 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -139.34 179.72 6.37 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-N 115.043 -0.98 . . . . 0.0 109.984 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 87.0 m -79.8 179.51 7.5 Favored 'General case' 0 N--CA 1.497 1.897 0 CA-C-N 114.959 -1.019 . . . . 0.0 112.98 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 69.8 p -130.85 31.82 4.43 Favored 'General case' 0 N--CA 1.495 1.822 0 CA-C-N 113.671 -1.604 . . . . 0.0 108.751 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 39.9 tp -79.86 -1.28 38.36 Favored 'General case' 0 N--CA 1.499 2.01 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.412 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 29.7 m-80 57.56 -174.84 0.07 Allowed 'General case' 0 N--CA 1.499 2.009 0 N-CA-C 114.181 1.178 . . . . 0.0 114.181 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 81.7 m -60.82 134.5 57.15 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-N 114.262 -1.335 . . . . 0.0 111.271 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -128.44 83.79 65.11 Favored Pre-proline 0 N--CA 1.498 1.941 0 O-C-N 123.885 0.74 . . . . 0.0 109.517 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -52.34 -24.44 21.26 Favored 'Trans proline' 0 N--CA 1.495 1.576 0 C-N-CA 122.867 2.378 . . . . 0.0 112.178 176.034 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 28.0 ttt85 -60.73 -50.92 71.55 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 17.6 mt -65.5 153.65 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 CA-C-O 122.066 0.936 . . . . 0.0 109.782 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -124.14 -59.61 1.48 Allowed 'General case' 0 N--CA 1.491 1.589 0 CA-C-N 111.957 -2.383 . . . . 0.0 109.218 -179.833 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 16.2 p90 -162.64 156.78 21.05 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 124.14 0.9 . . . . 0.0 112.189 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -88.84 103.7 3.0 Favored Glycine 0 N--CA 1.492 2.389 0 CA-C-N 112.816 -1.993 . . . . 0.0 113.235 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 34.2 m -81.25 99.07 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.185 0 CA-C-O 121.531 0.681 . . . . 0.0 109.985 179.708 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.6 m -79.16 125.89 82.69 Favored Pre-proline 0 N--CA 1.503 2.206 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.233 179.754 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -70.52 -60.61 0.06 OUTLIER 'Trans proline' 0 N--CA 1.492 1.397 0 C-N-CA 122.32 2.013 . . . . 0.0 108.516 171.106 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.16 108.52 1.69 Allowed 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 106.521 -1.659 . . . . 0.0 106.521 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 33.7 t -162.0 157.87 24.25 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 123.702 0.626 . . . . 0.0 110.586 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.9 tm-20 66.76 138.14 0.03 OUTLIER 'General case' 0 N--CA 1.504 2.266 0 O-C-N 124.873 1.358 . . . . 0.0 111.345 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -149.54 119.23 7.01 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-N 114.65 -1.159 . . . . 0.0 108.041 179.824 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 35.4 mmtp 58.09 89.99 0.05 OUTLIER 'General case' 0 N--CA 1.501 2.102 0 O-C-N 124.44 1.087 . . . . 0.0 112.232 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.421 ' HD2' ' H ' ' A' ' 57' ' ' LYS . 0.0 OUTLIER -94.73 -36.57 11.67 Favored 'General case' 0 N--CA 1.499 2.02 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.889 179.806 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 25.8 m120 -148.3 84.95 1.51 Allowed 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -153.9 -65.23 0.14 Allowed 'General case' 0 N--CA 1.494 1.758 0 CA-C-N 114.208 -1.36 . . . . 0.0 108.117 -179.841 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 17.2 ptp180 -86.22 33.11 0.61 Allowed 'General case' 0 N--CA 1.494 1.725 0 CA-C-N 114.047 -1.433 . . . . 0.0 110.554 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 10.6 tp -85.29 41.46 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 CA-C-O 122.059 0.933 . . . . 0.0 110.586 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 3.6 m -87.95 56.93 4.07 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-O 123.145 1.45 . . . . 0.0 109.88 179.77 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 25.5 p -90.07 177.42 6.46 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-N 112.038 -2.347 . . . . 0.0 110.333 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.49 ' ND2' ' H ' ' A' ' 67' ' ' ALA . 46.8 p-10 -161.46 -177.11 5.74 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-N 113.797 -1.547 . . . . 0.0 111.143 179.808 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' CYS . . . . . 0.416 ' SG ' ' CD2' ' A' ' 74' ' ' TYR . 11.1 t -91.51 -20.23 21.94 Favored 'General case' 0 N--CA 1.497 1.923 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.026 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 13.4 t -82.62 -61.78 1.79 Allowed 'General case' 0 N--CA 1.491 1.593 0 CA-C-N 113.731 -1.577 . . . . 0.0 112.731 -179.657 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.49 ' H ' ' ND2' ' A' ' 64' ' ' ASN . . . -90.35 60.85 4.84 Favored 'General case' 0 N--CA 1.499 1.996 0 CA-C-O 121.588 0.708 . . . . 0.0 112.205 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.484 ' H ' ' HB2' ' A' ' 87' ' ' SER . . . -126.18 -104.68 1.41 Allowed Glycine 0 N--CA 1.498 2.813 0 N-CA-C 108.812 -1.715 . . . . 0.0 108.812 179.755 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 3.4 t -155.65 111.45 3.06 Favored 'General case' 0 N--CA 1.502 2.13 0 N-CA-C 114.074 1.139 . . . . 0.0 114.074 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -65.93 103.59 0.96 Allowed 'General case' 0 N--CA 1.498 1.95 0 CA-C-N 114.331 -1.304 . . . . 0.0 107.679 179.66 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 143.09 -3.18 1.69 Allowed Glycine 0 N--CA 1.49 2.299 0 CA-C-N 114.384 -1.28 . . . . 0.0 110.927 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 72.8 m -124.0 155.14 38.77 Favored 'General case' 0 N--CA 1.499 1.982 0 C-N-CA 120.476 -0.489 . . . . 0.0 109.829 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.0 95.27 6.25 Favored 'General case' 0 N--CA 1.488 1.47 0 CA-C-N 115.036 -0.984 . . . . 0.0 108.644 -179.759 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.654 ' CD2' ' SG ' ' A' ' 83' ' ' CYS . 89.8 m-85 -44.78 137.61 3.9 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 124.694 1.246 . . . . 0.0 109.882 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 21.6 t80 -141.83 159.12 42.87 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 124.834 1.334 . . . . 0.0 110.844 -179.679 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 30.8 t -121.24 143.4 49.17 Favored 'General case' 0 N--CA 1.495 1.822 0 CA-C-N 112.748 -2.023 . . . . 0.0 116.089 -179.41 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.407 ' C ' ' H ' ' A' ' 79' ' ' GLY . 0.9 OUTLIER -48.91 -23.98 1.31 Allowed 'General case' 0 N--CA 1.498 1.952 0 CA-C-N 110.507 -3.042 . . . . 0.0 113.184 179.872 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 16.3 p30 -64.74 -0.67 1.54 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 124.223 0.952 . . . . 0.0 111.184 179.768 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.407 ' H ' ' C ' ' A' ' 77' ' ' ASP . . . 82.25 29.22 37.81 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 96.7 m -144.44 153.15 41.61 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 121.425 0.631 . . . . 0.0 111.903 -179.755 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -64.21 165.2 9.72 Favored 'General case' 0 N--CA 1.497 1.875 0 CA-C-N 113.466 -1.697 . . . . 0.0 110.565 179.806 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 89.4 t -128.28 -67.74 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 124.061 0.851 . . . . 0.0 112.07 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' CYS . . . . . 0.654 ' SG ' ' CD2' ' A' ' 74' ' ' TYR . 31.3 p -162.54 -178.07 6.01 Favored 'General case' 0 N--CA 1.503 2.178 0 C-N-CA 120.253 -0.579 . . . . 0.0 110.794 -179.636 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.401 ' HG2' ' N ' ' A' ' 85' ' ' GLY . 35.3 tt0 -96.49 158.02 15.63 Favored 'General case' 0 N--CA 1.505 2.306 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.16 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.501 ' HA2' ' CE2' ' A' ' 74' ' ' TYR . . . -58.73 106.05 0.79 Allowed Glycine 0 N--CA 1.498 2.778 0 CA-C-O 118.894 -0.948 . . . . 0.0 111.501 179.756 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 30.1 mm-40 -113.01 37.9 2.99 Favored 'General case' 0 N--CA 1.505 2.283 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 179.803 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.484 ' HB2' ' H ' ' A' ' 68' ' ' GLY . 9.0 t -115.45 63.31 0.69 Allowed 'General case' 0 N--CA 1.493 1.722 0 CA-C-N 114.267 -1.333 . . . . 0.0 109.491 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.411 ' HB3' ' ND2' ' A' ' 91' ' ' ASN . 3.5 t70 -81.57 114.57 50.84 Favored Pre-proline 0 N--CA 1.492 1.627 0 CA-C-N 114.08 -1.418 . . . . 0.0 110.355 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -66.1 -16.89 53.85 Favored 'Trans proline' 0 N--CA 1.492 1.419 0 C-N-CA 122.136 1.891 . . . . 0.0 111.361 -174.599 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 52.7 tpt85 -73.13 -31.07 64.06 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 123.812 0.695 . . . . 0.0 112.203 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.411 ' ND2' ' HB3' ' A' ' 88' ' ' ASP . 15.3 p30 -84.4 131.68 49.57 Favored Pre-proline 0 N--CA 1.497 1.9 0 C-N-CA 118.546 -1.262 . . . . 0.0 110.808 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -80.96 71.22 7.18 Favored 'Trans proline' 0 N--CA 1.49 1.287 0 C-N-CA 123.114 2.543 . . . . 0.0 108.325 162.306 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 58.4 tptt -149.87 154.07 37.76 Favored 'General case' 0 N--CA 1.497 1.889 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.607 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -131.32 -172.92 2.97 Favored 'General case' 0 N--CA 1.498 1.957 0 CA-C-N 113.925 -1.488 . . . . 0.0 109.487 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 3.7 m -149.42 150.93 32.5 Favored Pre-proline 0 N--CA 1.5 2.072 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -75.8 98.23 1.17 Allowed 'Trans proline' 0 N--CA 1.493 1.443 0 C-N-CA 122.711 2.274 . . . . 0.0 110.039 172.158 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 -146.73 57.07 1.16 Allowed 'General case' 0 N--CA 1.499 2.018 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -55.35 96.85 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.844 0 CA-C-N 113.446 -1.706 . . . . 0.0 114.618 -179.738 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 78.6 m 55.01 130.01 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.156 0 N-CA-C 117.331 2.345 . . . . 0.0 117.331 179.683 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 63.8 t0 -127.79 77.34 76.42 Favored Pre-proline 0 N--CA 1.502 2.142 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.78 179.704 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -63.07 -24.89 73.41 Favored 'Trans proline' 0 N--CA 1.493 1.442 0 C-N-CA 122.604 2.202 . . . . 0.0 111.611 173.52 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -67.69 -19.8 65.22 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 123.96 0.787 . . . . 0.0 112.105 -179.824 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 10.5 tt -79.61 169.65 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.115 0 C-N-CA 119.133 -1.027 . . . . 0.0 110.241 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -130.99 -55.15 1.05 Allowed 'General case' 0 N--CA 1.495 1.784 0 CA-C-N 114.883 -1.053 . . . . 0.0 108.833 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 27.7 p90 -171.59 168.3 6.37 Favored 'General case' 0 N--CA 1.497 1.904 0 CA-C-N 114.842 -1.072 . . . . 0.0 110.008 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -105.6 121.96 7.0 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 109.716 -1.353 . . . . 0.0 109.716 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 87.2 mt -79.4 94.05 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 14.6 m -79.66 156.16 75.53 Favored Pre-proline 0 N--CA 1.493 1.69 0 CA-C-N 114.117 -1.401 . . . . 0.0 107.38 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -51.36 -46.29 32.26 Favored 'Trans proline' 0 N--CA 1.495 1.593 0 C-N-CA 122.631 2.22 . . . . 0.0 111.532 -175.293 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.56 ' H ' HD23 ' A' ' 110' ' ' LEU . 2.0 pt? -79.55 -27.67 41.24 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-N 114.935 -1.03 . . . . 0.0 111.199 179.844 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 1.908 0 CA-C-O 116.877 -1.535 . . . . 0.0 110.837 -179.987 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 50.7 t0 . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.489 ' NE ' ' HA ' ' A' ' 2' ' ' ARG . 14.5 mmp_? -77.2 133.39 38.93 Favored 'General case' 0 N--CA 1.498 1.933 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.5 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.3 tp -69.58 84.87 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 CA-C-N 114.835 -1.075 . . . . 0.0 111.552 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 14.8 m -92.2 51.02 1.72 Allowed 'General case' 0 N--CA 1.491 1.619 0 CA-C-N 114.195 -1.366 . . . . 0.0 111.521 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 15.1 t -90.71 -173.67 3.81 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-N 113.229 -1.805 . . . . 0.0 108.862 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 24.1 p30 -160.22 -175.15 4.89 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 124.742 1.276 . . . . 0.0 108.285 179.696 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.6 t -118.26 -33.35 4.4 Favored 'General case' 0 N--CA 1.499 1.978 0 C-N-CA 119.772 -0.771 . . . . 0.0 110.332 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 25.1 t -62.54 -60.39 3.6 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-N 114.704 -1.135 . . . . 0.0 108.64 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.436 ' HB2' ' SG ' ' A' ' 37' ' ' CYS . . . -90.28 19.82 4.86 Favored 'General case' 0 N--CA 1.498 1.97 0 CA-C-N 113.83 -1.532 . . . . 0.0 109.561 179.785 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -75.19 -151.0 2.67 Favored Glycine 0 N--CA 1.493 2.48 0 CA-C-N 115.445 -0.798 . . . . 0.0 112.472 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 40.1 p -126.98 100.08 5.99 Favored 'General case' 0 N--CA 1.498 1.925 0 CA-C-N 114.709 -0.746 . . . . 0.0 109.299 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -52.12 147.79 7.05 Favored 'General case' 0 N--CA 1.5 2.035 0 CA-C-N 115.787 -0.642 . . . . 0.0 112.249 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 98.92 -33.51 6.06 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 107.88 -2.088 . . . . 0.0 107.88 -179.649 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 55.3 m -91.39 114.18 26.64 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.421 ' HB2' ' NZ ' ' A' ' 15' ' ' LYS . 10.4 mtmp? -68.72 88.31 0.36 Allowed 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 111.762 -2.472 . . . . 0.0 111.718 -179.675 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.515 ' HB2' ' SG ' ' A' ' 25' ' ' CYS . 31.6 m-85 -53.01 119.76 5.05 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 105.361 -2.088 . . . . 0.0 105.361 179.456 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -135.16 153.66 51.9 Favored 'General case' 0 C--N 1.296 -1.723 0 CA-C-N 111.876 -2.42 . . . . 0.0 113.347 -179.036 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 41.9 t -92.17 133.33 35.89 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-N 112.838 -1.983 . . . . 0.0 109.389 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.561 ' H ' ' HB2' ' A' ' 46' ' ' ALA . 5.8 p-10 -51.97 -24.01 5.89 Favored 'General case' 0 N--CA 1.498 1.96 0 CA-C-N 113.363 -1.744 . . . . 0.0 114.21 -179.797 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 32.6 p30 -58.99 -10.47 2.55 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 124.197 0.935 . . . . 0.0 112.365 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 99.68 29.39 6.99 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 87.1 m -140.06 138.08 35.08 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 124.026 0.486 . . . . 0.0 110.622 -179.871 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.403 ' CG ' ' N ' ' A' ' 24' ' ' VAL . 49.1 t80 -70.55 162.0 29.63 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 124.443 1.09 . . . . 0.0 110.46 179.743 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.403 ' N ' ' CG ' ' A' ' 23' ' ' PHE . 61.0 t -129.48 -72.93 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 124.198 0.936 . . . . 0.0 110.978 -179.825 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.515 ' SG ' ' HB2' ' A' ' 16' ' ' TYR . 14.8 p -149.82 -169.62 3.43 Favored 'General case' 0 N--CA 1.504 2.241 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -137.51 147.22 45.03 Favored 'General case' 0 N--CA 1.502 2.128 0 N-CA-C 105.652 -1.981 . . . . 0.0 105.652 179.251 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -50.55 157.92 2.04 Favored Glycine 0 N--CA 1.5 2.915 0 C-N-CA 120.371 -0.918 . . . . 0.0 115.01 -179.577 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -121.11 -33.25 3.75 Favored 'General case' 0 N--CA 1.496 1.851 0 CA-C-N 113.603 -1.298 . . . . 0.0 110.807 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 32.4 m -95.12 131.48 41.09 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 123.595 0.559 . . . . 0.0 111.273 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.529 ' H ' HD21 ' A' ' 33' ' ' ASN . 16.4 t70 -81.33 143.96 52.92 Favored Pre-proline 0 N--CA 1.493 1.715 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_endo -61.77 73.91 0.09 OUTLIER 'Trans proline' 0 N--CA 1.499 1.838 0 C-N-CA 122.904 2.402 . . . . 0.0 112.111 172.721 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 36.2 mmt180 -162.72 -47.9 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.734 0 CA-C-N 113.387 -1.733 . . . . 0.0 106.802 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.529 HD21 ' H ' ' A' ' 30' ' ' ASP . 6.5 p30 -90.44 119.44 69.13 Favored Pre-proline 0 N--CA 1.494 1.762 0 O-C-N 124.234 0.959 . . . . 0.0 110.816 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -81.02 49.98 3.42 Favored 'Trans proline' 0 N--CA 1.494 1.534 0 C-N-CA 123.419 2.746 . . . . 0.0 111.298 174.528 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.4 ' HE2' ' HA ' ' A' ' 35' ' ' LYS . 6.4 mmpt? -74.65 124.5 26.82 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -99.14 96.1 7.55 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-N 114.744 -1.117 . . . . 0.0 110.754 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.436 ' SG ' ' HB2' ' A' ' 9' ' ' ALA . 78.0 m -79.71 -39.82 30.31 Favored 'General case' 0 N--CA 1.497 1.917 0 CA-C-N 114.709 -1.132 . . . . 0.0 108.678 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 63.0 m 59.71 80.45 0.2 Allowed 'General case' 0 N--CA 1.496 1.853 0 CA-C-N 114.049 -1.432 . . . . 0.0 111.295 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 32.4 tp -84.2 7.79 17.86 Favored 'General case' 0 N--CA 1.499 2.006 0 CA-C-N 114.696 -1.138 . . . . 0.0 108.911 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 13.2 m120 55.52 56.2 6.51 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.453 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 80.8 m 61.42 132.93 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.006 0 CA-C-N 113.29 -1.777 . . . . 0.0 114.044 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -115.68 87.27 17.31 Favored Pre-proline 0 N--CA 1.497 1.908 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.447 179.667 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -64.52 -17.04 58.27 Favored 'Trans proline' 0 N--CA 1.492 1.421 0 C-N-CA 122.844 2.363 . . . . 0.0 111.568 170.058 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.434 ' N ' ' HD3' ' A' ' 44' ' ' ARG . 0.0 OUTLIER -70.27 -10.4 58.82 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 123.688 0.618 . . . . 0.0 109.992 -179.971 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.411 ' CG2' ' N ' ' A' ' 46' ' ' ALA . 46.2 mt -119.9 159.98 20.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 CA-C-O 122.14 0.972 . . . . 0.0 110.66 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.561 ' HB2' ' H ' ' A' ' 19' ' ' ASP . . . -119.6 -55.26 2.12 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-N 111.695 -2.502 . . . . 0.0 108.182 179.755 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 5.8 p90 -167.21 153.55 8.12 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 124.129 0.893 . . . . 0.0 112.644 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -81.99 102.39 2.26 Favored Glycine 0 N--CA 1.492 2.428 0 CA-C-N 112.884 -1.962 . . . . 0.0 112.659 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 47.4 t -79.6 90.28 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 124.051 0.5 . . . . 0.0 112.18 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.4 ' SG ' ' HA ' ' A' ' 55' ' ' GLU . 1.5 m -79.33 120.38 80.28 Favored Pre-proline 0 N--CA 1.504 2.229 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 179.459 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -71.1 -60.13 0.06 OUTLIER 'Trans proline' 0 N--CA 1.492 1.405 0 C-N-CA 122.534 2.156 . . . . 0.0 109.735 -173.861 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -80.17 128.72 33.85 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-N 114.482 -1.236 . . . . 0.0 109.577 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 82.0 p 44.96 -158.78 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.182 0 O-C-N 125.034 1.459 . . . . 0.0 113.194 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -70.59 -50.95 31.82 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 109.165 -0.679 . . . . 0.0 109.165 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.4 ' HA ' ' SG ' ' A' ' 50' ' ' CYS . 12.2 pt-20 179.3 -173.23 0.18 Allowed 'General case' 0 N--CA 1.502 2.154 0 O-C-N 124.485 1.116 . . . . 0.0 109.587 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.491 ' HZ2' ' HB3' ' A' ' 56' ' ' LYS . 0.0 OUTLIER -62.41 133.53 55.17 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 105.963 -1.866 . . . . 0.0 105.963 179.462 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.445 ' H ' ' HZ3' ' A' ' 56' ' ' LYS . 5.9 ptpp? 38.7 47.79 1.21 Allowed 'General case' 0 N--CA 1.504 2.227 0 O-C-N 124.874 1.359 . . . . 0.0 110.982 -179.78 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 10.5 m-80 -6.82 127.07 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.142 0 CA-C-N 111.16 -2.745 . . . . 0.0 117.273 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -77.92 28.97 0.17 Allowed 'General case' 0 N--CA 1.499 2.013 0 CA-C-N 114.808 -1.087 . . . . 0.0 111.627 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.419 ' HD2' ' N ' ' A' ' 60' ' ' ARG . 2.0 mpt_? 68.49 137.97 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.098 0 C-N-CA 123.929 0.892 . . . . 0.0 109.806 -179.739 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 7.2 tp -39.61 94.97 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 O-C-N 124.811 1.319 . . . . 0.0 113.49 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.52 ' HA ' ' HA ' ' A' ' 99' ' ' CYS . 6.8 m -99.88 34.7 2.21 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 123.349 1.547 . . . . 0.0 113.037 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 95.1 m -91.08 138.42 31.62 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-N 111.584 -2.553 . . . . 0.0 106.777 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.526 ' ND2' ' H ' ' A' ' 67' ' ' ALA . 28.4 p-10 -160.74 151.04 17.93 Favored 'General case' 0 N--CA 1.499 2.01 0 C-N-CA 120.011 -0.676 . . . . 0.0 111.286 179.76 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' CYS . . . . . 0.406 ' SG ' ' NH1' ' A' ' 97' ' ' ARG . 0.7 OUTLIER -60.05 -28.78 68.05 Favored 'General case' 0 N--CA 1.495 1.789 0 CA-C-N 114.316 -1.311 . . . . 0.0 114.072 -179.842 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 40.1 t -79.78 -69.05 0.61 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 124.168 0.918 . . . . 0.0 111.81 -179.691 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.526 ' H ' ' ND2' ' A' ' 64' ' ' ASN . . . -88.37 45.26 1.27 Allowed 'General case' 0 N--CA 1.497 1.898 0 O-C-N 124.848 1.342 . . . . 0.0 109.812 -179.806 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -85.58 -143.55 6.87 Favored Glycine 0 N--CA 1.489 2.201 0 CA-C-N 114.365 -1.288 . . . . 0.0 111.264 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 35.5 p -139.85 116.21 10.6 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 114.826 -0.687 . . . . 0.0 110.523 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -60.69 97.07 0.05 OUTLIER 'General case' 0 N--CA 1.5 2.048 0 O-C-N 124.135 0.897 . . . . 0.0 109.619 179.706 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 158.21 -17.91 0.31 Allowed Glycine 0 N--CA 1.494 2.558 0 CA-C-N 114.52 -1.218 . . . . 0.0 110.872 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 91.2 m -125.39 155.44 40.36 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 124.015 0.479 . . . . 0.0 110.373 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -103.1 94.3 5.47 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 124.192 0.933 . . . . 0.0 109.763 -179.809 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -51.02 128.77 22.35 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-N 113.647 -1.615 . . . . 0.0 109.333 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.475 ' CE2' ' HA ' ' A' ' 80' ' ' THR . 0.2 OUTLIER -134.6 153.88 51.76 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-N 113.606 -1.634 . . . . 0.0 113.678 -179.335 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.407 ' N ' HG23 ' A' ' 82' ' ' VAL . 31.6 t -112.74 129.6 56.36 Favored 'General case' 0 N--CA 1.498 1.964 0 CA-C-N 112.98 -1.918 . . . . 0.0 112.359 -179.718 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.446 ' H ' ' HB2' ' A' ' 104' ' ' ALA . 8.4 p-10 -61.88 -50.03 73.85 Favored 'General case' 0 N--CA 1.499 1.993 0 CA-C-N 114.622 -1.172 . . . . 0.0 109.546 179.833 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -90.81 18.24 6.77 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 112.825 -1.989 . . . . 0.0 111.641 -179.829 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -163.47 25.34 0.2 Allowed Glycine 0 N--CA 1.495 2.628 0 C-N-CA 118.915 -1.612 . . . . 0.0 113.141 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.475 ' HA ' ' CE2' ' A' ' 75' ' ' PHE . 6.7 t 42.48 -163.56 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.794 0 O-C-N 124.998 1.057 . . . . 0.0 113.22 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 22.8 t80 -48.28 127.94 13.55 Favored 'General case' 0 N--CA 1.497 1.889 0 CA-C-O 121.378 0.609 . . . . 0.0 111.592 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.407 HG23 ' N ' ' A' ' 76' ' ' SER . 63.5 t -94.79 -76.94 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' CYS . . . . . 0.488 ' SG ' ' N ' ' A' ' 84' ' ' GLU . 0.4 OUTLIER -168.09 -169.64 1.16 Allowed 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 179.696 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.488 ' N ' ' SG ' ' A' ' 83' ' ' CYS . 37.6 tt0 -96.01 162.01 13.74 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -72.01 107.1 2.09 Favored Glycine 0 N--CA 1.493 2.486 0 N-CA-C 105.078 -3.209 . . . . 0.0 105.078 179.63 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -93.13 25.06 3.44 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 -179.643 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 29.4 t -129.4 123.39 31.54 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-N 114.338 -1.301 . . . . 0.0 108.97 179.655 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -85.56 144.61 40.42 Favored Pre-proline 0 N--CA 1.492 1.671 0 CA-C-N 114.442 -1.253 . . . . 0.0 108.126 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_endo -61.86 79.76 0.09 OUTLIER 'Trans proline' 0 N--CA 1.496 1.64 0 C-N-CA 122.574 2.183 . . . . 0.0 108.414 165.131 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 58.2 ttt85 -169.78 -52.86 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 105.515 -2.032 . . . . 0.0 105.515 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -91.54 115.55 64.71 Favored Pre-proline 0 N--CA 1.497 1.92 0 O-C-N 124.83 1.331 . . . . 0.0 111.237 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -83.45 49.38 2.93 Favored 'Trans proline' 0 N--CA 1.495 1.571 0 C-N-CA 123.484 2.789 . . . . 0.0 109.549 170.835 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -106.56 152.4 23.75 Favored 'General case' 0 N--CA 1.498 1.938 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.79 -179.797 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -152.61 154.81 36.11 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-N 115.01 -0.996 . . . . 0.0 111.245 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 66.3 m -84.99 -179.53 1.5 Allowed Pre-proline 0 N--CA 1.498 1.94 0 CA-C-N 114.394 -1.276 . . . . 0.0 108.682 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_endo -62.98 65.94 0.15 Allowed 'Trans proline' 0 N--CA 1.494 1.525 0 C-N-CA 122.13 1.887 . . . . 0.0 110.318 148.485 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.406 ' NH1' ' SG ' ' A' ' 65' ' ' CYS . 34.6 ttm180 -160.14 26.85 0.17 Allowed 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 106.285 -1.746 . . . . 0.0 106.285 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 29.0 m120 -60.68 117.02 4.83 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-N 114.78 -1.1 . . . . 0.0 109.956 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.52 ' HA ' ' HA ' ' A' ' 62' ' ' CYS . 65.0 m 54.1 86.49 0.05 OUTLIER 'General case' 0 N--CA 1.496 1.87 0 O-C-N 124.854 1.346 . . . . 0.0 110.665 -179.878 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.41 ' O ' HG22 ' A' ' 103' ' ' ILE . 10.7 t70 -71.01 109.22 4.79 Favored Pre-proline 0 N--CA 1.498 1.942 0 CA-C-N 115.683 -0.689 . . . . 0.0 111.58 -179.769 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_endo -69.71 -38.9 7.26 Favored 'Trans proline' 0 N--CA 1.494 1.538 0 C-N-CA 122.157 1.905 . . . . 0.0 109.857 -171.377 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 35.2 mmt180 -71.27 -11.68 61.05 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-N 113.984 -1.462 . . . . 0.0 113.828 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.41 HG22 ' O ' ' A' ' 100' ' ' ASP . 8.9 tt -73.38 178.55 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 C-N-CA 118.614 -1.234 . . . . 0.0 109.293 -179.792 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.446 ' HB2' ' H ' ' A' ' 77' ' ' ASP . . . -134.7 -60.23 0.79 Allowed 'General case' 0 N--CA 1.494 1.741 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.788 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 15.8 p90 -168.7 166.69 11.64 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-N 114.757 -1.11 . . . . 0.0 110.366 -179.809 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -99.38 116.22 5.52 Favored Glycine 0 N--CA 1.49 2.265 0 CA-C-N 113.861 -1.518 . . . . 0.0 109.417 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 96.2 mt -78.65 92.86 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 N-CA-C 105.766 -1.938 . . . . 0.0 105.766 179.816 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 17.1 m -79.43 121.03 82.32 Favored Pre-proline 0 N--CA 1.493 1.676 0 CA-C-N 113.995 -1.457 . . . . 0.0 109.096 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -66.19 127.18 17.02 Favored 'Trans proline' 0 N--CA 1.493 1.469 0 C-N-CA 122.259 1.972 . . . . 0.0 110.359 -179.07 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -79.59 104.13 9.97 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 105.688 -1.967 . . . . 0.0 105.688 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.501 2.102 0 CA-C-O 117.568 -1.206 . . . . 0.0 112.198 -179.946 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 30.7 t70 . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.439 HH11 ' HB2' ' A' ' 4' ' ' CYS . 2.5 tmm_? 55.55 64.5 1.74 Allowed 'General case' 0 N--CA 1.5 2.048 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 8.3 tp -90.43 51.71 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 CA-C-N 114.257 -1.338 . . . . 0.0 110.293 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.519 ' HA ' ' HA ' ' A' ' 41' ' ' CYS . 1.6 m -82.73 41.14 0.71 Allowed 'General case' 0 N--CA 1.495 1.813 0 CA-C-O 123.056 1.408 . . . . 0.0 114.389 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 91.8 m -91.47 112.86 24.95 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-N 112.657 -2.065 . . . . 0.0 109.127 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.466 ' ND2' ' HA ' ' A' ' 40' ' ' ASN . 40.3 p-10 -115.94 176.93 4.87 Favored 'General case' 0 N--CA 1.501 2.092 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 179.545 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.457 ' SG ' ' CD2' ' A' ' 16' ' ' TYR . 1.8 t -73.08 -27.69 61.87 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 114.322 1.23 . . . . 0.0 114.322 -179.557 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.484 ' SG ' ' N ' ' A' ' 37' ' ' CYS . 53.0 t -80.14 -63.14 1.48 Allowed 'General case' 0 N--CA 1.492 1.674 0 CA-C-N 114.374 -1.285 . . . . 0.0 113.936 -179.602 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -90.22 19.38 5.11 Favored 'General case' 0 N--CA 1.502 2.16 0 N-CA-C 113.619 0.97 . . . . 0.0 113.619 -179.792 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -83.45 -111.57 0.54 Allowed Glycine 0 N--CA 1.499 2.852 0 C-N-CA 120.6 -0.81 . . . . 0.0 111.57 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 40.7 p -137.08 112.22 9.07 Favored 'General case' 0 N--CA 1.504 2.235 0 CA-C-O 121.073 0.463 . . . . 0.0 111.892 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 8.5 tmtt? -62.53 150.19 41.0 Favored 'General case' 0 N--CA 1.487 1.389 0 CA-C-O 121.241 0.543 . . . . 0.0 111.154 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 76.45 -10.27 17.68 Favored Glycine 0 N--CA 1.489 2.195 0 CA-C-N 114.301 -1.318 . . . . 0.0 111.806 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 69.0 m -102.52 127.73 49.46 Favored 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 119.561 -0.856 . . . . 0.0 108.901 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -70.84 92.36 0.9 Allowed 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 113.267 -1.788 . . . . 0.0 109.112 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.665 ' CD2' ' SG ' ' A' ' 25' ' ' CYS . 78.6 m-85 -44.94 131.13 7.35 Favored 'General case' 0 N--CA 1.502 2.161 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 179.753 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -144.99 150.38 36.82 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 125.139 1.524 . . . . 0.0 112.532 -179.421 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 40.5 t -96.1 134.46 39.14 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-N 111.969 -2.378 . . . . 0.0 111.828 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.427 ' H ' ' HB2' ' A' ' 46' ' ' ALA . 4.5 p-10 -51.05 -24.73 4.1 Favored 'General case' 0 N--CA 1.501 2.097 0 CA-C-N 112.941 -1.936 . . . . 0.0 113.9 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 25.7 p30 -59.59 -8.86 2.15 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 124.178 0.924 . . . . 0.0 112.361 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 97.07 28.71 8.47 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 86.5 m -140.64 143.07 34.96 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 123.998 0.47 . . . . 0.0 110.399 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.452 ' CG ' ' N ' ' A' ' 24' ' ' VAL . 39.1 t80 -69.54 167.92 15.77 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 124.802 1.314 . . . . 0.0 111.132 179.8 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.452 ' N ' ' CG ' ' A' ' 23' ' ' PHE . 98.6 t -132.51 -74.45 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 123.842 0.714 . . . . 0.0 112.885 -179.79 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.665 ' SG ' ' CD2' ' A' ' 16' ' ' TYR . 20.5 p -147.24 -175.7 4.94 Favored 'General case' 0 N--CA 1.509 2.506 0 C-N-CA 121.04 -0.264 . . . . 0.0 110.708 -179.623 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 7.4 tm-20 -103.74 143.83 32.28 Favored 'General case' 0 N--CA 1.508 2.467 0 N-CA-C 113.402 0.89 . . . . 0.0 113.402 -179.776 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.622 ' HA2' ' CE2' ' A' ' 16' ' ' TYR . . . -43.98 105.62 0.08 OUTLIER Glycine 0 N--CA 1.501 3.013 0 O-C-N 124.437 1.085 . . . . 0.0 115.039 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -122.63 37.22 4.45 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 17.5 t -121.82 65.97 0.91 Allowed 'General case' 0 N--CA 1.499 1.996 0 CA-C-O 121.815 0.816 . . . . 0.0 110.959 -179.866 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -88.37 142.61 31.53 Favored Pre-proline 0 N--CA 1.493 1.72 0 CA-C-N 113.886 -1.506 . . . . 0.0 108.528 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -56.64 -4.72 0.92 Allowed 'Trans proline' 0 N--CA 1.497 1.727 0 C-N-CA 122.316 2.011 . . . . 0.0 114.568 175.163 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.419 ' NE ' ' HA ' ' A' ' 32' ' ' ARG . 12.3 mmp_? -94.48 -27.76 15.82 Favored 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 113.148 0.795 . . . . 0.0 113.148 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -66.05 121.85 78.2 Favored Pre-proline 0 N--CA 1.497 1.898 0 C-N-CA 119.039 -1.064 . . . . 0.0 112.006 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -75.09 123.13 7.61 Favored 'Trans proline' 0 N--CA 1.492 1.423 0 C-N-CA 122.714 2.276 . . . . 0.0 109.963 178.086 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 62.64 160.52 0.08 Allowed 'General case' 0 N--CA 1.502 2.16 0 O-C-N 124.614 1.196 . . . . 0.0 112.954 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -79.92 -167.1 1.16 Allowed 'General case' 0 N--CA 1.496 1.841 0 CA-C-N 114.694 -1.139 . . . . 0.0 110.099 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.484 ' N ' ' SG ' ' A' ' 8' ' ' CYS . 4.4 m -129.97 160.19 34.38 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 123.712 0.633 . . . . 0.0 110.016 -179.863 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 77.0 m 42.27 -104.72 0.06 Allowed 'General case' 0 N--CA 1.497 1.899 0 CA-C-N 114.261 -1.336 . . . . 0.0 113.167 179.736 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 96.1 mt -142.18 4.03 1.6 Allowed 'General case' 0 N--CA 1.498 1.962 0 O-C-N 123.585 0.553 . . . . 0.0 112.441 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.466 ' HA ' ' ND2' ' A' ' 6' ' ' ASN . 1.6 m-80 59.07 -174.33 0.1 Allowed 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 114.174 1.176 . . . . 0.0 114.174 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.519 ' HA ' ' HA ' ' A' ' 4' ' ' CYS . 56.8 m 59.88 100.87 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 CA-C-N 113.185 -1.825 . . . . 0.0 113.04 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -120.56 101.66 45.88 Favored Pre-proline 0 N--CA 1.496 1.873 0 CA-C-N 115.32 -0.855 . . . . 0.0 108.789 179.695 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -60.49 -31.57 92.62 Favored 'Trans proline' 0 N--CA 1.494 1.518 0 C-N-CA 122.622 2.215 . . . . 0.0 111.728 -176.23 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 21.6 tpp85 -57.52 -39.91 77.59 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 124.107 0.879 . . . . 0.0 109.175 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 13.7 mt -71.26 152.49 8.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 CA-C-O 122.192 0.996 . . . . 0.0 109.827 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.427 ' HB2' ' H ' ' A' ' 19' ' ' ASP . . . -121.14 -51.2 2.11 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-N 111.773 -2.467 . . . . 0.0 106.503 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 15.8 p90 -172.7 158.9 4.17 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-N 113.186 -1.825 . . . . 0.0 109.736 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -97.86 123.41 7.82 Favored Glycine 0 N--CA 1.49 2.288 0 CA-C-N 113.313 -1.767 . . . . 0.0 108.973 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 27.2 m -90.2 101.05 11.88 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 CA-C-O 122.052 0.929 . . . . 0.0 110.678 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.6 m -79.03 164.03 57.04 Favored Pre-proline 0 N--CA 1.502 2.14 0 CA-C-N 114.502 -1.226 . . . . 0.0 108.98 179.729 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -57.21 154.0 36.66 Favored 'Trans proline' 0 N--CA 1.494 1.55 0 C-N-CA 122.369 2.046 . . . . 0.0 111.313 173.059 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.481 ' NE ' ' HA ' ' A' ' 52' ' ' ARG . 14.8 mmp_? -79.94 115.76 19.7 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-N 115.183 -0.917 . . . . 0.0 109.988 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 56.4 m -66.37 149.42 50.42 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-N 114.882 -1.054 . . . . 0.0 109.708 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -153.92 131.83 11.65 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-N 115.265 -0.88 . . . . 0.0 109.943 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 27.5 mm-40 -106.46 79.99 1.43 Allowed 'General case' 0 N--CA 1.492 1.657 0 CA-C-N 114.927 -1.033 . . . . 0.0 111.185 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 9.2 mtpm? -85.67 -71.77 0.52 Allowed 'General case' 0 N--CA 1.494 1.758 0 CA-C-N 113.844 -1.526 . . . . 0.0 109.763 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -160.0 150.96 19.15 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 123.954 0.784 . . . . 0.0 109.397 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 26.9 m120 49.51 34.14 6.52 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 124.24 0.962 . . . . 0.0 112.275 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -65.14 166.9 8.86 Favored 'General case' 0 N--CA 1.495 1.822 0 CA-C-N 115.064 -0.971 . . . . 0.0 111.251 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 62.4 ttm-85 -44.31 -38.42 3.89 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 124.473 1.108 . . . . 0.0 112.576 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 6.7 tp -69.52 86.56 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 124.296 0.998 . . . . 0.0 111.554 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.524 ' HA ' ' HA ' ' A' ' 99' ' ' CYS . 1.7 m -94.34 44.07 1.11 Allowed 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 123.02 1.39 . . . . 0.0 112.075 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 52.0 m -90.66 151.02 21.44 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 112.626 -2.079 . . . . 0.0 108.892 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 52.1 p-10 -127.86 -171.06 2.35 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 17.0 t -101.95 -29.97 11.5 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 123.663 0.602 . . . . 0.0 110.95 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 37.2 t -61.87 -55.35 30.64 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 124.102 0.876 . . . . 0.0 109.947 -179.748 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -87.68 63.86 7.74 Favored 'General case' 0 N--CA 1.499 2.025 0 N-CA-C 106.23 -1.767 . . . . 0.0 106.23 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -106.33 -115.87 4.08 Favored Glycine 0 N--CA 1.488 2.164 0 CA-C-N 113.963 -1.471 . . . . 0.0 112.322 -179.762 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.509 ' H ' ' CA ' ' A' ' 85' ' ' GLY . 2.6 t 179.29 110.67 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 125.278 1.222 . . . . 0.0 109.402 -179.851 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 11.4 mmmm -64.79 88.38 0.06 Allowed 'General case' 0 N--CA 1.499 1.996 0 CA-C-N 114.954 -1.021 . . . . 0.0 108.307 179.731 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 171.79 -31.73 0.13 Allowed Glycine 0 N--CA 1.487 2.055 0 CA-C-N 113.908 -1.496 . . . . 0.0 110.937 -179.82 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' CYS . . . . . 0.419 ' HA ' ' HA ' ' A' ' 108' ' ' CYS . 67.9 m -112.71 167.15 10.72 Favored 'General case' 0 N--CA 1.5 2.058 0 C-N-CA 119.46 -0.896 . . . . 0.0 111.139 -179.818 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 61.1 mtpt -111.14 100.91 9.48 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-N 114.074 -1.421 . . . . 0.0 113.775 -179.673 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.414 ' CG ' HD11 ' A' ' 103' ' ' ILE . 5.0 m-85 -52.71 141.63 20.56 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 124.265 0.978 . . . . 0.0 109.988 179.466 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -154.77 159.45 40.64 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 113.684 -1.598 . . . . 0.0 112.964 -179.426 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 73.0 p -100.24 135.08 42.21 Favored 'General case' 0 N--CA 1.486 1.358 0 CA-C-N 114.014 -1.448 . . . . 0.0 113.179 -179.768 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.547 ' H ' ' HB2' ' A' ' 104' ' ' ALA . 4.6 p-10 -40.01 -47.19 2.22 Favored 'General case' 0 N--CA 1.499 2.005 0 CA-C-N 112.82 -1.991 . . . . 0.0 115.978 -179.867 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -52.9 -36.05 58.95 Favored 'General case' 0 N--CA 1.497 1.88 0 CA-C-N 114.724 -1.125 . . . . 0.0 112.38 -179.794 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 128.43 42.68 0.24 Allowed Glycine 0 N--CA 1.494 2.539 0 O-C-N 124.772 1.295 . . . . 0.0 111.594 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 95.1 m -140.84 114.07 8.58 Favored 'General case' 0 N--CA 1.497 1.876 0 C-N-CA 119.469 -0.893 . . . . 0.0 112.739 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -54.18 139.69 34.83 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.639 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 99.5 t -103.88 -63.98 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 CA-C-N 114.571 -1.195 . . . . 0.0 112.183 -179.702 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' CYS . . . . . 0.415 ' SG ' ' N ' ' A' ' 84' ' ' GLU . 1.8 p -160.28 -162.98 1.03 Allowed 'General case' 0 N--CA 1.501 2.083 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 -179.8 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.415 ' N ' ' SG ' ' A' ' 83' ' ' CYS . 30.4 tt0 -118.36 144.7 45.69 Favored 'General case' 0 N--CA 1.5 2.069 0 N-CA-C 105.992 -1.855 . . . . 0.0 105.992 179.298 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.509 ' CA ' ' H ' ' A' ' 69' ' ' THR . . . -60.17 135.78 50.03 Favored Glycine 0 N--CA 1.496 2.689 0 N-CA-C 108.154 -1.979 . . . . 0.0 108.154 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -105.71 -7.89 18.17 Favored 'General case' 0 N--CA 1.503 2.195 0 N-CA-C 116.722 2.119 . . . . 0.0 116.722 -179.581 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 26.8 t -70.06 97.09 1.12 Allowed 'General case' 0 N--CA 1.501 2.115 0 C-N-CA 119.001 -1.08 . . . . 0.0 108.757 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -79.74 143.81 59.18 Favored Pre-proline 0 N--CA 1.494 1.74 0 CA-C-N 114.855 -1.066 . . . . 0.0 109.765 -179.792 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -46.66 -22.34 1.79 Allowed 'Trans proline' 0 N--CA 1.499 1.817 0 C-N-CA 122.887 2.392 . . . . 0.0 113.017 170.717 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.432 ' NE ' ' HA ' ' A' ' 90' ' ' ARG . 3.7 tpm_? -62.14 -53.08 60.42 Favored 'General case' 0 N--CA 1.495 1.775 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.412 HD22 ' H ' ' A' ' 93' ' ' LYS . 2.4 p-10 -84.63 131.95 48.16 Favored Pre-proline 0 N--CA 1.492 1.663 0 CA-C-N 115.079 -0.964 . . . . 0.0 108.99 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -79.26 56.9 6.23 Favored 'Trans proline' 0 N--CA 1.492 1.388 0 C-N-CA 123.029 2.486 . . . . 0.0 108.181 163.912 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.412 ' H ' HD22 ' A' ' 91' ' ' ASN . 27.7 mtpp 65.29 121.31 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.082 0 CA-C-N 114.585 -1.188 . . . . 0.0 110.923 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -153.25 68.21 0.8 Allowed 'General case' 0 N--CA 1.496 1.839 0 CA-C-N 114.665 -1.152 . . . . 0.0 108.134 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 89.7 m -154.11 160.56 30.8 Favored Pre-proline 0 N--CA 1.496 1.855 0 CA-C-N 114.263 -1.335 . . . . 0.0 111.967 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -73.41 -159.27 0.08 OUTLIER 'Trans proline' 0 N--CA 1.493 1.442 0 C-N-CA 122.973 2.449 . . . . 0.0 109.792 160.864 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.55 52.25 1.12 Allowed 'General case' 0 N--CA 1.494 1.772 0 CA-C-O 122.392 1.092 . . . . 0.0 108.284 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -47.04 113.9 0.75 Allowed 'General case' 0 N--CA 1.5 2.051 0 CA-C-N 113.054 -1.885 . . . . 0.0 110.565 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.524 ' HA ' ' HA ' ' A' ' 62' ' ' CYS . 56.2 m -60.07 121.7 12.53 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 119.926 -0.709 . . . . 0.0 111.095 -179.836 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 42.0 t0 -112.22 91.09 15.24 Favored Pre-proline 0 N--CA 1.494 1.762 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -58.34 -31.44 93.88 Favored 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 122.708 2.272 . . . . 0.0 111.143 -169.033 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 15.7 tpt180 -73.04 -40.39 65.16 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-N 114.366 -1.288 . . . . 0.0 112.305 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.414 HD11 ' CG ' ' A' ' 74' ' ' TYR . 3.3 tt -58.67 162.54 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 O-C-N 123.524 0.515 . . . . 0.0 112.048 -179.592 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.547 ' HB2' ' H ' ' A' ' 77' ' ' ASP . . . -139.96 -57.81 0.56 Allowed 'General case' 0 N--CA 1.495 1.824 0 CA-C-N 114.411 -1.268 . . . . 0.0 109.172 179.807 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 15.3 p90 -165.62 163.41 19.25 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-N 114.816 -1.084 . . . . 0.0 110.917 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -111.32 115.22 3.87 Favored Glycine 0 N--CA 1.493 2.444 0 CA-C-N 114.077 -1.419 . . . . 0.0 111.974 -179.826 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 51.5 mm -93.01 124.54 45.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 124.52 0.777 . . . . 0.0 110.054 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' CYS . . . . . 0.419 ' HA ' ' HA ' ' A' ' 72' ' ' CYS . 1.7 m -79.61 148.17 68.99 Favored Pre-proline 0 N--CA 1.495 1.82 0 O-C-N 124.024 0.827 . . . . 0.0 109.706 179.685 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -56.47 144.59 83.49 Favored 'Trans proline' 0 N--CA 1.494 1.559 0 C-N-CA 122.866 2.378 . . . . 0.0 111.457 -175.249 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 3.2 pp -154.48 175.17 13.92 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 124.406 1.066 . . . . 0.0 111.281 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.85 0 CA-C-O 116.308 -1.806 . . . . 0.0 110.52 -179.997 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 86.3 mtm180 51.94 39.81 26.82 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 124.31 1.006 . . . . 0.0 111.51 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 8.7 tp -84.04 48.5 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 CA-C-N 114.445 -1.252 . . . . 0.0 109.982 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.494 ' HA ' ' HA ' ' A' ' 41' ' ' CYS . 1.5 m -83.42 57.29 3.94 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 115.668 1.729 . . . . 0.0 115.668 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 37.3 p -91.8 176.6 6.47 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-N 113.143 -1.844 . . . . 0.0 110.183 179.657 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.524 HD21 ' N ' ' A' ' 37' ' ' CYS . 34.2 p30 -162.04 -172.72 3.35 Favored 'General case' 0 N--CA 1.495 1.807 0 CA-C-N 114.276 -1.329 . . . . 0.0 108.026 179.189 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.8 t -75.98 -10.15 59.19 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 115.737 1.754 . . . . 0.0 115.737 -179.472 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 6.7 t -91.79 -37.52 12.91 Favored 'General case' 0 N--CA 1.503 2.177 0 CA-C-O 121.587 0.708 . . . . 0.0 111.667 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -74.34 57.76 0.7 Allowed 'General case' 0 N--CA 1.497 1.909 0 CA-C-N 113.085 -1.87 . . . . 0.0 113.568 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -162.16 -121.9 0.59 Allowed Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.763 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 86.7 m -140.29 124.28 17.5 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 123.88 0.4 . . . . 0.0 111.851 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 40.4 ttpt -67.42 86.67 0.18 Allowed 'General case' 0 N--CA 1.496 1.865 0 O-C-N 124.618 1.199 . . . . 0.0 109.308 179.7 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.459 ' H ' ' HA3' ' A' ' 27' ' ' GLY . . . 156.15 -19.13 0.47 Allowed Glycine 0 N--CA 1.494 2.56 0 CA-C-N 114.855 -1.066 . . . . 0.0 110.661 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 87.7 m -89.43 -177.8 5.43 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -130.54 101.97 5.94 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 123.477 0.486 . . . . 0.0 110.218 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.632 ' CD1' ' SG ' ' A' ' 25' ' ' CYS . 85.0 m-85 -55.85 141.66 38.09 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 124.116 0.885 . . . . 0.0 109.08 179.806 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -149.65 151.71 34.18 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 124.874 1.359 . . . . 0.0 112.699 -179.685 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 96.2 p -101.69 132.7 47.25 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-N 113.272 -1.786 . . . . 0.0 112.476 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.469 ' H ' ' CB ' ' A' ' 46' ' ' ALA . 6.1 p-10 -45.24 -31.17 1.42 Allowed 'General case' 0 N--CA 1.504 2.239 0 N-CA-C 116.643 2.09 . . . . 0.0 116.643 -179.709 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -55.2 -15.87 2.7 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 123.989 0.805 . . . . 0.0 112.738 -179.807 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 108.88 25.28 5.72 Favored Glycine 0 N--CA 1.493 2.448 0 O-C-N 124.419 1.074 . . . . 0.0 111.003 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 57.0 m -135.64 152.06 50.85 Favored 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 120.437 -0.505 . . . . 0.0 110.513 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.406 ' CG ' ' N ' ' A' ' 24' ' ' VAL . 17.5 t80 -74.67 169.54 17.63 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-N 114.546 -1.207 . . . . 0.0 109.824 179.706 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.406 ' N ' ' CG ' ' A' ' 23' ' ' PHE . 93.8 t -131.25 -67.85 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 O-C-N 123.689 0.618 . . . . 0.0 112.635 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.632 ' SG ' ' CD1' ' A' ' 16' ' ' TYR . 11.9 p -153.75 -172.62 4.28 Favored 'General case' 0 N--CA 1.504 2.228 0 C-N-CA 120.256 -0.577 . . . . 0.0 109.469 -179.771 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -126.67 143.2 51.31 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 123.705 0.628 . . . . 0.0 110.906 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.459 ' HA3' ' H ' ' A' ' 13' ' ' GLY . . . -27.41 124.43 0.06 OUTLIER Glycine 0 N--CA 1.495 2.621 0 O-C-N 124.941 1.401 . . . . 0.0 116.09 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -114.69 -22.42 9.72 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 124.582 0.813 . . . . 0.0 110.244 179.849 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 47.4 t -156.56 154.38 30.17 Favored 'General case' 0 N--CA 1.497 1.916 0 CA-C-O 121.522 0.677 . . . . 0.0 111.153 -179.798 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -78.85 141.28 59.13 Favored Pre-proline 0 N--CA 1.496 1.856 0 CA-C-N 113.401 -1.727 . . . . 0.0 108.76 -179.813 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -61.61 -12.94 27.05 Favored 'Trans proline' 0 N--CA 1.496 1.647 0 C-N-CA 122.766 2.311 . . . . 0.0 113.452 -165.889 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 23.5 mmm180 -56.88 -23.51 45.07 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 123.792 0.683 . . . . 0.0 110.968 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 22.1 p-10 -64.28 112.95 8.74 Favored Pre-proline 0 N--CA 1.492 1.639 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 179.779 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -81.24 39.02 0.81 Allowed 'Trans proline' 0 N--CA 1.496 1.675 0 C-N-CA 123.222 2.615 . . . . 0.0 112.203 -175.216 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -175.82 155.87 1.73 Allowed 'General case' 0 N--CA 1.497 1.91 0 CA-C-N 115.197 -0.911 . . . . 0.0 111.831 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -82.95 143.48 30.65 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 179.666 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.524 ' N ' HD21 ' A' ' 6' ' ' ASN . 1.6 m -105.69 -140.58 0.37 Allowed 'General case' 0 N--CA 1.499 2.0 0 O-C-N 123.725 0.641 . . . . 0.0 109.322 -179.788 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 58.5 p 35.33 -141.59 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.186 0 N-CA-C 114.081 1.141 . . . . 0.0 114.081 179.728 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.459 ' CD2' ' H ' ' A' ' 39' ' ' LEU . 1.6 pt? -80.32 -7.09 58.9 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 123.713 0.633 . . . . 0.0 111.776 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 39.4 m-80 62.62 158.07 0.06 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 124.756 1.285 . . . . 0.0 112.972 -179.825 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.494 ' HA ' ' HA ' ' A' ' 4' ' ' CYS . 82.4 m 54.76 116.51 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 116.341 1.978 . . . . 0.0 116.341 -179.817 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -148.11 90.97 4.93 Favored Pre-proline 0 N--CA 1.491 1.619 0 CA-C-N 113.707 -1.588 . . . . 0.0 108.979 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -62.07 -17.55 56.87 Favored 'Trans proline' 0 N--CA 1.492 1.4 0 C-N-CA 122.58 2.187 . . . . 0.0 111.922 175.515 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 33.3 mmt180 -64.01 -33.6 76.11 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 123.844 0.715 . . . . 0.0 109.987 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 4.3 mt -68.79 137.13 24.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 CA-C-O 121.959 0.885 . . . . 0.0 111.401 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.469 ' CB ' ' H ' ' A' ' 19' ' ' ASP . . . -127.58 -53.73 1.35 Allowed 'General case' 0 N--CA 1.494 1.739 0 CA-C-N 112.327 -2.215 . . . . 0.0 109.372 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 30.5 m-85 -137.01 -166.37 1.9 Allowed 'General case' 0 N--CA 1.494 1.764 0 CA-C-N 114.332 -1.303 . . . . 0.0 108.591 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -160.63 104.81 0.25 Allowed Glycine 0 N--CA 1.489 2.178 0 N-CA-C 107.519 -2.232 . . . . 0.0 107.519 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.2 p -79.75 123.3 36.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 -179.837 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 57.1 m -102.27 148.55 35.58 Favored Pre-proline 0 N--CA 1.496 1.871 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.919 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -72.68 107.0 2.22 Favored 'Trans proline' 0 N--CA 1.492 1.41 0 C-N-CA 122.652 2.234 . . . . 0.0 108.56 173.307 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 32.3 ttp-105 -79.53 -25.3 41.74 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 123.996 0.81 . . . . 0.0 110.374 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 36.9 t -146.4 137.46 24.33 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 123.762 0.664 . . . . 0.0 110.26 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 63.27 139.29 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.107 0 O-C-N 125.071 1.482 . . . . 0.0 113.248 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.516 ' H ' ' CD ' ' A' ' 55' ' ' GLU . 0.0 OUTLIER -86.52 -167.3 1.82 Allowed 'General case' 0 N--CA 1.498 1.975 0 CA-C-N 114.152 -1.386 . . . . 0.0 110.012 179.876 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.66 2.59 2.94 Favored 'General case' 0 N--CA 1.496 1.875 0 CA-C-N 115.001 -1.0 . . . . 0.0 110.679 179.745 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 41.2 ttmt -151.9 135.08 15.86 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 23.9 m120 -86.61 53.81 2.94 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.603 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -103.57 40.31 1.44 Allowed 'General case' 0 N--CA 1.496 1.864 0 CA-C-N 114.617 -1.174 . . . . 0.0 109.58 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.429 ' H ' ' HE ' ' A' ' 60' ' ' ARG . 0.8 OUTLIER -53.07 -35.53 59.65 Favored 'General case' 0 N--CA 1.499 1.981 0 CA-C-N 115.036 -0.984 . . . . 0.0 109.656 179.936 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 5.8 tp -77.84 80.73 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 179.608 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.449 ' HA ' ' HA ' ' A' ' 99' ' ' CYS . 1.8 m -85.91 44.87 1.16 Allowed 'General case' 0 N--CA 1.493 1.684 0 CA-C-O 122.933 1.349 . . . . 0.0 112.492 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 52.8 m -90.43 167.75 12.38 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 112.628 -2.078 . . . . 0.0 109.088 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 40.8 p30 -151.84 -175.43 5.22 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-N 114.816 -1.084 . . . . 0.0 108.441 179.818 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 37.1 t -94.19 -29.0 15.34 Favored 'General case' 0 N--CA 1.497 1.893 0 C-N-CA 120.168 -0.613 . . . . 0.0 112.311 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 37.5 t -59.7 -57.85 11.14 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 124.209 0.943 . . . . 0.0 111.166 -179.735 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -88.11 41.43 1.0 Allowed 'General case' 0 N--CA 1.494 1.768 0 CA-C-N 112.946 -1.934 . . . . 0.0 109.184 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -79.85 -136.0 1.41 Allowed Glycine 0 N--CA 1.492 2.433 0 N-CA-C 110.092 -1.203 . . . . 0.0 110.092 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 97.3 m -159.07 95.8 1.29 Allowed 'General case' 0 N--CA 1.501 2.081 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 39.9 mmtt -45.72 117.04 1.33 Allowed 'General case' 0 N--CA 1.505 2.305 0 O-C-N 123.731 0.644 . . . . 0.0 112.0 179.817 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 133.04 -34.64 2.42 Favored Glycine 0 N--CA 1.494 2.507 0 O-C-N 124.643 1.214 . . . . 0.0 110.368 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 63.6 m -101.77 136.8 40.99 Favored 'General case' 0 N--CA 1.494 1.743 0 CA-C-O 121.571 0.701 . . . . 0.0 110.686 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.444 ' HD2' ' N ' ' A' ' 73' ' ' LYS . 4.3 mptp? -85.02 88.99 7.5 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 113.315 -1.766 . . . . 0.0 109.589 -179.834 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.439 ' HA ' ' HA2' ' A' ' 106' ' ' GLY . 35.3 m-85 -48.46 129.2 15.8 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 124.346 1.029 . . . . 0.0 109.107 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -141.0 152.54 45.0 Favored 'General case' 0 C--N 1.303 -1.413 0 CA-C-N 112.491 -2.14 . . . . 0.0 113.219 -179.109 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 80.6 p -92.86 136.28 33.39 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-N 113.056 -1.884 . . . . 0.0 114.744 -179.859 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -49.45 -29.53 6.7 Favored 'General case' 0 N--CA 1.5 2.035 0 CA-C-N 112.689 -2.05 . . . . 0.0 115.523 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -57.91 -15.33 8.35 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 123.855 0.722 . . . . 0.0 112.548 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 108.62 27.7 4.84 Favored Glycine 0 N--CA 1.494 2.526 0 O-C-N 124.33 1.019 . . . . 0.0 111.149 179.784 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 60.4 m -138.85 160.01 40.75 Favored 'General case' 0 N--CA 1.496 1.852 0 C-N-CA 120.534 -0.466 . . . . 0.0 110.028 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.432 ' CG ' ' N ' ' A' ' 82' ' ' VAL . 57.4 t80 -79.7 168.3 19.52 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-N 114.758 -1.11 . . . . 0.0 110.554 179.761 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.432 ' N ' ' CG ' ' A' ' 81' ' ' PHE . 89.1 t -133.12 -73.52 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 124.054 0.846 . . . . 0.0 110.335 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' CYS . . . . . 0.422 ' SG ' ' N ' ' A' ' 84' ' ' GLU . 1.1 p -154.72 -167.23 2.54 Favored 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 -179.771 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.422 ' N ' ' SG ' ' A' ' 83' ' ' CYS . 32.4 tt0 -118.93 152.53 36.16 Favored 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 104.124 -2.547 . . . . 0.0 104.124 179.335 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -53.77 127.85 38.6 Favored Glycine 0 N--CA 1.498 2.777 0 C-N-CA 119.834 -1.174 . . . . 0.0 110.187 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -89.58 -25.15 21.49 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 123.905 0.414 . . . . 0.0 111.625 -179.859 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 70.9 p -69.6 96.14 0.91 Allowed 'General case' 0 N--CA 1.49 1.549 0 CA-C-O 121.765 0.793 . . . . 0.0 111.113 -179.779 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -97.25 136.4 21.44 Favored Pre-proline 0 N--CA 1.493 1.719 0 N-CA-C 106.807 -1.553 . . . . 0.0 106.807 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo -43.83 -26.52 1.31 Allowed 'Trans proline' 0 N--CA 1.501 1.962 0 C-N-CA 122.659 2.239 . . . . 0.0 111.515 167.902 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 37.4 ttp85 -65.85 -54.66 23.84 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-N 113.849 -1.523 . . . . 0.0 109.395 179.772 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 21.6 p30 -90.05 138.93 27.29 Favored Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 124.097 0.873 . . . . 0.0 111.961 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -81.17 49.82 3.35 Favored 'Trans proline' 0 N--CA 1.49 1.268 0 C-N-CA 123.068 2.512 . . . . 0.0 109.25 160.544 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.514 ' NZ ' ' H ' ' A' ' 94' ' ' ALA . 0.2 OUTLIER -67.32 148.47 51.63 Favored 'General case' 0 N--CA 1.498 1.935 0 CA-C-O 121.506 0.669 . . . . 0.0 110.214 -179.961 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.514 ' H ' ' NZ ' ' A' ' 93' ' ' LYS . . . -160.32 152.96 21.04 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-N 113.491 -1.686 . . . . 0.0 110.354 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 86.1 m -156.34 167.47 14.32 Favored Pre-proline 0 N--CA 1.498 1.969 0 CA-C-N 114.644 -1.162 . . . . 0.0 109.245 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -55.37 -161.59 0.01 OUTLIER 'Trans proline' 0 N--CA 1.497 1.721 0 C-N-CA 122.717 2.278 . . . . 0.0 112.642 164.901 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 79.9 mtp180 -78.88 -43.2 25.47 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 18.4 m120 46.53 54.98 8.07 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 124.945 1.403 . . . . 0.0 108.874 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.449 ' HA ' ' HA ' ' A' ' 62' ' ' CYS . 60.2 m -42.93 125.87 3.64 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-N 113.471 -1.695 . . . . 0.0 113.714 -179.675 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 45.0 t0 -116.93 86.27 19.29 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 124.687 1.242 . . . . 0.0 107.853 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -52.9 -26.52 31.59 Favored 'Trans proline' 0 N--CA 1.496 1.653 0 C-N-CA 122.808 2.339 . . . . 0.0 112.833 -178.138 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 78.0 ttt-85 -82.37 -33.93 28.59 Favored 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 114.552 1.315 . . . . 0.0 114.552 -179.622 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 8.8 tt -63.97 168.68 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.239 0 C-N-CA 120.192 -0.603 . . . . 0.0 110.92 -179.607 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -145.93 -72.3 0.24 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 123.81 0.694 . . . . 0.0 111.327 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 27.4 p90 -149.8 158.99 44.7 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 123.94 0.775 . . . . 0.0 112.041 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.439 ' HA2' ' HA ' ' A' ' 74' ' ' TYR . . . -98.73 114.28 4.98 Favored Glycine 0 N--CA 1.491 2.323 0 CA-C-N 112.949 -1.932 . . . . 0.0 111.444 -179.837 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 70.6 mt -79.85 97.38 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 CA-C-N 114.282 -0.959 . . . . 0.0 111.137 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 1.6 m -79.35 148.82 71.3 Favored Pre-proline 0 N--CA 1.502 2.172 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 179.521 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -65.74 141.26 65.09 Favored 'Trans proline' 0 N--CA 1.493 1.458 0 C-N-CA 122.549 2.166 . . . . 0.0 110.527 -179.384 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.458 HD22 ' N ' ' A' ' 110' ' ' LEU . 3.0 mm? -79.88 113.42 18.02 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.09 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 1.881 0 CA-C-O 116.331 -1.795 . . . . 0.0 111.297 -179.999 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 18.7 t70 . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 8.4 ptp180 -157.11 -23.8 0.09 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 124.34 1.025 . . . . 0.0 110.67 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 46.1 mm -77.85 91.61 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 124.132 0.895 . . . . 0.0 108.915 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.525 ' H ' ' HB3' ' A' ' 41' ' ' CYS . 0.5 OUTLIER -84.52 -160.23 0.46 Allowed 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 106.04 -1.837 . . . . 0.0 106.04 -179.997 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.8 t -73.48 -169.26 0.65 Allowed 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 179.536 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 58.8 t30 -122.65 166.84 14.24 Favored 'General case' 0 N--CA 1.497 1.893 0 CA-C-O 122.614 1.197 . . . . 0.0 112.356 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.534 ' HA ' ' CE2' ' A' ' 16' ' ' TYR . 19.9 t 43.28 26.29 0.09 Allowed 'General case' 0 N--CA 1.493 1.71 0 CA-C-N 111.189 -2.732 . . . . 0.0 113.925 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 28.0 t -90.14 -68.46 0.78 Allowed 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 116.639 2.089 . . . . 0.0 116.639 -179.635 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -57.6 -4.47 0.27 Allowed 'General case' 0 N--CA 1.506 2.37 0 N-CA-C 118.367 2.729 . . . . 0.0 118.367 -179.494 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.414 ' N ' ' OH ' ' A' ' 16' ' ' TYR . . . -65.0 -39.22 96.29 Favored Glycine 0 N--CA 1.493 2.465 0 N-CA-C 110.941 -0.864 . . . . 0.0 110.941 -179.791 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 38.8 m 68.49 112.22 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.844 0 O-C-N 125.62 1.424 . . . . 0.0 107.164 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 14.8 tppt? -37.99 98.43 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.088 0 O-C-N 124.693 1.245 . . . . 0.0 113.0 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 157.82 -22.15 0.39 Allowed Glycine 0 N--CA 1.49 2.262 0 CA-C-N 112.686 -2.052 . . . . 0.0 108.686 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 90.9 m -103.98 169.25 8.61 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 62.3 mttp -124.32 95.12 4.42 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 123.972 0.795 . . . . 0.0 112.18 -179.637 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.612 ' HB2' ' SG ' ' A' ' 25' ' ' CYS . 6.5 m-85 -49.42 144.76 5.26 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-N 114.104 -1.407 . . . . 0.0 112.122 179.541 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -154.8 164.16 39.21 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 112.914 -1.948 . . . . 0.0 112.057 -179.39 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 40.0 t -118.04 138.83 51.95 Favored 'General case' 0 N--CA 1.495 1.823 0 CA-C-N 113.577 -1.647 . . . . 0.0 112.167 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.403 ' H ' ' HB2' ' A' ' 46' ' ' ALA . 5.3 p-10 -46.39 -24.42 0.49 Allowed 'General case' 0 N--CA 1.499 2.025 0 CA-C-N 111.76 -2.473 . . . . 0.0 113.912 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 14.7 p30 -60.87 -6.14 1.67 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 124.117 0.885 . . . . 0.0 112.126 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 92.37 27.2 15.94 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 110.401 -1.08 . . . . 0.0 110.401 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 96.5 m -144.39 141.9 29.98 Favored 'General case' 0 N--CA 1.494 1.761 0 C-N-CA 120.187 -0.605 . . . . 0.0 111.892 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 10.3 t80 -62.77 161.92 11.74 Favored 'General case' 0 N--CA 1.497 1.921 0 CA-C-N 114.14 -1.391 . . . . 0.0 109.915 179.727 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 62.5 t -131.7 -57.16 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 123.893 0.745 . . . . 0.0 112.745 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.612 ' SG ' ' HB2' ' A' ' 16' ' ' TYR . 7.5 p -158.62 -167.29 2.1 Favored 'General case' 0 N--CA 1.503 2.221 0 C-N-CA 119.657 -0.817 . . . . 0.0 109.749 -179.686 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -122.18 136.89 54.97 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 106.547 -1.649 . . . . 0.0 106.547 179.463 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -40.35 129.41 2.93 Favored Glycine 0 N--CA 1.503 3.127 0 O-C-N 123.657 0.598 . . . . 0.0 112.322 179.857 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -79.81 -52.78 7.48 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 114.023 1.12 . . . . 0.0 114.023 -179.806 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 55.7 m -50.28 86.61 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 116.425 2.009 . . . . 0.0 116.425 -179.281 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.642 ' H ' HD21 ' A' ' 33' ' ' ASN . 29.5 t70 -86.63 126.09 65.08 Favored Pre-proline 0 N--CA 1.489 1.511 0 N-CA-C 105.358 -2.09 . . . . 0.0 105.358 179.752 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_endo -63.45 73.83 0.14 Allowed 'Trans proline' 0 N--CA 1.5 1.863 0 C-N-CA 123.687 2.925 . . . . 0.0 113.585 -153.029 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.409 ' N ' ' O ' ' A' ' 30' ' ' ASP . 1.5 mpp_? -158.84 -47.13 0.06 Allowed 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 105.384 -2.08 . . . . 0.0 105.384 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.642 HD21 ' H ' ' A' ' 30' ' ' ASP . 12.6 p30 -78.33 136.59 60.55 Favored Pre-proline 0 N--CA 1.494 1.76 0 C-N-CA 119.526 -0.87 . . . . 0.0 109.708 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -68.8 119.73 6.7 Favored 'Trans proline' 0 N--CA 1.493 1.489 0 C-N-CA 122.736 2.291 . . . . 0.0 110.184 -178.232 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 14.3 ptmm? -107.08 157.4 17.86 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 124.18 0.925 . . . . 0.0 110.415 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -160.39 73.71 0.52 Allowed 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 27.9 m -152.8 -174.45 4.92 Favored 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 121.949 0.881 . . . . 0.0 111.744 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.486 ' HB ' ' SG ' ' A' ' 41' ' ' CYS . 83.6 m -141.51 157.81 44.66 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 104.464 -2.421 . . . . 0.0 104.464 179.638 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.461 HD12 ' N ' ' A' ' 39' ' ' LEU . 5.0 mp -79.45 -21.38 45.56 Favored 'General case' 0 N--CA 1.498 1.946 0 C-N-CA 119.439 -0.904 . . . . 0.0 110.361 -179.788 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -94.37 37.92 1.1 Allowed 'General case' 0 N--CA 1.497 1.879 0 CA-C-O 121.976 0.893 . . . . 0.0 110.165 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.525 ' HB3' ' H ' ' A' ' 4' ' ' CYS . 67.4 m -98.71 -95.5 0.23 Allowed 'General case' 0 N--CA 1.494 1.769 0 CA-C-N 113.598 -1.637 . . . . 0.0 107.409 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -54.13 131.12 59.9 Favored Pre-proline 0 N--CA 1.501 2.117 0 C-N-CA 120.601 -0.44 . . . . 0.0 110.401 179.796 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -68.78 -23.28 35.82 Favored 'Trans proline' 0 N--CA 1.493 1.489 0 C-N-CA 122.27 1.98 . . . . 0.0 111.633 -164.054 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 58.4 ttt85 -58.14 -38.42 76.54 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 124.031 0.832 . . . . 0.0 110.611 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.578 HD13 ' CD1' ' A' ' 16' ' ' TYR . 15.4 mt -98.85 154.15 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 CA-C-O 122.67 1.224 . . . . 0.0 113.857 -179.826 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.403 ' HB2' ' H ' ' A' ' 19' ' ' ASP . . . -112.17 -56.16 2.43 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-N 110.907 -2.86 . . . . 0.0 107.766 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 53.6 p90 -166.49 173.53 9.77 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-N 114.776 -1.102 . . . . 0.0 109.621 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -125.86 122.13 4.39 Favored Glycine 0 N--CA 1.494 2.502 0 CA-C-N 114.198 -1.365 . . . . 0.0 110.128 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.5 p -79.5 122.71 35.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 11.3 m -100.09 104.93 32.39 Favored Pre-proline 0 N--CA 1.496 1.828 0 CA-C-N 115.083 -0.962 . . . . 0.0 108.729 -179.838 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -79.41 -69.25 0.02 OUTLIER 'Trans proline' 0 N--CA 1.49 1.302 0 C-N-CA 122.381 2.054 . . . . 0.0 109.798 -176.258 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 8.3 ptp180 -160.32 -15.36 0.05 Allowed 'General case' 0 N--CA 1.497 1.896 0 CA-C-N 114.393 -1.276 . . . . 0.0 110.751 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 61.7 m -56.04 153.23 9.22 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 124.057 0.848 . . . . 0.0 113.138 -179.826 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -171.26 -33.69 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.883 0 CA-C-N 114.077 -1.42 . . . . 0.0 108.273 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 69.41 131.2 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.134 0 O-C-N 125.202 1.564 . . . . 0.0 112.149 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 24.8 ttpp -65.6 -38.06 88.41 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-N 114.499 -1.228 . . . . 0.0 108.611 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 4.9 ttmp? -144.12 129.15 18.57 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-N 114.425 -1.261 . . . . 0.0 107.991 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -158.67 161.39 37.12 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-N 114.876 -1.056 . . . . 0.0 108.195 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 38.0 t70 58.98 14.93 3.62 Favored 'General case' 0 N--CA 1.504 2.268 0 O-C-N 123.996 0.81 . . . . 0.0 110.175 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.4 ' HG3' ' H ' ' A' ' 60' ' ' ARG . 0.0 OUTLIER -73.22 8.24 1.78 Allowed 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 113.955 1.094 . . . . 0.0 113.955 -179.848 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.419 HG23 ' HA ' ' A' ' 101' ' ' PRO . 3.5 tp -39.69 102.45 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 O-C-N 124.475 1.11 . . . . 0.0 111.495 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 7.7 m -86.14 55.17 3.42 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 115.601 1.704 . . . . 0.0 115.601 -179.769 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 7.9 p -90.38 173.67 7.98 Favored 'General case' 0 N--CA 1.495 1.81 0 CA-C-N 114.174 -1.376 . . . . 0.0 109.084 179.616 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -161.38 149.46 15.43 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-N 114.631 -1.168 . . . . 0.0 108.782 179.772 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 11.2 t -55.86 -17.37 6.2 Favored 'General case' 0 N--CA 1.5 2.069 0 N-CA-C 113.97 1.1 . . . . 0.0 113.97 -179.659 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 52.1 t -82.72 -43.41 16.85 Favored 'General case' 0 N--CA 1.498 1.96 0 CA-C-N 114.138 -1.392 . . . . 0.0 112.553 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -73.62 61.91 0.75 Allowed 'General case' 0 N--CA 1.5 2.074 0 O-C-N 125.765 1.915 . . . . 0.0 114.784 -179.575 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -169.52 -155.12 9.68 Favored Glycine 0 N--CA 1.486 1.983 0 CA-C-N 112.726 -2.034 . . . . 0.0 108.303 179.599 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 57.5 p -145.31 159.71 42.63 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 124.018 0.481 . . . . 0.0 110.505 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 59.0 mtpt -71.76 38.51 0.07 Allowed 'General case' 0 N--CA 1.502 2.173 0 O-C-N 125.469 1.731 . . . . 0.0 113.938 179.695 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -132.83 1.92 4.75 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 108.448 -1.861 . . . . 0.0 108.448 179.675 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' CYS . . . . . 0.411 ' HA ' ' HA ' ' A' ' 108' ' ' CYS . 96.0 m -135.54 170.73 15.49 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 123.905 0.415 . . . . 0.0 111.729 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 48.6 mtmt -130.06 105.67 8.11 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.234 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.696 ' CD1' ' SG ' ' A' ' 83' ' ' CYS . 88.2 m-85 -53.82 144.29 18.82 Favored 'General case' 0 N--CA 1.505 2.285 0 O-C-N 123.525 0.515 . . . . 0.0 110.122 179.8 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.548 ' CE2' ' HA ' ' A' ' 80' ' ' THR . 9.3 t80 -149.32 158.01 43.82 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 124.653 1.221 . . . . 0.0 113.287 -179.572 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 28.2 t -121.12 129.71 53.41 Favored 'General case' 0 N--CA 1.499 1.993 0 CA-C-N 112.05 -2.341 . . . . 0.0 112.145 -179.723 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.429 ' H ' ' HB2' ' A' ' 104' ' ' ALA . 9.2 p-10 -47.66 -59.19 3.46 Favored 'General case' 0 N--CA 1.495 1.81 0 CA-C-N 113.127 -1.851 . . . . 0.0 112.74 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.408 ' H ' ' CG ' ' A' ' 77' ' ' ASP . 17.7 p-10 -107.2 25.46 11.38 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-N 114.556 -1.202 . . . . 0.0 110.624 -179.777 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -146.93 15.52 1.55 Allowed Glycine 0 N--CA 1.494 2.507 0 O-C-N 124.179 0.924 . . . . 0.0 111.578 -179.863 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.548 ' HA ' ' CE2' ' A' ' 75' ' ' PHE . 6.6 t 41.61 -160.56 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.899 0 O-C-N 124.934 1.02 . . . . 0.0 113.405 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 72.4 t80 -40.01 132.4 1.84 Allowed 'General case' 0 N--CA 1.5 2.074 0 O-C-N 123.634 0.584 . . . . 0.0 112.213 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 76.6 t -107.48 -61.03 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 CA-C-N 114.381 -1.281 . . . . 0.0 109.93 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' CYS . . . . . 0.696 ' SG ' ' CD1' ' A' ' 74' ' ' TYR . 0.8 OUTLIER -163.66 -166.74 1.25 Allowed 'General case' 0 N--CA 1.502 2.136 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 -179.89 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.475 ' N ' ' SG ' ' A' ' 83' ' ' CYS . 35.2 mt-10 -130.65 163.68 26.66 Favored 'General case' 0 N--CA 1.485 1.316 0 CA-C-N 114.995 -1.002 . . . . 0.0 109.362 179.511 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -43.24 120.15 2.67 Favored Glycine 0 N--CA 1.499 2.891 0 O-C-N 124.092 0.87 . . . . 0.0 113.681 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -108.71 32.1 5.13 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 36.3 t -153.91 129.26 9.8 Favored 'General case' 0 N--CA 1.498 1.958 0 C-N-CA 120.323 -0.551 . . . . 0.0 109.616 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -100.22 144.28 28.12 Favored Pre-proline 0 N--CA 1.494 1.762 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -46.61 -23.37 2.24 Favored 'Trans proline' 0 N--CA 1.499 1.834 0 C-N-CA 122.846 2.364 . . . . 0.0 112.564 170.339 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 52.8 ttp85 -60.68 -53.23 59.96 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-N 114.967 -1.015 . . . . 0.0 108.682 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -90.5 114.42 61.1 Favored Pre-proline 0 N--CA 1.494 1.725 0 O-C-N 124.839 1.337 . . . . 0.0 110.635 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -83.68 45.13 1.73 Allowed 'Trans proline' 0 N--CA 1.495 1.593 0 C-N-CA 123.427 2.752 . . . . 0.0 110.633 173.912 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 64.2 mtpt -79.13 125.59 29.62 Favored 'General case' 0 N--CA 1.497 1.894 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.954 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -88.75 120.67 30.35 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 114.596 -1.184 . . . . 0.0 109.603 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 31.0 m -79.94 145.37 61.37 Favored Pre-proline 0 N--CA 1.497 1.906 0 CA-C-N 115.202 -0.908 . . . . 0.0 108.928 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -70.31 -87.13 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.482 0 C-N-CA 122.249 1.966 . . . . 0.0 110.253 -177.188 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 86.7 mtm180 -145.32 -67.28 0.31 Allowed 'General case' 0 N--CA 1.497 1.912 0 O-C-N 123.737 0.648 . . . . 0.0 109.397 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 28.5 m120 46.22 48.43 13.12 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 124.39 1.056 . . . . 0.0 110.67 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 90.7 m -36.21 127.26 0.76 Allowed 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 115.251 1.574 . . . . 0.0 115.251 -179.716 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -122.31 79.99 45.05 Favored Pre-proline 0 N--CA 1.496 1.858 0 O-C-N 124.295 0.997 . . . . 0.0 109.091 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.419 ' HA ' HG23 ' A' ' 61' ' ' ILE . 5.4 Cg_endo -59.34 -25.91 80.06 Favored 'Trans proline' 0 N--CA 1.495 1.605 0 C-N-CA 123.293 2.662 . . . . 0.0 111.707 -178.704 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 25.0 tpt180 -66.66 -37.39 84.7 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-N 115.118 -0.946 . . . . 0.0 111.726 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.457 ' CG2' ' N ' ' A' ' 104' ' ' ALA . 6.3 mt -60.06 167.01 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 CA-C-O 121.855 0.836 . . . . 0.0 111.516 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.457 ' N ' ' CG2' ' A' ' 103' ' ' ILE . . . -138.69 -44.81 0.48 Allowed 'General case' 0 N--CA 1.489 1.497 0 CA-C-N 113.462 -1.699 . . . . 0.0 107.762 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 40.7 p90 -173.07 -170.84 0.68 Allowed 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -136.45 130.15 5.14 Favored Glycine 0 N--CA 1.493 2.5 0 C-N-CA 120.554 -0.831 . . . . 0.0 111.228 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.451 ' N ' HD12 ' A' ' 107' ' ' ILE . 2.9 mp -79.89 110.46 15.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 N-CA-C 105.788 -1.93 . . . . 0.0 105.788 179.893 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' CYS . . . . . 0.411 ' HA ' ' HA ' ' A' ' 72' ' ' CYS . 60.9 m -100.19 109.57 56.95 Favored Pre-proline 0 N--CA 1.495 1.809 0 O-C-N 124.143 0.902 . . . . 0.0 110.405 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.31 -55.68 0.08 OUTLIER 'Trans proline' 0 N--CA 1.492 1.42 0 C-N-CA 122.6 2.2 . . . . 0.0 109.905 179.528 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 85.9 mt -79.72 -54.91 5.4 Favored 'General case' 0 N--CA 1.495 1.78 0 CA-C-N 114.514 -1.221 . . . . 0.0 109.048 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 1.911 0 CA-C-O 116.668 -1.634 . . . . 0.0 111.258 179.862 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 24.8 t70 . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 58.83 -169.46 0.13 Allowed 'General case' 0 N--CA 1.501 2.114 0 O-C-N 124.446 1.092 . . . . 0.0 111.374 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.1 tp -67.49 91.27 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 CA-C-O 121.985 0.898 . . . . 0.0 110.814 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 7.5 m -90.36 45.28 1.25 Allowed 'General case' 0 N--CA 1.493 1.72 0 CA-C-O 122.726 1.25 . . . . 0.0 112.472 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 51.8 m -90.74 171.07 9.6 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 113.001 -1.909 . . . . 0.0 109.275 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 28.0 m120 -160.0 171.91 18.5 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 124.567 1.167 . . . . 0.0 107.998 179.798 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 9.6 t -70.14 -11.14 60.68 Favored 'General case' 0 N--CA 1.501 2.096 0 C-N-CA 118.968 -1.093 . . . . 0.0 110.837 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 34.4 t -91.11 -50.4 5.86 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-N 113.905 -1.498 . . . . 0.0 109.137 179.734 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -39.58 -67.26 0.23 Allowed 'General case' 0 N--CA 1.501 2.084 0 N-CA-C 115.965 1.839 . . . . 0.0 115.965 -179.662 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -54.66 160.51 5.08 Favored Glycine 0 N--CA 1.502 3.057 0 C-N-CA 121.099 -0.572 . . . . 0.0 112.325 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 7.3 t -71.43 138.29 48.95 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 -179.744 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -62.33 114.1 3.29 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-N 114.121 -1.399 . . . . 0.0 109.2 179.769 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 134.39 -21.92 3.79 Favored Glycine 0 N--CA 1.495 2.594 0 O-C-N 124.431 1.082 . . . . 0.0 110.577 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 88.2 m -86.77 -173.08 4.3 Favored 'General case' 0 N--CA 1.5 2.028 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 60.7 mtpt -133.46 103.27 5.86 Favored 'General case' 0 N--CA 1.494 1.765 0 C-N-CA 119.793 -0.763 . . . . 0.0 110.998 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.733 ' CD2' ' SG ' ' A' ' 25' ' ' CYS . 90.8 m-85 -54.75 138.21 42.69 Favored 'General case' 0 N--CA 1.499 2.015 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.67 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -149.22 146.25 27.52 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 124.886 1.366 . . . . 0.0 113.26 -179.701 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 45.4 t -106.03 120.99 43.2 Favored 'General case' 0 N--CA 1.5 2.055 0 CA-C-N 112.822 -1.99 . . . . 0.0 110.722 -179.821 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.564 ' H ' ' HB2' ' A' ' 46' ' ' ALA . 6.5 p-10 -57.61 -53.34 59.32 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 126.476 2.36 . . . . 0.0 112.19 -179.817 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -72.95 1.61 8.47 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 112.264 -2.244 . . . . 0.0 112.236 -179.665 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -136.39 -85.39 0.18 Allowed Glycine 0 N--CA 1.482 1.727 0 C-N-CA 119.626 -1.273 . . . . 0.0 111.951 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.469 ' CG2' ' N ' ' A' ' 23' ' ' PHE . 1.2 m 172.7 -171.16 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.166 0 N-CA-C 106.002 -1.851 . . . . 0.0 106.002 -179.137 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.469 ' N ' ' CG2' ' A' ' 22' ' ' THR . 33.2 t80 -41.79 144.05 0.45 Allowed 'General case' 0 N--CA 1.502 2.146 0 CA-C-O 121.369 0.605 . . . . 0.0 112.065 179.53 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 71.9 t -110.38 -68.21 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 CA-C-N 114.06 -1.427 . . . . 0.0 112.353 -179.656 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.733 ' SG ' ' CD2' ' A' ' 16' ' ' TYR . 14.5 p -155.14 -167.55 2.6 Favored 'General case' 0 N--CA 1.502 2.153 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 -179.717 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 8.7 tm-20 -117.45 154.89 30.62 Favored 'General case' 0 N--CA 1.505 2.282 0 O-C-N 123.373 0.42 . . . . 0.0 110.735 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.474 ' HA2' ' CE2' ' A' ' 16' ' ' TYR . . . -46.48 110.7 0.55 Allowed Glycine 0 N--CA 1.503 3.128 0 CA-C-O 118.857 -0.968 . . . . 0.0 112.583 179.869 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -97.33 -9.19 27.97 Favored 'General case' 0 N--CA 1.505 2.32 0 N-CA-C 114.684 1.365 . . . . 0.0 114.684 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 38.4 t -156.07 131.17 9.29 Favored 'General case' 0 N--CA 1.501 2.083 0 C-N-CA 119.647 -0.821 . . . . 0.0 111.607 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -93.54 143.59 26.87 Favored Pre-proline 0 N--CA 1.494 1.771 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 179.812 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -66.26 75.7 0.35 Allowed 'Trans proline' 0 N--CA 1.494 1.558 0 C-N-CA 122.579 2.186 . . . . 0.0 108.236 162.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 35.2 ttp-105 -168.09 -41.28 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 113.208 -1.814 . . . . 0.0 106.832 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.514 ' C ' HD21 ' A' ' 33' ' ' ASN . 0.3 OUTLIER -86.99 152.84 54.02 Favored Pre-proline 0 N--CA 1.493 1.705 0 O-C-N 124.175 0.922 . . . . 0.0 110.936 -179.934 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -79.85 45.6 2.0 Allowed 'Trans proline' 0 N--CA 1.496 1.635 0 C-N-CA 123.443 2.762 . . . . 0.0 112.319 174.481 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.483 ' HE3' ' HA ' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -102.12 152.9 20.46 Favored 'General case' 0 N--CA 1.501 2.109 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.163 -179.981 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -156.39 165.24 36.9 Favored 'General case' 0 N--CA 1.498 1.93 0 CA-C-N 114.674 -1.148 . . . . 0.0 109.571 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 28.0 m -146.19 179.16 7.69 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 123.779 0.674 . . . . 0.0 110.282 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 44.5 p -138.72 54.7 1.74 Allowed 'General case' 0 N--CA 1.5 2.066 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.671 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 54.2 tp -93.63 -25.24 17.59 Favored 'General case' 0 N--CA 1.499 2.017 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.005 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 11.4 m120 62.54 153.64 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.118 0 O-C-N 124.487 1.117 . . . . 0.0 113.536 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 59.4 m -18.61 130.38 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.274 0 N-CA-C 116.63 2.085 . . . . 0.0 116.63 -179.849 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -113.82 86.13 10.53 Favored Pre-proline 0 N--CA 1.498 1.955 0 O-C-N 124.062 0.851 . . . . 0.0 108.971 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -62.13 -18.41 61.78 Favored 'Trans proline' 0 N--CA 1.497 1.724 0 C-N-CA 122.633 2.222 . . . . 0.0 113.803 -170.753 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 5.9 ptp85 -89.09 -20.15 24.68 Favored 'General case' 0 N--CA 1.501 2.078 0 N-CA-C 116.393 1.997 . . . . 0.0 116.393 -179.636 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 16.3 tt -78.13 155.44 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.303 0 C-N-CA 118.566 -1.254 . . . . 0.0 109.694 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.564 ' HB2' ' H ' ' A' ' 19' ' ' ASP . . . -90.4 -66.3 0.94 Allowed 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 179.627 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 3.3 p90 -177.63 171.91 1.83 Allowed 'General case' 0 N--CA 1.492 1.651 0 CA-C-N 112.786 -2.006 . . . . 0.0 108.513 -179.783 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.406 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -91.05 110.37 3.81 Favored Glycine 0 N--CA 1.49 2.279 0 CA-C-N 114.979 -1.009 . . . . 0.0 110.701 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 20.1 m -78.84 105.84 8.76 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 N-CA-C 106.107 -1.812 . . . . 0.0 106.107 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 48.1 m -83.28 161.74 56.23 Favored Pre-proline 0 N--CA 1.495 1.798 0 CA-C-N 113.375 -1.739 . . . . 0.0 111.264 -179.772 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -52.44 -47.95 24.37 Favored 'Trans proline' 0 N--CA 1.494 1.536 0 C-N-CA 122.345 2.03 . . . . 0.0 109.675 166.65 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 39.7 mtm105 -146.23 157.08 43.79 Favored 'General case' 0 N--CA 1.497 1.912 0 CA-C-N 114.751 -1.113 . . . . 0.0 109.55 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 67.1 m -140.04 38.54 1.95 Allowed 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 179.841 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -67.68 144.44 55.48 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-N 114.033 -1.44 . . . . 0.0 111.544 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.463 ' HG2' ' N ' ' A' ' 56' ' ' LYS . 33.3 tt0 -108.91 166.28 10.94 Favored 'General case' 0 N--CA 1.497 1.883 0 CA-C-N 113.879 -1.51 . . . . 0.0 107.648 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.463 ' N ' ' HG2' ' A' ' 55' ' ' GLU . 85.0 tttt -146.43 45.08 1.22 Allowed 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 106.009 -1.848 . . . . 0.0 106.009 179.579 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.405 ' H ' ' HG2' ' A' ' 55' ' ' GLU . 4.6 tmmm? -113.29 -72.03 0.72 Allowed 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 104.288 -2.486 . . . . 0.0 104.288 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -150.92 83.19 1.33 Allowed 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 105.742 -1.947 . . . . 0.0 105.742 179.853 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -162.64 -39.47 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 CA-C-N 113.498 -1.683 . . . . 0.0 108.775 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 22.2 mmm180 -65.22 -68.87 0.33 Allowed 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.472 ' CG1' ' H ' ' A' ' 99' ' ' CYS . 1.9 tp -90.45 175.06 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 N-CA-C 105.345 -2.095 . . . . 0.0 105.345 179.693 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.46 ' HB2' ' HB3' ' A' ' 99' ' ' CYS . 1.6 m -79.98 -165.06 0.76 Allowed 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 119.569 -0.853 . . . . 0.0 109.166 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.5 p -63.91 138.71 58.59 Favored 'General case' 0 N--CA 1.495 1.824 0 C-N-CA 119.067 -1.053 . . . . 0.0 112.558 179.872 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -155.11 154.59 32.6 Favored 'General case' 0 N--CA 1.499 2.009 0 CA-C-N 112.14 -2.3 . . . . 0.0 110.209 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 52.8 t -52.71 -51.2 61.4 Favored 'General case' 0 N--CA 1.501 2.084 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 179.745 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 17.7 t -60.91 -54.46 44.78 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-N 110.996 -2.82 . . . . 0.0 112.658 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -39.46 -45.06 1.47 Allowed 'General case' 0 N--CA 1.504 2.227 0 O-C-N 125.921 2.013 . . . . 0.0 110.511 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.424 ' HA3' ' H ' ' A' ' 87' ' ' SER . . . 73.38 162.94 7.75 Favored Glycine 0 N--CA 1.476 1.351 0 N-CA-C 116.951 1.54 . . . . 0.0 116.951 179.583 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 3.6 t 176.64 42.56 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 104.49 -2.411 . . . . 0.0 104.49 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.519 ' HA ' ' HE2' ' A' ' 70' ' ' LYS . 0.6 OUTLIER -10.35 94.08 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.065 0 CA-C-N 113.165 -1.834 . . . . 0.0 115.545 -179.553 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 136.37 -47.56 0.96 Allowed Glycine 0 N--CA 1.493 2.497 0 CA-C-N 114.461 -1.245 . . . . 0.0 111.94 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' CYS . . . . . 0.438 ' HA ' ' HA ' ' A' ' 108' ' ' CYS . 76.5 m -79.93 122.75 27.09 Favored 'General case' 0 N--CA 1.497 1.914 0 C-N-CA 119.166 -1.014 . . . . 0.0 110.761 -179.79 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.476 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 37.0 mtmm -73.2 89.48 1.53 Allowed 'General case' 0 N--CA 1.487 1.384 0 CA-C-N 112.535 -2.12 . . . . 0.0 115.152 -179.604 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.437 ' N ' ' O ' ' A' ' 83' ' ' CYS . 41.9 m-85 -45.55 136.8 5.5 Favored 'General case' 0 N--CA 1.504 2.234 0 O-C-N 124.32 1.012 . . . . 0.0 108.399 179.488 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -154.17 145.8 23.26 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 114.851 -1.068 . . . . 0.0 112.144 -179.478 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 89.0 p -90.12 141.51 28.61 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 112.05 -2.341 . . . . 0.0 115.806 -179.667 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -51.34 -33.92 31.55 Favored 'General case' 0 N--CA 1.499 2.01 0 CA-C-N 112.288 -2.233 . . . . 0.0 114.313 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -57.85 -13.98 5.27 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 123.994 0.808 . . . . 0.0 112.156 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 102.7 37.46 3.21 Favored Glycine 0 N--CA 1.491 2.325 0 O-C-N 124.311 1.007 . . . . 0.0 111.487 179.783 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 90.7 m -140.79 149.07 41.6 Favored 'General case' 0 N--CA 1.496 1.858 0 C-N-CA 119.8 -0.76 . . . . 0.0 111.826 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 21.3 t80 -77.45 142.86 38.97 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-N 114.937 -1.029 . . . . 0.0 108.253 179.549 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 92.2 t -107.22 -67.27 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 CA-C-N 114.933 -1.031 . . . . 0.0 108.842 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' CYS . . . . . 0.437 ' O ' ' N ' ' A' ' 74' ' ' TYR . 39.2 m -159.8 -160.56 0.82 Allowed 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.476 ' HA ' ' HA ' ' A' ' 73' ' ' LYS . 36.3 tt0 -139.41 160.19 40.4 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 102.739 -3.06 . . . . 0.0 102.739 178.986 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.445 ' HA3' ' N ' ' A' ' 70' ' ' LYS . . . -38.24 100.18 0.01 OUTLIER Glycine 0 N--CA 1.494 2.527 0 CA-C-O 119.301 -0.722 . . . . 0.0 114.463 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -79.08 -3.81 47.14 Favored 'General case' 0 N--CA 1.502 2.169 0 C-N-CA 119.618 -0.833 . . . . 0.0 111.316 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.424 ' H ' ' HA3' ' A' ' 68' ' ' GLY . 44.0 t -142.93 128.57 19.18 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -84.01 145.67 46.98 Favored Pre-proline 0 N--CA 1.493 1.681 0 CA-C-N 114.588 -1.187 . . . . 0.0 109.147 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -56.62 80.97 0.04 OUTLIER 'Trans proline' 0 N--CA 1.499 1.84 0 C-N-CA 123.279 2.653 . . . . 0.0 108.528 163.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 50.8 ttp85 -173.71 -62.54 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 104.027 -2.583 . . . . 0.0 104.027 -179.635 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 11.2 p-10 -91.88 113.49 59.08 Favored Pre-proline 0 N--CA 1.492 1.651 0 CA-C-N 114.12 -1.4 . . . . 0.0 109.04 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -74.38 89.48 1.07 Allowed 'Trans proline' 0 N--CA 1.492 1.393 0 C-N-CA 122.467 2.111 . . . . 0.0 110.571 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -122.15 123.1 40.73 Favored 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -150.64 151.88 33.17 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.46 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 81.6 m -119.46 98.22 50.19 Favored Pre-proline 0 N--CA 1.497 1.898 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -68.53 93.1 0.42 Allowed 'Trans proline' 0 N--CA 1.493 1.452 0 C-N-CA 122.301 2.001 . . . . 0.0 109.013 177.106 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 28.4 mmt85 -134.72 47.88 2.34 Favored 'General case' 0 N--CA 1.498 1.954 0 CA-C-N 114.651 -1.159 . . . . 0.0 108.029 -179.856 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 14.5 m120 54.42 41.3 32.05 Favored 'General case' 0 N--CA 1.504 2.236 0 CA-C-O 122.797 1.284 . . . . 0.0 108.094 -179.742 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.472 ' H ' ' CG1' ' A' ' 61' ' ' ILE . 5.3 m 57.95 -167.43 0.14 Allowed 'General case' 0 N--CA 1.488 1.439 0 CA-C-N 112.031 -2.35 . . . . 0.0 108.722 -179.662 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -106.22 99.64 24.72 Favored Pre-proline 0 N--CA 1.498 1.943 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 179.75 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -64.53 -31.13 61.13 Favored 'Trans proline' 0 N--CA 1.493 1.46 0 C-N-CA 122.336 2.024 . . . . 0.0 111.639 -169.656 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 74.9 ttt-85 -71.89 -31.22 66.19 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 123.967 0.792 . . . . 0.0 111.226 -179.842 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 12.0 mt -68.53 157.24 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 CA-C-O 122.261 1.029 . . . . 0.0 111.427 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -124.92 -56.41 1.56 Allowed 'General case' 0 N--CA 1.492 1.63 0 CA-C-N 111.969 -2.378 . . . . 0.0 107.555 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 38.1 p90 -164.88 170.12 15.73 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-N 114.254 -1.339 . . . . 0.0 109.922 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -110.84 123.85 6.73 Favored Glycine 0 N--CA 1.492 2.426 0 CA-C-N 113.911 -1.495 . . . . 0.0 110.944 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.486 ' N ' HD12 ' A' ' 107' ' ' ILE . 2.9 mp -79.31 99.65 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' CYS . . . . . 0.438 ' HA ' ' HA ' ' A' ' 72' ' ' CYS . 25.2 m -79.79 163.9 56.01 Favored Pre-proline 0 N--CA 1.491 1.622 0 CA-C-N 114.169 -1.378 . . . . 0.0 108.754 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_exo -47.85 -23.46 4.11 Favored 'Trans proline' 0 N--CA 1.498 1.76 0 C-N-CA 122.558 2.172 . . . . 0.0 112.589 173.793 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 83.9 mt -118.95 -55.81 2.15 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 124.218 0.949 . . . . 0.0 108.511 179.871 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 1.983 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.837 179.936 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 38.8 ttm180 -140.37 57.48 1.59 Allowed 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 107.135 -1.431 . . . . 0.0 107.135 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 8.6 tp -86.77 53.67 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 CA-C-N 114.092 -1.413 . . . . 0.0 109.093 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.473 ' HA ' ' HA ' ' A' ' 41' ' ' CYS . 63.5 m -84.19 40.58 0.77 Allowed 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 115.031 1.493 . . . . 0.0 115.031 -179.829 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.409 ' HB ' HG21 ' A' ' 45' ' ' ILE . 53.3 m -90.6 158.91 16.71 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 105.167 -2.16 . . . . 0.0 105.167 179.641 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -147.48 169.36 19.71 Favored 'General case' 0 N--CA 1.497 1.918 0 CA-C-O 122.427 1.108 . . . . 0.0 112.551 -179.761 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.7 t -62.76 -53.14 58.91 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-N 112.268 -2.242 . . . . 0.0 111.952 -179.836 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 51.4 t -67.63 -55.7 12.26 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-N 113.946 -1.479 . . . . 0.0 109.375 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -54.83 -18.03 4.31 Favored 'General case' 0 N--CA 1.497 1.921 0 CA-C-N 113.786 -1.552 . . . . 0.0 113.062 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -59.53 160.72 17.74 Favored Glycine 0 N--CA 1.496 2.676 0 C-N-CA 120.613 -0.804 . . . . 0.0 111.453 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 9.7 t -76.45 129.4 36.48 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 115.732 1.753 . . . . 0.0 115.732 -179.768 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.423 ' HB3' ' NZ ' ' A' ' 12' ' ' LYS . 3.1 mmmp? -62.34 93.23 0.05 OUTLIER 'General case' 0 N--CA 1.5 2.073 0 CA-C-N 114.195 -1.366 . . . . 0.0 109.032 179.572 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 157.18 -28.09 0.51 Allowed Glycine 0 N--CA 1.49 2.279 0 CA-C-O 118.52 -1.156 . . . . 0.0 112.913 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 84.2 m -117.55 169.7 9.34 Favored 'General case' 0 N--CA 1.503 2.183 0 C-N-CA 119.438 -0.905 . . . . 0.0 112.603 -179.766 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 36.0 mtmm -102.69 96.67 7.02 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-N 113.982 -1.463 . . . . 0.0 111.312 -179.714 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.423 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 24.0 m-85 -59.94 127.9 34.19 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-O 122.884 1.326 . . . . 0.0 108.023 179.654 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -135.2 151.96 51.12 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 111.29 -2.687 . . . . 0.0 112.655 -179.145 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 87.8 p -91.03 133.06 35.61 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 112.991 -1.913 . . . . 0.0 113.924 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -47.73 -29.12 2.84 Favored 'General case' 0 N--CA 1.5 2.035 0 CA-C-N 113.11 -1.859 . . . . 0.0 116.012 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -57.64 -18.35 19.73 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 123.611 0.57 . . . . 0.0 112.519 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 112.46 26.96 4.05 Favored Glycine 0 N--CA 1.494 2.52 0 O-C-N 124.366 1.041 . . . . 0.0 111.098 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 62.4 m -135.91 156.06 49.35 Favored 'General case' 0 N--CA 1.496 1.853 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.458 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 22.6 t80 -85.85 149.25 25.37 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-N 114.89 -1.05 . . . . 0.0 110.16 179.727 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 96.0 t -108.47 -79.0 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 N-CA-C 107.03 -1.471 . . . . 0.0 107.03 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.458 ' SG ' ' O ' ' A' ' 26' ' ' GLU . 0.1 OUTLIER -164.76 179.91 6.26 Favored 'General case' 0 N--CA 1.5 2.044 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 179.743 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.458 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 30.7 tt0 -85.64 157.05 20.44 Favored 'General case' 0 N--CA 1.502 2.138 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 179.87 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -74.14 116.43 5.26 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 104.729 -3.349 . . . . 0.0 104.729 179.613 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -98.64 21.94 10.62 Favored 'General case' 0 N--CA 1.505 2.285 0 N-CA-C 114.757 1.392 . . . . 0.0 114.757 -179.633 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 37.7 t -137.97 117.88 13.31 Favored 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 179.671 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -79.42 132.52 62.06 Favored Pre-proline 0 N--CA 1.493 1.692 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_endo -67.11 85.33 0.33 Allowed 'Trans proline' 0 N--CA 1.492 1.441 0 C-N-CA 122.6 2.2 . . . . 0.0 109.908 178.534 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 12.0 mtp180 176.52 -41.71 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.938 0 CA-C-N 113.925 -1.488 . . . . 0.0 108.216 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -77.22 146.11 74.08 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 123.991 0.807 . . . . 0.0 111.88 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -81.54 48.23 2.79 Favored 'Trans proline' 0 N--CA 1.492 1.407 0 C-N-CA 123.407 2.738 . . . . 0.0 109.525 163.061 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 65.0 tttp -68.23 150.71 47.95 Favored 'General case' 0 N--CA 1.497 1.891 0 CA-C-O 121.544 0.688 . . . . 0.0 111.617 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -91.42 131.03 37.16 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-N 113.608 -1.633 . . . . 0.0 108.005 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 5.2 m -142.85 -178.41 5.79 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 -179.868 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 96.2 m -83.25 113.87 20.99 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-N 113.645 -1.616 . . . . 0.0 108.413 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 9.8 mp -79.5 0.58 29.07 Favored 'General case' 0 N--CA 1.498 1.953 0 CA-C-N 115.299 -0.864 . . . . 0.0 112.164 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -59.19 119.61 7.67 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 123.546 0.529 . . . . 0.0 109.719 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.473 ' HA ' ' HA ' ' A' ' 4' ' ' CYS . 85.0 m -68.55 92.26 0.45 Allowed 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.412 ' O ' HG22 ' A' ' 45' ' ' ILE . 10.0 t70 -63.35 101.88 0.29 Allowed Pre-proline 0 N--CA 1.495 1.792 0 CA-C-N 115.252 -0.885 . . . . 0.0 110.19 -179.681 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo -67.32 -37.88 16.7 Favored 'Trans proline' 0 N--CA 1.492 1.399 0 C-N-CA 122.159 1.906 . . . . 0.0 110.779 -160.234 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 28.0 ptt-85 -78.27 -23.1 47.39 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-N 114.233 -1.349 . . . . 0.0 114.013 -179.77 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.412 HG22 ' O ' ' A' ' 42' ' ' ASP . 7.9 tt -55.27 159.04 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.278 0 C-N-CA 120.1 -0.64 . . . . 0.0 110.476 -179.554 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -141.85 -62.64 0.45 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 123.803 0.69 . . . . 0.0 112.575 -179.812 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 28.1 p90 -156.17 161.63 40.29 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-O 121.871 0.843 . . . . 0.0 113.04 -179.79 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.423 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -92.17 95.3 2.01 Favored Glycine 0 N--CA 1.489 2.194 0 CA-C-N 112.785 -2.007 . . . . 0.0 110.593 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 4.7 p -81.74 110.55 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 C-N-CA 119.108 -1.037 . . . . 0.0 109.012 179.649 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.6 m -79.04 154.43 77.55 Favored Pre-proline 0 N--CA 1.498 1.928 0 CA-C-N 115.472 -0.786 . . . . 0.0 109.414 179.832 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -56.35 -33.51 91.76 Favored 'Trans proline' 0 N--CA 1.497 1.692 0 C-N-CA 122.71 2.273 . . . . 0.0 111.623 -173.506 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.89 169.99 22.35 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 124.28 0.987 . . . . 0.0 109.855 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 57.2 m -71.2 105.28 3.37 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -68.61 124.86 24.75 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 107.529 -1.286 . . . . 0.0 107.529 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 21.1 mm-40 -104.46 -71.43 0.74 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 123.933 0.77 . . . . 0.0 111.07 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 7.0 ttpm? 53.39 87.7 0.04 OUTLIER 'General case' 0 N--CA 1.504 2.228 0 O-C-N 124.108 0.88 . . . . 0.0 110.73 -179.751 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 41.7 ttmt -155.64 129.71 8.74 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-N 114.698 -1.137 . . . . 0.0 108.982 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -160.4 143.43 13.43 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.518 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -85.57 76.26 10.04 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-N 114.957 -1.02 . . . . 0.0 108.453 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 58.1 mmm-85 -66.82 96.77 0.43 Allowed 'General case' 0 N--CA 1.496 1.832 0 CA-C-N 114.414 -1.266 . . . . 0.0 110.398 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 5.9 tp -80.39 68.25 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 CA-C-N 114.022 -1.444 . . . . 0.0 110.647 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.462 ' HA ' ' HA ' ' A' ' 99' ' ' CYS . 1.6 m -89.37 55.67 3.34 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 123.128 1.442 . . . . 0.0 114.455 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.41 ' O ' ' N ' ' A' ' 100' ' ' ASP . 1.8 p -90.86 160.87 15.5 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-N 112.64 -2.073 . . . . 0.0 108.05 179.456 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 32.5 p-10 -161.63 148.48 14.32 Favored 'General case' 0 N--CA 1.501 2.108 0 C-N-CA 119.891 -0.723 . . . . 0.0 110.22 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' CYS . . . . . 0.489 ' HA ' ' CD2' ' A' ' 74' ' ' TYR . 7.1 t -65.45 -15.45 62.64 Favored 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 113.661 0.986 . . . . 0.0 113.661 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 29.4 t -80.52 -66.77 0.84 Allowed 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 116.295 1.961 . . . . 0.0 116.295 -179.499 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -77.82 63.31 2.84 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 125.545 1.778 . . . . 0.0 114.832 -179.25 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -123.98 -150.3 7.91 Favored Glycine 0 N--CA 1.494 2.522 0 CA-C-N 112.729 -2.032 . . . . 0.0 109.946 179.558 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 4.8 t -136.44 121.18 18.51 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-N 114.102 -1.049 . . . . 0.0 108.924 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 6.2 ptpp? -58.16 89.95 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.853 0 CA-C-O 122.648 1.214 . . . . 0.0 111.371 179.678 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 161.89 -42.08 0.38 Allowed Glycine 0 N--CA 1.49 2.24 0 N-CA-C 108.368 -1.893 . . . . 0.0 108.368 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' CYS . . . . . 0.434 ' HA ' ' HA ' ' A' ' 108' ' ' CYS . 90.3 m -79.43 128.29 33.16 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 179.925 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 35.4 mmtp -80.37 83.31 6.22 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 115.581 1.697 . . . . 0.0 115.581 -179.321 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.489 ' CD2' ' HA ' ' A' ' 65' ' ' CYS . 2.1 m-85 -43.55 126.36 4.39 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 124.235 0.959 . . . . 0.0 109.181 179.379 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -141.08 152.04 44.48 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-N 114.321 -1.309 . . . . 0.0 112.325 -179.34 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 30.2 t -101.66 143.24 31.86 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 116.059 1.874 . . . . 0.0 116.059 -179.57 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -49.69 -26.11 3.48 Favored 'General case' 0 N--CA 1.5 2.074 0 CA-C-N 111.231 -2.713 . . . . 0.0 113.435 179.746 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 13.8 p30 -62.33 -3.18 1.24 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 124.178 0.924 . . . . 0.0 111.853 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 86.87 28.96 24.72 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 90.3 m -142.33 143.93 32.98 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 120.47 -0.492 . . . . 0.0 110.9 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 52.6 t80 -67.94 160.25 28.95 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-N 114.17 -1.377 . . . . 0.0 110.497 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 91.1 t -122.95 -74.77 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 CA-C-N 114.624 -1.171 . . . . 0.0 110.477 -179.831 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' CYS . . . . . 0.492 ' SG ' ' N ' ' A' ' 84' ' ' GLU . 0.5 OUTLIER -157.13 -163.07 1.32 Allowed 'General case' 0 N--CA 1.502 2.163 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 -179.874 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.492 ' N ' ' SG ' ' A' ' 83' ' ' CYS . 38.2 tt0 -119.56 164.37 15.93 Favored 'General case' 0 N--CA 1.503 2.205 0 N-CA-C 104.722 -2.325 . . . . 0.0 104.722 179.18 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.42 ' N ' ' HG2' ' A' ' 84' ' ' GLU . . . -60.91 113.57 5.74 Favored Glycine 0 N--CA 1.497 2.743 0 C-N-CA 119.315 -1.422 . . . . 0.0 110.302 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -86.0 21.68 1.9 Allowed 'General case' 0 N--CA 1.501 2.11 0 CA-C-O 121.722 0.772 . . . . 0.0 111.297 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 3.5 m -133.4 160.54 37.08 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 113.996 -1.456 . . . . 0.0 107.224 179.735 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.406 ' H ' ' HB3' ' A' ' 91' ' ' ASN . 21.3 t70 -79.66 145.9 63.77 Favored Pre-proline 0 N--CA 1.493 1.689 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -47.7 -15.22 0.31 Allowed 'Trans proline' 0 N--CA 1.499 1.848 0 C-N-CA 122.835 2.356 . . . . 0.0 114.037 171.397 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 72.5 ttt-85 -139.93 53.05 1.68 Allowed 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.406 ' HB3' ' H ' ' A' ' 88' ' ' ASP . 18.2 p-10 -90.05 128.28 50.37 Favored Pre-proline 0 N--CA 1.496 1.828 0 CA-C-N 114.522 -1.217 . . . . 0.0 111.447 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -83.89 48.1 2.46 Favored 'Trans proline' 0 N--CA 1.491 1.362 0 C-N-CA 123.245 2.63 . . . . 0.0 109.125 159.22 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -130.39 147.52 52.1 Favored 'General case' 0 N--CA 1.503 2.184 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.681 -179.804 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -160.54 125.2 3.72 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-N 114.875 -1.057 . . . . 0.0 109.501 179.856 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 68.7 m -79.74 162.79 61.48 Favored Pre-proline 0 N--CA 1.5 2.03 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -69.97 4.92 2.0 Allowed 'Trans proline' 0 N--CA 1.495 1.587 0 C-N-CA 122.118 1.879 . . . . 0.0 111.146 163.5 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 80.5 mmt-85 -94.21 22.13 6.23 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 123.647 0.592 . . . . 0.0 110.616 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -63.21 158.07 20.95 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.167 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.462 ' HA ' ' HA ' ' A' ' 62' ' ' CYS . 74.0 m 61.75 125.59 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.888 0 O-C-N 125.193 1.558 . . . . 0.0 112.215 -179.771 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.41 ' N ' ' O ' ' A' ' 63' ' ' THR . 30.8 t70 -156.22 84.88 3.21 Favored Pre-proline 0 N--CA 1.494 1.761 0 CA-C-N 114.876 -1.056 . . . . 0.0 110.154 -179.778 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_exo -52.44 -18.26 7.85 Favored 'Trans proline' 0 N--CA 1.495 1.594 0 C-N-CA 122.457 2.104 . . . . 0.0 112.455 174.731 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.69 -54.02 38.25 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 105.974 -1.862 . . . . 0.0 105.974 179.855 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 15.3 tt -79.95 157.52 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 C-N-CA 119.215 -0.994 . . . . 0.0 109.747 -179.777 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -113.28 -61.35 1.75 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 124.372 1.045 . . . . 0.0 112.588 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 7.4 p90 -162.65 160.06 25.22 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 123.886 0.741 . . . . 0.0 112.162 -179.799 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -97.13 127.44 9.21 Favored Glycine 0 N--CA 1.492 2.414 0 CA-C-N 113.848 -1.523 . . . . 0.0 111.716 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 48.0 mm -80.91 97.88 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' CYS . . . . . 0.434 ' HA ' ' HA ' ' A' ' 72' ' ' CYS . 35.0 m -79.67 143.07 58.06 Favored Pre-proline 0 N--CA 1.494 1.729 0 CA-C-N 114.744 -1.116 . . . . 0.0 109.244 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -51.13 137.76 45.12 Favored 'Trans proline' 0 N--CA 1.496 1.627 0 C-N-CA 122.999 2.466 . . . . 0.0 112.053 -174.136 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.401 HD23 ' N ' ' A' ' 110' ' ' LEU . 1.7 pt? -157.66 -9.32 0.08 Allowed 'General case' 0 N--CA 1.497 1.893 0 CA-C-N 114.803 -1.09 . . . . 0.0 110.999 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 1.987 0 CA-C-O 114.74 -2.552 . . . . 0.0 110.704 -179.948 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 25.0 t70 . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 5.9 mmp_? -87.78 58.52 4.92 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-N 114.783 -1.099 . . . . 0.0 108.209 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 10.2 tp -85.15 44.46 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 CA-C-N 114.374 -1.285 . . . . 0.0 109.528 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.409 ' HA ' ' HA ' ' A' ' 41' ' ' CYS . 5.7 m -85.16 59.5 5.67 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 122.582 1.182 . . . . 0.0 112.938 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.2 t -90.03 167.87 12.43 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-N 113.145 -1.843 . . . . 0.0 107.178 179.675 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 15.9 p30 -145.72 150.59 36.54 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.949 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.7 t -67.34 -20.12 65.54 Favored 'General case' 0 N--CA 1.496 1.847 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.805 -179.794 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 35.7 t -54.94 -55.67 28.16 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 179.765 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -71.69 -23.24 61.61 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-N 112.853 -1.976 . . . . 0.0 110.098 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -52.72 142.38 26.09 Favored Glycine 0 N--CA 1.493 2.494 0 O-C-N 124.199 0.937 . . . . 0.0 112.572 -179.805 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 41.0 p -61.15 109.15 1.03 Allowed 'General case' 0 N--CA 1.492 1.639 0 CA-C-N 111.711 -2.244 . . . . 0.0 111.976 -179.713 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -68.81 88.64 0.38 Allowed 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 122.457 1.123 . . . . 0.0 108.677 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 163.87 -22.6 0.17 Allowed Glycine 0 N--CA 1.488 2.111 0 CA-C-N 112.611 -2.086 . . . . 0.0 109.639 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 76.0 m -107.63 138.12 44.42 Favored 'General case' 0 N--CA 1.497 1.902 0 CA-C-O 121.533 0.683 . . . . 0.0 110.567 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 61.3 mtpt -83.38 84.82 7.37 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-N 113.821 -1.536 . . . . 0.0 110.914 -179.518 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 -49.78 128.93 19.17 Favored 'General case' 0 N--CA 1.498 1.951 0 CA-C-O 122.37 1.081 . . . . 0.0 109.982 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -136.8 161.01 37.16 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-N 112.262 -2.245 . . . . 0.0 112.554 -179.264 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 32.8 t -104.33 133.12 49.77 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 113.613 -1.63 . . . . 0.0 112.19 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -47.73 -25.06 1.1 Allowed 'General case' 0 N--CA 1.5 2.032 0 CA-C-N 112.895 -1.957 . . . . 0.0 114.18 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 29.3 p30 -60.17 -7.66 2.02 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 124.095 0.872 . . . . 0.0 112.573 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 95.61 27.23 10.74 Favored Glycine 0 N--CA 1.494 2.537 0 N-CA-C 109.894 -1.282 . . . . 0.0 109.894 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 88.3 m -141.29 139.41 33.66 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 123.926 0.427 . . . . 0.0 110.161 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.43 ' CG ' ' N ' ' A' ' 24' ' ' VAL . 48.8 t80 -67.15 164.64 17.63 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 124.63 1.206 . . . . 0.0 110.787 179.809 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.43 ' N ' ' CG ' ' A' ' 23' ' ' PHE . 96.8 t -129.66 -73.05 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 124.093 0.871 . . . . 0.0 112.544 -179.842 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 20.3 p -150.58 -172.01 4.07 Favored 'General case' 0 N--CA 1.501 2.084 0 CA-C-O 121.615 0.721 . . . . 0.0 111.359 -179.496 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -123.51 138.77 54.5 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 104.585 -2.376 . . . . 0.0 104.585 179.447 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -55.99 155.52 12.3 Favored Glycine 0 N--CA 1.503 3.111 0 C-N-CA 120.137 -1.03 . . . . 0.0 114.597 -179.712 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -112.89 -29.55 7.34 Favored 'General case' 0 N--CA 1.505 2.29 0 CA-C-N 114.837 -0.681 . . . . 0.0 111.891 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 32.0 t -110.44 124.54 51.95 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 107.3 -1.371 . . . . 0.0 107.3 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -77.81 144.1 68.03 Favored Pre-proline 0 N--CA 1.495 1.792 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 -179.714 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -41.46 -21.36 0.13 Allowed 'Trans proline' 0 N--CA 1.501 1.925 0 C-N-CA 124.02 3.146 . . . . 0.0 115.617 177.551 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 30.9 tpt180 -57.63 -30.34 65.28 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 123.708 0.63 . . . . 0.0 110.657 179.831 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.506 ' N ' HD22 ' A' ' 33' ' ' ASN . 0.0 OUTLIER -53.96 120.96 26.74 Favored Pre-proline 0 N--CA 1.496 1.839 0 CA-C-N 114.956 -1.02 . . . . 0.0 112.902 179.991 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -82.19 40.51 0.98 Allowed 'Trans proline' 0 N--CA 1.494 1.546 0 C-N-CA 122.979 2.453 . . . . 0.0 110.356 167.854 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 57.5 tptt -170.07 160.21 8.0 Favored 'General case' 0 N--CA 1.498 1.951 0 CA-C-N 114.577 -1.192 . . . . 0.0 108.578 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -140.4 151.68 45.14 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 123.866 0.729 . . . . 0.0 109.934 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 6.7 m -79.48 143.51 34.87 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 90.2 m -148.79 92.03 1.94 Allowed 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.4 HD23 ' C ' ' A' ' 39' ' ' LEU . 5.9 tt -157.94 -68.92 0.09 Allowed 'General case' 0 N--CA 1.496 1.839 0 CA-C-N 115.339 -0.846 . . . . 0.0 108.917 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -70.33 146.6 50.4 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 123.766 0.666 . . . . 0.0 111.993 -179.836 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.409 ' HA ' ' HA ' ' A' ' 4' ' ' CYS . 79.1 m -105.11 132.17 51.67 Favored 'General case' 0 N--CA 1.496 1.826 0 CA-C-N 114.411 -1.268 . . . . 0.0 109.68 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -135.2 77.44 54.95 Favored Pre-proline 0 N--CA 1.497 1.911 0 O-C-N 123.849 0.718 . . . . 0.0 110.291 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_endo -62.75 -27.19 75.39 Favored 'Trans proline' 0 N--CA 1.494 1.515 0 C-N-CA 123.066 2.511 . . . . 0.0 112.794 -172.473 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 6.0 ptp85 -65.99 -34.8 78.93 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 124.189 0.931 . . . . 0.0 112.47 -179.797 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.0 mt -59.41 136.96 22.49 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.099 0 C-N-CA 118.642 -1.223 . . . . 0.0 112.347 -179.773 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -123.93 -53.02 1.76 Allowed 'General case' 0 N--CA 1.492 1.675 0 CA-C-N 111.911 -2.404 . . . . 0.0 106.737 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 17.3 p90 -170.1 158.44 6.98 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-N 113.667 -1.606 . . . . 0.0 109.8 179.842 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -112.83 133.93 11.65 Favored Glycine 0 N--CA 1.494 2.517 0 CA-C-N 113.746 -1.57 . . . . 0.0 112.112 -179.764 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.3 p -82.92 105.22 12.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 8.9 m -79.96 112.18 27.85 Favored Pre-proline 0 N--CA 1.493 1.718 0 CA-C-N 113.93 -1.486 . . . . 0.0 108.681 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_endo -73.72 148.07 40.98 Favored 'Trans proline' 0 N--CA 1.492 1.425 0 C-N-CA 122.445 2.096 . . . . 0.0 111.018 -172.899 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 86.7 mtm180 -83.59 179.36 7.65 Favored 'General case' 0 N--CA 1.498 1.926 0 CA-C-N 114.968 -1.015 . . . . 0.0 110.471 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 80.8 p -70.99 -179.53 2.32 Favored 'General case' 0 N--CA 1.499 1.979 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.501 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -68.65 172.89 5.67 Favored 'General case' 0 N--CA 1.497 1.905 0 C-N-CA 120.268 -0.573 . . . . 0.0 111.59 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 22.1 pt-20 -78.65 153.59 30.9 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-N 114.341 -1.3 . . . . 0.0 108.845 179.768 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.426 ' HG2' HH12 ' A' ' 97' ' ' ARG . 2.6 tmtp? -137.04 -62.04 0.64 Allowed 'General case' 0 N--CA 1.502 2.17 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 -179.772 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.452 ' HD2' ' N ' ' A' ' 57' ' ' LYS . 13.5 mptt -78.97 17.63 0.72 Allowed 'General case' 0 N--CA 1.504 2.27 0 CA-C-O 121.45 0.643 . . . . 0.0 111.638 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.62 ' ND2' ' H ' ' A' ' 60' ' ' ARG . 10.1 p-10 -77.38 -42.33 36.82 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-N 114.834 -1.076 . . . . 0.0 112.152 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 59.24 37.53 23.7 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 124.432 1.083 . . . . 0.0 108.764 -179.715 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.62 ' H ' ' ND2' ' A' ' 58' ' ' ASN . 2.0 tpp180 -99.62 172.21 7.43 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-N 113.074 -1.876 . . . . 0.0 108.476 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 6.6 tp -61.26 85.93 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 124.107 0.88 . . . . 0.0 111.512 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 10.1 m -93.97 56.82 2.34 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-O 122.558 1.17 . . . . 0.0 112.509 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 97.4 m -78.27 162.69 26.35 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 113.355 -1.748 . . . . 0.0 108.52 179.772 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 46.0 p-10 -160.67 156.65 25.83 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 120.317 -0.553 . . . . 0.0 110.582 179.802 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' CYS . . . . . 0.551 ' SG ' ' HB2' ' A' ' 74' ' ' TYR . 53.0 t -83.48 -12.56 56.15 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-N 115.043 -0.981 . . . . 0.0 110.169 179.773 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 53.4 t -65.02 -59.83 3.71 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 179.844 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -90.54 34.55 0.89 Allowed 'General case' 0 N--CA 1.494 1.761 0 CA-C-N 114.167 -1.379 . . . . 0.0 108.69 179.706 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -74.62 -122.1 0.1 Allowed Glycine 0 N--CA 1.495 2.597 0 CA-C-N 115.353 -0.84 . . . . 0.0 111.053 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 14.8 t -159.81 107.33 1.69 Allowed 'General case' 0 N--CA 1.495 1.807 0 CA-C-O 122.497 1.141 . . . . 0.0 109.465 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 2.7 tmmm? -57.32 101.76 0.07 Allowed 'General case' 0 N--CA 1.493 1.689 0 CA-C-N 113.266 -1.788 . . . . 0.0 107.196 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.404 ' O ' ' SG ' ' A' ' 108' ' ' CYS . . . 165.41 -32.74 0.24 Allowed Glycine 0 N--CA 1.485 1.96 0 CA-C-N 113.225 -1.807 . . . . 0.0 109.366 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 57.7 m -124.36 175.11 7.3 Favored 'General case' 0 N--CA 1.503 2.18 0 C-N-CA 120.017 -0.673 . . . . 0.0 110.733 -179.88 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.448 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 94.0 mttt -110.61 97.86 7.18 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 124.607 1.192 . . . . 0.0 109.174 -179.796 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.551 ' HB2' ' SG ' ' A' ' 65' ' ' CYS . 26.8 m-85 -54.37 131.36 41.92 Favored 'General case' 0 N--CA 1.497 1.89 0 CA-C-N 114.808 -1.087 . . . . 0.0 109.135 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -139.9 147.51 40.7 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 112.956 -1.929 . . . . 0.0 113.475 -179.366 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.403 ' N ' HG23 ' A' ' 82' ' ' VAL . 30.9 t -99.58 117.03 33.07 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-N 111.378 -2.646 . . . . 0.0 108.599 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.578 ' H ' ' HB2' ' A' ' 104' ' ' ALA . 7.6 p-10 -59.97 -54.19 49.04 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 125.186 1.553 . . . . 0.0 112.996 -179.652 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -84.14 13.51 5.09 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 113.603 -1.635 . . . . 0.0 110.882 -179.673 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -129.13 -88.87 0.56 Allowed Glycine 0 N--CA 1.48 1.627 0 N-CA-C 108.962 -1.655 . . . . 0.0 108.962 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.451 ' CG2' ' N ' ' A' ' 81' ' ' PHE . 1.2 m 171.78 -175.71 0.05 OUTLIER 'General case' 0 N--CA 1.5 2.066 0 N-CA-C 105.902 -1.888 . . . . 0.0 105.902 -179.381 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.451 ' N ' ' CG2' ' A' ' 80' ' ' THR . 19.2 t80 -53.52 136.3 38.58 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 179.504 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.403 HG23 ' N ' ' A' ' 76' ' ' SER . 92.9 t -94.78 -73.61 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 CA-C-N 114.606 -1.179 . . . . 0.0 109.196 -179.558 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' CYS . . . . . 0.423 ' C ' ' SG ' ' A' ' 65' ' ' CYS . 0.1 OUTLIER -168.44 178.53 4.79 Favored 'General case' 0 N--CA 1.504 2.268 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 179.882 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.448 ' HA ' ' HA ' ' A' ' 73' ' ' LYS . 38.6 tt0 -93.02 152.46 19.29 Favored 'General case' 0 N--CA 1.5 2.034 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -50.29 102.05 0.06 OUTLIER Glycine 0 N--CA 1.495 2.589 0 O-C-N 123.739 0.649 . . . . 0.0 111.513 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -79.83 -12.15 59.78 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-N 114.862 -0.669 . . . . 0.0 110.146 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 35.1 t -77.79 84.31 4.11 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 121.464 0.65 . . . . 0.0 109.708 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -79.38 132.1 63.42 Favored Pre-proline 0 N--CA 1.495 1.803 0 N-CA-C 106.399 -1.704 . . . . 0.0 106.399 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -52.49 -22.39 16.4 Favored 'Trans proline' 0 N--CA 1.498 1.741 0 C-N-CA 122.823 2.349 . . . . 0.0 113.705 -169.701 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 53.0 mmm-85 -83.71 12.82 5.35 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 123.802 0.689 . . . . 0.0 111.648 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.411 ' C ' ' H ' ' A' ' 93' ' ' LYS . 40.6 p-10 -87.71 135.2 34.24 Favored Pre-proline 0 N--CA 1.494 1.742 0 O-C-N 123.45 0.469 . . . . 0.0 111.148 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -81.95 28.97 0.55 Allowed 'Trans proline' 0 N--CA 1.493 1.453 0 C-N-CA 122.967 2.445 . . . . 0.0 111.409 162.317 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.411 ' H ' ' C ' ' A' ' 91' ' ' ASN . 44.3 mmtm 58.21 124.23 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.162 0 CA-C-N 113.76 -1.564 . . . . 0.0 112.846 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -149.32 79.67 1.4 Allowed 'General case' 0 N--CA 1.497 1.913 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.628 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 79.2 m -153.24 124.21 3.57 Favored Pre-proline 0 N--CA 1.496 1.857 0 CA-C-N 114.476 -1.238 . . . . 0.0 108.43 179.831 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -60.73 -85.57 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.502 0 C-N-CA 122.046 1.831 . . . . 0.0 110.592 177.06 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.426 HH12 ' HG2' ' A' ' 56' ' ' LYS . 2.7 mpt_? -142.25 -60.35 0.45 Allowed 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 10.3 m120 51.51 48.28 23.21 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 124.592 1.182 . . . . 0.0 110.243 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 77.9 m -41.17 128.0 2.83 Favored 'General case' 0 N--CA 1.499 2.009 0 CA-C-N 114.112 -1.404 . . . . 0.0 112.734 -179.88 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -139.03 79.32 27.09 Favored Pre-proline 0 N--CA 1.496 1.831 0 O-C-N 124.125 0.89 . . . . 0.0 110.882 -179.733 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -59.43 -33.91 97.35 Favored 'Trans proline' 0 N--CA 1.494 1.523 0 C-N-CA 122.87 2.38 . . . . 0.0 113.024 171.606 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 33.2 ptt180 -63.96 -16.93 62.67 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 123.919 0.762 . . . . 0.0 112.3 -179.878 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 9.6 tp -48.86 152.64 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 O-C-N 124.019 0.824 . . . . 0.0 112.452 -179.83 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.578 ' HB2' ' H ' ' A' ' 77' ' ' ASP . . . -124.59 -71.96 0.69 Allowed 'General case' 0 N--CA 1.492 1.659 0 CA-C-N 114.686 -1.143 . . . . 0.0 108.261 179.792 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 76.3 m-85 -156.14 -162.99 1.37 Allowed 'General case' 0 N--CA 1.499 2.001 0 O-C-N 124.685 1.241 . . . . 0.0 109.042 -179.725 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -119.87 93.26 0.54 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 104.966 -3.253 . . . . 0.0 104.966 179.714 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 43.7 mm -78.77 105.7 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 C-N-CA 119.626 -0.83 . . . . 0.0 110.546 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' CYS . . . . . 0.404 ' SG ' ' O ' ' A' ' 71' ' ' GLY . 1.6 m -78.61 151.4 77.19 Favored Pre-proline 0 N--CA 1.499 1.995 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.688 179.895 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -59.56 114.3 1.99 Allowed 'Trans proline' 0 N--CA 1.494 1.528 0 C-N-CA 122.752 2.302 . . . . 0.0 111.151 -172.716 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 2.3 pp -79.86 -177.3 5.88 Favored 'General case' 0 N--CA 1.496 1.827 0 CA-C-N 114.928 -1.033 . . . . 0.0 111.892 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.836 0 CA-C-O 116.209 -1.853 . . . . 0.0 110.718 -179.911 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 24.3 t70 . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 109.489 -0.559 . . . . 0.0 109.489 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 10.4 mmm180 -102.83 -47.56 4.35 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-N 114.954 -1.021 . . . . 0.0 111.004 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 4.8 tp -65.62 85.99 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 124.212 0.945 . . . . 0.0 111.228 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.558 ' HA ' ' HA ' ' A' ' 41' ' ' CYS . 1.6 m -92.88 61.03 3.46 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-O 123.372 1.558 . . . . 0.0 113.731 179.814 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 6.8 t -90.15 161.47 15.74 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 104.475 -2.417 . . . . 0.0 104.475 179.517 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -161.54 -166.42 1.5 Allowed 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 8.8 t -117.58 -36.88 3.58 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 179.832 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 49.5 t -62.5 -61.46 2.42 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 123.917 0.761 . . . . 0.0 110.402 -179.59 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -90.06 27.51 1.59 Allowed 'General case' 0 N--CA 1.496 1.871 0 CA-C-N 113.525 -1.67 . . . . 0.0 109.178 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -72.67 -117.9 0.06 OUTLIER Glycine 0 N--CA 1.492 2.411 0 CA-C-N 115.141 -0.936 . . . . 0.0 111.271 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 97.3 m -154.62 91.82 1.43 Allowed 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 107.518 -1.289 . . . . 0.0 107.518 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.484 ' HB3' ' NZ ' ' A' ' 12' ' ' LYS . 0.0 OUTLIER -54.6 112.77 1.08 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 123.739 0.649 . . . . 0.0 110.146 -179.847 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 135.16 -30.06 2.86 Favored Glycine 0 N--CA 1.494 2.531 0 CA-C-N 113.641 -1.618 . . . . 0.0 109.781 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 82.6 m -88.97 -178.38 5.7 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 123.659 0.27 . . . . 0.0 110.955 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 33.3 mmtp -129.82 92.26 3.29 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 124.062 0.851 . . . . 0.0 111.294 -179.546 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.436 ' HB2' ' SG ' ' A' ' 25' ' ' CYS . 51.3 m-85 -58.87 131.64 51.59 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 124.53 1.144 . . . . 0.0 108.268 179.72 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -142.04 159.66 41.78 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-N 113.102 -1.863 . . . . 0.0 113.43 -179.162 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 30.6 t -105.11 134.04 48.89 Favored 'General case' 0 N--CA 1.497 1.893 0 CA-C-N 113.689 -1.596 . . . . 0.0 111.619 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -48.22 -28.27 2.93 Favored 'General case' 0 N--CA 1.501 2.122 0 CA-C-N 112.948 -1.933 . . . . 0.0 115.814 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -52.09 -22.75 4.43 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 124.036 0.835 . . . . 0.0 111.602 -179.843 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 112.13 27.2 4.05 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 108.871 -1.692 . . . . 0.0 108.871 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 89.7 m -138.75 142.06 38.83 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 120.527 -0.469 . . . . 0.0 110.959 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 49.6 t80 -69.41 160.98 30.35 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-N 114.151 -1.386 . . . . 0.0 109.761 179.745 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 58.5 t -127.2 -71.6 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 124.091 0.87 . . . . 0.0 112.179 -179.832 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.436 ' SG ' ' HB2' ' A' ' 16' ' ' TYR . 0.5 OUTLIER -144.52 -177.93 5.73 Favored 'General case' 0 N--CA 1.5 2.068 0 CA-C-O 121.402 0.62 . . . . 0.0 110.818 -179.709 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -113.04 145.0 41.63 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 104.067 -2.568 . . . . 0.0 104.067 179.485 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -57.3 152.04 26.23 Favored Glycine 0 N--CA 1.498 2.773 0 C-N-CA 119.301 -1.428 . . . . 0.0 111.184 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -126.42 -10.06 6.32 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 123.976 0.457 . . . . 0.0 111.265 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 33.4 t -71.63 91.26 1.08 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 123.728 0.643 . . . . 0.0 110.714 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -99.11 111.88 61.88 Favored Pre-proline 0 N--CA 1.491 1.586 0 CA-C-N 114.618 -1.173 . . . . 0.0 108.752 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_endo -58.48 -17.07 32.42 Favored 'Trans proline' 0 N--CA 1.495 1.609 0 C-N-CA 122.869 2.38 . . . . 0.0 113.114 -168.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 74.7 ttt-85 -61.01 -50.01 75.1 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -90.84 122.85 66.31 Favored Pre-proline 0 N--CA 1.496 1.843 0 O-C-N 124.271 0.982 . . . . 0.0 110.772 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_endo -78.11 121.62 5.41 Favored 'Trans proline' 0 N--CA 1.492 1.417 0 C-N-CA 122.813 2.342 . . . . 0.0 108.999 165.303 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 56.8 tptt -159.05 153.94 24.87 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 123.62 0.575 . . . . 0.0 110.568 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.85 171.62 9.79 Favored 'General case' 0 N--CA 1.497 1.912 0 CA-C-N 114.321 -1.309 . . . . 0.0 111.315 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 89.7 m -153.58 162.76 40.95 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-N 115.323 -0.853 . . . . 0.0 112.22 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 100.0 m -109.38 91.16 3.53 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 105.46 -2.052 . . . . 0.0 105.46 179.745 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.479 HD12 ' N ' ' A' ' 39' ' ' LEU . 6.4 mp -79.65 -66.43 0.87 Allowed 'General case' 0 N--CA 1.494 1.725 0 CA-C-N 114.882 -1.054 . . . . 0.0 109.892 -179.728 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 5.6 m120 49.17 31.84 3.82 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 124.637 1.211 . . . . 0.0 111.185 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.558 ' HA ' ' HA ' ' A' ' 4' ' ' CYS . 1.7 m 55.7 131.98 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 116.668 2.099 . . . . 0.0 116.668 -179.831 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -120.37 81.13 30.06 Favored Pre-proline 0 N--CA 1.5 2.064 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.296 179.667 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -58.58 -15.29 24.76 Favored 'Trans proline' 0 N--CA 1.495 1.574 0 C-N-CA 122.578 2.186 . . . . 0.0 112.308 176.863 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.456 ' H ' ' CD ' ' A' ' 44' ' ' ARG . 1.4 mpt_? -62.41 -43.23 99.31 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 26.6 mt -83.09 155.81 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 CA-C-O 122.317 1.056 . . . . 0.0 110.201 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -116.2 -53.84 2.51 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-N 111.731 -2.486 . . . . 0.0 108.025 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 50.9 p90 -165.75 167.31 17.14 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-N 114.41 -1.268 . . . . 0.0 109.287 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -119.93 118.48 3.92 Favored Glycine 0 N--CA 1.49 2.251 0 CA-C-N 113.557 -1.656 . . . . 0.0 110.56 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.9 p -79.31 133.99 28.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 20.9 m -111.27 90.76 12.28 Favored Pre-proline 0 N--CA 1.494 1.745 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 -179.806 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -51.91 -16.95 4.76 Favored 'Trans proline' 0 N--CA 1.499 1.801 0 C-N-CA 123.244 2.629 . . . . 0.0 114.423 -177.1 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.64 ' H ' ' HD2' ' A' ' 52' ' ' ARG . 0.0 OUTLIER -81.02 66.57 6.6 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-O 122.292 1.044 . . . . 0.0 110.524 179.959 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 63.3 p -116.03 149.89 38.16 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-N 113.715 -1.584 . . . . 0.0 109.389 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 67.38 148.24 0.05 Allowed 'General case' 0 N--CA 1.504 2.248 0 O-C-N 124.608 1.193 . . . . 0.0 110.339 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 57.87 -168.32 0.13 Allowed 'General case' 0 N--CA 1.504 2.258 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.581 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.439 ' HD2' ' N ' ' A' ' 56' ' ' LYS . 0.0 OUTLIER -161.84 -152.09 0.23 Allowed 'General case' 0 N--CA 1.495 1.799 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.249 -179.977 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.425 ' C ' ' H ' ' A' ' 59' ' ' ASP . 0.0 OUTLIER -77.0 23.16 0.18 Allowed 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 113.489 0.922 . . . . 0.0 113.489 179.989 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 8.3 p-10 -72.52 18.31 0.09 Allowed 'General case' 0 N--CA 1.502 2.14 0 CA-C-N 115.853 -0.612 . . . . 0.0 112.442 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.425 ' H ' ' C ' ' A' ' 57' ' ' LYS . 5.8 m-20 -70.78 -79.66 0.06 Allowed 'General case' 0 N--CA 1.491 1.613 0 CA-C-N 115.69 -0.687 . . . . 0.0 110.47 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 22.2 tpp85 -168.53 135.36 1.95 Allowed 'General case' 0 N--CA 1.499 1.984 0 O-C-N 123.774 0.671 . . . . 0.0 111.132 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 6.6 tp -84.27 68.15 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 CA-C-N 114.704 -1.135 . . . . 0.0 109.17 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.46 ' HA ' ' HA ' ' A' ' 99' ' ' CYS . 1.6 m -84.24 40.44 0.77 Allowed 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 115.618 1.71 . . . . 0.0 115.618 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 36.0 m -91.51 109.71 21.01 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 113.175 -1.83 . . . . 0.0 107.893 179.816 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.57 HD22 ' HB3' ' A' ' 67' ' ' ALA . 0.1 OUTLIER -107.83 -165.72 1.08 Allowed 'General case' 0 N--CA 1.503 2.184 0 C-N-CA 120.264 -0.574 . . . . 0.0 109.651 179.84 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 65' ' ' CYS . . . . . 0.409 ' SG ' ' O ' ' A' ' 84' ' ' GLU . 1.5 t -121.22 -33.91 3.59 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 123.904 0.753 . . . . 0.0 111.362 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 32.6 t -57.07 -58.6 7.48 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-O 121.71 0.766 . . . . 0.0 110.12 -179.805 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.57 ' HB3' HD22 ' A' ' 64' ' ' ASN . . . -79.42 -10.56 59.83 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-N 113.088 -1.869 . . . . 0.0 109.737 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -67.47 156.57 52.31 Favored Glycine 0 N--CA 1.494 2.551 0 C-N-CA 120.823 -0.703 . . . . 0.0 111.588 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.461 ' C ' ' H ' ' A' ' 71' ' ' GLY . 57.0 p -68.49 124.27 23.09 Favored 'General case' 0 N--CA 1.498 1.951 0 CA-C-N 114.14 -1.03 . . . . 0.0 111.127 -179.809 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.86 20.72 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.173 0 N-CA-C 115.958 1.836 . . . . 0.0 115.958 -179.853 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.461 ' H ' ' C ' ' A' ' 69' ' ' THR . . . -119.58 -25.85 2.52 Favored Glycine 0 N--CA 1.49 2.29 0 CA-C-N 113.623 -1.626 . . . . 0.0 109.319 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' CYS . . . . . 0.4 ' HA ' ' HA ' ' A' ' 108' ' ' CYS . 94.6 m -93.36 134.54 35.48 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 120.333 -0.547 . . . . 0.0 109.801 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 60.0 mtpt -88.77 84.27 6.69 Favored 'General case' 0 N--CA 1.485 1.316 0 CA-C-N 113.501 -1.681 . . . . 0.0 109.545 -179.632 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.487 ' HB2' ' SG ' ' A' ' 83' ' ' CYS . 82.0 m-85 -50.08 126.11 13.74 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-N 114.855 -1.066 . . . . 0.0 108.418 179.87 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -132.5 162.88 30.08 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 112.986 -1.915 . . . . 0.0 112.625 -179.327 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 42.6 t -109.21 138.52 45.44 Favored 'General case' 0 N--CA 1.497 1.889 0 CA-C-N 114.309 -1.314 . . . . 0.0 112.376 -179.864 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.44 ' H ' ' CB ' ' A' ' 104' ' ' ALA . 7.0 p-10 -47.45 -27.25 1.63 Allowed 'General case' 0 N--CA 1.5 2.042 0 CA-C-N 112.18 -2.282 . . . . 0.0 114.38 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 13.6 p30 -59.11 -7.62 1.21 Allowed 'General case' 0 N--CA 1.497 1.899 0 O-C-N 124.335 1.022 . . . . 0.0 112.492 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 92.91 28.57 11.83 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 95.8 m -143.08 138.8 30.14 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 124.095 0.526 . . . . 0.0 110.554 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.429 ' CG ' ' N ' ' A' ' 82' ' ' VAL . 37.1 t80 -64.19 164.96 10.01 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 124.878 1.361 . . . . 0.0 110.849 179.853 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.429 ' N ' ' CG ' ' A' ' 81' ' ' PHE . 92.4 t -129.03 -71.56 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 124.188 0.93 . . . . 0.0 112.991 -179.805 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' CYS . . . . . 0.487 ' SG ' ' HB2' ' A' ' 74' ' ' TYR . 25.4 p -152.58 -173.08 4.44 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 123.708 0.63 . . . . 0.0 109.346 -179.561 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.409 ' O ' ' SG ' ' A' ' 65' ' ' CYS . 40.5 tt0 -128.49 149.63 50.51 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 102.602 -3.111 . . . . 0.0 102.602 179.324 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -58.8 169.89 5.36 Favored Glycine 0 N--CA 1.501 3.023 0 C-N-CA 118.631 -1.747 . . . . 0.0 114.966 -179.66 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -126.15 -13.88 6.11 Favored 'General case' 0 N--CA 1.502 2.145 0 CA-C-N 114.218 -0.991 . . . . 0.0 110.991 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 34.5 t -81.55 121.59 26.5 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -98.32 143.3 26.04 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 124.779 1.299 . . . . 0.0 107.785 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_exo -43.18 -28.07 1.29 Allowed 'Trans proline' 0 N--CA 1.5 1.866 0 C-N-CA 123.4 2.733 . . . . 0.0 114.022 175.073 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -60.09 -50.38 73.92 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 123.911 0.757 . . . . 0.0 109.278 179.863 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -91.06 116.39 66.32 Favored Pre-proline 0 N--CA 1.497 1.892 0 O-C-N 124.748 1.28 . . . . 0.0 111.806 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -85.02 102.76 0.8 Allowed 'Trans proline' 0 N--CA 1.491 1.342 0 C-N-CA 123.072 2.514 . . . . 0.0 108.044 161.476 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 22.2 ptmt -161.18 162.95 31.49 Favored 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 113.188 0.81 . . . . 0.0 113.188 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -108.86 -166.86 1.15 Allowed 'General case' 0 N--CA 1.496 1.844 0 CA-C-N 113.56 -1.654 . . . . 0.0 108.406 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 76.9 m -146.99 159.94 41.61 Favored Pre-proline 0 N--CA 1.499 1.984 0 O-C-N 123.653 0.595 . . . . 0.0 110.958 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.418 ' C ' ' HE ' ' A' ' 97' ' ' ARG . 11.9 Cg_endo -73.15 -18.19 23.94 Favored 'Trans proline' 0 N--CA 1.493 1.461 0 C-N-CA 122.36 2.04 . . . . 0.0 109.45 161.522 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.418 ' HE ' ' C ' ' A' ' 96' ' ' PRO . 0.0 OUTLIER -79.64 4.44 16.05 Favored 'General case' 0 N--CA 1.497 1.9 0 CA-C-N 114.949 -1.023 . . . . 0.0 111.376 -179.994 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 -54.89 154.41 5.27 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.46 ' HA ' ' HA ' ' A' ' 62' ' ' CYS . 52.4 m 58.37 104.19 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 CA-C-N 113.227 -1.806 . . . . 0.0 113.583 -179.896 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -125.36 107.1 27.27 Favored Pre-proline 0 N--CA 1.498 1.97 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.616 179.814 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -62.4 -25.79 76.4 Favored 'Trans proline' 0 N--CA 1.493 1.491 0 C-N-CA 122.639 2.226 . . . . 0.0 111.453 179.824 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 23.5 mtp-105 -57.93 -38.18 75.43 Favored 'General case' 0 N--CA 1.5 2.048 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 26.7 mt -79.31 154.85 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 CA-C-N 114.815 -1.084 . . . . 0.0 110.079 179.734 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.44 ' CB ' ' H ' ' A' ' 77' ' ' ASP . . . -132.36 -46.24 0.91 Allowed 'General case' 0 N--CA 1.495 1.794 0 CA-C-N 111.955 -2.384 . . . . 0.0 109.441 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 49.1 m-85 -140.0 -163.55 1.53 Allowed 'General case' 0 N--CA 1.493 1.706 0 CA-C-N 114.519 -1.219 . . . . 0.0 109.594 -179.846 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -152.65 107.77 0.34 Allowed Glycine 0 N--CA 1.49 2.235 0 N-CA-C 107.339 -2.304 . . . . 0.0 107.339 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 88.9 mt -79.44 84.41 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 N-CA-C 108.245 -1.021 . . . . 0.0 108.245 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' CYS . . . . . 0.4 ' HA ' ' HA ' ' A' ' 72' ' ' CYS . 13.6 m -79.97 112.46 30.18 Favored Pre-proline 0 N--CA 1.494 1.729 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -69.65 -71.0 0.02 OUTLIER 'Trans proline' 0 N--CA 1.493 1.442 0 C-N-CA 122.236 1.957 . . . . 0.0 111.306 -167.496 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 84.5 mt -90.02 45.08 1.24 Allowed 'General case' 0 N--CA 1.498 1.963 0 O-C-N 124.211 0.945 . . . . 0.0 110.402 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 1.968 0 CA-C-O 116.362 -1.78 . . . . 0.0 110.7 -179.987 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 31.6 t70 . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 121.059 0.457 . . . . 0.0 109.972 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 72.7 mtp85 -70.76 127.57 33.09 Favored 'General case' 0 N--CA 1.495 1.801 0 CA-C-N 114.774 -1.103 . . . . 0.0 110.472 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 9.8 tp -87.0 44.11 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 124.169 0.918 . . . . 0.0 109.031 179.856 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.408 ' HA ' ' HA ' ' A' ' 41' ' ' CYS . 1.7 m -82.78 60.35 5.28 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 114.336 1.236 . . . . 0.0 114.336 -179.851 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 17.8 p -90.92 172.4 8.62 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-N 113.501 -1.681 . . . . 0.0 109.37 179.601 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 32.3 p-10 -161.8 146.06 12.73 Favored 'General case' 0 N--CA 1.497 1.925 0 CA-C-N 115.002 -0.999 . . . . 0.0 109.681 179.687 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.4 ' HA ' ' CD2' ' A' ' 16' ' ' TYR . 40.3 t -63.4 -16.54 60.82 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 113.469 0.915 . . . . 0.0 113.469 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 43.8 t -80.77 -63.46 1.4 Allowed 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 114.789 1.403 . . . . 0.0 114.789 -179.515 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -85.21 62.33 7.43 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-N 114.664 -1.153 . . . . 0.0 112.377 -179.646 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -106.96 -111.79 3.61 Favored Glycine 0 N--CA 1.495 2.578 0 CA-C-N 113.699 -1.591 . . . . 0.0 110.257 179.715 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.561 ' H ' ' HA3' ' A' ' 27' ' ' GLY . 53.4 m -166.64 117.83 0.96 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 125.211 1.183 . . . . 0.0 109.622 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 11.0 mmmm -67.9 83.34 0.21 Allowed 'General case' 0 N--CA 1.502 2.158 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 179.504 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 168.48 -20.26 0.08 OUTLIER Glycine 0 N--CA 1.49 2.282 0 CA-C-N 114.758 -1.11 . . . . 0.0 112.226 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 68.1 m -117.71 -176.68 3.08 Favored 'General case' 0 N--CA 1.5 2.031 0 CA-C-N 117.921 0.86 . . . . 0.0 108.879 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.431 ' HB3' ' HZ2' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -130.84 116.78 18.4 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 118.463 -1.295 . . . . 0.0 113.494 -179.657 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.44 ' N ' ' O ' ' A' ' 25' ' ' CYS . 8.2 m-85 -56.61 136.31 54.66 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-N 113.784 -1.553 . . . . 0.0 107.759 179.331 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -151.06 149.69 29.83 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 113.322 -1.763 . . . . 0.0 111.261 -179.452 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 38.1 t -98.73 134.33 41.78 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-N 111.914 -2.403 . . . . 0.0 112.174 -179.784 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.446 ' H ' ' HB2' ' A' ' 46' ' ' ALA . 3.3 p30 -51.58 -26.44 8.74 Favored 'General case' 0 N--CA 1.5 2.061 0 CA-C-N 112.701 -2.045 . . . . 0.0 114.24 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 52.0 p-10 -59.28 -10.21 2.82 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 124.079 0.862 . . . . 0.0 112.244 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 97.62 29.65 7.67 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 108.718 -1.753 . . . . 0.0 108.718 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 56.2 m -136.06 145.86 46.45 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 124.135 0.55 . . . . 0.0 109.744 -179.799 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.426 ' CG ' ' N ' ' A' ' 24' ' ' VAL . 54.3 t80 -75.48 164.42 26.38 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 124.61 1.194 . . . . 0.0 110.612 179.753 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.426 ' N ' ' CG ' ' A' ' 23' ' ' PHE . 87.2 t -128.49 -75.9 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 124.075 0.859 . . . . 0.0 110.5 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.54 ' SG ' ' N ' ' A' ' 26' ' ' GLU . 0.5 OUTLIER -155.0 -164.87 1.89 Allowed 'General case' 0 N--CA 1.505 2.296 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 -179.898 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.54 ' N ' ' SG ' ' A' ' 25' ' ' CYS . 3.6 tm-20 -111.43 137.65 48.95 Favored 'General case' 0 N--CA 1.504 2.259 0 N-CA-C 106.63 -1.618 . . . . 0.0 106.63 179.588 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.561 ' HA3' ' H ' ' A' ' 11' ' ' THR . . . -54.9 117.45 8.17 Favored Glycine 0 N--CA 1.5 2.963 0 N-CA-C 110.53 -1.028 . . . . 0.0 110.53 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 39.8 mm-40 -93.5 10.35 32.81 Favored 'General case' 0 N--CA 1.499 2.022 0 N-CA-C 115.808 1.781 . . . . 0.0 115.808 -179.496 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 32.2 t -76.1 96.55 3.87 Favored 'General case' 0 N--CA 1.499 2.019 0 C-N-CA 118.651 -1.22 . . . . 0.0 108.734 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -87.74 145.91 37.93 Favored Pre-proline 0 N--CA 1.493 1.688 0 CA-C-N 114.31 -1.314 . . . . 0.0 108.486 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_exo -47.12 111.95 0.46 Allowed 'Trans proline' 0 N--CA 1.494 1.533 0 C-N-CA 122.366 2.044 . . . . 0.0 110.148 169.399 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 79.1 mtp180 57.07 48.94 14.58 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 124.439 1.087 . . . . 0.0 109.687 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -58.89 140.02 86.62 Favored Pre-proline 0 N--CA 1.498 1.928 0 CA-C-N 114.024 -1.444 . . . . 0.0 110.856 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -66.14 129.18 21.12 Favored 'Trans proline' 0 N--CA 1.492 1.409 0 C-N-CA 122.367 2.045 . . . . 0.0 110.599 -178.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 59.3 mttp 62.42 162.69 0.09 Allowed 'General case' 0 N--CA 1.503 2.222 0 O-C-N 124.742 1.276 . . . . 0.0 113.351 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -89.05 168.55 12.24 Favored 'General case' 0 N--CA 1.498 1.937 0 CA-C-N 114.528 -1.215 . . . . 0.0 110.293 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 71.3 m -79.86 163.5 24.32 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.946 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 43.7 m -138.19 7.98 2.68 Favored 'General case' 0 N--CA 1.497 1.91 0 CA-C-N 114.768 -1.106 . . . . 0.0 110.025 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 88.2 mt -79.33 -65.23 1.03 Allowed 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 10.5 m120 56.73 116.34 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 114.911 1.448 . . . . 0.0 114.911 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.408 ' HA ' ' HA ' ' A' ' 4' ' ' CYS . 82.0 m 58.41 122.15 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 116.164 1.913 . . . . 0.0 116.164 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -144.42 90.37 6.6 Favored Pre-proline 0 N--CA 1.496 1.845 0 CA-C-N 114.637 -1.165 . . . . 0.0 109.838 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -57.39 -28.23 79.31 Favored 'Trans proline' 0 N--CA 1.493 1.482 0 C-N-CA 122.805 2.337 . . . . 0.0 113.051 179.372 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 15.5 tpt180 -58.17 -41.06 83.04 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 123.934 0.771 . . . . 0.0 109.476 179.857 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 14.3 mt -70.24 154.57 8.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 CA-C-O 122.121 0.962 . . . . 0.0 110.163 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.446 ' HB2' ' H ' ' A' ' 19' ' ' ASP . . . -121.15 -50.66 2.13 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-N 111.938 -2.392 . . . . 0.0 107.343 179.884 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 19.5 p90 -171.85 164.18 6.39 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-N 114.242 -1.345 . . . . 0.0 111.214 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -104.01 91.36 0.8 Allowed Glycine 0 N--CA 1.492 2.401 0 N-CA-C 107.159 -2.376 . . . . 0.0 107.159 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.1 p -84.25 126.66 40.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 C-N-CA 119.123 -1.031 . . . . 0.0 112.893 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.6 m -79.64 154.0 75.99 Favored Pre-proline 0 N--CA 1.496 1.868 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 179.615 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -71.35 81.6 1.2 Allowed 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 122.739 2.292 . . . . 0.0 109.743 -173.167 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 25.5 mtp-105 -148.54 161.3 41.94 Favored 'General case' 0 N--CA 1.496 1.856 0 CA-C-N 114.199 -1.364 . . . . 0.0 108.656 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 45.1 t -69.52 115.62 8.98 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -66.29 -43.6 85.89 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 123.879 0.737 . . . . 0.0 109.878 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.436 ' HG2' ' H ' ' A' ' 62' ' ' CYS . 19.4 mp0 -93.43 121.15 34.52 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 179.715 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.435 ' HB2' ' NZ ' ' A' ' 56' ' ' LYS . 10.4 mtmp? -139.16 -50.47 0.52 Allowed 'General case' 0 N--CA 1.495 1.791 0 CA-C-N 114.44 -1.254 . . . . 0.0 108.875 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -86.73 -76.97 0.34 Allowed 'General case' 0 N--CA 1.496 1.827 0 CA-C-N 115.047 -0.979 . . . . 0.0 110.002 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 36.8 t30 -162.07 51.76 0.22 Allowed 'General case' 0 N--CA 1.498 1.974 0 CA-C-O 121.976 0.893 . . . . 0.0 109.126 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -92.76 37.61 1.02 Allowed 'General case' 0 N--CA 1.498 1.948 0 CA-C-N 114.501 -1.227 . . . . 0.0 109.362 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 59.3 ttt85 57.45 95.01 0.03 OUTLIER 'General case' 0 N--CA 1.504 2.243 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 -179.832 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 8.2 tp -39.4 102.93 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 124.364 1.04 . . . . 0.0 113.685 -179.655 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.545 ' HA ' ' HA ' ' A' ' 99' ' ' CYS . 1.7 m -131.47 39.34 3.52 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 113.852 -1.522 . . . . 0.0 111.607 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 87.0 m -90.52 171.64 9.27 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-N 112.255 -2.248 . . . . 0.0 107.625 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.452 HD21 ' HB3' ' A' ' 67' ' ' ALA . 0.1 OUTLIER -160.37 -162.7 1.0 Allowed 'General case' 0 N--CA 1.5 2.061 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 179.952 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 65' ' ' CYS . . . . . 0.469 ' SG ' ' CD2' ' A' ' 74' ' ' TYR . 3.9 t -107.01 -28.26 10.14 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 124.071 0.857 . . . . 0.0 109.78 179.766 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' CYS . . . . . 0.451 ' SG ' ' CE ' ' A' ' 93' ' ' LYS . 51.0 t -73.88 -57.63 3.85 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 114.918 1.451 . . . . 0.0 114.918 -179.669 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.452 ' HB3' HD21 ' A' ' 64' ' ' ASN . . . -80.75 60.09 3.9 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 124.833 1.333 . . . . 0.0 112.565 -179.782 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -145.57 -139.91 3.45 Favored Glycine 0 N--CA 1.497 2.73 0 N-CA-C 108.253 -1.939 . . . . 0.0 108.253 179.625 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.432 ' C ' ' H ' ' A' ' 71' ' ' GLY . 92.4 m -154.03 150.72 28.54 Favored 'General case' 0 N--CA 1.505 2.319 0 N-CA-C 114.434 1.272 . . . . 0.0 114.434 -179.825 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 24.0 mmtt -72.63 35.87 0.07 Allowed 'General case' 0 N--CA 1.505 2.304 0 CA-C-N 113.042 -1.89 . . . . 0.0 112.689 179.634 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.432 ' H ' ' C ' ' A' ' 69' ' ' THR . . . -131.92 2.52 5.19 Favored Glycine 0 N--CA 1.485 1.923 0 N-CA-C 109.141 -1.584 . . . . 0.0 109.141 179.867 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 94.1 m -141.7 167.01 23.17 Favored 'General case' 0 N--CA 1.497 1.916 0 C-N-CA 119.384 -0.926 . . . . 0.0 111.376 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -119.89 105.45 11.1 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 124.184 0.928 . . . . 0.0 109.67 -179.637 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.648 ' CD2' ' SG ' ' A' ' 83' ' ' CYS . 74.0 m-85 -51.13 135.88 24.81 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 124.047 0.842 . . . . 0.0 110.382 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -146.96 157.22 43.57 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 -179.571 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 42.9 t -110.4 130.99 55.44 Favored 'General case' 0 N--CA 1.501 2.085 0 CA-C-N 113.441 -1.709 . . . . 0.0 113.281 -179.725 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.585 ' H ' ' HB2' ' A' ' 104' ' ' ALA . 7.3 p-10 -46.08 -31.5 2.37 Favored 'General case' 0 N--CA 1.502 2.141 0 CA-C-N 112.562 -2.108 . . . . 0.0 115.349 -179.861 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 39.1 p30 -57.42 -10.09 1.29 Allowed 'General case' 0 N--CA 1.497 1.901 0 O-C-N 124.268 0.98 . . . . 0.0 112.794 -179.833 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 99.1 23.84 11.03 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 110.159 -1.177 . . . . 0.0 110.159 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -131.31 146.87 52.48 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 124.211 0.595 . . . . 0.0 109.631 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 45.1 t80 -77.53 154.92 31.97 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 114.124 -1.398 . . . . 0.0 110.714 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 92.8 t -113.08 -73.45 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 124.19 0.931 . . . . 0.0 112.767 -179.723 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' CYS . . . . . 0.648 ' SG ' ' CD2' ' A' ' 74' ' ' TYR . 29.7 p -157.3 -174.0 4.69 Favored 'General case' 0 N--CA 1.503 2.181 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 -179.585 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -119.43 155.92 31.11 Favored 'General case' 0 N--CA 1.505 2.282 0 CA-C-O 119.003 -0.522 . . . . 0.0 109.793 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.44 ' HA2' ' CE2' ' A' ' 74' ' ' TYR . . . -31.22 111.78 0.05 OUTLIER Glycine 0 N--CA 1.502 3.048 0 O-C-N 124.838 1.337 . . . . 0.0 112.599 179.901 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -100.84 27.54 5.88 Favored 'General case' 0 N--CA 1.498 1.932 0 C-N-CA 119.97 -0.692 . . . . 0.0 109.199 -179.788 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 42.6 t -140.55 95.95 2.95 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-O 121.469 0.652 . . . . 0.0 111.959 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -84.72 148.08 50.58 Favored Pre-proline 0 N--CA 1.496 1.845 0 N-CA-C 106.15 -1.796 . . . . 0.0 106.15 179.717 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.411 ' O ' ' HG3' ' A' ' 90' ' ' ARG . 10.1 Cg_endo -64.67 86.56 0.17 Allowed 'Trans proline' 0 N--CA 1.493 1.447 0 N-CA-C 108.265 -1.475 . . . . 0.0 108.265 165.99 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.411 ' HG3' ' O ' ' A' ' 89' ' ' PRO . 44.2 mtm180 150.82 -27.04 0.01 OUTLIER 'General case' 0 N--CA 1.513 2.693 0 O-C-N 125.741 1.901 . . . . 0.0 109.753 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.446 ' N ' HD21 ' A' ' 91' ' ' ASN . 0.1 OUTLIER -41.51 116.17 1.5 Allowed Pre-proline 0 N--CA 1.501 2.083 0 N-CA-C 114.177 1.177 . . . . 0.0 114.177 -179.713 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -76.62 77.11 3.76 Favored 'Trans proline' 0 N--CA 1.493 1.474 0 C-N-CA 122.721 2.281 . . . . 0.0 109.565 174.423 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.451 ' CE ' ' SG ' ' A' ' 66' ' ' CYS . 21.4 ptmt -167.9 170.46 10.61 Favored 'General case' 0 N--CA 1.498 1.93 0 CA-C-N 114.759 -1.109 . . . . 0.0 110.685 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -160.19 147.42 16.2 Favored 'General case' 0 N--CA 1.497 1.883 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.322 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 58.2 m -153.54 130.31 5.69 Favored Pre-proline 0 N--CA 1.497 1.879 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.379 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -63.51 -78.37 0.01 OUTLIER 'Trans proline' 0 N--CA 1.493 1.489 0 C-N-CA 122.316 2.01 . . . . 0.0 111.511 171.721 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 60.6 mmt-85 -135.68 -44.89 0.67 Allowed 'General case' 0 N--CA 1.499 2.007 0 O-C-N 123.995 0.809 . . . . 0.0 112.432 -179.829 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 8.8 m120 49.44 58.62 5.21 Favored 'General case' 0 N--CA 1.503 2.197 0 O-C-N 124.313 1.008 . . . . 0.0 108.367 -179.864 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.545 ' HA ' ' HA ' ' A' ' 62' ' ' CYS . 37.1 m -35.77 127.57 0.67 Allowed 'General case' 0 N--CA 1.494 1.735 0 CA-C-N 113.573 -1.649 . . . . 0.0 115.25 -179.523 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -129.35 98.78 22.34 Favored Pre-proline 0 N--CA 1.493 1.708 0 CA-C-N 114.25 -1.341 . . . . 0.0 110.268 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -63.85 -12.0 29.61 Favored 'Trans proline' 0 N--CA 1.494 1.522 0 C-N-CA 122.011 1.807 . . . . 0.0 112.166 -178.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 80.8 mtm180 -80.28 -30.55 38.32 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 112.675 0.621 . . . . 0.0 112.675 -179.847 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.414 HG12 ' N ' ' A' ' 104' ' ' ALA . 11.8 tt -90.88 164.07 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.164 0 C-N-CA 120.036 -0.665 . . . . 0.0 110.097 -179.864 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.585 ' HB2' ' H ' ' A' ' 77' ' ' ASP . . . -124.15 -59.67 1.47 Allowed 'General case' 0 N--CA 1.496 1.848 0 CA-C-N 114.758 -1.11 . . . . 0.0 108.394 179.826 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 21.7 p90 -161.33 161.79 30.64 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-N 114.631 -1.168 . . . . 0.0 111.03 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -94.95 115.24 5.05 Favored Glycine 0 N--CA 1.492 2.389 0 CA-C-N 113.59 -1.641 . . . . 0.0 111.575 -179.847 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 12.4 pt -83.63 102.44 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.27 0 N-CA-C 105.725 -1.954 . . . . 0.0 105.725 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 13.4 m -79.48 133.04 60.35 Favored Pre-proline 0 N--CA 1.49 1.554 0 CA-C-N 113.8 -1.545 . . . . 0.0 110.295 -179.632 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -73.72 88.15 1.07 Allowed 'Trans proline' 0 N--CA 1.492 1.433 0 C-N-CA 122.599 2.199 . . . . 0.0 110.46 -177.127 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 84.7 mt -79.75 -42.39 24.65 Favored 'General case' 0 N--CA 1.498 1.949 0 CA-C-N 115.261 -0.881 . . . . 0.0 108.867 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.833 0 CA-C-O 116.773 -1.584 . . . . 0.0 110.66 179.972 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 93.6 mtt-85 . . . . . 0 N--CA 1.496 1.841 0 N-CA-C 110.213 -0.292 . . . . 0.0 110.213 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 7.9 tp -83.79 52.92 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 CA-C-N 115.052 -0.976 . . . . 0.0 109.636 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.514 ' HA ' ' HA ' ' A' ' 41' ' ' CYS . 1.5 m -82.72 51.75 1.96 Allowed 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 117.061 2.245 . . . . 0.0 117.061 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 7.2 p -91.75 164.63 13.64 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-N 113.169 -1.832 . . . . 0.0 109.035 179.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.464 ' ND2' ' H ' ' A' ' 9' ' ' ALA . 37.7 p-10 -160.88 148.13 15.47 Favored 'General case' 0 N--CA 1.499 1.985 0 C-N-CA 119.917 -0.713 . . . . 0.0 110.058 179.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 18.4 t -67.11 -20.24 65.75 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-N 114.864 -1.062 . . . . 0.0 112.892 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 43.7 t -81.34 -64.46 1.18 Allowed 'General case' 0 N--CA 1.497 1.878 0 O-C-N 123.607 0.567 . . . . 0.0 112.128 -179.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.464 ' H ' ' ND2' ' A' ' 6' ' ' ASN . . . -89.22 45.12 1.26 Allowed 'General case' 0 N--CA 1.5 2.044 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.896 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -84.17 -147.13 7.93 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 110.337 -1.105 . . . . 0.0 110.337 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 40.4 p -137.62 95.29 3.03 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.11 112.98 0.81 Allowed 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 144.97 -34.58 1.55 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 108.301 -1.92 . . . . 0.0 108.301 -179.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 35.4 m -106.09 130.29 54.02 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -83.11 91.61 7.25 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 113.627 -1.624 . . . . 0.0 110.132 -179.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.409 ' N ' ' O ' ' A' ' 25' ' ' CYS . 39.8 m-85 -50.09 122.1 6.32 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-N 114.028 -1.442 . . . . 0.0 109.081 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -132.44 153.32 50.97 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-N 112.316 -2.22 . . . . 0.0 110.643 -179.67 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 31.2 t -99.15 141.18 32.25 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-N 111.679 -2.509 . . . . 0.0 115.628 -179.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -52.17 -25.05 8.1 Favored 'General case' 0 N--CA 1.499 1.983 0 CA-C-N 111.002 -2.817 . . . . 0.0 113.269 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 52.5 p-10 -62.59 -4.79 2.16 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 124.092 0.87 . . . . 0.0 111.609 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 88.92 30.15 15.72 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 108.781 -1.728 . . . . 0.0 108.781 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 87.0 m -141.66 146.87 36.65 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 124.087 0.522 . . . . 0.0 110.585 -179.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 39.9 t80 -73.02 162.81 29.05 Favored 'General case' 0 N--CA 1.496 1.827 0 CA-C-N 114.35 -1.296 . . . . 0.0 110.04 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 58.7 t -127.56 -79.44 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 CA-C-N 115.282 -0.872 . . . . 0.0 108.991 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.57 ' SG ' ' N ' ' A' ' 26' ' ' GLU . 0.1 OUTLIER -156.99 -170.47 3.3 Favored 'General case' 0 N--CA 1.504 2.258 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 179.971 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.57 ' N ' ' SG ' ' A' ' 25' ' ' CYS . 37.6 tt0 -118.64 154.29 32.91 Favored 'General case' 0 N--CA 1.503 2.214 0 N-CA-C 106.079 -1.823 . . . . 0.0 106.079 179.444 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -50.15 116.9 4.38 Favored Glycine 0 N--CA 1.498 2.791 0 C-N-CA 120.088 -1.053 . . . . 0.0 112.721 -179.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -79.66 -17.2 54.24 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 41.1 t -112.38 112.96 24.9 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.646 ' H ' HD21 ' A' ' 33' ' ' ASN . 16.0 t0 -79.38 138.55 55.56 Favored Pre-proline 0 N--CA 1.494 1.735 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_endo -65.48 75.22 0.27 Allowed 'Trans proline' 0 N--CA 1.498 1.746 0 C-N-CA 122.705 2.27 . . . . 0.0 106.577 161.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 43.1 ttp85 -173.0 -53.43 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 104.982 -2.229 . . . . 0.0 104.982 -179.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.646 HD21 ' H ' ' A' ' 30' ' ' ASP . 25.9 p30 -90.7 156.44 44.95 Favored Pre-proline 0 N--CA 1.494 1.759 0 CA-C-N 114.638 -1.165 . . . . 0.0 110.978 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -71.54 177.16 7.11 Favored 'Trans proline' 0 N--CA 1.493 1.469 0 C-N-CA 122.643 2.229 . . . . 0.0 110.311 168.004 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.439 ' HD2' ' N ' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -161.41 153.07 19.15 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.247 179.983 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -148.12 62.37 1.11 Allowed 'General case' 0 N--CA 1.495 1.819 0 CA-C-N 115.067 -0.969 . . . . 0.0 109.127 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 72.4 m -79.57 -50.48 10.64 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-N 114.388 -1.278 . . . . 0.0 109.358 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 26.3 m 64.31 -9.12 0.17 Allowed 'General case' 0 N--CA 1.503 2.176 0 O-C-N 124.781 1.301 . . . . 0.0 113.448 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.441 ' HG ' ' H ' ' A' ' 40' ' ' ASN . 2.1 pp -79.56 -55.59 4.92 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 120.251 -0.58 . . . . 0.0 109.559 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.441 ' H ' ' HG ' ' A' ' 39' ' ' LEU . 33.6 m120 47.42 -177.77 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 115.927 1.825 . . . . 0.0 115.927 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.514 ' HA ' ' HA ' ' A' ' 4' ' ' CYS . 58.1 m 48.63 119.36 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 116.667 2.099 . . . . 0.0 116.667 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 60.1 t0 -152.16 94.97 3.21 Favored Pre-proline 0 N--CA 1.489 1.517 0 CA-C-N 113.789 -1.55 . . . . 0.0 108.46 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -53.63 -17.86 10.69 Favored 'Trans proline' 0 N--CA 1.495 1.591 0 C-N-CA 122.896 2.398 . . . . 0.0 113.046 178.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 10.9 tpt180 -59.06 -50.82 72.61 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.44 ' CG2' ' N ' ' A' ' 46' ' ' ALA . 2.0 mp -62.89 159.2 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 CA-C-O 122.623 1.201 . . . . 0.0 112.264 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.44 ' N ' ' CG2' ' A' ' 45' ' ' ILE . . . -127.29 -48.63 1.44 Allowed 'General case' 0 N--CA 1.492 1.641 0 CA-C-N 111.33 -2.668 . . . . 0.0 106.267 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 51.8 p90 -166.23 -163.42 0.6 Allowed 'General case' 0 N--CA 1.495 1.817 0 CA-C-N 113.637 -1.619 . . . . 0.0 107.373 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -145.83 113.15 0.67 Allowed Glycine 0 N--CA 1.495 2.567 0 N-CA-C 108.621 -1.791 . . . . 0.0 108.621 179.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.7 p -79.77 105.91 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 N-CA-C 114.284 1.216 . . . . 0.0 114.284 -179.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.7 m -81.81 117.45 68.35 Favored Pre-proline 0 N--CA 1.5 2.068 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 179.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo . . . . . 0 N--CA 1.494 1.531 0 C-N-CA 122.05 1.833 . . . . 0.0 110.623 178.383 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.501 ' HA ' ' HA ' ' A' ' 99' ' ' CYS . 1.6 m . . . . . 0 N--CA 1.495 1.816 0 N-CA-C 115.916 1.821 . . . . 0.0 115.916 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -91.59 148.0 22.6 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-N 112.272 -2.24 . . . . 0.0 107.353 179.512 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.419 ' HB3' ' H ' ' A' ' 100' ' ' ASP . 15.2 p30 -162.05 147.78 13.2 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 114.469 1.285 . . . . 0.0 114.469 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -63.25 -20.67 65.66 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-N 114.351 -1.295 . . . . 0.0 112.582 179.621 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 41.8 t -90.65 -74.78 0.48 Allowed 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -89.5 35.57 0.82 Allowed 'General case' 0 N--CA 1.497 1.895 0 CA-C-N 114.433 -1.258 . . . . 0.0 113.139 -179.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.415 ' HA3' ' CZ ' ' A' ' 74' ' ' TYR . . . -81.04 -112.34 0.32 Allowed Glycine 0 N--CA 1.494 2.531 0 N-CA-C 109.135 -1.586 . . . . 0.0 109.135 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.54 ' H ' ' HA3' ' A' ' 85' ' ' GLY . 38.2 p -153.7 123.03 6.58 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 179.671 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -70.21 93.87 0.87 Allowed 'General case' 0 N--CA 1.502 2.125 0 CA-C-O 122.089 0.947 . . . . 0.0 109.516 179.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 162.99 -27.21 0.23 Allowed Glycine 0 N--CA 1.487 2.058 0 CA-C-N 113.107 -1.86 . . . . 0.0 109.947 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 36.1 m -108.8 141.65 40.51 Favored 'General case' 0 N--CA 1.497 1.902 0 C-N-CA 120.024 -0.67 . . . . 0.0 110.209 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.471 ' HB3' ' CE1' ' A' ' 81' ' ' PHE . 58.6 mtpt -83.7 89.11 7.09 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 113.726 -1.579 . . . . 0.0 109.683 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.415 ' CZ ' ' HA3' ' A' ' 68' ' ' GLY . 27.7 m-85 -59.56 116.45 4.01 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 106.13 -1.804 . . . . 0.0 106.13 179.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -121.14 146.86 46.32 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 111.483 -2.599 . . . . 0.0 112.516 -179.449 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.416 ' CB ' ' HE ' ' A' ' 102' ' ' ARG . 32.0 t -91.31 144.23 25.81 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-N 112.363 -2.199 . . . . 0.0 116.312 -179.586 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -53.09 -21.16 4.39 Favored 'General case' 0 N--CA 1.497 1.901 0 CA-C-N 110.603 -2.999 . . . . 0.0 113.322 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 18.4 p30 -66.77 -0.15 2.79 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 124.183 0.927 . . . . 0.0 110.773 179.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 83.48 29.83 31.84 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 93.6 m -142.83 142.86 31.91 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 120.394 -0.522 . . . . 0.0 110.939 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.471 ' CE1' ' HB3' ' A' ' 73' ' ' LYS . 9.7 t80 -73.93 143.41 45.72 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-N 114.373 -1.285 . . . . 0.0 109.705 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 67.6 t -104.58 -77.91 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -166.97 172.85 9.83 Favored 'General case' 0 N--CA 1.503 2.219 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 179.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.456 ' HG2' ' N ' ' A' ' 85' ' ' GLY . 22.7 tt0 -79.64 150.22 31.03 Favored 'General case' 0 N--CA 1.501 2.085 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 179.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.54 ' HA3' ' H ' ' A' ' 69' ' ' THR . . . -65.74 127.67 31.27 Favored Glycine 0 N--CA 1.494 2.522 0 N-CA-C 104.251 -3.54 . . . . 0.0 104.251 179.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -93.75 23.42 4.77 Favored 'General case' 0 N--CA 1.497 1.905 0 CA-C-N 118.049 0.924 . . . . 0.0 113.337 -179.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 25.1 t -84.26 98.53 10.03 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-N 114.529 -1.214 . . . . 0.0 108.288 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -79.86 155.37 75.46 Favored Pre-proline 0 N--CA 1.496 1.834 0 N-CA-C 107.529 -1.285 . . . . 0.0 107.529 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo -38.58 108.21 0.07 OUTLIER 'Trans proline' 0 N--CA 1.493 1.483 0 C-N-CA 122.386 2.057 . . . . 0.0 112.147 162.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER 59.06 50.89 7.63 Favored 'General case' 0 N--CA 1.497 1.92 0 CA-C-N 114.676 -1.147 . . . . 0.0 110.876 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.676 ' H ' HD22 ' A' ' 91' ' ' ASN . 0.5 OUTLIER -79.43 119.61 77.56 Favored Pre-proline 0 N--CA 1.497 1.875 0 CA-C-N 113.898 -1.501 . . . . 0.0 111.878 -179.96 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -79.87 79.36 3.37 Favored 'Trans proline' 0 N--CA 1.493 1.474 0 C-N-CA 123.093 2.529 . . . . 0.0 109.986 172.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 14.1 ptmm? -166.06 144.56 5.79 Favored 'General case' 0 N--CA 1.5 2.029 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.721 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -160.12 103.29 1.46 Allowed 'General case' 0 N--CA 1.496 1.854 0 CA-C-N 114.649 -1.16 . . . . 0.0 108.575 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 35.1 m -79.77 168.67 24.51 Favored Pre-proline 0 N--CA 1.498 1.959 0 CA-C-N 115.122 -0.944 . . . . 0.0 109.297 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -57.91 -5.7 2.14 Favored 'Trans proline' 0 N--CA 1.496 1.672 0 C-N-CA 122.292 1.995 . . . . 0.0 112.404 162.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 35.2 mmt180 -79.52 7.26 8.51 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 123.49 0.494 . . . . 0.0 111.828 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -50.03 117.39 2.3 Favored 'General case' 0 N--CA 1.503 2.196 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.501 ' HA ' ' HA ' ' A' ' 62' ' ' CYS . 91.4 m 56.07 65.38 1.46 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 124.538 1.149 . . . . 0.0 108.048 -179.572 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.419 ' H ' ' HB3' ' A' ' 64' ' ' ASN . 18.9 t70 -62.35 109.55 2.45 Favored Pre-proline 0 N--CA 1.498 1.926 0 CA-C-N 114.356 -1.293 . . . . 0.0 112.287 -179.582 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -69.44 -34.75 14.98 Favored 'Trans proline' 0 N--CA 1.493 1.463 0 C-N-CA 122.049 1.833 . . . . 0.0 109.783 -174.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.416 ' HE ' ' CB ' ' A' ' 76' ' ' SER . 0.0 OUTLIER -63.48 -21.37 66.28 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-N 114.447 -1.252 . . . . 0.0 111.659 -179.96 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 4.4 tp -76.49 177.7 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 C-N-CA 119.218 -0.993 . . . . 0.0 108.403 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -130.37 -61.32 0.97 Allowed 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 -147.73 -161.61 1.37 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 124.48 1.113 . . . . 0.0 109.042 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -142.35 95.13 0.19 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 106.016 -2.834 . . . . 0.0 106.016 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 42.5 mm -78.72 98.86 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 N-CA-C 113.792 1.034 . . . . 0.0 113.792 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 1.6 m -79.52 153.63 76.19 Favored Pre-proline 0 N--CA 1.501 2.091 0 CA-C-N 114.952 -1.022 . . . . 0.0 108.262 179.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo . . . . . 0 N--CA 1.494 1.502 0 C-N-CA 122.542 2.162 . . . . 0.0 109.942 179.445 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 61.7 ttm-85 . . . . . 0 N--CA 1.494 1.728 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.405 HG22 ' H ' ' A' ' 3' ' ' ILE . 6.0 tp -79.85 71.88 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 CA-C-N 114.399 -1.273 . . . . 0.0 110.038 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.6 m -89.97 57.47 3.82 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 122.849 1.309 . . . . 0.0 114.159 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.446 ' O ' ' N ' ' A' ' 42' ' ' ASP . 1.1 p -90.06 157.05 17.97 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 104.275 -2.491 . . . . 0.0 104.275 179.204 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.424 ' HB3' ' H ' ' A' ' 9' ' ' ALA . 6.7 t-20 -160.77 -177.3 6.06 Favored 'General case' 0 N--CA 1.5 2.036 0 C-N-CA 118.149 -1.42 . . . . 0.0 112.083 -179.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.476 ' SG ' ' CD2' ' A' ' 16' ' ' TYR . 1.8 t -76.78 -32.98 58.04 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-N 113.328 -1.76 . . . . 0.0 107.115 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 34.1 t -82.12 -57.57 3.34 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-N 112.003 -2.362 . . . . 0.0 107.609 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.424 ' H ' ' HB3' ' A' ' 6' ' ' ASN . . . -57.56 -23.43 50.5 Favored 'General case' 0 N--CA 1.497 1.912 0 CA-C-N 114.484 -1.235 . . . . 0.0 110.77 179.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -71.41 -168.09 8.79 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 110.756 -0.938 . . . . 0.0 110.756 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 41.1 p -104.71 103.19 12.78 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.462 ' HA ' ' CA ' ' A' ' 27' ' ' GLY . 39.1 ttpt -48.16 104.97 0.07 Allowed 'General case' 0 N--CA 1.5 2.048 0 O-C-N 123.737 0.648 . . . . 0.0 111.322 179.673 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 149.69 -20.42 1.15 Allowed Glycine 0 N--CA 1.491 2.36 0 CA-C-N 114.364 -1.289 . . . . 0.0 111.033 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 96.2 m -107.41 149.45 27.88 Favored 'General case' 0 N--CA 1.499 2.023 0 C-N-CA 120.316 -0.554 . . . . 0.0 112.069 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -83.13 93.71 7.68 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-N 114.273 -1.33 . . . . 0.0 107.754 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.476 ' CD2' ' SG ' ' A' ' 7' ' ' CYS . 48.6 m-85 -52.76 130.07 31.69 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-N 113.997 -1.456 . . . . 0.0 109.027 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -143.47 155.03 44.25 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-N 113.174 -1.83 . . . . 0.0 112.339 -179.438 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 38.3 t -101.37 136.01 41.92 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-N 112.449 -2.16 . . . . 0.0 112.577 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.473 ' H ' ' HB2' ' A' ' 46' ' ' ALA . 5.6 p-10 -50.04 -25.11 3.08 Favored 'General case' 0 N--CA 1.502 2.129 0 CA-C-N 112.626 -2.079 . . . . 0.0 114.186 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 27.4 p30 -59.69 -7.49 1.58 Allowed 'General case' 0 N--CA 1.498 1.952 0 O-C-N 124.228 0.955 . . . . 0.0 112.288 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 94.25 28.36 10.82 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 88.5 m -141.43 142.79 33.67 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 124.149 0.558 . . . . 0.0 110.144 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.408 ' CG ' ' N ' ' A' ' 24' ' ' VAL . 40.5 t80 -68.79 166.93 16.52 Favored 'General case' 0 N--CA 1.497 1.878 0 CA-C-N 114.194 -1.366 . . . . 0.0 110.82 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.408 ' N ' ' CG ' ' A' ' 23' ' ' PHE . 97.5 t -128.89 -72.31 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 123.996 0.81 . . . . 0.0 111.82 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.462 ' SG ' ' HD2' ' A' ' 16' ' ' TYR . 20.8 p -154.31 -168.6 2.98 Favored 'General case' 0 N--CA 1.503 2.199 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 -179.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 60.5 tt0 -139.66 151.12 45.69 Favored 'General case' 0 N--CA 1.501 2.096 0 CA-C-O 121.446 0.641 . . . . 0.0 111.369 179.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.462 ' CA ' ' HA ' ' A' ' 12' ' ' LYS . . . -7.25 103.71 0.01 OUTLIER Glycine 0 N--CA 1.497 2.716 0 N-CA-C 119.333 2.493 . . . . 0.0 119.333 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -99.48 -52.25 3.54 Favored 'General case' 0 N--CA 1.501 2.112 0 C-N-CA 119.71 -0.796 . . . . 0.0 110.355 179.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.425 ' CA ' ' HB2' ' A' ' 12' ' ' LYS . 6.5 p -149.83 142.18 24.24 Favored 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.419 ' HB2' ' HB3' ' A' ' 12' ' ' LYS . 10.5 t70 -101.88 144.85 29.4 Favored Pre-proline 0 N--CA 1.498 1.943 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_exo -45.12 -25.2 1.69 Allowed 'Trans proline' 0 N--CA 1.498 1.778 0 C-N-CA 122.918 2.412 . . . . 0.0 112.868 170.087 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.437 ' NE ' ' HA ' ' A' ' 32' ' ' ARG . 3.6 tpm_? -62.9 -53.45 54.0 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -85.65 129.41 54.95 Favored Pre-proline 0 N--CA 1.494 1.73 0 CA-C-N 115.133 -0.94 . . . . 0.0 109.221 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -65.38 108.2 1.14 Allowed 'Trans proline' 0 N--CA 1.493 1.5 0 C-N-CA 122.317 2.011 . . . . 0.0 109.471 -179.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.504 ' HD3' ' H ' ' A' ' 36' ' ' ALA . 6.1 tmtt? -154.53 142.12 19.81 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.504 ' H ' ' HD3' ' A' ' 35' ' ' LYS . . . -149.3 111.07 4.54 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-N 113.382 -1.736 . . . . 0.0 107.644 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.461 ' H ' HD21 ' A' ' 40' ' ' ASN . 70.3 m -79.96 -168.73 1.73 Allowed 'General case' 0 N--CA 1.495 1.815 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.104 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 9.2 t -104.94 13.84 30.4 Favored 'General case' 0 N--CA 1.497 1.911 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.351 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -160.38 64.66 0.33 Allowed 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.461 HD21 ' H ' ' A' ' 37' ' ' CYS . 12.0 m120 -88.65 46.15 1.36 Allowed 'General case' 0 N--CA 1.498 1.939 0 CA-C-N 114.292 -1.322 . . . . 0.0 111.172 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 80.4 m -145.16 139.29 27.16 Favored 'General case' 0 N--CA 1.499 2.02 0 CA-C-N 115.014 -0.993 . . . . 0.0 108.547 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.446 ' N ' ' O ' ' A' ' 5' ' ' THR . 34.2 t70 -166.2 88.35 0.87 Allowed Pre-proline 0 N--CA 1.497 1.896 0 O-C-N 123.794 0.684 . . . . 0.0 110.207 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_exo -53.53 -15.29 5.98 Favored 'Trans proline' 0 N--CA 1.495 1.617 0 C-N-CA 122.466 2.111 . . . . 0.0 112.961 173.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 41.5 ttm180 -76.89 -39.06 52.31 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 113.302 0.853 . . . . 0.0 113.302 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 7.6 tt -75.8 142.9 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.175 0 C-N-CA 118.746 -1.181 . . . . 0.0 111.714 -179.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.473 ' HB2' ' H ' ' A' ' 19' ' ' ASP . . . -104.84 -49.84 3.41 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-N 113.638 -1.619 . . . . 0.0 107.737 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 52.1 p90 -163.52 -163.07 0.78 Allowed 'General case' 0 N--CA 1.496 1.868 0 CA-C-N 114.07 -1.423 . . . . 0.0 107.423 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -144.98 122.27 1.7 Allowed Glycine 0 N--CA 1.494 2.549 0 N-CA-C 109.13 -1.588 . . . . 0.0 109.13 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.6 p -88.69 108.75 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 CA-C-O 121.545 0.688 . . . . 0.0 112.799 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.7 m -79.78 137.13 54.46 Favored Pre-proline 0 N--CA 1.499 1.987 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.218 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo . . . . . 0 N--CA 1.494 1.507 0 C-N-CA 122.376 2.051 . . . . 0.0 110.063 177.292 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.696 ' HA ' ' HA ' ' A' ' 99' ' ' CYS . 1.7 m . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 123.916 1.817 . . . . 0.0 115.453 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 61.2 m -91.42 139.86 30.32 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 110.399 -3.091 . . . . 0.0 103.189 179.247 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 38.1 p-10 -160.81 161.32 31.96 Favored 'General case' 0 N--CA 1.497 1.898 0 C-N-CA 119.771 -0.772 . . . . 0.0 112.988 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 1.3 t -55.75 -23.22 28.15 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-N 113.511 -1.677 . . . . 0.0 112.227 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 52.8 t -89.38 -70.46 0.66 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 124.146 0.904 . . . . 0.0 110.502 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.441 ' HB2' ' SG ' ' A' ' 95' ' ' CYS . . . -90.18 62.15 5.38 Favored 'General case' 0 N--CA 1.499 2.007 0 CA-C-O 121.633 0.73 . . . . 0.0 109.497 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -113.19 -137.59 6.85 Favored Glycine 0 N--CA 1.493 2.481 0 CA-C-N 114.396 -1.274 . . . . 0.0 111.478 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.436 ' N ' ' HA3' ' A' ' 85' ' ' GLY . 37.7 p -128.44 117.61 21.67 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-N 114.494 -0.853 . . . . 0.0 109.464 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 61.5 mtpt -69.65 86.91 0.48 Allowed 'General case' 0 N--CA 1.498 1.967 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.018 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 164.75 -31.02 0.24 Allowed Glycine 0 N--CA 1.489 2.196 0 CA-C-N 114.095 -1.412 . . . . 0.0 110.613 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 74.6 m -105.12 131.71 52.27 Favored 'General case' 0 N--CA 1.5 2.034 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.8 mppt? -83.98 87.48 7.12 Favored 'General case' 0 N--CA 1.484 1.254 0 O-C-N 124.808 1.318 . . . . 0.0 110.398 -179.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 8.9 m-30 -51.84 129.43 26.59 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -133.03 157.26 45.67 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-N 113.433 -1.712 . . . . 0.0 111.79 -179.34 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 44.3 t -102.36 136.58 41.94 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-N 113.157 -1.838 . . . . 0.0 112.867 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 8.6 p30 -53.11 -23.57 8.29 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 115.538 1.681 . . . . 0.0 115.538 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 18.7 p-10 -62.61 -7.45 4.76 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 123.704 0.628 . . . . 0.0 111.024 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 94.49 29.96 9.0 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 108.507 -1.837 . . . . 0.0 108.507 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 46.1 m -133.97 135.93 43.81 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 124.162 0.566 . . . . 0.0 110.204 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.484 ' CZ ' ' HA ' ' A' ' 83' ' ' CYS . 8.0 t80 -76.02 141.63 42.07 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-N 114.703 -1.135 . . . . 0.0 108.776 179.787 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 45.5 t -97.29 -78.38 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . 0.484 ' HA ' ' CZ ' ' A' ' 81' ' ' PHE . 0.1 OUTLIER -178.5 171.67 1.54 Allowed 'General case' 0 N--CA 1.505 2.308 0 O-C-N 123.51 0.507 . . . . 0.0 110.005 179.705 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.408 ' O ' ' SG ' ' A' ' 83' ' ' CYS . 39.9 tt0 -86.07 150.93 24.1 Favored 'General case' 0 N--CA 1.503 2.203 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 179.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.436 ' HA3' ' N ' ' A' ' 69' ' ' THR . . . -53.25 133.58 41.97 Favored Glycine 0 N--CA 1.5 2.945 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -99.81 29.18 4.28 Favored 'General case' 0 N--CA 1.502 2.15 0 CA-C-O 121.892 0.853 . . . . 0.0 109.445 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 44.9 t -146.38 131.73 18.57 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 107.532 -1.285 . . . . 0.0 107.532 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.547 ' H ' HD21 ' A' ' 91' ' ' ASN . 2.4 t70 -79.38 136.16 56.72 Favored Pre-proline 0 N--CA 1.493 1.71 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_endo -67.95 70.93 0.82 Allowed 'Trans proline' 0 N--CA 1.5 1.872 0 C-N-CA 123.688 2.925 . . . . 0.0 113.554 -176.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 82.8 mtt85 -162.88 -51.7 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 103.74 -2.689 . . . . 0.0 103.74 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.547 HD21 ' H ' ' A' ' 88' ' ' ASP . 1.5 p-10 -91.09 116.0 65.51 Favored Pre-proline 0 N--CA 1.493 1.719 0 CA-C-N 113.275 -1.784 . . . . 0.0 110.748 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -78.17 93.76 1.09 Allowed 'Trans proline' 0 N--CA 1.492 1.398 0 C-N-CA 122.694 2.262 . . . . 0.0 110.041 173.366 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 44.7 mmtm -70.67 127.48 32.82 Favored 'General case' 0 N--CA 1.497 1.909 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.707 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -85.33 79.37 9.52 Favored 'General case' 0 N--CA 1.495 1.788 0 CA-C-N 114.666 -1.152 . . . . 0.0 108.941 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . 0.441 ' SG ' ' HB2' ' A' ' 67' ' ' ALA . 88.5 m -79.66 146.83 65.89 Favored Pre-proline 0 N--CA 1.494 1.764 0 CA-C-N 114.504 -1.225 . . . . 0.0 111.364 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -73.9 -4.35 15.28 Favored 'Trans proline' 0 N--CA 1.493 1.451 0 C-N-CA 122.891 2.394 . . . . 0.0 110.586 165.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 23.0 tpp180 -79.1 -54.78 5.65 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 38.9 m-80 52.24 -161.14 0.1 Allowed 'General case' 0 N--CA 1.501 2.118 0 O-C-N 124.401 1.063 . . . . 0.0 111.549 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.696 ' HA ' ' HA ' ' A' ' 62' ' ' CYS . 5.2 m -36.67 110.06 0.11 Allowed 'General case' 0 N--CA 1.5 2.045 0 N-CA-C 113.909 1.078 . . . . 0.0 113.909 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 20.5 t0 -91.22 111.85 50.87 Favored Pre-proline 0 N--CA 1.494 1.727 0 CA-C-N 113.843 -1.526 . . . . 0.0 110.564 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -64.7 -21.92 64.66 Favored 'Trans proline' 0 N--CA 1.494 1.522 0 C-N-CA 121.848 1.699 . . . . 0.0 110.312 -179.274 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 27.6 ttm-85 -82.27 -23.51 35.24 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 113.952 1.093 . . . . 0.0 113.952 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 12.2 tt -70.19 142.38 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 C-N-CA 117.835 -1.546 . . . . 0.0 110.21 -179.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -131.78 -43.77 0.99 Allowed 'General case' 0 N--CA 1.494 1.734 0 CA-C-N 114.486 -1.234 . . . . 0.0 109.748 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 49.8 m-85 -141.23 -164.12 1.69 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 124.398 1.061 . . . . 0.0 109.387 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -153.87 108.69 0.38 Allowed Glycine 0 N--CA 1.492 2.408 0 N-CA-C 106.582 -2.607 . . . . 0.0 106.582 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 50.4 mm -80.6 84.11 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 27.0 m -80.99 149.44 66.76 Favored Pre-proline 0 N--CA 1.494 1.755 0 CA-C-N 114.101 -1.408 . . . . 0.0 108.848 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo . . . . . 0 N--CA 1.495 1.594 0 C-N-CA 122.71 2.273 . . . . 0.0 110.859 175.09 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 2.7 tmt_? . . . . . 0 N--CA 1.504 2.274 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.6 tp -55.44 137.02 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 123.626 0.579 . . . . 0.0 112.123 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.472 ' HA ' ' HA ' ' A' ' 41' ' ' CYS . 1.5 m -140.61 57.88 1.57 Allowed 'General case' 0 C--N 1.31 -1.128 0 CA-C-O 122.797 1.284 . . . . 0.0 114.444 179.615 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 7.1 t -90.73 161.1 15.49 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-N 113.322 -1.763 . . . . 0.0 106.746 179.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 10.5 p-10 -161.1 151.84 18.24 Favored 'General case' 0 N--CA 1.499 2.02 0 C-N-CA 120.118 -0.633 . . . . 0.0 111.693 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.45 ' HA ' ' CE2' ' A' ' 16' ' ' TYR . 19.6 t -57.68 -38.03 74.46 Favored 'General case' 0 N--CA 1.497 1.914 0 CA-C-N 114.639 -1.164 . . . . 0.0 113.303 -179.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 46.4 t -61.99 -51.59 67.41 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 125.336 1.647 . . . . 0.0 110.721 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -51.6 -26.08 8.14 Favored 'General case' 0 N--CA 1.503 2.224 0 O-C-N 124.945 1.403 . . . . 0.0 110.376 179.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.407 ' HA3' ' N ' ' A' ' 29' ' ' SER . . . 63.23 161.06 0.28 Allowed Glycine 0 N--CA 1.479 1.558 0 CA-C-N 114.618 -1.174 . . . . 0.0 115.891 179.529 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.456 ' H ' ' HA3' ' A' ' 27' ' ' GLY . 99.5 m -153.11 53.87 0.76 Allowed 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 104.576 -2.379 . . . . 0.0 104.576 179.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 63.4 pttt 41.67 -146.11 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.065 0 CA-C-N 114.203 -1.362 . . . . 0.0 112.409 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -70.23 26.69 0.44 Allowed Glycine 0 N--CA 1.494 2.501 0 CA-C-N 114.886 -1.052 . . . . 0.0 114.252 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 88.4 m -105.42 120.99 42.98 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 107.097 -1.445 . . . . 0.0 107.097 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.425 ' HA ' ' HA ' ' A' ' 26' ' ' GLU . 63.0 mtpt -64.92 100.34 0.41 Allowed 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 113.027 -1.897 . . . . 0.0 113.962 -179.666 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.45 ' CE2' ' HA ' ' A' ' 7' ' ' CYS . 8.8 m-85 -48.3 128.59 14.59 Favored 'General case' 0 N--CA 1.505 2.316 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 179.48 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -144.3 153.03 41.59 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 115.079 -0.964 . . . . 0.0 113.047 -179.349 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 34.2 t -99.08 134.78 41.43 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-N 112.599 -2.091 . . . . 0.0 112.659 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -50.14 -24.87 3.03 Favored 'General case' 0 N--CA 1.502 2.168 0 CA-C-N 112.713 -2.039 . . . . 0.0 114.009 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 29.7 p30 -59.81 -8.01 1.93 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 124.144 0.902 . . . . 0.0 112.276 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 95.08 29.2 9.2 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 86.9 m -141.91 143.23 33.18 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 124.078 0.517 . . . . 0.0 111.233 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 20.0 t80 -68.96 161.28 29.21 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-N 114.042 -1.435 . . . . 0.0 110.318 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 88.2 t -126.71 -71.29 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 CA-C-N 114.995 -1.002 . . . . 0.0 109.443 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.589 ' SG ' ' N ' ' A' ' 26' ' ' GLU . 0.3 OUTLIER -151.57 -166.67 2.58 Favored 'General case' 0 N--CA 1.5 2.049 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 179.998 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.589 ' N ' ' SG ' ' A' ' 25' ' ' CYS . 2.1 tm-20 -121.07 147.4 45.57 Favored 'General case' 0 N--CA 1.501 2.116 0 N-CA-C 106.374 -1.713 . . . . 0.0 106.374 179.565 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.456 ' HA3' ' H ' ' A' ' 11' ' ' THR . . . -55.1 109.8 1.46 Allowed Glycine 0 N--CA 1.501 2.972 0 N-CA-C 110.358 -1.097 . . . . 0.0 110.358 179.822 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 -86.31 12.29 10.33 Favored 'General case' 0 N--CA 1.501 2.12 0 N-CA-C 113.613 0.968 . . . . 0.0 113.613 -179.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.407 ' N ' ' HA3' ' A' ' 10' ' ' GLY . 20.9 t -169.62 -174.53 1.91 Allowed 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -79.23 143.38 60.5 Favored Pre-proline 0 N--CA 1.496 1.845 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo -52.34 -32.36 51.2 Favored 'Trans proline' 0 N--CA 1.498 1.772 0 C-N-CA 122.38 2.053 . . . . 0.0 112.15 175.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 87.6 mtm180 -113.99 35.24 4.21 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-N 114.74 -1.118 . . . . 0.0 109.232 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 24.2 p-10 -65.96 127.05 92.88 Favored Pre-proline 0 N--CA 1.497 1.881 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.98 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_endo -76.51 81.53 2.48 Favored 'Trans proline' 0 N--CA 1.49 1.289 0 C-N-CA 122.492 2.128 . . . . 0.0 107.973 167.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 23.6 tptm -150.85 153.43 35.35 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-N 114.851 -1.068 . . . . 0.0 110.124 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -99.52 155.6 17.48 Favored 'General case' 0 N--CA 1.496 1.826 0 CA-C-N 114.066 -1.424 . . . . 0.0 110.221 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 84.8 m -147.44 177.26 9.38 Favored 'General case' 0 N--CA 1.497 1.879 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.643 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 64.5 p -132.98 -18.28 2.35 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-N 113.893 -1.503 . . . . 0.0 108.976 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.3 tt -89.63 24.6 2.26 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 24.2 m120 -56.83 152.88 11.77 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-N 115.308 -0.86 . . . . 0.0 112.744 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.472 ' HA ' ' HA ' ' A' ' 4' ' ' CYS . 68.0 m 59.68 124.4 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.753 0 CA-C-N 113.467 -1.697 . . . . 0.0 114.318 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -152.33 84.04 4.87 Favored Pre-proline 0 N--CA 1.494 1.728 0 CA-C-N 114.389 -1.278 . . . . 0.0 109.338 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -57.67 -20.11 40.88 Favored 'Trans proline' 0 N--CA 1.493 1.464 0 C-N-CA 122.769 2.313 . . . . 0.0 112.86 178.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 74.5 mtp180 -62.31 -42.29 99.24 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 26.4 mt -68.21 157.77 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 CA-C-O 122.414 1.102 . . . . 0.0 110.691 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -125.37 -51.14 1.64 Allowed 'General case' 0 N--CA 1.491 1.614 0 CA-C-N 111.719 -2.491 . . . . 0.0 107.786 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 13.1 p90 -171.14 160.98 6.58 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-N 114.172 -1.376 . . . . 0.0 111.237 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -96.87 121.39 7.02 Favored Glycine 0 N--CA 1.493 2.456 0 CA-C-N 113.651 -1.613 . . . . 0.0 109.248 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 29.4 m -94.71 103.96 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.7 m -79.88 115.26 52.73 Favored Pre-proline 0 N--CA 1.5 2.045 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 179.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo . . . . . 0 N--CA 1.496 1.657 0 C-N-CA 122.458 2.105 . . . . 0.0 112.457 -171.8 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 1.7 m . . . . . 0 N--CA 1.49 1.528 0 CA-C-O 122.413 1.102 . . . . 0.0 113.337 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 33.9 m -90.22 168.3 12.03 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 113.666 -1.606 . . . . 0.0 109.154 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 24.3 p30 -142.94 176.06 9.36 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 124.416 1.073 . . . . 0.0 109.297 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 47.0 t -92.79 -31.69 14.94 Favored 'General case' 0 N--CA 1.499 2.021 0 N-CA-C 114.469 1.285 . . . . 0.0 114.469 -179.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 42.7 t -63.56 -58.37 7.18 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 123.934 0.771 . . . . 0.0 110.352 -179.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -89.83 36.31 0.85 Allowed 'General case' 0 N--CA 1.495 1.803 0 CA-C-N 114.294 -1.321 . . . . 0.0 110.227 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -76.67 -115.78 0.14 Allowed Glycine 0 N--CA 1.493 2.478 0 N-CA-C 109.317 -1.513 . . . . 0.0 109.317 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 95.6 m -156.27 96.63 1.7 Allowed 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -52.16 104.2 0.08 Allowed 'General case' 0 N--CA 1.501 2.12 0 C-N-CA 120.034 -0.666 . . . . 0.0 111.345 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 146.91 -31.0 1.48 Allowed Glycine 0 N--CA 1.495 2.629 0 CA-C-N 114.835 -1.075 . . . . 0.0 112.625 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 88.2 m -95.26 174.8 6.87 Favored 'General case' 0 N--CA 1.502 2.169 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -121.9 87.35 2.74 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 106.452 -1.684 . . . . 0.0 106.452 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 61.0 m-85 -48.58 140.93 7.55 Favored 'General case' 0 N--CA 1.499 1.984 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.013 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.582 ' CE2' ' HA ' ' A' ' 80' ' ' THR . 4.8 t80 -137.1 164.43 28.45 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 125.207 1.567 . . . . 0.0 114.543 -179.222 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 12.0 t -124.13 130.76 53.09 Favored 'General case' 0 N--CA 1.505 2.275 0 CA-C-N 113.153 -1.839 . . . . 0.0 112.529 -179.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -54.98 -49.61 71.04 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-N 113.405 -1.725 . . . . 0.0 111.025 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 13.5 p-10 -108.1 28.58 8.13 Favored 'General case' 0 N--CA 1.488 1.472 0 CA-C-N 113.123 -1.853 . . . . 0.0 111.22 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -160.79 18.09 0.2 Allowed Glycine 0 N--CA 1.494 2.554 0 C-N-CA 119.356 -1.402 . . . . 0.0 112.341 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.582 ' HA ' ' CE2' ' A' ' 75' ' ' PHE . 6.4 t 42.03 -160.23 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.793 0 O-C-N 124.924 1.014 . . . . 0.0 113.1 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 47.1 t80 -42.37 121.11 1.83 Allowed 'General case' 0 N--CA 1.499 1.978 0 CA-C-O 121.459 0.647 . . . . 0.0 111.681 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 61.5 t -92.18 -68.2 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 CA-C-N 113.835 -1.529 . . . . 0.0 111.731 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 1.8 p -158.28 -177.28 6.43 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 123.924 0.765 . . . . 0.0 109.597 -179.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -102.46 151.97 21.68 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 104.54 -2.393 . . . . 0.0 104.54 179.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -64.55 128.04 34.98 Favored Glycine 0 N--CA 1.493 2.494 0 N-CA-C 108.638 -1.785 . . . . 0.0 108.638 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 40.7 mm-40 -113.67 11.97 18.29 Favored 'General case' 0 N--CA 1.498 1.929 0 C-N-CA 120.359 -0.536 . . . . 0.0 110.728 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 38.6 t -79.0 87.76 4.79 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -98.36 137.93 20.78 Favored Pre-proline 0 N--CA 1.493 1.688 0 CA-C-N 112.938 -1.937 . . . . 0.0 108.138 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -65.23 -40.47 19.39 Favored 'Trans proline' 0 N--CA 1.493 1.5 0 C-N-CA 122.12 1.88 . . . . 0.0 111.52 -179.074 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 72.5 ttt-85 -81.37 4.27 21.38 Favored 'General case' 0 N--CA 1.498 1.955 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.961 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.504 HD22 ' N ' ' A' ' 91' ' ' ASN . 0.0 OUTLIER -44.75 112.37 1.46 Allowed Pre-proline 0 N--CA 1.502 2.17 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -179.889 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -81.94 43.92 1.61 Allowed 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 123.112 2.541 . . . . 0.0 111.191 178.039 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 24.6 ttmm -164.29 153.44 13.57 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.173 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -94.46 129.04 41.38 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-N 114.095 -1.411 . . . . 0.0 108.186 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 83.1 m -79.82 148.18 68.17 Favored Pre-proline 0 N--CA 1.495 1.825 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -71.99 144.12 42.11 Favored 'Trans proline' 0 N--CA 1.489 1.245 0 C-N-CA 122.791 2.327 . . . . 0.0 109.258 163.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 21.1 tpp180 -100.16 31.88 3.19 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 27.9 m-20 -58.4 163.62 2.97 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 114.6 1.333 . . . . 0.0 114.6 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 66.9 m -100.61 133.95 44.29 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-N 113.358 -1.746 . . . . 0.0 110.868 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 60.5 t0 -117.4 84.39 18.16 Favored Pre-proline 0 N--CA 1.497 1.879 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 179.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_endo -57.29 -36.21 98.95 Favored 'Trans proline' 0 N--CA 1.496 1.657 0 C-N-CA 122.702 2.268 . . . . 0.0 111.283 -174.433 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 20.9 mmt180 -62.47 -39.63 94.03 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 124.284 0.99 . . . . 0.0 111.848 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 3.1 tt -53.45 155.16 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 O-C-N 123.905 0.753 . . . . 0.0 110.051 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -149.18 -42.24 0.14 Allowed 'General case' 0 N--CA 1.491 1.618 0 CA-C-N 115.364 -0.834 . . . . 0.0 111.458 -179.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 -138.45 -164.35 1.62 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 124.341 1.026 . . . . 0.0 110.599 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -153.23 103.99 0.25 Allowed Glycine 0 N--CA 1.487 2.08 0 N-CA-C 106.063 -2.815 . . . . 0.0 106.063 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 90.3 mt -78.91 88.18 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 57.9 m -81.9 149.53 63.52 Favored Pre-proline 0 N--CA 1.493 1.696 0 CA-C-N 113.944 -1.48 . . . . 0.0 109.006 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.495 1.565 0 C-N-CA 122.618 2.212 . . . . 0.0 111.056 179.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.747 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 7.2 tp -61.48 133.48 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 CA-C-N 114.49 -1.232 . . . . 0.0 109.145 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.428 ' HA ' ' HA ' ' A' ' 41' ' ' CYS . 1.7 m -140.38 45.71 1.83 Allowed 'General case' 0 N--CA 1.483 1.19 0 CA-C-O 122.583 1.182 . . . . 0.0 112.683 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 22.7 p -90.35 178.16 6.21 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-N 113.053 -1.885 . . . . 0.0 110.311 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 36.3 p-10 -155.85 -169.57 3.13 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-N 113.958 -1.474 . . . . 0.0 108.77 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.44 ' SG ' ' CD2' ' A' ' 16' ' ' TYR . 2.3 t -81.25 -27.36 35.23 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -179.796 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 23.3 t -80.32 -59.55 2.66 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-N 114.483 -1.235 . . . . 0.0 110.988 -179.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -90.41 64.79 6.01 Favored 'General case' 0 N--CA 1.5 2.036 0 CA-C-O 121.89 0.852 . . . . 0.0 110.074 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.47 ' H ' ' HB2' ' A' ' 29' ' ' SER . . . -135.89 -115.76 1.5 Allowed Glycine 0 N--CA 1.498 2.824 0 CA-C-N 113.97 -1.468 . . . . 0.0 110.264 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 91.1 m -139.73 111.23 7.16 Favored 'General case' 0 N--CA 1.502 2.146 0 CA-C-O 120.788 0.328 . . . . 0.0 111.264 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.574 ' NZ ' HH21 ' A' ' 32' ' ' ARG . 39.4 ttpt -58.59 146.52 35.59 Favored 'General case' 0 N--CA 1.497 1.883 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.803 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 79.75 -16.49 11.19 Favored Glycine 0 N--CA 1.492 2.418 0 CA-C-N 114.542 -1.208 . . . . 0.0 112.858 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 90.2 m -93.77 129.8 39.99 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.43 ' HD2' ' N ' ' A' ' 15' ' ' LYS . 0.9 OUTLIER -77.6 94.11 4.31 Favored 'General case' 0 N--CA 1.486 1.343 0 CA-C-N 114.435 -1.257 . . . . 0.0 110.19 -179.365 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.703 ' CD2' ' SG ' ' A' ' 25' ' ' CYS . 95.4 m-85 -46.17 137.14 6.33 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 124.925 1.391 . . . . 0.0 109.074 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -147.74 152.73 38.25 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 125.085 1.491 . . . . 0.0 111.876 -179.438 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 28.9 t -107.8 136.44 47.52 Favored 'General case' 0 N--CA 1.497 1.901 0 CA-C-N 111.748 -2.478 . . . . 0.0 113.778 -179.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -52.12 -24.79 7.49 Favored 'General case' 0 N--CA 1.5 2.072 0 CA-C-N 112.645 -2.07 . . . . 0.0 115.157 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -57.27 -17.49 12.14 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 123.849 0.718 . . . . 0.0 110.966 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 105.03 29.63 5.12 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 108.537 -1.825 . . . . 0.0 108.537 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 58.2 m -138.28 154.56 49.03 Favored 'General case' 0 N--CA 1.493 1.702 0 CA-C-O 121.374 0.607 . . . . 0.0 111.03 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 57.7 t80 -73.98 166.76 22.81 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-N 113.663 -1.608 . . . . 0.0 109.615 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 90.3 t -129.06 -68.3 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 123.909 0.756 . . . . 0.0 110.889 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.703 ' SG ' ' CD2' ' A' ' 16' ' ' TYR . 22.8 p -162.32 -171.4 2.79 Favored 'General case' 0 N--CA 1.504 2.255 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -111.95 145.11 40.17 Favored 'General case' 0 N--CA 1.506 2.331 0 CA-C-O 120.74 0.305 . . . . 0.0 111.535 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.56 ' HA2' ' CE2' ' A' ' 16' ' ' TYR . . . -39.98 107.13 0.07 OUTLIER Glycine 0 N--CA 1.496 2.682 0 O-C-N 124.545 1.153 . . . . 0.0 114.613 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -124.73 43.75 2.94 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 105.943 -1.873 . . . . 0.0 105.943 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.47 ' HB2' ' H ' ' A' ' 10' ' ' GLY . 10.4 t -125.66 81.16 1.96 Allowed 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 -179.634 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -88.11 120.36 70.62 Favored Pre-proline 0 N--CA 1.495 1.801 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 179.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -66.73 -29.21 43.08 Favored 'Trans proline' 0 N--CA 1.494 1.538 0 C-N-CA 121.983 1.788 . . . . 0.0 110.773 177.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.574 HH21 ' NZ ' ' A' ' 12' ' ' LYS . 84.9 mtm180 -78.87 3.28 17.36 Favored 'General case' 0 N--CA 1.498 1.95 0 CA-C-N 114.946 -1.025 . . . . 0.0 112.107 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.496 HD22 ' H ' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -60.21 130.63 89.51 Favored Pre-proline 0 N--CA 1.495 1.798 0 O-C-N 123.339 0.399 . . . . 0.0 111.918 -179.86 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -82.28 46.13 2.12 Favored 'Trans proline' 0 N--CA 1.493 1.49 0 C-N-CA 123.026 2.484 . . . . 0.0 108.642 162.157 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -137.55 -177.0 4.6 Favored 'General case' 0 N--CA 1.497 1.9 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.49 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -143.92 118.13 9.55 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-N 114.867 -1.061 . . . . 0.0 108.423 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 75.4 m -79.76 168.72 18.94 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 8.6 t -85.21 166.47 16.52 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-N 113.856 -1.52 . . . . 0.0 109.558 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.54 HD13 ' H ' ' A' ' 39' ' ' LEU . 0.0 OUTLIER -104.18 19.46 20.11 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-N 114.849 -1.069 . . . . 0.0 111.902 -179.895 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -55.12 135.57 49.13 Favored 'General case' 0 N--CA 1.498 1.951 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.128 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.428 ' HA ' ' HA ' ' A' ' 4' ' ' CYS . 58.2 m -90.32 131.3 36.19 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-N 114.796 -1.093 . . . . 0.0 110.874 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -127.35 78.02 75.04 Favored Pre-proline 0 N--CA 1.498 1.947 0 O-C-N 124.103 0.877 . . . . 0.0 109.514 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -63.77 -27.12 67.95 Favored 'Trans proline' 0 N--CA 1.494 1.524 0 C-N-CA 122.855 2.37 . . . . 0.0 113.515 -170.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 8.4 ptp180 -56.24 -33.19 65.18 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 123.956 0.785 . . . . 0.0 111.205 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 15.1 tt -50.41 150.91 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 CA-C-N 114.696 -1.138 . . . . 0.0 113.102 -179.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -133.21 -51.43 0.88 Allowed 'General case' 0 N--CA 1.492 1.652 0 CA-C-N 113.492 -1.685 . . . . 0.0 106.903 179.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 51.5 p90 -170.41 177.26 4.13 Favored 'General case' 0 N--CA 1.494 1.748 0 CA-C-N 113.819 -1.537 . . . . 0.0 108.684 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -124.52 120.55 4.07 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 107.341 -2.303 . . . . 0.0 107.341 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.1 p -79.27 100.65 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 CA-C-O 123.015 1.388 . . . . 0.0 108.778 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 3.8 m -79.58 163.66 57.67 Favored Pre-proline 0 N--CA 1.493 1.705 0 CA-C-N 112.889 -1.96 . . . . 0.0 108.383 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_exo . . . . . 0 N--CA 1.499 1.806 0 C-N-CA 122.705 2.27 . . . . 0.0 111.847 175.169 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.59 ' HA ' ' HA ' ' A' ' 99' ' ' CYS . 1.3 m . . . . . 0 N--CA 1.479 1.016 0 N-CA-C 118.037 2.606 . . . . 0.0 118.037 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.3 p -90.75 160.36 15.85 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-N 113.679 -1.601 . . . . 0.0 106.685 179.121 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.537 HD22 HD22 ' A' ' 98' ' ' ASN . 40.0 t30 -160.58 161.59 32.63 Favored 'General case' 0 N--CA 1.497 1.901 0 CA-C-O 122.399 1.095 . . . . 0.0 112.598 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 7.4 t -58.51 -20.35 45.12 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-N 112.014 -2.357 . . . . 0.0 111.836 179.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 40.7 t -86.27 -71.06 0.56 Allowed 'General case' 0 N--CA 1.494 1.756 0 CA-C-N 114.999 -1.0 . . . . 0.0 111.642 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -54.33 -19.71 5.93 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-N 113.881 -1.509 . . . . 0.0 113.097 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -60.58 159.95 25.05 Favored Glycine 0 N--CA 1.491 2.357 0 O-C-N 123.998 0.811 . . . . 0.0 111.837 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.481 ' C ' ' H ' ' A' ' 71' ' ' GLY . 12.4 t -85.56 139.24 31.61 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-N 113.934 -1.133 . . . . 0.0 108.922 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 23.1 ttmm -80.02 35.03 0.31 Allowed 'General case' 0 N--CA 1.499 2.003 0 CA-C-O 122.543 1.164 . . . . 0.0 110.578 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.481 ' H ' ' C ' ' A' ' 69' ' ' THR . . . -123.64 -8.51 6.28 Favored Glycine 0 N--CA 1.491 2.367 0 N-CA-C 108.542 -1.823 . . . . 0.0 108.542 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . 0.407 ' HA ' ' HA ' ' A' ' 108' ' ' CYS . 78.9 m -137.33 148.12 46.09 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 123.931 0.43 . . . . 0.0 109.915 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.474 ' HB3' ' CE1' ' A' ' 81' ' ' PHE . 27.6 mtpp -101.4 88.59 3.5 Favored 'General case' 0 N--CA 1.485 1.314 0 O-C-N 124.917 1.386 . . . . 0.0 108.203 -179.485 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -49.76 133.99 20.98 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-N 114.175 -1.375 . . . . 0.0 108.688 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.489 ' CE2' ' HA ' ' A' ' 80' ' ' THR . 1.2 t80 -132.72 154.62 50.01 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 113.13 -1.85 . . . . 0.0 114.06 -179.218 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.427 ' N ' HG23 ' A' ' 82' ' ' VAL . 25.8 t -115.84 129.92 56.63 Favored 'General case' 0 N--CA 1.497 1.913 0 CA-C-N 112.145 -2.298 . . . . 0.0 111.746 -179.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.479 ' H ' ' HB2' ' A' ' 104' ' ' ALA . 7.7 p-10 -64.67 -46.74 81.16 Favored 'General case' 0 N--CA 1.497 1.897 0 CA-C-N 114.773 -1.103 . . . . 0.0 108.596 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -92.18 19.71 6.67 Favored 'General case' 0 N--CA 1.485 1.283 0 CA-C-N 112.772 -2.013 . . . . 0.0 110.953 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -165.21 24.53 0.16 Allowed Glycine 0 N--CA 1.497 2.715 0 C-N-CA 118.62 -1.753 . . . . 0.0 113.184 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.489 ' HA ' ' CE2' ' A' ' 75' ' ' PHE . 6.5 t 42.11 -161.55 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.926 0 O-C-N 124.969 1.041 . . . . 0.0 112.887 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.474 ' CE1' ' HB3' ' A' ' 73' ' ' LYS . 11.0 t80 -49.68 121.97 5.84 Favored 'General case' 0 N--CA 1.497 1.882 0 CA-C-O 121.34 0.591 . . . . 0.0 110.879 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.427 HG23 ' N ' ' A' ' 76' ' ' SER . 88.9 t -86.11 -73.34 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . 0.409 ' SG ' ' O ' ' A' ' 84' ' ' GLU . 0.1 OUTLIER -175.49 171.35 2.83 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 124.002 0.813 . . . . 0.0 110.459 179.779 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.462 ' HA ' ' HA ' ' A' ' 73' ' ' LYS . 32.3 tt0 -93.28 146.93 23.34 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 105.718 -1.956 . . . . 0.0 105.718 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -53.03 135.38 39.74 Favored Glycine 0 N--CA 1.501 2.967 0 C-N-CA 119.514 -1.327 . . . . 0.0 114.452 -179.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -100.37 27.91 5.39 Favored 'General case' 0 N--CA 1.505 2.301 0 CA-C-O 121.595 0.712 . . . . 0.0 110.032 179.744 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 22.2 t -160.93 -176.57 5.58 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.438 ' N ' HD21 ' A' ' 91' ' ' ASN . 7.5 t70 -144.61 140.01 16.09 Favored Pre-proline 0 N--CA 1.488 1.438 0 N-CA-C 105.343 -2.095 . . . . 0.0 105.343 179.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_exo -41.79 -28.04 0.66 Allowed 'Trans proline' 0 N--CA 1.5 1.895 0 C-N-CA 123.671 2.914 . . . . 0.0 114.824 -174.274 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.87 -51.34 16.54 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 123.93 0.769 . . . . 0.0 111.898 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.438 HD21 ' N ' ' A' ' 88' ' ' ASP . 2.4 p30 -90.23 138.26 27.35 Favored Pre-proline 0 N--CA 1.502 2.166 0 C-N-CA 119.55 -0.86 . . . . 0.0 110.622 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -75.53 170.25 20.64 Favored 'Trans proline' 0 N--CA 1.493 1.476 0 C-N-CA 122.929 2.419 . . . . 0.0 109.861 161.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 27.8 tptp -160.3 154.68 23.58 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 123.67 0.606 . . . . 0.0 110.3 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -98.39 139.51 34.04 Favored 'General case' 0 N--CA 1.498 1.96 0 CA-C-N 114.591 -1.186 . . . . 0.0 111.122 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . 0.419 ' HB3' ' HD2' ' A' ' 96' ' ' PRO . 98.5 m -159.32 167.46 14.22 Favored Pre-proline 0 N--CA 1.501 2.076 0 O-C-N 124.057 0.848 . . . . 0.0 111.066 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.419 ' HD2' ' HB3' ' A' ' 95' ' ' CYS . 50.1 Cg_exo -27.09 -66.13 0.05 OUTLIER 'Trans proline' 0 N--CA 1.494 1.528 0 C-N-CA 124.275 3.316 . . . . 0.0 115.628 170.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 79.0 ttt180 -153.77 -77.92 0.11 Allowed 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.537 HD22 HD22 ' A' ' 64' ' ' ASN . 7.8 m120 133.72 -170.22 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.412 0 O-C-N 126.545 2.403 . . . . 0.0 107.726 -179.559 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.59 ' HA ' ' HA ' ' A' ' 62' ' ' CYS . 61.5 m 62.95 121.45 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 124.952 1.301 . . . . 0.0 112.454 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -141.17 80.98 16.27 Favored Pre-proline 0 N--CA 1.494 1.73 0 CA-C-N 114.372 -1.286 . . . . 0.0 111.252 -179.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -49.16 -27.76 13.16 Favored 'Trans proline' 0 N--CA 1.496 1.669 0 C-N-CA 123.183 2.589 . . . . 0.0 113.812 172.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.06 -27.28 69.29 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 123.687 0.617 . . . . 0.0 111.635 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 12.7 tt -52.35 167.62 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 124.253 0.971 . . . . 0.0 112.625 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.479 ' HB2' ' H ' ' A' ' 77' ' ' ASP . . . -142.8 -55.66 0.42 Allowed 'General case' 0 N--CA 1.49 1.532 0 CA-C-N 114.352 -1.295 . . . . 0.0 109.604 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -149.2 -159.92 1.1 Allowed 'General case' 0 N--CA 1.498 1.925 0 O-C-N 124.465 1.103 . . . . 0.0 109.134 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -142.89 108.97 0.54 Allowed Glycine 0 N--CA 1.489 2.173 0 N-CA-C 105.917 -2.873 . . . . 0.0 105.917 179.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 93.4 mt -79.37 85.68 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' CYS . . . . . 0.407 ' HA ' ' HA ' ' A' ' 72' ' ' CYS . 22.2 m -79.68 121.34 82.35 Favored Pre-proline 0 N--CA 1.492 1.634 0 CA-C-N 113.799 -1.546 . . . . 0.0 108.553 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_endo . . . . . 0 N--CA 1.493 1.45 0 C-N-CA 122.394 2.063 . . . . 0.0 110.375 -176.66 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 8.2 ptp180 . . . . . 0 N--CA 1.498 1.957 0 N-CA-C 106.175 -1.787 . . . . 0.0 106.175 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.7 tp -90.16 77.79 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 CA-C-N 113.252 -1.795 . . . . 0.0 108.345 179.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.7 m -85.81 28.99 0.74 Allowed 'General case' 0 N--CA 1.497 1.925 0 N-CA-C 116.201 1.926 . . . . 0.0 116.201 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 12.6 t -92.35 169.51 10.52 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-N 113.058 -1.883 . . . . 0.0 106.508 179.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.42 ' ND2' ' H ' ' A' ' 9' ' ' ALA . 40.0 p-10 -160.48 161.87 32.95 Favored 'General case' 0 N--CA 1.497 1.901 0 C-N-CA 119.367 -0.933 . . . . 0.0 112.629 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -63.24 -22.68 67.02 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 113.856 -1.52 . . . . 0.0 112.561 179.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 42.4 t -89.96 -69.02 0.74 Allowed 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 115.252 1.575 . . . . 0.0 115.252 -179.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.42 ' H ' ' ND2' ' A' ' 6' ' ' ASN . . . -85.66 63.07 7.85 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 124.598 1.186 . . . . 0.0 111.25 -179.556 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -119.89 -115.05 2.5 Favored Glycine 0 N--CA 1.492 2.379 0 CA-C-N 113.282 -1.781 . . . . 0.0 109.799 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.0 t -166.31 123.44 1.35 Allowed 'General case' 0 N--CA 1.496 1.848 0 CA-C-O 121.373 0.606 . . . . 0.0 110.585 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.82 143.73 20.28 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-N 114.714 -1.13 . . . . 0.0 109.843 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 106.37 -35.47 5.02 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.195 -1.562 . . . . 0.0 109.195 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.401 ' HB3' ' HA3' ' A' ' 48' ' ' GLY . 52.1 m -94.64 116.21 28.49 Favored 'General case' 0 N--CA 1.497 1.906 0 C-N-CA 119.422 -0.911 . . . . 0.0 110.222 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 4.0 mptp? -72.24 88.15 1.14 Allowed 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 112.792 -2.003 . . . . 0.0 111.627 -179.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.446 ' N ' ' O ' ' A' ' 25' ' ' CYS . 10.7 m-85 -46.72 127.9 10.14 Favored 'General case' 0 N--CA 1.498 1.96 0 CA-C-O 122.468 1.128 . . . . 0.0 108.237 179.583 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.547 ' CE2' ' HA ' ' A' ' 22' ' ' THR . 0.1 OUTLIER -135.96 158.72 43.73 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-N 111.623 -2.535 . . . . 0.0 113.096 -178.965 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 29.1 t -110.78 128.86 55.91 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-N 112.72 -2.036 . . . . 0.0 111.054 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.461 ' H ' ' HB2' ' A' ' 46' ' ' ALA . 7.7 p-10 -62.71 -45.35 93.15 Favored 'General case' 0 N--CA 1.497 1.911 0 CA-C-N 114.119 -1.4 . . . . 0.0 109.203 179.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -94.25 19.94 8.76 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 112.624 -2.08 . . . . 0.0 111.624 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -171.22 28.89 0.11 Allowed Glycine 0 N--CA 1.497 2.731 0 C-N-CA 118.146 -1.978 . . . . 0.0 113.934 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.547 ' HA ' ' CE2' ' A' ' 17' ' ' PHE . 6.5 t 42.81 -166.68 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 73.9 t80 -40.05 139.81 0.65 Allowed 'General case' 0 N--CA 1.5 2.063 0 N-CA-C 114.074 1.138 . . . . 0.0 114.074 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 88.4 t -114.53 -79.42 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 CA-C-N 113.131 -1.85 . . . . 0.0 108.05 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.525 ' SG ' ' N ' ' A' ' 26' ' ' GLU . 0.1 OUTLIER -152.21 -169.38 3.34 Favored 'General case' 0 N--CA 1.502 2.17 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 179.86 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.525 ' N ' ' SG ' ' A' ' 25' ' ' CYS . 60.8 tt0 -114.62 158.3 21.92 Favored 'General case' 0 N--CA 1.504 2.228 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 179.425 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -54.07 109.65 1.22 Allowed Glycine 0 N--CA 1.497 2.731 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.69 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -85.82 19.55 2.48 Favored 'General case' 0 N--CA 1.5 2.028 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 36.6 t -105.44 92.76 4.33 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.197 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -130.35 142.42 45.4 Favored Pre-proline 0 N--CA 1.495 1.786 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 179.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_endo -63.16 79.0 0.12 Allowed 'Trans proline' 0 N--CA 1.496 1.639 0 C-N-CA 122.561 2.174 . . . . 0.0 109.891 169.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 79.6 ttt180 -178.13 -51.26 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 105.592 -2.003 . . . . 0.0 105.592 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 26.5 p30 -90.44 168.21 14.78 Favored Pre-proline 0 N--CA 1.497 1.9 0 CA-C-N 114.27 -1.332 . . . . 0.0 110.781 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -62.55 127.2 20.13 Favored 'Trans proline' 0 N--CA 1.49 1.304 0 C-N-CA 122.436 2.09 . . . . 0.0 109.021 160.241 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -92.83 22.44 4.84 Favored 'General case' 0 N--CA 1.5 2.074 0 CA-C-O 122.677 1.227 . . . . 0.0 112.749 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -146.22 153.39 40.56 Favored 'General case' 0 N--CA 1.498 1.947 0 CA-C-N 112.274 -2.239 . . . . 0.0 111.739 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 57.1 m -146.51 -124.19 0.07 Allowed 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 33.5 m -146.76 18.37 1.29 Allowed 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 44.6 tp -79.71 -43.3 22.92 Favored 'General case' 0 N--CA 1.497 1.897 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.334 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 25.2 m-80 53.11 -163.63 0.09 Allowed 'General case' 0 N--CA 1.504 2.243 0 O-C-N 124.064 0.852 . . . . 0.0 112.03 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 56.3 m -43.85 118.85 1.54 Allowed 'General case' 0 N--CA 1.502 2.133 0 O-C-N 124.033 0.833 . . . . 0.0 110.232 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.4 t0 -101.41 106.41 45.62 Favored Pre-proline 0 N--CA 1.495 1.807 0 O-C-N 124.022 0.827 . . . . 0.0 109.398 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -67.6 -33.12 29.33 Favored 'Trans proline' 0 N--CA 1.494 1.525 0 C-N-CA 122.046 1.831 . . . . 0.0 111.101 -168.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 29.0 mmt85 -86.32 -13.36 46.81 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 -179.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 5.9 tt -73.43 179.33 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 C-N-CA 118.68 -1.208 . . . . 0.0 108.738 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.461 ' HB2' ' H ' ' A' ' 19' ' ' ASP . . . -139.92 -58.61 0.56 Allowed 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 120.556 -0.458 . . . . 0.0 112.073 -179.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 7.3 p90 -170.46 160.68 7.57 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 124.146 0.904 . . . . 0.0 112.719 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.407 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -88.92 107.65 3.39 Favored Glycine 0 N--CA 1.487 2.096 0 CA-C-N 113.235 -1.802 . . . . 0.0 108.892 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 23.4 t -78.24 86.75 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 124.287 0.639 . . . . 0.0 112.661 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.6 m -79.27 145.91 65.53 Favored Pre-proline 0 N--CA 1.503 2.212 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 179.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo . . . . . 0 N--CA 1.5 1.861 0 C-N-CA 123.74 2.96 . . . . 0.0 116.465 -170.145 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.4 ' HA ' ' HA ' ' A' ' 99' ' ' CYS . 1.7 m . . . . . 0 N--CA 1.494 1.738 0 CA-C-O 122.695 1.236 . . . . 0.0 113.94 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 64.3 m -90.54 166.39 13.24 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 113.309 -1.769 . . . . 0.0 108.201 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -146.53 155.05 42.22 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 124.079 0.862 . . . . 0.0 109.765 179.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 41.1 t -56.75 -32.84 65.97 Favored 'General case' 0 N--CA 1.497 1.916 0 CA-C-N 114.767 -1.106 . . . . 0.0 113.582 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 18.1 t -66.54 -46.19 76.91 Favored 'General case' 0 N--CA 1.495 1.796 0 CA-C-N 114.726 -1.124 . . . . 0.0 110.219 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -86.17 62.27 7.33 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-N 113.689 -1.596 . . . . 0.0 110.655 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -143.8 165.11 27.33 Favored Glycine 0 N--CA 1.496 2.637 0 CA-C-N 114.272 -1.331 . . . . 0.0 111.078 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.463 ' C ' ' H ' ' A' ' 71' ' ' GLY . 9.5 t -85.3 127.33 34.29 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-N 115.036 -0.582 . . . . 0.0 110.517 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -81.09 36.64 0.41 Allowed 'General case' 0 N--CA 1.501 2.078 0 CA-C-O 122.484 1.135 . . . . 0.0 110.432 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.463 ' H ' ' C ' ' A' ' 69' ' ' THR . . . -132.27 -1.28 4.42 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 108.547 -1.821 . . . . 0.0 108.547 179.735 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 64.1 m -143.39 141.62 30.95 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.464 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 7.7 ptmm? -92.46 96.61 10.34 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 124.447 1.092 . . . . 0.0 110.95 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.416 ' N ' ' O ' ' A' ' 83' ' ' CYS . 57.4 m-85 -52.15 134.02 33.22 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-N 114.429 -1.26 . . . . 0.0 109.692 179.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -141.4 158.37 43.96 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 112.998 -1.91 . . . . 0.0 112.762 -179.37 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 57.8 p -96.08 139.41 32.3 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 114.743 1.386 . . . . 0.0 114.743 -179.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.409 ' H ' ' HB2' ' A' ' 104' ' ' ALA . 5.5 p-10 -45.35 -48.23 13.33 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 126.044 2.09 . . . . 0.0 114.848 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -52.27 -30.58 28.59 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 124.329 1.018 . . . . 0.0 111.785 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 119.72 43.83 0.48 Allowed Glycine 0 N--CA 1.491 2.348 0 O-C-N 124.742 1.276 . . . . 0.0 111.043 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 57.3 m -139.13 111.21 7.35 Favored 'General case' 0 N--CA 1.5 2.03 0 C-N-CA 119.648 -0.821 . . . . 0.0 112.077 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 17.4 t80 -53.43 137.21 36.35 Favored 'General case' 0 N--CA 1.494 1.775 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.694 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 64.1 t -98.02 -73.4 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 CA-C-N 114.348 -1.297 . . . . 0.0 111.474 -179.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . 0.48 ' SG ' ' N ' ' A' ' 84' ' ' GLU . 0.5 OUTLIER -167.3 -172.65 2.04 Favored 'General case' 0 N--CA 1.505 2.3 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 -179.854 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.48 ' N ' ' SG ' ' A' ' 83' ' ' CYS . 33.3 tt0 -112.66 145.03 41.16 Favored 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 103.234 -2.876 . . . . 0.0 103.234 179.26 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -52.33 140.58 28.12 Favored Glycine 0 N--CA 1.503 3.157 0 C-N-CA 118.993 -1.575 . . . . 0.0 112.696 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -88.62 -4.98 58.45 Favored 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 27.8 t -117.97 107.91 14.63 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.476 ' H ' HD21 ' A' ' 91' ' ' ASN . 14.3 t70 -79.05 141.49 58.52 Favored Pre-proline 0 N--CA 1.494 1.749 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -34.62 -31.5 0.06 OUTLIER 'Trans proline' 0 N--CA 1.497 1.729 0 C-N-CA 123.712 2.941 . . . . 0.0 113.784 175.004 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.437 ' N ' ' HD2' ' A' ' 90' ' ' ARG . 1.7 mpt_? -79.33 -53.93 6.44 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 123.869 0.73 . . . . 0.0 110.215 179.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.476 HD21 ' H ' ' A' ' 88' ' ' ASP . 1.7 p-10 -91.3 126.0 56.29 Favored Pre-proline 0 N--CA 1.5 2.062 0 C-N-CA 119.976 -0.69 . . . . 0.0 112.326 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -75.52 150.67 36.29 Favored 'Trans proline' 0 N--CA 1.492 1.39 0 C-N-CA 122.586 2.191 . . . . 0.0 109.396 165.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 32.4 mmmt -132.99 127.5 34.3 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 124.02 0.825 . . . . 0.0 109.029 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -84.06 73.96 10.32 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 123.97 0.794 . . . . 0.0 108.967 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 85.1 m -79.96 163.33 58.45 Favored Pre-proline 0 N--CA 1.496 1.838 0 CA-C-N 114.404 -1.271 . . . . 0.0 112.848 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.405 ' HA ' ' CZ ' ' A' ' 97' ' ' ARG . 4.9 Cg_endo -70.0 -151.43 0.03 OUTLIER 'Trans proline' 0 N--CA 1.491 1.376 0 C-N-CA 122.563 2.175 . . . . 0.0 109.292 159.392 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.425 ' HD2' ' N ' ' A' ' 97' ' ' ARG . 0.1 OUTLIER -154.3 50.38 0.64 Allowed 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 121.754 0.787 . . . . 0.0 111.67 179.991 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.488 ' H ' HD22 ' A' ' 98' ' ' ASN . 2.8 m-80 -60.5 157.16 14.7 Favored 'General case' 0 N--CA 1.5 2.065 0 CA-C-N 114.722 -1.126 . . . . 0.0 111.459 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.4 ' HA ' ' HA ' ' A' ' 62' ' ' CYS . 86.0 m -98.47 131.37 44.78 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-N 114.989 -1.005 . . . . 0.0 111.552 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.406 ' O ' HG22 ' A' ' 103' ' ' ILE . 51.0 t0 -121.34 79.85 36.69 Favored Pre-proline 0 N--CA 1.496 1.873 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 179.665 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -54.71 -17.29 12.97 Favored 'Trans proline' 0 N--CA 1.497 1.697 0 C-N-CA 122.696 2.264 . . . . 0.0 113.326 -176.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 73.0 ttp85 -88.49 -35.85 16.77 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 -179.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.406 HG22 ' O ' ' A' ' 100' ' ' ASP . 11.1 tt -54.35 159.82 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.403 0 O-C-N 123.307 0.38 . . . . 0.0 110.949 -179.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.409 ' HB2' ' H ' ' A' ' 77' ' ' ASP . . . -150.79 -68.01 0.19 Allowed 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 -179.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 51.1 m-85 -114.28 -161.64 0.78 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 124.189 0.931 . . . . 0.0 111.321 -179.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -160.2 106.99 0.3 Allowed Glycine 0 N--CA 1.486 2.024 0 N-CA-C 104.836 -3.306 . . . . 0.0 104.836 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.469 ' N ' HD12 ' A' ' 107' ' ' ILE . 2.1 mp -79.14 104.67 7.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 CA-C-O 121.949 0.881 . . . . 0.0 108.92 -179.653 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 16.0 m -86.79 159.71 51.48 Favored Pre-proline 0 N--CA 1.495 1.777 0 CA-C-N 114.272 -1.331 . . . . 0.0 108.641 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo . . . . . 0 N--CA 1.494 1.549 0 C-N-CA 122.382 2.055 . . . . 0.0 110.015 173.965 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 67.7 mmt-85 . . . . . 0 N--CA 1.499 2.005 0 N-CA-C 111.77 0.285 . . . . 0.0 111.77 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.0 tp -60.46 96.96 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 CA-C-O 121.922 0.867 . . . . 0.0 111.28 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.7 m -93.06 49.04 1.38 Allowed 'General case' 0 N--CA 1.491 1.598 0 CA-C-N 114.486 -1.234 . . . . 0.0 112.293 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 13.5 t -90.57 177.03 6.46 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-N 113.404 -1.725 . . . . 0.0 107.733 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.518 HD22 ' H ' ' A' ' 40' ' ' ASN . 14.3 p30 -160.04 167.98 26.62 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 123.994 0.809 . . . . 0.0 112.136 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 38.0 t -53.99 -42.52 69.11 Favored 'General case' 0 N--CA 1.497 1.877 0 CA-C-N 114.225 -1.352 . . . . 0.0 112.036 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 53.4 t -52.85 -44.48 66.81 Favored 'General case' 0 N--CA 1.496 1.862 0 CA-C-N 113.221 -1.808 . . . . 0.0 109.413 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -89.73 28.94 1.23 Allowed 'General case' 0 N--CA 1.499 2.018 0 CA-C-N 112.944 -1.935 . . . . 0.0 110.835 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -83.31 -138.44 3.36 Favored Glycine 0 N--CA 1.496 2.667 0 N-CA-C 110.743 -0.943 . . . . 0.0 110.743 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 39.9 p -158.09 104.88 1.91 Allowed 'General case' 0 N--CA 1.503 2.183 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 16.2 ptpt -53.55 95.05 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.108 0 CA-C-O 122.586 1.184 . . . . 0.0 111.811 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 168.24 -35.25 0.2 Allowed Glycine 0 N--CA 1.488 2.166 0 CA-C-N 113.788 -1.551 . . . . 0.0 110.345 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 49.9 m -112.12 161.28 16.69 Favored 'General case' 0 N--CA 1.502 2.151 0 C-N-CA 119.47 -0.892 . . . . 0.0 111.913 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -101.18 92.31 4.92 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-N 114.182 -1.372 . . . . 0.0 108.278 -179.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.409 ' N ' ' O ' ' A' ' 25' ' ' CYS . 47.4 m-85 -47.33 136.85 9.0 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 124.636 1.21 . . . . 0.0 110.712 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 10.7 t80 -146.19 159.58 43.12 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-N 112.853 -1.976 . . . . 0.0 112.789 -179.217 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 35.1 t -112.75 134.84 54.07 Favored 'General case' 0 N--CA 1.498 1.968 0 CA-C-N 112.285 -2.234 . . . . 0.0 114.753 -179.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.49 ' H ' ' HB2' ' A' ' 46' ' ' ALA . 1.2 p30 -51.17 -26.34 6.68 Favored 'General case' 0 N--CA 1.501 2.087 0 CA-C-N 112.457 -2.156 . . . . 0.0 115.031 -179.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 24.0 p30 -64.39 -2.12 2.07 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 123.999 0.812 . . . . 0.0 112.085 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 89.61 28.83 18.0 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 58.6 m -134.89 150.54 50.45 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 71.8 t80 -78.24 158.78 28.82 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-N 114.321 -1.309 . . . . 0.0 110.386 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 95.2 t -116.35 -73.77 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 CA-C-N 114.939 -1.028 . . . . 0.0 109.124 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.506 ' SG ' ' N ' ' A' ' 26' ' ' GLU . 1.7 p -168.41 -161.25 0.34 Allowed 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.506 ' N ' ' SG ' ' A' ' 25' ' ' CYS . 40.8 tt0 -127.87 145.57 50.9 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 104.669 -2.345 . . . . 0.0 104.669 179.231 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -32.72 102.13 0.01 OUTLIER Glycine 0 N--CA 1.499 2.891 0 N-CA-C 115.988 1.155 . . . . 0.0 115.988 -179.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -102.82 32.86 3.46 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 29.9 t -122.55 148.08 45.63 Favored 'General case' 0 N--CA 1.497 1.924 0 CA-C-N 114.124 -1.398 . . . . 0.0 107.681 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.401 ' H ' ' HZ1' ' A' ' 35' ' ' LYS . 41.8 t0 -128.2 92.9 40.29 Favored Pre-proline 0 N--CA 1.493 1.722 0 O-C-N 124.717 1.26 . . . . 0.0 110.82 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -52.43 -15.89 4.5 Favored 'Trans proline' 0 N--CA 1.495 1.59 0 C-N-CA 123.002 2.468 . . . . 0.0 113.03 178.239 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 16.7 tpt180 -61.2 -51.82 67.39 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 108.147 -1.056 . . . . 0.0 108.147 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 15.3 p30 -90.65 138.91 26.35 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 124.327 1.017 . . . . 0.0 110.016 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -74.38 116.77 4.74 Favored 'Trans proline' 0 N--CA 1.493 1.458 0 C-N-CA 123.017 2.478 . . . . 0.0 110.394 175.311 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.401 ' HZ1' ' H ' ' A' ' 30' ' ' ASP . 0.0 OUTLIER -167.51 176.19 6.68 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 123.98 0.8 . . . . 0.0 111.957 179.92 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -160.03 122.19 3.31 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-N 114.89 -1.05 . . . . 0.0 108.784 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 33.4 m -79.87 -71.58 0.45 Allowed 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 47.5 m 34.22 69.91 0.14 Allowed 'General case' 0 N--CA 1.498 1.96 0 O-C-N 124.787 1.305 . . . . 0.0 113.414 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.3 pp -143.55 -36.87 0.35 Allowed 'General case' 0 N--CA 1.495 1.789 0 CA-C-N 114.936 -1.029 . . . . 0.0 108.973 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.518 ' H ' HD22 ' A' ' 6' ' ' ASN . 20.5 m120 -94.02 138.68 31.84 Favored 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 105.648 -1.982 . . . . 0.0 105.648 179.473 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 75.0 m -101.01 131.02 47.08 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 123.698 0.624 . . . . 0.0 112.644 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 62.9 t0 -122.95 76.46 49.73 Favored Pre-proline 0 N--CA 1.497 1.922 0 O-C-N 124.213 0.945 . . . . 0.0 109.149 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -63.74 -37.64 44.67 Favored 'Trans proline' 0 N--CA 1.496 1.63 0 C-N-CA 123.309 2.672 . . . . 0.0 111.584 -176.131 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.402 ' H ' ' HG3' ' A' ' 44' ' ' ARG . 0.0 OUTLIER -74.6 -7.6 53.68 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 115.088 1.514 . . . . 0.0 115.088 -179.758 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 15.9 tt -57.04 156.74 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.25 0 C-N-CA 119.879 -0.729 . . . . 0.0 111.856 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.49 ' HB2' ' H ' ' A' ' 19' ' ' ASP . . . -137.13 -66.95 0.5 Allowed 'General case' 0 N--CA 1.497 1.914 0 O-C-N 124.006 0.816 . . . . 0.0 110.289 179.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 46.8 p90 -160.96 167.99 25.45 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-N 115.183 -0.917 . . . . 0.0 109.836 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -115.95 111.44 2.4 Favored Glycine 0 N--CA 1.492 2.428 0 O-C-N 125.17 1.544 . . . . 0.0 109.709 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.5 p -80.04 111.32 16.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 C-N-CA 119.731 -0.788 . . . . 0.0 111.973 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.7 m -79.33 149.48 72.45 Favored Pre-proline 0 N--CA 1.499 1.984 0 CA-C-N 115.135 -0.939 . . . . 0.0 109.055 179.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo . . . . . 0 N--CA 1.495 1.6 0 C-N-CA 122.749 2.299 . . . . 0.0 111.965 -169.619 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.477 ' HA ' ' HA ' ' A' ' 99' ' ' CYS . 1.7 m . . . . . 0 N--CA 1.48 1.054 0 CA-C-O 123.037 1.398 . . . . 0.0 111.897 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 93.2 m -90.3 168.24 12.05 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 112.516 -2.129 . . . . 0.0 108.72 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 42.3 p-10 -152.9 177.64 10.53 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 123.965 0.79 . . . . 0.0 110.072 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 4.5 t -73.17 1.12 9.85 Favored 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 46.1 t -91.64 -36.29 13.73 Favored 'General case' 0 N--CA 1.496 1.845 0 CA-C-N 114.751 -1.113 . . . . 0.0 110.584 179.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -71.1 59.21 0.24 Allowed 'General case' 0 N--CA 1.5 2.063 0 CA-C-N 112.466 -2.152 . . . . 0.0 114.148 -179.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -174.22 -150.33 7.6 Favored Glycine 0 N--CA 1.487 2.06 0 N-CA-C 107.863 -2.095 . . . . 0.0 107.863 179.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.458 ' C ' ' H ' ' A' ' 71' ' ' GLY . 66.5 p -146.11 157.42 43.84 Favored 'General case' 0 N--CA 1.502 2.13 0 C-N-CA 120.781 -0.367 . . . . 0.0 111.211 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 59.4 mtpt -71.07 33.23 0.05 OUTLIER 'General case' 0 N--CA 1.507 2.415 0 O-C-N 125.117 1.511 . . . . 0.0 113.627 179.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.458 ' H ' ' C ' ' A' ' 69' ' ' THR . . . -137.0 14.21 3.81 Favored Glycine 0 N--CA 1.486 1.987 0 N-CA-C 108.054 -2.018 . . . . 0.0 108.054 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . 0.421 ' HA ' ' HA ' ' A' ' 108' ' ' CYS . 86.8 m -140.44 175.21 9.79 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 123.901 0.412 . . . . 0.0 111.006 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 34.2 mtmm -131.16 106.57 8.43 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 123.953 0.783 . . . . 0.0 110.279 -179.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.681 ' CD2' ' SG ' ' A' ' 83' ' ' CYS . 97.8 m-85 -56.31 137.98 51.48 Favored 'General case' 0 N--CA 1.501 2.102 0 C-N-CA 120.133 -0.627 . . . . 0.0 109.827 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 15.4 t80 -143.07 162.38 35.66 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 124.69 1.244 . . . . 0.0 111.977 -179.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 47.3 t -120.5 139.08 53.41 Favored 'General case' 0 N--CA 1.5 2.058 0 CA-C-N 113.2 -1.818 . . . . 0.0 115.084 -179.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.588 ' H ' ' HB2' ' A' ' 104' ' ' ALA . 4.3 p-10 -48.84 -28.23 3.58 Favored 'General case' 0 N--CA 1.5 2.055 0 CA-C-N 111.341 -2.663 . . . . 0.0 114.033 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 17.8 p30 -61.09 -5.25 1.36 Allowed 'General case' 0 N--CA 1.497 1.886 0 O-C-N 124.35 1.031 . . . . 0.0 112.073 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 89.64 29.08 17.19 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.396 -1.482 . . . . 0.0 109.396 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 88.2 m -142.17 149.96 40.42 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 121.43 0.633 . . . . 0.0 111.008 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 34.0 t80 -67.52 164.69 18.37 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-N 113.583 -1.644 . . . . 0.0 110.508 179.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 92.7 t -126.27 -71.49 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 O-C-N 124.074 0.859 . . . . 0.0 111.146 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . 0.681 ' SG ' ' CD2' ' A' ' 74' ' ' TYR . 17.2 p -155.11 -172.18 4.09 Favored 'General case' 0 N--CA 1.499 2.021 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 -179.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.405 ' CD ' ' N ' ' A' ' 85' ' ' GLY . 10.5 tm-20 -116.77 164.2 15.0 Favored 'General case' 0 N--CA 1.501 2.086 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.447 ' HA3' ' O ' ' A' ' 69' ' ' THR . . . -49.63 107.82 0.37 Allowed Glycine 0 N--CA 1.494 2.545 0 CA-C-O 119.013 -0.882 . . . . 0.0 110.937 179.659 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -108.84 34.18 3.83 Favored 'General case' 0 N--CA 1.5 2.074 0 CA-C-O 121.535 0.683 . . . . 0.0 110.655 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 45.4 t -145.4 119.43 9.39 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -81.02 127.97 72.67 Favored Pre-proline 0 N--CA 1.494 1.769 0 C-N-CA 119.592 -0.843 . . . . 0.0 110.036 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_endo -58.56 -17.46 34.88 Favored 'Trans proline' 0 N--CA 1.495 1.605 0 C-N-CA 122.549 2.166 . . . . 0.0 113.019 -177.38 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 30.4 tpt180 -59.74 -41.48 91.06 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 123.717 0.636 . . . . 0.0 110.511 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -90.3 118.93 69.18 Favored Pre-proline 0 N--CA 1.496 1.85 0 O-C-N 124.396 1.06 . . . . 0.0 111.573 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -83.39 41.31 1.05 Allowed 'Trans proline' 0 N--CA 1.494 1.558 0 C-N-CA 123.365 2.71 . . . . 0.0 110.236 166.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.18 175.76 5.76 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-N 114.622 -1.172 . . . . 0.0 112.154 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -103.63 126.95 51.1 Favored 'General case' 0 N--CA 1.495 1.823 0 CA-C-N 114.826 -1.079 . . . . 0.0 109.359 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 42.6 m -79.94 163.74 56.44 Favored Pre-proline 0 N--CA 1.496 1.825 0 O-C-N 123.887 0.742 . . . . 0.0 111.732 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.451 ' C ' ' HE ' ' A' ' 97' ' ' ARG . 13.1 Cg_endo -68.66 155.39 69.01 Favored 'Trans proline' 0 N--CA 1.49 1.285 0 C-N-CA 122.511 2.14 . . . . 0.0 110.196 170.201 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.451 ' HE ' ' C ' ' A' ' 96' ' ' PRO . 0.0 OUTLIER -83.23 16.43 2.46 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-N 114.699 -1.137 . . . . 0.0 111.083 -179.919 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -48.0 131.28 15.63 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 123.89 0.743 . . . . 0.0 109.759 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.477 ' HA ' ' HA ' ' A' ' 62' ' ' CYS . 60.1 m -99.64 132.46 44.97 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 114.005 1.113 . . . . 0.0 114.005 -179.599 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 64.7 t0 -129.49 76.3 78.86 Favored Pre-proline 0 N--CA 1.5 2.058 0 O-C-N 124.231 0.957 . . . . 0.0 110.845 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -59.85 -13.78 24.16 Favored 'Trans proline' 0 N--CA 1.494 1.54 0 C-N-CA 122.501 2.134 . . . . 0.0 112.222 176.234 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 69.5 mtp85 -90.31 18.45 6.07 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 124.011 0.819 . . . . 0.0 111.779 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 9.9 tt -116.34 175.7 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.314 0 O-C-N 123.71 0.631 . . . . 0.0 110.497 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.588 ' HB2' ' H ' ' A' ' 77' ' ' ASP . . . -146.01 -62.64 0.32 Allowed 'General case' 0 N--CA 1.498 1.928 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.863 179.683 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 27.9 p90 -161.22 163.93 30.74 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 124.053 0.846 . . . . 0.0 110.978 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -98.27 112.86 4.57 Favored Glycine 0 N--CA 1.492 2.375 0 CA-C-N 113.688 -1.596 . . . . 0.0 111.979 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 93.8 mt -79.54 105.65 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 N-CA-C 106.5 -1.667 . . . . 0.0 106.5 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' CYS . . . . . 0.421 ' HA ' ' HA ' ' A' ' 72' ' ' CYS . 31.2 m -89.07 140.9 29.05 Favored Pre-proline 0 N--CA 1.491 1.599 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo . . . . . 0 N--CA 1.493 1.481 0 C-N-CA 122.41 2.073 . . . . 0.0 109.085 -176.048 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 62.1 ttm-85 . . . . . 0 N--CA 1.502 2.158 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 4.9 tp -62.35 94.77 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 CA-C-N 114.398 -1.274 . . . . 0.0 109.461 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.7 m -89.73 36.77 0.86 Allowed 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 116.881 2.178 . . . . 0.0 116.881 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 14.6 p -91.68 166.37 12.83 Favored 'General case' 0 N--CA 1.496 1.849 0 CA-C-N 113.518 -1.674 . . . . 0.0 108.901 179.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 14.0 p30 -161.42 142.65 11.36 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-N 114.861 -1.063 . . . . 0.0 111.791 179.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -61.69 -18.76 60.89 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-N 114.436 -1.256 . . . . 0.0 112.843 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 46.8 t -89.46 -69.54 0.71 Allowed 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 113.464 0.913 . . . . 0.0 113.464 -179.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.41 ' N ' ' SG ' ' A' ' 37' ' ' CYS . . . -75.45 1.19 14.67 Favored 'General case' 0 N--CA 1.5 2.043 0 N-CA-C 113.547 0.943 . . . . 0.0 113.547 -179.617 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -67.44 165.5 43.54 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 110.426 -1.07 . . . . 0.0 110.426 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 8.9 t -73.12 125.13 26.97 Favored 'General case' 0 N--CA 1.493 1.711 0 CA-C-O 121.508 0.671 . . . . 0.0 110.204 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 7.1 ttpm? -72.2 87.75 1.11 Allowed 'General case' 0 N--CA 1.49 1.551 0 CA-C-N 114.239 -1.346 . . . . 0.0 108.719 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 171.1 -34.36 0.16 Allowed Glycine 0 N--CA 1.488 2.134 0 CA-C-N 113.282 -1.781 . . . . 0.0 108.882 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 83.9 m -101.55 133.61 45.96 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.487 ' HB3' ' CE1' ' A' ' 23' ' ' PHE . 9.0 mtpm? -81.92 88.96 6.34 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 113.428 -1.714 . . . . 0.0 113.732 -179.278 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -54.48 126.22 22.66 Favored 'General case' 0 N--CA 1.499 2.018 0 N-CA-C 105.911 -1.885 . . . . 0.0 105.911 179.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -132.28 146.45 52.0 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 112.788 -2.005 . . . . 0.0 112.969 -179.188 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 40.2 t -84.5 139.81 31.9 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-N 112.563 -2.108 . . . . 0.0 114.866 -179.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -51.91 -32.14 31.45 Favored 'General case' 0 N--CA 1.499 1.981 0 CA-C-N 111.826 -2.443 . . . . 0.0 114.854 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -54.29 -21.67 9.87 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 123.981 0.8 . . . . 0.0 111.62 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 109.16 32.41 3.03 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 108.646 -1.782 . . . . 0.0 108.646 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 90.7 m -137.26 147.38 45.68 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 124.08 0.518 . . . . 0.0 110.961 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.487 ' CE1' ' HB3' ' A' ' 15' ' ' LYS . 8.6 t80 -80.43 140.93 35.74 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-N 114.637 -1.165 . . . . 0.0 110.216 179.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 98.0 t -100.42 -78.26 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 106.22 -1.77 . . . . 0.0 106.22 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -172.12 168.07 5.86 Favored 'General case' 0 N--CA 1.504 2.226 0 O-C-N 123.579 0.549 . . . . 0.0 110.404 179.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -87.59 155.38 19.99 Favored 'General case' 0 N--CA 1.501 2.114 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -48.22 131.71 19.65 Favored Glycine 0 N--CA 1.501 2.994 0 C-N-CA 120.026 -1.083 . . . . 0.0 111.48 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -101.91 33.21 3.11 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 37.1 t -149.58 137.4 20.29 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-N 114.502 -1.226 . . . . 0.0 107.922 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -79.59 134.1 58.35 Favored Pre-proline 0 N--CA 1.494 1.754 0 O-C-N 123.987 0.804 . . . . 0.0 109.007 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -57.0 -13.76 12.64 Favored 'Trans proline' 0 N--CA 1.497 1.7 0 C-N-CA 122.423 2.082 . . . . 0.0 112.789 -177.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 79.8 ttt180 -68.59 -43.04 77.34 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 123.658 0.599 . . . . 0.0 111.878 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -73.64 128.59 86.75 Favored Pre-proline 0 N--CA 1.495 1.792 0 C-N-CA 119.523 -0.871 . . . . 0.0 112.285 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -82.61 85.2 1.65 Allowed 'Trans proline' 0 N--CA 1.492 1.406 0 C-N-CA 123.509 2.806 . . . . 0.0 111.486 169.223 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 20.7 pttp -164.11 166.39 21.32 Favored 'General case' 0 N--CA 1.501 2.101 0 C-N-CA 120.621 -0.432 . . . . 0.0 111.829 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -129.14 158.79 38.0 Favored 'General case' 0 N--CA 1.497 1.883 0 CA-C-N 114.592 -1.186 . . . . 0.0 110.144 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.41 ' SG ' ' N ' ' A' ' 9' ' ' ALA . 85.2 m -88.55 -178.68 5.89 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-N 114.865 -1.061 . . . . 0.0 110.744 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 63.7 p -81.01 -2.16 46.84 Favored 'General case' 0 N--CA 1.497 1.91 0 CA-C-N 114.925 -1.034 . . . . 0.0 110.669 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.44 ' N ' HD22 ' A' ' 39' ' ' LEU . 3.1 mm? -79.41 -57.45 3.7 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 33.6 m120 53.52 103.0 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.982 0 O-C-N 124.83 1.331 . . . . 0.0 112.808 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 60.9 m 63.98 135.12 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.937 0 CA-C-N 114.602 -1.181 . . . . 0.0 112.963 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 46.3 t0 -135.81 102.03 10.42 Favored Pre-proline 0 N--CA 1.498 1.951 0 C-N-CA 120.305 -0.558 . . . . 0.0 111.674 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -57.22 -29.39 83.47 Favored 'Trans proline' 0 N--CA 1.494 1.543 0 C-N-CA 122.758 2.305 . . . . 0.0 111.467 174.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -62.75 -39.44 94.12 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 123.997 0.811 . . . . 0.0 109.309 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.426 ' CG2' ' N ' ' A' ' 46' ' ' ALA . 20.3 mt -76.97 161.8 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 CA-C-O 121.927 0.87 . . . . 0.0 109.505 179.776 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.426 ' N ' ' CG2' ' A' ' 45' ' ' ILE . . . -122.65 -54.21 1.86 Allowed 'General case' 0 N--CA 1.494 1.756 0 CA-C-N 112.423 -2.171 . . . . 0.0 109.054 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 14.4 p90 -171.15 159.32 5.88 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-N 114.727 -1.124 . . . . 0.0 111.523 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -92.31 111.55 4.07 Favored Glycine 0 N--CA 1.493 2.484 0 CA-C-N 113.523 -1.671 . . . . 0.0 111.073 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 33.0 m -79.95 98.1 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 N-CA-C 105.068 -2.197 . . . . 0.0 105.068 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 8.0 m -79.63 121.25 82.32 Favored Pre-proline 0 N--CA 1.492 1.633 0 CA-C-N 113.496 -1.684 . . . . 0.0 108.019 -179.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo . . . . . 0 N--CA 1.495 1.602 0 C-N-CA 122.806 2.337 . . . . 0.0 113.173 -165.14 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.425 ' HA ' ' HA ' ' A' ' 99' ' ' CYS . 56.2 m . . . . . 0 N--CA 1.489 1.484 0 CA-C-O 123.297 1.522 . . . . 0.0 112.593 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 61.3 m -90.7 133.29 35.26 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 111.466 -2.606 . . . . 0.0 104.307 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.453 ' ND2' ' H ' ' A' ' 67' ' ' ALA . 34.6 p-10 -153.82 154.45 33.98 Favored 'General case' 0 N--CA 1.503 2.194 0 N-CA-C 113.855 1.058 . . . . 0.0 113.855 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -67.18 -22.92 65.72 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-N 113.74 -1.573 . . . . 0.0 114.513 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 51.4 t -89.81 -68.71 0.76 Allowed 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 113.381 0.882 . . . . 0.0 113.381 -179.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.453 ' H ' ' ND2' ' A' ' 64' ' ' ASN . . . -71.47 -2.05 15.36 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 123.812 0.695 . . . . 0.0 111.833 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.425 ' HA3' ' CZ ' ' A' ' 74' ' ' TYR . . . -65.88 166.95 35.27 Favored Glycine 0 N--CA 1.491 2.307 0 O-C-N 123.829 0.706 . . . . 0.0 111.621 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 6.8 t -77.47 129.27 35.51 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 124.245 0.615 . . . . 0.0 111.954 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -71.64 81.6 0.84 Allowed 'General case' 0 N--CA 1.494 1.756 0 CA-C-N 114.378 -1.283 . . . . 0.0 110.899 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 174.66 -36.14 0.11 Allowed Glycine 0 N--CA 1.488 2.154 0 CA-C-N 113.11 -1.859 . . . . 0.0 108.728 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 46.3 m -94.86 129.55 41.81 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 13.3 mmmm -75.47 84.96 2.57 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 112.912 -1.949 . . . . 0.0 111.279 -179.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.425 ' CZ ' ' HA3' ' A' ' 68' ' ' GLY . 42.8 m-85 -50.61 121.7 6.16 Favored 'General case' 0 N--CA 1.503 2.215 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 179.673 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -129.88 150.64 51.09 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 111.896 -2.411 . . . . 0.0 113.417 -179.182 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 33.1 t -90.33 136.59 32.96 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-N 112.65 -2.068 . . . . 0.0 114.103 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.438 ' HB3' ' HB2' ' A' ' 104' ' ' ALA . 0.9 OUTLIER -51.32 -28.15 11.45 Favored 'General case' 0 N--CA 1.5 2.044 0 CA-C-N 112.386 -2.188 . . . . 0.0 114.705 179.833 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -54.16 -22.47 11.32 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 123.93 0.769 . . . . 0.0 111.466 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 110.66 29.74 3.51 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 108.637 -1.785 . . . . 0.0 108.637 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 85.4 m -139.7 146.49 39.69 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 123.985 0.462 . . . . 0.0 111.102 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.405 ' CZ ' ' HA ' ' A' ' 83' ' ' CYS . 21.5 t80 -76.06 154.0 35.98 Favored 'General case' 0 N--CA 1.493 1.725 0 CA-C-N 114.352 -1.295 . . . . 0.0 110.438 179.778 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 57.9 t -117.11 -79.68 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . 0.405 ' HA ' ' CZ ' ' A' ' 81' ' ' PHE . 0.2 OUTLIER -162.69 179.65 7.53 Favored 'General case' 0 N--CA 1.505 2.286 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 179.726 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -97.69 159.37 14.97 Favored 'General case' 0 N--CA 1.507 2.392 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 179.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -53.15 132.32 41.82 Favored Glycine 0 N--CA 1.5 2.944 0 C-N-CA 119.42 -1.372 . . . . 0.0 110.306 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -101.92 33.02 3.18 Favored 'General case' 0 N--CA 1.499 2.0 0 CA-C-O 122.143 0.973 . . . . 0.0 108.391 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 41.2 t -157.6 152.8 25.89 Favored 'General case' 0 N--CA 1.495 1.801 0 CA-C-N 114.533 -1.212 . . . . 0.0 109.345 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -97.14 138.05 21.24 Favored Pre-proline 0 N--CA 1.494 1.74 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -64.48 86.59 0.16 Allowed 'Trans proline' 0 N--CA 1.494 1.53 0 C-N-CA 122.131 1.887 . . . . 0.0 108.178 173.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 3.5 mtp-105 178.25 -31.31 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.011 0 CA-C-N 114.031 -1.44 . . . . 0.0 109.352 -179.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 9.0 p-10 -53.02 125.93 41.99 Favored Pre-proline 0 N--CA 1.497 1.923 0 O-C-N 124.04 0.838 . . . . 0.0 112.919 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -82.73 48.0 2.63 Favored 'Trans proline' 0 N--CA 1.49 1.301 0 C-N-CA 122.916 2.411 . . . . 0.0 108.684 160.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 45.8 mmtm -126.13 169.57 12.67 Favored 'General case' 0 N--CA 1.498 1.965 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.462 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -145.58 135.86 23.95 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-N 114.707 -1.133 . . . . 0.0 109.529 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . 0.478 ' HB3' ' H ' ' A' ' 97' ' ' ARG . 86.9 m -79.96 157.76 73.43 Favored Pre-proline 0 N--CA 1.495 1.809 0 CA-C-N 115.076 -0.965 . . . . 0.0 111.696 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -69.28 -5.61 16.32 Favored 'Trans proline' 0 N--CA 1.496 1.639 0 C-N-CA 122.841 2.361 . . . . 0.0 110.369 160.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.478 ' H ' ' HB3' ' A' ' 95' ' ' CYS . 17.5 tpp85 -79.31 -50.13 11.37 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 43.3 m-80 54.05 -159.67 0.16 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 124.797 1.311 . . . . 0.0 110.401 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.425 ' HA ' ' HA ' ' A' ' 62' ' ' CYS . 64.6 m -51.61 120.01 4.75 Favored 'General case' 0 N--CA 1.497 1.913 0 CA-C-N 115.208 -0.905 . . . . 0.0 108.773 179.769 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -107.64 99.31 28.48 Favored Pre-proline 0 N--CA 1.499 2.01 0 O-C-N 123.684 0.615 . . . . 0.0 111.293 -179.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -64.18 -27.82 64.66 Favored 'Trans proline' 0 N--CA 1.494 1.555 0 C-N-CA 122.634 2.223 . . . . 0.0 111.328 -176.137 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 25.8 mtm105 -60.01 -39.85 87.22 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 18.0 mt -76.0 160.98 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 CA-C-N 113.927 -1.488 . . . . 0.0 111.121 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.438 ' HB2' ' HB3' ' A' ' 77' ' ' ASP . . . -123.79 -61.77 1.35 Allowed 'General case' 0 N--CA 1.491 1.612 0 CA-C-N 112.176 -2.284 . . . . 0.0 109.72 -179.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 20.0 p90 -160.49 157.23 27.19 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-N 114.806 -1.088 . . . . 0.0 111.941 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.415 ' HA2' ' HA ' ' A' ' 74' ' ' TYR . . . -94.96 109.79 3.9 Favored Glycine 0 N--CA 1.488 2.162 0 CA-C-N 112.864 -1.971 . . . . 0.0 111.406 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 65.0 mt -79.17 95.73 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 CA-C-N 114.577 -0.811 . . . . 0.0 110.913 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 1.5 m -79.09 143.32 60.93 Favored Pre-proline 0 N--CA 1.503 2.203 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 179.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo . . . . . 0 N--CA 1.494 1.53 0 C-N-CA 122.613 2.208 . . . . 0.0 111.555 -179.559 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 74.4 ttt-85 . . . . . 0 N--CA 1.495 1.796 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.433 ' O ' ' HA ' ' A' ' 41' ' ' CYS . 9.1 tp -85.89 53.13 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 123.213 0.321 . . . . 0.0 110.647 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.61 ' HA ' ' CA ' ' A' ' 41' ' ' CYS . 1.6 m -79.31 39.08 0.38 Allowed 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 117.279 2.325 . . . . 0.0 117.279 -179.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.1 p -91.23 151.05 21.08 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 112.176 -2.284 . . . . 0.0 106.357 179.197 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 45.4 p-10 -160.71 173.86 14.81 Favored 'General case' 0 N--CA 1.494 1.774 0 CA-C-N 113.453 -1.703 . . . . 0.0 109.644 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 4.2 t -72.01 -24.89 61.63 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-N 114.698 -1.137 . . . . 0.0 112.863 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 40.4 t -89.25 -69.54 0.71 Allowed 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 113.68 0.993 . . . . 0.0 113.68 -179.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -81.78 36.83 0.45 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 124.531 1.144 . . . . 0.0 112.543 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -82.0 -119.51 0.54 Allowed Glycine 0 N--CA 1.493 2.473 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 37.0 p -155.74 123.86 5.78 Favored 'General case' 0 N--CA 1.5 2.035 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.67 144.58 42.87 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-N 115.034 -0.985 . . . . 0.0 110.928 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 91.5 -18.18 53.35 Favored Glycine 0 N--CA 1.492 2.43 0 CA-C-N 114.486 -1.234 . . . . 0.0 110.959 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 91.4 m -99.54 171.65 7.8 Favored 'General case' 0 N--CA 1.498 1.935 0 C-N-CA 120.118 -0.633 . . . . 0.0 110.707 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 60.8 mttp -129.79 90.1 2.92 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-N 115.066 -0.97 . . . . 0.0 109.667 -179.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 40.8 m-85 -54.79 133.8 47.59 Favored 'General case' 0 N--CA 1.495 1.777 0 CA-C-N 114.133 -1.394 . . . . 0.0 109.384 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -137.73 157.22 46.93 Favored 'General case' 0 N--CA 1.487 1.415 0 CA-C-N 112.934 -1.939 . . . . 0.0 113.682 -179.22 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 30.9 t -103.82 134.43 47.14 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-N 112.685 -2.052 . . . . 0.0 113.211 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.42 ' HB3' ' HB2' ' A' ' 46' ' ' ALA . 1.0 OUTLIER -50.05 -27.16 5.15 Favored 'General case' 0 N--CA 1.503 2.219 0 N-CA-C 115.541 1.682 . . . . 0.0 115.541 -179.99 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -55.67 -16.66 4.45 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 123.836 0.71 . . . . 0.0 111.749 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 104.26 29.42 5.43 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 108.442 -1.863 . . . . 0.0 108.442 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 59.9 m -137.2 144.39 42.84 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 124.088 0.522 . . . . 0.0 110.579 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 21.7 t80 -77.08 145.36 37.91 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-N 114.266 -1.334 . . . . 0.0 109.59 179.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 91.4 t -100.17 -76.39 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.441 ' SG ' ' O ' ' A' ' 26' ' ' GLU . 0.1 OUTLIER -171.06 179.76 2.97 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 123.399 0.437 . . . . 0.0 110.889 179.823 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.441 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 35.6 tt0 -81.76 149.64 28.32 Favored 'General case' 0 N--CA 1.501 2.11 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.318 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -70.58 118.4 7.72 Favored Glycine 0 N--CA 1.497 2.763 0 N-CA-C 106.643 -2.583 . . . . 0.0 106.643 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -96.87 26.64 4.46 Favored 'General case' 0 N--CA 1.501 2.086 0 CA-C-O 121.481 0.658 . . . . 0.0 111.317 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 45.7 t -106.15 120.51 42.0 Favored 'General case' 0 N--CA 1.495 1.776 0 CA-C-N 114.349 -1.296 . . . . 0.0 109.993 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.455 ' H ' HD21 ' A' ' 33' ' ' ASN . 12.5 t70 -132.27 140.98 39.67 Favored Pre-proline 0 N--CA 1.494 1.75 0 N-CA-C 106.543 -1.651 . . . . 0.0 106.543 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -67.12 79.51 0.4 Allowed 'Trans proline' 0 N--CA 1.494 1.525 0 C-N-CA 122.584 2.19 . . . . 0.0 110.238 175.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 5.2 mmt-85 178.21 -46.13 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.77 0 CA-C-N 113.59 -1.641 . . . . 0.0 108.008 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.455 HD21 ' H ' ' A' ' 30' ' ' ASP . 28.5 p30 -83.02 149.28 58.79 Favored Pre-proline 0 N--CA 1.495 1.776 0 O-C-N 124.043 0.84 . . . . 0.0 111.755 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_endo -76.77 119.2 5.06 Favored 'Trans proline' 0 N--CA 1.491 1.333 0 C-N-CA 122.875 2.383 . . . . 0.0 108.696 165.078 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 41.3 mtmt -72.37 117.73 14.39 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -160.68 101.13 1.31 Allowed 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 113.997 1.11 . . . . 0.0 113.997 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 1.6 m -160.42 -53.05 0.05 Allowed 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 105.193 -2.151 . . . . 0.0 105.193 179.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 95.2 m -121.59 160.5 24.21 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-N 112.808 -1.996 . . . . 0.0 108.844 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -93.21 26.65 2.8 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-N 114.663 -1.153 . . . . 0.0 110.896 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 4.0 m120 60.54 -177.83 0.1 Allowed 'General case' 0 N--CA 1.501 2.095 0 CA-C-N 114.257 -1.338 . . . . 0.0 113.192 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.61 ' CA ' ' HA ' ' A' ' 4' ' ' CYS . 1.7 m 52.27 79.73 0.1 Allowed 'General case' 0 N--CA 1.495 1.803 0 CA-C-O 123.723 1.725 . . . . 0.0 112.674 -179.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.4 ' O ' HG22 ' A' ' 45' ' ' ILE . 11.2 t70 -91.78 110.13 41.52 Favored Pre-proline 0 N--CA 1.484 1.273 0 CA-C-N 110.091 -3.231 . . . . 0.0 106.844 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_endo -63.92 -19.53 66.81 Favored 'Trans proline' 0 N--CA 1.495 1.614 0 C-N-CA 121.791 1.661 . . . . 0.0 112.365 -170.358 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.502 ' N ' ' HD2' ' A' ' 44' ' ' ARG . 2.1 mpt_? -90.56 -26.89 19.48 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 112.918 0.711 . . . . 0.0 112.918 -179.764 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.4 HG22 ' O ' ' A' ' 42' ' ' ASP . 6.3 tt -64.56 169.05 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 123.558 0.536 . . . . 0.0 111.939 -179.536 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.42 ' HB2' ' HB3' ' A' ' 19' ' ' ASP . . . -140.86 -59.12 0.51 Allowed 'General case' 0 N--CA 1.494 1.751 0 CA-C-N 114.806 -1.088 . . . . 0.0 110.044 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 41.4 p90 -165.52 165.52 18.94 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-N 114.659 -1.155 . . . . 0.0 109.416 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -117.18 121.08 5.02 Favored Glycine 0 N--CA 1.491 2.315 0 O-C-N 125.386 1.678 . . . . 0.0 110.878 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 8.4 p -79.29 133.71 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 N-CA-C 106.114 -1.81 . . . . 0.0 106.114 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 7.8 m -114.97 76.24 4.29 Favored Pre-proline 0 N--CA 1.499 1.987 0 O-C-N 123.742 0.651 . . . . 0.0 110.441 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo . . . . . 0 N--CA 1.493 1.447 0 C-N-CA 122.952 2.435 . . . . 0.0 110.704 -176.659 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 1.7 m . . . . . 0 N--CA 1.495 1.778 0 N-CA-C 113.993 1.109 . . . . 0.0 113.993 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 12.6 t -90.72 -174.93 4.24 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-N 113.379 -1.737 . . . . 0.0 108.195 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -157.03 155.04 30.53 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 106.388 -1.708 . . . . 0.0 106.388 179.65 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 27.6 t -54.82 -26.87 37.8 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 114.343 1.238 . . . . 0.0 114.343 -179.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 44.2 t -76.41 -48.47 19.65 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-N 114.386 -1.279 . . . . 0.0 111.391 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -79.49 57.19 2.34 Favored 'General case' 0 N--CA 1.497 1.895 0 CA-C-N 113.348 -1.751 . . . . 0.0 112.829 -179.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -147.46 152.59 24.7 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 6.8 t -65.56 128.4 35.76 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-N 113.255 -1.472 . . . . 0.0 109.565 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -73.53 88.1 1.63 Allowed 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 106.22 -1.77 . . . . 0.0 106.22 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 168.98 -25.46 0.11 Allowed Glycine 0 N--CA 1.488 2.132 0 CA-C-N 112.673 -2.058 . . . . 0.0 110.07 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 56.2 m -100.4 124.08 45.44 Favored 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 122.094 0.95 . . . . 0.0 111.541 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 28.1 mtpp -73.49 93.59 2.01 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 112.681 -2.054 . . . . 0.0 112.157 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.473 ' CD1' HD13 ' A' ' 103' ' ' ILE . 8.3 m-85 -48.83 128.25 15.31 Favored 'General case' 0 N--CA 1.501 2.118 0 N-CA-C 106.704 -1.591 . . . . 0.0 106.704 179.413 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -142.87 155.24 44.73 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 114.706 -1.134 . . . . 0.0 112.348 -179.467 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 40.2 t -101.52 133.83 45.57 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-N 113.231 -1.804 . . . . 0.0 110.939 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -48.87 -28.74 3.98 Favored 'General case' 0 N--CA 1.502 2.132 0 N-CA-C 115.834 1.79 . . . . 0.0 115.834 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -52.0 -24.25 6.32 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 123.946 0.779 . . . . 0.0 111.738 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 113.63 28.27 3.28 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 108.616 -1.794 . . . . 0.0 108.616 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 88.6 m -139.17 140.6 37.88 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 124.045 0.497 . . . . 0.0 110.981 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 12.5 t80 -68.57 159.08 32.59 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-N 114.198 -1.365 . . . . 0.0 110.804 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 91.3 t -121.42 -71.4 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 CA-C-N 114.823 -1.081 . . . . 0.0 110.104 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . 0.576 ' SG ' ' N ' ' A' ' 84' ' ' GLU . 0.5 OUTLIER -153.48 -163.02 1.57 Allowed 'General case' 0 N--CA 1.501 2.105 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 -179.875 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.576 ' N ' ' SG ' ' A' ' 83' ' ' CYS . 12.5 tp10 -129.03 146.62 50.95 Favored 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 179.433 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -59.01 138.65 49.45 Favored Glycine 0 N--CA 1.501 2.991 0 N-CA-C 109.257 -1.537 . . . . 0.0 109.257 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 35.8 mm-40 -113.89 31.76 6.32 Favored 'General case' 0 N--CA 1.501 2.098 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 36.8 t -156.0 105.42 2.35 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -79.26 144.73 62.95 Favored Pre-proline 0 N--CA 1.495 1.796 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -64.76 70.97 0.24 Allowed 'Trans proline' 0 N--CA 1.498 1.744 0 C-N-CA 123.088 2.525 . . . . 0.0 110.861 164.127 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 31.4 mtm105 -163.6 -49.95 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 104.868 -2.271 . . . . 0.0 104.868 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -90.41 133.23 33.43 Favored Pre-proline 0 N--CA 1.489 1.487 0 CA-C-N 114.053 -1.43 . . . . 0.0 110.356 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -79.9 50.26 3.47 Favored 'Trans proline' 0 N--CA 1.495 1.598 0 C-N-CA 123.521 2.814 . . . . 0.0 112.1 173.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -80.47 124.8 29.23 Favored 'General case' 0 N--CA 1.5 2.047 0 C-N-CA 120.126 -0.63 . . . . 0.0 111.076 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -80.1 166.13 21.81 Favored 'General case' 0 N--CA 1.497 1.878 0 CA-C-N 114.679 -1.146 . . . . 0.0 109.525 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 97.0 m -151.44 160.55 31.64 Favored Pre-proline 0 N--CA 1.497 1.906 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -60.33 130.17 32.84 Favored 'Trans proline' 0 N--CA 1.493 1.47 0 C-N-CA 122.709 2.273 . . . . 0.0 109.401 166.128 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.527 ' HA ' ' NE ' ' A' ' 97' ' ' ARG . 3.4 tpm_? -81.27 10.28 5.77 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 123.991 0.807 . . . . 0.0 110.203 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.6 ' H ' HD22 ' A' ' 98' ' ' ASN . 2.7 m-80 -52.47 153.83 2.83 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 114.105 1.15 . . . . 0.0 114.105 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 63.0 m -91.93 137.56 32.26 Favored 'General case' 0 N--CA 1.495 1.776 0 CA-C-N 113.897 -1.501 . . . . 0.0 111.402 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -119.98 88.36 40.43 Favored Pre-proline 0 N--CA 1.497 1.917 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 179.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -63.98 -33.35 63.27 Favored 'Trans proline' 0 N--CA 1.491 1.327 0 C-N-CA 122.683 2.255 . . . . 0.0 112.545 -170.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 15.9 ptm180 -64.98 -30.18 71.15 Favored 'General case' 0 N--CA 1.497 1.895 0 C-N-CA 119.574 -0.85 . . . . 0.0 111.965 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.473 HD13 ' CD1' ' A' ' 74' ' ' TYR . 11.9 mt -70.38 156.04 7.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 C-N-CA 118.907 -1.117 . . . . 0.0 109.66 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -137.94 -40.44 0.54 Allowed 'General case' 0 N--CA 1.491 1.58 0 CA-C-N 112.617 -2.083 . . . . 0.0 110.132 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 46.1 m-85 -143.0 -165.28 2.03 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 124.333 1.02 . . . . 0.0 110.635 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -154.97 94.07 0.14 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 103.907 -3.677 . . . . 0.0 103.907 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 37.7 mm -79.16 96.28 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 N-CA-C 116.066 1.876 . . . . 0.0 116.066 -179.464 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 1.7 m -79.96 150.94 72.78 Favored Pre-proline 0 N--CA 1.5 2.052 0 N-CA-C 105.861 -1.903 . . . . 0.0 105.861 179.238 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo . . . . . 0 N--CA 1.497 1.682 0 C-N-CA 123.115 2.543 . . . . 0.0 112.394 -172.313 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 47.8 tpt85 . . . . . 0 N--CA 1.494 1.763 0 CA-C-O 120.905 0.383 . . . . 0.0 110.37 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 7.6 tp -84.5 49.21 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 CA-C-N 114.634 -1.166 . . . . 0.0 110.077 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.434 ' HA ' ' HA ' ' A' ' 41' ' ' CYS . 1.6 m -82.38 59.76 4.73 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 115.24 1.57 . . . . 0.0 115.24 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 38.6 m -91.03 163.43 14.31 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 105.092 -2.188 . . . . 0.0 105.092 179.393 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.477 ' ND2' ' H ' ' A' ' 9' ' ' ALA . 40.8 p-10 -158.5 175.66 13.4 Favored 'General case' 0 N--CA 1.499 2.023 0 C-N-CA 118.895 -1.122 . . . . 0.0 113.057 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 45.3 t -78.44 -32.47 48.54 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-N 113.198 -1.819 . . . . 0.0 113.704 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 38.3 t -77.01 -62.86 1.51 Allowed 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 113.892 1.071 . . . . 0.0 113.892 -179.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.477 ' H ' ' ND2' ' A' ' 6' ' ' ASN . . . -84.81 63.97 8.33 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 124.743 1.277 . . . . 0.0 111.376 -179.702 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -137.54 -169.61 11.67 Favored Glycine 0 N--CA 1.498 2.823 0 CA-C-N 113.559 -1.655 . . . . 0.0 111.518 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.414 ' N ' ' OH ' ' A' ' 16' ' ' TYR . 4.5 t -102.62 111.62 24.02 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 114.191 1.182 . . . . 0.0 114.191 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.404 ' HA ' ' HA3' ' A' ' 27' ' ' GLY . 21.8 pttp -64.87 81.7 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.958 0 CA-C-N 113.608 -1.633 . . . . 0.0 110.789 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -175.18 -31.57 0.04 OUTLIER Glycine 0 N--CA 1.486 2.028 0 CA-C-N 113.057 -1.883 . . . . 0.0 109.629 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.445 ' HA ' ' HA ' ' A' ' 50' ' ' CYS . 21.9 m -104.64 148.19 26.81 Favored 'General case' 0 N--CA 1.501 2.085 0 C-N-CA 118.775 -1.17 . . . . 0.0 112.964 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -92.95 88.3 6.1 Favored 'General case' 0 N--CA 1.484 1.23 0 CA-C-N 113.307 -1.77 . . . . 0.0 107.428 -179.397 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.414 ' OH ' ' N ' ' A' ' 11' ' ' THR . 11.0 m-30 -46.4 134.95 8.64 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-N 113.59 -1.641 . . . . 0.0 108.494 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 10.8 t80 -145.16 156.16 43.71 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-N 113.232 -1.804 . . . . 0.0 111.511 -179.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 28.8 t -112.53 136.11 52.45 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-N 111.838 -2.437 . . . . 0.0 115.313 -179.462 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -52.14 -21.47 3.32 Favored 'General case' 0 N--CA 1.499 1.989 0 CA-C-N 112.266 -2.243 . . . . 0.0 113.715 179.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 43.6 p30 -64.19 -1.86 1.81 Allowed 'General case' 0 N--CA 1.497 1.917 0 O-C-N 124.04 0.838 . . . . 0.0 111.231 179.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 85.74 29.15 27.29 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 108.94 -1.664 . . . . 0.0 108.94 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 95.5 m -141.21 150.47 42.73 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 121.831 0.824 . . . . 0.0 110.557 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 24.2 t80 -73.52 155.65 38.97 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-N 113.144 -1.844 . . . . 0.0 111.979 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 90.9 t -115.27 -77.0 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 CA-C-N 114.673 -1.149 . . . . 0.0 109.056 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.654 ' SG ' ' N ' ' A' ' 26' ' ' GLU . 0.1 OUTLIER -166.97 -168.61 1.13 Allowed 'General case' 0 N--CA 1.507 2.393 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 179.979 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.654 ' N ' ' SG ' ' A' ' 25' ' ' CYS . 3.5 tm-20 -128.36 140.96 51.58 Favored 'General case' 0 N--CA 1.5 2.046 0 N-CA-C 104.52 -2.4 . . . . 0.0 104.52 179.496 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.404 ' HA3' ' HA ' ' A' ' 12' ' ' LYS . . . -39.27 117.82 0.78 Allowed Glycine 0 N--CA 1.5 2.928 0 CA-C-O 122.041 0.8 . . . . 0.0 114.869 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -92.87 0.66 57.45 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-N 113.072 -1.564 . . . . 0.0 112.061 -179.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 27.5 t -156.22 170.3 22.56 Favored 'General case' 0 N--CA 1.501 2.103 0 C-N-CA 119.609 -0.837 . . . . 0.0 111.467 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -79.29 143.84 61.12 Favored Pre-proline 0 N--CA 1.493 1.694 0 CA-C-N 114.626 -1.17 . . . . 0.0 107.883 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -70.37 67.67 2.08 Favored 'Trans proline' 0 N--CA 1.5 1.9 0 C-N-CA 123.158 2.572 . . . . 0.0 111.073 172.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 67.0 mtp85 -160.33 -39.44 0.05 Allowed 'General case' 0 N--CA 1.496 1.855 0 CA-C-N 113.246 -1.797 . . . . 0.0 107.764 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.537 HD22 ' N ' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -39.71 102.98 0.27 Allowed Pre-proline 0 N--CA 1.498 1.945 0 O-C-N 124.876 1.36 . . . . 0.0 114.416 -179.877 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -76.4 179.57 6.26 Favored 'Trans proline' 0 N--CA 1.494 1.54 0 C-N-CA 122.821 2.348 . . . . 0.0 111.029 -179.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 25.7 ttpp 62.9 155.25 0.05 OUTLIER 'General case' 0 N--CA 1.5 2.071 0 O-C-N 124.673 1.233 . . . . 0.0 112.618 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -79.87 147.33 31.76 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-N 114.639 -1.164 . . . . 0.0 110.124 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.579 ' H ' HD21 ' A' ' 40' ' ' ASN . 98.4 m -79.66 -87.91 0.07 Allowed 'General case' 0 N--CA 1.492 1.663 0 CA-C-N 114.66 -1.154 . . . . 0.0 110.593 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.418 ' H ' ' H ' ' A' ' 39' ' ' LEU . 7.9 t -168.9 -15.53 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.019 0 O-C-N 123.616 0.573 . . . . 0.0 110.732 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.418 ' H ' ' H ' ' A' ' 38' ' ' THR . 0.8 OUTLIER -153.44 64.92 0.75 Allowed 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 103.837 -2.653 . . . . 0.0 103.837 -179.955 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.579 HD21 ' H ' ' A' ' 37' ' ' CYS . 13.4 m120 -84.15 47.59 1.35 Allowed 'General case' 0 N--CA 1.491 1.602 0 CA-C-N 112.702 -2.045 . . . . 0.0 112.959 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.434 ' HA ' ' HA ' ' A' ' 4' ' ' CYS . 75.3 m -158.04 126.31 5.42 Favored 'General case' 0 N--CA 1.498 1.93 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.781 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -147.83 81.36 8.43 Favored Pre-proline 0 N--CA 1.496 1.852 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.313 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -60.82 -31.11 91.39 Favored 'Trans proline' 0 N--CA 1.493 1.496 0 C-N-CA 122.744 2.296 . . . . 0.0 114.391 -173.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 7.3 ptm180 -58.59 -30.73 67.43 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 123.813 0.696 . . . . 0.0 111.955 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 13.9 tt -47.33 156.79 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 O-C-N 124.226 0.954 . . . . 0.0 113.279 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -137.85 -50.76 0.6 Allowed 'General case' 0 N--CA 1.492 1.636 0 CA-C-N 113.967 -1.469 . . . . 0.0 107.102 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 46.9 p90 -168.32 167.14 12.22 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-N 113.883 -1.508 . . . . 0.0 109.485 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -118.49 108.69 1.64 Allowed Glycine 0 N--CA 1.491 2.316 0 N-CA-C 107.861 -2.096 . . . . 0.0 107.861 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 5.6 p -80.15 111.42 16.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 C-N-CA 118.895 -1.122 . . . . 0.0 110.233 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.445 ' HA ' ' HA ' ' A' ' 14' ' ' CYS . 1.7 m -78.57 110.15 13.02 Favored Pre-proline 0 N--CA 1.499 2.014 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.484 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo . . . . . 0 N--CA 1.49 1.307 0 C-N-CA 122.816 2.344 . . . . 0.0 108.415 -175.553 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.419 ' HA ' ' HA ' ' A' ' 99' ' ' CYS . 1.7 m . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 122.814 1.292 . . . . 0.0 114.222 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.6 p -91.25 159.09 16.22 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-N 112.889 -1.96 . . . . 0.0 109.573 179.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.62 HD21 ' H ' ' A' ' 99' ' ' CYS . 64.1 m-20 -152.94 157.02 40.0 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 125.018 1.448 . . . . 0.0 111.259 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' CYS . . . . . 0.492 ' HA ' ' CD2' ' A' ' 74' ' ' TYR . 3.6 t -62.1 -38.37 88.63 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-N 114.541 -1.209 . . . . 0.0 108.427 179.65 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 43.0 t -66.99 -50.85 60.97 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 112.363 -2.199 . . . . 0.0 110.634 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -79.36 -114.2 0.02 OUTLIER 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 113.924 -1.489 . . . . 0.0 110.701 -179.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 46.16 -129.89 10.62 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 111.044 -0.822 . . . . 0.0 111.044 -179.512 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 40.7 p -150.94 135.19 16.88 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 123.879 0.399 . . . . 0.0 111.689 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -61.1 104.2 0.35 Allowed 'General case' 0 N--CA 1.499 2.015 0 O-C-N 124.249 0.968 . . . . 0.0 110.309 179.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 141.43 -24.75 2.49 Favored Glycine 0 N--CA 1.494 2.551 0 O-C-N 123.93 0.769 . . . . 0.0 111.659 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 94.7 m -91.74 133.29 35.73 Favored 'General case' 0 N--CA 1.498 1.927 0 C-N-CA 120.736 -0.386 . . . . 0.0 110.441 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.7 mppt? -88.04 88.7 7.73 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 124.057 0.848 . . . . 0.0 110.46 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.515 ' CE2' ' HA2' ' A' ' 85' ' ' GLY . 77.7 m-85 -40.71 136.14 1.46 Allowed 'General case' 0 N--CA 1.503 2.176 0 O-C-N 124.613 1.196 . . . . 0.0 109.761 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -148.17 145.23 28.23 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 124.753 1.283 . . . . 0.0 113.399 -179.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.409 ' N ' HG23 ' A' ' 82' ' ' VAL . 42.0 t -106.81 118.69 37.35 Favored 'General case' 0 N--CA 1.499 1.995 0 CA-C-N 112.653 -2.067 . . . . 0.0 111.902 -179.675 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.516 ' HB3' ' HB2' ' A' ' 104' ' ' ALA . 6.1 p-10 -55.16 -52.89 61.87 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 126.323 2.264 . . . . 0.0 112.703 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -69.55 -0.74 7.14 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 112.108 -2.315 . . . . 0.0 112.541 -179.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -139.46 -84.4 0.1 Allowed Glycine 0 N--CA 1.482 1.702 0 C-N-CA 119.202 -1.475 . . . . 0.0 112.209 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.485 ' CG2' ' H ' ' A' ' 81' ' ' PHE . 1.2 m 175.79 -170.33 0.06 Allowed 'General case' 0 N--CA 1.5 2.04 0 O-C-N 126.22 1.777 . . . . 0.0 106.252 -179.166 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.485 ' H ' ' CG2' ' A' ' 80' ' ' THR . 75.8 t80 -42.62 146.55 0.35 Allowed 'General case' 0 N--CA 1.498 1.955 0 C-N-CA 123.554 0.742 . . . . 0.0 112.636 179.527 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.409 HG23 ' N ' ' A' ' 76' ' ' SER . 88.4 t -111.17 -70.93 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 CA-C-N 113.878 -1.51 . . . . 0.0 111.585 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . 0.534 ' SG ' ' N ' ' A' ' 84' ' ' GLU . 0.1 OUTLIER -160.25 -170.57 2.87 Favored 'General case' 0 N--CA 1.506 2.37 0 C-N-CA 120.41 -0.516 . . . . 0.0 110.827 -179.881 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.534 ' N ' ' SG ' ' A' ' 83' ' ' CYS . 38.9 tt0 -114.09 149.74 35.08 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 123.307 0.379 . . . . 0.0 110.716 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.515 ' HA2' ' CE2' ' A' ' 74' ' ' TYR . . . -36.8 105.7 0.04 OUTLIER Glycine 0 N--CA 1.501 2.992 0 O-C-N 124.833 1.333 . . . . 0.0 115.135 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -94.12 -8.86 38.35 Favored 'General case' 0 N--CA 1.502 2.145 0 C-N-CA 119.128 -1.029 . . . . 0.0 113.726 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 15.6 m -85.13 90.86 7.97 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -79.33 106.72 4.96 Favored Pre-proline 0 N--CA 1.49 1.536 0 N-CA-C 104.107 -2.553 . . . . 0.0 104.107 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -40.15 -34.81 1.08 Allowed 'Trans proline' 0 N--CA 1.501 1.938 0 C-N-CA 124.819 3.679 . . . . 0.0 116.265 -145.12 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 8.9 ptm180 -58.73 -14.02 7.5 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 123.861 0.726 . . . . 0.0 112.891 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.595 HD22 ' H ' ' A' ' 91' ' ' ASN . 0.1 OUTLIER -75.28 129.31 82.74 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 123.948 0.78 . . . . 0.0 110.936 -179.918 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -83.32 44.97 1.74 Allowed 'Trans proline' 0 N--CA 1.493 1.461 0 C-N-CA 123.275 2.65 . . . . 0.0 109.769 162.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.468 ' HE3' ' HA ' ' A' ' 93' ' ' LYS . 0.0 OUTLIER 64.98 168.94 0.19 Allowed 'General case' 0 N--CA 1.507 2.396 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.01 -179.877 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -160.21 44.82 0.21 Allowed 'General case' 0 N--CA 1.5 2.048 0 C-N-CA 120.061 -0.656 . . . . 0.0 112.759 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 61.0 m -156.77 130.76 4.84 Favored Pre-proline 0 N--CA 1.501 2.101 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.829 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_endo -76.4 35.25 0.46 Allowed 'Trans proline' 0 N--CA 1.496 1.624 0 C-N-CA 123.039 2.493 . . . . 0.0 111.209 163.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 83.3 mmt-85 -108.99 37.07 2.66 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.553 ' H ' HD22 ' A' ' 98' ' ' ASN . 4.9 m-80 -54.25 135.51 44.21 Favored 'General case' 0 N--CA 1.495 1.789 0 CA-C-N 113.813 -1.54 . . . . 0.0 112.425 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.62 ' H ' HD21 ' A' ' 64' ' ' ASN . 34.4 m 57.51 127.84 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.822 0 O-C-N 125.232 1.582 . . . . 0.0 114.747 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -122.99 93.12 48.67 Favored Pre-proline 0 N--CA 1.5 2.061 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_endo -62.11 -13.7 33.38 Favored 'Trans proline' 0 N--CA 1.496 1.635 0 C-N-CA 122.126 1.884 . . . . 0.0 113.505 -175.374 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 77.8 ttt-85 -90.17 -25.36 20.7 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 114.238 1.199 . . . . 0.0 114.238 -179.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 11.6 tt -74.12 141.95 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 C-N-CA 118.658 -1.217 . . . . 0.0 110.473 -179.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.516 ' HB2' ' HB3' ' A' ' 77' ' ' ASP . . . -79.82 -58.85 2.97 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 105.791 -1.929 . . . . 0.0 105.791 179.715 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 4.3 p90 174.96 171.83 0.25 Allowed 'General case' 0 N--CA 1.488 1.473 0 CA-C-N 111.402 -2.635 . . . . 0.0 106.819 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -94.8 132.19 11.03 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 110.183 -1.167 . . . . 0.0 110.183 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 39.4 mm -78.45 90.86 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 N-CA-C 103.932 -2.618 . . . . 0.0 103.932 179.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 19.5 m -84.28 127.34 66.67 Favored Pre-proline 0 N--CA 1.493 1.716 0 CA-C-N 113.37 -1.741 . . . . 0.0 111.08 -179.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo . . . . . 0 N--CA 1.491 1.367 0 C-N-CA 122.386 2.057 . . . . 0.0 107.951 146.678 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 71.4 ttt-85 . . . . . 0 N--CA 1.492 1.645 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.427 HD13 ' H ' ' A' ' 5' ' ' THR . 0.0 OUTLIER -73.93 109.6 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 179.997 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.514 ' HA ' ' HA ' ' A' ' 41' ' ' CYS . 1.6 m -132.59 29.3 4.22 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 115.78 1.77 . . . . 0.0 115.78 179.625 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.427 ' H ' HD13 ' A' ' 3' ' ' ILE . 2.5 p -92.33 147.34 22.99 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-N 112.427 -2.169 . . . . 0.0 108.588 179.631 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.616 HD22 ' H ' ' A' ' 41' ' ' CYS . 20.7 p30 -160.61 158.26 28.67 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 124.722 1.263 . . . . 0.0 109.858 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 5.3 t -71.21 -30.12 65.98 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 115.287 1.588 . . . . 0.0 115.287 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 43.1 t -80.81 -65.29 1.03 Allowed 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 -179.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -88.79 39.7 0.94 Allowed 'General case' 0 N--CA 1.499 2.012 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.03 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -76.54 -133.61 0.52 Allowed Glycine 0 N--CA 1.492 2.392 0 CA-C-N 114.943 -1.026 . . . . 0.0 111.23 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 35.3 p -152.56 103.69 2.83 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 35.2 ttpt -51.87 108.22 0.26 Allowed 'General case' 0 N--CA 1.5 2.041 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.529 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 143.26 -20.89 2.26 Favored Glycine 0 N--CA 1.496 2.659 0 N-CA-C 110.314 -1.114 . . . . 0.0 110.314 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 80.7 m -114.56 150.35 35.11 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 124.244 0.614 . . . . 0.0 109.84 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.432 ' N ' ' HE2' ' A' ' 15' ' ' LYS . 0.2 OUTLIER -93.81 94.43 8.52 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 124.159 0.912 . . . . 0.0 111.503 -179.781 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 31.3 m-85 -59.34 115.33 3.17 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 106.662 -1.607 . . . . 0.0 106.662 179.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.525 ' CE2' ' HA ' ' A' ' 22' ' ' THR . 0.0 OUTLIER -129.42 147.71 51.26 Favored 'General case' 0 N--CA 1.486 1.363 0 CA-C-N 112.008 -2.36 . . . . 0.0 112.836 -179.343 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.427 ' HA ' ' H ' ' A' ' 46' ' ' ALA . 46.6 t -98.21 123.93 42.53 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-N 112.87 -1.968 . . . . 0.0 112.05 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.461 ' HB3' ' HB2' ' A' ' 46' ' ' ALA . 5.5 p-10 -60.53 -43.15 97.47 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-N 113.916 -1.493 . . . . 0.0 108.444 179.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -94.98 18.37 12.14 Favored 'General case' 0 N--CA 1.487 1.394 0 CA-C-N 112.182 -2.281 . . . . 0.0 112.024 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -170.71 31.53 0.14 Allowed Glycine 0 N--CA 1.498 2.777 0 C-N-CA 118.528 -1.796 . . . . 0.0 113.75 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.525 ' HA ' ' CE2' ' A' ' 17' ' ' PHE . 6.1 t 44.19 -168.79 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 114.214 1.19 . . . . 0.0 114.214 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 62.8 t80 -47.84 133.62 13.98 Favored 'General case' 0 N--CA 1.498 1.95 0 CA-C-O 121.697 0.761 . . . . 0.0 112.805 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 98.2 t -104.04 -78.65 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 CA-C-N 113.044 -1.889 . . . . 0.0 106.799 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.458 ' SG ' ' N ' ' A' ' 26' ' ' GLU . 0.2 OUTLIER -157.31 -171.4 3.59 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 179.732 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.458 ' N ' ' SG ' ' A' ' 25' ' ' CYS . 16.1 mt-10 -109.06 157.12 19.01 Favored 'General case' 0 N--CA 1.495 1.775 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 179.715 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -49.69 106.68 0.24 Allowed Glycine 0 N--CA 1.496 2.663 0 O-C-N 124.124 0.89 . . . . 0.0 112.05 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -79.44 -9.23 59.56 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-N 114.93 -0.635 . . . . 0.0 110.297 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 34.0 t -79.72 97.11 6.45 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.552 ' H ' HD21 ' A' ' 33' ' ' ASN . 10.8 t70 -79.82 137.23 54.29 Favored Pre-proline 0 N--CA 1.495 1.785 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -71.48 68.65 2.76 Favored 'Trans proline' 0 N--CA 1.497 1.711 0 C-N-CA 123.567 2.845 . . . . 0.0 111.411 176.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.497 ' NE ' ' HA ' ' A' ' 32' ' ' ARG . 3.9 mmp_? -158.0 -44.99 0.06 Allowed 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 105.293 -2.114 . . . . 0.0 105.293 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.552 HD21 ' H ' ' A' ' 30' ' ' ASP . 13.4 p30 -90.35 150.54 43.15 Favored Pre-proline 0 N--CA 1.495 1.783 0 O-C-N 124.275 0.985 . . . . 0.0 110.522 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.13 169.82 21.72 Favored 'Trans proline' 0 N--CA 1.491 1.343 0 C-N-CA 122.843 2.362 . . . . 0.0 108.916 159.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 22.4 ptmt -69.56 147.04 51.3 Favored 'General case' 0 N--CA 1.496 1.853 0 C-N-CA 120.124 -0.63 . . . . 0.0 110.4 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -158.81 41.56 0.24 Allowed 'General case' 0 N--CA 1.496 1.839 0 CA-C-N 115.322 -0.854 . . . . 0.0 108.849 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 76.4 m -108.23 178.68 4.43 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-N 114.069 -1.423 . . . . 0.0 111.595 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 8.4 t -134.15 -3.17 2.79 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-N 113.537 -1.665 . . . . 0.0 108.269 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.17 30.59 2.72 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.487 ' H ' HD22 ' A' ' 40' ' ' ASN . 6.9 m-80 -57.75 123.22 14.96 Favored 'General case' 0 N--CA 1.497 1.923 0 CA-C-N 114.712 -1.131 . . . . 0.0 109.358 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.616 ' H ' HD22 ' A' ' 6' ' ' ASN . 70.9 m 58.01 107.56 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.856 0 O-C-N 125.079 1.487 . . . . 0.0 110.616 -179.612 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -108.76 102.99 50.32 Favored Pre-proline 0 N--CA 1.499 2.007 0 CA-C-N 115.243 -0.889 . . . . 0.0 112.654 -179.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -67.34 -7.05 17.89 Favored 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 121.888 1.725 . . . . 0.0 112.216 178.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 60.9 mtt85 -89.97 -14.59 33.75 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 123.643 0.589 . . . . 0.0 111.967 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 15.3 tt -106.79 160.74 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.461 ' HB2' ' HB3' ' A' ' 19' ' ' ASP . . . -83.85 -74.65 0.37 Allowed 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 105.378 -2.082 . . . . 0.0 105.378 179.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 50.9 p90 179.71 176.37 0.69 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 124.769 1.293 . . . . 0.0 109.552 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -79.94 102.02 1.99 Allowed Glycine 0 N--CA 1.49 2.243 0 CA-C-N 114.125 -1.398 . . . . 0.0 111.797 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 17.7 m -78.54 98.38 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 N-CA-C 106.258 -1.756 . . . . 0.0 106.258 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.9 m -79.93 176.29 3.92 Favored Pre-proline 0 N--CA 1.495 1.779 0 CA-C-N 113.218 -1.81 . . . . 0.0 108.26 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo . . . . . 0 N--CA 1.495 1.583 0 C-N-CA 122.219 1.946 . . . . 0.0 112.3 173.05 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.507 ' HA ' ' HA ' ' A' ' 99' ' ' CYS . 1.7 m . . . . . 0 N--CA 1.487 1.411 0 CA-C-O 123.336 1.541 . . . . 0.0 115.076 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 60.2 m -91.38 118.38 30.48 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-N 111.756 -2.474 . . . . 0.0 104.87 179.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.593 ' ND2' ' H ' ' A' ' 67' ' ' ALA . 20.8 p-10 -140.46 161.02 38.71 Favored 'General case' 0 N--CA 1.502 2.158 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 1.4 t -65.53 -36.69 84.57 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-N 113.539 -1.664 . . . . 0.0 115.296 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 51.0 t -75.35 -64.48 1.05 Allowed 'General case' 0 N--CA 1.497 1.913 0 O-C-N 123.775 0.672 . . . . 0.0 110.669 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.593 ' H ' ' ND2' ' A' ' 64' ' ' ASN . . . -90.13 52.41 2.26 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -88.53 -138.65 6.4 Favored Glycine 0 N--CA 1.493 2.449 0 CA-C-N 114.256 -1.338 . . . . 0.0 112.205 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 94.8 m -140.91 105.75 4.94 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 124.48 0.753 . . . . 0.0 110.758 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 10.9 tptm -56.02 104.19 0.13 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 124.208 0.943 . . . . 0.0 108.613 179.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 140.32 -1.78 2.2 Favored Glycine 0 N--CA 1.492 2.401 0 CA-C-N 114.517 -1.22 . . . . 0.0 110.82 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 91.9 m -141.44 146.95 37.15 Favored 'General case' 0 N--CA 1.498 1.934 0 CA-C-N 117.074 0.437 . . . . 0.0 111.282 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.475 ' HB3' ' CE1' ' A' ' 81' ' ' PHE . 8.0 mtpm? -89.33 90.39 8.31 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-N 114.875 -1.057 . . . . 0.0 111.89 -179.683 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -53.96 120.96 7.06 Favored 'General case' 0 N--CA 1.5 2.052 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -124.38 160.71 27.54 Favored 'General case' 0 N--CA 1.493 1.701 0 CA-C-N 113.184 -1.825 . . . . 0.0 113.731 -179.383 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 29.8 t -104.06 131.89 50.86 Favored 'General case' 0 N--CA 1.498 1.93 0 CA-C-N 113.834 -1.53 . . . . 0.0 112.597 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.408 ' HB3' ' CB ' ' A' ' 104' ' ' ALA . 4.1 p-10 -46.24 -29.83 1.76 Allowed 'General case' 0 N--CA 1.502 2.17 0 N-CA-C 116.117 1.895 . . . . 0.0 116.117 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -51.82 -24.41 6.05 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 123.955 0.784 . . . . 0.0 111.818 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 113.7 26.95 3.71 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 108.851 -1.7 . . . . 0.0 108.851 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 86.3 m -138.67 139.49 38.49 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 124.005 0.473 . . . . 0.0 110.875 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.475 ' CE1' ' HB3' ' A' ' 73' ' ' LYS . 13.0 t80 -71.97 150.76 43.8 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-N 114.312 -1.313 . . . . 0.0 109.648 179.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 97.2 t -110.1 -78.89 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -159.36 175.21 13.63 Favored 'General case' 0 N--CA 1.501 2.099 0 C-N-CA 120.675 -0.41 . . . . 0.0 110.022 179.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -92.72 141.23 28.69 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -45.6 105.59 0.09 OUTLIER Glycine 0 N--CA 1.5 2.956 0 O-C-N 124.166 0.916 . . . . 0.0 111.557 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -79.47 7.15 8.61 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-N 114.526 -0.837 . . . . 0.0 112.456 -179.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 46.9 t -132.93 119.65 20.42 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -79.23 143.92 61.53 Favored Pre-proline 0 N--CA 1.495 1.777 0 O-C-N 124.105 0.878 . . . . 0.0 108.675 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -70.15 64.18 2.03 Favored 'Trans proline' 0 N--CA 1.5 1.903 0 C-N-CA 123.614 2.876 . . . . 0.0 112.402 176.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 53.5 mmm-85 -158.68 -44.42 0.06 Allowed 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 105.616 -1.994 . . . . 0.0 105.616 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -90.78 121.69 67.83 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 124.274 0.984 . . . . 0.0 109.664 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -80.27 50.14 3.44 Favored 'Trans proline' 0 N--CA 1.495 1.604 0 C-N-CA 123.427 2.751 . . . . 0.0 111.686 174.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -82.21 124.72 30.16 Favored 'General case' 0 N--CA 1.496 1.874 0 C-N-CA 120.346 -0.542 . . . . 0.0 111.057 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -87.38 -176.97 5.82 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-N 114.357 -1.292 . . . . 0.0 109.803 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 77.6 m -153.94 158.68 32.51 Favored Pre-proline 0 N--CA 1.496 1.868 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.939 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -70.2 -25.72 26.26 Favored 'Trans proline' 0 N--CA 1.491 1.34 0 C-N-CA 122.069 1.846 . . . . 0.0 108.239 159.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 5.2 mmp_? -83.5 5.04 25.34 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-N 114.324 -1.307 . . . . 0.0 112.319 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -50.27 136.15 20.36 Favored 'General case' 0 N--CA 1.503 2.224 0 C-N-CA 120.499 -0.48 . . . . 0.0 110.927 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.507 ' HA ' ' HA ' ' A' ' 62' ' ' CYS . 59.8 m 61.96 114.5 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.773 0 O-C-N 125.309 1.63 . . . . 0.0 111.58 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -125.6 97.29 36.67 Favored Pre-proline 0 N--CA 1.499 2.008 0 N-CA-C 113.21 0.819 . . . . 0.0 113.21 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -48.63 -32.49 21.54 Favored 'Trans proline' 0 N--CA 1.495 1.585 0 C-N-CA 123.189 2.593 . . . . 0.0 112.425 174.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 31.1 ttp-105 -61.02 -50.04 74.98 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 106.46 -1.681 . . . . 0.0 106.46 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 4.0 mt -67.91 155.89 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 179.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.408 ' CB ' ' HB3' ' A' ' 77' ' ' ASP . . . -141.77 -34.5 0.47 Allowed 'General case' 0 N--CA 1.49 1.57 0 CA-C-N 113.484 -1.689 . . . . 0.0 111.334 -179.695 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 51.7 m-85 -139.65 -164.3 1.66 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 124.255 0.972 . . . . 0.0 111.149 -179.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -153.33 104.14 0.25 Allowed Glycine 0 N--CA 1.488 2.131 0 N-CA-C 105.983 -2.847 . . . . 0.0 105.983 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 51.2 mm -79.21 93.53 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 -179.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 8.0 m -79.44 149.17 71.6 Favored Pre-proline 0 N--CA 1.493 1.718 0 CA-C-N 113.718 -1.583 . . . . 0.0 108.923 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo . . . . . 0 N--CA 1.494 1.507 0 C-N-CA 122.496 2.131 . . . . 0.0 110.253 -175.631 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 41.6 ttm180 . . . . . 0 N--CA 1.496 1.861 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 8.5 tp -83.67 54.53 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 CA-C-N 114.449 -1.25 . . . . 0.0 109.912 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 42.7 m -87.52 54.66 3.21 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-O 122.479 1.133 . . . . 0.0 112.808 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 17.2 p -89.49 170.8 10.2 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-N 113.128 -1.851 . . . . 0.0 108.809 179.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 18.4 p-10 -162.55 135.76 5.97 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 124.24 0.963 . . . . 0.0 113.548 179.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -59.11 -31.56 69.03 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-N 114.563 -1.199 . . . . 0.0 113.884 179.716 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 48.4 t -68.76 -59.42 3.11 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-N 114.808 -1.087 . . . . 0.0 112.386 -179.584 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -74.5 -96.23 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.863 0 C-N-CA 118.714 -1.194 . . . . 0.0 110.052 -179.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 52.27 -126.57 31.06 Favored Glycine 0 N--CA 1.488 2.105 0 O-C-N 123.567 0.542 . . . . 0.0 112.042 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 92.5 m -152.18 119.21 5.83 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 22.5 ttmm -68.54 91.64 0.42 Allowed 'General case' 0 N--CA 1.494 1.766 0 CA-C-O 122.283 1.039 . . . . 0.0 109.048 179.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 163.59 -34.19 0.29 Allowed Glycine 0 N--CA 1.488 2.163 0 CA-C-N 112.9 -1.954 . . . . 0.0 109.007 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 50.5 m -105.16 130.55 53.3 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-O 121.528 0.68 . . . . 0.0 109.229 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.485 ' HB3' ' CE1' ' A' ' 23' ' ' PHE . 57.5 mtpt -78.36 91.22 4.43 Favored 'General case' 0 N--CA 1.485 1.319 0 CA-C-N 113.171 -1.832 . . . . 0.0 112.55 -179.54 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 75.5 m-85 -58.87 121.22 10.6 Favored 'General case' 0 N--CA 1.501 2.113 0 N-CA-C 105.784 -1.932 . . . . 0.0 105.784 179.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -128.71 147.51 50.76 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 110.664 -2.971 . . . . 0.0 112.933 -179.218 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 40.1 t -83.44 136.32 34.35 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-N 111.83 -2.441 . . . . 0.0 112.895 -179.748 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -52.18 -30.25 26.05 Favored 'General case' 0 N--CA 1.498 1.958 0 CA-C-N 112.481 -2.145 . . . . 0.0 113.833 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 44.3 p-10 -58.06 -14.16 6.15 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 124.013 0.821 . . . . 0.0 112.268 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 99.97 35.22 4.61 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 108.464 -1.855 . . . . 0.0 108.464 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 55.9 m -136.29 132.49 35.79 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 124.025 0.485 . . . . 0.0 110.241 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.485 ' CE1' ' HB3' ' A' ' 15' ' ' LYS . 8.1 t80 -74.78 141.52 44.37 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 179.671 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 41.0 t -102.53 -79.53 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 N-CA-C 105.666 -1.976 . . . . 0.0 105.666 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -169.0 166.21 11.13 Favored 'General case' 0 N--CA 1.501 2.117 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 179.594 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.469 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 36.8 tt0 -82.13 161.51 22.81 Favored 'General case' 0 N--CA 1.503 2.223 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 179.789 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.443 ' N ' ' HG2' ' A' ' 26' ' ' GLU . . . -61.13 120.39 22.59 Favored Glycine 0 N--CA 1.496 2.657 0 N-CA-C 107.52 -2.232 . . . . 0.0 107.52 179.7 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -86.18 21.33 2.05 Favored 'General case' 0 N--CA 1.499 1.999 0 C-N-CA 119.295 -0.962 . . . . 0.0 110.379 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 35.3 t -139.22 112.57 8.21 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-N 114.801 -1.09 . . . . 0.0 108.537 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -81.01 142.71 52.09 Favored Pre-proline 0 N--CA 1.493 1.721 0 CA-C-N 114.246 -1.343 . . . . 0.0 107.706 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -69.75 68.71 1.68 Allowed 'Trans proline' 0 N--CA 1.499 1.852 0 C-N-CA 122.993 2.462 . . . . 0.0 111.844 176.387 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 35.3 mmt180 -160.65 -39.37 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 CA-C-N 113.546 -1.661 . . . . 0.0 107.416 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 24.7 p30 -71.28 151.94 94.36 Favored Pre-proline 0 N--CA 1.498 1.974 0 C-N-CA 119.902 -0.719 . . . . 0.0 111.253 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo -69.44 167.77 23.06 Favored 'Trans proline' 0 N--CA 1.494 1.514 0 C-N-CA 122.745 2.297 . . . . 0.0 111.7 179.227 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 22.4 ptmt 39.44 -163.81 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.252 0 N-CA-C 115.682 1.734 . . . . 0.0 115.682 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -139.34 179.72 6.37 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-N 115.043 -0.98 . . . . 0.0 109.984 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 87.0 m -79.8 179.51 7.5 Favored 'General case' 0 N--CA 1.497 1.897 0 CA-C-N 114.959 -1.019 . . . . 0.0 112.98 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 69.8 p -130.85 31.82 4.43 Favored 'General case' 0 N--CA 1.495 1.822 0 CA-C-N 113.671 -1.604 . . . . 0.0 108.751 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 39.9 tp -79.86 -1.28 38.36 Favored 'General case' 0 N--CA 1.499 2.01 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.412 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 29.7 m-80 57.56 -174.84 0.07 Allowed 'General case' 0 N--CA 1.499 2.009 0 N-CA-C 114.181 1.178 . . . . 0.0 114.181 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 81.7 m -60.82 134.5 57.15 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-N 114.262 -1.335 . . . . 0.0 111.271 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -128.44 83.79 65.11 Favored Pre-proline 0 N--CA 1.498 1.941 0 O-C-N 123.885 0.74 . . . . 0.0 109.517 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -52.34 -24.44 21.26 Favored 'Trans proline' 0 N--CA 1.495 1.576 0 C-N-CA 122.867 2.378 . . . . 0.0 112.178 176.034 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 28.0 ttt85 -60.73 -50.92 71.55 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 17.6 mt -65.5 153.65 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 CA-C-O 122.066 0.936 . . . . 0.0 109.782 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -124.14 -59.61 1.48 Allowed 'General case' 0 N--CA 1.491 1.589 0 CA-C-N 111.957 -2.383 . . . . 0.0 109.218 -179.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 16.2 p90 -162.64 156.78 21.05 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 124.14 0.9 . . . . 0.0 112.189 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -88.84 103.7 3.0 Favored Glycine 0 N--CA 1.492 2.389 0 CA-C-N 112.816 -1.993 . . . . 0.0 113.235 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 34.2 m -81.25 99.07 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.185 0 CA-C-O 121.531 0.681 . . . . 0.0 109.985 179.708 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.6 m -79.16 125.89 82.69 Favored Pre-proline 0 N--CA 1.503 2.206 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.233 179.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo . . . . . 0 N--CA 1.492 1.397 0 C-N-CA 122.32 2.013 . . . . 0.0 108.516 171.106 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 3.6 m . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 123.145 1.45 . . . . 0.0 109.88 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 25.5 p -90.07 177.42 6.46 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-N 112.038 -2.347 . . . . 0.0 110.333 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.49 ' ND2' ' H ' ' A' ' 67' ' ' ALA . 46.8 p-10 -161.46 -177.11 5.74 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-N 113.797 -1.547 . . . . 0.0 111.143 179.808 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' CYS . . . . . 0.416 ' SG ' ' CD2' ' A' ' 74' ' ' TYR . 11.1 t -91.51 -20.23 21.94 Favored 'General case' 0 N--CA 1.497 1.923 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.026 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 13.4 t -82.62 -61.78 1.79 Allowed 'General case' 0 N--CA 1.491 1.593 0 CA-C-N 113.731 -1.577 . . . . 0.0 112.731 -179.657 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.49 ' H ' ' ND2' ' A' ' 64' ' ' ASN . . . -90.35 60.85 4.84 Favored 'General case' 0 N--CA 1.499 1.996 0 CA-C-O 121.588 0.708 . . . . 0.0 112.205 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.484 ' H ' ' HB2' ' A' ' 87' ' ' SER . . . -126.18 -104.68 1.41 Allowed Glycine 0 N--CA 1.498 2.813 0 N-CA-C 108.812 -1.715 . . . . 0.0 108.812 179.755 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 3.4 t -155.65 111.45 3.06 Favored 'General case' 0 N--CA 1.502 2.13 0 N-CA-C 114.074 1.139 . . . . 0.0 114.074 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -65.93 103.59 0.96 Allowed 'General case' 0 N--CA 1.498 1.95 0 CA-C-N 114.331 -1.304 . . . . 0.0 107.679 179.66 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 143.09 -3.18 1.69 Allowed Glycine 0 N--CA 1.49 2.299 0 CA-C-N 114.384 -1.28 . . . . 0.0 110.927 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 72.8 m -124.0 155.14 38.77 Favored 'General case' 0 N--CA 1.499 1.982 0 C-N-CA 120.476 -0.489 . . . . 0.0 109.829 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.0 95.27 6.25 Favored 'General case' 0 N--CA 1.488 1.47 0 CA-C-N 115.036 -0.984 . . . . 0.0 108.644 -179.759 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.654 ' CD2' ' SG ' ' A' ' 83' ' ' CYS . 89.8 m-85 -44.78 137.61 3.9 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 124.694 1.246 . . . . 0.0 109.882 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 21.6 t80 -141.83 159.12 42.87 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 124.834 1.334 . . . . 0.0 110.844 -179.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 30.8 t -121.24 143.4 49.17 Favored 'General case' 0 N--CA 1.495 1.822 0 CA-C-N 112.748 -2.023 . . . . 0.0 116.089 -179.41 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.407 ' C ' ' H ' ' A' ' 79' ' ' GLY . 0.9 OUTLIER -48.91 -23.98 1.31 Allowed 'General case' 0 N--CA 1.498 1.952 0 CA-C-N 110.507 -3.042 . . . . 0.0 113.184 179.872 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 16.3 p30 -64.74 -0.67 1.54 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 124.223 0.952 . . . . 0.0 111.184 179.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.407 ' H ' ' C ' ' A' ' 77' ' ' ASP . . . 82.25 29.22 37.81 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 96.7 m -144.44 153.15 41.61 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 121.425 0.631 . . . . 0.0 111.903 -179.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -64.21 165.2 9.72 Favored 'General case' 0 N--CA 1.497 1.875 0 CA-C-N 113.466 -1.697 . . . . 0.0 110.565 179.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 89.4 t -128.28 -67.74 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 124.061 0.851 . . . . 0.0 112.07 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . 0.654 ' SG ' ' CD2' ' A' ' 74' ' ' TYR . 31.3 p -162.54 -178.07 6.01 Favored 'General case' 0 N--CA 1.503 2.178 0 C-N-CA 120.253 -0.579 . . . . 0.0 110.794 -179.636 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.401 ' HG2' ' N ' ' A' ' 85' ' ' GLY . 35.3 tt0 -96.49 158.02 15.63 Favored 'General case' 0 N--CA 1.505 2.306 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.16 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.501 ' HA2' ' CE2' ' A' ' 74' ' ' TYR . . . -58.73 106.05 0.79 Allowed Glycine 0 N--CA 1.498 2.778 0 CA-C-O 118.894 -0.948 . . . . 0.0 111.501 179.756 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 30.1 mm-40 -113.01 37.9 2.99 Favored 'General case' 0 N--CA 1.505 2.283 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 179.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.484 ' HB2' ' H ' ' A' ' 68' ' ' GLY . 9.0 t -115.45 63.31 0.69 Allowed 'General case' 0 N--CA 1.493 1.722 0 CA-C-N 114.267 -1.333 . . . . 0.0 109.491 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -81.57 114.57 50.84 Favored Pre-proline 0 N--CA 1.492 1.627 0 CA-C-N 114.08 -1.418 . . . . 0.0 110.355 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -66.1 -16.89 53.85 Favored 'Trans proline' 0 N--CA 1.492 1.419 0 C-N-CA 122.136 1.891 . . . . 0.0 111.361 -174.599 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 52.7 tpt85 -73.13 -31.07 64.06 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 123.812 0.695 . . . . 0.0 112.203 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.427 HD22 ' H ' ' A' ' 93' ' ' LYS . 1.2 p-10 -84.4 131.68 49.57 Favored Pre-proline 0 N--CA 1.497 1.9 0 C-N-CA 118.546 -1.262 . . . . 0.0 110.808 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -80.96 71.22 7.18 Favored 'Trans proline' 0 N--CA 1.49 1.287 0 C-N-CA 123.114 2.543 . . . . 0.0 108.325 162.306 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.427 ' H ' HD22 ' A' ' 91' ' ' ASN . 58.4 tptt -149.87 154.07 37.76 Favored 'General case' 0 N--CA 1.497 1.889 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.607 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -131.32 -172.92 2.97 Favored 'General case' 0 N--CA 1.498 1.957 0 CA-C-N 113.925 -1.488 . . . . 0.0 109.487 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 3.7 m -149.42 150.93 32.5 Favored Pre-proline 0 N--CA 1.5 2.072 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -75.8 98.23 1.17 Allowed 'Trans proline' 0 N--CA 1.493 1.443 0 C-N-CA 122.711 2.274 . . . . 0.0 110.039 172.158 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 -146.73 57.07 1.16 Allowed 'General case' 0 N--CA 1.499 2.018 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -55.35 96.85 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.844 0 CA-C-N 113.446 -1.706 . . . . 0.0 114.618 -179.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 78.6 m 55.01 130.01 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.156 0 N-CA-C 117.331 2.345 . . . . 0.0 117.331 179.683 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 63.8 t0 -127.79 77.34 76.42 Favored Pre-proline 0 N--CA 1.502 2.142 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.78 179.704 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -63.07 -24.89 73.41 Favored 'Trans proline' 0 N--CA 1.493 1.442 0 C-N-CA 122.604 2.202 . . . . 0.0 111.611 173.52 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -67.69 -19.8 65.22 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 123.96 0.787 . . . . 0.0 112.105 -179.824 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 10.5 tt -79.61 169.65 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.115 0 C-N-CA 119.133 -1.027 . . . . 0.0 110.241 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -130.99 -55.15 1.05 Allowed 'General case' 0 N--CA 1.495 1.784 0 CA-C-N 114.883 -1.053 . . . . 0.0 108.833 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 27.7 p90 -171.59 168.3 6.37 Favored 'General case' 0 N--CA 1.497 1.904 0 CA-C-N 114.842 -1.072 . . . . 0.0 110.008 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -105.6 121.96 7.0 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 109.716 -1.353 . . . . 0.0 109.716 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 87.2 mt -79.4 94.05 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 14.6 m -79.66 156.16 75.53 Favored Pre-proline 0 N--CA 1.493 1.69 0 CA-C-N 114.117 -1.401 . . . . 0.0 107.38 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo . . . . . 0 N--CA 1.495 1.593 0 C-N-CA 122.631 2.22 . . . . 0.0 111.532 -175.293 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . 0.489 ' NE ' ' HA ' ' A' ' 2' ' ' ARG . 14.5 mmp_? . . . . . 0 N--CA 1.498 1.933 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.3 tp -69.58 84.87 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 CA-C-N 114.835 -1.075 . . . . 0.0 111.552 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 14.8 m -92.2 51.02 1.72 Allowed 'General case' 0 N--CA 1.491 1.619 0 CA-C-N 114.195 -1.366 . . . . 0.0 111.521 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 15.1 t -90.71 -173.67 3.81 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-N 113.229 -1.805 . . . . 0.0 108.862 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 24.1 p30 -160.22 -175.15 4.89 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 124.742 1.276 . . . . 0.0 108.285 179.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.6 t -118.26 -33.35 4.4 Favored 'General case' 0 N--CA 1.499 1.978 0 C-N-CA 119.772 -0.771 . . . . 0.0 110.332 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 25.1 t -62.54 -60.39 3.6 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-N 114.704 -1.135 . . . . 0.0 108.64 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.436 ' HB2' ' SG ' ' A' ' 37' ' ' CYS . . . -90.28 19.82 4.86 Favored 'General case' 0 N--CA 1.498 1.97 0 CA-C-N 113.83 -1.532 . . . . 0.0 109.561 179.785 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -75.19 -151.0 2.67 Favored Glycine 0 N--CA 1.493 2.48 0 CA-C-N 115.445 -0.798 . . . . 0.0 112.472 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 40.1 p -126.98 100.08 5.99 Favored 'General case' 0 N--CA 1.498 1.925 0 CA-C-N 114.709 -0.746 . . . . 0.0 109.299 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -52.12 147.79 7.05 Favored 'General case' 0 N--CA 1.5 2.035 0 CA-C-N 115.787 -0.642 . . . . 0.0 112.249 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 98.92 -33.51 6.06 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 107.88 -2.088 . . . . 0.0 107.88 -179.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 55.3 m -91.39 114.18 26.64 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.421 ' HB2' ' NZ ' ' A' ' 15' ' ' LYS . 10.4 mtmp? -68.72 88.31 0.36 Allowed 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 111.762 -2.472 . . . . 0.0 111.718 -179.675 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.515 ' HB2' ' SG ' ' A' ' 25' ' ' CYS . 31.6 m-85 -53.01 119.76 5.05 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 105.361 -2.088 . . . . 0.0 105.361 179.456 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -135.16 153.66 51.9 Favored 'General case' 0 C--N 1.296 -1.723 0 CA-C-N 111.876 -2.42 . . . . 0.0 113.347 -179.036 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 41.9 t -92.17 133.33 35.89 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-N 112.838 -1.983 . . . . 0.0 109.389 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.561 ' H ' ' HB2' ' A' ' 46' ' ' ALA . 5.8 p-10 -51.97 -24.01 5.89 Favored 'General case' 0 N--CA 1.498 1.96 0 CA-C-N 113.363 -1.744 . . . . 0.0 114.21 -179.797 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 32.6 p30 -58.99 -10.47 2.55 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 124.197 0.935 . . . . 0.0 112.365 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 99.68 29.39 6.99 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 87.1 m -140.06 138.08 35.08 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 124.026 0.486 . . . . 0.0 110.622 -179.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.403 ' CG ' ' N ' ' A' ' 24' ' ' VAL . 49.1 t80 -70.55 162.0 29.63 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 124.443 1.09 . . . . 0.0 110.46 179.743 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.403 ' N ' ' CG ' ' A' ' 23' ' ' PHE . 61.0 t -129.48 -72.93 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 124.198 0.936 . . . . 0.0 110.978 -179.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.515 ' SG ' ' HB2' ' A' ' 16' ' ' TYR . 14.8 p -149.82 -169.62 3.43 Favored 'General case' 0 N--CA 1.504 2.241 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -137.51 147.22 45.03 Favored 'General case' 0 N--CA 1.502 2.128 0 N-CA-C 105.652 -1.981 . . . . 0.0 105.652 179.251 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -50.55 157.92 2.04 Favored Glycine 0 N--CA 1.5 2.915 0 C-N-CA 120.371 -0.918 . . . . 0.0 115.01 -179.577 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -121.11 -33.25 3.75 Favored 'General case' 0 N--CA 1.496 1.851 0 CA-C-N 113.603 -1.298 . . . . 0.0 110.807 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 32.4 m -95.12 131.48 41.09 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 123.595 0.559 . . . . 0.0 111.273 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.529 ' H ' HD21 ' A' ' 33' ' ' ASN . 16.4 t70 -81.33 143.96 52.92 Favored Pre-proline 0 N--CA 1.493 1.715 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_endo -61.77 73.91 0.09 OUTLIER 'Trans proline' 0 N--CA 1.499 1.838 0 C-N-CA 122.904 2.402 . . . . 0.0 112.111 172.721 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 36.2 mmt180 -162.72 -47.9 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.734 0 CA-C-N 113.387 -1.733 . . . . 0.0 106.802 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.529 HD21 ' H ' ' A' ' 30' ' ' ASP . 6.5 p30 -90.44 119.44 69.13 Favored Pre-proline 0 N--CA 1.494 1.762 0 O-C-N 124.234 0.959 . . . . 0.0 110.816 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -81.02 49.98 3.42 Favored 'Trans proline' 0 N--CA 1.494 1.534 0 C-N-CA 123.419 2.746 . . . . 0.0 111.298 174.528 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.4 ' HE2' ' HA ' ' A' ' 35' ' ' LYS . 6.4 mmpt? -74.65 124.5 26.82 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -99.14 96.1 7.55 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-N 114.744 -1.117 . . . . 0.0 110.754 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.436 ' SG ' ' HB2' ' A' ' 9' ' ' ALA . 78.0 m -79.71 -39.82 30.31 Favored 'General case' 0 N--CA 1.497 1.917 0 CA-C-N 114.709 -1.132 . . . . 0.0 108.678 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 63.0 m 59.71 80.45 0.2 Allowed 'General case' 0 N--CA 1.496 1.853 0 CA-C-N 114.049 -1.432 . . . . 0.0 111.295 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 32.4 tp -84.2 7.79 17.86 Favored 'General case' 0 N--CA 1.499 2.006 0 CA-C-N 114.696 -1.138 . . . . 0.0 108.911 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 13.2 m120 55.52 56.2 6.51 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.453 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 80.8 m 61.42 132.93 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.006 0 CA-C-N 113.29 -1.777 . . . . 0.0 114.044 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -115.68 87.27 17.31 Favored Pre-proline 0 N--CA 1.497 1.908 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.447 179.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -64.52 -17.04 58.27 Favored 'Trans proline' 0 N--CA 1.492 1.421 0 C-N-CA 122.844 2.363 . . . . 0.0 111.568 170.058 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.434 ' N ' ' HD3' ' A' ' 44' ' ' ARG . 0.0 OUTLIER -70.27 -10.4 58.82 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 123.688 0.618 . . . . 0.0 109.992 -179.971 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.411 ' CG2' ' N ' ' A' ' 46' ' ' ALA . 46.2 mt -119.9 159.98 20.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 CA-C-O 122.14 0.972 . . . . 0.0 110.66 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.561 ' HB2' ' H ' ' A' ' 19' ' ' ASP . . . -119.6 -55.26 2.12 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-N 111.695 -2.502 . . . . 0.0 108.182 179.755 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 5.8 p90 -167.21 153.55 8.12 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 124.129 0.893 . . . . 0.0 112.644 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -81.99 102.39 2.26 Favored Glycine 0 N--CA 1.492 2.428 0 CA-C-N 112.884 -1.962 . . . . 0.0 112.659 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 47.4 t -79.6 90.28 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 124.051 0.5 . . . . 0.0 112.18 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.5 m -79.33 120.38 80.28 Favored Pre-proline 0 N--CA 1.504 2.229 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 179.459 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo . . . . . 0 N--CA 1.492 1.405 0 C-N-CA 122.534 2.156 . . . . 0.0 109.735 -173.861 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.52 ' HA ' ' HA ' ' A' ' 99' ' ' CYS . 6.8 m . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 123.349 1.547 . . . . 0.0 113.037 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 95.1 m -91.08 138.42 31.62 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-N 111.584 -2.553 . . . . 0.0 106.777 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.526 ' ND2' ' H ' ' A' ' 67' ' ' ALA . 28.4 p-10 -160.74 151.04 17.93 Favored 'General case' 0 N--CA 1.499 2.01 0 C-N-CA 120.011 -0.676 . . . . 0.0 111.286 179.76 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' CYS . . . . . 0.406 ' SG ' ' NH1' ' A' ' 97' ' ' ARG . 0.7 OUTLIER -60.05 -28.78 68.05 Favored 'General case' 0 N--CA 1.495 1.789 0 CA-C-N 114.316 -1.311 . . . . 0.0 114.072 -179.842 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 40.1 t -79.78 -69.05 0.61 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 124.168 0.918 . . . . 0.0 111.81 -179.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.526 ' H ' ' ND2' ' A' ' 64' ' ' ASN . . . -88.37 45.26 1.27 Allowed 'General case' 0 N--CA 1.497 1.898 0 O-C-N 124.848 1.342 . . . . 0.0 109.812 -179.806 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -85.58 -143.55 6.87 Favored Glycine 0 N--CA 1.489 2.201 0 CA-C-N 114.365 -1.288 . . . . 0.0 111.264 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 35.5 p -139.85 116.21 10.6 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 114.826 -0.687 . . . . 0.0 110.523 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -60.69 97.07 0.05 OUTLIER 'General case' 0 N--CA 1.5 2.048 0 O-C-N 124.135 0.897 . . . . 0.0 109.619 179.706 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 158.21 -17.91 0.31 Allowed Glycine 0 N--CA 1.494 2.558 0 CA-C-N 114.52 -1.218 . . . . 0.0 110.872 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 91.2 m -125.39 155.44 40.36 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 124.015 0.479 . . . . 0.0 110.373 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -103.1 94.3 5.47 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 124.192 0.933 . . . . 0.0 109.763 -179.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -51.02 128.77 22.35 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-N 113.647 -1.615 . . . . 0.0 109.333 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.475 ' CE2' ' HA ' ' A' ' 80' ' ' THR . 0.2 OUTLIER -134.6 153.88 51.76 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-N 113.606 -1.634 . . . . 0.0 113.678 -179.335 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.407 ' N ' HG23 ' A' ' 82' ' ' VAL . 31.6 t -112.74 129.6 56.36 Favored 'General case' 0 N--CA 1.498 1.964 0 CA-C-N 112.98 -1.918 . . . . 0.0 112.359 -179.718 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.446 ' H ' ' HB2' ' A' ' 104' ' ' ALA . 8.4 p-10 -61.88 -50.03 73.85 Favored 'General case' 0 N--CA 1.499 1.993 0 CA-C-N 114.622 -1.172 . . . . 0.0 109.546 179.833 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -90.81 18.24 6.77 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 112.825 -1.989 . . . . 0.0 111.641 -179.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -163.47 25.34 0.2 Allowed Glycine 0 N--CA 1.495 2.628 0 C-N-CA 118.915 -1.612 . . . . 0.0 113.141 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.475 ' HA ' ' CE2' ' A' ' 75' ' ' PHE . 6.7 t 42.48 -163.56 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.794 0 O-C-N 124.998 1.057 . . . . 0.0 113.22 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 22.8 t80 -48.28 127.94 13.55 Favored 'General case' 0 N--CA 1.497 1.889 0 CA-C-O 121.378 0.609 . . . . 0.0 111.592 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.407 HG23 ' N ' ' A' ' 76' ' ' SER . 63.5 t -94.79 -76.94 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . 0.488 ' SG ' ' N ' ' A' ' 84' ' ' GLU . 0.4 OUTLIER -168.09 -169.64 1.16 Allowed 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 179.696 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.488 ' N ' ' SG ' ' A' ' 83' ' ' CYS . 37.6 tt0 -96.01 162.01 13.74 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -72.01 107.1 2.09 Favored Glycine 0 N--CA 1.493 2.486 0 N-CA-C 105.078 -3.209 . . . . 0.0 105.078 179.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -93.13 25.06 3.44 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 -179.643 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 29.4 t -129.4 123.39 31.54 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-N 114.338 -1.301 . . . . 0.0 108.97 179.655 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.69 ' H ' HD21 ' A' ' 91' ' ' ASN . 16.4 t70 -85.56 144.61 40.42 Favored Pre-proline 0 N--CA 1.492 1.671 0 CA-C-N 114.442 -1.253 . . . . 0.0 108.126 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_endo -61.86 79.76 0.09 OUTLIER 'Trans proline' 0 N--CA 1.496 1.64 0 C-N-CA 122.574 2.183 . . . . 0.0 108.414 165.131 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 58.2 ttt85 -169.78 -52.86 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 105.515 -2.032 . . . . 0.0 105.515 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.69 HD21 ' H ' ' A' ' 88' ' ' ASP . 2.7 p30 -91.54 115.55 64.71 Favored Pre-proline 0 N--CA 1.497 1.92 0 O-C-N 124.83 1.331 . . . . 0.0 111.237 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -83.45 49.38 2.93 Favored 'Trans proline' 0 N--CA 1.495 1.571 0 C-N-CA 123.484 2.789 . . . . 0.0 109.549 170.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -106.56 152.4 23.75 Favored 'General case' 0 N--CA 1.498 1.938 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.79 -179.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -152.61 154.81 36.11 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-N 115.01 -0.996 . . . . 0.0 111.245 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 66.3 m -84.99 -179.53 1.5 Allowed Pre-proline 0 N--CA 1.498 1.94 0 CA-C-N 114.394 -1.276 . . . . 0.0 108.682 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_endo -62.98 65.94 0.15 Allowed 'Trans proline' 0 N--CA 1.494 1.525 0 C-N-CA 122.13 1.887 . . . . 0.0 110.318 148.485 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.406 ' NH1' ' SG ' ' A' ' 65' ' ' CYS . 34.6 ttm180 -160.14 26.85 0.17 Allowed 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 106.285 -1.746 . . . . 0.0 106.285 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 29.0 m120 -60.68 117.02 4.83 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-N 114.78 -1.1 . . . . 0.0 109.956 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.52 ' HA ' ' HA ' ' A' ' 62' ' ' CYS . 65.0 m 54.1 86.49 0.05 OUTLIER 'General case' 0 N--CA 1.496 1.87 0 O-C-N 124.854 1.346 . . . . 0.0 110.665 -179.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.41 ' O ' HG22 ' A' ' 103' ' ' ILE . 10.7 t70 -71.01 109.22 4.79 Favored Pre-proline 0 N--CA 1.498 1.942 0 CA-C-N 115.683 -0.689 . . . . 0.0 111.58 -179.769 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_endo -69.71 -38.9 7.26 Favored 'Trans proline' 0 N--CA 1.494 1.538 0 C-N-CA 122.157 1.905 . . . . 0.0 109.857 -171.377 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 35.2 mmt180 -71.27 -11.68 61.05 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-N 113.984 -1.462 . . . . 0.0 113.828 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.41 HG22 ' O ' ' A' ' 100' ' ' ASP . 8.9 tt -73.38 178.55 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 C-N-CA 118.614 -1.234 . . . . 0.0 109.293 -179.792 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.446 ' HB2' ' H ' ' A' ' 77' ' ' ASP . . . -134.7 -60.23 0.79 Allowed 'General case' 0 N--CA 1.494 1.741 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.788 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 15.8 p90 -168.7 166.69 11.64 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-N 114.757 -1.11 . . . . 0.0 110.366 -179.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -99.38 116.22 5.52 Favored Glycine 0 N--CA 1.49 2.265 0 CA-C-N 113.861 -1.518 . . . . 0.0 109.417 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 96.2 mt -78.65 92.86 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 N-CA-C 105.766 -1.938 . . . . 0.0 105.766 179.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 17.1 m -79.43 121.03 82.32 Favored Pre-proline 0 N--CA 1.493 1.676 0 CA-C-N 113.995 -1.457 . . . . 0.0 109.096 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo . . . . . 0 N--CA 1.493 1.469 0 C-N-CA 122.259 1.972 . . . . 0.0 110.359 -179.07 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . 0.439 HH11 ' HB2' ' A' ' 4' ' ' CYS . 2.5 tmm_? . . . . . 0 N--CA 1.5 2.048 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 8.3 tp -90.43 51.71 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 CA-C-N 114.257 -1.338 . . . . 0.0 110.293 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.519 ' HA ' ' HA ' ' A' ' 41' ' ' CYS . 1.6 m -82.73 41.14 0.71 Allowed 'General case' 0 N--CA 1.495 1.813 0 CA-C-O 123.056 1.408 . . . . 0.0 114.389 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 91.8 m -91.47 112.86 24.95 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-N 112.657 -2.065 . . . . 0.0 109.127 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.466 ' ND2' ' HA ' ' A' ' 40' ' ' ASN . 40.3 p-10 -115.94 176.93 4.87 Favored 'General case' 0 N--CA 1.501 2.092 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 179.545 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.457 ' SG ' ' CD2' ' A' ' 16' ' ' TYR . 1.8 t -73.08 -27.69 61.87 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 114.322 1.23 . . . . 0.0 114.322 -179.557 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.484 ' SG ' ' N ' ' A' ' 37' ' ' CYS . 53.0 t -80.14 -63.14 1.48 Allowed 'General case' 0 N--CA 1.492 1.674 0 CA-C-N 114.374 -1.285 . . . . 0.0 113.936 -179.602 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -90.22 19.38 5.11 Favored 'General case' 0 N--CA 1.502 2.16 0 N-CA-C 113.619 0.97 . . . . 0.0 113.619 -179.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -83.45 -111.57 0.54 Allowed Glycine 0 N--CA 1.499 2.852 0 C-N-CA 120.6 -0.81 . . . . 0.0 111.57 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 40.7 p -137.08 112.22 9.07 Favored 'General case' 0 N--CA 1.504 2.235 0 CA-C-O 121.073 0.463 . . . . 0.0 111.892 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 8.5 tmtt? -62.53 150.19 41.0 Favored 'General case' 0 N--CA 1.487 1.389 0 CA-C-O 121.241 0.543 . . . . 0.0 111.154 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 76.45 -10.27 17.68 Favored Glycine 0 N--CA 1.489 2.195 0 CA-C-N 114.301 -1.318 . . . . 0.0 111.806 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 69.0 m -102.52 127.73 49.46 Favored 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 119.561 -0.856 . . . . 0.0 108.901 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -70.84 92.36 0.9 Allowed 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 113.267 -1.788 . . . . 0.0 109.112 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.665 ' CD2' ' SG ' ' A' ' 25' ' ' CYS . 78.6 m-85 -44.94 131.13 7.35 Favored 'General case' 0 N--CA 1.502 2.161 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 179.753 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -144.99 150.38 36.82 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 125.139 1.524 . . . . 0.0 112.532 -179.421 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 40.5 t -96.1 134.46 39.14 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-N 111.969 -2.378 . . . . 0.0 111.828 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.427 ' H ' ' HB2' ' A' ' 46' ' ' ALA . 4.5 p-10 -51.05 -24.73 4.1 Favored 'General case' 0 N--CA 1.501 2.097 0 CA-C-N 112.941 -1.936 . . . . 0.0 113.9 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 25.7 p30 -59.59 -8.86 2.15 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 124.178 0.924 . . . . 0.0 112.361 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 97.07 28.71 8.47 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 86.5 m -140.64 143.07 34.96 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 123.998 0.47 . . . . 0.0 110.399 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.452 ' CG ' ' N ' ' A' ' 24' ' ' VAL . 39.1 t80 -69.54 167.92 15.77 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 124.802 1.314 . . . . 0.0 111.132 179.8 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.452 ' N ' ' CG ' ' A' ' 23' ' ' PHE . 98.6 t -132.51 -74.45 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 123.842 0.714 . . . . 0.0 112.885 -179.79 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.665 ' SG ' ' CD2' ' A' ' 16' ' ' TYR . 20.5 p -147.24 -175.7 4.94 Favored 'General case' 0 N--CA 1.509 2.506 0 C-N-CA 121.04 -0.264 . . . . 0.0 110.708 -179.623 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 7.4 tm-20 -103.74 143.83 32.28 Favored 'General case' 0 N--CA 1.508 2.467 0 N-CA-C 113.402 0.89 . . . . 0.0 113.402 -179.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.622 ' HA2' ' CE2' ' A' ' 16' ' ' TYR . . . -43.98 105.62 0.08 OUTLIER Glycine 0 N--CA 1.501 3.013 0 O-C-N 124.437 1.085 . . . . 0.0 115.039 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -122.63 37.22 4.45 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 17.5 t -121.82 65.97 0.91 Allowed 'General case' 0 N--CA 1.499 1.996 0 CA-C-O 121.815 0.816 . . . . 0.0 110.959 -179.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.443 ' H ' ' ND2' ' A' ' 33' ' ' ASN . 14.3 t70 -88.37 142.61 31.53 Favored Pre-proline 0 N--CA 1.493 1.72 0 CA-C-N 113.886 -1.506 . . . . 0.0 108.528 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -56.64 -4.72 0.92 Allowed 'Trans proline' 0 N--CA 1.497 1.727 0 C-N-CA 122.316 2.011 . . . . 0.0 114.568 175.163 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.419 ' NE ' ' HA ' ' A' ' 32' ' ' ARG . 12.3 mmp_? -94.48 -27.76 15.82 Favored 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 113.148 0.795 . . . . 0.0 113.148 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.443 ' ND2' ' H ' ' A' ' 30' ' ' ASP . 19.2 p30 -66.05 121.85 78.2 Favored Pre-proline 0 N--CA 1.497 1.898 0 C-N-CA 119.039 -1.064 . . . . 0.0 112.006 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -75.09 123.13 7.61 Favored 'Trans proline' 0 N--CA 1.492 1.423 0 C-N-CA 122.714 2.276 . . . . 0.0 109.963 178.086 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 62.64 160.52 0.08 Allowed 'General case' 0 N--CA 1.502 2.16 0 O-C-N 124.614 1.196 . . . . 0.0 112.954 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -79.92 -167.1 1.16 Allowed 'General case' 0 N--CA 1.496 1.841 0 CA-C-N 114.694 -1.139 . . . . 0.0 110.099 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.484 ' N ' ' SG ' ' A' ' 8' ' ' CYS . 4.4 m -129.97 160.19 34.38 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 123.712 0.633 . . . . 0.0 110.016 -179.863 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 77.0 m 42.27 -104.72 0.06 Allowed 'General case' 0 N--CA 1.497 1.899 0 CA-C-N 114.261 -1.336 . . . . 0.0 113.167 179.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 96.1 mt -142.18 4.03 1.6 Allowed 'General case' 0 N--CA 1.498 1.962 0 O-C-N 123.585 0.553 . . . . 0.0 112.441 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.466 ' HA ' ' ND2' ' A' ' 6' ' ' ASN . 1.6 m-80 59.07 -174.33 0.1 Allowed 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 114.174 1.176 . . . . 0.0 114.174 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.519 ' HA ' ' HA ' ' A' ' 4' ' ' CYS . 56.8 m 59.88 100.87 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 CA-C-N 113.185 -1.825 . . . . 0.0 113.04 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -120.56 101.66 45.88 Favored Pre-proline 0 N--CA 1.496 1.873 0 CA-C-N 115.32 -0.855 . . . . 0.0 108.789 179.695 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -60.49 -31.57 92.62 Favored 'Trans proline' 0 N--CA 1.494 1.518 0 C-N-CA 122.622 2.215 . . . . 0.0 111.728 -176.23 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 21.6 tpp85 -57.52 -39.91 77.59 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 124.107 0.879 . . . . 0.0 109.175 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 13.7 mt -71.26 152.49 8.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 CA-C-O 122.192 0.996 . . . . 0.0 109.827 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.427 ' HB2' ' H ' ' A' ' 19' ' ' ASP . . . -121.14 -51.2 2.11 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-N 111.773 -2.467 . . . . 0.0 106.503 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 15.8 p90 -172.7 158.9 4.17 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-N 113.186 -1.825 . . . . 0.0 109.736 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -97.86 123.41 7.82 Favored Glycine 0 N--CA 1.49 2.288 0 CA-C-N 113.313 -1.767 . . . . 0.0 108.973 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 27.2 m -90.2 101.05 11.88 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 CA-C-O 122.052 0.929 . . . . 0.0 110.678 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.6 m -79.03 164.03 57.04 Favored Pre-proline 0 N--CA 1.502 2.14 0 CA-C-N 114.502 -1.226 . . . . 0.0 108.98 179.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo . . . . . 0 N--CA 1.494 1.55 0 C-N-CA 122.369 2.046 . . . . 0.0 111.313 173.059 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.524 ' HA ' ' HA ' ' A' ' 99' ' ' CYS . 1.7 m . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 123.02 1.39 . . . . 0.0 112.075 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 52.0 m -90.66 151.02 21.44 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 112.626 -2.079 . . . . 0.0 108.892 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 52.1 p-10 -127.86 -171.06 2.35 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 17.0 t -101.95 -29.97 11.5 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 123.663 0.602 . . . . 0.0 110.95 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 37.2 t -61.87 -55.35 30.64 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 124.102 0.876 . . . . 0.0 109.947 -179.748 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -87.68 63.86 7.74 Favored 'General case' 0 N--CA 1.499 2.025 0 N-CA-C 106.23 -1.767 . . . . 0.0 106.23 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -106.33 -115.87 4.08 Favored Glycine 0 N--CA 1.488 2.164 0 CA-C-N 113.963 -1.471 . . . . 0.0 112.322 -179.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.509 ' H ' ' CA ' ' A' ' 85' ' ' GLY . 2.6 t 179.29 110.67 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 125.278 1.222 . . . . 0.0 109.402 -179.851 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 11.4 mmmm -64.79 88.38 0.06 Allowed 'General case' 0 N--CA 1.499 1.996 0 CA-C-N 114.954 -1.021 . . . . 0.0 108.307 179.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 171.79 -31.73 0.13 Allowed Glycine 0 N--CA 1.487 2.055 0 CA-C-N 113.908 -1.496 . . . . 0.0 110.937 -179.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . 0.419 ' HA ' ' HA ' ' A' ' 108' ' ' CYS . 67.9 m -112.71 167.15 10.72 Favored 'General case' 0 N--CA 1.5 2.058 0 C-N-CA 119.46 -0.896 . . . . 0.0 111.139 -179.818 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 61.1 mtpt -111.14 100.91 9.48 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-N 114.074 -1.421 . . . . 0.0 113.775 -179.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.414 ' CG ' HD11 ' A' ' 103' ' ' ILE . 5.0 m-85 -52.71 141.63 20.56 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 124.265 0.978 . . . . 0.0 109.988 179.466 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -154.77 159.45 40.64 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 113.684 -1.598 . . . . 0.0 112.964 -179.426 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 73.0 p -100.24 135.08 42.21 Favored 'General case' 0 N--CA 1.486 1.358 0 CA-C-N 114.014 -1.448 . . . . 0.0 113.179 -179.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.547 ' H ' ' HB2' ' A' ' 104' ' ' ALA . 4.6 p-10 -40.01 -47.19 2.22 Favored 'General case' 0 N--CA 1.499 2.005 0 CA-C-N 112.82 -1.991 . . . . 0.0 115.978 -179.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -52.9 -36.05 58.95 Favored 'General case' 0 N--CA 1.497 1.88 0 CA-C-N 114.724 -1.125 . . . . 0.0 112.38 -179.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 128.43 42.68 0.24 Allowed Glycine 0 N--CA 1.494 2.539 0 O-C-N 124.772 1.295 . . . . 0.0 111.594 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 95.1 m -140.84 114.07 8.58 Favored 'General case' 0 N--CA 1.497 1.876 0 C-N-CA 119.469 -0.893 . . . . 0.0 112.739 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -54.18 139.69 34.83 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.639 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 99.5 t -103.88 -63.98 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 CA-C-N 114.571 -1.195 . . . . 0.0 112.183 -179.702 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . 0.415 ' SG ' ' N ' ' A' ' 84' ' ' GLU . 1.8 p -160.28 -162.98 1.03 Allowed 'General case' 0 N--CA 1.501 2.083 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 -179.8 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.415 ' N ' ' SG ' ' A' ' 83' ' ' CYS . 30.4 tt0 -118.36 144.7 45.69 Favored 'General case' 0 N--CA 1.5 2.069 0 N-CA-C 105.992 -1.855 . . . . 0.0 105.992 179.298 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.509 ' CA ' ' H ' ' A' ' 69' ' ' THR . . . -60.17 135.78 50.03 Favored Glycine 0 N--CA 1.496 2.689 0 N-CA-C 108.154 -1.979 . . . . 0.0 108.154 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -105.71 -7.89 18.17 Favored 'General case' 0 N--CA 1.503 2.195 0 N-CA-C 116.722 2.119 . . . . 0.0 116.722 -179.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 26.8 t -70.06 97.09 1.12 Allowed 'General case' 0 N--CA 1.501 2.115 0 C-N-CA 119.001 -1.08 . . . . 0.0 108.757 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -79.74 143.81 59.18 Favored Pre-proline 0 N--CA 1.494 1.74 0 CA-C-N 114.855 -1.066 . . . . 0.0 109.765 -179.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -46.66 -22.34 1.79 Allowed 'Trans proline' 0 N--CA 1.499 1.817 0 C-N-CA 122.887 2.392 . . . . 0.0 113.017 170.717 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.432 ' NE ' ' HA ' ' A' ' 90' ' ' ARG . 3.7 tpm_? -62.14 -53.08 60.42 Favored 'General case' 0 N--CA 1.495 1.775 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.412 HD22 ' H ' ' A' ' 93' ' ' LYS . 2.4 p-10 -84.63 131.95 48.16 Favored Pre-proline 0 N--CA 1.492 1.663 0 CA-C-N 115.079 -0.964 . . . . 0.0 108.99 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -79.26 56.9 6.23 Favored 'Trans proline' 0 N--CA 1.492 1.388 0 C-N-CA 123.029 2.486 . . . . 0.0 108.181 163.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.412 ' H ' HD22 ' A' ' 91' ' ' ASN . 27.7 mtpp 65.29 121.31 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.082 0 CA-C-N 114.585 -1.188 . . . . 0.0 110.923 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -153.25 68.21 0.8 Allowed 'General case' 0 N--CA 1.496 1.839 0 CA-C-N 114.665 -1.152 . . . . 0.0 108.134 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 89.7 m -154.11 160.56 30.8 Favored Pre-proline 0 N--CA 1.496 1.855 0 CA-C-N 114.263 -1.335 . . . . 0.0 111.967 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -73.41 -159.27 0.08 OUTLIER 'Trans proline' 0 N--CA 1.493 1.442 0 C-N-CA 122.973 2.449 . . . . 0.0 109.792 160.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.55 52.25 1.12 Allowed 'General case' 0 N--CA 1.494 1.772 0 CA-C-O 122.392 1.092 . . . . 0.0 108.284 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -47.04 113.9 0.75 Allowed 'General case' 0 N--CA 1.5 2.051 0 CA-C-N 113.054 -1.885 . . . . 0.0 110.565 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.524 ' HA ' ' HA ' ' A' ' 62' ' ' CYS . 56.2 m -60.07 121.7 12.53 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 119.926 -0.709 . . . . 0.0 111.095 -179.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 42.0 t0 -112.22 91.09 15.24 Favored Pre-proline 0 N--CA 1.494 1.762 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -58.34 -31.44 93.88 Favored 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 122.708 2.272 . . . . 0.0 111.143 -169.033 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 15.7 tpt180 -73.04 -40.39 65.16 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-N 114.366 -1.288 . . . . 0.0 112.305 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.414 HD11 ' CG ' ' A' ' 74' ' ' TYR . 3.3 tt -58.67 162.54 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 O-C-N 123.524 0.515 . . . . 0.0 112.048 -179.592 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.547 ' HB2' ' H ' ' A' ' 77' ' ' ASP . . . -139.96 -57.81 0.56 Allowed 'General case' 0 N--CA 1.495 1.824 0 CA-C-N 114.411 -1.268 . . . . 0.0 109.172 179.807 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 15.3 p90 -165.62 163.41 19.25 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-N 114.816 -1.084 . . . . 0.0 110.917 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -111.32 115.22 3.87 Favored Glycine 0 N--CA 1.493 2.444 0 CA-C-N 114.077 -1.419 . . . . 0.0 111.974 -179.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 51.5 mm -93.01 124.54 45.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 124.52 0.777 . . . . 0.0 110.054 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' CYS . . . . . 0.419 ' HA ' ' HA ' ' A' ' 72' ' ' CYS . 1.7 m -79.61 148.17 68.99 Favored Pre-proline 0 N--CA 1.495 1.82 0 O-C-N 124.024 0.827 . . . . 0.0 109.706 179.685 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo . . . . . 0 N--CA 1.494 1.559 0 C-N-CA 122.866 2.378 . . . . 0.0 111.457 -175.249 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 86.3 mtm180 . . . . . 0 N--CA 1.501 2.099 0 CA-C-O 121.619 0.723 . . . . 0.0 111.51 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 8.7 tp -84.04 48.5 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 CA-C-N 114.445 -1.252 . . . . 0.0 109.982 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.494 ' HA ' ' HA ' ' A' ' 41' ' ' CYS . 1.5 m -83.42 57.29 3.94 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 115.668 1.729 . . . . 0.0 115.668 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 37.3 p -91.8 176.6 6.47 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-N 113.143 -1.844 . . . . 0.0 110.183 179.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.524 HD21 ' N ' ' A' ' 37' ' ' CYS . 34.2 p30 -162.04 -172.72 3.35 Favored 'General case' 0 N--CA 1.495 1.807 0 CA-C-N 114.276 -1.329 . . . . 0.0 108.026 179.189 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.8 t -75.98 -10.15 59.19 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 115.737 1.754 . . . . 0.0 115.737 -179.472 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 6.7 t -91.79 -37.52 12.91 Favored 'General case' 0 N--CA 1.503 2.177 0 CA-C-O 121.587 0.708 . . . . 0.0 111.667 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -74.34 57.76 0.7 Allowed 'General case' 0 N--CA 1.497 1.909 0 CA-C-N 113.085 -1.87 . . . . 0.0 113.568 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -162.16 -121.9 0.59 Allowed Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 86.7 m -140.29 124.28 17.5 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 123.88 0.4 . . . . 0.0 111.851 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 40.4 ttpt -67.42 86.67 0.18 Allowed 'General case' 0 N--CA 1.496 1.865 0 O-C-N 124.618 1.199 . . . . 0.0 109.308 179.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.459 ' H ' ' HA3' ' A' ' 27' ' ' GLY . . . 156.15 -19.13 0.47 Allowed Glycine 0 N--CA 1.494 2.56 0 CA-C-N 114.855 -1.066 . . . . 0.0 110.661 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 87.7 m -89.43 -177.8 5.43 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -130.54 101.97 5.94 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 123.477 0.486 . . . . 0.0 110.218 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.632 ' CD1' ' SG ' ' A' ' 25' ' ' CYS . 85.0 m-85 -55.85 141.66 38.09 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 124.116 0.885 . . . . 0.0 109.08 179.806 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -149.65 151.71 34.18 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 124.874 1.359 . . . . 0.0 112.699 -179.685 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 96.2 p -101.69 132.7 47.25 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-N 113.272 -1.786 . . . . 0.0 112.476 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.469 ' H ' ' CB ' ' A' ' 46' ' ' ALA . 6.1 p-10 -45.24 -31.17 1.42 Allowed 'General case' 0 N--CA 1.504 2.239 0 N-CA-C 116.643 2.09 . . . . 0.0 116.643 -179.709 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -55.2 -15.87 2.7 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 123.989 0.805 . . . . 0.0 112.738 -179.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 108.88 25.28 5.72 Favored Glycine 0 N--CA 1.493 2.448 0 O-C-N 124.419 1.074 . . . . 0.0 111.003 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 57.0 m -135.64 152.06 50.85 Favored 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 120.437 -0.505 . . . . 0.0 110.513 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.406 ' CG ' ' N ' ' A' ' 24' ' ' VAL . 17.5 t80 -74.67 169.54 17.63 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-N 114.546 -1.207 . . . . 0.0 109.824 179.706 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.406 ' N ' ' CG ' ' A' ' 23' ' ' PHE . 93.8 t -131.25 -67.85 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 O-C-N 123.689 0.618 . . . . 0.0 112.635 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.632 ' SG ' ' CD1' ' A' ' 16' ' ' TYR . 11.9 p -153.75 -172.62 4.28 Favored 'General case' 0 N--CA 1.504 2.228 0 C-N-CA 120.256 -0.577 . . . . 0.0 109.469 -179.771 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -126.67 143.2 51.31 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 123.705 0.628 . . . . 0.0 110.906 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.459 ' HA3' ' H ' ' A' ' 13' ' ' GLY . . . -27.41 124.43 0.06 OUTLIER Glycine 0 N--CA 1.495 2.621 0 O-C-N 124.941 1.401 . . . . 0.0 116.09 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -114.69 -22.42 9.72 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 124.582 0.813 . . . . 0.0 110.244 179.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 47.4 t -156.56 154.38 30.17 Favored 'General case' 0 N--CA 1.497 1.916 0 CA-C-O 121.522 0.677 . . . . 0.0 111.153 -179.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -78.85 141.28 59.13 Favored Pre-proline 0 N--CA 1.496 1.856 0 CA-C-N 113.401 -1.727 . . . . 0.0 108.76 -179.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -61.61 -12.94 27.05 Favored 'Trans proline' 0 N--CA 1.496 1.647 0 C-N-CA 122.766 2.311 . . . . 0.0 113.452 -165.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 23.5 mmm180 -56.88 -23.51 45.07 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 123.792 0.683 . . . . 0.0 110.968 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.55 ' H ' HD22 ' A' ' 33' ' ' ASN . 0.0 OUTLIER -64.28 112.95 8.74 Favored Pre-proline 0 N--CA 1.492 1.639 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 179.779 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -81.24 39.02 0.81 Allowed 'Trans proline' 0 N--CA 1.496 1.675 0 C-N-CA 123.222 2.615 . . . . 0.0 112.203 -175.216 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -175.82 155.87 1.73 Allowed 'General case' 0 N--CA 1.497 1.91 0 CA-C-N 115.197 -0.911 . . . . 0.0 111.831 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.409 ' HB3' HD22 ' A' ' 40' ' ' ASN . . . -82.95 143.48 30.65 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 179.666 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.524 ' N ' HD21 ' A' ' 6' ' ' ASN . 1.6 m -105.69 -140.58 0.37 Allowed 'General case' 0 N--CA 1.499 2.0 0 O-C-N 123.725 0.641 . . . . 0.0 109.322 -179.788 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 58.5 p 35.33 -141.59 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.186 0 N-CA-C 114.081 1.141 . . . . 0.0 114.081 179.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.459 ' CD2' ' H ' ' A' ' 39' ' ' LEU . 1.6 pt? -80.32 -7.09 58.9 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 123.713 0.633 . . . . 0.0 111.776 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.409 HD22 ' HB3' ' A' ' 36' ' ' ALA . 19.1 m120 62.62 158.07 0.06 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 124.756 1.285 . . . . 0.0 112.972 -179.825 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.494 ' HA ' ' HA ' ' A' ' 4' ' ' CYS . 82.4 m 54.76 116.51 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 116.341 1.978 . . . . 0.0 116.341 -179.817 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -148.11 90.97 4.93 Favored Pre-proline 0 N--CA 1.491 1.619 0 CA-C-N 113.707 -1.588 . . . . 0.0 108.979 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -62.07 -17.55 56.87 Favored 'Trans proline' 0 N--CA 1.492 1.4 0 C-N-CA 122.58 2.187 . . . . 0.0 111.922 175.515 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 33.3 mmt180 -64.01 -33.6 76.11 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 123.844 0.715 . . . . 0.0 109.987 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 4.3 mt -68.79 137.13 24.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 CA-C-O 121.959 0.885 . . . . 0.0 111.401 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.469 ' CB ' ' H ' ' A' ' 19' ' ' ASP . . . -127.58 -53.73 1.35 Allowed 'General case' 0 N--CA 1.494 1.739 0 CA-C-N 112.327 -2.215 . . . . 0.0 109.372 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 30.5 m-85 -137.01 -166.37 1.9 Allowed 'General case' 0 N--CA 1.494 1.764 0 CA-C-N 114.332 -1.303 . . . . 0.0 108.591 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -160.63 104.81 0.25 Allowed Glycine 0 N--CA 1.489 2.178 0 N-CA-C 107.519 -2.232 . . . . 0.0 107.519 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.2 p -79.75 123.3 36.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 -179.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 57.1 m -102.27 148.55 35.58 Favored Pre-proline 0 N--CA 1.496 1.871 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.919 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo . . . . . 0 N--CA 1.492 1.41 0 C-N-CA 122.652 2.234 . . . . 0.0 108.56 173.307 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.449 ' HA ' ' HA ' ' A' ' 99' ' ' CYS . 1.8 m . . . . . 0 N--CA 1.493 1.684 0 CA-C-O 122.933 1.349 . . . . 0.0 112.492 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 52.8 m -90.43 167.75 12.38 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 112.628 -2.078 . . . . 0.0 109.088 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 40.8 p30 -151.84 -175.43 5.22 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-N 114.816 -1.084 . . . . 0.0 108.441 179.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 37.1 t -94.19 -29.0 15.34 Favored 'General case' 0 N--CA 1.497 1.893 0 C-N-CA 120.168 -0.613 . . . . 0.0 112.311 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 37.5 t -59.7 -57.85 11.14 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 124.209 0.943 . . . . 0.0 111.166 -179.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -88.11 41.43 1.0 Allowed 'General case' 0 N--CA 1.494 1.768 0 CA-C-N 112.946 -1.934 . . . . 0.0 109.184 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -79.85 -136.0 1.41 Allowed Glycine 0 N--CA 1.492 2.433 0 N-CA-C 110.092 -1.203 . . . . 0.0 110.092 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 97.3 m -159.07 95.8 1.29 Allowed 'General case' 0 N--CA 1.501 2.081 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 39.9 mmtt -45.72 117.04 1.33 Allowed 'General case' 0 N--CA 1.505 2.305 0 O-C-N 123.731 0.644 . . . . 0.0 112.0 179.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 133.04 -34.64 2.42 Favored Glycine 0 N--CA 1.494 2.507 0 O-C-N 124.643 1.214 . . . . 0.0 110.368 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 63.6 m -101.77 136.8 40.99 Favored 'General case' 0 N--CA 1.494 1.743 0 CA-C-O 121.571 0.701 . . . . 0.0 110.686 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.444 ' HD2' ' N ' ' A' ' 73' ' ' LYS . 4.3 mptp? -85.02 88.99 7.5 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 113.315 -1.766 . . . . 0.0 109.589 -179.834 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.439 ' HA ' ' HA2' ' A' ' 106' ' ' GLY . 35.3 m-85 -48.46 129.2 15.8 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 124.346 1.029 . . . . 0.0 109.107 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -141.0 152.54 45.0 Favored 'General case' 0 C--N 1.303 -1.413 0 CA-C-N 112.491 -2.14 . . . . 0.0 113.219 -179.109 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 80.6 p -92.86 136.28 33.39 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-N 113.056 -1.884 . . . . 0.0 114.744 -179.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -49.45 -29.53 6.7 Favored 'General case' 0 N--CA 1.5 2.035 0 CA-C-N 112.689 -2.05 . . . . 0.0 115.523 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -57.91 -15.33 8.35 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 123.855 0.722 . . . . 0.0 112.548 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 108.62 27.7 4.84 Favored Glycine 0 N--CA 1.494 2.526 0 O-C-N 124.33 1.019 . . . . 0.0 111.149 179.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 60.4 m -138.85 160.01 40.75 Favored 'General case' 0 N--CA 1.496 1.852 0 C-N-CA 120.534 -0.466 . . . . 0.0 110.028 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.432 ' CG ' ' N ' ' A' ' 82' ' ' VAL . 57.4 t80 -79.7 168.3 19.52 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-N 114.758 -1.11 . . . . 0.0 110.554 179.761 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.432 ' N ' ' CG ' ' A' ' 81' ' ' PHE . 89.1 t -133.12 -73.52 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 124.054 0.846 . . . . 0.0 110.335 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . 0.422 ' SG ' ' N ' ' A' ' 84' ' ' GLU . 1.1 p -154.72 -167.23 2.54 Favored 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 -179.771 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.422 ' N ' ' SG ' ' A' ' 83' ' ' CYS . 32.4 tt0 -118.93 152.53 36.16 Favored 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 104.124 -2.547 . . . . 0.0 104.124 179.335 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -53.77 127.85 38.6 Favored Glycine 0 N--CA 1.498 2.777 0 C-N-CA 119.834 -1.174 . . . . 0.0 110.187 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -89.58 -25.15 21.49 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 123.905 0.414 . . . . 0.0 111.625 -179.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 70.9 p -69.6 96.14 0.91 Allowed 'General case' 0 N--CA 1.49 1.549 0 CA-C-O 121.765 0.793 . . . . 0.0 111.113 -179.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -97.25 136.4 21.44 Favored Pre-proline 0 N--CA 1.493 1.719 0 N-CA-C 106.807 -1.553 . . . . 0.0 106.807 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo -43.83 -26.52 1.31 Allowed 'Trans proline' 0 N--CA 1.501 1.962 0 C-N-CA 122.659 2.239 . . . . 0.0 111.515 167.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 37.4 ttp85 -65.85 -54.66 23.84 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-N 113.849 -1.523 . . . . 0.0 109.395 179.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 21.6 p30 -90.05 138.93 27.29 Favored Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 124.097 0.873 . . . . 0.0 111.961 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -81.17 49.82 3.35 Favored 'Trans proline' 0 N--CA 1.49 1.268 0 C-N-CA 123.068 2.512 . . . . 0.0 109.25 160.544 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.514 ' NZ ' ' H ' ' A' ' 94' ' ' ALA . 0.2 OUTLIER -67.32 148.47 51.63 Favored 'General case' 0 N--CA 1.498 1.935 0 CA-C-O 121.506 0.669 . . . . 0.0 110.214 -179.961 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.514 ' H ' ' NZ ' ' A' ' 93' ' ' LYS . . . -160.32 152.96 21.04 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-N 113.491 -1.686 . . . . 0.0 110.354 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 86.1 m -156.34 167.47 14.32 Favored Pre-proline 0 N--CA 1.498 1.969 0 CA-C-N 114.644 -1.162 . . . . 0.0 109.245 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -55.37 -161.59 0.01 OUTLIER 'Trans proline' 0 N--CA 1.497 1.721 0 C-N-CA 122.717 2.278 . . . . 0.0 112.642 164.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 79.9 mtp180 -78.88 -43.2 25.47 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 36.3 m-80 46.53 54.98 8.07 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 124.945 1.403 . . . . 0.0 108.874 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.449 ' HA ' ' HA ' ' A' ' 62' ' ' CYS . 60.2 m -42.93 125.87 3.64 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-N 113.471 -1.695 . . . . 0.0 113.714 -179.675 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 45.0 t0 -116.93 86.27 19.29 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 124.687 1.242 . . . . 0.0 107.853 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -52.9 -26.52 31.59 Favored 'Trans proline' 0 N--CA 1.496 1.653 0 C-N-CA 122.808 2.339 . . . . 0.0 112.833 -178.138 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 78.0 ttt-85 -82.37 -33.93 28.59 Favored 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 114.552 1.315 . . . . 0.0 114.552 -179.622 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 8.8 tt -63.97 168.68 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.239 0 C-N-CA 120.192 -0.603 . . . . 0.0 110.92 -179.607 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -145.93 -72.3 0.24 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 123.81 0.694 . . . . 0.0 111.327 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 27.4 p90 -149.8 158.99 44.7 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 123.94 0.775 . . . . 0.0 112.041 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.439 ' HA2' ' HA ' ' A' ' 74' ' ' TYR . . . -98.73 114.28 4.98 Favored Glycine 0 N--CA 1.491 2.323 0 CA-C-N 112.949 -1.932 . . . . 0.0 111.444 -179.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 70.6 mt -79.85 97.38 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 CA-C-N 114.282 -0.959 . . . . 0.0 111.137 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 1.6 m -79.35 148.82 71.3 Favored Pre-proline 0 N--CA 1.502 2.172 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 179.521 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo . . . . . 0 N--CA 1.493 1.458 0 C-N-CA 122.549 2.166 . . . . 0.0 110.527 -179.384 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 8.4 ptp180 . . . . . 0 N--CA 1.496 1.856 0 CA-C-O 120.549 0.214 . . . . 0.0 110.67 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 46.1 mm -77.85 91.61 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 124.132 0.895 . . . . 0.0 108.915 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.525 ' H ' ' HB3' ' A' ' 41' ' ' CYS . 0.5 OUTLIER -84.52 -160.23 0.46 Allowed 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 106.04 -1.837 . . . . 0.0 106.04 -179.997 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.8 t -73.48 -169.26 0.65 Allowed 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 179.536 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.502 ' ND2' HD12 ' A' ' 45' ' ' ILE . 4.4 t-20 -122.65 166.84 14.24 Favored 'General case' 0 N--CA 1.497 1.893 0 CA-C-O 122.614 1.197 . . . . 0.0 112.356 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.534 ' HA ' ' CE2' ' A' ' 16' ' ' TYR . 19.9 t 43.28 26.29 0.09 Allowed 'General case' 0 N--CA 1.493 1.71 0 CA-C-N 111.189 -2.732 . . . . 0.0 113.925 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 28.0 t -90.14 -68.46 0.78 Allowed 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 116.639 2.089 . . . . 0.0 116.639 -179.635 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -57.6 -4.47 0.27 Allowed 'General case' 0 N--CA 1.506 2.37 0 N-CA-C 118.367 2.729 . . . . 0.0 118.367 -179.494 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.414 ' N ' ' OH ' ' A' ' 16' ' ' TYR . . . -65.0 -39.22 96.29 Favored Glycine 0 N--CA 1.493 2.465 0 N-CA-C 110.941 -0.864 . . . . 0.0 110.941 -179.791 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 38.8 m 68.49 112.22 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.844 0 O-C-N 125.62 1.424 . . . . 0.0 107.164 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 14.8 tppt? -37.99 98.43 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.088 0 O-C-N 124.693 1.245 . . . . 0.0 113.0 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 157.82 -22.15 0.39 Allowed Glycine 0 N--CA 1.49 2.262 0 CA-C-N 112.686 -2.052 . . . . 0.0 108.686 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 90.9 m -103.98 169.25 8.61 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 62.3 mttp -124.32 95.12 4.42 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 123.972 0.795 . . . . 0.0 112.18 -179.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.612 ' HB2' ' SG ' ' A' ' 25' ' ' CYS . 6.5 m-85 -49.42 144.76 5.26 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-N 114.104 -1.407 . . . . 0.0 112.122 179.541 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -154.8 164.16 39.21 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 112.914 -1.948 . . . . 0.0 112.057 -179.39 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 40.0 t -118.04 138.83 51.95 Favored 'General case' 0 N--CA 1.495 1.823 0 CA-C-N 113.577 -1.647 . . . . 0.0 112.167 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.403 ' H ' ' HB2' ' A' ' 46' ' ' ALA . 5.3 p-10 -46.39 -24.42 0.49 Allowed 'General case' 0 N--CA 1.499 2.025 0 CA-C-N 111.76 -2.473 . . . . 0.0 113.912 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 14.7 p30 -60.87 -6.14 1.67 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 124.117 0.885 . . . . 0.0 112.126 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 92.37 27.2 15.94 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 110.401 -1.08 . . . . 0.0 110.401 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 96.5 m -144.39 141.9 29.98 Favored 'General case' 0 N--CA 1.494 1.761 0 C-N-CA 120.187 -0.605 . . . . 0.0 111.892 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 10.3 t80 -62.77 161.92 11.74 Favored 'General case' 0 N--CA 1.497 1.921 0 CA-C-N 114.14 -1.391 . . . . 0.0 109.915 179.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 62.5 t -131.7 -57.16 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 123.893 0.745 . . . . 0.0 112.745 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.612 ' SG ' ' HB2' ' A' ' 16' ' ' TYR . 7.5 p -158.62 -167.29 2.1 Favored 'General case' 0 N--CA 1.503 2.221 0 C-N-CA 119.657 -0.817 . . . . 0.0 109.749 -179.686 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -122.18 136.89 54.97 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 106.547 -1.649 . . . . 0.0 106.547 179.463 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -40.35 129.41 2.93 Favored Glycine 0 N--CA 1.503 3.127 0 O-C-N 123.657 0.598 . . . . 0.0 112.322 179.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -79.81 -52.78 7.48 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 114.023 1.12 . . . . 0.0 114.023 -179.806 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 55.7 m -50.28 86.61 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 116.425 2.009 . . . . 0.0 116.425 -179.281 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.642 ' H ' HD21 ' A' ' 33' ' ' ASN . 29.5 t70 -86.63 126.09 65.08 Favored Pre-proline 0 N--CA 1.489 1.511 0 N-CA-C 105.358 -2.09 . . . . 0.0 105.358 179.752 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_endo -63.45 73.83 0.14 Allowed 'Trans proline' 0 N--CA 1.5 1.863 0 C-N-CA 123.687 2.925 . . . . 0.0 113.585 -153.029 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.409 ' N ' ' O ' ' A' ' 30' ' ' ASP . 1.5 mpp_? -158.84 -47.13 0.06 Allowed 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 105.384 -2.08 . . . . 0.0 105.384 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.642 HD21 ' H ' ' A' ' 30' ' ' ASP . 12.6 p30 -78.33 136.59 60.55 Favored Pre-proline 0 N--CA 1.494 1.76 0 C-N-CA 119.526 -0.87 . . . . 0.0 109.708 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -68.8 119.73 6.7 Favored 'Trans proline' 0 N--CA 1.493 1.489 0 C-N-CA 122.736 2.291 . . . . 0.0 110.184 -178.232 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 14.3 ptmm? -107.08 157.4 17.86 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 124.18 0.925 . . . . 0.0 110.415 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -160.39 73.71 0.52 Allowed 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 27.9 m -152.8 -174.45 4.92 Favored 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 121.949 0.881 . . . . 0.0 111.744 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.486 ' HB ' ' SG ' ' A' ' 41' ' ' CYS . 83.6 m -141.51 157.81 44.66 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 104.464 -2.421 . . . . 0.0 104.464 179.638 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.461 HD12 ' N ' ' A' ' 39' ' ' LEU . 5.0 mp -79.45 -21.38 45.56 Favored 'General case' 0 N--CA 1.498 1.946 0 C-N-CA 119.439 -0.904 . . . . 0.0 110.361 -179.788 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -94.37 37.92 1.1 Allowed 'General case' 0 N--CA 1.497 1.879 0 CA-C-O 121.976 0.893 . . . . 0.0 110.165 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.525 ' HB3' ' H ' ' A' ' 4' ' ' CYS . 67.4 m -98.71 -95.5 0.23 Allowed 'General case' 0 N--CA 1.494 1.769 0 CA-C-N 113.598 -1.637 . . . . 0.0 107.409 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.467 ' HB3' HD22 ' A' ' 6' ' ' ASN . 16.7 t70 -54.13 131.12 59.9 Favored Pre-proline 0 N--CA 1.501 2.117 0 C-N-CA 120.601 -0.44 . . . . 0.0 110.401 179.796 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -68.78 -23.28 35.82 Favored 'Trans proline' 0 N--CA 1.493 1.489 0 C-N-CA 122.27 1.98 . . . . 0.0 111.633 -164.054 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 58.4 ttt85 -58.14 -38.42 76.54 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 124.031 0.832 . . . . 0.0 110.611 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.578 HD13 ' CD1' ' A' ' 16' ' ' TYR . 15.4 mt -98.85 154.15 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 CA-C-O 122.67 1.224 . . . . 0.0 113.857 -179.826 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.403 ' HB2' ' H ' ' A' ' 19' ' ' ASP . . . -112.17 -56.16 2.43 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-N 110.907 -2.86 . . . . 0.0 107.766 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 53.6 p90 -166.49 173.53 9.77 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-N 114.776 -1.102 . . . . 0.0 109.621 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -125.86 122.13 4.39 Favored Glycine 0 N--CA 1.494 2.502 0 CA-C-N 114.198 -1.365 . . . . 0.0 110.128 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.5 p -79.5 122.71 35.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 11.3 m -100.09 104.93 32.39 Favored Pre-proline 0 N--CA 1.496 1.828 0 CA-C-N 115.083 -0.962 . . . . 0.0 108.729 -179.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo . . . . . 0 N--CA 1.49 1.302 0 C-N-CA 122.381 2.054 . . . . 0.0 109.798 -176.258 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 7.7 m . . . . . 0 N--CA 1.491 1.616 0 N-CA-C 115.601 1.704 . . . . 0.0 115.601 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 7.9 p -90.38 173.67 7.98 Favored 'General case' 0 N--CA 1.495 1.81 0 CA-C-N 114.174 -1.376 . . . . 0.0 109.084 179.616 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -161.38 149.46 15.43 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-N 114.631 -1.168 . . . . 0.0 108.782 179.772 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 11.2 t -55.86 -17.37 6.2 Favored 'General case' 0 N--CA 1.5 2.069 0 N-CA-C 113.97 1.1 . . . . 0.0 113.97 -179.659 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 52.1 t -82.72 -43.41 16.85 Favored 'General case' 0 N--CA 1.498 1.96 0 CA-C-N 114.138 -1.392 . . . . 0.0 112.553 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -73.62 61.91 0.75 Allowed 'General case' 0 N--CA 1.5 2.074 0 O-C-N 125.765 1.915 . . . . 0.0 114.784 -179.575 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -169.52 -155.12 9.68 Favored Glycine 0 N--CA 1.486 1.983 0 CA-C-N 112.726 -2.034 . . . . 0.0 108.303 179.599 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 57.5 p -145.31 159.71 42.63 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 124.018 0.481 . . . . 0.0 110.505 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 59.0 mtpt -71.76 38.51 0.07 Allowed 'General case' 0 N--CA 1.502 2.173 0 O-C-N 125.469 1.731 . . . . 0.0 113.938 179.695 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -132.83 1.92 4.75 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 108.448 -1.861 . . . . 0.0 108.448 179.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . 0.411 ' HA ' ' HA ' ' A' ' 108' ' ' CYS . 96.0 m -135.54 170.73 15.49 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 123.905 0.415 . . . . 0.0 111.729 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 48.6 mtmt -130.06 105.67 8.11 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.234 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.696 ' CD1' ' SG ' ' A' ' 83' ' ' CYS . 88.2 m-85 -53.82 144.29 18.82 Favored 'General case' 0 N--CA 1.505 2.285 0 O-C-N 123.525 0.515 . . . . 0.0 110.122 179.8 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.548 ' CE2' ' HA ' ' A' ' 80' ' ' THR . 9.3 t80 -149.32 158.01 43.82 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 124.653 1.221 . . . . 0.0 113.287 -179.572 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 28.2 t -121.12 129.71 53.41 Favored 'General case' 0 N--CA 1.499 1.993 0 CA-C-N 112.05 -2.341 . . . . 0.0 112.145 -179.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.429 ' H ' ' HB2' ' A' ' 104' ' ' ALA . 9.2 p-10 -47.66 -59.19 3.46 Favored 'General case' 0 N--CA 1.495 1.81 0 CA-C-N 113.127 -1.851 . . . . 0.0 112.74 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.408 ' H ' ' CG ' ' A' ' 77' ' ' ASP . 17.7 p-10 -107.2 25.46 11.38 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-N 114.556 -1.202 . . . . 0.0 110.624 -179.777 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -146.93 15.52 1.55 Allowed Glycine 0 N--CA 1.494 2.507 0 O-C-N 124.179 0.924 . . . . 0.0 111.578 -179.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.548 ' HA ' ' CE2' ' A' ' 75' ' ' PHE . 6.6 t 41.61 -160.56 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.899 0 O-C-N 124.934 1.02 . . . . 0.0 113.405 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 72.4 t80 -40.01 132.4 1.84 Allowed 'General case' 0 N--CA 1.5 2.074 0 O-C-N 123.634 0.584 . . . . 0.0 112.213 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 76.6 t -107.48 -61.03 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 CA-C-N 114.381 -1.281 . . . . 0.0 109.93 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . 0.696 ' SG ' ' CD1' ' A' ' 74' ' ' TYR . 0.8 OUTLIER -163.66 -166.74 1.25 Allowed 'General case' 0 N--CA 1.502 2.136 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 -179.89 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.475 ' N ' ' SG ' ' A' ' 83' ' ' CYS . 35.2 mt-10 -130.65 163.68 26.66 Favored 'General case' 0 N--CA 1.485 1.316 0 CA-C-N 114.995 -1.002 . . . . 0.0 109.362 179.511 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -43.24 120.15 2.67 Favored Glycine 0 N--CA 1.499 2.891 0 O-C-N 124.092 0.87 . . . . 0.0 113.681 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -108.71 32.1 5.13 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 36.3 t -153.91 129.26 9.8 Favored 'General case' 0 N--CA 1.498 1.958 0 C-N-CA 120.323 -0.551 . . . . 0.0 109.616 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -100.22 144.28 28.12 Favored Pre-proline 0 N--CA 1.494 1.762 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -46.61 -23.37 2.24 Favored 'Trans proline' 0 N--CA 1.499 1.834 0 C-N-CA 122.846 2.364 . . . . 0.0 112.564 170.339 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 52.8 ttp85 -60.68 -53.23 59.96 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-N 114.967 -1.015 . . . . 0.0 108.682 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -90.5 114.42 61.1 Favored Pre-proline 0 N--CA 1.494 1.725 0 O-C-N 124.839 1.337 . . . . 0.0 110.635 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -83.68 45.13 1.73 Allowed 'Trans proline' 0 N--CA 1.495 1.593 0 C-N-CA 123.427 2.752 . . . . 0.0 110.633 173.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 64.2 mtpt -79.13 125.59 29.62 Favored 'General case' 0 N--CA 1.497 1.894 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.954 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -88.75 120.67 30.35 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 114.596 -1.184 . . . . 0.0 109.603 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 31.0 m -79.94 145.37 61.37 Favored Pre-proline 0 N--CA 1.497 1.906 0 CA-C-N 115.202 -0.908 . . . . 0.0 108.928 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -70.31 -87.13 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.482 0 C-N-CA 122.249 1.966 . . . . 0.0 110.253 -177.188 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 86.7 mtm180 -145.32 -67.28 0.31 Allowed 'General case' 0 N--CA 1.497 1.912 0 O-C-N 123.737 0.648 . . . . 0.0 109.397 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 28.5 m120 46.22 48.43 13.12 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 124.39 1.056 . . . . 0.0 110.67 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 90.7 m -36.21 127.26 0.76 Allowed 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 115.251 1.574 . . . . 0.0 115.251 -179.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -122.31 79.99 45.05 Favored Pre-proline 0 N--CA 1.496 1.858 0 O-C-N 124.295 0.997 . . . . 0.0 109.091 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -59.34 -25.91 80.06 Favored 'Trans proline' 0 N--CA 1.495 1.605 0 C-N-CA 123.293 2.662 . . . . 0.0 111.707 -178.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 25.0 tpt180 -66.66 -37.39 84.7 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-N 115.118 -0.946 . . . . 0.0 111.726 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.457 ' CG2' ' N ' ' A' ' 104' ' ' ALA . 6.3 mt -60.06 167.01 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 CA-C-O 121.855 0.836 . . . . 0.0 111.516 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.457 ' N ' ' CG2' ' A' ' 103' ' ' ILE . . . -138.69 -44.81 0.48 Allowed 'General case' 0 N--CA 1.489 1.497 0 CA-C-N 113.462 -1.699 . . . . 0.0 107.762 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 40.7 p90 -173.07 -170.84 0.68 Allowed 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -136.45 130.15 5.14 Favored Glycine 0 N--CA 1.493 2.5 0 C-N-CA 120.554 -0.831 . . . . 0.0 111.228 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.451 ' N ' HD12 ' A' ' 107' ' ' ILE . 2.9 mp -79.89 110.46 15.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 N-CA-C 105.788 -1.93 . . . . 0.0 105.788 179.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' CYS . . . . . 0.411 ' HA ' ' HA ' ' A' ' 72' ' ' CYS . 60.9 m -100.19 109.57 56.95 Favored Pre-proline 0 N--CA 1.495 1.809 0 O-C-N 124.143 0.902 . . . . 0.0 110.405 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo . . . . . 0 N--CA 1.492 1.42 0 C-N-CA 122.6 2.2 . . . . 0.0 109.905 179.528 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 . . . . . 0 N--CA 1.501 2.114 0 CA-C-O 120.6 0.238 . . . . 0.0 111.374 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.1 tp -67.49 91.27 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 CA-C-O 121.985 0.898 . . . . 0.0 110.814 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 7.5 m -90.36 45.28 1.25 Allowed 'General case' 0 N--CA 1.493 1.72 0 CA-C-O 122.726 1.25 . . . . 0.0 112.472 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 51.8 m -90.74 171.07 9.6 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 113.001 -1.909 . . . . 0.0 109.275 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 69.0 m-80 -160.0 171.91 18.5 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 124.567 1.167 . . . . 0.0 107.998 179.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 9.6 t -70.14 -11.14 60.68 Favored 'General case' 0 N--CA 1.501 2.096 0 C-N-CA 118.968 -1.093 . . . . 0.0 110.837 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 34.4 t -91.11 -50.4 5.86 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-N 113.905 -1.498 . . . . 0.0 109.137 179.734 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -39.58 -67.26 0.23 Allowed 'General case' 0 N--CA 1.501 2.084 0 N-CA-C 115.965 1.839 . . . . 0.0 115.965 -179.662 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -54.66 160.51 5.08 Favored Glycine 0 N--CA 1.502 3.057 0 C-N-CA 121.099 -0.572 . . . . 0.0 112.325 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 7.3 t -71.43 138.29 48.95 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 -179.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -62.33 114.1 3.29 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-N 114.121 -1.399 . . . . 0.0 109.2 179.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 134.39 -21.92 3.79 Favored Glycine 0 N--CA 1.495 2.594 0 O-C-N 124.431 1.082 . . . . 0.0 110.577 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 88.2 m -86.77 -173.08 4.3 Favored 'General case' 0 N--CA 1.5 2.028 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 60.7 mtpt -133.46 103.27 5.86 Favored 'General case' 0 N--CA 1.494 1.765 0 C-N-CA 119.793 -0.763 . . . . 0.0 110.998 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.733 ' CD2' ' SG ' ' A' ' 25' ' ' CYS . 90.8 m-85 -54.75 138.21 42.69 Favored 'General case' 0 N--CA 1.499 2.015 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.67 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -149.22 146.25 27.52 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 124.886 1.366 . . . . 0.0 113.26 -179.701 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 45.4 t -106.03 120.99 43.2 Favored 'General case' 0 N--CA 1.5 2.055 0 CA-C-N 112.822 -1.99 . . . . 0.0 110.722 -179.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.564 ' H ' ' HB2' ' A' ' 46' ' ' ALA . 6.5 p-10 -57.61 -53.34 59.32 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 126.476 2.36 . . . . 0.0 112.19 -179.817 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -72.95 1.61 8.47 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 112.264 -2.244 . . . . 0.0 112.236 -179.665 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -136.39 -85.39 0.18 Allowed Glycine 0 N--CA 1.482 1.727 0 C-N-CA 119.626 -1.273 . . . . 0.0 111.951 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.469 ' CG2' ' N ' ' A' ' 23' ' ' PHE . 1.2 m 172.7 -171.16 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.166 0 N-CA-C 106.002 -1.851 . . . . 0.0 106.002 -179.137 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.469 ' N ' ' CG2' ' A' ' 22' ' ' THR . 33.2 t80 -41.79 144.05 0.45 Allowed 'General case' 0 N--CA 1.502 2.146 0 CA-C-O 121.369 0.605 . . . . 0.0 112.065 179.53 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 71.9 t -110.38 -68.21 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 CA-C-N 114.06 -1.427 . . . . 0.0 112.353 -179.656 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.733 ' SG ' ' CD2' ' A' ' 16' ' ' TYR . 14.5 p -155.14 -167.55 2.6 Favored 'General case' 0 N--CA 1.502 2.153 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 -179.717 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 8.7 tm-20 -117.45 154.89 30.62 Favored 'General case' 0 N--CA 1.505 2.282 0 O-C-N 123.373 0.42 . . . . 0.0 110.735 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.474 ' HA2' ' CE2' ' A' ' 16' ' ' TYR . . . -46.48 110.7 0.55 Allowed Glycine 0 N--CA 1.503 3.128 0 CA-C-O 118.857 -0.968 . . . . 0.0 112.583 179.869 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -97.33 -9.19 27.97 Favored 'General case' 0 N--CA 1.505 2.32 0 N-CA-C 114.684 1.365 . . . . 0.0 114.684 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 38.4 t -156.07 131.17 9.29 Favored 'General case' 0 N--CA 1.501 2.083 0 C-N-CA 119.647 -0.821 . . . . 0.0 111.607 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.541 ' H ' HD21 ' A' ' 33' ' ' ASN . 11.7 t70 -93.54 143.59 26.87 Favored Pre-proline 0 N--CA 1.494 1.771 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 179.812 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -66.26 75.7 0.35 Allowed 'Trans proline' 0 N--CA 1.494 1.558 0 C-N-CA 122.579 2.186 . . . . 0.0 108.236 162.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 35.2 ttp-105 -168.09 -41.28 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 113.208 -1.814 . . . . 0.0 106.832 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.541 HD21 ' H ' ' A' ' 30' ' ' ASP . 29.8 p30 -86.99 152.84 54.02 Favored Pre-proline 0 N--CA 1.493 1.705 0 O-C-N 124.175 0.922 . . . . 0.0 110.936 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -79.85 45.6 2.0 Allowed 'Trans proline' 0 N--CA 1.496 1.635 0 C-N-CA 123.443 2.762 . . . . 0.0 112.319 174.481 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.483 ' HE3' ' HA ' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -102.12 152.9 20.46 Favored 'General case' 0 N--CA 1.501 2.109 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.163 -179.981 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -156.39 165.24 36.9 Favored 'General case' 0 N--CA 1.498 1.93 0 CA-C-N 114.674 -1.148 . . . . 0.0 109.571 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 28.0 m -146.19 179.16 7.69 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 123.779 0.674 . . . . 0.0 110.282 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 44.5 p -138.72 54.7 1.74 Allowed 'General case' 0 N--CA 1.5 2.066 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.671 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 54.2 tp -93.63 -25.24 17.59 Favored 'General case' 0 N--CA 1.499 2.017 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.005 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 11.4 m120 62.54 153.64 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.118 0 O-C-N 124.487 1.117 . . . . 0.0 113.536 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 59.4 m -18.61 130.38 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.274 0 N-CA-C 116.63 2.085 . . . . 0.0 116.63 -179.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -113.82 86.13 10.53 Favored Pre-proline 0 N--CA 1.498 1.955 0 O-C-N 124.062 0.851 . . . . 0.0 108.971 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -62.13 -18.41 61.78 Favored 'Trans proline' 0 N--CA 1.497 1.724 0 C-N-CA 122.633 2.222 . . . . 0.0 113.803 -170.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 5.9 ptp85 -89.09 -20.15 24.68 Favored 'General case' 0 N--CA 1.501 2.078 0 N-CA-C 116.393 1.997 . . . . 0.0 116.393 -179.636 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 16.3 tt -78.13 155.44 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.303 0 C-N-CA 118.566 -1.254 . . . . 0.0 109.694 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.564 ' HB2' ' H ' ' A' ' 19' ' ' ASP . . . -90.4 -66.3 0.94 Allowed 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 179.627 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 3.3 p90 -177.63 171.91 1.83 Allowed 'General case' 0 N--CA 1.492 1.651 0 CA-C-N 112.786 -2.006 . . . . 0.0 108.513 -179.783 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.406 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -91.05 110.37 3.81 Favored Glycine 0 N--CA 1.49 2.279 0 CA-C-N 114.979 -1.009 . . . . 0.0 110.701 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 20.1 m -78.84 105.84 8.76 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 N-CA-C 106.107 -1.812 . . . . 0.0 106.107 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 48.1 m -83.28 161.74 56.23 Favored Pre-proline 0 N--CA 1.495 1.798 0 CA-C-N 113.375 -1.739 . . . . 0.0 111.264 -179.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo . . . . . 0 N--CA 1.494 1.536 0 C-N-CA 122.345 2.03 . . . . 0.0 109.675 166.65 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.5 ' N ' ' SG ' ' A' ' 99' ' ' CYS . 1.6 m . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.5 p -63.91 138.71 58.59 Favored 'General case' 0 N--CA 1.495 1.824 0 C-N-CA 119.067 -1.053 . . . . 0.0 112.558 179.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -155.11 154.59 32.6 Favored 'General case' 0 N--CA 1.499 2.009 0 CA-C-N 112.14 -2.3 . . . . 0.0 110.209 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 52.8 t -52.71 -51.2 61.4 Favored 'General case' 0 N--CA 1.501 2.084 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 179.745 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 17.7 t -60.91 -54.46 44.78 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-N 110.996 -2.82 . . . . 0.0 112.658 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -39.46 -45.06 1.47 Allowed 'General case' 0 N--CA 1.504 2.227 0 O-C-N 125.921 2.013 . . . . 0.0 110.511 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.424 ' HA3' ' H ' ' A' ' 87' ' ' SER . . . 73.38 162.94 7.75 Favored Glycine 0 N--CA 1.476 1.351 0 N-CA-C 116.951 1.54 . . . . 0.0 116.951 179.583 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 3.6 t 176.64 42.56 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 104.49 -2.411 . . . . 0.0 104.49 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.519 ' HA ' ' HE2' ' A' ' 70' ' ' LYS . 0.6 OUTLIER -10.35 94.08 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.065 0 CA-C-N 113.165 -1.834 . . . . 0.0 115.545 -179.553 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 136.37 -47.56 0.96 Allowed Glycine 0 N--CA 1.493 2.497 0 CA-C-N 114.461 -1.245 . . . . 0.0 111.94 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . 0.438 ' HA ' ' HA ' ' A' ' 108' ' ' CYS . 76.5 m -79.93 122.75 27.09 Favored 'General case' 0 N--CA 1.497 1.914 0 C-N-CA 119.166 -1.014 . . . . 0.0 110.761 -179.79 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.476 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 37.0 mtmm -73.2 89.48 1.53 Allowed 'General case' 0 N--CA 1.487 1.384 0 CA-C-N 112.535 -2.12 . . . . 0.0 115.152 -179.604 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.437 ' N ' ' O ' ' A' ' 83' ' ' CYS . 41.9 m-85 -45.55 136.8 5.5 Favored 'General case' 0 N--CA 1.504 2.234 0 O-C-N 124.32 1.012 . . . . 0.0 108.399 179.488 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -154.17 145.8 23.26 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 114.851 -1.068 . . . . 0.0 112.144 -179.478 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 89.0 p -90.12 141.51 28.61 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 112.05 -2.341 . . . . 0.0 115.806 -179.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -51.34 -33.92 31.55 Favored 'General case' 0 N--CA 1.499 2.01 0 CA-C-N 112.288 -2.233 . . . . 0.0 114.313 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -57.85 -13.98 5.27 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 123.994 0.808 . . . . 0.0 112.156 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 102.7 37.46 3.21 Favored Glycine 0 N--CA 1.491 2.325 0 O-C-N 124.311 1.007 . . . . 0.0 111.487 179.783 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 90.7 m -140.79 149.07 41.6 Favored 'General case' 0 N--CA 1.496 1.858 0 C-N-CA 119.8 -0.76 . . . . 0.0 111.826 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 21.3 t80 -77.45 142.86 38.97 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-N 114.937 -1.029 . . . . 0.0 108.253 179.549 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 92.2 t -107.22 -67.27 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 CA-C-N 114.933 -1.031 . . . . 0.0 108.842 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . 0.437 ' O ' ' N ' ' A' ' 74' ' ' TYR . 39.2 m -159.8 -160.56 0.82 Allowed 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.476 ' HA ' ' HA ' ' A' ' 73' ' ' LYS . 36.3 tt0 -139.41 160.19 40.4 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 102.739 -3.06 . . . . 0.0 102.739 178.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.445 ' HA3' ' N ' ' A' ' 70' ' ' LYS . . . -38.24 100.18 0.01 OUTLIER Glycine 0 N--CA 1.494 2.527 0 CA-C-O 119.301 -0.722 . . . . 0.0 114.463 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -79.08 -3.81 47.14 Favored 'General case' 0 N--CA 1.502 2.169 0 C-N-CA 119.618 -0.833 . . . . 0.0 111.316 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.424 ' H ' ' HA3' ' A' ' 68' ' ' GLY . 44.0 t -142.93 128.57 19.18 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.662 ' H ' HD21 ' A' ' 91' ' ' ASN . 15.4 t70 -84.01 145.67 46.98 Favored Pre-proline 0 N--CA 1.493 1.681 0 CA-C-N 114.588 -1.187 . . . . 0.0 109.147 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -56.62 80.97 0.04 OUTLIER 'Trans proline' 0 N--CA 1.499 1.84 0 C-N-CA 123.279 2.653 . . . . 0.0 108.528 163.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 50.8 ttp85 -173.71 -62.54 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 104.027 -2.583 . . . . 0.0 104.027 -179.635 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.662 HD21 ' H ' ' A' ' 88' ' ' ASP . 0.7 OUTLIER -91.88 113.49 59.08 Favored Pre-proline 0 N--CA 1.492 1.651 0 CA-C-N 114.12 -1.4 . . . . 0.0 109.04 179.915 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -74.38 89.48 1.07 Allowed 'Trans proline' 0 N--CA 1.492 1.393 0 C-N-CA 122.467 2.111 . . . . 0.0 110.571 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -122.15 123.1 40.73 Favored 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -150.64 151.88 33.17 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.46 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 81.6 m -119.46 98.22 50.19 Favored Pre-proline 0 N--CA 1.497 1.898 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -68.53 93.1 0.42 Allowed 'Trans proline' 0 N--CA 1.493 1.452 0 C-N-CA 122.301 2.001 . . . . 0.0 109.013 177.106 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 28.4 mmt85 -134.72 47.88 2.34 Favored 'General case' 0 N--CA 1.498 1.954 0 CA-C-N 114.651 -1.159 . . . . 0.0 108.029 -179.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 14.5 m120 54.42 41.3 32.05 Favored 'General case' 0 N--CA 1.504 2.236 0 CA-C-O 122.797 1.284 . . . . 0.0 108.094 -179.742 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.5 ' SG ' ' N ' ' A' ' 62' ' ' CYS . 5.3 m 57.95 -167.43 0.14 Allowed 'General case' 0 N--CA 1.488 1.439 0 CA-C-N 112.031 -2.35 . . . . 0.0 108.722 -179.662 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -106.22 99.64 24.72 Favored Pre-proline 0 N--CA 1.498 1.943 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 179.75 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -64.53 -31.13 61.13 Favored 'Trans proline' 0 N--CA 1.493 1.46 0 C-N-CA 122.336 2.024 . . . . 0.0 111.639 -169.656 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 74.9 ttt-85 -71.89 -31.22 66.19 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 123.967 0.792 . . . . 0.0 111.226 -179.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 12.0 mt -68.53 157.24 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 CA-C-O 122.261 1.029 . . . . 0.0 111.427 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -124.92 -56.41 1.56 Allowed 'General case' 0 N--CA 1.492 1.63 0 CA-C-N 111.969 -2.378 . . . . 0.0 107.555 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 38.1 p90 -164.88 170.12 15.73 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-N 114.254 -1.339 . . . . 0.0 109.922 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -110.84 123.85 6.73 Favored Glycine 0 N--CA 1.492 2.426 0 CA-C-N 113.911 -1.495 . . . . 0.0 110.944 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.486 ' N ' HD12 ' A' ' 107' ' ' ILE . 2.9 mp -79.31 99.65 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' CYS . . . . . 0.438 ' HA ' ' HA ' ' A' ' 72' ' ' CYS . 25.2 m -79.79 163.9 56.01 Favored Pre-proline 0 N--CA 1.491 1.622 0 CA-C-N 114.169 -1.378 . . . . 0.0 108.754 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_exo . . . . . 0 N--CA 1.498 1.76 0 C-N-CA 122.558 2.172 . . . . 0.0 112.589 173.793 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 38.8 ttm180 . . . . . 0 N--CA 1.495 1.818 0 N-CA-C 107.135 -1.431 . . . . 0.0 107.135 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 8.6 tp -86.77 53.67 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 CA-C-N 114.092 -1.413 . . . . 0.0 109.093 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.473 ' HA ' ' HA ' ' A' ' 41' ' ' CYS . 63.5 m -84.19 40.58 0.77 Allowed 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 115.031 1.493 . . . . 0.0 115.031 -179.829 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.409 ' HB ' HG21 ' A' ' 45' ' ' ILE . 53.3 m -90.6 158.91 16.71 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 105.167 -2.16 . . . . 0.0 105.167 179.641 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -147.48 169.36 19.71 Favored 'General case' 0 N--CA 1.497 1.918 0 CA-C-O 122.427 1.108 . . . . 0.0 112.551 -179.761 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.7 t -62.76 -53.14 58.91 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-N 112.268 -2.242 . . . . 0.0 111.952 -179.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 51.4 t -67.63 -55.7 12.26 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-N 113.946 -1.479 . . . . 0.0 109.375 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -54.83 -18.03 4.31 Favored 'General case' 0 N--CA 1.497 1.921 0 CA-C-N 113.786 -1.552 . . . . 0.0 113.062 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -59.53 160.72 17.74 Favored Glycine 0 N--CA 1.496 2.676 0 C-N-CA 120.613 -0.804 . . . . 0.0 111.453 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 9.7 t -76.45 129.4 36.48 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 115.732 1.753 . . . . 0.0 115.732 -179.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.423 ' HB3' ' NZ ' ' A' ' 12' ' ' LYS . 3.1 mmmp? -62.34 93.23 0.05 OUTLIER 'General case' 0 N--CA 1.5 2.073 0 CA-C-N 114.195 -1.366 . . . . 0.0 109.032 179.572 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 157.18 -28.09 0.51 Allowed Glycine 0 N--CA 1.49 2.279 0 CA-C-O 118.52 -1.156 . . . . 0.0 112.913 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 84.2 m -117.55 169.7 9.34 Favored 'General case' 0 N--CA 1.503 2.183 0 C-N-CA 119.438 -0.905 . . . . 0.0 112.603 -179.766 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 36.0 mtmm -102.69 96.67 7.02 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-N 113.982 -1.463 . . . . 0.0 111.312 -179.714 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.423 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 24.0 m-85 -59.94 127.9 34.19 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-O 122.884 1.326 . . . . 0.0 108.023 179.654 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -135.2 151.96 51.12 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 111.29 -2.687 . . . . 0.0 112.655 -179.145 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 87.8 p -91.03 133.06 35.61 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 112.991 -1.913 . . . . 0.0 113.924 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -47.73 -29.12 2.84 Favored 'General case' 0 N--CA 1.5 2.035 0 CA-C-N 113.11 -1.859 . . . . 0.0 116.012 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -57.64 -18.35 19.73 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 123.611 0.57 . . . . 0.0 112.519 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 112.46 26.96 4.05 Favored Glycine 0 N--CA 1.494 2.52 0 O-C-N 124.366 1.041 . . . . 0.0 111.098 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 62.4 m -135.91 156.06 49.35 Favored 'General case' 0 N--CA 1.496 1.853 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.458 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 22.6 t80 -85.85 149.25 25.37 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-N 114.89 -1.05 . . . . 0.0 110.16 179.727 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 96.0 t -108.47 -79.0 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 N-CA-C 107.03 -1.471 . . . . 0.0 107.03 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.458 ' SG ' ' O ' ' A' ' 26' ' ' GLU . 0.1 OUTLIER -164.76 179.91 6.26 Favored 'General case' 0 N--CA 1.5 2.044 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 179.743 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.458 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 30.7 tt0 -85.64 157.05 20.44 Favored 'General case' 0 N--CA 1.502 2.138 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 179.87 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -74.14 116.43 5.26 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 104.729 -3.349 . . . . 0.0 104.729 179.613 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -98.64 21.94 10.62 Favored 'General case' 0 N--CA 1.505 2.285 0 N-CA-C 114.757 1.392 . . . . 0.0 114.757 -179.633 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 37.7 t -137.97 117.88 13.31 Favored 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 179.671 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.633 ' H ' HD21 ' A' ' 33' ' ' ASN . 16.3 t70 -79.42 132.52 62.06 Favored Pre-proline 0 N--CA 1.493 1.692 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_endo -67.11 85.33 0.33 Allowed 'Trans proline' 0 N--CA 1.492 1.441 0 C-N-CA 122.6 2.2 . . . . 0.0 109.908 178.534 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 12.0 mtp180 176.52 -41.71 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.938 0 CA-C-N 113.925 -1.488 . . . . 0.0 108.216 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.633 HD21 ' H ' ' A' ' 30' ' ' ASP . 24.4 p30 -77.22 146.11 74.08 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 123.991 0.807 . . . . 0.0 111.88 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -81.54 48.23 2.79 Favored 'Trans proline' 0 N--CA 1.492 1.407 0 C-N-CA 123.407 2.738 . . . . 0.0 109.525 163.061 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 65.0 tttp -68.23 150.71 47.95 Favored 'General case' 0 N--CA 1.497 1.891 0 CA-C-O 121.544 0.688 . . . . 0.0 111.617 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -91.42 131.03 37.16 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-N 113.608 -1.633 . . . . 0.0 108.005 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 5.2 m -142.85 -178.41 5.79 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 -179.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 96.2 m -83.25 113.87 20.99 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-N 113.645 -1.616 . . . . 0.0 108.413 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 9.8 mp -79.5 0.58 29.07 Favored 'General case' 0 N--CA 1.498 1.953 0 CA-C-N 115.299 -0.864 . . . . 0.0 112.164 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -59.19 119.61 7.67 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 123.546 0.529 . . . . 0.0 109.719 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.473 ' HA ' ' HA ' ' A' ' 4' ' ' CYS . 85.0 m -68.55 92.26 0.45 Allowed 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.412 ' O ' HG22 ' A' ' 45' ' ' ILE . 10.0 t70 -63.35 101.88 0.29 Allowed Pre-proline 0 N--CA 1.495 1.792 0 CA-C-N 115.252 -0.885 . . . . 0.0 110.19 -179.681 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo -67.32 -37.88 16.7 Favored 'Trans proline' 0 N--CA 1.492 1.399 0 C-N-CA 122.159 1.906 . . . . 0.0 110.779 -160.234 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 28.0 ptt-85 -78.27 -23.1 47.39 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-N 114.233 -1.349 . . . . 0.0 114.013 -179.77 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.412 HG22 ' O ' ' A' ' 42' ' ' ASP . 7.9 tt -55.27 159.04 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.278 0 C-N-CA 120.1 -0.64 . . . . 0.0 110.476 -179.554 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -141.85 -62.64 0.45 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 123.803 0.69 . . . . 0.0 112.575 -179.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 28.1 p90 -156.17 161.63 40.29 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-O 121.871 0.843 . . . . 0.0 113.04 -179.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.423 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -92.17 95.3 2.01 Favored Glycine 0 N--CA 1.489 2.194 0 CA-C-N 112.785 -2.007 . . . . 0.0 110.593 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 4.7 p -81.74 110.55 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 C-N-CA 119.108 -1.037 . . . . 0.0 109.012 179.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.6 m -79.04 154.43 77.55 Favored Pre-proline 0 N--CA 1.498 1.928 0 CA-C-N 115.472 -0.786 . . . . 0.0 109.414 179.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo . . . . . 0 N--CA 1.497 1.692 0 C-N-CA 122.71 2.273 . . . . 0.0 111.623 -173.506 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.462 ' HA ' ' HA ' ' A' ' 99' ' ' CYS . 1.6 m . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 123.128 1.442 . . . . 0.0 114.455 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.41 ' O ' ' N ' ' A' ' 100' ' ' ASP . 1.8 p -90.86 160.87 15.5 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-N 112.64 -2.073 . . . . 0.0 108.05 179.456 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 32.5 p-10 -161.63 148.48 14.32 Favored 'General case' 0 N--CA 1.501 2.108 0 C-N-CA 119.891 -0.723 . . . . 0.0 110.22 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' CYS . . . . . 0.489 ' HA ' ' CD2' ' A' ' 74' ' ' TYR . 7.1 t -65.45 -15.45 62.64 Favored 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 113.661 0.986 . . . . 0.0 113.661 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 29.4 t -80.52 -66.77 0.84 Allowed 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 116.295 1.961 . . . . 0.0 116.295 -179.499 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -77.82 63.31 2.84 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 125.545 1.778 . . . . 0.0 114.832 -179.25 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -123.98 -150.3 7.91 Favored Glycine 0 N--CA 1.494 2.522 0 CA-C-N 112.729 -2.032 . . . . 0.0 109.946 179.558 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 4.8 t -136.44 121.18 18.51 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-N 114.102 -1.049 . . . . 0.0 108.924 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 6.2 ptpp? -58.16 89.95 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.853 0 CA-C-O 122.648 1.214 . . . . 0.0 111.371 179.678 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 161.89 -42.08 0.38 Allowed Glycine 0 N--CA 1.49 2.24 0 N-CA-C 108.368 -1.893 . . . . 0.0 108.368 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . 0.434 ' HA ' ' HA ' ' A' ' 108' ' ' CYS . 90.3 m -79.43 128.29 33.16 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 179.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 35.4 mmtp -80.37 83.31 6.22 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 115.581 1.697 . . . . 0.0 115.581 -179.321 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.489 ' CD2' ' HA ' ' A' ' 65' ' ' CYS . 2.1 m-85 -43.55 126.36 4.39 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 124.235 0.959 . . . . 0.0 109.181 179.379 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -141.08 152.04 44.48 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-N 114.321 -1.309 . . . . 0.0 112.325 -179.34 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 30.2 t -101.66 143.24 31.86 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 116.059 1.874 . . . . 0.0 116.059 -179.57 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -49.69 -26.11 3.48 Favored 'General case' 0 N--CA 1.5 2.074 0 CA-C-N 111.231 -2.713 . . . . 0.0 113.435 179.746 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 13.8 p30 -62.33 -3.18 1.24 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 124.178 0.924 . . . . 0.0 111.853 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 86.87 28.96 24.72 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 90.3 m -142.33 143.93 32.98 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 120.47 -0.492 . . . . 0.0 110.9 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 52.6 t80 -67.94 160.25 28.95 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-N 114.17 -1.377 . . . . 0.0 110.497 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 91.1 t -122.95 -74.77 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 CA-C-N 114.624 -1.171 . . . . 0.0 110.477 -179.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . 0.492 ' SG ' ' N ' ' A' ' 84' ' ' GLU . 0.5 OUTLIER -157.13 -163.07 1.32 Allowed 'General case' 0 N--CA 1.502 2.163 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 -179.874 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.492 ' N ' ' SG ' ' A' ' 83' ' ' CYS . 38.2 tt0 -119.56 164.37 15.93 Favored 'General case' 0 N--CA 1.503 2.205 0 N-CA-C 104.722 -2.325 . . . . 0.0 104.722 179.18 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.42 ' N ' ' HG2' ' A' ' 84' ' ' GLU . . . -60.91 113.57 5.74 Favored Glycine 0 N--CA 1.497 2.743 0 C-N-CA 119.315 -1.422 . . . . 0.0 110.302 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -86.0 21.68 1.9 Allowed 'General case' 0 N--CA 1.501 2.11 0 CA-C-O 121.722 0.772 . . . . 0.0 111.297 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 3.5 m -133.4 160.54 37.08 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 113.996 -1.456 . . . . 0.0 107.224 179.735 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.406 ' H ' ' HB3' ' A' ' 91' ' ' ASN . 21.3 t70 -79.66 145.9 63.77 Favored Pre-proline 0 N--CA 1.493 1.689 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -47.7 -15.22 0.31 Allowed 'Trans proline' 0 N--CA 1.499 1.848 0 C-N-CA 122.835 2.356 . . . . 0.0 114.037 171.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 72.5 ttt-85 -139.93 53.05 1.68 Allowed 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.406 ' HB3' ' H ' ' A' ' 88' ' ' ASP . 18.2 p-10 -90.05 128.28 50.37 Favored Pre-proline 0 N--CA 1.496 1.828 0 CA-C-N 114.522 -1.217 . . . . 0.0 111.447 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -83.89 48.1 2.46 Favored 'Trans proline' 0 N--CA 1.491 1.362 0 C-N-CA 123.245 2.63 . . . . 0.0 109.125 159.22 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -130.39 147.52 52.1 Favored 'General case' 0 N--CA 1.503 2.184 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.681 -179.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -160.54 125.2 3.72 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-N 114.875 -1.057 . . . . 0.0 109.501 179.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 68.7 m -79.74 162.79 61.48 Favored Pre-proline 0 N--CA 1.5 2.03 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -69.97 4.92 2.0 Allowed 'Trans proline' 0 N--CA 1.495 1.587 0 C-N-CA 122.118 1.879 . . . . 0.0 111.146 163.5 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 80.5 mmt-85 -94.21 22.13 6.23 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 123.647 0.592 . . . . 0.0 110.616 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -63.21 158.07 20.95 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.167 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.462 ' HA ' ' HA ' ' A' ' 62' ' ' CYS . 74.0 m 61.75 125.59 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.888 0 O-C-N 125.193 1.558 . . . . 0.0 112.215 -179.771 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.41 ' N ' ' O ' ' A' ' 63' ' ' THR . 30.8 t70 -156.22 84.88 3.21 Favored Pre-proline 0 N--CA 1.494 1.761 0 CA-C-N 114.876 -1.056 . . . . 0.0 110.154 -179.778 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_exo -52.44 -18.26 7.85 Favored 'Trans proline' 0 N--CA 1.495 1.594 0 C-N-CA 122.457 2.104 . . . . 0.0 112.455 174.731 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.69 -54.02 38.25 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 105.974 -1.862 . . . . 0.0 105.974 179.855 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 15.3 tt -79.95 157.52 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 C-N-CA 119.215 -0.994 . . . . 0.0 109.747 -179.777 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -113.28 -61.35 1.75 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 124.372 1.045 . . . . 0.0 112.588 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 7.4 p90 -162.65 160.06 25.22 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 123.886 0.741 . . . . 0.0 112.162 -179.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -97.13 127.44 9.21 Favored Glycine 0 N--CA 1.492 2.414 0 CA-C-N 113.848 -1.523 . . . . 0.0 111.716 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 48.0 mm -80.91 97.88 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' CYS . . . . . 0.434 ' HA ' ' HA ' ' A' ' 72' ' ' CYS . 35.0 m -79.67 143.07 58.06 Favored Pre-proline 0 N--CA 1.494 1.729 0 CA-C-N 114.744 -1.116 . . . . 0.0 109.244 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo . . . . . 0 N--CA 1.496 1.627 0 C-N-CA 122.999 2.466 . . . . 0.0 112.053 -174.136 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 5.9 mmp_? . . . . . 0 N--CA 1.493 1.7 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 10.2 tp -85.15 44.46 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 CA-C-N 114.374 -1.285 . . . . 0.0 109.528 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.409 ' HA ' ' HA ' ' A' ' 41' ' ' CYS . 5.7 m -85.16 59.5 5.67 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 122.582 1.182 . . . . 0.0 112.938 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.2 t -90.03 167.87 12.43 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-N 113.145 -1.843 . . . . 0.0 107.178 179.675 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 15.9 p30 -145.72 150.59 36.54 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.949 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.7 t -67.34 -20.12 65.54 Favored 'General case' 0 N--CA 1.496 1.847 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.805 -179.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 35.7 t -54.94 -55.67 28.16 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 179.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -71.69 -23.24 61.61 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-N 112.853 -1.976 . . . . 0.0 110.098 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -52.72 142.38 26.09 Favored Glycine 0 N--CA 1.493 2.494 0 O-C-N 124.199 0.937 . . . . 0.0 112.572 -179.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 41.0 p -61.15 109.15 1.03 Allowed 'General case' 0 N--CA 1.492 1.639 0 CA-C-N 111.711 -2.244 . . . . 0.0 111.976 -179.713 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -68.81 88.64 0.38 Allowed 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 122.457 1.123 . . . . 0.0 108.677 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 163.87 -22.6 0.17 Allowed Glycine 0 N--CA 1.488 2.111 0 CA-C-N 112.611 -2.086 . . . . 0.0 109.639 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 76.0 m -107.63 138.12 44.42 Favored 'General case' 0 N--CA 1.497 1.902 0 CA-C-O 121.533 0.683 . . . . 0.0 110.567 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 61.3 mtpt -83.38 84.82 7.37 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-N 113.821 -1.536 . . . . 0.0 110.914 -179.518 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 -49.78 128.93 19.17 Favored 'General case' 0 N--CA 1.498 1.951 0 CA-C-O 122.37 1.081 . . . . 0.0 109.982 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -136.8 161.01 37.16 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-N 112.262 -2.245 . . . . 0.0 112.554 -179.264 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 32.8 t -104.33 133.12 49.77 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 113.613 -1.63 . . . . 0.0 112.19 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -47.73 -25.06 1.1 Allowed 'General case' 0 N--CA 1.5 2.032 0 CA-C-N 112.895 -1.957 . . . . 0.0 114.18 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 29.3 p30 -60.17 -7.66 2.02 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 124.095 0.872 . . . . 0.0 112.573 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 95.61 27.23 10.74 Favored Glycine 0 N--CA 1.494 2.537 0 N-CA-C 109.894 -1.282 . . . . 0.0 109.894 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 88.3 m -141.29 139.41 33.66 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 123.926 0.427 . . . . 0.0 110.161 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.43 ' CG ' ' N ' ' A' ' 24' ' ' VAL . 48.8 t80 -67.15 164.64 17.63 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 124.63 1.206 . . . . 0.0 110.787 179.809 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.43 ' N ' ' CG ' ' A' ' 23' ' ' PHE . 96.8 t -129.66 -73.05 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 124.093 0.871 . . . . 0.0 112.544 -179.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 20.3 p -150.58 -172.01 4.07 Favored 'General case' 0 N--CA 1.501 2.084 0 CA-C-O 121.615 0.721 . . . . 0.0 111.359 -179.496 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -123.51 138.77 54.5 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 104.585 -2.376 . . . . 0.0 104.585 179.447 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -55.99 155.52 12.3 Favored Glycine 0 N--CA 1.503 3.111 0 C-N-CA 120.137 -1.03 . . . . 0.0 114.597 -179.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -112.89 -29.55 7.34 Favored 'General case' 0 N--CA 1.505 2.29 0 CA-C-N 114.837 -0.681 . . . . 0.0 111.891 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 32.0 t -110.44 124.54 51.95 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 107.3 -1.371 . . . . 0.0 107.3 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -77.81 144.1 68.03 Favored Pre-proline 0 N--CA 1.495 1.792 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 -179.714 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -41.46 -21.36 0.13 Allowed 'Trans proline' 0 N--CA 1.501 1.925 0 C-N-CA 124.02 3.146 . . . . 0.0 115.617 177.551 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 30.9 tpt180 -57.63 -30.34 65.28 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 123.708 0.63 . . . . 0.0 110.657 179.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.506 ' N ' HD22 ' A' ' 33' ' ' ASN . 0.0 OUTLIER -53.96 120.96 26.74 Favored Pre-proline 0 N--CA 1.496 1.839 0 CA-C-N 114.956 -1.02 . . . . 0.0 112.902 179.991 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -82.19 40.51 0.98 Allowed 'Trans proline' 0 N--CA 1.494 1.546 0 C-N-CA 122.979 2.453 . . . . 0.0 110.356 167.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 57.5 tptt -170.07 160.21 8.0 Favored 'General case' 0 N--CA 1.498 1.951 0 CA-C-N 114.577 -1.192 . . . . 0.0 108.578 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -140.4 151.68 45.14 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 123.866 0.729 . . . . 0.0 109.934 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 6.7 m -79.48 143.51 34.87 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 90.2 m -148.79 92.03 1.94 Allowed 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.4 HD23 ' C ' ' A' ' 39' ' ' LEU . 5.9 tt -157.94 -68.92 0.09 Allowed 'General case' 0 N--CA 1.496 1.839 0 CA-C-N 115.339 -0.846 . . . . 0.0 108.917 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -70.33 146.6 50.4 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 123.766 0.666 . . . . 0.0 111.993 -179.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.409 ' HA ' ' HA ' ' A' ' 4' ' ' CYS . 79.1 m -105.11 132.17 51.67 Favored 'General case' 0 N--CA 1.496 1.826 0 CA-C-N 114.411 -1.268 . . . . 0.0 109.68 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -135.2 77.44 54.95 Favored Pre-proline 0 N--CA 1.497 1.911 0 O-C-N 123.849 0.718 . . . . 0.0 110.291 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_endo -62.75 -27.19 75.39 Favored 'Trans proline' 0 N--CA 1.494 1.515 0 C-N-CA 123.066 2.511 . . . . 0.0 112.794 -172.473 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 6.0 ptp85 -65.99 -34.8 78.93 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 124.189 0.931 . . . . 0.0 112.47 -179.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.0 mt -59.41 136.96 22.49 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.099 0 C-N-CA 118.642 -1.223 . . . . 0.0 112.347 -179.773 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -123.93 -53.02 1.76 Allowed 'General case' 0 N--CA 1.492 1.675 0 CA-C-N 111.911 -2.404 . . . . 0.0 106.737 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 17.3 p90 -170.1 158.44 6.98 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-N 113.667 -1.606 . . . . 0.0 109.8 179.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -112.83 133.93 11.65 Favored Glycine 0 N--CA 1.494 2.517 0 CA-C-N 113.746 -1.57 . . . . 0.0 112.112 -179.764 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.3 p -82.92 105.22 12.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 8.9 m -79.96 112.18 27.85 Favored Pre-proline 0 N--CA 1.493 1.718 0 CA-C-N 113.93 -1.486 . . . . 0.0 108.681 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_endo . . . . . 0 N--CA 1.492 1.425 0 C-N-CA 122.445 2.096 . . . . 0.0 111.018 -172.899 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 10.1 m . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 122.558 1.17 . . . . 0.0 112.509 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 97.4 m -78.27 162.69 26.35 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 113.355 -1.748 . . . . 0.0 108.52 179.772 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 46.0 p-10 -160.67 156.65 25.83 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 120.317 -0.553 . . . . 0.0 110.582 179.802 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' CYS . . . . . 0.551 ' SG ' ' HB2' ' A' ' 74' ' ' TYR . 53.0 t -83.48 -12.56 56.15 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-N 115.043 -0.981 . . . . 0.0 110.169 179.773 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 53.4 t -65.02 -59.83 3.71 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 179.844 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -90.54 34.55 0.89 Allowed 'General case' 0 N--CA 1.494 1.761 0 CA-C-N 114.167 -1.379 . . . . 0.0 108.69 179.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -74.62 -122.1 0.1 Allowed Glycine 0 N--CA 1.495 2.597 0 CA-C-N 115.353 -0.84 . . . . 0.0 111.053 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 14.8 t -159.81 107.33 1.69 Allowed 'General case' 0 N--CA 1.495 1.807 0 CA-C-O 122.497 1.141 . . . . 0.0 109.465 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 2.7 tmmm? -57.32 101.76 0.07 Allowed 'General case' 0 N--CA 1.493 1.689 0 CA-C-N 113.266 -1.788 . . . . 0.0 107.196 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.404 ' O ' ' SG ' ' A' ' 108' ' ' CYS . . . 165.41 -32.74 0.24 Allowed Glycine 0 N--CA 1.485 1.96 0 CA-C-N 113.225 -1.807 . . . . 0.0 109.366 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 57.7 m -124.36 175.11 7.3 Favored 'General case' 0 N--CA 1.503 2.18 0 C-N-CA 120.017 -0.673 . . . . 0.0 110.733 -179.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.448 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 94.0 mttt -110.61 97.86 7.18 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 124.607 1.192 . . . . 0.0 109.174 -179.796 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.551 ' HB2' ' SG ' ' A' ' 65' ' ' CYS . 26.8 m-85 -54.37 131.36 41.92 Favored 'General case' 0 N--CA 1.497 1.89 0 CA-C-N 114.808 -1.087 . . . . 0.0 109.135 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -139.9 147.51 40.7 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 112.956 -1.929 . . . . 0.0 113.475 -179.366 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.403 ' N ' HG23 ' A' ' 82' ' ' VAL . 30.9 t -99.58 117.03 33.07 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-N 111.378 -2.646 . . . . 0.0 108.599 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.578 ' H ' ' HB2' ' A' ' 104' ' ' ALA . 7.6 p-10 -59.97 -54.19 49.04 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 125.186 1.553 . . . . 0.0 112.996 -179.652 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -84.14 13.51 5.09 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 113.603 -1.635 . . . . 0.0 110.882 -179.673 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -129.13 -88.87 0.56 Allowed Glycine 0 N--CA 1.48 1.627 0 N-CA-C 108.962 -1.655 . . . . 0.0 108.962 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.451 ' CG2' ' N ' ' A' ' 81' ' ' PHE . 1.2 m 171.78 -175.71 0.05 OUTLIER 'General case' 0 N--CA 1.5 2.066 0 N-CA-C 105.902 -1.888 . . . . 0.0 105.902 -179.381 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.451 ' N ' ' CG2' ' A' ' 80' ' ' THR . 19.2 t80 -53.52 136.3 38.58 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 179.504 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.403 HG23 ' N ' ' A' ' 76' ' ' SER . 92.9 t -94.78 -73.61 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 CA-C-N 114.606 -1.179 . . . . 0.0 109.196 -179.558 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . 0.423 ' C ' ' SG ' ' A' ' 65' ' ' CYS . 0.1 OUTLIER -168.44 178.53 4.79 Favored 'General case' 0 N--CA 1.504 2.268 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 179.882 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.448 ' HA ' ' HA ' ' A' ' 73' ' ' LYS . 38.6 tt0 -93.02 152.46 19.29 Favored 'General case' 0 N--CA 1.5 2.034 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -50.29 102.05 0.06 OUTLIER Glycine 0 N--CA 1.495 2.589 0 O-C-N 123.739 0.649 . . . . 0.0 111.513 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -79.83 -12.15 59.78 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-N 114.862 -0.669 . . . . 0.0 110.146 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 35.1 t -77.79 84.31 4.11 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 121.464 0.65 . . . . 0.0 109.708 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -79.38 132.1 63.42 Favored Pre-proline 0 N--CA 1.495 1.803 0 N-CA-C 106.399 -1.704 . . . . 0.0 106.399 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -52.49 -22.39 16.4 Favored 'Trans proline' 0 N--CA 1.498 1.741 0 C-N-CA 122.823 2.349 . . . . 0.0 113.705 -169.701 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 53.0 mmm-85 -83.71 12.82 5.35 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 123.802 0.689 . . . . 0.0 111.648 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.411 ' C ' ' H ' ' A' ' 93' ' ' LYS . 40.6 p-10 -87.71 135.2 34.24 Favored Pre-proline 0 N--CA 1.494 1.742 0 O-C-N 123.45 0.469 . . . . 0.0 111.148 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -81.95 28.97 0.55 Allowed 'Trans proline' 0 N--CA 1.493 1.453 0 C-N-CA 122.967 2.445 . . . . 0.0 111.409 162.317 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.411 ' H ' ' C ' ' A' ' 91' ' ' ASN . 44.3 mmtm 58.21 124.23 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.162 0 CA-C-N 113.76 -1.564 . . . . 0.0 112.846 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -149.32 79.67 1.4 Allowed 'General case' 0 N--CA 1.497 1.913 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.628 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 79.2 m -153.24 124.21 3.57 Favored Pre-proline 0 N--CA 1.496 1.857 0 CA-C-N 114.476 -1.238 . . . . 0.0 108.43 179.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -60.73 -85.57 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.502 0 C-N-CA 122.046 1.831 . . . . 0.0 110.592 177.06 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -142.25 -60.35 0.45 Allowed 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 7.9 m-80 51.51 48.28 23.21 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 124.592 1.182 . . . . 0.0 110.243 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 77.9 m -41.17 128.0 2.83 Favored 'General case' 0 N--CA 1.499 2.009 0 CA-C-N 114.112 -1.404 . . . . 0.0 112.734 -179.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -139.03 79.32 27.09 Favored Pre-proline 0 N--CA 1.496 1.831 0 O-C-N 124.125 0.89 . . . . 0.0 110.882 -179.733 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -59.43 -33.91 97.35 Favored 'Trans proline' 0 N--CA 1.494 1.523 0 C-N-CA 122.87 2.38 . . . . 0.0 113.024 171.606 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 33.2 ptt180 -63.96 -16.93 62.67 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 123.919 0.762 . . . . 0.0 112.3 -179.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 9.6 tp -48.86 152.64 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 O-C-N 124.019 0.824 . . . . 0.0 112.452 -179.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.578 ' HB2' ' H ' ' A' ' 77' ' ' ASP . . . -124.59 -71.96 0.69 Allowed 'General case' 0 N--CA 1.492 1.659 0 CA-C-N 114.686 -1.143 . . . . 0.0 108.261 179.792 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 76.3 m-85 -156.14 -162.99 1.37 Allowed 'General case' 0 N--CA 1.499 2.001 0 O-C-N 124.685 1.241 . . . . 0.0 109.042 -179.725 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -119.87 93.26 0.54 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 104.966 -3.253 . . . . 0.0 104.966 179.714 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 43.7 mm -78.77 105.7 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 C-N-CA 119.626 -0.83 . . . . 0.0 110.546 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' CYS . . . . . 0.404 ' SG ' ' O ' ' A' ' 71' ' ' GLY . 1.6 m -78.61 151.4 77.19 Favored Pre-proline 0 N--CA 1.499 1.995 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.688 179.895 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo . . . . . 0 N--CA 1.494 1.528 0 C-N-CA 122.752 2.302 . . . . 0.0 111.151 -172.716 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 10.4 mmm180 . . . . . 0 N--CA 1.496 1.836 0 CA-C-O 119.927 -0.082 . . . . 0.0 111.004 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 4.8 tp -65.62 85.99 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 124.212 0.945 . . . . 0.0 111.228 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.558 ' HA ' ' HA ' ' A' ' 41' ' ' CYS . 1.6 m -92.88 61.03 3.46 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-O 123.372 1.558 . . . . 0.0 113.731 179.814 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 6.8 t -90.15 161.47 15.74 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 104.475 -2.417 . . . . 0.0 104.475 179.517 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.522 ' ND2' ' H ' ' A' ' 9' ' ' ALA . 3.2 p-10 -161.54 -166.42 1.5 Allowed 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 -179.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 8.8 t -117.58 -36.88 3.58 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 179.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 49.5 t -62.5 -61.46 2.42 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 123.917 0.761 . . . . 0.0 110.402 -179.59 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.522 ' H ' ' ND2' ' A' ' 6' ' ' ASN . . . -90.06 27.51 1.59 Allowed 'General case' 0 N--CA 1.496 1.871 0 CA-C-N 113.525 -1.67 . . . . 0.0 109.178 179.859 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -72.67 -117.9 0.06 OUTLIER Glycine 0 N--CA 1.492 2.411 0 CA-C-N 115.141 -0.936 . . . . 0.0 111.271 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 97.3 m -154.62 91.82 1.43 Allowed 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 107.518 -1.289 . . . . 0.0 107.518 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.484 ' HB3' ' NZ ' ' A' ' 12' ' ' LYS . 0.0 OUTLIER -54.6 112.77 1.08 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 123.739 0.649 . . . . 0.0 110.146 -179.847 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 135.16 -30.06 2.86 Favored Glycine 0 N--CA 1.494 2.531 0 CA-C-N 113.641 -1.618 . . . . 0.0 109.781 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 82.6 m -88.97 -178.38 5.7 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 123.659 0.27 . . . . 0.0 110.955 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 33.3 mmtp -129.82 92.26 3.29 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 124.062 0.851 . . . . 0.0 111.294 -179.546 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.436 ' HB2' ' SG ' ' A' ' 25' ' ' CYS . 51.3 m-85 -58.87 131.64 51.59 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 124.53 1.144 . . . . 0.0 108.268 179.72 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -142.04 159.66 41.78 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-N 113.102 -1.863 . . . . 0.0 113.43 -179.162 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 30.6 t -105.11 134.04 48.89 Favored 'General case' 0 N--CA 1.497 1.893 0 CA-C-N 113.689 -1.596 . . . . 0.0 111.619 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -48.22 -28.27 2.93 Favored 'General case' 0 N--CA 1.501 2.122 0 CA-C-N 112.948 -1.933 . . . . 0.0 115.814 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -52.09 -22.75 4.43 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 124.036 0.835 . . . . 0.0 111.602 -179.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 112.13 27.2 4.05 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 108.871 -1.692 . . . . 0.0 108.871 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 89.7 m -138.75 142.06 38.83 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 120.527 -0.469 . . . . 0.0 110.959 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 49.6 t80 -69.41 160.98 30.35 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-N 114.151 -1.386 . . . . 0.0 109.761 179.745 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 58.5 t -127.2 -71.6 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 124.091 0.87 . . . . 0.0 112.179 -179.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.436 ' SG ' ' HB2' ' A' ' 16' ' ' TYR . 0.5 OUTLIER -144.52 -177.93 5.73 Favored 'General case' 0 N--CA 1.5 2.068 0 CA-C-O 121.402 0.62 . . . . 0.0 110.818 -179.709 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -113.04 145.0 41.63 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 104.067 -2.568 . . . . 0.0 104.067 179.485 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -57.3 152.04 26.23 Favored Glycine 0 N--CA 1.498 2.773 0 C-N-CA 119.301 -1.428 . . . . 0.0 111.184 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -126.42 -10.06 6.32 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 123.976 0.457 . . . . 0.0 111.265 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 33.4 t -71.63 91.26 1.08 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 123.728 0.643 . . . . 0.0 110.714 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -99.11 111.88 61.88 Favored Pre-proline 0 N--CA 1.491 1.586 0 CA-C-N 114.618 -1.173 . . . . 0.0 108.752 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_endo -58.48 -17.07 32.42 Favored 'Trans proline' 0 N--CA 1.495 1.609 0 C-N-CA 122.869 2.38 . . . . 0.0 113.114 -168.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 74.7 ttt-85 -61.01 -50.01 75.1 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -90.84 122.85 66.31 Favored Pre-proline 0 N--CA 1.496 1.843 0 O-C-N 124.271 0.982 . . . . 0.0 110.772 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_endo -78.11 121.62 5.41 Favored 'Trans proline' 0 N--CA 1.492 1.417 0 C-N-CA 122.813 2.342 . . . . 0.0 108.999 165.303 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 56.8 tptt -159.05 153.94 24.87 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 123.62 0.575 . . . . 0.0 110.568 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.85 171.62 9.79 Favored 'General case' 0 N--CA 1.497 1.912 0 CA-C-N 114.321 -1.309 . . . . 0.0 111.315 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 89.7 m -153.58 162.76 40.95 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-N 115.323 -0.853 . . . . 0.0 112.22 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 100.0 m -109.38 91.16 3.53 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 105.46 -2.052 . . . . 0.0 105.46 179.745 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.479 HD12 ' N ' ' A' ' 39' ' ' LEU . 6.4 mp -79.65 -66.43 0.87 Allowed 'General case' 0 N--CA 1.494 1.725 0 CA-C-N 114.882 -1.054 . . . . 0.0 109.892 -179.728 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 5.6 m120 49.17 31.84 3.82 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 124.637 1.211 . . . . 0.0 111.185 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.558 ' HA ' ' HA ' ' A' ' 4' ' ' CYS . 1.7 m 55.7 131.98 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 116.668 2.099 . . . . 0.0 116.668 -179.831 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -120.37 81.13 30.06 Favored Pre-proline 0 N--CA 1.5 2.064 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.296 179.667 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -58.58 -15.29 24.76 Favored 'Trans proline' 0 N--CA 1.495 1.574 0 C-N-CA 122.578 2.186 . . . . 0.0 112.308 176.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.456 ' H ' ' CD ' ' A' ' 44' ' ' ARG . 1.4 mpt_? -62.41 -43.23 99.31 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 26.6 mt -83.09 155.81 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 CA-C-O 122.317 1.056 . . . . 0.0 110.201 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -116.2 -53.84 2.51 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-N 111.731 -2.486 . . . . 0.0 108.025 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 50.9 p90 -165.75 167.31 17.14 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-N 114.41 -1.268 . . . . 0.0 109.287 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -119.93 118.48 3.92 Favored Glycine 0 N--CA 1.49 2.251 0 CA-C-N 113.557 -1.656 . . . . 0.0 110.56 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.9 p -79.31 133.99 28.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 20.9 m -111.27 90.76 12.28 Favored Pre-proline 0 N--CA 1.494 1.745 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 -179.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo . . . . . 0 N--CA 1.499 1.801 0 C-N-CA 123.244 2.629 . . . . 0.0 114.423 -177.1 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.46 ' HA ' ' HA ' ' A' ' 99' ' ' CYS . 1.6 m . . . . . 0 N--CA 1.494 1.76 0 N-CA-C 115.618 1.71 . . . . 0.0 115.618 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 36.0 m -91.51 109.71 21.01 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 113.175 -1.83 . . . . 0.0 107.893 179.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.539 ' ND2' ' H ' ' A' ' 67' ' ' ALA . 29.8 p-10 -107.83 -165.72 1.08 Allowed 'General case' 0 N--CA 1.503 2.184 0 C-N-CA 120.264 -0.574 . . . . 0.0 109.651 179.84 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' CYS . . . . . 0.409 ' SG ' ' O ' ' A' ' 84' ' ' GLU . 1.5 t -121.22 -33.91 3.59 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 123.904 0.753 . . . . 0.0 111.362 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 32.6 t -57.07 -58.6 7.48 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-O 121.71 0.766 . . . . 0.0 110.12 -179.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.539 ' H ' ' ND2' ' A' ' 64' ' ' ASN . . . -79.42 -10.56 59.83 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-N 113.088 -1.869 . . . . 0.0 109.737 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -67.47 156.57 52.31 Favored Glycine 0 N--CA 1.494 2.551 0 C-N-CA 120.823 -0.703 . . . . 0.0 111.588 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.461 ' C ' ' H ' ' A' ' 71' ' ' GLY . 57.0 p -68.49 124.27 23.09 Favored 'General case' 0 N--CA 1.498 1.951 0 CA-C-N 114.14 -1.03 . . . . 0.0 111.127 -179.809 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.86 20.72 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.173 0 N-CA-C 115.958 1.836 . . . . 0.0 115.958 -179.853 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.461 ' H ' ' C ' ' A' ' 69' ' ' THR . . . -119.58 -25.85 2.52 Favored Glycine 0 N--CA 1.49 2.29 0 CA-C-N 113.623 -1.626 . . . . 0.0 109.319 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . 0.4 ' HA ' ' HA ' ' A' ' 108' ' ' CYS . 94.6 m -93.36 134.54 35.48 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 120.333 -0.547 . . . . 0.0 109.801 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 60.0 mtpt -88.77 84.27 6.69 Favored 'General case' 0 N--CA 1.485 1.316 0 CA-C-N 113.501 -1.681 . . . . 0.0 109.545 -179.632 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.487 ' HB2' ' SG ' ' A' ' 83' ' ' CYS . 82.0 m-85 -50.08 126.11 13.74 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-N 114.855 -1.066 . . . . 0.0 108.418 179.87 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -132.5 162.88 30.08 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 112.986 -1.915 . . . . 0.0 112.625 -179.327 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 42.6 t -109.21 138.52 45.44 Favored 'General case' 0 N--CA 1.497 1.889 0 CA-C-N 114.309 -1.314 . . . . 0.0 112.376 -179.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.44 ' H ' ' CB ' ' A' ' 104' ' ' ALA . 7.0 p-10 -47.45 -27.25 1.63 Allowed 'General case' 0 N--CA 1.5 2.042 0 CA-C-N 112.18 -2.282 . . . . 0.0 114.38 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 13.6 p30 -59.11 -7.62 1.21 Allowed 'General case' 0 N--CA 1.497 1.899 0 O-C-N 124.335 1.022 . . . . 0.0 112.492 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 92.91 28.57 11.83 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 95.8 m -143.08 138.8 30.14 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 124.095 0.526 . . . . 0.0 110.554 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.429 ' CG ' ' N ' ' A' ' 82' ' ' VAL . 37.1 t80 -64.19 164.96 10.01 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 124.878 1.361 . . . . 0.0 110.849 179.853 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.429 ' N ' ' CG ' ' A' ' 81' ' ' PHE . 92.4 t -129.03 -71.56 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 124.188 0.93 . . . . 0.0 112.991 -179.805 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . 0.487 ' SG ' ' HB2' ' A' ' 74' ' ' TYR . 25.4 p -152.58 -173.08 4.44 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 123.708 0.63 . . . . 0.0 109.346 -179.561 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.409 ' O ' ' SG ' ' A' ' 65' ' ' CYS . 40.5 tt0 -128.49 149.63 50.51 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 102.602 -3.111 . . . . 0.0 102.602 179.324 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -58.8 169.89 5.36 Favored Glycine 0 N--CA 1.501 3.023 0 C-N-CA 118.631 -1.747 . . . . 0.0 114.966 -179.66 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -126.15 -13.88 6.11 Favored 'General case' 0 N--CA 1.502 2.145 0 CA-C-N 114.218 -0.991 . . . . 0.0 110.991 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 34.5 t -81.55 121.59 26.5 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -98.32 143.3 26.04 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 124.779 1.299 . . . . 0.0 107.785 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_exo -43.18 -28.07 1.29 Allowed 'Trans proline' 0 N--CA 1.5 1.866 0 C-N-CA 123.4 2.733 . . . . 0.0 114.022 175.073 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -60.09 -50.38 73.92 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 123.911 0.757 . . . . 0.0 109.278 179.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -91.06 116.39 66.32 Favored Pre-proline 0 N--CA 1.497 1.892 0 O-C-N 124.748 1.28 . . . . 0.0 111.806 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -85.02 102.76 0.8 Allowed 'Trans proline' 0 N--CA 1.491 1.342 0 C-N-CA 123.072 2.514 . . . . 0.0 108.044 161.476 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 22.2 ptmt -161.18 162.95 31.49 Favored 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 113.188 0.81 . . . . 0.0 113.188 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -108.86 -166.86 1.15 Allowed 'General case' 0 N--CA 1.496 1.844 0 CA-C-N 113.56 -1.654 . . . . 0.0 108.406 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 76.9 m -146.99 159.94 41.61 Favored Pre-proline 0 N--CA 1.499 1.984 0 O-C-N 123.653 0.595 . . . . 0.0 110.958 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.418 ' C ' ' HE ' ' A' ' 97' ' ' ARG . 11.9 Cg_endo -73.15 -18.19 23.94 Favored 'Trans proline' 0 N--CA 1.493 1.461 0 C-N-CA 122.36 2.04 . . . . 0.0 109.45 161.522 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.418 ' HE ' ' C ' ' A' ' 96' ' ' PRO . 0.0 OUTLIER -79.64 4.44 16.05 Favored 'General case' 0 N--CA 1.497 1.9 0 CA-C-N 114.949 -1.023 . . . . 0.0 111.376 -179.994 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 -54.89 154.41 5.27 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.46 ' HA ' ' HA ' ' A' ' 62' ' ' CYS . 52.4 m 58.37 104.19 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 CA-C-N 113.227 -1.806 . . . . 0.0 113.583 -179.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -125.36 107.1 27.27 Favored Pre-proline 0 N--CA 1.498 1.97 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.616 179.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -62.4 -25.79 76.4 Favored 'Trans proline' 0 N--CA 1.493 1.491 0 C-N-CA 122.639 2.226 . . . . 0.0 111.453 179.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 23.5 mtp-105 -57.93 -38.18 75.43 Favored 'General case' 0 N--CA 1.5 2.048 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 26.7 mt -79.31 154.85 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 CA-C-N 114.815 -1.084 . . . . 0.0 110.079 179.734 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.44 ' CB ' ' H ' ' A' ' 77' ' ' ASP . . . -132.36 -46.24 0.91 Allowed 'General case' 0 N--CA 1.495 1.794 0 CA-C-N 111.955 -2.384 . . . . 0.0 109.441 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 49.1 m-85 -140.0 -163.55 1.53 Allowed 'General case' 0 N--CA 1.493 1.706 0 CA-C-N 114.519 -1.219 . . . . 0.0 109.594 -179.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -152.65 107.77 0.34 Allowed Glycine 0 N--CA 1.49 2.235 0 N-CA-C 107.339 -2.304 . . . . 0.0 107.339 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 88.9 mt -79.44 84.41 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 N-CA-C 108.245 -1.021 . . . . 0.0 108.245 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' CYS . . . . . 0.4 ' HA ' ' HA ' ' A' ' 72' ' ' CYS . 13.6 m -79.97 112.46 30.18 Favored Pre-proline 0 N--CA 1.494 1.729 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo . . . . . 0 N--CA 1.493 1.442 0 C-N-CA 122.236 1.957 . . . . 0.0 111.306 -167.496 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 72.7 mtp85 . . . . . 0 N--CA 1.495 1.801 0 CA-C-O 120.52 0.2 . . . . 0.0 110.472 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 9.8 tp -87.0 44.11 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 124.169 0.918 . . . . 0.0 109.031 179.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.408 ' HA ' ' HA ' ' A' ' 41' ' ' CYS . 1.7 m -82.78 60.35 5.28 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 114.336 1.236 . . . . 0.0 114.336 -179.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 17.8 p -90.92 172.4 8.62 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-N 113.501 -1.681 . . . . 0.0 109.37 179.601 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 32.3 p-10 -161.8 146.06 12.73 Favored 'General case' 0 N--CA 1.497 1.925 0 CA-C-N 115.002 -0.999 . . . . 0.0 109.681 179.687 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.4 ' HA ' ' CD2' ' A' ' 16' ' ' TYR . 40.3 t -63.4 -16.54 60.82 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 113.469 0.915 . . . . 0.0 113.469 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 43.8 t -80.77 -63.46 1.4 Allowed 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 114.789 1.403 . . . . 0.0 114.789 -179.515 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -85.21 62.33 7.43 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-N 114.664 -1.153 . . . . 0.0 112.377 -179.646 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -106.96 -111.79 3.61 Favored Glycine 0 N--CA 1.495 2.578 0 CA-C-N 113.699 -1.591 . . . . 0.0 110.257 179.715 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.561 ' H ' ' HA3' ' A' ' 27' ' ' GLY . 53.4 m -166.64 117.83 0.96 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 125.211 1.183 . . . . 0.0 109.622 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 11.0 mmmm -67.9 83.34 0.21 Allowed 'General case' 0 N--CA 1.502 2.158 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 179.504 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 168.48 -20.26 0.08 OUTLIER Glycine 0 N--CA 1.49 2.282 0 CA-C-N 114.758 -1.11 . . . . 0.0 112.226 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 68.1 m -117.71 -176.68 3.08 Favored 'General case' 0 N--CA 1.5 2.031 0 CA-C-N 117.921 0.86 . . . . 0.0 108.879 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.431 ' HB3' ' HZ2' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -130.84 116.78 18.4 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 118.463 -1.295 . . . . 0.0 113.494 -179.657 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.44 ' N ' ' O ' ' A' ' 25' ' ' CYS . 8.2 m-85 -56.61 136.31 54.66 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-N 113.784 -1.553 . . . . 0.0 107.759 179.331 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -151.06 149.69 29.83 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 113.322 -1.763 . . . . 0.0 111.261 -179.452 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 38.1 t -98.73 134.33 41.78 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-N 111.914 -2.403 . . . . 0.0 112.174 -179.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.446 ' H ' ' HB2' ' A' ' 46' ' ' ALA . 3.3 p30 -51.58 -26.44 8.74 Favored 'General case' 0 N--CA 1.5 2.061 0 CA-C-N 112.701 -2.045 . . . . 0.0 114.24 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 52.0 p-10 -59.28 -10.21 2.82 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 124.079 0.862 . . . . 0.0 112.244 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 97.62 29.65 7.67 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 108.718 -1.753 . . . . 0.0 108.718 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 56.2 m -136.06 145.86 46.45 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 124.135 0.55 . . . . 0.0 109.744 -179.799 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.426 ' CG ' ' N ' ' A' ' 24' ' ' VAL . 54.3 t80 -75.48 164.42 26.38 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 124.61 1.194 . . . . 0.0 110.612 179.753 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.426 ' N ' ' CG ' ' A' ' 23' ' ' PHE . 87.2 t -128.49 -75.9 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 124.075 0.859 . . . . 0.0 110.5 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.54 ' SG ' ' N ' ' A' ' 26' ' ' GLU . 0.5 OUTLIER -155.0 -164.87 1.89 Allowed 'General case' 0 N--CA 1.505 2.296 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 -179.898 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.54 ' N ' ' SG ' ' A' ' 25' ' ' CYS . 3.6 tm-20 -111.43 137.65 48.95 Favored 'General case' 0 N--CA 1.504 2.259 0 N-CA-C 106.63 -1.618 . . . . 0.0 106.63 179.588 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.561 ' HA3' ' H ' ' A' ' 11' ' ' THR . . . -54.9 117.45 8.17 Favored Glycine 0 N--CA 1.5 2.963 0 N-CA-C 110.53 -1.028 . . . . 0.0 110.53 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 39.8 mm-40 -93.5 10.35 32.81 Favored 'General case' 0 N--CA 1.499 2.022 0 N-CA-C 115.808 1.781 . . . . 0.0 115.808 -179.496 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 32.2 t -76.1 96.55 3.87 Favored 'General case' 0 N--CA 1.499 2.019 0 C-N-CA 118.651 -1.22 . . . . 0.0 108.734 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -87.74 145.91 37.93 Favored Pre-proline 0 N--CA 1.493 1.688 0 CA-C-N 114.31 -1.314 . . . . 0.0 108.486 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_exo -47.12 111.95 0.46 Allowed 'Trans proline' 0 N--CA 1.494 1.533 0 C-N-CA 122.366 2.044 . . . . 0.0 110.148 169.399 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 79.1 mtp180 57.07 48.94 14.58 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 124.439 1.087 . . . . 0.0 109.687 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -58.89 140.02 86.62 Favored Pre-proline 0 N--CA 1.498 1.928 0 CA-C-N 114.024 -1.444 . . . . 0.0 110.856 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -66.14 129.18 21.12 Favored 'Trans proline' 0 N--CA 1.492 1.409 0 C-N-CA 122.367 2.045 . . . . 0.0 110.599 -178.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 59.3 mttp 62.42 162.69 0.09 Allowed 'General case' 0 N--CA 1.503 2.222 0 O-C-N 124.742 1.276 . . . . 0.0 113.351 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -89.05 168.55 12.24 Favored 'General case' 0 N--CA 1.498 1.937 0 CA-C-N 114.528 -1.215 . . . . 0.0 110.293 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 71.3 m -79.86 163.5 24.32 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.946 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 43.7 m -138.19 7.98 2.68 Favored 'General case' 0 N--CA 1.497 1.91 0 CA-C-N 114.768 -1.106 . . . . 0.0 110.025 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 88.2 mt -79.33 -65.23 1.03 Allowed 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 7.8 m-80 56.73 116.34 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 114.911 1.448 . . . . 0.0 114.911 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.408 ' HA ' ' HA ' ' A' ' 4' ' ' CYS . 82.0 m 58.41 122.15 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 116.164 1.913 . . . . 0.0 116.164 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -144.42 90.37 6.6 Favored Pre-proline 0 N--CA 1.496 1.845 0 CA-C-N 114.637 -1.165 . . . . 0.0 109.838 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -57.39 -28.23 79.31 Favored 'Trans proline' 0 N--CA 1.493 1.482 0 C-N-CA 122.805 2.337 . . . . 0.0 113.051 179.372 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 15.5 tpt180 -58.17 -41.06 83.04 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 123.934 0.771 . . . . 0.0 109.476 179.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 14.3 mt -70.24 154.57 8.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 CA-C-O 122.121 0.962 . . . . 0.0 110.163 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.446 ' HB2' ' H ' ' A' ' 19' ' ' ASP . . . -121.15 -50.66 2.13 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-N 111.938 -2.392 . . . . 0.0 107.343 179.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 19.5 p90 -171.85 164.18 6.39 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-N 114.242 -1.345 . . . . 0.0 111.214 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -104.01 91.36 0.8 Allowed Glycine 0 N--CA 1.492 2.401 0 N-CA-C 107.159 -2.376 . . . . 0.0 107.159 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.1 p -84.25 126.66 40.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 C-N-CA 119.123 -1.031 . . . . 0.0 112.893 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.6 m -79.64 154.0 75.99 Favored Pre-proline 0 N--CA 1.496 1.868 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 179.615 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo . . . . . 0 N--CA 1.494 1.537 0 C-N-CA 122.739 2.292 . . . . 0.0 109.743 -173.167 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.545 ' HA ' ' HA ' ' A' ' 99' ' ' CYS . 1.7 m . . . . . 0 N--CA 1.479 0.997 0 CA-C-O 123.204 1.478 . . . . 0.0 111.607 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 87.0 m -90.52 171.64 9.27 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-N 112.255 -2.248 . . . . 0.0 107.625 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.452 HD21 ' HB3' ' A' ' 67' ' ' ALA . 0.1 OUTLIER -160.37 -162.7 1.0 Allowed 'General case' 0 N--CA 1.5 2.061 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 179.952 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' CYS . . . . . 0.469 ' SG ' ' CD2' ' A' ' 74' ' ' TYR . 3.9 t -107.01 -28.26 10.14 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 124.071 0.857 . . . . 0.0 109.78 179.766 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . 0.451 ' SG ' ' CE ' ' A' ' 93' ' ' LYS . 51.0 t -73.88 -57.63 3.85 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 114.918 1.451 . . . . 0.0 114.918 -179.669 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.452 ' HB3' HD21 ' A' ' 64' ' ' ASN . . . -80.75 60.09 3.9 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 124.833 1.333 . . . . 0.0 112.565 -179.782 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -145.57 -139.91 3.45 Favored Glycine 0 N--CA 1.497 2.73 0 N-CA-C 108.253 -1.939 . . . . 0.0 108.253 179.625 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.432 ' C ' ' H ' ' A' ' 71' ' ' GLY . 92.4 m -154.03 150.72 28.54 Favored 'General case' 0 N--CA 1.505 2.319 0 N-CA-C 114.434 1.272 . . . . 0.0 114.434 -179.825 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 24.0 mmtt -72.63 35.87 0.07 Allowed 'General case' 0 N--CA 1.505 2.304 0 CA-C-N 113.042 -1.89 . . . . 0.0 112.689 179.634 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.432 ' H ' ' C ' ' A' ' 69' ' ' THR . . . -131.92 2.52 5.19 Favored Glycine 0 N--CA 1.485 1.923 0 N-CA-C 109.141 -1.584 . . . . 0.0 109.141 179.867 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 94.1 m -141.7 167.01 23.17 Favored 'General case' 0 N--CA 1.497 1.916 0 C-N-CA 119.384 -0.926 . . . . 0.0 111.376 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -119.89 105.45 11.1 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 124.184 0.928 . . . . 0.0 109.67 -179.637 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.648 ' CD2' ' SG ' ' A' ' 83' ' ' CYS . 74.0 m-85 -51.13 135.88 24.81 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 124.047 0.842 . . . . 0.0 110.382 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -146.96 157.22 43.57 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 -179.571 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 42.9 t -110.4 130.99 55.44 Favored 'General case' 0 N--CA 1.501 2.085 0 CA-C-N 113.441 -1.709 . . . . 0.0 113.281 -179.725 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.585 ' H ' ' HB2' ' A' ' 104' ' ' ALA . 7.3 p-10 -46.08 -31.5 2.37 Favored 'General case' 0 N--CA 1.502 2.141 0 CA-C-N 112.562 -2.108 . . . . 0.0 115.349 -179.861 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 39.1 p30 -57.42 -10.09 1.29 Allowed 'General case' 0 N--CA 1.497 1.901 0 O-C-N 124.268 0.98 . . . . 0.0 112.794 -179.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 99.1 23.84 11.03 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 110.159 -1.177 . . . . 0.0 110.159 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -131.31 146.87 52.48 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 124.211 0.595 . . . . 0.0 109.631 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 45.1 t80 -77.53 154.92 31.97 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 114.124 -1.398 . . . . 0.0 110.714 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 92.8 t -113.08 -73.45 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 124.19 0.931 . . . . 0.0 112.767 -179.723 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . 0.648 ' SG ' ' CD2' ' A' ' 74' ' ' TYR . 29.7 p -157.3 -174.0 4.69 Favored 'General case' 0 N--CA 1.503 2.181 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 -179.585 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -119.43 155.92 31.11 Favored 'General case' 0 N--CA 1.505 2.282 0 CA-C-O 119.003 -0.522 . . . . 0.0 109.793 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.44 ' HA2' ' CE2' ' A' ' 74' ' ' TYR . . . -31.22 111.78 0.05 OUTLIER Glycine 0 N--CA 1.502 3.048 0 O-C-N 124.838 1.337 . . . . 0.0 112.599 179.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -100.84 27.54 5.88 Favored 'General case' 0 N--CA 1.498 1.932 0 C-N-CA 119.97 -0.692 . . . . 0.0 109.199 -179.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 42.6 t -140.55 95.95 2.95 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-O 121.469 0.652 . . . . 0.0 111.959 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -84.72 148.08 50.58 Favored Pre-proline 0 N--CA 1.496 1.845 0 N-CA-C 106.15 -1.796 . . . . 0.0 106.15 179.717 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.411 ' O ' ' HG3' ' A' ' 90' ' ' ARG . 10.1 Cg_endo -64.67 86.56 0.17 Allowed 'Trans proline' 0 N--CA 1.493 1.447 0 N-CA-C 108.265 -1.475 . . . . 0.0 108.265 165.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.411 ' HG3' ' O ' ' A' ' 89' ' ' PRO . 44.2 mtm180 150.82 -27.04 0.01 OUTLIER 'General case' 0 N--CA 1.513 2.693 0 O-C-N 125.741 1.901 . . . . 0.0 109.753 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 31.3 p-10 -41.51 116.17 1.5 Allowed Pre-proline 0 N--CA 1.501 2.083 0 N-CA-C 114.177 1.177 . . . . 0.0 114.177 -179.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -76.62 77.11 3.76 Favored 'Trans proline' 0 N--CA 1.493 1.474 0 C-N-CA 122.721 2.281 . . . . 0.0 109.565 174.423 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.451 ' CE ' ' SG ' ' A' ' 66' ' ' CYS . 21.4 ptmt -167.9 170.46 10.61 Favored 'General case' 0 N--CA 1.498 1.93 0 CA-C-N 114.759 -1.109 . . . . 0.0 110.685 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -160.19 147.42 16.2 Favored 'General case' 0 N--CA 1.497 1.883 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.322 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 58.2 m -153.54 130.31 5.69 Favored Pre-proline 0 N--CA 1.497 1.879 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.379 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.459 ' HD2' HD21 ' A' ' 98' ' ' ASN . 18.4 Cg_endo -63.51 -78.37 0.01 OUTLIER 'Trans proline' 0 N--CA 1.493 1.489 0 C-N-CA 122.316 2.01 . . . . 0.0 111.511 171.721 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 60.6 mmt-85 -135.68 -44.89 0.67 Allowed 'General case' 0 N--CA 1.499 2.007 0 O-C-N 123.995 0.809 . . . . 0.0 112.432 -179.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.459 HD21 ' HD2' ' A' ' 96' ' ' PRO . 3.5 m-80 49.44 58.62 5.21 Favored 'General case' 0 N--CA 1.503 2.197 0 O-C-N 124.313 1.008 . . . . 0.0 108.367 -179.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.545 ' HA ' ' HA ' ' A' ' 62' ' ' CYS . 37.1 m -35.77 127.57 0.67 Allowed 'General case' 0 N--CA 1.494 1.735 0 CA-C-N 113.573 -1.649 . . . . 0.0 115.25 -179.523 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -129.35 98.78 22.34 Favored Pre-proline 0 N--CA 1.493 1.708 0 CA-C-N 114.25 -1.341 . . . . 0.0 110.268 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -63.85 -12.0 29.61 Favored 'Trans proline' 0 N--CA 1.494 1.522 0 C-N-CA 122.011 1.807 . . . . 0.0 112.166 -178.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 80.8 mtm180 -80.28 -30.55 38.32 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 112.675 0.621 . . . . 0.0 112.675 -179.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.414 HG12 ' N ' ' A' ' 104' ' ' ALA . 11.8 tt -90.88 164.07 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.164 0 C-N-CA 120.036 -0.665 . . . . 0.0 110.097 -179.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.585 ' HB2' ' H ' ' A' ' 77' ' ' ASP . . . -124.15 -59.67 1.47 Allowed 'General case' 0 N--CA 1.496 1.848 0 CA-C-N 114.758 -1.11 . . . . 0.0 108.394 179.826 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 21.7 p90 -161.33 161.79 30.64 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-N 114.631 -1.168 . . . . 0.0 111.03 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -94.95 115.24 5.05 Favored Glycine 0 N--CA 1.492 2.389 0 CA-C-N 113.59 -1.641 . . . . 0.0 111.575 -179.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 12.4 pt -83.63 102.44 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.27 0 N-CA-C 105.725 -1.954 . . . . 0.0 105.725 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 13.4 m -79.48 133.04 60.35 Favored Pre-proline 0 N--CA 1.49 1.554 0 CA-C-N 113.8 -1.545 . . . . 0.0 110.295 -179.632 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo . . . . . 0 N--CA 1.492 1.433 0 C-N-CA 122.599 2.199 . . . . 0.0 110.46 -177.127 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 120.945 0.402 . . . . 0.0 109.961 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 93.6 mtt-85 -72.65 138.69 46.85 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.213 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 7.9 tp -83.79 52.92 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 CA-C-N 115.052 -0.976 . . . . 0.0 109.636 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.514 ' HA ' ' HA ' ' A' ' 41' ' ' CYS . 1.5 m -82.72 51.75 1.96 Allowed 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 117.061 2.245 . . . . 0.0 117.061 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 7.2 p -91.75 164.63 13.64 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-N 113.169 -1.832 . . . . 0.0 109.035 179.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.464 ' ND2' ' H ' ' A' ' 9' ' ' ALA . 37.7 p-10 -160.88 148.13 15.47 Favored 'General case' 0 N--CA 1.499 1.985 0 C-N-CA 119.917 -0.713 . . . . 0.0 110.058 179.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 18.4 t -67.11 -20.24 65.75 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-N 114.864 -1.062 . . . . 0.0 112.892 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 43.7 t -81.34 -64.46 1.18 Allowed 'General case' 0 N--CA 1.497 1.878 0 O-C-N 123.607 0.567 . . . . 0.0 112.128 -179.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.464 ' H ' ' ND2' ' A' ' 6' ' ' ASN . . . -89.22 45.12 1.26 Allowed 'General case' 0 N--CA 1.5 2.044 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.896 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -84.17 -147.13 7.93 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 110.337 -1.105 . . . . 0.0 110.337 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 40.4 p -137.62 95.29 3.03 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.11 112.98 0.81 Allowed 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 144.97 -34.58 1.55 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 108.301 -1.92 . . . . 0.0 108.301 -179.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 35.4 m -106.09 130.29 54.02 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -83.11 91.61 7.25 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 113.627 -1.624 . . . . 0.0 110.132 -179.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.409 ' N ' ' O ' ' A' ' 25' ' ' CYS . 39.8 m-85 -50.09 122.1 6.32 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-N 114.028 -1.442 . . . . 0.0 109.081 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -132.44 153.32 50.97 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-N 112.316 -2.22 . . . . 0.0 110.643 -179.67 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 31.2 t -99.15 141.18 32.25 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-N 111.679 -2.509 . . . . 0.0 115.628 -179.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -52.17 -25.05 8.1 Favored 'General case' 0 N--CA 1.499 1.983 0 CA-C-N 111.002 -2.817 . . . . 0.0 113.269 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 52.5 p-10 -62.59 -4.79 2.16 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 124.092 0.87 . . . . 0.0 111.609 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 88.92 30.15 15.72 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 108.781 -1.728 . . . . 0.0 108.781 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 87.0 m -141.66 146.87 36.65 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 124.087 0.522 . . . . 0.0 110.585 -179.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 39.9 t80 -73.02 162.81 29.05 Favored 'General case' 0 N--CA 1.496 1.827 0 CA-C-N 114.35 -1.296 . . . . 0.0 110.04 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 58.7 t -127.56 -79.44 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 CA-C-N 115.282 -0.872 . . . . 0.0 108.991 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.57 ' SG ' ' N ' ' A' ' 26' ' ' GLU . 0.1 OUTLIER -156.99 -170.47 3.3 Favored 'General case' 0 N--CA 1.504 2.258 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 179.971 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.57 ' N ' ' SG ' ' A' ' 25' ' ' CYS . 37.6 tt0 -118.64 154.29 32.91 Favored 'General case' 0 N--CA 1.503 2.214 0 N-CA-C 106.079 -1.823 . . . . 0.0 106.079 179.444 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -50.15 116.9 4.38 Favored Glycine 0 N--CA 1.498 2.791 0 C-N-CA 120.088 -1.053 . . . . 0.0 112.721 -179.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -79.66 -17.2 54.24 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 41.1 t -112.38 112.96 24.9 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.646 ' H ' HD21 ' A' ' 33' ' ' ASN . 16.0 t0 -79.38 138.55 55.56 Favored Pre-proline 0 N--CA 1.494 1.735 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_endo -65.48 75.22 0.27 Allowed 'Trans proline' 0 N--CA 1.498 1.746 0 C-N-CA 122.705 2.27 . . . . 0.0 106.577 161.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 43.1 ttp85 -173.0 -53.43 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 104.982 -2.229 . . . . 0.0 104.982 -179.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.646 HD21 ' H ' ' A' ' 30' ' ' ASP . 25.9 p30 -90.7 156.44 44.95 Favored Pre-proline 0 N--CA 1.494 1.759 0 CA-C-N 114.638 -1.165 . . . . 0.0 110.978 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -71.54 177.16 7.11 Favored 'Trans proline' 0 N--CA 1.493 1.469 0 C-N-CA 122.643 2.229 . . . . 0.0 110.311 168.004 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.439 ' HD2' ' N ' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -161.41 153.07 19.15 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.247 179.983 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -148.12 62.37 1.11 Allowed 'General case' 0 N--CA 1.495 1.819 0 CA-C-N 115.067 -0.969 . . . . 0.0 109.127 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 72.4 m -79.57 -50.48 10.64 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-N 114.388 -1.278 . . . . 0.0 109.358 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 26.3 m 64.31 -9.12 0.17 Allowed 'General case' 0 N--CA 1.503 2.176 0 O-C-N 124.781 1.301 . . . . 0.0 113.448 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.441 ' HG ' ' H ' ' A' ' 40' ' ' ASN . 2.1 pp -79.56 -55.59 4.92 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 120.251 -0.58 . . . . 0.0 109.559 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.441 ' H ' ' HG ' ' A' ' 39' ' ' LEU . 33.6 m120 47.42 -177.77 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 115.927 1.825 . . . . 0.0 115.927 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.514 ' HA ' ' HA ' ' A' ' 4' ' ' CYS . 58.1 m 48.63 119.36 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 116.667 2.099 . . . . 0.0 116.667 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 60.1 t0 -152.16 94.97 3.21 Favored Pre-proline 0 N--CA 1.489 1.517 0 CA-C-N 113.789 -1.55 . . . . 0.0 108.46 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -53.63 -17.86 10.69 Favored 'Trans proline' 0 N--CA 1.495 1.591 0 C-N-CA 122.896 2.398 . . . . 0.0 113.046 178.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 10.9 tpt180 -59.06 -50.82 72.61 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.44 ' CG2' ' N ' ' A' ' 46' ' ' ALA . 2.0 mp -62.89 159.2 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 CA-C-O 122.623 1.201 . . . . 0.0 112.264 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.44 ' N ' ' CG2' ' A' ' 45' ' ' ILE . . . -127.29 -48.63 1.44 Allowed 'General case' 0 N--CA 1.492 1.641 0 CA-C-N 111.33 -2.668 . . . . 0.0 106.267 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 51.8 p90 -166.23 -163.42 0.6 Allowed 'General case' 0 N--CA 1.495 1.817 0 CA-C-N 113.637 -1.619 . . . . 0.0 107.373 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -145.83 113.15 0.67 Allowed Glycine 0 N--CA 1.495 2.567 0 N-CA-C 108.621 -1.791 . . . . 0.0 108.621 179.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.7 p -79.77 105.91 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 N-CA-C 114.284 1.216 . . . . 0.0 114.284 -179.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.7 m -81.81 117.45 68.35 Favored Pre-proline 0 N--CA 1.5 2.068 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 179.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -67.65 150.26 79.48 Favored 'Trans proline' 0 N--CA 1.494 1.531 0 C-N-CA 122.05 1.833 . . . . 0.0 110.623 178.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.485 ' NE ' ' HA ' ' A' ' 52' ' ' ARG . 6.5 tpm_? -152.92 -66.83 0.16 Allowed 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 22.9 t 52.91 42.27 32.05 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 124.335 1.022 . . . . 0.0 112.313 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -168.39 8.09 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.105 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.996 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -55.81 -42.51 75.77 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 123.776 0.672 . . . . 0.0 110.109 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -73.71 177.37 5.5 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-N 114.867 -1.06 . . . . 0.0 110.714 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 61.6 tttp 51.79 78.2 0.13 Allowed 'General case' 0 N--CA 1.499 1.995 0 O-C-N 124.314 1.009 . . . . 0.0 110.412 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 11.5 p-10 -161.6 -39.82 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.78 0 CA-C-N 113.868 -1.514 . . . . 0.0 108.995 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -72.88 -46.25 53.84 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-N 114.575 -1.193 . . . . 0.0 108.834 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 28.3 mmt85 7.29 -73.59 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.241 0 O-C-N 126.013 2.071 . . . . 0.0 116.471 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 10.3 tp -82.99 50.49 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 123.839 0.712 . . . . 0.0 110.926 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.501 ' HA ' ' HA ' ' A' ' 99' ' ' CYS . 1.6 m -81.44 29.88 0.36 Allowed 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 115.916 1.821 . . . . 0.0 115.916 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -91.59 148.0 22.6 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-N 112.272 -2.24 . . . . 0.0 107.353 179.512 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.419 ' HB3' ' H ' ' A' ' 100' ' ' ASP . 15.2 p30 -162.05 147.78 13.2 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 114.469 1.285 . . . . 0.0 114.469 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -63.25 -20.67 65.66 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-N 114.351 -1.295 . . . . 0.0 112.582 179.621 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 41.8 t -90.65 -74.78 0.48 Allowed 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -89.5 35.57 0.82 Allowed 'General case' 0 N--CA 1.497 1.895 0 CA-C-N 114.433 -1.258 . . . . 0.0 113.139 -179.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.415 ' HA3' ' CZ ' ' A' ' 74' ' ' TYR . . . -81.04 -112.34 0.32 Allowed Glycine 0 N--CA 1.494 2.531 0 N-CA-C 109.135 -1.586 . . . . 0.0 109.135 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.54 ' H ' ' HA3' ' A' ' 85' ' ' GLY . 38.2 p -153.7 123.03 6.58 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 179.671 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -70.21 93.87 0.87 Allowed 'General case' 0 N--CA 1.502 2.125 0 CA-C-O 122.089 0.947 . . . . 0.0 109.516 179.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 162.99 -27.21 0.23 Allowed Glycine 0 N--CA 1.487 2.058 0 CA-C-N 113.107 -1.86 . . . . 0.0 109.947 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 36.1 m -108.8 141.65 40.51 Favored 'General case' 0 N--CA 1.497 1.902 0 C-N-CA 120.024 -0.67 . . . . 0.0 110.209 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.471 ' HB3' ' CE1' ' A' ' 81' ' ' PHE . 58.6 mtpt -83.7 89.11 7.09 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 113.726 -1.579 . . . . 0.0 109.683 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.415 ' CZ ' ' HA3' ' A' ' 68' ' ' GLY . 27.7 m-85 -59.56 116.45 4.01 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 106.13 -1.804 . . . . 0.0 106.13 179.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -121.14 146.86 46.32 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 111.483 -2.599 . . . . 0.0 112.516 -179.449 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.416 ' CB ' ' HE ' ' A' ' 102' ' ' ARG . 32.0 t -91.31 144.23 25.81 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-N 112.363 -2.199 . . . . 0.0 116.312 -179.586 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -53.09 -21.16 4.39 Favored 'General case' 0 N--CA 1.497 1.901 0 CA-C-N 110.603 -2.999 . . . . 0.0 113.322 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 18.4 p30 -66.77 -0.15 2.79 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 124.183 0.927 . . . . 0.0 110.773 179.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 83.48 29.83 31.84 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 93.6 m -142.83 142.86 31.91 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 120.394 -0.522 . . . . 0.0 110.939 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.471 ' CE1' ' HB3' ' A' ' 73' ' ' LYS . 9.7 t80 -73.93 143.41 45.72 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-N 114.373 -1.285 . . . . 0.0 109.705 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 67.6 t -104.58 -77.91 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -166.97 172.85 9.83 Favored 'General case' 0 N--CA 1.503 2.219 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 179.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.456 ' HG2' ' N ' ' A' ' 85' ' ' GLY . 22.7 tt0 -79.64 150.22 31.03 Favored 'General case' 0 N--CA 1.501 2.085 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 179.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.54 ' HA3' ' H ' ' A' ' 69' ' ' THR . . . -65.74 127.67 31.27 Favored Glycine 0 N--CA 1.494 2.522 0 N-CA-C 104.251 -3.54 . . . . 0.0 104.251 179.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -93.75 23.42 4.77 Favored 'General case' 0 N--CA 1.497 1.905 0 CA-C-N 118.049 0.924 . . . . 0.0 113.337 -179.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 25.1 t -84.26 98.53 10.03 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-N 114.529 -1.214 . . . . 0.0 108.288 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -79.86 155.37 75.46 Favored Pre-proline 0 N--CA 1.496 1.834 0 N-CA-C 107.529 -1.285 . . . . 0.0 107.529 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo -38.58 108.21 0.07 OUTLIER 'Trans proline' 0 N--CA 1.493 1.483 0 C-N-CA 122.386 2.057 . . . . 0.0 112.147 162.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER 59.06 50.89 7.63 Favored 'General case' 0 N--CA 1.497 1.92 0 CA-C-N 114.676 -1.147 . . . . 0.0 110.876 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.676 ' H ' HD22 ' A' ' 91' ' ' ASN . 0.5 OUTLIER -79.43 119.61 77.56 Favored Pre-proline 0 N--CA 1.497 1.875 0 CA-C-N 113.898 -1.501 . . . . 0.0 111.878 -179.96 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -79.87 79.36 3.37 Favored 'Trans proline' 0 N--CA 1.493 1.474 0 C-N-CA 123.093 2.529 . . . . 0.0 109.986 172.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 14.1 ptmm? -166.06 144.56 5.79 Favored 'General case' 0 N--CA 1.5 2.029 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.721 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -160.12 103.29 1.46 Allowed 'General case' 0 N--CA 1.496 1.854 0 CA-C-N 114.649 -1.16 . . . . 0.0 108.575 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 35.1 m -79.77 168.67 24.51 Favored Pre-proline 0 N--CA 1.498 1.959 0 CA-C-N 115.122 -0.944 . . . . 0.0 109.297 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -57.91 -5.7 2.14 Favored 'Trans proline' 0 N--CA 1.496 1.672 0 C-N-CA 122.292 1.995 . . . . 0.0 112.404 162.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 35.2 mmt180 -79.52 7.26 8.51 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 123.49 0.494 . . . . 0.0 111.828 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -50.03 117.39 2.3 Favored 'General case' 0 N--CA 1.503 2.196 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.501 ' HA ' ' HA ' ' A' ' 62' ' ' CYS . 91.4 m 56.07 65.38 1.46 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 124.538 1.149 . . . . 0.0 108.048 -179.572 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.419 ' H ' ' HB3' ' A' ' 64' ' ' ASN . 18.9 t70 -62.35 109.55 2.45 Favored Pre-proline 0 N--CA 1.498 1.926 0 CA-C-N 114.356 -1.293 . . . . 0.0 112.287 -179.582 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -69.44 -34.75 14.98 Favored 'Trans proline' 0 N--CA 1.493 1.463 0 C-N-CA 122.049 1.833 . . . . 0.0 109.783 -174.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.416 ' HE ' ' CB ' ' A' ' 76' ' ' SER . 0.0 OUTLIER -63.48 -21.37 66.28 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-N 114.447 -1.252 . . . . 0.0 111.659 -179.96 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 4.4 tp -76.49 177.7 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 C-N-CA 119.218 -0.993 . . . . 0.0 108.403 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -130.37 -61.32 0.97 Allowed 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 -147.73 -161.61 1.37 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 124.48 1.113 . . . . 0.0 109.042 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -142.35 95.13 0.19 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 106.016 -2.834 . . . . 0.0 106.016 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 42.5 mm -78.72 98.86 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 N-CA-C 113.792 1.034 . . . . 0.0 113.792 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 1.6 m -79.52 153.63 76.19 Favored Pre-proline 0 N--CA 1.501 2.091 0 CA-C-N 114.952 -1.022 . . . . 0.0 108.262 179.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -64.75 119.79 6.91 Favored 'Trans proline' 0 N--CA 1.494 1.502 0 C-N-CA 122.542 2.162 . . . . 0.0 109.942 179.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.4 tt -79.87 98.41 7.09 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 1.876 0 CA-C-O 116.847 -1.549 . . . . 0.0 110.689 179.948 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 . . . . . 0 N--CA 1.491 1.607 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 61.7 ttm-85 -90.25 62.88 5.56 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.405 HG22 ' H ' ' A' ' 3' ' ' ILE . 6.0 tp -79.85 71.88 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 CA-C-N 114.399 -1.273 . . . . 0.0 110.038 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.6 m -89.97 57.47 3.82 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 122.849 1.309 . . . . 0.0 114.159 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.446 ' O ' ' N ' ' A' ' 42' ' ' ASP . 1.1 p -90.06 157.05 17.97 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 104.275 -2.491 . . . . 0.0 104.275 179.204 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.424 ' HB3' ' H ' ' A' ' 9' ' ' ALA . 6.7 t-20 -160.77 -177.3 6.06 Favored 'General case' 0 N--CA 1.5 2.036 0 C-N-CA 118.149 -1.42 . . . . 0.0 112.083 -179.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.476 ' SG ' ' CD2' ' A' ' 16' ' ' TYR . 1.8 t -76.78 -32.98 58.04 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-N 113.328 -1.76 . . . . 0.0 107.115 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 34.1 t -82.12 -57.57 3.34 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-N 112.003 -2.362 . . . . 0.0 107.609 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.424 ' H ' ' HB3' ' A' ' 6' ' ' ASN . . . -57.56 -23.43 50.5 Favored 'General case' 0 N--CA 1.497 1.912 0 CA-C-N 114.484 -1.235 . . . . 0.0 110.77 179.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -71.41 -168.09 8.79 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 110.756 -0.938 . . . . 0.0 110.756 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 41.1 p -104.71 103.19 12.78 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.462 ' HA ' ' CA ' ' A' ' 27' ' ' GLY . 39.1 ttpt -48.16 104.97 0.07 Allowed 'General case' 0 N--CA 1.5 2.048 0 O-C-N 123.737 0.648 . . . . 0.0 111.322 179.673 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 149.69 -20.42 1.15 Allowed Glycine 0 N--CA 1.491 2.36 0 CA-C-N 114.364 -1.289 . . . . 0.0 111.033 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 96.2 m -107.41 149.45 27.88 Favored 'General case' 0 N--CA 1.499 2.023 0 C-N-CA 120.316 -0.554 . . . . 0.0 112.069 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -83.13 93.71 7.68 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-N 114.273 -1.33 . . . . 0.0 107.754 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.476 ' CD2' ' SG ' ' A' ' 7' ' ' CYS . 48.6 m-85 -52.76 130.07 31.69 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-N 113.997 -1.456 . . . . 0.0 109.027 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -143.47 155.03 44.25 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-N 113.174 -1.83 . . . . 0.0 112.339 -179.438 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 38.3 t -101.37 136.01 41.92 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-N 112.449 -2.16 . . . . 0.0 112.577 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.473 ' H ' ' HB2' ' A' ' 46' ' ' ALA . 5.6 p-10 -50.04 -25.11 3.08 Favored 'General case' 0 N--CA 1.502 2.129 0 CA-C-N 112.626 -2.079 . . . . 0.0 114.186 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 27.4 p30 -59.69 -7.49 1.58 Allowed 'General case' 0 N--CA 1.498 1.952 0 O-C-N 124.228 0.955 . . . . 0.0 112.288 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 94.25 28.36 10.82 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 88.5 m -141.43 142.79 33.67 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 124.149 0.558 . . . . 0.0 110.144 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.408 ' CG ' ' N ' ' A' ' 24' ' ' VAL . 40.5 t80 -68.79 166.93 16.52 Favored 'General case' 0 N--CA 1.497 1.878 0 CA-C-N 114.194 -1.366 . . . . 0.0 110.82 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.408 ' N ' ' CG ' ' A' ' 23' ' ' PHE . 97.5 t -128.89 -72.31 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 123.996 0.81 . . . . 0.0 111.82 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.462 ' SG ' ' HD2' ' A' ' 16' ' ' TYR . 20.8 p -154.31 -168.6 2.98 Favored 'General case' 0 N--CA 1.503 2.199 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 -179.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 60.5 tt0 -139.66 151.12 45.69 Favored 'General case' 0 N--CA 1.501 2.096 0 CA-C-O 121.446 0.641 . . . . 0.0 111.369 179.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.462 ' CA ' ' HA ' ' A' ' 12' ' ' LYS . . . -7.25 103.71 0.01 OUTLIER Glycine 0 N--CA 1.497 2.716 0 N-CA-C 119.333 2.493 . . . . 0.0 119.333 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -99.48 -52.25 3.54 Favored 'General case' 0 N--CA 1.501 2.112 0 C-N-CA 119.71 -0.796 . . . . 0.0 110.355 179.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.425 ' CA ' ' HB2' ' A' ' 12' ' ' LYS . 6.5 p -149.83 142.18 24.24 Favored 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.419 ' HB2' ' HB3' ' A' ' 12' ' ' LYS . 10.5 t70 -101.88 144.85 29.4 Favored Pre-proline 0 N--CA 1.498 1.943 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_exo -45.12 -25.2 1.69 Allowed 'Trans proline' 0 N--CA 1.498 1.778 0 C-N-CA 122.918 2.412 . . . . 0.0 112.868 170.087 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.437 ' NE ' ' HA ' ' A' ' 32' ' ' ARG . 3.6 tpm_? -62.9 -53.45 54.0 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -85.65 129.41 54.95 Favored Pre-proline 0 N--CA 1.494 1.73 0 CA-C-N 115.133 -0.94 . . . . 0.0 109.221 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -65.38 108.2 1.14 Allowed 'Trans proline' 0 N--CA 1.493 1.5 0 C-N-CA 122.317 2.011 . . . . 0.0 109.471 -179.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.504 ' HD3' ' H ' ' A' ' 36' ' ' ALA . 6.1 tmtt? -154.53 142.12 19.81 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.504 ' H ' ' HD3' ' A' ' 35' ' ' LYS . . . -149.3 111.07 4.54 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-N 113.382 -1.736 . . . . 0.0 107.644 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.461 ' H ' HD21 ' A' ' 40' ' ' ASN . 70.3 m -79.96 -168.73 1.73 Allowed 'General case' 0 N--CA 1.495 1.815 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.104 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 9.2 t -104.94 13.84 30.4 Favored 'General case' 0 N--CA 1.497 1.911 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.351 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -160.38 64.66 0.33 Allowed 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.461 HD21 ' H ' ' A' ' 37' ' ' CYS . 12.0 m120 -88.65 46.15 1.36 Allowed 'General case' 0 N--CA 1.498 1.939 0 CA-C-N 114.292 -1.322 . . . . 0.0 111.172 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 80.4 m -145.16 139.29 27.16 Favored 'General case' 0 N--CA 1.499 2.02 0 CA-C-N 115.014 -0.993 . . . . 0.0 108.547 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.446 ' N ' ' O ' ' A' ' 5' ' ' THR . 34.2 t70 -166.2 88.35 0.87 Allowed Pre-proline 0 N--CA 1.497 1.896 0 O-C-N 123.794 0.684 . . . . 0.0 110.207 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_exo -53.53 -15.29 5.98 Favored 'Trans proline' 0 N--CA 1.495 1.617 0 C-N-CA 122.466 2.111 . . . . 0.0 112.961 173.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 41.5 ttm180 -76.89 -39.06 52.31 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 113.302 0.853 . . . . 0.0 113.302 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 7.6 tt -75.8 142.9 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.175 0 C-N-CA 118.746 -1.181 . . . . 0.0 111.714 -179.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.473 ' HB2' ' H ' ' A' ' 19' ' ' ASP . . . -104.84 -49.84 3.41 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-N 113.638 -1.619 . . . . 0.0 107.737 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 52.1 p90 -163.52 -163.07 0.78 Allowed 'General case' 0 N--CA 1.496 1.868 0 CA-C-N 114.07 -1.423 . . . . 0.0 107.423 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -144.98 122.27 1.7 Allowed Glycine 0 N--CA 1.494 2.549 0 N-CA-C 109.13 -1.588 . . . . 0.0 109.13 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.6 p -88.69 108.75 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 CA-C-O 121.545 0.688 . . . . 0.0 112.799 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.7 m -79.78 137.13 54.46 Favored Pre-proline 0 N--CA 1.499 1.987 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.218 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -64.18 -29.97 64.76 Favored 'Trans proline' 0 N--CA 1.494 1.507 0 C-N-CA 122.376 2.051 . . . . 0.0 110.063 177.292 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 11.1 mmm180 -110.49 37.19 2.82 Favored 'General case' 0 N--CA 1.495 1.789 0 CA-C-N 114.734 -1.121 . . . . 0.0 110.086 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 41.2 t -68.45 101.03 1.17 Allowed 'General case' 0 N--CA 1.496 1.829 0 CA-C-N 115.318 -0.855 . . . . 0.0 109.012 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -70.92 146.29 49.63 Favored 'General case' 0 N--CA 1.494 1.766 0 CA-C-N 115.486 -0.779 . . . . 0.0 112.154 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -122.87 -17.59 6.75 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-N 113.165 -1.834 . . . . 0.0 107.502 179.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 6.1 mtpm? -55.14 -67.95 0.23 Allowed 'General case' 0 N--CA 1.492 1.672 0 CA-C-N 114.26 -1.337 . . . . 0.0 111.627 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.421 ' HE2' ' HA ' ' A' ' 57' ' ' LYS . 7.1 mmpt? 65.62 147.57 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.168 0 O-C-N 125.04 1.462 . . . . 0.0 110.023 -179.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 14.2 m-80 64.48 -78.76 0.03 OUTLIER 'General case' 0 N--CA 1.504 2.243 0 O-C-N 124.124 0.89 . . . . 0.0 109.791 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 22.8 t70 61.98 166.67 0.11 Allowed 'General case' 0 N--CA 1.5 2.064 0 N-CA-C 113.091 0.775 . . . . 0.0 113.091 179.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 5.1 tpp180 -60.84 151.22 30.46 Favored 'General case' 0 N--CA 1.496 1.847 0 CA-C-N 114.752 -1.113 . . . . 0.0 109.972 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 5.7 tp -57.69 85.39 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 124.667 1.229 . . . . 0.0 111.97 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.696 ' HA ' ' HA ' ' A' ' 99' ' ' CYS . 1.7 m -93.26 33.92 1.18 Allowed 'General case' 0 N--CA 1.49 1.572 0 CA-C-O 123.916 1.817 . . . . 0.0 115.453 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 61.2 m -91.42 139.86 30.32 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 110.399 -3.091 . . . . 0.0 103.189 179.247 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 38.1 p-10 -160.81 161.32 31.96 Favored 'General case' 0 N--CA 1.497 1.898 0 C-N-CA 119.771 -0.772 . . . . 0.0 112.988 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 1.3 t -55.75 -23.22 28.15 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-N 113.511 -1.677 . . . . 0.0 112.227 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 52.8 t -89.38 -70.46 0.66 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 124.146 0.904 . . . . 0.0 110.502 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.441 ' HB2' ' SG ' ' A' ' 95' ' ' CYS . . . -90.18 62.15 5.38 Favored 'General case' 0 N--CA 1.499 2.007 0 CA-C-O 121.633 0.73 . . . . 0.0 109.497 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -113.19 -137.59 6.85 Favored Glycine 0 N--CA 1.493 2.481 0 CA-C-N 114.396 -1.274 . . . . 0.0 111.478 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.436 ' N ' ' HA3' ' A' ' 85' ' ' GLY . 37.7 p -128.44 117.61 21.67 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-N 114.494 -0.853 . . . . 0.0 109.464 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 61.5 mtpt -69.65 86.91 0.48 Allowed 'General case' 0 N--CA 1.498 1.967 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.018 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 164.75 -31.02 0.24 Allowed Glycine 0 N--CA 1.489 2.196 0 CA-C-N 114.095 -1.412 . . . . 0.0 110.613 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 74.6 m -105.12 131.71 52.27 Favored 'General case' 0 N--CA 1.5 2.034 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.8 mppt? -83.98 87.48 7.12 Favored 'General case' 0 N--CA 1.484 1.254 0 O-C-N 124.808 1.318 . . . . 0.0 110.398 -179.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 8.9 m-30 -51.84 129.43 26.59 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -133.03 157.26 45.67 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-N 113.433 -1.712 . . . . 0.0 111.79 -179.34 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 44.3 t -102.36 136.58 41.94 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-N 113.157 -1.838 . . . . 0.0 112.867 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 8.6 p30 -53.11 -23.57 8.29 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 115.538 1.681 . . . . 0.0 115.538 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 18.7 p-10 -62.61 -7.45 4.76 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 123.704 0.628 . . . . 0.0 111.024 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 94.49 29.96 9.0 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 108.507 -1.837 . . . . 0.0 108.507 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 46.1 m -133.97 135.93 43.81 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 124.162 0.566 . . . . 0.0 110.204 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.484 ' CZ ' ' HA ' ' A' ' 83' ' ' CYS . 8.0 t80 -76.02 141.63 42.07 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-N 114.703 -1.135 . . . . 0.0 108.776 179.787 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 45.5 t -97.29 -78.38 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . 0.484 ' HA ' ' CZ ' ' A' ' 81' ' ' PHE . 0.1 OUTLIER -178.5 171.67 1.54 Allowed 'General case' 0 N--CA 1.505 2.308 0 O-C-N 123.51 0.507 . . . . 0.0 110.005 179.705 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.408 ' O ' ' SG ' ' A' ' 83' ' ' CYS . 39.9 tt0 -86.07 150.93 24.1 Favored 'General case' 0 N--CA 1.503 2.203 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 179.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.436 ' HA3' ' N ' ' A' ' 69' ' ' THR . . . -53.25 133.58 41.97 Favored Glycine 0 N--CA 1.5 2.945 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -99.81 29.18 4.28 Favored 'General case' 0 N--CA 1.502 2.15 0 CA-C-O 121.892 0.853 . . . . 0.0 109.445 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 44.9 t -146.38 131.73 18.57 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 107.532 -1.285 . . . . 0.0 107.532 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.547 ' H ' HD21 ' A' ' 91' ' ' ASN . 2.4 t70 -79.38 136.16 56.72 Favored Pre-proline 0 N--CA 1.493 1.71 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_endo -67.95 70.93 0.82 Allowed 'Trans proline' 0 N--CA 1.5 1.872 0 C-N-CA 123.688 2.925 . . . . 0.0 113.554 -176.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 82.8 mtt85 -162.88 -51.7 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 103.74 -2.689 . . . . 0.0 103.74 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.547 HD21 ' H ' ' A' ' 88' ' ' ASP . 1.5 p-10 -91.09 116.0 65.51 Favored Pre-proline 0 N--CA 1.493 1.719 0 CA-C-N 113.275 -1.784 . . . . 0.0 110.748 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -78.17 93.76 1.09 Allowed 'Trans proline' 0 N--CA 1.492 1.398 0 C-N-CA 122.694 2.262 . . . . 0.0 110.041 173.366 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 44.7 mmtm -70.67 127.48 32.82 Favored 'General case' 0 N--CA 1.497 1.909 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.707 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -85.33 79.37 9.52 Favored 'General case' 0 N--CA 1.495 1.788 0 CA-C-N 114.666 -1.152 . . . . 0.0 108.941 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . 0.441 ' SG ' ' HB2' ' A' ' 67' ' ' ALA . 88.5 m -79.66 146.83 65.89 Favored Pre-proline 0 N--CA 1.494 1.764 0 CA-C-N 114.504 -1.225 . . . . 0.0 111.364 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -73.9 -4.35 15.28 Favored 'Trans proline' 0 N--CA 1.493 1.451 0 C-N-CA 122.891 2.394 . . . . 0.0 110.586 165.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 23.0 tpp180 -79.1 -54.78 5.65 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 38.9 m-80 52.24 -161.14 0.1 Allowed 'General case' 0 N--CA 1.501 2.118 0 O-C-N 124.401 1.063 . . . . 0.0 111.549 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.696 ' HA ' ' HA ' ' A' ' 62' ' ' CYS . 5.2 m -36.67 110.06 0.11 Allowed 'General case' 0 N--CA 1.5 2.045 0 N-CA-C 113.909 1.078 . . . . 0.0 113.909 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 20.5 t0 -91.22 111.85 50.87 Favored Pre-proline 0 N--CA 1.494 1.727 0 CA-C-N 113.843 -1.526 . . . . 0.0 110.564 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -64.7 -21.92 64.66 Favored 'Trans proline' 0 N--CA 1.494 1.522 0 C-N-CA 121.848 1.699 . . . . 0.0 110.312 -179.274 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 27.6 ttm-85 -82.27 -23.51 35.24 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 113.952 1.093 . . . . 0.0 113.952 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 12.2 tt -70.19 142.38 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 C-N-CA 117.835 -1.546 . . . . 0.0 110.21 -179.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -131.78 -43.77 0.99 Allowed 'General case' 0 N--CA 1.494 1.734 0 CA-C-N 114.486 -1.234 . . . . 0.0 109.748 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 49.8 m-85 -141.23 -164.12 1.69 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 124.398 1.061 . . . . 0.0 109.387 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -153.87 108.69 0.38 Allowed Glycine 0 N--CA 1.492 2.408 0 N-CA-C 106.582 -2.607 . . . . 0.0 106.582 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 50.4 mm -80.6 84.11 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 27.0 m -80.99 149.44 66.76 Favored Pre-proline 0 N--CA 1.494 1.755 0 CA-C-N 114.101 -1.408 . . . . 0.0 108.848 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -66.32 -21.3 54.51 Favored 'Trans proline' 0 N--CA 1.495 1.594 0 C-N-CA 122.71 2.273 . . . . 0.0 110.859 175.09 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.458 HD23 ' N ' ' A' ' 110' ' ' LEU . 2.0 pt? -159.96 167.76 27.24 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 124.156 0.91 . . . . 0.0 110.147 -180.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.826 0 CA-C-O 116.37 -1.776 . . . . 0.0 110.901 179.887 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 119.549 -0.262 . . . . 0.0 110.814 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 2.7 tmt_? 76.92 -65.8 0.27 Allowed 'General case' 0 N--CA 1.504 2.274 0 O-C-N 125.263 1.602 . . . . 0.0 108.377 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.6 tp -55.44 137.02 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 123.626 0.579 . . . . 0.0 112.123 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.472 ' HA ' ' HA ' ' A' ' 41' ' ' CYS . 1.5 m -140.61 57.88 1.57 Allowed 'General case' 0 C--N 1.31 -1.128 0 CA-C-O 122.797 1.284 . . . . 0.0 114.444 179.615 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 7.1 t -90.73 161.1 15.49 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-N 113.322 -1.763 . . . . 0.0 106.746 179.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 10.5 p-10 -161.1 151.84 18.24 Favored 'General case' 0 N--CA 1.499 2.02 0 C-N-CA 120.118 -0.633 . . . . 0.0 111.693 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.45 ' HA ' ' CE2' ' A' ' 16' ' ' TYR . 19.6 t -57.68 -38.03 74.46 Favored 'General case' 0 N--CA 1.497 1.914 0 CA-C-N 114.639 -1.164 . . . . 0.0 113.303 -179.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 46.4 t -61.99 -51.59 67.41 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 125.336 1.647 . . . . 0.0 110.721 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -51.6 -26.08 8.14 Favored 'General case' 0 N--CA 1.503 2.224 0 O-C-N 124.945 1.403 . . . . 0.0 110.376 179.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.407 ' HA3' ' N ' ' A' ' 29' ' ' SER . . . 63.23 161.06 0.28 Allowed Glycine 0 N--CA 1.479 1.558 0 CA-C-N 114.618 -1.174 . . . . 0.0 115.891 179.529 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.456 ' H ' ' HA3' ' A' ' 27' ' ' GLY . 99.5 m -153.11 53.87 0.76 Allowed 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 104.576 -2.379 . . . . 0.0 104.576 179.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 63.4 pttt 41.67 -146.11 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.065 0 CA-C-N 114.203 -1.362 . . . . 0.0 112.409 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -70.23 26.69 0.44 Allowed Glycine 0 N--CA 1.494 2.501 0 CA-C-N 114.886 -1.052 . . . . 0.0 114.252 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 88.4 m -105.42 120.99 42.98 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 107.097 -1.445 . . . . 0.0 107.097 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.425 ' HA ' ' HA ' ' A' ' 26' ' ' GLU . 63.0 mtpt -64.92 100.34 0.41 Allowed 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 113.027 -1.897 . . . . 0.0 113.962 -179.666 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.45 ' CE2' ' HA ' ' A' ' 7' ' ' CYS . 8.8 m-85 -48.3 128.59 14.59 Favored 'General case' 0 N--CA 1.505 2.316 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 179.48 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -144.3 153.03 41.59 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 115.079 -0.964 . . . . 0.0 113.047 -179.349 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 34.2 t -99.08 134.78 41.43 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-N 112.599 -2.091 . . . . 0.0 112.659 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -50.14 -24.87 3.03 Favored 'General case' 0 N--CA 1.502 2.168 0 CA-C-N 112.713 -2.039 . . . . 0.0 114.009 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 29.7 p30 -59.81 -8.01 1.93 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 124.144 0.902 . . . . 0.0 112.276 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 95.08 29.2 9.2 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 86.9 m -141.91 143.23 33.18 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 124.078 0.517 . . . . 0.0 111.233 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 20.0 t80 -68.96 161.28 29.21 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-N 114.042 -1.435 . . . . 0.0 110.318 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 88.2 t -126.71 -71.29 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 CA-C-N 114.995 -1.002 . . . . 0.0 109.443 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.589 ' SG ' ' N ' ' A' ' 26' ' ' GLU . 0.3 OUTLIER -151.57 -166.67 2.58 Favored 'General case' 0 N--CA 1.5 2.049 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 179.998 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.589 ' N ' ' SG ' ' A' ' 25' ' ' CYS . 2.1 tm-20 -121.07 147.4 45.57 Favored 'General case' 0 N--CA 1.501 2.116 0 N-CA-C 106.374 -1.713 . . . . 0.0 106.374 179.565 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.456 ' HA3' ' H ' ' A' ' 11' ' ' THR . . . -55.1 109.8 1.46 Allowed Glycine 0 N--CA 1.501 2.972 0 N-CA-C 110.358 -1.097 . . . . 0.0 110.358 179.822 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 -86.31 12.29 10.33 Favored 'General case' 0 N--CA 1.501 2.12 0 N-CA-C 113.613 0.968 . . . . 0.0 113.613 -179.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.407 ' N ' ' HA3' ' A' ' 10' ' ' GLY . 20.9 t -169.62 -174.53 1.91 Allowed 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -79.23 143.38 60.5 Favored Pre-proline 0 N--CA 1.496 1.845 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo -52.34 -32.36 51.2 Favored 'Trans proline' 0 N--CA 1.498 1.772 0 C-N-CA 122.38 2.053 . . . . 0.0 112.15 175.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 87.6 mtm180 -113.99 35.24 4.21 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-N 114.74 -1.118 . . . . 0.0 109.232 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 24.2 p-10 -65.96 127.05 92.88 Favored Pre-proline 0 N--CA 1.497 1.881 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.98 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_endo -76.51 81.53 2.48 Favored 'Trans proline' 0 N--CA 1.49 1.289 0 C-N-CA 122.492 2.128 . . . . 0.0 107.973 167.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 23.6 tptm -150.85 153.43 35.35 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-N 114.851 -1.068 . . . . 0.0 110.124 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -99.52 155.6 17.48 Favored 'General case' 0 N--CA 1.496 1.826 0 CA-C-N 114.066 -1.424 . . . . 0.0 110.221 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 84.8 m -147.44 177.26 9.38 Favored 'General case' 0 N--CA 1.497 1.879 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.643 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 64.5 p -132.98 -18.28 2.35 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-N 113.893 -1.503 . . . . 0.0 108.976 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.3 tt -89.63 24.6 2.26 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 24.2 m120 -56.83 152.88 11.77 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-N 115.308 -0.86 . . . . 0.0 112.744 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.472 ' HA ' ' HA ' ' A' ' 4' ' ' CYS . 68.0 m 59.68 124.4 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.753 0 CA-C-N 113.467 -1.697 . . . . 0.0 114.318 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -152.33 84.04 4.87 Favored Pre-proline 0 N--CA 1.494 1.728 0 CA-C-N 114.389 -1.278 . . . . 0.0 109.338 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -57.67 -20.11 40.88 Favored 'Trans proline' 0 N--CA 1.493 1.464 0 C-N-CA 122.769 2.313 . . . . 0.0 112.86 178.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 74.5 mtp180 -62.31 -42.29 99.24 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 26.4 mt -68.21 157.77 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 CA-C-O 122.414 1.102 . . . . 0.0 110.691 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -125.37 -51.14 1.64 Allowed 'General case' 0 N--CA 1.491 1.614 0 CA-C-N 111.719 -2.491 . . . . 0.0 107.786 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 13.1 p90 -171.14 160.98 6.58 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-N 114.172 -1.376 . . . . 0.0 111.237 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -96.87 121.39 7.02 Favored Glycine 0 N--CA 1.493 2.456 0 CA-C-N 113.651 -1.613 . . . . 0.0 109.248 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 29.4 m -94.71 103.96 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.7 m -79.88 115.26 52.73 Favored Pre-proline 0 N--CA 1.5 2.045 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 179.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -62.98 167.59 11.99 Favored 'Trans proline' 0 N--CA 1.496 1.657 0 C-N-CA 122.458 2.105 . . . . 0.0 112.457 -171.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.422 ' N ' ' HD2' ' A' ' 52' ' ' ARG . 0.0 OUTLIER -159.72 150.3 19.09 Favored 'General case' 0 N--CA 1.497 1.883 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.218 -179.887 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 49.2 m -77.98 126.06 30.27 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 66.01 118.63 0.03 OUTLIER 'General case' 0 N--CA 1.504 2.239 0 O-C-N 124.755 1.285 . . . . 0.0 109.851 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -158.68 -40.05 0.06 Allowed 'General case' 0 N--CA 1.497 1.876 0 CA-C-N 115.027 -0.988 . . . . 0.0 111.101 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.429 ' NZ ' ' HB2' ' A' ' 56' ' ' LYS . 10.1 mtmp? -110.53 -162.86 0.82 Allowed 'General case' 0 N--CA 1.497 1.92 0 O-C-N 124.139 0.899 . . . . 0.0 109.9 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt 57.63 64.16 1.64 Allowed 'General case' 0 N--CA 1.5 2.045 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 32.3 m120 -134.93 -47.71 0.73 Allowed 'General case' 0 N--CA 1.495 1.811 0 CA-C-N 113.812 -1.54 . . . . 0.0 109.191 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -107.0 -55.56 2.31 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 124.426 1.078 . . . . 0.0 110.71 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 42.6 ptt85 22.27 61.46 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.225 0 O-C-N 125.073 1.483 . . . . 0.0 114.927 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 7.6 tp -61.02 124.82 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 CA-C-N 114.096 -1.411 . . . . 0.0 111.588 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 1.7 m -125.0 46.12 2.41 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-O 122.413 1.102 . . . . 0.0 113.337 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 33.9 m -90.22 168.3 12.03 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 113.666 -1.606 . . . . 0.0 109.154 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 24.3 p30 -142.94 176.06 9.36 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 124.416 1.073 . . . . 0.0 109.297 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 47.0 t -92.79 -31.69 14.94 Favored 'General case' 0 N--CA 1.499 2.021 0 N-CA-C 114.469 1.285 . . . . 0.0 114.469 -179.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 42.7 t -63.56 -58.37 7.18 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 123.934 0.771 . . . . 0.0 110.352 -179.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -89.83 36.31 0.85 Allowed 'General case' 0 N--CA 1.495 1.803 0 CA-C-N 114.294 -1.321 . . . . 0.0 110.227 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -76.67 -115.78 0.14 Allowed Glycine 0 N--CA 1.493 2.478 0 N-CA-C 109.317 -1.513 . . . . 0.0 109.317 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 95.6 m -156.27 96.63 1.7 Allowed 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -52.16 104.2 0.08 Allowed 'General case' 0 N--CA 1.501 2.12 0 C-N-CA 120.034 -0.666 . . . . 0.0 111.345 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 146.91 -31.0 1.48 Allowed Glycine 0 N--CA 1.495 2.629 0 CA-C-N 114.835 -1.075 . . . . 0.0 112.625 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 88.2 m -95.26 174.8 6.87 Favored 'General case' 0 N--CA 1.502 2.169 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -121.9 87.35 2.74 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 106.452 -1.684 . . . . 0.0 106.452 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 61.0 m-85 -48.58 140.93 7.55 Favored 'General case' 0 N--CA 1.499 1.984 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.013 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.582 ' CE2' ' HA ' ' A' ' 80' ' ' THR . 4.8 t80 -137.1 164.43 28.45 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 125.207 1.567 . . . . 0.0 114.543 -179.222 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 12.0 t -124.13 130.76 53.09 Favored 'General case' 0 N--CA 1.505 2.275 0 CA-C-N 113.153 -1.839 . . . . 0.0 112.529 -179.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -54.98 -49.61 71.04 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-N 113.405 -1.725 . . . . 0.0 111.025 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 13.5 p-10 -108.1 28.58 8.13 Favored 'General case' 0 N--CA 1.488 1.472 0 CA-C-N 113.123 -1.853 . . . . 0.0 111.22 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -160.79 18.09 0.2 Allowed Glycine 0 N--CA 1.494 2.554 0 C-N-CA 119.356 -1.402 . . . . 0.0 112.341 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.582 ' HA ' ' CE2' ' A' ' 75' ' ' PHE . 6.4 t 42.03 -160.23 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.793 0 O-C-N 124.924 1.014 . . . . 0.0 113.1 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 47.1 t80 -42.37 121.11 1.83 Allowed 'General case' 0 N--CA 1.499 1.978 0 CA-C-O 121.459 0.647 . . . . 0.0 111.681 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 61.5 t -92.18 -68.2 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 CA-C-N 113.835 -1.529 . . . . 0.0 111.731 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 1.8 p -158.28 -177.28 6.43 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 123.924 0.765 . . . . 0.0 109.597 -179.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -102.46 151.97 21.68 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 104.54 -2.393 . . . . 0.0 104.54 179.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -64.55 128.04 34.98 Favored Glycine 0 N--CA 1.493 2.494 0 N-CA-C 108.638 -1.785 . . . . 0.0 108.638 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 40.7 mm-40 -113.67 11.97 18.29 Favored 'General case' 0 N--CA 1.498 1.929 0 C-N-CA 120.359 -0.536 . . . . 0.0 110.728 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 38.6 t -79.0 87.76 4.79 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -98.36 137.93 20.78 Favored Pre-proline 0 N--CA 1.493 1.688 0 CA-C-N 112.938 -1.937 . . . . 0.0 108.138 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -65.23 -40.47 19.39 Favored 'Trans proline' 0 N--CA 1.493 1.5 0 C-N-CA 122.12 1.88 . . . . 0.0 111.52 -179.074 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 72.5 ttt-85 -81.37 4.27 21.38 Favored 'General case' 0 N--CA 1.498 1.955 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.961 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.504 HD22 ' N ' ' A' ' 91' ' ' ASN . 0.0 OUTLIER -44.75 112.37 1.46 Allowed Pre-proline 0 N--CA 1.502 2.17 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -179.889 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -81.94 43.92 1.61 Allowed 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 123.112 2.541 . . . . 0.0 111.191 178.039 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 24.6 ttmm -164.29 153.44 13.57 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.173 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -94.46 129.04 41.38 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-N 114.095 -1.411 . . . . 0.0 108.186 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 83.1 m -79.82 148.18 68.17 Favored Pre-proline 0 N--CA 1.495 1.825 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -71.99 144.12 42.11 Favored 'Trans proline' 0 N--CA 1.489 1.245 0 C-N-CA 122.791 2.327 . . . . 0.0 109.258 163.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 21.1 tpp180 -100.16 31.88 3.19 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 27.9 m-20 -58.4 163.62 2.97 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 114.6 1.333 . . . . 0.0 114.6 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 66.9 m -100.61 133.95 44.29 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-N 113.358 -1.746 . . . . 0.0 110.868 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 60.5 t0 -117.4 84.39 18.16 Favored Pre-proline 0 N--CA 1.497 1.879 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 179.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_endo -57.29 -36.21 98.95 Favored 'Trans proline' 0 N--CA 1.496 1.657 0 C-N-CA 122.702 2.268 . . . . 0.0 111.283 -174.433 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 20.9 mmt180 -62.47 -39.63 94.03 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 124.284 0.99 . . . . 0.0 111.848 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 3.1 tt -53.45 155.16 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 O-C-N 123.905 0.753 . . . . 0.0 110.051 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -149.18 -42.24 0.14 Allowed 'General case' 0 N--CA 1.491 1.618 0 CA-C-N 115.364 -0.834 . . . . 0.0 111.458 -179.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 -138.45 -164.35 1.62 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 124.341 1.026 . . . . 0.0 110.599 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -153.23 103.99 0.25 Allowed Glycine 0 N--CA 1.487 2.08 0 N-CA-C 106.063 -2.815 . . . . 0.0 106.063 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 90.3 mt -78.91 88.18 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 57.9 m -81.9 149.53 63.52 Favored Pre-proline 0 N--CA 1.493 1.696 0 CA-C-N 113.944 -1.48 . . . . 0.0 109.006 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -57.0 140.7 93.26 Favored 'Trans proline' 0 N--CA 1.495 1.565 0 C-N-CA 122.618 2.212 . . . . 0.0 111.056 179.332 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 69.8 tp -79.67 133.21 36.37 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-N 115.179 -0.918 . . . . 0.0 110.473 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.768 0 CA-C-O 116.677 -1.63 . . . . 0.0 110.098 179.864 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 . . . . . 0 N--CA 1.491 1.588 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.77 -48.34 74.84 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 7.2 tp -61.48 133.48 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 CA-C-N 114.49 -1.232 . . . . 0.0 109.145 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.428 ' HA ' ' HA ' ' A' ' 41' ' ' CYS . 1.7 m -140.38 45.71 1.83 Allowed 'General case' 0 N--CA 1.483 1.19 0 CA-C-O 122.583 1.182 . . . . 0.0 112.683 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 22.7 p -90.35 178.16 6.21 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-N 113.053 -1.885 . . . . 0.0 110.311 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 36.3 p-10 -155.85 -169.57 3.13 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-N 113.958 -1.474 . . . . 0.0 108.77 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.44 ' SG ' ' CD2' ' A' ' 16' ' ' TYR . 2.3 t -81.25 -27.36 35.23 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -179.796 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 23.3 t -80.32 -59.55 2.66 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-N 114.483 -1.235 . . . . 0.0 110.988 -179.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -90.41 64.79 6.01 Favored 'General case' 0 N--CA 1.5 2.036 0 CA-C-O 121.89 0.852 . . . . 0.0 110.074 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.47 ' H ' ' HB2' ' A' ' 29' ' ' SER . . . -135.89 -115.76 1.5 Allowed Glycine 0 N--CA 1.498 2.824 0 CA-C-N 113.97 -1.468 . . . . 0.0 110.264 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 91.1 m -139.73 111.23 7.16 Favored 'General case' 0 N--CA 1.502 2.146 0 CA-C-O 120.788 0.328 . . . . 0.0 111.264 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.574 ' NZ ' HH21 ' A' ' 32' ' ' ARG . 39.4 ttpt -58.59 146.52 35.59 Favored 'General case' 0 N--CA 1.497 1.883 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.803 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 79.75 -16.49 11.19 Favored Glycine 0 N--CA 1.492 2.418 0 CA-C-N 114.542 -1.208 . . . . 0.0 112.858 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 90.2 m -93.77 129.8 39.99 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.43 ' HD2' ' N ' ' A' ' 15' ' ' LYS . 0.9 OUTLIER -77.6 94.11 4.31 Favored 'General case' 0 N--CA 1.486 1.343 0 CA-C-N 114.435 -1.257 . . . . 0.0 110.19 -179.365 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.703 ' CD2' ' SG ' ' A' ' 25' ' ' CYS . 95.4 m-85 -46.17 137.14 6.33 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 124.925 1.391 . . . . 0.0 109.074 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -147.74 152.73 38.25 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 125.085 1.491 . . . . 0.0 111.876 -179.438 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 28.9 t -107.8 136.44 47.52 Favored 'General case' 0 N--CA 1.497 1.901 0 CA-C-N 111.748 -2.478 . . . . 0.0 113.778 -179.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -52.12 -24.79 7.49 Favored 'General case' 0 N--CA 1.5 2.072 0 CA-C-N 112.645 -2.07 . . . . 0.0 115.157 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -57.27 -17.49 12.14 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 123.849 0.718 . . . . 0.0 110.966 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 105.03 29.63 5.12 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 108.537 -1.825 . . . . 0.0 108.537 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 58.2 m -138.28 154.56 49.03 Favored 'General case' 0 N--CA 1.493 1.702 0 CA-C-O 121.374 0.607 . . . . 0.0 111.03 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 57.7 t80 -73.98 166.76 22.81 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-N 113.663 -1.608 . . . . 0.0 109.615 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 90.3 t -129.06 -68.3 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 123.909 0.756 . . . . 0.0 110.889 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.703 ' SG ' ' CD2' ' A' ' 16' ' ' TYR . 22.8 p -162.32 -171.4 2.79 Favored 'General case' 0 N--CA 1.504 2.255 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -111.95 145.11 40.17 Favored 'General case' 0 N--CA 1.506 2.331 0 CA-C-O 120.74 0.305 . . . . 0.0 111.535 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.56 ' HA2' ' CE2' ' A' ' 16' ' ' TYR . . . -39.98 107.13 0.07 OUTLIER Glycine 0 N--CA 1.496 2.682 0 O-C-N 124.545 1.153 . . . . 0.0 114.613 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -124.73 43.75 2.94 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 105.943 -1.873 . . . . 0.0 105.943 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.47 ' HB2' ' H ' ' A' ' 10' ' ' GLY . 10.4 t -125.66 81.16 1.96 Allowed 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 -179.634 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -88.11 120.36 70.62 Favored Pre-proline 0 N--CA 1.495 1.801 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 179.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -66.73 -29.21 43.08 Favored 'Trans proline' 0 N--CA 1.494 1.538 0 C-N-CA 121.983 1.788 . . . . 0.0 110.773 177.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.574 HH21 ' NZ ' ' A' ' 12' ' ' LYS . 84.9 mtm180 -78.87 3.28 17.36 Favored 'General case' 0 N--CA 1.498 1.95 0 CA-C-N 114.946 -1.025 . . . . 0.0 112.107 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.496 HD22 ' H ' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -60.21 130.63 89.51 Favored Pre-proline 0 N--CA 1.495 1.798 0 O-C-N 123.339 0.399 . . . . 0.0 111.918 -179.86 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -82.28 46.13 2.12 Favored 'Trans proline' 0 N--CA 1.493 1.49 0 C-N-CA 123.026 2.484 . . . . 0.0 108.642 162.157 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -137.55 -177.0 4.6 Favored 'General case' 0 N--CA 1.497 1.9 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.49 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -143.92 118.13 9.55 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-N 114.867 -1.061 . . . . 0.0 108.423 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 75.4 m -79.76 168.72 18.94 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 8.6 t -85.21 166.47 16.52 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-N 113.856 -1.52 . . . . 0.0 109.558 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.54 HD13 ' H ' ' A' ' 39' ' ' LEU . 0.0 OUTLIER -104.18 19.46 20.11 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-N 114.849 -1.069 . . . . 0.0 111.902 -179.895 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -55.12 135.57 49.13 Favored 'General case' 0 N--CA 1.498 1.951 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.128 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.428 ' HA ' ' HA ' ' A' ' 4' ' ' CYS . 58.2 m -90.32 131.3 36.19 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-N 114.796 -1.093 . . . . 0.0 110.874 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -127.35 78.02 75.04 Favored Pre-proline 0 N--CA 1.498 1.947 0 O-C-N 124.103 0.877 . . . . 0.0 109.514 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -63.77 -27.12 67.95 Favored 'Trans proline' 0 N--CA 1.494 1.524 0 C-N-CA 122.855 2.37 . . . . 0.0 113.515 -170.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 8.4 ptp180 -56.24 -33.19 65.18 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 123.956 0.785 . . . . 0.0 111.205 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 15.1 tt -50.41 150.91 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 CA-C-N 114.696 -1.138 . . . . 0.0 113.102 -179.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -133.21 -51.43 0.88 Allowed 'General case' 0 N--CA 1.492 1.652 0 CA-C-N 113.492 -1.685 . . . . 0.0 106.903 179.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 51.5 p90 -170.41 177.26 4.13 Favored 'General case' 0 N--CA 1.494 1.748 0 CA-C-N 113.819 -1.537 . . . . 0.0 108.684 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -124.52 120.55 4.07 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 107.341 -2.303 . . . . 0.0 107.341 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.1 p -79.27 100.65 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 CA-C-O 123.015 1.388 . . . . 0.0 108.778 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 3.8 m -79.58 163.66 57.67 Favored Pre-proline 0 N--CA 1.493 1.705 0 CA-C-N 112.889 -1.96 . . . . 0.0 108.383 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_exo -46.34 -32.45 10.85 Favored 'Trans proline' 0 N--CA 1.499 1.806 0 C-N-CA 122.705 2.27 . . . . 0.0 111.847 175.169 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 63.5 mtp85 -79.79 -86.58 0.08 Allowed 'General case' 0 N--CA 1.491 1.605 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.037 179.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 64.3 m 50.31 90.41 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.993 0 O-C-N 124.219 0.949 . . . . 0.0 112.188 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -88.59 25.7 1.65 Allowed 'General case' 0 N--CA 1.498 1.951 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.07 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.402 ' CD ' ' N ' ' A' ' 55' ' ' GLU . 14.8 mp0 -121.46 118.72 30.07 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 106.509 -1.663 . . . . 0.0 106.509 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 32.3 mmtp -136.37 165.88 24.77 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 123.745 0.653 . . . . 0.0 111.925 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 28.5 tptp -77.16 -106.75 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 114.47 1.285 . . . . 0.0 114.47 -179.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 30.4 m120 -74.86 -57.92 3.61 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 113.781 1.03 . . . . 0.0 113.781 -179.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 67.45 156.49 0.12 Allowed 'General case' 0 N--CA 1.503 2.196 0 O-C-N 124.692 1.245 . . . . 0.0 111.213 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 16.5 ptm180 41.03 22.57 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.419 0 N-CA-C 114.401 1.259 . . . . 0.0 114.401 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.517 ' C ' HD13 ' A' ' 61' ' ' ILE . 0.0 OUTLIER -90.57 116.79 32.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 CA-C-N 114.993 -1.003 . . . . 0.0 109.197 -179.887 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.59 ' HA ' ' HA ' ' A' ' 99' ' ' CYS . 1.3 m -139.36 43.9 2.0 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 118.037 2.606 . . . . 0.0 118.037 179.45 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.3 p -90.75 160.36 15.85 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-N 113.679 -1.601 . . . . 0.0 106.685 179.121 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.537 HD22 HD22 ' A' ' 98' ' ' ASN . 40.0 t30 -160.58 161.59 32.63 Favored 'General case' 0 N--CA 1.497 1.901 0 CA-C-O 122.399 1.095 . . . . 0.0 112.598 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 7.4 t -58.51 -20.35 45.12 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-N 112.014 -2.357 . . . . 0.0 111.836 179.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 40.7 t -86.27 -71.06 0.56 Allowed 'General case' 0 N--CA 1.494 1.756 0 CA-C-N 114.999 -1.0 . . . . 0.0 111.642 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -54.33 -19.71 5.93 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-N 113.881 -1.509 . . . . 0.0 113.097 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -60.58 159.95 25.05 Favored Glycine 0 N--CA 1.491 2.357 0 O-C-N 123.998 0.811 . . . . 0.0 111.837 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.481 ' C ' ' H ' ' A' ' 71' ' ' GLY . 12.4 t -85.56 139.24 31.61 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-N 113.934 -1.133 . . . . 0.0 108.922 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 23.1 ttmm -80.02 35.03 0.31 Allowed 'General case' 0 N--CA 1.499 2.003 0 CA-C-O 122.543 1.164 . . . . 0.0 110.578 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.481 ' H ' ' C ' ' A' ' 69' ' ' THR . . . -123.64 -8.51 6.28 Favored Glycine 0 N--CA 1.491 2.367 0 N-CA-C 108.542 -1.823 . . . . 0.0 108.542 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . 0.407 ' HA ' ' HA ' ' A' ' 108' ' ' CYS . 78.9 m -137.33 148.12 46.09 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 123.931 0.43 . . . . 0.0 109.915 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.474 ' HB3' ' CE1' ' A' ' 81' ' ' PHE . 27.6 mtpp -101.4 88.59 3.5 Favored 'General case' 0 N--CA 1.485 1.314 0 O-C-N 124.917 1.386 . . . . 0.0 108.203 -179.485 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -49.76 133.99 20.98 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-N 114.175 -1.375 . . . . 0.0 108.688 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.489 ' CE2' ' HA ' ' A' ' 80' ' ' THR . 1.2 t80 -132.72 154.62 50.01 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 113.13 -1.85 . . . . 0.0 114.06 -179.218 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.427 ' N ' HG23 ' A' ' 82' ' ' VAL . 25.8 t -115.84 129.92 56.63 Favored 'General case' 0 N--CA 1.497 1.913 0 CA-C-N 112.145 -2.298 . . . . 0.0 111.746 -179.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.479 ' H ' ' HB2' ' A' ' 104' ' ' ALA . 7.7 p-10 -64.67 -46.74 81.16 Favored 'General case' 0 N--CA 1.497 1.897 0 CA-C-N 114.773 -1.103 . . . . 0.0 108.596 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -92.18 19.71 6.67 Favored 'General case' 0 N--CA 1.485 1.283 0 CA-C-N 112.772 -2.013 . . . . 0.0 110.953 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -165.21 24.53 0.16 Allowed Glycine 0 N--CA 1.497 2.715 0 C-N-CA 118.62 -1.753 . . . . 0.0 113.184 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.489 ' HA ' ' CE2' ' A' ' 75' ' ' PHE . 6.5 t 42.11 -161.55 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.926 0 O-C-N 124.969 1.041 . . . . 0.0 112.887 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.474 ' CE1' ' HB3' ' A' ' 73' ' ' LYS . 11.0 t80 -49.68 121.97 5.84 Favored 'General case' 0 N--CA 1.497 1.882 0 CA-C-O 121.34 0.591 . . . . 0.0 110.879 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.427 HG23 ' N ' ' A' ' 76' ' ' SER . 88.9 t -86.11 -73.34 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . 0.409 ' SG ' ' O ' ' A' ' 84' ' ' GLU . 0.1 OUTLIER -175.49 171.35 2.83 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 124.002 0.813 . . . . 0.0 110.459 179.779 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.462 ' HA ' ' HA ' ' A' ' 73' ' ' LYS . 32.3 tt0 -93.28 146.93 23.34 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 105.718 -1.956 . . . . 0.0 105.718 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -53.03 135.38 39.74 Favored Glycine 0 N--CA 1.501 2.967 0 C-N-CA 119.514 -1.327 . . . . 0.0 114.452 -179.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -100.37 27.91 5.39 Favored 'General case' 0 N--CA 1.505 2.301 0 CA-C-O 121.595 0.712 . . . . 0.0 110.032 179.744 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 22.2 t -160.93 -176.57 5.58 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.438 ' N ' HD21 ' A' ' 91' ' ' ASN . 7.5 t70 -144.61 140.01 16.09 Favored Pre-proline 0 N--CA 1.488 1.438 0 N-CA-C 105.343 -2.095 . . . . 0.0 105.343 179.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_exo -41.79 -28.04 0.66 Allowed 'Trans proline' 0 N--CA 1.5 1.895 0 C-N-CA 123.671 2.914 . . . . 0.0 114.824 -174.274 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.87 -51.34 16.54 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 123.93 0.769 . . . . 0.0 111.898 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.438 HD21 ' N ' ' A' ' 88' ' ' ASP . 2.4 p30 -90.23 138.26 27.35 Favored Pre-proline 0 N--CA 1.502 2.166 0 C-N-CA 119.55 -0.86 . . . . 0.0 110.622 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -75.53 170.25 20.64 Favored 'Trans proline' 0 N--CA 1.493 1.476 0 C-N-CA 122.929 2.419 . . . . 0.0 109.861 161.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 27.8 tptp -160.3 154.68 23.58 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 123.67 0.606 . . . . 0.0 110.3 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -98.39 139.51 34.04 Favored 'General case' 0 N--CA 1.498 1.96 0 CA-C-N 114.591 -1.186 . . . . 0.0 111.122 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . 0.419 ' HB3' ' HD2' ' A' ' 96' ' ' PRO . 98.5 m -159.32 167.46 14.22 Favored Pre-proline 0 N--CA 1.501 2.076 0 O-C-N 124.057 0.848 . . . . 0.0 111.066 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.419 ' HD2' ' HB3' ' A' ' 95' ' ' CYS . 50.1 Cg_exo -27.09 -66.13 0.05 OUTLIER 'Trans proline' 0 N--CA 1.494 1.528 0 C-N-CA 124.275 3.316 . . . . 0.0 115.628 170.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 79.0 ttt180 -153.77 -77.92 0.11 Allowed 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.537 HD22 HD22 ' A' ' 64' ' ' ASN . 7.8 m120 133.72 -170.22 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.412 0 O-C-N 126.545 2.403 . . . . 0.0 107.726 -179.559 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.59 ' HA ' ' HA ' ' A' ' 62' ' ' CYS . 61.5 m 62.95 121.45 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 124.952 1.301 . . . . 0.0 112.454 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -141.17 80.98 16.27 Favored Pre-proline 0 N--CA 1.494 1.73 0 CA-C-N 114.372 -1.286 . . . . 0.0 111.252 -179.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -49.16 -27.76 13.16 Favored 'Trans proline' 0 N--CA 1.496 1.669 0 C-N-CA 123.183 2.589 . . . . 0.0 113.812 172.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.06 -27.28 69.29 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 123.687 0.617 . . . . 0.0 111.635 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 12.7 tt -52.35 167.62 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 124.253 0.971 . . . . 0.0 112.625 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.479 ' HB2' ' H ' ' A' ' 77' ' ' ASP . . . -142.8 -55.66 0.42 Allowed 'General case' 0 N--CA 1.49 1.532 0 CA-C-N 114.352 -1.295 . . . . 0.0 109.604 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -149.2 -159.92 1.1 Allowed 'General case' 0 N--CA 1.498 1.925 0 O-C-N 124.465 1.103 . . . . 0.0 109.134 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -142.89 108.97 0.54 Allowed Glycine 0 N--CA 1.489 2.173 0 N-CA-C 105.917 -2.873 . . . . 0.0 105.917 179.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 93.4 mt -79.37 85.68 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' CYS . . . . . 0.407 ' HA ' ' HA ' ' A' ' 72' ' ' CYS . 22.2 m -79.68 121.34 82.35 Favored Pre-proline 0 N--CA 1.492 1.634 0 CA-C-N 113.799 -1.546 . . . . 0.0 108.553 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_endo -61.6 112.5 1.48 Allowed 'Trans proline' 0 N--CA 1.493 1.45 0 C-N-CA 122.394 2.063 . . . . 0.0 110.375 -176.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 74.5 mt -79.8 -3.16 46.51 Favored 'General case' 0 N--CA 1.498 1.926 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.245 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.827 0 CA-C-O 116.97 -1.49 . . . . 0.0 109.892 179.913 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 . . . . . 0 N--CA 1.489 1.523 0 CA-C-O 120.404 0.145 . . . . 0.0 110.889 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 8.2 ptp180 -67.73 -36.31 80.35 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 106.175 -1.787 . . . . 0.0 106.175 179.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.7 tp -90.16 77.79 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 CA-C-N 113.252 -1.795 . . . . 0.0 108.345 179.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.7 m -85.81 28.99 0.74 Allowed 'General case' 0 N--CA 1.497 1.925 0 N-CA-C 116.201 1.926 . . . . 0.0 116.201 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 12.6 t -92.35 169.51 10.52 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-N 113.058 -1.883 . . . . 0.0 106.508 179.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.42 ' ND2' ' H ' ' A' ' 9' ' ' ALA . 40.0 p-10 -160.48 161.87 32.95 Favored 'General case' 0 N--CA 1.497 1.901 0 C-N-CA 119.367 -0.933 . . . . 0.0 112.629 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -63.24 -22.68 67.02 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 113.856 -1.52 . . . . 0.0 112.561 179.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 42.4 t -89.96 -69.02 0.74 Allowed 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 115.252 1.575 . . . . 0.0 115.252 -179.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.42 ' H ' ' ND2' ' A' ' 6' ' ' ASN . . . -85.66 63.07 7.85 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 124.598 1.186 . . . . 0.0 111.25 -179.556 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -119.89 -115.05 2.5 Favored Glycine 0 N--CA 1.492 2.379 0 CA-C-N 113.282 -1.781 . . . . 0.0 109.799 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.0 t -166.31 123.44 1.35 Allowed 'General case' 0 N--CA 1.496 1.848 0 CA-C-O 121.373 0.606 . . . . 0.0 110.585 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.82 143.73 20.28 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-N 114.714 -1.13 . . . . 0.0 109.843 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 106.37 -35.47 5.02 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.195 -1.562 . . . . 0.0 109.195 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.401 ' HB3' ' HA3' ' A' ' 48' ' ' GLY . 52.1 m -94.64 116.21 28.49 Favored 'General case' 0 N--CA 1.497 1.906 0 C-N-CA 119.422 -0.911 . . . . 0.0 110.222 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 4.0 mptp? -72.24 88.15 1.14 Allowed 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 112.792 -2.003 . . . . 0.0 111.627 -179.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.446 ' N ' ' O ' ' A' ' 25' ' ' CYS . 10.7 m-85 -46.72 127.9 10.14 Favored 'General case' 0 N--CA 1.498 1.96 0 CA-C-O 122.468 1.128 . . . . 0.0 108.237 179.583 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.547 ' CE2' ' HA ' ' A' ' 22' ' ' THR . 0.1 OUTLIER -135.96 158.72 43.73 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-N 111.623 -2.535 . . . . 0.0 113.096 -178.965 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 29.1 t -110.78 128.86 55.91 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-N 112.72 -2.036 . . . . 0.0 111.054 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.461 ' H ' ' HB2' ' A' ' 46' ' ' ALA . 7.7 p-10 -62.71 -45.35 93.15 Favored 'General case' 0 N--CA 1.497 1.911 0 CA-C-N 114.119 -1.4 . . . . 0.0 109.203 179.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -94.25 19.94 8.76 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 112.624 -2.08 . . . . 0.0 111.624 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -171.22 28.89 0.11 Allowed Glycine 0 N--CA 1.497 2.731 0 C-N-CA 118.146 -1.978 . . . . 0.0 113.934 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.547 ' HA ' ' CE2' ' A' ' 17' ' ' PHE . 6.5 t 42.81 -166.68 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 73.9 t80 -40.05 139.81 0.65 Allowed 'General case' 0 N--CA 1.5 2.063 0 N-CA-C 114.074 1.138 . . . . 0.0 114.074 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 88.4 t -114.53 -79.42 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 CA-C-N 113.131 -1.85 . . . . 0.0 108.05 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.525 ' SG ' ' N ' ' A' ' 26' ' ' GLU . 0.1 OUTLIER -152.21 -169.38 3.34 Favored 'General case' 0 N--CA 1.502 2.17 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 179.86 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.525 ' N ' ' SG ' ' A' ' 25' ' ' CYS . 60.8 tt0 -114.62 158.3 21.92 Favored 'General case' 0 N--CA 1.504 2.228 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 179.425 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -54.07 109.65 1.22 Allowed Glycine 0 N--CA 1.497 2.731 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.69 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -85.82 19.55 2.48 Favored 'General case' 0 N--CA 1.5 2.028 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 36.6 t -105.44 92.76 4.33 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.197 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -130.35 142.42 45.4 Favored Pre-proline 0 N--CA 1.495 1.786 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 179.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_endo -63.16 79.0 0.12 Allowed 'Trans proline' 0 N--CA 1.496 1.639 0 C-N-CA 122.561 2.174 . . . . 0.0 109.891 169.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 79.6 ttt180 -178.13 -51.26 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 105.592 -2.003 . . . . 0.0 105.592 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 26.5 p30 -90.44 168.21 14.78 Favored Pre-proline 0 N--CA 1.497 1.9 0 CA-C-N 114.27 -1.332 . . . . 0.0 110.781 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -62.55 127.2 20.13 Favored 'Trans proline' 0 N--CA 1.49 1.304 0 C-N-CA 122.436 2.09 . . . . 0.0 109.021 160.241 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -92.83 22.44 4.84 Favored 'General case' 0 N--CA 1.5 2.074 0 CA-C-O 122.677 1.227 . . . . 0.0 112.749 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -146.22 153.39 40.56 Favored 'General case' 0 N--CA 1.498 1.947 0 CA-C-N 112.274 -2.239 . . . . 0.0 111.739 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 57.1 m -146.51 -124.19 0.07 Allowed 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 33.5 m -146.76 18.37 1.29 Allowed 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 44.6 tp -79.71 -43.3 22.92 Favored 'General case' 0 N--CA 1.497 1.897 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.334 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 25.2 m-80 53.11 -163.63 0.09 Allowed 'General case' 0 N--CA 1.504 2.243 0 O-C-N 124.064 0.852 . . . . 0.0 112.03 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 56.3 m -43.85 118.85 1.54 Allowed 'General case' 0 N--CA 1.502 2.133 0 O-C-N 124.033 0.833 . . . . 0.0 110.232 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.4 t0 -101.41 106.41 45.62 Favored Pre-proline 0 N--CA 1.495 1.807 0 O-C-N 124.022 0.827 . . . . 0.0 109.398 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -67.6 -33.12 29.33 Favored 'Trans proline' 0 N--CA 1.494 1.525 0 C-N-CA 122.046 1.831 . . . . 0.0 111.101 -168.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 29.0 mmt85 -86.32 -13.36 46.81 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 -179.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 5.9 tt -73.43 179.33 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 C-N-CA 118.68 -1.208 . . . . 0.0 108.738 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.461 ' HB2' ' H ' ' A' ' 19' ' ' ASP . . . -139.92 -58.61 0.56 Allowed 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 120.556 -0.458 . . . . 0.0 112.073 -179.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 7.3 p90 -170.46 160.68 7.57 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 124.146 0.904 . . . . 0.0 112.719 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.407 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -88.92 107.65 3.39 Favored Glycine 0 N--CA 1.487 2.096 0 CA-C-N 113.235 -1.802 . . . . 0.0 108.892 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 23.4 t -78.24 86.75 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 124.287 0.639 . . . . 0.0 112.661 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.6 m -79.27 145.91 65.53 Favored Pre-proline 0 N--CA 1.503 2.212 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 179.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -75.87 54.22 3.98 Favored 'Trans proline' 0 N--CA 1.5 1.861 0 C-N-CA 123.74 2.96 . . . . 0.0 116.465 -170.145 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.61 169.22 23.34 Favored 'General case' 0 N--CA 1.501 2.097 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 28.3 t 62.64 170.29 0.14 Allowed 'General case' 0 N--CA 1.503 2.21 0 O-C-N 124.454 1.097 . . . . 0.0 111.299 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -144.72 -112.51 0.1 Allowed 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 60.95 129.73 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.113 0 C-N-CA 124.184 0.994 . . . . 0.0 113.445 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 32.3 mmtp -141.9 -159.69 1.0 Allowed 'General case' 0 N--CA 1.498 1.929 0 CA-C-N 114.426 -1.261 . . . . 0.0 107.96 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.421 ' N ' ' HD3' ' A' ' 57' ' ' LYS . 3.0 mppt? 56.49 -167.99 0.11 Allowed 'General case' 0 N--CA 1.504 2.228 0 O-C-N 123.433 0.458 . . . . 0.0 110.17 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 7.5 m-80 -74.97 -7.04 52.46 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 179.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -66.61 120.03 12.74 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.801 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 56.6 ttt85 -174.29 -106.02 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 105.508 -2.034 . . . . 0.0 105.508 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 5.9 tp -79.03 84.29 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 179.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.4 ' HA ' ' HA ' ' A' ' 99' ' ' CYS . 1.7 m -85.81 44.54 1.12 Allowed 'General case' 0 N--CA 1.494 1.738 0 CA-C-N 114.474 -1.239 . . . . 0.0 113.94 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 64.3 m -90.54 166.39 13.24 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 113.309 -1.769 . . . . 0.0 108.201 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -146.53 155.05 42.22 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 124.079 0.862 . . . . 0.0 109.765 179.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 41.1 t -56.75 -32.84 65.97 Favored 'General case' 0 N--CA 1.497 1.916 0 CA-C-N 114.767 -1.106 . . . . 0.0 113.582 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 18.1 t -66.54 -46.19 76.91 Favored 'General case' 0 N--CA 1.495 1.796 0 CA-C-N 114.726 -1.124 . . . . 0.0 110.219 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -86.17 62.27 7.33 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-N 113.689 -1.596 . . . . 0.0 110.655 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -143.8 165.11 27.33 Favored Glycine 0 N--CA 1.496 2.637 0 CA-C-N 114.272 -1.331 . . . . 0.0 111.078 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.463 ' C ' ' H ' ' A' ' 71' ' ' GLY . 9.5 t -85.3 127.33 34.29 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-N 115.036 -0.582 . . . . 0.0 110.517 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -81.09 36.64 0.41 Allowed 'General case' 0 N--CA 1.501 2.078 0 CA-C-O 122.484 1.135 . . . . 0.0 110.432 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.463 ' H ' ' C ' ' A' ' 69' ' ' THR . . . -132.27 -1.28 4.42 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 108.547 -1.821 . . . . 0.0 108.547 179.735 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 64.1 m -143.39 141.62 30.95 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.464 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 7.7 ptmm? -92.46 96.61 10.34 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 124.447 1.092 . . . . 0.0 110.95 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.416 ' N ' ' O ' ' A' ' 83' ' ' CYS . 57.4 m-85 -52.15 134.02 33.22 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-N 114.429 -1.26 . . . . 0.0 109.692 179.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -141.4 158.37 43.96 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 112.998 -1.91 . . . . 0.0 112.762 -179.37 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 57.8 p -96.08 139.41 32.3 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 114.743 1.386 . . . . 0.0 114.743 -179.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.409 ' H ' ' HB2' ' A' ' 104' ' ' ALA . 5.5 p-10 -45.35 -48.23 13.33 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 126.044 2.09 . . . . 0.0 114.848 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -52.27 -30.58 28.59 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 124.329 1.018 . . . . 0.0 111.785 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 119.72 43.83 0.48 Allowed Glycine 0 N--CA 1.491 2.348 0 O-C-N 124.742 1.276 . . . . 0.0 111.043 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 57.3 m -139.13 111.21 7.35 Favored 'General case' 0 N--CA 1.5 2.03 0 C-N-CA 119.648 -0.821 . . . . 0.0 112.077 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 17.4 t80 -53.43 137.21 36.35 Favored 'General case' 0 N--CA 1.494 1.775 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.694 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 64.1 t -98.02 -73.4 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 CA-C-N 114.348 -1.297 . . . . 0.0 111.474 -179.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . 0.48 ' SG ' ' N ' ' A' ' 84' ' ' GLU . 0.5 OUTLIER -167.3 -172.65 2.04 Favored 'General case' 0 N--CA 1.505 2.3 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 -179.854 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.48 ' N ' ' SG ' ' A' ' 83' ' ' CYS . 33.3 tt0 -112.66 145.03 41.16 Favored 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 103.234 -2.876 . . . . 0.0 103.234 179.26 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -52.33 140.58 28.12 Favored Glycine 0 N--CA 1.503 3.157 0 C-N-CA 118.993 -1.575 . . . . 0.0 112.696 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -88.62 -4.98 58.45 Favored 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 27.8 t -117.97 107.91 14.63 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.476 ' H ' HD21 ' A' ' 91' ' ' ASN . 14.3 t70 -79.05 141.49 58.52 Favored Pre-proline 0 N--CA 1.494 1.749 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -34.62 -31.5 0.06 OUTLIER 'Trans proline' 0 N--CA 1.497 1.729 0 C-N-CA 123.712 2.941 . . . . 0.0 113.784 175.004 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.437 ' N ' ' HD2' ' A' ' 90' ' ' ARG . 1.7 mpt_? -79.33 -53.93 6.44 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 123.869 0.73 . . . . 0.0 110.215 179.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.476 HD21 ' H ' ' A' ' 88' ' ' ASP . 1.7 p-10 -91.3 126.0 56.29 Favored Pre-proline 0 N--CA 1.5 2.062 0 C-N-CA 119.976 -0.69 . . . . 0.0 112.326 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -75.52 150.67 36.29 Favored 'Trans proline' 0 N--CA 1.492 1.39 0 C-N-CA 122.586 2.191 . . . . 0.0 109.396 165.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 32.4 mmmt -132.99 127.5 34.3 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 124.02 0.825 . . . . 0.0 109.029 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -84.06 73.96 10.32 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 123.97 0.794 . . . . 0.0 108.967 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 85.1 m -79.96 163.33 58.45 Favored Pre-proline 0 N--CA 1.496 1.838 0 CA-C-N 114.404 -1.271 . . . . 0.0 112.848 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.405 ' HA ' ' CZ ' ' A' ' 97' ' ' ARG . 4.9 Cg_endo -70.0 -151.43 0.03 OUTLIER 'Trans proline' 0 N--CA 1.491 1.376 0 C-N-CA 122.563 2.175 . . . . 0.0 109.292 159.392 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.425 ' HD2' ' N ' ' A' ' 97' ' ' ARG . 0.1 OUTLIER -154.3 50.38 0.64 Allowed 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 121.754 0.787 . . . . 0.0 111.67 179.991 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.488 ' H ' HD22 ' A' ' 98' ' ' ASN . 2.8 m-80 -60.5 157.16 14.7 Favored 'General case' 0 N--CA 1.5 2.065 0 CA-C-N 114.722 -1.126 . . . . 0.0 111.459 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.4 ' HA ' ' HA ' ' A' ' 62' ' ' CYS . 86.0 m -98.47 131.37 44.78 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-N 114.989 -1.005 . . . . 0.0 111.552 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.406 ' O ' HG22 ' A' ' 103' ' ' ILE . 51.0 t0 -121.34 79.85 36.69 Favored Pre-proline 0 N--CA 1.496 1.873 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 179.665 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -54.71 -17.29 12.97 Favored 'Trans proline' 0 N--CA 1.497 1.697 0 C-N-CA 122.696 2.264 . . . . 0.0 113.326 -176.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 73.0 ttp85 -88.49 -35.85 16.77 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 -179.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.406 HG22 ' O ' ' A' ' 100' ' ' ASP . 11.1 tt -54.35 159.82 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.403 0 O-C-N 123.307 0.38 . . . . 0.0 110.949 -179.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.409 ' HB2' ' H ' ' A' ' 77' ' ' ASP . . . -150.79 -68.01 0.19 Allowed 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 -179.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 51.1 m-85 -114.28 -161.64 0.78 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 124.189 0.931 . . . . 0.0 111.321 -179.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -160.2 106.99 0.3 Allowed Glycine 0 N--CA 1.486 2.024 0 N-CA-C 104.836 -3.306 . . . . 0.0 104.836 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.469 ' N ' HD12 ' A' ' 107' ' ' ILE . 2.1 mp -79.14 104.67 7.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 CA-C-O 121.949 0.881 . . . . 0.0 108.92 -179.653 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 16.0 m -86.79 159.71 51.48 Favored Pre-proline 0 N--CA 1.495 1.777 0 CA-C-N 114.272 -1.331 . . . . 0.0 108.641 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -58.8 -36.64 96.73 Favored 'Trans proline' 0 N--CA 1.494 1.549 0 C-N-CA 122.382 2.055 . . . . 0.0 110.015 173.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.4 pp -79.58 -16.43 55.89 Favored 'General case' 0 N--CA 1.495 1.807 0 CA-C-N 114.914 -1.039 . . . . 0.0 111.096 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.787 0 CA-C-O 116.685 -1.626 . . . . 0.0 109.889 179.946 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 . . . . . 0 N--CA 1.491 1.575 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 67.7 mmt-85 -71.74 4.6 3.1 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 123.174 0.297 . . . . 0.0 111.77 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.0 tp -60.46 96.96 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 CA-C-O 121.922 0.867 . . . . 0.0 111.28 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.7 m -93.06 49.04 1.38 Allowed 'General case' 0 N--CA 1.491 1.598 0 CA-C-N 114.486 -1.234 . . . . 0.0 112.293 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 13.5 t -90.57 177.03 6.46 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-N 113.404 -1.725 . . . . 0.0 107.733 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.518 HD22 ' H ' ' A' ' 40' ' ' ASN . 14.3 p30 -160.04 167.98 26.62 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 123.994 0.809 . . . . 0.0 112.136 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 38.0 t -53.99 -42.52 69.11 Favored 'General case' 0 N--CA 1.497 1.877 0 CA-C-N 114.225 -1.352 . . . . 0.0 112.036 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 53.4 t -52.85 -44.48 66.81 Favored 'General case' 0 N--CA 1.496 1.862 0 CA-C-N 113.221 -1.808 . . . . 0.0 109.413 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -89.73 28.94 1.23 Allowed 'General case' 0 N--CA 1.499 2.018 0 CA-C-N 112.944 -1.935 . . . . 0.0 110.835 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -83.31 -138.44 3.36 Favored Glycine 0 N--CA 1.496 2.667 0 N-CA-C 110.743 -0.943 . . . . 0.0 110.743 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 39.9 p -158.09 104.88 1.91 Allowed 'General case' 0 N--CA 1.503 2.183 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 16.2 ptpt -53.55 95.05 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.108 0 CA-C-O 122.586 1.184 . . . . 0.0 111.811 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 168.24 -35.25 0.2 Allowed Glycine 0 N--CA 1.488 2.166 0 CA-C-N 113.788 -1.551 . . . . 0.0 110.345 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 49.9 m -112.12 161.28 16.69 Favored 'General case' 0 N--CA 1.502 2.151 0 C-N-CA 119.47 -0.892 . . . . 0.0 111.913 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -101.18 92.31 4.92 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-N 114.182 -1.372 . . . . 0.0 108.278 -179.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.409 ' N ' ' O ' ' A' ' 25' ' ' CYS . 47.4 m-85 -47.33 136.85 9.0 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 124.636 1.21 . . . . 0.0 110.712 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 10.7 t80 -146.19 159.58 43.12 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-N 112.853 -1.976 . . . . 0.0 112.789 -179.217 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 35.1 t -112.75 134.84 54.07 Favored 'General case' 0 N--CA 1.498 1.968 0 CA-C-N 112.285 -2.234 . . . . 0.0 114.753 -179.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.49 ' H ' ' HB2' ' A' ' 46' ' ' ALA . 1.2 p30 -51.17 -26.34 6.68 Favored 'General case' 0 N--CA 1.501 2.087 0 CA-C-N 112.457 -2.156 . . . . 0.0 115.031 -179.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 24.0 p30 -64.39 -2.12 2.07 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 123.999 0.812 . . . . 0.0 112.085 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 89.61 28.83 18.0 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 58.6 m -134.89 150.54 50.45 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 71.8 t80 -78.24 158.78 28.82 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-N 114.321 -1.309 . . . . 0.0 110.386 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 95.2 t -116.35 -73.77 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 CA-C-N 114.939 -1.028 . . . . 0.0 109.124 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.506 ' SG ' ' N ' ' A' ' 26' ' ' GLU . 1.7 p -168.41 -161.25 0.34 Allowed 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.506 ' N ' ' SG ' ' A' ' 25' ' ' CYS . 40.8 tt0 -127.87 145.57 50.9 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 104.669 -2.345 . . . . 0.0 104.669 179.231 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -32.72 102.13 0.01 OUTLIER Glycine 0 N--CA 1.499 2.891 0 N-CA-C 115.988 1.155 . . . . 0.0 115.988 -179.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -102.82 32.86 3.46 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 29.9 t -122.55 148.08 45.63 Favored 'General case' 0 N--CA 1.497 1.924 0 CA-C-N 114.124 -1.398 . . . . 0.0 107.681 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.401 ' H ' ' HZ1' ' A' ' 35' ' ' LYS . 41.8 t0 -128.2 92.9 40.29 Favored Pre-proline 0 N--CA 1.493 1.722 0 O-C-N 124.717 1.26 . . . . 0.0 110.82 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -52.43 -15.89 4.5 Favored 'Trans proline' 0 N--CA 1.495 1.59 0 C-N-CA 123.002 2.468 . . . . 0.0 113.03 178.239 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 16.7 tpt180 -61.2 -51.82 67.39 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 108.147 -1.056 . . . . 0.0 108.147 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 15.3 p30 -90.65 138.91 26.35 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 124.327 1.017 . . . . 0.0 110.016 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -74.38 116.77 4.74 Favored 'Trans proline' 0 N--CA 1.493 1.458 0 C-N-CA 123.017 2.478 . . . . 0.0 110.394 175.311 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.401 ' HZ1' ' H ' ' A' ' 30' ' ' ASP . 0.0 OUTLIER -167.51 176.19 6.68 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 123.98 0.8 . . . . 0.0 111.957 179.92 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -160.03 122.19 3.31 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-N 114.89 -1.05 . . . . 0.0 108.784 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 33.4 m -79.87 -71.58 0.45 Allowed 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 47.5 m 34.22 69.91 0.14 Allowed 'General case' 0 N--CA 1.498 1.96 0 O-C-N 124.787 1.305 . . . . 0.0 113.414 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.3 pp -143.55 -36.87 0.35 Allowed 'General case' 0 N--CA 1.495 1.789 0 CA-C-N 114.936 -1.029 . . . . 0.0 108.973 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.518 ' H ' HD22 ' A' ' 6' ' ' ASN . 20.5 m120 -94.02 138.68 31.84 Favored 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 105.648 -1.982 . . . . 0.0 105.648 179.473 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 75.0 m -101.01 131.02 47.08 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 123.698 0.624 . . . . 0.0 112.644 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 62.9 t0 -122.95 76.46 49.73 Favored Pre-proline 0 N--CA 1.497 1.922 0 O-C-N 124.213 0.945 . . . . 0.0 109.149 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -63.74 -37.64 44.67 Favored 'Trans proline' 0 N--CA 1.496 1.63 0 C-N-CA 123.309 2.672 . . . . 0.0 111.584 -176.131 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.402 ' H ' ' HG3' ' A' ' 44' ' ' ARG . 0.0 OUTLIER -74.6 -7.6 53.68 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 115.088 1.514 . . . . 0.0 115.088 -179.758 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 15.9 tt -57.04 156.74 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.25 0 C-N-CA 119.879 -0.729 . . . . 0.0 111.856 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.49 ' HB2' ' H ' ' A' ' 19' ' ' ASP . . . -137.13 -66.95 0.5 Allowed 'General case' 0 N--CA 1.497 1.914 0 O-C-N 124.006 0.816 . . . . 0.0 110.289 179.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 46.8 p90 -160.96 167.99 25.45 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-N 115.183 -0.917 . . . . 0.0 109.836 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -115.95 111.44 2.4 Favored Glycine 0 N--CA 1.492 2.428 0 O-C-N 125.17 1.544 . . . . 0.0 109.709 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.5 p -80.04 111.32 16.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 C-N-CA 119.731 -0.788 . . . . 0.0 111.973 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.7 m -79.33 149.48 72.45 Favored Pre-proline 0 N--CA 1.499 1.984 0 CA-C-N 115.135 -0.939 . . . . 0.0 109.055 179.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -61.68 -68.66 0.04 OUTLIER 'Trans proline' 0 N--CA 1.495 1.6 0 C-N-CA 122.749 2.299 . . . . 0.0 111.965 -169.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 12.6 ptp180 -155.0 -116.06 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.882 0 O-C-N 124.068 0.855 . . . . 0.0 110.889 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 45.9 m 58.54 46.15 15.28 Favored 'General case' 0 N--CA 1.502 2.135 0 CA-C-O 122.005 0.907 . . . . 0.0 109.782 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -143.35 -34.17 0.42 Allowed 'General case' 0 N--CA 1.496 1.847 0 CA-C-N 113.603 -1.635 . . . . 0.0 109.136 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 52.1 36.32 18.66 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 124.277 0.985 . . . . 0.0 112.264 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.445 ' NZ ' ' HB3' ' A' ' 56' ' ' LYS . 2.5 ttpm? -54.2 -71.26 0.08 Allowed 'General case' 0 N--CA 1.498 1.927 0 CA-C-N 114.739 -1.119 . . . . 0.0 109.214 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.422 ' HB2' ' NZ ' ' A' ' 57' ' ' LYS . 4.9 ttmp? -88.91 94.31 9.89 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 105.975 -1.861 . . . . 0.0 105.975 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 65.61 168.23 0.2 Allowed 'General case' 0 N--CA 1.502 2.127 0 O-C-N 124.678 1.236 . . . . 0.0 110.928 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -65.75 165.46 12.68 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-N 115.173 -0.921 . . . . 0.0 112.095 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.414 ' N ' ' HD3' ' A' ' 60' ' ' ARG . 0.0 OUTLIER -56.12 123.61 15.06 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 124.168 0.917 . . . . 0.0 111.087 -179.988 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.422 ' CD1' ' C ' ' A' ' 61' ' ' ILE . 0.0 OUTLIER -90.21 114.22 27.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 N-CA-C 107.78 -1.192 . . . . 0.0 107.78 179.957 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.477 ' HA ' ' HA ' ' A' ' 99' ' ' CYS . 1.7 m -139.58 52.33 1.72 Allowed 'General case' 0 C--N 1.311 -1.087 0 CA-C-O 123.037 1.398 . . . . 0.0 111.897 179.632 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.416 ' H ' HD13 ' A' ' 61' ' ' ILE . 93.2 m -90.3 168.24 12.05 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 112.516 -2.129 . . . . 0.0 108.72 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 42.3 p-10 -152.9 177.64 10.53 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 123.965 0.79 . . . . 0.0 110.072 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 4.5 t -73.17 1.12 9.85 Favored 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 46.1 t -91.64 -36.29 13.73 Favored 'General case' 0 N--CA 1.496 1.845 0 CA-C-N 114.751 -1.113 . . . . 0.0 110.584 179.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -71.1 59.21 0.24 Allowed 'General case' 0 N--CA 1.5 2.063 0 CA-C-N 112.466 -2.152 . . . . 0.0 114.148 -179.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -174.22 -150.33 7.6 Favored Glycine 0 N--CA 1.487 2.06 0 N-CA-C 107.863 -2.095 . . . . 0.0 107.863 179.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.458 ' C ' ' H ' ' A' ' 71' ' ' GLY . 66.5 p -146.11 157.42 43.84 Favored 'General case' 0 N--CA 1.502 2.13 0 C-N-CA 120.781 -0.367 . . . . 0.0 111.211 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 59.4 mtpt -71.07 33.23 0.05 OUTLIER 'General case' 0 N--CA 1.507 2.415 0 O-C-N 125.117 1.511 . . . . 0.0 113.627 179.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.458 ' H ' ' C ' ' A' ' 69' ' ' THR . . . -137.0 14.21 3.81 Favored Glycine 0 N--CA 1.486 1.987 0 N-CA-C 108.054 -2.018 . . . . 0.0 108.054 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . 0.421 ' HA ' ' HA ' ' A' ' 108' ' ' CYS . 86.8 m -140.44 175.21 9.79 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 123.901 0.412 . . . . 0.0 111.006 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 34.2 mtmm -131.16 106.57 8.43 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 123.953 0.783 . . . . 0.0 110.279 -179.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.681 ' CD2' ' SG ' ' A' ' 83' ' ' CYS . 97.8 m-85 -56.31 137.98 51.48 Favored 'General case' 0 N--CA 1.501 2.102 0 C-N-CA 120.133 -0.627 . . . . 0.0 109.827 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 15.4 t80 -143.07 162.38 35.66 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 124.69 1.244 . . . . 0.0 111.977 -179.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 47.3 t -120.5 139.08 53.41 Favored 'General case' 0 N--CA 1.5 2.058 0 CA-C-N 113.2 -1.818 . . . . 0.0 115.084 -179.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.588 ' H ' ' HB2' ' A' ' 104' ' ' ALA . 4.3 p-10 -48.84 -28.23 3.58 Favored 'General case' 0 N--CA 1.5 2.055 0 CA-C-N 111.341 -2.663 . . . . 0.0 114.033 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 17.8 p30 -61.09 -5.25 1.36 Allowed 'General case' 0 N--CA 1.497 1.886 0 O-C-N 124.35 1.031 . . . . 0.0 112.073 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 89.64 29.08 17.19 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.396 -1.482 . . . . 0.0 109.396 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 88.2 m -142.17 149.96 40.42 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 121.43 0.633 . . . . 0.0 111.008 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 34.0 t80 -67.52 164.69 18.37 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-N 113.583 -1.644 . . . . 0.0 110.508 179.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 92.7 t -126.27 -71.49 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 O-C-N 124.074 0.859 . . . . 0.0 111.146 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . 0.681 ' SG ' ' CD2' ' A' ' 74' ' ' TYR . 17.2 p -155.11 -172.18 4.09 Favored 'General case' 0 N--CA 1.499 2.021 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 -179.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.405 ' CD ' ' N ' ' A' ' 85' ' ' GLY . 10.5 tm-20 -116.77 164.2 15.0 Favored 'General case' 0 N--CA 1.501 2.086 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.447 ' HA3' ' O ' ' A' ' 69' ' ' THR . . . -49.63 107.82 0.37 Allowed Glycine 0 N--CA 1.494 2.545 0 CA-C-O 119.013 -0.882 . . . . 0.0 110.937 179.659 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -108.84 34.18 3.83 Favored 'General case' 0 N--CA 1.5 2.074 0 CA-C-O 121.535 0.683 . . . . 0.0 110.655 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 45.4 t -145.4 119.43 9.39 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -81.02 127.97 72.67 Favored Pre-proline 0 N--CA 1.494 1.769 0 C-N-CA 119.592 -0.843 . . . . 0.0 110.036 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_endo -58.56 -17.46 34.88 Favored 'Trans proline' 0 N--CA 1.495 1.605 0 C-N-CA 122.549 2.166 . . . . 0.0 113.019 -177.38 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 30.4 tpt180 -59.74 -41.48 91.06 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 123.717 0.636 . . . . 0.0 110.511 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -90.3 118.93 69.18 Favored Pre-proline 0 N--CA 1.496 1.85 0 O-C-N 124.396 1.06 . . . . 0.0 111.573 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -83.39 41.31 1.05 Allowed 'Trans proline' 0 N--CA 1.494 1.558 0 C-N-CA 123.365 2.71 . . . . 0.0 110.236 166.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.18 175.76 5.76 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-N 114.622 -1.172 . . . . 0.0 112.154 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -103.63 126.95 51.1 Favored 'General case' 0 N--CA 1.495 1.823 0 CA-C-N 114.826 -1.079 . . . . 0.0 109.359 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 42.6 m -79.94 163.74 56.44 Favored Pre-proline 0 N--CA 1.496 1.825 0 O-C-N 123.887 0.742 . . . . 0.0 111.732 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.451 ' C ' ' HE ' ' A' ' 97' ' ' ARG . 13.1 Cg_endo -68.66 155.39 69.01 Favored 'Trans proline' 0 N--CA 1.49 1.285 0 C-N-CA 122.511 2.14 . . . . 0.0 110.196 170.201 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.451 ' HE ' ' C ' ' A' ' 96' ' ' PRO . 0.0 OUTLIER -83.23 16.43 2.46 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-N 114.699 -1.137 . . . . 0.0 111.083 -179.919 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -48.0 131.28 15.63 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 123.89 0.743 . . . . 0.0 109.759 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.477 ' HA ' ' HA ' ' A' ' 62' ' ' CYS . 60.1 m -99.64 132.46 44.97 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 114.005 1.113 . . . . 0.0 114.005 -179.599 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 64.7 t0 -129.49 76.3 78.86 Favored Pre-proline 0 N--CA 1.5 2.058 0 O-C-N 124.231 0.957 . . . . 0.0 110.845 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -59.85 -13.78 24.16 Favored 'Trans proline' 0 N--CA 1.494 1.54 0 C-N-CA 122.501 2.134 . . . . 0.0 112.222 176.234 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 69.5 mtp85 -90.31 18.45 6.07 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 124.011 0.819 . . . . 0.0 111.779 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 9.9 tt -116.34 175.7 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.314 0 O-C-N 123.71 0.631 . . . . 0.0 110.497 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.588 ' HB2' ' H ' ' A' ' 77' ' ' ASP . . . -146.01 -62.64 0.32 Allowed 'General case' 0 N--CA 1.498 1.928 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.863 179.683 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 27.9 p90 -161.22 163.93 30.74 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 124.053 0.846 . . . . 0.0 110.978 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -98.27 112.86 4.57 Favored Glycine 0 N--CA 1.492 2.375 0 CA-C-N 113.688 -1.596 . . . . 0.0 111.979 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 93.8 mt -79.54 105.65 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 N-CA-C 106.5 -1.667 . . . . 0.0 106.5 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' CYS . . . . . 0.421 ' HA ' ' HA ' ' A' ' 72' ' ' CYS . 31.2 m -89.07 140.9 29.05 Favored Pre-proline 0 N--CA 1.491 1.599 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -70.87 87.2 0.7 Allowed 'Trans proline' 0 N--CA 1.493 1.481 0 C-N-CA 122.41 2.073 . . . . 0.0 109.085 -176.048 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 68.4 tp -159.98 -50.88 0.05 Allowed 'General case' 0 N--CA 1.495 1.796 0 CA-C-N 114.237 -1.347 . . . . 0.0 108.035 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.855 0 CA-C-O 116.658 -1.639 . . . . 0.0 110.9 179.966 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 62.1 ttm-85 63.14 151.79 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.158 0 O-C-N 124.824 1.328 . . . . 0.0 112.871 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 4.9 tp -62.35 94.77 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 CA-C-N 114.398 -1.274 . . . . 0.0 109.461 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.7 m -89.73 36.77 0.86 Allowed 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 116.881 2.178 . . . . 0.0 116.881 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 14.6 p -91.68 166.37 12.83 Favored 'General case' 0 N--CA 1.496 1.849 0 CA-C-N 113.518 -1.674 . . . . 0.0 108.901 179.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 14.0 p30 -161.42 142.65 11.36 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-N 114.861 -1.063 . . . . 0.0 111.791 179.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -61.69 -18.76 60.89 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-N 114.436 -1.256 . . . . 0.0 112.843 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 46.8 t -89.46 -69.54 0.71 Allowed 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 113.464 0.913 . . . . 0.0 113.464 -179.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.41 ' N ' ' SG ' ' A' ' 37' ' ' CYS . . . -75.45 1.19 14.67 Favored 'General case' 0 N--CA 1.5 2.043 0 N-CA-C 113.547 0.943 . . . . 0.0 113.547 -179.617 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -67.44 165.5 43.54 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 110.426 -1.07 . . . . 0.0 110.426 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 8.9 t -73.12 125.13 26.97 Favored 'General case' 0 N--CA 1.493 1.711 0 CA-C-O 121.508 0.671 . . . . 0.0 110.204 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 7.1 ttpm? -72.2 87.75 1.11 Allowed 'General case' 0 N--CA 1.49 1.551 0 CA-C-N 114.239 -1.346 . . . . 0.0 108.719 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 171.1 -34.36 0.16 Allowed Glycine 0 N--CA 1.488 2.134 0 CA-C-N 113.282 -1.781 . . . . 0.0 108.882 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 83.9 m -101.55 133.61 45.96 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.487 ' HB3' ' CE1' ' A' ' 23' ' ' PHE . 9.0 mtpm? -81.92 88.96 6.34 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 113.428 -1.714 . . . . 0.0 113.732 -179.278 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -54.48 126.22 22.66 Favored 'General case' 0 N--CA 1.499 2.018 0 N-CA-C 105.911 -1.885 . . . . 0.0 105.911 179.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -132.28 146.45 52.0 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 112.788 -2.005 . . . . 0.0 112.969 -179.188 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 40.2 t -84.5 139.81 31.9 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-N 112.563 -2.108 . . . . 0.0 114.866 -179.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -51.91 -32.14 31.45 Favored 'General case' 0 N--CA 1.499 1.981 0 CA-C-N 111.826 -2.443 . . . . 0.0 114.854 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -54.29 -21.67 9.87 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 123.981 0.8 . . . . 0.0 111.62 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 109.16 32.41 3.03 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 108.646 -1.782 . . . . 0.0 108.646 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 90.7 m -137.26 147.38 45.68 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 124.08 0.518 . . . . 0.0 110.961 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.487 ' CE1' ' HB3' ' A' ' 15' ' ' LYS . 8.6 t80 -80.43 140.93 35.74 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-N 114.637 -1.165 . . . . 0.0 110.216 179.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 98.0 t -100.42 -78.26 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 106.22 -1.77 . . . . 0.0 106.22 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -172.12 168.07 5.86 Favored 'General case' 0 N--CA 1.504 2.226 0 O-C-N 123.579 0.549 . . . . 0.0 110.404 179.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -87.59 155.38 19.99 Favored 'General case' 0 N--CA 1.501 2.114 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -48.22 131.71 19.65 Favored Glycine 0 N--CA 1.501 2.994 0 C-N-CA 120.026 -1.083 . . . . 0.0 111.48 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -101.91 33.21 3.11 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 37.1 t -149.58 137.4 20.29 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-N 114.502 -1.226 . . . . 0.0 107.922 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -79.59 134.1 58.35 Favored Pre-proline 0 N--CA 1.494 1.754 0 O-C-N 123.987 0.804 . . . . 0.0 109.007 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -57.0 -13.76 12.64 Favored 'Trans proline' 0 N--CA 1.497 1.7 0 C-N-CA 122.423 2.082 . . . . 0.0 112.789 -177.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 79.8 ttt180 -68.59 -43.04 77.34 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 123.658 0.599 . . . . 0.0 111.878 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -73.64 128.59 86.75 Favored Pre-proline 0 N--CA 1.495 1.792 0 C-N-CA 119.523 -0.871 . . . . 0.0 112.285 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -82.61 85.2 1.65 Allowed 'Trans proline' 0 N--CA 1.492 1.406 0 C-N-CA 123.509 2.806 . . . . 0.0 111.486 169.223 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 20.7 pttp -164.11 166.39 21.32 Favored 'General case' 0 N--CA 1.501 2.101 0 C-N-CA 120.621 -0.432 . . . . 0.0 111.829 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -129.14 158.79 38.0 Favored 'General case' 0 N--CA 1.497 1.883 0 CA-C-N 114.592 -1.186 . . . . 0.0 110.144 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.41 ' SG ' ' N ' ' A' ' 9' ' ' ALA . 85.2 m -88.55 -178.68 5.89 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-N 114.865 -1.061 . . . . 0.0 110.744 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 63.7 p -81.01 -2.16 46.84 Favored 'General case' 0 N--CA 1.497 1.91 0 CA-C-N 114.925 -1.034 . . . . 0.0 110.669 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.44 ' N ' HD22 ' A' ' 39' ' ' LEU . 3.1 mm? -79.41 -57.45 3.7 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 33.6 m120 53.52 103.0 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.982 0 O-C-N 124.83 1.331 . . . . 0.0 112.808 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 60.9 m 63.98 135.12 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.937 0 CA-C-N 114.602 -1.181 . . . . 0.0 112.963 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 46.3 t0 -135.81 102.03 10.42 Favored Pre-proline 0 N--CA 1.498 1.951 0 C-N-CA 120.305 -0.558 . . . . 0.0 111.674 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -57.22 -29.39 83.47 Favored 'Trans proline' 0 N--CA 1.494 1.543 0 C-N-CA 122.758 2.305 . . . . 0.0 111.467 174.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -62.75 -39.44 94.12 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 123.997 0.811 . . . . 0.0 109.309 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.426 ' CG2' ' N ' ' A' ' 46' ' ' ALA . 20.3 mt -76.97 161.8 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 CA-C-O 121.927 0.87 . . . . 0.0 109.505 179.776 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.426 ' N ' ' CG2' ' A' ' 45' ' ' ILE . . . -122.65 -54.21 1.86 Allowed 'General case' 0 N--CA 1.494 1.756 0 CA-C-N 112.423 -2.171 . . . . 0.0 109.054 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 14.4 p90 -171.15 159.32 5.88 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-N 114.727 -1.124 . . . . 0.0 111.523 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -92.31 111.55 4.07 Favored Glycine 0 N--CA 1.493 2.484 0 CA-C-N 113.523 -1.671 . . . . 0.0 111.073 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 33.0 m -79.95 98.1 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 N-CA-C 105.068 -2.197 . . . . 0.0 105.068 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 8.0 m -79.63 121.25 82.32 Favored Pre-proline 0 N--CA 1.492 1.633 0 CA-C-N 113.496 -1.684 . . . . 0.0 108.019 -179.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -62.58 128.85 24.59 Favored 'Trans proline' 0 N--CA 1.495 1.602 0 C-N-CA 122.806 2.337 . . . . 0.0 113.173 -165.14 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.98 76.14 9.43 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 104.594 -2.372 . . . . 0.0 104.594 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 68.4 p -103.29 -45.24 4.95 Favored 'General case' 0 N--CA 1.498 1.94 0 CA-C-N 114.169 -1.378 . . . . 0.0 110.679 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.42 ' N ' ' CD ' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -51.43 -22.64 3.16 Favored 'General case' 0 N--CA 1.497 1.904 0 CA-C-N 114.226 -1.352 . . . . 0.0 112.757 179.902 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 25.3 tp10 50.42 53.96 11.99 Favored 'General case' 0 N--CA 1.498 1.941 0 CA-C-O 122.192 0.996 . . . . 0.0 109.693 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 17.6 tppt? -86.76 114.7 23.65 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-N 113.746 -1.57 . . . . 0.0 112.833 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -83.2 167.17 17.96 Favored 'General case' 0 N--CA 1.501 2.075 0 CA-C-N 114.836 -1.075 . . . . 0.0 108.772 179.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 17.3 t-20 -90.33 48.13 1.52 Allowed 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 59.88 10.05 1.96 Allowed 'General case' 0 N--CA 1.502 2.154 0 CA-C-N 114.455 -1.248 . . . . 0.0 111.978 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 40.8 mmt180 -141.41 143.44 33.93 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 6.1 tp -84.1 65.99 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 CA-C-O 122.116 0.96 . . . . 0.0 109.851 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.425 ' HA ' ' HA ' ' A' ' 99' ' ' CYS . 56.2 m -90.75 36.54 0.9 Allowed 'General case' 0 N--CA 1.489 1.484 0 CA-C-O 123.297 1.522 . . . . 0.0 112.593 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 61.3 m -90.7 133.29 35.26 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 111.466 -2.606 . . . . 0.0 104.307 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.453 ' ND2' ' H ' ' A' ' 67' ' ' ALA . 34.6 p-10 -153.82 154.45 33.98 Favored 'General case' 0 N--CA 1.503 2.194 0 N-CA-C 113.855 1.058 . . . . 0.0 113.855 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -67.18 -22.92 65.72 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-N 113.74 -1.573 . . . . 0.0 114.513 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 51.4 t -89.81 -68.71 0.76 Allowed 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 113.381 0.882 . . . . 0.0 113.381 -179.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.453 ' H ' ' ND2' ' A' ' 64' ' ' ASN . . . -71.47 -2.05 15.36 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 123.812 0.695 . . . . 0.0 111.833 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.425 ' HA3' ' CZ ' ' A' ' 74' ' ' TYR . . . -65.88 166.95 35.27 Favored Glycine 0 N--CA 1.491 2.307 0 O-C-N 123.829 0.706 . . . . 0.0 111.621 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 6.8 t -77.47 129.27 35.51 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 124.245 0.615 . . . . 0.0 111.954 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -71.64 81.6 0.84 Allowed 'General case' 0 N--CA 1.494 1.756 0 CA-C-N 114.378 -1.283 . . . . 0.0 110.899 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 174.66 -36.14 0.11 Allowed Glycine 0 N--CA 1.488 2.154 0 CA-C-N 113.11 -1.859 . . . . 0.0 108.728 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 46.3 m -94.86 129.55 41.81 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 13.3 mmmm -75.47 84.96 2.57 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 112.912 -1.949 . . . . 0.0 111.279 -179.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.425 ' CZ ' ' HA3' ' A' ' 68' ' ' GLY . 42.8 m-85 -50.61 121.7 6.16 Favored 'General case' 0 N--CA 1.503 2.215 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 179.673 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -129.88 150.64 51.09 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 111.896 -2.411 . . . . 0.0 113.417 -179.182 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 33.1 t -90.33 136.59 32.96 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-N 112.65 -2.068 . . . . 0.0 114.103 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.438 ' HB3' ' HB2' ' A' ' 104' ' ' ALA . 0.9 OUTLIER -51.32 -28.15 11.45 Favored 'General case' 0 N--CA 1.5 2.044 0 CA-C-N 112.386 -2.188 . . . . 0.0 114.705 179.833 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -54.16 -22.47 11.32 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 123.93 0.769 . . . . 0.0 111.466 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 110.66 29.74 3.51 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 108.637 -1.785 . . . . 0.0 108.637 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 85.4 m -139.7 146.49 39.69 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 123.985 0.462 . . . . 0.0 111.102 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.405 ' CZ ' ' HA ' ' A' ' 83' ' ' CYS . 21.5 t80 -76.06 154.0 35.98 Favored 'General case' 0 N--CA 1.493 1.725 0 CA-C-N 114.352 -1.295 . . . . 0.0 110.438 179.778 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 57.9 t -117.11 -79.68 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . 0.405 ' HA ' ' CZ ' ' A' ' 81' ' ' PHE . 0.2 OUTLIER -162.69 179.65 7.53 Favored 'General case' 0 N--CA 1.505 2.286 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 179.726 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -97.69 159.37 14.97 Favored 'General case' 0 N--CA 1.507 2.392 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 179.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -53.15 132.32 41.82 Favored Glycine 0 N--CA 1.5 2.944 0 C-N-CA 119.42 -1.372 . . . . 0.0 110.306 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -101.92 33.02 3.18 Favored 'General case' 0 N--CA 1.499 2.0 0 CA-C-O 122.143 0.973 . . . . 0.0 108.391 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 41.2 t -157.6 152.8 25.89 Favored 'General case' 0 N--CA 1.495 1.801 0 CA-C-N 114.533 -1.212 . . . . 0.0 109.345 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -97.14 138.05 21.24 Favored Pre-proline 0 N--CA 1.494 1.74 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -64.48 86.59 0.16 Allowed 'Trans proline' 0 N--CA 1.494 1.53 0 C-N-CA 122.131 1.887 . . . . 0.0 108.178 173.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 3.5 mtp-105 178.25 -31.31 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.011 0 CA-C-N 114.031 -1.44 . . . . 0.0 109.352 -179.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 9.0 p-10 -53.02 125.93 41.99 Favored Pre-proline 0 N--CA 1.497 1.923 0 O-C-N 124.04 0.838 . . . . 0.0 112.919 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -82.73 48.0 2.63 Favored 'Trans proline' 0 N--CA 1.49 1.301 0 C-N-CA 122.916 2.411 . . . . 0.0 108.684 160.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 45.8 mmtm -126.13 169.57 12.67 Favored 'General case' 0 N--CA 1.498 1.965 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.462 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -145.58 135.86 23.95 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-N 114.707 -1.133 . . . . 0.0 109.529 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . 0.478 ' HB3' ' H ' ' A' ' 97' ' ' ARG . 86.9 m -79.96 157.76 73.43 Favored Pre-proline 0 N--CA 1.495 1.809 0 CA-C-N 115.076 -0.965 . . . . 0.0 111.696 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -69.28 -5.61 16.32 Favored 'Trans proline' 0 N--CA 1.496 1.639 0 C-N-CA 122.841 2.361 . . . . 0.0 110.369 160.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.478 ' H ' ' HB3' ' A' ' 95' ' ' CYS . 17.5 tpp85 -79.31 -50.13 11.37 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 43.3 m-80 54.05 -159.67 0.16 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 124.797 1.311 . . . . 0.0 110.401 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.425 ' HA ' ' HA ' ' A' ' 62' ' ' CYS . 64.6 m -51.61 120.01 4.75 Favored 'General case' 0 N--CA 1.497 1.913 0 CA-C-N 115.208 -0.905 . . . . 0.0 108.773 179.769 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -107.64 99.31 28.48 Favored Pre-proline 0 N--CA 1.499 2.01 0 O-C-N 123.684 0.615 . . . . 0.0 111.293 -179.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -64.18 -27.82 64.66 Favored 'Trans proline' 0 N--CA 1.494 1.555 0 C-N-CA 122.634 2.223 . . . . 0.0 111.328 -176.137 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 25.8 mtm105 -60.01 -39.85 87.22 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 18.0 mt -76.0 160.98 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 CA-C-N 113.927 -1.488 . . . . 0.0 111.121 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.438 ' HB2' ' HB3' ' A' ' 77' ' ' ASP . . . -123.79 -61.77 1.35 Allowed 'General case' 0 N--CA 1.491 1.612 0 CA-C-N 112.176 -2.284 . . . . 0.0 109.72 -179.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 20.0 p90 -160.49 157.23 27.19 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-N 114.806 -1.088 . . . . 0.0 111.941 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.415 ' HA2' ' HA ' ' A' ' 74' ' ' TYR . . . -94.96 109.79 3.9 Favored Glycine 0 N--CA 1.488 2.162 0 CA-C-N 112.864 -1.971 . . . . 0.0 111.406 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 65.0 mt -79.17 95.73 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 CA-C-N 114.577 -0.811 . . . . 0.0 110.913 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 1.5 m -79.09 143.32 60.93 Favored Pre-proline 0 N--CA 1.503 2.203 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 179.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -65.4 164.99 23.87 Favored 'Trans proline' 0 N--CA 1.494 1.53 0 C-N-CA 122.613 2.208 . . . . 0.0 111.555 -179.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 64.2 tp -153.93 -47.21 0.09 Allowed 'General case' 0 N--CA 1.496 1.868 0 CA-C-N 114.969 -1.014 . . . . 0.0 109.465 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.503 2.177 0 CA-C-O 117.644 -1.169 . . . . 0.0 112.753 -179.942 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 74.4 ttt-85 -87.44 -108.24 0.07 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 124.118 0.886 . . . . 0.0 109.004 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.433 ' O ' ' HA ' ' A' ' 41' ' ' CYS . 9.1 tp -85.89 53.13 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 123.213 0.321 . . . . 0.0 110.647 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.61 ' HA ' ' CA ' ' A' ' 41' ' ' CYS . 1.6 m -79.31 39.08 0.38 Allowed 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 117.279 2.325 . . . . 0.0 117.279 -179.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.1 p -91.23 151.05 21.08 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 112.176 -2.284 . . . . 0.0 106.357 179.197 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 45.4 p-10 -160.71 173.86 14.81 Favored 'General case' 0 N--CA 1.494 1.774 0 CA-C-N 113.453 -1.703 . . . . 0.0 109.644 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 4.2 t -72.01 -24.89 61.63 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-N 114.698 -1.137 . . . . 0.0 112.863 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 40.4 t -89.25 -69.54 0.71 Allowed 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 113.68 0.993 . . . . 0.0 113.68 -179.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -81.78 36.83 0.45 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 124.531 1.144 . . . . 0.0 112.543 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -82.0 -119.51 0.54 Allowed Glycine 0 N--CA 1.493 2.473 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 37.0 p -155.74 123.86 5.78 Favored 'General case' 0 N--CA 1.5 2.035 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.67 144.58 42.87 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-N 115.034 -0.985 . . . . 0.0 110.928 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 91.5 -18.18 53.35 Favored Glycine 0 N--CA 1.492 2.43 0 CA-C-N 114.486 -1.234 . . . . 0.0 110.959 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 91.4 m -99.54 171.65 7.8 Favored 'General case' 0 N--CA 1.498 1.935 0 C-N-CA 120.118 -0.633 . . . . 0.0 110.707 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 60.8 mttp -129.79 90.1 2.92 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-N 115.066 -0.97 . . . . 0.0 109.667 -179.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 40.8 m-85 -54.79 133.8 47.59 Favored 'General case' 0 N--CA 1.495 1.777 0 CA-C-N 114.133 -1.394 . . . . 0.0 109.384 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -137.73 157.22 46.93 Favored 'General case' 0 N--CA 1.487 1.415 0 CA-C-N 112.934 -1.939 . . . . 0.0 113.682 -179.22 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 30.9 t -103.82 134.43 47.14 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-N 112.685 -2.052 . . . . 0.0 113.211 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.42 ' HB3' ' HB2' ' A' ' 46' ' ' ALA . 1.0 OUTLIER -50.05 -27.16 5.15 Favored 'General case' 0 N--CA 1.503 2.219 0 N-CA-C 115.541 1.682 . . . . 0.0 115.541 -179.99 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -55.67 -16.66 4.45 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 123.836 0.71 . . . . 0.0 111.749 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 104.26 29.42 5.43 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 108.442 -1.863 . . . . 0.0 108.442 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 59.9 m -137.2 144.39 42.84 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 124.088 0.522 . . . . 0.0 110.579 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 21.7 t80 -77.08 145.36 37.91 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-N 114.266 -1.334 . . . . 0.0 109.59 179.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 91.4 t -100.17 -76.39 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.441 ' SG ' ' O ' ' A' ' 26' ' ' GLU . 0.1 OUTLIER -171.06 179.76 2.97 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 123.399 0.437 . . . . 0.0 110.889 179.823 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.441 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 35.6 tt0 -81.76 149.64 28.32 Favored 'General case' 0 N--CA 1.501 2.11 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.318 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -70.58 118.4 7.72 Favored Glycine 0 N--CA 1.497 2.763 0 N-CA-C 106.643 -2.583 . . . . 0.0 106.643 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -96.87 26.64 4.46 Favored 'General case' 0 N--CA 1.501 2.086 0 CA-C-O 121.481 0.658 . . . . 0.0 111.317 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 45.7 t -106.15 120.51 42.0 Favored 'General case' 0 N--CA 1.495 1.776 0 CA-C-N 114.349 -1.296 . . . . 0.0 109.993 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.455 ' H ' HD21 ' A' ' 33' ' ' ASN . 12.5 t70 -132.27 140.98 39.67 Favored Pre-proline 0 N--CA 1.494 1.75 0 N-CA-C 106.543 -1.651 . . . . 0.0 106.543 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -67.12 79.51 0.4 Allowed 'Trans proline' 0 N--CA 1.494 1.525 0 C-N-CA 122.584 2.19 . . . . 0.0 110.238 175.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 5.2 mmt-85 178.21 -46.13 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.77 0 CA-C-N 113.59 -1.641 . . . . 0.0 108.008 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.455 HD21 ' H ' ' A' ' 30' ' ' ASP . 28.5 p30 -83.02 149.28 58.79 Favored Pre-proline 0 N--CA 1.495 1.776 0 O-C-N 124.043 0.84 . . . . 0.0 111.755 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_endo -76.77 119.2 5.06 Favored 'Trans proline' 0 N--CA 1.491 1.333 0 C-N-CA 122.875 2.383 . . . . 0.0 108.696 165.078 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 41.3 mtmt -72.37 117.73 14.39 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -160.68 101.13 1.31 Allowed 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 113.997 1.11 . . . . 0.0 113.997 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 1.6 m -160.42 -53.05 0.05 Allowed 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 105.193 -2.151 . . . . 0.0 105.193 179.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 95.2 m -121.59 160.5 24.21 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-N 112.808 -1.996 . . . . 0.0 108.844 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -93.21 26.65 2.8 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-N 114.663 -1.153 . . . . 0.0 110.896 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 4.0 m120 60.54 -177.83 0.1 Allowed 'General case' 0 N--CA 1.501 2.095 0 CA-C-N 114.257 -1.338 . . . . 0.0 113.192 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.61 ' CA ' ' HA ' ' A' ' 4' ' ' CYS . 1.7 m 52.27 79.73 0.1 Allowed 'General case' 0 N--CA 1.495 1.803 0 CA-C-O 123.723 1.725 . . . . 0.0 112.674 -179.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.4 ' O ' HG22 ' A' ' 45' ' ' ILE . 11.2 t70 -91.78 110.13 41.52 Favored Pre-proline 0 N--CA 1.484 1.273 0 CA-C-N 110.091 -3.231 . . . . 0.0 106.844 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_endo -63.92 -19.53 66.81 Favored 'Trans proline' 0 N--CA 1.495 1.614 0 C-N-CA 121.791 1.661 . . . . 0.0 112.365 -170.358 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.502 ' N ' ' HD2' ' A' ' 44' ' ' ARG . 2.1 mpt_? -90.56 -26.89 19.48 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 112.918 0.711 . . . . 0.0 112.918 -179.764 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.4 HG22 ' O ' ' A' ' 42' ' ' ASP . 6.3 tt -64.56 169.05 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 123.558 0.536 . . . . 0.0 111.939 -179.536 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.42 ' HB2' ' HB3' ' A' ' 19' ' ' ASP . . . -140.86 -59.12 0.51 Allowed 'General case' 0 N--CA 1.494 1.751 0 CA-C-N 114.806 -1.088 . . . . 0.0 110.044 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 41.4 p90 -165.52 165.52 18.94 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-N 114.659 -1.155 . . . . 0.0 109.416 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -117.18 121.08 5.02 Favored Glycine 0 N--CA 1.491 2.315 0 O-C-N 125.386 1.678 . . . . 0.0 110.878 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 8.4 p -79.29 133.71 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 N-CA-C 106.114 -1.81 . . . . 0.0 106.114 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 7.8 m -114.97 76.24 4.29 Favored Pre-proline 0 N--CA 1.499 1.987 0 O-C-N 123.742 0.651 . . . . 0.0 110.441 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -73.65 -54.17 0.11 Allowed 'Trans proline' 0 N--CA 1.493 1.447 0 C-N-CA 122.952 2.435 . . . . 0.0 110.704 -176.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.486 HH12 ' H ' ' A' ' 56' ' ' LYS . 4.1 mmp_? -119.32 73.1 0.93 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 124.69 1.244 . . . . 0.0 110.733 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 43.3 t -82.6 -44.99 15.15 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 179.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 43.7 mm-40 -117.72 116.03 26.22 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -63.14 113.74 3.33 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 123.974 0.796 . . . . 0.0 109.021 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.486 ' H ' HH12 ' A' ' 52' ' ' ARG . 25.0 pttm -87.27 63.28 7.7 Favored 'General case' 0 N--CA 1.5 2.027 0 CA-C-N 115.131 -0.94 . . . . 0.0 113.456 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 24.4 ttmm 55.99 97.17 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.114 0 CA-C-N 114.818 -1.083 . . . . 0.0 112.471 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -168.83 -27.25 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.971 0 CA-C-N 113.871 -1.513 . . . . 0.0 107.221 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -42.03 -36.79 1.21 Allowed 'General case' 0 N--CA 1.497 1.922 0 O-C-N 125.012 1.445 . . . . 0.0 112.163 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 16.1 ptm180 -53.49 114.11 1.4 Allowed 'General case' 0 N--CA 1.494 1.751 0 CA-C-N 114.575 -1.193 . . . . 0.0 111.02 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 7.7 tp -87.92 65.82 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 CA-C-N 114.498 -1.228 . . . . 0.0 111.147 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 1.7 m -85.16 40.24 0.81 Allowed 'General case' 0 N--CA 1.495 1.778 0 CA-C-N 114.608 -1.178 . . . . 0.0 113.993 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 12.6 t -90.72 -174.93 4.24 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-N 113.379 -1.737 . . . . 0.0 108.195 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -157.03 155.04 30.53 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 106.388 -1.708 . . . . 0.0 106.388 179.65 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 27.6 t -54.82 -26.87 37.8 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 114.343 1.238 . . . . 0.0 114.343 -179.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 44.2 t -76.41 -48.47 19.65 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-N 114.386 -1.279 . . . . 0.0 111.391 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -79.49 57.19 2.34 Favored 'General case' 0 N--CA 1.497 1.895 0 CA-C-N 113.348 -1.751 . . . . 0.0 112.829 -179.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -147.46 152.59 24.7 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 6.8 t -65.56 128.4 35.76 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-N 113.255 -1.472 . . . . 0.0 109.565 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -73.53 88.1 1.63 Allowed 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 106.22 -1.77 . . . . 0.0 106.22 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 168.98 -25.46 0.11 Allowed Glycine 0 N--CA 1.488 2.132 0 CA-C-N 112.673 -2.058 . . . . 0.0 110.07 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 56.2 m -100.4 124.08 45.44 Favored 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 122.094 0.95 . . . . 0.0 111.541 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 28.1 mtpp -73.49 93.59 2.01 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 112.681 -2.054 . . . . 0.0 112.157 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.473 ' CD1' HD13 ' A' ' 103' ' ' ILE . 8.3 m-85 -48.83 128.25 15.31 Favored 'General case' 0 N--CA 1.501 2.118 0 N-CA-C 106.704 -1.591 . . . . 0.0 106.704 179.413 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -142.87 155.24 44.73 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 114.706 -1.134 . . . . 0.0 112.348 -179.467 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 40.2 t -101.52 133.83 45.57 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-N 113.231 -1.804 . . . . 0.0 110.939 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -48.87 -28.74 3.98 Favored 'General case' 0 N--CA 1.502 2.132 0 N-CA-C 115.834 1.79 . . . . 0.0 115.834 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -52.0 -24.25 6.32 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 123.946 0.779 . . . . 0.0 111.738 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 113.63 28.27 3.28 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 108.616 -1.794 . . . . 0.0 108.616 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 88.6 m -139.17 140.6 37.88 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 124.045 0.497 . . . . 0.0 110.981 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 12.5 t80 -68.57 159.08 32.59 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-N 114.198 -1.365 . . . . 0.0 110.804 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 91.3 t -121.42 -71.4 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 CA-C-N 114.823 -1.081 . . . . 0.0 110.104 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . 0.576 ' SG ' ' N ' ' A' ' 84' ' ' GLU . 0.5 OUTLIER -153.48 -163.02 1.57 Allowed 'General case' 0 N--CA 1.501 2.105 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 -179.875 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.576 ' N ' ' SG ' ' A' ' 83' ' ' CYS . 12.5 tp10 -129.03 146.62 50.95 Favored 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 179.433 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -59.01 138.65 49.45 Favored Glycine 0 N--CA 1.501 2.991 0 N-CA-C 109.257 -1.537 . . . . 0.0 109.257 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 35.8 mm-40 -113.89 31.76 6.32 Favored 'General case' 0 N--CA 1.501 2.098 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 36.8 t -156.0 105.42 2.35 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -79.26 144.73 62.95 Favored Pre-proline 0 N--CA 1.495 1.796 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -64.76 70.97 0.24 Allowed 'Trans proline' 0 N--CA 1.498 1.744 0 C-N-CA 123.088 2.525 . . . . 0.0 110.861 164.127 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 31.4 mtm105 -163.6 -49.95 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 104.868 -2.271 . . . . 0.0 104.868 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -90.41 133.23 33.43 Favored Pre-proline 0 N--CA 1.489 1.487 0 CA-C-N 114.053 -1.43 . . . . 0.0 110.356 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -79.9 50.26 3.47 Favored 'Trans proline' 0 N--CA 1.495 1.598 0 C-N-CA 123.521 2.814 . . . . 0.0 112.1 173.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -80.47 124.8 29.23 Favored 'General case' 0 N--CA 1.5 2.047 0 C-N-CA 120.126 -0.63 . . . . 0.0 111.076 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -80.1 166.13 21.81 Favored 'General case' 0 N--CA 1.497 1.878 0 CA-C-N 114.679 -1.146 . . . . 0.0 109.525 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 97.0 m -151.44 160.55 31.64 Favored Pre-proline 0 N--CA 1.497 1.906 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -60.33 130.17 32.84 Favored 'Trans proline' 0 N--CA 1.493 1.47 0 C-N-CA 122.709 2.273 . . . . 0.0 109.401 166.128 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.527 ' HA ' ' NE ' ' A' ' 97' ' ' ARG . 3.4 tpm_? -81.27 10.28 5.77 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 123.991 0.807 . . . . 0.0 110.203 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.6 ' H ' HD22 ' A' ' 98' ' ' ASN . 2.7 m-80 -52.47 153.83 2.83 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 114.105 1.15 . . . . 0.0 114.105 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 63.0 m -91.93 137.56 32.26 Favored 'General case' 0 N--CA 1.495 1.776 0 CA-C-N 113.897 -1.501 . . . . 0.0 111.402 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -119.98 88.36 40.43 Favored Pre-proline 0 N--CA 1.497 1.917 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 179.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -63.98 -33.35 63.27 Favored 'Trans proline' 0 N--CA 1.491 1.327 0 C-N-CA 122.683 2.255 . . . . 0.0 112.545 -170.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 15.9 ptm180 -64.98 -30.18 71.15 Favored 'General case' 0 N--CA 1.497 1.895 0 C-N-CA 119.574 -0.85 . . . . 0.0 111.965 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.473 HD13 ' CD1' ' A' ' 74' ' ' TYR . 11.9 mt -70.38 156.04 7.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 C-N-CA 118.907 -1.117 . . . . 0.0 109.66 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -137.94 -40.44 0.54 Allowed 'General case' 0 N--CA 1.491 1.58 0 CA-C-N 112.617 -2.083 . . . . 0.0 110.132 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 46.1 m-85 -143.0 -165.28 2.03 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 124.333 1.02 . . . . 0.0 110.635 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -154.97 94.07 0.14 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 103.907 -3.677 . . . . 0.0 103.907 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 37.7 mm -79.16 96.28 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 N-CA-C 116.066 1.876 . . . . 0.0 116.066 -179.464 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 1.7 m -79.96 150.94 72.78 Favored Pre-proline 0 N--CA 1.5 2.052 0 N-CA-C 105.861 -1.903 . . . . 0.0 105.861 179.238 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -44.82 111.82 0.32 Allowed 'Trans proline' 0 N--CA 1.497 1.682 0 C-N-CA 123.115 2.543 . . . . 0.0 112.394 -172.313 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.4 ' C ' HD12 ' A' ' 110' ' ' LEU . 3.9 pp -148.53 0.4 0.58 Allowed 'General case' 0 N--CA 1.497 1.897 0 CA-C-N 114.867 -1.061 . . . . 0.0 112.327 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 1.99 0 CA-C-O 115.056 -2.402 . . . . 0.0 111.726 -179.967 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 47.8 tpt85 -68.66 133.43 48.43 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-N 115.179 -0.918 . . . . 0.0 110.37 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 7.6 tp -84.5 49.21 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 CA-C-N 114.634 -1.166 . . . . 0.0 110.077 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.434 ' HA ' ' HA ' ' A' ' 41' ' ' CYS . 1.6 m -82.38 59.76 4.73 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 115.24 1.57 . . . . 0.0 115.24 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 38.6 m -91.03 163.43 14.31 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 105.092 -2.188 . . . . 0.0 105.092 179.393 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.477 ' ND2' ' H ' ' A' ' 9' ' ' ALA . 40.8 p-10 -158.5 175.66 13.4 Favored 'General case' 0 N--CA 1.499 2.023 0 C-N-CA 118.895 -1.122 . . . . 0.0 113.057 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 45.3 t -78.44 -32.47 48.54 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-N 113.198 -1.819 . . . . 0.0 113.704 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 38.3 t -77.01 -62.86 1.51 Allowed 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 113.892 1.071 . . . . 0.0 113.892 -179.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.477 ' H ' ' ND2' ' A' ' 6' ' ' ASN . . . -84.81 63.97 8.33 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 124.743 1.277 . . . . 0.0 111.376 -179.702 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -137.54 -169.61 11.67 Favored Glycine 0 N--CA 1.498 2.823 0 CA-C-N 113.559 -1.655 . . . . 0.0 111.518 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.414 ' N ' ' OH ' ' A' ' 16' ' ' TYR . 4.5 t -102.62 111.62 24.02 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 114.191 1.182 . . . . 0.0 114.191 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.404 ' HA ' ' HA3' ' A' ' 27' ' ' GLY . 21.8 pttp -64.87 81.7 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.958 0 CA-C-N 113.608 -1.633 . . . . 0.0 110.789 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -175.18 -31.57 0.04 OUTLIER Glycine 0 N--CA 1.486 2.028 0 CA-C-N 113.057 -1.883 . . . . 0.0 109.629 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.445 ' HA ' ' HA ' ' A' ' 50' ' ' CYS . 21.9 m -104.64 148.19 26.81 Favored 'General case' 0 N--CA 1.501 2.085 0 C-N-CA 118.775 -1.17 . . . . 0.0 112.964 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.654 ' HZ2' HH12 ' A' ' 60' ' ' ARG . 38.2 ttpt -92.95 88.3 6.1 Favored 'General case' 0 N--CA 1.484 1.23 0 CA-C-N 113.307 -1.77 . . . . 0.0 107.428 -179.397 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.414 ' OH ' ' N ' ' A' ' 11' ' ' THR . 11.0 m-30 -46.4 134.95 8.64 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-N 113.59 -1.641 . . . . 0.0 108.494 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 10.8 t80 -145.16 156.16 43.71 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-N 113.232 -1.804 . . . . 0.0 111.511 -179.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 28.8 t -112.53 136.11 52.45 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-N 111.838 -2.437 . . . . 0.0 115.313 -179.462 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -52.14 -21.47 3.32 Favored 'General case' 0 N--CA 1.499 1.989 0 CA-C-N 112.266 -2.243 . . . . 0.0 113.715 179.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 43.6 p30 -64.19 -1.86 1.81 Allowed 'General case' 0 N--CA 1.497 1.917 0 O-C-N 124.04 0.838 . . . . 0.0 111.231 179.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 85.74 29.15 27.29 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 108.94 -1.664 . . . . 0.0 108.94 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 95.5 m -141.21 150.47 42.73 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 121.831 0.824 . . . . 0.0 110.557 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 24.2 t80 -73.52 155.65 38.97 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-N 113.144 -1.844 . . . . 0.0 111.979 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 90.9 t -115.27 -77.0 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 CA-C-N 114.673 -1.149 . . . . 0.0 109.056 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.654 ' SG ' ' N ' ' A' ' 26' ' ' GLU . 0.1 OUTLIER -166.97 -168.61 1.13 Allowed 'General case' 0 N--CA 1.507 2.393 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 179.979 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.654 ' N ' ' SG ' ' A' ' 25' ' ' CYS . 3.5 tm-20 -128.36 140.96 51.58 Favored 'General case' 0 N--CA 1.5 2.046 0 N-CA-C 104.52 -2.4 . . . . 0.0 104.52 179.496 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.404 ' HA3' ' HA ' ' A' ' 12' ' ' LYS . . . -39.27 117.82 0.78 Allowed Glycine 0 N--CA 1.5 2.928 0 CA-C-O 122.041 0.8 . . . . 0.0 114.869 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -92.87 0.66 57.45 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-N 113.072 -1.564 . . . . 0.0 112.061 -179.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 27.5 t -156.22 170.3 22.56 Favored 'General case' 0 N--CA 1.501 2.103 0 C-N-CA 119.609 -0.837 . . . . 0.0 111.467 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -79.29 143.84 61.12 Favored Pre-proline 0 N--CA 1.493 1.694 0 CA-C-N 114.626 -1.17 . . . . 0.0 107.883 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -70.37 67.67 2.08 Favored 'Trans proline' 0 N--CA 1.5 1.9 0 C-N-CA 123.158 2.572 . . . . 0.0 111.073 172.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 67.0 mtp85 -160.33 -39.44 0.05 Allowed 'General case' 0 N--CA 1.496 1.855 0 CA-C-N 113.246 -1.797 . . . . 0.0 107.764 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.537 HD22 ' N ' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -39.71 102.98 0.27 Allowed Pre-proline 0 N--CA 1.498 1.945 0 O-C-N 124.876 1.36 . . . . 0.0 114.416 -179.877 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -76.4 179.57 6.26 Favored 'Trans proline' 0 N--CA 1.494 1.54 0 C-N-CA 122.821 2.348 . . . . 0.0 111.029 -179.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 25.7 ttpp 62.9 155.25 0.05 OUTLIER 'General case' 0 N--CA 1.5 2.071 0 O-C-N 124.673 1.233 . . . . 0.0 112.618 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -79.87 147.33 31.76 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-N 114.639 -1.164 . . . . 0.0 110.124 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.579 ' H ' HD21 ' A' ' 40' ' ' ASN . 98.4 m -79.66 -87.91 0.07 Allowed 'General case' 0 N--CA 1.492 1.663 0 CA-C-N 114.66 -1.154 . . . . 0.0 110.593 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.418 ' H ' ' H ' ' A' ' 39' ' ' LEU . 7.9 t -168.9 -15.53 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.019 0 O-C-N 123.616 0.573 . . . . 0.0 110.732 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.418 ' H ' ' H ' ' A' ' 38' ' ' THR . 0.8 OUTLIER -153.44 64.92 0.75 Allowed 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 103.837 -2.653 . . . . 0.0 103.837 -179.955 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.579 HD21 ' H ' ' A' ' 37' ' ' CYS . 13.4 m120 -84.15 47.59 1.35 Allowed 'General case' 0 N--CA 1.491 1.602 0 CA-C-N 112.702 -2.045 . . . . 0.0 112.959 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.434 ' HA ' ' HA ' ' A' ' 4' ' ' CYS . 75.3 m -158.04 126.31 5.42 Favored 'General case' 0 N--CA 1.498 1.93 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.781 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -147.83 81.36 8.43 Favored Pre-proline 0 N--CA 1.496 1.852 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.313 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -60.82 -31.11 91.39 Favored 'Trans proline' 0 N--CA 1.493 1.496 0 C-N-CA 122.744 2.296 . . . . 0.0 114.391 -173.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 7.3 ptm180 -58.59 -30.73 67.43 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 123.813 0.696 . . . . 0.0 111.955 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 13.9 tt -47.33 156.79 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 O-C-N 124.226 0.954 . . . . 0.0 113.279 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -137.85 -50.76 0.6 Allowed 'General case' 0 N--CA 1.492 1.636 0 CA-C-N 113.967 -1.469 . . . . 0.0 107.102 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 46.9 p90 -168.32 167.14 12.22 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-N 113.883 -1.508 . . . . 0.0 109.485 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -118.49 108.69 1.64 Allowed Glycine 0 N--CA 1.491 2.316 0 N-CA-C 107.861 -2.096 . . . . 0.0 107.861 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 5.6 p -80.15 111.42 16.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 C-N-CA 118.895 -1.122 . . . . 0.0 110.233 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.445 ' HA ' ' HA ' ' A' ' 14' ' ' CYS . 1.7 m -78.57 110.15 13.02 Favored Pre-proline 0 N--CA 1.499 2.014 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.484 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -82.44 102.87 1.21 Allowed 'Trans proline' 0 N--CA 1.49 1.307 0 C-N-CA 122.816 2.344 . . . . 0.0 108.415 -175.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 15.2 ptp180 -160.08 -22.27 0.06 Allowed 'General case' 0 N--CA 1.498 1.93 0 CA-C-N 115.417 -0.81 . . . . 0.0 111.313 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 40.6 t -64.01 138.6 58.53 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 123.917 0.761 . . . . 0.0 109.832 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 59.88 111.91 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.116 0 O-C-N 124.872 1.358 . . . . 0.0 113.181 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -91.2 73.27 6.25 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 28.7 tptp -161.07 56.54 0.3 Allowed 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 83.7 tttt 49.63 44.1 24.39 Favored 'General case' 0 N--CA 1.501 2.09 0 CA-C-N 114.045 -1.434 . . . . 0.0 109.989 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -60.75 -60.18 4.21 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-N 114.203 -1.362 . . . . 0.0 110.217 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -74.8 -78.69 0.1 Allowed 'General case' 0 N--CA 1.492 1.674 0 CA-C-N 115.248 -0.887 . . . . 0.0 108.72 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.654 HH12 ' HZ2' ' A' ' 15' ' ' LYS . 84.9 mtm-85 -142.92 -162.95 1.53 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 124.247 0.967 . . . . 0.0 108.67 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 9.6 tp -82.41 49.93 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 CA-C-O 121.768 0.795 . . . . 0.0 110.145 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.419 ' HA ' ' HA ' ' A' ' 99' ' ' CYS . 1.7 m -83.53 38.94 0.65 Allowed 'General case' 0 N--CA 1.492 1.663 0 CA-C-O 122.814 1.292 . . . . 0.0 114.222 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.6 p -91.25 159.09 16.22 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-N 112.889 -1.96 . . . . 0.0 109.573 179.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.62 HD21 ' H ' ' A' ' 99' ' ' CYS . 64.1 m-20 -152.94 157.02 40.0 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 125.018 1.448 . . . . 0.0 111.259 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' CYS . . . . . 0.492 ' HA ' ' CD2' ' A' ' 74' ' ' TYR . 3.6 t -62.1 -38.37 88.63 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-N 114.541 -1.209 . . . . 0.0 108.427 179.65 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 43.0 t -66.99 -50.85 60.97 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 112.363 -2.199 . . . . 0.0 110.634 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -79.36 -114.2 0.02 OUTLIER 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 113.924 -1.489 . . . . 0.0 110.701 -179.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 46.16 -129.89 10.62 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 111.044 -0.822 . . . . 0.0 111.044 -179.512 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 40.7 p -150.94 135.19 16.88 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 123.879 0.399 . . . . 0.0 111.689 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -61.1 104.2 0.35 Allowed 'General case' 0 N--CA 1.499 2.015 0 O-C-N 124.249 0.968 . . . . 0.0 110.309 179.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 141.43 -24.75 2.49 Favored Glycine 0 N--CA 1.494 2.551 0 O-C-N 123.93 0.769 . . . . 0.0 111.659 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . 0.422 ' SG ' ' HA ' ' A' ' 111' ' ' ALA . 94.7 m -91.74 133.29 35.73 Favored 'General case' 0 N--CA 1.498 1.927 0 C-N-CA 120.736 -0.386 . . . . 0.0 110.441 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.7 mppt? -88.04 88.7 7.73 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 124.057 0.848 . . . . 0.0 110.46 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.515 ' CE2' ' HA2' ' A' ' 85' ' ' GLY . 77.7 m-85 -40.71 136.14 1.46 Allowed 'General case' 0 N--CA 1.503 2.176 0 O-C-N 124.613 1.196 . . . . 0.0 109.761 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -148.17 145.23 28.23 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 124.753 1.283 . . . . 0.0 113.399 -179.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.409 ' N ' HG23 ' A' ' 82' ' ' VAL . 42.0 t -106.81 118.69 37.35 Favored 'General case' 0 N--CA 1.499 1.995 0 CA-C-N 112.653 -2.067 . . . . 0.0 111.902 -179.675 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.516 ' HB3' ' HB2' ' A' ' 104' ' ' ALA . 6.1 p-10 -55.16 -52.89 61.87 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 126.323 2.264 . . . . 0.0 112.703 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -69.55 -0.74 7.14 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 112.108 -2.315 . . . . 0.0 112.541 -179.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -139.46 -84.4 0.1 Allowed Glycine 0 N--CA 1.482 1.702 0 C-N-CA 119.202 -1.475 . . . . 0.0 112.209 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.485 ' CG2' ' H ' ' A' ' 81' ' ' PHE . 1.2 m 175.79 -170.33 0.06 Allowed 'General case' 0 N--CA 1.5 2.04 0 O-C-N 126.22 1.777 . . . . 0.0 106.252 -179.166 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.485 ' H ' ' CG2' ' A' ' 80' ' ' THR . 75.8 t80 -42.62 146.55 0.35 Allowed 'General case' 0 N--CA 1.498 1.955 0 C-N-CA 123.554 0.742 . . . . 0.0 112.636 179.527 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.409 HG23 ' N ' ' A' ' 76' ' ' SER . 88.4 t -111.17 -70.93 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 CA-C-N 113.878 -1.51 . . . . 0.0 111.585 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . 0.534 ' SG ' ' N ' ' A' ' 84' ' ' GLU . 0.1 OUTLIER -160.25 -170.57 2.87 Favored 'General case' 0 N--CA 1.506 2.37 0 C-N-CA 120.41 -0.516 . . . . 0.0 110.827 -179.881 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.534 ' N ' ' SG ' ' A' ' 83' ' ' CYS . 38.9 tt0 -114.09 149.74 35.08 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 123.307 0.379 . . . . 0.0 110.716 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.515 ' HA2' ' CE2' ' A' ' 74' ' ' TYR . . . -36.8 105.7 0.04 OUTLIER Glycine 0 N--CA 1.501 2.992 0 O-C-N 124.833 1.333 . . . . 0.0 115.135 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -94.12 -8.86 38.35 Favored 'General case' 0 N--CA 1.502 2.145 0 C-N-CA 119.128 -1.029 . . . . 0.0 113.726 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 15.6 m -85.13 90.86 7.97 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -79.33 106.72 4.96 Favored Pre-proline 0 N--CA 1.49 1.536 0 N-CA-C 104.107 -2.553 . . . . 0.0 104.107 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -40.15 -34.81 1.08 Allowed 'Trans proline' 0 N--CA 1.501 1.938 0 C-N-CA 124.819 3.679 . . . . 0.0 116.265 -145.12 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 8.9 ptm180 -58.73 -14.02 7.5 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 123.861 0.726 . . . . 0.0 112.891 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.595 HD22 ' H ' ' A' ' 91' ' ' ASN . 0.1 OUTLIER -75.28 129.31 82.74 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 123.948 0.78 . . . . 0.0 110.936 -179.918 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -83.32 44.97 1.74 Allowed 'Trans proline' 0 N--CA 1.493 1.461 0 C-N-CA 123.275 2.65 . . . . 0.0 109.769 162.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.468 ' HE3' ' HA ' ' A' ' 93' ' ' LYS . 0.0 OUTLIER 64.98 168.94 0.19 Allowed 'General case' 0 N--CA 1.507 2.396 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.01 -179.877 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -160.21 44.82 0.21 Allowed 'General case' 0 N--CA 1.5 2.048 0 C-N-CA 120.061 -0.656 . . . . 0.0 112.759 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 61.0 m -156.77 130.76 4.84 Favored Pre-proline 0 N--CA 1.501 2.101 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.829 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_endo -76.4 35.25 0.46 Allowed 'Trans proline' 0 N--CA 1.496 1.624 0 C-N-CA 123.039 2.493 . . . . 0.0 111.209 163.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 83.3 mmt-85 -108.99 37.07 2.66 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.553 ' H ' HD22 ' A' ' 98' ' ' ASN . 4.9 m-80 -54.25 135.51 44.21 Favored 'General case' 0 N--CA 1.495 1.789 0 CA-C-N 113.813 -1.54 . . . . 0.0 112.425 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.62 ' H ' HD21 ' A' ' 64' ' ' ASN . 34.4 m 57.51 127.84 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.822 0 O-C-N 125.232 1.582 . . . . 0.0 114.747 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -122.99 93.12 48.67 Favored Pre-proline 0 N--CA 1.5 2.061 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_endo -62.11 -13.7 33.38 Favored 'Trans proline' 0 N--CA 1.496 1.635 0 C-N-CA 122.126 1.884 . . . . 0.0 113.505 -175.374 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 77.8 ttt-85 -90.17 -25.36 20.7 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 114.238 1.199 . . . . 0.0 114.238 -179.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 11.6 tt -74.12 141.95 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 C-N-CA 118.658 -1.217 . . . . 0.0 110.473 -179.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.516 ' HB2' ' HB3' ' A' ' 77' ' ' ASP . . . -79.82 -58.85 2.97 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 105.791 -1.929 . . . . 0.0 105.791 179.715 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 4.3 p90 174.96 171.83 0.25 Allowed 'General case' 0 N--CA 1.488 1.473 0 CA-C-N 111.402 -2.635 . . . . 0.0 106.819 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -94.8 132.19 11.03 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 110.183 -1.167 . . . . 0.0 110.183 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 39.4 mm -78.45 90.86 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 N-CA-C 103.932 -2.618 . . . . 0.0 103.932 179.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 19.5 m -84.28 127.34 66.67 Favored Pre-proline 0 N--CA 1.493 1.716 0 CA-C-N 113.37 -1.741 . . . . 0.0 111.08 -179.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -73.96 -32.73 6.83 Favored 'Trans proline' 0 N--CA 1.491 1.367 0 C-N-CA 122.386 2.057 . . . . 0.0 107.951 146.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -159.75 162.75 34.96 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-N 114.692 -1.14 . . . . 0.0 109.482 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.422 ' HA ' ' SG ' ' A' ' 72' ' ' CYS . . . . . . . . 0 N--CA 1.499 2.012 0 CA-C-O 115.748 -2.072 . . . . 0.0 111.884 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 27.9 t70 . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 121.283 0.563 . . . . 0.0 110.362 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 71.4 ttt-85 -151.79 64.69 0.86 Allowed 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.427 HD13 ' H ' ' A' ' 5' ' ' THR . 0.0 OUTLIER -73.93 109.6 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 179.997 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.514 ' HA ' ' HA ' ' A' ' 41' ' ' CYS . 1.6 m -132.59 29.3 4.22 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 115.78 1.77 . . . . 0.0 115.78 179.625 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.427 ' H ' HD13 ' A' ' 3' ' ' ILE . 2.5 p -92.33 147.34 22.99 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-N 112.427 -2.169 . . . . 0.0 108.588 179.631 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.616 HD22 ' H ' ' A' ' 41' ' ' CYS . 20.7 p30 -160.61 158.26 28.67 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 124.722 1.263 . . . . 0.0 109.858 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 5.3 t -71.21 -30.12 65.98 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 115.287 1.588 . . . . 0.0 115.287 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 43.1 t -80.81 -65.29 1.03 Allowed 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 -179.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -88.79 39.7 0.94 Allowed 'General case' 0 N--CA 1.499 2.012 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.03 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -76.54 -133.61 0.52 Allowed Glycine 0 N--CA 1.492 2.392 0 CA-C-N 114.943 -1.026 . . . . 0.0 111.23 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 35.3 p -152.56 103.69 2.83 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 35.2 ttpt -51.87 108.22 0.26 Allowed 'General case' 0 N--CA 1.5 2.041 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.529 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 143.26 -20.89 2.26 Favored Glycine 0 N--CA 1.496 2.659 0 N-CA-C 110.314 -1.114 . . . . 0.0 110.314 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 80.7 m -114.56 150.35 35.11 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 124.244 0.614 . . . . 0.0 109.84 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.432 ' N ' ' HE2' ' A' ' 15' ' ' LYS . 0.2 OUTLIER -93.81 94.43 8.52 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 124.159 0.912 . . . . 0.0 111.503 -179.781 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 31.3 m-85 -59.34 115.33 3.17 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 106.662 -1.607 . . . . 0.0 106.662 179.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.525 ' CE2' ' HA ' ' A' ' 22' ' ' THR . 0.0 OUTLIER -129.42 147.71 51.26 Favored 'General case' 0 N--CA 1.486 1.363 0 CA-C-N 112.008 -2.36 . . . . 0.0 112.836 -179.343 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.427 ' HA ' ' H ' ' A' ' 46' ' ' ALA . 46.6 t -98.21 123.93 42.53 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-N 112.87 -1.968 . . . . 0.0 112.05 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.461 ' HB3' ' HB2' ' A' ' 46' ' ' ALA . 5.5 p-10 -60.53 -43.15 97.47 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-N 113.916 -1.493 . . . . 0.0 108.444 179.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -94.98 18.37 12.14 Favored 'General case' 0 N--CA 1.487 1.394 0 CA-C-N 112.182 -2.281 . . . . 0.0 112.024 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -170.71 31.53 0.14 Allowed Glycine 0 N--CA 1.498 2.777 0 C-N-CA 118.528 -1.796 . . . . 0.0 113.75 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.525 ' HA ' ' CE2' ' A' ' 17' ' ' PHE . 6.1 t 44.19 -168.79 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 114.214 1.19 . . . . 0.0 114.214 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 62.8 t80 -47.84 133.62 13.98 Favored 'General case' 0 N--CA 1.498 1.95 0 CA-C-O 121.697 0.761 . . . . 0.0 112.805 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 98.2 t -104.04 -78.65 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 CA-C-N 113.044 -1.889 . . . . 0.0 106.799 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.458 ' SG ' ' N ' ' A' ' 26' ' ' GLU . 0.2 OUTLIER -157.31 -171.4 3.59 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 179.732 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.458 ' N ' ' SG ' ' A' ' 25' ' ' CYS . 16.1 mt-10 -109.06 157.12 19.01 Favored 'General case' 0 N--CA 1.495 1.775 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 179.715 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -49.69 106.68 0.24 Allowed Glycine 0 N--CA 1.496 2.663 0 O-C-N 124.124 0.89 . . . . 0.0 112.05 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -79.44 -9.23 59.56 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-N 114.93 -0.635 . . . . 0.0 110.297 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 34.0 t -79.72 97.11 6.45 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.552 ' H ' HD21 ' A' ' 33' ' ' ASN . 10.8 t70 -79.82 137.23 54.29 Favored Pre-proline 0 N--CA 1.495 1.785 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -71.48 68.65 2.76 Favored 'Trans proline' 0 N--CA 1.497 1.711 0 C-N-CA 123.567 2.845 . . . . 0.0 111.411 176.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.497 ' NE ' ' HA ' ' A' ' 32' ' ' ARG . 3.9 mmp_? -158.0 -44.99 0.06 Allowed 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 105.293 -2.114 . . . . 0.0 105.293 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.552 HD21 ' H ' ' A' ' 30' ' ' ASP . 13.4 p30 -90.35 150.54 43.15 Favored Pre-proline 0 N--CA 1.495 1.783 0 O-C-N 124.275 0.985 . . . . 0.0 110.522 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.13 169.82 21.72 Favored 'Trans proline' 0 N--CA 1.491 1.343 0 C-N-CA 122.843 2.362 . . . . 0.0 108.916 159.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 22.4 ptmt -69.56 147.04 51.3 Favored 'General case' 0 N--CA 1.496 1.853 0 C-N-CA 120.124 -0.63 . . . . 0.0 110.4 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -158.81 41.56 0.24 Allowed 'General case' 0 N--CA 1.496 1.839 0 CA-C-N 115.322 -0.854 . . . . 0.0 108.849 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 76.4 m -108.23 178.68 4.43 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-N 114.069 -1.423 . . . . 0.0 111.595 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 8.4 t -134.15 -3.17 2.79 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-N 113.537 -1.665 . . . . 0.0 108.269 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.17 30.59 2.72 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.487 ' H ' HD22 ' A' ' 40' ' ' ASN . 6.9 m-80 -57.75 123.22 14.96 Favored 'General case' 0 N--CA 1.497 1.923 0 CA-C-N 114.712 -1.131 . . . . 0.0 109.358 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.616 ' H ' HD22 ' A' ' 6' ' ' ASN . 70.9 m 58.01 107.56 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.856 0 O-C-N 125.079 1.487 . . . . 0.0 110.616 -179.612 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -108.76 102.99 50.32 Favored Pre-proline 0 N--CA 1.499 2.007 0 CA-C-N 115.243 -0.889 . . . . 0.0 112.654 -179.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -67.34 -7.05 17.89 Favored 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 121.888 1.725 . . . . 0.0 112.216 178.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 60.9 mtt85 -89.97 -14.59 33.75 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 123.643 0.589 . . . . 0.0 111.967 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 15.3 tt -106.79 160.74 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.461 ' HB2' ' HB3' ' A' ' 19' ' ' ASP . . . -83.85 -74.65 0.37 Allowed 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 105.378 -2.082 . . . . 0.0 105.378 179.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 50.9 p90 179.71 176.37 0.69 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 124.769 1.293 . . . . 0.0 109.552 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -79.94 102.02 1.99 Allowed Glycine 0 N--CA 1.49 2.243 0 CA-C-N 114.125 -1.398 . . . . 0.0 111.797 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 17.7 m -78.54 98.38 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 N-CA-C 106.258 -1.756 . . . . 0.0 106.258 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.9 m -79.93 176.29 3.92 Favored Pre-proline 0 N--CA 1.495 1.779 0 CA-C-N 113.218 -1.81 . . . . 0.0 108.26 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -70.35 2.69 3.62 Favored 'Trans proline' 0 N--CA 1.495 1.583 0 C-N-CA 122.219 1.946 . . . . 0.0 112.3 173.05 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 12.2 mmm180 -88.28 4.47 45.81 Favored 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 12.5 t 74.38 -26.62 0.19 Allowed 'General case' 0 N--CA 1.508 2.459 0 O-C-N 124.206 0.941 . . . . 0.0 112.033 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.414 ' N ' ' CD ' ' A' ' 54' ' ' GLU . 6.3 mp0 55.72 80.16 0.15 Allowed 'General case' 0 N--CA 1.497 1.913 0 CA-C-O 121.746 0.784 . . . . 0.0 111.844 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -102.36 109.5 21.17 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 105.892 -1.892 . . . . 0.0 105.892 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.487 ' N ' ' HD3' ' A' ' 56' ' ' LYS . 0.1 OUTLIER -156.66 151.97 26.53 Favored 'General case' 0 N--CA 1.494 1.759 0 CA-C-N 115.463 -0.789 . . . . 0.0 112.377 -179.759 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -164.16 81.33 0.41 Allowed 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 103.896 -2.631 . . . . 0.0 103.896 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 -118.62 89.41 3.12 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-N 114.015 -1.448 . . . . 0.0 108.769 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -163.92 57.35 0.16 Allowed 'General case' 0 N--CA 1.495 1.785 0 CA-C-N 114.127 -1.397 . . . . 0.0 109.287 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? -146.09 -40.3 0.22 Allowed 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.53 HD13 ' H ' ' A' ' 63' ' ' THR . 0.0 OUTLIER -48.91 110.87 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.838 -179.977 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.507 ' HA ' ' HA ' ' A' ' 99' ' ' CYS . 1.7 m -130.68 30.9 4.6 Favored 'General case' 0 N--CA 1.487 1.411 0 CA-C-O 123.336 1.541 . . . . 0.0 115.076 179.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.53 ' H ' HD13 ' A' ' 61' ' ' ILE . 60.2 m -91.38 118.38 30.48 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-N 111.756 -2.474 . . . . 0.0 104.87 179.57 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.593 ' ND2' ' H ' ' A' ' 67' ' ' ALA . 20.8 p-10 -140.46 161.02 38.71 Favored 'General case' 0 N--CA 1.502 2.158 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 1.4 t -65.53 -36.69 84.57 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-N 113.539 -1.664 . . . . 0.0 115.296 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 51.0 t -75.35 -64.48 1.05 Allowed 'General case' 0 N--CA 1.497 1.913 0 O-C-N 123.775 0.672 . . . . 0.0 110.669 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.593 ' H ' ' ND2' ' A' ' 64' ' ' ASN . . . -90.13 52.41 2.26 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -88.53 -138.65 6.4 Favored Glycine 0 N--CA 1.493 2.449 0 CA-C-N 114.256 -1.338 . . . . 0.0 112.205 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 94.8 m -140.91 105.75 4.94 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 124.48 0.753 . . . . 0.0 110.758 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 10.9 tptm -56.02 104.19 0.13 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 124.208 0.943 . . . . 0.0 108.613 179.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 140.32 -1.78 2.2 Favored Glycine 0 N--CA 1.492 2.401 0 CA-C-N 114.517 -1.22 . . . . 0.0 110.82 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 91.9 m -141.44 146.95 37.15 Favored 'General case' 0 N--CA 1.498 1.934 0 CA-C-N 117.074 0.437 . . . . 0.0 111.282 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.475 ' HB3' ' CE1' ' A' ' 81' ' ' PHE . 8.0 mtpm? -89.33 90.39 8.31 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-N 114.875 -1.057 . . . . 0.0 111.89 -179.683 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -53.96 120.96 7.06 Favored 'General case' 0 N--CA 1.5 2.052 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -124.38 160.71 27.54 Favored 'General case' 0 N--CA 1.493 1.701 0 CA-C-N 113.184 -1.825 . . . . 0.0 113.731 -179.383 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 29.8 t -104.06 131.89 50.86 Favored 'General case' 0 N--CA 1.498 1.93 0 CA-C-N 113.834 -1.53 . . . . 0.0 112.597 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.408 ' HB3' ' CB ' ' A' ' 104' ' ' ALA . 4.1 p-10 -46.24 -29.83 1.76 Allowed 'General case' 0 N--CA 1.502 2.17 0 N-CA-C 116.117 1.895 . . . . 0.0 116.117 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -51.82 -24.41 6.05 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 123.955 0.784 . . . . 0.0 111.818 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 113.7 26.95 3.71 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 108.851 -1.7 . . . . 0.0 108.851 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 86.3 m -138.67 139.49 38.49 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 124.005 0.473 . . . . 0.0 110.875 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.475 ' CE1' ' HB3' ' A' ' 73' ' ' LYS . 13.0 t80 -71.97 150.76 43.8 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-N 114.312 -1.313 . . . . 0.0 109.648 179.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 97.2 t -110.1 -78.89 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -159.36 175.21 13.63 Favored 'General case' 0 N--CA 1.501 2.099 0 C-N-CA 120.675 -0.41 . . . . 0.0 110.022 179.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -92.72 141.23 28.69 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -45.6 105.59 0.09 OUTLIER Glycine 0 N--CA 1.5 2.956 0 O-C-N 124.166 0.916 . . . . 0.0 111.557 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -79.47 7.15 8.61 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-N 114.526 -0.837 . . . . 0.0 112.456 -179.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 46.9 t -132.93 119.65 20.42 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -79.23 143.92 61.53 Favored Pre-proline 0 N--CA 1.495 1.777 0 O-C-N 124.105 0.878 . . . . 0.0 108.675 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -70.15 64.18 2.03 Favored 'Trans proline' 0 N--CA 1.5 1.903 0 C-N-CA 123.614 2.876 . . . . 0.0 112.402 176.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 53.5 mmm-85 -158.68 -44.42 0.06 Allowed 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 105.616 -1.994 . . . . 0.0 105.616 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -90.78 121.69 67.83 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 124.274 0.984 . . . . 0.0 109.664 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -80.27 50.14 3.44 Favored 'Trans proline' 0 N--CA 1.495 1.604 0 C-N-CA 123.427 2.751 . . . . 0.0 111.686 174.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -82.21 124.72 30.16 Favored 'General case' 0 N--CA 1.496 1.874 0 C-N-CA 120.346 -0.542 . . . . 0.0 111.057 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -87.38 -176.97 5.82 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-N 114.357 -1.292 . . . . 0.0 109.803 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 77.6 m -153.94 158.68 32.51 Favored Pre-proline 0 N--CA 1.496 1.868 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.939 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -70.2 -25.72 26.26 Favored 'Trans proline' 0 N--CA 1.491 1.34 0 C-N-CA 122.069 1.846 . . . . 0.0 108.239 159.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 5.2 mmp_? -83.5 5.04 25.34 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-N 114.324 -1.307 . . . . 0.0 112.319 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -50.27 136.15 20.36 Favored 'General case' 0 N--CA 1.503 2.224 0 C-N-CA 120.499 -0.48 . . . . 0.0 110.927 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.507 ' HA ' ' HA ' ' A' ' 62' ' ' CYS . 59.8 m 61.96 114.5 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.773 0 O-C-N 125.309 1.63 . . . . 0.0 111.58 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -125.6 97.29 36.67 Favored Pre-proline 0 N--CA 1.499 2.008 0 N-CA-C 113.21 0.819 . . . . 0.0 113.21 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -48.63 -32.49 21.54 Favored 'Trans proline' 0 N--CA 1.495 1.585 0 C-N-CA 123.189 2.593 . . . . 0.0 112.425 174.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 31.1 ttp-105 -61.02 -50.04 74.98 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 106.46 -1.681 . . . . 0.0 106.46 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 4.0 mt -67.91 155.89 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 179.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.408 ' CB ' ' HB3' ' A' ' 77' ' ' ASP . . . -141.77 -34.5 0.47 Allowed 'General case' 0 N--CA 1.49 1.57 0 CA-C-N 113.484 -1.689 . . . . 0.0 111.334 -179.695 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 51.7 m-85 -139.65 -164.3 1.66 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 124.255 0.972 . . . . 0.0 111.149 -179.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -153.33 104.14 0.25 Allowed Glycine 0 N--CA 1.488 2.131 0 N-CA-C 105.983 -2.847 . . . . 0.0 105.983 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 51.2 mm -79.21 93.53 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 -179.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 8.0 m -79.44 149.17 71.6 Favored Pre-proline 0 N--CA 1.493 1.718 0 CA-C-N 113.718 -1.583 . . . . 0.0 108.923 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -64.73 104.87 0.59 Allowed 'Trans proline' 0 N--CA 1.494 1.507 0 C-N-CA 122.496 2.131 . . . . 0.0 110.253 -175.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 64.6 tp -79.91 -46.58 16.52 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-N 114.963 -1.017 . . . . 0.0 109.778 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.502 2.138 0 CA-C-O 117.005 -1.474 . . . . 0.0 113.279 -179.969 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 13.2 t70 . . . . . 0 N--CA 1.489 1.514 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 41.6 ttm180 57.95 85.9 0.08 Allowed 'General case' 0 N--CA 1.496 1.861 0 O-C-N 124.793 1.308 . . . . 0.0 109.086 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 8.5 tp -83.67 54.53 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 CA-C-N 114.449 -1.25 . . . . 0.0 109.912 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 42.7 m -87.52 54.66 3.21 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-O 122.479 1.133 . . . . 0.0 112.808 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 17.2 p -89.49 170.8 10.2 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-N 113.128 -1.851 . . . . 0.0 108.809 179.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 18.4 p-10 -162.55 135.76 5.97 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 124.24 0.963 . . . . 0.0 113.548 179.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -59.11 -31.56 69.03 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-N 114.563 -1.199 . . . . 0.0 113.884 179.716 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 48.4 t -68.76 -59.42 3.11 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-N 114.808 -1.087 . . . . 0.0 112.386 -179.584 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -74.5 -96.23 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.863 0 C-N-CA 118.714 -1.194 . . . . 0.0 110.052 -179.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 52.27 -126.57 31.06 Favored Glycine 0 N--CA 1.488 2.105 0 O-C-N 123.567 0.542 . . . . 0.0 112.042 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 92.5 m -152.18 119.21 5.83 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 22.5 ttmm -68.54 91.64 0.42 Allowed 'General case' 0 N--CA 1.494 1.766 0 CA-C-O 122.283 1.039 . . . . 0.0 109.048 179.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 163.59 -34.19 0.29 Allowed Glycine 0 N--CA 1.488 2.163 0 CA-C-N 112.9 -1.954 . . . . 0.0 109.007 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 50.5 m -105.16 130.55 53.3 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-O 121.528 0.68 . . . . 0.0 109.229 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.485 ' HB3' ' CE1' ' A' ' 23' ' ' PHE . 57.5 mtpt -78.36 91.22 4.43 Favored 'General case' 0 N--CA 1.485 1.319 0 CA-C-N 113.171 -1.832 . . . . 0.0 112.55 -179.54 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 75.5 m-85 -58.87 121.22 10.6 Favored 'General case' 0 N--CA 1.501 2.113 0 N-CA-C 105.784 -1.932 . . . . 0.0 105.784 179.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -128.71 147.51 50.76 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 110.664 -2.971 . . . . 0.0 112.933 -179.218 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 40.1 t -83.44 136.32 34.35 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-N 111.83 -2.441 . . . . 0.0 112.895 -179.748 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -52.18 -30.25 26.05 Favored 'General case' 0 N--CA 1.498 1.958 0 CA-C-N 112.481 -2.145 . . . . 0.0 113.833 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 44.3 p-10 -58.06 -14.16 6.15 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 124.013 0.821 . . . . 0.0 112.268 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 99.97 35.22 4.61 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 108.464 -1.855 . . . . 0.0 108.464 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 55.9 m -136.29 132.49 35.79 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 124.025 0.485 . . . . 0.0 110.241 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.485 ' CE1' ' HB3' ' A' ' 15' ' ' LYS . 8.1 t80 -74.78 141.52 44.37 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 179.671 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 41.0 t -102.53 -79.53 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 N-CA-C 105.666 -1.976 . . . . 0.0 105.666 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -169.0 166.21 11.13 Favored 'General case' 0 N--CA 1.501 2.117 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 179.594 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.469 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 36.8 tt0 -82.13 161.51 22.81 Favored 'General case' 0 N--CA 1.503 2.223 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 179.789 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.443 ' N ' ' HG2' ' A' ' 26' ' ' GLU . . . -61.13 120.39 22.59 Favored Glycine 0 N--CA 1.496 2.657 0 N-CA-C 107.52 -2.232 . . . . 0.0 107.52 179.7 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -86.18 21.33 2.05 Favored 'General case' 0 N--CA 1.499 1.999 0 C-N-CA 119.295 -0.962 . . . . 0.0 110.379 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 35.3 t -139.22 112.57 8.21 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-N 114.801 -1.09 . . . . 0.0 108.537 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -81.01 142.71 52.09 Favored Pre-proline 0 N--CA 1.493 1.721 0 CA-C-N 114.246 -1.343 . . . . 0.0 107.706 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -69.75 68.71 1.68 Allowed 'Trans proline' 0 N--CA 1.499 1.852 0 C-N-CA 122.993 2.462 . . . . 0.0 111.844 176.387 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 35.3 mmt180 -160.65 -39.37 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 CA-C-N 113.546 -1.661 . . . . 0.0 107.416 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 24.7 p30 -71.28 151.94 94.36 Favored Pre-proline 0 N--CA 1.498 1.974 0 C-N-CA 119.902 -0.719 . . . . 0.0 111.253 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo -69.44 167.77 23.06 Favored 'Trans proline' 0 N--CA 1.494 1.514 0 C-N-CA 122.745 2.297 . . . . 0.0 111.7 179.227 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 22.4 ptmt 39.44 -163.81 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.252 0 N-CA-C 115.682 1.734 . . . . 0.0 115.682 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -139.34 179.72 6.37 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-N 115.043 -0.98 . . . . 0.0 109.984 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 87.0 m -79.8 179.51 7.5 Favored 'General case' 0 N--CA 1.497 1.897 0 CA-C-N 114.959 -1.019 . . . . 0.0 112.98 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 69.8 p -130.85 31.82 4.43 Favored 'General case' 0 N--CA 1.495 1.822 0 CA-C-N 113.671 -1.604 . . . . 0.0 108.751 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 39.9 tp -79.86 -1.28 38.36 Favored 'General case' 0 N--CA 1.499 2.01 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.412 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 29.7 m-80 57.56 -174.84 0.07 Allowed 'General case' 0 N--CA 1.499 2.009 0 N-CA-C 114.181 1.178 . . . . 0.0 114.181 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 81.7 m -60.82 134.5 57.15 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-N 114.262 -1.335 . . . . 0.0 111.271 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -128.44 83.79 65.11 Favored Pre-proline 0 N--CA 1.498 1.941 0 O-C-N 123.885 0.74 . . . . 0.0 109.517 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -52.34 -24.44 21.26 Favored 'Trans proline' 0 N--CA 1.495 1.576 0 C-N-CA 122.867 2.378 . . . . 0.0 112.178 176.034 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 28.0 ttt85 -60.73 -50.92 71.55 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 17.6 mt -65.5 153.65 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 CA-C-O 122.066 0.936 . . . . 0.0 109.782 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -124.14 -59.61 1.48 Allowed 'General case' 0 N--CA 1.491 1.589 0 CA-C-N 111.957 -2.383 . . . . 0.0 109.218 -179.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 16.2 p90 -162.64 156.78 21.05 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 124.14 0.9 . . . . 0.0 112.189 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -88.84 103.7 3.0 Favored Glycine 0 N--CA 1.492 2.389 0 CA-C-N 112.816 -1.993 . . . . 0.0 113.235 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 34.2 m -81.25 99.07 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.185 0 CA-C-O 121.531 0.681 . . . . 0.0 109.985 179.708 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.6 m -79.16 125.89 82.69 Favored Pre-proline 0 N--CA 1.503 2.206 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.233 179.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -70.52 -60.61 0.06 OUTLIER 'Trans proline' 0 N--CA 1.492 1.397 0 C-N-CA 122.32 2.013 . . . . 0.0 108.516 171.106 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.16 108.52 1.69 Allowed 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 106.521 -1.659 . . . . 0.0 106.521 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 33.7 t -162.0 157.87 24.25 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 123.702 0.626 . . . . 0.0 110.586 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.9 tm-20 66.76 138.14 0.03 OUTLIER 'General case' 0 N--CA 1.504 2.266 0 O-C-N 124.873 1.358 . . . . 0.0 111.345 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -149.54 119.23 7.01 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-N 114.65 -1.159 . . . . 0.0 108.041 179.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 35.4 mmtp 58.09 89.99 0.05 OUTLIER 'General case' 0 N--CA 1.501 2.102 0 O-C-N 124.44 1.087 . . . . 0.0 112.232 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.421 ' HD2' ' H ' ' A' ' 57' ' ' LYS . 0.0 OUTLIER -94.73 -36.57 11.67 Favored 'General case' 0 N--CA 1.499 2.02 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.889 179.806 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 25.8 m120 -148.3 84.95 1.51 Allowed 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -153.9 -65.23 0.14 Allowed 'General case' 0 N--CA 1.494 1.758 0 CA-C-N 114.208 -1.36 . . . . 0.0 108.117 -179.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 17.2 ptp180 -86.22 33.11 0.61 Allowed 'General case' 0 N--CA 1.494 1.725 0 CA-C-N 114.047 -1.433 . . . . 0.0 110.554 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 10.6 tp -85.29 41.46 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 CA-C-O 122.059 0.933 . . . . 0.0 110.586 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 3.6 m -87.95 56.93 4.07 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-O 123.145 1.45 . . . . 0.0 109.88 179.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 25.5 p -90.07 177.42 6.46 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-N 112.038 -2.347 . . . . 0.0 110.333 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.49 ' ND2' ' H ' ' A' ' 67' ' ' ALA . 46.8 p-10 -161.46 -177.11 5.74 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-N 113.797 -1.547 . . . . 0.0 111.143 179.808 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' CYS . . . . . 0.416 ' SG ' ' CD2' ' A' ' 74' ' ' TYR . 11.1 t -91.51 -20.23 21.94 Favored 'General case' 0 N--CA 1.497 1.923 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.026 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 13.4 t -82.62 -61.78 1.79 Allowed 'General case' 0 N--CA 1.491 1.593 0 CA-C-N 113.731 -1.577 . . . . 0.0 112.731 -179.657 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.49 ' H ' ' ND2' ' A' ' 64' ' ' ASN . . . -90.35 60.85 4.84 Favored 'General case' 0 N--CA 1.499 1.996 0 CA-C-O 121.588 0.708 . . . . 0.0 112.205 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.484 ' H ' ' HB2' ' A' ' 87' ' ' SER . . . -126.18 -104.68 1.41 Allowed Glycine 0 N--CA 1.498 2.813 0 N-CA-C 108.812 -1.715 . . . . 0.0 108.812 179.755 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 3.4 t -155.65 111.45 3.06 Favored 'General case' 0 N--CA 1.502 2.13 0 N-CA-C 114.074 1.139 . . . . 0.0 114.074 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -65.93 103.59 0.96 Allowed 'General case' 0 N--CA 1.498 1.95 0 CA-C-N 114.331 -1.304 . . . . 0.0 107.679 179.66 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 143.09 -3.18 1.69 Allowed Glycine 0 N--CA 1.49 2.299 0 CA-C-N 114.384 -1.28 . . . . 0.0 110.927 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 72.8 m -124.0 155.14 38.77 Favored 'General case' 0 N--CA 1.499 1.982 0 C-N-CA 120.476 -0.489 . . . . 0.0 109.829 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.0 95.27 6.25 Favored 'General case' 0 N--CA 1.488 1.47 0 CA-C-N 115.036 -0.984 . . . . 0.0 108.644 -179.759 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.654 ' CD2' ' SG ' ' A' ' 83' ' ' CYS . 89.8 m-85 -44.78 137.61 3.9 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 124.694 1.246 . . . . 0.0 109.882 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 21.6 t80 -141.83 159.12 42.87 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 124.834 1.334 . . . . 0.0 110.844 -179.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 30.8 t -121.24 143.4 49.17 Favored 'General case' 0 N--CA 1.495 1.822 0 CA-C-N 112.748 -2.023 . . . . 0.0 116.089 -179.41 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.407 ' C ' ' H ' ' A' ' 79' ' ' GLY . 0.9 OUTLIER -48.91 -23.98 1.31 Allowed 'General case' 0 N--CA 1.498 1.952 0 CA-C-N 110.507 -3.042 . . . . 0.0 113.184 179.872 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 16.3 p30 -64.74 -0.67 1.54 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 124.223 0.952 . . . . 0.0 111.184 179.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.407 ' H ' ' C ' ' A' ' 77' ' ' ASP . . . 82.25 29.22 37.81 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 96.7 m -144.44 153.15 41.61 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 121.425 0.631 . . . . 0.0 111.903 -179.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -64.21 165.2 9.72 Favored 'General case' 0 N--CA 1.497 1.875 0 CA-C-N 113.466 -1.697 . . . . 0.0 110.565 179.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 89.4 t -128.28 -67.74 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 124.061 0.851 . . . . 0.0 112.07 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . 0.654 ' SG ' ' CD2' ' A' ' 74' ' ' TYR . 31.3 p -162.54 -178.07 6.01 Favored 'General case' 0 N--CA 1.503 2.178 0 C-N-CA 120.253 -0.579 . . . . 0.0 110.794 -179.636 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.401 ' HG2' ' N ' ' A' ' 85' ' ' GLY . 35.3 tt0 -96.49 158.02 15.63 Favored 'General case' 0 N--CA 1.505 2.306 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.16 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.501 ' HA2' ' CE2' ' A' ' 74' ' ' TYR . . . -58.73 106.05 0.79 Allowed Glycine 0 N--CA 1.498 2.778 0 CA-C-O 118.894 -0.948 . . . . 0.0 111.501 179.756 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 30.1 mm-40 -113.01 37.9 2.99 Favored 'General case' 0 N--CA 1.505 2.283 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 179.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.484 ' HB2' ' H ' ' A' ' 68' ' ' GLY . 9.0 t -115.45 63.31 0.69 Allowed 'General case' 0 N--CA 1.493 1.722 0 CA-C-N 114.267 -1.333 . . . . 0.0 109.491 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -81.57 114.57 50.84 Favored Pre-proline 0 N--CA 1.492 1.627 0 CA-C-N 114.08 -1.418 . . . . 0.0 110.355 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -66.1 -16.89 53.85 Favored 'Trans proline' 0 N--CA 1.492 1.419 0 C-N-CA 122.136 1.891 . . . . 0.0 111.361 -174.599 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 52.7 tpt85 -73.13 -31.07 64.06 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 123.812 0.695 . . . . 0.0 112.203 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.427 HD22 ' H ' ' A' ' 93' ' ' LYS . 1.2 p-10 -84.4 131.68 49.57 Favored Pre-proline 0 N--CA 1.497 1.9 0 C-N-CA 118.546 -1.262 . . . . 0.0 110.808 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -80.96 71.22 7.18 Favored 'Trans proline' 0 N--CA 1.49 1.287 0 C-N-CA 123.114 2.543 . . . . 0.0 108.325 162.306 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.427 ' H ' HD22 ' A' ' 91' ' ' ASN . 58.4 tptt -149.87 154.07 37.76 Favored 'General case' 0 N--CA 1.497 1.889 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.607 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -131.32 -172.92 2.97 Favored 'General case' 0 N--CA 1.498 1.957 0 CA-C-N 113.925 -1.488 . . . . 0.0 109.487 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 3.7 m -149.42 150.93 32.5 Favored Pre-proline 0 N--CA 1.5 2.072 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -75.8 98.23 1.17 Allowed 'Trans proline' 0 N--CA 1.493 1.443 0 C-N-CA 122.711 2.274 . . . . 0.0 110.039 172.158 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 -146.73 57.07 1.16 Allowed 'General case' 0 N--CA 1.499 2.018 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -55.35 96.85 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.844 0 CA-C-N 113.446 -1.706 . . . . 0.0 114.618 -179.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 78.6 m 55.01 130.01 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.156 0 N-CA-C 117.331 2.345 . . . . 0.0 117.331 179.683 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 63.8 t0 -127.79 77.34 76.42 Favored Pre-proline 0 N--CA 1.502 2.142 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.78 179.704 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -63.07 -24.89 73.41 Favored 'Trans proline' 0 N--CA 1.493 1.442 0 C-N-CA 122.604 2.202 . . . . 0.0 111.611 173.52 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -67.69 -19.8 65.22 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 123.96 0.787 . . . . 0.0 112.105 -179.824 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 10.5 tt -79.61 169.65 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.115 0 C-N-CA 119.133 -1.027 . . . . 0.0 110.241 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -130.99 -55.15 1.05 Allowed 'General case' 0 N--CA 1.495 1.784 0 CA-C-N 114.883 -1.053 . . . . 0.0 108.833 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 27.7 p90 -171.59 168.3 6.37 Favored 'General case' 0 N--CA 1.497 1.904 0 CA-C-N 114.842 -1.072 . . . . 0.0 110.008 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -105.6 121.96 7.0 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 109.716 -1.353 . . . . 0.0 109.716 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 87.2 mt -79.4 94.05 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 14.6 m -79.66 156.16 75.53 Favored Pre-proline 0 N--CA 1.493 1.69 0 CA-C-N 114.117 -1.401 . . . . 0.0 107.38 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -51.36 -46.29 32.26 Favored 'Trans proline' 0 N--CA 1.495 1.593 0 C-N-CA 122.631 2.22 . . . . 0.0 111.532 -175.293 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.56 ' H ' HD23 ' A' ' 110' ' ' LEU . 2.0 pt? -79.55 -27.67 41.24 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-N 114.935 -1.03 . . . . 0.0 111.199 179.844 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 1.908 0 CA-C-O 116.877 -1.535 . . . . 0.0 110.837 -179.987 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 50.7 t0 . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.489 ' NE ' ' HA ' ' A' ' 2' ' ' ARG . 14.5 mmp_? -77.2 133.39 38.93 Favored 'General case' 0 N--CA 1.498 1.933 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.5 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.3 tp -69.58 84.87 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 CA-C-N 114.835 -1.075 . . . . 0.0 111.552 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 14.8 m -92.2 51.02 1.72 Allowed 'General case' 0 N--CA 1.491 1.619 0 CA-C-N 114.195 -1.366 . . . . 0.0 111.521 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 15.1 t -90.71 -173.67 3.81 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-N 113.229 -1.805 . . . . 0.0 108.862 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 24.1 p30 -160.22 -175.15 4.89 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 124.742 1.276 . . . . 0.0 108.285 179.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.6 t -118.26 -33.35 4.4 Favored 'General case' 0 N--CA 1.499 1.978 0 C-N-CA 119.772 -0.771 . . . . 0.0 110.332 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 25.1 t -62.54 -60.39 3.6 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-N 114.704 -1.135 . . . . 0.0 108.64 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.436 ' HB2' ' SG ' ' A' ' 37' ' ' CYS . . . -90.28 19.82 4.86 Favored 'General case' 0 N--CA 1.498 1.97 0 CA-C-N 113.83 -1.532 . . . . 0.0 109.561 179.785 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -75.19 -151.0 2.67 Favored Glycine 0 N--CA 1.493 2.48 0 CA-C-N 115.445 -0.798 . . . . 0.0 112.472 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 40.1 p -126.98 100.08 5.99 Favored 'General case' 0 N--CA 1.498 1.925 0 CA-C-N 114.709 -0.746 . . . . 0.0 109.299 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -52.12 147.79 7.05 Favored 'General case' 0 N--CA 1.5 2.035 0 CA-C-N 115.787 -0.642 . . . . 0.0 112.249 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 98.92 -33.51 6.06 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 107.88 -2.088 . . . . 0.0 107.88 -179.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 55.3 m -91.39 114.18 26.64 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.421 ' HB2' ' NZ ' ' A' ' 15' ' ' LYS . 10.4 mtmp? -68.72 88.31 0.36 Allowed 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 111.762 -2.472 . . . . 0.0 111.718 -179.675 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.515 ' HB2' ' SG ' ' A' ' 25' ' ' CYS . 31.6 m-85 -53.01 119.76 5.05 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 105.361 -2.088 . . . . 0.0 105.361 179.456 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -135.16 153.66 51.9 Favored 'General case' 0 C--N 1.296 -1.723 0 CA-C-N 111.876 -2.42 . . . . 0.0 113.347 -179.036 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 41.9 t -92.17 133.33 35.89 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-N 112.838 -1.983 . . . . 0.0 109.389 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.561 ' H ' ' HB2' ' A' ' 46' ' ' ALA . 5.8 p-10 -51.97 -24.01 5.89 Favored 'General case' 0 N--CA 1.498 1.96 0 CA-C-N 113.363 -1.744 . . . . 0.0 114.21 -179.797 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 32.6 p30 -58.99 -10.47 2.55 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 124.197 0.935 . . . . 0.0 112.365 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 99.68 29.39 6.99 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 87.1 m -140.06 138.08 35.08 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 124.026 0.486 . . . . 0.0 110.622 -179.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.403 ' CG ' ' N ' ' A' ' 24' ' ' VAL . 49.1 t80 -70.55 162.0 29.63 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 124.443 1.09 . . . . 0.0 110.46 179.743 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.403 ' N ' ' CG ' ' A' ' 23' ' ' PHE . 61.0 t -129.48 -72.93 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 124.198 0.936 . . . . 0.0 110.978 -179.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.515 ' SG ' ' HB2' ' A' ' 16' ' ' TYR . 14.8 p -149.82 -169.62 3.43 Favored 'General case' 0 N--CA 1.504 2.241 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -137.51 147.22 45.03 Favored 'General case' 0 N--CA 1.502 2.128 0 N-CA-C 105.652 -1.981 . . . . 0.0 105.652 179.251 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -50.55 157.92 2.04 Favored Glycine 0 N--CA 1.5 2.915 0 C-N-CA 120.371 -0.918 . . . . 0.0 115.01 -179.577 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -121.11 -33.25 3.75 Favored 'General case' 0 N--CA 1.496 1.851 0 CA-C-N 113.603 -1.298 . . . . 0.0 110.807 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 32.4 m -95.12 131.48 41.09 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 123.595 0.559 . . . . 0.0 111.273 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.529 ' H ' HD21 ' A' ' 33' ' ' ASN . 16.4 t70 -81.33 143.96 52.92 Favored Pre-proline 0 N--CA 1.493 1.715 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_endo -61.77 73.91 0.09 OUTLIER 'Trans proline' 0 N--CA 1.499 1.838 0 C-N-CA 122.904 2.402 . . . . 0.0 112.111 172.721 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 36.2 mmt180 -162.72 -47.9 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.734 0 CA-C-N 113.387 -1.733 . . . . 0.0 106.802 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.529 HD21 ' H ' ' A' ' 30' ' ' ASP . 6.5 p30 -90.44 119.44 69.13 Favored Pre-proline 0 N--CA 1.494 1.762 0 O-C-N 124.234 0.959 . . . . 0.0 110.816 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -81.02 49.98 3.42 Favored 'Trans proline' 0 N--CA 1.494 1.534 0 C-N-CA 123.419 2.746 . . . . 0.0 111.298 174.528 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.4 ' HE2' ' HA ' ' A' ' 35' ' ' LYS . 6.4 mmpt? -74.65 124.5 26.82 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -99.14 96.1 7.55 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-N 114.744 -1.117 . . . . 0.0 110.754 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.436 ' SG ' ' HB2' ' A' ' 9' ' ' ALA . 78.0 m -79.71 -39.82 30.31 Favored 'General case' 0 N--CA 1.497 1.917 0 CA-C-N 114.709 -1.132 . . . . 0.0 108.678 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 63.0 m 59.71 80.45 0.2 Allowed 'General case' 0 N--CA 1.496 1.853 0 CA-C-N 114.049 -1.432 . . . . 0.0 111.295 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 32.4 tp -84.2 7.79 17.86 Favored 'General case' 0 N--CA 1.499 2.006 0 CA-C-N 114.696 -1.138 . . . . 0.0 108.911 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 13.2 m120 55.52 56.2 6.51 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.453 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 80.8 m 61.42 132.93 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.006 0 CA-C-N 113.29 -1.777 . . . . 0.0 114.044 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -115.68 87.27 17.31 Favored Pre-proline 0 N--CA 1.497 1.908 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.447 179.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -64.52 -17.04 58.27 Favored 'Trans proline' 0 N--CA 1.492 1.421 0 C-N-CA 122.844 2.363 . . . . 0.0 111.568 170.058 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.434 ' N ' ' HD3' ' A' ' 44' ' ' ARG . 0.0 OUTLIER -70.27 -10.4 58.82 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 123.688 0.618 . . . . 0.0 109.992 -179.971 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.411 ' CG2' ' N ' ' A' ' 46' ' ' ALA . 46.2 mt -119.9 159.98 20.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 CA-C-O 122.14 0.972 . . . . 0.0 110.66 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.561 ' HB2' ' H ' ' A' ' 19' ' ' ASP . . . -119.6 -55.26 2.12 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-N 111.695 -2.502 . . . . 0.0 108.182 179.755 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 5.8 p90 -167.21 153.55 8.12 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 124.129 0.893 . . . . 0.0 112.644 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -81.99 102.39 2.26 Favored Glycine 0 N--CA 1.492 2.428 0 CA-C-N 112.884 -1.962 . . . . 0.0 112.659 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 47.4 t -79.6 90.28 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 124.051 0.5 . . . . 0.0 112.18 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.4 ' SG ' ' HA ' ' A' ' 55' ' ' GLU . 1.5 m -79.33 120.38 80.28 Favored Pre-proline 0 N--CA 1.504 2.229 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 179.459 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -71.1 -60.13 0.06 OUTLIER 'Trans proline' 0 N--CA 1.492 1.405 0 C-N-CA 122.534 2.156 . . . . 0.0 109.735 -173.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -80.17 128.72 33.85 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-N 114.482 -1.236 . . . . 0.0 109.577 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 82.0 p 44.96 -158.78 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.182 0 O-C-N 125.034 1.459 . . . . 0.0 113.194 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -70.59 -50.95 31.82 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 109.165 -0.679 . . . . 0.0 109.165 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.4 ' HA ' ' SG ' ' A' ' 50' ' ' CYS . 12.2 pt-20 179.3 -173.23 0.18 Allowed 'General case' 0 N--CA 1.502 2.154 0 O-C-N 124.485 1.116 . . . . 0.0 109.587 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.491 ' HZ2' ' HB3' ' A' ' 56' ' ' LYS . 0.0 OUTLIER -62.41 133.53 55.17 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 105.963 -1.866 . . . . 0.0 105.963 179.462 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.445 ' H ' ' HZ3' ' A' ' 56' ' ' LYS . 5.9 ptpp? 38.7 47.79 1.21 Allowed 'General case' 0 N--CA 1.504 2.227 0 O-C-N 124.874 1.359 . . . . 0.0 110.982 -179.78 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 10.5 m-80 -6.82 127.07 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.142 0 CA-C-N 111.16 -2.745 . . . . 0.0 117.273 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -77.92 28.97 0.17 Allowed 'General case' 0 N--CA 1.499 2.013 0 CA-C-N 114.808 -1.087 . . . . 0.0 111.627 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.419 ' HD2' ' N ' ' A' ' 60' ' ' ARG . 2.0 mpt_? 68.49 137.97 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.098 0 C-N-CA 123.929 0.892 . . . . 0.0 109.806 -179.739 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 7.2 tp -39.61 94.97 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 O-C-N 124.811 1.319 . . . . 0.0 113.49 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.52 ' HA ' ' HA ' ' A' ' 99' ' ' CYS . 6.8 m -99.88 34.7 2.21 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 123.349 1.547 . . . . 0.0 113.037 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 95.1 m -91.08 138.42 31.62 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-N 111.584 -2.553 . . . . 0.0 106.777 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.526 ' ND2' ' H ' ' A' ' 67' ' ' ALA . 28.4 p-10 -160.74 151.04 17.93 Favored 'General case' 0 N--CA 1.499 2.01 0 C-N-CA 120.011 -0.676 . . . . 0.0 111.286 179.76 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' CYS . . . . . 0.406 ' SG ' ' NH1' ' A' ' 97' ' ' ARG . 0.7 OUTLIER -60.05 -28.78 68.05 Favored 'General case' 0 N--CA 1.495 1.789 0 CA-C-N 114.316 -1.311 . . . . 0.0 114.072 -179.842 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 40.1 t -79.78 -69.05 0.61 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 124.168 0.918 . . . . 0.0 111.81 -179.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.526 ' H ' ' ND2' ' A' ' 64' ' ' ASN . . . -88.37 45.26 1.27 Allowed 'General case' 0 N--CA 1.497 1.898 0 O-C-N 124.848 1.342 . . . . 0.0 109.812 -179.806 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -85.58 -143.55 6.87 Favored Glycine 0 N--CA 1.489 2.201 0 CA-C-N 114.365 -1.288 . . . . 0.0 111.264 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 35.5 p -139.85 116.21 10.6 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 114.826 -0.687 . . . . 0.0 110.523 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -60.69 97.07 0.05 OUTLIER 'General case' 0 N--CA 1.5 2.048 0 O-C-N 124.135 0.897 . . . . 0.0 109.619 179.706 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 158.21 -17.91 0.31 Allowed Glycine 0 N--CA 1.494 2.558 0 CA-C-N 114.52 -1.218 . . . . 0.0 110.872 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 91.2 m -125.39 155.44 40.36 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 124.015 0.479 . . . . 0.0 110.373 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -103.1 94.3 5.47 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 124.192 0.933 . . . . 0.0 109.763 -179.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -51.02 128.77 22.35 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-N 113.647 -1.615 . . . . 0.0 109.333 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.475 ' CE2' ' HA ' ' A' ' 80' ' ' THR . 0.2 OUTLIER -134.6 153.88 51.76 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-N 113.606 -1.634 . . . . 0.0 113.678 -179.335 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.407 ' N ' HG23 ' A' ' 82' ' ' VAL . 31.6 t -112.74 129.6 56.36 Favored 'General case' 0 N--CA 1.498 1.964 0 CA-C-N 112.98 -1.918 . . . . 0.0 112.359 -179.718 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.446 ' H ' ' HB2' ' A' ' 104' ' ' ALA . 8.4 p-10 -61.88 -50.03 73.85 Favored 'General case' 0 N--CA 1.499 1.993 0 CA-C-N 114.622 -1.172 . . . . 0.0 109.546 179.833 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -90.81 18.24 6.77 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 112.825 -1.989 . . . . 0.0 111.641 -179.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -163.47 25.34 0.2 Allowed Glycine 0 N--CA 1.495 2.628 0 C-N-CA 118.915 -1.612 . . . . 0.0 113.141 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.475 ' HA ' ' CE2' ' A' ' 75' ' ' PHE . 6.7 t 42.48 -163.56 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.794 0 O-C-N 124.998 1.057 . . . . 0.0 113.22 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 22.8 t80 -48.28 127.94 13.55 Favored 'General case' 0 N--CA 1.497 1.889 0 CA-C-O 121.378 0.609 . . . . 0.0 111.592 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.407 HG23 ' N ' ' A' ' 76' ' ' SER . 63.5 t -94.79 -76.94 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . 0.488 ' SG ' ' N ' ' A' ' 84' ' ' GLU . 0.4 OUTLIER -168.09 -169.64 1.16 Allowed 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 179.696 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.488 ' N ' ' SG ' ' A' ' 83' ' ' CYS . 37.6 tt0 -96.01 162.01 13.74 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -72.01 107.1 2.09 Favored Glycine 0 N--CA 1.493 2.486 0 N-CA-C 105.078 -3.209 . . . . 0.0 105.078 179.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -93.13 25.06 3.44 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 -179.643 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 29.4 t -129.4 123.39 31.54 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-N 114.338 -1.301 . . . . 0.0 108.97 179.655 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.69 ' H ' HD21 ' A' ' 91' ' ' ASN . 16.4 t70 -85.56 144.61 40.42 Favored Pre-proline 0 N--CA 1.492 1.671 0 CA-C-N 114.442 -1.253 . . . . 0.0 108.126 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_endo -61.86 79.76 0.09 OUTLIER 'Trans proline' 0 N--CA 1.496 1.64 0 C-N-CA 122.574 2.183 . . . . 0.0 108.414 165.131 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 58.2 ttt85 -169.78 -52.86 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 105.515 -2.032 . . . . 0.0 105.515 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.69 HD21 ' H ' ' A' ' 88' ' ' ASP . 2.7 p30 -91.54 115.55 64.71 Favored Pre-proline 0 N--CA 1.497 1.92 0 O-C-N 124.83 1.331 . . . . 0.0 111.237 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -83.45 49.38 2.93 Favored 'Trans proline' 0 N--CA 1.495 1.571 0 C-N-CA 123.484 2.789 . . . . 0.0 109.549 170.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -106.56 152.4 23.75 Favored 'General case' 0 N--CA 1.498 1.938 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.79 -179.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -152.61 154.81 36.11 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-N 115.01 -0.996 . . . . 0.0 111.245 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 66.3 m -84.99 -179.53 1.5 Allowed Pre-proline 0 N--CA 1.498 1.94 0 CA-C-N 114.394 -1.276 . . . . 0.0 108.682 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_endo -62.98 65.94 0.15 Allowed 'Trans proline' 0 N--CA 1.494 1.525 0 C-N-CA 122.13 1.887 . . . . 0.0 110.318 148.485 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.406 ' NH1' ' SG ' ' A' ' 65' ' ' CYS . 34.6 ttm180 -160.14 26.85 0.17 Allowed 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 106.285 -1.746 . . . . 0.0 106.285 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 29.0 m120 -60.68 117.02 4.83 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-N 114.78 -1.1 . . . . 0.0 109.956 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.52 ' HA ' ' HA ' ' A' ' 62' ' ' CYS . 65.0 m 54.1 86.49 0.05 OUTLIER 'General case' 0 N--CA 1.496 1.87 0 O-C-N 124.854 1.346 . . . . 0.0 110.665 -179.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.41 ' O ' HG22 ' A' ' 103' ' ' ILE . 10.7 t70 -71.01 109.22 4.79 Favored Pre-proline 0 N--CA 1.498 1.942 0 CA-C-N 115.683 -0.689 . . . . 0.0 111.58 -179.769 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_endo -69.71 -38.9 7.26 Favored 'Trans proline' 0 N--CA 1.494 1.538 0 C-N-CA 122.157 1.905 . . . . 0.0 109.857 -171.377 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 35.2 mmt180 -71.27 -11.68 61.05 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-N 113.984 -1.462 . . . . 0.0 113.828 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.41 HG22 ' O ' ' A' ' 100' ' ' ASP . 8.9 tt -73.38 178.55 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 C-N-CA 118.614 -1.234 . . . . 0.0 109.293 -179.792 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.446 ' HB2' ' H ' ' A' ' 77' ' ' ASP . . . -134.7 -60.23 0.79 Allowed 'General case' 0 N--CA 1.494 1.741 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.788 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 15.8 p90 -168.7 166.69 11.64 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-N 114.757 -1.11 . . . . 0.0 110.366 -179.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -99.38 116.22 5.52 Favored Glycine 0 N--CA 1.49 2.265 0 CA-C-N 113.861 -1.518 . . . . 0.0 109.417 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 96.2 mt -78.65 92.86 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 N-CA-C 105.766 -1.938 . . . . 0.0 105.766 179.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 17.1 m -79.43 121.03 82.32 Favored Pre-proline 0 N--CA 1.493 1.676 0 CA-C-N 113.995 -1.457 . . . . 0.0 109.096 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -66.19 127.18 17.02 Favored 'Trans proline' 0 N--CA 1.493 1.469 0 C-N-CA 122.259 1.972 . . . . 0.0 110.359 -179.07 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -79.59 104.13 9.97 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 105.688 -1.967 . . . . 0.0 105.688 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.501 2.102 0 CA-C-O 117.568 -1.206 . . . . 0.0 112.198 -179.946 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 30.7 t70 . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.439 HH11 ' HB2' ' A' ' 4' ' ' CYS . 2.5 tmm_? 55.55 64.5 1.74 Allowed 'General case' 0 N--CA 1.5 2.048 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 8.3 tp -90.43 51.71 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 CA-C-N 114.257 -1.338 . . . . 0.0 110.293 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.519 ' HA ' ' HA ' ' A' ' 41' ' ' CYS . 1.6 m -82.73 41.14 0.71 Allowed 'General case' 0 N--CA 1.495 1.813 0 CA-C-O 123.056 1.408 . . . . 0.0 114.389 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 91.8 m -91.47 112.86 24.95 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-N 112.657 -2.065 . . . . 0.0 109.127 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.466 ' ND2' ' HA ' ' A' ' 40' ' ' ASN . 40.3 p-10 -115.94 176.93 4.87 Favored 'General case' 0 N--CA 1.501 2.092 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 179.545 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.457 ' SG ' ' CD2' ' A' ' 16' ' ' TYR . 1.8 t -73.08 -27.69 61.87 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 114.322 1.23 . . . . 0.0 114.322 -179.557 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.484 ' SG ' ' N ' ' A' ' 37' ' ' CYS . 53.0 t -80.14 -63.14 1.48 Allowed 'General case' 0 N--CA 1.492 1.674 0 CA-C-N 114.374 -1.285 . . . . 0.0 113.936 -179.602 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -90.22 19.38 5.11 Favored 'General case' 0 N--CA 1.502 2.16 0 N-CA-C 113.619 0.97 . . . . 0.0 113.619 -179.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -83.45 -111.57 0.54 Allowed Glycine 0 N--CA 1.499 2.852 0 C-N-CA 120.6 -0.81 . . . . 0.0 111.57 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 40.7 p -137.08 112.22 9.07 Favored 'General case' 0 N--CA 1.504 2.235 0 CA-C-O 121.073 0.463 . . . . 0.0 111.892 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 8.5 tmtt? -62.53 150.19 41.0 Favored 'General case' 0 N--CA 1.487 1.389 0 CA-C-O 121.241 0.543 . . . . 0.0 111.154 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 76.45 -10.27 17.68 Favored Glycine 0 N--CA 1.489 2.195 0 CA-C-N 114.301 -1.318 . . . . 0.0 111.806 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 69.0 m -102.52 127.73 49.46 Favored 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 119.561 -0.856 . . . . 0.0 108.901 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -70.84 92.36 0.9 Allowed 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 113.267 -1.788 . . . . 0.0 109.112 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.665 ' CD2' ' SG ' ' A' ' 25' ' ' CYS . 78.6 m-85 -44.94 131.13 7.35 Favored 'General case' 0 N--CA 1.502 2.161 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 179.753 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -144.99 150.38 36.82 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 125.139 1.524 . . . . 0.0 112.532 -179.421 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 40.5 t -96.1 134.46 39.14 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-N 111.969 -2.378 . . . . 0.0 111.828 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.427 ' H ' ' HB2' ' A' ' 46' ' ' ALA . 4.5 p-10 -51.05 -24.73 4.1 Favored 'General case' 0 N--CA 1.501 2.097 0 CA-C-N 112.941 -1.936 . . . . 0.0 113.9 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 25.7 p30 -59.59 -8.86 2.15 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 124.178 0.924 . . . . 0.0 112.361 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 97.07 28.71 8.47 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 86.5 m -140.64 143.07 34.96 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 123.998 0.47 . . . . 0.0 110.399 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.452 ' CG ' ' N ' ' A' ' 24' ' ' VAL . 39.1 t80 -69.54 167.92 15.77 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 124.802 1.314 . . . . 0.0 111.132 179.8 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.452 ' N ' ' CG ' ' A' ' 23' ' ' PHE . 98.6 t -132.51 -74.45 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 123.842 0.714 . . . . 0.0 112.885 -179.79 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.665 ' SG ' ' CD2' ' A' ' 16' ' ' TYR . 20.5 p -147.24 -175.7 4.94 Favored 'General case' 0 N--CA 1.509 2.506 0 C-N-CA 121.04 -0.264 . . . . 0.0 110.708 -179.623 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 7.4 tm-20 -103.74 143.83 32.28 Favored 'General case' 0 N--CA 1.508 2.467 0 N-CA-C 113.402 0.89 . . . . 0.0 113.402 -179.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.622 ' HA2' ' CE2' ' A' ' 16' ' ' TYR . . . -43.98 105.62 0.08 OUTLIER Glycine 0 N--CA 1.501 3.013 0 O-C-N 124.437 1.085 . . . . 0.0 115.039 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -122.63 37.22 4.45 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 17.5 t -121.82 65.97 0.91 Allowed 'General case' 0 N--CA 1.499 1.996 0 CA-C-O 121.815 0.816 . . . . 0.0 110.959 -179.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.443 ' H ' ' ND2' ' A' ' 33' ' ' ASN . 14.3 t70 -88.37 142.61 31.53 Favored Pre-proline 0 N--CA 1.493 1.72 0 CA-C-N 113.886 -1.506 . . . . 0.0 108.528 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -56.64 -4.72 0.92 Allowed 'Trans proline' 0 N--CA 1.497 1.727 0 C-N-CA 122.316 2.011 . . . . 0.0 114.568 175.163 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.419 ' NE ' ' HA ' ' A' ' 32' ' ' ARG . 12.3 mmp_? -94.48 -27.76 15.82 Favored 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 113.148 0.795 . . . . 0.0 113.148 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.443 ' ND2' ' H ' ' A' ' 30' ' ' ASP . 19.2 p30 -66.05 121.85 78.2 Favored Pre-proline 0 N--CA 1.497 1.898 0 C-N-CA 119.039 -1.064 . . . . 0.0 112.006 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -75.09 123.13 7.61 Favored 'Trans proline' 0 N--CA 1.492 1.423 0 C-N-CA 122.714 2.276 . . . . 0.0 109.963 178.086 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 62.64 160.52 0.08 Allowed 'General case' 0 N--CA 1.502 2.16 0 O-C-N 124.614 1.196 . . . . 0.0 112.954 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -79.92 -167.1 1.16 Allowed 'General case' 0 N--CA 1.496 1.841 0 CA-C-N 114.694 -1.139 . . . . 0.0 110.099 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.484 ' N ' ' SG ' ' A' ' 8' ' ' CYS . 4.4 m -129.97 160.19 34.38 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 123.712 0.633 . . . . 0.0 110.016 -179.863 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 77.0 m 42.27 -104.72 0.06 Allowed 'General case' 0 N--CA 1.497 1.899 0 CA-C-N 114.261 -1.336 . . . . 0.0 113.167 179.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 96.1 mt -142.18 4.03 1.6 Allowed 'General case' 0 N--CA 1.498 1.962 0 O-C-N 123.585 0.553 . . . . 0.0 112.441 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.466 ' HA ' ' ND2' ' A' ' 6' ' ' ASN . 1.6 m-80 59.07 -174.33 0.1 Allowed 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 114.174 1.176 . . . . 0.0 114.174 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.519 ' HA ' ' HA ' ' A' ' 4' ' ' CYS . 56.8 m 59.88 100.87 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 CA-C-N 113.185 -1.825 . . . . 0.0 113.04 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -120.56 101.66 45.88 Favored Pre-proline 0 N--CA 1.496 1.873 0 CA-C-N 115.32 -0.855 . . . . 0.0 108.789 179.695 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -60.49 -31.57 92.62 Favored 'Trans proline' 0 N--CA 1.494 1.518 0 C-N-CA 122.622 2.215 . . . . 0.0 111.728 -176.23 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 21.6 tpp85 -57.52 -39.91 77.59 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 124.107 0.879 . . . . 0.0 109.175 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 13.7 mt -71.26 152.49 8.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 CA-C-O 122.192 0.996 . . . . 0.0 109.827 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.427 ' HB2' ' H ' ' A' ' 19' ' ' ASP . . . -121.14 -51.2 2.11 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-N 111.773 -2.467 . . . . 0.0 106.503 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 15.8 p90 -172.7 158.9 4.17 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-N 113.186 -1.825 . . . . 0.0 109.736 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -97.86 123.41 7.82 Favored Glycine 0 N--CA 1.49 2.288 0 CA-C-N 113.313 -1.767 . . . . 0.0 108.973 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 27.2 m -90.2 101.05 11.88 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 CA-C-O 122.052 0.929 . . . . 0.0 110.678 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.6 m -79.03 164.03 57.04 Favored Pre-proline 0 N--CA 1.502 2.14 0 CA-C-N 114.502 -1.226 . . . . 0.0 108.98 179.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -57.21 154.0 36.66 Favored 'Trans proline' 0 N--CA 1.494 1.55 0 C-N-CA 122.369 2.046 . . . . 0.0 111.313 173.059 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.481 ' NE ' ' HA ' ' A' ' 52' ' ' ARG . 14.8 mmp_? -79.94 115.76 19.7 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-N 115.183 -0.917 . . . . 0.0 109.988 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 56.4 m -66.37 149.42 50.42 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-N 114.882 -1.054 . . . . 0.0 109.708 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -153.92 131.83 11.65 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-N 115.265 -0.88 . . . . 0.0 109.943 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 27.5 mm-40 -106.46 79.99 1.43 Allowed 'General case' 0 N--CA 1.492 1.657 0 CA-C-N 114.927 -1.033 . . . . 0.0 111.185 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 9.2 mtpm? -85.67 -71.77 0.52 Allowed 'General case' 0 N--CA 1.494 1.758 0 CA-C-N 113.844 -1.526 . . . . 0.0 109.763 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -160.0 150.96 19.15 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 123.954 0.784 . . . . 0.0 109.397 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 26.9 m120 49.51 34.14 6.52 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 124.24 0.962 . . . . 0.0 112.275 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -65.14 166.9 8.86 Favored 'General case' 0 N--CA 1.495 1.822 0 CA-C-N 115.064 -0.971 . . . . 0.0 111.251 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 62.4 ttm-85 -44.31 -38.42 3.89 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 124.473 1.108 . . . . 0.0 112.576 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 6.7 tp -69.52 86.56 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 124.296 0.998 . . . . 0.0 111.554 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.524 ' HA ' ' HA ' ' A' ' 99' ' ' CYS . 1.7 m -94.34 44.07 1.11 Allowed 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 123.02 1.39 . . . . 0.0 112.075 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 52.0 m -90.66 151.02 21.44 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 112.626 -2.079 . . . . 0.0 108.892 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 52.1 p-10 -127.86 -171.06 2.35 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 17.0 t -101.95 -29.97 11.5 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 123.663 0.602 . . . . 0.0 110.95 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 37.2 t -61.87 -55.35 30.64 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 124.102 0.876 . . . . 0.0 109.947 -179.748 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -87.68 63.86 7.74 Favored 'General case' 0 N--CA 1.499 2.025 0 N-CA-C 106.23 -1.767 . . . . 0.0 106.23 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -106.33 -115.87 4.08 Favored Glycine 0 N--CA 1.488 2.164 0 CA-C-N 113.963 -1.471 . . . . 0.0 112.322 -179.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.509 ' H ' ' CA ' ' A' ' 85' ' ' GLY . 2.6 t 179.29 110.67 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 125.278 1.222 . . . . 0.0 109.402 -179.851 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 11.4 mmmm -64.79 88.38 0.06 Allowed 'General case' 0 N--CA 1.499 1.996 0 CA-C-N 114.954 -1.021 . . . . 0.0 108.307 179.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 171.79 -31.73 0.13 Allowed Glycine 0 N--CA 1.487 2.055 0 CA-C-N 113.908 -1.496 . . . . 0.0 110.937 -179.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . 0.419 ' HA ' ' HA ' ' A' ' 108' ' ' CYS . 67.9 m -112.71 167.15 10.72 Favored 'General case' 0 N--CA 1.5 2.058 0 C-N-CA 119.46 -0.896 . . . . 0.0 111.139 -179.818 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 61.1 mtpt -111.14 100.91 9.48 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-N 114.074 -1.421 . . . . 0.0 113.775 -179.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.414 ' CG ' HD11 ' A' ' 103' ' ' ILE . 5.0 m-85 -52.71 141.63 20.56 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 124.265 0.978 . . . . 0.0 109.988 179.466 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -154.77 159.45 40.64 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 113.684 -1.598 . . . . 0.0 112.964 -179.426 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 73.0 p -100.24 135.08 42.21 Favored 'General case' 0 N--CA 1.486 1.358 0 CA-C-N 114.014 -1.448 . . . . 0.0 113.179 -179.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.547 ' H ' ' HB2' ' A' ' 104' ' ' ALA . 4.6 p-10 -40.01 -47.19 2.22 Favored 'General case' 0 N--CA 1.499 2.005 0 CA-C-N 112.82 -1.991 . . . . 0.0 115.978 -179.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -52.9 -36.05 58.95 Favored 'General case' 0 N--CA 1.497 1.88 0 CA-C-N 114.724 -1.125 . . . . 0.0 112.38 -179.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 128.43 42.68 0.24 Allowed Glycine 0 N--CA 1.494 2.539 0 O-C-N 124.772 1.295 . . . . 0.0 111.594 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 95.1 m -140.84 114.07 8.58 Favored 'General case' 0 N--CA 1.497 1.876 0 C-N-CA 119.469 -0.893 . . . . 0.0 112.739 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -54.18 139.69 34.83 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.639 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 99.5 t -103.88 -63.98 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 CA-C-N 114.571 -1.195 . . . . 0.0 112.183 -179.702 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . 0.415 ' SG ' ' N ' ' A' ' 84' ' ' GLU . 1.8 p -160.28 -162.98 1.03 Allowed 'General case' 0 N--CA 1.501 2.083 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 -179.8 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.415 ' N ' ' SG ' ' A' ' 83' ' ' CYS . 30.4 tt0 -118.36 144.7 45.69 Favored 'General case' 0 N--CA 1.5 2.069 0 N-CA-C 105.992 -1.855 . . . . 0.0 105.992 179.298 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.509 ' CA ' ' H ' ' A' ' 69' ' ' THR . . . -60.17 135.78 50.03 Favored Glycine 0 N--CA 1.496 2.689 0 N-CA-C 108.154 -1.979 . . . . 0.0 108.154 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -105.71 -7.89 18.17 Favored 'General case' 0 N--CA 1.503 2.195 0 N-CA-C 116.722 2.119 . . . . 0.0 116.722 -179.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 26.8 t -70.06 97.09 1.12 Allowed 'General case' 0 N--CA 1.501 2.115 0 C-N-CA 119.001 -1.08 . . . . 0.0 108.757 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -79.74 143.81 59.18 Favored Pre-proline 0 N--CA 1.494 1.74 0 CA-C-N 114.855 -1.066 . . . . 0.0 109.765 -179.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -46.66 -22.34 1.79 Allowed 'Trans proline' 0 N--CA 1.499 1.817 0 C-N-CA 122.887 2.392 . . . . 0.0 113.017 170.717 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.432 ' NE ' ' HA ' ' A' ' 90' ' ' ARG . 3.7 tpm_? -62.14 -53.08 60.42 Favored 'General case' 0 N--CA 1.495 1.775 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.412 HD22 ' H ' ' A' ' 93' ' ' LYS . 2.4 p-10 -84.63 131.95 48.16 Favored Pre-proline 0 N--CA 1.492 1.663 0 CA-C-N 115.079 -0.964 . . . . 0.0 108.99 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -79.26 56.9 6.23 Favored 'Trans proline' 0 N--CA 1.492 1.388 0 C-N-CA 123.029 2.486 . . . . 0.0 108.181 163.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.412 ' H ' HD22 ' A' ' 91' ' ' ASN . 27.7 mtpp 65.29 121.31 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.082 0 CA-C-N 114.585 -1.188 . . . . 0.0 110.923 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -153.25 68.21 0.8 Allowed 'General case' 0 N--CA 1.496 1.839 0 CA-C-N 114.665 -1.152 . . . . 0.0 108.134 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 89.7 m -154.11 160.56 30.8 Favored Pre-proline 0 N--CA 1.496 1.855 0 CA-C-N 114.263 -1.335 . . . . 0.0 111.967 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -73.41 -159.27 0.08 OUTLIER 'Trans proline' 0 N--CA 1.493 1.442 0 C-N-CA 122.973 2.449 . . . . 0.0 109.792 160.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.55 52.25 1.12 Allowed 'General case' 0 N--CA 1.494 1.772 0 CA-C-O 122.392 1.092 . . . . 0.0 108.284 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -47.04 113.9 0.75 Allowed 'General case' 0 N--CA 1.5 2.051 0 CA-C-N 113.054 -1.885 . . . . 0.0 110.565 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.524 ' HA ' ' HA ' ' A' ' 62' ' ' CYS . 56.2 m -60.07 121.7 12.53 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 119.926 -0.709 . . . . 0.0 111.095 -179.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 42.0 t0 -112.22 91.09 15.24 Favored Pre-proline 0 N--CA 1.494 1.762 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -58.34 -31.44 93.88 Favored 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 122.708 2.272 . . . . 0.0 111.143 -169.033 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 15.7 tpt180 -73.04 -40.39 65.16 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-N 114.366 -1.288 . . . . 0.0 112.305 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.414 HD11 ' CG ' ' A' ' 74' ' ' TYR . 3.3 tt -58.67 162.54 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 O-C-N 123.524 0.515 . . . . 0.0 112.048 -179.592 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.547 ' HB2' ' H ' ' A' ' 77' ' ' ASP . . . -139.96 -57.81 0.56 Allowed 'General case' 0 N--CA 1.495 1.824 0 CA-C-N 114.411 -1.268 . . . . 0.0 109.172 179.807 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 15.3 p90 -165.62 163.41 19.25 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-N 114.816 -1.084 . . . . 0.0 110.917 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -111.32 115.22 3.87 Favored Glycine 0 N--CA 1.493 2.444 0 CA-C-N 114.077 -1.419 . . . . 0.0 111.974 -179.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 51.5 mm -93.01 124.54 45.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 124.52 0.777 . . . . 0.0 110.054 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' CYS . . . . . 0.419 ' HA ' ' HA ' ' A' ' 72' ' ' CYS . 1.7 m -79.61 148.17 68.99 Favored Pre-proline 0 N--CA 1.495 1.82 0 O-C-N 124.024 0.827 . . . . 0.0 109.706 179.685 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -56.47 144.59 83.49 Favored 'Trans proline' 0 N--CA 1.494 1.559 0 C-N-CA 122.866 2.378 . . . . 0.0 111.457 -175.249 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 3.2 pp -154.48 175.17 13.92 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 124.406 1.066 . . . . 0.0 111.281 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.85 0 CA-C-O 116.308 -1.806 . . . . 0.0 110.52 -179.997 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 86.3 mtm180 51.94 39.81 26.82 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 124.31 1.006 . . . . 0.0 111.51 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 8.7 tp -84.04 48.5 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 CA-C-N 114.445 -1.252 . . . . 0.0 109.982 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.494 ' HA ' ' HA ' ' A' ' 41' ' ' CYS . 1.5 m -83.42 57.29 3.94 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 115.668 1.729 . . . . 0.0 115.668 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 37.3 p -91.8 176.6 6.47 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-N 113.143 -1.844 . . . . 0.0 110.183 179.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.524 HD21 ' N ' ' A' ' 37' ' ' CYS . 34.2 p30 -162.04 -172.72 3.35 Favored 'General case' 0 N--CA 1.495 1.807 0 CA-C-N 114.276 -1.329 . . . . 0.0 108.026 179.189 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.8 t -75.98 -10.15 59.19 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 115.737 1.754 . . . . 0.0 115.737 -179.472 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 6.7 t -91.79 -37.52 12.91 Favored 'General case' 0 N--CA 1.503 2.177 0 CA-C-O 121.587 0.708 . . . . 0.0 111.667 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -74.34 57.76 0.7 Allowed 'General case' 0 N--CA 1.497 1.909 0 CA-C-N 113.085 -1.87 . . . . 0.0 113.568 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -162.16 -121.9 0.59 Allowed Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 86.7 m -140.29 124.28 17.5 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 123.88 0.4 . . . . 0.0 111.851 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 40.4 ttpt -67.42 86.67 0.18 Allowed 'General case' 0 N--CA 1.496 1.865 0 O-C-N 124.618 1.199 . . . . 0.0 109.308 179.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.459 ' H ' ' HA3' ' A' ' 27' ' ' GLY . . . 156.15 -19.13 0.47 Allowed Glycine 0 N--CA 1.494 2.56 0 CA-C-N 114.855 -1.066 . . . . 0.0 110.661 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 87.7 m -89.43 -177.8 5.43 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -130.54 101.97 5.94 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 123.477 0.486 . . . . 0.0 110.218 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.632 ' CD1' ' SG ' ' A' ' 25' ' ' CYS . 85.0 m-85 -55.85 141.66 38.09 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 124.116 0.885 . . . . 0.0 109.08 179.806 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -149.65 151.71 34.18 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 124.874 1.359 . . . . 0.0 112.699 -179.685 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 96.2 p -101.69 132.7 47.25 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-N 113.272 -1.786 . . . . 0.0 112.476 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.469 ' H ' ' CB ' ' A' ' 46' ' ' ALA . 6.1 p-10 -45.24 -31.17 1.42 Allowed 'General case' 0 N--CA 1.504 2.239 0 N-CA-C 116.643 2.09 . . . . 0.0 116.643 -179.709 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -55.2 -15.87 2.7 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 123.989 0.805 . . . . 0.0 112.738 -179.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 108.88 25.28 5.72 Favored Glycine 0 N--CA 1.493 2.448 0 O-C-N 124.419 1.074 . . . . 0.0 111.003 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 57.0 m -135.64 152.06 50.85 Favored 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 120.437 -0.505 . . . . 0.0 110.513 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.406 ' CG ' ' N ' ' A' ' 24' ' ' VAL . 17.5 t80 -74.67 169.54 17.63 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-N 114.546 -1.207 . . . . 0.0 109.824 179.706 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.406 ' N ' ' CG ' ' A' ' 23' ' ' PHE . 93.8 t -131.25 -67.85 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 O-C-N 123.689 0.618 . . . . 0.0 112.635 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.632 ' SG ' ' CD1' ' A' ' 16' ' ' TYR . 11.9 p -153.75 -172.62 4.28 Favored 'General case' 0 N--CA 1.504 2.228 0 C-N-CA 120.256 -0.577 . . . . 0.0 109.469 -179.771 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -126.67 143.2 51.31 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 123.705 0.628 . . . . 0.0 110.906 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.459 ' HA3' ' H ' ' A' ' 13' ' ' GLY . . . -27.41 124.43 0.06 OUTLIER Glycine 0 N--CA 1.495 2.621 0 O-C-N 124.941 1.401 . . . . 0.0 116.09 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -114.69 -22.42 9.72 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 124.582 0.813 . . . . 0.0 110.244 179.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 47.4 t -156.56 154.38 30.17 Favored 'General case' 0 N--CA 1.497 1.916 0 CA-C-O 121.522 0.677 . . . . 0.0 111.153 -179.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -78.85 141.28 59.13 Favored Pre-proline 0 N--CA 1.496 1.856 0 CA-C-N 113.401 -1.727 . . . . 0.0 108.76 -179.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -61.61 -12.94 27.05 Favored 'Trans proline' 0 N--CA 1.496 1.647 0 C-N-CA 122.766 2.311 . . . . 0.0 113.452 -165.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 23.5 mmm180 -56.88 -23.51 45.07 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 123.792 0.683 . . . . 0.0 110.968 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.55 HD22 ' H ' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -64.28 112.95 8.74 Favored Pre-proline 0 N--CA 1.492 1.639 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 179.779 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -81.24 39.02 0.81 Allowed 'Trans proline' 0 N--CA 1.496 1.675 0 C-N-CA 123.222 2.615 . . . . 0.0 112.203 -175.216 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -175.82 155.87 1.73 Allowed 'General case' 0 N--CA 1.497 1.91 0 CA-C-N 115.197 -0.911 . . . . 0.0 111.831 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.409 ' HB3' HD22 ' A' ' 40' ' ' ASN . . . -82.95 143.48 30.65 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 179.666 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.524 ' N ' HD21 ' A' ' 6' ' ' ASN . 1.6 m -105.69 -140.58 0.37 Allowed 'General case' 0 N--CA 1.499 2.0 0 O-C-N 123.725 0.641 . . . . 0.0 109.322 -179.788 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 58.5 p 35.33 -141.59 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.186 0 N-CA-C 114.081 1.141 . . . . 0.0 114.081 179.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.459 ' H ' ' CD2' ' A' ' 39' ' ' LEU . 1.6 pt? -80.32 -7.09 58.9 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 123.713 0.633 . . . . 0.0 111.776 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.409 HD22 ' HB3' ' A' ' 36' ' ' ALA . 19.1 m120 62.62 158.07 0.06 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 124.756 1.285 . . . . 0.0 112.972 -179.825 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.494 ' HA ' ' HA ' ' A' ' 4' ' ' CYS . 82.4 m 54.76 116.51 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 116.341 1.978 . . . . 0.0 116.341 -179.817 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -148.11 90.97 4.93 Favored Pre-proline 0 N--CA 1.491 1.619 0 CA-C-N 113.707 -1.588 . . . . 0.0 108.979 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -62.07 -17.55 56.87 Favored 'Trans proline' 0 N--CA 1.492 1.4 0 C-N-CA 122.58 2.187 . . . . 0.0 111.922 175.515 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 33.3 mmt180 -64.01 -33.6 76.11 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 123.844 0.715 . . . . 0.0 109.987 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 4.3 mt -68.79 137.13 24.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 CA-C-O 121.959 0.885 . . . . 0.0 111.401 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.469 ' CB ' ' H ' ' A' ' 19' ' ' ASP . . . -127.58 -53.73 1.35 Allowed 'General case' 0 N--CA 1.494 1.739 0 CA-C-N 112.327 -2.215 . . . . 0.0 109.372 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 30.5 m-85 -137.01 -166.37 1.9 Allowed 'General case' 0 N--CA 1.494 1.764 0 CA-C-N 114.332 -1.303 . . . . 0.0 108.591 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -160.63 104.81 0.25 Allowed Glycine 0 N--CA 1.489 2.178 0 N-CA-C 107.519 -2.232 . . . . 0.0 107.519 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.2 p -79.75 123.3 36.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 -179.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 57.1 m -102.27 148.55 35.58 Favored Pre-proline 0 N--CA 1.496 1.871 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.919 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -72.68 107.0 2.22 Favored 'Trans proline' 0 N--CA 1.492 1.41 0 C-N-CA 122.652 2.234 . . . . 0.0 108.56 173.307 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 32.3 ttp-105 -79.53 -25.3 41.74 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 123.996 0.81 . . . . 0.0 110.374 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 36.9 t -146.4 137.46 24.33 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 123.762 0.664 . . . . 0.0 110.26 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 63.27 139.29 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.107 0 O-C-N 125.071 1.482 . . . . 0.0 113.248 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.516 ' CD ' ' H ' ' A' ' 55' ' ' GLU . 0.0 OUTLIER -86.52 -167.3 1.82 Allowed 'General case' 0 N--CA 1.498 1.975 0 CA-C-N 114.152 -1.386 . . . . 0.0 110.012 179.876 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.66 2.59 2.94 Favored 'General case' 0 N--CA 1.496 1.875 0 CA-C-N 115.001 -1.0 . . . . 0.0 110.679 179.745 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 41.2 ttmt -151.9 135.08 15.86 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 23.9 m120 -86.61 53.81 2.94 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.603 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -103.57 40.31 1.44 Allowed 'General case' 0 N--CA 1.496 1.864 0 CA-C-N 114.617 -1.174 . . . . 0.0 109.58 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.429 ' H ' ' HE ' ' A' ' 60' ' ' ARG . 0.8 OUTLIER -53.07 -35.53 59.65 Favored 'General case' 0 N--CA 1.499 1.981 0 CA-C-N 115.036 -0.984 . . . . 0.0 109.656 179.936 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 5.8 tp -77.84 80.73 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 179.608 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.449 ' HA ' ' HA ' ' A' ' 99' ' ' CYS . 1.8 m -85.91 44.87 1.16 Allowed 'General case' 0 N--CA 1.493 1.684 0 CA-C-O 122.933 1.349 . . . . 0.0 112.492 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 52.8 m -90.43 167.75 12.38 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 112.628 -2.078 . . . . 0.0 109.088 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 40.8 p30 -151.84 -175.43 5.22 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-N 114.816 -1.084 . . . . 0.0 108.441 179.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 37.1 t -94.19 -29.0 15.34 Favored 'General case' 0 N--CA 1.497 1.893 0 C-N-CA 120.168 -0.613 . . . . 0.0 112.311 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 37.5 t -59.7 -57.85 11.14 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 124.209 0.943 . . . . 0.0 111.166 -179.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -88.11 41.43 1.0 Allowed 'General case' 0 N--CA 1.494 1.768 0 CA-C-N 112.946 -1.934 . . . . 0.0 109.184 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -79.85 -136.0 1.41 Allowed Glycine 0 N--CA 1.492 2.433 0 N-CA-C 110.092 -1.203 . . . . 0.0 110.092 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 97.3 m -159.07 95.8 1.29 Allowed 'General case' 0 N--CA 1.501 2.081 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 39.9 mmtt -45.72 117.04 1.33 Allowed 'General case' 0 N--CA 1.505 2.305 0 O-C-N 123.731 0.644 . . . . 0.0 112.0 179.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 133.04 -34.64 2.42 Favored Glycine 0 N--CA 1.494 2.507 0 O-C-N 124.643 1.214 . . . . 0.0 110.368 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 63.6 m -101.77 136.8 40.99 Favored 'General case' 0 N--CA 1.494 1.743 0 CA-C-O 121.571 0.701 . . . . 0.0 110.686 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.444 ' HD2' ' N ' ' A' ' 73' ' ' LYS . 4.3 mptp? -85.02 88.99 7.5 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 113.315 -1.766 . . . . 0.0 109.589 -179.834 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.439 ' HA ' ' HA2' ' A' ' 106' ' ' GLY . 35.3 m-85 -48.46 129.2 15.8 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 124.346 1.029 . . . . 0.0 109.107 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -141.0 152.54 45.0 Favored 'General case' 0 C--N 1.303 -1.413 0 CA-C-N 112.491 -2.14 . . . . 0.0 113.219 -179.109 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 80.6 p -92.86 136.28 33.39 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-N 113.056 -1.884 . . . . 0.0 114.744 -179.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -49.45 -29.53 6.7 Favored 'General case' 0 N--CA 1.5 2.035 0 CA-C-N 112.689 -2.05 . . . . 0.0 115.523 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -57.91 -15.33 8.35 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 123.855 0.722 . . . . 0.0 112.548 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 108.62 27.7 4.84 Favored Glycine 0 N--CA 1.494 2.526 0 O-C-N 124.33 1.019 . . . . 0.0 111.149 179.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 60.4 m -138.85 160.01 40.75 Favored 'General case' 0 N--CA 1.496 1.852 0 C-N-CA 120.534 -0.466 . . . . 0.0 110.028 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.432 ' CG ' ' N ' ' A' ' 82' ' ' VAL . 57.4 t80 -79.7 168.3 19.52 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-N 114.758 -1.11 . . . . 0.0 110.554 179.761 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.432 ' N ' ' CG ' ' A' ' 81' ' ' PHE . 89.1 t -133.12 -73.52 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 124.054 0.846 . . . . 0.0 110.335 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . 0.422 ' SG ' ' N ' ' A' ' 84' ' ' GLU . 1.1 p -154.72 -167.23 2.54 Favored 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 -179.771 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.422 ' N ' ' SG ' ' A' ' 83' ' ' CYS . 32.4 tt0 -118.93 152.53 36.16 Favored 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 104.124 -2.547 . . . . 0.0 104.124 179.335 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -53.77 127.85 38.6 Favored Glycine 0 N--CA 1.498 2.777 0 C-N-CA 119.834 -1.174 . . . . 0.0 110.187 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -89.58 -25.15 21.49 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 123.905 0.414 . . . . 0.0 111.625 -179.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 70.9 p -69.6 96.14 0.91 Allowed 'General case' 0 N--CA 1.49 1.549 0 CA-C-O 121.765 0.793 . . . . 0.0 111.113 -179.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -97.25 136.4 21.44 Favored Pre-proline 0 N--CA 1.493 1.719 0 N-CA-C 106.807 -1.553 . . . . 0.0 106.807 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo -43.83 -26.52 1.31 Allowed 'Trans proline' 0 N--CA 1.501 1.962 0 C-N-CA 122.659 2.239 . . . . 0.0 111.515 167.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 37.4 ttp85 -65.85 -54.66 23.84 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-N 113.849 -1.523 . . . . 0.0 109.395 179.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 21.6 p30 -90.05 138.93 27.29 Favored Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 124.097 0.873 . . . . 0.0 111.961 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -81.17 49.82 3.35 Favored 'Trans proline' 0 N--CA 1.49 1.268 0 C-N-CA 123.068 2.512 . . . . 0.0 109.25 160.544 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.514 ' NZ ' ' H ' ' A' ' 94' ' ' ALA . 0.2 OUTLIER -67.32 148.47 51.63 Favored 'General case' 0 N--CA 1.498 1.935 0 CA-C-O 121.506 0.669 . . . . 0.0 110.214 -179.961 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.514 ' H ' ' NZ ' ' A' ' 93' ' ' LYS . . . -160.32 152.96 21.04 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-N 113.491 -1.686 . . . . 0.0 110.354 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 86.1 m -156.34 167.47 14.32 Favored Pre-proline 0 N--CA 1.498 1.969 0 CA-C-N 114.644 -1.162 . . . . 0.0 109.245 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -55.37 -161.59 0.01 OUTLIER 'Trans proline' 0 N--CA 1.497 1.721 0 C-N-CA 122.717 2.278 . . . . 0.0 112.642 164.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 79.9 mtp180 -78.88 -43.2 25.47 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 36.3 m-80 46.53 54.98 8.07 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 124.945 1.403 . . . . 0.0 108.874 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.449 ' HA ' ' HA ' ' A' ' 62' ' ' CYS . 60.2 m -42.93 125.87 3.64 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-N 113.471 -1.695 . . . . 0.0 113.714 -179.675 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 45.0 t0 -116.93 86.27 19.29 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 124.687 1.242 . . . . 0.0 107.853 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -52.9 -26.52 31.59 Favored 'Trans proline' 0 N--CA 1.496 1.653 0 C-N-CA 122.808 2.339 . . . . 0.0 112.833 -178.138 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 78.0 ttt-85 -82.37 -33.93 28.59 Favored 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 114.552 1.315 . . . . 0.0 114.552 -179.622 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 8.8 tt -63.97 168.68 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.239 0 C-N-CA 120.192 -0.603 . . . . 0.0 110.92 -179.607 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -145.93 -72.3 0.24 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 123.81 0.694 . . . . 0.0 111.327 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 27.4 p90 -149.8 158.99 44.7 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 123.94 0.775 . . . . 0.0 112.041 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.439 ' HA2' ' HA ' ' A' ' 74' ' ' TYR . . . -98.73 114.28 4.98 Favored Glycine 0 N--CA 1.491 2.323 0 CA-C-N 112.949 -1.932 . . . . 0.0 111.444 -179.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 70.6 mt -79.85 97.38 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 CA-C-N 114.282 -0.959 . . . . 0.0 111.137 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 1.6 m -79.35 148.82 71.3 Favored Pre-proline 0 N--CA 1.502 2.172 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 179.521 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -65.74 141.26 65.09 Favored 'Trans proline' 0 N--CA 1.493 1.458 0 C-N-CA 122.549 2.166 . . . . 0.0 110.527 -179.384 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.458 ' N ' HD22 ' A' ' 110' ' ' LEU . 3.0 mm? -79.88 113.42 18.02 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.09 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 1.881 0 CA-C-O 116.331 -1.795 . . . . 0.0 111.297 -179.999 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 18.7 t70 . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 8.4 ptp180 -157.11 -23.8 0.09 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 124.34 1.025 . . . . 0.0 110.67 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 46.1 mm -77.85 91.61 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 124.132 0.895 . . . . 0.0 108.915 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.525 ' H ' ' HB3' ' A' ' 41' ' ' CYS . 0.5 OUTLIER -84.52 -160.23 0.46 Allowed 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 106.04 -1.837 . . . . 0.0 106.04 -179.997 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.8 t -73.48 -169.26 0.65 Allowed 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 179.536 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.502 ' ND2' HD12 ' A' ' 45' ' ' ILE . 4.4 t-20 -122.65 166.84 14.24 Favored 'General case' 0 N--CA 1.497 1.893 0 CA-C-O 122.614 1.197 . . . . 0.0 112.356 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.534 ' HA ' ' CE2' ' A' ' 16' ' ' TYR . 19.9 t 43.28 26.29 0.09 Allowed 'General case' 0 N--CA 1.493 1.71 0 CA-C-N 111.189 -2.732 . . . . 0.0 113.925 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 28.0 t -90.14 -68.46 0.78 Allowed 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 116.639 2.089 . . . . 0.0 116.639 -179.635 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -57.6 -4.47 0.27 Allowed 'General case' 0 N--CA 1.506 2.37 0 N-CA-C 118.367 2.729 . . . . 0.0 118.367 -179.494 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.414 ' N ' ' OH ' ' A' ' 16' ' ' TYR . . . -65.0 -39.22 96.29 Favored Glycine 0 N--CA 1.493 2.465 0 N-CA-C 110.941 -0.864 . . . . 0.0 110.941 -179.791 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 38.8 m 68.49 112.22 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.844 0 O-C-N 125.62 1.424 . . . . 0.0 107.164 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 14.8 tppt? -37.99 98.43 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.088 0 O-C-N 124.693 1.245 . . . . 0.0 113.0 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 157.82 -22.15 0.39 Allowed Glycine 0 N--CA 1.49 2.262 0 CA-C-N 112.686 -2.052 . . . . 0.0 108.686 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 90.9 m -103.98 169.25 8.61 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 62.3 mttp -124.32 95.12 4.42 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 123.972 0.795 . . . . 0.0 112.18 -179.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.612 ' HB2' ' SG ' ' A' ' 25' ' ' CYS . 6.5 m-85 -49.42 144.76 5.26 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-N 114.104 -1.407 . . . . 0.0 112.122 179.541 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -154.8 164.16 39.21 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 112.914 -1.948 . . . . 0.0 112.057 -179.39 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 40.0 t -118.04 138.83 51.95 Favored 'General case' 0 N--CA 1.495 1.823 0 CA-C-N 113.577 -1.647 . . . . 0.0 112.167 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.403 ' H ' ' HB2' ' A' ' 46' ' ' ALA . 5.3 p-10 -46.39 -24.42 0.49 Allowed 'General case' 0 N--CA 1.499 2.025 0 CA-C-N 111.76 -2.473 . . . . 0.0 113.912 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 14.7 p30 -60.87 -6.14 1.67 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 124.117 0.885 . . . . 0.0 112.126 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 92.37 27.2 15.94 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 110.401 -1.08 . . . . 0.0 110.401 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 96.5 m -144.39 141.9 29.98 Favored 'General case' 0 N--CA 1.494 1.761 0 C-N-CA 120.187 -0.605 . . . . 0.0 111.892 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 10.3 t80 -62.77 161.92 11.74 Favored 'General case' 0 N--CA 1.497 1.921 0 CA-C-N 114.14 -1.391 . . . . 0.0 109.915 179.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 62.5 t -131.7 -57.16 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 123.893 0.745 . . . . 0.0 112.745 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.612 ' SG ' ' HB2' ' A' ' 16' ' ' TYR . 7.5 p -158.62 -167.29 2.1 Favored 'General case' 0 N--CA 1.503 2.221 0 C-N-CA 119.657 -0.817 . . . . 0.0 109.749 -179.686 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -122.18 136.89 54.97 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 106.547 -1.649 . . . . 0.0 106.547 179.463 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -40.35 129.41 2.93 Favored Glycine 0 N--CA 1.503 3.127 0 O-C-N 123.657 0.598 . . . . 0.0 112.322 179.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -79.81 -52.78 7.48 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 114.023 1.12 . . . . 0.0 114.023 -179.806 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 55.7 m -50.28 86.61 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 116.425 2.009 . . . . 0.0 116.425 -179.281 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.642 ' H ' HD21 ' A' ' 33' ' ' ASN . 29.5 t70 -86.63 126.09 65.08 Favored Pre-proline 0 N--CA 1.489 1.511 0 N-CA-C 105.358 -2.09 . . . . 0.0 105.358 179.752 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_endo -63.45 73.83 0.14 Allowed 'Trans proline' 0 N--CA 1.5 1.863 0 C-N-CA 123.687 2.925 . . . . 0.0 113.585 -153.029 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.409 ' N ' ' O ' ' A' ' 30' ' ' ASP . 1.5 mpp_? -158.84 -47.13 0.06 Allowed 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 105.384 -2.08 . . . . 0.0 105.384 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.642 HD21 ' H ' ' A' ' 30' ' ' ASP . 12.6 p30 -78.33 136.59 60.55 Favored Pre-proline 0 N--CA 1.494 1.76 0 C-N-CA 119.526 -0.87 . . . . 0.0 109.708 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -68.8 119.73 6.7 Favored 'Trans proline' 0 N--CA 1.493 1.489 0 C-N-CA 122.736 2.291 . . . . 0.0 110.184 -178.232 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 14.3 ptmm? -107.08 157.4 17.86 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 124.18 0.925 . . . . 0.0 110.415 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -160.39 73.71 0.52 Allowed 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 27.9 m -152.8 -174.45 4.92 Favored 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 121.949 0.881 . . . . 0.0 111.744 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.486 ' HB ' ' SG ' ' A' ' 41' ' ' CYS . 83.6 m -141.51 157.81 44.66 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 104.464 -2.421 . . . . 0.0 104.464 179.638 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.461 HD12 ' N ' ' A' ' 39' ' ' LEU . 5.0 mp -79.45 -21.38 45.56 Favored 'General case' 0 N--CA 1.498 1.946 0 C-N-CA 119.439 -0.904 . . . . 0.0 110.361 -179.788 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -94.37 37.92 1.1 Allowed 'General case' 0 N--CA 1.497 1.879 0 CA-C-O 121.976 0.893 . . . . 0.0 110.165 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.525 ' HB3' ' H ' ' A' ' 4' ' ' CYS . 67.4 m -98.71 -95.5 0.23 Allowed 'General case' 0 N--CA 1.494 1.769 0 CA-C-N 113.598 -1.637 . . . . 0.0 107.409 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.467 ' HB3' HD22 ' A' ' 6' ' ' ASN . 16.7 t70 -54.13 131.12 59.9 Favored Pre-proline 0 N--CA 1.501 2.117 0 C-N-CA 120.601 -0.44 . . . . 0.0 110.401 179.796 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -68.78 -23.28 35.82 Favored 'Trans proline' 0 N--CA 1.493 1.489 0 C-N-CA 122.27 1.98 . . . . 0.0 111.633 -164.054 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 58.4 ttt85 -58.14 -38.42 76.54 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 124.031 0.832 . . . . 0.0 110.611 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.578 HD13 ' CD1' ' A' ' 16' ' ' TYR . 15.4 mt -98.85 154.15 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 CA-C-O 122.67 1.224 . . . . 0.0 113.857 -179.826 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.403 ' HB2' ' H ' ' A' ' 19' ' ' ASP . . . -112.17 -56.16 2.43 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-N 110.907 -2.86 . . . . 0.0 107.766 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 53.6 p90 -166.49 173.53 9.77 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-N 114.776 -1.102 . . . . 0.0 109.621 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -125.86 122.13 4.39 Favored Glycine 0 N--CA 1.494 2.502 0 CA-C-N 114.198 -1.365 . . . . 0.0 110.128 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.5 p -79.5 122.71 35.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 11.3 m -100.09 104.93 32.39 Favored Pre-proline 0 N--CA 1.496 1.828 0 CA-C-N 115.083 -0.962 . . . . 0.0 108.729 -179.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -79.41 -69.25 0.02 OUTLIER 'Trans proline' 0 N--CA 1.49 1.302 0 C-N-CA 122.381 2.054 . . . . 0.0 109.798 -176.258 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 8.3 ptp180 -160.32 -15.36 0.05 Allowed 'General case' 0 N--CA 1.497 1.896 0 CA-C-N 114.393 -1.276 . . . . 0.0 110.751 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 61.7 m -56.04 153.23 9.22 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 124.057 0.848 . . . . 0.0 113.138 -179.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -171.26 -33.69 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.883 0 CA-C-N 114.077 -1.42 . . . . 0.0 108.273 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 69.41 131.2 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.134 0 O-C-N 125.202 1.564 . . . . 0.0 112.149 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 24.8 ttpp -65.6 -38.06 88.41 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-N 114.499 -1.228 . . . . 0.0 108.611 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 4.9 ttmp? -144.12 129.15 18.57 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-N 114.425 -1.261 . . . . 0.0 107.991 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -158.67 161.39 37.12 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-N 114.876 -1.056 . . . . 0.0 108.195 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 38.0 t70 58.98 14.93 3.62 Favored 'General case' 0 N--CA 1.504 2.268 0 O-C-N 123.996 0.81 . . . . 0.0 110.175 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.4 ' HG3' ' H ' ' A' ' 60' ' ' ARG . 0.0 OUTLIER -73.22 8.24 1.78 Allowed 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 113.955 1.094 . . . . 0.0 113.955 -179.848 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.419 HG23 ' HA ' ' A' ' 101' ' ' PRO . 3.5 tp -39.69 102.45 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 O-C-N 124.475 1.11 . . . . 0.0 111.495 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 7.7 m -86.14 55.17 3.42 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 115.601 1.704 . . . . 0.0 115.601 -179.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 7.9 p -90.38 173.67 7.98 Favored 'General case' 0 N--CA 1.495 1.81 0 CA-C-N 114.174 -1.376 . . . . 0.0 109.084 179.616 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -161.38 149.46 15.43 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-N 114.631 -1.168 . . . . 0.0 108.782 179.772 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 11.2 t -55.86 -17.37 6.2 Favored 'General case' 0 N--CA 1.5 2.069 0 N-CA-C 113.97 1.1 . . . . 0.0 113.97 -179.659 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 52.1 t -82.72 -43.41 16.85 Favored 'General case' 0 N--CA 1.498 1.96 0 CA-C-N 114.138 -1.392 . . . . 0.0 112.553 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -73.62 61.91 0.75 Allowed 'General case' 0 N--CA 1.5 2.074 0 O-C-N 125.765 1.915 . . . . 0.0 114.784 -179.575 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -169.52 -155.12 9.68 Favored Glycine 0 N--CA 1.486 1.983 0 CA-C-N 112.726 -2.034 . . . . 0.0 108.303 179.599 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 57.5 p -145.31 159.71 42.63 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 124.018 0.481 . . . . 0.0 110.505 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 59.0 mtpt -71.76 38.51 0.07 Allowed 'General case' 0 N--CA 1.502 2.173 0 O-C-N 125.469 1.731 . . . . 0.0 113.938 179.695 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -132.83 1.92 4.75 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 108.448 -1.861 . . . . 0.0 108.448 179.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . 0.411 ' HA ' ' HA ' ' A' ' 108' ' ' CYS . 96.0 m -135.54 170.73 15.49 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 123.905 0.415 . . . . 0.0 111.729 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 48.6 mtmt -130.06 105.67 8.11 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.234 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.696 ' CD1' ' SG ' ' A' ' 83' ' ' CYS . 88.2 m-85 -53.82 144.29 18.82 Favored 'General case' 0 N--CA 1.505 2.285 0 O-C-N 123.525 0.515 . . . . 0.0 110.122 179.8 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.548 ' CE2' ' HA ' ' A' ' 80' ' ' THR . 9.3 t80 -149.32 158.01 43.82 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 124.653 1.221 . . . . 0.0 113.287 -179.572 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 28.2 t -121.12 129.71 53.41 Favored 'General case' 0 N--CA 1.499 1.993 0 CA-C-N 112.05 -2.341 . . . . 0.0 112.145 -179.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.429 ' H ' ' HB2' ' A' ' 104' ' ' ALA . 9.2 p-10 -47.66 -59.19 3.46 Favored 'General case' 0 N--CA 1.495 1.81 0 CA-C-N 113.127 -1.851 . . . . 0.0 112.74 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.408 ' H ' ' CG ' ' A' ' 77' ' ' ASP . 17.7 p-10 -107.2 25.46 11.38 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-N 114.556 -1.202 . . . . 0.0 110.624 -179.777 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -146.93 15.52 1.55 Allowed Glycine 0 N--CA 1.494 2.507 0 O-C-N 124.179 0.924 . . . . 0.0 111.578 -179.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.548 ' HA ' ' CE2' ' A' ' 75' ' ' PHE . 6.6 t 41.61 -160.56 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.899 0 O-C-N 124.934 1.02 . . . . 0.0 113.405 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 72.4 t80 -40.01 132.4 1.84 Allowed 'General case' 0 N--CA 1.5 2.074 0 O-C-N 123.634 0.584 . . . . 0.0 112.213 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 76.6 t -107.48 -61.03 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 CA-C-N 114.381 -1.281 . . . . 0.0 109.93 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . 0.696 ' SG ' ' CD1' ' A' ' 74' ' ' TYR . 0.8 OUTLIER -163.66 -166.74 1.25 Allowed 'General case' 0 N--CA 1.502 2.136 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 -179.89 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.475 ' N ' ' SG ' ' A' ' 83' ' ' CYS . 35.2 mt-10 -130.65 163.68 26.66 Favored 'General case' 0 N--CA 1.485 1.316 0 CA-C-N 114.995 -1.002 . . . . 0.0 109.362 179.511 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -43.24 120.15 2.67 Favored Glycine 0 N--CA 1.499 2.891 0 O-C-N 124.092 0.87 . . . . 0.0 113.681 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -108.71 32.1 5.13 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 36.3 t -153.91 129.26 9.8 Favored 'General case' 0 N--CA 1.498 1.958 0 C-N-CA 120.323 -0.551 . . . . 0.0 109.616 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -100.22 144.28 28.12 Favored Pre-proline 0 N--CA 1.494 1.762 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -46.61 -23.37 2.24 Favored 'Trans proline' 0 N--CA 1.499 1.834 0 C-N-CA 122.846 2.364 . . . . 0.0 112.564 170.339 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 52.8 ttp85 -60.68 -53.23 59.96 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-N 114.967 -1.015 . . . . 0.0 108.682 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -90.5 114.42 61.1 Favored Pre-proline 0 N--CA 1.494 1.725 0 O-C-N 124.839 1.337 . . . . 0.0 110.635 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -83.68 45.13 1.73 Allowed 'Trans proline' 0 N--CA 1.495 1.593 0 C-N-CA 123.427 2.752 . . . . 0.0 110.633 173.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 64.2 mtpt -79.13 125.59 29.62 Favored 'General case' 0 N--CA 1.497 1.894 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.954 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -88.75 120.67 30.35 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 114.596 -1.184 . . . . 0.0 109.603 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 31.0 m -79.94 145.37 61.37 Favored Pre-proline 0 N--CA 1.497 1.906 0 CA-C-N 115.202 -0.908 . . . . 0.0 108.928 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -70.31 -87.13 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.482 0 C-N-CA 122.249 1.966 . . . . 0.0 110.253 -177.188 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 86.7 mtm180 -145.32 -67.28 0.31 Allowed 'General case' 0 N--CA 1.497 1.912 0 O-C-N 123.737 0.648 . . . . 0.0 109.397 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 28.5 m120 46.22 48.43 13.12 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 124.39 1.056 . . . . 0.0 110.67 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 90.7 m -36.21 127.26 0.76 Allowed 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 115.251 1.574 . . . . 0.0 115.251 -179.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -122.31 79.99 45.05 Favored Pre-proline 0 N--CA 1.496 1.858 0 O-C-N 124.295 0.997 . . . . 0.0 109.091 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.419 ' HA ' HG23 ' A' ' 61' ' ' ILE . 5.4 Cg_endo -59.34 -25.91 80.06 Favored 'Trans proline' 0 N--CA 1.495 1.605 0 C-N-CA 123.293 2.662 . . . . 0.0 111.707 -178.704 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 25.0 tpt180 -66.66 -37.39 84.7 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-N 115.118 -0.946 . . . . 0.0 111.726 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.457 ' CG2' ' N ' ' A' ' 104' ' ' ALA . 6.3 mt -60.06 167.01 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 CA-C-O 121.855 0.836 . . . . 0.0 111.516 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.457 ' N ' ' CG2' ' A' ' 103' ' ' ILE . . . -138.69 -44.81 0.48 Allowed 'General case' 0 N--CA 1.489 1.497 0 CA-C-N 113.462 -1.699 . . . . 0.0 107.762 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 40.7 p90 -173.07 -170.84 0.68 Allowed 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -136.45 130.15 5.14 Favored Glycine 0 N--CA 1.493 2.5 0 C-N-CA 120.554 -0.831 . . . . 0.0 111.228 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.451 ' N ' HD12 ' A' ' 107' ' ' ILE . 2.9 mp -79.89 110.46 15.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 N-CA-C 105.788 -1.93 . . . . 0.0 105.788 179.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' CYS . . . . . 0.411 ' HA ' ' HA ' ' A' ' 72' ' ' CYS . 60.9 m -100.19 109.57 56.95 Favored Pre-proline 0 N--CA 1.495 1.809 0 O-C-N 124.143 0.902 . . . . 0.0 110.405 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.31 -55.68 0.08 OUTLIER 'Trans proline' 0 N--CA 1.492 1.42 0 C-N-CA 122.6 2.2 . . . . 0.0 109.905 179.528 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 85.9 mt -79.72 -54.91 5.4 Favored 'General case' 0 N--CA 1.495 1.78 0 CA-C-N 114.514 -1.221 . . . . 0.0 109.048 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 1.911 0 CA-C-O 116.668 -1.634 . . . . 0.0 111.258 179.862 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 24.8 t70 . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 58.83 -169.46 0.13 Allowed 'General case' 0 N--CA 1.501 2.114 0 O-C-N 124.446 1.092 . . . . 0.0 111.374 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.1 tp -67.49 91.27 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 CA-C-O 121.985 0.898 . . . . 0.0 110.814 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 7.5 m -90.36 45.28 1.25 Allowed 'General case' 0 N--CA 1.493 1.72 0 CA-C-O 122.726 1.25 . . . . 0.0 112.472 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 51.8 m -90.74 171.07 9.6 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 113.001 -1.909 . . . . 0.0 109.275 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 69.0 m-80 -160.0 171.91 18.5 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 124.567 1.167 . . . . 0.0 107.998 179.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 9.6 t -70.14 -11.14 60.68 Favored 'General case' 0 N--CA 1.501 2.096 0 C-N-CA 118.968 -1.093 . . . . 0.0 110.837 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 34.4 t -91.11 -50.4 5.86 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-N 113.905 -1.498 . . . . 0.0 109.137 179.734 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -39.58 -67.26 0.23 Allowed 'General case' 0 N--CA 1.501 2.084 0 N-CA-C 115.965 1.839 . . . . 0.0 115.965 -179.662 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -54.66 160.51 5.08 Favored Glycine 0 N--CA 1.502 3.057 0 C-N-CA 121.099 -0.572 . . . . 0.0 112.325 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 7.3 t -71.43 138.29 48.95 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 -179.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -62.33 114.1 3.29 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-N 114.121 -1.399 . . . . 0.0 109.2 179.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 134.39 -21.92 3.79 Favored Glycine 0 N--CA 1.495 2.594 0 O-C-N 124.431 1.082 . . . . 0.0 110.577 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 88.2 m -86.77 -173.08 4.3 Favored 'General case' 0 N--CA 1.5 2.028 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 60.7 mtpt -133.46 103.27 5.86 Favored 'General case' 0 N--CA 1.494 1.765 0 C-N-CA 119.793 -0.763 . . . . 0.0 110.998 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.733 ' CD2' ' SG ' ' A' ' 25' ' ' CYS . 90.8 m-85 -54.75 138.21 42.69 Favored 'General case' 0 N--CA 1.499 2.015 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.67 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -149.22 146.25 27.52 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 124.886 1.366 . . . . 0.0 113.26 -179.701 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 45.4 t -106.03 120.99 43.2 Favored 'General case' 0 N--CA 1.5 2.055 0 CA-C-N 112.822 -1.99 . . . . 0.0 110.722 -179.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.564 ' H ' ' HB2' ' A' ' 46' ' ' ALA . 6.5 p-10 -57.61 -53.34 59.32 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 126.476 2.36 . . . . 0.0 112.19 -179.817 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -72.95 1.61 8.47 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 112.264 -2.244 . . . . 0.0 112.236 -179.665 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -136.39 -85.39 0.18 Allowed Glycine 0 N--CA 1.482 1.727 0 C-N-CA 119.626 -1.273 . . . . 0.0 111.951 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.469 ' CG2' ' N ' ' A' ' 23' ' ' PHE . 1.2 m 172.7 -171.16 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.166 0 N-CA-C 106.002 -1.851 . . . . 0.0 106.002 -179.137 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.469 ' N ' ' CG2' ' A' ' 22' ' ' THR . 33.2 t80 -41.79 144.05 0.45 Allowed 'General case' 0 N--CA 1.502 2.146 0 CA-C-O 121.369 0.605 . . . . 0.0 112.065 179.53 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 71.9 t -110.38 -68.21 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 CA-C-N 114.06 -1.427 . . . . 0.0 112.353 -179.656 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.733 ' SG ' ' CD2' ' A' ' 16' ' ' TYR . 14.5 p -155.14 -167.55 2.6 Favored 'General case' 0 N--CA 1.502 2.153 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 -179.717 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 8.7 tm-20 -117.45 154.89 30.62 Favored 'General case' 0 N--CA 1.505 2.282 0 O-C-N 123.373 0.42 . . . . 0.0 110.735 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.474 ' HA2' ' CE2' ' A' ' 16' ' ' TYR . . . -46.48 110.7 0.55 Allowed Glycine 0 N--CA 1.503 3.128 0 CA-C-O 118.857 -0.968 . . . . 0.0 112.583 179.869 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -97.33 -9.19 27.97 Favored 'General case' 0 N--CA 1.505 2.32 0 N-CA-C 114.684 1.365 . . . . 0.0 114.684 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 38.4 t -156.07 131.17 9.29 Favored 'General case' 0 N--CA 1.501 2.083 0 C-N-CA 119.647 -0.821 . . . . 0.0 111.607 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.541 ' H ' HD21 ' A' ' 33' ' ' ASN . 11.7 t70 -93.54 143.59 26.87 Favored Pre-proline 0 N--CA 1.494 1.771 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 179.812 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -66.26 75.7 0.35 Allowed 'Trans proline' 0 N--CA 1.494 1.558 0 C-N-CA 122.579 2.186 . . . . 0.0 108.236 162.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 35.2 ttp-105 -168.09 -41.28 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 113.208 -1.814 . . . . 0.0 106.832 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.541 HD21 ' H ' ' A' ' 30' ' ' ASP . 29.8 p30 -86.99 152.84 54.02 Favored Pre-proline 0 N--CA 1.493 1.705 0 O-C-N 124.175 0.922 . . . . 0.0 110.936 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -79.85 45.6 2.0 Allowed 'Trans proline' 0 N--CA 1.496 1.635 0 C-N-CA 123.443 2.762 . . . . 0.0 112.319 174.481 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.483 ' HE3' ' HA ' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -102.12 152.9 20.46 Favored 'General case' 0 N--CA 1.501 2.109 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.163 -179.981 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -156.39 165.24 36.9 Favored 'General case' 0 N--CA 1.498 1.93 0 CA-C-N 114.674 -1.148 . . . . 0.0 109.571 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 28.0 m -146.19 179.16 7.69 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 123.779 0.674 . . . . 0.0 110.282 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 44.5 p -138.72 54.7 1.74 Allowed 'General case' 0 N--CA 1.5 2.066 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.671 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 54.2 tp -93.63 -25.24 17.59 Favored 'General case' 0 N--CA 1.499 2.017 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.005 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 11.4 m120 62.54 153.64 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.118 0 O-C-N 124.487 1.117 . . . . 0.0 113.536 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 59.4 m -18.61 130.38 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.274 0 N-CA-C 116.63 2.085 . . . . 0.0 116.63 -179.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -113.82 86.13 10.53 Favored Pre-proline 0 N--CA 1.498 1.955 0 O-C-N 124.062 0.851 . . . . 0.0 108.971 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -62.13 -18.41 61.78 Favored 'Trans proline' 0 N--CA 1.497 1.724 0 C-N-CA 122.633 2.222 . . . . 0.0 113.803 -170.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 5.9 ptp85 -89.09 -20.15 24.68 Favored 'General case' 0 N--CA 1.501 2.078 0 N-CA-C 116.393 1.997 . . . . 0.0 116.393 -179.636 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 16.3 tt -78.13 155.44 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.303 0 C-N-CA 118.566 -1.254 . . . . 0.0 109.694 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.564 ' HB2' ' H ' ' A' ' 19' ' ' ASP . . . -90.4 -66.3 0.94 Allowed 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 179.627 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 3.3 p90 -177.63 171.91 1.83 Allowed 'General case' 0 N--CA 1.492 1.651 0 CA-C-N 112.786 -2.006 . . . . 0.0 108.513 -179.783 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.406 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -91.05 110.37 3.81 Favored Glycine 0 N--CA 1.49 2.279 0 CA-C-N 114.979 -1.009 . . . . 0.0 110.701 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 20.1 m -78.84 105.84 8.76 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 N-CA-C 106.107 -1.812 . . . . 0.0 106.107 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 48.1 m -83.28 161.74 56.23 Favored Pre-proline 0 N--CA 1.495 1.798 0 CA-C-N 113.375 -1.739 . . . . 0.0 111.264 -179.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -52.44 -47.95 24.37 Favored 'Trans proline' 0 N--CA 1.494 1.536 0 C-N-CA 122.345 2.03 . . . . 0.0 109.675 166.65 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 39.7 mtm105 -146.23 157.08 43.79 Favored 'General case' 0 N--CA 1.497 1.912 0 CA-C-N 114.751 -1.113 . . . . 0.0 109.55 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 67.1 m -140.04 38.54 1.95 Allowed 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 179.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -67.68 144.44 55.48 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-N 114.033 -1.44 . . . . 0.0 111.544 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.463 ' HG2' ' N ' ' A' ' 56' ' ' LYS . 33.3 tt0 -108.91 166.28 10.94 Favored 'General case' 0 N--CA 1.497 1.883 0 CA-C-N 113.879 -1.51 . . . . 0.0 107.648 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.463 ' N ' ' HG2' ' A' ' 55' ' ' GLU . 85.0 tttt -146.43 45.08 1.22 Allowed 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 106.009 -1.848 . . . . 0.0 106.009 179.579 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.405 ' H ' ' HG2' ' A' ' 55' ' ' GLU . 4.6 tmmm? -113.29 -72.03 0.72 Allowed 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 104.288 -2.486 . . . . 0.0 104.288 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 33.8 t-20 -150.92 83.19 1.33 Allowed 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 105.742 -1.947 . . . . 0.0 105.742 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -162.64 -39.47 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 CA-C-N 113.498 -1.683 . . . . 0.0 108.775 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 22.2 mmm180 -65.22 -68.87 0.33 Allowed 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.472 ' CG1' ' H ' ' A' ' 99' ' ' CYS . 1.9 tp -90.45 175.06 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 N-CA-C 105.345 -2.095 . . . . 0.0 105.345 179.693 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.46 ' HB2' ' HB3' ' A' ' 99' ' ' CYS . 1.6 m -79.98 -165.06 0.76 Allowed 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 119.569 -0.853 . . . . 0.0 109.166 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.5 p -63.91 138.71 58.59 Favored 'General case' 0 N--CA 1.495 1.824 0 C-N-CA 119.067 -1.053 . . . . 0.0 112.558 179.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -155.11 154.59 32.6 Favored 'General case' 0 N--CA 1.499 2.009 0 CA-C-N 112.14 -2.3 . . . . 0.0 110.209 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 52.8 t -52.71 -51.2 61.4 Favored 'General case' 0 N--CA 1.501 2.084 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 179.745 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 17.7 t -60.91 -54.46 44.78 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-N 110.996 -2.82 . . . . 0.0 112.658 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -39.46 -45.06 1.47 Allowed 'General case' 0 N--CA 1.504 2.227 0 O-C-N 125.921 2.013 . . . . 0.0 110.511 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.424 ' HA3' ' H ' ' A' ' 87' ' ' SER . . . 73.38 162.94 7.75 Favored Glycine 0 N--CA 1.476 1.351 0 N-CA-C 116.951 1.54 . . . . 0.0 116.951 179.583 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 3.6 t 176.64 42.56 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 104.49 -2.411 . . . . 0.0 104.49 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.519 ' HA ' ' HE2' ' A' ' 70' ' ' LYS . 0.6 OUTLIER -10.35 94.08 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.065 0 CA-C-N 113.165 -1.834 . . . . 0.0 115.545 -179.553 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 136.37 -47.56 0.96 Allowed Glycine 0 N--CA 1.493 2.497 0 CA-C-N 114.461 -1.245 . . . . 0.0 111.94 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . 0.438 ' HA ' ' HA ' ' A' ' 108' ' ' CYS . 76.5 m -79.93 122.75 27.09 Favored 'General case' 0 N--CA 1.497 1.914 0 C-N-CA 119.166 -1.014 . . . . 0.0 110.761 -179.79 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.476 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 37.0 mtmm -73.2 89.48 1.53 Allowed 'General case' 0 N--CA 1.487 1.384 0 CA-C-N 112.535 -2.12 . . . . 0.0 115.152 -179.604 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.437 ' N ' ' O ' ' A' ' 83' ' ' CYS . 41.9 m-85 -45.55 136.8 5.5 Favored 'General case' 0 N--CA 1.504 2.234 0 O-C-N 124.32 1.012 . . . . 0.0 108.399 179.488 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -154.17 145.8 23.26 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 114.851 -1.068 . . . . 0.0 112.144 -179.478 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 89.0 p -90.12 141.51 28.61 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 112.05 -2.341 . . . . 0.0 115.806 -179.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -51.34 -33.92 31.55 Favored 'General case' 0 N--CA 1.499 2.01 0 CA-C-N 112.288 -2.233 . . . . 0.0 114.313 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -57.85 -13.98 5.27 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 123.994 0.808 . . . . 0.0 112.156 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 102.7 37.46 3.21 Favored Glycine 0 N--CA 1.491 2.325 0 O-C-N 124.311 1.007 . . . . 0.0 111.487 179.783 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 90.7 m -140.79 149.07 41.6 Favored 'General case' 0 N--CA 1.496 1.858 0 C-N-CA 119.8 -0.76 . . . . 0.0 111.826 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 21.3 t80 -77.45 142.86 38.97 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-N 114.937 -1.029 . . . . 0.0 108.253 179.549 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 92.2 t -107.22 -67.27 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 CA-C-N 114.933 -1.031 . . . . 0.0 108.842 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . 0.437 ' O ' ' N ' ' A' ' 74' ' ' TYR . 39.2 m -159.8 -160.56 0.82 Allowed 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.476 ' HA ' ' HA ' ' A' ' 73' ' ' LYS . 36.3 tt0 -139.41 160.19 40.4 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 102.739 -3.06 . . . . 0.0 102.739 178.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.445 ' HA3' ' N ' ' A' ' 70' ' ' LYS . . . -38.24 100.18 0.01 OUTLIER Glycine 0 N--CA 1.494 2.527 0 CA-C-O 119.301 -0.722 . . . . 0.0 114.463 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -79.08 -3.81 47.14 Favored 'General case' 0 N--CA 1.502 2.169 0 C-N-CA 119.618 -0.833 . . . . 0.0 111.316 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.424 ' H ' ' HA3' ' A' ' 68' ' ' GLY . 44.0 t -142.93 128.57 19.18 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.662 ' H ' HD21 ' A' ' 91' ' ' ASN . 15.4 t70 -84.01 145.67 46.98 Favored Pre-proline 0 N--CA 1.493 1.681 0 CA-C-N 114.588 -1.187 . . . . 0.0 109.147 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -56.62 80.97 0.04 OUTLIER 'Trans proline' 0 N--CA 1.499 1.84 0 C-N-CA 123.279 2.653 . . . . 0.0 108.528 163.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 50.8 ttp85 -173.71 -62.54 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 104.027 -2.583 . . . . 0.0 104.027 -179.635 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.662 HD21 ' H ' ' A' ' 88' ' ' ASP . 0.7 OUTLIER -91.88 113.49 59.08 Favored Pre-proline 0 N--CA 1.492 1.651 0 CA-C-N 114.12 -1.4 . . . . 0.0 109.04 179.915 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -74.38 89.48 1.07 Allowed 'Trans proline' 0 N--CA 1.492 1.393 0 C-N-CA 122.467 2.111 . . . . 0.0 110.571 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -122.15 123.1 40.73 Favored 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -150.64 151.88 33.17 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.46 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 81.6 m -119.46 98.22 50.19 Favored Pre-proline 0 N--CA 1.497 1.898 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -68.53 93.1 0.42 Allowed 'Trans proline' 0 N--CA 1.493 1.452 0 C-N-CA 122.301 2.001 . . . . 0.0 109.013 177.106 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 28.4 mmt85 -134.72 47.88 2.34 Favored 'General case' 0 N--CA 1.498 1.954 0 CA-C-N 114.651 -1.159 . . . . 0.0 108.029 -179.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 14.5 m120 54.42 41.3 32.05 Favored 'General case' 0 N--CA 1.504 2.236 0 CA-C-O 122.797 1.284 . . . . 0.0 108.094 -179.742 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.472 ' H ' ' CG1' ' A' ' 61' ' ' ILE . 5.3 m 57.95 -167.43 0.14 Allowed 'General case' 0 N--CA 1.488 1.439 0 CA-C-N 112.031 -2.35 . . . . 0.0 108.722 -179.662 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -106.22 99.64 24.72 Favored Pre-proline 0 N--CA 1.498 1.943 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 179.75 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -64.53 -31.13 61.13 Favored 'Trans proline' 0 N--CA 1.493 1.46 0 C-N-CA 122.336 2.024 . . . . 0.0 111.639 -169.656 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 74.9 ttt-85 -71.89 -31.22 66.19 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 123.967 0.792 . . . . 0.0 111.226 -179.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 12.0 mt -68.53 157.24 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 CA-C-O 122.261 1.029 . . . . 0.0 111.427 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -124.92 -56.41 1.56 Allowed 'General case' 0 N--CA 1.492 1.63 0 CA-C-N 111.969 -2.378 . . . . 0.0 107.555 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 38.1 p90 -164.88 170.12 15.73 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-N 114.254 -1.339 . . . . 0.0 109.922 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -110.84 123.85 6.73 Favored Glycine 0 N--CA 1.492 2.426 0 CA-C-N 113.911 -1.495 . . . . 0.0 110.944 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.486 ' N ' HD12 ' A' ' 107' ' ' ILE . 2.9 mp -79.31 99.65 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' CYS . . . . . 0.438 ' HA ' ' HA ' ' A' ' 72' ' ' CYS . 25.2 m -79.79 163.9 56.01 Favored Pre-proline 0 N--CA 1.491 1.622 0 CA-C-N 114.169 -1.378 . . . . 0.0 108.754 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_exo -47.85 -23.46 4.11 Favored 'Trans proline' 0 N--CA 1.498 1.76 0 C-N-CA 122.558 2.172 . . . . 0.0 112.589 173.793 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 83.9 mt -118.95 -55.81 2.15 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 124.218 0.949 . . . . 0.0 108.511 179.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 1.983 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.837 179.936 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 38.8 ttm180 -140.37 57.48 1.59 Allowed 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 107.135 -1.431 . . . . 0.0 107.135 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 8.6 tp -86.77 53.67 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 CA-C-N 114.092 -1.413 . . . . 0.0 109.093 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.473 ' HA ' ' HA ' ' A' ' 41' ' ' CYS . 63.5 m -84.19 40.58 0.77 Allowed 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 115.031 1.493 . . . . 0.0 115.031 -179.829 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.409 ' HB ' HG21 ' A' ' 45' ' ' ILE . 53.3 m -90.6 158.91 16.71 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 105.167 -2.16 . . . . 0.0 105.167 179.641 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -147.48 169.36 19.71 Favored 'General case' 0 N--CA 1.497 1.918 0 CA-C-O 122.427 1.108 . . . . 0.0 112.551 -179.761 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.7 t -62.76 -53.14 58.91 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-N 112.268 -2.242 . . . . 0.0 111.952 -179.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 51.4 t -67.63 -55.7 12.26 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-N 113.946 -1.479 . . . . 0.0 109.375 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -54.83 -18.03 4.31 Favored 'General case' 0 N--CA 1.497 1.921 0 CA-C-N 113.786 -1.552 . . . . 0.0 113.062 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -59.53 160.72 17.74 Favored Glycine 0 N--CA 1.496 2.676 0 C-N-CA 120.613 -0.804 . . . . 0.0 111.453 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 9.7 t -76.45 129.4 36.48 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 115.732 1.753 . . . . 0.0 115.732 -179.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.423 ' HB3' ' NZ ' ' A' ' 12' ' ' LYS . 3.1 mmmp? -62.34 93.23 0.05 OUTLIER 'General case' 0 N--CA 1.5 2.073 0 CA-C-N 114.195 -1.366 . . . . 0.0 109.032 179.572 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 157.18 -28.09 0.51 Allowed Glycine 0 N--CA 1.49 2.279 0 CA-C-O 118.52 -1.156 . . . . 0.0 112.913 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 84.2 m -117.55 169.7 9.34 Favored 'General case' 0 N--CA 1.503 2.183 0 C-N-CA 119.438 -0.905 . . . . 0.0 112.603 -179.766 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 36.0 mtmm -102.69 96.67 7.02 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-N 113.982 -1.463 . . . . 0.0 111.312 -179.714 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.423 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 24.0 m-85 -59.94 127.9 34.19 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-O 122.884 1.326 . . . . 0.0 108.023 179.654 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -135.2 151.96 51.12 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 111.29 -2.687 . . . . 0.0 112.655 -179.145 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 87.8 p -91.03 133.06 35.61 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 112.991 -1.913 . . . . 0.0 113.924 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -47.73 -29.12 2.84 Favored 'General case' 0 N--CA 1.5 2.035 0 CA-C-N 113.11 -1.859 . . . . 0.0 116.012 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -57.64 -18.35 19.73 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 123.611 0.57 . . . . 0.0 112.519 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 112.46 26.96 4.05 Favored Glycine 0 N--CA 1.494 2.52 0 O-C-N 124.366 1.041 . . . . 0.0 111.098 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 62.4 m -135.91 156.06 49.35 Favored 'General case' 0 N--CA 1.496 1.853 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.458 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 22.6 t80 -85.85 149.25 25.37 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-N 114.89 -1.05 . . . . 0.0 110.16 179.727 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 96.0 t -108.47 -79.0 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 N-CA-C 107.03 -1.471 . . . . 0.0 107.03 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.458 ' SG ' ' O ' ' A' ' 26' ' ' GLU . 0.1 OUTLIER -164.76 179.91 6.26 Favored 'General case' 0 N--CA 1.5 2.044 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 179.743 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.458 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 30.7 tt0 -85.64 157.05 20.44 Favored 'General case' 0 N--CA 1.502 2.138 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 179.87 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -74.14 116.43 5.26 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 104.729 -3.349 . . . . 0.0 104.729 179.613 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -98.64 21.94 10.62 Favored 'General case' 0 N--CA 1.505 2.285 0 N-CA-C 114.757 1.392 . . . . 0.0 114.757 -179.633 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 37.7 t -137.97 117.88 13.31 Favored 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 179.671 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.633 ' H ' HD21 ' A' ' 33' ' ' ASN . 16.3 t70 -79.42 132.52 62.06 Favored Pre-proline 0 N--CA 1.493 1.692 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_endo -67.11 85.33 0.33 Allowed 'Trans proline' 0 N--CA 1.492 1.441 0 C-N-CA 122.6 2.2 . . . . 0.0 109.908 178.534 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 12.0 mtp180 176.52 -41.71 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.938 0 CA-C-N 113.925 -1.488 . . . . 0.0 108.216 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.633 HD21 ' H ' ' A' ' 30' ' ' ASP . 24.4 p30 -77.22 146.11 74.08 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 123.991 0.807 . . . . 0.0 111.88 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -81.54 48.23 2.79 Favored 'Trans proline' 0 N--CA 1.492 1.407 0 C-N-CA 123.407 2.738 . . . . 0.0 109.525 163.061 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 65.0 tttp -68.23 150.71 47.95 Favored 'General case' 0 N--CA 1.497 1.891 0 CA-C-O 121.544 0.688 . . . . 0.0 111.617 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -91.42 131.03 37.16 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-N 113.608 -1.633 . . . . 0.0 108.005 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 5.2 m -142.85 -178.41 5.79 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 -179.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 96.2 m -83.25 113.87 20.99 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-N 113.645 -1.616 . . . . 0.0 108.413 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 9.8 mp -79.5 0.58 29.07 Favored 'General case' 0 N--CA 1.498 1.953 0 CA-C-N 115.299 -0.864 . . . . 0.0 112.164 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -59.19 119.61 7.67 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 123.546 0.529 . . . . 0.0 109.719 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.473 ' HA ' ' HA ' ' A' ' 4' ' ' CYS . 85.0 m -68.55 92.26 0.45 Allowed 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.412 ' O ' HG22 ' A' ' 45' ' ' ILE . 10.0 t70 -63.35 101.88 0.29 Allowed Pre-proline 0 N--CA 1.495 1.792 0 CA-C-N 115.252 -0.885 . . . . 0.0 110.19 -179.681 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo -67.32 -37.88 16.7 Favored 'Trans proline' 0 N--CA 1.492 1.399 0 C-N-CA 122.159 1.906 . . . . 0.0 110.779 -160.234 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 28.0 ptt-85 -78.27 -23.1 47.39 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-N 114.233 -1.349 . . . . 0.0 114.013 -179.77 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.412 HG22 ' O ' ' A' ' 42' ' ' ASP . 7.9 tt -55.27 159.04 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.278 0 C-N-CA 120.1 -0.64 . . . . 0.0 110.476 -179.554 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -141.85 -62.64 0.45 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 123.803 0.69 . . . . 0.0 112.575 -179.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 28.1 p90 -156.17 161.63 40.29 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-O 121.871 0.843 . . . . 0.0 113.04 -179.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.423 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -92.17 95.3 2.01 Favored Glycine 0 N--CA 1.489 2.194 0 CA-C-N 112.785 -2.007 . . . . 0.0 110.593 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 4.7 p -81.74 110.55 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 C-N-CA 119.108 -1.037 . . . . 0.0 109.012 179.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.6 m -79.04 154.43 77.55 Favored Pre-proline 0 N--CA 1.498 1.928 0 CA-C-N 115.472 -0.786 . . . . 0.0 109.414 179.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -56.35 -33.51 91.76 Favored 'Trans proline' 0 N--CA 1.497 1.692 0 C-N-CA 122.71 2.273 . . . . 0.0 111.623 -173.506 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.89 169.99 22.35 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 124.28 0.987 . . . . 0.0 109.855 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 57.2 m -71.2 105.28 3.37 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -68.61 124.86 24.75 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 107.529 -1.286 . . . . 0.0 107.529 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 21.1 mm-40 -104.46 -71.43 0.74 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 123.933 0.77 . . . . 0.0 111.07 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 7.0 ttpm? 53.39 87.7 0.04 OUTLIER 'General case' 0 N--CA 1.504 2.228 0 O-C-N 124.108 0.88 . . . . 0.0 110.73 -179.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 41.7 ttmt -155.64 129.71 8.74 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-N 114.698 -1.137 . . . . 0.0 108.982 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -160.4 143.43 13.43 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.518 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -85.57 76.26 10.04 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-N 114.957 -1.02 . . . . 0.0 108.453 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 58.1 mmm-85 -66.82 96.77 0.43 Allowed 'General case' 0 N--CA 1.496 1.832 0 CA-C-N 114.414 -1.266 . . . . 0.0 110.398 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 5.9 tp -80.39 68.25 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 CA-C-N 114.022 -1.444 . . . . 0.0 110.647 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.462 ' HA ' ' HA ' ' A' ' 99' ' ' CYS . 1.6 m -89.37 55.67 3.34 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 123.128 1.442 . . . . 0.0 114.455 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.41 ' O ' ' N ' ' A' ' 100' ' ' ASP . 1.8 p -90.86 160.87 15.5 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-N 112.64 -2.073 . . . . 0.0 108.05 179.456 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 32.5 p-10 -161.63 148.48 14.32 Favored 'General case' 0 N--CA 1.501 2.108 0 C-N-CA 119.891 -0.723 . . . . 0.0 110.22 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' CYS . . . . . 0.489 ' HA ' ' CD2' ' A' ' 74' ' ' TYR . 7.1 t -65.45 -15.45 62.64 Favored 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 113.661 0.986 . . . . 0.0 113.661 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 29.4 t -80.52 -66.77 0.84 Allowed 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 116.295 1.961 . . . . 0.0 116.295 -179.499 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -77.82 63.31 2.84 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 125.545 1.778 . . . . 0.0 114.832 -179.25 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -123.98 -150.3 7.91 Favored Glycine 0 N--CA 1.494 2.522 0 CA-C-N 112.729 -2.032 . . . . 0.0 109.946 179.558 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 4.8 t -136.44 121.18 18.51 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-N 114.102 -1.049 . . . . 0.0 108.924 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 6.2 ptpp? -58.16 89.95 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.853 0 CA-C-O 122.648 1.214 . . . . 0.0 111.371 179.678 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 161.89 -42.08 0.38 Allowed Glycine 0 N--CA 1.49 2.24 0 N-CA-C 108.368 -1.893 . . . . 0.0 108.368 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . 0.434 ' HA ' ' HA ' ' A' ' 108' ' ' CYS . 90.3 m -79.43 128.29 33.16 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 179.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 35.4 mmtp -80.37 83.31 6.22 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 115.581 1.697 . . . . 0.0 115.581 -179.321 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.489 ' CD2' ' HA ' ' A' ' 65' ' ' CYS . 2.1 m-85 -43.55 126.36 4.39 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 124.235 0.959 . . . . 0.0 109.181 179.379 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -141.08 152.04 44.48 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-N 114.321 -1.309 . . . . 0.0 112.325 -179.34 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 30.2 t -101.66 143.24 31.86 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 116.059 1.874 . . . . 0.0 116.059 -179.57 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -49.69 -26.11 3.48 Favored 'General case' 0 N--CA 1.5 2.074 0 CA-C-N 111.231 -2.713 . . . . 0.0 113.435 179.746 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 13.8 p30 -62.33 -3.18 1.24 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 124.178 0.924 . . . . 0.0 111.853 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 86.87 28.96 24.72 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 90.3 m -142.33 143.93 32.98 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 120.47 -0.492 . . . . 0.0 110.9 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 52.6 t80 -67.94 160.25 28.95 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-N 114.17 -1.377 . . . . 0.0 110.497 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 91.1 t -122.95 -74.77 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 CA-C-N 114.624 -1.171 . . . . 0.0 110.477 -179.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . 0.492 ' SG ' ' N ' ' A' ' 84' ' ' GLU . 0.5 OUTLIER -157.13 -163.07 1.32 Allowed 'General case' 0 N--CA 1.502 2.163 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 -179.874 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.492 ' N ' ' SG ' ' A' ' 83' ' ' CYS . 38.2 tt0 -119.56 164.37 15.93 Favored 'General case' 0 N--CA 1.503 2.205 0 N-CA-C 104.722 -2.325 . . . . 0.0 104.722 179.18 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.42 ' N ' ' HG2' ' A' ' 84' ' ' GLU . . . -60.91 113.57 5.74 Favored Glycine 0 N--CA 1.497 2.743 0 C-N-CA 119.315 -1.422 . . . . 0.0 110.302 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -86.0 21.68 1.9 Allowed 'General case' 0 N--CA 1.501 2.11 0 CA-C-O 121.722 0.772 . . . . 0.0 111.297 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 3.5 m -133.4 160.54 37.08 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 113.996 -1.456 . . . . 0.0 107.224 179.735 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.406 ' H ' ' HB3' ' A' ' 91' ' ' ASN . 21.3 t70 -79.66 145.9 63.77 Favored Pre-proline 0 N--CA 1.493 1.689 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -47.7 -15.22 0.31 Allowed 'Trans proline' 0 N--CA 1.499 1.848 0 C-N-CA 122.835 2.356 . . . . 0.0 114.037 171.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 72.5 ttt-85 -139.93 53.05 1.68 Allowed 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.406 ' HB3' ' H ' ' A' ' 88' ' ' ASP . 18.2 p-10 -90.05 128.28 50.37 Favored Pre-proline 0 N--CA 1.496 1.828 0 CA-C-N 114.522 -1.217 . . . . 0.0 111.447 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -83.89 48.1 2.46 Favored 'Trans proline' 0 N--CA 1.491 1.362 0 C-N-CA 123.245 2.63 . . . . 0.0 109.125 159.22 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -130.39 147.52 52.1 Favored 'General case' 0 N--CA 1.503 2.184 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.681 -179.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -160.54 125.2 3.72 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-N 114.875 -1.057 . . . . 0.0 109.501 179.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 68.7 m -79.74 162.79 61.48 Favored Pre-proline 0 N--CA 1.5 2.03 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -69.97 4.92 2.0 Allowed 'Trans proline' 0 N--CA 1.495 1.587 0 C-N-CA 122.118 1.879 . . . . 0.0 111.146 163.5 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 80.5 mmt-85 -94.21 22.13 6.23 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 123.647 0.592 . . . . 0.0 110.616 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -63.21 158.07 20.95 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.167 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.462 ' HA ' ' HA ' ' A' ' 62' ' ' CYS . 74.0 m 61.75 125.59 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.888 0 O-C-N 125.193 1.558 . . . . 0.0 112.215 -179.771 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.41 ' N ' ' O ' ' A' ' 63' ' ' THR . 30.8 t70 -156.22 84.88 3.21 Favored Pre-proline 0 N--CA 1.494 1.761 0 CA-C-N 114.876 -1.056 . . . . 0.0 110.154 -179.778 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_exo -52.44 -18.26 7.85 Favored 'Trans proline' 0 N--CA 1.495 1.594 0 C-N-CA 122.457 2.104 . . . . 0.0 112.455 174.731 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.69 -54.02 38.25 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 105.974 -1.862 . . . . 0.0 105.974 179.855 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 15.3 tt -79.95 157.52 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 C-N-CA 119.215 -0.994 . . . . 0.0 109.747 -179.777 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -113.28 -61.35 1.75 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 124.372 1.045 . . . . 0.0 112.588 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 7.4 p90 -162.65 160.06 25.22 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 123.886 0.741 . . . . 0.0 112.162 -179.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -97.13 127.44 9.21 Favored Glycine 0 N--CA 1.492 2.414 0 CA-C-N 113.848 -1.523 . . . . 0.0 111.716 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 48.0 mm -80.91 97.88 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' CYS . . . . . 0.434 ' HA ' ' HA ' ' A' ' 72' ' ' CYS . 35.0 m -79.67 143.07 58.06 Favored Pre-proline 0 N--CA 1.494 1.729 0 CA-C-N 114.744 -1.116 . . . . 0.0 109.244 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -51.13 137.76 45.12 Favored 'Trans proline' 0 N--CA 1.496 1.627 0 C-N-CA 122.999 2.466 . . . . 0.0 112.053 -174.136 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.401 HD23 ' N ' ' A' ' 110' ' ' LEU . 1.7 pt? -157.66 -9.32 0.08 Allowed 'General case' 0 N--CA 1.497 1.893 0 CA-C-N 114.803 -1.09 . . . . 0.0 110.999 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 1.987 0 CA-C-O 114.74 -2.552 . . . . 0.0 110.704 -179.948 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 25.0 t70 . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 5.9 mmp_? -87.78 58.52 4.92 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-N 114.783 -1.099 . . . . 0.0 108.209 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 10.2 tp -85.15 44.46 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 CA-C-N 114.374 -1.285 . . . . 0.0 109.528 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.409 ' HA ' ' HA ' ' A' ' 41' ' ' CYS . 5.7 m -85.16 59.5 5.67 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 122.582 1.182 . . . . 0.0 112.938 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.2 t -90.03 167.87 12.43 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-N 113.145 -1.843 . . . . 0.0 107.178 179.675 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 15.9 p30 -145.72 150.59 36.54 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.949 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.7 t -67.34 -20.12 65.54 Favored 'General case' 0 N--CA 1.496 1.847 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.805 -179.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 35.7 t -54.94 -55.67 28.16 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 179.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -71.69 -23.24 61.61 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-N 112.853 -1.976 . . . . 0.0 110.098 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -52.72 142.38 26.09 Favored Glycine 0 N--CA 1.493 2.494 0 O-C-N 124.199 0.937 . . . . 0.0 112.572 -179.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 41.0 p -61.15 109.15 1.03 Allowed 'General case' 0 N--CA 1.492 1.639 0 CA-C-N 111.711 -2.244 . . . . 0.0 111.976 -179.713 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -68.81 88.64 0.38 Allowed 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 122.457 1.123 . . . . 0.0 108.677 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 163.87 -22.6 0.17 Allowed Glycine 0 N--CA 1.488 2.111 0 CA-C-N 112.611 -2.086 . . . . 0.0 109.639 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 76.0 m -107.63 138.12 44.42 Favored 'General case' 0 N--CA 1.497 1.902 0 CA-C-O 121.533 0.683 . . . . 0.0 110.567 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 61.3 mtpt -83.38 84.82 7.37 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-N 113.821 -1.536 . . . . 0.0 110.914 -179.518 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 -49.78 128.93 19.17 Favored 'General case' 0 N--CA 1.498 1.951 0 CA-C-O 122.37 1.081 . . . . 0.0 109.982 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -136.8 161.01 37.16 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-N 112.262 -2.245 . . . . 0.0 112.554 -179.264 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 32.8 t -104.33 133.12 49.77 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 113.613 -1.63 . . . . 0.0 112.19 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -47.73 -25.06 1.1 Allowed 'General case' 0 N--CA 1.5 2.032 0 CA-C-N 112.895 -1.957 . . . . 0.0 114.18 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 29.3 p30 -60.17 -7.66 2.02 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 124.095 0.872 . . . . 0.0 112.573 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 95.61 27.23 10.74 Favored Glycine 0 N--CA 1.494 2.537 0 N-CA-C 109.894 -1.282 . . . . 0.0 109.894 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 88.3 m -141.29 139.41 33.66 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 123.926 0.427 . . . . 0.0 110.161 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.43 ' CG ' ' N ' ' A' ' 24' ' ' VAL . 48.8 t80 -67.15 164.64 17.63 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 124.63 1.206 . . . . 0.0 110.787 179.809 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.43 ' N ' ' CG ' ' A' ' 23' ' ' PHE . 96.8 t -129.66 -73.05 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 124.093 0.871 . . . . 0.0 112.544 -179.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 20.3 p -150.58 -172.01 4.07 Favored 'General case' 0 N--CA 1.501 2.084 0 CA-C-O 121.615 0.721 . . . . 0.0 111.359 -179.496 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -123.51 138.77 54.5 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 104.585 -2.376 . . . . 0.0 104.585 179.447 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -55.99 155.52 12.3 Favored Glycine 0 N--CA 1.503 3.111 0 C-N-CA 120.137 -1.03 . . . . 0.0 114.597 -179.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -112.89 -29.55 7.34 Favored 'General case' 0 N--CA 1.505 2.29 0 CA-C-N 114.837 -0.681 . . . . 0.0 111.891 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 32.0 t -110.44 124.54 51.95 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 107.3 -1.371 . . . . 0.0 107.3 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -77.81 144.1 68.03 Favored Pre-proline 0 N--CA 1.495 1.792 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 -179.714 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -41.46 -21.36 0.13 Allowed 'Trans proline' 0 N--CA 1.501 1.925 0 C-N-CA 124.02 3.146 . . . . 0.0 115.617 177.551 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 30.9 tpt180 -57.63 -30.34 65.28 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 123.708 0.63 . . . . 0.0 110.657 179.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.506 ' N ' HD22 ' A' ' 33' ' ' ASN . 0.0 OUTLIER -53.96 120.96 26.74 Favored Pre-proline 0 N--CA 1.496 1.839 0 CA-C-N 114.956 -1.02 . . . . 0.0 112.902 179.991 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -82.19 40.51 0.98 Allowed 'Trans proline' 0 N--CA 1.494 1.546 0 C-N-CA 122.979 2.453 . . . . 0.0 110.356 167.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 57.5 tptt -170.07 160.21 8.0 Favored 'General case' 0 N--CA 1.498 1.951 0 CA-C-N 114.577 -1.192 . . . . 0.0 108.578 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -140.4 151.68 45.14 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 123.866 0.729 . . . . 0.0 109.934 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 6.7 m -79.48 143.51 34.87 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 90.2 m -148.79 92.03 1.94 Allowed 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.4 HD23 ' C ' ' A' ' 39' ' ' LEU . 5.9 tt -157.94 -68.92 0.09 Allowed 'General case' 0 N--CA 1.496 1.839 0 CA-C-N 115.339 -0.846 . . . . 0.0 108.917 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -70.33 146.6 50.4 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 123.766 0.666 . . . . 0.0 111.993 -179.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.409 ' HA ' ' HA ' ' A' ' 4' ' ' CYS . 79.1 m -105.11 132.17 51.67 Favored 'General case' 0 N--CA 1.496 1.826 0 CA-C-N 114.411 -1.268 . . . . 0.0 109.68 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -135.2 77.44 54.95 Favored Pre-proline 0 N--CA 1.497 1.911 0 O-C-N 123.849 0.718 . . . . 0.0 110.291 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_endo -62.75 -27.19 75.39 Favored 'Trans proline' 0 N--CA 1.494 1.515 0 C-N-CA 123.066 2.511 . . . . 0.0 112.794 -172.473 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 6.0 ptp85 -65.99 -34.8 78.93 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 124.189 0.931 . . . . 0.0 112.47 -179.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.0 mt -59.41 136.96 22.49 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.099 0 C-N-CA 118.642 -1.223 . . . . 0.0 112.347 -179.773 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -123.93 -53.02 1.76 Allowed 'General case' 0 N--CA 1.492 1.675 0 CA-C-N 111.911 -2.404 . . . . 0.0 106.737 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 17.3 p90 -170.1 158.44 6.98 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-N 113.667 -1.606 . . . . 0.0 109.8 179.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -112.83 133.93 11.65 Favored Glycine 0 N--CA 1.494 2.517 0 CA-C-N 113.746 -1.57 . . . . 0.0 112.112 -179.764 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.3 p -82.92 105.22 12.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 8.9 m -79.96 112.18 27.85 Favored Pre-proline 0 N--CA 1.493 1.718 0 CA-C-N 113.93 -1.486 . . . . 0.0 108.681 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_endo -73.72 148.07 40.98 Favored 'Trans proline' 0 N--CA 1.492 1.425 0 C-N-CA 122.445 2.096 . . . . 0.0 111.018 -172.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 86.7 mtm180 -83.59 179.36 7.65 Favored 'General case' 0 N--CA 1.498 1.926 0 CA-C-N 114.968 -1.015 . . . . 0.0 110.471 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 80.8 p -70.99 -179.53 2.32 Favored 'General case' 0 N--CA 1.499 1.979 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.501 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -68.65 172.89 5.67 Favored 'General case' 0 N--CA 1.497 1.905 0 C-N-CA 120.268 -0.573 . . . . 0.0 111.59 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 22.1 pt-20 -78.65 153.59 30.9 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-N 114.341 -1.3 . . . . 0.0 108.845 179.768 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.426 ' HG2' HH12 ' A' ' 97' ' ' ARG . 2.6 tmtp? -137.04 -62.04 0.64 Allowed 'General case' 0 N--CA 1.502 2.17 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 -179.772 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.452 ' HD2' ' N ' ' A' ' 57' ' ' LYS . 13.5 mptt -78.97 17.63 0.72 Allowed 'General case' 0 N--CA 1.504 2.27 0 CA-C-O 121.45 0.643 . . . . 0.0 111.638 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.62 ' ND2' ' H ' ' A' ' 60' ' ' ARG . 10.1 p-10 -77.38 -42.33 36.82 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-N 114.834 -1.076 . . . . 0.0 112.152 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 59.24 37.53 23.7 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 124.432 1.083 . . . . 0.0 108.764 -179.715 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.62 ' H ' ' ND2' ' A' ' 58' ' ' ASN . 2.0 tpp180 -99.62 172.21 7.43 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-N 113.074 -1.876 . . . . 0.0 108.476 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 6.6 tp -61.26 85.93 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 124.107 0.88 . . . . 0.0 111.512 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 10.1 m -93.97 56.82 2.34 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-O 122.558 1.17 . . . . 0.0 112.509 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 97.4 m -78.27 162.69 26.35 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 113.355 -1.748 . . . . 0.0 108.52 179.772 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 46.0 p-10 -160.67 156.65 25.83 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 120.317 -0.553 . . . . 0.0 110.582 179.802 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' CYS . . . . . 0.551 ' SG ' ' HB2' ' A' ' 74' ' ' TYR . 53.0 t -83.48 -12.56 56.15 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-N 115.043 -0.981 . . . . 0.0 110.169 179.773 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 53.4 t -65.02 -59.83 3.71 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 179.844 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -90.54 34.55 0.89 Allowed 'General case' 0 N--CA 1.494 1.761 0 CA-C-N 114.167 -1.379 . . . . 0.0 108.69 179.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -74.62 -122.1 0.1 Allowed Glycine 0 N--CA 1.495 2.597 0 CA-C-N 115.353 -0.84 . . . . 0.0 111.053 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 14.8 t -159.81 107.33 1.69 Allowed 'General case' 0 N--CA 1.495 1.807 0 CA-C-O 122.497 1.141 . . . . 0.0 109.465 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 2.7 tmmm? -57.32 101.76 0.07 Allowed 'General case' 0 N--CA 1.493 1.689 0 CA-C-N 113.266 -1.788 . . . . 0.0 107.196 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.404 ' O ' ' SG ' ' A' ' 108' ' ' CYS . . . 165.41 -32.74 0.24 Allowed Glycine 0 N--CA 1.485 1.96 0 CA-C-N 113.225 -1.807 . . . . 0.0 109.366 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 57.7 m -124.36 175.11 7.3 Favored 'General case' 0 N--CA 1.503 2.18 0 C-N-CA 120.017 -0.673 . . . . 0.0 110.733 -179.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.448 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 94.0 mttt -110.61 97.86 7.18 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 124.607 1.192 . . . . 0.0 109.174 -179.796 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.551 ' HB2' ' SG ' ' A' ' 65' ' ' CYS . 26.8 m-85 -54.37 131.36 41.92 Favored 'General case' 0 N--CA 1.497 1.89 0 CA-C-N 114.808 -1.087 . . . . 0.0 109.135 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -139.9 147.51 40.7 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 112.956 -1.929 . . . . 0.0 113.475 -179.366 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.403 ' N ' HG23 ' A' ' 82' ' ' VAL . 30.9 t -99.58 117.03 33.07 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-N 111.378 -2.646 . . . . 0.0 108.599 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.578 ' H ' ' HB2' ' A' ' 104' ' ' ALA . 7.6 p-10 -59.97 -54.19 49.04 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 125.186 1.553 . . . . 0.0 112.996 -179.652 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -84.14 13.51 5.09 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 113.603 -1.635 . . . . 0.0 110.882 -179.673 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -129.13 -88.87 0.56 Allowed Glycine 0 N--CA 1.48 1.627 0 N-CA-C 108.962 -1.655 . . . . 0.0 108.962 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.451 ' CG2' ' N ' ' A' ' 81' ' ' PHE . 1.2 m 171.78 -175.71 0.05 OUTLIER 'General case' 0 N--CA 1.5 2.066 0 N-CA-C 105.902 -1.888 . . . . 0.0 105.902 -179.381 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.451 ' N ' ' CG2' ' A' ' 80' ' ' THR . 19.2 t80 -53.52 136.3 38.58 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 179.504 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.403 HG23 ' N ' ' A' ' 76' ' ' SER . 92.9 t -94.78 -73.61 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 CA-C-N 114.606 -1.179 . . . . 0.0 109.196 -179.558 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . 0.423 ' C ' ' SG ' ' A' ' 65' ' ' CYS . 0.1 OUTLIER -168.44 178.53 4.79 Favored 'General case' 0 N--CA 1.504 2.268 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 179.882 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.448 ' HA ' ' HA ' ' A' ' 73' ' ' LYS . 38.6 tt0 -93.02 152.46 19.29 Favored 'General case' 0 N--CA 1.5 2.034 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -50.29 102.05 0.06 OUTLIER Glycine 0 N--CA 1.495 2.589 0 O-C-N 123.739 0.649 . . . . 0.0 111.513 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -79.83 -12.15 59.78 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-N 114.862 -0.669 . . . . 0.0 110.146 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 35.1 t -77.79 84.31 4.11 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 121.464 0.65 . . . . 0.0 109.708 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -79.38 132.1 63.42 Favored Pre-proline 0 N--CA 1.495 1.803 0 N-CA-C 106.399 -1.704 . . . . 0.0 106.399 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -52.49 -22.39 16.4 Favored 'Trans proline' 0 N--CA 1.498 1.741 0 C-N-CA 122.823 2.349 . . . . 0.0 113.705 -169.701 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 53.0 mmm-85 -83.71 12.82 5.35 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 123.802 0.689 . . . . 0.0 111.648 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.411 ' C ' ' H ' ' A' ' 93' ' ' LYS . 40.6 p-10 -87.71 135.2 34.24 Favored Pre-proline 0 N--CA 1.494 1.742 0 O-C-N 123.45 0.469 . . . . 0.0 111.148 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -81.95 28.97 0.55 Allowed 'Trans proline' 0 N--CA 1.493 1.453 0 C-N-CA 122.967 2.445 . . . . 0.0 111.409 162.317 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.411 ' H ' ' C ' ' A' ' 91' ' ' ASN . 44.3 mmtm 58.21 124.23 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.162 0 CA-C-N 113.76 -1.564 . . . . 0.0 112.846 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -149.32 79.67 1.4 Allowed 'General case' 0 N--CA 1.497 1.913 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.628 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 79.2 m -153.24 124.21 3.57 Favored Pre-proline 0 N--CA 1.496 1.857 0 CA-C-N 114.476 -1.238 . . . . 0.0 108.43 179.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -60.73 -85.57 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.502 0 C-N-CA 122.046 1.831 . . . . 0.0 110.592 177.06 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.426 HH12 ' HG2' ' A' ' 56' ' ' LYS . 2.7 mpt_? -142.25 -60.35 0.45 Allowed 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 7.9 m-80 51.51 48.28 23.21 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 124.592 1.182 . . . . 0.0 110.243 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 77.9 m -41.17 128.0 2.83 Favored 'General case' 0 N--CA 1.499 2.009 0 CA-C-N 114.112 -1.404 . . . . 0.0 112.734 -179.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -139.03 79.32 27.09 Favored Pre-proline 0 N--CA 1.496 1.831 0 O-C-N 124.125 0.89 . . . . 0.0 110.882 -179.733 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -59.43 -33.91 97.35 Favored 'Trans proline' 0 N--CA 1.494 1.523 0 C-N-CA 122.87 2.38 . . . . 0.0 113.024 171.606 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 33.2 ptt180 -63.96 -16.93 62.67 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 123.919 0.762 . . . . 0.0 112.3 -179.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 9.6 tp -48.86 152.64 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 O-C-N 124.019 0.824 . . . . 0.0 112.452 -179.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.578 ' HB2' ' H ' ' A' ' 77' ' ' ASP . . . -124.59 -71.96 0.69 Allowed 'General case' 0 N--CA 1.492 1.659 0 CA-C-N 114.686 -1.143 . . . . 0.0 108.261 179.792 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 76.3 m-85 -156.14 -162.99 1.37 Allowed 'General case' 0 N--CA 1.499 2.001 0 O-C-N 124.685 1.241 . . . . 0.0 109.042 -179.725 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -119.87 93.26 0.54 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 104.966 -3.253 . . . . 0.0 104.966 179.714 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 43.7 mm -78.77 105.7 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 C-N-CA 119.626 -0.83 . . . . 0.0 110.546 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' CYS . . . . . 0.404 ' SG ' ' O ' ' A' ' 71' ' ' GLY . 1.6 m -78.61 151.4 77.19 Favored Pre-proline 0 N--CA 1.499 1.995 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.688 179.895 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -59.56 114.3 1.99 Allowed 'Trans proline' 0 N--CA 1.494 1.528 0 C-N-CA 122.752 2.302 . . . . 0.0 111.151 -172.716 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 2.3 pp -79.86 -177.3 5.88 Favored 'General case' 0 N--CA 1.496 1.827 0 CA-C-N 114.928 -1.033 . . . . 0.0 111.892 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.836 0 CA-C-O 116.209 -1.853 . . . . 0.0 110.718 -179.911 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 24.3 t70 . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 109.489 -0.559 . . . . 0.0 109.489 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 10.4 mmm180 -102.83 -47.56 4.35 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-N 114.954 -1.021 . . . . 0.0 111.004 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 4.8 tp -65.62 85.99 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 124.212 0.945 . . . . 0.0 111.228 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.558 ' HA ' ' HA ' ' A' ' 41' ' ' CYS . 1.6 m -92.88 61.03 3.46 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-O 123.372 1.558 . . . . 0.0 113.731 179.814 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 6.8 t -90.15 161.47 15.74 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 104.475 -2.417 . . . . 0.0 104.475 179.517 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.522 ' ND2' ' H ' ' A' ' 9' ' ' ALA . 3.2 p-10 -161.54 -166.42 1.5 Allowed 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 -179.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 8.8 t -117.58 -36.88 3.58 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 179.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 49.5 t -62.5 -61.46 2.42 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 123.917 0.761 . . . . 0.0 110.402 -179.59 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.522 ' H ' ' ND2' ' A' ' 6' ' ' ASN . . . -90.06 27.51 1.59 Allowed 'General case' 0 N--CA 1.496 1.871 0 CA-C-N 113.525 -1.67 . . . . 0.0 109.178 179.859 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -72.67 -117.9 0.06 OUTLIER Glycine 0 N--CA 1.492 2.411 0 CA-C-N 115.141 -0.936 . . . . 0.0 111.271 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 97.3 m -154.62 91.82 1.43 Allowed 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 107.518 -1.289 . . . . 0.0 107.518 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.484 ' HB3' ' NZ ' ' A' ' 12' ' ' LYS . 0.0 OUTLIER -54.6 112.77 1.08 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 123.739 0.649 . . . . 0.0 110.146 -179.847 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 135.16 -30.06 2.86 Favored Glycine 0 N--CA 1.494 2.531 0 CA-C-N 113.641 -1.618 . . . . 0.0 109.781 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 82.6 m -88.97 -178.38 5.7 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 123.659 0.27 . . . . 0.0 110.955 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 33.3 mmtp -129.82 92.26 3.29 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 124.062 0.851 . . . . 0.0 111.294 -179.546 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.436 ' HB2' ' SG ' ' A' ' 25' ' ' CYS . 51.3 m-85 -58.87 131.64 51.59 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 124.53 1.144 . . . . 0.0 108.268 179.72 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -142.04 159.66 41.78 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-N 113.102 -1.863 . . . . 0.0 113.43 -179.162 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 30.6 t -105.11 134.04 48.89 Favored 'General case' 0 N--CA 1.497 1.893 0 CA-C-N 113.689 -1.596 . . . . 0.0 111.619 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -48.22 -28.27 2.93 Favored 'General case' 0 N--CA 1.501 2.122 0 CA-C-N 112.948 -1.933 . . . . 0.0 115.814 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -52.09 -22.75 4.43 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 124.036 0.835 . . . . 0.0 111.602 -179.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 112.13 27.2 4.05 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 108.871 -1.692 . . . . 0.0 108.871 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 89.7 m -138.75 142.06 38.83 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 120.527 -0.469 . . . . 0.0 110.959 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 49.6 t80 -69.41 160.98 30.35 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-N 114.151 -1.386 . . . . 0.0 109.761 179.745 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 58.5 t -127.2 -71.6 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 124.091 0.87 . . . . 0.0 112.179 -179.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.436 ' SG ' ' HB2' ' A' ' 16' ' ' TYR . 0.5 OUTLIER -144.52 -177.93 5.73 Favored 'General case' 0 N--CA 1.5 2.068 0 CA-C-O 121.402 0.62 . . . . 0.0 110.818 -179.709 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -113.04 145.0 41.63 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 104.067 -2.568 . . . . 0.0 104.067 179.485 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -57.3 152.04 26.23 Favored Glycine 0 N--CA 1.498 2.773 0 C-N-CA 119.301 -1.428 . . . . 0.0 111.184 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -126.42 -10.06 6.32 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 123.976 0.457 . . . . 0.0 111.265 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 33.4 t -71.63 91.26 1.08 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 123.728 0.643 . . . . 0.0 110.714 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -99.11 111.88 61.88 Favored Pre-proline 0 N--CA 1.491 1.586 0 CA-C-N 114.618 -1.173 . . . . 0.0 108.752 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_endo -58.48 -17.07 32.42 Favored 'Trans proline' 0 N--CA 1.495 1.609 0 C-N-CA 122.869 2.38 . . . . 0.0 113.114 -168.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 74.7 ttt-85 -61.01 -50.01 75.1 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -90.84 122.85 66.31 Favored Pre-proline 0 N--CA 1.496 1.843 0 O-C-N 124.271 0.982 . . . . 0.0 110.772 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_endo -78.11 121.62 5.41 Favored 'Trans proline' 0 N--CA 1.492 1.417 0 C-N-CA 122.813 2.342 . . . . 0.0 108.999 165.303 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 56.8 tptt -159.05 153.94 24.87 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 123.62 0.575 . . . . 0.0 110.568 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.85 171.62 9.79 Favored 'General case' 0 N--CA 1.497 1.912 0 CA-C-N 114.321 -1.309 . . . . 0.0 111.315 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 89.7 m -153.58 162.76 40.95 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-N 115.323 -0.853 . . . . 0.0 112.22 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 100.0 m -109.38 91.16 3.53 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 105.46 -2.052 . . . . 0.0 105.46 179.745 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.479 HD12 ' N ' ' A' ' 39' ' ' LEU . 6.4 mp -79.65 -66.43 0.87 Allowed 'General case' 0 N--CA 1.494 1.725 0 CA-C-N 114.882 -1.054 . . . . 0.0 109.892 -179.728 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 5.6 m120 49.17 31.84 3.82 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 124.637 1.211 . . . . 0.0 111.185 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.558 ' HA ' ' HA ' ' A' ' 4' ' ' CYS . 1.7 m 55.7 131.98 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 116.668 2.099 . . . . 0.0 116.668 -179.831 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -120.37 81.13 30.06 Favored Pre-proline 0 N--CA 1.5 2.064 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.296 179.667 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -58.58 -15.29 24.76 Favored 'Trans proline' 0 N--CA 1.495 1.574 0 C-N-CA 122.578 2.186 . . . . 0.0 112.308 176.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.456 ' H ' ' CD ' ' A' ' 44' ' ' ARG . 1.4 mpt_? -62.41 -43.23 99.31 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 26.6 mt -83.09 155.81 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 CA-C-O 122.317 1.056 . . . . 0.0 110.201 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -116.2 -53.84 2.51 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-N 111.731 -2.486 . . . . 0.0 108.025 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 50.9 p90 -165.75 167.31 17.14 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-N 114.41 -1.268 . . . . 0.0 109.287 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -119.93 118.48 3.92 Favored Glycine 0 N--CA 1.49 2.251 0 CA-C-N 113.557 -1.656 . . . . 0.0 110.56 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.9 p -79.31 133.99 28.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 20.9 m -111.27 90.76 12.28 Favored Pre-proline 0 N--CA 1.494 1.745 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 -179.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -51.91 -16.95 4.76 Favored 'Trans proline' 0 N--CA 1.499 1.801 0 C-N-CA 123.244 2.629 . . . . 0.0 114.423 -177.1 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.64 ' H ' ' HD2' ' A' ' 52' ' ' ARG . 0.0 OUTLIER -81.02 66.57 6.6 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-O 122.292 1.044 . . . . 0.0 110.524 179.959 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 63.3 p -116.03 149.89 38.16 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-N 113.715 -1.584 . . . . 0.0 109.389 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 67.38 148.24 0.05 Allowed 'General case' 0 N--CA 1.504 2.248 0 O-C-N 124.608 1.193 . . . . 0.0 110.339 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 57.87 -168.32 0.13 Allowed 'General case' 0 N--CA 1.504 2.258 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.581 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.506 ' H ' ' ND2' ' A' ' 58' ' ' ASN . 0.0 OUTLIER -161.84 -152.09 0.23 Allowed 'General case' 0 N--CA 1.495 1.799 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.249 -179.977 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.425 ' C ' ' H ' ' A' ' 59' ' ' ASP . 0.0 OUTLIER -77.0 23.16 0.18 Allowed 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 113.489 0.922 . . . . 0.0 113.489 179.989 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.506 ' ND2' ' H ' ' A' ' 56' ' ' LYS . 3.8 p30 -72.52 18.31 0.09 Allowed 'General case' 0 N--CA 1.502 2.14 0 CA-C-N 115.853 -0.612 . . . . 0.0 112.442 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.425 ' H ' ' C ' ' A' ' 57' ' ' LYS . 5.8 m-20 -70.78 -79.66 0.06 Allowed 'General case' 0 N--CA 1.491 1.613 0 CA-C-N 115.69 -0.687 . . . . 0.0 110.47 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 22.2 tpp85 -168.53 135.36 1.95 Allowed 'General case' 0 N--CA 1.499 1.984 0 O-C-N 123.774 0.671 . . . . 0.0 111.132 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 6.6 tp -84.27 68.15 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 CA-C-N 114.704 -1.135 . . . . 0.0 109.17 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.46 ' HA ' ' HA ' ' A' ' 99' ' ' CYS . 1.6 m -84.24 40.44 0.77 Allowed 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 115.618 1.71 . . . . 0.0 115.618 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 36.0 m -91.51 109.71 21.01 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 113.175 -1.83 . . . . 0.0 107.893 179.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.539 ' ND2' ' H ' ' A' ' 67' ' ' ALA . 29.8 p-10 -107.83 -165.72 1.08 Allowed 'General case' 0 N--CA 1.503 2.184 0 C-N-CA 120.264 -0.574 . . . . 0.0 109.651 179.84 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' CYS . . . . . 0.409 ' SG ' ' O ' ' A' ' 84' ' ' GLU . 1.5 t -121.22 -33.91 3.59 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 123.904 0.753 . . . . 0.0 111.362 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 32.6 t -57.07 -58.6 7.48 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-O 121.71 0.766 . . . . 0.0 110.12 -179.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.539 ' H ' ' ND2' ' A' ' 64' ' ' ASN . . . -79.42 -10.56 59.83 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-N 113.088 -1.869 . . . . 0.0 109.737 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -67.47 156.57 52.31 Favored Glycine 0 N--CA 1.494 2.551 0 C-N-CA 120.823 -0.703 . . . . 0.0 111.588 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.461 ' C ' ' H ' ' A' ' 71' ' ' GLY . 57.0 p -68.49 124.27 23.09 Favored 'General case' 0 N--CA 1.498 1.951 0 CA-C-N 114.14 -1.03 . . . . 0.0 111.127 -179.809 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.86 20.72 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.173 0 N-CA-C 115.958 1.836 . . . . 0.0 115.958 -179.853 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.461 ' H ' ' C ' ' A' ' 69' ' ' THR . . . -119.58 -25.85 2.52 Favored Glycine 0 N--CA 1.49 2.29 0 CA-C-N 113.623 -1.626 . . . . 0.0 109.319 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . 0.4 ' HA ' ' HA ' ' A' ' 108' ' ' CYS . 94.6 m -93.36 134.54 35.48 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 120.333 -0.547 . . . . 0.0 109.801 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 60.0 mtpt -88.77 84.27 6.69 Favored 'General case' 0 N--CA 1.485 1.316 0 CA-C-N 113.501 -1.681 . . . . 0.0 109.545 -179.632 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.487 ' HB2' ' SG ' ' A' ' 83' ' ' CYS . 82.0 m-85 -50.08 126.11 13.74 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-N 114.855 -1.066 . . . . 0.0 108.418 179.87 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -132.5 162.88 30.08 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 112.986 -1.915 . . . . 0.0 112.625 -179.327 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 42.6 t -109.21 138.52 45.44 Favored 'General case' 0 N--CA 1.497 1.889 0 CA-C-N 114.309 -1.314 . . . . 0.0 112.376 -179.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.44 ' H ' ' CB ' ' A' ' 104' ' ' ALA . 7.0 p-10 -47.45 -27.25 1.63 Allowed 'General case' 0 N--CA 1.5 2.042 0 CA-C-N 112.18 -2.282 . . . . 0.0 114.38 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 13.6 p30 -59.11 -7.62 1.21 Allowed 'General case' 0 N--CA 1.497 1.899 0 O-C-N 124.335 1.022 . . . . 0.0 112.492 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 92.91 28.57 11.83 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 95.8 m -143.08 138.8 30.14 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 124.095 0.526 . . . . 0.0 110.554 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.429 ' CG ' ' N ' ' A' ' 82' ' ' VAL . 37.1 t80 -64.19 164.96 10.01 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 124.878 1.361 . . . . 0.0 110.849 179.853 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.429 ' N ' ' CG ' ' A' ' 81' ' ' PHE . 92.4 t -129.03 -71.56 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 124.188 0.93 . . . . 0.0 112.991 -179.805 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . 0.487 ' SG ' ' HB2' ' A' ' 74' ' ' TYR . 25.4 p -152.58 -173.08 4.44 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 123.708 0.63 . . . . 0.0 109.346 -179.561 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.409 ' O ' ' SG ' ' A' ' 65' ' ' CYS . 40.5 tt0 -128.49 149.63 50.51 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 102.602 -3.111 . . . . 0.0 102.602 179.324 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -58.8 169.89 5.36 Favored Glycine 0 N--CA 1.501 3.023 0 C-N-CA 118.631 -1.747 . . . . 0.0 114.966 -179.66 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -126.15 -13.88 6.11 Favored 'General case' 0 N--CA 1.502 2.145 0 CA-C-N 114.218 -0.991 . . . . 0.0 110.991 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 34.5 t -81.55 121.59 26.5 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -98.32 143.3 26.04 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 124.779 1.299 . . . . 0.0 107.785 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_exo -43.18 -28.07 1.29 Allowed 'Trans proline' 0 N--CA 1.5 1.866 0 C-N-CA 123.4 2.733 . . . . 0.0 114.022 175.073 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -60.09 -50.38 73.92 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 123.911 0.757 . . . . 0.0 109.278 179.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -91.06 116.39 66.32 Favored Pre-proline 0 N--CA 1.497 1.892 0 O-C-N 124.748 1.28 . . . . 0.0 111.806 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -85.02 102.76 0.8 Allowed 'Trans proline' 0 N--CA 1.491 1.342 0 C-N-CA 123.072 2.514 . . . . 0.0 108.044 161.476 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 22.2 ptmt -161.18 162.95 31.49 Favored 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 113.188 0.81 . . . . 0.0 113.188 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -108.86 -166.86 1.15 Allowed 'General case' 0 N--CA 1.496 1.844 0 CA-C-N 113.56 -1.654 . . . . 0.0 108.406 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 76.9 m -146.99 159.94 41.61 Favored Pre-proline 0 N--CA 1.499 1.984 0 O-C-N 123.653 0.595 . . . . 0.0 110.958 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.418 ' C ' ' HE ' ' A' ' 97' ' ' ARG . 11.9 Cg_endo -73.15 -18.19 23.94 Favored 'Trans proline' 0 N--CA 1.493 1.461 0 C-N-CA 122.36 2.04 . . . . 0.0 109.45 161.522 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.418 ' HE ' ' C ' ' A' ' 96' ' ' PRO . 0.0 OUTLIER -79.64 4.44 16.05 Favored 'General case' 0 N--CA 1.497 1.9 0 CA-C-N 114.949 -1.023 . . . . 0.0 111.376 -179.994 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 -54.89 154.41 5.27 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.46 ' HA ' ' HA ' ' A' ' 62' ' ' CYS . 52.4 m 58.37 104.19 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 CA-C-N 113.227 -1.806 . . . . 0.0 113.583 -179.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -125.36 107.1 27.27 Favored Pre-proline 0 N--CA 1.498 1.97 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.616 179.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -62.4 -25.79 76.4 Favored 'Trans proline' 0 N--CA 1.493 1.491 0 C-N-CA 122.639 2.226 . . . . 0.0 111.453 179.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 23.5 mtp-105 -57.93 -38.18 75.43 Favored 'General case' 0 N--CA 1.5 2.048 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 26.7 mt -79.31 154.85 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 CA-C-N 114.815 -1.084 . . . . 0.0 110.079 179.734 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.44 ' CB ' ' H ' ' A' ' 77' ' ' ASP . . . -132.36 -46.24 0.91 Allowed 'General case' 0 N--CA 1.495 1.794 0 CA-C-N 111.955 -2.384 . . . . 0.0 109.441 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 49.1 m-85 -140.0 -163.55 1.53 Allowed 'General case' 0 N--CA 1.493 1.706 0 CA-C-N 114.519 -1.219 . . . . 0.0 109.594 -179.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -152.65 107.77 0.34 Allowed Glycine 0 N--CA 1.49 2.235 0 N-CA-C 107.339 -2.304 . . . . 0.0 107.339 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 88.9 mt -79.44 84.41 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 N-CA-C 108.245 -1.021 . . . . 0.0 108.245 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' CYS . . . . . 0.4 ' HA ' ' HA ' ' A' ' 72' ' ' CYS . 13.6 m -79.97 112.46 30.18 Favored Pre-proline 0 N--CA 1.494 1.729 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -69.65 -71.0 0.02 OUTLIER 'Trans proline' 0 N--CA 1.493 1.442 0 C-N-CA 122.236 1.957 . . . . 0.0 111.306 -167.496 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 84.5 mt -90.02 45.08 1.24 Allowed 'General case' 0 N--CA 1.498 1.963 0 O-C-N 124.211 0.945 . . . . 0.0 110.402 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 1.968 0 CA-C-O 116.362 -1.78 . . . . 0.0 110.7 -179.987 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 31.6 t70 . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 121.059 0.457 . . . . 0.0 109.972 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 72.7 mtp85 -70.76 127.57 33.09 Favored 'General case' 0 N--CA 1.495 1.801 0 CA-C-N 114.774 -1.103 . . . . 0.0 110.472 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 9.8 tp -87.0 44.11 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 124.169 0.918 . . . . 0.0 109.031 179.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.408 ' HA ' ' HA ' ' A' ' 41' ' ' CYS . 1.7 m -82.78 60.35 5.28 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 114.336 1.236 . . . . 0.0 114.336 -179.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 17.8 p -90.92 172.4 8.62 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-N 113.501 -1.681 . . . . 0.0 109.37 179.601 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 32.3 p-10 -161.8 146.06 12.73 Favored 'General case' 0 N--CA 1.497 1.925 0 CA-C-N 115.002 -0.999 . . . . 0.0 109.681 179.687 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.4 ' HA ' ' CD2' ' A' ' 16' ' ' TYR . 40.3 t -63.4 -16.54 60.82 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 113.469 0.915 . . . . 0.0 113.469 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 43.8 t -80.77 -63.46 1.4 Allowed 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 114.789 1.403 . . . . 0.0 114.789 -179.515 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -85.21 62.33 7.43 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-N 114.664 -1.153 . . . . 0.0 112.377 -179.646 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -106.96 -111.79 3.61 Favored Glycine 0 N--CA 1.495 2.578 0 CA-C-N 113.699 -1.591 . . . . 0.0 110.257 179.715 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.561 ' H ' ' HA3' ' A' ' 27' ' ' GLY . 53.4 m -166.64 117.83 0.96 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 125.211 1.183 . . . . 0.0 109.622 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 11.0 mmmm -67.9 83.34 0.21 Allowed 'General case' 0 N--CA 1.502 2.158 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 179.504 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 168.48 -20.26 0.08 OUTLIER Glycine 0 N--CA 1.49 2.282 0 CA-C-N 114.758 -1.11 . . . . 0.0 112.226 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 68.1 m -117.71 -176.68 3.08 Favored 'General case' 0 N--CA 1.5 2.031 0 CA-C-N 117.921 0.86 . . . . 0.0 108.879 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.431 ' HB3' ' HZ2' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -130.84 116.78 18.4 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 118.463 -1.295 . . . . 0.0 113.494 -179.657 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.44 ' N ' ' O ' ' A' ' 25' ' ' CYS . 8.2 m-85 -56.61 136.31 54.66 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-N 113.784 -1.553 . . . . 0.0 107.759 179.331 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -151.06 149.69 29.83 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 113.322 -1.763 . . . . 0.0 111.261 -179.452 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 38.1 t -98.73 134.33 41.78 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-N 111.914 -2.403 . . . . 0.0 112.174 -179.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.446 ' H ' ' HB2' ' A' ' 46' ' ' ALA . 3.3 p30 -51.58 -26.44 8.74 Favored 'General case' 0 N--CA 1.5 2.061 0 CA-C-N 112.701 -2.045 . . . . 0.0 114.24 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 52.0 p-10 -59.28 -10.21 2.82 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 124.079 0.862 . . . . 0.0 112.244 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 97.62 29.65 7.67 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 108.718 -1.753 . . . . 0.0 108.718 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 56.2 m -136.06 145.86 46.45 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 124.135 0.55 . . . . 0.0 109.744 -179.799 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.426 ' CG ' ' N ' ' A' ' 24' ' ' VAL . 54.3 t80 -75.48 164.42 26.38 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 124.61 1.194 . . . . 0.0 110.612 179.753 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.426 ' N ' ' CG ' ' A' ' 23' ' ' PHE . 87.2 t -128.49 -75.9 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 124.075 0.859 . . . . 0.0 110.5 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.54 ' SG ' ' N ' ' A' ' 26' ' ' GLU . 0.5 OUTLIER -155.0 -164.87 1.89 Allowed 'General case' 0 N--CA 1.505 2.296 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 -179.898 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.54 ' N ' ' SG ' ' A' ' 25' ' ' CYS . 3.6 tm-20 -111.43 137.65 48.95 Favored 'General case' 0 N--CA 1.504 2.259 0 N-CA-C 106.63 -1.618 . . . . 0.0 106.63 179.588 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.561 ' HA3' ' H ' ' A' ' 11' ' ' THR . . . -54.9 117.45 8.17 Favored Glycine 0 N--CA 1.5 2.963 0 N-CA-C 110.53 -1.028 . . . . 0.0 110.53 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 39.8 mm-40 -93.5 10.35 32.81 Favored 'General case' 0 N--CA 1.499 2.022 0 N-CA-C 115.808 1.781 . . . . 0.0 115.808 -179.496 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 32.2 t -76.1 96.55 3.87 Favored 'General case' 0 N--CA 1.499 2.019 0 C-N-CA 118.651 -1.22 . . . . 0.0 108.734 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -87.74 145.91 37.93 Favored Pre-proline 0 N--CA 1.493 1.688 0 CA-C-N 114.31 -1.314 . . . . 0.0 108.486 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_exo -47.12 111.95 0.46 Allowed 'Trans proline' 0 N--CA 1.494 1.533 0 C-N-CA 122.366 2.044 . . . . 0.0 110.148 169.399 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 79.1 mtp180 57.07 48.94 14.58 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 124.439 1.087 . . . . 0.0 109.687 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -58.89 140.02 86.62 Favored Pre-proline 0 N--CA 1.498 1.928 0 CA-C-N 114.024 -1.444 . . . . 0.0 110.856 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -66.14 129.18 21.12 Favored 'Trans proline' 0 N--CA 1.492 1.409 0 C-N-CA 122.367 2.045 . . . . 0.0 110.599 -178.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 59.3 mttp 62.42 162.69 0.09 Allowed 'General case' 0 N--CA 1.503 2.222 0 O-C-N 124.742 1.276 . . . . 0.0 113.351 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -89.05 168.55 12.24 Favored 'General case' 0 N--CA 1.498 1.937 0 CA-C-N 114.528 -1.215 . . . . 0.0 110.293 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 71.3 m -79.86 163.5 24.32 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.946 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 43.7 m -138.19 7.98 2.68 Favored 'General case' 0 N--CA 1.497 1.91 0 CA-C-N 114.768 -1.106 . . . . 0.0 110.025 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 88.2 mt -79.33 -65.23 1.03 Allowed 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 7.8 m-80 56.73 116.34 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 114.911 1.448 . . . . 0.0 114.911 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.408 ' HA ' ' HA ' ' A' ' 4' ' ' CYS . 82.0 m 58.41 122.15 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 116.164 1.913 . . . . 0.0 116.164 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -144.42 90.37 6.6 Favored Pre-proline 0 N--CA 1.496 1.845 0 CA-C-N 114.637 -1.165 . . . . 0.0 109.838 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -57.39 -28.23 79.31 Favored 'Trans proline' 0 N--CA 1.493 1.482 0 C-N-CA 122.805 2.337 . . . . 0.0 113.051 179.372 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 15.5 tpt180 -58.17 -41.06 83.04 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 123.934 0.771 . . . . 0.0 109.476 179.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 14.3 mt -70.24 154.57 8.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 CA-C-O 122.121 0.962 . . . . 0.0 110.163 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.446 ' HB2' ' H ' ' A' ' 19' ' ' ASP . . . -121.15 -50.66 2.13 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-N 111.938 -2.392 . . . . 0.0 107.343 179.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 19.5 p90 -171.85 164.18 6.39 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-N 114.242 -1.345 . . . . 0.0 111.214 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -104.01 91.36 0.8 Allowed Glycine 0 N--CA 1.492 2.401 0 N-CA-C 107.159 -2.376 . . . . 0.0 107.159 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.1 p -84.25 126.66 40.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 C-N-CA 119.123 -1.031 . . . . 0.0 112.893 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.6 m -79.64 154.0 75.99 Favored Pre-proline 0 N--CA 1.496 1.868 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 179.615 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -71.35 81.6 1.2 Allowed 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 122.739 2.292 . . . . 0.0 109.743 -173.167 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 25.5 mtp-105 -148.54 161.3 41.94 Favored 'General case' 0 N--CA 1.496 1.856 0 CA-C-N 114.199 -1.364 . . . . 0.0 108.656 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 45.1 t -69.52 115.62 8.98 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -66.29 -43.6 85.89 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 123.879 0.737 . . . . 0.0 109.878 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.436 ' HG2' ' H ' ' A' ' 62' ' ' CYS . 19.4 mp0 -93.43 121.15 34.52 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 179.715 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.435 ' HB2' ' NZ ' ' A' ' 56' ' ' LYS . 10.4 mtmp? -139.16 -50.47 0.52 Allowed 'General case' 0 N--CA 1.495 1.791 0 CA-C-N 114.44 -1.254 . . . . 0.0 108.875 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -86.73 -76.97 0.34 Allowed 'General case' 0 N--CA 1.496 1.827 0 CA-C-N 115.047 -0.979 . . . . 0.0 110.002 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 36.8 t30 -162.07 51.76 0.22 Allowed 'General case' 0 N--CA 1.498 1.974 0 CA-C-O 121.976 0.893 . . . . 0.0 109.126 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -92.76 37.61 1.02 Allowed 'General case' 0 N--CA 1.498 1.948 0 CA-C-N 114.501 -1.227 . . . . 0.0 109.362 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 59.3 ttt85 57.45 95.01 0.03 OUTLIER 'General case' 0 N--CA 1.504 2.243 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 -179.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 8.2 tp -39.4 102.93 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 124.364 1.04 . . . . 0.0 113.685 -179.655 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.545 ' HA ' ' HA ' ' A' ' 99' ' ' CYS . 1.7 m -131.47 39.34 3.52 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 113.852 -1.522 . . . . 0.0 111.607 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 87.0 m -90.52 171.64 9.27 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-N 112.255 -2.248 . . . . 0.0 107.625 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.452 HD21 ' HB3' ' A' ' 67' ' ' ALA . 0.1 OUTLIER -160.37 -162.7 1.0 Allowed 'General case' 0 N--CA 1.5 2.061 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 179.952 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' CYS . . . . . 0.469 ' SG ' ' CD2' ' A' ' 74' ' ' TYR . 3.9 t -107.01 -28.26 10.14 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 124.071 0.857 . . . . 0.0 109.78 179.766 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . 0.451 ' SG ' ' CE ' ' A' ' 93' ' ' LYS . 51.0 t -73.88 -57.63 3.85 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 114.918 1.451 . . . . 0.0 114.918 -179.669 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.452 ' HB3' HD21 ' A' ' 64' ' ' ASN . . . -80.75 60.09 3.9 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 124.833 1.333 . . . . 0.0 112.565 -179.782 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -145.57 -139.91 3.45 Favored Glycine 0 N--CA 1.497 2.73 0 N-CA-C 108.253 -1.939 . . . . 0.0 108.253 179.625 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.432 ' C ' ' H ' ' A' ' 71' ' ' GLY . 92.4 m -154.03 150.72 28.54 Favored 'General case' 0 N--CA 1.505 2.319 0 N-CA-C 114.434 1.272 . . . . 0.0 114.434 -179.825 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 24.0 mmtt -72.63 35.87 0.07 Allowed 'General case' 0 N--CA 1.505 2.304 0 CA-C-N 113.042 -1.89 . . . . 0.0 112.689 179.634 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.432 ' H ' ' C ' ' A' ' 69' ' ' THR . . . -131.92 2.52 5.19 Favored Glycine 0 N--CA 1.485 1.923 0 N-CA-C 109.141 -1.584 . . . . 0.0 109.141 179.867 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 94.1 m -141.7 167.01 23.17 Favored 'General case' 0 N--CA 1.497 1.916 0 C-N-CA 119.384 -0.926 . . . . 0.0 111.376 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -119.89 105.45 11.1 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 124.184 0.928 . . . . 0.0 109.67 -179.637 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.648 ' CD2' ' SG ' ' A' ' 83' ' ' CYS . 74.0 m-85 -51.13 135.88 24.81 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 124.047 0.842 . . . . 0.0 110.382 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -146.96 157.22 43.57 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 -179.571 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 42.9 t -110.4 130.99 55.44 Favored 'General case' 0 N--CA 1.501 2.085 0 CA-C-N 113.441 -1.709 . . . . 0.0 113.281 -179.725 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.585 ' H ' ' HB2' ' A' ' 104' ' ' ALA . 7.3 p-10 -46.08 -31.5 2.37 Favored 'General case' 0 N--CA 1.502 2.141 0 CA-C-N 112.562 -2.108 . . . . 0.0 115.349 -179.861 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 39.1 p30 -57.42 -10.09 1.29 Allowed 'General case' 0 N--CA 1.497 1.901 0 O-C-N 124.268 0.98 . . . . 0.0 112.794 -179.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 99.1 23.84 11.03 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 110.159 -1.177 . . . . 0.0 110.159 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -131.31 146.87 52.48 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 124.211 0.595 . . . . 0.0 109.631 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 45.1 t80 -77.53 154.92 31.97 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 114.124 -1.398 . . . . 0.0 110.714 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 92.8 t -113.08 -73.45 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 124.19 0.931 . . . . 0.0 112.767 -179.723 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . 0.648 ' SG ' ' CD2' ' A' ' 74' ' ' TYR . 29.7 p -157.3 -174.0 4.69 Favored 'General case' 0 N--CA 1.503 2.181 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 -179.585 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -119.43 155.92 31.11 Favored 'General case' 0 N--CA 1.505 2.282 0 CA-C-O 119.003 -0.522 . . . . 0.0 109.793 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.44 ' HA2' ' CE2' ' A' ' 74' ' ' TYR . . . -31.22 111.78 0.05 OUTLIER Glycine 0 N--CA 1.502 3.048 0 O-C-N 124.838 1.337 . . . . 0.0 112.599 179.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -100.84 27.54 5.88 Favored 'General case' 0 N--CA 1.498 1.932 0 C-N-CA 119.97 -0.692 . . . . 0.0 109.199 -179.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 42.6 t -140.55 95.95 2.95 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-O 121.469 0.652 . . . . 0.0 111.959 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -84.72 148.08 50.58 Favored Pre-proline 0 N--CA 1.496 1.845 0 N-CA-C 106.15 -1.796 . . . . 0.0 106.15 179.717 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.411 ' O ' ' HG3' ' A' ' 90' ' ' ARG . 10.1 Cg_endo -64.67 86.56 0.17 Allowed 'Trans proline' 0 N--CA 1.493 1.447 0 N-CA-C 108.265 -1.475 . . . . 0.0 108.265 165.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.411 ' HG3' ' O ' ' A' ' 89' ' ' PRO . 44.2 mtm180 150.82 -27.04 0.01 OUTLIER 'General case' 0 N--CA 1.513 2.693 0 O-C-N 125.741 1.901 . . . . 0.0 109.753 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 31.3 p-10 -41.51 116.17 1.5 Allowed Pre-proline 0 N--CA 1.501 2.083 0 N-CA-C 114.177 1.177 . . . . 0.0 114.177 -179.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -76.62 77.11 3.76 Favored 'Trans proline' 0 N--CA 1.493 1.474 0 C-N-CA 122.721 2.281 . . . . 0.0 109.565 174.423 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.451 ' CE ' ' SG ' ' A' ' 66' ' ' CYS . 21.4 ptmt -167.9 170.46 10.61 Favored 'General case' 0 N--CA 1.498 1.93 0 CA-C-N 114.759 -1.109 . . . . 0.0 110.685 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -160.19 147.42 16.2 Favored 'General case' 0 N--CA 1.497 1.883 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.322 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 58.2 m -153.54 130.31 5.69 Favored Pre-proline 0 N--CA 1.497 1.879 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.379 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.459 ' HD2' HD21 ' A' ' 98' ' ' ASN . 18.4 Cg_endo -63.51 -78.37 0.01 OUTLIER 'Trans proline' 0 N--CA 1.493 1.489 0 C-N-CA 122.316 2.01 . . . . 0.0 111.511 171.721 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 60.6 mmt-85 -135.68 -44.89 0.67 Allowed 'General case' 0 N--CA 1.499 2.007 0 O-C-N 123.995 0.809 . . . . 0.0 112.432 -179.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.459 HD21 ' HD2' ' A' ' 96' ' ' PRO . 3.5 m-80 49.44 58.62 5.21 Favored 'General case' 0 N--CA 1.503 2.197 0 O-C-N 124.313 1.008 . . . . 0.0 108.367 -179.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.545 ' HA ' ' HA ' ' A' ' 62' ' ' CYS . 37.1 m -35.77 127.57 0.67 Allowed 'General case' 0 N--CA 1.494 1.735 0 CA-C-N 113.573 -1.649 . . . . 0.0 115.25 -179.523 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -129.35 98.78 22.34 Favored Pre-proline 0 N--CA 1.493 1.708 0 CA-C-N 114.25 -1.341 . . . . 0.0 110.268 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -63.85 -12.0 29.61 Favored 'Trans proline' 0 N--CA 1.494 1.522 0 C-N-CA 122.011 1.807 . . . . 0.0 112.166 -178.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 80.8 mtm180 -80.28 -30.55 38.32 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 112.675 0.621 . . . . 0.0 112.675 -179.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.414 HG12 ' N ' ' A' ' 104' ' ' ALA . 11.8 tt -90.88 164.07 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.164 0 C-N-CA 120.036 -0.665 . . . . 0.0 110.097 -179.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.585 ' HB2' ' H ' ' A' ' 77' ' ' ASP . . . -124.15 -59.67 1.47 Allowed 'General case' 0 N--CA 1.496 1.848 0 CA-C-N 114.758 -1.11 . . . . 0.0 108.394 179.826 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 21.7 p90 -161.33 161.79 30.64 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-N 114.631 -1.168 . . . . 0.0 111.03 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -94.95 115.24 5.05 Favored Glycine 0 N--CA 1.492 2.389 0 CA-C-N 113.59 -1.641 . . . . 0.0 111.575 -179.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 12.4 pt -83.63 102.44 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.27 0 N-CA-C 105.725 -1.954 . . . . 0.0 105.725 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 13.4 m -79.48 133.04 60.35 Favored Pre-proline 0 N--CA 1.49 1.554 0 CA-C-N 113.8 -1.545 . . . . 0.0 110.295 -179.632 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -73.72 88.15 1.07 Allowed 'Trans proline' 0 N--CA 1.492 1.433 0 C-N-CA 122.599 2.199 . . . . 0.0 110.46 -177.127 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 84.7 mt -79.75 -42.39 24.65 Favored 'General case' 0 N--CA 1.498 1.949 0 CA-C-N 115.261 -0.881 . . . . 0.0 108.867 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.833 0 CA-C-O 116.773 -1.584 . . . . 0.0 110.66 179.972 . . . . . . . . 0 0 . 1 stop_ save_